PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Reddel, RR; Bryan, TM				Reddel, RR; Bryan, TM			Alternative lengthening of telomeres: dangerous road less travelled	LANCET			English	Editorial Material							MECHANISM; CELLS		Childrens Med Res Inst, Canc Res Unit, Sydney, NSW 2145, Australia; Childrens Med Res Inst, Cell Biol Unit, Sydney, NSW 2145, Australia	Children's Medical Research Institute - Australia; University of Sydney; Children's Medical Research Institute - Australia; University of Sydney	Reddel, RR (corresponding author), Childrens Med Res Inst, Canc Res Unit, Sydney, NSW 2145, Australia.		Reddel, Roger R/A-6635-2014; Bryan, Tracy M/B-8468-2014	Reddel, Roger R/0000-0002-6302-6107; Bryan, Tracy/0000-0002-7990-5501				Blasco MA, 2002, NAT REV CANCER, V2, P627, DOI 10.1038/nrc862; Bryan TM, 1997, NAT MED, V3, P1271, DOI 10.1038/nm1197-1271; Chang S, 2003, GENE DEV, V17, P88, DOI 10.1101/gad.1029903; Dunham MA, 2000, NAT GENET, V26, P447, DOI 10.1038/82586; Greenwood E, 2003, NAT REV CANCER, V3, P84, DOI 10.1038/nrc1008; Hakin-Smith V, 2003, LANCET, V361, P836, DOI 10.1016/S0140-6736(03)12681-5; Henson JD, 2002, ONCOGENE, V21, P598, DOI 10.1038/sj.onc.1205058; Shay JW, 1997, EUR J CANCER, V33, P787, DOI 10.1016/S0959-8049(97)00062-2; Stewart SA, 2002, P NATL ACAD SCI USA, V99, P12606, DOI 10.1073/pnas.182407599; Ulaner GA, 2003, CANCER RES, V63, P1759	10	32	34	1	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 31	2003	361	9372					1840	1841		10.1016/S0140-6736(03)13538-6	http://dx.doi.org/10.1016/S0140-6736(03)13538-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	684KL	12788566				2022-12-24	WOS:000183205800004
J	Stanley, B; Fraser, J				Stanley, B; Fraser, J			Uptake of HIV screening in genitourinary medicine after change to "opt-out" consent	BMJ-BRITISH MEDICAL JOURNAL			English	Article							TRANSMISSION		Cumberland Infirm, N Cumbria Acute Hosp Trust, Dept Genitourinary Med, Carlisle CA2 7HY, England; N Cumbria Acute Hosp Trust, Dept Dermatol, Carlisle, England		Stanley, B (corresponding author), Cumberland Infirm, N Cumbria Acute Hosp Trust, Dept Genitourinary Med, Carlisle CA2 7HY, England.	Belinda.Stanley@ncumbria-acute.nhs.uk						Bird SM, 2001, BMJ-BRIT MED J, V323, P1174, DOI 10.1136/bmj.323.7322.1174; Carne C, 2000, SEX TRANSM INFECT, V76, P307, DOI 10.1136/sti.76.4.307; Catchpole MA, 1996, BRIT MED J, V312, P539, DOI 10.1136/bmj.312.7030.539; Department of Health, 2001, NAT STRAT SEX HLTH H; *UNL AN SURV STEER, 2001, PREV HIV HEP INF UK	5	37	38	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 31	2003	326	7400					1174	1174		10.1136/bmj.326.7400.1174	http://dx.doi.org/10.1136/bmj.326.7400.1174			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	686FC	12775616	Green Published, Bronze			2022-12-24	WOS:000183309900018
J	Eastham, JA; Riedel, E; Scardino, PT; Shike, M; Fleisher, M; Schatzkin, A; Lanza, E; Latkany, L; Begg, CB				Eastham, JA; Riedel, E; Scardino, PT; Shike, M; Fleisher, M; Schatzkin, A; Lanza, E; Latkany, L; Begg, CB		Poly Prevention Trial Study Grp	Variation of serum prostate-specific antigen levels - An evaluation of year-to-year fluctuations	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DIGITAL RECTAL EXAMINATION; HIGH-FIBER DIET; RADICAL PROSTATECTOMY; BIOLOGICAL VARIATION; CANCER MORTALITY; LOW-FAT; MEN; TRIAL; AGE; BIOPSY	Context Serum prostate-specific antigen (PSA) testing is frequently used in early detection programs for prostate cancer. While PSA testing has resulted in an increase in prostate cancer detection, its routine use has been questioned because of a lack of specificity. Objective To determine whether year-to-year fluctuations in PSA levels are due to natural variation and render a single PSA test result unreliable. Design, Setting, and Participants Retrospective analysis of an unscreened population of 972 men (median age, 62 years) participating in the Polyp Prevention Trial (1991-1998). Five consecutive blood samples were obtained during a 4-year period and were assessed for total and free PSA levels. Main Outcome Measure Abnormal PSA test result based on a PSA level higher than 4 ng/mL; a PSA level higher than 2.5 ng/mL; a PSA level above the age-specific cutoff; a PSA level in the range of 4 to 10 ng/mL and a free-to-total ratio of less than 0.25 ng/mL; or a PSA velocity higher than 0.75 ng/mL per year. Results Prostate biopsy would have been recommended in 207 participants (21%) with a PSA level higher than 4 ng/mL; in 358 (37%) with a level higher than 2.5 ng/mL; in 172 (18%) with a level above the age-specific cutoff; in 190 (20%) with a level between 4 and 10 ng/mL and a free-to-total ratio of less than 0.25 ng/mL; and in 145 (15%) with a velocity higher than 0.75 ng/mL per year. Among men with an abnormal PSA finding, a high proportion had a normal PSA finding at 1 or more subsequent visits during 4-year follow-up: 68 (44%) of 154 participants with a PSA level higher than 4 ng/mL; 116 (40%) of 291 had a level higher than 2.5 ng/mL; 64 (55%) of 117 had an elevated level above the age-specific cutoff; and 76 (53%) of 143 had a level between 4 and 10 ng/mL and a free-to-total ratio of less than 0.25 ng/mL. Conclusion An isolated elevation in PSA level should be confirmed several weeks later before proceeding with further testing, including prostate biopsy.	Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; NCI, Nutr Epidemiol Branch, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA	Memorial Sloan Kettering Cancer Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Eastham, JA (corresponding author), 353 E 68th St,Suite 527, New York, NY 10021 USA.	easthamj@mskcc.org		Russo, Lianne/0000-0002-6966-250X	NCI NIH HHS [N01-SC-05318] Funding Source: Medline; DIVISION OF CLINICAL SCIENCES - NCI [N01SC005318] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [Z01CN000151] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); DIVISION OF CLINICAL SCIENCES - NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bartsch G, 2001, UROLOGY, V58, P417, DOI 10.1016/S0090-4295(01)01264-X; CARTER HB, 1992, CANCER RES, V52, P3323; Carter HB, 1999, UROLOGY, V53, P126, DOI 10.1016/S0090-4295(98)00466-X; Catalona WJ, 2000, UROLOGY, V55, P791, DOI 10.1016/S0090-4295(99)00602-0; CATALONA WJ, 1991, NEW ENGL J MED, V324, P1156, DOI 10.1056/NEJM199104253241702; Catalona WJ, 1998, JAMA-J AM MED ASSOC, V279, P1542, DOI 10.1001/jama.279.19.1542; CATALONA WJ, 1994, J UROLOGY, V151, P1283, DOI 10.1016/S0022-5347(17)35233-3; Chapple A, 2002, BRIT MED J, V325, P737, DOI 10.1136/bmj.325.7367.737; COPLEN DE, 1991, J UROLOGY, V146, P75, DOI 10.1016/S0022-5347(17)37717-0; Crawford ED, 1999, PROSTATE, V38, P296; EPSTEIN JI, 1994, J UROLOGY, V152, P1721, DOI 10.1016/S0022-5347(17)32370-4; Epstein JI, 2001, J UROLOGY, V166, P1688, DOI 10.1016/S0022-5347(05)65654-6; FEIGHTNER JW, 1994, CANADIAN GUIDE CLIN, P812; GANN PH, 1995, JAMA-J AM MED ASSOC, V273, P289, DOI 10.1001/jama.273.4.289; Hakama M, 2001, J UROLOGY, V166, P2189, DOI 10.1016/S0022-5347(05)65532-2; HAMMER P, 1996, J UROLOGY, V151, P99; Holmberg L, 2002, NEW ENGL J MED, V347, P781, DOI 10.1056/NEJMoa012794; JACOBSEN SJ, 1995, UROLOGY, V45, P447, DOI 10.1016/S0090-4295(99)80014-4; Jemal A, 2002, CA-CANCER J CLIN, V52, P23, DOI 10.3322/canjclin.52.1.23; Lanza E, 1996, CANCER EPIDEM BIOMAR, V5, P385; Lu-Yao G, 2002, BMJ-BRIT MED J, V325, P740, DOI 10.1136/bmj.325.7367.740; Nixon RG, 1997, J UROLOGY, V157, P2183, DOI 10.1016/S0022-5347(01)64711-6; OESTERLING JE, 1993, JAMA-J AM MED ASSOC, V270, P860, DOI 10.1001/jama.270.7.860; OHORI M, 1994, J UROLOGY, V152, P1714, DOI 10.1016/S0022-5347(17)32369-8; Ornstein DK, 1997, J UROLOGY, V157, P2179, DOI 10.1016/S0022-5347(01)64708-6; Schatzkin A, 2000, NEW ENGL J MED, V342, P1149, DOI 10.1056/NEJM200004203421601; Schatzkin A, 1996, CANCER EPIDEM BIOMAR, V5, P375; Shike M, 2002, J CLIN ONCOL, V20, P3592, DOI 10.1200/JCO.2002.02.040; STAMEY TA, 1989, J UROLOGY, V141, P1070; Steele CB, 2000, AM J PUBLIC HEALTH, V90, P1595, DOI 10.2105/AJPH.90.10.1595; STENMAN UH, 1991, CANCER RES, V51, P222; Tchetgen MBN, 1997, UROL CLIN N AM, V24, P283, DOI 10.1016/S0094-0143(05)70374-8; *US PREV SERV TASK, REC RAT SCREEN PROST; *US PREV SERV TASK, REC PROST CANC SCREE	34	168	175	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 28	2003	289	20					2695	2700		10.1001/jama.289.20.2695	http://dx.doi.org/10.1001/jama.289.20.2695			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	682DG	12771116	Bronze			2022-12-24	WOS:000183075600028
J	Hwang, HY; Olson, SK; Esko, JD; Horvitz, HR				Hwang, HY; Olson, SK; Esko, JD; Horvitz, HR			Caenorhabditis elegans early embryogenesis and vulval morphogenesis require chondroitin biosynthesis	NATURE			English	Article							UDP-GLUCURONIC ACID; HEPARAN-SULFATE; EPITHELIAL INVAGINATION; MOLECULAR-CLONING; GENE; PROTEOGLYCAN; EXPRESSION; SQV-7; GLYCOSAMINOGLYCANS; GALACTOSE	Defects in glycosaminoglycan biosynthesis disrupt animal development and can cause human disease(1-4). So far much of the focus on glycosaminoglycans has been on heparan sulphate. Mutations in eight squashed vulva (sqv) genes in Caenorhabditis elegans cause defects in cytokinesis during embryogenesis and in vulval morphogenesis during postembryonic development(5,6). Seven of the eight sqv genes have been shown to control the biosynthesis of the glycosaminoglycans chondroitin and heparan sulphate(6-11). Here we present the molecular identification and characterization of the eighth gene, sqv-5. This gene encodes a bifunctional glycosyltransferase that is probably localized to the Golgi apparatus and is responsible for the biosynthesis of chondroitin but not heparan sulphate. Our findings show that chondroitin is crucial for both cytokinesis and morphogenesis during C. elegans development.	MIT, Dept Biol, Howard Hughes Med Inst, Cambridge, MA 02139 USA; Univ Calif San Diego, Dept Cellular & Mol Med, Glycobiol Res & Training Ctr, La Jolla, CA 92093 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); University of California System; University of California San Diego	Horvitz, HR (corresponding author), MIT, Dept Biol, Howard Hughes Med Inst, Room 68-425,77 Massachusetts Ave, Cambridge, MA 02139 USA.			Hwang, Ho-Yon/0000-0003-0204-8932				Almeida R, 1999, J BIOL CHEM, V274, P26165, DOI 10.1074/jbc.274.37.26165; Austin C. R., 1965, FERTILIZATION; Berninsone P, 2001, P NATL ACAD SCI USA, V98, P3738, DOI 10.1073/pnas.061593098; Bulik DA, 2000, P NATL ACAD SCI USA, V97, P10838, DOI 10.1073/pnas.97.20.10838; COMPER WD, 1978, PHYSIOL REV, V58, P255, DOI 10.1152/physrev.1978.58.1.255; ELLIS RE, 1995, GENETICS, V139, P561; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; ESKO JD, 1993, CURRENT PROTOCOLS MO; FRITZ TA, 1994, J BIOL CHEM, V269, P28809; Herman T, 1999, P NATL ACAD SCI USA, V96, P968, DOI 10.1073/pnas.96.3.968; Herman T, 1999, P NATL ACAD SCI USA, V96, P974, DOI 10.1073/pnas.96.3.974; Hwang HY, 2003, J BIOL CHEM, V278, P11735, DOI 10.1074/jbc.C200518200; Hwang HY, 2002, P NATL ACAD SCI USA, V99, P14218, DOI 10.1073/pnas.172522199; Hwang HY, 2002, P NATL ACAD SCI USA, V99, P14224, DOI 10.1073/pnas.172522499; Jansen G, 1997, NAT GENET, V17, P119, DOI 10.1038/ng0997-119; Kitagawa H, 2001, J BIOL CHEM, V276, P38721, DOI 10.1074/jbc.M106871200; LANE MC, 1993, DEVELOPMENT, V117, P1049; NAGASAWA K, 1977, CARBOHYD RES, V58, P47, DOI 10.1016/S0008-6215(00)83402-3; Okajima T, 1999, J BIOL CHEM, V274, P28841, DOI 10.1074/jbc.274.41.28841; Perrimon N, 2000, NATURE, V404, P725, DOI 10.1038/35008000; QUENTIN E, 1990, P NATL ACAD SCI USA, V87, P1342, DOI 10.1073/pnas.87.4.1342; RUOSLAHTI E, 1988, ANNU REV CELL BIOL, V4, P229, DOI 10.1146/annurev.cb.04.110188.001305; Schwartz NB, 2002, GLYCOBIOLOGY, V12, p57R, DOI 10.1093/glycob/12.4.57R; Silbert JE, 2002, IUBMB LIFE, V54, P177, DOI 10.1080/15216540214923; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Toyoda H, 2000, J BIOL CHEM, V275, P2269, DOI 10.1074/jbc.275.4.2269; Uyama T, 2002, J BIOL CHEM, V277, P8841, DOI 10.1074/jbc.M111434200; Wei G, 2000, J BIOL CHEM, V275, P27733; Yamada S, 1999, FEBS LETT, V459, P327, DOI 10.1016/S0014-5793(99)01286-7; Zak BM, 2002, BBA-GEN SUBJECTS, V1573, P346, DOI 10.1016/S0304-4165(02)00402-6	30	154	158	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 22	2003	423	6938					439	443		10.1038/nature01634	http://dx.doi.org/10.1038/nature01634			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681AJ	12761549				2022-12-24	WOS:000183012000042
J	Pergams, ORW; Barnes, WM; Nyberg, D				Pergams, ORW; Barnes, WM; Nyberg, D			Rapid change in mouse mitochondrial DNA	NATURE			English	Article							PCR; AMPLIFICATION; FIDELITY		Univ Illinois, Dept Biol Sci, Chicago, IL 60607 USA; Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Washington University (WUSTL)	Pergams, ORW (corresponding author), Nature Conservancy, Chicago Zool Soc, Dept Conservat Biol, Brookfield, IL 60513 USA.							BARNES WM, 1994, TRENDS BIOCHEM SCI, V19, P342, DOI 10.1016/0968-0004(94)90075-2; BARNES WM, 1994, P NATL ACAD SCI USA, V91, P2216, DOI 10.1073/pnas.91.6.2216; BARNES WM, 1992, GENE, V112, P29, DOI 10.1016/0378-1119(92)90299-5; BARNES WM, 1995, Patent No. 5436149; Baskaran N, 1996, GENOME RES, V6, P633, DOI 10.1101/gr.6.7.633; GOODYEAR PD, 1994, BIOTECHNIQUES, V16, P232; Pergams ORW, 2001, J MAMMAL, V82, P984, DOI 10.1644/1545-1542(2001)082<0984:MCOMCT>2.0.CO;2; PERGAMS ORW, UNPUB P R SOC LOND B; Steinberg EK, 1999, MOL ECOL, V8, P1075; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018	10	33	35	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 22	2003	423	6938					397	397		10.1038/423397a	http://dx.doi.org/10.1038/423397a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681AJ	12761536	Bronze			2022-12-24	WOS:000183012000027
J	Foy, E; Li, K; Wang, CF; Sumpter, R; Ikeda, M; Lemon, SM; Gale, M				Foy, E; Li, K; Wang, CF; Sumpter, R; Ikeda, M; Lemon, SM; Gale, M			Regulation of interferon regulatory factor-3 by the hepatitis C virus serine protease	SCIENCE			English	Article							IRF-3; PHOSPHORYLATION; TRANSACTIVATION; LOCALIZATION; INFECTION; DISTINCT; THERAPY; KINASE; PKR	Persistent infections with hepatitis C virus (HCV) are likely to depend on viral inhibition of host defenses. We show that the HCV NS3/4A serine protease blocks the phosphorylation and effector action of interferon regulatory factor -3 (IRF-3), a key cellular antiviral signaling molecule. Disruption of NS3/4A protease function by mutation or a ketoamide peptidomimetic inhibitor relieved this blockade and restored IRF-3 phosphorylation after cellular challenge with an unrelated virus. Furthermore, dominant-negative or constitutively active IRF-3 mutants, respectively, enhanced or suppressed HCV RNA replication in hepatoma cells. Thus, the NS3/4A protease represents a dual therapeutic target, the inhibition of which may both block viral replication and restore IRF-3 control of HCV infection.	Univ Texas, SW Med Ctr, Dept Microbiol, Dallas, TX 75390 USA; Univ Texas, Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Medical Branch Galveston	Gale, M (corresponding author), Univ Texas, SW Med Ctr, Dept Microbiol, Dallas, TX 75390 USA.	Michael.Gale@UTSouthwestern.edu	IKEDA, Masanori/B-2279-2011; Sumpter, Jr., Rhea/N-8152-2018	Gale, Michael/0000-0002-6332-7436	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI048235, U19AI040035] Funding Source: NIH RePORTER; NIAID NIH HHS [U01-AI48235, U19-AI40035] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Barnes B, 2002, J INTERF CYTOK RES, V22, P59, DOI 10.1089/107999002753452665; Blight KJ, 2000, SCIENCE, V290, P1972, DOI 10.1126/science.290.5498.1972; De Francesco R, 2000, CURR TOP MICROBIOL, V242, P149; Farci P, 2002, P NATL ACAD SCI USA, V99, P3081, DOI 10.1073/pnas.052712599; Forns X, 1999, Clin Liver Dis, V3, P693, DOI 10.1016/S1089-3261(05)70234-8; Fredericksen B, 2002, VIRAL IMMUNOL, V15, P29, DOI 10.1089/088282402317340215; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Grandvaux N, 2002, J VIROL, V76, P5532, DOI 10.1128/JVI.76.11.5532-5539.2002; Ikeda M, 2002, J VIROL, V76, P2997, DOI 10.1128/JVI.76.6.2997-3006.2002; Katze MG, 2002, NAT REV IMMUNOL, V2, P675, DOI 10.1038/nri888; LEMON SM, UNPUB; Lin RT, 1999, MOL CELL BIOL, V19, P2465; Lin RT, 1998, MOL CELL BIOL, V18, P2986, DOI 10.1128/MCB.18.5.2986; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; McHutchison JG, 2002, HEPATOLOGY, V36, pS245, DOI 10.1053/jhep.2002.36795; Nakaya T, 2001, BIOCHEM BIOPH RES CO, V283, P1150, DOI 10.1006/bbrc.2001.4913; Pflugheber J, 2002, P NATL ACAD SCI USA, V99, P4650, DOI 10.1073/pnas.062055699; Reed KE, 1998, CURR STUD HEMATOL BL, P1; Reich NC, 2002, J INTERF CYTOK RES, V22, P103, DOI 10.1089/107999002753452719; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; SCHERING CORP CORVAS, 2002, Patent No. 0208244; Sen GC, 2001, ANNU REV MICROBIOL, V55, P255, DOI 10.1146/annurev.micro.55.1.255; Servant MJ, 2001, J BIOL CHEM, V276, P355, DOI 10.1074/jbc.M007790200; Smith EJ, 2001, J BIOL CHEM, V276, P8951, DOI 10.1074/jbc.M008717200; Tai CL, 2001, J VIROL, V75, P8289, DOI 10.1128/JVI.75.17.8289-8297.2001; Taylor DR, 1999, SCIENCE, V285, P107, DOI 10.1126/science.285.5424.107; Yoneyama M, 1998, EMBO J, V17, P1087, DOI 10.1093/emboj/17.4.1087; Zhu NL, 2001, VIROLOGY, V283, P178, DOI 10.1006/viro.2001.0896	28	636	691	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 16	2003	300	5622					1145	1148		10.1126/science.1082604	http://dx.doi.org/10.1126/science.1082604			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678VC	12702807	Green Submitted			2022-12-24	WOS:000182886500046
J	Huang, E; Cheng, SH; Dressman, H; Pittman, J; Tsou, MH; Horng, CF; Bild, A; Iversen, ES; Liao, M; Chen, CM; West, M; Nevins, JR; Huang, AT				Huang, E; Cheng, SH; Dressman, H; Pittman, J; Tsou, MH; Horng, CF; Bild, A; Iversen, ES; Liao, M; Chen, CM; West, M; Nevins, JR; Huang, AT			Gene expression predictors of breast cancer outcomes	LANCET			English	Article							LYMPH-NODE METASTASIS; PROGNOSTIC FACTORS; CLASSIFICATION; DISCOVERY	Background Correlation of risk factors with genomic data promises to provide specific treatment for individual patients, and needs interpretation of complex, multivariate patterns in gene expression data, as well as assessment of their ability to improve clinical predictions. We aimed to predict nodal metastatic states and relapse for breast cancer patients.. Methods We analysed DNA microarray data from samples of primary breast tumours, using non-linear statistical analyses to assess multiple patterns of interactions of groups of genes that have predictive value for the individual patient, with respect to lymph node metastasis and cancer recurrence. Findings We identified aggregate patterns of gene expression (metagenes) that associate with lymph node status and recurrence, and that are capable of predicting outcomes in individual patients with about 90% accuracy. The metagenes defined distinct groups of genes, suggesting different biological processes underlying these two characteristics of breast cancer. Initial external validation came from similarly accurate predictions of nodal status of a small sample in a distinct population. Interpretation Multiple aggregate measures of profiles of gene expression define valuable predictive associations with lymph node metastasis and disease recurrence for individual patients. Gene expression data have the potential to aid accurate, individualised, prognosis. Importantly, these data are assessed in terms of precise numerical predictions, with ranges of probabilities of outcome. Precise and statistically valid assessments of risks specific for patients, will ultimately be of most value to clinicians faced with treatment decisions.	Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27708 USA; Duke Univ, Dept Med, Durham, NC 27708 USA; Duke Univ, Dept Biostat & Bioinformat, Durham, NC 27708 USA; Duke Univ, Inst Stat & Decis Sci, Durham, NC 27708 USA; Koo Fdn Sun Yat Sen Canc Ctr, Taipei, Taiwan; Howard Hughes Med Inst, Durham, NC USA	Duke University; Duke University; Duke University; Duke University; Howard Hughes Medical Institute	Nevins, JR (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27708 USA.		Huang, Erich/B-1894-2008	Huang, Erich/0000-0001-5547-9408; Clarke, Jennifer/0000-0002-2723-7249				Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Cheng SH, 2000, BREAST CANCER RES TR, V63, P213, DOI 10.1023/A:1006468514396; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Jatoi I, 1999, J CLIN ONCOL, V17, P2334, DOI 10.1200/JCO.1999.17.8.2334; Krag D, 1998, NEW ENGL J MED, V339, P941, DOI 10.1056/NEJM199810013391401; MCGUIRE WL, 1987, BREAST CANCER RES TR, V10, P5, DOI 10.1007/BF01806129; MITTRA I, 1991, EUR J CANCER, V27, P1574, DOI 10.1016/0277-5379(91)90418-D; Overgaard M, 1997, NEW ENGL J MED, V337, P949, DOI 10.1056/NEJM199710023371401; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Singletary SE, 2002, J CLIN ONCOL, V20, P3628, DOI 10.1200/JCO.2002.02.026; Spang Rainer, 2002, In Silico Biology, V2, P369; TANDON AK, 1989, J CLIN ONCOL, V7, P1120, DOI 10.1200/JCO.1989.7.8.1120; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; West M, 2001, P NATL ACAD SCI USA, V98, P11462, DOI 10.1073/pnas.201162998; Yeoh EJ, 2002, CANCER CELL, V1, P133, DOI 10.1016/S1535-6108(02)00032-6; 2001, LANCET, V352, P930	17	494	534	0	16	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 10	2003	361	9369					1590	1596		10.1016/S0140-6736(03)13308-9	http://dx.doi.org/10.1016/S0140-6736(03)13308-9			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	676HY	12747878				2022-12-24	WOS:000182746300008
J	Vasconcelos, PFC				Vasconcelos, PFC			Diagnosis of viral disease	LANCET			English	Editorial Material									Minist Hlth, FUNASA, Inst Evandro Chagas, Dept Arbovirus, BR-66090000 Belem, Para, Brazil	Instituto Evandro Chagas	Vasconcelos, PFC (corresponding author), Minist Hlth, FUNASA, Inst Evandro Chagas, Dept Arbovirus, BR-66090000 Belem, Para, Brazil.		Vasconcelos, Pedro/AAH-3142-2019						0	1	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 10	2003	361	9369					1589	1589		10.1016/S0140-6736(03)13307-7	http://dx.doi.org/10.1016/S0140-6736(03)13307-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	676HY	12747877				2022-12-24	WOS:000182746300007
J	Ashworth, AC; Thompson, FC				Ashworth, AC; Thompson, FC			A fly in the biogeographic ointment	NATURE			English	Article							TRANSANTARCTIC MOUNTAINS; SIRIUS GROUP; ANTARCTICA		N Dakota State Univ, Dept Geosci, Fargo, ND 58105 USA; Smithsonian Inst, USDA, Systemat Entomol Lab, Washington, DC 20560 USA	North Dakota State University Fargo; Smithsonian Institution; Smithsonian National Museum of Natural History; United States Department of Agriculture (USDA)	Ashworth, AC (corresponding author), N Dakota State Univ, Dept Geosci, Fargo, ND 58105 USA.							Ashworth AC, 2003, PALAEOGEOGR PALAEOCL, V191, P191, DOI 10.1016/S0031-0182(02)00712-5; Ashworth AC, 2003, J MOLLUS STUD, V69, P89, DOI 10.1093/mollus/69.1.89; Askin RA., 2000, TERRA ANTARTICA, V7, P493; CONEY P, 1996, EUR J ENTOMOL, V93, P1; de Souza DA, 2002, ANN SOC ENTOMOL FR, V38, P177; DeConto RM, 2003, NATURE, V421, P245, DOI 10.1038/nature01290; Hill RS, 1996, REV PALAEOBOT PALYNO, V94, P11, DOI 10.1016/S0034-6667(96)00003-6; Marchant DR, 2002, GEOL SOC AM BULL, V114, P718, DOI 10.1130/0016-7606(2002)114<0718:FOPGAS>2.0.CO;2; Webb PN, 1996, MAR MICROPALEONTOL, V27, P273, DOI 10.1016/0377-8398(95)00066-6; WYGODZINSKY P, 1966, PAC INSECTS MONOGR, V9, P1; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412	11	22	22	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 8	2003	423	6936					135	136		10.1038/423135a	http://dx.doi.org/10.1038/423135a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675MR	12736672				2022-12-24	WOS:000182699600033
J	Looger, LL; Dwyer, MA; Smith, JJ; Hellinga, HW				Looger, LL; Dwyer, MA; Smith, JJ; Hellinga, HW			Computational design of receptor and sensor proteins with novel functions	NATURE			English	Article							BINDING; CHALLENGES; DOMAIN	The formation of complexes between proteins and ligands is fundamental to biological processes at the molecular level. Manipulation of molecular recognition between ligands and proteins is therefore important for basic biological studies(1) and has many biotechnological applications, including the construction of enzymes(2-4), biosensors(5,6), genetic circuits(7), signal transduction pathways(8) and chiral separations(9). The systematic manipulation of binding sites remains a major challenge. Computational design offers enormous generality for engineering protein structure and function(10). Here we present a structure-based computational method that can drastically redesign protein ligand-binding specificities. This method was used to construct soluble receptors that bind trinitrotoluene, L-lactate or serotonin with high selectivity and affinity. These engineered receptors can function as biosensors for their new ligands; we also incorporated them into synthetic bacterial signal transduction pathways, regulating gene expression in response to extracellular trinitrotoluene or L-lactate. The use of various ligands and proteins shows that a high degree of control over biomolecular recognition has been established computationally. The biological and biosensing activities of the designed receptors illustrate potential applications of computational design.	Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA	Duke University	Hellinga, HW (corresponding author), Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA.	hwh@biochem.duke.edu						Arnold FH, 2001, NATURE, V409, P253, DOI 10.1038/35051731; BAUMGARTNER JW, 1994, J BACTERIOL, V176, P1157, DOI 10.1128/JB.176.4.1157-1163.1994; Benson DE, 2002, BIOCHEMISTRY-US, V41, P3262, DOI 10.1021/bi011359i; Bishop A, 2000, ANNU REV BIOPH BIOM, V29, P577, DOI 10.1146/annurev.biophys.29.1.577; Bolon DN, 2001, P NATL ACAD SCI USA, V98, P14274, DOI 10.1073/pnas.251555398; Burlage R. S., 1999, U.S. Patent, Patent No. [5,972,638., 5972638, US5972638A]; BURTIS CA, 1999, TIME TXB CLIN CHEM; Cumming CJ, 2001, IEEE T GEOSCI REMOTE, V39, P1119, DOI 10.1109/36.927423; Dahiyat BI, 1996, PROTEIN SCI, V5, P895, DOI 10.1002/pro.5560050511; Dahiyat BI, 1997, SCIENCE, V278, P82, DOI 10.1126/science.278.5335.82; Daunert S, 2000, CHEM REV, V100, P2705, DOI 10.1021/cr990115p; De Lorimier RM, 2002, PROTEIN SCI, V11, P2655, DOI 10.1110/ps.021860; Fersht A. R., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; Harris JL, 1998, CURR OPIN CHEM BIOL, V2, P127, DOI 10.1016/S1367-5931(98)80044-6; Hasty J, 2002, NATURE, V420, P224, DOI 10.1038/nature01257; Hellinga HW, 1998, TRENDS BIOTECHNOL, V16, P183, DOI 10.1016/S0167-7799(98)01174-3; Koh JT, 2002, CHEM BIOL, V9, P17, DOI 10.1016/S1074-5521(02)00087-X; Kuntz ID, 1999, P NATL ACAD SCI USA, V96, P9997, DOI 10.1073/pnas.96.18.9997; Looger LL, 2001, J MOL BIOL, V307, P429, DOI 10.1006/jmbi.2000.4424; Maier NM, 2001, J CHROMATOGR A, V906, P3, DOI 10.1016/S0021-9673(00)00532-X; Mead KS, 2002, TRENDS BIOTECHNOL, V20, P276, DOI 10.1016/S0167-7799(02)01979-0; MOWBRAY SL, 1992, J MOL BIOL, V225, P155, DOI 10.1016/0022-2836(92)91033-L; QUIOCHO FA, 1984, NATURE, V310, P381, DOI 10.1038/310381a0; Reina J, 2002, NAT STRUCT BIOL, V9, P621, DOI 10.1038/nsb815; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Sun YJ, 1998, J MOL BIOL, V278, P219, DOI 10.1006/jmbi.1998.1675; TAM R, 1993, MICROBIOL REV, V57, P320, DOI 10.1128/MMBR.57.2.320-346.1993; VYAS MN, 1994, BIOCHEMISTRY-US, V33, P4762, DOI 10.1021/bi00182a003; YAO NH, 1994, BIOCHEMISTRY-US, V33, P4769, DOI 10.1021/bi00182a004; Yinon J, 2002, TRAC-TREND ANAL CHEM, V21, P292, DOI 10.1016/S0165-9936(02)00408-9	30	506	546	4	105	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 8	2003	423	6936					185	190		10.1038/nature01556	http://dx.doi.org/10.1038/nature01556			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675MR	12736688				2022-12-24	WOS:000182699600050
J	Trotter, CL; McVernon, J; Andrews, NJ; Burrage, M; Ramsay, ME				Trotter, CL; McVernon, J; Andrews, NJ; Burrage, M; Ramsay, ME			Antibody to Haemophilus influenzae type b after routine and catch-up vaccination	LANCET			English	Article								Since 1999, the number of cases of Haemophilus Influenzae type b (Hib) disease in the UK has risen. We investigated the role of population immunity in this change by testing more than 2600 serum samples from children aged 1-15 years. After the introduction of the routine Hib conjugate vaccination programme for infants, median antibody titres rose significantly in 1-year-olds. Individuals who received their first dose of vaccine at age 1-4 years in the original catch-up campaign initially had much higher concentrations of antibody than those who had been immunised in infancy. A second catch-up campaign in children aged 6 months to 4 years should be highly effective in boosting immunity and reducing disease in the short term.	Hlth Protect Agcy, Ctr Communicable Dis Surveillance, Immunisat Div, London NW9 5EQ, England; Hlth Protect Agcy, Ctr Appl Microbiol & Res, Immunoassay Lab, Salisbury, Wilts, England	Health Protection Agency; Health Protection Agency	Trotter, CL (corresponding author), Hlth Protect Agcy, Ctr Communicable Dis Surveillance, Immunisat Div, 61 Colindale Ave, London NW9 5EQ, England.	caroline.trotter@hpa.org.uk	Trotter, Caroline L/H-5077-2013; Ramsay, Mary Elizabeth/S-8281-2016	McVernon, Jodie/0000-0001-9774-1961; Ramsay, Mary Elizabeth/0000-0002-7156-7640; Trotter, Caroline/0000-0003-4000-2708				Heath PT, 2000, JAMA-J AM MED ASSOC, V284, P2334, DOI 10.1001/jama.284.18.2334; KAYHTY H, 1983, J INFECT DIS, V147, P1100; PHIPPS DC, 1990, J IMMUNOL METHODS, V135, P121, DOI 10.1016/0022-1759(90)90264-V; Trotter C L, 2003, Commun Dis Public Health, V6, P55; van Alphen L, 1997, J PEDIATR-US, V131, P869, DOI 10.1016/S0022-3476(97)70035-0	5	54	55	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 3	2003	361	9368					1523	1524		10.1016/S0140-6736(03)13172-8	http://dx.doi.org/10.1016/S0140-6736(03)13172-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	674WB	12737867				2022-12-24	WOS:000182658900015
J	Morillon, A; O'Sullivan, J; Azad, A; Proudfoot, N; Mellor, J				Morillon, A; O'Sullivan, J; Azad, A; Proudfoot, N; Mellor, J			Regulation of elongating RNA polymerase II by forkhead transcription factors in yeast	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; CELL-CYCLE; ENVIRONMENTAL-CHANGES; PROCESSING FACTORS; TERMINAL DOMAIN; GENE-EXPRESSION; INITIATION; PROMOTER; KINASE; FKH1P	The elongation phase of transcription by RNA polymerase II (RNAPII) is highly regulated and tightly linked to pre-messenger RNA (pre-mRNA) processing. Recent studies have implicated an early elongation checkpoint that facilitates the link to pre-mRNA processing. Here we show that the yeast forkhead transcription factors, Fkh1p and Fkh2p, associate with the coding regions of active genes and influence, in opposing ways, transcriptional elongation and termination. These events are coordinated with serine-5 and -2 phosphorylation of the heptad repeat of the carboxy-terminal domain (CTD) of RNAPII. Our results suggest that, in addition to their documented promoter function, Fkh1p and Fkh2p coordinate early transcription elongation and pre-mRNA processing. This may reflect a general feature of gene regulation in eukaryotes.	Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	University of Oxford; University of Oxford	Mellor, J (corresponding author), Univ Oxford, Dept Biochem, S Parks Rd, Oxford OX1 3QU, England.		O'Sullivan, Justin/HDO-1639-2022; Pillay, Nischalan/F-9536-2012; Morillon, Antonin/M-4751-2017	O'Sullivan, Justin/0000-0003-2927-450X; Morillon, Antonin/0000-0002-0575-5264; Proudfoot, Nicholas/0000-0001-8646-3222				Carlsson P, 2002, DEV BIOL, V250, P1, DOI 10.1006/dbio.2002.0780; Causton HC, 2001, MOL BIOL CELL, V12, P323, DOI 10.1091/mbc.12.2.323; Cho EJ, 2001, GENE DEV, V15, P3319, DOI 10.1101/gad.935901; Cirillo LA, 1998, EMBO J, V17, P244, DOI 10.1093/emboj/17.1.244; CLARK KL, 1993, NATURE, V364, P412, DOI 10.1038/364412a0; Dye MJ, 1999, MOL CELL, V3, P371, DOI 10.1016/S1097-2765(00)80464-5; EXINGER F, 1992, CURR GENET, V22, P9, DOI 10.1007/BF00351735; Fish RN, 2002, BBA-GENE STRUCT EXPR, V1577, P287, DOI 10.1016/S0167-4781(02)00459-1; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Greger IH, 1998, EMBO J, V17, P4771, DOI 10.1093/emboj/17.16.4771; Greger IH, 2000, P NATL ACAD SCI USA, V97, P8415, DOI 10.1073/pnas.140217697; Hartzog GA, 1998, GENE DEV, V12, P357, DOI 10.1101/gad.12.3.357; Hollenhorst PC, 2000, GENETICS, V154, P1533; Hollenhorst PC, 2001, GENE DEV, V15, P2445, DOI 10.1101/gad.906201; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; Koranda M, 2000, NATURE, V406, P94, DOI 10.1038/35017589; Kumar R, 2000, CURR BIOL, V10, P896, DOI 10.1016/S0960-9822(00)00618-7; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Licatalosi DD, 2002, MOL CELL, V9, P1101, DOI 10.1016/S1097-2765(02)00518-X; Orphanides G, 2002, CELL, V108, P439, DOI 10.1016/S0092-8674(02)00655-4; Pic A, 2000, EMBO J, V19, P3750, DOI 10.1093/emboj/19.14.3750; Pokholok DK, 2002, MOL CELL, V9, P799, DOI 10.1016/S1097-2765(02)00502-6; Rodriguez CR, 2000, MOL CELL BIOL, V20, P104, DOI 10.1128/MCB.20.1.104-112.2000; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Shaw RJ, 2000, MOL CELL BIOL, V20, P7427, DOI 10.1128/MCB.20.20.7427-7437.2000; Simon I, 2001, CELL, V106, P697, DOI 10.1016/S0092-8674(01)00494-9; Zhu GF, 2000, NATURE, V406, P90, DOI 10.1038/35017581	27	56	56	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 18	2003	300	5618					492	495		10.1126/science.1081379	http://dx.doi.org/10.1126/science.1081379			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668LR	12702877				2022-12-24	WOS:000182295900042
J	Schultz, CH; Koenig, KL; Lewis, RJ				Schultz, CH; Koenig, KL; Lewis, RJ			Implications of hospital evacuation after the Northridge, California, earthquake	NEW ENGLAND JOURNAL OF MEDICINE			English	Article								BACKGROUND: On January 17, 1994, an earthquake with a moment magnitude (total energy release) of 6.7 occurred in Northridge, California, leading to the evacuation of patients from several hospitals. We examined the reasons for and methods of evacuation and the emergency-management strategies used. The experience in California may have implications for hospital strategies for responding to any major disaster, including an act of terrorism. METHODS: From September 1995 to September 1996, we surveyed all acute care hospitals in Los Angeles County that reported having evacuated patients after the Northridge earthquake. Physicians, nurses, hospital administrators, and staff on duty at the hospitals during the evacuation responded to a 58-item structured questionnaire. RESULTS: Eight of 91 acute care hospitals (9 percent) were evacuated. Six hospitals evacuated patients within 24 hours (the immediate-evacuation group), four completely and two partially. All six cited nonstructural damage such as water damage and loss of electrical power as a major reason for evacuation. Five hospitals evacuated the most seriously ill patients first, and one hospital evacuated the healthiest patients first. All hospitals used available equipment to transport patients (blankets, backboards, and gurneys) rather than specialized devices. No deaths resulted from evacuation. One hospital evacuated patients after 3 days and another after 14 days because of structural damage, even though initial inspections had shown no damage (the delayed-evacuation group). Both hospitals required demolition. Some hospitals identified destinations for their evacuated patients independently, whereas others sought the assistance of the Los Angeles County Emergency Operations Center; the two strategies were equally effective. CONCLUSIONS: After even a moderate earthquake, hospitals are at risk for both immediate nonstructural damage that may force them to evacuate patients and the delayed discovery of structural damage resulting in permanent closure. Evacuation of large numbers of inpatients from multiple hospitals can be accomplished quickly and safely with the use of available resources and personnel.	Univ Calif Irvine, Irvine Med Ctr, Emergency Dept, Orange, CA 92668 USA; Univ Calif Irvine, Coll Med, Irvine, CA 92717 USA; George Washington Univ, Sch Med & Hlth Sci, Washington, DC 20052 USA; Dept Vet Affairs, Vet Hlth Adm, Hlth Sci & Emergency Management Strateg Healthcar, Washington, DC USA; Univ Calif Los Angeles, Sch Med, Los Angeles, CA USA; Harbor UCLA Med Ctr, Dept Emergency Med, Torrance, CA 90509 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; George Washington University; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center	Schultz, CH (corresponding author), Univ Calif Irvine, Irvine Med Ctr, Emergency Dept, Rte 128,101 City Dr, Orange, CA 92668 USA.	schultzc@uci.edu						ARNOLD C, 1983, HOSP SAN FERNANDO EA; BLASER M J, 1985, Journal of Emergency Medicine, V3, P387, DOI 10.1016/0736-4679(85)90323-3; Chavez C W, 1996, J Emerg Med, V14, P445, DOI 10.1016/0736-4679(96)00083-2; De Lorenzo R A, 1996, Prehosp Disaster Med, V11, P270; FISHER HL, 1986, MIL MED, V151, P154, DOI 10.1093/milmed/151.3.154; Gretenkort Peter, 2002, Prehosp Disaster Med, V17, P42; JONES L, 1994, SCIENCE, V266, P389, DOI 10.1126/science.266.5184.398; KOBAYASHI H, 1996, JPN J DISASTER MED, V1, P73; *OFF STAT HLTH PLA, 2001, SUMM HOSP SEISM PERF; Schultz CH, 1996, NEW ENGL J MED, V334, P438, DOI 10.1056/NEJM199602153340706; Tanaka H, 1998, J Emerg Med, V16, P439, DOI 10.1016/S0736-4679(98)00014-6; TSUBOI S, 1996, JPN J DISASTER MED, V1, P36; Ukai T, 1997, RENAL FAILURE, V19, P633, DOI 10.3109/08860229709109029; *US ARM SOLD BIOL, 2002, MASS CAS CAR STRAT B	14	105	105	1	26	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 3	2003	348	14					1349	1355		10.1056/NEJMsa021807	http://dx.doi.org/10.1056/NEJMsa021807			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	662LW	12672863				2022-12-24	WOS:000181949100007
J	Anand, K; Ziebuhr, J; Wadhwani, P; Mesters, JR; Hilgenfeld, R				Anand, K; Ziebuhr, J; Wadhwani, P; Mesters, JR; Hilgenfeld, R			Coronavirus main proteinase (3CL(pro)) structure: Basis for design of anti-SARS drugs	SCIENCE			English	Article							VIRUS-ENCODED PROTEINASES; 229E 3C-LIKE PROTEINASE; PROTEASES	A novel coronavirus has been identified as the causative agent of severe acute respiratory syndrome (SARS). The viral main proteinase (M-pro, also called 3CL(pro)), which controls the activities of the coronavirus replication complex, is an attractive target for therapy. We determined crystal structures for human coronavirus (strain 229E) M-pro and for an inhibitor complex of porcine coronavirus [ transmissible gastroenteritis virus ( TGEV)] Mpro, and we constructed a homology model for SARS coronavirus (SARS-CoV) M-pro. The structures reveal a remarkable degree of conservation of the substrate-binding sites, which is further supported by recombinant SARS-CoV M-pro-mediated cleavage of a TGEV Mpro substrate. Molecular modeling suggests that available rhinovirus 3C(pro) inhibitors may be modified to make them useful for treating SARS.	Univ Lubeck, Inst Biochem, D-23538 Lubeck, Germany; Inst Mol Biotechnol, D-07745 Jena, Germany; Univ Wurzburg, Inst Virol & Immunol, D-97078 Wurzburg, Germany; Univ Jena, Inst Mol Biol, D-07745 Jena, Germany	University of Lubeck; University of Wurzburg; Friedrich Schiller University of Jena	Hilgenfeld, R (corresponding author), Univ Lubeck, Inst Biochem, Ratzeburger Allee 160, D-23538 Lubeck, Germany.	hilgenfeld@biochem.uni-luebeck.de	Hilgenfeld, Rolf/C-9675-2011; Ziebuhr, John/G-7669-2015	Mesters, Jeroen/0000-0001-8532-6699; Wadhwani, Parvesh/0000-0002-7290-5154; Ziebuhr, John/0000-0002-5741-8825				Anand K, 2002, EMBO J, V21, P3213, DOI 10.1093/emboj/cdf327; Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747; Hegyi A, 2002, J GEN VIROL, V83, P595, DOI 10.1099/0022-1317-83-3-595; Hegyi A, 2002, J GEN VIROL, V83, P581, DOI 10.1099/0022-1317-83-3-581; HEROLD J, 1993, VIROLOGY, V195, P680, DOI 10.1006/viro.1993.1419; KRAUSSLICH HG, 1988, ANNU REV BIOCHEM, V57, P701, DOI 10.1146/annurev.bi.57.070188.003413; Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781; Lee N, 2003, NEW ENGL J MED, V348, P1986, DOI 10.1056/NEJMoa030685; MARRA M, 2003, SCIENCE, V30, P1399, DOI DOI 10.1126/SC2ENCE.1085953; Matthews DA, 1999, P NATL ACAD SCI USA, V96, P11000, DOI 10.1073/pnas.96.20.11000; Rota PA, 2003, SCIENCE, V300, P1394, DOI 10.1126/science.1085952; Ryan MD, 1997, J GEN VIROL, V78, P699, DOI 10.1099/0022-1317-78-4-699; Siddell S.G., 1995, CORONAVIRIDAE, P389; Siddell SG., 1995, CORONAVIRIDAE INTRO, DOI [10.1007/978-1-4899-1531-3, DOI 10.1007/978-1-4899-1531-3]; Thiel V, 2001, J VIROL, V75, P6676, DOI 10.1128/JVI.75.14.6676-6681.2001; Ziebuhr J, 1997, J VIROL, V71, P3992, DOI 10.1128/JVI.71.5.3992-3997.1997; Ziebuhr J, 2000, J GEN VIROL, V81, P853, DOI 10.1099/0022-1317-81-4-853; ZIEBUHR J, 1995, J VIROL, V69, P4331, DOI 10.1128/JVI.69.7.4331-4338.1995	18	1132	1227	31	169	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 13	2003	300	5626					1763	1767		10.1126/science.1085658	http://dx.doi.org/10.1126/science.1085658			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688WF	12746549				2022-12-24	WOS:000183459700056
J	Kanemaki, M; Sanchez-Diaz, A; Gambus, A; Labib, K				Kanemaki, M; Sanchez-Diaz, A; Gambus, A; Labib, K			Functional proteomic identification of DNA replication proteins by induced proteolysis in vivo	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; YEAST PROTEOME; FIRING ORIGINS; BUDDING YEAST; S-PHASE; PURIFICATION; COMPLEXES; CDC7	Evolutionarily diverse eukaryotic cells share many conserved proteins of unknown function. Some are essential for cell viability(1,2), emphasising their importance for fundamental processes of cell biology but complicating their analysis. We have developed an approach to the large-scale characterization of such proteins, based on conditional and rapid degradation of the target protein in vivo, so that the immediate consequences of bulk protein depletion can be examined(3). Budding yeast strains have been constructed in which essential proteins of unknown function have been fused to a 'heat-inducible-degron' cassette that targets the protein for proteolysis at 37 degreesC (ref. 4). By screening the collection for defects in cell-cycle progression, here we identify three DNA replication factors that interact with each other and that have uncharacterized homologues in human cells. We have used the degron strains to show that these proteins are required for the establishment and normal progression of DNA replication forks. The degron collection could also be used to identify other, essential, proteins with roles in many other processes of eukaryotic cell biology.	Christie Hosp NHS Trust, Paterson Inst Canc Res, Canc Res UK, Manchester M20 4BX, Lancs, England	Cancer Research UK; Christie NHS Foundation Trust; Christie Hospital; Paterson Institute for Cancer Research; University of Manchester	Labib, K (corresponding author), Christie Hosp NHS Trust, Paterson Inst Canc Res, Canc Res UK, Wilmslow Rd, Manchester M20 4BX, Lancs, England.		Sanchez-Diaz, Alberto/L-2320-2014; Gambus, Aga/AAK-4687-2021; Kanemaki, Masato/Q-3246-2019	Sanchez-Diaz, Alberto/0000-0002-3308-4824; Gambus, Aga/0000-0002-4648-0332; Kanemaki, Masato/0000-0002-7657-1649				Belli G, 1998, YEAST, V14, P1127, DOI 10.1002/(SICI)1097-0061(19980915)14:12<1127::AID-YEA300>3.0.CO;2-#; Bousset K, 1998, GENE DEV, V12, P480, DOI 10.1101/gad.12.4.480; Desdouets C, 1998, EMBO J, V17, P4139, DOI 10.1093/emboj/17.14.4139; DOHMEN RJ, 1994, SCIENCE, V263, P1273, DOI 10.1126/science.8122109; Donaldson AD, 1998, MOL CELL, V2, P173, DOI 10.1016/S1097-2765(00)80127-6; Donaldson AD, 1998, GENE DEV, V12, P491, DOI 10.1101/gad.12.4.491; Dragon F, 2002, NATURE, V417, P967, DOI 10.1038/nature00769; Drury LS, 1997, EMBO J, V16, P5966, DOI 10.1093/emboj/16.19.5966; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kamimura Y, 2001, EMBO J, V20, P2097, DOI 10.1093/emboj/20.8.2097; Kubota Y, 2003, GENE DEV, V17, P1141, DOI 10.1101/gad.1070003; Kumar A, 2002, GENE DEV, V16, P707, DOI 10.1101/gad.970902; Labib K, 2000, SCIENCE, V288, P1643, DOI 10.1126/science.288.5471.1643; Labib K, 1999, NAT CELL BIOL, V1, P415, DOI 10.1038/15649; Levy F, 1999, EUR J BIOCHEM, V259, P244, DOI 10.1046/j.1432-1327.1999.00024.x; Lindner K, 2002, MOL BIOL CELL, V13, P435, DOI 10.1091/mbc.01-11-0537; MCCARROLL RM, 1988, CELL, V54, P505, DOI 10.1016/0092-8674(88)90072-4; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Santocanale C, 1998, NATURE, V395, P615, DOI 10.1038/27001; Takayama Y, 2003, GENE DEV, V17, P1153, DOI 10.1101/gad.1065903; Tasto JJ, 2001, YEAST, V18, P657, DOI 10.1002/yea.713; Tercero JA, 2000, EMBO J, V19, P2082, DOI 10.1093/emboj/19.9.2082; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Wu LF, 2002, NAT GENET, V31, P255, DOI 10.1038/ng906; Yabuki N, 2002, GENES CELLS, V7, P781, DOI 10.1046/j.1365-2443.2002.00559.x	29	200	208	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 12	2003	423	6941					720	724		10.1038/nature01692	http://dx.doi.org/10.1038/nature01692			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688PA	12768207				2022-12-24	WOS:000183443400035
J	Prag, G; Misra, S; Jones, EA; Ghirlando, R; Davies, BA; Horazdovsky, BF; Hurley, JH				Prag, G; Misra, S; Jones, EA; Ghirlando, R; Davies, BA; Horazdovsky, BF; Hurley, JH			Mechanism of ubiquitin recognition by the CUE domain of Vps9p	CELL			English	Article							INTERACTING MOTIF; UBA DOMAINS; BINDS UBIQUITIN; PROTEIN; SURFACE; DEGRADATION; PATHWAY; COMPLEX; REPAIR; RECEPTOR	Coupling of ubiquitin conjugation to ER degradation (CUE) domains are similar to50 amino acid monoubiquitin binding motifs found in proteins of trafficking and ubiquitination pathways. The 2.3 Angstrom structure of the Vps9p-CUE domain is a dimeric domain-swapped variant of the ubiquitin binding UBA domain. The 1.7 Angstrom structure of the CUE:ubiquitin complex shows that one CUE dimer binds one ubiquitin molecule. The bound CUE dimer is kinked relative to the unbound CUE dimer and wraps around ubiquitin. The CUE monomer contains two ubiquitin binding surfaces on opposite faces of the molecule that cannot bind simultaneously to a single ubiquitin molecule. Dimerization of the CUE domain allows both surfaces to contact a single ubiquitin molecule, providing a mechanism for high-affinity binding to monoubiquitin.	NIDDKD, Mol Biol Lab, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA; Mayo Clin & Mayo Fdn, Mayo Clin Canc Ctr, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Biochem & Mol Biol, Rochester, MN 55905 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Mayo Clinic; Mayo Clinic	Hurley, JH (corresponding author), NIDDKD, Mol Biol Lab, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA.	james.hurley@nih.gov	Ghirlando, Rodolfo/A-8880-2009	Misra, Saurav/0000-0002-1385-8554	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK036118] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM55301] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; Beal R, 1996, P NATL ACAD SCI USA, V93, P861, DOI 10.1073/pnas.93.2.861; Bertolaet BL, 2001, NAT STRUCT BIOL, V8, P417, DOI 10.1038/87575; Bertolaet BL, 2001, J MOL BIOL, V313, P955, DOI 10.1006/jmbi.2001.5105; Biederer T, 1997, SCIENCE, V278, P1806, DOI 10.1126/science.278.5344.1806; Bilodeau PS, 2002, NAT CELL BIOL, V4, P534, DOI 10.1038/ncb815; BONIFACINO JS, 2003, IN PRESS ANN REV BIO; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buchberger A, 2002, TRENDS CELL BIOL, V12, P216, DOI 10.1016/S0962-8924(02)02269-9; Burdon MA, 1996, CURR OPIN NEUROL, V9, P16, DOI 10.1097/00019052-199602000-00004; Burns K, 2000, NAT CELL BIOL, V2, P346, DOI 10.1038/35014038; Chen L, 2001, EMBO REP, V2, P933, DOI 10.1093/embo-reports/kve203; DAVIES BA, 2003, VPS9P CUE DOMAIN UBI; DEVERAUX Q, 1994, J BIOL CHEM, V269, P7059; Dieckmann T, 1998, NAT STRUCT BIOL, V5, P1042, DOI 10.1038/4220; Donaldson KM, 2003, CURR BIOL, V13, P258, DOI 10.1016/S0960-9822(03)00043-5; Fang SY, 2001, P NATL ACAD SCI USA, V98, P14422, DOI 10.1073/pnas.251401598; Funakoshi M, 2002, P NATL ACAD SCI USA, V99, P745, DOI 10.1073/pnas.012585199; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hama H, 1999, J BIOL CHEM, V274, P15284, DOI 10.1074/jbc.274.21.15284; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hicke L, 2001, CELL, V106, P527, DOI 10.1016/S0092-8674(01)00485-8; Hochstrasser M, 2000, NAT CELL BIOL, V2, pE153, DOI 10.1038/35019643; Hofmann K, 1996, TRENDS BIOCHEM SCI, V21, P172, DOI 10.1016/S0968-0004(96)30015-7; Hofmann K, 2001, TRENDS BIOCHEM SCI, V26, P347, DOI 10.1016/S0968-0004(01)01835-7; Jenkins TM, 1996, J BIOL CHEM, V271, P7712, DOI 10.1074/jbc.271.13.7712; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; JULLIENFLORES V, 1995, J BIOL CHEM, V270, P22473, DOI 10.1074/jbc.270.38.22473; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Klapisz E, 2002, J BIOL CHEM, V277, P30746, DOI 10.1074/jbc.M203004200; Liu Y, 2002, PROTEIN SCI, V11, P1285, DOI 10.1110/ps.0201402; Longenecker KL, 2001, ACTA CRYSTALLOGR D, V57, P679, DOI 10.1107/S0907444901003122; Mueller TD, 2002, J MOL BIOL, V319, P1243, DOI 10.1016/S0022-2836(02)00302-9; Oldham CE, 2002, CURR BIOL, V12, P1112, DOI 10.1016/S0960-9822(02)00900-4; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PERKINS SJ, 1986, EUR J BIOCHEM, V157, P169, DOI 10.1111/j.1432-1033.1986.tb09653.x; Pickart CM, 2001, MOL CELL, V8, P499, DOI 10.1016/S1097-2765(01)00347-1; Polo S, 2002, NATURE, V416, P451, DOI 10.1038/416451a; Ponting CP, 2000, BIOCHEM J, V351, P527, DOI 10.1042/0264-6021:3510527; Ponting CP, 2002, NUCLEIC ACIDS RES, V30, P3643, DOI 10.1093/nar/gkf498; Pornillos O, 2002, EMBO J, V21, P2397, DOI 10.1093/emboj/21.10.2397; Raiborg C, 2002, NAT CELL BIOL, V4, P394, DOI 10.1038/ncb791; Shekhtman A, 2002, BIOCHEM BIOPH RES CO, V296, P1222, DOI 10.1016/S0006-291X(02)02006-5; Shih SC, 2000, EMBO J, V19, P187, DOI 10.1093/emboj/19.2.187; Shih SC, 2002, NAT CELL BIOL, V4, P389, DOI 10.1038/ncb790; Shih SC, 2003, EMBO J, V22, P1273, DOI 10.1093/emboj/cdg140; Sloper-Mould KE, 2001, J BIOL CHEM, V276, P30483, DOI 10.1074/jbc.M103248200; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Vadlamudi RK, 1996, J BIOL CHEM, V271, P20235, DOI 10.1074/jbc.271.34.20235; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; VIJAYKUMAR S, 1987, J MOL BIOL, V194, P531, DOI 10.1016/0022-2836(87)90679-6; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; Wilkinson CRM, 2001, NAT CELL BIOL, V3, P939, DOI 10.1038/ncb1001-939; Withers-Ward ES, 2000, BIOCHEMISTRY-US, V39, P14103, DOI 10.1021/bi0017071; Woudstra EC, 2002, NATURE, V415, P929, DOI 10.1038/415929a	57	181	184	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 30	2003	113	5					609	620		10.1016/S0092-8674(03)00364-7	http://dx.doi.org/10.1016/S0092-8674(03)00364-7			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	687VL	12787502	Bronze			2022-12-24	WOS:000183397600011
J	Li, DW; Zhao, R; Lilyestrom, W; Gai, DH; Zhang, RG; DeCaprio, JA; Fanning, E; Jochimiak, A; Szakonyi, G; Chen, XJS				Li, DW; Zhao, R; Lilyestrom, W; Gai, DH; Zhang, RG; DeCaprio, JA; Fanning, E; Jochimiak, A; Szakonyi, G; Chen, XJS			Structure of the replicative helicase of the oncoprotein SV40 large tumour antigen	NATURE			English	Article							LARGE T-ANTIGEN; TEMPERATURE-SENSITIVE MUTANTS; ORIGIN DNA-BINDING; CRYSTAL-STRUCTURE; DOUBLE HEXAMERS; VIRAL ORIGIN; RAS ONCOGENE; IN-VITRO; SIMIAN-VIRUS-40; INITIATION	The oncoprotein large tumour antigen (LTag) is encoded by the DNA tumour virus simian virus 40. LTag transforms cells and induces tumours in animals by altering the functions of tumour suppressors (including pRB and p53) and other key cellular proteins. LTag is also a molecular machine that distorts/melts the replication origin of the viral genome and unwinds duplex DNA. LTag therefore seems to be a functional homologue of the eukaryotic minichromosome maintenance (MCM) complex. Here we present the X-ray structure of a hexameric LTag with DNA helicase activity. The structure identifies the p53-binding surface and reveals the structural basis of hexamerization. The hexamer contains a long, positively charged channel with an unusually large central chamber that binds both single-stranded and double-stranded DNA. The hexamer organizes into two tiers that can potentially rotate relative to each other through connecting alpha-helices to expand/constrict the channel, producing an 'iris' effect that could be used for distorting or melting the origin and unwinding DNA at the replication fork.	Univ Colorado, Hlth Sci Ctr, Sch Med, Dept Biochem & Mol Genet, Denver, CO 80262 USA; Argonne Natl Lab, Adv Photon Source, SBC, Argonne, IL 60439 USA; Dana Farber Canc Inst, Boston, MA 02115 USA; Vanderbilt Univ, VU Stn B 1634, Nashville, TN 37235 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; United States Department of Energy (DOE); Argonne National Laboratory; Harvard University; Dana-Farber Cancer Institute; Vanderbilt University	Chen, XJS (corresponding author), Univ Colorado, Hlth Sci Ctr, Sch Med, Dept Biochem & Mol Genet, Denver, CO 80262 USA.	xiaojiang.chen@uchsc.edu	Li, Dawei/I-8751-2016	Li, Dawei/0000-0003-4133-1263				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beachy TM, 2002, J VIROL, V76, P3145, DOI 10.1128/JVI.76.7.3145-3157.2002; Bochtler M, 2000, NATURE, V403, P800, DOI 10.1038/35001629; BOROWIEC JA, 1988, EMBO J, V7, P3149, DOI 10.1002/j.1460-2075.1988.tb03182.x; BOROWIEC JA, 1990, CELL, V60, P181, DOI 10.1016/0092-8674(90)90730-3; Bullock PA, 1997, CRIT REV BIOCHEM MOL, V32, P503, DOI 10.3109/10409239709082001; CAVENDER JF, 1995, J VIROL, V69, P923, DOI 10.1128/JVI.69.2.923-934.1995; CHO YJ, 1994, SCIENCE, V265, P346, DOI 10.1126/science.8023157; Cook PR, 1999, SCIENCE, V284, P1790, DOI 10.1126/science.284.5421.1790; DEAN FB, 1987, P NATL ACAD SCI USA, V84, P16, DOI 10.1073/pnas.84.1.16; Edwards MC, 2002, J BIOL CHEM, V277, P33049, DOI 10.1074/jbc.M204438200; FANNING E, 1992, ANNU REV BIOCHEM, V61, P55; FARBER JM, 1987, J VIROL, V61, P436, DOI 10.1128/JVI.61.2.436-445.1987; Fletcher RJ, 2003, NAT STRUCT BIOL, V10, P160, DOI 10.1038/nsb893; Joo WS, 1998, MOL CELL BIOL, V18, P2677, DOI 10.1128/MCB.18.5.2677; KIERSTEAD TD, 1993, J VIROL, V67, P1817, DOI 10.1128/JVI.67.4.1817-1829.1993; KOONIN EV, 1993, NUCLEIC ACIDS RES, V21, P2541, DOI 10.1093/nar/21.11.2541; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lenzen CU, 1998, CELL, V94, P525, DOI 10.1016/S0092-8674(00)81593-7; LIN JY, 1991, J VIROL, V65, P6447, DOI 10.1128/JVI.65.12.6447-6453.1991; LIN JY, 1991, J VIROL, V65, P2066, DOI 10.1128/JVI.65.4.2066-2072.1991; LOEBER G, 1989, J VIROL, V63, P94, DOI 10.1128/JVI.63.1.94-100.1989; LOEBER G, 1989, J VIROL, V63, P4426, DOI 10.1128/JVI.63.10.4426-4430.1989; Luo XL, 1996, NAT STRUCT BIOL, V3, P1034, DOI 10.1038/nsb1296-1034; MASTRANGELO IA, 1989, NATURE, V338, P658, DOI 10.1038/338658a0; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Neuwald AF, 1999, GENOME RES, V9, P27; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PEDEN KWC, 1989, VIROLOGY, V168, P13, DOI 10.1016/0042-6822(89)90398-X; PIPAS JM, 1992, J VIROL, V66, P3979, DOI 10.1128/JVI.66.7.3979-3985.1992; Putnam CD, 2001, J MOL BIOL, V311, P297, DOI 10.1006/jmbi.2001.4852; RAY S, 1992, J VIROL, V66, P6509, DOI 10.1128/JVI.66.11.6509-6516.1992; Rouiller I, 2002, NAT STRUCT BIOL, V9, P950, DOI 10.1038/nsb872; Sawaya MR, 1999, CELL, V99, P167, DOI 10.1016/S0092-8674(00)81648-7; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Simmons DT, 2000, ADV VIRUS RES, V55, P75, DOI 10.1016/S0065-3527(00)55002-7; Singleton MR, 2000, CELL, V101, P589, DOI 10.1016/S0092-8674(00)80871-5; Smelkova NV, 1998, J VIROL, V72, P8676, DOI 10.1128/JVI.72.11.8676-8681.1998; Sousa MC, 2000, CELL, V103, P633, DOI 10.1016/S0092-8674(00)00166-5; STILLMAN B, 1994, CELL, V78, P725, DOI 10.1016/S0092-8674(94)90362-X; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; TSURIMOTO T, 1990, NATURE, V346, P534, DOI 10.1038/346534a0; TSURIMOTO T, 1991, J BIOL CHEM, V266, P1961; Valle M, 2000, MOL CELL BIOL, V20, P34, DOI 10.1128/MCB.20.1.34-41.2000; WESSEL R, 1992, J VIROL, V66, P804, DOI 10.1128/JVI.66.2.804-815.1992; WOLD MS, 1987, P NATL ACAD SCI USA, V84, P3643, DOI 10.1073/pnas.84.11.3643; Wu CX, 1998, J VIROL, V72, P10256, DOI 10.1128/JVI.72.12.10256-10259.1998; Wu CX, 2001, J VIROL, V75, P2839, DOI 10.1128/JVI.75.6.2839-2847.2001; WUNKIM K, 1990, J VIROL, V64, P2014, DOI 10.1128/JVI.64.5.2014-2020.1990	50	240	247	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 29	2003	423	6939					512	518		10.1038/nature01691	http://dx.doi.org/10.1038/nature01691			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	683RH	12774115				2022-12-24	WOS:000183162900036
J	Hsu, AL; Murphy, CT; Kenyon, C				Hsu, AL; Murphy, CT; Kenyon, C			Regulation of aging and age-related disease by DAF-16 and heat-shock factor	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; GENE-EXPRESSION; EXTENDED LIFE; LONGEVITY; LONG; IDENTIFICATION; RESISTANCE; STRESS; MUTANT	The Caenorhabditis elegans transcription factor HSF-1, which regulates the heat-shock response, also influences aging. Reducing hsf-1 activity accelerates tissue aging and shortens life-span, and we show that hsf-1 overexpression extends life-span. We find that HSF-1, like the transcription factor DAF-16, is required for daf-2-insulin/IGF-1 receptor mutations to extend life-span. Our findings suggest this is because HSF-1 and DAF-16 together activate expression of specific genes, including genes encoding small heat-shock proteins, which in turn promote longevity. The small heat-shock proteins also delay the onset of polyglutamine-expansion protein aggregation, suggesting that these proteins couple the normal aging process to this type of age-related disease.	Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Kenyon, C (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.		Hsu, Ao-Lin Allen/AAX-1856-2020	Hsu, Ao-Lin/0000-0002-2864-3134; Kenyon, Cynthia/0000-0003-3446-2636				Barsyte D, 2001, FASEB J, V15, P627, DOI 10.1096/fj.99-0966com; Clark JI, 2000, CURR OPIN STRUC BIOL, V10, P52, DOI 10.1016/S0959-440X(99)00048-2; Feng JL, 2001, DEV CELL, V1, P633, DOI 10.1016/S1534-5807(01)00071-5; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Garigan D, 2002, GENETICS, V161, P1101; Gems D, 2001, CURR OPIN GENET DEV, V11, P287, DOI 10.1016/S0959-437X(00)00192-1; Gems D, 1998, GENETICS, V150, P129; GLESE KC, 2002, J BIOL CHEM, V277, P46310; Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700; GuhaThakurta D, 2002, GENOME RES, V12, P701, DOI 10.1101/gr.228902; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; Honda Y, 1999, FASEB J, V13, P1385, DOI 10.1096/fasebj.13.11.1385; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kurapati R, 2000, J GERONTOL A-BIOL, V55, pB552, DOI 10.1093/gerona/55.11.B552; Lakowski B, 1998, P NATL ACAD SCI USA, V95, P13091, DOI 10.1073/pnas.95.22.13091; Lee RYN, 2001, CURR BIOL, V11, P1950, DOI 10.1016/S0960-9822(01)00595-4; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; LITHGOW GJ, 1995, P NATL ACAD SCI USA, V92, P7540, DOI 10.1073/pnas.92.16.7540; MORIMOTO R, COMMUNICATION; Morley JF, 2002, P NATL ACAD SCI USA, V99, P10417, DOI 10.1073/pnas.152161099; MURPHY CT, IN PRESS NATURE; SORGER PK, 1991, CELL, V65, P363, DOI 10.1016/0092-8674(91)90452-5; Tatar M, 1997, NATURE, V390, P30, DOI 10.1038/36237; Van Montfort R, 2002, ADV PROTEIN CHEM, V59, P105; Verbeke P, 2001, CELL BIOL INT, V25, P845, DOI 10.1006/cbir.2001.0789; Walker GA, 2001, J GERONTOL A-BIOL, V56, pB281, DOI 10.1093/gerona/56.7.B281; Yokoyama K, 2002, FEBS LETT, V516, P53, DOI 10.1016/S0014-5793(02)02470-5; Yu H, 2001, J MOL BIOL, V314, P1017, DOI 10.1006/jmbi.2000.5210	29	1075	1134	6	135	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 16	2003	300	5622					1142	1145		10.1126/science.1083701	http://dx.doi.org/10.1126/science.1083701			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	678VC	12750521				2022-12-24	WOS:000182886500045
J	Brivanlou, AH; Gage, FH; Jaenisch, R; Jessell, T; Melton, D; Rossant, J				Brivanlou, AH; Gage, FH; Jaenisch, R; Jessell, T; Melton, D; Rossant, J			Setting standards for human embryonic stem cells	SCIENCE			English	Editorial Material							HUMAN BLASTOCYSTS; MOUSE EMBRYOS; IN-VITRO; DIFFERENTIATION; LINES; ESTABLISHMENT; CULTURE; GROWTH		Rockefeller Univ, New York, NY 10021 USA; Salk Inst Biol Studies, La Jolla, CA 92037 USA; Whitehead Inst, Cambridge, MA 02142 USA; Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA; Harvard Univ, Cambridge, MA 02138 USA; Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada	Rockefeller University; Salk Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute; Columbia University; Howard Hughes Medical Institute; Harvard University; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto	Brivanlou, AH (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA.		Young, Richard A/F-6495-2012	Young, Richard A/0000-0001-8855-8647				Amit M, 2000, DEV BIOL, V227, P271, DOI 10.1006/dbio.2000.9912; Assady S, 2001, DIABETES, V50, P1691, DOI 10.2337/diabetes.50.8.1691; BRADLEY A, 1984, NATURE, V309, P255, DOI 10.1038/309255a0; Eiges R, 2001, CURR BIOL, V11, P514, DOI 10.1016/S0960-9822(01)00144-0; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Itskovitz-Eldor J, 2000, MOL MED, V6, P88, DOI 10.1007/BF03401776; Kaufman DS, 2001, P NATL ACAD SCI USA, V98, P10716, DOI 10.1073/pnas.191362598; Kehat I, 2001, J CLIN INVEST, V108, P407, DOI 10.1172/JCI12131; Lagasse E, 2001, IMMUNITY, V14, P425, DOI 10.1016/S1074-7613(01)00123-6; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; MCKAY R, 2002, WORKSH SPONS NEW YOR; Reubinoff BE, 2001, NAT BIOTECHNOL, V19, P1134, DOI 10.1038/nbt1201-1134; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; Richards M, 2002, NAT BIOTECHNOL, V20, P933, DOI 10.1038/nbt726; Rossant J, 2001, STEM CELLS, V19, P477, DOI 10.1634/stemcells.19-6-477; Schuldiner M, 2000, P NATL ACAD SCI USA, V97, P11307, DOI 10.1073/pnas.97.21.11307; Schuldiner M, 2001, BRAIN RES, V913, P201, DOI 10.1016/S0006-8993(01)02776-7; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129	20	247	272	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 9	2003	300	5621					913	+		10.1126/science.1082940	http://dx.doi.org/10.1126/science.1082940			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675WD	12738841				2022-12-24	WOS:000182719800033
J	Marmottant, P; Hilgenfeldt, S				Marmottant, P; Hilgenfeldt, S			Controlled vesicle deformation and lysis by single oscillating bubbles	NATURE			English	Article							SONOLUMINESCENCE; CAVITATION; ULTRASOUND; SONOPORATION; BOUNDARY; DYNAMICS; FLOW	The ability of collapsing (cavitating) bubbles to focus and concentrate energy, forces and stresses is at the root of phenomena such as cavitation damage, sonochemistry or sonoluminescence(1,2). In a biomedical context, ultrasound-driven microbubbles have been used to enhance contrast in ultrasonic images(3). The observation of bubble-enhanced sonoporation(4-6)-acoustically induced rupture of membranes-has also opened up intriguing possibilities for the therapeutic application of sonoporation as an alternative to cell-wall permeation techniques such as electroporation(7) and particle guns(8). However, these pioneering experiments have not been able to pinpoint the mechanism by which the violently collapsing bubble opens pores or larger holes in membranes. Here we present an experiment in which gentle (linear) bubble oscillations are sufficient to achieve rupture of lipid membranes. In this regime, the bubble dynamics and the ensuing sonoporation can be accurately controlled. The use of microbubbles as focusing agents makes acoustics on the micrometre scale (microacoustics) a viable tool, with possible applications in cell manipulation and cell-wall permeation as well as in microfluidic devices.	Univ Twente, Fac Appl Phys, NL-7500 AE Enschede, Netherlands	University of Twente	Marmottant, P (corresponding author), Univ Twente, Fac Appl Phys, POB 217, NL-7500 AE Enschede, Netherlands.		Hilgenfeldt, Sascha/B-7356-2009; Marmottant, Philippe/D-6808-2012; Hilgenfeldt, Sascha/A-4593-2014	Hilgenfeldt, Sascha/0000-0002-6799-2118				BLAKE JR, 1974, J ENG MATH, V8, P23, DOI 10.1007/BF02353701; Boal D. H., 2002, MECH CELL; Brujan EA, 2001, J FLUID MECH, V433, P251, DOI 10.1017/S0022112000003347; Chang D.C., 1992, GUIDE ELECTROPORATIO; CHANG DC, 1993, ADV ECHO IMAGING USI; DAVIDSON BJ, 1971, J SOUND VIB, V15, P217, DOI 10.1016/0022-460X(71)90536-0; DIMITROV DS, 1987, PROG COLLOID POLYM S, V73, P48; ELDER SA, 1959, J ACOUST SOC AM, V31, P54, DOI 10.1121/1.1907611; Greenleaf WJ, 1998, ULTRASOUND MED BIOL, V24, P587, DOI 10.1016/S0301-5629(98)00003-9; Hilgenfeldt S, 2000, J ACOUST SOC AM, V107, P3530, DOI 10.1121/1.429438; Hilgenfeldt S, 1999, NATURE, V398, P402, DOI 10.1038/18842; Leighton T.G., 1994, ACOUSTIC BUBBLE, DOI DOI 10.1121/1.410082; LIGHTHILL J, 1978, J SOUND VIB, V61, P391, DOI 10.1016/0022-460X(78)90388-7; Longuet-Higgins MS, 1998, P ROY SOC A-MATH PHY, V454, P725, DOI 10.1098/rspa.1998.0183; MILLER DL, 1988, J ACOUST SOC AM, V84, P1378, DOI 10.1121/1.396636; MILLER DL, 1979, SCIENCE, V205, P505, DOI 10.1126/science.451616; Miller DL, 2000, ULTRASOUND MED BIOL, V26, P661, DOI 10.1016/S0301-5629(99)00170-2; PLESSET MS, 1977, ANNU REV FLUID MECH, V9, P145, DOI 10.1146/annurev.fl.09.010177.001045; Popinet S, 1999, INT J NUMER METH FL, V30, P775, DOI 10.1002/(SICI)1097-0363(19990730)30:6<775::AID-FLD864>3.0.CO;2-#; Pozrikidis C., 1992, BOUNDARY INTEGRAL SI; Prosperetti A, 1997, J ACOUST SOC AM, V101, P2003, DOI 10.1121/1.418133; Rawicz W, 2000, BIOPHYS J, V79, P328, DOI 10.1016/S0006-3495(00)76295-3; RILEY N, 1966, Q J MECH APPL MATH, V19, P461, DOI 10.1093/qjmam/19.4.461; ROONEY JA, 1970, SCIENCE, V169, P869, DOI 10.1126/science.169.3948.869; Seifert U, 1999, EUR PHYS J B, V8, P405, DOI 10.1007/s100510050706; SEKI M, 1991, PLANT MOL BIOL, V17, P259, DOI 10.1007/BF00039501; SUSLICK KS, 1990, SCIENCE, V247, P1439, DOI 10.1126/science.247.4949.1439; Tachibana K, 1999, LANCET, V353, P1409, DOI 10.1016/S0140-6736(99)01244-1; Wang ZQ, 1999, PHYS REV E, V59, P1777, DOI 10.1103/PhysRevE.59.1777; Ward M, 2000, ULTRASOUND MED BIOL, V26, P1169, DOI 10.1016/S0301-5629(00)00260-X	30	626	645	10	280	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 8	2003	423	6936					153	156		10.1038/nature01613	http://dx.doi.org/10.1038/nature01613			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675MR	12736680	Bronze			2022-12-24	WOS:000182699600041
J	Palmer, LI				Palmer, LI			The legal and political future of physician-assisted suicide	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							OREGON		Univ Louisville, Louisville, KY 40292 USA	University of Louisville	Palmer, LI (corresponding author), Univ Louisville, Louisville, KY 40292 USA.							ASHCROFT J, 2001, COMMUNCIATION   1106; Ganzini L, 2001, JAMA-J AM MED ASSOC, V285, P2363, DOI 10.1001/jama.285.18.2363; Quill TE, 1997, JAMA-J AM MED ASSOC, V278, P2099, DOI 10.1001/jama.278.23.2099; Steinbrook R, 2002, NEW ENGL J MED, V346, P460, DOI 10.1056/NEJM200202073460624; 2001, FED REG         1109, V66, P56607	5	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 7	2003	289	17					2283	2283		10.1001/jama.289.17.2283	http://dx.doi.org/10.1001/jama.289.17.2283			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	675ET	12734144	Green Published, Bronze			2022-12-24	WOS:000182680700035
J	Bingham, SA; Day, NE; Luben, R; Ferrari, P; Slimani, N; Norat, T; Clavel-Chapelon, F; Kesse, E; Nieters, A; Boeing, H; Tjonneland, A; Overvad, K; Martinez, C; Dorronsoro, M; Gonzalez, CA; Key, TJ; Trichopoulou, A; Naska, A; Vineis, P; Tumino, R; Krogh, V; Bueno-de-Mesquita, HB; Peeters, PHM; Berglund, G; Hallmans, G; Lund, E; Skeie, G; Kaaks, R; Riboli, E				Bingham, SA; Day, NE; Luben, R; Ferrari, P; Slimani, N; Norat, T; Clavel-Chapelon, F; Kesse, E; Nieters, A; Boeing, H; Tjonneland, A; Overvad, K; Martinez, C; Dorronsoro, M; Gonzalez, CA; Key, TJ; Trichopoulou, A; Naska, A; Vineis, P; Tumino, R; Krogh, V; Bueno-de-Mesquita, HB; Peeters, PHM; Berglund, G; Hallmans, G; Lund, E; Skeie, G; Kaaks, R; Riboli, E			Dietary fibre in food and protection against colorectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC): an observational study	LANCET			English	Article							RISK; RECURRENCE; CALIBRATION; VEGETABLES; ADENOMA; COHORT; FRUIT	Background Dietary fibre is thought to protect against colorectal cancer but this view has been challenged by recent prospective and intervention studies that showed no protective effect. Methods We prospectively examined the association between dietary fibre intake and incidence of colorectal cancer in 519 978 individuals aged 25-70 years taking part in the EPIC study, recruited from ten European countries. Participants completed a dietary questionnaire in 1992-98 and were followed up for cancer incidence. Relative risk estimates were obtained from fibre intake, categorised by sex-specific, cohort-wide quintiles, and from linear models relating the hazard ratio to fibre intake expressed as a continuous variable. Findings Follow-up consisted of 1939 011 person-years, and data for 1065 reported cases of colorectal cancer were included in the analysis. Dietary fibre in foods was inversely related to incidence of large bowel cancer (adjusted relative risk 0.75 [95% CI 0.59-0.95] for the highest versus lowest quintile of intake), the protective effect being greatest for the left side of the colon, and least for the rectum. After calibration with more detailed dietary data, the adjusted relative risk for the highest versus lowest quintile of fibre from food intake was 0.58 (0.41-0.85). No food source of fibre was significantly more protective than others, and non-food supplement sources of fibre were not investigated. Interpretation In populations with low average intake of dietary fibre, an approximate doubling of total fibre intake from foods could reduce the risk of colorectal cancer by 40%.	Int Agcy Res Canc, WHO, Unit Nutr & Canc, F-69372 Lyon 08, France; Univ Cambridge, Strangeways Res Lab, Cambridge CB2 1TN, England; MRC, Dunn Human Nutr Unit, Cambridge, England; Inst Gustave Roussy, INSERM, U521, F-94805 Villejuif, France; German Canc Res Ctr, D-6900 Heidelberg, Germany; German Inst Human Nutr, Potsdam, Germany; Danish Canc Soc, Inst Canc Epidemiol, Copenhagen, Denmark; Aalborg Hosp, Dept Clin Epidemiol, Aalborg, Denmark; Univ Aarhus, Dept Epidemiol & Social Med, DK-8000 Aarhus C, Denmark; Aarhus Univ Hosp, DK-8000 Aarhus, Denmark; Andalusian Sch Publ Hlth, Granada, Spain; Dept Publ Hlth Guipuzkoa, San Sebastian, Spain; Catalan Inst Oncol, Barcelona, Spain; Radcliffe Infirm, Canc Res UK, Oxford OX2 6HE, England; Univ Athens, Sch Med, GR-10679 Athens, Greece; Univ Turin, Turin, Italy; CPO Piemonte, Turin, Italy; Ragusa Canc Registry, Ragusa, Sicily, Italy; Natl Canc Inst, Dept Epidemiol, I-20133 Milan, Italy; Natl Inst Publ Hlth & Environm, NL-3720 BA Bilthoven, Netherlands; Univ Med Ctr, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; Lund Univ, Malmo Diet & Canc Study, Malmo, Sweden; Umea Univ, Dept Nutr Res, S-90187 Umea, Sweden; Univ Tromso, Inst Community Med, N-9001 Tromso, Norway	World Health Organization; International Agency for Research on Cancer (IARC); University of Cambridge; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; Helmholtz Association; German Cancer Research Center (DKFZ); Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Danish Cancer Society; Aalborg University; Aalborg University Hospital; Aarhus University; Aarhus University; Escuela Andaluza de Salud Publica; Catalan Institute of Oncology; Cancer Research UK; Radcliffe Infirmary; Athens Medical School; National & Kapodistrian University of Athens; University of Turin; Centro di Riferimento per Epidemiologia e la Prevenzione Oncologica in Piemonte; Fondazione IRCCS Istituto Nazionale Tumori Milan; Netherlands National Institute for Public Health & the Environment; Utrecht University; Utrecht University Medical Center; Lund University; Umea University; UiT The Arctic University of Tromso	Riboli, E (corresponding author), Int Agcy Res Canc, WHO, Unit Nutr & Canc, 150 Cours Albert Thomas, F-69372 Lyon 08, France.	ntr@iarc.fr	Krogh, Vittorio/AAA-9171-2019; TRICHOPOULOU, ANTONIA/ABF-8727-2021; Kesse-Guyot, Emmanuelle/ABH-7347-2020; Luben, Robert N/H-5519-2015; Krogh, Vittorio/K-2628-2016; Kesse-Guyot, Emmanuelle/K-4689-2012; Kesse-Guyot, Emmanuelle/F-2692-2017; Clavel-Chapelon, Francoise/G-6733-2014	Krogh, Vittorio/0000-0003-0122-8624; TRICHOPOULOU, ANTONIA/0000-0002-7204-6396; Luben, Robert N/0000-0002-5088-6343; Krogh, Vittorio/0000-0003-0122-8624; Kesse-Guyot, Emmanuelle/0000-0002-9715-3534; Riboli, Elio/0000-0001-6795-6080; Overvad, Kim/0000-0001-6429-7921; tumino, rosario/0000-0003-2666-414X; Tjonneland, Anne/0000-0003-4385-2097; Lund, Eiliv/0000-0002-8071-8711; Skeie, Guri/0000-0003-2476-4251				Agudo A, 2002, PUBLIC HEALTH NUTR, V5, P1179, DOI 10.1079/PHN2002398; Alberts DS, 2000, NEW ENGL J MED, V342, P1156, DOI 10.1056/NEJM200004203421602; BINGHAM SA, 1990, P NUTR SOC, V49, P153, DOI 10.1079/PNS19900021; BOFFA LC, 1992, CANCER RES, V52, P5906; Bonithon-Kopp C, 2000, LANCET, V356, P1300, DOI 10.1016/S0140-6736(00)02813-0; BRESLOW NE, 1987, IARC SCI PUBL, V82; Chai F, 2000, CARCINOGENESIS, V21, P7, DOI 10.1093/carcin/21.1.7; *COMA WORK GROUP D, 1998, 48 UK DEP HLTH COMA; Day NE, 2001, INT J EPIDEMIOL, V30, P309, DOI 10.1093/ije/30.2.309; Deharveng G, 1999, EUR J CLIN NUTR, V53, P60, DOI 10.1038/sj.ejcn.1600677; *DEP HLTH, 1991, 41 UK DEP HLTH; Domon-Dell C, 2002, GUT, V50, P525, DOI 10.1136/gut.50.4.525; Fuchs CS, 1999, NEW ENGL J MED, V340, P169, DOI 10.1056/NEJM199901213400301; Holland B., 1991, MCCANCE WIDDOWSONS C, V5; KAAKS R, 1995, AM J EPIDEMIOL, V142, P548, DOI 10.1093/oxfordjournals.aje.a117673; Key TJ, 1998, PUBLIC HEALTH NUTR, V1, P33, DOI 10.1079/PHN19980006; Kipnis V, 2001, AM J EPIDEMIOL, V153, P394, DOI 10.1093/aje/153.4.394; MCNEIL NI, 1981, DIS COLON RECTUM, V24, P596, DOI 10.1007/BF02605753; Pietinen P, 1999, CANCER CAUSE CONTROL, V10, P387, DOI 10.1023/A:1008962219408; Riboli E, 2002, PUBLIC HEALTH NUTR, V5, P1113, DOI 10.1079/PHN2002394; Riboli E, 1997, INT J EPIDEMIOL, V26, pS6, DOI 10.1093/ije/26.suppl_1.S6; Rosner B, 2001, AM J EPIDEMIOL, V154, P827, DOI 10.1093/aje/154.9.827; ROSNER B, 1989, STAT MED, V8, P1051, DOI 10.1002/sim.4780080905; Schatzkin A, 2000, NEW ENGL J MED, V342, P1149, DOI 10.1056/NEJM200004203421601; Slimani N, 2002, PUBLIC HEALTH NUTR, V5, P1125, DOI 10.1079/PHN2002395; Terry P, 2001, JNCI-J NATL CANCER I, V93, P525, DOI 10.1093/jnci/93.7.525; Wirfalt E, 2002, PUBLIC HEALTH NUTR, V5, P1197, DOI 10.1079/PHN2002399; World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR), 1997, FOOD NUTR PREV CANC	28	752	805	3	140	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 3	2003	361	9368					1496	1501		10.1016/S0140-6736(03)13174-1	http://dx.doi.org/10.1016/S0140-6736(03)13174-1			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	674WB	12737858				2022-12-24	WOS:000182658900007
J	Cassman, M				Cassman, M			Counting on the neuron	SCIENCE			English	Editorial Material									Univ Calif San Francisco, Calif Inst Quantitat Biomed Res, San Francisco, CA 94131 USA	University of California System; University of California San Francisco	Cassman, M (corresponding author), Univ Calif San Francisco, Calif Inst Quantitat Biomed Res, San Francisco, CA 94131 USA.	mcassman@research.ucsf.edu						[Anonymous], 2002, NATURE, V420, P703; *NY AC SCI, 2002, COMP MOD MAMM CELL N; Waddington CH, 1942, NATURE, V150, P563, DOI 10.1038/150563a0; NATL RESOURCE CELL A	4	4	4	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 2	2003	300	5620					756	757		10.1126/science.1082371	http://dx.doi.org/10.1126/science.1082371			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673KH	12730591				2022-12-24	WOS:000182579800037
J	Spitz, F; Gonzalez, F; Duboule, D				Spitz, F; Gonzalez, F; Duboule, D			A global control region defines a chromosomal regulatory landscape containing the HoxD cluster	CELL			English	Article							GENE-EXPRESSION; TRANSGENIC ANALYSIS; SONIC-HEDGEHOG; LIMB BUD; COMPLEX; MOUSE; SEQUENCE; ULNALESS; DNA; GENOME	During limb development, coordinated expression of several Hoxd genes is required in presumptive digits. We searched for the underlying control sequences upstream from the cluster and found Lunapark (Lnp), a gene which shares limb and CNS expression specificities with both Hoxd genes and Evx2, another gene located nearby. We used a targeted enhancer-trap approach to identify a DNA segment capable of directing reporter gene expression in both digits and CNS, following Lnp, Evx2, and Hoxd-specific patterns. This DNA region showed an unusual interspecies conservation, including with its pufferfish counterpart. It contains a cluster of global enhancers capable of controlling transcription of several genes unrelated in structure or function, thus defining large regulatory domains. These domains were interrupted in the Ulna-less mutation, a balanced inversion that modified the topography of the locus. We discuss the heuristic value of these results in term of locus specific versus gene-specific regulation.	Univ Geneva, Dept Zool & Anim Biol, CH-1211 Geneva 4, Switzerland; Univ Geneva, NCCR Frontiers Genet, CH-1211 Geneva, Switzerland	University of Geneva; University of Geneva	Duboule, D (corresponding author), Univ Geneva, Dept Zool & Anim Biol, Quai Ernest Ansermet 30, CH-1211 Geneva 4, Switzerland.			Spitz, Francois/0000-0002-1960-829X; duboule, denis/0000-0001-9961-2960; Gonzalez Grassi, Federico/0000-0002-7147-2246				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Aparicio S, 2002, SCIENCE, V297, P1301, DOI 10.1126/science.1072104; Becker M, 1998, COMPUT PHYS, V12, P125; Beckers J, 1998, DEV DYNAM, V213, P1; Biery MC, 2000, NUCLEIC ACIDS RES, V28, P1067, DOI 10.1093/nar/28.5.1067; Capdevila J, 2001, ANNU REV CELL DEV BI, V17, P87, DOI 10.1146/annurev.cellbio.17.1.87; Carvajal JJ, 2001, DEVELOPMENT, V128, P1857; DAVIS AP, 1995, NATURE, V375, P791, DOI 10.1038/375791a0; DAVISSON MT, 1990, J HERED, V81, P151; Dermitzakis ET, 2002, NATURE, V420, P578, DOI 10.1038/nature01251; DOLLE P, 1994, DEVELOPMENT, P143; DOLLE P, 1989, NATURE, V342, P767, DOI 10.1038/342767a0; FromentalRamain C, 1996, DEVELOPMENT, V122, P2997; GERARD M, 1993, EMBO J, V12, P3539, DOI 10.1002/j.1460-2075.1993.tb06028.x; Goodman FR, 2002, AM J HUM GENET, V70, P547, DOI 10.1086/338921; Gould A, 1997, GENE DEV, V11, P900, DOI 10.1101/gad.11.7.900; Herault Y, 1997, DEVELOPMENT, V124, P3493; Herault Y, 1999, DEV BIOL, V208, P157, DOI 10.1006/dbio.1998.9179; Herault Y, 1996, EMBO J, V15, P6727, DOI 10.1002/j.1460-2075.1996.tb01062.x; JIN JR, 1995, DNA CELL BIOL, V14, P267, DOI 10.1089/dna.1995.14.267; Kleinjan DA, 2001, HUM MOL GENET, V10, P2049, DOI 10.1093/hmg/10.19.2049; Kmita M, 2000, NAT GENET, V26, P451, DOI 10.1038/82593; Kmita M, 2002, DEVELOPMENT, V129, P5521, DOI 10.1242/dev.00151; Kondo T, 1999, CELL, V97, P407, DOI 10.1016/S0092-8674(00)80749-7; KRUMLAUF R, 1994, CELL, V78, P191, DOI 10.1016/0092-8674(94)90290-9; LAUFER E, 1994, CELL, V79, P993, DOI 10.1016/0092-8674(94)90030-2; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; Lercher MJ, 2002, NAT GENET, V31, P180, DOI 10.1038/ng887; Lettice LA, 2002, P NATL ACAD SCI USA, V99, P7548, DOI 10.1073/pnas.112212199; Mayor C, 2000, BIOINFORMATICS, V16, P1046, DOI 10.1093/bioinformatics/16.11.1046; Monge I, 2003, DEV BIOL, V256, P212, DOI 10.1016/S0012-1606(02)00136-7; Morgan BA, 1996, P NATL ACAD SCI USA, V93, P2801, DOI 10.1073/pnas.93.7.2801; Muyrers JPP, 1999, NUCLEIC ACIDS RES, V27, P1555, DOI 10.1093/nar/27.6.1555; Nelson CE, 1996, DEVELOPMENT, V122, P1449; Niehrs C, 1999, NATURE, V402, P483, DOI 10.1038/990025; Oliver Brian, 2002, J Biol, V1, P4; Orford M, 2000, Nucleic Acids Res, V28, pE84, DOI 10.1093/nar/28.18.e84; Peichel CL, 1997, DEVELOPMENT, V124, P3481; Peichel CL, 1996, GENETICS, V144, P1757; Pfeifer D, 1999, AM J HUM GENET, V65, P111, DOI 10.1086/302455; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; RIJL, 1997, CURR OPIN GENET DEV, V7, P481; Roy PJ, 2002, NATURE, V418, P975, DOI 10.1038/nature01012; Schwartz S, 2000, GENOME RES, V10, P577, DOI 10.1101/gr.10.4.577; Shubin N, 1997, NATURE, V388, P639, DOI 10.1038/41710; SORDINO P, 1995, NATURE, V375, P678, DOI 10.1038/375678a0; Spellman Paul T, 2002, J Biol, V1, P5, DOI 10.1186/1475-4924-1-5; Spitz F, 2001, GENE DEV, V15, P2209, DOI 10.1101/gad.205701; Sumiyama K, 2002, P NATL ACAD SCI USA, V99, P780, DOI 10.1073/pnas.012584999; vanderHoeven F, 1996, CELL, V85, P1025, DOI 10.1016/S0092-8674(00)81303-3; Wiles MV, 2000, NAT GENET, V24, P13, DOI 10.1038/71622; Zakany J, 1999, NATURE, V401, P761, DOI 10.1038/44511; Zakany J, 1997, P NATL ACAD SCI USA, V94, P13695, DOI 10.1073/pnas.94.25.13695; Zakany J, 1996, NATURE, V384, P69, DOI 10.1038/384069a0; Zakany J, 1999, CELL TISSUE RES, V296, P19, DOI 10.1007/s004410051262	55	358	373	0	19	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 2	2003	113	3					405	417		10.1016/S0092-8674(03)00310-6	http://dx.doi.org/10.1016/S0092-8674(03)00310-6			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	674MP	12732147	Bronze			2022-12-24	WOS:000182640800014
J	Sweeney, A; Jiggins, C; Johnsen, S				Sweeney, A; Jiggins, C; Johnsen, S			Insect communication: Polarized light as a butterfly mating signal	NATURE			English	Article							COLOR		Duke Univ, Dept Biol, Durham, NC 27708 USA; Smithsonian Trop Res Inst, Balboa, Panama; Univ Edinburgh, Inst Cell Anim & Populat Biol, Edinburgh EH9 3JT, Midlothian, Scotland	Duke University; Smithsonian Institution; Smithsonian Tropical Research Institute; University of Edinburgh	Sweeney, A (corresponding author), Duke Univ, Dept Biol, Durham, NC 27708 USA.		Jiggins, Chris/T-4296-2019; Jiggins, Chris D/B-9960-2008	Jiggins, Chris/0000-0002-7809-062X; Jiggins, Chris D/0000-0002-7809-062X				[Anonymous], 2002, AQUACULTURE, V235, P13, DOI [10.1016/j.aquaculture.2003.11.035, DOI 10.1016/J.AQUACULTURE.2003.11.035, DOI 10.1016/S1369-7021(02)00929-X]; Beltran M, 2002, MOL BIOL EVOL, V19, P2176, DOI 10.1093/oxfordjournals.molbev.a004042; ENDLER JA, 1993, ECOL MONOGR, V63, P1, DOI 10.2307/2937121; Estrada C, 2002, ECOL ENTOMOL, V27, P448, DOI 10.1046/j.1365-2311.2002.00434.x; Jiggins CD, 2001, NATURE, V411, P302, DOI 10.1038/35077075; Kelber A, 1999, NATURE, V402, P251, DOI 10.1038/46204; Kemp DJ, 2002, TRENDS ECOL EVOL, V17, P298, DOI 10.1016/S0169-5347(02)02516-8; Kinoshita M, 1997, NATURWISSENSCHAFTEN, V84, P199, DOI 10.1007/s001140050377; Shashar N, 1998, BIOTROPICA, V30, P275, DOI 10.1111/j.1744-7429.1998.tb00061.x; Shashar N, 2000, VISION RES, V40, P71, DOI 10.1016/S0042-6989(99)00158-3; Vukusic P, 2000, NATURE, V404, P457, DOI 10.1038/35006561; Vukusic P, 2002, P ROY SOC B-BIOL SCI, V269, P7, DOI 10.1098/rspb.2001.1836	12	188	197	3	78	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 1	2003	423	6935					31	32		10.1038/423031a	http://dx.doi.org/10.1038/423031a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673CG	12721616				2022-12-24	WOS:000182561600030
J	McGill, BJ				McGill, BJ			A test of the unified neutral theory of biodiversity	NATURE			English	Article							RAIN-FOREST; ABUNDANCE; COMMUNITIES; DIVERSITY; PATTERNS	One of the fundamental questions of ecology is what controls biodiversity. Recent theory suggests that biodiversity is controlled predominantly by neutral drift of species abundances(1-4). This theory has generated considerable controversy(5-12), because it claims that many mechanisms that have long been studied by ecologists (such as niches) have little involvement in structuring communities. The theory predicts that the species abundance distribution within a community should follow a zero-sum multinomial distribution (ZSM), but this has not, so far, been rigorously tested. Specifically, it remains to be shown that the ZSM fits the data significantly better than reasonable null models. Here I test whether the ZSM fits several empirical data sets better than the lognormal distribution. It does not. Not only does the ZSM fail to fit empirical data better than the lognormal distribution 95% of the time, it also fails to fit empirical data better even a majority of the time. This means that there is no evidence that the ZSM predicts abundances better than the much more parsimonious null hypothesis.	Univ Arizona, Dept Ecol & Evolut Biol, Tucson, AZ 85721 USA	University of Arizona	McGill, BJ (corresponding author), Univ Arizona, Dept Ecol & Evolut Biol, Tucson, AZ 85721 USA.	mail@brianmcgill.org	McGill, Brian J/A-3476-2008	McGill, Brian J/0000-0002-0850-1913				Abrams PA, 2001, NATURE, V412, P858, DOI 10.1038/35091120; Bell G, 2001, SCIENCE, V293, P2413, DOI 10.1126/science.293.5539.2413; Burslem DFRP, 2000, J ECOL, V88, P1063, DOI 10.1046/j.1365-2745.2000.00517.x; Condit R, 2002, SCIENCE, V295, P666, DOI 10.1126/science.1066854; de Mazancourt C, 2001, SCIENCE, V293, P1772; Dewdney AK, 2000, BIOL BULL-US, V198, P152, DOI 10.2307/1542811; Enquist BJ, 2002, SCIENCE, V295, P1835; Gaston KJ, 2000, PATTERN PROCESS MACR, DOI [10.1002/9780470999592, DOI 10.1002/9780470999592]; Grimmett G., 1992, PROBABILITY RANDOM P; Harte J, 1999, SCIENCE, V284, P334, DOI 10.1126/science.284.5412.334; Hilborn Ray, 1997, V28; HUBBELL SP, 1979, SCIENCE, V203, P1299, DOI 10.1126/science.203.4387.1299; HUBBELL SP, 1975, COMMUNITY ECOLOGY, P314; Hubbell Stephen P., 2001, V32, pi; Kimura M, 1985, NEUTRAL THEORY MOL E; Laurance WF, 1998, ECOLOGY, V79, P2032, DOI 10.1890/0012-9658(1998)079[2032:RFFATD]2.0.CO;2; Levine JM, 2002, TRENDS ECOL EVOL, V17, P99; May R.M., 1975, P81; MCGILL BJ, IN PRESS OIKOS; PIELOU E C, 1969, P286; PRICE J, 1995, SUMMER ATLAS N AM BI; Pyke CR, 2001, J VEG SCI, V12, P553, DOI 10.2307/3237007; ROBBINS C. S., 1986, RESOURCE PUBLICATION, V157, piii; SAUER JR, 2001, N AM BREEDINB BIRD S; Terborgh J, 1996, ECOLOGY, V77, P561, DOI 10.2307/2265630; TOKESHI M, 1993, ADV ECOL RES, V24, P111, DOI 10.1016/S0065-2504(08)60042-2; Yu DW, 1998, ECOL LETT, V1, P193; Yu DW, 2002, TRENDS ECOL EVOL, V17, P353, DOI 10.1016/S0169-5347(02)02575-2	28	347	374	4	174	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 24	2003	422	6934					881	885		10.1038/nature01583	http://dx.doi.org/10.1038/nature01583			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670WR	12692564				2022-12-24	WOS:000182432600052
J	Kusminsky, RE				Kusminsky, RE			One more time	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 23	2003	289	16					2037	2038		10.1001/jama.289.16.2037	http://dx.doi.org/10.1001/jama.289.16.2037			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	669WW	12709445				2022-12-24	WOS:000182374300001
J	Wilson, BJ; Watson, MS; Prescott, GJ; Sunderland, S; Campbell, DM; Hannaford, P; Smith, WCS				Wilson, BJ; Watson, MS; Prescott, GJ; Sunderland, S; Campbell, DM; Hannaford, P; Smith, WCS			Hypertensive diseases of pregnancy and risk of hypertension and stroke in later life: results from cohort study	BRITISH MEDICAL JOURNAL			English	Article							CORONARY DEATHS; HEART-DISEASE; FOLLOW-UP; HEALTH; WOMEN; PREECLAMPSIA; ECLAMPSIA; PROGNOSIS; MOTHERS; RECALL	Objective To examine the association between hypertensive diseases of pregnancy (gestational hypertension and pre-eclampsia) and the development of circulatory diseases in later life. Design Cohort study of women who had pre-eclampsia during their first singleton pregnancy. Two comparison groups were matched for age and year of delivery, one with gestational hypertension and one with no history of raised blood pressure. Setting Maternity services. in the Grampian region of Scotland. Participants Women selected from the Aberdeen maternity and neonatal databank who were resident in Aberdeen and who delivered a first, live singleton from 1951 to 1970. Main outcome measures Current vital and cardiovascular health status ascertained through postal questionnaire survey, clinical examination, linkage to hospital discharge, and mortality data. Results There were significant positive associations between pre-eclampsia/eclampsia or gestational hypertension and later hypertension in all measures. The adjusted relative risks varied from 1.13-3.72 for gestational hypertension and 1.40-3.98 for pre-eclampsia or eclampsia. The adjusted incident rate ratio for death from stroke for the pre-eclampsia/eclampsia group was 3.59 (95% confidence interval 1.04 to 12.4). Conclusions Hypertensive diseases of pregnancy seem to be associated in later life with diseases related to hypertension. If greater awareness of this association leads to earlier diagnosis and improved management, there may be scope for reducing a proportion of the morbidity and mortality from such diseases.	Univ Aberdeen, Dept Publ Hlth, Aberdeen AB25 2ZD, Scotland; Univ Aberdeen, Dept Obstet & Gynaecol, Aberdeen AB9 1FX, Scotland; Univ Aberdeen, Dept Gen Practice & Primary Care, Aberdeen AB9 1FX, Scotland	University of Aberdeen; University of Aberdeen; University of Aberdeen	Smith, WCS (corresponding author), Univ Aberdeen, Dept Publ Hlth, Aberdeen AB25 2ZD, Scotland.		Hannaford, Philip C/B-7867-2012	Prescott, Gordon/0000-0002-9156-2361				ADAMS EM, 1961, LANCET, V2, P1373; BERAL V, 1985, J EPIDEMIOL COMMUN H, V39, P343, DOI 10.1136/jech.39.4.343; CAMPBELL DM, 2000, HDB HYPERTENSION, V20; CARELTON H, 1988, AM J OBSTET GYNECOL, V159, P156; CARLETON H, 1988, AM J OBSTET GYNECOL, V159, P156, DOI 10.1016/0002-9378(88)90513-3; DUFFUS GM, 1968, LANCET, V1, P994; GIBSON GB, 1959, BRIT MED J, V2, P159, DOI 10.1136/bmj.2.5145.159; HAKIM RB, 1992, AM J EPIDEMIOL, V136, P566, DOI 10.1093/oxfordjournals.aje.a116534; Hall MH, 1992, EFFECTS SMOKING FETU, P81; Hannaford P, 1997, HEART, V77, P154, DOI 10.1136/hrt.77.2.154; Irgens HU, 2001, BRIT MED J, V323, P1213, DOI 10.1136/bmj.323.7323.1213; Kendrick Stephen, 1993, Health Bulletin (Edinburgh), V51, P72; KOTCHEN JM, 1982, AM J EPIDEMIOL, V115, P861, DOI 10.1093/oxfordjournals.aje.a113373; LINDEBERG S, 1988, ACTA OBSTET GYN SCAN, V67, P605, DOI 10.3109/00016348809004272; *NAT HIGH BLOOD PR, REP HIGH BLOOD PRESS; NEUGEBAUER R, 1990, J CLIN EPIDEMIOL, V43, P1337, DOI 10.1016/0895-4356(90)90100-4; *OFF POP CENS SURV, 1992, MORT STAT DH2, V19; PLESS CE, 1995, ARCH PEDIAT ADOL MED, V149, P553, DOI 10.1001/archpedi.1995.02170180083016; SAMPHIER ML, 1981, PROSPECTIVE LONGITUD; SELVAGGI L, 1988, INT J GYNECOL OBSTET, V27, P45, DOI 10.1016/0020-7292(88)90086-0; SIBAI BM, 1992, AM J OBSTET GYNECOL, V166, P1757, DOI 10.1016/0002-9378(92)91566-S; SIBAI BM, 1986, AM J OBSTET GYNECOL, V155, P1011, DOI 10.1016/0002-9378(86)90336-4; SINGH MM, 1974, J OBSTET GYN BR COMM, V81, P903; Smith GCS, 2001, LANCET, V357, P2002, DOI 10.1016/S0140-6736(00)05112-6; SMITH WCS, 1989, SCOT MED J, V34, P550, DOI 10.1177/003693308903400603; SMITH WCS, 1990, BRIT HEART J, V64, P295; Svensson A, 1983, J Hypertens Suppl, V1, P94; Todd G. F., 1969, STAT SMOKING UK; TUNSTALLPEDOE H, 1994, CIRCULATION, V90, P583, DOI 10.1161/01.CIR.90.1.583; Womersley J, 1996, J PUBLIC HEALTH MED, V18, P465, DOI 10.1093/oxfordjournals.pubmed.a024546; Yawn BP, 1998, J CLIN EPIDEMIOL, V51, P399, DOI 10.1016/S0895-4356(97)00304-1	31	460	504	2	68	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 19	2003	326	7394					845	849		10.1136/bmj.326.7394.845	http://dx.doi.org/10.1136/bmj.326.7394.845			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	670BF	12702615	Green Published, Bronze, Green Accepted			2022-12-24	WOS:000182386800015
J	Canfield, RL; Henderson, CR; Cory-Slechta, DA; Cox, C; Jusko, TA; Lanphear, BP				Canfield, RL; Henderson, CR; Cory-Slechta, DA; Cox, C; Jusko, TA; Lanphear, BP			Intellectual impairment in children with blood lead concentrations below 10 mu g per deciliter	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	21st Annual Meeting of the Behavioral-Toxicology-Society	APR 20-22, 2002	RES TRIANGLE PK, NORTH CAROLINA	Behav Toxicol Soc			PORT-PIRIE COHORT; ENVIRONMENTAL LEAD; COGNITIVE FUNCTION; NEUROPSYCHOLOGICAL DEVELOPMENT; PRESCHOOL-CHILDREN; PRIMARY PREVENTION; BONE LEAD; EXPOSURE; INTELLIGENCE; LEVEL	BACKGROUND: Despite dramatic declines in children's blood lead concentrations and a lowering of the Centers for Disease Control and Prevention's level of concern to 10 microg per deciliter (0.483 micromol per liter), little is known about children's neurobehavioral functioning at lead concentrations below this level. METHODS: We measured blood lead concentrations in 172 children at 6, 12, 18, 24, 36, 48, and 60 months of age and administered the Stanford-Binet Intelligence Scale at the ages of 3 and 5 years. The relation between IQ and blood lead concentration was estimated with the use of linear and nonlinear mixed models, with adjustment for maternal IQ, quality of the home environment, and other potential confounders. RESULTS: The blood lead concentration was inversely and significantly associated with IQ. In the linear model, each increase of 10 microg per deciliter in the lifetime average blood lead concentration was associated with a 4.6-point decrease in IQ (P=0.004), whereas for the subsample of 101 children whose maximal lead concentrations remained below 10 microg per deciliter, the change in IQ associated with a given change in lead concentration was greater. When estimated in a nonlinear model with the full sample, IQ declined by 7.4 points as lifetime average blood lead concentrations increased from 1 to 10 microg per deciliter. CONCLUSIONS: Blood lead concentrations, even those below 10 microg per deciliter, are inversely associated with children's IQ scores at three and five years of age, and associated declines in IQ are greater at these concentrations than at higher concentrations. These findings suggest that more U.S. children may be adversely affected by environmental lead than previously estimated.	Cornell Univ, Coll Human Ecol, Div Nutr Sci, Ithaca, NY 14853 USA; Cornell Univ, Coll Human Ecol, Dept Human Dev, Ithaca, NY USA; Univ Rochester, Sch Med, Dept Environm Med, Rochester, NY USA; Univ Rochester, Sch Med, Dept Biostat & Computat Biol, Rochester, NY USA; NICHHD, Div Epidemiol Stat & Prevent, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA; Univ Washington, Sch Publ Hlth & Community Med, Dept Epidemiol, Seattle, WA 98195 USA; Childrens Hosp, Med Ctr, Cincinnati Childrens Environm Hlth Ctr, Cincinnati, OH 45229 USA	Cornell University; Cornell University; University of Rochester; University of Rochester; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Washington; University of Washington Seattle; Cincinnati Children's Hospital Medical Center	Canfield, RL (corresponding author), Cornell Univ, Coll Human Ecol, Div Nutr Sci, Ithaca, NY 14853 USA.				NIEHS NIH HHS [R01 ES08388, ES01247, R01 ES008388, P30 ES001247] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES001247, R01ES008388] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Bae DS, 2001, TOXICOL SCI, V63, P132, DOI 10.1093/toxsci/63.1.132; BAGHURST PA, 1992, NEW ENGL J MED, V327, P1279, DOI 10.1056/NEJM199210293271805; BELLINGER D, 1994, PEDIATR ANN, V23, P600, DOI 10.3928/0090-4481-19941101-08; BELLINGER D, 1991, PEDIATRICS, V87, P219; BELLINGER D, 1994, PEDIATRICS, V93, pA28; BELLINGER DC, 1983, J PEDIATR-US, V102, P523, DOI 10.1016/S0022-3476(83)80178-4; BELLINGER DC, 1992, PEDIATRICS, V90, P855; BUCK SF, 1960, J ROY STAT SOC B, V22, P302; Caldwell BM, 1984, HOME OBSERVATION MEA; Centers for Disease Control, 1991, PREV LEAD POIS YOUNG; Cheng YW, 2001, AM J EPIDEMIOL, V153, P164, DOI 10.1093/aje/153.2.164; CORYSLECHTA DA, 1995, ANNU REV PHARMACOL, V35, P391, DOI 10.1146/annurev.pharmtox.35.1.391; DIETRICH KN, 1993, NEUROTOXICOL TERATOL, V15, P37, DOI 10.1016/0892-0362(93)90043-N; Dietrich KN, 2001, NEUROTOXICOL TERATOL, V23, P511, DOI 10.1016/S0892-0362(01)00184-2; FULTON M, 1987, LANCET, V1, P1221; HENDERSON CR, 1982, BIOMETRICS, V38, P623, DOI 10.2307/2530044; International Programme on Chemical Safety, 1995, ENV HLTH CRIT, V165; *JM SATTL, 1992, ASS CHILDR; Langford IH, 1998, J ROY STAT SOC A STA, V161, P121, DOI 10.1111/1467-985X.00094; Lanphear BP, 2000, PUBLIC HEALTH REP, V115, P521, DOI 10.1093/phr/115.6.521; Lanphear BP, 1999, PEDIATRICS, V103, P772, DOI 10.1542/peds.103.4.772; Lanphear BP, 1998, SCIENCE, V281, P1617, DOI 10.1126/science.281.5383.1617; Lanphear BP, 1998, SCIENCE, V282, P51; Lanphear BP, 1996, AM J PUBLIC HEALTH, V86, P1416, DOI 10.2105/AJPH.86.10.1416; Lin JL, 2003, NEW ENGL J MED, V348, P277, DOI 10.1056/NEJMoa021672; Marsden PA, 2003, NEW ENGL J MED, V348, P345, DOI 10.1056/NEJMe020164; MCCROWELL KL, 1994, J PSYCHOEDUC ASSESS, V12, P126, DOI 10.1177/073428299401200202; MCMICHAEL AJ, 1992, NEUROTOXICOL TERATOL, V14, P321, DOI 10.1016/0892-0362(92)90038-C; MCMICHAEL AJ, 1988, NEW ENGL J MED, V319, P468, DOI 10.1056/NEJM198808253190803; Moss ME, 1999, JAMA-J AM MED ASSOC, V281, P2294, DOI 10.1001/jama.281.24.2294; NEEDLEMAN HL, 1990, JAMA-J AM MED ASSOC, V263, P673, DOI 10.1001/jama.263.5.673; Needleman HL, 1996, JAMA-J AM MED ASSOC, V275, P363, DOI 10.1001/jama.275.5.363; PEOPLES CE, 1995, INTELLIGENCE, V21, P69, DOI 10.1016/0160-2896(95)90039-X; POCOCK SJ, 1994, BRIT MED J, V309, P1189, DOI 10.1136/bmj.309.6963.1189; RICE DC, 1993, NEUROTOXICOLOGY, V14, P167; Rogan WJ, 2001, NEW ENGL J MED, V344, P1421, DOI 10.1056/NEJM200105103441902; Rosen JF, 2001, NEW ENGL J MED, V344, P1470, DOI 10.1056/NEJM200105103441910; Ruppert D., 2003, SEMIPARAMETRIC REGRE; SCHWARTZ J, 1995, ARCH ENVIRON HEALTH, V50, P31, DOI 10.1080/00039896.1995.9955010; SCHWARTZ J, 1994, ENVIRON RES, V65, P42, DOI 10.1006/enrs.1994.1020; SCHWARTZ J, 1993, NEUROTOXICOLOGY, V14, P237; Searle S.R., 1971, LINEAR MODELS; Segal N., 1985, HDB INTELLIGENCE THE, P391; Stone B. M., 2003, ARCH CLIN NEUROPSYCH, V613, P1; THORNDIKE RL, 1986, STANFORDBINET INTELL; Tong S, 1998, JAMA-J AM MED ASSOC, V280, P1915, DOI 10.1001/jama.280.22.1915; Tong S, 1996, BRIT MED J, V313, P198; Tong SL, 1996, BRIT MED J, V312, P1569, DOI 10.1136/bmj.312.7046.1569; Tong SL, 2001, ANN EPIDEMIOL, V11, P38, DOI 10.1016/S1047-2797(00)00176-9; Wasserman GA, 1997, ENVIRON HEALTH PERSP, V105, P956, DOI 10.1289/ehp.97105956; Wasserman GA, 2000, NEUROTOXICOL TERATOL, V22, P811, DOI 10.1016/S0892-0362(00)00106-9; Wasserman GA, 1998, AM J PUBLIC HEALTH, V88, P481, DOI 10.2105/AJPH.88.3.481; WINNEKE G, 1994, NEUROTOXICOLOGY, V15, P705	53	1483	1549	3	133	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 17	2003	348	16					1517	1526		10.1056/NEJMoa022848	http://dx.doi.org/10.1056/NEJMoa022848			10	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	667TT	12700371	Bronze, Green Accepted			2022-12-24	WOS:000182248900002
J	Shi, YJ; Sawada, J; Sui, GC; Affar, EB; Whetstine, JR; Lan, F; Ogawa, H; Luke, MPS; Nakatani, Y; Shi, Y				Shi, YJ; Sawada, J; Sui, GC; Affar, EB; Whetstine, JR; Lan, F; Ogawa, H; Luke, MPS; Nakatani, Y; Shi, Y			Coordinated histone modifications mediated by a CtBP co-repressor complex	NATURE			English	Article							COREPRESSOR; PROTEIN; TRANSCRIPTION; TRANSFORMATION; METHYLATION; EXPRESSION; FAMILY; GENES	The transcriptional co-repressor CtBP (C-terminal binding protein) is implicated in tumorigenesis because it is targeted by the adenovirus E1A protein during oncogenic transformation(1). Genetic studies have also identified a crucial function for CtBP in animal development(2). CtBP is recruited to DNA by transcription factors that contain a PXDLS motif(3,4), but the detailed molecular events after the recruitment of CtBP to DNA and the mechanism of CtBP function in tumorigenesis are largely unknown. Here we report the identification of a CtBP complex that contains the essential components for both gene targeting and coordinated histone modifications, allowing for the effective repression of genes targeted by CtBP. Inhibiting the expression of CtBP and its associated histone-modifying activities by RNA-mediated interference resulted in alterations of histone modifications at the promoter of the tumour invasion suppressor gene E-cadherin and increased promoter activity in a reporter assay. These findings identify a molecular mechanism by which CtBP mediates transcriptional repression and provide insight into CtBP participation in oncogenesis.	Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Dana Farber Canc Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute	Shi, Y (corresponding author), Harvard Univ, Sch Med, Dept Pathol, 200 Longwood Ave, Boston, MA 02115 USA.	yang_shi@hms.harvard.edu	Ogawa, Hidesato/M-3778-2019; Ogawa, Hidesato/A-2079-2016	Ogawa, Hidesato/0000-0001-9740-9010; Sui, Guangchao/0000-0002-8164-5585				Ballas N, 2001, NEURON, V31, P353, DOI 10.1016/S0896-6273(01)00371-3; BOYD JM, 1993, EMBO J, V12, P469, DOI 10.1002/j.1460-2075.1993.tb05679.x; Chinnadurai G, 2003, BIOESSAYS, V25, P9, DOI 10.1002/bies.10212; Chinnadurai G, 2002, MOL CELL, V9, P213, DOI 10.1016/S1097-2765(02)00443-4; Collins C, 1998, P NATL ACAD SCI USA, V95, P8703, DOI 10.1073/pnas.95.15.8703; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; Grooteclaes ML, 2000, ONCOGENE, V19, P3823, DOI 10.1038/sj.onc.1203721; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kouzarides T, 2002, CURR OPIN GENET DEV, V12, P198, DOI 10.1016/S0959-437X(02)00287-3; Kumar V, 2002, MOL CELL, V10, P857, DOI 10.1016/S1097-2765(02)00650-0; Lahn BT, 1999, NAT GENET, V21, P429, DOI 10.1038/7771; Nibu Y, 1998, SCIENCE, V280, P101, DOI 10.1126/science.280.5360.101; Ogawa H, 2002, SCIENCE, V296, P1132, DOI 10.1126/science.1069861; Postigo AA, 1999, P NATL ACAD SCI USA, V96, P6683, DOI 10.1073/pnas.96.12.6683; Satijn DPE, 1997, MOL CELL BIOL, V17, P6076, DOI 10.1128/MCB.17.10.6076; Schmitz F, 2000, NEURON, V28, P857, DOI 10.1016/S0896-6273(00)00159-8; Sewalt RGAB, 1999, MOL CELL BIOL, V19, P777; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Sui GC, 2002, P NATL ACAD SCI USA, V99, P5515, DOI 10.1073/pnas.082117599; Tachibana M, 2001, J BIOL CHEM, V276, P25309, DOI 10.1074/jbc.M101914200; Taunton J, 1996, SCIENCE, V272, P408, DOI 10.1126/science.272.5260.408; You A, 2001, P NATL ACAD SCI USA, V98, P1454, DOI 10.1073/pnas.98.4.1454; Zhang QH, 2002, SCIENCE, V295, P1895; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301	24	609	638	1	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 17	2003	422	6933					735	738		10.1038/nature01550	http://dx.doi.org/10.1038/nature01550			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668CG	12700765				2022-12-24	WOS:000182272300045
J	Skelly, M; Hoffman, J; Fabbri, M; Holzman, RS; Clarkson, AB; Merali, S				Skelly, M; Hoffman, J; Fabbri, M; Holzman, RS; Clarkson, AB; Merali, S			S-adenosylmethionine concentrations in diagnosis of Pneumocystis carinii pneumonia	LANCET			English	Article								Pneumocystis carinii is unable to synthesise S-adenosylmethionine and thus scavenges this intermediate. We aimed to test whether measurement of concentrations of this metabolic intermediate in plasma could provide a new method for rapid diagnosis of Pneumocystis carinii pneumonia (PCP). We measured S-adenosylmethionine plasma concentrations in 12 healthy controls, 16 patients with confirmed or suspected PCP, and 36 patients with other infections. Median concentration in healthy controls was 106 nmol/L (range 86-128), but the protein was undetectable in eight patients with histologically proven and seven with suspected PCP, and was 8 nmol/L in another confirmed case (p<0.0001). In 36 patients with other infections, S-adenosylmethionine concentrations were much the same as in controls: IS had bacterial pneumonia, two tuberculosis, five cryptococcal meningitis, three had other infections, and eight had asymptomatic HIV-1 infection. After treatment for PCP, S-adenosylmethionine concentrations rose rapidly in all but one patient who died of the disease. Measurement of plasma S-adenosylmethlonine concentrations could prove useful for diagnosis of PCP and assessment of patients' response to treatment.	NYU, Sch Med, Dept Med & Mol Parasitol, New York, NY 10010 USA; NYU, Bellevue Hosp Ctr, Dept Med, New York, NY 10016 USA	New York University; Bellevue Hospital Center; New York University	Merali, S (corresponding author), NYU, Sch Med, Dept Med & Mol Parasitol, New York, NY 10010 USA.							Barry S M, 2001, HIV Med, V2, P123, DOI 10.1046/j.1468-1293.2001.00062.x; Chiang PK, 1996, FASEB J, V10, P471, DOI 10.1096/fasebj.10.4.8647346; Kaplan JE, 2000, CLIN INFECT DIS, V30, pS5, DOI 10.1086/313843; Merali S, 2000, J BIOL CHEM, V275, P14958, DOI 10.1074/jbc.275.20.14958; Merali S, 1999, P NATL ACAD SCI USA, V96, P2402, DOI 10.1073/pnas.96.5.2402	5	43	45	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 12	2003	361	9365					1267	1268		10.1016/S0140-6736(03)12984-4	http://dx.doi.org/10.1016/S0140-6736(03)12984-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	666DM	12699956				2022-12-24	WOS:000182161600012
J	Yin, YX; Liu, YX; Jin, YJ; Hall, EJ; Barrett, JC				Yin, YX; Liu, YX; Jin, YJ; Hall, EJ; Barrett, JC			PAC1 phosphatase is a transcription target of p53 in signalling apoptosis and growth suppression	NATURE			English	Article							OXIDATIVE STRESS; DNA-BINDING; ACTIVATION; DEFICIENCY; DOMAIN; P21	p53 has a role in many cellular processes through the transcriptional regulation of target genes(1,2). PAC1 ( phosphatase of activated cells 1; also known as dual specificity phosphatase 2, DUSP2) is a dual threonine/tyrosine phosphatase that specifically dephosphorylates and inactivates mitogen-activated protein (MAP) kinases(3,4). Here we show that during apoptosis, p53 activates transcription of PAC1 by binding to a palindromic site in the PAC1 promoter. PAC1 transcription is induced in response to serum deprivation and oxidative stress, which results in p53-dependent apoptosis, but not in response to gamma-irradiation, which causes cell cycle arrest(5,6). Reduction of PAC1 transcription using small interfering RNA inhibits p53-mediated apoptosis, whereas overexpression of PAC1 increases susceptibility to apoptosis and suppresses tumour formation. Moreover, activation of p53 significantly inhibits MAP kinase activity. We conclude that, under specific stress conditions, p53 regulates transcription of PAC1 through a new p53-binding site, and that PAC1 is necessary and sufficient for p53-mediated apoptosis. Identification of a palindromic motif as a p53-binding site may reveal a novel mechanism whereby p53 regulates its target genes.	Columbia Univ, Coll Phys & Surg, Dept Radiat Oncol, New York, NY 10032 USA; NCI, Lab Biosyst & Canc, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	Columbia University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Yin, YX (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Radiat Oncol, 630 W 168th St, New York, NY 10032 USA.	yy151@columbia.edu			DIVISION OF BASIC SCIENCES - NCI [Z01BC010417] Funding Source: NIH RePORTER	DIVISION OF BASIC SCIENCES - NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALMASAN A, 1995, P NATL ACAD SCI USA, V92, P5436, DOI 10.1073/pnas.92.12.5436; BAKER SJ, 1990, SCIENCE, V249, P912, DOI 10.1126/science.2144057; BRUGAROLAS J, 1995, NATURE, V377, P552, DOI 10.1038/377552a0; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; ELDEIRY WS, 1995, CANCER RES, V55, P2910; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; FOORD OS, 1991, NUCLEIC ACIDS RES, V19, P5191, DOI 10.1093/nar/19.19.5191; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Maiyar AC, 1996, J BIOL CHEM, V271, P12414, DOI 10.1074/jbc.271.21.12414; MINDEN A, 1994, MOL CELL BIOL, V14, P6683, DOI 10.1128/MCB.14.10.6683; NISHIDA E, 1993, TRENDS BIOCHEM SCI, V18, P128, DOI 10.1016/0968-0004(93)90019-J; ROHAN PJ, 1993, SCIENCE, V259, P1763, DOI 10.1126/science.7681221; SHAW P, 1992, P NATL ACAD SCI USA, V89, P4495, DOI 10.1073/pnas.89.10.4495; SUIT G, 2002, P NATL ACAD SCI USA, V99, P5515; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; WARD Y, 1994, NATURE, V367, P651, DOI 10.1038/367651a0; Yin YX, 1999, MOL CARCINOGEN, V24, P15, DOI 10.1002/(SICI)1098-2744(199901)24:1<15::AID-MC3>3.3.CO;2-P; Yin YX, 1998, NATURE, V391, P707, DOI 10.1038/35648; Zhao RB, 2000, GENE DEV, V14, P981	21	117	122	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 3	2003	422	6931					527	531		10.1038/nature01519	http://dx.doi.org/10.1038/nature01519			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	662TW	12673251				2022-12-24	WOS:000181965400039
J	Savvidou, MD; Hingorani, AD; Tsikas, D; Frolich, JC; Vallance, P; Nicolaides, KH				Savvidou, MD; Hingorani, AD; Tsikas, D; Frolich, JC; Vallance, P; Nicolaides, KH			Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop pre-eclampsia	LANCET			English	Article							NITRIC-OXIDE SYNTHASE; HYPERTENSIVE DISORDERS; MEDIATED VASODILATION; ENOS-GENE; RISK; INHIBITOR; LOCUS	Background Maternal endothelial dysfunction is a feature of established pre-eclampsia but whether this is a cause or consequence of the disorder is not clear. We tested the hypothesis that endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine (ADMA), the endogenous inhibitor of endothelial nitric oxide synthase, precede and contribute to the development of pre-eclampsia. Methods We assessed uterine artery doppler waveforms in 86 women, at 23-25 weeks' gestation. We tested endothelial function in all women using flow-mediated dilation of the brachial artery at 23-25 weeks' gestation. Plasma concentrations of ADMA were also measured. Findings 43 women had normal uterine artery doppler waveforms and subsequently had a normal outcome. The second group of 43 had evidence of impaired placental perfusion and of these, 19 (44%) had normal outcome, 14 (33%) developed intrauterine growth restriction of the fetus (IUGR), and pre-eclampsia arose in ten (23%). Women who developed pre-eclampsia had significantly lower flow-mediated dilation than did women who had normal outcome (3-58% [SD 2.76] vs 8.59% [2.76]; p<0.0001). Irrespective of pregnancy outcome, women with evidence of impaired placental perfusion had significantly higher levels of ADMA than did women with normal doppler waveforms (2.4 mu mol/L [IQR 1.97-3.14] vs 0.81 mu mol/L [0.49-1.08]; p<0.0001). There was a strong inverse correlation between ADMA and flow-mediated dilation but only in the group of women who eventually developed pre-eclampsia (r= -0.8, p=0.005). Interpretation Maternal endothelial function is impaired in women who eventually develop pre-eclampsia and it occurs before the development of the clinical syndrome. Furthermore, women with high resistance placental circulation at risk of pre-eclampsia, IUGR, or both have raised concentrations of ADMA, which is a potential contributory factor for pre-eclampsia, and is associated with endothelial dysfunction in some women.	Kings Coll Hosp London, Harris Birthright Res Ctr Fetal Med, London SE5 8RS, England; UCL, Dept Med, British Heart Fdn Labs, Ctr Clin Pharmacol, London WC1E 6BT, England; Hannover Med Sch, Inst Clin Pharmacol, D-3000 Hannover, Germany	King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; King's College London; University of London; University College London; Hannover Medical School	Nicolaides, KH (corresponding author), Kings Coll Hosp London, Harris Birthright Res Ctr Fetal Med, Denmark Hill, London SE5 8RS, England.	Kypros@technocom.com		Nicolaides, Kypros/0000-0003-1266-0711; Hingorani, Aroon/0000-0001-8365-0081; SAVVIDOU, MAKRINA/0000-0002-0125-2299				Albaiges G, 2000, OBSTET GYNECOL, V96, P559, DOI 10.1016/S0029-7844(00)00946-7; Arngrimsson R, 1997, AM J HUM GENET, V61, P354, DOI 10.1086/514843; Bosio PM, 1999, OBSTET GYNECOL, V94, P978, DOI 10.1016/S0029-7844(99)00430-5; CALVER A, 1993, J HUM HYPERTENS, V7, P193; CELERMAJER DS, 1992, LANCET, V340, P1111, DOI 10.1016/0140-6736(92)93147-F; Cockell AP, 1997, HYPERTENSION, V30, P247, DOI 10.1161/01.HYP.30.2.247; DAVEY DA, 1988, AM J OBSTET GYNECOL, V158, P892, DOI 10.1016/0002-9378(88)90090-7; Dorup I, 1999, AM J PHYSIOL-HEART C, V276, pH821; GARDOSI J, 1992, LANCET, V339, P283, DOI 10.1016/0140-6736(92)91342-6; Holden DP, 1998, AM J OBSTET GYNECOL, V178, P551, DOI 10.1016/S0002-9378(98)70437-5; Kielstein JT, 2002, J AM SOC NEPHROL, V13, P170, DOI 10.1681/ASN.V131170; Lade JA, 1999, HYPERTENS PREGNANCY, V18, P81, DOI 10.3109/10641959909009613; Leiper J, 1999, CARDIOVASC RES, V43, P542, DOI 10.1016/S0008-6363(99)00162-5; Leiper JM, 1999, BIOCHEM J, V343, P209, DOI 10.1042/0264-6021:3430209; MACALLISTER RJ, 1994, KIDNEY INT, V45, P737, DOI 10.1038/ki.1994.98; Meis PJ, 1998, AM J OBSTET GYNECOL, V178, P562, DOI 10.1016/S0002-9378(98)70439-9; MEREDITH JT, 1996, AM J PHYSIOL, V270, pH1435; Murray-Rust J, 2001, NAT STRUCT BIOL, V8, P679, DOI 10.1038/90387; Redman CWG, 1999, AM J OBSTET GYNECOL, V180, P499, DOI 10.1016/S0002-9378(99)70239-5; ROBERTS JM, 1993, LANCET, V341, P1447, DOI 10.1016/0140-6736(93)90889-O; ROBSON SC, 1989, AM J PHYSIOL, V256, pH1060, DOI 10.1152/ajpheart.1989.256.4.H1060; Savvidou MD, 2001, HYPERTENSION, V38, P1289, DOI 10.1161/hy1201.097305; Savvidou MD, 2000, ULTRASOUND OBST GYN, V15, P502, DOI 10.1046/j.1469-0705.2000.00131.x; Sibai BM, 2000, AM J OBSTET GYNECOL, V182, P938, DOI 10.1016/S0002-9378(00)70350-4; Sibai BM, 2000, AM J OBSTET GYNECOL, V182, P364, DOI 10.1016/S0002-9378(00)70225-0; Sikkema JM, 2001, PLACENTA, V22, P304, DOI 10.1053/plac.2001.0629; Tsikas D, 1998, J CHROMATOGR B, V705, P174; Valkonen VP, 2001, LANCET, V358, P2127, DOI 10.1016/S0140-6736(01)07184-7; VALLANCE P, 1992, LANCET, V339, P572; Williams DJ, 1997, AM J PHYSIOL-HEART C, V272, pH748, DOI 10.1152/ajpheart.1997.272.2.H748	30	383	414	0	15	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 3	2003	361	9368					1511	1517		10.1016/S0140-6736(03)13177-7	http://dx.doi.org/10.1016/S0140-6736(03)13177-7			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	674WB	12737861				2022-12-24	WOS:000182658900010
J	Vetter, N				Vetter, N			Inappropriately delayed discharge from hospital: What do we know?	BRITISH MEDICAL JOURNAL			English	Article							APPROPRIATENESS EVALUATION PROTOCOL; CARE; HOME; BEDS		Univ Wales Coll Med, Dept Epidemiol & Stat, Cardiff CF14 4XL, S Glam, Wales; Univ Wales Coll Med, Dept Publ Hlth, Cardiff CF14 4XL, S Glam, Wales	Cardiff University; Cardiff University	Vetter, N (corresponding author), Univ Wales Coll Med, Dept Epidemiol & Stat, Heath Pk, Cardiff CF14 4XL, S Glam, Wales.							ANDERSON P, 1988, BRIT MED J, V297, P910, DOI 10.1136/bmj.297.6653.910; Chopard P, 1998, INT J EPIDEMIOL, V27, P513, DOI 10.1093/ije/27.3.513; Coast J, 1996, INT J QUAL HEALTH C, V8, P31, DOI 10.1093/intqhc/8.1.31; Epstein J, 2001, SOC WORK HEALTH CARE, V32, P43, DOI 10.1300/J010v32n04_03; FALCONE D, 1991, HEALTH SERV RES, V26, P339; GERTMAN PM, 1981, MED CARE, V19, P855, DOI 10.1097/00005650-198108000-00005; Hermans E, 1996, SCAND J CARING SCI, V10, P81, DOI 10.1111/j.1471-6712.1996.tb00316.x; HIRSCH CH, 1990, J AM GERIATR SOC, V38, P1296, DOI 10.1111/j.1532-5415.1990.tb03451.x; Hyde CJ, 2000, AGE AGEING, V29, P271, DOI 10.1093/ageing/29.3.271; LEWIS H, 1988, NEW ZEAL MED J, V101, P575; McDonagh MS, 2000, HEALTH POLICY, V53, P157, DOI 10.1016/S0168-8510(00)00092-0; Minichiello T M, 2001, Eff Clin Pract, V4, P250; Patterson CJ, 1999, CLIN REHABIL, V13, P101, DOI 10.1191/026921599677096598; STRUMWASSER I, 1990, MED CARE, V28, P95, DOI 10.1097/00005650-199002000-00001; STYRBORN K, 1993, SCAND J SOC MED, V21, P272, DOI 10.1177/140349489302100407	15	33	34	0	5	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 26	2003	326	7395					927	928		10.1136/bmj.326.7395.927	http://dx.doi.org/10.1136/bmj.326.7395.927			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	673WQ	12714477	Green Published			2022-12-24	WOS:000182603600024
J	Bloomfield, FH; Oliver, MH; Hawkins, P; Campbell, M; Phillips, DJ; Gluckman, PD; Challis, JRG; Harding, JE				Bloomfield, FH; Oliver, MH; Hawkins, P; Campbell, M; Phillips, DJ; Gluckman, PD; Challis, JRG; Harding, JE			A periconceptional nutritional origin for noninfectious preterm birth	SCIENCE			English	Article									Univ Toronto, Dept Physiol, Toronto, ON, Canada; Univ Auckland, Liggins Inst, Auckland 1, New Zealand; Monash Univ, Ctr Mol Reprod & Endocrinol, Clayton, Vic 3168, Australia	University of Toronto; University of Auckland; Monash University	Bloomfield, FH (corresponding author), Univ Toronto, Dept Physiol, Toronto, ON, Canada.	f.bloomfield@auckland.ac.nz	Phillips, David/A-5007-2009; Challis, John RG/E-7419-2014; Bloomfield, Frank/A-1374-2008; Harding, Jane E/J-5853-2015	Harding, Jane E/0000-0003-2697-1422; Oliver, Mark/0000-0002-0359-2297; Bloomfield, Frank/0000-0001-6424-6577				Challis JRG, 2000, ENDOCR REV, V21, P514, DOI 10.1210/er.21.5.514; Dole N, 2003, AM J EPIDEMIOL, V157, P14, DOI 10.1093/aje/kwf176; Fadalti M, 2000, ANN NY ACAD SCI, V900, P89; FALL CM, COMMUNICATION; Goldenberg RL, 2000, NEW ENGL J MED, V342, P1500, DOI 10.1056/NEJM200005183422007; LIGGINS GC, 1972, PEDIATRICS, V50, P515	6	202	203	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 25	2003	300	5619					606	606		10.1126/science.1080803	http://dx.doi.org/10.1126/science.1080803			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671FB	12714735				2022-12-24	WOS:000182453700031
J	Fujita, N; Jaye, DL; Kajita, M; Geigerman, C; Moreno, CS; Wade, PA				Fujita, N; Jaye, DL; Kajita, M; Geigerman, C; Moreno, CS; Wade, PA			MTA3, a Mi-2/NuRD complex subunit, an invasive growth pathway in breast	CELL			English	Article							CHROMATIN-REMODELING COMPLEX; TRANSCRIPTION FACTOR SNAIL; CELL-CELL-ADHESION; HISTONE DEACETYLASE; ESTROGEN-RECEPTOR; GENE-EXPRESSION; E-CADHERIN; MAMMARY ADENOCARCINOMA; EPITHELIAL-CELLS; DNA METHYLATION	Estrogen receptor is a key regulator of proliferation and differentiation in mammary epithelia and represents a crucial prognostic indicator and therapeutic target in breast cancer. Mechanistically, estrogen receptor induces changes in gene expression through direct gene activation and also through the biological functions of target loci. Here, we identify the product of human MTA3 as an estrogen-dependent component of the Mi-2/NuRD transcriptional corepressor in breast epithelial cells and demonstrate that MTA3 constitutes a key component of an estrogen-dependent pathway regulating growth and differentiation. The absence of estrogen receptor or of MTA3 leads to aberrant expression of the transcriptional repressor Snail, a master regulator of epithelial to mesenchymal transitions. Aberrant Snail expression results in loss of expression of the cell adhesion molecule E-cadherin, an event associated with changes in epithelial architecture and invasive growth. These results establish a mechanistic link between estrogen receptor status and invasive growth of breast cancers.	Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA	Emory University	Wade, PA (corresponding author), Emory Univ, Sch Med, Dept Pathol & Lab Med, Whitehead Biomed Res Bldg,Room 142,615 Michael St, Atlanta, GA 30322 USA.		Moreno, Carlos S/B-3863-2009; Wade, Paul A/D-2374-2019; Larue, Lionel/I-6532-2016	Moreno, Carlos S/0000-0002-5582-0028; Wade, Paul A/0000-0002-6042-357X; jaye, david/0000-0001-7977-6909	NCI NIH HHS [K22-CA96560-01] Funding Source: Medline; NICHD NIH HHS [5K22HD01238] Funding Source: Medline; NIDDK NIH HHS [DK60647] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K22HD001238] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [K22CA096560] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK060647] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adams CL, 1998, CURR OPIN CELL BIOL, V10, P572, DOI 10.1016/S0955-0674(98)80031-8; Armstrong JA, 1998, CELL, V95, P93, DOI 10.1016/S0092-8674(00)81785-7; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; BEHRENS J, 1989, J CELL BIOL, V108, P2435, DOI 10.1083/jcb.108.6.2435; Blanco MJ, 2002, ONCOGENE, V21, P3241, DOI 10.1038/sj.onc.1205416; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Ch'ng Q, 1999, DEVELOPMENT, V126, P3303; Coffee B, 1999, NAT GENET, V22, P98, DOI 10.1038/8807; Couse JF, 1999, ENDOCR REV, V20, P358, DOI 10.1210/er.20.3.358; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fujita N, 2000, MOL CELL BIOL, V20, P5107, DOI 10.1128/MCB.20.14.5107-5118.2000; Gruber CJ, 2002, NEW ENGL J MED, V346, P340, DOI 10.1056/NEJMra000471; Hajra KM, 2002, CANCER RES, V62, P1613; Hajra KM, 2002, GENE CHROMOSOME CANC, V34, P255, DOI 10.1002/gcc.10083; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hirohashi S, 1998, AM J PATHOL, V153, P333, DOI 10.1016/S0002-9440(10)65575-7; IMHOF BA, 1983, CELL, V35, P667, DOI 10.1016/0092-8674(83)90099-5; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Kehle J, 1998, SCIENCE, V282, P1897, DOI 10.1126/science.282.5395.1897; Kurdistani SK, 2002, NAT GENET, V31, P248, DOI 10.1038/ng907; Lapidus RG, 1998, J MAMMARY GLAND BIOL, V3, P85, DOI 10.1023/A:1018778403001; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; MASOOD S, 1992, DIAGN CYTOPATHOL, V8, P475, DOI 10.1002/dc.2840080508; Mazumdar A, 2001, NAT CELL BIOL, V3, P30, DOI 10.1038/35050532; McDonnell DP, 2002, SCIENCE, V296, P1642, DOI 10.1126/science.1071884; McDonnell DP, 2002, AM J CARDIOL, V90, p35F, DOI 10.1016/S0002-9149(01)02221-4; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Nie ZQ, 2000, MOL CELL BIOL, V20, P8879, DOI 10.1128/MCB.20.23.8879-8888.2000; Nilsson S, 2001, PHYSIOL REV, V81, P1535, DOI 10.1152/physrev.2001.81.4.1535; PENCIL SD, 1993, BREAST CANCER RES TR, V25, P165, DOI 10.1007/BF00662141; Prall OWJ, 1998, J STEROID BIOCHEM, V65, P169, DOI 10.1016/S0960-0760(98)00021-1; REDDEL RR, 1984, EUR J CANCER CLIN ON, V20, P1419, DOI 10.1016/0277-5379(84)90062-2; Solari F, 1999, DEVELOPMENT, V126, P2483; Sommer S, 2001, SEMIN CANCER BIOL, V11, P339, DOI 10.1006/scbi.2001.0389; Sporn MB, 1996, LANCET, V347, P1377, DOI 10.1016/S0140-6736(96)91015-6; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Toh Y, 1997, INT J CANCER, V74, P459, DOI 10.1002/(SICI)1097-0215(19970822)74:4<459::AID-IJC18>3.3.CO;2-H; TOH Y, 1994, J BIOL CHEM, V269, P22958; Tong JK, 1998, NATURE, V395, P917, DOI 10.1038/27699; TSAI MJ, 1994, ANNU REV BIOCHEM, V63, P451, DOI 10.1146/annurev.biochem.63.1.451; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wade PA, 1998, CURR BIOL, V8, P843, DOI 10.1016/S0960-9822(98)70328-8; Wade PA, 1999, NAT GENET, V23, P62, DOI 10.1038/12664; Wang WD, 1996, GENE DEV, V10, P2117, DOI 10.1101/gad.10.17.2117; Xue YT, 1998, MOL CELL, V2, P851, DOI 10.1016/S1097-2765(00)80299-3; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924; Zhang Y, 1998, CELL, V95, P279, DOI 10.1016/S0092-8674(00)81758-4	47	415	448	1	26	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 18	2003	113	2					207	219		10.1016/S0092-8674(03)00234-4	http://dx.doi.org/10.1016/S0092-8674(03)00234-4			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	672EP	12705869	Bronze			2022-12-24	WOS:000182508500010
J	Gould, WS				Gould, WS			The "magic" word	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 16	2003	289	15					1899	1900		10.1001/jama.289.15.1899	http://dx.doi.org/10.1001/jama.289.15.1899			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	667VC	12697774				2022-12-24	WOS:000182253900001
J	Snyder, M; Gerstein, M				Snyder, M; Gerstein, M			Genomics - Defining genes in the genomics era	SCIENCE			English	Editorial Material							PROTEIN-CODING GENES; SACCHAROMYCES-CEREVISIAE GENOME; YEAST GENOME; TRANSCRIPTIONAL ACTIVITY; TOTAL NUMBER; PSEUDOGENES; EVOLUTION; DNA		Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Yale University; Yale University	Snyder, M (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.			Snyder, Michael/0000-0003-0784-7987				Blandin G, 2000, FEBS LETT, V487, P31, DOI 10.1016/S0014-5793(00)02275-4; Brown PO, 1999, NAT GENET, V21, P33, DOI 10.1038/4462; Burge CB, 1998, CURR OPIN STRUC BIOL, V8, P346, DOI 10.1016/S0959-440X(98)80069-9; Coelho PSR, 2000, CURR OPIN MICROBIOL, V3, P309, DOI 10.1016/S1369-5274(00)00095-3; Coelho PSR, 2002, GENE DEV, V16, P2755, DOI 10.1101/gad.1035002; Das M, 2001, GENOMICS, V77, P71, DOI 10.1006/geno.2001.6620; Eddy SR, 2002, CELL, V109, P137, DOI 10.1016/S0092-8674(02)00727-4; FALK R, 1986, STUD HIST PHILOS SCI, V17, P133, DOI 10.1016/0039-3681(86)90024-5; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Harrison P, 2002, J MOL BIOL, V316, P409, DOI 10.1006/jmbi.2001.5343; Harrison PM, 2002, NUCLEIC ACIDS RES, V30, P1083, DOI 10.1093/nar/30.5.1083; Harrison PM, 2002, J MOL BIOL, V318, P1155, DOI 10.1016/S0022-2836(02)00109-2; Horak Christine E, 2002, Funct Integr Genomics, V2, P171; Kapranov P, 2002, SCIENCE, V296, P916, DOI 10.1126/science.1068597; Kowalczuk M, 1999, YEAST, V15, P1031, DOI 10.1002/(SICI)1097-0061(199908)15:11<1031::AID-YEA431>3.0.CO;2-G; Kumar A, 2002, NAT BIOTECHNOL, V20, P58, DOI 10.1038/nbt0102-58; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Liu HP, 1996, GENETICS, V144, P967; Mackiewicz P, 2002, YEAST, V19, P619, DOI 10.1002/yea.865; Mewes HW, 1997, NATURE, V387, P7, DOI 10.1038/387s007; Modrek B, 2002, NAT GENET, V30, P13, DOI 10.1038/ng0102-13; Morange M, 2001, MISUNDERSTOOD GENE; Rinn JL, 2003, GENE DEV, V17, P529, DOI 10.1101/gad.1055203; Tycowski KT, 1996, NATURE, V379, P464, DOI 10.1038/379464a0; Velculescu VE, 1997, CELL, V88, P243, DOI 10.1016/S0092-8674(00)81845-0; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Zhang CT, 2000, NUCLEIC ACIDS RES, V28, P2804, DOI 10.1093/nar/28.14.2804; Zhang MQ, 2002, NAT REV GENET, V3, P698, DOI 10.1038/nrg890; Zhang ZL, 2002, GENOME RES, V12, P1466, DOI 10.1101/gr.331902	29	90	107	0	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 11	2003	300	5617					258	260		10.1126/science.1084354	http://dx.doi.org/10.1126/science.1084354			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665RQ	12690176				2022-12-24	WOS:000182135400032
J	Anselmi, M; Avanzini, F; Moreira, JM; Montalvo, G; Armani, D; Prandi, R; Marquez, M; Caicedo, C; Colombo, F; Tognoni, G				Anselmi, M; Avanzini, F; Moreira, JM; Montalvo, G; Armani, D; Prandi, R; Marquez, M; Caicedo, C; Colombo, F; Tognoni, G			Treatment and control of arterial hypertension in a rural community in Ecuador	LANCET			English	Article								Cardiovascular diseases are widespread in developing countries, but little is known about cardiovascular risk profiles in rural communities. To assess the importance of arterial hypertension in a rural district of Ecuador, we screened 4284 of the 8876 adults who lived in the area. 1542 (36%) individuals had hypertension, only four (0.3%) of whom were well controlled by treatment. We monitored all deaths for 2.5 years, and noted that cardiovascular diseases were the primary cause of death in the adult population. Furthermore, of the individuals who died of a cardiovascular disease, four out of five had a history of hypertension. Our findings indicate that in this rural area of Ecuador the high prevalence of uncontrolled hypertension is a major cause of total mortality.	Mario Negri Inst Pharmacol Res, I-20157 Milan, Italy; CECOMET, Esmeraldas, Ecuador; Minist Salud Publ, Borbon, Ecuador; Osped S Cuore, Ctr Malattie Trop, Verona, Italy	Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Avanzini, F (corresponding author), Mario Negri Inst Pharmacol Res, Via Eritrea 62, I-20157 Milan, Italy.	avanzini@marionegri.it		Avanzini, Fausto/0000-0002-4029-2891				CHANDRAMOHAN D, 1994, INT J EPIDEMIOL, V23, P213, DOI 10.1093/ije/23.2.213; Cooper R, 1997, AM J PUBLIC HEALTH, V87, P160, DOI 10.2105/AJPH.87.2.160; Ordunez P, 2001, Rev Panam Salud Publica, V10, P226, DOI 10.1590/S1020-49892001001000002; Reddy KS, 1998, CIRCULATION, V97, P596; [No title captured]	5	22	23	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 5	2003	361	9364					1186	1187		10.1016/S0140-6736(03)12918-2	http://dx.doi.org/10.1016/S0140-6736(03)12918-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	664ZF	12686043				2022-12-24	WOS:000182094600014
J	Juurlink, DN; Mamdani, M; Kopp, A; Laupacis, A; Redelmeier, DA				Juurlink, DN; Mamdani, M; Kopp, A; Laupacis, A; Redelmeier, DA			Drug-drug interactions among elderly patients hospitalized for drug toxicity	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	Annual North American Congress of Clinical Toxicology	SEP 24-29, 2002	PALM SPRINGS, CA				CONVERTING ENZYME-INHIBITORS; DIGOXIN TOXICITY; P-GLYCOPROTEIN; CISAPRIDE; CLARITHROMYCIN; HYPERKALEMIA; ASSOCIATION; EVENTS; CYP2C9; SULFAMETHOXAZOLE	Context Drug-drug interactions are a preventable cause of morbidity and mortality, yet their consequences in the community are not well characterized. Objective To determine whether elderly patients admitted to hospital with specific drug toxicities were likely to have been,prescribed an interacting drug in the week prior to admission. Design Three population-based, nested case-control studies. Setting Ontario, Canada, from January 1, 1994, to December 31, 2000. Patients All Ontario residents aged 66 years or older treated with glyburide, digoxin, or an angiotensin-converting enzyme (ACE) inhibitor. Case patients were those admitted to hospital for drug-related toxicity. Prescription records of cases were compared with those of controls (matched on age, sex, use of the same medication, and presence or absence of renal disease) for receipt of interacting medications (co-trimoxazole with glyburide, clarithromycin with digoxin, and potassium-sparing diuretics with ACE inhibitors). Main Outcome Measure Odds ratio for association between hospital admission for drug toxicity (hypoglycemia, digoxin toxicity, or hyperkalemia, respectively) and use of an interacting medication in the preceding-week, adjusted for diagnoses, receipt of other medications, the number of prescription drugs, and the number of hospital admissions in the year preceding the index date. Results During the 7-year study period, 909 elderly patients receiving glyburide were admitted with a diagnosis of hypoglycemia. In the primary analysis, those patients admitted for hypoglycemia were more than 6 times as likely to have been treated with co-trimoxazole in the previous week (adjusted odds ratio, 6.6; 95% confidence interval, 4.5-9.7). Patients admitted with digoxin toxicity (n=1051) were about 12 times more likely to have been treated with clarithromycin (adjusted odds ratio, 11.7; 95% confidence interval, 7.5-18.2) in the previous week, and patients treated with ACE inhibitors admitted with a diagnosis of hyperkalemia (n=523) were about 20 times more likely to have been treated with a potassium-sparing diuretic (adjusted odds ratio, 20.3; 95% confidence interval, 13.4-30.7) in the previous week. No increased risk of drug toxicity was found for drugs with similar indications but no known interactions (amoxicillin, cefuroxime, and indapamide, respectively). Conclusions Many hospital admissions of elderly patients for drug toxicity occur after administration of a drug known to cause drug-drug interactions. Many of these interactions could have been avoided.	Univ Toronto, Sunnybrook & Womens Coll Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada; Univ Toronto, Clin Epidemiol & Healthcare Res Program, Toronto, ON M4N 3M5, Canada; Univ Toronto, Dept Med, Toronto, ON M4N 3M5, Canada; Univ Toronto, Dept Pharm, Toronto, ON M4N 3M5, Canada; Inst Clin Evaluat Sci, Toronto, ON, Canada	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University of Toronto; University of Toronto; University of Toronto	Juurlink, DN (corresponding author), Univ Toronto, Sunnybrook & Womens Coll Hlth Sci Ctr, G Wing 106,2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.	david.juurlink@ices.on.ca						Ahuja TS, 2000, AM J NEPHROL, V20, P268, DOI 10.1159/000013599; Alvarez-Requejo A, 1998, EUR J CLIN PHARMACOL, V54, P483, DOI 10.1007/s002280050498; Atkin PA, 1999, DRUG AGING, V14, P141, DOI 10.2165/00002512-199914020-00005; BATES DW, 1995, JAMA-J AM MED ASSOC, V274, P29, DOI 10.1001/jama.274.1.29; Bell CM, 2001, NEW ENGL J MED, V345, P663, DOI 10.1056/NEJMsa003376; BRIAN WR, 2000, METABOLIC DRUG INTER, P529; Brown BA, 1997, CLIN INFECT DIS, V24, P92, DOI 10.1093/clinids/24.1.92; Cavuto NJ, 1996, JAMA-J AM MED ASSOC, V275, P1086, DOI 10.1001/jama.275.14.1086; CHRISTENSEN LK, 1969, ACTA DIABETOLOGICA S, V1, P116; Crighton EJ, 2001, BMC HEALTH SERV RES, V1, DOI 10.1186/1472-6963-1-7; Del Fiol G, 2000, J AM MED INFORM ASSN, P171; DUSSUSKE LM, 1999, CLIN THER, V21, P281; Efron Bradley., 1994, INTRO BOOTSTRAP; EINARSON TR, 1993, ANN PHARMACOTHER, V27, P832, DOI 10.1177/106002809302700702; Glassman PA, 2002, MED CARE, V40, P1161, DOI 10.1097/00005650-200212000-00004; Gooderham MJ, 1999, ANN PHARMACOTHER, V33, P796, DOI 10.1345/aph.18330; Guerriero SE, 1997, PHARMACOTHERAPY, V17, P1035; Guzey C, 2002, DRUG SAFETY, V25, P553; Halkin H, 2001, CLIN PHARMACOL THER, V69, P260, DOI 10.1067/mcp.2001.114228; Hansten P D, 2001, J Am Pharm Assoc (Wash), V41, P161; Hazlet T K, 2001, J Am Pharm Assoc (Wash), V41, P200; Heeley E, 2001, LANCET, V358, P1872, DOI 10.1016/S0140-6736(01)06898-2; Jha AK, 2001, PHARMACOEPIDEM DR S, V10, P113, DOI 10.1002/pds.568; JOHNSON JF, 1990, DICP ANN PHARMAC, V24, P250, DOI 10.1177/106002809002400307; Jones JK, 2001, JAMA-J AM MED ASSOC, V286, P1607, DOI 10.1001/jama.286.13.1607; KIFOR I, 1991, ENDOCRINOLOGY, V129, P823, DOI 10.1210/endo-129-2-823; Kirchheiner J, 2002, CLIN PHARMACOL THER, V71, P286, DOI 10.1067/mcp.2002.122476; KLEINBAUM DG, 1982, EPIDEMIOLOGIC RES; Koren G, 1998, VET HUM TOXICOL, V40, P45; Langdorf MI, 2000, ACAD EMERG MED, V7, P1321, DOI 10.1111/j.1553-2712.2000.tb00483.x; Lazarou J, 1998, JAMA-J AM MED ASSOC, V279, P1200, DOI 10.1001/jama.279.15.1200; LEAPE LL, 1991, NEW ENGL J MED, V324, P377, DOI 10.1056/NEJM199102073240605; Lehmann DF, 2000, J CLIN PHARMACOL, V40, P939, DOI 10.1177/00912700022009675; Mamdani MM, 2000, CAN MED ASSOC J, V162, P1421; Mamdani MM, 2000, AM J MED, V108, P418, DOI 10.1016/S0002-9343(99)00452-0; Michalets EL, 2000, CLIN PHARMACOKINET, V39, P49, DOI 10.2165/00003088-200039010-00004; MIETTINE.OS, 1974, AM J EPIDEMIOL, V99, P325, DOI 10.1093/oxfordjournals.aje.a121617; MONAHAN BP, 1990, JAMA-J AM MED ASSOC, V264, P2788, DOI 10.1001/jama.264.21.2788; Moride Y, 1997, BRIT J CLIN PHARMACO, V43, P177, DOI 10.1046/j.1365-2125.1997.05417.x; Niemi M, 2002, CLIN PHARMACOL THER, V72, P326, DOI 10.1067/mcp.2002.127495; Peterson J F, 2001, J Am Pharm Assoc (Wash), V41, P159; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Potasman I, 1980, Harefuah, V98, P78; *PRACT MAN INF COR, 2003, INT CLASS DIS; Ray JG, 2001, ARCH INTERN MED, V161, P1405, DOI 10.1001/archinte.161.11.1405; Reardon LC, 1998, ARCH INTERN MED, V158, P26, DOI 10.1001/archinte.158.1.26; Roberts RL, 2002, NEW ZEAL MED J, V115, P137; Rockhill B, 1998, AM J PUBLIC HEALTH, V88, P15, DOI 10.2105/AJPH.88.1.15; Roden DM, 2002, NAT REV DRUG DISCOV, V1, P37, DOI 10.1038/nrd705; Rosholm JU, 1998, DAN MED BULL, V45, P210; Schepkens H, 2001, AM J MED, V110, P438, DOI 10.1016/S0002-9343(01)00642-8; Schlesselman JJ, 1982, CASE CONTROL STUDIES; Schneeweiss S, 2001, AM J EPIDEMIOL, V154, P854, DOI 10.1093/aje/154.9.854; Seymour RM, 1998, DRUG AGING, V12, P485, DOI 10.2165/00002512-199812060-00006; Shaoul R, 2002, PEDIATRICS, V109, P1118, DOI 10.1542/peds.109.6.1118; Shapiro LE, 1999, CAN MED ASSOC J, V161, P1266; Statistics Canada, 2010, POP AG GROUP; Tamblyn RM, 1996, CAN MED ASSOC J, V154, P1177; Wakasugi H, 1998, CLIN PHARMACOL THER, V64, P123, DOI 10.1016/S0009-9236(98)90030-3; Weideman RA, 1999, AM J HEALTH-SYST PH, V56, P1524, DOI 10.1093/ajhp/56.15.1524; Wen X, 2002, DRUG METAB DISPOS, V30, P631, DOI 10.1124/dmd.30.6.631; Wynn Richard L., 1993, General Dentistry, V41, P27; Wysowski DK, 1996, NEW ENGL J MED, V335, P290, DOI 10.1056/NEJM199607253350416; Wysowski DK, 2001, AM J GASTROENTEROL, V96, P1698, DOI 10.1016/S0002-9270(01)02490-X; ZECHNICH AD, 1994, WESTERN J MED, V160, P321	65	493	512	1	32	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 2	2003	289	13					1652	1658		10.1001/jama.289.13.1652	http://dx.doi.org/10.1001/jama.289.13.1652			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	662JX	12672733	Green Published			2022-12-24	WOS:000181944500028
J	Nash, D; Magder, L; Lustberg, M; Sherwin, RW; Rubin, RJ; Kaufmann, RB; Silbergeld, EK				Nash, D; Magder, L; Lustberg, M; Sherwin, RW; Rubin, RJ; Kaufmann, RB; Silbergeld, EK			Blood lead, blood pressure, and hypertension in perimenopausal and postmenopausal women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NUTRITION EXAMINATION SURVEY; BONE-MINERAL CONTENT; 3RD NATIONAL-HEALTH; MIDDLE-AGED WOMEN; CARDIOVASCULAR-DISEASE; UNITED-STATES; POPULATION; EXPOSURE; RISK; OSTEOPOROSIS	Context Lead exposures have been shown to be associated with increased blood pressure and risk of hypertension in older men. In perimenopausal women, skeletal lead stores are an important source of endogenous lead exposure due to increased bone demineralization. Objective To examine the relationship of blood lead level with blood pressure and hypertension prevalence in a population-based sample of perimenopausal and postmenopausal women in the United States. Design, Setting, and Participants Cross-sectional sample of 2165 women aged 40 to 59 years, who participated in a household interview and physical examination, from the Third National Health and Nutrition Examination Survey conducted from 1988 to 1994. Main Outcome Measures Associations of blood lead with blood pressure and hypertension, with age, race and ethnicity, cigarette smoking status, body mass index, alcohol use, and kidney function as covariates. Results A change in blood lead levels from the lowest (quartile 1: range, 0.5-1.6 mug/dL) to the highest (quartile 4: range, 4.0-31.1 mug/dL) was associated with small statistically significant adjusted changes in systolic and diastolic blood pressures. Women in quartile 4 had increased risks of diastolic (>90 mm Hg) hypertension (adjusted odds ratio [OR], 3.4; 95% confidence interval [CI], 1.3-8.7), as well as moderately increased risks for general hypertension (adjusted OR, 1.4; 95% CI, 0.92-2.0) and systolic (>140 mm Hg) hypertension (adjusted OR, 1.5; 95% CI, 0.72-3.2). This association was strongest in postmenopausal women in whom adjusted ORs for diastolic hypertension increased with increasing quartile of blood lead level compared with quartile 1 (adjusted OR, 4.6; 95% CI, 1.1-19.2 for quartile 2; adjusted OR, 5.9; 95% CI, 1.5-23.1 for quartile 3; adjusted OR, 8.1; 95% CI, 2.6-24.7 for quartile 4). Conclusions At levels well below the current US occupational exposure limit guidelines (40 mug/dL); blood lead level is positively associated with both systolic and diastolic blood pressure and risks of both systolic and diastolic hypertension among women aged 40 to 59 years. The relationship between blood lead level and systolic and diastolic hypertension is most pronounced in postmenopausal women. These results provide support for continued efforts to reduce lead levels in the general population, especially women.	New York City Dept Hlth & Mental Hyg, HIV AIDS Surveillance & Epidemiol Program, New York, NY 10013 USA; Univ Maryland, Sch Med, Dept Epidemiol & Prevent Med, Baltimore, MD 21201 USA; Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA USA; Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD USA; Ctr Dis Control & Prevent, Natl Ctr Environm Hlth, Atlanta, GA USA	New York City Department of Health & Mental Hygiene; University System of Maryland; University of Maryland Baltimore; Tulane University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Centers for Disease Control & Prevention - USA	Nash, D (corresponding author), New York City Dept Hlth & Mental Hyg, HIV AIDS Surveillance & Epidemiol Program, 346 Broadway,Room 706, New York, NY 10013 USA.		Nash, Denis/AFI-7485-2022; Lustberg, Mark/AAO-9924-2020	Nash, Denis/0000-0002-3280-5386	ATSDR CDC HHS [TS-288-14/14] Funding Source: Medline	ATSDR CDC HHS		BATUMAN V, 1983, NEW ENGL J MED, V309, P17, DOI 10.1056/NEJM198307073090104; BRODY DJ, 1994, JAMA-J AM MED ASSOC, V272, P277, DOI 10.1001/jama.272.4.277; BURT VL, 1995, HYPERTENSION, V25, P305, DOI 10.1161/01.HYP.25.3.305; Cake KM, 1996, AM J IND MED, V29, P440, DOI 10.1002/(SICI)1097-0274(199605)29:5<440::AID-AJIM2>3.0.CO;2-Q; Cowley AW, 1996, JAMA-J AM MED ASSOC, V275, P1581, DOI 10.1001/jama.275.20.1581; ELWOOD PC, 1988, ENVIRON HEALTH PERSP, V78, P119, DOI 10.2307/3430511; ELWOOD PC, 1988, AM J EPIDEMIOL, V127, P942, DOI 10.1093/oxfordjournals.aje.a114897; EZZATI T, 1992, PUBLICATION PHS; GRANDJEAN P, 1992, SCAND J CLIN LAB INV, V52, P321, DOI 10.3109/00365519209088366; GRANDJEAN P, 1989, AM J EPIDEMIOL, V129, P732, DOI 10.1093/oxfordjournals.aje.a115188; GULSON BL, 1995, J LAB CLIN MED, V125, P703; Gulson BL, 1997, J LAB CLIN MED, V130, P51, DOI 10.1016/S0022-2143(97)90058-5; HARLAN WR, 1985, JAMA-J AM MED ASSOC, V253, P530, DOI 10.1001/jama.253.4.530; HARLAN WR, 1988, ENVIRON HEALTH PERSP, V78, P9; HEANEY RP, 1978, J LAB CLIN MED, V92, P964; HENSE HW, 1993, EPIDEMIOLOGY, V4, P173, DOI 10.1097/00001648-199303000-00014; HENSE HW, 1994, EPIDEMIOLOGY, V5, P120, DOI 10.1097/00001648-199401000-00018; HERTZPICCIOTTO I, 1993, EPIDEMIOL REV, V15, P352, DOI 10.1093/oxfordjournals.epirev.a036125; Hu FB, 2002, AM J CARDIOL, V90, p26F, DOI 10.1016/S0002-9149(01)02219-6; Hu H, 1998, ENVIRON HEALTH PERSP, V106, P1, DOI 10.2307/3433626; Hu H, 1996, JAMA-J AM MED ASSOC, V275, P1171, DOI 10.1001/jama.275.15.1171; Kim R, 1996, JAMA-J AM MED ASSOC, V275, P1177, DOI 10.1001/jama.275.15.1177; KNIGHT EM, 1994, J NUTR, V124, pS943, DOI 10.1093/jn/124.suppl_6.943S; KOPP SJ, 1988, ENVIRON HEALTH PERSP, V78, P91, DOI 10.2307/3430507; Korrick SA, 1999, AM J PUBLIC HEALTH, V89, P330, DOI 10.2105/AJPH.89.3.330; KROLNER B, 1982, CLIN SCI, V62, P329, DOI 10.1042/cs0620329; LAGERKVIST BJ, 1993, SCAND J WORK ENV HEA, V19, P50; LINDQUIST O, 1981, SCAND J CLIN LAB INV, V41, P215, DOI 10.3109/00365518109092037; LINDSAY R, 1976, LANCET, V1, P1038; Lustberg M, 2002, ARCH INTERN MED, V162, P2443, DOI 10.1001/archinte.162.21.2443; MOLLER L, 1992, AM J EPIDEMIOL, V136, P1091, DOI 10.1093/oxfordjournals.aje.a116574; MULDOON SB, 1994, AM J EPIDEMIOL, V139, P599, DOI 10.1093/oxfordjournals.aje.a117049; MULDOON SB, 1997, SOC EP RES JUN CALG; Nash D, 1998, AM J EPIDEMIOL, V147, pS93; NERI LC, 1988, ENVIRON HEALTH PERSP, V78, P123, DOI 10.2307/3430512; NORDIN BEC, 1983, OSTEOPOROTIC SYNDROM; NOWACK R, 1993, EUR J CLIN INVEST, V23, P433, DOI 10.1111/j.1365-2362.1993.tb00787.x; PIRKLE JL, 1994, JAMA-J AM MED ASSOC, V272, P284, DOI 10.1001/jama.272.4.284; PIRKLE JL, 1985, AM J EPIDEMIOL, V121, P246, DOI 10.1093/oxfordjournals.aje.a113995; POCOCK SJ, 1988, ENVIRON HEALTH PERSP, V78, P23, DOI 10.2307/3430494; Proctor SP, 1996, INT J EPIDEMIOL, V25, P528, DOI 10.1093/ije/25.3.528; Reckelhoff JF, 2001, HYPERTENSION, V37, P1199, DOI 10.1161/01.HYP.37.5.1199; RIGGS BL, 1986, NEW ENGL J MED, V314, P1676, DOI 10.1056/NEJM198606263142605; SCHWARTZ J, 1995, ARCH ENVIRON HEALTH, V50, P31, DOI 10.1080/00039896.1995.9955010; SCHWARTZ J, 1991, ENVIRON HEALTH PERSP, V91, P71, DOI 10.2307/3430985; SCHWARTZ J, 1988, ENVIRON HEALTH PERSP, V78, P15, DOI 10.2307/3430493; SHARP DS, 1987, MED TOXICOL ADV DRUG, V2, P210, DOI 10.1007/BF03259865; SHARP DS, 1990, AM J EPIDEMIOL, V131, P845, DOI 10.1093/oxfordjournals.aje.a115575; SHARP DS, 1989, ARCH ENVIRON HEALTH, V44, P18, DOI 10.1080/00039896.1989.9935867; SHARP DS, 1988, ENVIRON HEALTH PERSP, V78, P131, DOI 10.2307/3430514; Silbergeld E., 1995, FUNDAM APPL TOXICOL, V25, P167; SILBERGELD E, 2001, PROGR ENV SCI, V1, P53; SILBERGELD EK, 1988, ENVIRON RES, V47, P79, DOI 10.1016/S0013-9351(88)80023-9; Smith DR, 1996, ENVIRON HEALTH PERSP, V104, P60, DOI 10.2307/3432761; STAESSEN J, 1991, J HUM HYPERTENS, V5, P485; Staessen J, 1995, Verh K Acad Geneeskd Belg, V57, P527; Staessen JA, 1998, J HUM HYPERTENS, V12, P587, DOI 10.1038/sj.jhh.1000670; Staessen JA, 1996, JAMA-J AM MED ASSOC, V275, P1563, DOI 10.1001/jama.275.20.1563; SYMANSKI E, 1995, AM J EPIDEMIOL, V141, P1047, DOI 10.1093/oxfordjournals.aje.a117369; VANDER AJ, 1988, ENVIRON HEALTH PERSP, V78, P77, DOI 10.2307/3430505; Webber CE, 1995, ENVIRON HEALTH PERSP, V103, P1150, DOI 10.2307/3432612; West WL, 1994, J NUTR, V124, P981	62	180	182	0	7	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 26	2003	289	12					1523	1532		10.1001/jama.289.12.1523	http://dx.doi.org/10.1001/jama.289.12.1523			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	659XE	12672769	Bronze			2022-12-24	WOS:000181803100030
J	Larson, DR; Zipfel, WR; Williams, RM; Clark, SW; Bruchez, MP; Wise, FW; Webb, WW				Larson, DR; Zipfel, WR; Williams, RM; Clark, SW; Bruchez, MP; Wise, FW; Webb, WW			Water-soluble quantum dots for multiphoton fluorescence imaging in vivo	SCIENCE			English	Article							CORRELATION SPECTROSCOPY; MICROSCOPY; NANOCRYSTALS; EXCITATION; INTERMITTENCY	The use of semiconductor nanocrystals (quantum dots) as fluorescent labels for multiphoton microscopy enables multicolor imaging in demanding biological environments such as living tissue. We characterized water-soluble cadmium selenide-zinc sulfide quantum dots for multiphoton imaging in live animals. These fluorescent probes have two-photon action cross sections as high as 47,000 Goeppert-Mayer units, by far the largest of any label used in multiphoton microscopy. We visualized quantum dots dynamically through the skin of living mice, in capillaries hundreds of micrometers deep. We found no evidence of blinking (fluorescence intermittency) in solution on nanosecond to millisecond time scales.	Cornell Univ, Sch Appl & Engn Phys, Ithaca, NY 14853 USA; Quantum Dot Corp, Hayward, CA 94545 USA	Cornell University	Webb, WW (corresponding author), Cornell Univ, Sch Appl & Engn Phys, Ithaca, NY 14853 USA.		Larson, Daniel R/B-9829-2008; Webb, Watt W./B-5905-2011; Bruchez, Marcel P/C-2271-2009	Larson, Daniel R/0000-0001-9253-3055; Bruchez, Marcel P/0000-0002-7370-4848; Williams, Rebecca/0000-0002-1391-5846	NCI NIH HHS [R44CA8839102] Funding Source: Medline; NCRR NIH HHS [RR10675, NCRR P41-RR04224] Funding Source: Medline; PHS HHS [R33-645644] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R44CA088391] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR004224] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Albota M, 1998, SCIENCE, V281, P1653, DOI 10.1126/science.281.5383.1653; BLANTON SA, 1994, CHEM PHYS LETT, V229, P317, DOI 10.1016/0009-2614(94)01057-9; Bruchez M, 1998, SCIENCE, V281, P2013, DOI 10.1126/science.281.5385.2013; CHAN W, 2002, CURR OPIN BIOTECH, V13, P140; Chan WCW, 1998, SCIENCE, V281, P2016, DOI 10.1126/science.281.5385.2016; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Dubertret B, 2002, SCIENCE, V298, P1759, DOI 10.1126/science.1077194; Ebenstein Y, 2002, APPL PHYS LETT, V80, P4033, DOI 10.1063/1.1482785; Gerion D, 2001, J PHYS CHEM B, V105, P8861, DOI 10.1021/jp0105488; Kuno M, 2000, J CHEM PHYS, V112, P3117, DOI 10.1063/1.480896; Lounis B, 2000, CHEM PHYS LETT, V329, P399, DOI 10.1016/S0009-2614(00)01042-3; MAGDE D, 1972, PHYS REV LETT, V29, P705, DOI 10.1103/PhysRevLett.29.705; Mattoussi H, 2000, J AM CHEM SOC, V122, P12142, DOI 10.1021/ja002535y; Neuhauser RG, 2000, PHYS REV LETT, V85, P3301, DOI 10.1103/PhysRevLett.85.3301; Nirmal M, 1996, NATURE, V383, P802, DOI 10.1038/383802a0; WIDENGREN J, 1995, J PHYS CHEM-US, V99, P13368, DOI 10.1021/j100036a009; Williams RM, 2001, CURR OPIN CHEM BIOL, V5, P603, DOI 10.1016/S1367-5931(00)00241-6; Wu XY, 2003, NAT BIOTECHNOL, V21, P41, DOI 10.1038/nbt764; Xu C, 1996, P NATL ACAD SCI USA, V93, P10763, DOI 10.1073/pnas.93.20.10763; Yoder EJ, 2002, MICROSC RES TECHNIQ, V56, P304, DOI 10.1002/jemt.10002	20	2003	2124	14	900	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 30	2003	300	5624					1434	1436		10.1126/science.1083780	http://dx.doi.org/10.1126/science.1083780			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	683ZW	12775841				2022-12-24	WOS:000183181800046
J	Kalnay, E; Cai, M				Kalnay, E; Cai, M			Impact of urbanization and land-use change on climate	NATURE			English	Article							TEMPERATURE TRENDS; HEAT-ISLAND	The most important anthropogenic influences on climate are the emission of greenhouse gases(1) and changes in land use, such as urbanization and agriculture(2). But it has been difficult to separate these two influences because both tend to increase the daily mean surface temperature(3,4). The impact of urbanization has been estimated by comparing observations in cities with those in surrounding rural areas, but the results differ significantly depending on whether population data(5) or satellite measurements of night light(6-8) are used to classify urban and rural areas(7,8). Here we use the difference between trends in observed surface temperatures in the continental United States and the corresponding trends in a reconstruction of surface temperatures determined from a reanalysis of global weather over the past 50 years, which is insensitive to surface observations, to estimate the impact of land-use changes on surface warming. Our results suggest that half of the observed decrease in diurnal temperature range is due to urban and other land-use changes. Moreover, our estimate of 0.27degreesC mean surface warming per century due to land-use changes is at least twice as high as previous estimates based on urbanization alone(7,8).	Univ Maryland, College Pk, MD 20770 USA	University System of Maryland; University of Maryland College Park	Kalnay, E (corresponding author), Univ Maryland, College Pk, MD 20770 USA.	ekalnay@atmos.umd.edu	Kalnay, Eugenia/F-4393-2010	Kalnay, Eugenia/0000-0002-9984-9906				Easterling DR, 1997, SCIENCE, V277, P364, DOI 10.1126/science.277.5324.364; Gallezot P, 1996, APPL CATAL B-ENVIRON, V9, pL11; Gallo KP, 1999, J CLIMATE, V12, P1344, DOI 10.1175/1520-0442(1999)012<1344:TTOTUS>2.0.CO;2; Gallo KP, 1999, J APPL METEOROL, V38, P806, DOI 10.1175/1520-0450(1993)032<0899:TUONAD>2.0.CO;2; Hansen J, 2001, J GEOPHYS RES-ATMOS, V106, P23947, DOI 10.1029/2001JD000354; IPCC, 2001, ADV CLIM CHANG RES; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Kistler R, 2001, B AM METEOROL SOC, V82, P247, DOI 10.1175/1520-0477(2001)082<0247:TNNYRM>2.3.CO;2; NRC, 2000, REV US NAV EXP STAND, P1; Owen TW, 1998, INT J REMOTE SENS, V19, P3451, DOI 10.1080/014311698214127; Pielke RA, 2002, PHILOS T ROY SOC A, V360, P1705, DOI 10.1098/rsta.2002.1027; Runnalls KE, 2000, PHYS GEOGR, V21, P283, DOI 10.1080/02723646.2000.10642711; Travis DJ, 2002, NATURE, V418, P601, DOI 10.1038/418601a	13	1497	1703	70	1344	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 29	2003	423	6939					528	531		10.1038/nature01675	http://dx.doi.org/10.1038/nature01675			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	683RH	12774119	Bronze			2022-12-24	WOS:000183162900040
J	Wang, ZL; Benoit, G; Liu, JS; Prasad, S; Aarnisalo, P; Liu, XH; Xu, HD; Walker, NPC; Perlmann, T				Wang, ZL; Benoit, G; Liu, JS; Prasad, S; Aarnisalo, P; Liu, XH; Xu, HD; Walker, NPC; Perlmann, T			Structure and function of Nurr1 identifies a class of ligand-independent nuclear receptors	NATURE			English	Article							BINDING DOMAIN; TRANSCRIPTION FACTOR; CRYSTAL-STRUCTURE; SUPERFAMILY; ACTIVATION; EVOLUTION	Members of the nuclear receptor (NR) superfamily of transcription factors modulate gene transcription in response to small lipophilic molecules(1). Transcriptional activity is regulated by ligands binding to the carboxy-terminal ligand-binding domains (LBDs) of cognate NRs. A subgroup of NRs referred to as 'orphan receptors' lack identified ligands, however, raising issues about the function of their LBDs(2). Here we report the crystal structure of the LBD of the orphan receptor Nurr1 at 2.2 Angstrom resolution. The Nurr1 LBD adopts a canonical protein fold resembling that of agonist-bound, transcriptionally active LBDs in NRs(3), but the structure has two distinctive features. First, the Nurr1 LBD contains no cavity as a result of the tight packing of side chains from several bulky hydrophobic residues in the region normally occupied by ligands. Second, Nurr1 lacks a 'classical' binding site for coactivators. Despite these differences, the Nurr1 LBD can be regulated in mammalian cells. Notably, transcriptional activity is correlated with the Nurr1 LBD adopting a more stable conformation. Our findings highlight a unique structural class of NRs and define a model for ligand-independent NR function.	Tularik Inc, Dept Biol Struct, San Francisco, CA 94080 USA; Karolinska Inst, Dept Cell Biol, Ludwig Inst Canc Res, S-17177 Stockholm, Sweden; Karolinska Inst, Dept Mol Biol, Ludwig Inst Canc Res, S-17177 Stockholm, Sweden	Karolinska Institutet; Ludwig Institute for Cancer Research; Karolinska Institutet; Ludwig Institute for Cancer Research	Walker, NPC (corresponding author), Tularik Inc, Dept Biol Struct, 1120 Vet Blvd, San Francisco, CA 94080 USA.	walker@tularik.com; thomas.perlmann@licr.ki.se		BENOIT, Gerard/0000-0001-9462-6570				Aarnisalo P, 2002, J BIOL CHEM, V277, P35118, DOI 10.1074/jbc.M201707200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645; Castro DS, 1999, J BIOL CHEM, V274, P37483, DOI 10.1074/jbc.274.52.37483; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; Darimont BD, 1998, GENE DEV, V12, P3343, DOI 10.1101/gad.12.21.3343; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; DESCOTEAUX A, 1993, METHODS MOL GENETICS, V1, P22; Dhe-Paganon S, 2002, J BIOL CHEM, V277, P37973, DOI 10.1074/jbc.C200420200; Escriva H, 1997, P NATL ACAD SCI USA, V94, P6803, DOI 10.1073/pnas.94.13.6803; Giguere V, 1999, ENDOCR REV, V20, P689, DOI 10.1210/er.20.5.689; Greschik H, 2002, MOL CELL, V9, P303, DOI 10.1016/S1097-2765(02)00444-6; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kliewer SA, 1999, SCIENCE, V284, P757, DOI 10.1126/science.284.5415.757; Laudet V, 1997, J MOL ENDOCRINOL, V19, P207, DOI 10.1677/jme.0.0190207; LAW SW, 1992, MOL ENDOCRINOL, V6, P2129, DOI 10.1210/me.6.12.2129; Le WD, 2003, NAT GENET, V33, P85, DOI 10.1038/ng1066; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Maruyama K, 1998, INT J ONCOL, V12, P1237; Moras D, 1998, CURR OPIN CELL BIOL, V10, P384, DOI 10.1016/S0955-0674(98)80015-X; Nolte RT, 1998, NATURE, V395, P137, DOI 10.1038/25931; Pissios P, 2000, MOL CELL, V6, P245, DOI 10.1016/S1097-2765(00)00026-5; RENAUD JP, 1995, NATURE, V378, P681, DOI 10.1038/378681a0; Renaud JP, 2000, MOL ENDOCRINOL, V14, P700, DOI 10.1210/me.14.5.700; Saucedo-Cardenas O, 1998, P NATL ACAD SCI USA, V95, P4013, DOI 10.1073/pnas.95.7.4013; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Wisely GB, 2002, STRUCTURE, V10, P1225, DOI 10.1016/S0969-2126(02)00829-8; Wurtz JM, 1996, NAT STRUCT BIOL, V3, P87, DOI 10.1038/nsb0196-87; Zetterstrom RH, 1997, SCIENCE, V276, P248, DOI 10.1126/science.276.5310.248	30	442	465	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 29	2003	423	6939					555	560		10.1038/nature01645	http://dx.doi.org/10.1038/nature01645			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	683RH	12774125				2022-12-24	WOS:000183162900047
J	Liu, JG; Ouyang, ZY; Pimm, SL; Raven, PH; Wang, XK; Miao, H; Han, NY				Liu, JG; Ouyang, ZY; Pimm, SL; Raven, PH; Wang, XK; Miao, H; Han, NY			Protecting China's biodiversity	SCIENCE			English	Editorial Material							GIANT		Michigan State Univ, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA; Chinese Acad Sci, Ecoenvironm Sci Res Ctr, Key Lab Syst Ecol, Beijing, Peoples R China; Duke Univ, Nicholas Sch Environm & Earth Sci, Durham, NC USA; Missouri Bot Garden, St Louis, MO 63166 USA; Chinas Natl Comm Man & Biosphere, Beijing, Peoples R China	Michigan State University; Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES); Duke University; Missouri Botanical Gardens	Liu, JG (corresponding author), Michigan State Univ, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA.	jliu@panda.msu.edu	Liu, Jianguo/G-5211-2015; pimm, stuart/ABF-1082-2020	Liu, Jianguo/0000-0001-6344-0087; 	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD039789] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD39789] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		An L, 2001, ECOL MODEL, V140, P31, DOI 10.1016/S0304-3800(01)00267-8; [Anonymous], 2002, PEOPLES REPUBLIC CHI; Axelrod A.I., 1998, FLORISTIC CHARACTERI, P43; China's National Committee on Man and Biosphere, 2000, STUD SUST MAN POL CH; *COMP GROUP, 1998, CHIN BIOD COUNT STUD; Dale VH, 2002, CAM STU LAN, P265, DOI 10.1017/CBO9780511613654.015; Ferraro PJ, 2002, SCIENCE, V298, P1718, DOI 10.1126/science.1078104; HAN N, 2000, STUDY SUSTAINABLE MA, P1; LI W, 2000, STUD SUST MAN POL CH, P92; Liu JG, 2001, SCIENCE, V293, P603; Liu JG, 1999, POPUL ENVIRON, V21, P45, DOI 10.1023/A:1022101026466; Liu JG, 1999, CONSERV BIOL, V13, P1360, DOI 10.1046/j.1523-1739.1999.98418.x; Miao H, 2000, STUDY SUSTAINABLE MA, P57; RAVEN PH, 1994, P INT WORKSH SCI FRO, P137; WANG X, 2000, STUDY SUSTAINABLE MA, P81; *WORLD BANK, 2001, WORLD DEV IND 2001; XU H, 2000, STUDY SUSTAINABLE MA, P72; 1994, ACTION PLAN BIODIVER	18	198	235	10	170	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 23	2003	300	5623					1240	1241		10.1126/science.1078868	http://dx.doi.org/10.1126/science.1078868			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681NN	12764180				2022-12-24	WOS:000183042400029
J	Jumaa, H; Bossaller, L; Portugal, K; Storch, B; Lotz, M; Flemming, A; Schrappe, M; Postila, V; Riikonen, P; Pelkonen, J; Niemeyer, CM; Reth, M				Jumaa, H; Bossaller, L; Portugal, K; Storch, B; Lotz, M; Flemming, A; Schrappe, M; Postila, V; Riikonen, P; Pelkonen, J; Niemeyer, CM; Reth, M			Deficiency of the adaptor SLP-65 in pre-B-cell acute lymphoblastic leukaemia	NATURE			English	Article							DROSOPHILA-TRITHORAX; ANTIGEN RECEPTOR; ACUTE LEUKEMIAS; LINKER PROTEIN; EXPRESSION; CHILDHOOD; TRANSLOCATIONS; ACTIVATION; GENE; MICE	Acute lymphoblastic leukaemia (ALL) is the commonest form of childhood malignancy, and most cases arise from B-cell clones arrested at the pre-B-cell stage of differentiation(1,2). The molecular events that arrest pre-B-cell differentiation in the leukaemic pre-B cells have not been well characterized. Here we show that the differentiation regulator SLP-65 (an adaptor protein also called BLNK or BASH(3-6)) inhibits pre-B-cell leukaemia in mice. Reconstitution of SLP-65 expression in a SLP-65(-/-) pre-B-cell line led to enhanced differentiation in vitro and prevented the development of pre-B-cell leukaemia in immune-deficient mice. Tyrosine 96 of SLP-65 was required for this activity. The murine SLP-65(-/-) pre-B-cell leukaemia resembles human childhood pre-B ALL. Indeed, 16 of the 34 childhood pre-B ALL samples that were tested showed a complete loss or drastic reduction of SLP-65 expression. This loss is probably due to the incorporation of alternative exons into SLP-65 transcripts, leading to premature stop codons. Thus, the somatic loss of SLP-65 and the accompanying block in pre-B-cell differentiation might be one of the primary causes of childhood pre-B ALL.	Univ Freiburg, D-79108 Freiburg, Germany; Max Planck Inst Immunobiol, D-79108 Freiburg, Germany; Med Sch Hanover, Childrens Hosp, D-30625 Hannover, Germany; Univ Kuopio, Dept Clin Microbiol, FIN-70211 Kuopio, Finland; Kuopio Univ Hosp, Dept Clin Microbiol, FIN-70211 Kuopio, Finland; Kuopio Univ Hosp, Dept Pediat, FIN-70211 Kuopio, Finland; Freiburg Univ Hosp, Dept Pediat & Adolescent Med, Div Pediat Hematol & Oncol, D-79106 Freiburg, Germany	University of Freiburg; Max Planck Society; University of Eastern Finland; Kuopio University Hospital; Kuopio University Hospital; University of Freiburg	Reth, M (corresponding author), Univ Freiburg, D-79108 Freiburg, Germany.		Schrappe, Martin/A-8109-2010; Schrappe, Martin/ABA-6144-2020	Bossaller, Lukas/0000-0003-0789-4062				Advani AS, 2002, LEUKEMIA RES, V26, P713, DOI 10.1016/S0145-2126(01)00197-7; Armstrong SA, 2002, NAT GENET, V30, P41, DOI 10.1038/ng765; BEISHUIZEN A, 1991, LEUKEMIA, V5, P657; Chiu CW, 2002, EMBO J, V21, P6461, DOI 10.1093/emboj/cdf658; DISANTO JP, 1995, P NATL ACAD SCI USA, V92, P377, DOI 10.1073/pnas.92.2.377; DOMER PH, 1993, P NATL ACAD SCI USA, V90, P7884, DOI 10.1073/pnas.90.16.7884; EDERY I, 1983, J BIOL CHEM, V258, P1398; Flemming A, 2003, NAT IMMUNOL, V4, P38, DOI 10.1038/ni862; Fu C, 1998, IMMUNITY, V9, P93, DOI 10.1016/S1074-7613(00)80591-9; Goitsuka R, 1998, J IMMUNOL, V161, P5804; Goodman PA, 2001, ONCOGENE, V20, P3969, DOI 10.1038/sj.onc.1204515; GU Y, 1992, CELL, V71, P701, DOI 10.1016/0092-8674(92)90603-A; Hayashi K, 2000, P NATL ACAD SCI USA, V97, P2755, DOI 10.1073/pnas.040575697; Hilleren P, 1999, ANNU REV GENET, V33, P229, DOI 10.1146/annurev.genet.33.1.229; Jennings CD, 1997, BLOOD, V90, P2863, DOI 10.1182/blood.V90.8.2863; Jumaa H, 1999, IMMUNITY, V11, P547, DOI 10.1016/S1074-7613(00)80130-2; Ma SK, 1999, HEMATOL ONCOL, V17, P91, DOI 10.1002/(SICI)1099-1069(199909)17:3<91::AID-HON643>3.0.CO;2-Y; Minegishi Y, 1999, SCIENCE, V286, P1954, DOI 10.1126/science.286.5446.1954; Nishii K, 2000, INT J HEMATOL, V71, P372; NORDQVIST K, 1994, MOL CELL BIOL, V14, P437, DOI 10.1128/MCB.14.1.437; Pappu R, 1999, SCIENCE, V286, P1949, DOI 10.1126/science.286.5446.1949; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Schrappe M, 2000, LEUKEMIA, V14, P2205, DOI 10.1038/sj.leu.2401973; TKACHUK DC, 1992, CELL, V71, P691, DOI 10.1016/0092-8674(92)90602-9; UMIEL T, 1993, LEUKEMIA, V7, P435; Wienands J, 1998, J EXP MED, V188, P791, DOI 10.1084/jem.188.4.791; Xu SL, 2000, INT IMMUNOL, V12, P397, DOI 10.1093/intimm/12.3.397; Zhu CM, 2002, CELL, V109, P811, DOI 10.1016/S0092-8674(02)00770-5	28	109	111	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 22	2003	423	6938					452	456		10.1038/nature01608	http://dx.doi.org/10.1038/nature01608			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681AJ	12761551				2022-12-24	WOS:000183012000045
J	Griffith, CA; Owen, T; Geballe, TR; Rayner, J; Rannou, P				Griffith, CA; Owen, T; Geballe, TR; Rayner, J; Rannou, P			Evidence for the exposure of water ice on Titan's surface	SCIENCE			English	Article							5 MU-M; CARBON-MONOXIDE; JOVIAN PLANETS; ATMOSPHERE; AEROSOLS; METHANE; CLOUDS; SPECTROPHOTOMETRY; SPECTRUM; IMAGES	The smoggy stratosphere of Saturn's largest moon, Titan, veils its surface from view, except at narrow wavelengths centered at 0.83, 0.94, 1.07, 1.28, 1.58, 2.0, 2.9, and 5.0 micrometers. We derived a spectrum of Titan's surface within these "windows" and detected features characteristic of water ice. Therefore, despite the hundreds of meters of organic liquids and solids hypothesized to exist on Titan's surface, its icy bedrock lies extensively exposed.	Univ Arizona, Dept Planetary Sci, Tucson, AZ 85721 USA; Univ Hawaii, Inst Astron, Honolulu, HI 96822 USA; Gemini Observ, Hilo, HI 96720 USA; Univ Paris 06, Paris, France	University of Arizona; University of Hawaii System; UDICE-French Research Universities; Sorbonne Universite	Griffith, CA (corresponding author), Univ Arizona, Dept Planetary Sci, 1629 E Univ Blvd, Tucson, AZ 85721 USA.		RANNOU, Pascal/I-9059-2012	RANNOU, pascal/0000-0003-0836-723X				Combes M, 1997, ICARUS, V129, P482, DOI 10.1006/icar.1997.5772; COUSTENIS A, 1995, ICARUS, V118, P87, DOI 10.1006/icar.1995.1179; CRUIKSHANK DP, 1991, ICARUS, V94, P345, DOI 10.1016/0019-1035(91)90233-J; FLASAR FM, 1983, SCIENCE, V221, P55, DOI 10.1126/science.221.4605.55; Gibbard SG, 1999, ICARUS, V139, P189, DOI 10.1006/icar.1999.6095; Griffith CA, 2000, SCIENCE, V290, P509, DOI 10.1126/science.290.5491.509; GRIFFITH CA, 1993, NATURE, V364, P511, DOI 10.1038/364511a0; GRIFFITH CA, 1991, ICARUS, V93, P362, DOI 10.1016/0019-1035(91)90219-J; Griffith CA, 1998, NATURE, V395, P575, DOI 10.1038/26920; Grundy WM, 2002, ICARUS, V155, P486, DOI 10.1006/icar.2001.6726; Hidayat T, 1998, ICARUS, V133, P109, DOI 10.1006/icar.1998.5908; HUSSON N, 1991, GEISA DATA BANK 1991; KARKOSCHKA E, 1994, ICARUS, V111, P174, DOI 10.1006/icar.1994.1139; Karkoschka E, 1998, ICARUS, V133, P134, DOI 10.1006/icar.1998.5913; KHARE BN, 1984, ICARUS, V60, P127, DOI 10.1016/0019-1035(84)90142-8; LELLOUCH E, 1989, ICARUS, V79, P328, DOI 10.1016/0019-1035(89)90081-X; LEMMON MT, 1993, ICARUS, V103, P329, DOI 10.1006/icar.1993.1074; LUNINE JI, 1983, SCIENCE, V222, P1229, DOI 10.1126/science.222.4629.1229; LUTZ BL, 1983, SCIENCE, V220, P1374, DOI 10.1126/science.220.4604.1374; McCord TB, 1998, J GEOPHYS RES-PLANET, V103, P8603, DOI 10.1029/98JE00788; MCCORD TB, COMMUNICATION; MCKAY CP, 1989, ICARUS, V80, P23, DOI 10.1016/0019-1035(89)90160-7; McKay CP, 2001, PLANET SPACE SCI, V49, P79, DOI 10.1016/S0032-0633(00)00051-9; Meier R, 2000, ICARUS, V145, P462, DOI 10.1006/icar.2000.6360; Noll KS, 1996, ICARUS, V124, P625, DOI 10.1006/icar.1996.0236; RAGES K, 1983, J GEOPHYS RES-SPACE, V88, P8721, DOI 10.1029/JA088iA11p08721; Rannou P, 1997, J GEOPHYS RES-PLANET, V102, P10997, DOI 10.1029/97JE00719; Rannou P, 1995, ICARUS, V118, P355, DOI 10.1006/icar.1995.1196; Rayner JT, 2003, PUBL ASTRON SOC PAC, V115, P362, DOI 10.1086/367745; RICHARDSON J, UNPUB; ROUSH TL, 2002, C 33 LUN PLAN I HOUS; Smith PH, 1996, ICARUS, V119, P336, DOI 10.1006/icar.1996.0023; STAMNES K, 1988, APPL OPTICS, V27, P2502, DOI 10.1364/AO.27.002502; TOMASKO MG, 1982, ICARUS, V51, P65, DOI 10.1016/0019-1035(82)90030-6; TOMASKO MG, 1997, ESA SP PUBL, V1177, P109; TOON OB, 1992, ICARUS, V95, P24, DOI 10.1016/0019-1035(92)90188-D; WEST RA, 1991, ICARUS, V90, P330, DOI 10.1016/0019-1035(91)90113-8; WEST RA, 1983, J GEOPHYS RES-SPACE, V88, P8699, DOI 10.1029/JA088iA11p08699; YELLE RV, 1997, ESA SP PUBL, V1177, P243; YUNG YL, 1984, ASTROPHYS J SUPPL S, V55, P465, DOI 10.1086/190963	40	116	117	1	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 25	2003	300	5619					628	630		10.1126/science.1081897	http://dx.doi.org/10.1126/science.1081897			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671FB	12714742				2022-12-24	WOS:000182453700038
J	Umeda, H; Nomoto, K				Umeda, H; Nomoto, K			First-generation black-hole-forming supernovae and the metal abundance pattern of a very iron-poor star	NATURE			English	Article							II SUPERNOVAE; 1ST STARS; NUCLEOSYNTHESIS; EVOLUTION; PECULIAR	It has been proposed(1) theoretically that the first generation of stars in the Universe (population III) would be as massive as 100 solar masses (100 M.), because of inefficient cooling(2-4) of the precursor gas clouds. Recently, the most iron-deficient (but still carbon-rich) low-mass star-HE0107-5240-was discovered(5). If this is a population III star that gained its metals (elements heavier than helium) after its formation, it would challenge the theoretical picture of the formation of the first stars. Here we report that the patterns of elemental abundance in HE0107-5240 (and other extremely metal-poor stars) are in good accord with the nucleosynthesis that occurs in stars with masses of 20-130 M. when they become supernovae if, during the explosions, the ejecta undergo substantial mixing and fall-back to form massive black holes. Such supernovae have been observed(7). The abundance patterns are not, however, consistent with enrichment by supernovae from stars in the range 130-300 M. We accordingly infer that the first-generation supernovae came mostly from explosions of similar to20-130 M. stars; some of these produced iron-poor but carbon- and oxygen-rich ejecta. Low-mass second-generation stars, like HE0107-5240, could form because the carbon and oxygen provided pathways for the gas to cool.	Univ Tokyo, Dept Astron, Sch Sci, Tokyo 1130033, Japan	University of Tokyo	Nomoto, K (corresponding author), Univ Tokyo, Dept Astron, Sch Sci, Tokyo 1130033, Japan.	nomoto@astron.s.u-tokyo.ac.jp						Abel T, 2002, SCIENCE, V295, P93, DOI 10.1126/science.1063991; Aoki W, 2002, ASTROPHYS J, V567, P1166, DOI 10.1086/338756; AUDOUZE J, 1995, ASTROPHYS J, V451, pL49, DOI 10.1086/309687; Blake LAJ, 2001, NUCL PHYS A, V688, p502C; Christlieb N, 2002, NATURE, V419, P904, DOI 10.1038/nature01142; Depagne E, 2002, ASTRON ASTROPHYS, V390, P187, DOI 10.1051/0004-6361:20020687; Fujimoto MY, 2000, ASTROPHYS J, V529, pL25, DOI 10.1086/312453; HACHISU I, 1990, ASTROPHYS J, V358, pL57, DOI 10.1086/185779; Heger A, 2002, ASTROPHYS J, V567, P532, DOI 10.1086/338487; Kifonidis K, 2000, ASTROPHYS J, V531, pL123, DOI 10.1086/312541; MAEDA K, UNPUB ASTROPHYS J; MCWILLIAM A, 1995, ASTRON J, V109, P2757, DOI 10.1086/117486; Nakamura F, 1999, ASTROPHYS J, V515, P239, DOI 10.1086/307020; NOMOTO K, 2002, ASTROPH0209064; NOMOTO K, IN PRESS MASSIVE STA; Norris JE, 2001, ASTROPHYS J, V561, P1034, DOI 10.1086/323429; Omukai K, 1998, ASTROPHYS J, V508, P141, DOI 10.1086/306395; RYAN SG, IN PRESS CNO UNIVERS; RYAN SG, 2002, ASTROPH0211608; Sackmann IJ, 1999, ASTROPHYS J, V510, P217, DOI 10.1086/306545; Schneider R, 2002, ASTROPHYS J, V571, P30, DOI 10.1086/339917; Shigeyama T, 1998, ASTROPHYS J, V507, pL135, DOI 10.1086/311699; Siess L, 2002, ASTROPHYS J, V570, P329, DOI 10.1086/339733; Turatto M, 1998, ASTROPHYS J, V498, pL129, DOI 10.1086/311324; Umeda H, 2002, ASTROPHYS J, V565, P385, DOI 10.1086/323946; YOSHII Y, 1981, ASTRON ASTROPHYS, V97, P280; Zampieri L, 2003, MON NOT R ASTRON SOC, V338, P711, DOI 10.1046/j.1365-8711.2003.06082.x	27	326	330	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 24	2003	422	6934					871	873		10.1038/nature01571	http://dx.doi.org/10.1038/nature01571			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670WR	12712199	Green Submitted			2022-12-24	WOS:000182432600048
J	Ng, J; O'Grady, G; Pettit, T; Frith, R				Ng, J; O'Grady, G; Pettit, T; Frith, R			Nitrous oxide use in first-year students at Auckland University	LANCET			English	Article								In a recent Lancet Case report, a patient presented with subacute combined degeneration of the spinal cord after recreational use of nitrous oxide (N2O). There is very little information about use of this substance as a recreational drug. In a questionnaire-based study, we surveyed 1782 students in their first year at the University of Auckland, New Zealand. 1360 (76%) questionnaires were completed and consistent. 780 (57%) students were aware of recreational use of N2O, 158 (12%) used the substance recreationally, and 39 (3%) inhaled It at least monthly. Users were most likely to be white and to be men. Our results show a high frequency of recreational N2O use in first-year students at Auckland University. Although this study does not accurately reflect use of this substance in the wider community, the high prevalence suggests that presentations of subacute myelopathy in an otherwise fit young person should prompt an enquiry about use of N2O.	Auckland Hosp, Dept Neurol, Auckland 1001, New Zealand	Auckland City Hospital	Frith, R (corresponding author), Auckland Hosp, Dept Neurol, Auckland 1001, New Zealand.							DEACON R, 1978, LANCET, V2, P1023, DOI 10.1016/S0140-6736(78)92341-3; Ng J, 2002, LANCET, V360, P384, DOI 10.1016/S0140-6736(02)09611-3; *STAT NZ, 1998, GUID COLL COMM INF, P7	3	42	44	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 19	2003	361	9366					1349	1350		10.1016/S0140-6736(03)13045-0	http://dx.doi.org/10.1016/S0140-6736(03)13045-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	669HP	12711474				2022-12-24	WOS:000182346100016
J	Biezeveld, MH; Kuipers, IM; Geisser, J; Lam, J; Ottenkamp, JJ; Hack, CE; Kuijpers, TW				Biezeveld, MH; Kuipers, IM; Geisser, J; Lam, J; Ottenkamp, JJ; Hack, CE; Kuijpers, TW			Association of mannose-binding lectin genotype with cardiovascular abnormalities in Kawasaki disease	LANCET			English	Article								Kawasaki disease is an acute vasculitis of possible infectious cause, which in particular affects the coronary arteries. Young children rely mostly on their innate immune system for protection against invading microorganisms, of which mannose-binding lectin is an important component. We aimed to investigate the possible role of the gene for this molecule (MBL) in white Dutch patients with Kawasaki disease. In 90 patients, frequency of mutations in the MBL gene was higher than in healthy children. In children younger than I year, those with mutations were at higher risk of development of coronary artery lesions than were those without (odds ratio 15-7, 95% CI 1.4-176.5, p=0.026). Our findings suggest that the innate immune system contributes differently to pathophysiology of Kawasaki disease at various ages.	Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, NL-1105 AZ Amsterdam, Netherlands; Univ Amsterdam, Netherlands Blood Transfus Serv, Cent Lab, Amsterdam, Netherlands; Univ Amsterdam, Expt & Clin Immunol Lab, Amsterdam, Netherlands	Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; University of Amsterdam	Kuijpers, TW (corresponding author), Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.		Levi, Marcel/AAZ-8559-2020					KAWASAKI T, 1974, PEDIATRICS, V54, P271; MADSEN HO, 1995, J IMMUNOL, V155, P3013; Rowley AH, 1999, PEDIATR CLIN N AM, V46, P313, DOI 10.1016/S0031-3955(05)70120-6; Turner M W, 2000, Rev Immunogenet, V2, P305; Zhang T, 2002, ACTA PAEDIATR, V91, P517, DOI 10.1080/080352502753711623	5	53	55	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 12	2003	361	9365					1268	1270		10.1016/S0140-6736(03)12985-6	http://dx.doi.org/10.1016/S0140-6736(03)12985-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	666DM	12699957				2022-12-24	WOS:000182161600013
J	van Walraven, C; Mamdani, M; Cohn, A; Katib, Y; Walker, M; Rodger, MA				van Walraven, C; Mamdani, M; Cohn, A; Katib, Y; Walker, M; Rodger, MA			Risk of subsequent thromboembolism for patients wit pre-eclampsia	BRITISH MEDICAL JOURNAL			English	Article							THROMBOPHILIA; PREECLAMPSIA		Ottawa Hlth Res Inst, Ottawa, ON K1Y 4E9, Canada; Inst Clin Evaluat Sci, Toronto, ON M4N 3N5, Canada; Univ Ottawa, Ottawa, ON K1H 8M5, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Toronto; University of Ottawa	van Walraven, C (corresponding author), Ottawa Hlth Res Inst, Ottawa, ON K1Y 4E9, Canada.			Rodger, Marc/0000-0001-8166-3487				Grandone E, 1997, THROMB HAEMOSTASIS, V77, P1052; Gris JC, 1997, THROMB HAEMOSTASIS, V77, P1096; Kupferminc MJ, 1999, NEW ENGL J MED, V340, P9, DOI 10.1056/NEJM199901073400102; REDMAN CWG, 1990, NEW ENGL J MED, V323, P478, DOI 10.1056/NEJM199008163230710; Rodeghiero F, 1997, THROMB HAEMOSTASIS, V78, P636	5	35	35	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 12	2003	326	7393					791	792		10.1136/bmj.326.7393.791	http://dx.doi.org/10.1136/bmj.326.7393.791			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	670BE	12689975	Bronze, Green Published			2022-12-24	WOS:000182386700017
J	Steinbrook, R				Steinbrook, R			How best to ventilate? Trial design and patient safety in studies of the acute respiratory distress syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ACUTE LUNG INJURY; CONTROLLED CLINICAL-TRIAL; MECHANICAL VENTILATION; METAANALYSIS; STRATEGY											Amato MBP, 1998, NEW ENGL J MED, V338, P347, DOI 10.1056/NEJM199802053380602; Anzueto A, 1996, NEW ENGL J MED, V334, P1417, DOI 10.1056/NEJM199605303342201; Bernard GR, 2000, JAMA-J AM MED ASSOC, V283, P2568, DOI 10.1001/jama.283.19.2568; Brochard L, 1998, AM J RESP CRIT CARE, V158, P1831, DOI 10.1164/ajrccm.158.6.9801044; Brower RG, 1999, CRIT CARE MED, V27, P1492, DOI 10.1097/00003246-199908000-00015; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Brower RG, 2002, AM J RESP CRIT CARE, V166, P1515, DOI 10.1164/ajrccm.166.11.340; CAROME MA, 2002, COMMUNICATION   1007; CAROME MA, 2002, COMMUNICATION   0828; Eichacker PQ, 2002, AM J RESP CRIT CARE, V166, P1510, DOI 10.1164/rccm.200208-956OC; Eichacker PQ, 2003, AM J RESP CRIT CARE, V167, P798; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; Hebert PC, 1999, NEW ENGL J MED, V340, P1056; MARTIN TR, 2002, COMMUNICATION   1212; MARTIN TR, 2003, COMMUNICATION   0106; MEYER RJ, 2002, COMMUNICATION   0208; Oba Y, 2000, NEW ENGL J MED, V343, P813; Rubenfeld G, 2001, AM J RESP CRIT CARE, V163, pA295; Rubenfeld GD, 2003, CRIT CARE MED, V31, pS276, DOI 10.1097/01.CCM.0000057904.62683.2B; SEEMAN BT, 2002, FEDS DEMAND DATA LUN; SEEMAN BT, 2002, SAFETY WARNINGS HALT; SHARAV VN, 2002, COMMUNICATION   0729; Stewart TE, 2002, AM J RESP CRIT CARE, V166, P1421, DOI 10.1164/rccm.2210002; Stewart TE, 1998, NEW ENGL J MED, V338, P355, DOI 10.1056/NEJM199802053380603; TANSEY B, 2002, SAN FRANCISCO C 0728, pA1; Thompson BT, 2001, CHEST, V120, P1622, DOI 10.1378/chest.120.5.1622; Tobin MJ, 2000, NEW ENGL J MED, V342, P1360, DOI 10.1056/NEJM200005043421808; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; WEIL CJ, 2002, COMMUNICATION   1007; WEINERT CR, IN PRESS AM J RESP C	30	59	59	0	1	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 3	2003	348	14					1393	1401		10.1056/NEJMhpr030349	http://dx.doi.org/10.1056/NEJMhpr030349			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	662LW	12672870				2022-12-24	WOS:000181949100015
J	Phiel, CJ; Wilson, CA; Lee, VMY; Klein, PS				Phiel, CJ; Wilson, CA; Lee, VMY; Klein, PS			GSK-3 alpha regulates production of Alzheimer's disease amyloid-beta peptides	NATURE			English	Article							GLYCOGEN-SYNTHASE KINASE-3-BETA; PRECURSOR PROTEIN; INTRACELLULAR DOMAIN; SECRETASE CLEAVAGE; HUMAN NEURONS; PRESENILIN; CELLS; LITHIUM; NOTCH; PHOSPHORYLATION	Alzheimer's disease is associated with increased production and aggregation of amyloid-beta (Abeta) peptides(1). Abeta peptides are derived from the amyloid precursor protein (APP) by sequential proteolysis, catalysed by the aspartyl protease BACE(2), followed by presenilin-dependent gamma-secretase cleavage(3). Presenilin interacts with nicastrin(4,5), APH-1 and PEN-2 (ref. 6), all of which are required for gamma-secretase function. Presenilins also interact with alpha-catenin, beta-catenin(7,8) and glycogen synthase kinase-3beta (GSK-3beta)(9-11), but a functional role for these proteins in gamma-secretase activity has not been established. Here we show that therapeutic concentrations of lithium, a GSK-3 inhibitor(12), block the production of Abeta peptides by interfering with APP cleavage at the gamma-secretase step, but do not inhibit Notch processing. Importantly, lithium also blocks the accumulation of Abeta peptides in the brains of mice that overproduce APP. The target of lithium in this setting is GSK-3alpha, which is required for maximal processing of APP. Since GSK-3 also phosphorylates tau protein, the principal component of neurofibrillary tangles, inhibition of GSK-3alpha offers a new approach to reduce the formation of both amyloid plaques and neurofibrillary tangles, two pathological hallmarks of Alzheimer's disease.	Univ Penn, Sch Med, Dept Med, Div Hematol Oncol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Howard Hughes Med Inst, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Pathol & Lab Med, Ctr Neurodegenerat Dis Res, Philadelphia, PA 19104 USA	University of Pennsylvania; Howard Hughes Medical Institute; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Klein, PS (corresponding author), Univ Penn, Sch Med, Dept Med, Div Hematol Oncol, 415 Curie Blvd, Philadelphia, PA 19104 USA.							Alvarez G, 2002, BIPOLAR DISORD, V4, P153, DOI 10.1034/j.1399-5618.2002.01150.x; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Cook DG, 1997, NAT MED, V3, P1021, DOI 10.1038/nm0997-1021; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Edbauer D, 2002, P NATL ACAD SCI USA, V99, P8666, DOI 10.1073/pnas.132277899; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Esler WP, 2002, P NATL ACAD SCI USA, V99, P2720, DOI 10.1073/pnas.052436599; Forman MS, 1997, J BIOL CHEM, V272, P32247, DOI 10.1074/jbc.272.51.32247; Francis R, 2002, DEV CELL, V3, P85, DOI 10.1016/S1534-5807(02)00189-2; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Kang DE, 1999, J NEUROSCI, V19, P4229; Kang DE, 2002, CELL, V110, P751, DOI 10.1016/S0092-8674(02)00970-4; Kirschenbaum F, 2001, J BIOL CHEM, V276, P7366, DOI 10.1074/jbc.M004697200; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Phiel CJ, 2001, ANNU REV PHARMACOL, V41, P789, DOI 10.1146/annurev.pharmtox.41.1.789; PLEASURE SJ, 1992, J NEUROSCI, V12, P1802; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Selkoe DJ, 2001, P NATL ACAD SCI USA, V98, P11039, DOI 10.1073/pnas.211352598; Siman R, 2000, J NEUROSCI, V20, P8717; Soriano S, 2001, J CELL BIOL, V152, P785, DOI 10.1083/jcb.152.4.785; Sun X, 2002, NEUROSCI LETT, V321, P61, DOI 10.1016/S0304-3940(01)02583-6; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; Takashima A, 1998, P NATL ACAD SCI USA, V95, P9637, DOI 10.1073/pnas.95.16.9637; Turner RS, 1996, J BIOL CHEM, V271, P8966, DOI 10.1074/jbc.271.15.8966; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Weggen S, 2001, NATURE, V414, P212, DOI 10.1038/35102591; Wilson CA, 2002, NAT NEUROSCI, V5, P849, DOI 10.1038/nn898; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Yu G, 2000, NATURE, V407, P48, DOI 10.1038/35024009	30	988	1057	1	90	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 22	2003	423	6938					435	439		10.1038/nature01640	http://dx.doi.org/10.1038/nature01640			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681AJ	12761548				2022-12-24	WOS:000183012000041
J	Read, J; Winceslaus, SJ				Read, J; Winceslaus, SJ			New strategies for increasing the detection of HIV: analysis of routine data	BRITISH MEDICAL JOURNAL			English	Article									Preston Hall Hosp, Maidstone ME17 7NJ, Kent, England; Guys King Coll, London SE5 9RJ, England; St Thomass Sch Med, London SE5 9RJ, England	University of London; King's College London; University of London; King's College London	Winceslaus, SJ (corresponding author), Preston Hall Hosp, Maidstone ME17 7NJ, Kent, England.			Winceslaus, SJ/0000-0002-9757-1007				Department of Health, 2001, NAT STRAT SEX HLTH H; *PUBL HLTH LAB SER, 2000, TRENDS SEX TRANSM IN; *PUBL HLTH LAB SER, 2001, PHLS EP HIV AIDS	3	5	5	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 17	2003	326	7398					1066	1067		10.1136/bmj.326.7398.1066	http://dx.doi.org/10.1136/bmj.326.7398.1066			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	681ZD	12750208	Green Published, Bronze			2022-12-24	WOS:000183064700016
J	Cao, D; Parker, R				Cao, D; Parker, R			Computational modeling and experimental analysis of nonsense-mediated decay in yeast	CELL			English	Article							MESSENGER-RNA SURVEILLANCE; SACCHAROMYCES-CEREVISIAE; TRANSLATION INITIATION; TURNOVER; DEADENYLATION; MECHANISMS; MUTATIONS; STABILITY; ELEMENTS; PROTEIN	A conserved mRNA surveillance system, referred to as nonsense-mediated decay (NMD), exists in eukaryotic cells to degrade mRNAs containing nonsense codons. This process is important in checking that mRNAs; have been properly synthesized and functions, at least in part, to increase the fidelity of gene expression by degrading aberrant mRNAs; that, if translated, would produce truncated proteins. Using computational modeling and experimental analysis, we define the alterations in mRNA turnover triggered by NMD in yeast. We demonstrate that the nonsense-containing transcripts are efficiently recognized, targeted for deadenylation-independent decapping, and show NMD triggered accelerated deadenylation regardless of the position of the nonsense codon. We also show that 5' nonsense codons trigger faster rates of decapping than 3' nonsense codons, thereby providing a mechanistic basis for the polar effect of NMD. Finally, we construct a computational model that accurately describes the process of NMD and serves as an explanatory and predictive tool.	Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA; Univ Arizona, Howard Hughes Med Inst, Tucson, AZ 85721 USA	University of Arizona; Howard Hughes Medical Institute; University of Arizona	Parker, R (corresponding author), Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM045443, R01GM045443] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM045443-13, GM45443] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAUMANN B, 1985, EMBO J, V4, P351, DOI 10.1002/j.1460-2075.1985.tb03636.x; Brogna S, 1999, RNA, V5, P562, DOI 10.1017/S1355838299981359; Cao D, 2001, RNA, V7, P1192, DOI 10.1017/S1355838201010330; CAPONIGRO G, 1995, GENE DEV, V9, P2421, DOI 10.1101/gad.9.19.2421; CHENG J, 1993, MOL CELL BIOL, V13, P1892, DOI 10.1128/MCB.13.3.1892; Dahlseid JN, 1998, GENETICS, V150, P1019; DECKER CJ, 1993, GENE DEV, V7, P1632, DOI 10.1101/gad.7.8.1632; Dunckley T, 1999, EMBO J, V18, P5411, DOI 10.1093/emboj/18.19.5411; Gonzalez CI, 2001, GENE, V274, P15, DOI 10.1016/S0378-1119(01)00552-2; HAGAN KW, 1995, MOL CELL BIOL, V15, P809; Hilleren P, 1999, ANNU REV GENET, V33, P229, DOI 10.1146/annurev.genet.33.1.229; Hilleren P, 2001, RNA, V7, P753, DOI 10.1017/S1355838201010147; Ishigaki Y, 2001, CELL, V106, P607, DOI 10.1016/S0092-8674(01)00475-5; LEEDS P, 1991, GENE DEV, V5, P2303, DOI 10.1101/gad.5.12a.2303; LOSSON R, 1979, P NATL ACAD SCI USA, V76, P5134, DOI 10.1073/pnas.76.10.5134; MAQUAT LE, 1995, RNA, V1, P453; Mendell JT, 2000, MOL CELL BIOL, V20, P8944, DOI 10.1128/MCB.20.23.8944-8957.2000; MUHLRAD D, 1995, MOL CELL BIOL, V15, P2145; MUHLRAD D, 1994, NATURE, V370, P578, DOI 10.1038/370578a0; Muhlrad D, 1999, MOL BIOL CELL, V10, P3971, DOI 10.1091/mbc.10.11.3971; PELTZ SW, 1993, GENE DEV, V7, P1737, DOI 10.1101/gad.7.9.1737; PULAK R, 1993, GENE DEV, V7, P1885, DOI 10.1101/gad.7.10.1885; Ruiz-Echevarria MJ, 2001, J BIOL CHEM, V276, P30995, DOI 10.1074/jbc.M010833200; SHYU AB, 1991, GENE DEV, V5, P221, DOI 10.1101/gad.5.2.221; TARUN SZ, 1995, GENE DEV, V9, P2997, DOI 10.1101/gad.9.23.2997; Tharun S, 1999, GENETICS, V151, P1273; Tucker M, 2000, ANNU REV BIOCHEM, V69, P571, DOI 10.1146/annurev.biochem.69.1.571; Tucker M, 2002, EMBO J, V21, P1427, DOI 10.1093/emboj/21.6.1427; Tucker M, 2001, CELL, V104, P377, DOI 10.1016/S0092-8674(01)00225-2; vanHoof A, 1996, PLANT J, V10, P415, DOI 10.1046/j.1365-313x.1996.10030415.x; Wang J, 2002, EMBO REP, V3, P274, DOI 10.1093/embo-reports/kvf036; Wilusz CJ, 2001, GENE DEV, V15, P2781	32	113	115	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 16	2003	113	4					533	545		10.1016/S0092-8674(03)00353-2	http://dx.doi.org/10.1016/S0092-8674(03)00353-2			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	680MG	12757713	Bronze			2022-12-24	WOS:000182981500014
J	Chen, HK; Fernandez-Funez, P; Acevedo, SF; Lam, YC; Kaytor, MD; Fernandez, MH; Aitken, A; Skoulakis, EMC; Orr, HT; Botas, J; Zoghbi, HY				Chen, HK; Fernandez-Funez, P; Acevedo, SF; Lam, YC; Kaytor, MD; Fernandez, MH; Aitken, A; Skoulakis, EMC; Orr, HT; Botas, J; Zoghbi, HY			Interaction of Akt-phosphorylated ataxin-1 with 14-3-3 mediates neurodegeneration in spinocerebellar ataxia type 1	CELL			English	Article							SELECTIVE NEURODEGENERATION; SIGNALING PATHWAY; ALPHA-SYNUCLEIN; PROTEIN; GROWTH; DROSOPHILA; DISEASE; 14-3-3-PROTEINS; SCA1; CELL	Spinocerebellar ataxia type 1 (SCA1) is one of several neurological disorders caused by a CAG repeat expansion. In SCA1, this expansion produces an abnormally long polyglutamine tract in the protein ataxin-1. Mutant polyglutamine proteins accumulate in neurons, inducing neurodegeneration, but the mechanism underlying this accumulation has been unclear. We have discovered that the 14-3-3 protein, a multifunctional regulatory molecule, mediates the neurotoxicity of ataxin-1 by binding to and stabilizing ataxin-1, thereby slowing its normal degradation. The association of ataxin-1 with 14-3-3 is regulated by Akt phosphorylation, and in a Drosophila model of SCA1, both 14-3-3 and Akt modulate neurodegeneration. Our finding that phosphatidylinositol 3-kinase/Akt signaling and 14-3-3 cooperate to modulate the neurotoxicity of ataxin-1 provides insight into SCA1 pathogenesis and identifies potential targets for therapeutic intervention.	Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Baylor Coll Med, Div Neurosci, Houston, TX 77030 USA; Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; Univ Minnesota, Inst Human Genet, Minneapolis, MN 55455 USA; Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA; Texas A&M Univ, Genet Program, College Stn, TX 77843 USA; CSRC A Fleming, Inst Mol Biol & Genet, Vari 16672, Greece; Univ Edinburgh, Div Biomed & Clin Lab Sci, Edinburgh EH8 9XD, Midlothian, Scotland	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; University of Minnesota System; University of Minnesota Twin Cities; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; University of Edinburgh	Zoghbi, HY (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, 1 Baylor Plaza, Houston, TX 77030 USA.			Orr, Harry/0000-0001-6118-741X; Chen, Hung-Kai/0000-0002-2169-4924; Zoghbi, Huda/0000-0002-0700-3349; Acevedo, Summer/0000-0002-3206-6819	NICHD NIH HHS [HD24064] Funding Source: Medline; NINDS NIH HHS [NS27699, NS42179, NS22920] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042179, R01NS022920, R37NS027699, R56NS042179, R37NS022920, R01NS027699] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Baxter HC, 2002, NEUROSCIENCE, V109, P5, DOI 10.1016/S0306-4522(01)00492-4; Brazil DP, 2002, CELL, V111, P293, DOI 10.1016/S0092-8674(02)01083-8; Brunet A, 2001, CURR OPIN NEUROBIOL, V11, P297, DOI 10.1016/S0959-4388(00)00211-7; Brunet A, 2002, J CELL BIOL, V156, P817, DOI 10.1083/jcb.200112059; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Cho KS, 2001, P NATL ACAD SCI USA, V98, P6144, DOI 10.1073/pnas.101596998; Cummings CJ, 1998, NAT GENET, V19, P148, DOI 10.1038/502; Dawson TM, 2002, NEURON, V35, P219, DOI 10.1016/S0896-6273(02)00780-8; Dore S, 1997, P NATL ACAD SCI USA, V94, P4772, DOI 10.1073/pnas.94.9.4772; Emamian ES, 2003, NEURON, V38, P375, DOI 10.1016/S0896-6273(03)00258-7; Fernandez-Funez P, 2000, NATURE, V408, P101, DOI 10.1038/35040584; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Hashiguchi M, 2000, J BIOL CHEM, V275, P25247, DOI 10.1074/jbc.M003738200; Humbert S, 2002, DEV CELL, V2, P831, DOI 10.1016/S1534-5807(02)00188-0; Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8; IRIE K, 1994, SCIENCE, V265, P1716, DOI 10.1126/science.8085159; Jackson GR, 2002, NEURON, V34, P509, DOI 10.1016/S0896-6273(02)00706-7; Jeanclos EM, 2001, J BIOL CHEM, V276, P28281, DOI 10.1074/jbc.M011549200; Kawamoto Y, 2002, J NEUROPATH EXP NEUR, V61, P245, DOI 10.1093/jnen/61.3.245; Kaytor MD, 1999, J BIOL CHEM, V274, P37507, DOI 10.1074/jbc.274.53.37507; Layfield R, 1996, NEUROSCI LETT, V209, P57, DOI 10.1016/0304-3940(96)12598-2; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Leevers SJ, 1996, EMBO J, V15, P6584, DOI 10.1002/j.1460-2075.1996.tb01049.x; Lucas JJ, 2001, EMBO J, V20, P27, DOI 10.1093/emboj/20.1.27; Nakamura K, 2001, HUM MOL GENET, V10, P1441, DOI 10.1093/hmg/10.14.1441; Ostrerova N, 1999, J NEUROSCI, V19, P5782, DOI 10.1523/JNEUROSCI.19-14-05782.1999; Tzivion G, 2002, J BIOL CHEM, V277, P3061, DOI 10.1074/jbc.R100059200; Verdu J, 1999, NAT CELL BIOL, V1, P500, DOI 10.1038/70293; Watase K, 2002, NEURON, V34, P905, DOI 10.1016/S0896-6273(02)00733-X; Wei WL, 2002, J BIOL CHEM, V277, P17649, DOI 10.1074/jbc.M111704200; Xu J, 2002, NAT MED, V8, P600, DOI 10.1038/nm0602-600; Yaffe MB, 2001, NAT BIOTECHNOL, V19, P348, DOI 10.1038/86737; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	33	322	339	0	9	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 16	2003	113	4					457	468		10.1016/S0092-8674(03)00349-0	http://dx.doi.org/10.1016/S0092-8674(03)00349-0			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	680MG	12757707	Bronze			2022-12-24	WOS:000182981500008
J	Iakova, P; Awad, SS; Timchenko, NA				Iakova, P; Awad, SS; Timchenko, NA			Aging reduces proliferative capacities of liver by switching pathways of C/EBP alpha growth arrest	CELL			English	Article							TERMINAL ADIPOCYTE DIFFERENTIATION; ENHANCER BINDING-PROTEIN; RETINOBLASTOMA PROTEIN; NEWBORN MICE; C-MYC; REGENERATION; TARGET; GRANULOPOIESIS; ADIPOGENESIS; EXPRESSION	The liver is capable of completely regenerating itself in response to injury and after partial hepatectomy. In liver of old animals, the proliferative response is dramatically reduced, the mechanism for which is unknown. The liver specific protein, C/EBPalpha, normally arrests proliferation of hepatocytes through inhibiting cyclin dependent kinases (cdks). We present evidence that aging switches the liver-specific pathway of C/EBPalpha growth arrest to repression of E2F transcription. We identified an age-specific C/EBPalpha-Rb-E2F4 complex that binds to E2F-dependent promoters and represses these genes. The C/EBPalpha-Rb-E2F4 complex occupies the c-myc promoter and blocks induction of c-myc in livers of old animals after partial hepatectomy. Our results show that the age-dependent switch from cdk inhibition to repression of E2F transcription causes a loss of proliferative response in the liver because of an inability to induce E2F target genes after partial hepatectomy providing a possible mechanism for the age-dependent loss of liver regenerative capacity.	Baylor Coll Med, Huffington Ctr Aging, Houston, TX 77030 USA; Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; Baylor Coll Med, Michael E DeBakey Dept Surg, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Timchenko, NA (corresponding author), Baylor Coll Med, Huffington Ctr Aging, 1 Baylor Plaza, Houston, TX 77030 USA.				NIA NIH HHS [AG20752-01, AG00765] Funding Source: Medline; NIGMS NIH HHS [GM55188] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P01AG020752] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Arora V, 2000, J PHARMACOL EXP THER, V292, P921; BIRKENMEIER EH, 1989, GENE DEV, V3, P1146, DOI 10.1101/gad.3.8.1146; BUCHER NLR, 1964, CANCER RES, V24, P509; Chen PL, 1996, GENE DEV, V10, P2794, DOI 10.1101/gad.10.21.2794; DUNAIEF JL, 1994, CELL, V79, P119, DOI 10.1016/0092-8674(94)90405-7; Fausto N, 2000, J HEPATOL, V32, P19, DOI 10.1016/S0168-8278(00)80412-2; FREYTAG SO, 1992, SCIENCE, V256, P379, DOI 10.1126/science.256.5055.379; FRY M, 1984, J CELL PHYSIOL, V118, P225, DOI 10.1002/jcp.1041180302; JANSENDURR P, 1994, CELL CYCLE MAT METHO, P243; Johansen LM, 2001, MOL CELL BIOL, V21, P3789, DOI 10.1128/MCB.21.11.3789-3806.2001; Pedersen TA, 2001, GENE DEV, V15, P3208, DOI 10.1101/gad.209901; Porse BT, 2001, CELL, V107, P247, DOI 10.1016/S0092-8674(01)00516-5; Reyes JC, 1998, EMBO J, V17, P6979, DOI 10.1093/emboj/17.23.6979; Slomiany BA, 2000, MOL CELL BIOL, V20, P5986, DOI 10.1128/MCB.20.16.5986-5997.2000; STROBER BE, 1996, MOL CELL BIOL, V16, P1567; Taub R, 1996, FASEB J, V10, P413, DOI 10.1096/fasebj.10.4.8647340; Timchenko NA, 1999, NUCLEIC ACIDS RES, V27, P3621, DOI 10.1093/nar/27.17.3621; Timchenko NA, 1998, NUCLEIC ACIDS RES, V26, P3293, DOI 10.1093/nar/26.13.3293; Timchenko NA, 1996, GENE DEV, V10, P804, DOI 10.1101/gad.10.7.804; Timchenko NA, 1997, MOL CELL BIOL, V17, P7353, DOI 10.1128/MCB.17.12.7353; Timchenko NA, 1999, MOL CELL BIOL, V19, P2936; UMEK RM, 1991, SCIENCE, V251, P288, DOI 10.1126/science.1987644; Wang HM, 2002, EMBO J, V21, P930, DOI 10.1093/emboj/21.5.930; Wells J, 2000, MOL CELL BIOL, V20, P5797, DOI 10.1128/MCB.20.16.5797-5807.2000; Wells J, 2002, P NATL ACAD SCI USA, V99, P3890, DOI 10.1073/pnas.062047499; YEH WC, 1995, GENE DEV, V9, P168, DOI 10.1101/gad.9.2.168	26	189	194	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 16	2003	113	4					495	506		10.1016/S0092-8674(03)00318-0	http://dx.doi.org/10.1016/S0092-8674(03)00318-0			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	680MG	12757710	Bronze			2022-12-24	WOS:000182981500011
J	Snyder, EL; Rinder, HM				Snyder, EL; Rinder, HM			Platelet storage - Time to come in from the cold?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Yale Univ, Sch Med, Dept Lab Med, Blood Bank Sect, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Lab Med, Hematol Sect, New Haven, CT 06510 USA	Yale University; Yale University	Snyder, EL (corresponding author), Yale Univ, Sch Med, Dept Lab Med, Blood Bank Sect, New Haven, CT 06510 USA.							BECKER GA, 1973, TRANSFUSION, V13, P61, DOI 10.1111/j.1537-2995.1973.tb05442.x; Gousset K, 2002, J CELL PHYSIOL, V190, P117, DOI 10.1002/jcp.10039; Hoffmeister KM, 2003, CELL, V112, P87, DOI 10.1016/S0092-8674(02)01253-9; Kermode JC, 1999, BLOOD, V94, P199, DOI 10.1182/blood.V94.1.199.413k14_199_207; Tablin F, 2000, J LAB CLIN MED, V135, P339, DOI 10.1067/mlc.2000.105619	5	19	19	0	1	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 15	2003	348	20					2032	2033		10.1056/NEJMcibr035099	http://dx.doi.org/10.1056/NEJMcibr035099			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	677TJ	12748320				2022-12-24	WOS:000182823400014
J	Zschocke, J; Schaefer, JR				Zschocke, J; Schaefer, JR			Homozygous familial hypercholesterolaemia in identical twins	LANCET			English	Editorial Material									Univ Heidelberg, Dept Paediat, D-69120 Heidelberg, Germany; Univ Heidelberg, Inst Human Genet, D-69120 Heidelberg, Germany; Univ Marburg, Dept Internal Med, D-35033 Marburg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Philipps University Marburg	Zschocke, J (corresponding author), Univ Heidelberg, Dept Paediat, D-69120 Heidelberg, Germany.		Zschocke, Johannes/C-5885-2013	Zschocke, Johannes/0000-0002-0046-8274					0	7	7	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 10	2003	361	9369					1641	1641		10.1016/S0140-6736(03)13303-X	http://dx.doi.org/10.1016/S0140-6736(03)13303-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	676HY	12747894				2022-12-24	WOS:000182746300024
J	Yu, EW; McDermott, G; Zgurskaya, HI; Nikaido, H; Koshland, DE				Yu, EW; McDermott, G; Zgurskaya, HI; Nikaido, H; Koshland, DE			Structural basis of multiple drug-binding capacity of the AcrB multidrug efflux pump	SCIENCE			English	Article							LARGE PERIPLASMIC LOOPS; GRAM-NEGATIVE BACTERIA; ESCHERICHIA-COLI; SUBSTRATE-SPECIFICITY; RESISTANCE; TRANSPORTER; RECOGNITION; MECHANISMS	Multidrug efflux pumps cause serious problems in cancer chemotherapy and treatment of bacterial infections. Yet high-resolution structures of ligand-transporter complexes have previously been unavailable. We obtained x-ray crystallographic structures of the trimeric AcrB pump from Escherichia coli with four structurally diverse ligands. The structures show that three molecules of ligands bind simultaneously to the extremely large central cavity of 5000 cubic angstroms, primarily by hydrophobic, aromatic stacking and van der Waals interactions. Each ligand uses a slightly different subset of AcrB residues for binding. The bound ligand molecules often interact with each other, stabilizing the binding.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley Ctr Struct Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Koshland, DE (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.				NIAID NIH HHS [AI 09644] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI009644, R37AI009644] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALBERT A, 1956, J CHEM SOC, P1294, DOI 10.1039/jr9560001294; Avila-Sakar AJ, 2001, J STRUCT BIOL, V136, P81, DOI 10.1006/jsbi.2001.4418; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Elkins CA, 2002, J BACTERIOL, V184, P6490, DOI 10.1128/JB.184.23.6490-6499.2002; Gottesman MM, 2002, ANNU REV MED, V53, P615, DOI 10.1146/annurev.med.53.082901.103929; Lewinson O, 2001, BIOCHEMISTRY-US, V40, P12612, DOI 10.1021/bi011040y; MA D, 1993, J BACTERIOL, V175, P6299, DOI 10.1128/JB.175.19.6299-6313.1993; Mao WM, 2002, MOL MICROBIOL, V46, P889, DOI 10.1046/j.1365-2958.2002.03223.x; Murakami S, 2002, NATURE, V419, P587, DOI 10.1038/nature01050; NIKAIDO H, 1993, ANTIMICROB AGENTS CH, V37, P1393, DOI 10.1128/AAC.37.7.1393; Nikaido H, 1996, J BACTERIOL, V178, P5853, DOI 10.1128/jb.178.20.5853-5859.1996; Paulsen IT, 1996, MICROBIOL REV, V60, P575, DOI 10.1128/MMBR.60.4.575-608.1996; Rosenberg MF, 1997, J BIOL CHEM, V272, P10685; Schumacher MA, 2001, SCIENCE, V294, P2158, DOI 10.1126/science.1066020; Tikhonova EB, 2002, J BACTERIOL, V184, P6499, DOI 10.1128/JB.184.23.6499-6507.2002; Yu EW, 2001, P NATL ACAD SCI USA, V98, P9517, DOI 10.1073/pnas.161239298; Zgurskaya HI, 2000, J BACTERIOL, V182, P4264, DOI 10.1128/JB.182.15.4264-4267.2000; Zgurskaya HI, 1999, J MOL BIOL, V285, P409, DOI 10.1006/jmbi.1998.2313; Zgurskaya HI, 2000, MOL MICROBIOL, V37, P219, DOI 10.1046/j.1365-2958.2000.01926.x; Zgurskaya HI, 1999, P NATL ACAD SCI USA, V96, P7190, DOI 10.1073/pnas.96.13.7190; Zheleznova EE, 1999, CELL, V96, P353, DOI 10.1016/S0092-8674(00)80548-6	21	322	339	1	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 9	2003	300	5621					976	980		10.1126/science.1083137	http://dx.doi.org/10.1126/science.1083137			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675WD	12738864				2022-12-24	WOS:000182719800056
J	Richmond, TJ; Davey, CA				Richmond, TJ; Davey, CA			The structure of DNA in the nucleosome core	NATURE			English	Article							B-DNA; HELIX GEOMETRY; SEQUENCE; CHROMATIN; PARTICLE; TRANSCRIPTION; RESOLUTION; CURVATURE; STABILITY; COMPLEXES	The 1.9-Angstrom-resolution crystal structure of the nucleosome core particle containing 147 DNA base pairs reveals the conformation of nucleosomal DNA with unprecedented accuracy. The DNA structure is remarkably different from that in oligonucleotides and nonhistone protein-DNA complexes. The DNA base-pair-step geometry has, overall, twice the curvature necessary to accommodate the DNA superhelical path in the nucleosome. DNA segments bent into the minor groove are either kinked or alternately shifted. The unusual DNA conformational parameters induced by the binding of histone protein have implications for sequence-dependent protein recognition and nucleosome positioning and mobility. Comparison of the 147-base-pair structure with two 146-base-pair structures reveals alterations in DNA twist that are evidently common in bulk chromatin, and which are of probable importance for chromatin fibre formation and chromatin remodelling.	ETH Honggerberg, Inst Mol Biol & Biophys, ETH Zurich, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Richmond, TJ (corresponding author), ETH Honggerberg, Inst Mol Biol & Biophys, ETH Zurich, CH-8093 Zurich, Switzerland.	richmond@mol.biol.ethz.ch	Davey, Curt A/A-2182-2011					Anselmi C, 1999, J MOL BIOL, V286, P1293, DOI 10.1006/jmbi.1998.2575; ARNOTT S, 1969, ACTA CRYSTALL B-STRU, VB 25, P2192, DOI 10.1107/S0567740869005450; CALLADINE CR, 1986, J MOL BIOL, V192, P907, DOI 10.1016/0022-2836(86)90036-7; CRICK FHC, 1975, NATURE, V255, P530, DOI 10.1038/255530a0; Davey CA, 2002, P NATL ACAD SCI USA, V99, P11169, DOI 10.1073/pnas.172271399; Davey CA, 2002, J MOL BIOL, V319, P1097, DOI 10.1016/S0022-2836(02)00386-8; Dickerson RE, 1997, BIOPOLYMERS, V44, P361, DOI 10.1002/(SICI)1097-0282(1997)44:4<361::AID-BIP4>3.0.CO;2-X; Dickerson RE, 1998, NUCLEIC ACIDS RES, V26, P1906, DOI 10.1093/nar/26.8.1906; El Hassan MA, 1998, J MOL BIOL, V282, P331, DOI 10.1006/jmbi.1998.1994; ELGIN SC, 2000, CHROMATIN STRUCTURE; ElHassan MA, 1997, PHILOS T R SOC A, V355, P43, DOI 10.1098/rsta.1997.0002; Flaus A, 1998, J MOL BIOL, V275, P427, DOI 10.1006/jmbi.1997.1464; FRATINI AV, 1982, J BIOL CHEM, V257, P4686; GOODSELL DS, 1994, NUCLEIC ACIDS RES, V22, P5497, DOI 10.1093/nar/22.24.5497; KLUG A, 1981, NUCLEIC ACIDS RES, V9, P4267, DOI 10.1093/nar/9.17.4267; KORNBERG RD, 1992, ANNU REV CELL BIOL, V8, P563, DOI 10.1146/annurev.cellbio.8.1.563; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; LAVERY R, 1988, J BIOMOL STRUCT DYN, V6, P63, DOI 10.1080/07391102.1988.10506483; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; MEERSSEMAN G, 1992, EMBO J, V11, P2951, DOI 10.1002/j.1460-2075.1992.tb05365.x; Olson WK, 1996, CURR OPIN STRUC BIOL, V6, P242, DOI 10.1016/S0959-440X(96)80082-0; Olson WK, 1998, P NATL ACAD SCI USA, V95, P11163, DOI 10.1073/pnas.95.19.11163; Packer MJ, 1998, J MOL BIOL, V280, P407, DOI 10.1006/jmbi.1998.1865; Packer MJ, 2001, J AM CHEM SOC, V123, P7399, DOI 10.1021/ja003385u; POLACH KJ, 1995, J MOL BIOL, V254, P130, DOI 10.1006/jmbi.1995.0606; PRYCIAK PM, 1992, CELL, V69, P769, DOI 10.1016/0092-8674(92)90289-O; Richmond TJ, 2000, CHROMATIN STRUCTURE, P1; SHIMIZU M, 1991, EMBO J, V10, P3033, DOI 10.1002/j.1460-2075.1991.tb07854.x; SHRADER TE, 1990, J MOL BIOL, V216, P69, DOI 10.1016/S0022-2836(05)80061-0; SIMPSON RT, 1991, PROG NUCLEIC ACID RE, V40, P143; Studitsky VM, 1997, SCIENCE, V278, P1960, DOI 10.1126/science.278.5345.1960; TRAVERS AA, 1987, PHILOS T ROY SOC B, V317, P537, DOI 10.1098/rstb.1987.0080; Tsukiyama T, 2002, NAT REV MOL CELL BIO, V3, P422, DOI 10.1038/nrm828; van Holde K.E., 1988, CHROMATIN; Widom J, 2001, Q REV BIOPHYS, V34, P269, DOI 10.1017/S0033583501003699; Wolffe AP, 1998, PROG NUCLEIC ACID RE, V61, P379, DOI 10.1016/S0079-6603(08)60832-6; Wyrick JJ, 1999, NATURE, V402, P418, DOI 10.1038/46567; YANAGI K, 1991, J MOL BIOL, V217, P201, DOI 10.1016/0022-2836(91)90620-L; YOUNG MA, 1995, BIOPHYS J, V68, P2454, DOI 10.1016/S0006-3495(95)80427-3; ZIVANOVIC Y, 1988, J MOL BIOL, V200, P267, DOI 10.1016/0022-2836(88)90239-2	40	912	940	4	139	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 8	2003	423	6936					145	150		10.1038/nature01595	http://dx.doi.org/10.1038/nature01595			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675MR	12736678				2022-12-24	WOS:000182699600039
J	Tishler, PV; Larkin, EK; Schluchter, MD; Redline, S				Tishler, PV; Larkin, EK; Schluchter, MD; Redline, S			Incidence of sleep-disordered breathing in an urban adult population - The relative importance of risk factors in the development of sleep-disordered breathing	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POSITIVE AIRWAY PRESSURE; CARDIOVASCULAR-DISEASE; FAMILIAL AGGREGATION; AFRICAN-AMERICANS; APNEA-HYPOPNEA; MEN; PREVALENCE; COMMUNITY; GENETICS; VALIDITY	Context Sleep-disordered breathing (SDB) is both prevalent and associated with serious chronic illness. The incidence of SDB and the effect of risk factors on this incidence are unknown. Objective To determine the 5-year incidence of SDB overall and as influenced by risk factors. Design, Setting, and Participants Of the 1149 participants in the Cleveland Family Study, those aged 18 years or older, from either case or control families, who had 2 in-home sleep studies 5 years apart. The first had to have been performed before June 30, 1997, and had to have normal results (apnea hypopnea index [AHI] <5). Data included questionnaire information on medical and family history, SDB symptoms; measurement of height, weight, blood pressure, waist and hip circumference, and serum cholesterol concentration; and overnight sleep monitoring. Main Outcome Measure Apnea hypopnea index, defined as number of apneas and hypopneas per hour of sleep. Sleep-disordered breathing was defined by an AHI of at least 10 (mild to moderate) or of at least 15 (moderate). Results Forty-seven (16%) of 286 eligible participants, (95% confidence interval [CI], 13%-21%) had a second-study AHI of at least 10 and 29 (10%) participants (95% CI, 7%-14%) had a second-study AHI result of at least 15. For the AHI results of at least 15, we estimate that about 2.5% may represent test variability. By ordinal logistic regression analysis, AHI was significantly associated with age (odds ratio [OR] per 10-year increase, 1.79; 95% CI, 1.41-2.27), body mass index (BMI; OR per 1-unit increase, 1.14; 95% CI, 1.10-1.19), sex (OR for men Vs women, 4.12; 95% CI, 2.29-7.43), waist-hip ratio (OR per 0.1 unit increase, 1.61; 95% CI, 1.04-2.28), and serum cholesterol concentration (OR per 10-mg/dL [0.25-mmol/L] increase, 1.11; 95% Cl, 1.03-1.19). Interactions were noted between age and both sex (P=.003) and BMI (P=.05). The OR for increased AHI per 10-year age increase was 2.41 in women (95% CI, 1.78-3.26) and 1.15 in men (95% CI, 0.78-1.68), with the male vs female OR decreasing from 5.04 (95% CI, 2.19-11.6) at age 30 years to 0.54 (95% CI, 0.15-1.99) at age 60 years. The OR for increased AHI per 1-unit increase in BMI decreased from 1.21 (95% CI, 1.11-1.31) at age 20 years to 1.05 (95% CI, 0.96-1.15) at age 60 years. Conclusions The 5-year incidence is about 7.5% for moderately severe SDB and 16% (or less) for mild to moderately severe SDB. Incidence of SDB is influenced independently by age, sex, BMI, waist-hip ratio, and serum cholesterol concentration. Predominance in men diminishes with increasing age, and by age 50 years, incidence rates among men and women are similar. The effect of BMI also decreases with age and may be negligible at age 60 years.	Vet Affairs Boston Healthcare Syst, Boston, MA USA; Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA; Harvard Univ, Sch Med, Boston, MA USA; Case Western Reserve Univ, Rainbow Babies & Childrens Hosp, Dept Pediat, Cleveland, OH 44106 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Rainbow Babies & Children's Hospital	Tishler, PV (corresponding author), Channing Labs, 181 Longwood Ave, Boston, MA 02115 USA.	peter.tishler@channing.harvard.edu			NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000080] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL046380, T32HL007567] Funding Source: NIH RePORTER; NCRR NIH HHS [M01 RR00080-39] Funding Source: Medline; NHLBI NIH HHS [T32-HL07567, HL46380] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Alchanatis M, 2001, RESPIRATION, V68, P566, DOI 10.1159/000050574; Asplund R, 1999, DRUG AGING, V14, P91, DOI 10.2165/00002512-199914020-00002; Bixler EO, 1998, AM J RESP CRIT CARE, V157, P144, DOI 10.1164/ajrccm.157.1.9706079; Bixler EO, 2001, AM J RESP CRIT CARE, V163, P608, DOI 10.1164/ajrccm.163.3.9911064; BRESNITZ EA, 1994, EPIDEMIOL REV, V16, P210, DOI 10.1093/oxfordjournals.epirev.a036151; Buxbaum SG, 2002, GENET EPIDEMIOL, V22, P243, DOI 10.1002/gepi.0170; Duran J, 2001, AM J RESP CRIT CARE, V163, P685, DOI 10.1164/ajrccm.163.3.2005065; Ficker JH, 1998, EUR RESPIR J, V11, P14, DOI 10.1183/09031936.98.11010014; Flemons WW, 1999, SLEEP, V22, P667, DOI 10.1093/sleep/22.5.667; FLIER JS, 1998, WILLIAMS TXB ENDOCRI, P1061; GISLASON T, 1988, J CLIN EPIDEMIOL, V41, P571, DOI 10.1016/0895-4356(88)90061-3; GORDON T, 1973, DHEW PUBLICATION NIH; Henriksson KM, 2001, EUR J EPIDEMIOL, V17, P521, DOI 10.1023/A:1014508422504; Ip MSM, 2001, CHEST, V119, P62, DOI 10.1378/chest.119.1.62; Javaheri S, 2000, CIRCULATION, V101, P392, DOI 10.1161/01.CIR.101.4.392; Kadotani H, 2001, JAMA-J AM MED ASSOC, V285, P2888, DOI 10.1001/jama.285.22.2888; KUMP K, 1994, AM J RESP CRIT CARE, V150, P735, DOI 10.1164/ajrccm.150.3.8087345; LAVIE P, 1995, SLEEP, V18, P149, DOI 10.1093/sleep/18.3.149; Leung RST, 2001, AM J RESP CRIT CARE, V164, P2147, DOI 10.1164/ajrccm.164.12.2107045; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.2307/2336267; Mooe T, 2001, AM J RESP CRIT CARE, V164, P1910, DOI 10.1164/ajrccm.164.10.2101072; Newman AB, 2001, AM J EPIDEMIOL, V154, P50, DOI 10.1093/aje/154.1.50; Peppard PE, 2000, JAMA-J AM MED ASSOC, V284, P3015, DOI 10.1001/jama.284.23.3015; Pepperell JCT, 2002, LANCET, V359, P204, DOI 10.1016/S0140-6736(02)07445-7; POULIOT MC, 1994, AM J CARDIOL, V73, P460, DOI 10.1016/0002-9149(94)90676-9; Quan SF, 2002, SLEEP, V25, P843; REDLINE S, 1995, AM J RESP CRIT CARE, V151, P682; Redline S, 1997, AM J RESP CRIT CARE, V155, P186, DOI 10.1164/ajrccm.155.1.9001310; REDLINE S, 1992, AM REV RESPIR DIS, V145, P440, DOI 10.1164/ajrccm/145.2_Pt_1.440; REDLINE S, 1991, CHEST, V100, P1281, DOI 10.1378/chest.100.5.1281; Redline S, 2002, LUNG BIOL HEALTH DIS, V166, P235; Redline S, 2001, SLEEP, V24, pA294; REDLINE S, 1994, AM J RESP CRIT CARE, V149, P722, DOI 10.1164/ajrccm.149.3.8118642; REDLINE S, 1991, SLEEP RESPIRATION AG, P189; Saarelainen S, 1998, CLIN GENET, V53, P147; SAHAR E, 2003, IN PRESS AM J RESP C; Shahar E, 2001, AM J RESP CRIT CARE, V163, P19, DOI 10.1164/ajrccm.163.1.2001008; Stokes ME, 2000, CATEGORICAL DATA ANA; Williamson JM, 1999, COMPUT METH PROG BIO, V58, P25, DOI 10.1016/S0169-2607(98)00063-7; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704	40	308	321	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 7	2003	289	17					2230	2237		10.1001/jama.289.17.2230	http://dx.doi.org/10.1001/jama.289.17.2230			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	675ET	12734134	Bronze			2022-12-24	WOS:000182680700025
J	Shulman, KI; Rochon, P; Sykora, K; Anderson, G; Mamdani, M; Bronskill, S; Tran, CTT				Shulman, KI; Rochon, P; Sykora, K; Anderson, G; Mamdani, M; Bronskill, S; Tran, CTT			Changing prescription patterns for lithium and valproic acid in old age: shifting practice without evidence	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Univ Toronto, Fac Med, Sunnybrook & Womens Coll Hlth Sci Ctr, Dept Psychiat, Toronto, ON M4N 3M5, Canada; Sunnybrook & Womens Coll Hlth Sci Ctr, ICES, Toronto, ON, Canada; Baycrest Ctr Geriatr Care, Kunin Lunenfeld Appl Res Unit, Toronto, ON M6S 2E1, Canada	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University Toronto Affiliates; Baycrest	Shulman, KI (corresponding author), Univ Toronto, Fac Med, Sunnybrook & Womens Coll Hlth Sci Ctr, Dept Psychiat, Toronto, ON M4N 3M5, Canada.	ken.shulman@sw.ca	Rochon, Paula A/J-2918-2016	Rochon, Paula A/0000-0002-5973-4151				Baldessarini R J, 1999, Bipolar Disord, V1, P17, DOI 10.1034/j.1399-5618.1999.10106.x; Dinan TG, 2002, BRIT MED J, V324, P989, DOI 10.1136/bmj.324.7344.989; Johnson G, 1998, NEUROPSYCHOPHARMACOL, V19, P200, DOI 10.1016/S0893-133X(98)00019-0; MACRITCHIE KA, 2001, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003196; Sival RC, 2002, INT J GERIATR PSYCH, V17, P579, DOI 10.1002/gps.653	5	67	69	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 3	2003	326	7396					960	961		10.1136/bmj.326.7396.960	http://dx.doi.org/10.1136/bmj.326.7396.960			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	676JC	12727769	Green Published, Bronze			2022-12-24	WOS:000182746700017
J	Abbott, A				Abbott, A			Human fatality adds fresh impetus to fight against bird flu	NATURE			English	News Item																		2003, NATURE, V422, P247	1	10	11	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 1	2003	423	6935					5	5		10.1038/423005b	http://dx.doi.org/10.1038/423005b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673CG	12721589	Bronze			2022-12-24	WOS:000182561600007
J	Chacron, MJ; Doiron, B; Maler, L; Longtin, A; Bastian, J				Chacron, MJ; Doiron, B; Maler, L; Longtin, A; Bastian, J			Non-classical receptive field mediates switch in a sensory neuron's frequency tuning	NATURE			English	Article							WEAKLY ELECTRIC FISH; LATERAL-LINE LOBE; GYMNOTIFORM FISH; SPIKE TRAINS; SIGNALS; REPRESENTATION; COMMUNICATION; ORGANIZATION; MECHANISMS; AFFERENTS	Animals have developed stereotyped communication calls to which specific sensory neurons are well tuned(1,2). These communication calls must be discriminated from environmental signals such as those produced by prey. Sensory systems might have evolved neural circuitry to encode both categories. In weakly electric fish, prey and communication signals differ in their spatial extent and frequency content(3,4). Here we show that stimuli of different spatial extents mimicking prey and communication signals cause a switch in the frequency tuning and spike-timing precision of electrosensory pyramidal neurons, resulting in the selective and optimal encoding of both stimulus categories. As in other sensory systems(5), pyramidal neurons respond only to stimuli located within a restricted region of space known as the classical receptive field (CRF)(6). In some systems, stimulation outside the CRF but within a non-classical receptive field (nCRF) can modulate the neural response to CRF stimulation even though nCRF stimulation alone fails to elicit responses(7,8). We show that pyramidal neurons possess a nCRF and that it can modulate the response to CRF stimuli to induce this neurobiological switch in frequency tuning.	Univ Ottawa, Dept Phys, Ottawa, ON K1N 6N5, Canada; Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON K1H 8M5, Canada; Univ Oklahoma, Dept Zool, Norman, OK 73019 USA	University of Ottawa; University of Ottawa; University of Oklahoma System; University of Oklahoma - Norman	Chacron, MJ (corresponding author), Univ Ottawa, Dept Phys, Ottawa, ON K1N 6N5, Canada.		Longtin, Andre/D-2443-2009	Chacron, Maurice/0000-0002-3032-452X				BASTCHELET E, 1981, CIRCULAR STAT BIOL; Bastian J, 2002, J NEUROSCI, V22, P4577, DOI 10.1523/JNEUROSCI.22-11-04577.2002; BASTIAN J, 1981, J COMP PHYSIOL, V144, P465, DOI 10.1007/BF01326832; Berman NJ, 1999, J EXP BIOL, V202, P1243; Bialek W., 1996, SPIKES EXPLORING NEU; Borst A, 1999, NAT NEUROSCI, V2, P947, DOI 10.1038/14731; CARR CE, 1982, J COMP NEUROL, V211, P139, DOI 10.1002/cne.902110204; Crampton William G. R., 1998, Anais da Academia Brasileira de Ciencias, V70, P805; Doiron B, 2003, NATURE, V421, P539, DOI 10.1038/nature01360; Gabbiani F, 1996, NATURE, V384, P564, DOI 10.1038/384564a0; Gabbiani F, 1996, NETWORK-COMP NEURAL, V7, P61, DOI 10.1080/0954898X.1996.11978655; HEILIGENBERG W, 1982, J COMP PHYSIOL, V148, P287, DOI 10.1007/BF00679013; Heiligenberg W., 1991, NEURAL NETS ELECT FI; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Machens CK, 2001, J NEUROSCI, V21, P3215, DOI 10.1523/JNEUROSCI.21-09-03215.2001; MacLeod K, 1996, SCIENCE, V274, P976, DOI 10.1126/science.274.5289.976; MAINEN ZF, 1995, SCIENCE, V268, P1503, DOI 10.1126/science.7770778; MALER L, 1994, J COMP NEUROL, V345, P224, DOI 10.1002/cne.903450206; MALER L, 1981, J COMP NEUROL, V195, P87, DOI 10.1002/cne.901950107; METZNER W, 1991, J COMP PHYSIOL A, V169, P135, DOI 10.1007/BF00215861; Metzner W, 1997, P NATL ACAD SCI USA, V94, P14798, DOI 10.1073/pnas.94.26.14798; Nelson ME, 1999, J EXP BIOL, V202, P1195; Rieke F, 1995, P ROY SOC B-BIOL SCI, V262, P259, DOI 10.1098/rspb.1995.0204; SILLITO AM, 1995, NATURE, V378, P492, DOI 10.1038/378492a0; Simoncelli EP, 2001, ANNU REV NEUROSCI, V24, P1193, DOI 10.1146/annurev.neuro.24.1.1193; vanSteveninck RRD, 1997, SCIENCE, V275, P1805, DOI 10.1126/science.275.5307.1805; Vinje WE, 2000, SCIENCE, V287, P1273, DOI 10.1126/science.287.5456.1273; VOSS RF, 1978, J ACOUST SOC AM, V63, P258, DOI 10.1121/1.381721; Zhang H, 1999, J COMP PHYSIOL A, V184, P85, DOI 10.1007/s003590050308; ZUPANC GKH, 1993, CAN J ZOOL, V71, P2301, DOI 10.1139/z93-323	30	143	144	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 1	2003	423	6935					77	81		10.1038/nature01590	http://dx.doi.org/10.1038/nature01590			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673CG	12721628				2022-12-24	WOS:000182561600042
J	Lim, BCB; Ariens, RAS; Carter, AM; Weisel, JW; Grant, PJ				Lim, BCB; Ariens, RAS; Carter, AM; Weisel, JW; Grant, PJ			Genetic regulation of fibrin structure and function: complex gene-environment interactions may modulate vascular risk	LANCET			English	Article							FACTOR-XIII GENE; COAGULATION-FACTOR-XIII; MYOCARDIAL-INFARCTION; THR312ALA POLYMORPHISM; VAL34LEU POLYMORPHISM; COMMON POLYMORPHISM; PLASMA-FIBRINOGEN; FXIII VAL34LEU; HEART-DISEASE; ASSOCIATION	Background Polymorphisms in the fibrinogen and factor XIII genes are associated with atherothrombotic risk, but clinical studies have produced inconsistent results and laboratory studies have not explained these findings. We aimed to investigate interactions between polymorphisms in the factor XIII and fibrinogen genes, fibrinogen concentrations, and other cardiovascular risk factors in relation to fibrin structure and function. Methods We used permeation analysis and electron microscopy to investigate interactions between fibrin structure, factor XIII Val34Leu, fibrinogen Aalpha Thr312Ala, fibrinogen 130 Arg448Lys, and fibrinogen concentrations in plasma and purified systems. Findings Increased fibrinogen concentrations were associated with decreases in permeability, with tighter clot structures in the presence of factor XIII 34Val alleles compared with those in the presence of 34Leu alleles. Findings were confirmed by scanning electron microscopy of fibrin. Similar changes in permeability were noted for Aalpha fibrinogen 312Ala compared with that for 312Thr. Interpretation Our results show interactions between coding polymorphisms in fibrinogen and factor XIII and fibrinogen concentrations that modify fibrin and explain the apparent paradox between epidemiological studies of factor XIII 34Leu and reported in-vitro effects on fibrin structure and function. We suggest a potential complexity of gene-gene and gene-environment interactions in determining cardiovascular risk.	Univ Leeds, Acad Unit Mol Vasc Med, Leeds, W Yorkshire, England; Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	University of Leeds; University of Pennsylvania	Grant, PJ (corresponding author), Gen Infirm, Acad Unit Mol Vasc Med, G Floor,Martin Wing, Leeds LS1 3EX, W Yorkshire, England.	p.j.grant@leeds.ac.uk		Ariens, Robert/0000-0002-6310-5745	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL030954] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL30954] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ariens RAS, 2000, BLOOD, V96, P988, DOI 10.1182/blood.V96.3.988.015k57_988_995; BAUMANN RE, 1993, BLOOD, V82, P2117; Behague I, 1996, CIRCULATION, V93, P440, DOI 10.1161/01.CIR.93.3.440; Bennett JS, 2001, ANN NY ACAD SCI, V936, P340; BLOMBACK B, 1989, BIOCHIM BIOPHYS ACTA, V997, P96, DOI 10.1016/0167-4838(89)90140-4; Carter AM, 2000, BLOOD, V96, P1177, DOI 10.1182/blood.V96.3.1177.015k25_1177_1179; Carter AM, 1999, CIRCULATION, V99, P2423, DOI 10.1161/01.CIR.99.18.2423; Carter AM, 1997, ARTERIOSCL THROM VAS, V17, P589, DOI 10.1161/01.ATV.17.3.589; Catto AJ, 1998, STROKE, V29, P813, DOI 10.1161/01.STR.29.4.813; Catto AJ, 1999, BLOOD, V93, P906, DOI 10.1182/blood.V93.3.906.403k24_906_908; COLLET JP, 1993, BLOOD, V82, P2462; Collet JP, 2000, ARTERIOSCL THROM VAS, V20, P1354, DOI 10.1161/01.ATV.20.5.1354; Corral J, 2000, HAEMATOLOGICA, V85, P293; Dotevall Annika, 1994, Annals of Epidemiology, V4, P369; Elbaz A, 2000, BLOOD, V95, P586, DOI 10.1182/blood.V95.2.586; FATAH K, 1992, THROMB HAEMOSTASIS, V68, P130; Fatah K, 1996, THROMB HAEMOSTASIS, V76, P535; Franco RF, 2000, HAEMATOLOGICA, V85, P67; Gemmati D, 2001, AM J HEMATOL, V67, P183, DOI 10.1002/ajh.1104; Hunter KA, 2001, CLIN SCI, V100, P459, DOI 10.1042/CS20000228; Kohler HP, 1998, THROMB HAEMOSTASIS, V79, P8, DOI 10.1055/s-0037-1614250; Lane DA, 2000, BLOOD, V95, P1517, DOI 10.1182/blood.V95.5.1517.005k48_1517_1532; Ma J, 1999, J AM COLL CARDIOL, V33, P1347, DOI 10.1016/S0735-1097(99)00007-8; MEADE TW, 1986, LANCET, V2, P533, DOI 10.1016/S0140-6736(86)90111-X; Tuut M, 2001, ANN EPIDEMIOL, V11, P232, DOI 10.1016/S1047-2797(00)00226-X; Warner D, 2001, THROMB HAEMOSTASIS, V85, P408; Wartiovaara U, 1999, ATHEROSCLEROSIS, V142, P295, DOI 10.1016/S0021-9150(98)00241-X; WEISEL JW, 1992, BIOPHYS J, V63, P111, DOI 10.1016/S0006-3495(92)81594-1; WILHELMSEN L, 1984, NEW ENGL J MED, V311, P501, DOI 10.1056/NEJM198408233110804; Woodhead JL, 1996, J BIOL CHEM, V271, P4946	30	169	171	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 26	2003	361	9367					1424	1431		10.1016/S0140-6736(03)13135-2	http://dx.doi.org/10.1016/S0140-6736(03)13135-2			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	672HZ	12727396				2022-12-24	WOS:000182516300011
J	Rodger, A; Jaffar, S; Paynter, S; Hayward, A; Carless, J; Maguire, H				Rodger, A; Jaffar, S; Paynter, S; Hayward, A; Carless, J; Maguire, H			Delay in the diagnosis of pulmonary tuberculosis, London, 1998-2000: analysis of surveillance data	BRITISH MEDICAL JOURNAL			English	Article									Univ London London Sch Hyg & Trop Med, Infect Dis Epidemiol Unit, London WC1E 7HT, England; Univ London London Sch Hyg & Trop Med, European Ctr Hlth Soc Transit, London WC1E 7HT, England; UCL Royal Free & Univ Coll Med Sch, Ctr Infect Dis Epidemiol, Dept Primary Care & Populat Sci, London NW3 2PF, England; Ctr Communicable Dis Surveillance, London Reg Unit, London W2 3QR, England	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of London; University College London; UCL Medical School	Rodger, A (corresponding author), Univ London London Sch Hyg & Trop Med, Infect Dis Epidemiol Unit, Keppel St, London WC1E 7HT, England.	alison.rodger@lshtm.ac.uk	Paynter, Stuart/F-7916-2010; Hayward, Andrew C/C-3268-2013	Hayward, Andrew C/0000-0002-3549-6232; Jaffar, Shabbar/0000-0002-9615-1588				Chin DP, 2000, JAMA-J AM MED ASSOC, V283, P2968, DOI 10.1001/jama.283.22.2968; Rodrigo T, 2001, INT J TUBERC LUNG D, V5, P432; Wares DF, 1999, J PUBLIC HEALTH MED, V21, P355, DOI 10.1093/pubmed/21.3.355; WRIGHT A, 2001, COMMUNICABLE DIS SUR; Zahar JR, 2001, INTENS CARE MED, V27, P513, DOI 10.1007/s001340000849	5	48	50	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 26	2003	326	7395					909	910		10.1136/bmj.326.7395.909	http://dx.doi.org/10.1136/bmj.326.7395.909			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	673WQ	12714470	Green Published, Bronze, Green Accepted			2022-12-24	WOS:000182603600016
J	Hoag, H				Hoag, H			Atlantic cod meet icy death	NATURE			English	News Item																		Marsh R, 1999, FISH OCEANOGR, V8, P39, DOI 10.1046/j.1365-2419.1999.00092.x	1	18	18	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 24	2003	422	6934					792	792		10.1038/422792b	http://dx.doi.org/10.1038/422792b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670WR	12712158	Bronze			2022-12-24	WOS:000182432600009
J	Saveliev, A; Everett, C; Sharpe, T; Webster, Z; Festenstein, R				Saveliev, A; Everett, C; Sharpe, T; Webster, Z; Festenstein, R			DNA triplet repeats mediate heterochromatin-protein-1-sensitive variegated gene silencing	NATURE			English	Article							MYOTONIC-DYSTROPHY; TRINUCLEOTIDE REPEAT; TRANSGENIC MICE; HISTONE H3; HETEROCHROMATIN PROTEIN-1; CTG REPEAT; HIGH-LEVEL; LYSINE 9; IN-VIVO; EXPANSION	Gene repression is crucial to the maintenance of differentiated cell types in multicellular organisms, whereas aberrant silencing can lead to disease. The organization of DNA into chromatin and heterochromatin(1) is implicated in gene silencing. In chromatin, DNA wraps around histones, creating nucleosomes. Further condensation of chromatin, associated with large blocks of repetitive DNA sequences, is known as heterochromatin. Position effect variegation (PEV) occurs when a gene is located abnormally close to heterochromatin, silencing the affected gene in a proportion of cells(1). Here we show that the relatively short triplet-repeat expansions found inmyotonic dystrophy and Friedreich's ataxia confer variegation of expression on a linked transgene in mice. Silencing was correlated with a decrease in promoter accessibility and was enhanced by the classical PEV modifier heterochromatin protein 1 ( HP1). Notably, triplet-repeat-associated variegation was not restricted to classical heterochromatic regions but occurred irrespective of chromosomal location. Because the phenomenon described here shares important features with PEV, the mechanisms underlying heterochromatin-mediated silencing might have a role in gene regulation at many sites throughout the mammalian genome and modulate the extent of gene silencing and hence severity in several triplet-repeat diseases.	Univ London Imperial Coll Sci Technol & Med, Sch Med, CSC Gene Control Mechanisms & Dis Grp, Fac Med, London W12 0NN, England; MRC, Ctr Clin Sci, Transgen & Embryon Stem Cell Lab, London W12 0NN, England; Natl Hosp Neurol & Neurosurg, Inst Neurol, Dept Neurogenet, London WC1N 3BG, England	Imperial College London; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust	Festenstein, R (corresponding author), Univ London Imperial Coll Sci Technol & Med, Sch Med, CSC Gene Control Mechanisms & Dis Grp, Fac Med, Hammersmith Campus,Du Cane Rd, London W12 0NN, England.			Saveliev, Alexander/0000-0003-0840-4774				Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; CARANGO P, 1993, GENOMICS, V18, P340, DOI 10.1006/geno.1993.1474; Carter D, 2002, NAT GENET, V32, P623, DOI 10.1038/ng1051; Davis BM, 1997, P NATL ACAD SCI USA, V94, P7388, DOI 10.1073/pnas.94.14.7388; Dillon N, 2002, TRENDS GENET, V18, P252, DOI 10.1016/S0168-9525(02)02648-3; DORER DR, 1994, CELL, V77, P993, DOI 10.1016/0092-8674(94)90439-1; Festenstein R, 1999, NAT GENET, V23, P457, DOI 10.1038/70579; Festenstein R, 1996, SCIENCE, V271, P1123, DOI 10.1126/science.271.5252.1123; Garrick D, 1998, NAT GENET, V18, P56, DOI 10.1038/ng0198-56; GREAVES DR, 1989, CELL, V56, P979, DOI 10.1016/0092-8674(89)90631-4; GROSVELD F, 1987, CELL, V51, P975, DOI 10.1016/0092-8674(87)90584-8; Hwang KK, 2001, P NATL ACAD SCI USA, V98, P11423, DOI 10.1073/pnas.211303598; Kioussis D, 1997, CURR OPIN GENET DEV, V7, P614, DOI 10.1016/S0959-437X(97)80008-1; Klesert TR, 1997, NAT GENET, V16, P402, DOI 10.1038/ng0897-402; Klesert TR, 2000, NAT GENET, V25, P105, DOI 10.1038/75490; KRAHE R, 1995, GENOMICS, V28, P1, DOI 10.1006/geno.1995.1099; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; LAKE RA, 1990, EMBO J, V9, P3129, DOI 10.1002/j.1460-2075.1990.tb07510.x; Litt MD, 2001, SCIENCE, V293, P2453, DOI 10.1126/science.1064413; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; Mankodi A, 2000, SCIENCE, V289, P1769, DOI 10.1126/science.289.5485.1769; Milot E, 1996, CELL, V87, P105, DOI 10.1016/S0092-8674(00)81327-6; Nielsen SJ, 2001, NATURE, V412, P561, DOI 10.1038/35087620; Sakamoto N, 2001, J BIOL CHEM, V276, P27171, DOI 10.1074/jbc.M101879200; Sun FL, 2001, MOL CELL BIOL, V21, P2867, DOI 10.1128/MCB.21.8.2867-2879.2001; WANG YH, 1994, SCIENCE, V265, P669, DOI 10.1126/science.8036515; WELLS RD, 1988, FASEB J, V2, P2939, DOI 10.1096/fasebj.2.14.3053307; WIJGERDE M, 1995, NATURE, V377, P209, DOI 10.1038/377209a0	30	200	212	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 24	2003	422	6934					909	913		10.1038/nature01596	http://dx.doi.org/10.1038/nature01596			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670WR	12712207				2022-12-24	WOS:000182432600059
J	Chaudhuri, J; Tian, M; Khuong, C; Chua, K; Pinaud, E; Alt, FW				Chaudhuri, J; Tian, M; Khuong, C; Chua, K; Pinaud, E; Alt, FW			Transcription-targeted DNA deamination by the AID antibody diversification enzyme	NATURE			English	Article							IMMUNOGLOBULIN SWITCH REGIONS; SOMATIC HYPERMUTATION; MECHANISM; RECOMBINATION; SEQUENCES; COMPLEX; REPAIR	Activation-induced cytidine deaminase (AID), which is specific to B lymphocytes, is required for class switch recombination (CSR)-a process mediating isotype switching of immunoglobulin-and somatic hypermutation-the introduction of many point mutations into the immunoglobulin variable region genes(1,2). It has been suggested that AID may function as an RNA-editing enzyme(3) or as a cytidine deaminase on DNA(4),(5). However, the precise enzymatic activity of AID has not been assessed in previous studies. Similarly, although transcription of the target immunoglobulin locus sequences is required for both CSR and somatic hypermutation, the precise role of transcription has remained speculative(6-9). Here we use two different assays to demonstrate that AID can deaminate specifically cytidines on single-stranded (ss) DNA but not double-stranded (ds) DNA substrates in vitro. However, dsDNA can be deaminated by AID in vitro when the reaction is coupled to transcription. Moreover, a synthetic dsDNA sequence, which targets CSR in vivo in a manner dependent on transcriptional orientation(10), was deaminated by AID in vitro with the same transcriptional-orientation-dependence as observed for endogenous CSR. We conclude that transcription targets the DNA deamination activity of AID to dsDNA by generating secondary structures that provide ssDNA substrates.	Childrens Hosp, Howard Hughes Med Inst, Ctr Blood Res, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Howard Hughes Medical Institute; Harvard University; Harvard Medical School	Alt, FW (corresponding author), Childrens Hosp, Howard Hughes Med Inst, Ctr Blood Res, Boston, MA 02115 USA.	alt@enders.tch.harvard.edu	PINAUD, Eric/O-8443-2016	PINAUD, Eric/0000-0001-7405-9273				Artsimovitch I, 2002, CELL, V109, P193, DOI 10.1016/S0092-8674(02)00724-9; Bassing CH, 2002, CELL, V109, pS45, DOI 10.1016/S0092-8674(02)00675-X; Daniels GA, 1995, NUCLEIC ACIDS RES, V23, P5006, DOI 10.1093/nar/23.24.5006; Di Noia J, 2002, NATURE, V419, P43, DOI 10.1038/nature00981; Doi T, 2003, P NATL ACAD SCI USA, V100, P2634, DOI 10.1073/pnas.0437710100; DUNNICK W, 1993, NUCLEIC ACIDS RES, V21, P365, DOI 10.1093/nar/21.3.365; Faili A, 2002, NAT IMMUNOL, V3, P815, DOI 10.1038/ni826; Honjo T, 2002, ANNU REV IMMUNOL, V20, P165, DOI 10.1146/annurev.immunol.20.090501.112049; Luby TM, 2001, J EXP MED, V193, P159, DOI 10.1084/jem.193.2.159; Manis JP, 2002, TRENDS IMMUNOL, V23, P31, DOI 10.1016/S1471-4906(01)02111-1; Martin A, 2002, NAT REV IMMUNOL, V2, P605, DOI 10.1038/nri858; Martin A, 2002, NATURE, V415, P802, DOI 10.1038/nature714; Mizuta R, 2003, J BIOL CHEM, V278, P4431, DOI 10.1074/jbc.M209262200; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Papavasiliou FN, 2002, J EXP MED, V195, P1193, DOI 10.1084/jem.20011858; PAPAVASILIOU FN, 2002, CELL S1, V109, P35; Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862; Rada C, 2002, CURR BIOL, V12, P1748, DOI 10.1016/S0960-9822(02)01215-0; RAMIRO AR, IN PRESS NATURE IMMU; REABAN ME, 1990, NATURE, V348, P342, DOI 10.1038/348342a0; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Sartori AA, 2001, J BIOL CHEM, V276, P29979, DOI 10.1074/jbc.M102985200; Shanmugam A, 2000, J EXP MED, V191, P1365, DOI 10.1084/jem.191.8.1365; SHINKUTA R, IN PRESS NATURE IMMU; Stavnezer J, 2000, CURR TOP MICROBIOL, V245, P127; Storb U, 1998, IMMUNOL REV, V162, P153; Tashiro J, 2001, INT IMMUNOL, V13, P495, DOI 10.1093/intimm/13.4.495; Tian M, 2000, J BIOL CHEM, V275, P24163, DOI 10.1074/jbc.M003343200; Yoshikawa K, 2002, SCIENCE, V296, P2033, DOI 10.1126/science.1071556; YU K, IN PRESS NATURE IMMU	31	576	586	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 17	2003	422	6933					726	730		10.1038/nature01574	http://dx.doi.org/10.1038/nature01574			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668CG	12692563				2022-12-24	WOS:000182272300043
J	Clarke, T				Clarke, T			Infection risk puts the brakes on Canada's biomedical research	NATURE			English	News Item																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 17	2003	422	6933					652	652		10.1038/422652b	http://dx.doi.org/10.1038/422652b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668CG	12700726	Bronze			2022-12-24	WOS:000182272300009
J	Minto, CL; Liao, LM; Woodhouse, CRJ; Ransley, PG; Creighton, SM				Minto, CL; Liao, LM; Woodhouse, CRJ; Ransley, PG; Creighton, SM			The effect of clitoral surgery on sexual outcome in individuals who have intersex conditions with ambiguous genitalia: a cross-sectional study	LANCET			English	Article							FEMINIZING GENITOPLASTY; GENDER ASSIGNMENT; HERMAPHRODITISM; RECONSTRUCTION; MANAGEMENT	Background The effects on sexual function of surgical removal of parts of the clitoris are unknown. For infants with intersex conditions and ambiguous genitalia being raised female, this surgery is often undertaken in early childhood. Our aim was to assess the effects of surgery on sexual outcome in this population. Method We did a cross-sectional study to which we recruited 39 adults who had intersex conditions with ambiguous genitalia who were living as female from clinical (n=15) and peer-support (n=24) settings. We obtained data by use of a postal questionnaire, incorporating a validated sexual function assessment inventory. We also obtained hospital notes of 36 respondents who did not want to remain anonymous, and did genital examinations of 19 women. We assessed sexual problems in relation to surgical history and compared the results for our population to those of a healthy control group. Findings Of the 39 individuals enrolled, 28 had been sexually active and all had sexual difficulties. The 18 women who had undergone clitoral surgery had higher rates of non-sensuality (78%) and of inability to achieve orgasm (39%) than did the ten who had not had surgery (20% [p=0.002] and 0% [p=0.03], respectively). Interpretation Sexual function could be compromised by clitoral surgery. Debate on the ethics of the use of this surgery in children should be promoted and further multicentre research is needed to ensure representative samples and comprehensive outcome assessment. Meanwhile, parents and patients who consent to clitoral surgery should be fully informed of the potential risks to sexual function.	UCL Hosp NHS Trust, Elizabeth Garrett Anderson Hosp, Dept Obstet & Gynaecol, London WC1E 6DH, England; UCL Hosp NHS Trust, Middlesex Hosp, Inst Urol, London, England; Great Ormond St Hosp Sick Children, London WC1N 3JH, England	University College London Hospitals NHS Foundation Trust; University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Creighton, SM (corresponding author), UCL Hosp NHS Trust, Elizabeth Garrett Anderson Hosp, Dept Obstet & Gynaecol, Huntley St, London WC1E 6DH, England.	sarah.creighton@uclh.org						Baskin LS, 1999, J UROLOGY, V162, P1015, DOI 10.1016/S0022-5347(01)68052-2; Blackless M, 2000, AM J HUM BIOL, V12, P151, DOI 10.1002/(SICI)1520-6300(200003/04)12:2<151::AID-AJHB1>3.0.CO;2-F; Costa EMF, 1997, FERTIL STERIL, V67, P229; Creighton S, 2001, BMJ-BRIT MED J, V323, P1264, DOI 10.1136/bmj.323.7324.1264; DITTMANN RW, 1992, PSYCHONEUROENDOCRINO, V17, P153, DOI 10.1016/0306-4530(92)90054-B; Glassberg KI, 1999, J UROLOGY, V161, P1308, DOI 10.1016/S0022-5347(01)61676-8; GOLOMBOK S, 1984, BR J SEX MED, V11, P171; Golombok S., 1994, GENDER DEV; GONZALEZ R, 1990, J UROLOGY, V143, P776, DOI 10.1016/S0022-5347(17)40091-7; HAMPSON JL, 1961, SEX INTERNAL SECRETI, P1401; HINDERER UT, 1989, PLAST RECONSTR SURG, V84, P325, DOI 10.1097/00006534-198908000-00022; Jones Howard Wilbur, 1958, HERMAPHRODITISM GENI; May B, 1996, J Health Psychol, V1, P479, DOI 10.1177/135910539600100406; Meyer-Bahlburg HFL, 1999, J CLIN ENDOCR METAB, V84, P3455, DOI 10.1210/jc.84.10.3455; MINTO CL, IN PRESS FERTIL STER; MONEY J, 1955, B JOHNS HOPKINS HOSP, V97, P301; MONEY J, 1955, B JOHNS HOPKINS HOSP, V97, P284; NEWMAN K, 1992, J PEDIATR SURG, V27, P180, DOI 10.1016/0022-3468(92)90308-T; O'Connell HE, 1998, J UROLOGY, V159, P1892, DOI 10.1016/S0022-5347(01)63188-4; Passerini-Glazel G, 1999, J UROLOGY, V161, P1592, DOI 10.1016/S0022-5347(05)68987-2; RAJFER J, 1982, J UROLOGY, V128, P341, DOI 10.1016/S0022-5347(17)52916-X; Rink RC, 1998, WORLD J UROL, V16, P212, DOI 10.1007/s003450050055; RUST J, 1985, BRIT J CLIN PSYCHOL, V24, P63, DOI 10.1111/j.2044-8260.1985.tb01314.x; RUST J, 1986, INTERPERSONAL DIFFIC, P51; Slijper FME, 1998, ARCH SEX BEHAV, V27, P125, DOI 10.1023/A:1018670129611; Von Prader A, 1954, HELV PEDIAT ACTA, V9, P231; Young Hugh, 1937, GENITAL ABNORMALITIE; Zucker Kenneth J, 2002, J Pediatr Adolesc Gynecol, V15, P3, DOI 10.1016/S1083-3188(01)00133-4	28	186	199	0	16	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 12	2003	361	9365					1252	1257		10.1016/S0140-6736(03)12980-7	http://dx.doi.org/10.1016/S0140-6736(03)12980-7			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	666DM	12699952				2022-12-24	WOS:000182161600009
J	Schroder, R				Schroder, R			The genes orthodenticle and hunchback substitute for bicoid in the beetle Tribolium	NATURE			English	Article							DROSOPHILA EMBRYO; AXIS FORMATION; EXPRESSION; ANTERIOR; SEGMENTATION; INSECTS; RNA; PROTEIN; ELEGANS; PATTERN	In Drosophila, the morphogen Bicoid organizes anterior patterning in a concentration-dependent manner by activating the transcription of target genes such as orthodenticle (otd)(1) and hunchback (hb), and by repressing the translation of caudal(2),(3). Homologues of the bicoid gene have not been isolated in any organism apart from the higher Dipterans(4-7). In fact, head and thorax formation in other insects is poorly understood. To elucidate this process in a short-germband insect, I analysed the function of the conserved genes orthodenticle-1 (otd-1) and hb in the flour beetle Tribolium castaneum. Here I show that, in contrast to Drosophila, Tribolium otd-1 messenger RNA is maternally inherited by the embryo. Reduction of Tribolium otd-1 levels by RNA interference (RNAi) results in headless embryos. This shows that otd-1 is required for anterior patterning in Tribolium. As in Drosophila, Tribolium hb specifies posterior gnathal and thoracic segments. The head, thorax and the anterior abdomen fail to develop in otd-1/hb double-RNAi embryos. This phenotype is similar to that of strong bicoid mutants in Drosophila. I propose that otd-1 and hb are part of an ancestral anterior patterning system.	Univ Tubingen, Interfak Inst Zellbiol, Abt Genet Tiere, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen	Schroder, R (corresponding author), Univ Tubingen, Interfak Inst Zellbiol, Abt Genet Tiere, Morgenstelle 28, D-72076 Tubingen, Germany.			Schroder, Reinhard/0000-0002-3483-1916				Brown S, 2001, CURR BIOL, V11, pR43, DOI 10.1016/S0960-9822(01)00007-0; Brown SJ, 1999, EVOL DEV, V1, P11, DOI 10.1046/j.1525-142x.1999.99013.x; Bucher G, 2002, CURR BIOL, V12, pR85, DOI 10.1016/S0960-9822(02)00666-8; COHEN S, 1991, TRENDS GENET, V7, P267; Dearden P, 1999, CURR BIOL, V9, pR591, DOI 10.1016/S0960-9822(99)80381-9; Draper BW, 1996, CELL, V87, P205, DOI 10.1016/S0092-8674(00)81339-2; Dubnau J, 1996, NATURE, V379, P694, DOI 10.1038/379694a0; Falciani F, 1996, P NATL ACAD SCI USA, V93, P8479, DOI 10.1073/pnas.93.16.8479; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; FROHNHOFER HG, 1986, NATURE, V324, P120, DOI 10.1038/324120a0; Gamberi C, 2002, DEVELOPMENT, V129, P2699; Gao Q, 1998, DEVELOPMENT, V125, P4185; Isaacs HV, 1999, EVOL DEV, V1, P143, DOI 10.1046/j.1525-142x.1999.99020.x; Lall S, 2003, CURR BIOL, V13, P224, DOI 10.1016/S0960-9822(03)00045-9; Lall S, 2001, ANNU REV GENET, V35, P407, DOI 10.1146/annurev.genet.35.102401.090832; LEHMANN R, 1987, DEV BIOL, V119, P402, DOI 10.1016/0012-1606(87)90045-5; Li YB, 1996, DEV GENES EVOL, V206, P35, DOI 10.1007/s004270050028; Niessing D, 2000, MOL CELL, V5, P395, DOI 10.1016/S1097-2765(00)80434-7; Patel NH, 2001, DEVELOPMENT, V128, P3459; Pultz MA, 1999, DEVELOPMENT, V126, P701; RiveraPomar R, 1996, NATURE, V379, P746, DOI 10.1038/379746a0; SCHRODER R, 1993, ROUX ARCH DEV BIOL, V203, P34, DOI 10.1007/BF00539888; SIMPSONBROSE M, 1994, CELL, V78, P855, DOI 10.1016/S0092-8674(94)90622-X; SOMMER R, 1991, DEVELOPMENT, V113, P419; Stauber M, 1999, P NATL ACAD SCI USA, V96, P3786, DOI 10.1073/pnas.96.7.3786; Stauber M, 2002, P NATL ACAD SCI USA, V99, P274, DOI 10.1073/pnas.012292899; STJOHNSTON D, 1992, CELL, V68, P201; TAUTZ D, 1994, DEVELOPMENT, P193; Wimmer EA, 2000, SCIENCE, V287, P2476, DOI 10.1126/science.287.5462.2476; Wolff C, 1995, DEVELOPMENT, V121, P4227	30	141	148	1	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 10	2003	422	6932					621	625		10.1038/nature01536	http://dx.doi.org/10.1038/nature01536			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665GN	12687002				2022-12-24	WOS:000182111400044
J	Faivre, B; Gregoire, A; Preault, M; Cezilly, F; Sorci, G				Faivre, B; Gregoire, A; Preault, M; Cezilly, F; Sorci, G			Immune activation rapidly mirrored in a secondary sexual trait	SCIENCE			English	Article							CAROTENOIDS		Univ Bourgogne, CNRS, UMR Biogeosci 5561, Equipe Ecol Evolut, F-21000 Dijon, France; Univ Paris 06, CNRS, UMR 7103, Lab Parasitol Evolut, F-75252 Paris 05, France	Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Faivre, B (corresponding author), Univ Bourgogne, CNRS, UMR Biogeosci 5561, Equipe Ecol Evolut, 6 Blvd Gabriel, F-21000 Dijon, France.	bfaivre@u-bourgogne.fr	Gregoire, Arnaud/B-6321-2008	Gregoire, Arnaud/0000-0001-6103-355X; Sorci, Gabriele/0000-0002-0799-3995				Andersson Malte, 1994; BENDICH A, 1989, J NUTR, V119, P112, DOI 10.1093/jn/119.1.112; Bright A, 2002, ANIM BEHAV, V64, P207, DOI 10.1006/anbe.2002.3042; Faivre B, 2001, ANIM BEHAV, V61, P969, DOI 10.1006/anbe.2000.1669; JYONOUCHI H, 1994, NUTR CANCER, V21, P47, DOI 10.1080/01635589409514303; Mortensen A, 1997, FEBS LETT, V418, P91, DOI 10.1016/S0014-5793(97)01355-0; Olson VA, 1998, TRENDS ECOL EVOL, V13, P510, DOI 10.1016/S0169-5347(98)01484-0	7	334	340	3	83	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 4	2003	300	5616					103	103		10.1126/science.1081802	http://dx.doi.org/10.1126/science.1081802			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663CP	12677062				2022-12-24	WOS:000181988900040
J	Strauss, SH				Strauss, SH			Genetic technologies - Genomics, genetic engineering, and domestication of crops	SCIENCE			English	Editorial Material							TOLERANCE; BIOLOGY		Oregon State Univ, Dept Forest Sci, Corvallis, OR 97331 USA	Oregon State University	Strauss, SH (corresponding author), Oregon State Univ, Dept Forest Sci, Peavy Hall 154, Corvallis, OR 97331 USA.	Steve.Strauss@orst.edu						[Anonymous], 1982, AM HERITAGE DICT, VThird; Bennetzen J, 2002, SCIENCE, V296, P60, DOI 10.1126/science.1071402; Chen THH, 2002, CURR OPIN PLANT BIOL, V5, P250, DOI 10.1016/S1369-5266(02)00255-8; DUVICK D, 2001, COMMUNICATION; HANCOCK J, COMMUNICATION; KAUFMAN M, 2001, WASHINGTON POST 0301, pA17; Matsuoka M, 2001, ANNU REV PLANT PHYS, V52, P297, DOI 10.1146/annurev.arplant.52.1.297; *NAT RES COUNC, 2002, ENV EFF TRANSG PLANT; Siegal ML, 2002, P NATL ACAD SCI USA, V99, P10528, DOI 10.1073/pnas.102303999; Wolfenbarger LL, 2000, SCIENCE, V290, P2088, DOI 10.1126/science.290.5499.2088; Yeo A, 1998, J EXP BOT, V49, P915, DOI 10.1093/jexbot/49.323.915; 2002, FED REG, V68, P50578	12	51	53	3	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 4	2003	300	5616					61	62		10.1126/science.1079514	http://dx.doi.org/10.1126/science.1079514			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663CP	12677045				2022-12-24	WOS:000181988900023
J	Knapp, S				Knapp, S			Dynamic diversity	NATURE			English	Article									Nat Hist Museum, Dept Bot, London SW7 5BD, England	Natural History Museum London	Knapp, S (corresponding author), Nat Hist Museum, Dept Bot, Cromwell Rd, London SW7 5BD, England.		Knapp, Sandra/A-4856-2011	Knapp, Sandra/0000-0001-7698-3945				DALY HE, 2002, WORLD BANK ANN REV 2, P15; ORiordan T., 2002, BIODIVERSITY SUSTAIN; Orr DW, 2002, CONSERV BIOL, V16, P1457; Raven PH, 2002, SCIENCE, V297, P954, DOI 10.1126/science.297.5583.954; Rees WE, 2003, NATURE, V421, P898, DOI 10.1038/421898a; *ROYAL SOC WORK GR, 2003, MEAS BIOD	6	11	11	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 3	2003	422	6931					475	475		10.1038/422475a	http://dx.doi.org/10.1038/422475a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	662TW	12673231				2022-12-24	WOS:000181965400020
J	Schober, SE; Sinks, TH; Jones, RL; Bolger, PM; McDowell, M; Osterloh, J; Garrett, ES; Canady, RA; Dillon, CF; Sun, Y; Joseph, CB; Mahaffey, KR				Schober, SE; Sinks, TH; Jones, RL; Bolger, PM; McDowell, M; Osterloh, J; Garrett, ES; Canady, RA; Dillon, CF; Sun, Y; Joseph, CB; Mahaffey, KR			Blood mercury levels in US children and women of childbearing age, 1999-2000	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							METHYLMERCURY EXPOSURE; FISH CONSUMPTION; POPULATION; DISEASE; HAIR	Context Humans are exposed to methylmercury, a well-established neurotoxin, through fish consumption. The fetus is most sensitive to the adverse effects of, exposure. The extent of exposure to methylmercury in US women of reproductive age is not known. Objective To describe the distribution of blood mercury levels in US children and women of childbearing age and the association with sociodemographic characteristics and fish consumption. Design and Setting The 1999-2000 data from, the National Health and Nutrition Examination Survey, a cross-sectional survey of the noninstitutionalized US population. Participants In 1999-2000,1250 children aged 1 to 5 years and 2314 women aged 16 to 49 years were selected to participate in the survey. Household interviews, physical examinations, and blood mercury levels assessments were performed on 705 children (56% response rate) and 1709 women (74% response rate). Main Outcome Measure Blood concentration of total mercury. Results Blood mercury levels were approximately 3-fold higher in women compared with children. The geometric mean concentration of total blood mercury was 0.34 mug/L (95% confidence interval [CI], 0.30-0.39 mug/L) in children and 1.02 mug/L (95% Cl, 0.85-1.20 mug/L) in women. Geometric mean mercury levels were almost 4-fold higher among women who ate 3 or more servings of fish in the past 30 days compared with women who ate no fish in that period (1.94 mug/L vs 0.51 mug/L; P<.001). Conclusions Measures of mercury exposure in women of childbearing age and young children generally fall below levels of concern. However, approximately 8% of women had concentrations higher than the US Environmental Protection Agency's recommended reference dose (5.8 &mu;g/L), below which exposures are considered to be without adverse effects. Women who are pregnant or who intend to become pregnant should follow federal and state advisories on consumption of fish.	Ctr Dis Control & Prevent, Natl Ctr Hlth Stat, Hyattsville, MD 20782 USA; Ctr Dis Control & Prevent, Natl Ctr Environm Hlth, Atlanta, GA USA; US FDA, Ctr Food Safety & Appl Nutr, College Pk, MD USA; Natl Marine Fisheries Serv, Natl Ocean & Atmospher Adm, Pascagoula, MS USA; Orkand Corp, Falls Church, VA USA; US EPA, Off Sci Coordinat & Policy, Off Prevent Pesticides & Tox Subst, Washington, DC 20460 USA	Centers for Disease Control & Prevention - USA; CDC National Center for Health Statistics (NCHS); Centers for Disease Control & Prevention - USA; US Food & Drug Administration (FDA); National Aeronautics & Space Administration (NASA); National Oceanic Atmospheric Admin (NOAA) - USA; United States Environmental Protection Agency	Schober, SE (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Hlth Stat, 3311 Toledo Rd,Room 4210, Hyattsville, MD 20782 USA.	sschober@cdc.gov						ABERG B, 1969, ARCH ENVIRON HEALTH, V19, P478, DOI 10.1080/00039896.1969.10666872; Agency for Toxic Substances and Disease Registry, 1999, TOX PROF MERC UPD; BAKIR F, 1973, SCIENCE, V181, P230, DOI 10.1126/science.181.4096.230; Bellanger T M, 2000, J La State Med Soc, V152, P64; BRUNE D, 1991, SCI TOTAL ENVIRON, V100, P235, DOI 10.1016/0048-9697(91)90380-W; Burge P, 1994, J Ark Med Soc, V90, P542; *CDCP, 2 NAT REP HUM EXP EN; Chen HP, 1998, ATOM SPECTROSC, V19, P176; *CTR FOOD SAF APPL, IMP MESS PREGN WOM W; Davidson PW, 1998, JAMA-J AM MED ASSOC, V280, P701, DOI 10.1001/jama.280.8.701; Elinder C.G., 1994, BIOL MONITORING META; *FOOD STAND AG, 2003, AG UPD ADV PREGN BRE; Gerstenberger SL, 1997, J TOXICOL-CLIN TOXIC, V35, P377, DOI 10.3109/15563659709043370; Grandjean P, 1999, AM J EPIDEMIOL, V150, P301, DOI 10.1093/oxfordjournals.aje.a010002; Hall RA, 1978, SSRF721 NOAA NMFS; HARADA M, 1995, CRIT REV TOXICOL, V25, P1, DOI 10.3109/10408449509089885; Kales SN, 2002, J OCCUP ENVIRON MED, V44, P143, DOI 10.1097/00043764-200202000-00009; Kjellstrom T, 1989, 3642 NAT SWED ENV PR; KNOBELOCH LM, 1995, ENVIRON HEALTH PERSP, V103, P604, DOI 10.2307/3432438; Kris-Etherton PM, 2002, CIRCULATION, V106, P2747, DOI 10.1161/01.CIR.0000038493.65177.94; Mahaffey KR, 1999, PUBLIC HEALTH REP, V114, P397, DOI 10.1093/phr/114.5.397; Miettinen J. -K., 1973, MERCURY MERCURIALS M, P233; National Academy of Sciences, 2000, TOX EFF METH; National Center for Health Statistics, NAT HLTH NUTR EX SUR; Pichichero ME, 2002, LANCET, V360, P1737, DOI 10.1016/S0140-6736(02)11682-5; Rice DC, 2003, RISK ANAL, V23, P107, DOI 10.1111/1539-6924.00294; Seifert B, 2000, J EXPO ANAL ENV EPID, V10, P552, DOI 10.1038/sj.jea.7500111; SHERLOCK J, 1984, HUM TOXICOL, V3, P117, DOI 10.1177/096032718400300205; Stern AH, 2001, ARCH ENVIRON HEALTH, V56, P4, DOI 10.1080/00039890109604048; Toffleson L, 1986, ENV HLTH PERSPECT, V68, P203; Tsubaki T, 1977, MINAMATA DIS; *US EPA, 1997, MERC STUD REP C, V1; *US EPA, 2002, FISH ADV; *WHO, 1990, WHO ENV HLTH CRIT, V101; CANADA FOOD INSPECTI	35	220	227	1	22	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 2	2003	289	13					1667	1674		10.1001/jama.289.13.1667	http://dx.doi.org/10.1001/jama.289.13.1667			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	662JX	12672735	Bronze			2022-12-24	WOS:000181944500030
J	Cyranoski, D				Cyranoski, D			Japanese team makes stem cells	NATURE			English	News Item																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 5	2003	423	6940					577	577		10.1038/423577b	http://dx.doi.org/10.1038/423577b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686BT	12789307	Bronze			2022-12-24	WOS:000183301200012
J	Herr, AB; Ballister, ER; Bjorkman, PJ				Herr, AB; Ballister, ER; Bjorkman, PJ			Insights into IgA-mediated immune responses from the crystal structures of human Fc alpha RI and its complex with IgA1-Fc	NATURE			English	Article							INHIBITORY RECEPTOR; LIGAND-BINDING; IMMUNOGLOBULIN; DOMAIN; FRAGMENT; ACTIVATION; REVEALS; CD89; IDENTIFICATION; REFINEMENT	Immunoglobulin-alpha (IgA)-bound antigens induce immune effector responses by activating the IgA-specific receptor FcalphaRI (CD89) on immune cells. Here we present crystal structures of human FcalphaRI alone and in a complex with the Fcalpha region of IgA1 (Fcalpha). FcalphaRI has two immunoglobulin-like domains that are oriented at approximately right angles to each other. Fcalpha resembles the Fcs of immunoglobulins IgG and IgE, but has differently located interchain disulphide bonds and external rather than interdomain N-linked carbohydrates. Unlike 1:1 FcgammaRIII:IgG and FcepsilonRI:IgE complexes, two FcalphaRI molecules bind each Fcalpha dimer, one at each Calpha2-Calpha3 junction. The FcalphaRI-binding site on IgA1 overlaps the reported polymeric immunoglobulin receptor (pIgR)-binding site, which might explain why secretory IgA cannot initiate phagocytosis or bind to FcalphaRI-expressing cells in the absence of an integrin co-receptor.	CALTECH, Div Biol 114 96, Pasadena, CA 91125 USA; CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; La Salle High Sch, Pasadena, CA 91107 USA	California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute	Bjorkman, PJ (corresponding author), CALTECH, Div Biol 114 96, Pasadena, CA 91125 USA.	bjorkman@caltech.edu	Herr, Andrew/R-3049-2019	Herr, Andrew/0000-0002-3598-3399; Ballister, Edward/0000-0002-4478-2513				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bracke M, 2001, BLOOD, V97, P3478, DOI 10.1182/blood.V97.11.3478; Brandtzaeg P, 1999, IMMUNOL TODAY, V20, P141, DOI 10.1016/S0167-5699(98)01413-3; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carayannopoulos L, 1996, J EXP MED, V183, P1579, DOI 10.1084/jem.183.4.1579; Chapman TL, 2000, IMMUNITY, V13, P727, DOI 10.1016/S1074-7613(00)00071-6; Corper AL, 1997, NAT STRUCT BIOL, V4, P374, DOI 10.1038/nsb0597-374; DEISENHOFER J, 1981, BIOCHEMISTRY-US, V20, P2361, DOI 10.1021/bi00512a001; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; DeLano WL, 2000, SCIENCE, V287, P1279, DOI 10.1126/science.287.5456.1279; Fan QR, 1997, NATURE, V389, P96, DOI 10.1038/38028; Garman SC, 2000, NATURE, V406, P259, DOI 10.1038/35018500; Garman SC, 2001, J MOL BIOL, V311, P1049, DOI 10.1006/jmbi.2001.4929; Garman SC, 1998, CELL, V95, P951, DOI 10.1016/S0092-8674(00)81719-5; Herr AB, 2003, J MOL BIOL, V327, P645, DOI 10.1016/S0022-2836(03)00149-9; Hexham JM, 1999, J EXP MED, V189, P747, DOI 10.1084/jem.189.4.747; HUBER R, 1976, NATURE, V264, P415, DOI 10.1038/264415a0; Iikura M, 1998, J IMMUNOL, V161, P1510; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Martin WL, 2001, MOL CELL, V7, P867, DOI 10.1016/S1097-2765(01)00230-1; Maxwell KF, 1999, NAT STRUCT BIOL, V6, P437; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; MONTEIRO RC, 1990, J EXP MED, V171, P597, DOI 10.1084/jem.171.3.597; Monteiro RC, 2003, ANNU REV IMMUNOL, V21, P177, DOI 10.1146/annurev.immunol.21.120601.141011; Morton HC, 1999, J EXP MED, V189, P1715; Motegi Y, 1998, J IMMUNOL, V161, P4340; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Norderhaug IN, 1999, CRIT REV IMMUNOL, V19, P481; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pleass RJ, 1999, J BIOL CHEM, V274, P23508, DOI 10.1074/jbc.274.33.23508; PUTNAM FW, 1979, J BIOL CHEM, V254, P2865; Saphire EO, 2002, J MOL BIOL, V319, P9, DOI 10.1016/S0022-2836(02)00244-9; SAUERERIKSSON AE, 1995, STRUCTURE, V3, P265, DOI 10.1016/S0969-2126(01)00157-5; SHOGREN R, 1989, BIOCHEMISTRY-US, V28, P5525, DOI 10.1021/bi00439a029; Sondermann P, 2000, NATURE, V406, P267, DOI 10.1038/35018508; Sondermann P, 1999, EMBO J, V18, P1095, DOI 10.1093/emboj/18.5.1095; Su XD, 1998, SCIENCE, V281, P991, DOI 10.1126/science.281.5379.991; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; van Egmond M, 2000, NAT MED, V6, P680, DOI 10.1038/76261; van Spriel AB, 2001, BLOOD, V97, P2478, DOI 10.1182/blood.V97.8.2478; Vidarsson G, 2001, J IMMUNOL, V166, P6250, DOI 10.4049/jimmunol.166.10.6250; Wan T, 2002, NAT IMMUNOL, V3, P681, DOI 10.1038/ni811; WEISBART RH, 1988, NATURE, V332, P647, DOI 10.1038/332647a0; Wende H, 1999, MAMM GENOME, V10, P154, DOI 10.1007/s003359900961; White KD, 2002, J EXP MED, V196, P551, DOI 10.1084/jem.20020581; Wines BD, 1999, J IMMUNOL, V162, P2146; Wines BD, 2001, J IMMUNOL, V166, P1781, DOI 10.4049/jimmunol.166.3.1781; Wurzburg BA, 2000, IMMUNITY, V13, P375, DOI 10.1016/S1074-7613(00)00037-6; YANG CY, 1979, H-S Z PHYSIOL CHEM, V360, P1919	50	210	227	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 5	2003	423	6940					614	620		10.1038/nature01685	http://dx.doi.org/10.1038/nature01685			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686BT	12768205	Bronze			2022-12-24	WOS:000183301200033
J	Sobngwi, E; Boudou, P; Mauvais-Jarvis, F; Leblanc, H; Velho, G; Vexiau, P; Porcher, R; Hadjadj, S; Pratley, R; Tataranni, PA; Calvo, F; Gautier, JF				Sobngwi, E; Boudou, P; Mauvais-Jarvis, F; Leblanc, H; Velho, G; Vexiau, P; Porcher, R; Hadjadj, S; Pratley, R; Tataranni, PA; Calvo, F; Gautier, JF			Effect of a diabetic environment in utero on predisposition to type 2 diabetes	LANCET			English	Article							INSULIN SECRETORY DYSFUNCTION; IMPAIRED GLUCOSE-TOLERANCE; PIMA-INDIANS; LIFE-STYLE; MELLITUS; RESISTANCE; MOTHERS; PRECURSORS; NIDDM; RATS	Background Type 2 diabetes is affected by genetics and environmental factors. We aimed to assess the effect of an in-utero diabetic environment independently of the genetic background for type 2 diabetes. Methods We measured insulin sensitivity and insulin secretion in response to oral and intravenous glucose in 15 non-diabetic adult offspring of mothers with type 1 diabetes (exposed participants) and 16 offspring of type 1 diabetic fathers (controls). No participants had type 1 diabetes-associated autoantibodies. We also measured pancreatic polypeptide, a marker of parasympathetic drive to the pancreas. Findings There was no difference between the groups with respect to percent body fat and insulin sensitivity. Five of the 15 exposed participants, but none of the controls had impaired glucose tolerance (p=0.02). Early insulin secretion after an oral glucose tolerance test was lower in exposed participants than in controls: 8.6 IU/mmol (SD 5.4) in exposed participants with impaired glucose tolerance, 14.2 IU/mmol (6.5) in those with normal glucose tolerance and 17.7 IU/mmol (10.9) in controls (p=0.04). Mean insulin secretion rate during glucose infusion study was 4.7 pmol/kg per min (3.6) in people with impaired glucose tolerance, 5.5 pmol/kg per min (4.5) in exposed participants with normal glucose tolerance and 7.5 pmol/kg per min (6.1) in controls (p<0.0001). The area under the curve of pancreatic polypeptide 120 min after oral glucose ingestion was 1007 (429) in people with impaired glucose tolerance, 2829 (1701) in those with normal glucose tolerance, and 3224 (1352) in controls (p=0.04). Interpretation Exposure to a diabetic environment in utero is associated with increased occurence of impaired glucose tolerance and a defective insulin secretory response in adult offspring, independent of genetic predisposition to type 2 diabetes. This insulin secretory defect could be related to low parasympathetic tone. Epidemiological studies are needed to confirm our observations before therapeutic strategies can be devised.	Univ Paris 07, St Louis Hosp, Assistance Pub Hop Paris,Sch Med, Dept Endocrinol & Diabet, Paris, France; Univ Paris 07, St Louis Hosp, Assistance Pub Hop Paris,Sch Med, Clin Invest Ctr,INSERM CIC9504, Paris, France; Univ Paris 07, St Louis Hosp, Assistance Pub Hop Paris,Sch Med, Dept Biostat & Med Informat, Paris, France; Hop St Vincent de Paul, INSERM, U561, F-75674 Paris, France; Ctr Hosp Reg & Univ Poitiers, Dept Endocrinol & Diabet, Poitiers, France; NIDDKD, Phoenix Epidemiol & Clin Res Branch, NIH, Phoenix, AZ USA	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite de Franche-Comte; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite de Franche-Comte; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite de Franche-Comte; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CHU Poitiers; Universite de Poitiers; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Gautier, JF (corresponding author), Hop St Louis, INSERM, Dept Endocrinol & Diabet, Ave Claude Vellefaux, F-75010 Paris, France.		Velho, Gilberto/Q-6724-2017	Velho, Gilberto/0000-0001-8811-363X; calvo, fabien/0000-0002-0298-7633; Porcher, Raphael/0000-0002-5277-4679	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK069015, ZIADK069015] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bell GI, 2001, NATURE, V414, P788, DOI 10.1038/414788a; Boloker J, 2002, DIABETES, V51, P1499, DOI 10.2337/diabetes.51.5.1499; Dabelea D, 2000, DIABETES, V49, P2208, DOI 10.2337/diabetes.49.12.2208; DeFronzo RA, 1979, AM J PHYSIOL, V233, P214; EATON RP, 1980, J CLIN ENDOCR METAB, V51, P520, DOI 10.1210/jcem-51-3-520; Gautier JF, 2001, DIABETES, V50, P1828, DOI 10.2337/diabetes.50.8.1828; HAFFNER SM, 1995, DIABETES, V44, P1386, DOI 10.2337/diabetes.44.12.1386; HANSON RL, 1995, AM J HUM GENET, V57, P160; Harder T, 2001, NEUROSCI LETT, V299, P85, DOI 10.1016/S0304-3940(01)01495-1; Hovorka R, 1996, COMPUT METH PROG BIO, V50, P253, DOI 10.1016/0169-2607(96)01755-5; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; LILLIOJA S, 1993, NEW ENGL J MED, V329, P1988, DOI 10.1056/NEJM199312303292703; PETTITT DJ, 1988, DIABETES, V37, P622, DOI 10.2337/diabetes.37.5.622; Plagemann A, 1999, DEV NEUROSCI-BASEL, V21, P58, DOI 10.1159/000017367; Plagemann A, 1997, DIABETOLOGIA, V40, P1094, DOI 10.1007/s001250050792; SILVERMAN BL, 1995, DIABETES CARE, V18, P611, DOI 10.2337/diacare.18.5.611; Teixeira AS, 1999, LIFE SCI, V64, P655, DOI 10.1016/S0024-3205(98)00607-9; Tuomilehto Jaakko, 2001, New England Journal of Medicine, V344, P1343, DOI 10.1056/NEJM200105033441801; Van Assche FA, 2001, BRIT MED BULL, V60, P173, DOI 10.1093/bmb/60.1.173; VANCAUTER E, 1992, DIABETES, V41, P368, DOI 10.2337/diabetes.41.3.368; Weiss PAM, 2000, DIABETES CARE, V23, P905, DOI 10.2337/diacare.23.7.905; Weyer C, 1999, J CLIN INVEST, V104, P787, DOI 10.1172/JCI7231; *WHO, 1985, DIAB MELL REP STUD G	23	205	208	0	6	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 31	2003	361	9372					1861	1865		10.1016/S0140-6736(03)13505-2	http://dx.doi.org/10.1016/S0140-6736(03)13505-2			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	684KL	12788573				2022-12-24	WOS:000183205800011
J	McDonald, D; Wu, L; Bohks, SM; KewalRamani, VN; Unutmaz, D; Hope, TJ				McDonald, D; Wu, L; Bohks, SM; KewalRamani, VN; Unutmaz, D; Hope, TJ			Recruitment of HIV and its receptors to dendritic cell-T cell junctions	SCIENCE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; DC-SIGN; IMMUNOLOGICAL SYNAPSE; ANTIGEN	Monocyte-derived dendritic cells (MDDCs) can efficiently bind and transfer HIV infectivity without themselves becoming infected. Using live-cell microscopy, we found that HIV was recruited to sites of cell contact in MDDCs. Analysis of conjugates between MDDCs and T cells revealed that, in the absence of antigen-specific signaling, the HIV receptors CD4, CCR5, and CXCR4 on the T cell were recruited to the interface while the MDDCs concentrated HIV to the same region. We propose that contact between dendritic cells and T cells facilitates transmission of HIV by locally concentrating virus, receptor, and coreceptor during the formation of an infectious synapse.	Univ Illinois, Dept Microbiol & Immunol, Chicago, IL 60612 USA; NCI, HIV Drug Resistance Program, Frederick, MD 21702 USA; Vanderbilt Univ, Dept Microbiol & Immunol, Nashville, TN 37232 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Vanderbilt University	Hope, TJ (corresponding author), Univ Illinois, Dept Microbiol & Immunol, Chicago, IL 60612 USA.	thope@uic.edu	Wu, Li/E-4330-2011; Wu, Li/ABB-2813-2020; KewalRamani, Vineet/V-5084-2019	Wu, Li/0000-0002-5468-2487; Wu, Li/0000-0002-5468-2487; 	NIAID NIH HHS [R01 AI052051, R01-AI49131, R01-AI52051, R01-AI47770] Funding Source: Medline; NATIONAL CANCER INSTITUTE [Z01BC010485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047770, R01AI049131, R01AI052051] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alvarez CP, 2002, J VIROL, V76, P6841, DOI 10.1128/JVI.76.13.6841-6844.2002; Colmenares M, 2002, J BIOL CHEM, V277, P36766, DOI 10.1074/jbc.M205270200; Dustin ML, 2000, NAT IMMUNOL, V1, P23, DOI 10.1038/76877; Engering A, 2002, J IMMUNOL, V168, P2118, DOI 10.4049/jimmunol.168.5.2118; Frank I, 2002, J VIROL, V76, P2936, DOI 10.1128/JVI.76.6.2936-2951.2002; Geijtenbeek TBH, 2003, J EXP MED, V197, P7, DOI 10.1084/jem.20021229; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Halary F, 2002, IMMUNITY, V17, P653, DOI 10.1016/S1074-7613(02)00447-8; KIMPTON J, 1992, J VIROL, V66, P2232, DOI 10.1128/JVI.66.4.2232-2239.1992; Kwon DS, 2002, IMMUNITY, V16, P135, DOI 10.1016/S1074-7613(02)00259-5; LOZACH PY, J BIOL CHEM     0227; McDonald D, 2002, J CELL BIOL, V159, P441, DOI 10.1083/jcb.200203150; MCDONALD D, UNPUB; Revy P, 2001, NAT IMMUNOL, V2, P925, DOI 10.1038/ni713; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Sanders RW, 2002, J VIROL, V76, P7812, DOI 10.1128/JVI.76.15.7812-7821.2002; Tailleux L, 2003, J EXP MED, V197, P121, DOI 10.1084/jem.20021468; Turville SG, 2002, NAT IMMUNOL, V3, P975, DOI 10.1038/ni841	19	559	578	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 23	2003	300	5623					1295	1297		10.1126/science.1084238	http://dx.doi.org/10.1126/science.1084238			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681NN	12730499				2022-12-24	WOS:000183042400050
J	Cheung, WL; Ajiro, K; Samejima, K; Kloc, M; Cheung, P; Mizzen, CA; Beeser, A; Etkin, LD; Chernoff, J; Earnshaw, WC; Allis, CD				Cheung, WL; Ajiro, K; Samejima, K; Kloc, M; Cheung, P; Mizzen, CA; Beeser, A; Etkin, LD; Chernoff, J; Earnshaw, WC; Allis, CD			Apoptotic phosphorylation of histone H2B is mediated by mammalian sterile twenty kinase	CELL			English	Article							PROGRAMMED CELL-DEATH; STE20-LIKE PROTEIN-KINASE; HP1 CHROMO DOMAIN; DNA FRAGMENTATION; SACCHAROMYCES-CEREVISIAE; N-TERMINUS; LYSINE 9; H3; CONDENSATION; ACTIVATION	DNA in eukaryotic cells is associated with histone proteins; hence, hallmark properties of apoptosis, such as chromatin condensation, may be regulated by post-translational histone modifications. Here we report that phosphorylation of histone H2B at serine 14 (S14) correlates with cells undergoing programmed cell death in vertebrates. We identify a 34 kDa apoptosis-induced H2B kinase as caspase-cleaved Mst1 (mammalian sterile twenty) kinase. Mst1 can phosphorylate H2B at S14 in vitro and in vivo, and the onset of H2B S14 phosphorylation is dependent upon cleavage of Mst1 by caspase-3. These data reveal a histone modification that is uniquely associated with apoptotic chromatin in species ranging from frogs to humans and provide insights into a previously unrecognized physiological substrate for Mst1 kinase. Our data provide evidence for a potential apoptotic "histone code.".	Univ Virginia Hlth Syst, Dept Microbiol, Charlottesville, VA 22908 USA; Univ Virginia Hlth Syst, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA; Univ Edinburgh, Inst Cell & Mol Biol, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland; Univ Texas, MD Anderson Canc Ctr, Dept Mol Genet, Houston, TX 77030 USA; Fox Chase Canc Ctr, Philadelphia, PA 19111 USA	University of Virginia; University of Virginia; University of Edinburgh; University of Texas System; UTMD Anderson Cancer Center; Fox Chase Cancer Center	Allis, CD (corresponding author), Rockefeller Univ, Lab Chromatin Biol, 1230 York Ave, New York, NY 10021 USA.	alliscd@mail.rockefeller.edu	Kloc, Malgorzata/AAF-6982-2020; Earnshaw, William/AAY-7438-2020; Chernoff, Jonathan/I-7631-2014	Chernoff, Jonathan/0000-0002-4803-7836; Earnshaw, William/0000-0002-7191-0621	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054168, R01GM040922] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM40922, GM54168] Funding Source: Medline; Wellcome Trust [073915] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Wellcome Trust(Wellcome TrustEuropean Commission)		Ajiro K, 2000, J BIOL CHEM, V275, P439, DOI 10.1074/jbc.275.1.439; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Briggs SD, 2001, GENE DEV, V15, P3286, DOI 10.1101/gad.940201; Cheung P, 2000, CELL, V103, P263, DOI 10.1016/S0092-8674(00)00118-5; Creasy CL, 1996, J BIOL CHEM, V271, P21049, DOI 10.1074/jbc.271.35.21049; CREASY CL, 1995, J BIOL CHEM, V270, P21695, DOI 10.1074/jbc.270.37.21695; Dan I, 2001, TRENDS CELL BIOL, V11, P220, DOI 10.1016/S0962-8924(01)01980-8; de la Barre AE, 2001, EMBO J, V20, P6383, DOI 10.1093/emboj/20.22.6383; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; Duriez PJ, 1997, BIOCHEM CELL BIOL, V75, P337, DOI 10.1139/bcb-75-4-337; Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383; Graves JD, 2001, J BIOL CHEM, V276, P14909, DOI 10.1074/jbc.M010905200; Graves JD, 1998, EMBO J, V17, P2224, DOI 10.1093/emboj/17.8.2224; Grutter MG, 2000, CURR OPIN STRUC BIOL, V10, P649, DOI 10.1016/S0959-440X(00)00146-9; Haunstetter A, 2000, CARDIOVASC RES, V45, P795, DOI 10.1016/S0008-6363(99)00264-3; Hendzel MJ, 1998, J BIOL CHEM, V273, P24470, DOI 10.1074/jbc.273.38.24470; Jacobs SA, 2001, EMBO J, V20, P5232, DOI 10.1093/emboj/20.18.5232; Jacobson RH, 2000, SCIENCE, V288, P1422, DOI 10.1126/science.288.5470.1422; Jason LJM, 2001, J BIOL CHEM, V276, P14597, DOI 10.1074/jbc.M011153200; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Johnstone RW, 2002, CELL, V108, P153, DOI 10.1016/S0092-8674(02)00625-6; Kaufmann SH, 2001, TRENDS CELL BIOL, V11, P526, DOI 10.1016/S0962-8924(01)02173-0; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; KERR JFR, 1974, J CELL SCI, V14, P571; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee KK, 2001, J BIOL CHEM, V276, P19276, DOI 10.1074/jbc.M005109200; Liu XS, 1998, P NATL ACAD SCI USA, V95, P8461, DOI 10.1073/pnas.95.15.8461; Loetscher H, 2001, DRUG DISCOV TODAY, V6, P671, DOI 10.1016/S1359-6446(01)01826-8; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Madeo F, 1999, J CELL BIOL, V145, P757, DOI 10.1083/jcb.145.4.757; Martin LJ, 2001, INT J MOL MED, V7, P455; Mattson MP, 2001, APOPTOSIS, V6, P69, DOI 10.1023/A:1009676112184; Metzstein MM, 1998, TRENDS GENET, V14, P410, DOI 10.1016/S0168-9525(98)01573-X; PIKE CJ, 1991, BRAIN RES, V563, P311, DOI 10.1016/0006-8993(91)91553-D; Robertson JD, 2000, J STRUCT BIOL, V129, P346, DOI 10.1006/jsbi.2000.4254; Rogakou EP, 2000, J BIOL CHEM, V275, P9390, DOI 10.1074/jbc.275.13.9390; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Samejima K, 2001, J BIOL CHEM, V276, P45427, DOI 10.1074/jbc.M108844200; Sassone-Corsi P, 1999, SCIENCE, V285, P886, DOI 10.1126/science.285.5429.886; Sells MA, 1997, TRENDS CELL BIOL, V7, P162, DOI 10.1016/S0962-8924(97)01003-9; Severin FF, 2002, CURR BIOL, V12, pR233, DOI 10.1016/S0960-9822(02)00776-5; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Strahl BD, 2001, CURR BIOL, V11, P996, DOI 10.1016/S0960-9822(01)00294-9; Th'ng JPH, 2001, BIOCHEM CELL BIOL, V79, P305, DOI 10.1139/bcb-79-3-305; Turner BM, 2000, BIOESSAYS, V22, P836, DOI 10.1002/1521-1878(200009)22:9<836::AID-BIES9>3.0.CO;2-X; Ura S, 2001, P NATL ACAD SCI USA, V98, P10148, DOI 10.1073/pnas.181161698; USUKU G, 1965, DEV BIOL, V11, P352, DOI 10.1016/0012-1606(65)90044-8; VANHOLDE KE, 1988, CHROMATIN, P111; Wolffe AP, 1999, NUCLEIC ACIDS RES, V27, P711, DOI 10.1093/nar/27.3.711; Wyllie A H, 1980, Int Rev Cytol, V68, P251; WYLLIE AH, 1984, J PATHOL, V142, P67, DOI 10.1002/path.1711420112; WYLLIE AH, 1980, NATURE, V284, P555, DOI 10.1038/284555a0; YOSHIZATO K, 1989, INT REV CYTOL, V119, P97; Yun DJ, 1998, MOL CELL, V1, P807, DOI 10.1016/S1097-2765(00)80080-5	55	368	412	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 16	2003	113	4					507	517		10.1016/S0092-8674(03)00355-6	http://dx.doi.org/10.1016/S0092-8674(03)00355-6			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	680MG	12757711	Bronze			2022-12-24	WOS:000182981500012
J	Ren, SX; Gang, F; Jiang, XG; Zeng, R; Miao, YG; Xu, H; Zhang, YX; Xiong, H; Lu, G; Lu, LF; Jiang, HQ; Jia, J; Tu, YF; Jiang, JX; Gu, WY; Zhang, YQ; Cai, Z; Sheng, HH; Yin, HF; Zhang, Y; Zhu, GF; Wan, M; Huang, HL; Qian, Z; Wang, SY; Ma, W; Yao, ZJ; Shen, Y; Qiang, BQ; Xia, QC; Guo, XK; Danchin, A; Saint Girons, I; Somerville, RL; Wen, YM; Shi, MH; Chen, Z; Xu, JG; Zhao, GP				Ren, SX; Gang, F; Jiang, XG; Zeng, R; Miao, YG; Xu, H; Zhang, YX; Xiong, H; Lu, G; Lu, LF; Jiang, HQ; Jia, J; Tu, YF; Jiang, JX; Gu, WY; Zhang, YQ; Cai, Z; Sheng, HH; Yin, HF; Zhang, Y; Zhu, GF; Wan, M; Huang, HL; Qian, Z; Wang, SY; Ma, W; Yao, ZJ; Shen, Y; Qiang, BQ; Xia, QC; Guo, XK; Danchin, A; Saint Girons, I; Somerville, RL; Wen, YM; Shi, MH; Chen, Z; Xu, JG; Zhao, GP			Unique physiological and pathogenic features of Leptospira interrogans revealed by whole-genome sequencing	NATURE			English	Article							PLATELET-ACTIVATING-FACTOR; GENE; MOTILITY; SYNTHASE	Leptospirosis is a widely spread disease of global concern. Infection causes flu-like episodes with frequent severe renal and hepatic damage, such as haemorrhage and jaundice. In more severe cases, massive pulmonary haemorrhages, including fatal sudden haemoptysis, can occur(1). Here we report the complete genomic sequence of a representative virulent serovar type strain (Lai)(2) of Leptospira interrogans serogroup Icterohaemorrhagiae consisting of a 4.33-megabase large chromosome and a 359-kilobase small chromosome, with a total of 4,768 predicted genes. In terms of the genetic determinants of physiological characteristics, the facultatively parasitic L. interrogans differs extensively from two other strictly parasitic pathogenic spirochaetes, Treponema pallidum(3) and Borrelia burgdorferi(4), although similarities exist in the genes that govern their unique morphological features. A comprehensive analysis of the L. interrogans genes for chemotaxis/motility and lipopolysaccharide synthesis provides a basis for in-depth studies of virulence and pathogenesis. The discovery of a series of genes possibly related to adhesion, invasion and the haematological changes that characterize leptospirosis has provided clues about how an environmental organism might evolve into an important human pathogen.	Chinese Natl Human Genome Ctr Shanghai, Shanghai 201203, Peoples R China; Chinese Acad Sci, Bioinformat Ctr, Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China; Chinese Acad Sci, Inst Plant Physiol & Ecol, Biotechnol Res Ctr, Shanghai 200031, Peoples R China; Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China; Shanghai Med Univ 2, Rui Jin Hosp, Dept Microbiol & Parasitol, Shanghai 200025, Peoples R China; Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, ICDC, China CDC, Beijing 102206, Peoples R China; Chinese Natl Human Genome Ctr, Beijing 100170, Peoples R China; Fudan Univ, Dept Mol Virol, Med Ctr, Shanghai 200032, Peoples R China; HKU, Pasteur Res Ctr, Hong Kong, Hong Kong, Peoples R China; Inst Pasteur, Unite Bacteriol Mol & Med, F-75724 Paris 15, France; Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Fudan University; University of Hong Kong; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Zhao, GP (corresponding author), Chinese Natl Human Genome Ctr Shanghai, 250 Bi Bo Rd,Zhang Jiang High Tech Pk, Shanghai 201203, Peoples R China.	gpzhao@sibs.ac.cn	Yin, Haifeng/E-8787-2012; Ma, Wei/B-5999-2012	Zhao, Guo-Ping/0000-0002-7621-6620; Danchin, Antoine/0000-0002-6350-5001; Guo, Xiao-Kui/0000-0002-1595-9965				Arai H, 2002, J BIOCHEM, V131, P635, DOI 10.1093/oxfordjournals.jbchem.a003145; Bourhy P, 2000, FEMS MICROBIOL LETT, V191, P259, DOI 10.1016/S0378-1097(00)00393-1; Charon NW, 2002, ANNU REV GENET, V36, P47, DOI 10.1146/annurev.genet.36.041602.134359; CLAROS MG, 1994, COMPUT APPL BIOSCI, V10, P685; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Faine S, 1999, LEPTOSPIRA LEPTOSPIR, V2nd; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; Fraser CM, 1998, SCIENCE, V281, P375, DOI 10.1126/science.281.5375.375; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Heidelberg JF, 2000, NATURE, V406, P477, DOI 10.1038/35020000; Herter S, 2001, J BACTERIOL, V183, P4305, DOI 10.1128/JB.183.14.4305-4316.2001; Howell DM, 1999, J BACTERIOL, V181, P331, DOI 10.1128/JB.181.1.331-333.1999; Kmety E., 1993, CLASSIFICATION SPECI; KOHLHAW G, 1969, J BIOL CHEM, V244, P2218; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Matsushita O, 1999, J BACTERIOL, V181, P923, DOI 10.1128/JB.181.3.923-933.1999; Motaleb MA, 2000, P NATL ACAD SCI USA, V97, P10899, DOI 10.1073/pnas.200221797; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Olendzenski L, 2000, J MOL EVOL, V51, P587, DOI 10.1007/s002390010122; Picardeau M, 2001, MOL MICROBIOL, V40, P189, DOI 10.1046/j.1365-2958.2001.02374.x; RILEY M, 1993, MICROBIOL REV, V57, P862, DOI 10.1128/MMBR.57.4.862-952.1993; Rodrigo L, 2001, BIOCHEM J, V354, P1, DOI 10.1042/0264-6021:3540001; SAIER M, 2001, SPIROCHETES MOL CELL; Tuckwell D, 1999, BIOCHEM SOC T, V27, P835, DOI 10.1042/bst0270835; Werts C, 2001, NAT IMMUNOL, V2, P346, DOI 10.1038/86354; Wolf YI, 2001, BMC EVOL BIOL, V1, DOI 10.1186/1471-2148-1-8; Zhang CT, 2000, NUCLEIC ACIDS RES, V28, P2804, DOI 10.1093/nar/28.14.2804	29	425	895	4	73	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 24	2003	422	6934					888	893		10.1038/nature01597	http://dx.doi.org/10.1038/nature01597			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670WR	12712204	hybrid			2022-12-24	WOS:000182432600054
J	Rohani, P; Green, CJ; Mantilla-Beniers, NB; Grenfell, BT				Rohani, P; Green, CJ; Mantilla-Beniers, NB; Grenfell, BT			Ecological interference between fatal diseases	NATURE			English	Article							POPULATION; DETERMINANTS; MEASLES; DENGUE	An important issue in population biology is the dynamic interaction between pathogens. Interest has focused mainly on the indirect interaction of pathogen strains, mediated by cross immunity(1-4). However, a mechanism has recently been proposed for 'ecological interference' between pathogens through the removal of individuals from the susceptible pool after an acute infection. To explore this possibility, we have analysed and modelled historical measles and whooping cough records. Here we show that ecological interference is particularly strong when fatal infections permanently remove susceptibles. Disease interference has substantial dynamical consequences, making multi-annual outbreaks of different infections characteristically out of phase. So, when disease prevalence is high and is associated with significant mortality, it might be impossible to understand epidemic patterns by studying pathogens in isolation. This new ecological null model has important consequences for understanding the multi-strain dynamics of pathogens such as dengue and echoviruses.	Univ Georgia, Inst Ecol, Athens, GA 30602 USA; Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England	University System of Georgia; University of Georgia; University of Cambridge	Rohani, P (corresponding author), Univ Georgia, Inst Ecol, Athens, GA 30602 USA.	rohani@uga.edu		rohani, pejman/0000-0002-7221-3801				ANDERSON R M, 1991; ANDERSON RM, 1982, SCIENCE, V215, P1053, DOI 10.1126/science.7063839; BARTLETT MS, 1957, J R STAT SOC SER A-G, V120, P48, DOI 10.2307/2342553; BEHRMAN RE, 1998, NELSON ESSENTIALS PE; Buonaccorsi JP, 2001, ECOLOGY, V82, P1668, DOI 10.2307/2679809; Butler W, 1913, Proc R Soc Med, V6, P120; BUTLER W, 1947, P ROY SOC MED, V40, P384, DOI 10.1177/003591574704000710; Cherry JD, 1998, ANN INTERN MED, V128, P64, DOI 10.7326/0003-4819-128-1-199801010-00010; CREIGHTON C, 1994, HIST EPIDEMICS BRITA; DIETZ K, 1979, J MATH BIOL, V8, P291, DOI 10.1007/BF00276314; Earn DJD, 2000, SCIENCE, V287, P667, DOI 10.1126/science.287.5453.667; Focks DA, 2000, AM J TROP MED HYG, V62, P11, DOI 10.4269/ajtmh.2000.62.11; Gog JR, 2002, J MATH BIOL, V44, P169, DOI 10.1007/s002850100120; Gomes MGM, 2002, P ROY SOC B-BIOL SCI, V269, P227, DOI 10.1098/rspb.2001.1869; Grenfell BT, 2001, NATURE, V414, P716, DOI 10.1038/414716a; Gupta S, 1998, SCIENCE, V280, P912, DOI 10.1126/science.280.5365.912; Hales S, 2002, LANCET, V360, P830, DOI 10.1016/S0140-6736(02)09964-6; Kamo M, 2002, PHYSICA D, V165, P228, DOI 10.1016/S0167-2789(02)00389-5; Keeling MJ, 2001, PHYSICA D, V148, P317, DOI 10.1016/S0167-2789(00)00187-1; Kurane I., 1991, REV MED VIROL, V1, P211; LINNERT L, 1954, STAT REPORT MEASLES; MCLEAN AR, 1988, EPIDEMIOL INFECT, V100, P111, DOI 10.1017/S0950268800065614; Miller E, 1997, DEV BIOLOGICALS, V89, P15; RAND DA, 1991, P ROY SOC B-BIOL SCI, V246, P179, DOI 10.1098/rspb.1991.0142; Rohani P, 1999, SCIENCE, V286, P968, DOI 10.1126/science.286.5441.968; Rohani P, 1998, P ROY SOC B-BIOL SCI, V265, P2033, DOI 10.1098/rspb.1998.0537; Schenzle D, 1984, IMA J Math Appl Med Biol, V1, P169; Soper HE, 1929, J R STAT SOC, V92, P34, DOI 10.2307/2341437; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; WENJIE W, 1997, DENGUE B, V21	30	132	136	3	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 24	2003	422	6934					885	888		10.1038/nature01542	http://dx.doi.org/10.1038/nature01542			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670WR	12712203				2022-12-24	WOS:000182432600053
J	Simerly, C; Dominko, T; Navara, C; Payne, C; Capuano, S; Gosman, G; Chong, KY; Takahashi, D; Chace, C; Compton, D; Hewitson, L; Schatten, G				Simerly, C; Dominko, T; Navara, C; Payne, C; Capuano, S; Gosman, G; Chong, KY; Takahashi, D; Chace, C; Compton, D; Hewitson, L; Schatten, G			Molecular correlates of primate nuclear transfer failures	SCIENCE			English	Article							RHESUS-MONKEYS; FERTILIZATION; SPINDLE; EG5		Univ Pittsburgh, Sch Med, Dept Obstet Gynecol Reprod Sci, Magee Womens Res Inst,Pittsburgh Dev Ctr, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Sch Med, Dept Cell Biol Physiol, Pittsburgh, PA 15213 USA; Dartmouth Coll, Sch Med, Dept Biochem, Hanover, NH 03755 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Dartmouth College	Schatten, G (corresponding author), Univ Pittsburgh, Sch Med, Dept Obstet Gynecol Reprod Sci, Magee Womens Res Inst,Pittsburgh Dev Ctr, Pittsburgh, PA 15213 USA.		Schatten, Gerald/B-3253-2009; simerly, Calvin/AAC-9564-2021; Navara, Christopher/C-2813-2011	Schatten, Gerald/0000-0001-5206-7782; Compton, Duane/0000-0002-4445-9118				Blangy A, 1995, CELL, V83, P1159, DOI 10.1016/0092-8674(95)90142-6; Dominko T, 1999, Cloning, V1, P143, DOI 10.1089/15204559950019906; Hewitson L, 1999, NAT MED, V5, P431, DOI 10.1038/7430; Meng L, 1997, BIOL REPROD, V57, P454, DOI 10.1095/biolreprod57.2.454; Mitalipov SM, 2002, BIOL REPROD, V66, P1367, DOI 10.1095/biolreprod66.5.1367; Mountain V, 1999, J CELL BIOL, V147, P351, DOI 10.1083/jcb.147.2.351; NAVARA CS, 1994, DEV BIOL, V162, P29, DOI 10.1006/dbio.1994.1064; SCHATTEN G, 1994, DEV BIOL, V165, P299, DOI 10.1006/dbio.1994.1256; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Wilmut I, 2002, NAT MED, V8, P215, DOI 10.1038/nm0302-215	10	187	216	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 11	2003	300	5617					297	297		10.1126/science.1082091	http://dx.doi.org/10.1126/science.1082091			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665RQ	12690191				2022-12-24	WOS:000182135400047
J	Dalsgaard, T; Canfield, DE; Petersen, J; Thamdrup, B; Acuna-Gonzalez, J				Dalsgaard, T; Canfield, DE; Petersen, J; Thamdrup, B; Acuna-Gonzalez, J			N-2 production by the anammox reaction in the anoxic water column of Golfo Dulce, Costa Rica	NATURE			English	Article							ANAEROBIC AMMONIUM OXIDATION; OXYGEN-DEFICIENT CONDITIONS; SOUTH-PACIFIC OCEAN; MARINE-SEDIMENTS; NITRATE REDUCTION; ARABIAN SEA; DENITRIFICATION; NITROGEN; NITRIFICATION; MANGANESE	In oxygen-depleted zones of the open ocean, and in anoxic basins and fjords, denitrification (the bacterial reduction of nitrate to give N-2) is recognized as the only significant process converting fixed nitrogen to gaseous N-2. Primary production in the oceans is often limited by the availability of fixed nitrogen such as ammonium or nitrate(1), and nitrogen-removal processes consequently affect both ecosystem function and global biogeochemical cycles. It was recently discovered that the anaerobic oxidation of ammonium with nitrite-the 'anammox' reaction, performed by bacteria-was responsible for a significant fraction of N-2 production in some marine sediments(2). Here we show that this reaction is also important in the anoxic waters of Golfo Dulce, a 200-m-deep coastal bay in Costa Rica, where it accounts for 19-35% of the total N-2 formation in the water column. The water-column chemistry in Golfo Dulce is very similar to that in oxygen-depleted zones of the oceans-in which one-half to one-third of the global nitrogen removal is believed to occur(3,4). We therefore expect the anammox reaction to be a globally significant sink for oceanic nitrogen.	Natl Environm Res Inst, Dept Marine Ecol, DK-8600 Silkeborg, Denmark; Univ So Denmark, Inst Biol, Danish Ctr Earth Syst Sci, DK-5230 Odense M, Denmark; Univ Costa Rica, Ctr Invest Ciencias Mar & Limnol, CIMAR, San Jose, Costa Rica	Aarhus University; University of Southern Denmark; Universidad Costa Rica	Dalsgaard, T (corresponding author), Natl Environm Res Inst, Dept Marine Ecol, Vejlsovej 25,POB 314, DK-8600 Silkeborg, Denmark.		Canfield, Don/C-1735-2012; Thamdrup, Bo/F-3889-2016; Dalsgaard, Tage/J-6258-2014; Dalsgaard, Tage/B-5428-2008	Canfield, Don/0000-0001-7602-8366; Thamdrup, Bo/0000-0002-1221-7077; Dalsgaard, Tage/0000-0003-2604-6499; Dalsgaard, Tage/0000-0003-2604-6499				Bange HW, 2000, GLOBAL BIOGEOCHEM CY, V14, P1283, DOI 10.1029/1999GB001228; BRAMAN RS, 1989, ANAL CHEM, V61, P2715, DOI 10.1021/ac00199a007; CLINE JD, 1972, LIMNOL OCEANOGR, V17, P885, DOI 10.4319/lo.1972.17.6.0885; Codispoti LA, 2001, SCI MAR, V65, P85, DOI 10.3989/scimar.2001.65s285; CODISPOTI LA, 1985, MAR CHEM, V16, P277, DOI 10.1016/0304-4203(85)90051-9; Dalsgaard T, 2002, APPL ENVIRON MICROB, V68, P3802, DOI 10.1128/AEM.68.8.3802-3808.2002; Deutsch C, 2001, GLOBAL BIOGEOCHEM CY, V15, P483, DOI 10.1029/2000GB001291; Falkowski PG, 1998, SCIENCE, V281, P200, DOI 10.1126/science.281.5374.200; Grasshoff K., 1999, METHODS SEAWATER ANA; Gruber N, 1997, GLOBAL BIOGEOCHEM CY, V11, P235, DOI 10.1029/97GB00077; HALL PO, 1992, LIMNOL OCEANOGR, V37, P1113, DOI 10.4319/lo.1992.37.5.1113; Hulth S, 1999, GEOCHIM COSMOCHIM AC, V63, P49, DOI 10.1016/S0016-7037(98)00285-3; KNOWLES R, 1982, MICROBIOL REV, V46, P43, DOI 10.1128/MMBR.46.1.43-70.1982; LIPSCHULTZ F, 1990, DEEP-SEA RES, V37, P1513, DOI 10.1016/0198-0149(90)90060-9; Luther GW, 1997, GEOCHIM COSMOCHIM AC, V61, P4043, DOI 10.1016/S0016-7037(97)00239-1; MURRAY JW, 1999, ENV DEGRADATION BLAC, P75; NAQVI SWA, 1987, J MAR RES, V45, P1049, DOI 10.1357/002224087788327118; NIELSEN LP, 1992, FEMS MICROBIOL ECOL, V86, P357, DOI 10.1016/0378-1097(92)90800-4; Otte S, 1999, APPL ENVIRON MICROB, V65, P3148; Richards F. A., 1965, CHEM OCEANOGR, V1, P611; RICHARDS FA, 1965, ADV WATER POLLUTION, P215; Thamdrup B, 2002, APPL ENVIRON MICROB, V68, P1312, DOI 10.1128/AEM.68.3.1312-1318.2002; Thamdrup B, 1996, REV BIOL TROP, V44, P19; Van Mooy BAS, 2002, GEOCHIM COSMOCHIM AC, V66, P457, DOI 10.1016/S0016-7037(01)00787-6; VANDEGRAAF AA, 1995, APPL ENVIRON MICROB, V61, P1246, DOI 10.1128/AEM.61.4.1246-1251.1995; Vargas JA, 1996, REV BIOL TROP, V44, pU1	26	503	590	7	372	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 10	2003	422	6932					606	608		10.1038/nature01526	http://dx.doi.org/10.1038/nature01526			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665GN	12686998				2022-12-24	WOS:000182111400039
J	Phillips, PEM; Stuber, GD; Heien, MLAV; Wightman, RM; Carelli, RM				Phillips, PEM; Stuber, GD; Heien, MLAV; Wightman, RM; Carelli, RM			Subsecond dopamine release promotes cocaine seeking	NATURE			English	Article							VENTRAL TEGMENTAL AREA; NUCLEUS-ACCUMBENS; EXTRACELLULAR DOPAMINE; DRUG-ADDICTION; NEURONS; REWARD; RATS; ACTIVATION; NEUROBIOLOGY; INTEGRATION	The dopamine-containing projection from the ventral tegmental area of the midbrain to the nucleus accumbens is critically involved in mediating the reinforcing properties of cocaine(1,2). Although neurons in this area respond to rewards on a subsecond timescale(3,4), neurochemical studies have only addressed the role of dopamine in drug addiction by examining changes in the tonic (minute-to-minute) levels of extracellular dopamine(5-9). To investigate the role of phasic (subsecond) dopamine signalling(10), we measured dopamine every 100 ms in the nucleus accumbens using electrochemical technology(11). Rapid changes in extracellular dopamine concentration were observed at key aspects of drug-taking behaviour in rats. Before lever presses for cocaine, there was an increase in dopamine that coincided with the initiation of drug-seeking behaviours. Notably, these behaviours could be reproduced by electrically evoking dopamine release on this timescale. After lever presses, there were further increases in dopamine concentration at the concurrent presentation of cocaine-related cues. These cues alone also elicited similar, rapid dopamine signalling, but only in animals where they had previously been paired to cocaine delivery. These findings reveal an unprecedented role for dopamine in the regulation of drug taking in real time.	Univ N Carolina, Dept Psychol, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA; Univ N Carolina, Ctr Neurosci, Chapel Hill, NC 27599 USA; Univ N Carolina, Curriculum Neurobiol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Carelli, RM (corresponding author), Univ N Carolina, Dept Psychol, Chapel Hill, NC 27599 USA.	rcarelli@unc.edu	Phillips, Paul E. M./A-4463-2008; Phillips, Paul/E-7813-2013; Stuber, Garret/E-1160-2011; Heien, Michael/A-4731-2009	Phillips, Paul E. M./0000-0002-8749-7026; Phillips, Paul/0000-0002-8749-7026; Heien, Michael/0000-0001-5164-9596; Stuber, Garret/0000-0003-1730-4855	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007431] Funding Source: NIH RePORTER; NINDS NIH HHS [T32 NS007431] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bradberry CW, 2000, J NEUROSCI, V20, P3874, DOI 10.1523/JNEUROSCI.20-10-03874.2000; Breiter HC, 1997, NEURON, V19, P591, DOI 10.1016/S0896-6273(00)80374-8; Carelli Regina M, 2002, Behav Cogn Neurosci Rev, V1, P281, DOI 10.1177/1534582302238338; Carelli RM, 2000, SYNAPSE, V35, P238, DOI 10.1002/(SICI)1098-2396(20000301)35:3<238::AID-SYN10>3.0.CO;2-Y; Carelli RM, 2000, J NEUROSCI, V20, P4255; CARELLI RM, 1993, BRAIN RES, V626, P14, DOI 10.1016/0006-8993(93)90557-4; Childress AR, 1999, AM J PSYCHIAT, V156, P11, DOI 10.1176/ajp.156.1.11; Di Chiara G, 1999, EUR J PHARMACOL, V375, P13, DOI 10.1016/S0014-2999(99)00372-6; EINHORN LC, 1988, J NEUROSCI, V8, P100; Garris PA, 1997, J NEUROCHEM, V68, P152; GRACE AA, 1991, NEUROSCIENCE, V41, P1, DOI 10.1016/0306-4522(91)90196-U; Hyland BI, 2002, NEUROSCIENCE, V114, P475, DOI 10.1016/S0306-4522(02)00267-1; Ito R, 2000, J NEUROSCI, V20, P7489; Kiyatkin EA, 1996, J NEUROPHYSIOL, V75, P142, DOI 10.1152/jn.1996.75.1.142; Koob GF, 1997, J NEUROPSYCH CLIN N, V9, P482; LACEY MG, 1990, BRIT J PHARMACOL, V99, P731, DOI 10.1111/j.1476-5381.1990.tb12998.x; MARSDEN CA, 1988, NEUROSCIENCE, V25, P389, DOI 10.1016/0306-4522(88)90247-3; MILLAR J, 1985, EUR J PHARMACOL, V109, P341, DOI 10.1016/0014-2999(85)90394-2; MOGENSON GJ, 1987, PROG PSYCHOB PHYSIOL, V12, P117; PENNARTZ CMA, 1994, PROG NEUROBIOL, V42, P719, DOI 10.1016/0301-0082(94)90025-6; PETTIT HO, 1989, PHARMACOL BIOCHEM BE, V34, P899, DOI 10.1016/0091-3057(89)90291-8; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; SESACK SR, 1992, J COMP NEUROL, V320, P145, DOI 10.1002/cne.903200202; SESACK SR, 1990, BRAIN RES, V527, P266, DOI 10.1016/0006-8993(90)91146-8; Stamford JA, 1996, ANAL CHEM, V68, pA359, DOI 10.1021/ac961943a; Wightman RM, 2002, J NEUROCHEM, V82, P721, DOI 10.1046/j.1471-4159.2002.01005.x; Wise RA, 1996, CURR OPIN NEUROBIOL, V6, P243, DOI 10.1016/S0959-4388(96)80079-1; WISE RA, 1995, PSYCHOPHARMACOLOGY, V120, P10, DOI 10.1007/BF02246140; Wise RA, 1998, DRUG ALCOHOL DEPEN, V51, P13, DOI 10.1016/S0376-8716(98)00063-5	30	814	823	1	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 10	2003	422	6932					614	618		10.1038/nature01566	http://dx.doi.org/10.1038/nature01566			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665GN	12687000				2022-12-24	WOS:000182111400042
J	Schwimmer, JB; Burwinkle, TM; Varni, JW				Schwimmer, JB; Burwinkle, TM; Varni, JW			Health-related quality of life of severely obese children and adolescents	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GENERIC CORE SCALES; BODY-MASS INDEX; PERCEIVED PHYSICAL APPEARANCE; SCHOOL PERFORMANCE; SOCIAL-ADJUSTMENT; PEDSQL(TM); VALIDITY; RELIABILITY; OVERWEIGHT; RESPONSIVENESS	Context One in 7 US children and adolescents is obese, yet little is known about their health-related quality of life (QOL). Objective To examine the health-related QOL of obese children and adolescents compared with children and adolescents who are healthy or those diagnosed as having cancer. Design, Setting, and Participants Cross-sectional study of 106 children and adolescents (57 males) between the ages of 5 and 18 years (mean [SD], 12.1 [3] years), who had been referred to an academic children's hospital for evaluation of obesity between January and June 2002. Children and adolescents had a mean (SD) body mass index (BMI) of 34.7 (9.3) and BMI z score of 2.6 (0.5). Main Outcome Measures Child self-report and parent proxy report using a pediatric QOL inventory generic core scale (range, 0-100). The inventory was administered by an interviewer for children aged 5 through 7 years. Scores were compared with previously published scores for healthy children and adolescents and children and adolescents diagnosed as having cancer. Results Compared with healthy children and adolescents, obese children and adolescents reported significantly (P<.001) lower health-related QOL in all domains (mean [SD] total score, 67 [16.3] for obese children and adolescents; 83 [14.8] for healthy children and adolescents). Obese children and adolescents were more likely to have impaired health-related QOL than healthy children and adolescents (odds ratio [OR], 5.5; 95% confidence interval [CI], 3.4-8.7) and were similar to children and adolescents diagnosed As having cancer (OR, 1.3; 95% CI, 0.8-2.3). Children and adolescents with obstructive sleep apnea reported a significantly lower health-related QOL total score (mean [SD], 53.8 [13.3]) than obese children and adolescents without obstructive sleep apnea (mean [SD], 67.9 [16.2]). For parent proxy report, the child or adolescent's. BMI z score was significantly inversely correlated with total score (r=-0.246; P=.01), physical functioning (r=-0.263; P<.01), social functioning (r=-0.347; P<001), and psychosocial functioning (r=-0.209; P=.03). Conclusions Severely obese children and adolescents have lower health-related QOL than children and adolescents who are healthy and similar QOL as those diagnosed as having cancer. Physicians, parents, and teachers need to be informed of the risk for impaired health-related QOL among obese children and adolescents to target interventions that could enhance health outcomes.	Univ Calif San Diego, Sch Med, Div Pediat Gastroenterol Hepatol & Nutr, San Diego, CA 92103 USA; Childrens Hosp & Hlth Ctr, Ctr Child Hlth Outcomes, San Diego, CA USA; Texas A&M Univ, Dept Architecture, College Stn, TX USA; Texas A&M Univ, Dept Med, College Stn, TX USA	University of California System; University of California San Diego; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Schwimmer, JB (corresponding author), Univ Calif San Diego, Sch Med, Div Pediat Gastroenterol Hepatol & Nutr, 200 W Arbor Dr, San Diego, CA 92103 USA.	jschwimmer@ucsd.edu	Fahimifar, Sepideh/M-5303-2019	Schwimmer, Jeffrey/0000-0001-8538-2877	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000827] Funding Source: NIH RePORTER	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		BANIS HT, 1988, CHILD CARE HLTH DEV, V14, P157, DOI 10.1111/j.1365-2214.1988.tb00572.x; Barlow SE, 1998, PEDIATRICS, V102, DOI 10.1542/peds.102.3.e29; Birmaher B, 1996, J AM ACAD CHILD PSY, V35, P1427, DOI 10.1097/00004583-199611000-00011; *CDC, OV CHILDR AD 6 19 YE; Cohen J., 1988, STAT POWER ANAL BEHA; Diette GB, 2000, ARCH PEDIAT ADOL MED, V154, P923, DOI 10.1001/archpedi.154.9.923; Dietz WH, 1998, PEDIATRICS, V101, P518; Dietz WH, 1999, AM J CLIN NUTR, V70, p123S; Dietz WH, 1998, J PEDIATR-US, V132, P191; Doll HA, 2000, OBES RES, V8, P160, DOI 10.1038/oby.2000.17; EISER C, 2001, QUALITY LIFE CHILD A, P267; Epstein LH, 2000, OBES RES, V8, P575, DOI 10.1038/oby.2000.74; Fontaine KR, 1996, J FAM PRACTICE, V43, P265; Goodman E, 2002, PEDIATRICS, V110, P497, DOI 10.1542/peds.110.3.497; GORTMAKER SL, 1993, NEW ENGL J MED, V329, P1008, DOI 10.1056/NEJM199309303291406; Hollingshead A. B., 1975, 4 FACTOR INDEX SOCIA, V8, P21; Janicke DM, 2001, MED CARE, V39, P990, DOI 10.1097/00005650-200109000-00009; Jonides L, 2002, PEDIATRICS, V110, P215; KOLOTKIN RL, 1995, OBES RES, V3, P49, DOI 10.1002/j.1550-8528.1995.tb00120.x; Kolotkin RL, 2002, OBES RES, V10, P748, DOI 10.1038/oby.2002.102; MCHORNEY CA, 1993, MED CARE, V31, P247, DOI 10.1097/00005650-199303000-00006; MCHORNEY CA, 1992, MED CARE, V30, pMS253, DOI 10.1097/00005650-199205001-00025; Mo-Suwan L, 1999, INT J OBESITY, V23, P272, DOI 10.1038/sj.ijo.0800808; *NAT HEART LUNG BL, MORB MORT CHARTB; Nunnally JC, 1978, PSYCHOMETRIC THEORY, V2nd, DOI DOI 10.1037/018882; Ogden CL, 2002, JAMA-J AM MED ASSOC, V288, P1728, DOI 10.1001/jama.288.14.1728; Pedhazur EJ, 1991, MEASUREMENT DESIGN A; Ravens-Sieberer U, 2001, INT J OBESITY, V25, pS63, DOI 10.1038/sj.ijo.0801702; SPIRITO A, 1991, CLIN PSYCHOL REV, V11, P539, DOI 10.1016/0272-7358(91)90003-D; SPSS, 1998, SPSS VERS 8 0 WIND; Story MT, 2002, PEDIATRICS, V110, P210; SULLIVAN M, 1993, INT J OBESITY, V17, P503; UZARK K, IN PRESS PROGR PEDIA; VARNI JW, 1994, J DEV BEHAV PEDIATR, V15, P20, DOI 10.1097/00004703-199402000-00004; Varni JW, 2002, ARTHRITIS RHEUM-US, V46, P714, DOI 10.1002/art.10095; Varni JW, 2001, MED CARE, V39, P800, DOI 10.1097/00005650-200108000-00006; Varni JW, 1999, MED CARE, V37, P126, DOI 10.1097/00005650-199902000-00003; Varni JW, 2002, CANCER-AM CANCER SOC, V94, P2090, DOI 10.1002/cncr.10428; Varni JW, 2003, DIABETES CARE, V26, P631, DOI 10.2337/diacare.26.3.631; VARNI JW, 1995, J BEHAV MED, V18, P261, DOI 10.1007/BF01857873; Varni JW, 2002, J BEHAV MED, V25, P175, DOI 10.1023/A:1014836921812; VARNI JW, 1989, J DEV BEHAV PEDIATR, V10, P13; Varni JW, 1996, J CLIN CHILD PSYCHOL, V25, P201, DOI 10.1207/s15374424jccp2502_9; VARNI JW, 1992, AM J DIS CHILD, V146, P103, DOI 10.1001/archpedi.1992.02160130105030; Veale D, 2002, QUAL LIFE RES, V11, P389, DOI 10.1023/A:1015599326110; Vetiska J, 2000, DIABETES CARE, V23, P1706, DOI 10.2337/diacare.23.11.1706	46	1061	1078	2	73	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 9	2003	289	14					1813	1819		10.1001/jama.289.14.1813	http://dx.doi.org/10.1001/jama.289.14.1813			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	664ZJ	12684360	Bronze			2022-12-24	WOS:000182094900027
J	Rosenberg, AL; Hofer, TP; Strachan, C; Watts, CM; Hayward, RA				Rosenberg, AL; Hofer, TP; Strachan, C; Watts, CM; Hayward, RA			Accepting critically ill transfer patients: Adverse effect on a referral center's outcome and benchmark measures	ANNALS OF INTERNAL MEDICINE			English	Article							INTENSIVE-CARE-UNIT; QUALITY-OF-CARE; ACADEMIC-MEDICAL-CENTER; LEAD-TIME BIAS; MANAGED CARE; HOSPITAL MORTALITY; INTERHOSPITAL TRANSFERS; ACUTE PHYSIOLOGY; RISK ADJUSTMENT; SCORING SYSTEM	Background: Common methods of benchmarking clinical performance rarely, if ever, account for admission source and, in particular, the effect of a patient being transferred from one medical center to another. Small biases in comparisons of observed versus expected deaths can substantially affect how high-quality institutions compare with peer hospitals. With the most sophisticated and validated set of case-mix measures available for patients, the intensive care unit is an ideal setting in which to study the effect of a patient's being transferred from another hospital. Objective: To determine the extent of bias in benchmarking outcomes when performance measures do not account for transfer patients' greater severity of illness. Design: Prospectively developed cohort study. Setting: Medical intensive care unit (MICU) at a tertiary care university hospital. Patients: 4579 consecutive admissions for 4208 patients from 1 January 1994 to 1 April 1998. Measurements: MICU and hospital lengths of stay, MICU readmission, and hospital mortality rates. Results: Compared with directly admitted patients, MICU patients transferred from another hospital had significantly higher Acute Physiology Scores at the time of admission and discharge (P = 0.001). Even after full adjustment for case mix and severity of illness, transfer patients had a 38% longer MICU stay (95% CI, 32% to 45%), a 41% longer hospital stay (CI, 34% to 50%), and a 2.2 times greater odds of hospital mortality (CI, 1.7 to 2.8) than directly admitted patients. With identical efficiency and quality, a referral hospital with a 25% MICU transfer rate compared with another with a 0% transfer rate would be penalized by 14 excess deaths per 1000 admissions when a benchmarking program adjusts only for case mix and severity of illness and not for the source of admission. Conclusions: In a setting with the most thorough diagnostic-based, case-mix adjustment and the most physiologically precise severity-of-illness information, accepting transfer patients can adversely affect efficiency and quality benchmarks. Benchmarking and profiling efforts beyond intensive care units must also recognize and account for this phenomenon; otherwise, referral centers may have an incentive to refuse care for patients who could benefit from being transferred to their facility.	Univ Michigan, Ctr Med, Dept Anesthesiol & Crit Care, Ann Arbor, MI 48109 USA; Vet Affairs Ann Arbor Healthcare Syst, Dept Vet Affairs Hlth Serv Res & Dev Serv, Ann Arbor, MI USA	University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System	Rosenberg, AL (corresponding author), Univ Michigan, Ctr Med, Dept Anesthesiol & Crit Care, Room 1G323,Box 0048, Ann Arbor, MI 48109 USA.	arosen@umich.edu	Hofer, Timothy Philip/AAC-9238-2022	Hofer, Timothy/0000-0003-0434-8787				Albertson GA, 2000, J GEN INTERN MED, V15, P242, DOI 10.1111/j.1525-1497.2000.02208.x; Angus DC, 2000, CRIT CARE MED, V28, P2145, DOI 10.1097/00003246-200006000-00088; Bailey JE, 1999, JAMA-J AM MED ASSOC, V282, P1067, DOI 10.1001/jama.282.11.1067; Bernard AM, 1996, ACAD MED, V71, P262, DOI 10.1097/00001888-199603000-00019; Bindman AB, 1999, JAMA-J AM MED ASSOC, V281, P2142, DOI 10.1001/jama.281.22.2142; Blumenthal D, 1996, NEW ENGL J MED, V335, P891, DOI 10.1056/NEJM199609193351213; BORLASE BC, 1991, J TRAUMA, V31, P915, DOI 10.1097/00005373-199107000-00006; Chernew ME, 1998, MED CARE RES REV, V55, P259, DOI 10.1177/107755879805500301; CLEMMITT M, 2001, MED HLTH S, V55, P1; DRAGSTED L, 1989, CRIT CARE MED, V17, P418, DOI 10.1097/00003246-198905000-00008; DUNCAN RP, 1988, HOSP HEALTH SERV ADM, V33, P237; ESCARCE JJ, 1990, JAMA-J AM MED ASSOC, V264, P2389, DOI 10.1001/jama.264.18.2389; Fihn SD, 2000, JAMA-J AM MED ASSOC, V283, P1740, DOI 10.1001/jama.283.13.1740; FRANKLIN C, 1983, CRIT CARE MED, V11, P61, DOI 10.1097/00003246-198302000-00001; Goodman DC, 1996, JAMA-J AM MED ASSOC, V276, P1811, DOI 10.1001/jama.276.22.1811; Gordon HS, 1996, MED CARE, V34, P295, DOI 10.1097/00005650-199604000-00002; Green J, 1997, JAMA-J AM MED ASSOC, V277, P1152, DOI 10.1001/jama.277.14.1152; HANNAN EL, 1989, JAMA-J AM MED ASSOC, V262, P503, DOI 10.1001/jama.262.4.503; HAYWARD RA, 1995, J GEN INTERN MED, V10, P504, DOI 10.1007/BF02602402; Hofer T P, 1997, Jt Comm J Qual Improv, V23, P455; Hofer TP, 1999, JAMA-J AM MED ASSOC, V281, P2098, DOI 10.1001/jama.281.22.2098; Hofer TP, 1996, MED CARE, V34, P737, DOI 10.1097/00005650-199608000-00002; Huerta J A, 1995, J Clin Eng, V20, P48; HURLEY J, 1990, HEALTH SERV RES, V25, P239; Iezzoni LI, 1996, AM J PUBLIC HEALTH, V86, P1379, DOI 10.2105/AJPH.86.10.1379; Iezzoni LI, 1997, JAMA-J AM MED ASSOC, V278, P1600, DOI 10.1001/jama.278.19.1600; JACOBS P, 1990, CRIT CARE MED, V18, P1282, DOI 10.1097/00003246-199011000-00020; JENCKS SF, 1988, MED CARE, V26, P948, DOI 10.1097/00005650-198810000-00003; JENCKS SF, 1988, JAMA-J AM MED ASSOC, V260, P3611, DOI 10.1001/jama.260.24.3611; KEENE AR, 1983, CRIT CARE MED, V11, P1, DOI 10.1097/00003246-198301000-00001; KNAUS W, 1989, CRIT CARE MED, V17, pS176, DOI 10.1097/00003246-198912001-00005; KNAUS WA, 1991, CHEST, V100, P1619, DOI 10.1378/chest.100.6.1619; Krakauer H, 1998, J Eval Clin Pract, V4, P11, DOI 10.1046/j.1365-2753.1998.t01-1-00002.x; Kulu-Glasgow I, 1998, HEALTH POLICY, V45, P221, DOI 10.1016/S0168-8510(98)00045-1; Langenbrunner J C, 1989, Health Care Financ Rev, V10, P91; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; LEMESHOW S, 1994, JAMA-J AM MED ASSOC, V272, P1049, DOI 10.1001/jama.272.13.1049; MANT J, 1995, BMJ-BRIT MED J, V311, P793, DOI 10.1136/bmj.311.7008.793; MILLER MG, 1994, JAMA-J AM MED ASSOC, V271, P1493, DOI 10.1001/jama.271.19.1493; OBREMSKEY W, 1994, J TRAUMA, V36, P373, DOI 10.1097/00005373-199403000-00016; OYE RK, 1991, CHEST, V99, P685, DOI 10.1378/chest.99.3.685; *PHC4, 1995, FOC HEART ATT W PENN; RAPOPORT J, 1990, CRIT CARE MED, V18, P1231, DOI 10.1097/00003246-199011000-00009; RAPOPORT J, 1992, ARCH INTERN MED, V152, P2207, DOI 10.1001/archinte.152.11.2207; ROMANO PS, 1994, J CLIN EPIDEMIOL, V47, P249, DOI 10.1016/0895-4356(94)90006-X; Rosenberg AL, 2001, CRIT CARE MED, V29, P511, DOI 10.1097/00003246-200103000-00008; Rosenthal G E, 1997, Am J Med Qual, V12, P103, DOI 10.1177/0885713X9701200204; ROSENTHAL GE, 1994, JOINT COMM J QUAL IM, V20, P425, DOI 10.1016/S1070-3241(16)30088-8; Rubenfeld GD, 1999, AM J RESP CRIT CARE, V160, P358, DOI 10.1164/ajrccm.160.1.9807118; RUBIN HR, 1993, JAMA-J AM MED ASSOC, V270, P835, DOI 10.1001/jama.270.7.835; SCHIFF RL, 1986, NEW ENGL J MED, V314, P552, DOI 10.1056/NEJM198602273140905; Schroeder J, 1996, Am J Med Qual, V11, pS58; SCHWARTZ WB, 1987, JAMA-J AM MED ASSOC, V257, P220, DOI 10.1001/jama.257.2.220; SHAPIRO MF, 1994, HEALTH SERV RES, V29, P95; Spoeri RK, 1997, ANN INTERN MED, V127, P726, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00058; TERES D, 1993, CRIT CARE CLIN, V9, P543, DOI 10.1016/S0749-0704(18)30184-2; Tunnell RD, 1998, ANAESTHESIA, V53, P1045, DOI 10.1046/j.1365-2044.1998.00566.x; Weissman NW, 1999, J EVAL CLIN PRACT, V5, P269, DOI 10.1046/j.1365-2753.1999.00203.x; ZIMMERMAN JE, 1994, CRIT CARE MED, V22, P1373, DOI 10.1097/00003246-199409000-00005; Zimmerman JE, 1998, CRIT CARE MED, V26, P1317, DOI 10.1097/00003246-199808000-00012; Zimmerman JE, 2000, CRIT CARE MED, V28, P258, DOI 10.1097/00003246-200001000-00048; 2001, MED HEALTHC S, P6	62	171	172	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 3	2003	138	11					882	890		10.7326/0003-4819-138-11-200306030-00009	http://dx.doi.org/10.7326/0003-4819-138-11-200306030-00009			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	686AB	12779298				2022-12-24	WOS:000183296400003
J	Dalton, R				Dalton, R			Threat of closure hangs heavy over primate centre	NATURE			English	News Item																			0	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 29	2003	423	6939					471	471		10.1038/423471b	http://dx.doi.org/10.1038/423471b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	683RH	12774087	Bronze			2022-12-24	WOS:000183162900012
J	Gray, J; Orr, D; Majeed, A				Gray, J; Orr, D; Majeed, A			Use of Read codes in diabetes management in a south London primary care group: implications for establishing disease registers	BRITISH MEDICAL JOURNAL			English	Article							MELLITUS; PEOPLE	Objective To establish current practice in the use of Read codes for diabetes. Design Cross sectional study. Setting 17 practices in the Battersea primary care group in southwest London. Data sources Computerised medical records. Main outcome measures Number of codes in use in all practices; variation in the use of codes between practices; and prevalence of Read code use in diabetic patients. Results At least 9 separate Read code groupings and 25 individual diabetes codes were in use in the 17 general practices. Only one Read code (C 10, diabetes mellitus) and its subcodes was being used in all 17 practices, but its use varied from 14% to 98% of patients with diabetes. The use of other key Read codes for monitoring the care of patients with diabetes also varied widely between practices; for example, < 20% of practices used the code for the location of care. Less than half of patients (45%) with diabetes had their type of diabetes coded, and even fewer (21%) had measures such as the examination of the retina coded. Conclusions The use of Read codes for diabetes needs to be standardised and coding levels improved if valid diabetic registers are to be constructed and the quality of care is to be monitored effectively. Until all patients with diabetes have the C 10 Read code recorded, clinicians will have to use a wide range of Read codes and prescribing data to ensure that diabetes registers are complete.	Bolingbroke Hosp, Battersea Res Grp, London SW11 6HN, England; UCL, Sch Publ Policy, Primary Care Res Unit, London WC1H 9QU, England	University of London; University College London	Gray, J (corresponding author), Bolingbroke Hosp, Battersea Res Grp, London SW11 6HN, England.			Majeed, Azeem/0000-0002-2357-9858				Amos A F, 1997, Diabet Med, V14 Suppl 5, pS1; [Anonymous], 2002, HLTH STAT Q; BARDSLEY M, 2000, MAPPING HLTH PRIMARY; Benson T, 2002, BRIT MED J, V325, P1090, DOI 10.1136/bmj.325.7372.1090; BURNETT SD, 1992, BRIT MED J, V305, P627, DOI 10.1136/bmj.305.6854.627; Buxton C, 1996, DIABETIC MED, V13, pS122; CONNOLLY V, 1995, DIABETIC MED, V12, pS31; Currie CJ, 1997, DIABETIC MED, V14, P686, DOI 10.1002/(SICI)1096-9136(199708)14:8<686::AID-DIA434>3.0.CO;2-D; *DEP HLTH, 2002, DEL IT NHS; *DEP HLTH, 2000, CM4818; Department of Health, 2002, NAT SERV FRAM DIAB S; Gatling W, 1998, DIABETIC MED, V15, P1015, DOI 10.1002/(SICI)1096-9136(1998120)15:12<1015::AID-DIA719>3.0.CO;2-K; HOWITT AJ, 1993, BRIT MED J, V307, P1046, DOI 10.1136/bmj.307.6911.1046; Khunti K, 2001, BRIT J GEN PRACT, V51, P356; Khunti K, 2000, J ROY SOC MED, V93, P183, DOI 10.1177/014107680009300407; Laing SP, 1999, DIABETIC MED, V16, P459, DOI 10.1046/j.1464-5491.1999.00075.x; MACKINNON M, 1995, DIABETIC MED S, V12, pS10; Morris AD, 1997, BMJ-BRIT MED J, V315, P524, DOI 10.1136/bmj.315.7107.524; Okkes IM, 2000, FAM PRACT, V17, P101, DOI 10.1093/fampra/17.2.101; WHITFORD DL, 1995, DIABETIC MED, V12, P691, DOI 10.1111/j.1464-5491.1995.tb00571.x	20	53	53	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 24	2003	326	7399					1130	1132A		10.1136/bmj.326.7399.1130	http://dx.doi.org/10.1136/bmj.326.7399.1130			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	685DF	12763987	Green Published, Bronze			2022-12-24	WOS:000183245000024
J	McKone, EF; Emerson, SS; Edwards, KL; Aitken, ML				McKone, EF; Emerson, SS; Edwards, KL; Aitken, ML			Effect of genotype on phenotype and mortality in cystic fibrosis: a retrospective cohort study	LANCET			English	Article							DISEASE SEVERITY; MESSENGER-RNA; MUTATION; CFTR; GENE; IDENTIFICATION; DELTA-F508	Background Over 1000 mutations of the cystic fibrosis transmembrane conductance regulator gene (CFTR) that cause cystic fibrosis have been identified. We examined the effect of CFTR genotype on mortality and disease phenotype. Methods Using the US Cystic Fibrosis Foundation National Registry, we did a retrospective cohort study to compare standardised mortality rates for the 11 most common genotypes heterozygous for DeltaF508 with those homozygous for DeltaF508. Of the 28455 patients enrolled in the registry at the time of our analysis, :17 853 (63%) were genotyped. We also compared the clinical phenotype, including lung function, age at diagnosis, and nutritional measures, of 22 DeltaF508 heterozygous genotypes. Mortality rates and clinical phenotype were also compared between genotypes classified into six classes on the basis of their functional effect on CFTR production. Findings Between 1991 and 1999, genetic and clinical data were available for 17 853 patients with cystic fibrosis, which was 63% of the total cohort. There were :1547 deaths during the 9 years of follow-up. In the analysis of the 11 most common genotypes, DeltaF508/R117H, DeltaF508/DeltaI507, DeltaF508/3849+10 kbC-->T, and DeltaF508/2789+5G-->A had a significantly lower mortality rate (4.7, 8.0, 11.9, and 4.4, respectively) than the genotype homozygous for DeltaF508 (21.8, p=0.0060). DeltaF508/R117H, DeltaF508/DeltaI507, DeltaF508/ 3849+10 kbC-->T, DeltaF508/2789+5G-->A, and DeltaF508/A455E have a milder clinical phenotype. Outcomes for all functional classes were compared with that of class II (containing DeltaF508 homozygotes) and classes IV and V had a significantly lower mortality rate and milder clinical phenotype. Interpretation Patients with cystic fibrosis have distinct genetic subgroups that are associated with mild clinical manifestations and low mortality. These differences in phenotype are also related to the functional classification of CFTR genotype.	Univ Washington, Med Ctr, Div Pulm & Crit Care Med, Seattle, WA 98195 USA; Univ Washington, Adult Cyst Fibrosis Ctr, Seattle, WA 98195 USA; Univ Washington, Dept Biostat, Seattle, WA 98195 USA; Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	McKone, EF (corresponding author), Univ Washington, Med Ctr, Div Pulm & Crit Care Med, BB1253 Hlth Sci Bldg,Box 356522, Seattle, WA 98195 USA.				NCI NIH HHS [R01 CA149051] Funding Source: Medline; NHLBI NIH HHS [K23 HL/70849-01] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA149051] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL070849] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Accurso FJ, 2003, AM J RESP CRIT CARE, V167, P289, DOI 10.1164/rccm.2210006; [Anonymous], CYSTIC FIBROSIS MUTA; Cystic Fibrosis Foundation Patient Registry, 2000, 1999 ANN DAT REP; Drumm ML, 2001, RESPIR RES, V2, P125, DOI 10.1186/rr47; FITZSIMMONS SC, 1993, J PEDIATR-US, V122, P1, DOI 10.1016/S0022-3476(05)83478-X; GAN KH, 1995, NEW ENGL J MED, V333, P95, DOI 10.1056/NEJM199507133330204; HAMOSH A, 1993, NEW ENGL J MED, V329, P1308; Highsmith WE, 1997, HUM MUTAT, V9, P332, DOI 10.1002/(SICI)1098-1004(1997)9:4<332::AID-HUMU5>3.0.CO;2-7; HIGHSMITH WE, 1994, NEW ENGL J MED, V331, P974, DOI 10.1056/NEJM199410133311503; Hull J, 1998, THORAX, V53, P1018, DOI 10.1136/thx.53.12.1018; JOHANSEN HK, 1991, LANCET, V337, P631, DOI 10.1016/0140-6736(91)92449-C; Kerem B, 1996, EUR J HUM GENET, V4, P65; Kerem E, 1996, PEDIATR PULM, V22, P387, DOI 10.1002/(SICI)1099-0496(199612)22:6<387::AID-PPUL7>3.3.CO;2-Y; KEREM E, 1990, NEW ENGL J MED, V323, P1517, DOI 10.1056/NEJM199011293232203; KEREM E, 1992, NEW ENGL J MED, V326, P1187, DOI 10.1056/NEJM199204303261804; KIESEWETTER S, 1993, NAT GENET, V5, P274, DOI 10.1038/ng1193-274; KNUDSON RJ, 1983, AM REV RESPIR DIS, V127, P725; Koch C, 2001, PEDIATR PULM, V31, P1, DOI 10.1002/1099-0496(200101)31:1<1::AID-PPUL1000>3.0.CO;2-T; KRISTIDIS P, 1992, AM J HUM GENET, V50, P1178; Liou TG, 2001, AM J EPIDEMIOL, V153, P345, DOI 10.1093/aje/153.4.345; Massie RJH, 2001, EUR RESPIR J, V17, P1195, DOI 10.1183/09031936.01.00057001; Mickle JE, 2000, MED CLIN N AM, V84, P597, DOI 10.1016/S0025-7125(05)70243-1; RIORDAN JR, 1989, SCIENCE, V245, P1066; SANTIS G, 1990, LANCET, V336, P1081, DOI 10.1016/0140-6736(90)92566-Z; Schechter MS, 2001, AM J RESP CRIT CARE, V163, P1331, DOI 10.1164/ajrccm.163.6.9912100; STERN RC, 1995, LANCET, V346, P274, DOI 10.1016/S0140-6736(95)92165-6; TSUI LC, 1992, TRENDS GENET, V8, P392, DOI 10.1016/0168-9525(92)90301-J; Tzetis M, 2001, HUM GENET, V109, P592, DOI 10.1007/s00439-001-0631-0; WELSH MJ, 1993, CELL, V73, P1251, DOI 10.1016/0092-8674(93)90353-R; Welsh MJ, 2001, METABOLIC MOL BASES, P5121	30	288	294	0	13	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 17	2003	361	9370					1671	1676		10.1016/S0140-6736(03)13368-5	http://dx.doi.org/10.1016/S0140-6736(03)13368-5			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	679KB	12767731				2022-12-24	WOS:000182919700006
J	Moore, JD; Kirk, JA; Hunt, T				Moore, JD; Kirk, JA; Hunt, T			Unmasking the S-phase-promoting potential of cyclin B1	SCIENCE			English	Article							XENOPUS EGG EXTRACTS; CELL-CYCLE; NUCLEAR EXPORT; SACCHAROMYCES-CEREVISIAE; FISSION YEAST; LOCALIZATION; MITOSIS; SPECIFICITY; ACTIVATION; KINASE	In higher eukaryotes, the S phase and M phase of the cell cycle are triggered by different cyclin-dependent kinases (CDKs). For example, in frog egg extracts, Cdk1-cyclin B catalyzes entry into mitosis but cannot trigger DNA replication. Two hypotheses can explain this observation: Either Cdk1-cyclin B fails to recognize the key substrates of its S-phase-promoting counterparts, or its activity is somehow regulated to prevent it from activating DNA synthesis. Here, we show that Cdk1-cyclin B1 has cryptic S-phase-promoting abilities that can be unmasked by relocating it from the cytoplasm to the nucleus and moderately stimulating its activity. Subcellular localization of vertebrate CDKs and the control of their activity are thus critical factors for determining their specificity.	Canc Res UK London Res Inst, Clare Hall Labs, S Mimms EN6 3LD, Herts, England	Cancer Research UK	Hunt, T (corresponding author), Canc Res UK London Res Inst, Clare Hall Labs, Blanche Lane, S Mimms EN6 3LD, Herts, England.							AMON A, 1994, CELL, V77, P1037, DOI 10.1016/0092-8674(94)90443-X; BUENO A, 1993, MOL CELL BIOL, V13, P2286, DOI 10.1128/MCB.13.4.2286; Chen W, 2000, BIOCHEMISTRY-US, V39, P10781, DOI 10.1021/bi000909u; CLARKE PR, 1992, EMBO J, V11, P1751, DOI 10.1002/j.1460-2075.1992.tb05227.x; Cross FR, 1999, MOL CELL, V4, P11, DOI 10.1016/S1097-2765(00)80183-5; Draviam VM, 2001, J CELL BIOL, V152, P945, DOI 10.1083/jcb.152.5.945; Fisher DL, 1996, EMBO J, V15, P850, DOI 10.1002/j.1460-2075.1996.tb00420.x; Furuno N, 1999, J CELL BIOL, V147, P295, DOI 10.1083/jcb.147.2.295; GAUTIER J, 1991, EMBO J, V10, P177, DOI 10.1002/j.1460-2075.1991.tb07934.x; Haase SB, 1999, NATURE, V401, P394, DOI 10.1038/43930; Hagting A, 1998, EMBO J, V17, P4127, DOI 10.1093/emboj/17.14.4127; IZUMI T, 1993, MOL BIOL CELL, V4, P1337, DOI 10.1091/mbc.4.12.1337; JACKSON PK, 1995, J CELL BIOL, V130, P755, DOI 10.1083/jcb.130.4.755; JOHNSON RT, 1970, NATURE, V226, P717, DOI 10.1038/226717a0; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Miller ME, 2000, MOL CELL BIOL, V20, P542, DOI 10.1128/MCB.20.2.542-555.2000; Miller ME, 2001, J CELL SCI, V114, P1811; Moore JD, 2002, MOL BIOL CELL, V13, P4388, DOI 10.1091/mbc.e02-07-0449; Moore JD, 1999, J CELL BIOL, V144, P213, DOI 10.1083/jcb.144.2.213; MOORE JS, UNPUB; MUELLER PR, 1995, MOL BIOL CELL, V6, P119, DOI 10.1091/mbc.6.1.119; MUELLER PR, 1995, SCIENCE, V270, P86, DOI 10.1126/science.270.5233.86; PINES J, 1991, J CELL BIOL, V115, P1, DOI 10.1083/jcb.115.1.1; Pomerening JR, 2003, NAT CELL BIOL, V5, P346, DOI 10.1038/ncb954; SCHWOB E, 1994, CELL, V79, P233, DOI 10.1016/0092-8674(94)90193-7; SOLOMON MJ, 1990, CELL, V63, P1013, DOI 10.1016/0092-8674(90)90504-8; Stern B, 1996, TRENDS GENET, V12, P345; Strausfeld UP, 1996, J CELL SCI, V109, P1555; Toyoshima F, 1998, EMBO J, V17, P2728, DOI 10.1093/emboj/17.10.2728; Yang J, 1998, GENE DEV, V12, P2131, DOI 10.1101/gad.12.14.2131	30	108	108	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 9	2003	300	5621					987	990		10.1126/science.1081418	http://dx.doi.org/10.1126/science.1081418			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675WD	12738867				2022-12-24	WOS:000182719800059
J	Frey, JJ				Frey, JJ			Time to myself	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																		Williams William Carlos, 1968, SELECTED POEMS	1	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 7	2003	289	17					2185	2186		10.1001/jama.289.17.2185	http://dx.doi.org/10.1001/jama.289.17.2185			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	675ET	12734116				2022-12-24	WOS:000182680700001
J	Lorenz, K; Lynn, J				Lorenz, K; Lynn, J			Moral and practical challenges of physician-assisted suicide	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							OREGON; EUTHANASIA; DEATH		Vet Affairs Greater Los Angeles Healthcare Syst, Los Angeles, CA 90073 USA; Univ Calif Los Angeles, Geffen Sch Med, Los Angeles, CA USA; Washington Home Ctr Palliat Care Studies, Washington, DC USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Lorenz, K (corresponding author), Vet Affairs Greater Los Angeles Healthcare Syst, Los Angeles, CA 90073 USA.							Chin AE, 1999, NEW ENGL J MED, V340, P577, DOI 10.1056/NEJM199902183400724; Covinsky KE, 1996, ARCH INTERN MED, V156, P1737, DOI 10.1001/archinte.156.15.1737; CRENSHAW A, 2000, WASHINGTON POST 0425, P1; Drought Theresa S, 2002, Gerontologist, V42 Spec No 3, P114; Emanuel EJ, 2000, JAMA-J AM MED ASSOC, V284, P2460, DOI 10.1001/jama.284.19.2460; FIELD MJ, 1997, APPRAOCHING DEATH IM; Foley KM, 2001, IMPROVING PALLIATIVE; Ganzini L, 2000, NEW ENGL J MED, V342, P557, DOI 10.1056/NEJM200002243420806; Iwashyna TJ, 2002, HEALTH SERV RES, V37, P1531, DOI 10.1111/1475-6773.10562; Quill TE, 2000, ANN INTERN MED, V132, P408, DOI 10.7326/0003-4819-132-5-200003070-00012; Quill TE, 2003, ANN INTERN MED, V138, P208, DOI 10.7326/0003-4819-138-3-200302040-00013; *RW JOHNS FDN, 2003, ACC REP; Steinhauser AE, 2000, JAMA-J AM MED ASSOC, V284, P2476, DOI 10.1001/jama.284.19.2476; Sullivan AD, 2000, NEW ENGL J MED, V342, P598, DOI 10.1056/NEJM200002243420822; Veldink JH, 2002, NEW ENGL J MED, V346, P1638, DOI 10.1056/NEJMsa012739; Virnig BA, 2000, J AM GERIATR SOC, V48, P1117, DOI 10.1111/j.1532-5415.2000.tb04789.x; ZECH DFJ, 1995, PAIN, V63, P65, DOI 10.1016/0304-3959(95)00017-M	17	5	5	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 7	2003	289	17					2282	2282		10.1001/jama.289.17.2282	http://dx.doi.org/10.1001/jama.289.17.2282			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	675ET	12734143				2022-12-24	WOS:000182680700034
J	Clinton, WJ				Clinton, WJ			Turning the tide on the AIDS pandemic	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									William J Clinton Presidential Fdn, New York, NY USA		Clinton, WJ (corresponding author), William J Clinton Presidential Fdn, New York, NY USA.								0	31	32	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 1	2003	348	18					1800	1802		10.1056/NEJMsb023052	http://dx.doi.org/10.1056/NEJMsb023052			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	672VK	12724487				2022-12-24	WOS:000182543500010
J	Sordella, R; Jiang, W; Chen, GC; Curto, M; Settleman, J				Sordella, R; Jiang, W; Chen, GC; Curto, M; Settleman, J			Modulation of rho GTPase signaling regulates a switch between adipogenesis and myogenesis	CELL			English	Article							INSULIN-RECEPTOR SUBSTRATE-1; AXON OUTGROWTH; P190 RHOGAP; DIFFERENTIATION; SHP-2; CELL; EXPRESSION; FAMILY; ACTIN; GENE	Mature adipocytes and myocytes are derived from a common mesenchymal precursor. While IGF-1 promotes the differentiation of both cell types, the signaling pathways that specify the distinct cell fates are largely unknown. Here, we show that the Rho GTPase and its regulator, p190-B RhoGAP, are components of a critical switch in the adipogenesis-myogenesis "decision." Cells derived from embryos lacking p190-B RhoGAP exhibit excessive Rho activity, are defective for adipogenesis, but undergo myogenesis in response to IGF-1 exposure. In vitro, activation of Rhokinase by Rho inhibits adipogenesis and is required for myogenesis. The activation state of Rho following IGF-1 signaling is determined by the tyrosine-phosphorylation status of p190-B RhoGAP and its resulting subcellular relocalization. Moreover, adjusting Rho activity is sufficient to alter the differentiation program of adipocyte and myocyte precursors. Together, these results identify the Rho GTPase as an essential modulator of IGF-1 signals that direct the adipogenesis-myogenesis cell fate decision.	Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA; Harvard Med Sch, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital	Settleman, J (corresponding author), Massachusetts Gen Hosp, Ctr Canc, 149 13th St, Charlestown, MA 02129 USA.		Chen, Guang-Chao/P-1262-2019	Chen, Guang-Chao/0000-0002-4980-4718	NCI NIH HHS [CA69498] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Allen M, 2002, J MOL BIOL, V323, P411, DOI 10.1016/S0022-2836(02)00968-3; BAINS W, 1984, MOL CELL BIOL, V4, P1449, DOI 10.1128/MCB.4.8.1449; Begum N, 2002, J BIOL CHEM, V277, P6214, DOI 10.1074/jbc.M110508200; Bickel PE, 2002, AM J PHYSIOL-ENDOC M, V282, pE1, DOI 10.1152/ajpendo.2002.282.1.E1; Brouns MR, 2000, DEVELOPMENT, V127, P4891; Brouns MR, 2001, NAT CELL BIOL, V3, P361, DOI 10.1038/35070042; Burbelo PD, 1998, BBA-GENE STRUCT EXPR, V1443, P203, DOI 10.1016/S0167-4781(98)00207-3; Carnac G, 1998, MOL BIOL CELL, V9, P1891, DOI 10.1091/mbc.9.7.1891; Charrasse S, 2002, J CELL BIOL, V158, P953, DOI 10.1083/jcb.200202034; Fujisawa K, 1998, J BIOL CHEM, V273, P18943, DOI 10.1074/jbc.273.30.18943; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Henning SW, 1997, EMBO J, V16, P2397, DOI 10.1093/emboj/16.9.2397; Kontaridis MI, 2001, J CELL SCI, V114, P2187; Lacalle RA, 2002, J CELL BIOL, V157, P277, DOI 10.1083/jcb.200109031; Luo LQ, 1996, PERSPECT DEV NEUROBI, V4, P199; Maegawa H, 1999, J BIOL CHEM, V274, P30236, DOI 10.1074/jbc.274.42.30236; Marinissen MT, 2001, GENE DEV, V15, P535, DOI 10.1101/gad.855801; Miki H, 2001, MOL CELL BIOL, V21, P2521, DOI 10.1128/MCB.21.7.2521-2532.2001; O'Brien SP, 2000, P NATL ACAD SCI USA, V97, P12074, DOI 10.1073/pnas.97.22.12074; O'Reilly AM, 2000, MOL CELL BIOL, V20, P299, DOI 10.1128/MCB.20.1.299-311.2000; Reusch JEB, 2000, MOL CELL BIOL, V20, P1008, DOI 10.1128/MCB.20.3.1008-1020.2000; Rosen ED, 2000, ANNU REV CELL DEV BI, V16, P145, DOI 10.1146/annurev.cellbio.16.1.145; Settleman J, 1999, Prog Mol Subcell Biol, V22, P201; Sordella R, 2002, DEV CELL, V2, P553, DOI 10.1016/S1534-5807(02)00162-4; SUGAI M, 1992, J BIOL CHEM, V267, P2600; Symons M, 2000, TRENDS CELL BIOL, V10, P415, DOI 10.1016/S0962-8924(00)01832-8; Takano H, 1998, MOL CELL BIOL, V18, P1580, DOI 10.1128/MCB.18.3.1580; Taya S, 2001, J CELL BIOL, V155, P809, DOI 10.1083/jcb.200106139; Vincent S, 1999, EUR J CELL BIOL, V78, P539, DOI 10.1016/S0171-9335(99)80019-3; WILLIAMS IH, 1977, BIOCHEM BIOPH RES CO, V77, P175, DOI 10.1016/S0006-291X(77)80180-0; XU B, 1995, J BIOL CHEM, V270, P29825; Zhao M, 1999, MOL CELL BIOL, V19, P21	32	309	326	1	23	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 18	2003	113	2					147	158		10.1016/S0092-8674(03)00271-X	http://dx.doi.org/10.1016/S0092-8674(03)00271-X			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	672EP	12705864	Bronze			2022-12-24	WOS:000182508500005
J	Neff, BD				Neff, BD			Decisions about parental care in response to perceived paternity	NATURE			English	Article							BLUEGILL SUNFISH; LEPOMIS-MACROCHIRUS; EASTERN BLUEBIRDS; INVESTMENT; BEHAVIOR; CONFIDENCE; SUCCESS; SIZE	Evolutionary ecologists are attempting to explain how parents make behavioural decisions about how much care to provide to their young(1-4). Theory predicts that when genetic relatedness to young is decreased by cuckoldry, for example, parents should reduce their care in favour of alternative broods that provide greater reproductive success(5-7). Experimental manipulation of perceived paternity has been used to test the theory(8,9), but such studies have generated mixed results(10-13). Some manipulations can fail to alter a parent's perceived paternity(14), whereas others may directly affect parental behaviour when, for instance, the manipulation involves capturing the parent(15-18). No study has demonstrated parental care adjustment in a manner uncomplicated by experimental design or life history correlates. Here I test the theory using the fact that nest-tending parental male bluegill sunfish (Lepomis macrochirus) can assess their paternity using both the visual presence of parasitic cuckolder males during spawning(19), and olfactory cues released by newly hatched eggs(20,21). By manipulating both types of cues I show that parental males dynamically adjust their parental care, favouring broods that are apparently most closely related. These results confirm the importance of genetic relatedness in parental care decision-making.	Univ Western Ontario, Dept Biol, London, ON N6A 5B7, Canada	Western University (University of Western Ontario)	Neff, BD (corresponding author), Univ Western Ontario, Dept Biol, London, ON N6A 5B7, Canada.			Neff, Bryan/0000-0001-8499-250X				Brown GE, 1996, REV FISH BIOL FISHER, V6, P201; BURKE T, 1989, NATURE, V338, P249, DOI 10.1038/338249a0; Cargnelli LM, 1996, CAN J FISH AQUAT SCI, V53, P360, DOI 10.1139/cjfas-53-2-360; COLEMAN RM, 1991, ETHOLOGY, V87, P177, DOI 10.1111/j.1439-0310.1991.tb00245.x; DIXON A, 1994, NATURE, V371, P698, DOI 10.1038/371698a0; DOMINEY WJ, 1980, NATURE, V284, P546, DOI 10.1038/284546a0; Fu P, 2001, P ROY SOC B-BIOL SCI, V268, P1105, DOI 10.1098/rspb.2001.1625; GROSS MR, 1982, Z TIERPSYCHOL, V60, P1; Hunt J, 2002, J EVOLUTION BIOL, V15, P784, DOI 10.1046/j.1420-9101.2002.00442.x; Jamieson IG, 1997, AUK, V114, P291, DOI 10.2307/4089171; Kempenaers B, 1998, ANIM BEHAV, V55, P845, DOI 10.1006/anbe.1997.0667; Kempenaers B, 1997, ANIM BEHAV, V53, P423, DOI 10.1006/anbe.1996.0377; Kokko H, 1999, ECOL LETT, V2, P247, DOI 10.1046/j.1461-0248.1999.00075.x; Kokko H, 2000, TRENDS ECOL EVOL, V15, P440, DOI 10.1016/S0169-5347(00)01985-6; Lessells C.M., 1991, P32; MacDougall-Shackleton EA, 1998, BEHAV ECOL, V9, P201, DOI 10.1093/beheco/9.2.201; Neff BD, 2002, P ROY SOC B-BIOL SCI, V269, P1435, DOI 10.1098/rspb.2002.2028; Neff BD, 2001, J HERED, V92, P111, DOI 10.1093/jhered/92.2.111; Neff BD, 2001, P ROY SOC B-BIOL SCI, V268, P1559, DOI 10.1098/rspb.2001.1678; NEFF BD, UNPUB P R SOC LOND B; NEFF BD, IN PRESS ANIM COGN; Sargent R. C., 1993, BEHAV TELEOST FISHES, P275; Sheldon BC, 2002, PHILOS T R SOC B, V357, P341, DOI 10.1098/rstb.2001.0931; Sheldon BC, 1998, P ROY SOC B-BIOL SCI, V265, P1737, DOI 10.1098/rspb.1998.0496; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; Westneat David F., 1996, Trends in Ecology and Evolution, V11, P87, DOI 10.1016/0169-5347(96)81049-4; WESTNEAT DF, 1993, BEHAV ECOL, V4, P66, DOI 10.1093/beheco/4.1.66; Wright J., 1998, SPERM COMPETITION SE, P117, DOI 10.1016/B978-012100543-6/50029-5	28	123	126	0	92	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 17	2003	422	6933					716	719		10.1038/nature01528	http://dx.doi.org/10.1038/nature01528			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668CG	12700761				2022-12-24	WOS:000182272300040
J	Goldstein, LE; Muffat, JA; Cherny, RA; Moir, RD; Ericsson, MH; Huang, XD; Mavros, C; Coccia, JA; Faget, KY; Fitch, KA; Masters, CL; Tanzi, RE; Chylack, LT; Bush, AI				Goldstein, LE; Muffat, JA; Cherny, RA; Moir, RD; Ericsson, MH; Huang, XD; Mavros, C; Coccia, JA; Faget, KY; Fitch, KA; Masters, CL; Tanzi, RE; Chylack, LT; Bush, AI			Cytosolic beta-amyloid deposition and supranuclear cataracts in lenses from people with Alzheimer's disease	LANCET			English	Article							ALPHA-B-CRYSTALLIN; A-BETA; OXIDATIVE STRESS; PROTEIN; PRECURSOR; BRAIN; NEUROTOXICITY; TRANSPARENCY; ACCUMULATION; PEPTIDE	Background Pathological hallmarks of Alzheimer's disease include cerebral beta-amyloid (Abeta) deposition, amyloid accumulation, and neuritic plaque formation. We aimed to investigate the hypothesis that molecular pathological findings associated with Alzheimer's disease overlap in the lens and brain. Methods We obtained postmortem specimens of eyes and brain from nine individuals with Alzheimer's disease and eight controls without the disorder, and samples of primary aqueous humour from three people without the disorder who were undergoing cataract surgery. Dissected lenses were analysed by slit-lamp stereophotomicroscopy, western blot, tryptic-digest/mass spectrometry electrospray ionisation, and anti-Abeta surface-enhanced laser desorption ionisation (SELDI) mass spectrometry, immunohistochemistry, and immunogold electron microscopy. Aqueous humour was analysed by anti-Abeta SELDI mass spectrometry. We did binding and aggregation studies to investigate Abeta-lens protein interactions. Findings We identified Abeta1-40 and Abeta1-42 in lenses from people with and without Alzheimer's disease at concentrations comparable with brain, and Abeta1-40 in primary aqueous humour at concentrations comparable with cerebrospinal fluid. Abeta accumulated in lenses from individuals with Alzheimer's disease as electron-dense deposits located exclusively in the cytoplasm of supranuclear/cleep cortical lens fibre cells (n=4). We consistently saw equatorial supranuclear cataracts in lenses from people with Alzheimer's disease (n=9) but not in controls (n = 8). These supranuclear cataracts colocalised with enhanced Abeta immunoreactivity and birefringent Congo Red staining. Synthetic Abeta bound alphaB-crystallin, an abundant cytosolic lens protein. Abeta promoted lens protein aggregation that showed protofibrils, birefringent Congo Red staining, and Abeta/alphaB-crystallin coimmunoreactivity. Interpretation Abeta is present in the cytosol of lens fibre cells of people with Alzheimer's disease. Lens Abeta might promote regionally-specific lens protein aggregation, extracerebral amyloid formation, and supranuclear cataracts.	Massachusetts Gen Hosp, Genet & Aging Res Univ, Lab Oxidat Biol, Charlestown, MA 02129 USA; Brigham & Womens Hosp, Ctr Ophthalm Res, Boston, MA 02115 USA; Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; Ecole Normale Super, Dept Bioengn, Cachan, France; Univ Melbourne, Dept Pathol, Parkville, Vic 3052, Australia; Univ Melbourne, Mental Hlth Res Inst Victoria, Parkville, Vic 3052, Australia; Harvard Univ, Sch Med, Electron Microscope Facil, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; UDICE-French Research Universities; Universite Paris Saclay; University of Melbourne; University of Melbourne; Harvard University; Harvard Medical School	Bush, AI (corresponding author), Massachusetts Gen Hosp, Genet & Aging Res Univ, Lab Oxidat Biol, Bldg 114,16th St, Charlestown, MA 02129 USA.		Bush, Ashley/Y-2457-2019; Bush, Ashley I/A-1186-2007; Tanzi, Rudolph/AAE-9622-2019; Muffat, Julien/P-2298-2014; Moir, Robert/M-7612-2017	Bush, Ashley/0000-0001-8259-9069; Bush, Ashley I/0000-0001-8259-9069; Tanzi, Rudolph/0000-0002-7032-1454; Sommerville, Christine/0000-0002-9226-1691; Muffat, Julien/0000-0003-1889-7023; Moir, Robert/0000-0001-5431-3553; Goldstein, Lee/0000-0001-8419-9800	NIA NIH HHS [AG005134-19, AG12686] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R29AG012686, P50AG005134, R01AG012686] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BENEDEK GB, 1971, APPL OPTICS, V10, P459, DOI 10.1364/AO.10.000459; Bush A I, 2001, Novartis Found Symp, V235, P26; Butterfield DA, 2002, FREE RADICAL BIO MED, V32, P1050, DOI 10.1016/S0891-5849(02)00794-3; Cherny RA, 1999, J BIOL CHEM, V274, P23223, DOI 10.1074/jbc.274.33.23223; CHYLACK LT, 1984, CIBA F SYMP, V106, P3; CHYLACK LT, 1984, INVEST OPHTH VIS SCI, V25, P166; Fonte V, 2002, P NATL ACAD SCI USA, V99, P9439, DOI 10.1073/pnas.152313999; Frederikse PH, 1996, J BIOL CHEM, V271, P10169, DOI 10.1074/jbc.271.17.10169; Glabe C, 2001, J MOL NEUROSCI, V17, P137, DOI 10.1385/JMN:17:2:137; Gouras GK, 2000, AM J PATHOL, V156, P15, DOI 10.1016/S0002-9440(10)64700-1; GRIFFITHS G, 1993, FINE STRUCTURE IMMUN; Hanson SRA, 2000, EXP EYE RES, V71, P195, DOI 10.1006/exer.2000.0868; Harding JJ, 1997, ALZ DIS ASSOC DIS, V11, P123, DOI 10.1097/00002093-199709000-00002; Hartley DM, 1999, J NEUROSCI, V19, P8876, DOI 10.1523/JNEUROSCI.19-20-08876.1999; Holton JL, 2002, J NEUROPATH EXP NEUR, V61, P254, DOI 10.1093/jnen/61.3.254; Horwitz J, 2000, SEMIN CELL DEV BIOL, V11, P53, DOI 10.1006/scdb.1999.0351; JOACHIM CL, 1989, NATURE, V341, P226, DOI 10.1038/341226a0; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Liang JJN, 2000, FEBS LETT, V484, P98, DOI 10.1016/S0014-5793(00)02136-0; LOWE J, 1992, NEUROPATH APPL NEURO, V18, P341, DOI 10.1111/j.1365-2990.1992.tb00796.x; LOWE RF, 1949, BRIT J OPHTHALMOL, V33, P131, DOI 10.1136/bjo.33.3.131; McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; Moir RD, 1998, J BIOL CHEM, V273, P5013, DOI 10.1074/jbc.273.9.5013; Moir RD, 1999, BIOCHEMISTRY-US, V38, P4595, DOI 10.1021/bi982437d; Skovronsky DM, 1998, J CELL BIOL, V141, P1031, DOI 10.1083/jcb.141.4.1031; SPECTOR A, 1984, CIBA F SYMP, V106, P48; Stege GJJ, 1999, BIOCHEM BIOPH RES CO, V262, P152, DOI 10.1006/bbrc.1999.1167; Tanzi RE, 2001, NEURON, V32, P181, DOI 10.1016/S0896-6273(01)00476-7; VAEZY S, 1991, J MICROSC-OXFORD, V163, P85, DOI 10.1111/j.1365-2818.1991.tb03162.x	30	278	374	0	26	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 12	2003	361	9365					1258	1265		10.1016/S0140-6736(03)12981-9	http://dx.doi.org/10.1016/S0140-6736(03)12981-9			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	666DM	12699953				2022-12-24	WOS:000182161600010
J	Walsh, PD; Abernethy, KA; Bermejo, M; Beyersk, R; De Wachter, P; Akou, ME; Huljbregis, B; Mambounga, DI; Toham, AK; Kilbourn, AM; Lahm, SA; Latour, S; Maisels, F; Mbina, C; Mihindou, Y; Obiang, SN; Effa, EN; Starkey, MP; Telfer, P; Thibault, M; Tutin, CEG; White, LJT; Wilkie, DS				Walsh, PD; Abernethy, KA; Bermejo, M; Beyersk, R; De Wachter, P; Akou, ME; Huljbregis, B; Mambounga, DI; Toham, AK; Kilbourn, AM; Lahm, SA; Latour, S; Maisels, F; Mbina, C; Mihindou, Y; Obiang, SN; Effa, EN; Starkey, MP; Telfer, P; Thibault, M; Tutin, CEG; White, LJT; Wilkie, DS			Catastrophic ape decline in western equatorial Africa	NATURE			English	Article							GORILLA-GORILLA; CONSERVATION; FOREST	Because rapidly expanding human populations have devastated gorilla (Gorilla gorilla) and common chimpanzee (Pan troglodytes) habitats in East and West Africa, the relatively intact forests of western equatorial Africa have been viewed as the last stronghold of African apes(1). Gabon and the Republic of Congo alone are thought to hold roughly 80% of the world's gorillas(2) and most of the common chimpanzees(1). Here we present survey results conservatively indicating that ape populations in Gabon declined by more than half between 1983 and 2000. The primary cause of the decline in ape numbers during this period was commercial hunting, facilitated by the rapid expansion of mechanized logging. Furthermore, Ebola haemorrhagic fever is currently spreading through ape populations in Gabon and Congo and now rivals hunting as a threat to apes. Gorillas and common chimpanzees should be elevated immediately to 'critically endangered' status. Without aggressive investments in law enforcement, protected area management and Ebola prevention, the next decade will see our closest relatives pushed to the brink of extinction.	Princeton Univ, Dept Ecol & Evolut Biol, Princeton, NJ 08540 USA; Ctr Int Rech Med Franceville, Franceville, Gabon; Univ Stirling, Dept Biol & Mol Sci, Stirling FK9 4LA, Scotland; Univ Barcelona, Fac Biol, Dept Biol Anim Vertebrados, E-08028 Barcelona, Spain; Wildlife Conservat Soc, Bronx, NY 10460 USA; WWF, Cent Africa Reg Program Off, Libreville, Gabon; Minist Econ Forestiere Eaux Peche Charge Environm, Direct Faune & Chasse, Libreville, Gabon; Inst Rech Ecol Trop, Libreville, Gabon; Univ Edinburgh, Inst Cell Anim & Populat Biol, Edinburgh EH9 3JT, Midlothian, Scotland; Univ Cambridge, Dept Geog, Cambridge CB2 3EN, England; NYU, Dept Anthropol, New York, NY 10003 USA	Princeton University; University of Stirling; University of Barcelona; Wildlife Conservation Society; World Wildlife Fund; University of Edinburgh; University of Cambridge; New York University	Walsh, PD (corresponding author), Princeton Univ, Dept Ecol & Evolut Biol, Guyot Hall, Princeton, NJ 08540 USA.	pwalsh@princeton.edu	Phillips, Paul/E-7813-2013; Maisels, Fiona/E-7382-2015	Phillips, Paul/0000-0002-8749-7026; Maisels, Fiona/0000-0002-0778-0615; Abernethy, Katharine/0000-0002-0393-9342				ANGOUE C, 2000, AVENIR PEUPLES FORET, V3; BARNES RFW, 1991, AFR J ECOL, V29, P54, DOI 10.1111/j.1365-2028.1991.tb00820.x; Bermejo M, 1999, ORYX, V33, P323, DOI 10.1017/S0030605300030726; BLOM A, 2001, J SUST TOURISM, V8, P175; Brugiere D, 2001, J ZOOL, V255, P251, DOI 10.1017/S0952836901001315; Buckland S. T., 1993, Distance sampling: estimating abundance of biological populations.; CHAMBERLIN C, 1978, INT J AFR HIST STUD, V11, P429, DOI 10.2307/217312; *DIR FAUN CHASS, 1999, RAPP ACT LUTT ANT LU; Georges AJ, 1999, J INFECT DIS, V179, pS65, DOI 10.1086/514290; Harcourt AH, 1996, BIOL CONSERV, V75, P165, DOI 10.1016/0006-3207(95)00059-3; Hedley Sharon L., 1999, Journal of Cetacean Research and Management, V1, P255; HUIJBREGTS B, IN PRESS ORYX; Kingdon J., 1997, KINGDOM FIELD GUIDE; Lahm SA, 1993, ECOLOGY EC HUMAN WIL; Oates J.F., 1996, AFRICAN PRIMATES STA; POURTIER R., 1989, GABON ETAT DEVELOPPE, V2; ROBERTS L, 1998, WORLD RESOURCES, P292; TUTIN CEG, 1984, AM J PRIMATOL, V6, P313, DOI 10.1002/ajp.1350060403; Walsh PD, 1999, CONSERV BIOL, V13, P1194, DOI 10.1046/j.1523-1739.1999.98148.x; Wilkie D, 2000, CONSERV BIOL, V14, P1614, DOI [10.1111/j.1523-1739.2000.99102.x, 10.1046/j.1523-1739.2000.99102.x]; Wilkie DS, 1999, ORYX, V33, P339, DOI 10.1017/S003060530003074X	22	393	416	0	198	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 10	2003	422	6932					611	614		10.1038/nature01566	http://dx.doi.org/10.1038/nature01566			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665GN	12679788				2022-12-24	WOS:000182111400041
J	Bazzano, LA; He, J; Muntner, P; Vupputuri, S; Whelton, PK				Bazzano, LA; He, J; Muntner, P; Vupputuri, S; Whelton, PK			Relationship between cigarette smoking and novel risk factors for cardiovascular disease in the United States	ANNALS OF INTERNAL MEDICINE			English	Article							C-REACTIVE PROTEIN; CORONARY-ARTERY-DISEASE; APPARENTLY HEALTHY-MEN; PLASMA HOMOCYSTEINE; LIQUID-CHROMATOGRAPHY; HEART-DISEASE; FIBRINOGEN; INFLAMMATION; ASSOCIATION; SMOKERS	Background: Few studies have examined the relationship between cigarette smoking and novel risk factors for cardiovascular disease in a general population or have included a biochemical marker of current smoking. Objective: To examine the relationship between cigarette smoking and serum C-reactive protein, fibrinogen, and homocysteine levels. Design: Cross-sectional study. Setting: The U.S. general population. Patients: 4187 current smokers, 4791 former smokers, and 8375 never-smokers 18 years of age or older who participated in the Third National Health and Nutrition Examination Survey conducted between 1988 and 1994. Measurements: serum C-reactive protein levels were categorized as detectable (2.2 to 9.9 mg/L) or clinically elevated (greater than or equal to10 mg/L), and fibrinogen and homocysteine levels were defined as elevated if in the 85th percentile or greater (11.1 mumol/L and 12.7 mmol/L, respectively). Results: After adjustment for traditional cardiovascular disease risk factors, cigarette smoking was related to elevated levels of C-reactive protein, fibrinogen, and homocysteine. Compared with never smoking cigarettes, self-reported current cigarette smoking was associated with a C-reactive protein level in the detectable (odds ratio, 1.66 [95% CI, 1.40 to 1.97]; P < 0.001) or clinically elevated (odds ratio, 1.98 [CI, 1.57 to 2.51]; P < 0.001) ranges, with elevated levels of fibrinogen (odds ratio, 2.15 [CI, 1.65 to 2.80]; P < 0.001) and homocysteine (odds ratio, 2.10 [CI, 1.62 to 2.74]; P < 0.001). There were positive and significant dose-response relationships between measures of cigarette smoking (cigarettes per day, pack-years, and serum cotinine levels) and elevated levels of novel risk factors. Conclusions: These findings suggest that inflammation and hyperhomocysteinemia may be important mechanisms by which smoking promotes atherosclerotic disease.	Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA 70112 USA; Tulane Univ, Sch Med, New Orleans, LA 70112 USA; Natl Inst Environm Hlth Sci, Res Triangle Pk, NC USA	Tulane University; Tulane University; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	He, J (corresponding author), Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, 1430 Tulane Ave SL18, New Orleans, LA 70112 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060300] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL60300] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		*AM HEART ASS, 2001, 2002 HEART STROK STA; Anderson JL, 2000, CIRCULATION, V102, P1227, DOI 10.1161/01.CIR.102.11.1227; [Anonymous], 1994, VITAL HLTH STAT, P1; ARAKI A, 1987, J CHROMATOGR-BIOMED, V422, P43, DOI 10.1016/0378-4347(87)80438-3; Azar RR, 2000, AM J CARDIOL, V86, P205, DOI 10.1016/S0002-9149(00)00856-0; Bermudez EA, 2002, AM J CARDIOL, V89, P1117, DOI 10.1016/S0002-9149(02)02284-1; Bernert JT, 1997, CLIN CHEM, V43, P2281; BOUSHEY CJ, 1995, JAMA-J AM MED ASSOC, V274, P1049, DOI 10.1001/jama.274.13.1049; Campisi R, 1998, CIRCULATION, V98, P119, DOI 10.1161/01.CIR.98.2.119; Danesh J, 1998, JAMA-J AM MED ASSOC, V279, P1477, DOI 10.1001/jama.279.18.1477; DAS I, 1985, CLIN CHIM ACTA, V153, P9, DOI 10.1016/0009-8981(85)90133-0; de Bree A, 2001, AM J EPIDEMIOL, V154, P150, DOI 10.1093/aje/154.2.150; Erlinger TP, 2001, ARCH INTERN MED, V161, P1903, DOI 10.1001/archinte.161.15.1903; Fusegawa Y, 1999, THROMB RES, V93, P271, DOI 10.1016/S0049-3848(98)00184-4; GREEN D, 1994, ARTERIOSCLER THROMB, V14, P686, DOI 10.1161/01.ATV.14.5.686; Gunter EW, 1996, LAB PROCEDURES USED; He J, 2001, ARCH INTERN MED, V161, P996, DOI 10.1001/archinte.161.7.996; HUNG J, 1995, CIRCULATION, V92, P2432, DOI 10.1161/01.CIR.92.9.2432; Jacques PF, 2001, AM J CLIN NUTR, V73, P613; KANNEL WB, 1987, AM HEART J, V113, P1006, DOI 10.1016/0002-8703(87)90063-9; KROBOT K, 1992, ARTERIOSCLER THROMB, V12, P780, DOI 10.1161/01.ATV.12.7.780; Kuller LH, 1996, AM J EPIDEMIOL, V144, P537, DOI 10.1093/oxfordjournals.aje.a008963; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; MUSCAT JE, 1991, AM HEART J, V121, P141, DOI 10.1016/0002-8703(91)90967-M; Ockene IS, 1997, CIRCULATION, V96, P3243, DOI 10.1161/01.CIR.96.9.3243; Pirkle JL, 1996, JAMA-J AM MED ASSOC, V275, P1233, DOI 10.1001/jama.275.16.1233; Ridker PM, 1998, CIRCULATION, V98, P731, DOI 10.1161/01.CIR.98.8.731; Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401; Rohde LEP, 1999, AM J CARDIOL, V84, P1018, DOI 10.1016/S0002-9149(99)00491-9; SHAW ST, 1977, CRC CR REV CL LAB SC, V8, P145, DOI 10.3109/10408367709151695; Tracy RP, 1997, ARTERIOSCL THROM VAS, V17, P2167, DOI 10.1161/01.ATV.17.10.2167; US Department of Health and Human Services [Internet], 1990, HLTH BEN SMOK CESS R	32	273	284	0	12	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 3	2003	138	11					891	897		10.7326/0003-4819-138-11-200306030-00010	http://dx.doi.org/10.7326/0003-4819-138-11-200306030-00010			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	686AB	12779299				2022-12-24	WOS:000183296400004
J	Chambers, I; Colby, D; Robertson, M; Nichols, J; Lee, S; Tweedie, S; Smith, A				Chambers, I; Colby, D; Robertson, M; Nichols, J; Lee, S; Tweedie, S; Smith, A			Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells	CELL			English	Article							LEUKEMIA INHIBITORY FACTOR; PRIMORDIAL GERM-CELLS; SELF-RENEWAL; DIFFERENTIATION; GENE; RECEPTOR; MAINTENANCE; ACTIVATION; STAT3; GP130	Embryonic stem (ES) cells undergo extended proliferation while remaining poised for multilineage differentiation. A unique network of transcription factors may characterize self-renewal and simultaneously suppress differentiation. We applied expression cloning in mouse ES cells to isolate a self-renewal determinant. Nanog is a divergent homeodomain protein that directs propagation of undifferentiated ES cells. Nanog mRNA is present in pluripotent mouse and human cell lines, and absent from differentiated cells. In preimplantation embryos, Nanog is restricted to founder cells from which ES cells can be derived. Endogenous Nanog acts in parallel with cytokine stimulation of Stat3 to drive ES cell self-renewal. Elevated Nanog expression from transgene constructs is sufficient for clonal expansion of ES cells, bypassing Stat3 and maintaining Oct4 levels. Cytokine dependence, multilineage differentiation, and embryo colonization capacity are fully restored upon transgene excision. These findings establish a central role for Nanog in the transcription factor hierarchy that defines ES cell identity.	Univ Edinburgh, Inst Stem Cell Res, Edinburgh EH9 3JQ, Midlothian, Scotland	University of Edinburgh	Chambers, I (corresponding author), Univ Edinburgh, Inst Stem Cell Res, Kings Bldg,W Mains Rd, Edinburgh EH9 3JQ, Midlothian, Scotland.	ichambers@ed.ac.uk	Tweedie, Susan/B-3695-2019; Chambers, Ian/H-5416-2011	Tweedie, Susan/0000-0003-1818-8243; Chambers, Ian/0000-0003-2605-1597; Nichols, Jennifer/0000-0002-8650-1388; Smith, Austin/0000-0002-3029-4682				ASHFIELD R, 1994, EMBO J, V13, P5656, DOI 10.1002/j.1460-2075.1994.tb06904.x; Aubert J, 2002, NAT BIOTECHNOL, V20, P1240, DOI 10.1038/nbt763; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Brook FA, 1997, P NATL ACAD SCI USA, V94, P5709, DOI 10.1073/pnas.94.11.5709; Burdon T, 1999, DEV BIOL, V210, P30, DOI 10.1006/dbio.1999.9265; Burdon T, 1999, CELLS TISSUES ORGANS, V165, P131, DOI 10.1159/000016693; Chambers I, 1997, BIOCHEM J, V328, P879, DOI 10.1042/bj3280879; Dani C, 1998, DEV BIOL, V203, P149, DOI 10.1006/dbio.1998.9026; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Fuhrmann G, 2001, DEV CELL, V1, P377, DOI 10.1016/S1534-5807(01)00038-7; GALLI G, 1981, NATURE, V294, P626, DOI 10.1038/294626a0; GASSMANN M, 1995, P NATL ACAD SCI USA, V92, P1292, DOI 10.1073/pnas.92.5.1292; Hanna LA, 2002, GENE DEV, V16, P2650, DOI 10.1101/gad.1020502; Hirano T, 2000, ONCOGENE, V19, P2548, DOI 10.1038/sj.onc.1203551; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; LI M, 1995, NATURE, V378, P724, DOI 10.1038/378724a0; Li M, 1998, CURR BIOL, V8, P971, DOI 10.1016/S0960-9822(98)70399-9; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Matsuda T, 1999, EMBO J, V18, P4261, DOI 10.1093/emboj/18.15.4261; MATSUI Y, 1992, CELL, V70, P841, DOI 10.1016/0092-8674(92)90317-6; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; MOUNTFORD P, 1994, P NATL ACAD SCI USA, V91, P4303, DOI 10.1073/pnas.91.10.4303; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Nichols J, 2001, DEVELOPMENT, V128, P2333; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 2002, MOL CELL BIOL, V22, P1526, DOI 10.1128/MCB.22.5.1526-1536.2002; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Niwa H, 2001, CELL STRUCT FUNCT, V26, P137, DOI 10.1247/csf.26.137; PERA MF, 1989, DIFFERENTIATION, V42, P10, DOI 10.1111/j.1432-0436.1989.tb00602.x; Pesce M, 2001, STEM CELLS, V19, P271, DOI 10.1634/stemcells.19-4-271; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; RATHJEN PD, 1990, GENE DEV, V4, P2308, DOI 10.1101/gad.4.12b.2308; RESNICK JL, 1992, NATURE, V359, P550, DOI 10.1038/359550a0; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; RYSKOV AP, 1983, NUCLEIC ACIDS RES, V11, P6541, DOI 10.1093/nar/11.18.6541; Smith A, 2001, COLD SPRING HARBOR M, P205; Smith AG., 1991, J TISSUE CULT METHOD, V13, P89, DOI [10.1007/bf01666137, DOI 10.1007/BF01666137, 10.1007/BF01666137]; STEWART CL, 1992, NATURE, V359, P76, DOI 10.1038/359076a0; Takahashi-Tezuka M, 1998, MOL CELL BIOL, V18, P4109, DOI 10.1128/MCB.18.7.4109; Takeda K, 1997, P NATL ACAD SCI USA, V94, P3801, DOI 10.1073/pnas.94.8.3801; Thompson JE, 2002, BIOORG MED CHEM LETT, V12, P1219, DOI 10.1016/S0960-894X(02)00106-3; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Vernallis AB, 1997, J BIOL CHEM, V272, P26947, DOI 10.1074/jbc.272.43.26947; Wang SH, 2003, GENE EXPR PATTERNS, V3, P99, DOI 10.1016/S1567-133X(03)00005-X; Yoshida A, 1996, ASSIST REPROD REV, V67, P93; YOSHIDA K, 1994, MECH DEVELOP, V45, P163, DOI 10.1016/0925-4773(94)90030-2	48	2470	2784	4	272	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 30	2003	113	5					643	655		10.1016/S0092-8674(03)00392-1	http://dx.doi.org/10.1016/S0092-8674(03)00392-1			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	687VL	12787505	Bronze, Green Submitted			2022-12-24	WOS:000183397600014
J	Graef, IA; Wang, F; Charron, F; Chen, L; Neilson, J; Tessier-Lavigne, M; Crabtree, GR				Graef, IA; Wang, F; Charron, F; Chen, L; Neilson, J; Tessier-Lavigne, M; Crabtree, GR			Neurotrophins and netrins require calcineurin/NFAT signaling to stimulate outgrowth of embryonic axons	CELL			English	Article							LYMPHOCYTE-T ACTIVATION; MOTOR-NEURON POOLS; LIM HOMEOBOX GENES; NERVOUS-SYSTEM; TRANSCRIPTION FACTOR; CYCLOSPORINE-A; GROWTH; GUIDANCE; DROSOPHILA; PROTEIN	Axon outgrowth is the first step in the formation of neuronal connections, but the pathways that regulate axon extension are still poorly understood. We find that mice deficient in calcineurin-NFAT signaling have dramatic defects in axonal outgrowth, yet have little or no defect in neuronal differentiation or survival. In vitro, sensory and commissural neurons lacking calcineurin function or NFATc2, c3, and c4 are unable to respond to neurotrophins or netrin-1 with efficient axonal outgrowth. Neurotrophins and netrins stimulate calcineurin-dependent nuclear localization of NFATc4 and activation of NFAT-mediated gene transcription in cultured primary neurons. These data indicate that the ability of these embryonic axons to respond to growth factors with rapid outgrowth requires activation of calcineurin/NFAT signaling by these factors. The precise parsing of signals for elongation turning and survival could allow independent control of these processes during development.	Stanford Univ, Sch Med, Dept Biol Sci, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Beckman Ctr Mol & Genet Med, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University	Tessier-Lavigne, M (corresponding author), Stanford Univ, Sch Med, Dept Biol Sci, 300 Pasteur Dr, Stanford, CA 94305 USA.		Charron, Frederic/D-2140-2009; Charron, Frederic/O-8017-2019	Charron, Frederic/0000-0003-3483-8672; Charron, Frederic/0000-0003-3483-8672; Neilson, Joel R./0000-0002-3408-608X	NATIONAL CANCER INSTITUTE [R01CA039612, R37CA039612] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [P01DE008973] Funding Source: NIH RePORTER; NCI NIH HHS [CA 39612] Funding Source: Medline; NIDCR NIH HHS [P01 DE 08973] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Anderson DJ, 2001, NEURON, V30, P19, DOI 10.1016/S0896-6273(01)00260-4; Arber S, 2000, CELL, V101, P485, DOI 10.1016/S0092-8674(00)80859-4; Beals CR, 1997, SCIENCE, V275, P1930, DOI 10.1126/science.275.5308.1930; Behar O, 1996, NATURE, V383, P525, DOI 10.1038/383525a0; Brenman JE, 2001, DEV CELL, V1, P667, DOI 10.1016/S1534-5807(01)00072-7; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; BUCHMAN VL, 1993, DEVELOPMENT, V118, P989; CAMPENOT RB, 1977, P NATL ACAD SCI USA, V74, P4516, DOI 10.1073/pnas.74.10.4516; CLIPSTONE NA, 1992, NATURE, V357, P695, DOI 10.1038/357695a0; CRABTREE GR, 1989, SCIENCE, V243, P355, DOI 10.1126/science.2783497; Crabtree GR, 2002, CELL, V109, pS67, DOI 10.1016/S0092-8674(02)00699-2; de la Pompa JL, 1998, NATURE, V392, P182, DOI 10.1038/32419; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; Edlund T, 1999, CELL, V96, P211, DOI 10.1016/S0092-8674(00)80561-9; ERICSON J, 1992, SCIENCE, V256, P1555, DOI 10.1126/science.1350865; Fazeli A, 1997, NATURE, V386, P796, DOI 10.1038/386796a0; FLANAGAN WM, 1991, NATURE, V352, P803, DOI 10.1038/352803a0; Gao FB, 1999, GENE DEV, V13, P2549, DOI 10.1101/gad.13.19.2549; Giger RJ, 2001, CELL, V105, P1, DOI 10.1016/S0092-8674(01)00290-2; Graef IA, 2001, CURR OPIN GENET DEV, V11, P505, DOI 10.1016/S0959-437X(00)00225-2; Graef IA, 2001, CELL, V105, P863, DOI 10.1016/S0092-8674(01)00396-8; Graef IA, 1999, NATURE, V401, P703, DOI 10.1038/44378; GRIFFITH JP, 1995, CELL, V82, P507, DOI 10.1016/0092-8674(95)90439-5; Haase G, 2002, NEURON, V35, P893, DOI 10.1016/S0896-6273(02)00864-4; Hong K, 2000, NATURE, V403, P93, DOI 10.1038/47507; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Kania A, 2000, CELL, V102, P161, DOI 10.1016/S0092-8674(00)00022-2; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; KISSINGER CR, 1995, NATURE, V378, P641, DOI 10.1038/378641a0; KLEE CB, 1979, P NATL ACAD SCI USA, V76, P6270, DOI 10.1073/pnas.76.12.6270; Klee CB, 1998, J BIOL CHEM, V273, P13367, DOI 10.1074/jbc.273.22.13367; LANKFORD KL, 1989, J CELL BIOL, V109, P1229, DOI 10.1083/jcb.109.3.1229; Lin JH, 1998, CELL, V95, P393, DOI 10.1016/S0092-8674(00)81770-5; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Livet J, 2002, NEURON, V35, P877, DOI 10.1016/S0896-6273(02)00863-2; Ming GL, 2002, NATURE, V417, P411, DOI 10.1038/nature745; O'Connor R, 1999, NEURON, V24, P165, DOI 10.1016/S0896-6273(00)80830-2; Rao Y, 2000, P NATL ACAD SCI USA, V97, P5966, DOI 10.1073/pnas.110135297; Senti KA, 2000, DEVELOPMENT, V127, P2291; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; Sharma K, 1998, CELL, V95, P817, DOI 10.1016/S0092-8674(00)81704-3; SHAW JP, 1988, SCIENCE, V241, P202, DOI 10.1126/science.3260404; Shirasaki R, 2002, ANNU REV NEUROSCI, V25, P251, DOI 10.1146/annurev.neuro.25.112701.142916; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Thor S, 1999, NATURE, V397, P76, DOI 10.1038/16275; Timmerman LA, 1996, NATURE, V383, P837, DOI 10.1038/383837a0; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; Tucker KL, 2001, NAT NEUROSCI, V4, P29, DOI 10.1038/82868; von Schack D, 2001, NAT NEUROSCI, V4, P977, DOI 10.1038/nn730; Weimann JM, 1999, NEURON, V24, P819, DOI 10.1016/S0896-6273(00)81030-2; Zeng HK, 2001, CELL, V107, P617, DOI 10.1016/S0092-8674(01)00585-2	52	303	314	0	13	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 30	2003	113	5					657	670		10.1016/S0092-8674(03)00390-8	http://dx.doi.org/10.1016/S0092-8674(03)00390-8			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	687VL	12787506	Bronze			2022-12-24	WOS:000183397600015
J	Takahashi, K; Mitsui, K; Yamanaka, S				Takahashi, K; Mitsui, K; Yamanaka, S			Role of ERas in promoting tumour-like properties in mouse embryonic stem cells	NATURE			English	Article							PHOSPHATIDYLINOSITOL 3-KINASE; PROTEIN; KINASE; TRANSFORMATION; GENE; AKT; ESTABLISHMENT; SUPPRESSION; PTEN; LINE	Embryonic stem (ES) cells are pluripotent cells derived from early mammalian embryos(1,2). Their immortality and rapid growth make them attractive sources for stem cell therapies(3); however, they produce tumours (teratomas) when transplanted, which could preclude their therapeutic usage(4). Why ES cells, which lack chromosomal abnormalities, possess tumour-like properties is largely unknown. Here we show that mouse ES cells specifically express a Ras-like gene, which we have named ERas. We show that human HRasp, which is a recognized pseudogene, does not contain reported base substitutions and instead encodes the human orthologue of ERas. This protein contains amino-acid residues identical to those present in active mutants of Ras(5) and causes oncogenic transformation in NIH 3T3 cells. ERas interacts with phosphatidylinositol-3-OH kinase(6) but not with Raf(7,8). ERas-null ES cells maintain pluripotency but show significantly reduced growth and tumorigenicity, which are rescued by expression of ERas complementary DNA or by activated phosphatidylinositol-3-OH kinase. We conclude that the transforming oncogene ERas is important in the tumour-like growth properties of ES cells.	Nara Inst Sci & Technol, Res & Educ Ctr Genet Informat, Lab Anim Mol Technol, Nara 6300192, Japan	Nara Institute of Science & Technology	Yamanaka, S (corresponding author), Nara Inst Sci & Technol, Res & Educ Ctr Genet Informat, Lab Anim Mol Technol, Nara 6300192, Japan.		Takahashi, Kazutoshi/ABE-5504-2020; Mitsui, Kaoru/E-1464-2011	Takahashi, Kazutoshi/0000-0002-5329-8395; Mitsui, Kaoru/0000-0003-0534-9845				Burdon T, 1999, DEV BIOL, V210, P30, DOI 10.1006/dbio.1999.9265; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; CHEN ZQ, 1985, J VIROL, V56, P607, DOI 10.1128/JVI.56.2.607-612.1985; Cheng AM, 1998, CELL, V95, P793, DOI 10.1016/S0092-8674(00)81702-X; CLARK GJ, 1995, METHOD ENZYMOL, V255, P395; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; FASANO O, 1984, P NATL ACAD SCI-BIOL, V81, P4008, DOI 10.1073/pnas.81.13.4008; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Freed CR, 2002, P NATL ACAD SCI USA, V99, P1755, DOI 10.1073/pnas.062039699; GASSMANN M, 1995, P NATL ACAD SCI USA, V92, P1292, DOI 10.1073/pnas.92.5.1292; Jirmanova L, 2002, ONCOGENE, V21, P5515, DOI 10.1038/sj.onc.1205728; Klippel A, 1996, MOL CELL BIOL, V16, P4117; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Meiner VL, 1996, P NATL ACAD SCI USA, V93, P14041, DOI 10.1073/pnas.93.24.14041; MIYOSHI J, 1984, NUCLEIC ACIDS RES, V12, P1821, DOI 10.1093/nar/12.4.1821; MOODIE SA, 1993, SCIENCE, V260, P1658, DOI 10.1126/science.8503013; NICHOLS J, 1990, DEVELOPMENT, V110, P1341; Quilliam LA, 1999, J BIOL CHEM, V274, P23850, DOI 10.1074/jbc.274.34.23850; RodriguezViciana P, 1997, CELL, V89, P457, DOI 10.1016/S0092-8674(00)80226-3; RODRIGUEZVICIANA P, 1994, NATURE, V370, P527, DOI 10.1038/370527a0; Rosario M, 1999, EMBO J, V18, P1270, DOI 10.1093/emboj/18.5.1270; SEEBURG PH, 1984, NATURE, V312, P71, DOI 10.1038/312071a0; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sun H, 1999, P NATL ACAD SCI USA, V96, P6199, DOI 10.1073/pnas.96.11.6199; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; WILLUMSEN BM, 1984, NATURE, V310, P583, DOI 10.1038/310583a0; ZHANG XF, 1993, NATURE, V364, P308, DOI 10.1038/364308a0	30	272	305	3	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 29	2003	423	6939					541	545		10.1038/nature01646	http://dx.doi.org/10.1038/nature01646			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	683RH	12774123	Bronze			2022-12-24	WOS:000183162900044
J	Shu, YS; Hasenstaub, A; McCormick, DA				Shu, YS; Hasenstaub, A; McCormick, DA			Turning on and off recurrent balanced cortical activity	NATURE			English	Article							VISUAL-CORTEX; NEOCORTICAL NEURONS; PERSISTENT ACTIVITY; CAT; INHIBITION; INPUT; RAT; EXCITATION; MECHANISMS; COMPONENTS	The vast majority of synaptic connections onto neurons in the cerebral cortex arise from other cortical neurons, both excitatory and inhibitory, forming local and distant 'recurrent' networks. Although this is a basic theme of cortical organization, its study has been limited largely to theoretical investigations, which predict that local recurrent networks show a proportionality or balance between recurrent excitation and inhibition, allowing the generation of stable periods of activity(1-5). This recurrent activity might underlie such diverse operations as short-term memory(4,6,7), the modulation of neuronal excitability with attention(8,9), and the generation of spontaneous activity during sleep(5,10-14). Here we show that local cortical circuits do indeed operate through a proportional balance of excitation and inhibition generated through local recurrent connections, and that the operation of such circuits can generate self-sustaining activity that can be turned on and off by synaptic inputs. These results confirm the long-hypothesized role of recurrent activity as a basic operation of the cerebral cortex.	Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06510 USA	Yale University	McCormick, DA (corresponding author), Yale Univ, Sch Med, Dept Neurobiol, 333 Cedar St, New Haven, CT 06510 USA.		Shu, Yousheng/AAC-3881-2020; Kobelt, Liza/F-5926-2011	Shu, Yousheng/0000-0002-2834-2876; 				Anderson JS, 2000, J NEUROPHYSIOL, V84, P909, DOI 10.1152/jn.2000.84.2.909; Anderson JS, 2000, SCIENCE, V290, P1968, DOI 10.1126/science.290.5498.1968; BERNANDER O, 1991, P NATL ACAD SCI USA, V88, P11569, DOI 10.1073/pnas.88.24.11569; Borg-Graham LJ, 1998, NATURE, V393, P369, DOI 10.1038/30735; Brunel N, 2001, J COMPUT NEUROSCI, V11, P63, DOI 10.1023/A:1011204814320; CARANDINI M, 1994, SCIENCE, V264, P1333, DOI 10.1126/science.8191289; Chance FS, 2002, NEURON, V35, P773, DOI 10.1016/S0896-6273(02)00820-6; Compte A, 2003, J NEUROPHYSIOL, V89, P2707, DOI 10.1152/jn.00845.2002; COMPTE A, UNPUB J NEUROPHYSIOL; CONNORS BW, 1988, J PHYSIOL-LONDON, V406, P443, DOI 10.1113/jphysiol.1988.sp017390; Contreras D, 1996, J PHYSIOL-LONDON, V494, P251, DOI 10.1113/jphysiol.1996.sp021488; Cossart R, 2003, NATURE, V423, P283, DOI 10.1038/nature01614; COWAN RL, 1994, J NEUROPHYSIOL, V71, P17, DOI 10.1152/jn.1994.71.1.17; Durstewitz D, 2000, NAT NEUROSCI, V3, P1184, DOI 10.1038/81460; Egorov AV, 2002, NATURE, V420, P173, DOI 10.1038/nature01171; FUNAHASHI S, 1989, J NEUROPHYSIOL, V61, P331, DOI 10.1152/jn.1989.61.2.331; Fuster JM, 1995, MEMORY CEREBRAL CORT; Gutkin BS, 2001, J COMPUT NEUROSCI, V11, P121, DOI 10.1023/A:1012837415096; Hahnloser RHR, 2002, NEURAL COMPUT, V14, P1669, DOI 10.1162/08997660260028665; Hahnloser RHR, 2000, NATURE, V405, P947, DOI 10.1038/35016072; Hirsch JA, 1998, J NEUROSCI, V18, P9517; HIRSCH JA, 1991, J NEUROSCI, V11, P1800; Mao BQ, 2001, NEURON, V32, P883, DOI 10.1016/S0896-6273(01)00518-9; Sanchez-Vives MV, 2000, NAT NEUROSCI, V3, P1027, DOI 10.1038/79848; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Steriade M, 2001, J NEUROPHYSIOL, V85, P1969, DOI 10.1152/jn.2001.85.5.1969; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; STERN P, 1992, J PHYSIOL-LONDON, V449, P247, DOI 10.1113/jphysiol.1992.sp019085; van Vreeswijk C, 1998, NEURAL COMPUT, V10, P1321, DOI 10.1162/089976698300017214; Wang XJ, 2001, TRENDS NEUROSCI, V24, P455, DOI 10.1016/S0166-2236(00)01868-3	30	754	765	1	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 15	2003	423	6937					288	293		10.1038/nature01616	http://dx.doi.org/10.1038/nature01616			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678EX	12748642				2022-12-24	WOS:000182853100043
J	McVernon, J; Andrews, N; Slack, MPE; Ramsay, ME				McVernon, J; Andrews, N; Slack, MPE; Ramsay, ME			Risk of vaccine failure after Haemophilus influenzae type b (Hib) combination vaccines with acellular pertussis	LANCET			English	Article							CAPSULAR POLYSACCHARIDE	An increase in invasive Hib disease incidence in the UK has coincided with the distribution of combination vaccines that contain acellular pertussis (DTaP-Hib). These vaccines have been associated with reduced Immunogenicity of the Hib component, although there is little agreement on the clinical relevance of this finding. We retrospectively compared vaccine formulations given to fully vaccinated Hib cases with those administered to fully immunised age-matched controls Using conditional logistic regression. More cases than controls received all three doses of their infant primary course as DTaP-Hib, compared with two or three doses of another Hib vaccine (conditional odds ratio 6.77 [95% CI 3.26-14.07]).	Hlth Protect Agcy, Ctr Communicable Dis Surveillance, Immunisat Div, London NW9 5EQ, England; Univ Oxford, Dept Paediat, Oxford Vaccine Grp, Oxford, England; Hlth Protect Agcy, Haemophilus Reference Unit, Oxford, England	Health Protection Agency; University of Oxford; Health Protection Agency	McVernon, J (corresponding author), Hlth Protect Agcy, Ctr Communicable Dis Surveillance, Immunisat Div, London NW9 5EQ, England.		; Ramsay, Mary Elizabeth/S-8281-2016	McVernon, Jodie/0000-0001-9774-1961; Ramsay, Mary Elizabeth/0000-0002-7156-7640				Anderson P, 2000, PEDIATR INFECT DIS J, V19, P589, DOI 10.1097/00006454-200007000-00001; Daum RS, 2001, J INFECT DIS, V184, P1293, DOI 10.1086/324007; Eskola J, 1999, LANCET, V354, P2063, DOI 10.1016/S0140-6736(99)04377-9; RAMSAY ME, IN PRESS J INFECT DI; *UK CHIEF MED OFF, PLANN HIB VACC CATCH	5	133	137	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 3	2003	361	9368					1521	1523		10.1016/S0140-6736(03)13171-6	http://dx.doi.org/10.1016/S0140-6736(03)13171-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	674WB	12737866				2022-12-24	WOS:000182658900014
J	Sheth, U; Parker, R				Sheth, U; Parker, R			Decapping and decay of messenger RNA occur in cytoplasmic processing bodies	SCIENCE			English	Article							YEAST; PROTEINS; COMPLEX; DEADENYLATION; TRANSLATION; HELICASE; DEGRADATION; MECHANISMS; PARTICLES; MUTATIONS	A major pathway of eukaryotic messenger RNA ( mRNA) turnover begins with deadenylation, followed by decapping and 5' to 3' exonucleolytic decay. We provide evidence that mRNA decapping and 5' to 3' degradation occur in discrete cytoplasmic foci in yeast, which we call processing bodies ( P bodies). First, proteins that activate or catalyze decapping are concentrated in P bodies. Second, inhibiting mRNA turnover before decapping leads to loss of P bodies; however, inhibiting turnover at, or after, decapping, increases the abundance and size of P bodies. Finally, mRNA degradation intermediates are localized to P bodies. These results de. ne the flux of mRNAs between polysomes and P bodies as a critical aspect of cytoplasmic mRNA metabolism and a possible site for regulation of mRNA degradation.	Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA; Univ Arizona, Howard Hughes Med Inst, Tucson, AZ 85721 USA	University of Arizona; Howard Hughes Medical Institute; University of Arizona	Parker, R (corresponding author), Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA.	rrparker@u.arizona.edu			NIGMS NIH HHS [GM45443, R01 GM045443] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045443, R37GM045443] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anderson P, 2002, J CELL SCI, V115, P3227; BEELMAN CA, 1994, J BIOL CHEM, V269, P9687; Beelman CA, 1996, NATURE, V382, P642, DOI 10.1038/382642a0; Bertrand E, 1998, MOL CELL, V2, P437, DOI 10.1016/S1097-2765(00)80143-4; Bonnerot C, 2000, MOL CELL BIOL, V20, P5939, DOI 10.1128/MCB.20.16.5939-5946.2000; Bouveret E, 2000, EMBO J, V19, P1661, DOI 10.1093/emboj/19.7.1661; BRENGUES M, UNPUB; Coller JM, 2001, RNA, V7, P1717, DOI 10.1017/S135583820101994X; DECKER CJ, 1993, GENE DEV, V7, P1632, DOI 10.1101/gad.7.8.1632; Dunckley T, 1999, EMBO J, V18, P5411, DOI 10.1093/emboj/18.19.5411; HSU CL, 1993, MOL CELL BIOL, V13, P4826, DOI 10.1128/MCB.13.8.4826; Ingelfinger D, 2002, RNA, V8, P1489, DOI 10.1017/S1355838202021726; Kedersha N, 2002, MOL BIOL CELL, V13, P195, DOI 10.1091/mbc.01-05-0221; Ladomery M, 1997, NUCLEIC ACIDS RES, V25, P965, DOI 10.1093/nar/25.5.965; LaGrandeur T, 1999, RNA, V5, P420, DOI 10.1017/S1355838299981748; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.0.CO;2-U; Lykke-Andersen J, 2002, MOL CELL BIOL, V22, P8114, DOI 10.1128/MCB.22.23.8114-8121.2002; MUHLRAD D, 1992, GENE DEV, V6, P2100, DOI 10.1101/gad.6.11.2100; MUHLRAD D, 1994, GENE DEV, V8, P855, DOI 10.1101/gad.8.7.855; MUHLRAD D, 1995, MOL CELL BIOL, V15, P2145; Nakamura A, 2001, DEVELOPMENT, V128, P3233; Navarro RE, 2001, DEVELOPMENT, V128, P3221; Olivas W, 2000, EMBO J, V19, P6602, DOI 10.1093/emboj/19.23.6602; Schwartz DC, 2000, MOL CELL BIOL, V20, P7933, DOI 10.1128/MCB.20.21.7933-7942.2000; Schwartz DC, 1999, MOL CELL BIOL, V19, P5247; SHETH U, UNPUB; SHYU AB, 1991, GENE DEV, V5, P221, DOI 10.1101/gad.5.2.221; Tharun S, 2000, NATURE, V404, P515, DOI 10.1038/35006676; Tharun S, 2001, MOL CELL, V8, P1075, DOI 10.1016/S1097-2765(01)00395-1; Tucker M, 2000, ANNU REV BIOCHEM, V69, P571, DOI 10.1146/annurev.biochem.69.1.571; Tucker M, 2001, CELL, V104, P377, DOI 10.1016/S0092-8674(01)00225-2; van Dijk E, 2002, EMBO J, V21, P6915, DOI 10.1093/emboj/cdf678; van Hoof A, 2000, MOL CELL BIOL, V20, P8230, DOI 10.1128/MCB.20.21.8230-8243.2000	33	972	1010	5	71	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 2	2003	300	5620					805	808		10.1126/science.1082320	http://dx.doi.org/10.1126/science.1082320			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673KH	12730603	Green Accepted			2022-12-24	WOS:000182579800053
J	Oyranoski, D				Oyranoski, D			Critics slam treatment for SARS as ineffective and perhaps dangerous	NATURE			English	News Item																			0	33	34	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 1	2003	423	6935					4	4		10.1038/423004a	http://dx.doi.org/10.1038/423004a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673CG	12721587	Green Published, Bronze			2022-12-24	WOS:000182561600005
J	Groce, NE				Groce, NE			HIV/AIDS and people with disability	LANCET			English	Editorial Material							HIV; ADULTS; WOMEN		Yale Univ, Yale Sch Publ Hlth, Global Hlth Div, New Haven, CT 06520 USA	Yale University	Groce, NE (corresponding author), Yale Univ, Yale Sch Publ Hlth, Global Hlth Div, New Haven, CT 06520 USA.			Groce, Nora/0000-0002-7885-7042				ALTMAN B, 1997, J DISABIL POLICY STU, V8, P99; Blumberg SJ, 2003, JAIDS, V32, P77, DOI 10.1097/00126334-200301010-00011; Cambridge P, 1997, DISABIL SOC, V12, P427, DOI 10.1080/09687599727272; Chenoweth L., 1996, VIOLENCE AGAINST WOM, V2, P391, DOI [https://doi.org/10.1177/1077801296002004004, DOI 10.1177/1077801296002004004, 10.1177/1077801296002004004]; Collins PY, 2001, J URBAN HEALTH, V78, P162, DOI 10.1093/jurban/78.1.162; COURNOS F, 1990, HOSP COMMUNITY PSYCH, V41, P163; *EC SOC COMM AS PA, 1995, HIDD SIST WOM GIRLS; Gaskins S, 1999, J Assoc Nurses AIDS Care, V10, P75, DOI 10.1016/S1055-3290(06)60301-4; GASKINS S, 1999, J ASS NURSES AIDS CA, V35, P75; Helander E, 1993, PREJUDICE DIGNITY; Lishner DM, 1996, J RURAL HEALTH, V12, P45, DOI 10.1111/j.1748-0361.1996.tb00772.x; McGillivray JA, 1999, J APPL RES INTELLECT, V12, P113, DOI 10.1111/j.1468-3148.1999.tb00070.x; Moores DF, 1998, AM ANN DEAF, V143, P3, DOI 10.1353/aad.2012.0111; Nosek MA, 2001, VIOLENCE AGAINST WOM, V7, P477, DOI 10.1177/10778010122182569; ROBERTSON PE, 1991, J MENT DEFIC RES, V35, P475; *UNAIDS, 2002, REP GLOB HIV AIDS EP; *UNICEF, 1999, GLOB SURV AD DIS OV; Van Biema D, 1994, Time, V143, P76	18	65	67	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 26	2003	361	9367					1401	1402		10.1016/S0140-6736(03)13146-7	http://dx.doi.org/10.1016/S0140-6736(03)13146-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	672HZ	12727388				2022-12-24	WOS:000182516300003
J	Saunders, K; Bedford, ID; Yahara, T; Stanley, J				Saunders, K; Bedford, ID; Yahara, T; Stanley, J			The earliest recorded plant virus disease	NATURE			English	Article									John Innes Ctr Plant Sci Res, Dept Dis & Stress Biol, Norwich NR4 7UH, Norfolk, England; Kyushu Univ, Dept Biol, Fukuoka 8128581, Japan	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Kyushu University	Saunders, K (corresponding author), John Innes Ctr Plant Sci Res, Dept Dis & Stress Biol, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England.			Yahara, Tetsukazu/0000-0001-5105-7152; Saunders, Keith/0000-0002-5606-9627				Briddon RW, 2002, MOL BIOTECHNOL, V20, P315, DOI 10.1385/MB:20:3:315; Briddon RW, 2001, VIROLOGY, V285, P234, DOI 10.1006/viro.2001.0949; INOUYE T, 1980, Annals of the Phytopathological Society of Japan, V46, P49, DOI 10.3186/jjphytopath.46.49; KOCH R, 1884, MITTHEILUNGEN KAISER, V2; Mansoor S, 2003, TRENDS PLANT SCI, V8, P128, DOI 10.1016/S1360-1385(03)00007-4; Onuki Masatoshi, 2000, Journal of General Plant Pathology, V66, P176, DOI 10.1007/PL00012941; OSAKI T, 1979, Annals of the Phytopathological Society of Japan, V45, P62, DOI 10.3186/jjphytopath.45.62; Saunders K, 2001, VIROLOGY, V282, P38, DOI 10.1006/viro.2000.0832; Saunders K, 2000, P NATL ACAD SCI USA, V97, P6890, DOI 10.1073/pnas.97.12.6890; SUGA T, 1991, NANYOSHU COMPLETE EN; YAHARA T, 1993, OECOLOGIA, V96, P310, DOI 10.1007/BF00317499	11	84	94	1	10	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 24	2003	422	6934					831	831		10.1038/422831a	http://dx.doi.org/10.1038/422831a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670WR	12712190	Bronze			2022-12-24	WOS:000182432600038
J	Lassmann, H				Lassmann, H			Brain damage when multiple sclerosis is diagnosed clinically	LANCET			English	Editorial Material									Univ Vienna, Brain Res Inst, A-1090 Vienna, Austria	University of Vienna	Lassmann, H (corresponding author), Univ Vienna, Brain Res Inst, Waehringer Guertel 18, A-1090 Vienna, Austria.		Lassmann, Hans/Z-2269-2019	Lassmann, Hans/0000-0001-8617-5052				Aboul-Enein F, 2003, J NEUROPATH EXP NEUR, V62, P25, DOI 10.1093/jnen/62.1.25; BO L, 1994, J NEUROIMMUNOL, V51, P135, DOI 10.1016/0165-5728(94)90075-2; Dautry W, 2000, J CEREBR BLOOD F MET, V20, P789, DOI 10.1097/00004647-200005000-00005; Evangelou N, 2000, BRAIN, V123, P1845, DOI 10.1093/brain/123.9.1845; Filippi M, 2003, BRAIN, V126, P433, DOI 10.1093/brain/awg038; Kornek B, 1999, BRAIN PATHOL, V9, P651; Lassmann H, 1998, MCALPINES MULTIPLE S, P323; Smith KJ, 2002, LANCET NEUROL, V1, P232, DOI 10.1016/S1474-4422(02)00102-3	8	16	16	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 19	2003	361	9366					1317	1318		10.1016/S0140-6736(03)13088-7	http://dx.doi.org/10.1016/S0140-6736(03)13088-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	669HP	12711464				2022-12-24	WOS:000182346100006
J	Jain, S; Bates, FS				Jain, S; Bates, FS			On the origins of morphological complexity in block copolymer surfactants	SCIENCE			English	Article							MICROEMULSION NETWORKS; PHASE-SEPARATION; DIBLOCK COPOLYMERS; MICELLES; VESICLES; DILUTE; FLUIDS; WATER; MODEL	Amphiphilic compounds such as lipids and surfactants are fundamental building blocks of soft matter. We describe experiments with poly(1,2-butadiene-b-ethylene oxide) (PB-PEO) diblock copolymers, which form Y-junctions and three-dimensional networks in water at weight fractions of PEO intermediate to those associated with vesicle and wormlike micelle morphologies. Fragmentation of the network produces a nonergodic array of complex reticulated particles that have been imaged by cryogenic transmission electron microscopy. Data obtained with two sets of PB-PEO compounds indicate that this type of self-assembly appears above a critical molecular weight. These block copolymers represent versatile amphiphiles, mimicking certain low molecular weight three-component (surfactant/water/oil) microemulsions, without addition of a separate hydrophobe.	Univ Minnesota, Dept Chem Engn & Mat Sci, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Bates, FS (corresponding author), Univ Minnesota, Dept Chem Engn & Mat Sci, 421 Washington Ave SE, Minneapolis, MN 55455 USA.	bates@cems.umn.edu			NIBIB NIH HHS [1R21EB00989-01] Funding Source: Medline; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB000989] Funding Source: NIH RePORTER	NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))		Alexandridis P., 2000, AMPHIPHILIC BLOCK CO, DOI [10.1016/B978-0-444-82441-7.X5000-2, DOI 10.1016/B978-0-444-82441-7.X5000-2]; [Anonymous], 1992, INTERMOLECULAR SURFA; [Anonymous], 1980, VISCOELASTIC PROPERT; Bates FS, 1999, PHYS TODAY, V52, P32, DOI 10.1063/1.882522; Bernheim-Groswasser A, 1999, LANGMUIR, V15, P5448, DOI 10.1021/la990301q; Bernheim-Groswasser A, 2000, LANGMUIR, V16, P4131, DOI 10.1021/la991231q; Burke S, 2000, HIGH PERFORM POLYM, V12, P535, DOI 10.1088/0954-0083/12/4/308; Discher BM, 1999, SCIENCE, V284, P1143, DOI 10.1126/science.284.5417.1143; DRYE TJ, 1992, J CHEM PHYS, V96, P1367, DOI 10.1063/1.462172; EVANS DF, 1998, COLLOIDAL DOMAIN WHE; Gelbart WM, 1996, J PHYS CHEM-US, V100, P13169, DOI 10.1021/jp9606570; Hillmyer MA, 1996, MACROMOLECULES, V29, P6994, DOI 10.1021/ma960774t; KHATORY A, 1993, LANGMUIR, V9, P1456, DOI 10.1021/la00030a005; Kindt JT, 2002, J PHYS CHEM B, V106, P8223, DOI 10.1021/jp020670m; Krishnan K, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.098301; Kwon SY, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.258302; Panizza P, 1998, J PHYS-CONDENS MAT, V10, P11659, DOI 10.1088/0953-8984/10/50/006; PORTE G, 1986, J PHYS CHEM-US, V90, P5746, DOI 10.1021/j100280a055; Tlusty T, 2000, J PHYS-CONDENS MAT, V12, pA253, DOI 10.1088/0953-8984/12/8A/332; Tlusty T, 2000, SCIENCE, V290, P1328, DOI 10.1126/science.290.5495.1328; Tlusty T, 2000, PHYS REV LETT, V84, P1244, DOI 10.1103/PhysRevLett.84.1244; Won YY, 2000, J PHYS CHEM B, V104, P9054, DOI 10.1021/jp002934f; Won YY, 1999, SCIENCE, V283, P960, DOI 10.1126/science.283.5404.960; Won YY, 2003, MACROMOLECULES, V36, P953, DOI 10.1021/ma021439+; Won YY, 2002, J PHYS CHEM B, V106, P3354, DOI 10.1021/jp013639d; Yu K, 1996, LANGMUIR, V12, P5980, DOI 10.1021/la960894u; ZHANG LF, 1995, SCIENCE, V268, P1728, DOI 10.1126/science.268.5218.1728	27	1026	1042	17	602	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 18	2003	300	5618					460	464		10.1126/science.1082193	http://dx.doi.org/10.1126/science.1082193			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668LR	12702869				2022-12-24	WOS:000182295900031
J	Walther, TC; Alves, A; Pickersgill, H; Loiodice, I; Hetzer, M; Galy, V; Hulsmann, BB; Kocher, T; Wilm, M; Allen, T; Mattaj, LW; Doye, V				Walther, TC; Alves, A; Pickersgill, H; Loiodice, I; Hetzer, M; Galy, V; Hulsmann, BB; Kocher, T; Wilm, M; Allen, T; Mattaj, LW; Doye, V			The conserved Nup107-160 complex is critical for nuclear pore complex assembly	CELL			English	Article							NUCLEOCYTOPLASMIC TRANSPORT; PROTEOMIC ANALYSIS; PROTEIN; NUCLEOPORINS; ENVELOPE; NUP98; STEPS; RECONSTITUTION; IDENTIFICATION; INTERFERENCE	Nuclear pore complexes (NPCs) are large multiprotein assemblies that allow traffic between the cytoplasm and the nucleus. During mitosis in higher eukaryotes, the Nuclear Envelope (NE) breaks down and NPCs disassemble. How NPCs reassemble and incorporate into the NE upon mitotic exit is poorly understood. We demonstrate a function for the conserved Nup1107-160 complex in this process. Partial in vivo depletion of Nup133 or Nup107 via RNAi in HeLa cells resulted in reduced levels of multiple nucleoporins and decreased NPC density in the NE. Immunodepletion of the entire Nup1107-160 complex from in vitro nuclear assembly reactions produced nuclei with a continuous NE but no NPCs. This phenotype was reversible only if Nup107-160 complex was readded before closed NE formation. Depletion also prevented association of FG-repeat nucleoporins with chromatin. We propose a stepwise model in which postmitotic NPC assembly initiates on chromatin via early recruitment of the Nup107-160 complex.	European Mol Biol Lab, D-69117 Heidelberg, Germany; Inst Curie, CNRS, UMR 144, F-75248 Paris 05, France; Christie Hosp NHS Trust, Paterson Inst Canc Res, CRC Dept Struct Cell Biol, Manchester M20 9BX, Lancs, England	European Molecular Biology Laboratory (EMBL); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; Christie NHS Foundation Trust; Christie Hospital; Paterson Institute for Cancer Research	Mattaj, LW (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.	mattaj@embl-heidelberg.de		Mattaj, Iain/0000-0002-5537-8284; Wilm, Matthias/0000-0002-5461-6834; Koecher, Thomas/0000-0003-0827-1457; Walther, Tobias/0000-0003-1442-1327				Allen NPC, 2001, J BIOL CHEM, V276, P29268, DOI 10.1074/jbc.M102629200; Allen TD, 1998, METHOD CELL BIOL, V53, P125; Bagley S, 2000, J CELL SCI, V113, P3885; Belgareh N, 2001, J CELL BIOL, V154, P1147, DOI 10.1083/jcb.200101081; Bodoor K, 1999, J CELL SCI, V112, P2253; CHAUDHARY N, 1993, J CELL BIOL, V122, P295, DOI 10.1083/jcb.122.2.295; Conti E, 2001, CURR OPIN CELL BIOL, V13, P310, DOI 10.1016/S0955-0674(00)00213-1; CORNINGS DE, 1970, EXP CELL RES, V62, P293; COURVALIN JC, 1990, J CLIN INVEST, V86, P279, DOI 10.1172/JCI114696; Cronshaw JA, 2002, J CELL BIOL, V158, P915, DOI 10.1083/jcb.200206106; DABAUVALLE MC, 1990, CHROMOSOMA, V100, P56, DOI 10.1007/BF00337603; Daigle N, 2001, J CELL BIOL, V154, P71, DOI 10.1083/jcb.200101089; DAVIS LI, 1986, CELL, V45, P699, DOI 10.1016/0092-8674(86)90784-1; Doye V, 1997, CURR OPIN CELL BIOL, V9, P401, DOI 10.1016/S0955-0674(97)80014-2; Drummond SP, 2002, J CELL BIOL, V158, P53, DOI 10.1083/jcb.200108145; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; FINLAY DR, 1991, J CELL BIOL, V114, P169, DOI 10.1083/jcb.114.1.169; FINLAY DR, 1990, CELL, V60, P17, DOI 10.1016/0092-8674(90)90712-N; Fontoura BMA, 1999, J CELL BIOL, V144, P1097, DOI 10.1083/jcb.144.6.1097; FORBES DJ, 1983, CELL, V34, P13, DOI 10.1016/0092-8674(83)90132-0; GOLDBERG MW, 1992, J STRUCT BIOL, V108, P257, DOI 10.1016/1047-8477(92)90026-7; Goldberg MW, 1997, J CELL SCI, V110, P409; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Grandi P, 1997, MOL BIOL CELL, V8, P2017, DOI 10.1091/mbc.8.10.2017; Haraguchi T, 2000, J CELL SCI, V113, P779; Hetzer M, 2000, MOL CELL, V5, P1013, DOI 10.1016/S1097-2765(00)80266-X; Hetzer M, 2001, NAT CELL BIOL, V3, P1086, DOI 10.1038/ncb1201-1086; Imreh G, 2000, EXP CELL RES, V259, P180, DOI 10.1006/excr.2000.4935; Jordan M, 1996, NUCLEIC ACIDS RES, V24, P596, DOI 10.1093/nar/24.4.596; Kuznetsov NV, 2002, CHROMOSOMA, V111, P236, DOI 10.1007/s00412-002-0208-2; LOHKA MJ, 1983, SCIENCE, V220, P719, DOI 10.1126/science.6601299; Lutzmann M, 2002, EMBO J, V21, P387, DOI 10.1093/emboj/21.3.387; Macaulay C, 1996, J CELL BIOL, V132, P5, DOI 10.1083/jcb.132.1.5; Marelli M, 2001, J CELL BIOL, V153, P709, DOI 10.1083/jcb.153.4.709; Mattaj IW, 1998, ANNU REV BIOCHEM, V67, P265, DOI 10.1146/annurev.biochem.67.1.265; MAUL GG, 1977, J CELL BIOL, V74, P492, DOI 10.1083/jcb.74.2.492; NEWPORT J, 1987, CELL, V48, P205, DOI 10.1016/0092-8674(87)90424-7; Ohno M, 1998, CELL, V92, P327, DOI 10.1016/S0092-8674(00)80926-5; Palacios I, 1997, EMBO J, V16, P6783, DOI 10.1093/emboj/16.22.6783; Powers MA, 1997, J CELL BIOL, V136, P241, DOI 10.1083/jcb.136.2.241; RADU A, 1994, J BIOL CHEM, V269, P17600; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; Shevchenko A, 1997, RAPID COMMUN MASS SP, V11, P1015, DOI 10.1002/(SICI)1097-0231(19970615)11:9<1015::AID-RCM958>3.0.CO;2-H; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Siniossoglou S, 1996, CELL, V84, P265, DOI 10.1016/S0092-8674(00)80981-2; Siniossoglou S, 2000, J CELL BIOL, V149, P41, DOI 10.1083/jcb.149.1.41; Stoffler D, 1999, CURR OPIN CELL BIOL, V11, P391, DOI 10.1016/S0955-0674(99)80055-6; Vasu S, 2001, J CELL BIOL, V155, P339, DOI 10.1083/jcb.200108007; Vasu SK, 2001, CURR OPIN CELL BIOL, V13, P363, DOI 10.1016/S0955-0674(00)00221-0; Walther TC, 2002, J CELL BIOL, V158, P63, DOI 10.1083/jcb.200202088; Walther TC, 2001, EMBO J, V20, P5703, DOI 10.1093/emboj/20.20.5703; Wiese C, 1997, J CELL SCI, V110, P1489; Wu XS, 2001, P NATL ACAD SCI USA, V98, P3191, DOI 10.1073/pnas.051631598	54	310	315	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 18	2003	113	2					195	206		10.1016/S0092-8674(03)00235-6	http://dx.doi.org/10.1016/S0092-8674(03)00235-6			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	672EP	12705868	Bronze			2022-12-24	WOS:000182508500009
J	Gandhi, TK; Weingart, SN; Borus, J; Seger, AC; Peterson, J; Burdick, E; Seger, DL; Shu, K; Federico, F; Leape, LL; Bates, DW				Gandhi, TK; Weingart, SN; Borus, J; Seger, AC; Peterson, J; Burdick, E; Seger, DL; Shu, K; Federico, F; Leape, LL; Bates, DW			Adverse drug events in ambulatory care	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HOSPITALIZED-PATIENTS; RISK-FACTORS; OUTPATIENTS; PREVENTION; COSTS	BACKGROUND: Adverse events related to drugs occur frequently among inpatients, and many of these events are preventable. However, few data are available on adverse drug events among outpatients. We conducted a study to determine the rates, types, severity, and preventability of such events among outpatients and to identify preventive strategies. METHODS: We performed a prospective cohort study, including a survey of patients and a chart review, at four adult primary care practices in Boston (two hospital-based and two community-based), involving a total of 1202 outpatients who received at least one prescription during a four-week period. Prescriptions were computerized at two of the practices and handwritten at the other two. RESULTS: Of the 661 patients who responded to the survey (response rate, 55 percent), 162 had adverse drug events (25 percent; 95 percent confidence interval, 20 to 29 percent), with a total of 181 events (27 per 100 patients). Twenty-four of the events (13 percent) were serious, 51 (28 percent) were ameliorable, and 20 (11 percent) were preventable. Of the 51 ameliorable events, 32 (63 percent) were attributed to the physician's failure to respond to medication-related symptoms and 19 (37 percent) to the patient's failure to inform the physician of the symptoms. The medication classes most frequently involved in adverse drug events were selective serotonin-reuptake inhibitors (10 percent), beta-blockers (9 percent), angiotensin-converting-enzyme inhibitors (8 percent), and nonsteroidal antiinflammatory agents (8 percent). On multivariate analysis, only the number of medications taken was significantly associated with adverse events. CONCLUSIONS: Adverse events related to drugs are common in primary care, and many are preventable or ameliorable. Monitoring for and acting on symptoms are important. Improving communication between outpatients and providers may help prevent adverse events related to drugs.	Brigham & Womens Hosp, Div Gen Internal Med, Boston, MA 02115 USA; Beth Israel Deaconess Med Ctr, Div Gen Med & Primary Care, Boston, MA 02215 USA; Harvard Risk Management Fdn, Boston, MA USA; Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard University; Harvard T.H. Chan School of Public Health	Gandhi, TK (corresponding author), Brigham & Womens Hosp, Div Gen Med, 75 Francis St, Boston, MA 02115 USA.	tgandhi@partners.org						Bates DW, 1999, ARCH INTERN MED, V159, P2553, DOI 10.1001/archinte.159.21.2553; BATES DW, 1995, JAMA-J AM MED ASSOC, V274, P29, DOI 10.1001/jama.274.1.29; Bates DW, 1997, JAMA-J AM MED ASSOC, V277, P307, DOI 10.1001/jama.277.4.307; Borowitz SM, 1998, JAMA-J AM MED ASSOC, V280, P1321, DOI 10.1001/jama.280.15.1321; Classen DC, 1997, JAMA-J AM MED ASSOC, V277, P301, DOI 10.1001/jama.277.4.301; FOLLI HL, 1987, PEDIATRICS, V79, P718; Gandhi TK, 2000, J GEN INTERN MED, V15, P149, DOI 10.1046/j.1525-1497.2000.04199.x; Gurwitz JH, 2003, JAMA-J AM MED ASSOC, V289, P1107, DOI 10.1001/jama.289.9.1107; Hanlon JT, 1997, J AM GERIATR SOC, V45, P945, DOI 10.1111/j.1532-5415.1997.tb02964.x; HUTCHINSON TA, 1986, J CHRON DIS, V39, P533, DOI 10.1016/0021-9681(86)90198-0; Lazarou J, 1998, JAMA-J AM MED ASSOC, V279, P1200, DOI 10.1001/jama.279.15.1200; LEAPE LL, 1995, JAMA-J AM MED ASSOC, V274, P35, DOI 10.1001/jama.1995.03530010049034; LEAPE LL, 1991, NEW ENGL J MED, V324, P377, DOI 10.1056/NEJM199102073240605; Li YC, 2001, INT J MED INFORM, V61, P241, DOI 10.1016/S1386-5056(01)00146-0; ONEIL AC, 1993, ANN INTERN MED, V119, P370, DOI 10.7326/0003-4819-119-5-199309010-00004; SANDS DZ, 2001, HIMSS P, V3; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	17	912	934	1	30	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 17	2003	348	16					1556	1564		10.1056/NEJMsa020703	http://dx.doi.org/10.1056/NEJMsa020703			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	667TT	12700376	Bronze			2022-12-24	WOS:000182248900007
J	Emanuel, EJ; Young-Xu, Y; Levinsky, NG; Gazelle, G; Saynina, O; Ash, AS				Emanuel, EJ; Young-Xu, Y; Levinsky, NG; Gazelle, G; Saynina, O; Ash, AS			Chemotherapy use among medicare beneficiaries at the end of life	ANNALS OF INTERNAL MEDICINE			English	Article							CELL LUNG-CANCER; QUALITY-OF-LIFE; RANDOMIZED-TRIAL; EXPECTATIONS; CISPLATIN; ATTITUDES; MITOMYCIN; SURVIVAL	Background: Although many observers believe that cancer chef motherapy is overused at the end of life, there are no published data on this. Objective: To determine the frequency and duration of chemotherapy use in the last 6 months of life stratified by type of cancer, age, and sex. Design: Retrospective cohort Analysis. Setting: Administrative databases from Massachusetts and California. Patients: All Medicare patients Who died of cancer in Massachusetts and 5% of Medicare cancer decedents in California in 1996. Measurements: Use of intravenous chemotherapy agents, chemotherapy administration, or medical evaluation for chemotherapy from Medicare billing data for each patient in 30-day periods from the date of death backward. Results: in Massachusetts, 33% of cancer decedents older than 65 years of age received chemotherapy in the last 6 months of life, 23% in the last 3 months, and 9% in the last month. In California, the percentages were 26%, 20%, and 9%, respectively. Chemotherapy use greatly declined with age. Chemotherapy use was similar for patients with breast, colon, and ovarian cancer and those with cancer generally considered unresponsive to chemotherapy, such as pancreatic, hepatocellular, or renal-cell cancer or melanoma. Patients with types of cancer that are unresponsive to chemotherapy had shorter duration of chemotherapy use. Conclusion: Among patients who died of cancer, chemotherapy was used frequently in the last 3 months of life. The cancer's responsiveness to chemotherapy does not seem to influence whether dying patients receive chemotherapy at the end of life.	NIH, Dept Clin Bioeth, Warren G Magnuson Clin Ctr, Bethesda, MD 20892 USA; Natl Bur Econ Res, Palo Alto, CA USA; Harvard Vanguard Associates, Boston, MA USA; Boston Univ, Sch Med, Boston, MA 02118 USA	National Institutes of Health (NIH) - USA; National Bureau of Economic Research; Harvard Vanguard Medical Associates; Boston University	Emanuel, EJ (corresponding author), NIH, Dept Clin Bioeth, Warren G Magnuson Clin Ctr, Bldg 10,Room 1C118, Bethesda, MD 20892 USA.		Ash, Arlene/AAG-2914-2019	Ash, Arlene/0000-0002-8448-0253	CLINICAL CENTER [Z01CL010508] Funding Source: NIH RePORTER	CLINICAL CENTER		ABELOFF DM, 2000, CLIN ONCOLOGY, P1681; Annas G J, 1992, Health Matrix Clevel, V2, P119; Burris HA, 1997, J CLIN ONCOL, V15, P2403, DOI 10.1200/JCO.1997.15.6.2403; Cullen MH, 1999, J CLIN ONCOL, V17, P3188, DOI 10.1200/JCO.1999.17.10.3188; Cullen M, 2001, LANCET ONCOL, V2, P173, DOI 10.1016/S1470-2045(00)00260-6; Cunningham D, 1998, LANCET, V352, P1413, DOI 10.1016/S0140-6736(98)02309-5; DEVITA WT, 2001, CANC PRINCIPLES PRAC, V1126, P1262; Doyle C, 2001, J CLIN ONCOL, V19, P1266, DOI 10.1200/JCO.2001.19.5.1266; Earle CC, 2000, CHEST, V117, P1239, DOI 10.1378/chest.117.5.1239; ELLIS PA, 1995, BRIT J CANCER, V71, P366, DOI 10.1038/bjc.1995.74; FIELD MJ, 1997, APPROACHING DEATH IM, P12; GOUGH IR, 1981, CLIN ONCOL, V7, P5; MCKHANN CF, 1999, TIME DIE, P1; Miller M, 2000, HASTINGS CENT REP, V30, P34, DOI 10.2307/3527646; Schrag D, 2001, J NATL CANCER I, V93, P850, DOI 10.1093/jnci/93.11.850; SLEVIN ML, 1990, BRIT MED J, V300, P1458, DOI 10.1136/bmj.300.6737.1458; SONTAG S, 1978, ILLNES METAPHOR; Wan GJ, 1997, PSYCHO-ONCOL, V6, P1; YELLEN SB, 1995, J CLIN ONCOL, V13, P1255, DOI 10.1200/JCO.1995.13.5.1255; 1997, CANC EC          MAR, P1	20	217	219	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 15	2003	138	8					639	643		10.7326/0003-4819-138-8-200304150-00011	http://dx.doi.org/10.7326/0003-4819-138-8-200304150-00011			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	666JH	12693886				2022-12-24	WOS:000182173800006
J	Charron, F; Stein, E; Jeong, J; McMahon, AP; Tessier-Lavigne, M				Charron, F; Stein, E; Jeong, J; McMahon, AP; Tessier-Lavigne, M			The morphogen Sonic hedgehog is an axonal chemoattractant that collaborates with Netrin-1 in midline axon guidance	CELL			English	Article							CENTRAL-NERVOUS-SYSTEM; FLOOR PLATE; SPINAL-CORD; COMMISSURAL AXONS; GROWTH CONES; C-ELEGANS; CELL FATES; SPECIFICATION; RECEPTOR; GENE	Developing axons are guided to their targets by attractive and repulsive guidance cues. In the embryonic spinal cord, the floor plate chemoattractant Netrin-1 is required to guide commissural neuron axons to the midline. However, genetic evidence suggests that other chemoattractant(s) are also involved. We show that the morphogen Sonic hedgehog (Shh) can mimic the additional chemoattractant activity of the floor plate in vitro and can act directly as a chemoattractant on isolated axons. Cyclopamine-mediated inhibition of the Shh signaling mediator Smoothened (Smo) or conditional inactivation of Smo in commissural neurons indicate that Smo activity is important for the additional chemoattractant activity of the floor plate in vitro and for the normal projection of commissural axons to the floor plate in vivo. These results provide evidence that Shh, acting via Smo, is a midline-derived chemoattractant for commissural axons and show that a morphogen can also act as an axonal chemoattractant.	Stanford Univ, Howard Hughes Med Inst, Dept Biol Sci, Stanford, CA 94305 USA; Harvard Univ, Dept Mol & Cellular Biol, Biolabs, Cambridge, MA 02138 USA	Howard Hughes Medical Institute; Stanford University; Harvard University	Tessier-Lavigne, M (corresponding author), Stanford Univ, Howard Hughes Med Inst, Dept Biol Sci, Stanford, CA 94305 USA.		Charron, Frederic/D-2140-2009; McMahon, Andrew P/ABE-7520-2020; Charron, Frederic/O-8017-2019; Stein, Elke/E-8107-2013	Charron, Frederic/0000-0003-3483-8672; Charron, Frederic/0000-0003-3483-8672; Stein, Elke/0000-0001-8965-5692	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS033642, R01NS033642] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 33642] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Augsburger A, 1999, NEURON, V24, P127, DOI 10.1016/S0896-6273(00)80827-2; Briscoe J, 2001, MOL CELL, V7, P1279, DOI 10.1016/S1097-2765(01)00271-4; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; COLAMARINO SA, 1995, ANNU REV NEUROSCI, V18, P497, DOI 10.1146/annurev.ne.18.030195.002433; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; de la Torre JR, 1997, NEURON, V19, P1211, DOI 10.1016/S0896-6273(00)80413-4; Deshpande G, 2001, CELL, V106, P759, DOI 10.1016/S0092-8674(01)00488-3; Ding Q, 1998, DEVELOPMENT, V125, P2533; Ebens A, 1996, NEURON, V17, P1157, DOI 10.1016/S0896-6273(00)80247-0; Ericson J, 1996, CELL, V87, P661, DOI 10.1016/S0092-8674(00)81386-0; Fazeli A, 1997, NATURE, V386, P796, DOI 10.1038/386796a0; Frank-Kamenetsky Maria, 2002, J Biol, V1, P10, DOI 10.1186/1475-4924-1-10; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Hall AC, 2000, CELL, V100, P525, DOI 10.1016/S0092-8674(00)80689-3; Hao JC, 2001, NEURON, V32, P25, DOI 10.1016/S0896-6273(01)00448-2; Harris R, 1996, NEURON, V17, P217, DOI 10.1016/S0896-6273(00)80154-3; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; Incardona JP, 1998, DEVELOPMENT, V125, P3553; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; Lee KJ, 1999, ANNU REV NEUROSCI, V22, P261, DOI 10.1146/annurev.neuro.22.1.261; Long FX, 2001, DEVELOPMENT, V128, P5099; Marti E, 2002, TRENDS NEUROSCI, V25, P89, DOI 10.1016/S0166-2236(02)02062-3; Matise MP, 1999, DEVELOPMENT, V126, P3649; Matise MP, 1998, DEVELOPMENT, V125, P2759; Mitchell KJ, 1996, NEURON, V17, P203, DOI 10.1016/S0896-6273(00)80153-1; Mo R, 1997, DEVELOPMENT, V124, P113; O'Connor R, 1999, NEURON, V24, P165, DOI 10.1016/S0896-6273(00)80830-2; PLACZEK M, 1990, DEVELOPMENT, V110, P19; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Song HJ, 1997, NATURE, V388, P275, DOI 10.1038/40864; Stein E, 2001, SCIENCE, V291, P1928, DOI 10.1126/science.1058445; Stone DM, 1996, NATURE, V384, P129, DOI 10.1038/384129a0; TESSIERLAVIGNE M, 1988, NATURE, V336, P775, DOI 10.1038/336775a0; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Testaz S, 2001, P NATL ACAD SCI USA, V98, P12521, DOI 10.1073/pnas.221108698; Trousse F, 2001, DEVELOPMENT, V128, P3927; Wang YS, 2002, J NEUROSCI, V22, P8563; Wijgerde M, 2002, GENE DEV, V16, P2849, DOI 10.1101/gad.1025702; Zhang XM, 2001, CELL, V105, P781, DOI 10.1016/S0092-8674(01)00385-3; ZHENG JQ, 1994, NATURE, V368, P140, DOI 10.1038/368140a0	44	503	529	0	35	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 4	2003	113	1					11	23		10.1016/S0092-8674(03)00199-5	http://dx.doi.org/10.1016/S0092-8674(03)00199-5			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	668GX	12679031	Bronze			2022-12-24	WOS:000182282900003
J	Dalton, R				Dalton, R			Legal row looms for gene-map firm	NATURE			English	News Item																		2001, NATURE, V412, P105	1	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 29	2003	423	6939					470	470		10.1038/423470b	http://dx.doi.org/10.1038/423470b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	683RH	12774085	Bronze			2022-12-24	WOS:000183162900010
J	Eriksson, M; Brown, WT; Gordon, LB; Glynn, MW; Singer, J; Scott, L; Erdos, MR; Robbins, CM; Moses, TY; Berglund, P; Dutra, A; Pak, E; Durkin, S; Csoka, AB; Boehnke, M; Glover, TW; Collins, FS				Eriksson, M; Brown, WT; Gordon, LB; Glynn, MW; Singer, J; Scott, L; Erdos, MR; Robbins, CM; Moses, TY; Berglund, P; Dutra, A; Pak, E; Durkin, S; Csoka, AB; Boehnke, M; Glover, TW; Collins, FS			Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome	NATURE			English	Article							NUCLEAR-ENVELOPE; UNIPARENTAL DISOMY; CHROMOSOME-1; HOMOZYGOSITY; PATIENT; LMNA	Hutchinson-Gilford progeria syndrome (HGPS) is a rare genetic disorder characterized by features reminiscent of marked premature ageing(1,2). Here, we present evidence of mutations in lamin A (LMNA) as the cause of this disorder. The HGPS gene was initially localized to chromosome 1q by observing two cases of uniparental isodisomy of 1q - the inheritance of both copies of this material from one parent - and one case with a 6-megabase paternal interstitial deletion. Sequencing of LMNA, located in this interval and previously implicated in several other heritable disorders(3,4), revealed that 18 out of 20 classical cases of HGPS harboured an identical de novo ( that is, newly arisen and not inherited) single-base substitution, G608G( GGC > GGT), within exon 11. One additional case was identified with a different substitution within the same codon. Both of these mutations result in activation of a cryptic splice site within exon 11, resulting in production of a protein product that deletes 50 amino acids near the carboxy terminus. Immunofluorescence of HGPS fibroblasts with antibodies directed against lamin A revealed that many cells show visible abnormalities of the nuclear membrane. The discovery of the molecular basis of this disease may shed light on the general phenomenon of human ageing.	NHGRI, NIH, Bethesda, MD 20892 USA; NIAID, Viral Dis Lab, NIH, Bethesda, MD 20892 USA; New York State Inst Basic Res Dev Disabil, Dept Human Genet, Staten Isl, NY 10314 USA; Tufts Univ, Sch Med, Dept Anat & Cellular Biol, Boston, MA 02111 USA; Rhode Isl Hosp, Dept Pediat, Providence, RI 02903 USA; Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; Brown Univ, Dept Biochem Mol Biol & Cell Biol, Providence, RI 02912 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Institute for Basic Research in Developmental Disabilities; Tufts University; Lifespan Health Rhode Island; Rhode Island Hospital; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Brown University	Collins, FS (corresponding author), NHGRI, NIH, Bethesda, MD 20892 USA.	fc23a@nih.gov	Brown, William/GXN-2777-2022; Gordon, Leslie B./AAJ-5793-2021		NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG200305] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000658] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007544] Funding Source: NIH RePORTER	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAKER PB, 1981, ARCH PATHOL LAB MED, V105, P384; Bergo MO, 2002, P NATL ACAD SCI USA, V99, P13049, DOI 10.1073/pnas.192460799; BROWN WT, 1979, MECH AGEING DEV, V9, P325; BROWN WT, 1992, AM J CLIN NUTR, V55, P1222; BROWN WT, 1990, GENETIC EFFECTS AGIN, V2, P521; Burke B, 2002, NAT REV MOL CELL BIO, V3, P575, DOI 10.1038/nrm879; Casper AM, 2002, CELL, V111, P779, DOI 10.1016/S0092-8674(02)01113-3; De Sandre-Giovannoli A, 2002, AM J HUM GENET, V70, P726, DOI 10.1086/339274; DEBUSK FL, 1972, J PEDIATR-US, V80, P697, DOI 10.1016/S0022-3476(72)80229-4; EGGERT M, 1993, EUR J BIOCHEM, V213, P659, DOI 10.1111/j.1432-1033.1993.tb17806.x; FISHER DZ, 1986, P NATL ACAD SCI USA, V83, P6450, DOI 10.1073/pnas.83.17.6450; Gelb BD, 1998, AM J HUM GENET, V62, P848, DOI 10.1086/301795; Genschel J, 2000, HUM MUTAT, V16, P451, DOI 10.1002/1098-1004(200012)16:6<451::AID-HUMU1>3.0.CO;2-9; HENNEKES H, 1994, J CELL SCI, V107, P1019; KHALIFA MM, 1989, CLIN GENET, V35, P125; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; LIN F, 1993, J BIOL CHEM, V268, P16321; Luengo WD, 2002, AM J MED GENET, V113, P298, DOI 10.1002/ajmg.10753; LUTZ RJ, 1992, P NATL ACAD SCI USA, V89, P3000, DOI 10.1073/pnas.89.7.3000; Pendas AM, 2002, NAT GENET, V31, P94, DOI 10.1038/ng871; Pulkkinen L, 1997, AM J HUM GENET, V61, P611, DOI 10.1086/515524; SHIANG R, 1994, CELL, V78, P335, DOI 10.1016/0092-8674(94)90302-6; SINENSKY M, 1994, J CELL SCI, V107, P61; SMITH AS, 1993, AM J NEURORADIOL, V14, P441; SMITH CAB, 1953, J R STAT SOC B, V15, P153; Speckman, 2000, AM J HUM GENET, V67, P775; Sullivan T, 1999, J CELL BIOL, V147, P913, DOI 10.1083/jcb.147.5.913; TREVASMACIEL A, 1988, AM J MED GENET, V31, P483	28	1477	1536	5	207	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 15	2003	423	6937					293	298		10.1038/nature01629	http://dx.doi.org/10.1038/nature01629			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678EX	12714972	Green Published			2022-12-24	WOS:000182853100044
J	Groet, J; McElwaine, S; Spinelli, M; Rinaldi, A; Burtscher, I; Mulligan, C; Mensah, A; Cavani, S; Dagna-Bricarelli, F; Basso, G; Cotter, FE; Nizetic, D				Groet, J; McElwaine, S; Spinelli, M; Rinaldi, A; Burtscher, I; Mulligan, C; Mensah, A; Cavani, S; Dagna-Bricarelli, F; Basso, G; Cotter, FE; Nizetic, D			Acquired mutations in GATA1 in neonates with Down's syndrome with transient myeloid disorder	LANCET			English	Editorial Material							LEUKEMIA	Transient myeloid disorder Is a unique self-regressing neoplasia specific to Down's syndrome. The transcription factor GATA1 is needed for normal growth and maturation of erythroid cells and megakaryocytes. Mutations in GATA1 have been reported in acute megakaryoblastic leukaemia In Down's syndrome. We aimed to investigate changes in GATA1 in patients with Down's syndrome and either transient myeloid disorder (n=10) or acute megakaryoblastic leukaemia (n=6). We recorded mutations eliminating exon 2 from GATA1 In all patients with transient myeloid disorder (age 0-24 days) and In all with acute megakaryoblastic leukaemia (age 14-38 months). The range of mutations did not differ between patients with each disorder. Patients with transient myeloid disorder with mutations in GATA1 can regress spontaneously to complete remission, and mutations do not necessarily predict later acute megakaryoblastic leukaemia.	Univ London, Queen Marys Sch Med, St Bartholomews & Royal London Hosp, Dept Haematol, London E1 2AD, England; Univ Padua, Fac Med, Dept Pediat, Italian Natl Assoc Pediat Haematooncol, Padua, Italy; Galliera Hosp, Inst Human Genet, Genoa, Italy	Barts Health NHS Trust; Royal London Hospital; University of London; Queen Mary University London; University of Padua; Ente Ospedaliero Ospedali Galliera	Nizetic, D (corresponding author), Univ London, Queen Marys Sch Med, St Bartholomews & Royal London Hosp, Dept Haematol, Med Coll Bldg,Turner St, London E1 2AD, England.		Nizetic, Dean/F-9509-2015	BASSO, GIUSEPPE/0000-0002-2634-9302; Mensah, Afua Adjeiwaa/0000-0001-8113-3689; Nizetic, Dean/0000-0001-5486-5761	Telethon [C.51] Funding Source: Medline	Telethon(Fondazione Telethon)		Al-Kasim F, 2002, J PEDIAT HEMATOL ONC, V24, P9, DOI 10.1097/00043426-200201000-00004; GARNIS AS, 2002, J PEDIAT HEMATOL ONC, V24, P2; Orkin SH, 2000, NAT REV GENET, V1, P57, DOI 10.1038/35049577; Taub JW, 2002, J PEDIAT HEMATOL ONC, V24, P6, DOI 10.1097/00043426-200201000-00003; Wechsler J, 2002, NAT GENET, V32, P148, DOI 10.1038/ng955	5	126	131	1	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 10	2003	361	9369					1617	1620		10.1016/S0140-6736(03)13266-7	http://dx.doi.org/10.1016/S0140-6736(03)13266-7			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	676HY	12747884				2022-12-24	WOS:000182746300014
J	Hall, WD; Mant, A; Mitchell, PB; Rendle, VA; Hickie, IB; McManus, P				Hall, WD; Mant, A; Mitchell, PB; Rendle, VA; Hickie, IB; McManus, P			Association between antidepressant prescribing and suicide in Australia, 1991-2000: trend analysis	BRITISH MEDICAL JOURNAL			English	Article							DEPRESSION; RATES	Objective To examine die association between trends in antidepressant prescribing and suicide rates in Australia for 1991-2000. Design Analysis of databases of suicide and rates of antidepressant prescribing according to age and sex. Setting Australian Bureau of Statistics data, sales data from the Australian pharmaceutical industry, prescribing data in general practice. Subjects Men and women aged 15 years and over in 10 year age groups. Main outcome measures Trends in suicide rates and trends in antidepressant prescribing. Association measured by Spearman's rank correlations. Results While overall national rates of suicide did not fall significantly, incidence decreased in older men and women and increased in younger adults. In both men (r(s)=-0.91; P<0.01) and women (r(s)=-.0.76; P<0.05) the higher the exposure to antidepressants the larger the decline in rate of suicide. Conclusions Changes in suicide rates and exposure to antidepressants in Australia for 1991-2000 are significantly associated. This effect is most apparent in older age groups, in which rates of suicide decreased substantially in association with exposure to antidepressants. The increase in antidepressant prescribing may be a proxy marker for improved overall management of depression. If so, increased prescribing of selective serotonin reuptake inhibitors in general practice may have produced a quantifiable benefit in population mental health.	Univ New S Wales, Sch Psychiat, Randwick, NSW 2031, Australia; Beyond Blue Natl Depress Initiat, Melbourne, Vic 3122, Australia; Dept Hlth & Ageing, Drug Utilisat Subcomm, Canberra, ACT 2601, Australia; Univ Queensland, Inst Mol Biosci, Off Publ Policy & Eth, Brisbane, Qld 4072, Australia; Univ New S Wales, Sch Publ Hlth & Community Med, Sydney, NSW 2052, Australia	University of New South Wales Sydney; University of Queensland; University of New South Wales Sydney	Mant, A (corresponding author), Univ New S Wales, Sch Publ Hlth & Community Med, Sydney, NSW 2052, Australia.		Hickie, Ian B/K-8975-2015; anand, amit/A-7222-2009; Hall, Wayne D/A-3283-2008	Hickie, Ian B/0000-0001-8832-9895; Hall, Wayne D/0000-0003-1984-0096; Mitchell, Philip/0000-0002-7954-5235				*AUSTR BUR STAT, 2000, SUIC AUSTR; Australian Bureau of Statistics, AUSTR SOC TRENDS 200; Barbui C, 1999, SOC PSYCH PSYCH EPID, V34, P152, DOI 10.1007/s001270050127; Bridges-Webb C., 1992, MED J AUST S, V157, pS1; Bridges-Webb Charles, 1992, Medical Journal of Australia, V157, pS1; BRITT H, GEN PRACTICE SERIES, V8; BRITT H, 2001, GEN PRACTICE SERIES, V8; Britt H, 1999, GEN PRACTICE SERIES; Carlsten A, 2001, PHARMACOEPIDEM DR S, V10, P525, DOI 10.1002/pds.618; CATALANO P, 2001, NATL ALCOHOL INDICAT, V4; Cook T.C., 1979, QUASIEXPERIMENTATION; Headey B, 1999, AUSTRALAS J AGEING, V18, P32, DOI 10.1111/j.1741-6612.1999.tb00887.x; Hickie IB, 2002, MED J AUSTRALIA, V176, pS61; Hickie IB, 2001, MED J AUSTRALIA, V175, pS25; Isacsson G, 2000, ACTA PSYCHIAT SCAND, V102, P113, DOI 10.1034/j.1600-0447.2000.102002113.x; Isacsson G, 1996, J AFFECT DISORDERS, V41, P1, DOI 10.1016/0165-0327(96)00050-X; Jorm AF, 2000, AUST NZ J PSYCHIAT, V34, P619, DOI 10.1046/j.1440-1614.2000.00761.x; Mackay FR, 1999, BRIT J GEN PRACT, V49, P892; McManus P, 2000, MED J AUSTRALIA, V173, P458, DOI 10.5694/j.1326-5377.2000.tb139294.x; Morrell S, 2001, ECON LABOUR RELAT RE, V12, P4; Naismith SL, 2001, MED J AUSTRALIA, V175, pS42; PRESKORN SH, 1994, J CLIN PSYCHIAT, V55, P6; Rihmer Z, 2001, EUR PSYCHIAT, V16, P406, DOI 10.1016/S0924-9338(01)00598-3; Vagholkar S, 1996, Aust Fam Physician, V25, P370; Webb M., 2000, NATL ALCOHOL INDICAT, V2; *WHO COLL CTR DRUG, 1998, METH GUID ATC CLASS	26	215	222	1	14	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 10	2003	326	7397					1008	1011		10.1136/bmj.326.7397.1008	http://dx.doi.org/10.1136/bmj.326.7397.1008			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	679KG	12742921	Bronze, Green Published			2022-12-24	WOS:000182920500015
J	Nizak, C; Monier, S; del Nery, E; Moutel, S; Goud, B; Perez, F				Nizak, C; Monier, S; del Nery, E; Moutel, S; Goud, B; Perez, F			Recombinant antibodies to the small GTPase Rab6 as conformation sensors	SCIENCE			English	Article							TO-TGN TRANSPORT; IN-VIVO; COMPLEX; CELLS; GOLGI; SELECTION; PROTEINS; PATHWAY	Here we report an approach, based on antibody phage display, to generate molecular conformation sensors. Recombinant antibodies specific to the guanosine triphosphate (GTP)-bound conformation of the small guanosine triphosphatase (GTPase) Rab6, a regulator of membrane traffic, were generated and used to locate Rab6.GTP in fixed cells, and, after green fluorescent protein (GFP) tagging and intracellular expression, to follow Rab6.GTP in vivo. Rab6 was in its GTP-bound conformation on the Golgi apparatus and transport intermediates, and the geometry of transport intermediates was modulated by Rab6 activity. More generally, the same approach could be applied to other molecules that can be locked in a particular conformation in vitro.	Inst Curie, CNRS, UMR144, F-75248 Paris 05, France; Inst Curie, Translat Dept, F-75248 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Perez, F (corresponding author), Inst Curie, CNRS, UMR144, 26 Rue Ulm, F-75248 Paris 05, France.		Tschöpe, Solange Monier/L-9120-2018; Perez, Franck/A-1558-2014; Nizak, Clement/L-1334-2013; Nizak, Clement/HGV-1085-2022; Goud, Bruno/GWC-4807-2022	Perez, Franck/0000-0002-9129-9401; Nizak, Clement/0000-0002-4591-8240; Nizak, Clement/0000-0002-4591-8240; Moutel, Sandrine/0000-0002-9585-4855; DEL NERY, Elaine/0000-0002-9654-5202				BIOCCA S, 1995, TRENDS CELL BIOL, V5, P59; Cohen Pascale A, 2002, Methods Mol Biol, V178, P367; Darchen F, 2000, BIOCHIMIE, V82, P375, DOI 10.1016/S0300-9084(00)00219-4; DEMAUR AA, 2002, J BIOL CHEM, V277, P45075; Echard A, 2000, MOL BIOL CELL, V11, P3819, DOI 10.1091/mbc.11.11.3819; Kalab P, 2002, SCIENCE, V295, P2452, DOI 10.1126/science.1068798; Kim SH, 2000, J BIOL CHEM, V275, P36999, DOI 10.1074/jbc.M003430200; Kraynov VS, 2000, SCIENCE, V290, P333, DOI 10.1126/science.290.5490.333; Li Z, 2002, NEURON, V33, P741, DOI 10.1016/S0896-6273(02)00621-9; Mallard F, 2002, J CELL BIOL, V156, P653, DOI 10.1083/jcb.200110081; Matanis T, 2002, NAT CELL BIOL, V4, P986, DOI 10.1038/ncb891; Monier S, 2002, TRAFFIC, V3, P289, DOI 10.1034/j.1600-0854.2002.030406.x; MONIER S, UNPUB; NISHIMURA N, 1994, J BIOL CHEM, V269, P14191; NIZAK C, UNPUB; Plafker K, 2002, J BIOL CHEM, V277, P30121, DOI 10.1074/jbc.M203006200; Short B, 2002, CURR BIOL, V12, P1792, DOI 10.1016/S0960-9822(02)01221-6; Smothers JF, 2002, SCIENCE, V298, P621, DOI 10.1126/science.298.5593.621; STAHL B, 1994, J BIOL CHEM, V269, P24770; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Visintin M, 1999, P NATL ACAD SCI USA, V96, P11723, DOI 10.1073/pnas.96.21.11723; White J, 1999, J CELL BIOL, V147, P743, DOI 10.1083/jcb.147.4.743; WINTER G, 1994, ANNU REV IMMUNOL, V12, P433, DOI 10.1146/annurev.iy.12.040194.002245; Worn A, 2001, J MOL BIOL, V305, P989, DOI 10.1006/jmbi.2000.4265	24	102	111	1	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 9	2003	300	5621					984	987		10.1126/science.1083911	http://dx.doi.org/10.1126/science.1083911			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675WD	12738866				2022-12-24	WOS:000182719800058
J	Starzl, TE; Murase, N; Abu-Elmagd, K; Gray, EA; Shapiro, R; Eghtesad, B; Corry, RJ; Jordan, ML; Fontes, P; Gayowski, T; Bond, G; Scantlebury, VP; Potdar, S; Randhawa, P; Wu, T; Zeevi, A; Nalesnik, MA; Woodward, J; Marcos, A; Trucco, M; Demetris, AJ; Fung, JJ				Starzl, TE; Murase, N; Abu-Elmagd, K; Gray, EA; Shapiro, R; Eghtesad, B; Corry, RJ; Jordan, ML; Fontes, P; Gayowski, T; Bond, G; Scantlebury, VP; Potdar, S; Randhawa, P; Wu, T; Zeevi, A; Nalesnik, MA; Woodward, J; Marcos, A; Trucco, M; Demetris, AJ; Fung, JJ			Tolerogenic immunosuppression for organ transplantation	LANCET			English	Article							BONE-MARROW; ALLOGRAFT RECIPIENTS; GRAFT ACCEPTANCE; CELL-MIGRATION; LIVER; TOLERANCE; DONOR; CHIMERISM; REJECTION; KIDNEY	Background Insight into the mechanisms of organ engraftment and acquired tolerance has made it possible to facilitate these mechanisms, by tailoring the timing and dosage of immunosuppression in accordance with two therapeutic principles: recipient pretreatment, and minimum use of post-transplant immunosuppression. We aimed to apply these principles in recipients of renal and extrarenal organ transplants. Methods 82 patients awaiting kidney, liver, pancreas, or intestinal transplantation were pretreated with about 5 mg/kg of a broadly reacting rabbit antithymocyte globulin during several hours. Post-transplant immunosuppression was restricted to tacrolimus unless additional drugs were needed to treat breakthrough rejection. After 4 months, patients on tacrolimus monotherapy were considered for dose-spacing to every other day or longer intervals. Findings We frequently saw evidence of immune activation in graft biopsy samples, but unless this was associated with graft dysfunction or serious immune destruction, treatment usually was not intensified. Immunosuppression-related morbidity was virtually eliminated. 78 (95%) of 82 patients survived at 1 year and at 13-18 months. Graft survival was 73 (89%) of 82 at 1 year and 72 (88%) of 82 at 13-18 months. Of the 72 recipients with surviving grafts, 43 are on spaced doses of tacrolimus monotherapy: every other day (n=6), three times per week (11), twice per week (15), or once per week (11). Interpretation The striking ability to wean immunosuppression in these recipients indicates variable induction of tolerance. The simple therapeutic principles are neither drug-specific nor organ-specific. Systematic application of these principles should allow improvements in quality of life and long-term survival after organ transplantation.	Univ Pittsburgh, Med Ctr, Thomas E Starzl Transplantat Inst, Pittsburgh, PA USA; Univ Pittsburgh, Med Ctr, Dept Surg, Pittsburgh, PA USA; Univ Pittsburgh, Med Ctr, Dept Pathol, Pittsburgh, PA USA; Univ Pittsburgh, Med Ctr, Dept Paediat, Div Immunogenet, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Starzl, TE (corresponding author), UPMC Montefiore, Inst Transplantat, 7th Floor,S 3459 5th Ave, Pittsburgh, PA 15213 USA.		FUNG, John Julian/A-2679-2012; Randhawa, Parmjeet/H-4285-2019	FUNG, John Julian/0000-0002-3038-0441; 	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK029961, R37DK029961] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 29961, R01 DK029961-19] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abu-Elmagd K, 2001, ANN SURG, V234, P404, DOI 10.1097/00000658-200109000-00014; BARBER WH, 1989, TRANSPLANTATION, V47, P66, DOI 10.1097/00007890-198901000-00015; CALNE R, 1994, LANCET, V343, P67, DOI 10.1016/S0140-6736(94)90809-5; Calne R, 1998, LANCET, V351, P1701, DOI 10.1016/S0140-6736(05)77739-4; Demetris AJ, 1997, HEPATOLOGY, V25, P658; FONTES P, 1994, LANCET, V344, P151, DOI 10.1016/S0140-6736(94)92756-1; Garcia-Morales R, 1998, TRANSPLANTATION, V65, P956, DOI 10.1097/00007890-199804150-00016; Ichikawa N, 2000, LIVER TRANSPLANT, V6, P686, DOI 10.1053/jlts.2000.19029; Kirk AD, 1999, NAT MED, V5, P686, DOI 10.1038/9536; Larsen CP, 1996, NATURE, V381, P434, DOI 10.1038/381434a0; MURASE N, 1995, TRANSPLANTATION, V60, P158, DOI 10.1097/00007890-199507270-00009; MYBURGH JA, 1986, WORLD J SURG, V10, P369, DOI 10.1007/BF01655296; MYBURGH JA, 1991, PATHWAYS APPL IMMUNO, P87; Preville X, 2001, TRANSPLANTATION, V71, P460, DOI 10.1097/00007890-200102150-00021; Racusen LC, 1999, KIDNEY INT, V55, P713, DOI 10.1046/j.1523-1755.1999.00299.x; Sakamoto T, 1999, TRANSPLANTATION, V67, P833, DOI 10.1097/00007890-199903270-00009; Smiley ST, 2000, TRANSPLANTATION, V70, P415, DOI 10.1097/00007890-200008150-00005; STARZL TE, 1968, NEW ENGL J MED, V278, P642, DOI 10.1056/NEJM196803212781202; STARZL TE, 1963, SURG GYNECOL OBSTET, V117, P385; Starzl TE, 2002, J AM COLL SURGEONS, V195, P587, DOI 10.1016/S1072-7515(02)01498-9; STARZL TE, 1993, HEPATOLOGY, V17, P1127; Starzl TE, 2001, NAT REV IMMUNOL, V1, P233, DOI 10.1038/35105088; STARZL TE, 1992, LANCET, V339, P1579, DOI 10.1016/0140-6736(92)91840-5; Starzl TE, 1998, NEW ENGL J MED, V339, P1905, DOI 10.1056/NEJM199812243392607; STARZL TE, 1985, CHRONIC RENAL DIS, P507; Takatsuki M, 2001, TRANSPLANTATION, V72, P449, DOI 10.1097/00007890-200108150-00016; Wang CM, 2001, TRANSPLANTATION, V72, P44, DOI 10.1097/00007890-200107150-00011	27	364	385	1	14	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 3	2003	361	9368					1502	1510		10.1016/S0140-6736(03)13175-3	http://dx.doi.org/10.1016/S0140-6736(03)13175-3			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	674WB	12737859	Green Accepted			2022-12-24	WOS:000182658900008
J	Richard, C; Balavoine, F; Schultz, P; Ebbesen, TW; Mioskowski, C				Richard, C; Balavoine, F; Schultz, P; Ebbesen, TW; Mioskowski, C			Supramolecular self-assembly of lipid derivatives on carbon nanotubes	SCIENCE			English	Article							PROTEINS; CRYSTALLIZATION; FLUORESCENCE; ORGANIZATION; SURFACTANTS; MICROSCOPY; ELECTRODE	Images of the assembly of surfactants and synthetic lipids on the surface of carbon nanotubes were obtained by transmission electron microscopy. Above the critical micellar concentration, sodium dodecyl sulfate (SDS) forms supramolecular structures made of rolled-up half-cylinders on the nanotube surface. Depending on the symmetry and the diameter of the carbon nanotube, we observed rings, helices, or double helices. Similar self-assemblies were also obtained with several synthetic single-chain lipids designed for the immobilization of histidine-tagged proteins. At the nanotube-water interface, permanent assemblies were produced from mixed micelles of SDS and different water-insoluble double-chain lipids after dialysis of the surfactant. Such arrangements could be further exploited for the development of new biosensors and bioelectronic nanomaterials.	CEA Saclay, Serv Marquage Mol & Chim Bioorgan, F-91191 Gif Sur Yvette, France; Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France; Univ Strasbourg 1, ISIS, F-67000 Strasbourg, France; Fac Pharm, CNRS, UMR 7514, F-67401 Illkirch Graffenstaden, France	CEA; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Mioskowski, C (corresponding author), CEA Saclay, Serv Marquage Mol & Chim Bioorgan, Bat 547, F-91191 Gif Sur Yvette, France.		Richard, Cyrille/O-6802-2017	Richard, Cyrille/0000-0003-4896-6675; schultz, patrick/0000-0002-7310-6186				Ajayan PM, 1999, CHEM REV, V99, P1787, DOI 10.1021/cr970102g; Aksay IA, 1996, SCIENCE, V273, P892, DOI 10.1126/science.273.5277.892; Bahr JL, 2001, J AM CHEM SOC, V123, P6536, DOI 10.1021/ja010462s; Bonard JM, 1997, ADV MATER, V9, P827, DOI 10.1002/adma.19970091014; Burghard M, 1998, ADV MATER, V10, P584, DOI 10.1002/(SICI)1521-4095(199805)10:8<584::AID-ADMA584>3.0.CO;2-9; Chen J, 1998, SCIENCE, V282, P95, DOI 10.1126/science.282.5386.95; Dieckmann GR, 2003, J AM CHEM SOC, V125, P1770, DOI 10.1021/ja029084x; Dorn IT, 1998, J AM CHEM SOC, V120, P2753, DOI 10.1021/ja9735620; Dresselhaus M.S., 1996, SCI FULLERENES CARBO; DUBOCHET J, 1988, Q REV BIOPHYS, V21, P129, DOI 10.1017/S0033583500004297; Journet C, 1997, NATURE, V388, P756, DOI 10.1038/41972; KUBALEK EW, 1994, J STRUCT BIOL, V113, P117, DOI 10.1006/jsbi.1994.1039; MANNE S, 1994, LANGMUIR, V10, P4409, DOI 10.1021/la00024a003; MANNE S, 1995, SCIENCE, V270, P1480, DOI 10.1126/science.270.5241.1480; O'Connell MJ, 2002, SCIENCE, V297, P593, DOI 10.1126/science.1072631; Paborsky LR, 1996, ANAL BIOCHEM, V234, P60, DOI 10.1006/abio.1996.0050; Patrick HN, 2000, COLLOID SURFACE A, V162, P149, DOI 10.1016/S0927-7757(99)00187-9; RICHARD C, 2000, THESIS U PARIS SUD O; Schmid EL, 1997, ANAL CHEM, V69, P1979, DOI 10.1021/ac9700033; Sigal GB, 1996, ANAL CHEM, V68, P490, DOI 10.1021/ac9504023; Wanless EJ, 1996, J PHYS CHEM-US, V100, P3207, DOI 10.1021/jp952439x; Yakobson BI, 1997, AM SCI, V85, P324; ZETTLEMO.AC, 1968, J COLLOID INTERF SCI, V28, P343, DOI 10.1016/0021-9797(68)90066-0	24	694	717	4	285	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 2	2003	300	5620					775	778		10.1126/science.1080848	http://dx.doi.org/10.1126/science.1080848			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673KH	12730595				2022-12-24	WOS:000182579800043
J	Wood, ZA; Poole, LB; Karplus, PA				Wood, ZA; Poole, LB; Karplus, PA			Peroxiredoxin evolution and the regulation of hydrogen peroxide signaling	SCIENCE			English	Article							2-CYS PEROXIREDOXIN; MAMMALIAN PEROXIREDOXIN; THIOREDOXIN PEROXIDASE; ALKYL-HYDROPEROXIDE; CRYSTAL-STRUCTURE; OXIDATIVE STRESS; THIOL PEROXIDASE; SITE CYSTEINE; I EXPRESSION; NADH OXIDASE	Eukaryotic 2-Cys peroxiredoxins (2-Cys Prxs) not only act as antioxidants, but also appear to regulate hydrogen peroxide-mediated signal transduction. We show that bacterial 2-Cys Prxs are much less sensitive to oxidative inactivation than are eukaryotic 2-Cys Prxs. By identifying two sequence motifs unique to the sensitive 2-Cys Prxs and comparing the crystal structure of a bacterial 2-Cys Prx at 2.2 angstrom resolution with other Prx structures, we define the structural origins of sensitivity. We suggest this adaptation allows 2-Cys Prxs to act as floodgates, keeping resting levels of hydrogen peroxide low, while permitting higher levels during signal transduction.	Oregon State Univ, Dept Biochem & Biophys, Corvallis, OR 97333 USA; Wake Forest Univ, Bowman Gray Sch Med, Dept Biochem, Winston Salem, NC 27157 USA	Oregon State University; Wake Forest University; Wake Forest Baptist Medical Center	Karplus, PA (corresponding author), Oregon State Univ, Dept Biochem & Biophys, Corvallis, OR 97333 USA.	karplusp@ucs.orst.edu		Karplus, Paul/0000-0001-8725-6292	NIEHS NIH HHS [ES00210] Funding Source: Medline; NIGMS NIH HHS [R01 GM050389-10, GM50389, R01 GM050389] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000210] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050389] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allen RG, 2000, FREE RADICAL BIO MED, V28, P463, DOI 10.1016/S0891-5849(99)00242-7; Alphey MS, 2000, J MOL BIOL, V300, P903, DOI 10.1006/jmbi.2000.3881; Bryk R, 2000, NATURE, V407, P211, DOI 10.1038/35025109; Carmody RJ, 2001, REDOX REP, V6, P77, DOI 10.1179/135100001101536085; Cha MK, 2000, BIOCHEMISTRY-US, V39, P6944, DOI 10.1021/bi000034j; Chae HZ, 1999, DIABETES RES CLIN PR, V45, P101, DOI 10.1016/S0168-8227(99)00037-6; Chang JW, 2001, BIOCHEM BIOPH RES CO, V289, P507, DOI 10.1006/bbrc.2001.5989; Chang TS, 2002, J BIOL CHEM, V277, P25370, DOI 10.1074/jbc.M110432200; Chung YM, 2001, ANTICANCER RES, V21, P1129; Claiborne A, 1999, BIOCHEMISTRY-US, V38, P15407, DOI 10.1021/bi992025k; Delaunay A, 2002, CELL, V111, P471, DOI 10.1016/S0092-8674(02)01048-6; Dietz KJ, 2002, J EXP BOT, V53, P1321, DOI 10.1093/jexbot/53.372.1321; Fujii J, 2002, REDOX REP, V7, P123, DOI 10.1179/135100002125000352; Hancock JT, 2001, BIOCHEM SOC T, V29, P345, DOI 10.1042/BST0290345; Hirotsu S, 1999, P NATL ACAD SCI USA, V96, P12333, DOI 10.1073/pnas.96.22.12333; Hofmann B, 2002, BIOL CHEM, V383, P347, DOI 10.1515/BC.2002.040; Jin DY, 1997, J BIOL CHEM, V272, P30952, DOI 10.1074/jbc.272.49.30952; Kang SW, 1998, J BIOL CHEM, V273, P6297, DOI 10.1074/jbc.273.11.6297; Kim H, 2000, J BIOL CHEM, V275, P18266, DOI 10.1074/jbc.275.24.18266; Kinnula VL, 2002, J PATHOL, V196, P316, DOI 10.1002/path.1042; Konig J, 2002, P NATL ACAD SCI USA, V99, P5738, DOI 10.1073/pnas.072644999; Koo KH, 2002, ARCH BIOCHEM BIOPHYS, V397, P312, DOI 10.1006/abbi.2001.2700; Mu ZM, 2002, J BIOL CHEM, V277, P43175, DOI 10.1074/jbc.M206066200; NIIMURA Y, 1995, J BIOL CHEM, V270, P25645, DOI 10.1074/jbc.270.43.25645; Noh DY, 2001, ANTICANCER RES, V21, P2085; Park SG, 2000, J BIOL CHEM, V275, P5723, DOI 10.1074/jbc.275.8.5723; Park SH, 2000, CLIN CANCER RES, V6, P4915; Poole LB, 2000, FREE RADICAL BIO MED, V28, P108, DOI 10.1016/S0891-5849(99)00218-X; Rabilloud T, 2002, J BIOL CHEM, V277, P19396, DOI 10.1074/jbc.M106585200; Rabilloud T, 2001, PROTEOMICS, V1, P1105, DOI 10.1002/1615-9861(200109)1:9<1105::AID-PROT1105>3.0.CO;2-M; Ritz D, 2001, SCIENCE, V294, P158, DOI 10.1126/science.1063143; Schroder E, 2000, STRUCTURE, V8, P605, DOI 10.1016/S0969-2126(00)00147-7; Wagner E, 2002, BIOCHEM J, V366, P777, DOI 10.1042/BJ20020525; Wong CM, 2000, ANTIOXID REDOX SIGN, V2, P507, DOI 10.1089/15230860050192288; Wonsey DR, 2002, P NATL ACAD SCI USA, V99, P6649, DOI 10.1073/pnas.102523299; Wood ZA, 2002, BIOCHEMISTRY-US, V41, P5493, DOI 10.1021/bi012173m; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Yanagawa T, 2000, CANCER LETT, V156, P27, DOI 10.1016/S0304-3835(00)00434-1; Yanagawa T, 1999, CANCER LETT, V145, P127, DOI 10.1016/S0304-3835(99)00243-8; Yang KS, 2002, J BIOL CHEM, V277, P38029, DOI 10.1074/jbc.M206626200	40	1083	1133	5	135	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 25	2003	300	5619					650	653		10.1126/science.1080405	http://dx.doi.org/10.1126/science.1080405			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671FB	12714747				2022-12-24	WOS:000182453700045
J	Barkai, G; Arbuzova, S; Berkenstadt, M; Heifetz, S; Cuckle, H				Barkai, G; Arbuzova, S; Berkenstadt, M; Heifetz, S; Cuckle, H			Frequency of Down's syndrome and neural-tube defects in the same family	LANCET			English	Article							MATERNAL RISK-FACTORS; METHYLENETETRAHYDROFOLATE REDUCTASE; FOLIC-ACID; PLASMA HOMOCYSTEINE; FOLATE METABOLISM; SPINA-BIFIDA; PREGNANCY; GENE; POLYMORPHISM; MUTATION	Background There is evidence that some mothers of infants with Down's syndrome have abnormal metabolism of folate and methyl, as well as mutations in folate genes, which are features that are also seen in neural-tube defects (NTD). We therefore investigated whether Down's syndrome and NTD arise more often in the same family than would be expected from the incidence of each disorder considered separately. Methods We studied two series of families using information obtained from medical records about maternal age, pregnancy outcome, congenital malformations, and karyotype: the first, 493 families from Israel who were at high risk of NTD (445 with a history of NTD and 48 with isolated hydrocephalus); and the second, 516 families from the Ukraine at high risk of Down's syndrome. Findings In the families at risk of NTD, there were a total of 11 pregnancies affected by Down's syndrome in 1492 at-risk pregnancies (compared with 1.87 expected on the basis of maternal age), which was a significant increase (p<0.00001). In the families at risk of Down's syndrome, there were seven NTD pregnancies in 1847 at risk, compared with 1.37 expected (p<0.001). Interpretation In this study, we provide direct evidence of a link between Down's syndrome and NTD. Folate supplementation before conception has the potential to reduce the frequency of Down's syndrome.	Chaim Sheba Med Ctr, Danek Gertner Inst Human Genet, IL-52621 Tel Hashomer, Israel; Tel Aviv Univ, Sackler Sch Med, IL-52621 Tel Aviv, Israel; Interreg Medicogenet Ctr, Donetsk, Ukraine; Univ Leeds, Leeds, W Yorkshire, England	Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; University of Leeds	Barkai, G (corresponding author), Chaim Sheba Med Ctr, Danek Gertner Inst Human Genet, IL-52621 Tel Hashomer, Israel.		Arbuzova, Svetlana/W-5491-2018	Arbuzova, Svetlana/0000-0002-5846-1067				Arbuzova S, 2001, CLIN GENET, V60, P456, DOI 10.1034/j.1399-0004.2001.600609.x; ARBUZOVA S, 1998, DOWNS SYNDROME RES P, V5, P26; Ashfield-Watt PAL, 2002, AM J CLIN NUTR, V76, P180, DOI 10.1093/ajcn/76.1.180; Berry RJ, 1999, NEW ENGL J MED, V341, P1485, DOI 10.1056/NEJM199911113412001; Botto LD, 2000, AM J EPIDEMIOL, V151, P862; Brattstrom L, 1998, BMJ-BRIT MED J, V316, P894, DOI 10.1136/bmj.316.7135.894; Chadefaux-Vekemans B, 2002, PEDIATR RES, V51, P766, DOI 10.1203/01.PDR.0000017484.64723.43; Cuckle H, 1999, PRENATAL DIAG, V19, P1177, DOI 10.1002/(SICI)1097-0223(199912)19:12<1177::AID-PD714>3.0.CO;2-N; CUCKLE HS, 1987, BRIT J OBSTET GYNAEC, V94, P387, DOI 10.1111/j.1471-0528.1987.tb03115.x; Fenech M, 2001, MUTAT RES-FUND MOL M, V480, P51, DOI 10.1016/S0027-5107(01)00168-3; Hassold T, 2000, CLIN GENET, V57, P95, DOI 10.1034/j.1399-0004.2000.570201.x; Hobbs CA, 2000, AM J HUM GENET, V67, P623, DOI 10.1086/303055; Jacob RA, 1998, J NUTR, V128, P1204, DOI 10.1093/jn/128.7.1204; James SJ, 1999, AM J CLIN NUTR, V70, P495; KIRKE PN, 1993, Q J MED, V86, P703; Little J., 1992, EPIDEMIOLOGY CONTROL, P604; NANCE WE, 1969, NATURE, V224, P373, DOI 10.1038/224373a0; O'Leary VB, 2002, AM J MED GENET, V107, P151, DOI 10.1002/ajmg.10121; Petersen MB, 2001, AM J HUM GENET, V69, P323; Posey DL, 1996, LANCET, V347, P686, DOI 10.1016/S0140-6736(96)91236-2; PRYTKOV AN, 1978, GENETIKA+, V14, P1461; STEEGERSTHEUNISSEN RPM, 1994, METABOLISM, V43, P1475, DOI 10.1016/0026-0495(94)90004-3; Stuppia L, 2002, EUR J HUM GENET, V10, P388, DOI 10.1038/sj.ejhg.5200819; vanderPut NMJ, 1997, QJM-INT J MED, V90, P505, DOI 10.1093/qjmed/90.8.505; Vollset SE, 2000, AM J CLIN NUTR, V71, P962; WALD N, 1991, LANCET, V338, P131; Wald NJ, 2001, LANCET, V358, P2069, DOI 10.1016/S0140-6736(01)07104-5; Wilson A, 1999, MOL GENET METAB, V67, P317, DOI 10.1006/mgme.1999.2879; Zittoun J, 1998, METABOLISM, V47, P1413, DOI 10.1016/S0026-0495(98)90315-8	29	60	68	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 19	2003	361	9366					1331	1335		10.1016/S0140-6736(03)13080-2	http://dx.doi.org/10.1016/S0140-6736(03)13080-2			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	669HP	12711468				2022-12-24	WOS:000182346100010
J	El-Hashemite, N; Zhang, HB; Henske, EP; Kwiatkowski, DJ				El-Hashemite, N; Zhang, HB; Henske, EP; Kwiatkowski, DJ			Mutation in TSC2 and activation of mammalian target of rapamycin signalling pathway in renal angiomyolipoma	LANCET			English	Article							CELL-GROWTH; PROLIFERATION	Mutations that inactivate either TSC1 or TSC2 cause tuberous sclerosis. We have used immunoblotting and immunohistochemical analysis to see whether there is phosphorylation of p70 S6 kinase, and the ribosomal S6 protein in anglomyolipomas occurring in tuberous sclerosis. Hamartin (encoded by TSC1) and S6K was expressed in all samples. Tuberin (TSC2) was weak or absent in angiomyolipomas, but present in healthy kidney, whereas, phosphorylated p70 S6 kinase and p56 were present only in angiomyolipomas. Our results indicate activation of a mammalian target of rapamycin metabolic pathway in tuberous sclerosis lesions, which contributes to their growth. We suggest that treatment with rapamycin and its analogues could benefit such patients.	Brigham & Womens Hosp, Dept Med, Div Haematol, Boston, MA 02115 USA; Fox Chase Canc Ctr, Philadelphia, PA 19111 USA	Harvard University; Brigham & Women's Hospital; Fox Chase Cancer Center	Kwiatkowski, DJ (corresponding author), Brigham & Womens Hosp, Dept Med, Div Haematol, 75 Francis St, Boston, MA 02115 USA.							Gao XS, 2001, GENE DEV, V15, P1383, DOI 10.1101/gad.901101; Gingras AC, 2001, GENE DEV, V15, P807, DOI 10.1101/gad.887201; Kwiatkowski DJ, 2002, HUM MOL GENET, V11, P525, DOI 10.1093/hmg/11.5.525; Potter CJ, 2001, CELL, V105, P357, DOI 10.1016/S0092-8674(01)00333-6; Tapon N, 2001, CELL, V105, P345, DOI 10.1016/S0092-8674(01)00332-4	5	151	157	0	6	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 19	2003	361	9366					1348	1349		10.1016/S0140-6736(03)13044-9	http://dx.doi.org/10.1016/S0140-6736(03)13044-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	669HP	12711473				2022-12-24	WOS:000182346100015
J	Boshoff, HIM; Reed, MB; Barry, CE; Mizrahi, V				Boshoff, HIM; Reed, MB; Barry, CE; Mizrahi, V			DnaE2 polymerase contributes to in vivo survival and the emergence of drug resistance in Mycobacterium tuberculosis	CELL			English	Article							IRRADIATED ESCHERICHIA-COLI; POL-II; REPLICATION RESTART; DAMAGE INDUCTION; MUTATION-RATES; ERROR-PRONE; EXPRESSION; SMEGMATIS; REPAIR; GENES	The presence of multiple copies of the major replicative DNA polymerase (DnaE) in some organisms, including important pathogens and symbionts, has remained an unresolved enigma. We postulated that one copy might participate in error-prone DNA repair synthesis. We found that UV irradiation of Mycobacterium tuberculosis results in increased mutation frequency in the surviving fraction. We identified dnaE2 as a gene that is upregulated in vitro by several DNA damaging agents, as well as during infection of mice. Loss of this protein reduces both survival of the bacillus after UV irradiation and the virulence of the organism in mice. Our data suggest that DnaE2, and not a member of the Y family of error-prone DNA polymerases, is the primary mediator of survival through inducible mutagenesis and can contribute directly to the emergence of drug resistance in vivo. These results may indicate a potential new target for therapeutic intervention.	NIAID, TB Res Sect, Host Def Lab, NIH, Rockville, MD 20852 USA; Univ Witwatersrand, Sch Pathol, MRC, NHLS,WITS Mol Mycobacteriol Res Unit, Johannesburg, South Africa; Natl Hlth Lab Serv, Johannesburg, South Africa	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Health Laboratory Service; University of Witwatersrand; National Health Laboratory Service	Barry, CE (corresponding author), NIAID, TB Res Sect, Host Def Lab, NIH, Twinbrook 2,12441 Parklawn Dr, Rockville, MD 20852 USA.	clifton-barry@nih.gov; mizrahiv@pathology.wits.ac.za	Barry, Clifton E/ABE-7992-2020; Barry, III, Clifton/H-3839-2012	Barry, Clifton E/0000-0002-2927-270X; Barry, III, Clifton/0000-0002-2927-270X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000783, Z01AI000734] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 AI000783-11] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Bjorkholm B, 2001, P NATL ACAD SCI USA, V98, P14607, DOI 10.1073/pnas.241517298; Borden A, 2002, J BACTERIOL, V184, P2674, DOI 10.1128/JB.184.10.2674-2681.2002; Boshoff HIM, 2001, SCAND J INFECT DIS, V33, P101, DOI 10.1080/003655401753382567; Boshoff HIM, 2000, J BACTERIOL, V182, P5479, DOI 10.1128/JB.182.19.5479-5485.2000; Brooks PC, 2001, J BACTERIOL, V183, P4459, DOI 10.1128/JB.183.15.4459-4467.2001; Courcelle J, 2001, GENETICS, V158, P41; Dalrymple BP, 2001, P NATL ACAD SCI USA, V98, P11627, DOI 10.1073/pnas.191384398; Davis EO, 2002, MOL MICROBIOL, V46, P791, DOI 10.1046/j.1365-2958.2002.03199.x; Davis EO, 2002, J BACTERIOL, V184, P3287, DOI 10.1128/JB.184.12.3287-3295.2002; Dervyn E, 2001, SCIENCE, V294, P1716, DOI 10.1126/science.1066351; Durbach SI, 1997, MOL MICROBIOL, V26, P643, DOI 10.1046/j.1365-2958.1997.5731934.x; Dye C, 2002, SCIENCE, V295, P2042, DOI 10.1126/science.1063814; Espinal MA, 2000, JAMA-J AM MED ASSOC, V283, P2537, DOI 10.1001/jama.283.19.2537; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Frischkorn K, 1998, MOL MICROBIOL, V29, P1203, DOI 10.1046/j.1365-2958.1998.01003.x; Gao DX, 2001, J BIOL CHEM, V276, P4441, DOI 10.1074/jbc.M009830200; Goodman MF, 2002, ANNU REV BIOCHEM, V71, P17, DOI 10.1146/annurev.biochem.71.083101.124707; Huang YP, 1999, J MOL EVOL, V48, P756, DOI 10.1007/PL00006520; Inoue R, 2001, MOL GENET GENOMICS, V266, P564, DOI 10.1007/s004380100564; ITO J, 1991, NUCLEIC ACIDS RES, V19, P4045, DOI 10.1093/nar/19.15.4045; Karunakaran P, 2000, J BACTERIOL, V182, P3331, DOI 10.1128/JB.182.12.3331-3335.2000; Khil PP, 2002, MOL MICROBIOL, V44, P89, DOI 10.1046/j.1365-2958.2002.02878.x; Luria SE, 1943, GENETICS, V28, P491; Makarova KS, 2002, NUCLEIC ACIDS RES, V30, P482, DOI 10.1093/nar/30.2.482; Manca C, 2001, P NATL ACAD SCI USA, V98, P5752, DOI 10.1073/pnas.091096998; Manganelli R, 1999, MOL MICROBIOL, V31, P715, DOI 10.1046/j.1365-2958.1999.01212.x; Maor-Shoshani A, 2000, P NATL ACAD SCI USA, V97, P565, DOI 10.1073/pnas.97.2.565; McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074; Mdluli K, 1996, J INFECT DIS, V174, P1085, DOI 10.1093/infdis/174.5.1085; Metzgar D, 2000, CELL, V101, P581, DOI 10.1016/S0092-8674(00)80869-7; Mizrahi V, 2000, MOLECULAR GENETICS OF MYCOBACTERIA, P159; Morlock GP, 2000, ANTIMICROB AGENTS CH, V44, P3298, DOI 10.1128/AAC.44.12.3298-3301.2000; Napolitano R, 2000, EMBO J, V19, P6259, DOI 10.1093/emboj/19.22.6259; OGAORA P, 1997, MED PRIN PRACT, V6, P91; Oliver A, 2000, SCIENCE, V288, P1251, DOI 10.1126/science.288.5469.1251; Parish T, 2000, MICROBIOL-SGM, V146, P1969, DOI 10.1099/00221287-146-8-1969; Pham P, 2001, P NATL ACAD SCI USA, V98, P8350, DOI 10.1073/pnas.111007198; Ramaswamy S., 1998, Tubercle and Lung Disease, V79, P3, DOI 10.1054/tuld.1998.0002; Rangarajan S, 2002, MOL MICROBIOL, V43, P617, DOI 10.1046/j.1365-2958.2002.02747.x; Rangarajan S, 1999, P NATL ACAD SCI USA, V96, P9224, DOI 10.1073/pnas.96.16.9224; Rosche WA, 2000, METHODS, V20, P4, DOI 10.1006/meth.1999.0901; Russell DG, 2001, NAT REV MOL CELL BIO, V2, P569, DOI 10.1038/35085034; Schlosser-Silverman E, 2000, J BACTERIOL, V182, P5225, DOI 10.1128/JB.182.18.5225-5230.2000; Schoolnik GK, 2001, METHOD ENZYMOL, V336, P3, DOI 10.1016/S0076-6879(01)36573-4; Sherman DR, 2001, P NATL ACAD SCI USA, V98, P7534, DOI 10.1073/pnas.121172498; SNAPPER SB, 1990, MOL MICROBIOL, V4, P1911, DOI 10.1111/j.1365-2958.1990.tb02040.x; Sung HM, 2003, J BACTERIOL, V185, P2153, DOI 10.1128/JB.185.7.2153-2160.2003; Wilson W, 1999, P NATL ACAD SCI USA, V96, P12833, DOI 10.1073/pnas.96.22.12833	48	310	327	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 18	2003	113	2					183	193		10.1016/S0092-8674(03)00270-8	http://dx.doi.org/10.1016/S0092-8674(03)00270-8			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	672EP	12705867	Bronze			2022-12-24	WOS:000182508500008
J	Eden, A; Gaudet, F; Waghmare, A; Jaenisch, R				Eden, A; Gaudet, F; Waghmare, A; Jaenisch, R			Chromosomal instability and tumors promoted by DNA hypomethylation	SCIENCE			English	Article									MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02142 USA; Max Delbruck Ctr Mol Med, Berlin, Germany; Univ Munich, Dept Biol, Munich, Germany	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Munich	Jaenisch, R (corresponding author), MIT, Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	jaenisch@wi.mit.edu		Waghmare, Alpana/0000-0003-2268-9470	NATIONAL CANCER INSTITUTE [R01CA087869] Funding Source: NIH RePORTER; NCI NIH HHS [CA87869] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Cichowski K, 1999, SCIENCE, V286, P2172, DOI 10.1126/science.286.5447.2172; Eden A, 2003, SCIENCE, V300, P455, DOI 10.1126/science.1083557; FEINBERG AP, 1998, CANCER RES, V48, P1149; KENDAL WS, 1988, CANCER RES, V48, P1060; Schulz WA, 2002, GENE CHROMOSOME CANC, V35, P58, DOI 10.1002/gcc.10092; Wong N, 2001, AM J PATHOL, V159, P465, DOI 10.1016/S0002-9440(10)61718-X	6	986	1040	1	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 18	2003	300	5618					455	455		10.1126/science.1083557	http://dx.doi.org/10.1126/science.1083557			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668LR	12702868				2022-12-24	WOS:000182295900029
J	Magurran, AE; Henderson, PA				Magurran, AE; Henderson, PA			Explaining the excess of rare species in natural species abundance distributions	NATURE			English	Article							LOWER SEVERN ESTUARY; POPULATION STABILITY; DYNAMICS	The observation that a few species in ecological communities are exceptionally abundant, whereas most are rare, prompted the development of species abundance models(1-3). Nevertheless, despite the large literature on the commonness and rarity of species inspired by these pioneering studies, some widespread empirical patterns of species abundance resist easy explanation(4). Notable among these is the observation(5) that in large assemblages there are more rare species than the log normal model predicts(6,7). Here we use a long-term (21-year) data set, from an estuarine fish community, to show how an ecological community can be separated into two components. Core species, which are persistent, abundant and biologically associated with estuarine habitats, are log normally distributed. Occasional species occur infrequently in the record, are typically low in abundance and have different habitat requirements; they follow a log series distribution. These distributions are overlaid, producing the negative skew that characterizes real data sets.	Univ St Andrews, Sch Biol, Gatty Marine Lab, St Andrews KY16 8LB, Fife, Scotland; Pisces Conservat Ltd, Lymington SO41 8GN, Hants, England	University of St Andrews	Magurran, AE (corresponding author), Univ St Andrews, Sch Biol, Gatty Marine Lab, St Andrews KY16 8LB, Fife, Scotland.	aem1@st-andrews.ac.uk	Henderson, Peter Alan/Q-5145-2019; Magurran, Anne E/D-7463-2013	Henderson, Peter Alan/0000-0002-7461-1758; Magurran, Anne/0000-0002-0036-2795				Brown JH, 2001, SCIENCE, V293, P643, DOI 10.1126/science.293.5530.643; Brown JH, 2001, EVOLUTION, V55, P2137; Fisher RA, 1943, J ANIM ECOL, V12, P42, DOI 10.2307/1411; Gaston K.J., 2000, MACROECOLOGY; Harte J, 1999, SCIENCE, V284, P334, DOI 10.1126/science.284.5412.334; HENDERSON PA, 1990, J FISH BIOL, V37, P605; HENDERSON PA, 1994, NETH J SEA RES, V32, P321, DOI 10.1016/0077-7579(94)90009-4; Henderson PA, 1999, J FISH BIOL, V54, P1161, DOI 10.1111/j.1095-8649.1999.tb02046.x; Henderson PA, 1997, J FISH BIOL, V50, P280, DOI 10.1111/j.1095-8649.1997.tb01359.x; Henderson PA, 1998, J SEA RES, V40, P131, DOI 10.1016/S1385-1101(98)00020-3; HENDERSON PA, 1991, NETH J SEA RES, V27, P337, DOI 10.1016/0077-7579(91)90036-Z; Hubbell Stephen P., 2001, V32, pi; Krebs, 1999, ECOLOGICAL METHODOLO, DOI DOI 10.4404/HYSTRIX-21.2-4458; LYTHGOE J, 1971, FISHES SEA; Magurran A. E., 1988, ECOLOGICAL DIVERSITY, DOI DOI 10.1007/978-94-015-7358-0; May R.M., 1975, P81; Motomura I., 1932, JPN J ZOOL, V44, P379; NEE S, 1991, P ROY SOC B-BIOL SCI, V243, P161, DOI 10.1098/rspb.1991.0026; PRESTON FW, 1948, ECOLOGY, V29, P254, DOI 10.2307/1930989; Rodrigues ASL, 2000, P ROY SOC B-BIOL SCI, V267, P897, DOI 10.1098/rspb.2000.1087; Southwood R., 2000, ECOLOGICAL METHODS; Southwood TRE, 1996, PHILOS T R SOC B, V351, P1113, DOI 10.1098/rstb.1996.0097; SUGIHARA G, 1980, AM NAT, V116, P770, DOI 10.1086/283669; TURNPENNY AWH, 1981, CEGB PUBLICATION; WHEELER A, 1969, FISHES BRIT ISLES	25	609	650	7	218	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 17	2003	422	6933					714	716		10.1038/nature01547	http://dx.doi.org/10.1038/nature01547			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668CG	12700760				2022-12-24	WOS:000182272300039
J	Martin, GS; Mannino, DM; Eaton, S; Moss, M				Martin, GS; Mannino, DM; Eaton, S; Moss, M			The epidemiology of sepsis in the United States from 1979 through 2000	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; INFLAMMATORY RESPONSE SYNDROME; GRAM-NEGATIVE SEPSIS; SEPTIC SHOCK; NATURAL-HISTORY; SIRS; POLYMORPHISM; MORTALITY; SUSCEPTIBILITY; DEFINITIONS	BACKGROUND: Sepsis represents a substantial health care burden, and there is limited epidemiologic information about the demography of sepsis or about the temporal changes in its incidence and outcome. We investigated the epidemiology of sepsis in the United States, with specific examination of race and sex, causative organisms, the disposition of patients, and the incidence and outcome. METHODS: We analyzed the occurrence of sepsis from 1979 through 2000 using a nationally representative sample of all nonfederal acute care hospitals in the United States. Data on new cases were obtained from hospital discharge records coded according to the International Classification of Diseases, Ninth Revision, Clinical Modification. RESULTS: Review of discharge data on approximately 750 million hospitalizations in the United States over the 22-year period identified 10,319,418 cases of sepsis. Sepsis was more common among men than among women (mean annual relative risk, 1.28 [95 percent confidence interval, 1.24 to 1.32]) and among nonwhite persons than among white persons (mean annual relative risk, 1.90 [95 percent confidence interval, 1.81 to 2.00]). Between 1979 and 2000, there was an annualized increase in the incidence of sepsis of 8.7 percent, from about 164,000 cases (82.7 per 100,000 population) to nearly 660,000 cases (240.4 per 100,000 population). The rate of sepsis due to fungal organisms increased by 207 percent, with gram-positive bacteria becoming the predominant pathogens after 1987. The total in-hospital mortality rate fell from 27.8 percent during the period from 1979 through 1984 to 17.9 percent during the period from 1995 through 2000, yet the total number of deaths continued to increase. Mortality was highest among black men. Organ failure contributed cumulatively to mortality, with temporal improvements in survival among patients with fewer than three failing organs. The average length of the hospital stay decreased, and the rate of discharge to nonacute care medical facilities increased. CONCLUSIONS: The incidence of sepsis and the number of sepsis-related deaths are increasing, although the overall mortality rate among patients with sepsis is declining. There are also disparities among races and between men and women in the incidence of sepsis. Gram-positive bacteria and fungal organisms are increasingly common causes of sepsis.	Emory Univ, Sch Med, Dept Med, Div Pulm Allergy & Crit Care, Atlanta, GA USA; Ctr Dis Control & Prevent, Natl Ctr Environm Hlth, Atlanta, GA USA	Emory University; Centers for Disease Control & Prevention - USA	Martin, GS (corresponding author), Emory Univ, Grady Mem Hosp, Dept Med, Div Pulm Allergy & Crit Care, 69 Jesse Hill Jr Dr SE,Rm 2D-004, Atlanta, GA 30303 USA.	greg_martin@emory.org	Martin, Greg/B-4085-2009	Martin, Greg/0000-0002-9684-7593; NOIRI, Eisei/0000-0002-9515-7582; Mannino, David/0000-0003-3646-7828	NCRR NIH HHS [L30 RR020488-02, L30 RR020488] Funding Source: Medline; NHLBI NIH HHS [K23 HL067739, K23 HL067739-05, HL K23-67739] Funding Source: Medline; NIAAA NIH HHS [AA R01-11660] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL067739] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA011660] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Abel SJC, 1998, THORAX, V53, P292, DOI 10.1136/thx.53.4.292; Abraham E, 2000, CRIT CARE MED, V28, P232, DOI 10.1097/00003246-200001000-00039; ADAMS WL, 1993, JAMA-J AM MED ASSOC, V270, P1222, DOI 10.1001/jama.270.10.1222; ADAMS WL, 1993, JAMA-J AM MED ASSOC, V270, P2055; Alberti C, 2002, INTENS CARE MED, V28, P108, DOI 10.1007/s00134-001-1143-z; Alberti C, 2002, INTENS CARE MED, V28, P525, DOI 10.1007/s00134-002-1284-8; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Angus DC, 2000, JAMA-J AM MED ASSOC, V283, P1723, DOI 10.1001/jama.283.13.1723; BECKSAGUE CM, 1993, J INFECT DIS, V167, P1247, DOI 10.1093/infdis/167.5.1247; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; Bieler GS, 1997, ANAL SURVEY DATA USI; BONE RC, 1992, JAMA-J AM MED ASSOC, V268, P3452, DOI 10.1001/jama.268.24.3452; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Brun-Buisson C, 2000, INTENS CARE MED, V26, pS64, DOI 10.1007/s001340051121; BRUNBUISSON C, 1995, JAMA-J AM MED ASSOC, V274, P968, DOI 10.1001/jama.274.12.968; Centers for Disease Control (CDC), 1990, MMWR Morb Mortal Wkly Rep, V39, P31; CHALFIN DB, 1993, JAMA-J AM MED ASSOC, V269, P249, DOI 10.1001/jama.269.2.249; Eaton S, 2002, AM J RESP CRIT CARE, V165, pA471; El-Serag HB, 1999, NEW ENGL J MED, V340, P745, DOI 10.1056/NEJM199903113401001; Fang XM, 1999, CRIT CARE MED, V27, P1330, DOI 10.1097/00003246-199907000-00024; Friedman G, 1998, CRIT CARE MED, V26, P2078, DOI 10.1097/00003246-199812000-00045; Heyland DK, 2000, CRIT CARE MED, V28, P3599, DOI 10.1097/00003246-200011000-00006; HOYERT DL, 2001, NATL VITAL STAT REPO, V8; HSIA DC, 1990, NEW ENGL J MED, V322, P1540; HSIA DC, 1988, NEW ENGL J MED, V318, P352, DOI 10.1056/NEJM198802113180604; Hubacek JA, 2001, CRIT CARE MED, V29, P557, DOI 10.1097/00003246-200103000-00015; Iezzoni LI, 1997, ANN INTERN MED, V127, P666, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00048; KIEFT H, 1993, ARCH INTERN MED, V153, P2241, DOI 10.1001/archinte.153.19.2241; MILBERG JA, 1995, JAMA-J AM MED ASSOC, V273, P306, DOI 10.1001/jama.273.4.306; Mira JP, 1999, JAMA-J AM MED ASSOC, V282, P561, DOI 10.1001/jama.282.6.561; *NAT CTR HLTH STAT, 2002, NAT HOSP DISCH SURV; Ollendorf DA, 2002, VALUE HEALTH, V5, P79, DOI 10.1046/j.1524-4733.2002.52013.x; PARRILLO JE, 1990, ANN INTERN MED, V113, P227, DOI 10.7326/0003-4819-113-3-227; PERL TM, 1995, JAMA-J AM MED ASSOC, V274, P338, DOI 10.1001/jama.274.4.338; PITTET D, 1995, INTENS CARE MED, V21, P302, DOI 10.1007/BF01705408; RANGELFRAUSTO MS, 1995, JAMA-J AM MED ASSOC, V273, P117, DOI 10.1001/jama.273.2.117; Rubenfeld GD, 1999, AM J RESP CRIT CARE, V160, P358, DOI 10.1164/ajrccm.160.1.9807118; SALVO I, 1995, INTENS CARE MED, V21, pS244, DOI 10.1007/BF01740762; Sands KE, 1997, JAMA-J AM MED ASSOC, V278, P234, DOI 10.1001/jama.278.3.234; Stuber F, 1996, CRIT CARE MED, V24, P381, DOI 10.1097/00003246-199603000-00004; Vincent JL, 1997, CRIT CARE MED, V25, P372, DOI 10.1097/00003246-199702000-00029; Warren BL, 2001, JAMA-J AM MED ASSOC, V286, P1869, DOI 10.1001/jama.286.15.1869; Warren BL, 2002, JAMA-J AM MED ASSOC, V287, P192; Wenzel RP, 2001, EMERG INFECT DIS, V7, P174, DOI 10.3201/eid0702.010203; Wenzel RP, 2001, CRIT CARE MED, V29, P1472, DOI 10.1097/00003246-200107000-00028; Wenzel RP, 2000, NEW ENGL J MED, V343, P1961, DOI 10.1056/NEJM200012283432610; Wheeler AP, 1999, NEW ENGL J MED, V340, P207, DOI 10.1056/NEJM199901213400307; WHITTLE J, 1993, NEW ENGL J MED, V329, P621, DOI 10.1056/NEJM199308263290907; Wong MD, 2002, NEW ENGL J MED, V347, P1585, DOI 10.1056/NEJMsa012979	49	4304	4776	8	256	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 17	2003	348	16					1546	1554		10.1056/NEJMoa022139	http://dx.doi.org/10.1056/NEJMoa022139			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	667TT	12700374	Green Published, Bronze			2022-12-24	WOS:000182248900005
J	Sharma, L; Dunlop, DD; Song, J; Hayes, KW				Sharma, L; Dunlop, DD; Song, J; Hayes, KW			Quadriceps strength and osteoarthritis progression in maligned and lax knees	ANNALS OF INTERNAL MEDICINE			English	Article							EXERCISE; DISABILITY; RISK; PAIN; HIP	Background: Quadriceps muscle strengthening is a common goal in the management of knee osteoarthritis. In healthy knees, strength protects against new osteoarthritis. In arthritic knees, greater strength may protect joints and thereby delay osteoarthritis progression. Alternatively, in certain joint environments, such as malalignment or laxity, greater strength may, translate into damaging joint reaction forces. The relationship between quadriceps strength and progression of knee osteoarthritis may differ according to these factors. Objective: To determine whether greater quadriceps strength is associated with greater probability of tibiofemoral osteoarthritis progression in malaligned knees and in high-laxity knees. Design: Prospective, longitudinal cohort study. Setting: Academic medical center. Participants: 237 persons with primary knee osteoarthritis, definite tiblofemoral osteophytes, and at least some difficulty with knee-requiring activity. Two hundred thirty completed the 18-month evaluation. The current study primarily involved those without advanced osteoarthritis in either knee (n = 171). Measurements: Quadriceps strength, knee laxity and alignment, and osteoarthritis progression. Results: The predicted probability of tibiofemoral progression was 0.153 (95% Cl, 0.100 to 0.228) in high-strength knees and 0.098 (Cl, 0.061 to 0.155) in low-strength knees. In malaligned knees, high strength was associated with a significant increase (P = 0.03) in the likelihood of progression (predicted probability, 0.406 [Cl, 0.226 to 0.615] vs. 0.187 [Cl, 0.081 to 0.375] in high-strength vs. low-strength knees). Strength was also associated with increased likelihood of progression in high-laxity knees (P = 0.003 when high laxity was defined as greater than or equal to6.75 degrees). The probability of patellofemoral progression did not differ between high- and low-strength knees in the full sample or within subsets. Conclusions: Greater quadriceps strength at baseline was associated with increased likelihood of tibiofemoral osteoarthritis progression in malaligned knees and lax knees. Subset-specific approaches beyond strengthening exercises should be developed to enhance joint-protective muscle activity.	Northwestern Univ, Sch Med, Feinberg Sch Med, Div Rheumatol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Sharma, L (corresponding author), Northwestern Univ, Sch Med, Feinberg Sch Med, Div Rheumatol, 300 E Super Ave,Tarry Bldg 3-715, Chicago, IL 60611 USA.			Sharma, Leena/0000-0002-5571-1622	NCRR NIH HHS [RR-00048] Funding Source: Medline; NIAMS NIH HHS [AR-30692] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P60AR030692] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Altman R, 1996, OSTEOARTHR CARTILAGE, V4, P217, DOI 10.1016/S1063-4584(05)80101-3; Altman RD, 2000, ARTHRITIS RHEUM-US, V43, P1905; ALTMAN RD, 1995, OSTEOARTHR CARTILAGE, V3, P3; Baker K, 2000, CURR OPIN RHEUMATOL, V12, P456, DOI 10.1097/00002281-200009000-00020; BRAGE ME, 1994, CLIN ORTHOPAEDICS, V304, P184; Brandt KD, 1999, J RHEUMATOL, V26, P2431; BUCKLANDWRIGHT C, 1995, OSTEOARTHR CARTILAGE, V3, P71; Chaisson CE, 1999, ARTHRITIS RHEUM-US, V42, P33, DOI 10.1002/1529-0131(199901)42:1<33::AID-ANR4>3.0.CO;2-I; CHAO EYS, 1994, ORTHOP CLIN N AM, V25, P379; Dieppe P, 1995, OSTEOARTHRITIC DISOR, P481; Ettinger WH, 1997, JAMA-J AM MED ASSOC, V277, P25, DOI 10.1001/jama.277.1.25; FISHER NM, 1991, ARCH PHYS MED REHAB, V72, P365; Gerber L.H., 2001, OSTEOARTHRITIS DIAGN, P413; GUCCIONE AA, 1994, AM J PUBLIC HEALTH, V84, P351, DOI 10.2105/AJPH.84.3.351; HSU RWW, 1990, CLIN ORTHOP RELAT R, V255, P215; KANNUS P, 1989, AM J SPORT MED, V17, P83, DOI 10.1177/036354658901700114; KANNUS P, 1988, CLIN ORTHOP RELAT R, V226, P103; LANKHORST GJ, 1985, SCAND J REHABIL MED, V17, P167; MARKOLF KL, 1981, J BONE JOINT SURG AM, V63, P570, DOI 10.2106/00004623-198163040-00007; MARKS R, 1994, J THEOR BIOL, V170, P283, DOI 10.1006/jtbi.1994.1189; MCALINDON TE, 1993, ANN RHEUM DIS, V52, P258, DOI 10.1136/ard.52.4.258; POTTENGER LA, 1990, ARTHRITIS RHEUM-US, V33, P853, DOI 10.1002/art.1780330612; Rejeski WJ, 1996, J GERONTOL B-PSYCHOL, V51, pP24, DOI 10.1093/geronb/51B.1.P24; SCHIPPLEIN OD, 1991, J ORTHOPAED RES, V9, P113, DOI 10.1002/jor.1100090114; Sharma L, 1999, ARTHRITIS RHEUM, V42, P861, DOI 10.1002/1529-0131(199905)42:5<861::AID-ANR4>3.0.CO;2-N; Sharma L, 1999, ARTHRITIS RHEUM-US, V42, P25, DOI 10.1002/1529-0131(199901)42:1<25::AID-ANR3>3.0.CO;2-G; Sharma L, 2001, JAMA-J AM MED ASSOC, V286, P188, DOI 10.1001/jama.286.2.188; Slemenda C, 1998, ARTHRITIS RHEUM, V41, P1951, DOI 10.1002/1529-0131(199811)41:11<1951::AID-ART9>3.0.CO;2-9; Solomonow M, 1994, KNEE, P107; TETSWORTH K, 1994, ORTHOP CLIN N AM, V25, P367; Van Baar ME, 1999, ARTHRITIS RHEUM-US, V42, P1361, DOI 10.1002/1529-0131(199907)42:7<1361::AID-ANR9>3.0.CO;2-9; van Baar ME, 1998, J RHEUMATOL, V25, P125; Wada M, 1996, BRIT J RHEUMATOL, V35, P560; WASHBURN RA, 1993, J CLIN EPIDEMIOL, V46, P153, DOI 10.1016/0895-4356(93)90053-4; WOO SL, 2001, OSTEOARTHRITIS DIAGN, P145	35	222	225	0	12	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 15	2003	138	8					613	619		10.7326/0003-4819-138-8-200304150-00006	http://dx.doi.org/10.7326/0003-4819-138-8-200304150-00006			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	666JH	12693882	Green Submitted			2022-12-24	WOS:000182173800001
J	Barbosa-Cesnik, C; Schwartz, K; Foxman, B				Barbosa-Cesnik, C; Schwartz, K; Foxman, B			Lactation mastitis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							BREAST-FEEDING WOMEN; PUERPERAL MASTITIS; STAPHYLOCOCCUS-AUREUS; PROSPECTIVE COHORT; RISK-FACTORS; INFLAMMATION; MANAGEMENT; POSTPARTUM		Univ Michigan, Dept Epidemiol, Ann Arbor, MI 48109 USA; Univ Michigan, Ctr Mol & Clin Epidemiol Infect Dis, Ann Arbor, MI 48109 USA; Wayne State Univ, Dept Family Med, Detroit, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Wayne State University	Barbosa-Cesnik, C (corresponding author), Univ Michigan, Dept Epidemiol, 109 Observ St, Ann Arbor, MI 48109 USA.	cibele@umich.edu	Dahlen, Hannah/V-1034-2019	Dahlen, Hannah/0000-0002-4450-3078; Foxman, Betsy/0000-0001-6682-238X				Amir L H, 1999, J Hum Lact, V15, P221, DOI 10.1177/089033449901500312; Bedinghaus JM, 1997, PRIMARY CARE, V24, P147; BRODRIBB W, 1991, BREASTFEEDING MANAGE; Buescher ES, 2001, CELL IMMUNOL, V210, P87, DOI 10.1006/cimm.2001.1813; Castro M, 1999, J NURSE-MIDWIFERY, V44, P280, DOI 10.1016/S0091-2182(99)00040-3; DEVEREUX WP, 1970, AM J OBSTET GYNECOL, V108, P78, DOI 10.1016/0002-9378(70)90208-5; DIXON JM, 1988, BRIT MED J, V297, P1517, DOI 10.1136/bmj.297.6662.1517; EIDELMAN AI, 1979, OBSTET GYNECOL, V53, P550; EVANS M, 1995, BREASTFEED REV, V3, P65; Fetherston C, 2001, Breastfeed Rev, V9, P5; Fetherston C, 1997, Breastfeed Rev, V5, P13; Fetherston C, 1998, J Hum Lact, V14, P101, DOI 10.1177/089033449801400209; Fetherston C, 1997, Breastfeed Rev, V5, P5; Foxman B, 2002, AM J EPIDEMIOL, V155, P103, DOI 10.1093/aje/155.2.103; Fujiwara Y, 2001, Kansenshogaku Zasshi, V75, P898; Hager WD, 1992, INFECT PROTOCOLS OBS, P27; Herold BC, 1998, JAMA-J AM MED ASSOC, V279, P593, DOI 10.1001/jama.279.8.593; Hunt C, 1999, JAMA-J AM MED ASSOC, V282, P1123; JONSSON S, 1994, ANN CHIR GYNAECOL FE, V83, P84; KAUFMANN R, 1991, SOC SCI MED, V33, P701, DOI 10.1016/0277-9536(91)90024-7; Kinlay JR, 1998, MED J AUSTRALIA, V169, P310, DOI 10.5694/j.1326-5377.1998.tb140282.x; Kinlay JR, 2001, AUST NZ J PUBL HEAL, V25, P115, DOI 10.1111/j.1753-6405.2001.tb01831.x; Marchant DJ, 2002, OBSTET GYN CLIN N AM, V29, P89, DOI 10.1016/S0889-8545(03)00054-8; MARSHALL BR, 1975, JAMA-J AM MED ASSOC, V233, P1377, DOI 10.1001/jama.233.13.1377; MCLACHLAN Z, 1993, BREASTFEEDING REV, V2, P316; NIEBYL JR, 1978, J REPROD MED, V20, P97; OGLE KS, 1978, J FAM PRACTICE, V26, P139; OLSEN CG, 1990, AM FAM PHYSICIAN, V41, P1509; Osterman K L, 2000, J Hum Lact, V16, P297, DOI 10.1177/089033440001600405; Peacock SJ, 2001, TRENDS MICROBIOL, V9, P605, DOI 10.1016/S0966-842X(01)02254-5; Riordan J M, 1990, J Hum Lact, V6, P53, DOI 10.1177/089033449000600213; Ryan AS, 2002, PEDIATRICS, V110, P1103, DOI 10.1542/peds.110.6.1103; Schwartz K, 2002, J FAM PRACTICE, V51, P439; Shellshear M, 1981, Aust J Physiother, V27, P15, DOI 10.1016/S0004-9514(14)60742-X; THOMSEN AC, 1984, AM J OBSTET GYNECOL, V149, P492, DOI 10.1016/0002-9378(84)90022-X; THOMSEN AC, 1983, AM J OBSTET GYNECOL, V146, P938, DOI 10.1016/0002-9378(83)90969-9; Vogel A, 1999, BIRTH-ISS PERINAT C, V26, P218, DOI 10.1046/j.1523-536x.1999.00218.x; World Health Organization, 2000, MAST CAUS MAN	38	72	77	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 2	2003	289	13					1609	1612		10.1001/jama.289.13.1609	http://dx.doi.org/10.1001/jama.289.13.1609			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	662JX	12672715				2022-12-24	WOS:000181944500001
J	Dispenzieri, A; Kyle, RA; Gertz, MA; Therneau, TM; Miller, WL; Chandrasekaran, K; McConnell, JP; Burritt, MF; Jaffe, AS				Dispenzieri, A; Kyle, RA; Gertz, MA; Therneau, TM; Miller, WL; Chandrasekaran, K; McConnell, JP; Burritt, MF; Jaffe, AS			Survival in patients with primary systemic amyloidosis and raised serum cardiac troponins	LANCET			English	Article								Patients with primary systemic amyloidosis that affects the heart have a poor outlook. Cardiac troponins T and I (cTnT, cTnI) are highly specific and sensitive biomarkers of myocardial injury. Values of these troponins provide quantitative information about the disease. We retrospectively assessed 261 patients newly diagnosed as having primary systemic amyloidosis. Median survival for patients with detectable cTnT and cTnI (6 and 8 months, respectively), was worse than that for those with undetectable values (22 and 21 months, respectively). Median and 25th and, 75th percentile values for cTnT were 0.024 mug/l., less than 0.01 mug/L, and 0.084 mug/L, and for cTnI were 0.1 mug/L, 0.05 mug/L, and 0.24 mug/L, respectively. After multivariate analysis, cTnT proved a better predictor of survival than cTnI.	Mayo Clin, Div Haematol & Internal Med, Rochester, MN 55905 USA; Mayo Clin, Div Biostat, Rochester, MN 55905 USA; Mayo Clin, Div Cardiovasc Dis, Rochester, MN 55905 USA; Mayo Clin, Div Internal Med, Rochester, MN 55905 USA; Mayo Clin, Div Lab Genet, Rochester, MN 55905 USA; Mayo Clin, Div Clin Biochem & Immunol, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Dispenzieri, A (corresponding author), Mayo Clin, Div Haematol & Internal Med, Rochester, MN 55905 USA.		Gertz, Morie/K-2873-2019	Dispenzieri, Angela/0000-0001-8780-9512	NATIONAL CANCER INSTITUTE [R21CA091561, P01CA062242] Funding Source: NIH RePORTER; NCI NIH HHS [CA 91561, CA 62242] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Apple FS, 2002, AM HEART J, V144, P981, DOI 10.1067/mhj.2002.124048; CUETOGARCIA L, 1985, J AM COLL CARDIOL, V6, P737, DOI 10.1016/S0735-1097(85)80475-7; KYLE RA, 1995, SEMIN HEMATOL, V32, P45; KYLE RA, 1986, BLOOD, V68, P220; Miller WL, 2001, AM J CARDIOL, V88, P813, DOI 10.1016/S0002-9149(01)01877-X	5	216	233	0	5	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 24	2003	361	9371					1787	1789		10.1016/S0140-6736(03)13396-X	http://dx.doi.org/10.1016/S0140-6736(03)13396-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	682CY	12781539				2022-12-24	WOS:000183074800012
J	Hubner, K; Fuhrmann, G; Christenson, LK; Kehler, J; Reinbold, R; De La Fuente, R; Wood, J; Strauss, JF; Boiani, M; Scholer, HR				Hubner, K; Fuhrmann, G; Christenson, LK; Kehler, J; Reinbold, R; De La Fuente, R; Wood, J; Strauss, JF; Boiani, M; Scholer, HR			Derivation of oocytes from mouse embryonic stem cells	SCIENCE			English	Article							OCT-4 TRANSCRIPTION FACTOR; PRIMORDIAL GERM-CELLS; ZONA-PELLUCIDA GENES; H-Y ANTIGEN; CHROMOSOME SYNAPSIS; COORDINATE EXPRESSION; FIG-ALPHA; IN-VITRO; MICE; ACTIVATION	Continuation of mammalian species requires the formation and development of the sexually dimorphic germ cells. Cultured embryonic stem cells are generally considered pluripotent rather than totipotent because of the failure to detect germline cells under differentiating conditions. Here we show that mouse embryonic stem cells in culture can develop into oogonia that enter meiosis, recruit adjacent cells to form follicle-like structures, and later develop into blastocysts. Oogenesis in culture should contribute to various areas, including nuclear transfer and manipulation of the germ line, and advance studies on fertility treatment and germ and somatic cell interaction and differentiation.	Univ Penn, Sch Vet Med, Ctr Anim Transgenesis & Germ Cell Res, Germline Dev Grp,New Bolton Ctr, Kennett Sq, PA 19348 USA; Univ Penn, Sch Vet Med, Ctr Anim Transgenesis & Germ Cell Res, Female Germ Cell Biol Grp,New Bolton Ctr, Kennett Sq, PA 19348 USA; Ctr Neurochim, Lab Neurobiol Dev & Regenerat, CNRS, FRE 2373, F-67084 Strasbourg, France; Univ Penn, Sch Med, Ctr Res Reprod & Womens Hlth, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Pennsylvania; Pennsylvania Medicine	Scholer, HR (corresponding author), Univ Penn, Sch Vet Med, Ctr Anim Transgenesis & Germ Cell Res, Germline Dev Grp,New Bolton Ctr, 382 W St Rd, Kennett Sq, PA 19348 USA.		Boiani, Michele/M-3519-2015; , HS/AAB-4434-2019; reinbold, rolland/AAW-8940-2020; Christenson, Lane K/G-6435-2013	Boiani, Michele/0000-0003-2765-2781; , HS/0000-0003-2643-5136; 	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD007305, R01HD042011] Funding Source: NIH RePORTER; NICHD NIH HHS [HD06274, T32 HD07305, 1RO1HD42011-01] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Anderson R, 2000, MECH DEVELOP, V91, P61, DOI 10.1016/S0925-4773(99)00271-3; Boiani M, 2002, GENE DEV, V16, P1209, DOI 10.1101/gad.966002; CARNEY EW, 1993, MOL REPROD DEV, V34, P357, DOI 10.1002/mrd.1080340403; CHISHOLM JC, 1987, DEVELOPMENT, V101, P565; Christenson LK, 2001, J BIOL CHEM, V276, P27392, DOI 10.1074/jbc.M101650200; Chuma S, 2001, DEV BIOL, V229, P468, DOI 10.1006/dbio.2000.9989; Colvin JS, 2001, CELL, V104, P875, DOI 10.1016/S0092-8674(01)00284-7; Crawford PA, 1997, MOL CELL BIOL, V17, P3997, DOI 10.1128/MCB.17.7.3997; DOBSON MJ, 1994, J CELL SCI, V107, P2749; Dong JW, 1996, NATURE, V383, P531, DOI 10.1038/383531a0; EAST IJ, 1984, DEV BIOL, V104, P49, DOI 10.1016/0012-1606(84)90035-6; EPIFANO O, 1995, DEVELOPMENT, V121, P1947; Eppig JJ, 1996, CANCER RES, V56, P5047; Eppig JJ, 1996, BIOL REPROD, V54, P197, DOI 10.1095/biolreprod54.1.197; GUILLEMOT F, 1994, NATURE, V371, P333, DOI 10.1038/371333a0; HASHIMOTO N, 1994, NATURE, V370, P68, DOI 10.1038/370068a0; HUBNER K, UNPUB; LAWSON KA, 1994, CIBA F SYMP, V182, P68; Lawson KA, 1999, GENE DEV, V13, P424, DOI 10.1101/gad.13.4.424; Liang LF, 1997, DEVELOPMENT, V124, P4939; Matzuk MM, 2000, MOL CELL ENDOCRINOL, V163, P61, DOI 10.1016/S0303-7207(99)00241-5; McLaren A, 1997, DEV BIOL, V187, P107, DOI 10.1006/dbio.1997.8584; Nordhoff V, 2001, MAMM GENOME, V12, P309, DOI 10.1007/s003350010279; OHNO S, 1978, CYTOGENET CELL GENET, V20, P351, DOI 10.1159/000130863; PALMIERI SL, 1994, DEV BIOL, V166, P259, DOI 10.1006/dbio.1994.1312; Pesce M, 2000, MOL REPROD DEV, V55, P452, DOI 10.1002/(SICI)1098-2795(200004)55:4&lt;452::AID-MRD14&gt;3.0.CO;2-S; Pesce M, 1998, MECH DEVELOP, V71, P89, DOI 10.1016/S0925-4773(98)00002-1; Pesce M, 1998, BIOESSAYS, V20, P722, DOI 10.1002/(SICI)1521-1878(199809)20:9&lt;722::AID-BIES5&gt;3.0.CO;2-I; Pittman DL, 1998, MOL CELL, V1, P697, DOI 10.1016/S1097-2765(00)80069-6; Rankin T, 1999, DEVELOPMENT, V126, P3847; Saitou M, 2002, NATURE, V418, P293, DOI 10.1038/nature00927; Simpson E, 1997, ANNU REV IMMUNOL, V15, P39, DOI 10.1146/annurev.immunol.15.1.39; Soyal SM, 2000, DEVELOPMENT, V127, P4645; STEVENS LC, 1974, DEV BIOL, V37, P369, DOI 10.1016/0012-1606(74)90155-9; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; Tarsounas M, 1999, J CELL SCI, V112, P423; Tilmann C, 2002, RECENT PROG HORM RES, V57, P1, DOI 10.1210/rp.57.1.1; Toyooka Y, 2000, MECH DEVELOP, V93, P139, DOI 10.1016/S0925-4773(00)00283-5; Yoshida K, 1998, MOL CELL, V1, P707, DOI 10.1016/S1097-2765(00)80070-2; Yuan L, 2000, MOL CELL, V5, P73, DOI 10.1016/S1097-2765(00)80404-9; ZENZES MT, 1978, CYTOGENET CELL GENET, V20, P365, DOI 10.1159/000130864	41	793	888	2	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 23	2003	300	5623					1251	1256		10.1126/science.1083452	http://dx.doi.org/10.1126/science.1083452			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681NN	12730498				2022-12-24	WOS:000183042400038
J	Pages, V; Fuchs, RP				Pages, V; Fuchs, RP			Uncoupling of leading- and lagging-strand DNA replication during lesion bypass in vivo	SCIENCE			English	Article							POLYMERASES POL-II; FRAMESHIFT MUTATIONS; MUTAGENESIS; CELLS; FORKS; IV	Numerous agents attack DNA, forming lesions that impair normal replication. Specialized DNA polymerases transiently replace the replicative polymerase and copy past lesions, thus generating mutations, the major initiating cause of cancer. We monitored, in Escherichia coli, the kinetics of replication of both strands of DNA molecules containing a single replication block in either the leading or lagging strand. Despite a block in the leading strand, lagging-strand synthesis proceeded further, implying transient uncoupling of concurrent strand synthesis. Replication through the lesion requires specialized DNA polymerases and is achieved with similar kinetics and efficiencies in both strands.	Ecole Super Biotechnol, CNRS, Unite Propre Rech 9003, F-67400 Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Fuchs, RP (corresponding author), Ecole Super Biotechnol, CNRS, Unite Propre Rech 9003, Blvd S Brant, F-67400 Strasbourg, France.		Pagès, Vincent/L-8455-2016	Pagès, Vincent/0000-0002-3059-2903				Becherel OJ, 2001, P NATL ACAD SCI USA, V98, P8566, DOI 10.1073/pnas.141113398; Bresson A, 2002, EMBO J, V21, P3881, DOI 10.1093/emboj/cdf363; CORDEIROSTONE M, 1979, BIOPHYS J, V27, P287, DOI 10.1016/S0006-3495(79)85218-2; Courcelle J, 2003, SCIENCE, V299, P1064, DOI 10.1126/science.1081328; Friedberg EC, 2002, SCIENCE, V296, P1627, DOI 10.1126/science.1070236; FUCHS RPP, 1981, NATURE, V294, P657, DOI 10.1038/294657a0; Goodman MF, 2000, NAT REV MOL CELL BIO, V1, P101, DOI 10.1038/35040051; HIGGINS NP, 1976, J MOL BIOL, V101, P417, DOI 10.1016/0022-2836(76)90156-X; Hoffmann GR, 1997, CHEM RES TOXICOL, V10, P347, DOI 10.1021/tx960128n; McGlynn P, 2001, P NATL ACAD SCI USA, V98, P8235, DOI 10.1073/pnas.121007798; MILLER JA, 1970, CANCER RES, V30, P559; Napolitano R, 2000, EMBO J, V19, P6259, DOI 10.1093/emboj/19.22.6259; Ohmori H, 2001, MOL CELL, V8, P7, DOI 10.1016/S1097-2765(01)00278-7; Pages V, 2002, ONCOGENE, V21, P8957, DOI 10.1038/sj.onc.1206006; PAGES V, UNPUB; Prakash S, 2002, GENE DEV, V16, P1872, DOI 10.1101/gad.1009802; RUPP WD, 1968, J MOL BIOL, V31, P291, DOI 10.1016/0022-2836(68)90445-2; Seigneur M, 1998, CELL, V95, P419, DOI 10.1016/S0092-8674(00)81772-9; Sutton MD, 2001, P NATL ACAD SCI USA, V98, P8342, DOI 10.1073/pnas.111036998; TOMIZAWA JI, 1974, P NATL ACAD SCI USA, V71, P2260, DOI 10.1073/pnas.71.6.2260; Wagner J, 2002, DNA REPAIR, V1, P159, DOI 10.1016/S1568-7864(01)00012-X	21	159	161	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 23	2003	300	5623					1300	1303		10.1126/science.1083964	http://dx.doi.org/10.1126/science.1083964			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681NN	12764199				2022-12-24	WOS:000183042400052
J	Prescott, ED; Julius, D				Prescott, ED; Julius, D			A modular PIP2 binding site as a determinant of capsaicin receptor sensitivity	SCIENCE			English	Article							DIRECT ACTIVATION; CHANNELS; PAIN; HEAT; TRPV3; VR1	The capsaicin receptor (TRPV1), a heat-activated ion channel of the pain pathway, is sensitized by phosphatidylinositol-4,5-bisphosphate (PIP2) hydrolysis after phospholipase C activation. We identify a site within the C-terminal domain of TRPV1 that is required for PIP2-mediated inhibition of channel gating. Mutations that weaken PIP2-TRPV1 interaction reduce thresholds for chemical or thermal stimuli, whereas TRPV1 channels in which this region is replaced with a lipid-bindingdomain from PIP2-activated potassium channels remain inhibited by PIP2. The PIP2-interaction domain therefore serves as a critical determinant of thermal threshold and dynamic sensitivity range, tuning TRPV1, and thus the sensory neuron, to appropriately detect heat under normal or pathophysiological conditions.	Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Julius, D (corresponding author), Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA.	julius@cmp.ucsf.edu						Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chuang HH, 2001, NATURE, V411, P957, DOI 10.1038/35082088; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; Hardie RC, 2003, ANNU REV PHYSIOL, V65, P735, DOI 10.1146/annurev.physiol.65.092101.142505; Hilgemann D W, 2001, Sci STKE, V2001, pre19, DOI 10.1126/stke.2001.111.re19; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; Jordt SE, 2002, CELL, V108, P421, DOI 10.1016/S0092-8674(02)00637-2; Kobrinsky E, 2000, NAT CELL BIOL, V2, P507, DOI 10.1038/35019544; Numazaki M, 2002, J BIOL CHEM, V277, P13375, DOI 10.1074/jbc.C200104200; Peier AM, 2002, SCIENCE, V296, P2046, DOI 10.1126/science.1073140; Premkumar LS, 2000, NATURE, V408, P985, DOI 10.1038/35050121; PRESCOTT ED, UNPUB; Runnels LW, 2002, NAT CELL BIOL, V4, P329, DOI 10.1038/ncb781; Smith GD, 2002, NATURE, V418, P186, DOI 10.1038/nature00894; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Tominaga M, 2001, P NATL ACAD SCI USA, V98, P6951, DOI 10.1073/pnas.111025298; Vellani V, 2001, J PHYSIOL-LONDON, V534, P813, DOI 10.1111/j.1469-7793.2001.00813.x; Wiedemann C, 1996, EMBO J, V15, P2094, DOI 10.1002/j.1460-2075.1996.tb00563.x; Xu HX, 2002, NATURE, V418, P181, DOI 10.1038/nature00882; Zhang HL, 1999, NAT CELL BIOL, V1, P183, DOI 10.1038/11103; Zygmunt PM, 1999, NATURE, V400, P452, DOI 10.1038/22761	23	422	446	0	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 23	2003	300	5623					1284	1288		10.1126/science.1083646	http://dx.doi.org/10.1126/science.1083646			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681NN	12764195				2022-12-24	WOS:000183042400047
J	Rosenblum, A; Joseph, H; Fong, C; Kipnis, S; Cleland, C; Portenoy, RK				Rosenblum, A; Joseph, H; Fong, C; Kipnis, S; Cleland, C; Portenoy, RK			Prevalence and characteristics of chronic pain among chemically dependent patients in methadone maintenance and residential treatment facilities	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							AMBULATORY AIDS PATIENTS; OPIATE WITHDRAWAL; CANCER; MANAGEMENT; SEVERITY	Context Little is known about the prevalence and characteristics of chronic pain among patients with different types of chemical dependency. Objectives To estimate the prevalence and to examine the characteristics of chronic severe pain in chemically dependent populations receiving methadone maintenance or inpatient residential treatment. Design, Setting, and Particiloants Representative samples of 390 patients from 2 methadone maintenance treatment programs (MMTPs) and 531 patients from 13 short-term residential substance abuse treatment (inpatient) programs, all in New York State, were surveyed in late 2000 and early 2001. Main Outcome Measure Prevalence of chronic severe pain, defined as pain that persisted for more than 6 months and was of moderate to severe intensity or that significantly interfered with daily activities. Results Chronic severe pain was experienced by 37% of MMTP patients (95% confidence. interval [CI], 32%-41%) and 24% of inpatients (95% CI, 20%-28%; P=.03). Pain of any type or duration during the past week was reported by 80% of MMTP patients and 78% of inpatients. Among those with chronic severe pain, 65% of MMTP patients and 48% of inpatients reported high levels of pain-related interference in physical and psychosocial functioning. Among MMTP patients, correlates of chronic pain in a multivariate model were age (odds ratio [OR], 2.08; 95% CI, 1.17-3.70), chronic illness (OR, 1.88; 95% CI, 1.07-3.29), lifetime psychiatric illness (OR, 1.77; 95% CI, 1.06-2.97), psychiatric distress (OR, 1.63; 95% CI, 1.22-2.18), and time in treatment (OR, 2.23; 95% CI, 1.06-4.68). Among inpatients, the correlates of chronic pain were race (blacks vs whites: OR, 0.52; 95% CI, 0.31-6.90; Hispanics vs whites: OR, 0.48; 95% CI, 0.24-0.95), drug craving (OR, 2.78; 95% CI, 1.54-5.02), chronic illness (OR, 2.17; 95% CI, 1.37-3.43), and psychiatric distress (OR, 1.36; 95% CI, 1.03-1.81). Among those with chronic severe pain, inpatients were significantly more likely than MMTP patients to have used illicit drugs, as well as alcohol, to treat their pain complaint (51% vs 34%, P=.005) but were less likely to have been prescribed pain medications (52% vs 67%, P=.01). Conclusions Chronic severe pain is prevalent among patients in substance abuse treatment, especially MMTP patients. Pain is associated with functional impairment and correlates of pain vary with the population. Self-medication for pain with psychoactive drugs appears especially problematic among substance users who enroll in drug-free treatment programs. Substance abuse treatment programs need to develop comprehensive and structured pain management programs.	Natl Dev & Res Inst Inc, Inst Treatment & Serv Res, New York, NY 10010 USA; New York State Off Alcoholism & Subst Abuse Serv, New York, NY USA; New York State Off Alcoholism & Subst Abuse Serv, Albany, NY USA; Beth Israel Med Ctr, Dept Pain Med & Palliat Care, New York, NY 10003 USA	National Development & Research Institutes, Inc; Harvard University; Beth Israel Deaconess Medical Center	Rosenblum, A (corresponding author), Natl Dev & Res Inst Inc, Inst Treatment & Serv Res, 71 W 23rd St,8th Floor, New York, NY 10010 USA.			Cleland, Charles/0000-0002-6931-9904	NATIONAL INSTITUTE ON DRUG ABUSE [P30DA011041] Funding Source: NIH RePORTER; NIDA NIH HHS [P30DA11041] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		Breitbart W, 1996, PAIN, V68, P315, DOI 10.1016/S0304-3959(96)03215-0; Breitbart W, 1996, PAIN, V65, P243, DOI 10.1016/0304-3959(95)00217-0; Cleeland C. S., 1994, Annals Academy of Medicine Singapore, V23, P129; CLEELAND CS, 1994, NEW ENGL J MED, V330, P592, DOI 10.1056/NEJM199403033300902; COMPTON MA, 1994, J PAIN SYMPTOM MANAG, V9, P462, DOI 10.1016/0885-3924(94)90203-8; Compton P, 2001, DRUG ALCOHOL DEPEN, V63, P139, DOI 10.1016/S0376-8716(00)00200-3; Derogatis LR., 1983, SCL 90 R ADM SCORING; FARRELL M, 1994, ADDICTION, V89, P1471, DOI 10.1111/j.1360-0443.1994.tb03745.x; FAUCETT J, 1994, J PAIN SYMPTOM MANAG, V9, P383, DOI 10.1016/0885-3924(94)90175-9; Ford B.L., 1983, INCOMPLETE DATA SAMP, P185; Galea S, 2002, NEW ENGL J MED, V346, P982, DOI 10.1056/NEJMsa013404; Gureje O, 1998, JAMA-J AM MED ASSOC, V280, P147, DOI 10.1001/jama.280.2.147; HANDELSMAN L, 1987, AM J DRUG ALCOHOL AB, V13, P293, DOI 10.3109/00952998709001515; Hosmer DW, 1980, COMMUNICATIONS STA A, V10, P1043; Ihaka R., 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Jamison RN, 2000, J PAIN SYMPTOM MANAG, V19, P53, DOI 10.1016/S0885-3924(99)00144-X; Jordan MS, 1998, ARTHRIT CARE RES, V11, P80, DOI 10.1002/art.1790110203; MacLeod DB, 1996, AM J EMERG MED, V14, P323, DOI 10.1016/S0735-6757(96)90187-4; *OFF ALC SUBST AB, 1998, EXPL STUD PHEN STREE; PANKRATZ L, 1989, DRUG ALCOHOL DEPEN, V24, P115, DOI 10.1016/0376-8716(89)90073-2; PORTENOY RK, 1994, CANCER-AM CANCER SOC, V74, P907, DOI 10.1002/1097-0142(19940801)74:3<907::AID-CNCR2820740318>3.0.CO;2-#; PORTENOY RK, 1992, CANCER-AM CANCER SOC, V70, P1616, DOI 10.1002/1097-0142(19920915)70:6<1616::AID-CNCR2820700630>3.0.CO;2-7; Portenoy RK, 1997, JAMA-J AM MED ASSOC, V278, P592, DOI 10.1001/jama.278.7.592; PORTENOY RK, 1997, SUBSTANCE ABUSE COMP, P563; RETTIG RA, 1995, FED REG METHADONE TR; Rosen CS, 2000, ASSESSMENT, V7, P103, DOI 10.1177/107319110000700201; Sande IG, 1983, INCOMPLETE DATA SAMP, V3, P334; Savage SR, 1996, J PAIN SYMPTOM MANAG, V11, P274, DOI 10.1016/0885-3924(95)00202-2; Scimeca MM, 2000, MT SINAI J MED, V67, P412; SERLIN RC, 1995, PAIN, V61, P277, DOI 10.1016/0304-3959(94)00178-H; Verhaak PFM, 1998, PAIN, V77, P231, DOI 10.1016/S0304-3959(98)00117-1; Von Korff M, 2001, HDB PAIN ASSESSMENT, P603	32	353	357	0	20	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 14	2003	289	18					2370	2378		10.1001/jama.289.18.2370	http://dx.doi.org/10.1001/jama.289.18.2370			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	677WF	12746360	Bronze			2022-12-24	WOS:000182831200026
J	Hawton, K; Simkin, S; Deeks, J				Hawton, K; Simkin, S; Deeks, J			Co-proxamol and suicide: a study of national mortality statistics and local non-fatal self poisonings	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PARACETAMOL; PREVENTION	Objectives To examine the incidence of suicides due to co-proxamol compared with tricyclic antidepressants and paracetamol, and to compare fatality rates for self poisonings with these drugs. Design Analysis of routinely collected national and local data on suicides and self poisonings. Setting Records of suicides in England and Wales 1997-9; non-fatal self poisonings in Oxford District 1997-9. Data sources Office for National Statistics and Oxford monitoring system for attempted suicide. Main outcome measures Incidence of suicides with co-proxamol or tricyclic antidepressants or paracetamol. Ratios of fatal to non-fatal self poisonings. Results Co-proxamol alone accounted for 5% of all suicides. Of 4162 drug related suicides, 18% (766) involved co-proxamol alone, 22% (927) tricyclic antidepressants alone, and 9% (368) paracetamol alone. A higher proportion of suicides in the 10-24 yearn age group were due to co-proxamol than in the other age groups. The odds of dying after overdose with co-proxamol was 2.3 times (95% confidence interval 2.1 to 2.5) that for tricyclic antidepressants and 28.1 times (24.9 to 32.9) that for paracetamol. Conclusions Self poisoning with co-proxamol is particularly dangerous and contributes substantially to drug related suicides. Restricting availability of co-proxamol could have an important role in suicide prevention.	Univ Oxford, Warneford Hosp, Dept Psychiat, Ctr Suicide Res, Oxford OX3 7JX, England; Inst Hlth Sci, Ctr Stat Med, Oxford OX3 7LF, England	University of Oxford; University of Oxford	Hawton, K (corresponding author), Univ Oxford, Warneford Hosp, Dept Psychiat, Ctr Suicide Res, Oxford OX3 7JX, England.	keith.hawton@psych.ox.ac.uk	Deeks, Jon/AAV-5745-2020	Deeks, Jon/0000-0002-8850-1971				Bialas MC, 1996, QJM-INT J MED, V89, P893; *COMM SAF MED, 1985, CURR PROBL, V14; Department of Health, 2002, NAT SUIC PREV STRAT; Dollery C., 1999, THERAPEUTIC DRUGS; Fishbain D A, 1999, Semin Clin Neuropsychiatry, V4, P221; Haigh S, 1996, LANCET, V347, P1840, DOI 10.1016/S0140-6736(96)91665-7; HAWTON K, 1995, BRIT MED J, V310, P164, DOI 10.1136/bmj.310.6973.164; Hawton K, 2001, BMJ-BRIT MED J, V322, P1203, DOI 10.1136/bmj.322.7296.1203; Hawton K, 1997, BRIT J PSYCHIAT, V171, P556, DOI 10.1192/bjp.171.6.556; Malmberg A, 1999, BRIT J PSYCHIAT, V175, P103, DOI 10.1192/bjp.175.2.103; OLIVER RG, 1972, MED J AUSTRALIA, V2, P919, DOI 10.5694/j.1326-5377.1972.tb103635.x; PENTTINEN J, 1995, AM J PUBLIC HEALTH, V85, P1452, DOI 10.2105/AJPH.85.10.1452-a; Po ALW, 1997, BRIT MED J, V315, P1565, DOI 10.1136/bmj.315.7122.1565; SELLAR C, 1990, J EPIDEMIOL COMMUN H, V44, P313, DOI 10.1136/jech.44.4.313; Sykes JV, 1996, LANCET, V348, P408, DOI 10.1016/S0140-6736(05)65028-3; Taylor SJ, 1997, ACTA PSYCHIAT SCAND, V95, P457, DOI 10.1111/j.1600-0447.1997.tb10132.x; YOUNG RJ, 1980, BRIT MED J, V280, P1045, DOI 10.1136/bmj.280.6220.1045	17	49	51	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 10	2003	326	7397					1006	1008		10.1136/bmj.326.7397.1006	http://dx.doi.org/10.1136/bmj.326.7397.1006			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	679KG	12742920	Green Published, Bronze			2022-12-24	WOS:000182920500014
J	Davidson, DW; Cook, SC; Snelling, RR; Chua, TH				Davidson, DW; Cook, SC; Snelling, RR; Chua, TH			Explaining the abundance of ants in lowland tropical rainforest canopies	SCIENCE			English	Article							CANDIDATUS-BLOCHMANNIA; SYMBIOTIC BACTERIA; NITROGEN ISOTOPES; ENDOSYMBIONTS; APHIDS	The extraordinary abundance of ants in tropical rainforest canopies has led to speculation that numerous arboreal ant taxa feed principally as "herbivores" of plant and insect exudates. Based on nitrogen (N) isotope ratios of plants, known herbivores, arthropod predators, and ants from Amazonia and Borneo, we find that many arboreal ant species obtain little N through predation and scavenging. Microsymbionts of ants and their hemipteran trophobionts might play key roles in the nutrition of taxa specializing on N-poor exudates. For plants, the combined costs of biotic defenses and herbivory by ants and tended Hemiptera are substantial, and forest losses to insect herbivores vastly exceed current estimates.	Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; Nat Hist Museum Los Angeles, Entomol Sect, Los Angeles, CA 90007 USA; Univ Brunei Darussalam, Dept Biol, Bandar Seri Begawan, Brunei	Utah System of Higher Education; University of Utah; University Brunei Darussalam	Davidson, DW (corresponding author), Univ Utah, Dept Biol, 257 South,1400 East, Salt Lake City, UT 84112 USA.		Chua, Tock H./E-4157-2012	Chua, Tock H./0000-0002-8984-8723				BAKER HG, 1978, BOT GAZ, V139, P322, DOI 10.1086/337008; Bluthgen N, 2002, J ANIM ECOL, V71, P793, DOI 10.1046/j.1365-2656.2002.00647.x; BUCKLEY RC, 1987, ANNU REV ECOL SYST, V18, P111, DOI 10.1146/annurev.es.18.110187.000551; CAETANO F H, 1985, Naturalia (Rio Claro), V10, P37; CAETANO FH, 1994, LES INSECTES SOCIAUX, P391; Davidson D. W., 1996, NEOTROPICAL BIODIVER, P127; Davidson Diane W., 1993, Journal of Hymenoptera Research, V2, P13; Davidson DW, 1997, BIOL J LINN SOC, V61, P153, DOI 10.1006/bijl.1996.0128; Davidson DW, 1998, ECOL ENTOMOL, V23, P484, DOI 10.1046/j.1365-2311.1998.00145.x; DAVIDSON DW, UNPUB; Dejean A, 2000, SOCIOBIOLOGY, V35, P403; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; Douglas AE, 1998, ANNU REV ENTOMOL, V43, P17, DOI 10.1146/annurev.ento.43.1.17; Febvay G, 1999, J EXP BIOL, V202, P2639; Floren A, 2002, OECOLOGIA, V131, P137, DOI 10.1007/s00442-002-0874-z; FOLGARAIT PJ, 1995, OECOLOGIA, V104, P189, DOI 10.1007/BF00328584; Heil M, 1998, FUNCT ECOL, V12, P117, DOI 10.1046/j.1365-2435.1998.00158.x; Holldobler B., 1990, pi; Leigh Egbert G. Jr., 1996, P111; MACKO SA, 1986, GEOCHIM COSMOCHIM AC, V50, P2143, DOI 10.1016/0016-7037(86)90068-2; Moran NA, 2003, ENVIRON MICROBIOL, V5, P116, DOI 10.1046/j.1462-2920.2003.00391.x; Nakabachi A, 1997, INSECT BIOCHEM MOLEC, V27, P1057, DOI 10.1016/S0965-1748(97)00092-1; Sandstrom JP, 2001, PHYSIOL ENTOMOL, V26, P202, DOI 10.1046/j.0307-6962.2001.00235.x; Sauer C, 2000, INT J SYST EVOL MICR, V50, P1877, DOI 10.1099/00207713-50-5-1877; SCHUPP EW, 1991, ANT - PLANT INTERACTIONS, P175; Thao ML, 1998, CURR MICROBIOL, V36, P238, DOI 10.1007/s002849900301; Tobin John E., 1995, P129; Tobin John E., 1994, P279; van Borm S, 2002, P ROY SOC B-BIOL SCI, V269, P2023, DOI 10.1098/rspb.2002.2101; von Dohlen CD, 2001, NATURE, V412, P433, DOI 10.1038/35086563; Wernegreen JJ, 2002, MICROBIOL-SGM, V148, P2551, DOI 10.1099/00221287-148-8-2551; WHEELER GC, MEMOIRS ENTOMOLOGICA, V7; Wilkinson TL, 2001, J EXP BIOL, V204, P3027; Yoneyama T, 1997, NEW PHYTOL, V137, P205, DOI 10.1046/j.1469-8137.1997.00809.x	34	487	509	1	130	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 9	2003	300	5621					969	972		10.1126/science.1082074	http://dx.doi.org/10.1126/science.1082074			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675WD	12738862				2022-12-24	WOS:000182719800054
J	Garlaschelli, D; Caldarelli, G; Pietronero, L				Garlaschelli, D; Caldarelli, G; Pietronero, L			Universal scaling relations in food webs	NATURE			English	Article							COMPLEX NETWORKS; CONNECTANCE; PATTERNS; SIZE	The structure of ecological communities is usually represented by food webs(1-3). In these webs, we describe species by means of vertices connected by links representing the predations. We can therefore study different webs by considering the shape (topology) of these networks(4,5). Comparing food webs by searching for regularities is of fundamental importance, because universal patterns would reveal common principles underlying the organization of different ecosystems. However, features observed in small food webs(1-3,6) are different from those found in large ones(7-15). Furthermore, food webs (except in isolated cases(16,17)) do not share(18,19) general features with other types of network (including the Internet, the World Wide Web and biological webs). These features are a small-world character(4,5) and a scale-free (power-law) distribution of the degree(4,5) (the number of links per vertex). Here we propose to describe food webs as transportation networks(20) by extending to them the concept of allometric scaling(20-22) (how branching properties change with network size). We then decompose food webs in spanning trees and loop-forming links. We show that, whereas the number of loops varies significantly across real webs, spanning trees are characterized by universal scaling relations.	Univ Roma La Sapienza, INFM, UdR Roma 1, I-00185 Rome, Italy; Univ Roma La Sapienza, Dipartimento Fis, I-00185 Rome, Italy; Univ Siena, INFM, UdR Siena, I-53100 Siena, Italy; Univ Siena, Dipartimento Fis, I-53100 Siena, Italy; CNR, Ist Acust OM Corbino, I-00133 Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale per la Fisica della Materia (INFM-CNR); Sapienza University Rome; Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale per la Fisica della Materia (INFM-CNR); University of Siena; University of Siena; Consiglio Nazionale delle Ricerche (CNR)	Caldarelli, G (corresponding author), Univ Roma La Sapienza, INFM, UdR Roma 1, Piazzale Aldo Moro 5, I-00185 Rome, Italy.		Pietronero, Luciano/O-4473-2018; Garlaschelli, Diego/P-2795-2019; Caldarelli, Guido/A-5274-2010; Garlaschelli, Diego/O-4862-2014	Pietronero, Luciano/0000-0001-6424-8863; Caldarelli, Guido/0000-0001-9377-3616; Garlaschelli, Diego/0000-0001-6035-1783				Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Banavar JR, 1999, NATURE, V399, P130, DOI 10.1038/20144; Caldarelli G, 1998, J THEOR BIOL, V193, P345, DOI 10.1006/jtbi.1998.0706; Camacho J, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.228102; Christian RR, 1999, ECOL MODEL, V117, P99, DOI 10.1016/S0304-3800(99)00022-8; Cohen J.E., 1989, ECOLOGISTS COOPERATI; Cohen JE, 1990, COMMUNITY FOOD WEBS; COUSINS SH, 1991, TRENDS ECOL EVOL, V6, P190, DOI 10.1016/0169-5347(91)90212-G; Drossel B, 2001, J THEOR BIOL, V208, P91, DOI 10.1006/jtbi.2000.2203; Dunne JA, 2002, P NATL ACAD SCI USA, V99, P12917, DOI 10.1073/pnas.192407699; Dunne JA, 2002, ECOL LETT, V5, P558, DOI 10.1046/j.1461-0248.2002.00354.x; GOLDWASSER L, 1993, ECOLOGY, V74, P1216, DOI 10.2307/1940492; HALL SJ, 1991, J ANIM ECOL, V60, P823, DOI 10.2307/5416; Huxham M, 1996, OIKOS, V76, P284, DOI 10.2307/3546201; Lawton J.H., 1989, P43; MARTINEZ ND, 1991, ECOL MONOGR, V61, P367, DOI 10.2307/2937047; Martinez ND, 1999, ECOLOGY, V80, P1044, DOI 10.1890/0012-9658(1999)080[1044:EOSEOC]2.0.CO;2; MARTINEZ ND, 1992, AM NAT, V139, P1208, DOI 10.1086/285382; McMahon T.A., 1983, SIZE LIFE; Memmott J, 2000, J ANIM ECOL, V69, P1, DOI 10.1046/j.1365-2656.2000.00367.x; Montoya JM, 2002, J THEOR BIOL, V214, P405, DOI 10.1006/jtbi.2001.2460; Pimm S.L, 1982, FOOD WEBS; POLIS GA, 1991, AM NAT, V138, P123, DOI 10.1086/285208; RODRIGUEZITURBE.I, 1996, FRACTAL RIVER BASINS; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; WARREN PH, 1989, OIKOS, V55, P299, DOI 10.2307/3565588; West GB, 1999, SCIENCE, V284, P1677, DOI 10.1126/science.284.5420.1677; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122; Williams RJ, 2002, P NATL ACAD SCI USA, V99, P12913, DOI 10.1073/pnas.192448799; Williams RJ, 2000, NATURE, V404, P180, DOI 10.1038/35004572	30	207	214	0	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 8	2003	423	6936					165	168		10.1038/nature01604	http://dx.doi.org/10.1038/nature01604			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675MR	12736684				2022-12-24	WOS:000182699600045
J	Heo, WD; Meyer, T				Heo, WD; Meyer, T			Switch-of-function mutants based on morphology classification of Ras superfamily small GTPases	CELL			English	Article							GTP-BINDING PROTEINS; ACTIN CYTOSKELETON; RHO-GTPASE; FAMILY; DOMAIN; PATHWAYS; CDC42; ACTIVATION; COMPLEX; MEMBER	Signaling proteins from the same family can have markedly different roles in a given cellular context. Here, we show that expression of one hundred constitutively active human small GTPases induced cell morphologies that fell into nine distinct classes. We developed an algorithm for pairs of classes that predicted amino acid positions that can be exchanged to create mutants with switched functionality. The algorithm was validated by creating switch-of-function mutants for Rac1, CDC42, H-Ras, RalA, Rap2B, and R-Ras3. Contrary to expectations, the relevant residues were mostly outside known interaction surfaces and were structurally far apart from each other. Our study shows that specificity in protein families can be explored by combining genome-wide experimental functional classification with the creation of switch-of-function mutants.	Stanford Univ, Dept Mol Pharmacol, Sch Med, Stanford, CA 94305 USA	Stanford University	Meyer, T (corresponding author), Stanford Univ, Dept Mol Pharmacol, Sch Med, 269 Campus Dr,Room 3215, Stanford, CA 94305 USA.	tobias1@stanford.edu	Heo, Won-Do/C-1696-2011	Meyer, Tobias/0000-0003-4339-3804				Abdul-Manan N, 1999, NATURE, V399, P379, DOI 10.1038/20726; Bar-Sagi D, 2000, CELL, V103, P227, DOI 10.1016/S0092-8674(00)00115-X; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; CASARI G, 1995, NAT STRUCT BIOL, V2, P171, DOI 10.1038/nsb0295-171; Cherfils J, 1999, TRENDS BIOCHEM SCI, V24, P306, DOI 10.1016/S0968-0004(99)01429-2; Choy E, 1999, CELL, V98, P69, DOI 10.1016/S0092-8674(00)80607-8; COHEN L, 1994, P NATL ACAD SCI USA, V91, P12448, DOI 10.1073/pnas.91.26.12448; Fenwick C, 2000, SCIENCE, V287, P869, DOI 10.1126/science.287.5454.869; Finlin BS, 2000, BIOCHEM J, V347, P223, DOI 10.1042/0264-6021:3470223; Foster R, 1996, MOL CELL BIOL, V16, P2689; Gao Y, 2001, J BIOL CHEM, V276, P47530, DOI 10.1074/jbc.M108865200; Guasch RM, 1998, MOL CELL BIOL, V18, P4761, DOI 10.1128/MCB.18.8.4761; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hernandez-Alcoceba R, 2000, CELL MOL LIFE SCI, V57, P65, DOI 10.1007/s000180050499; KAZIRO Y, 1991, ANNU REV BIOCHEM, V60, P349, DOI 10.1146/annurev.bi.60.070191.002025; Krzanowski W. J., 1988, PRINCIPLES MULTIVARI; Lichtarge O, 1996, J MOL BIOL, V257, P342, DOI 10.1006/jmbi.1996.0167; Lichtarge O, 1996, P NATL ACAD SCI USA, V93, P7507, DOI 10.1073/pnas.93.15.7507; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Mackay DJG, 1998, J BIOL CHEM, V273, P20685, DOI 10.1074/jbc.273.33.20685; Morreale A, 2000, NAT STRUCT BIOL, V7, P384; Mott HR, 1999, NATURE, V399, P384, DOI 10.1038/20732; Nobes CD, 1998, J CELL BIOL, V141, P187, DOI 10.1083/jcb.141.1.187; PETERS PJ, 1995, J CELL BIOL, V128, P1003, DOI 10.1083/jcb.128.6.1003; REN MD, 1993, J CELL BIOL, V120, P313, DOI 10.1083/jcb.120.2.313; RIDLEY AJ, 1994, EMBO J, V13, P2600, DOI 10.1002/j.1460-2075.1994.tb06550.x; Ridley AJ, 2001, TRENDS CELL BIOL, V11, P471, DOI 10.1016/S0962-8924(01)02153-5; Roux P, 1997, CURR BIOL, V7, P629, DOI 10.1016/S0960-9822(06)00289-2; SERAFINI T, 1991, CELL, V67, P239, DOI 10.1016/0092-8674(91)90176-Y; Sowa ME, 2001, NAT STRUCT BIOL, V8, P234, DOI 10.1038/84974; Suel GM, 2003, NAT STRUCT BIOL, V10, P59, DOI 10.1038/nsb881; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Tanabe K, 2000, J NEUROSCI, V20, P4138; Vojtek AB, 1998, J BIOL CHEM, V273, P19925, DOI 10.1074/jbc.273.32.19925; Weiner OD, 2002, CURR OPIN CELL BIOL, V14, P196, DOI 10.1016/S0955-0674(02)00310-1; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	37	84	85	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 2	2003	113	3					315	328						14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	674MP	12732140				2022-12-24	WOS:000182640800007
J	Kasahara, T; Kato, T				Kasahara, T; Kato, T			A new redox-cofactor vitamin for mammals	NATURE			English	Article							PYRROLOQUINOLINE QUINONE; ALPHA-AMINOADIPATE; LYSINE; BIOSYNTHESIS		RIKEN, Brain Sci Inst, Lab Mol Dynam Mental Disorders, Wako, Saitama 3510198, Japan	RIKEN	Kasahara, T (corresponding author), RIKEN, Brain Sci Inst, Lab Mol Dynam Mental Disorders, Wako, Saitama 3510198, Japan.		Kato, Tadafumi/J-3583-2014; Kasahara, Takaoki/AAJ-5367-2020	Kato, Tadafumi/0000-0001-7856-3952; Kasahara, Takaoki/0000-0002-0953-5146				BHATTACHARJEE JK, 1985, CRC CR REV MICROBIOL, V12, P131, DOI 10.3109/10408418509104427; Ehmann DE, 1999, BIOCHEMISTRY-US, V38, P6171, DOI 10.1021/bi9829940; FLUCKIGER R, 1988, BIOCHEM BIOPH RES CO, V153, P353, DOI 10.1016/S0006-291X(88)81230-0; HIGASHINO K, 1971, ARCH BIOCHEM BIOPHYS, V142, P606, DOI 10.1016/0003-9861(71)90525-X; KILLGORE J, 1989, SCIENCE, V245, P850, DOI 10.1126/science.2549636; KUMAZAWA T, 1992, BIOCHIM BIOPHYS ACTA, V1156, P62, DOI 10.1016/0304-4165(92)90096-D; MATHEWS FS, 1995, METHOD ENZYMOL, V258, P191; Praphanphoj V, 2001, MOL GENET METAB, V72, P336, DOI 10.1006/mgme.2000.3138; SALISBURY SA, 1979, NATURE, V280, P843, DOI 10.1038/280843a0; STEINBERG FM, 1994, J NUTR, V124, P744, DOI 10.1093/jn/124.5.744	10	157	188	2	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 24	2003	422	6934					832	832		10.1038/422832a	http://dx.doi.org/10.1038/422832a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670WR	12712191				2022-12-24	WOS:000182432600039
J	Imai, Y; Parodo, J; Kajikawa, O; de Perrot, M; Fischer, S; Edwards, V; Cutz, E; Liu, MY; Keshavjee, S; Martin, TR; Marshall, JC; Ranieri, VM; Slutsky, AS				Imai, Y; Parodo, J; Kajikawa, O; de Perrot, M; Fischer, S; Edwards, V; Cutz, E; Liu, MY; Keshavjee, S; Martin, TR; Marshall, JC; Ranieri, VM; Slutsky, AS			Injurious mechanical ventilation and end-organ epithelial cell apoptosis and organ dysfunction in an experimental model of acute respiratory distress syndrome	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RENAL TUBULAR CELLS; INDUCED LUNG INJURY; SOLUBLE FAS-LIGAND; DEATH; FAILURE; SEPSIS; EXPRESSION; INDUCTION; CYTOKINES; ISCHEMIA	Context Recent clinical trials have demonstrated a decrease in multiple organ dysfunction syndrome (MODS) and mortality in patients with acute respiratory distress syndrome (ARDS) treated with a protective ventilatory strategy. Objective To examine the hypothesis that an injurious ventilatory strategy may lead to end-organ epithelial cell apoptosis and organ dysfunction. Design and Setting In vivo animals: 24 rabbits with acid-aspiration lung injury were ventilated with injurious or noninjurious ventilatory strategies. In vitro:,rabbit epithelial cells were exposed to plasma from in vivo rabbit studies. In vivo human: plasma samples from patients included in a previous randomized controlled trial examining a lung protective strategy were analyzed (lung protection group, n=9 and controls, n=11). Main Outcome Measures In vivo animals: biochemical markers of liver and renal dysfunction; apoptosis in end organs. In vitro: induction of apoptosis in LLC-RK1 renal tubular epithelial cells. In vivo human: correlation of plasma creatinine and soluble Fas ligand. Results The injurious ventilatory strategy led to increased rates of epithelial cell apoptosis in the kidney (mean [SE]: injurious, 10.9% [0.88%]; noninjurious, 1.86% [0.17%]; P<001) and small intestine villi (injurious, 6.7% [0.66%]; noninjurious, 0.97% [0.14%]; P<001), and led to the elevation of biochemical markers indicating renal dysfunction in vivo. Induction of apoptosis was increased in LLC-RK1 cells incubated with plasma from rabbits ventilated with injurious ventilatory strategy at 4 hours (P=.03) and 8 hours (P=.002). The Fas:Ig, a fusion protein that blocks soluble Fas ligand, attenuated induction of apoptosis in vitro. There was a significant correlation between changes in soluble Fas ligand and changes in creatinine in patients with ARDS (R=0.64, P=.002). Conclusions Mechanical ventilation can lead to epithelial cell apoptosis in the kidney and small intestine, Accompanied by biochemical evidence of organ dysfunction. This may partially explain the high rate of MODS observed in patients with ARDS and the decrease in morbidity and mortality in patients treated with a lung protective strategy.	Univ Toronto, St Michaels Hosp, Dept Crit Care, Toronto, ON M5B 1W8, Canada; Univ Hlth Network, Res Lab, Toronto, ON, Canada; Seattle Vet Adm Med Ctr, Seattle, WA USA; Hosp Sick Children, Res Inst, Dept Pediat Lab Med, Toronto, ON M5G 1X8, Canada; Univ Turin, Osped S Giovanni Battista, Sez Anestesiol & Rianimaz, Dipartimento Discipline Medicochirurg Div, Turin, Italy	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette; University of Turin	Slutsky, AS (corresponding author), Univ Toronto, St Michaels Hosp, Dept Crit Care, 30 Bond St,Queen Wing,Room 4-042, Toronto, ON M5B 1W8, Canada.	arthur.slutsky@utoronto.ca	Ranieri, Marco/AFX-8152-2022; Imai, Yumiko/GXW-1144-2022; Slutsky, Arthur/M-3325-2019; Slutsky, Arthur S/A-6013-2008	Slutsky, Arthur S/0000-0002-6063-3876; de Perrot, Marc/0000-0003-2000-9427; Liu, Mingyao/0000-0002-9188-8417; Keshavjee, Shaf/0000-0003-4547-8094				Amato MBP, 1998, NEW ENGL J MED, V338, P347, DOI 10.1056/NEJM199802053380602; [Anonymous], 1999, INTENS CARE MED, V25, P1444; BALK RA, 1995, JAMA-J AM MED ASSOC, V274, P127, DOI 10.1001/jama.1995.03530020045021; Belperio JA, 2002, J CLIN INVEST, V110, P1703, DOI 10.1172/JCI200215849; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; CARRICO CJ, 1986, ARCH SURG-CHICAGO, V121, P196; Coopersmith CM, 2002, JAMA-J AM MED ASSOC, V287, P1716, DOI 10.1001/jama.287.13.1716; Daemen MARC, 2001, TRANSPLANTATION, V71, P1007; de Perrot M, 2002, J THORAC CARDIOV SUR, V124, P1137, DOI 10.1067/mtc.2002.125056; Dreyfuss D, 1998, AM J RESP CRIT CARE, V157, P294, DOI 10.1164/ajrccm.157.1.9604014; Esteban A, 2002, JAMA-J AM MED ASSOC, V287, P345, DOI 10.1001/jama.287.3.345; Ferreira FL, 2001, JAMA-J AM MED ASSOC, V286, P1754, DOI 10.1001/jama.286.14.1754; Fink M P, 2000, Minerva Anestesiol, V66, P337; Fischer S, 2000, ANN SURG, V231, P424, DOI 10.1097/00000658-200003000-00016; Fry DE, 2000, AM SURGEON, V66, P126; Hashimoto S, 2000, AM J RESP CRIT CARE, V161, P237, DOI 10.1164/ajrccm.161.1.9810007; Healy E, 1998, KIDNEY INT, V54, P1955, DOI 10.1046/j.1523-1755.1998.00202.x; Hetts SW, 1998, JAMA-J AM MED ASSOC, V279, P300, DOI 10.1001/jama.279.4.300; Hiramatsu M, 1997, SHOCK, V7, P247, DOI 10.1097/00024382-199704000-00002; Hotchkiss RS, 2000, CRIT CARE MED, V28, P3207, DOI 10.1097/00003246-200009000-00016; Hotchkiss RS, 1999, CRIT CARE MED, V27, P1230, DOI 10.1097/00003246-199907000-00002; Hotchkiss RS, 1997, CRIT CARE MED, V25, P1298, DOI 10.1097/00003246-199708000-00015; Hudson LD, 1999, JAMA-J AM MED ASSOC, V282, P77, DOI 10.1001/jama.282.1.77; Imai Y, 2001, J APPL PHYSIOL, V91, P1836, DOI 10.1152/jappl.2001.91.4.1836; Iwama H, 2000, AM J EMERG MED, V18, P348, DOI 10.1016/S0735-6757(00)90141-4; Kajikawa O, 1997, J IMMUNOL METHODS, V205, P135, DOI 10.1016/S0022-1759(97)00066-5; Kajikawa O, 1996, J IMMUNOL METHODS, V197, P19, DOI 10.1016/0022-1759(96)00101-9; Koide N, 1996, FEMS IMMUNOL MED MIC, V16, P205, DOI 10.1111/j.1574-695X.1996.tb00137.x; Krammer P H, 1999, Adv Immunol, V71, P163; LeGall JR, 1996, JAMA-J AM MED ASSOC, V276, P802, DOI 10.1001/jama.276.10.802; MARSHALL JC, 1995, CRIT CARE MED, V23, P1638, DOI 10.1097/00003246-199510000-00007; Matute-Bello G, 1999, J IMMUNOL, V163, P2217; Matute-Bello G, 2001, AM J PHYSIOL-LUNG C, V281, pL328, DOI 10.1152/ajplung.2001.281.2.L328; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; OrtizArduan A, 1996, AM J PHYSIOL-RENAL, V271, pF1193; Papathanassoglou EDE, 2000, CRIT CARE MED, V28, P537, DOI 10.1097/00003246-200002000-00042; Perianayagam MC, 2000, J LAB CLIN MED, V136, P320, DOI 10.1067/mlc.2000.109318; Rana A, 2001, APOPTOSIS, V6, P83, DOI 10.1023/A:1009680229931; Ranieri VM, 2000, JAMA-J AM MED ASSOC, V284, P43, DOI 10.1001/jama.284.1.43; Ranieri VM, 1999, JAMA-J AM MED ASSOC, V282, P54, DOI 10.1001/jama.282.1.54; SCHUMER M, 1992, AM J PATHOL, V140, P831; Slutsky AS, 1998, AM J RESP CRIT CARE, V157, P1721, DOI 10.1164/ajrccm.157.6.9709092; Tesch GH, 1999, J CLIN INVEST, V103, P73, DOI 10.1172/JCI4876; Tremblay L, 1997, J CLIN INVEST, V99, P944, DOI 10.1172/JCI119259; Tremblay LN, 1998, P ASSOC AM PHYSICIAN, V110, P482; Ueda N, 1998, KIDNEY INT, V54, P399, DOI 10.1046/j.1523-1755.1998.00008.x; WARDLE EN, 1994, NEPHROL DIAL TRANSPL, V9, P104; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Watson RWG, 1997, J IMMUNOL, V158, P945; Wyncoll DLA, 1999, LANCET, V354, P497, DOI 10.1016/S0140-6736(98)08129-X	51	446	488	2	25	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 23	2003	289	16					2104	2112		10.1001/jama.289.16.2104	http://dx.doi.org/10.1001/jama.289.16.2104			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	669WW	12709468	Bronze			2022-12-24	WOS:000182374300026
J	Ayad, NG; Rankin, S; Murakami, M; Jebanathirajah, J; Gygi, S; Kirschner, MW				Ayad, NG; Rankin, S; Murakami, M; Jebanathirajah, J; Gygi, S; Kirschner, MW			Tome-1, a trigger of mitotic entry, is degraded during G1 via the APC	CELL			English	Article							SISTER-CHROMATID SEPARATION; ANAPHASE-PROMOTING COMPLEX; CELL-CYCLE; SUBSTRATE RECOGNITION; MITOSIS; KINASE; CDH1; DEGRADATION; PROTEOLYSIS; INHIBITOR	Entry into mitosis requires the activation of cdk1/ cyclin B, while mitotic exit is achieved when the same kinase activity decreases, as cyclin B is degraded. Cyclin B proteolysis is mediated by the anaphase promoting complex, or APC, an E3 ligase that is active at anaphase in mitosis through G1. We have identified a G1 substrate of the APC that we have termed Tome-1, for trigger of mitotic entry. Tome-1 is a cytosolic protein required for proper activation of cdk1/cyclin B and mitotic entry. Tome-1 associates with Skp-1 and is required for degradation of the cdk1 inhibitory tyrosine kinase wee1; Tome-1 therefore appears to be acting as part of an SCF-type E3 for wee1. Degradation of Tome-1 during G1 allows for wee 1 accumulation during interphase, thereby providing a critical link between the APC and SCF pathways in regulation of cclk1/cyclin B activity and thus mitotic entry and exit.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Taplin Biol Mass Spectrometry Facil, Boston, MA 02115 USA; NCI, Frederick, MD 21702 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Kirschner, MW (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, 200 Longwood Ave, Boston, MA 02115 USA.			Rankin, Susannah/0000-0002-4056-6610	NHGRI NIH HHS [HG00041] Funding Source: Medline	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		CohenFix O, 1996, GENE DEV, V10, P3081, DOI 10.1101/gad.10.24.3081; Fang CH, 1998, INT J MOL MED, V1, P163; Funabiki H, 2000, CELL, V102, P411, DOI 10.1016/S0092-8674(00)00047-7; GAUTIER J, 1991, CELL, V67, P197, DOI 10.1016/0092-8674(91)90583-K; HEALD R, 1993, CELL, V74, P463, DOI 10.1016/0092-8674(93)80048-J; Kawasaki H, 2001, EMBO J, V20, P4618, DOI 10.1093/emboj/20.16.4618; KING RW, 1995, CELL, V81, P279, DOI 10.1016/0092-8674(95)90338-0; King RW, 1996, SCIENCE, V274, P1652, DOI 10.1126/science.274.5293.1652; Kotani S, 1999, J CELL BIOL, V146, P791, DOI 10.1083/jcb.146.4.791; Kramer ER, 2000, MOL BIOL CELL, V11, P1555, DOI 10.1091/mbc.11.5.1555; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Lorca T, 1998, EMBO J, V17, P3565, DOI 10.1093/emboj/17.13.3565; Lustig KD, 1997, METHOD ENZYMOL, V283, P83; McGarry TJ, 1998, CELL, V93, P1043, DOI 10.1016/S0092-8674(00)81209-X; Michael WM, 1998, SCIENCE, V282, P1886, DOI 10.1126/science.282.5395.1886; MUELLER PR, 1995, MOL BIOL CELL, V6, P119, DOI 10.1091/mbc.6.1.119; MURRAY AW, 1991, METHOD CELL BIOL, V36, P581; Peters JM, 1998, CURR OPIN CELL BIOL, V10, P759, DOI 10.1016/S0955-0674(98)80119-1; Peters JM, 1999, EXP CELL RES, V248, P339, DOI 10.1006/excr.1999.4443; Pfleger CM, 2000, GENE DEV, V14, P655; Pfleger CM, 2001, GENE DEV, V15, P2396, DOI 10.1101/gad.918201; RUSSELL P, 1987, CELL, V49, P559, DOI 10.1016/0092-8674(87)90458-2; Schlosser A, 2001, ANAL CHEM, V73, P170, DOI 10.1021/ac000826j; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; SOLOMON MJ, 1991, COLD SH Q B, V56, P427; Stemmann O, 2001, CELL, V107, P715, DOI 10.1016/S0092-8674(01)00603-1; Visintin R, 1997, SCIENCE, V278, P460, DOI 10.1126/science.278.5337.460; WATANABE N, 1995, EMBO J, V14, P1878, DOI 10.1002/j.1460-2075.1995.tb07180.x; Winston JT, 1999, GENE DEV, V13, P270, DOI 10.1101/gad.13.3.270; Winston JT, 1999, CURR BIOL, V9, P1180, DOI 10.1016/S0960-9822(00)80021-4; Zhou PB, 1998, MOL CELL, V2, P571, DOI 10.1016/S1097-2765(00)80156-2; Zou H, 1999, SCIENCE, V285, P418, DOI 10.1126/science.285.5426.418	32	141	150	0	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 4	2003	113	1					101	113		10.1016/S0092-8674(03)00232-0	http://dx.doi.org/10.1016/S0092-8674(03)00232-0			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	668GX	12679038	Bronze			2022-12-24	WOS:000182282900010
J	Lyon, BE				Lyon, BE			Egg recognition and counting reduce costs of avian conspecific brood parasitism	NATURE			English	Article							NEST PARASITISM; CUCULUS-CANORUS; CLUTCH SIZE; DISCRIMINATION; COEVOLUTION; CUCKOO; COOTS; MODEL	Birds parasitized by interspecific brood parasites often adopt defences based on egg recognition but such behaviours are puzzlingly rare in species parasitized by members of the same species. Here I show that conspecific egg recognition is frequent, accurate and used in three defences that reduce the high costs of conspecific brood parasitism in American coots. Hosts recognized and rejected many parasitic eggs, reducing the fitness costs of parasitism by half. Recognition without rejection also occurred and some hosts banished parasitic eggs to inferior outer incubation positions. Clutch size comparisons revealed that females combine egg recognition and counting to make clutch size decisions - by counting their own eggs, while ignoring distinctive parasitic eggs, females avoid a maladaptive clutch size reduction. This is clear evidence that female birds use visual rather than tactile cues to regulate their clutch sizes, and provides a rare example of the ecological and evolutionary context of counting in animals.	Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz	Lyon, BE (corresponding author), Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA.	lyon@biology.ucsc.edu	Lyon, Bruce E/E-8491-2011					ANDERSSON M, 1982, AM NAT, V120, P1, DOI 10.1086/283965; Andersson M., 1984, ANIM BEHAV, V33, P1394; ARNOLD TW, 1987, CONDOR, V89, P675, DOI 10.2307/1368662; BERTRAM BCR, 1992, OSTRICH COMMUNAL NES, P109; BROOKE MD, 1988, NATURE, V335, P630; Davies N.B., 2000, CUCKOOS COWBIRDS OTH; Davies NB, 1996, P ROY SOC B-BIOL SCI, V263, P925, DOI 10.1098/rspb.1996.0137; DAVIES NB, 1989, J ANIM ECOL, V58, P225, DOI 10.2307/4996; Eadie J, 1998, BEHAVIORAL ECOLOGY AND CONSERVATION BIOLOGY, P306; GALLISTEL CR, 1988, BEHAV BRAIN SCI, V11, P585, DOI 10.1017/S0140525X00053504; Hauser MD, 2000, AM SCI, V88, P144, DOI 10.1511/2000.19.863; HAYWOOD S, 1993, Q REV BIOL, V68, P33, DOI 10.1086/417910; Jackson WM, 1998, OX ORN SER, V9, P407; Jamieson IG, 2000, AUK, V117, P250, DOI 10.1642/0004-8038(2000)117[0250:HROCBP]2.0.CO;2; KEMAL RE, 1988, ANIM BEHAV, V36, P175, DOI 10.1016/S0003-3472(88)80261-6; LYON BE, 1993, ANIM BEHAV, V46, P911, DOI 10.1006/anbe.1993.1273; Lyon BE, 2002, EVOLUTION, V56, P1253, DOI 10.1111/j.0014-3820.2002.tb01436.x; LYON BE, 1993, BEHAV ECOL SOCIOBIOL, V33, P87; Lyon BE, 1998, NATURE, V392, P380, DOI 10.1038/32878; LYON BE, 1992, ECOLOGY EVOLUTION CO; ROHWER FC, 1989, CAN J ZOOL, V67, P239, DOI 10.1139/z89-035; ROTHSTEIN SI, 1982, AM ZOOL, V22, P547; ROTHSTEIN SI, 1990, ANNU REV ECOL SYST, V21, P481, DOI 10.1146/annurev.es.21.110190.002405; SEIBT U, 1988, BEHAV BRAIN SCI, V11, P597, DOI 10.1017/S0140525X00053644; Sherman Paul W., 1997, P69; Shettleworth, 2010, COGNITION EVOLUTION	26	197	203	1	98	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 3	2003	422	6931					495	499		10.1038/nature01505	http://dx.doi.org/10.1038/nature01505			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	662TW	12673243				2022-12-24	WOS:000181965400030
J	Riley, S; Fraser, C; Donnelly, CA; Ghani, AC; Abu-Raddad, LJ; Hedley, AJ; Leung, GM; Ho, LM; Lam, TH; Thach, TQ; Chau, P; Chan, KP; Leung, PY; Tsang, T; Ho, W; Lee, KH; Lau, EMC; Ferguson, NM; Anderson, RM				Riley, S; Fraser, C; Donnelly, CA; Ghani, AC; Abu-Raddad, LJ; Hedley, AJ; Leung, GM; Ho, LM; Lam, TH; Thach, TQ; Chau, P; Chan, KP; Leung, PY; Tsang, T; Ho, W; Lee, KH; Lau, EMC; Ferguson, NM; Anderson, RM			Transmission dynamics of the etiological agent of SARS in Hong Kong: Impact of public health interventions	SCIENCE			English	Article							ACUTE RESPIRATORY SYNDROME; CORONAVIRUS	We present an analysis of the first 10 weeks of the severe acute respiratory syndrome (SARS) epidemic in Hong Kong. The epidemic to date has been characterized by two large clusters - initiated by two separate "super-spread" events (SSEs) - and by ongoing community transmission. By fitting a stochastic model to data on 1512 cases, including these clusters, we show that the etiological agent of SARS is moderately transmissible. Excluding SSEs, we estimate that 2.7 secondary infections were generated per case on average at the start of the epidemic, with a substantial contribution from hospital transmission. Transmission rates fell during the epidemic, primarily as a result of reductions in population contact rates and improved hospital infection control, but also because of more rapid hospital attendance by symptomatic individuals. As a result, the epidemic is now in decline, although continued vigilance is necessary for this to be maintained. Restrictions on longer range population movement are shown to be a potentially useful additional control measure in some contexts. We estimate that most currently infected persons are now hospitalized, which highlights the importance of control of nosocomial transmission.	Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Infect Dis Epidemiol, London SW7 2AZ, England; Univ Hong Kong, Dept Community Med, Pokfulam, Hong Kong, Peoples R China; Govt Hong Kong Special Adm Reg, Hlth Welf & Food Bur, Res Off, Hong Kong, Hong Kong, Peoples R China; Govt Hong Kong Special Adm Reg, Dept Hlth, Wanchai, Hong Kong, Peoples R China; Hong Kong Hosp Author, Kowloon, Hong Kong, Peoples R China; Chinese Univ Hong Kong, Sch Publ Hlth, Prince Wales Hosp, Dept Community & Family Med, Shatin, Hong Kong, Peoples R China	Imperial College London; University of Hong Kong; Chinese University of Hong Kong; Prince of Wales Hospital	Riley, S (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Infect Dis Epidemiol, Exhibit Rd, London SW7 2AZ, England.	s.riley@imperial.ac.uk	Leung, Gabriel Matthew/C-4336-2009; Ferguson, Neil/B-8578-2008; Ghani, Azra/B-8560-2009; Thach, Thuan-Quoc/C-4416-2009; Hedley, Anthony/C-4305-2009; Chan, King Pan/C-4523-2009; Abu-Raddad, Laith J/AAY-1441-2020; Fraser, Christophe/A-8109-2008; Hedley, Anthony J/A-9113-2013; Lam, Tai Hing/C-4317-2009	Ferguson, Neil/0000-0002-1154-8093; Thach, Thuan-Quoc/0000-0003-3404-3888; Abu-Raddad, Laith J/0000-0003-0790-0506; Fraser, Christophe/0000-0003-2399-9657; ho, lm/0000-0002-2709-927X; Donnelly, Christl/0000-0002-0195-2463; Anderson, Roy/0000-0002-9528-3175; Leung, Gabriel/0000-0002-2503-6283; Lam, Tai Hing/0000-0002-2033-9971; Riley, Steven/0000-0001-7904-4804; Ghani, Azra/0000-0002-0007-4910				ANDERSON R M, 1991; DIEKMANN O, 2002, MATH EPIDEMIOLOGY IN; DONNELLY CA, 2003, LANCET          0507; Ferguson NM, 2003, J ANTIMICROB CHEMOTH, V51, P977, DOI 10.1093/jac/dkg136; *HONG KONG DEP HLT, 2003, OUTBR SEV AC RESP SY; *HONG KONG POL DEC, UNPUB SEL DAIL REP S; Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781; Lee N, 2003, NEW ENGL J MED, V348, P1986, DOI 10.1056/NEJMoa030685; Marra MA, 2003, SCIENCE, V300, P1399, DOI 10.1126/science.1085953; Peiris JSM, 2003, LANCET, V361, P1319, DOI 10.1016/S0140-6736(03)13077-2; PEIRIS JSM, 2003, LANCET          0509; Poutanen SM, 2003, NEW ENGL J MED, V348, P1995, DOI 10.1056/NEJMoa030634	12	741	804	12	116	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 20	2003	300	5627					1961	1966		10.1126/science.1086478	http://dx.doi.org/10.1126/science.1086478			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691RN	12766206				2022-12-24	WOS:000183619400052
J	Amieva, MR; Vogelmann, R; Covacci, A; Tompkins, LS; Nelson, WJ; Falkow, S				Amieva, MR; Vogelmann, R; Covacci, A; Tompkins, LS; Nelson, WJ; Falkow, S			Disruption of the epithelial apical-junctional complex by Helicobacter pylori CagA	SCIENCE			English	Article							TYROSINE PHOSPHORYLATION; PATHOGENICITY ISLAND; IN-VIVO; CELLS; PROTEIN; TRANSLOCATION; PHOSPHATASE; INFECTION; INDUCTION; STRAINS	Helicobacter pylori translocates the protein CagA into gastric epithelial cells and has been linked to peptic ulcer disease and gastric carcinoma. We show that injected CagA associates with the epithelial tight-junction scaffolding protein ZO-1 and the transmembrane protein junctional adhesion molecule, causing an ectopic assembly of tight-junction components at sites of bacterial attachment, and altering the composition and function of the apical-junctional complex. Long-term CagA delivery to polarized epithelia caused a disruption of the epithelial barrier function and dysplastic alterations in epithelial cell morphology. CagA appears to target H. pylori to host cell intercellular junctions and to disrupt junction-mediated functions.	Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; Ist Ric Immunobiol Siena Chiron Vaccines, I-53100 Siena, Italy	Stanford University; Stanford University; Stanford University; Stanford University; Novartis	Amieva, MR (corresponding author), Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA.		Amieva, Manuel/U-2581-2017	Amieva, Manuel/0000-0002-5601-4490	NCI NIH HHS [CA92229, R01 CA092229] Funding Source: Medline; NIAID NIH HHS [AI38459, R01 AI038459] Funding Source: Medline; NIDCD NIH HHS [DDC DK56339] Funding Source: Medline; NIDDK NIH HHS [P30 DK056339] Funding Source: Medline; NIGMS NIH HHS [R01GM35227, R01 GM035527] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA092229] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI038459] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056339] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035527] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMIEVA MR, UNPUB; Bilder D, 2000, SCIENCE, V289, P113, DOI 10.1126/science.289.5476.113; BLASER MJ, 1995, CANCER RES, V55, P2111; Censini S, 1996, P NATL ACAD SCI USA, V93, P14648, DOI 10.1073/pnas.93.25.14648; Collares-Buzato CB, 1998, EUR J CELL BIOL, V76, P85, DOI 10.1016/S0171-9335(98)80020-4; Fischer W, 2001, MOL MICROBIOL, V42, P1337, DOI 10.1046/j.1365-2958.2001.02714.x; Guillemin K, 2002, P NATL ACAD SCI USA, V99, P15136, DOI 10.1073/pnas.182558799; HAZELL SL, 1986, J INFECT DIS, V153, P658, DOI 10.1093/infdis/153.4.658; Higashi H, 2002, SCIENCE, V295, P683, DOI 10.1126/science.1067147; Jamora C, 2002, NAT CELL BIOL, V4, pE101, DOI 10.1038/ncb0402-e101; Knust E, 2002, SCIENCE, V298, P1955, DOI 10.1126/science.1072161; Mimuro H, 2002, MOL CELL, V10, P745, DOI 10.1016/S1097-2765(02)00681-0; Nunbhakdi-Craig V, 2002, J CELL BIOL, V158, P967, DOI 10.1083/jcb.200206114; Odenbreit S, 2000, SCIENCE, V287, P1497, DOI 10.1126/science.287.5457.1497; Papini E, 1998, J CLIN INVEST, V102, P813, DOI 10.1172/JCI2764; Peek RM, 1995, LAB INVEST, V73, P760; Segal ED, 1999, P NATL ACAD SCI USA, V96, P14559, DOI 10.1073/pnas.96.25.14559; Selbach M, 2002, J BIOL CHEM, V277, P6775, DOI 10.1074/jbc.C100754200; STEER HW, 1984, GUT, V25, P1203, DOI 10.1136/gut.25.11.1203; Stein M, 2000, P NATL ACAD SCI USA, V97, P1263, DOI 10.1073/pnas.97.3.1263; Stein M, 2002, MOL MICROBIOL, V43, P971, DOI 10.1046/j.1365-2958.2002.02781.x; Yeaman C, 2001, J CELL BIOL, V155, P593, DOI 10.1083/jcb.200107088	22	569	598	2	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 30	2003	300	5624					1430	1434		10.1126/science.1081919	http://dx.doi.org/10.1126/science.1081919			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	683ZW	12775840	Green Accepted			2022-12-24	WOS:000183181800045
J	Ohashi, Y; Oka, A; Rodrigues-Pousada, R; Possenti, M; Ruberti, I; Morelli, G; Aoyama, T				Ohashi, Y; Oka, A; Rodrigues-Pousada, R; Possenti, M; Ruberti, I; Morelli, G; Aoyama, T			Modulation of phospholipid signaling by GLABRA2 in root-hair pattern formation	SCIENCE			English	Article							CELL-DIFFERENTIATION; TRANSGENIC PLANTS; ARABIDOPSIS ROOT; GENE-EXPRESSION; EPIDERMIS; PROTEIN; FAMILY	The root-hair pattern of Arabidopsis is determined through a regulatory circuit composed of transcription factor genes. The homeobox gene GLABRA2 (GL2) has been considered a key component, acting farthest downstream in this regulation. GL2 modified to include a transactivating function caused epidermal cells to develop ectopic root hairs or root hair-like structures. With this system, the phospholipase Dzeta1 gene (AtPLDzeta1) was identified as a direct target of GL2. Inducible expression of AtPLDzeta1 promoted ectopic root-hair initiation. We conclude that GL2 exerts its regulatory effect on root-hair development through modulation of phospholipid signaling.	Kyoto Univ, Inst Chem Res, Kyoto 6110011, Japan; Ist Nazl Ric Alimenti & Nutr, I-00178 Rome, Italy; Univ Roma La Sapienza, Dipartimento Genet & Biol Mol, Ctr Studio Acidi Nucl, I-00185 Rome, Italy	Kyoto University; Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA); Sapienza University Rome	Aoyama, T (corresponding author), Kyoto Univ, Inst Chem Res, Kyoto 6110011, Japan.		Morelli, Giorgio/A-5559-2016; Morelli, Giorgio/P-3334-2019; Ohashi, Yohei/AAT-4006-2021	Morelli, Giorgio/0000-0002-8994-4838; Morelli, Giorgio/0000-0002-8994-4838; Ohashi, Yohei/0000-0002-2288-130X; RODRIGUES POUSADA, Renato Alberto/0000-0003-2551-4705; Possenti, Marco/0000-0001-6707-3245				Abe M, 2001, PLANT J, V26, P487, DOI 10.1046/j.1365-313x.2001.01047.x; Aoyama T, 1997, PLANT J, V11, P605, DOI 10.1046/j.1365-313X.1997.11030605.x; Cho HT, 2002, PLANT CELL, V14, P3237, DOI 10.1105/tpc.006437; Cockcroft S, 2001, CELL MOL LIFE SCI, V58, P1674, DOI 10.1007/PL00000805; Di Cristina M, 1996, PLANT J, V10, P393, DOI 10.1046/j.1365-313X.1996.10030393.x; DOLAN L, 1994, DEVELOPMENT, V120, P2465; Dolan L, 2001, CURR OPIN PLANT BIOL, V4, P550, DOI 10.1016/S1369-5266(00)00214-4; GALWAY ME, 1994, DEV BIOL, V166, P740, DOI 10.1006/dbio.1994.1352; Hung CY, 1998, PLANT PHYSIOL, V117, P73, DOI 10.1104/pp.117.1.73; Lee MM, 1999, CELL, V99, P473, DOI 10.1016/S0092-8674(00)81536-6; Lee MM, 2002, PLANT CELL, V14, P611, DOI 10.1105/tpc.010434; Liscovitch M, 2000, BIOCHEM J, V345, P401, DOI 10.1042/0264-6021:3450401; Masucci JD, 1996, DEVELOPMENT, V122, P1253; Qin CB, 2002, PLANT PHYSIOL, V128, P1057, DOI 10.1104/pp.010928; RERIE WG, 1994, GENE DEV, V8, P1388, DOI 10.1101/gad.8.12.1388; RODRIGUESPOUSAD.R, UNPUB; Schiefelbein JW, 2000, PLANT PHYSIOL, V124, P1525, DOI 10.1104/pp.124.4.1525; Wada T, 1997, SCIENCE, V277, P1113, DOI 10.1126/science.277.5329.1113; Wang XM, 2000, PROG LIPID RES, V39, P109, DOI 10.1016/S0163-7827(00)00002-3; Zuo JR, 2000, PLANT J, V24, P265, DOI 10.1046/j.1365-313x.2000.00868.x	20	211	235	3	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 30	2003	300	5624					1427	1430		10.1126/science.1083695	http://dx.doi.org/10.1126/science.1083695			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	683ZW	12775839				2022-12-24	WOS:000183181800044
J	Rota, PA; Oberste, MS; Monroe, SS; Nix, WA; Campagnoli, R; Icenogle, JP; Penaranda, S; Bankamp, B; Maher, K; Chen, MH; Tong, SX; Tamin, A; Lowe, L; Frace, M; DeRisi, JL; Chen, Q; Wang, D; Erdman, DD; Peret, TCT; Burns, C; Ksiazek, TG; Rollin, PE; Sanchez, A; Liffick, S; Holloway, B; Limor, J; McCaustland, K; Olsen-Rasmussen, M; Fouchier, R; Gunther, S; Osterhaus, ADME; Drosten, C; Pallansch, MA; Anderson, LJ; Bellini, WJ				Rota, PA; Oberste, MS; Monroe, SS; Nix, WA; Campagnoli, R; Icenogle, JP; Penaranda, S; Bankamp, B; Maher, K; Chen, MH; Tong, SX; Tamin, A; Lowe, L; Frace, M; DeRisi, JL; Chen, Q; Wang, D; Erdman, DD; Peret, TCT; Burns, C; Ksiazek, TG; Rollin, PE; Sanchez, A; Liffick, S; Holloway, B; Limor, J; McCaustland, K; Olsen-Rasmussen, M; Fouchier, R; Gunther, S; Osterhaus, ADME; Drosten, C; Pallansch, MA; Anderson, LJ; Bellini, WJ			Characterization of a novel coronavirus associated with severe acute respiratory syndrome	SCIENCE			English	Article							TRANSMISSIBLE GASTROENTERITIS CORONAVIRUS; TARGETED RECOMBINATION; SPIKE GENE; VIRUS; DETERMINANT; ENTRY	In March 2003, a novel coronavirus (SARS-CoV) was discovered in association with cases of severe acute respiratory syndrome (SARS). The sequence of the complete genome of SARS-CoV was determined, and the initial characterization of the viral genome is presented in this report. The genome of SARS-CoV is 29,727 nucleotides in length and has 11 open reading frames, and its genome organization is similar to that of other coronaviruses. Phylogenetic analyses and sequence comparisons showed that SARS-CoV is not closely related to any of the previously characterized coronaviruses.	Ctr Dis Control, Natl Ctr Infect Dis, Atlanta, GA 30333 USA; Univ Calif San Francisco, Dept Biochem, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biophys, San Francisco, CA 94143 USA; Erasmus Univ, Dept Virol, NL-3000 DR Rotterdam, Netherlands; Bernhard Nocht Inst Trop Med, Dept Virol, D-20359 Hamburg, Germany	Centers for Disease Control & Prevention - USA; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Erasmus University Rotterdam; Bernhard Nocht Institut fur Tropenmedizin	Rota, PA (corresponding author), Ctr Dis Control, Natl Ctr Infect Dis, Atlanta, GA 30333 USA.	prota@cdc.gov	Fouchier, Ron A/A-1911-2014	Fouchier, Ron A/0000-0001-8095-2869; Rollin, Pierre/0000-0002-4608-2641; Campagnoli, Ray/0000-0003-0531-3893; Gunther, Stephan/0000-0002-6562-0230; Monroe, Stephan/0000-0002-5424-716X; Osterhaus, Albert/0000-0002-6074-1172; Guan, Yi/0000-0001-6057-9243				Centers for Disease Control and Prevention (CDC), 2003, MMWR-MORBID MORTAL W, V52, P357; de Haan CAM, 2002, VIRUS RES, V82, P77; de Haan CAM, 1998, J VIROL, V72, P6838, DOI 10.1128/JVI.72.8.6838-6850.1998; DROSTEN C, 2003, N ENGL J MED    0417; Escors D, 2001, J VIROL, V75, P1312, DOI 10.1128/JVI.75.3.1312-1324.2001; Fauquet C.M., 2000, VIRUS TAXONOMY CLASS, P835; Garoff H, 1998, MICROBIOL MOL BIOL R, V62, P1171, DOI 10.1128/MMBR.62.4.1171-1190.1998; HOLMES KV, 2001, FIELDS VIROLOGY, pCH36; Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781; LAI MMC, 2001, FIELDS VIROLOGY, pCH35; LEE N, 2003, N ENGL J MED    0417; Leparc-Goffart I, 1998, J VIROL, V72, P9628, DOI 10.1128/JVI.72.12.9628-9636.1998; LIU DX, 1992, J VIROL, V66, P6143, DOI 10.1128/JVI.66.10.6143-6154.1992; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Marra MA, 2003, SCIENCE, V300, P1399, DOI 10.1126/science.1085953; Peiris JSM, 2003, LANCET, V361, P1319, DOI 10.1016/S0140-6736(03)13077-2; POUTANEN SM, 2003, N ENGL J MED    0417; Sanchez CM, 1999, J VIROL, V73, P7607; Sawicki SG, 1998, ADV EXP MED BIOL, V440, P215; Siddell S, 1995, CORONAVIRIDAE; THIEL V, 1994, J GEN VIROL, V75, P3041, DOI 10.1099/0022-1317-75-11-3041; TSANG KW, 2003, N ENGL J MED    0417; Ziebuhr J, 2000, J GEN VIROL, V81, P853, DOI 10.1099/0022-1317-81-4-853	23	1876	2203	4	297	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 30	2003	300	5624					1394	1399		10.1126/science.1085952	http://dx.doi.org/10.1126/science.1085952			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	683ZW	12730500				2022-12-24	WOS:000183181800035
J	Zavialov, AV; Berglund, J; Pudney, AF; Fooks, LJ; Ibrahim, TM; MacIntyre, S; Knight, SD				Zavialov, AV; Berglund, J; Pudney, AF; Fooks, LJ; Ibrahim, TM; MacIntyre, S; Knight, SD			Structure and biogenesis of the capsular F1 antigen from Yersinia pestis: Preserved folding energy drives fiber formation	CELL			English	Article							PILUS BIOGENESIS; MACROMOLECULAR STRUCTURES; CHAPERONE FUNCTION; ESCHERICHIA-COLI; CAF1M; CRYSTALLOGRAPHY; REFINEMENT; PROTEINS; SURFACE; BINDING	Most gram-negative pathogens express fibrous adhesive virulence organelles that mediate targeting to the sites of infection. The F1 capsular antigen from the plague pathogen Yersinia pestis consists of linear fibers of a single subunit (Caf1) and serves as a prototype for nonpilus organelles assembled via the chaperone/usher pathway. Genetic data together with high-resolution X-ray structures corresponding to snapshots of the assembly process reveal the structural basis of fiber formation. Comparison of chaperone bound Caf1 subunit with the subunit in the fiber reveals a novel type of conformational change involving the entire hydrophobic core of the protein. The observed conformational change suggests that the chaperone traps a high-energy folding intermediate of Caf1. A model is proposed in which release of the subunit allows folding to be completed, driving fiber formation.	Univ Reading, Sch Anim & Microbial Sci, Div Microbiol, Reading RG6 6AJ, Berks, England; Swedish Univ Agr Sci, Uppsala Biomed Ctr, Dept Mol Biosci Struct Biol, SE-75124 Uppsala, Sweden	University of Reading; Swedish University of Agricultural Sciences	MacIntyre, S (corresponding author), Univ Reading, Sch Anim & Microbial Sci, Div Microbiol, Reading RG6 6AJ, Berks, England.		Zavialov, Anton V./C-7664-2015; Knight, Stefan/D-4315-2015	Zavialov, Anton V./0000-0001-6191-5931; Knight, Stefan/0000-0002-7180-8758				Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; *CCP4, 1994, ACTA CRYSTALLOGR D, V50, P780; Chapman DAG, 1999, J BACTERIOL, V181, P2422, DOI 10.1128/JB.181.8.2422-2429.1999; Choudhury D, 1999, SCIENCE, V285, P1061, DOI 10.1126/science.285.5430.1061; Du YD, 2002, INFECT IMMUN, V70, P1453, DOI 10.1128/IAI.70.3.1453-1460.2002; ESHDAT Y, 1981, J BACTERIOL, V148, P308, DOI 10.1128/JB.148.1.308-314.1981; Galimand M, 1997, NEW ENGL J MED, V337, P677, DOI 10.1056/NEJM199709043371004; Hung DL, 1996, EMBO J, V15, P3792, DOI 10.1002/j.1460-2075.1996.tb00753.x; JACOBDUBUISSON F, 1994, J BIOL CHEM, V269, P12447; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Keeling MJ, 2000, NATURE, V407, P903, DOI 10.1038/35038073; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; Knight SD, 2000, CURR OPIN CHEM BIOL, V4, P653, DOI 10.1016/S1367-5931(00)00144-7; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lamzin VS, 1997, METHOD ENZYMOL, V277, P269, DOI 10.1016/S0076-6879(97)77016-2; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; MacIntyre S, 2001, MOL MICROBIOL, V39, P12, DOI 10.1046/j.1365-2958.2001.02199.x; MILLER S, 1987, J MOL BIOL, V196, P641, DOI 10.1016/0022-2836(87)90038-6; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NICHOLLS A, 1993, GRASP GRAPHICAL REPR; Saibil H, 2000, CURR OPIN STRUC BIOL, V10, P251, DOI 10.1016/S0959-440X(00)00074-9; Sauer FG, 2002, CELL, V111, P543, DOI 10.1016/S0092-8674(02)01050-4; Sauer FG, 1999, SCIENCE, V285, P1058, DOI 10.1126/science.285.5430.1058; Soto GE, 1998, EMBO J, V17, P6155, DOI 10.1093/emboj/17.21.6155; Thanassi DG, 1998, CURR OPIN MICROBIOL, V1, P223, DOI 10.1016/S1369-5274(98)80015-5; Thanassi DG, 2002, J BACTERIOL, V184, P6260, DOI 10.1128/JB.184.22.6260-6269.2002; Titball RW, 2001, VACCINE, V19, P4175, DOI 10.1016/S0264-410X(01)00163-3; Vetsch M, 2002, J MOL BIOL, V322, P827, DOI 10.1016/S0022-2836(02)00845-8; Xu JA, 1998, PROTEIN SCI, V7, P158, DOI 10.1002/pro.5560070117; Zavialov A, 2003, ACTA CRYSTALLOGR D, V59, P359, DOI 10.1107/S0907444902021054; Zavialov AV, 2002, MOL MICROBIOL, V45, P983, DOI 10.1046/j.1365-2958.2002.03066.x; ZavYalov VP, 1997, BIOCHEM J, V324, P571, DOI 10.1042/bj3240571	33	213	229	0	17	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 30	2003	113	5					587	596		10.1016/S0092-8674(03)00351-9	http://dx.doi.org/10.1016/S0092-8674(03)00351-9			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	687VL	12787500	Bronze			2022-12-24	WOS:000183397600009
J	Puigserver, P; Rhee, J; Donovan, J; Walkey, CJ; Yoon, JC; Oriente, F; Kitamura, Y; Altomonte, J; Dong, HJ; Accili, D; Spiegelman, BM				Puigserver, P; Rhee, J; Donovan, J; Walkey, CJ; Yoon, JC; Oriente, F; Kitamura, Y; Altomonte, J; Dong, HJ; Accili, D; Spiegelman, BM			Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1 alpha interaction	NATURE			English	Article							FORKHEAD TRANSCRIPTION FACTOR; CARBOXYKINASE GTP GENE; PROTEIN-KINASE-B; PHOSPHOENOLPYRUVATE CARBOXYKINASE; COACTIVATOR PGC-1; FACTOR FOXO1; FACTOR FKHR; EXPRESSION; BETA; PHOSPHORYLATION	Hepatic gluconeogenesis is absolutely required for survival during prolonged fasting or starvation, but is inappropriately activated in diabetes mellitus. Glucocorticoids and glucagon have strong gluconeogenic actions on the liver. In contrast, insulin suppresses hepatic gluconeogenesis(1-3). Two components known to have important physiological roles in this process are the forkhead transcription factor FOXO1 (also known as FKHR) and peroxisome proliferative activated receptor-gamma co-activator 1 (PGC-1alpha; also known as PPARGC1), a transcriptional co-activator; whether and how these factors collaborate has not been clear. Using wild-type and mutant alleles of FOXO1, here we show that PGC-1alpha binds and co-activates FOXO1 in a manner inhibited by Akt-mediated phosphorylation. Furthermore, FOXO1 function is required for the robust activation of gluconeogenic gene expression in hepatic cells and in mouse liver by PGC-1alpha. Insulin suppresses gluconeogenesis stimulated by PGC-1alpha but co-expression of a mutant allele of FOXO1 insensitive to insulin completely reverses this suppression in hepatocytes or transgenic mice. We conclude that FOXO1 and PGC-1alpha interact in the execution of a programme of powerful, insulin-regulated gluconeogenesis.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Columbia Univ, Coll Phys & Surg, Naomi Berrie Diabet Ctr, New York, NY 10032 USA; Columbia Univ, Coll Phys & Surg, Dept Med, New York, NY 10032 USA; Mt Sinai Sch Med, Inst Human Gene Therapy & Mol Med, New York, NY 10029 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Columbia University; Columbia University; Icahn School of Medicine at Mount Sinai	Spiegelman, BM (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, 44 Binney St, Boston, MA 02115 USA.		Rhee, James/V-9973-2019; ORIENTE, Francesco/J-6652-2018	ORIENTE, Francesco/0000-0003-4375-4526; Dong, H. Henry/0000-0003-0279-5241; Altomonte, Jennifer/0000-0003-1079-3633				Arizmendi C, 1999, J BIOL CHEM, V274, P13033, DOI 10.1074/jbc.274.19.13033; Becard D, 2001, DIABETES, V50, P2425, DOI 10.2337/diabetes.50.11.2425; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; DARLINGTON GJ, 1995, CURR OPIN GENET DEV, V5, P565, DOI 10.1016/0959-437X(95)80024-7; Durham SK, 1999, ENDOCRINOLOGY, V140, P3140, DOI 10.1210/en.140.7.3140; Hall RK, 2000, J BIOL CHEM, V275, P30169, DOI 10.1074/jbc.M004898200; Hall Robert K., 1999, Journal of Basic and Clinical Physiology and Pharmacology, V10, P119; Hanson RW, 1997, ANNU REV BIOCHEM, V66, P581, DOI 10.1146/annurev.biochem.66.1.581; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Knutti D, 2000, MOL CELL BIOL, V20, P2411, DOI 10.1128/MCB.20.7.2411-2422.2000; Nakae J, 1999, J BIOL CHEM, V274, P15982, DOI 10.1074/jbc.274.23.15982; Nakae J, 2001, J CLIN INVEST, V108, P1359, DOI 10.1172/JCI200112876; Nakae J, 2003, DEV CELL, V4, P119, DOI 10.1016/S1534-5807(02)00401-X; Nakai J, 2002, NAT GENET, V32, P245, DOI 10.1038/ng890; Puigserver P, 1999, SCIENCE, V286, P1368, DOI 10.1126/science.286.5443.1368; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Rena G, 1999, J BIOL CHEM, V274, P17179, DOI 10.1074/jbc.274.24.17179; Rossetti L, 1996, J BIOL CHEM, V271, P203, DOI 10.1074/jbc.271.1.203; Schmoll D, 2000, J BIOL CHEM, V275, P36324, DOI 10.1074/jbc.M003616200; UNGER RH, 1985, DIABETOLOGIA, V28, P574, DOI 10.1007/BF00281991; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Zaher H, 1998, MOL PHARMACOL, V54, P313, DOI 10.1124/mol.54.2.313	22	1106	1156	7	112	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 29	2003	423	6939					550	555		10.1038/nature01667	http://dx.doi.org/10.1038/nature01667			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	683RH	12754525	Bronze			2022-12-24	WOS:000183162900046
J	Lodowski, DT; Pitcher, JA; Capel, WD; Lefkowitz, RJ; Tesmer, JJG				Lodowski, DT; Pitcher, JA; Capel, WD; Lefkowitz, RJ; Tesmer, JJG			Keeping G proteins at bay: A complex between G protein-coupled receptor kinase 2 and G beta gamma	SCIENCE			English	Article							PLECKSTRIN HOMOLOGY DOMAIN; GTPASE-ACTIVATING PROTEINS; HETEROTRIMERIC G-PROTEINS; PHOSPHOLIPASE-C-BETA; CRYSTAL-STRUCTURE; CATALYTIC SUBUNIT; G(BETA-GAMMA) SUBUNITS; STRUCTURAL BASIS; ALPHA-SUBUNITS; BINDING	The phosphorylation of heptahelical receptors by heterotrimeric guanine nucleotide-binding protein (G protein)-coupled receptor kinases (GRKs) is a universal regulatory mechanism that leads to desensitization of G protein signaling and to the activation of alternative signaling pathways. We determined the crystallographic structure of bovine GRK2 in complex with G protein beta(1)gamma(2) subunits. Our results show how the three domains of GRK2-the RGS (regulator of G protein signaling) homology, protein kinase, and pleckstrin homology domains-integrate their respective activities and recruit the enzyme to the cell membrane in an orientation that not only facilitates receptor phosphorylation, but also allows for the simultaneous inhibition of signaling by Galpha and Gbetagamma subunits.	Univ Texas, Dept Chem & Biochem, Inst Cellular & Mol Biol, Austin, TX 78712 USA; UCL, Dept Pharmacol, MRC, Lab Mol & Cell Biol, London WC1E 6BT, England; UCL, Dept Pharmacol, Cell Biol Unit, London WC1E 6BT, England; Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA	University of Texas System; University of Texas Austin; University of London; University College London; University of London; University College London; Duke University; Duke University	Tesmer, JJG (corresponding author), Univ Texas, Dept Chem & Biochem, Inst Cellular & Mol Biol, Austin, TX 78712 USA.	tesmer@mail.utexas.edu	Pitcher, Julie/ABH-2078-2020; Lefkowitz, Robert/AAW-2649-2021	Tesmer, John/0000-0003-1125-3727	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL016037, R01HL016037] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL16037] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BENOVIC JL, 1989, SCIENCE, V246, P235, DOI 10.1126/science.2552582; BENOVIC JL, 1986, P NATL ACAD SCI USA, V83, P2797, DOI 10.1073/pnas.83.9.2797; Berman DM, 1996, CELL, V86, P445, DOI 10.1016/S0092-8674(00)80117-8; Biondi RM, 2002, EMBO J, V21, P4219, DOI 10.1093/emboj/cdf437; Carman CV, 2000, J BIOL CHEM, V275, P10443, DOI 10.1074/jbc.275.14.10443; Carman CV, 1999, J BIOL CHEM, V274, P34483, DOI 10.1074/jbc.274.48.34483; Chen Z, 2001, NAT STRUCT BIOL, V8, P805, DOI 10.1038/nsb0901-805; Chestukhin A, 1996, J BIOL CHEM, V271, P10175, DOI 10.1074/jbc.271.17.10175; Claing A, 2002, PROG NEUROBIOL, V66, P61, DOI 10.1016/S0301-0082(01)00023-5; DebBurman SK, 1996, J BIOL CHEM, V271, P22552, DOI 10.1074/jbc.271.37.22552; Ferguson KM, 2000, MOL CELL, V6, P373, DOI 10.1016/S1097-2765(00)00037-X; FERGUSON KM, 1995, CELL, V83, P1037, DOI 10.1016/0092-8674(95)90219-8; Ford CE, 1998, SCIENCE, V280, P1271, DOI 10.1126/science.280.5367.1271; Fushman D, 1998, J BIOL CHEM, V273, P2835, DOI 10.1074/jbc.273.5.2835; Gaudet R, 1996, CELL, V87, P577, DOI 10.1016/S0092-8674(00)81376-8; Gonfloni S, 1997, EMBO J, V16, P7261, DOI 10.1093/emboj/16.24.7261; Hepler JR, 1997, P NATL ACAD SCI USA, V94, P428, DOI 10.1073/pnas.94.2.428; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Iaccarino G, 1999, P ASSOC AM PHYSICIAN, V111, P399, DOI 10.1111/paa.1999.111.5.399; KNIGHTON DR, 1991, SCIENCE, V253, P414, DOI 10.1126/science.1862343; KOCH WJ, 1993, J BIOL CHEM, V268, P8256; Krupnick JG, 1998, ANNU REV PHARMACOL, V38, P289, DOI 10.1146/annurev.pharmtox.38.1.289; LaFevre-Bernt M, 1998, J BIOL CHEM, V273, P32129, DOI 10.1074/jbc.273.48.32129; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; Lemmon MA, 2001, BIOCHEM SOC T, V29, P377, DOI 10.1042/BST0290377; Li Y, 1998, J BIOL CHEM, V273, P16265, DOI 10.1074/jbc.273.26.16265; Lodowski DT, 2003, ACTA CRYSTALLOGR D, V59, P936, DOI 10.1107/S0907444903002622; Loew A, 1998, STRUCT FOLD DES, V6, P1007, DOI 10.1016/S0969-2126(98)00102-6; Longenecker KL, 2001, STRUCTURE, V9, P559, DOI 10.1016/S0969-2126(01)00620-7; MAHADEVAN D, 1995, BIOCHEMISTRY-US, V34, P9111, DOI 10.1021/bi00028a021; Narayana N, 1997, STRUCTURE, V5, P921, DOI 10.1016/S0969-2126(97)00246-3; Newton AC, 2003, BIOCHEM J, V370, P361, DOI 10.1042/BJ20021626; PAO CS, 2002, SCI STKE, pPE42; Perry SJ, 2002, TRENDS CELL BIOL, V12, P130, DOI 10.1016/S0962-8924(01)02239-5; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; PITCHER JA, 1995, J BIOL CHEM, V270, P11707, DOI 10.1074/jbc.270.20.11707; PITCHER JA, 1992, SCIENCE, V257, P1264, DOI 10.1126/science.1325672; Pitcher JA, 1998, ANNU REV BIOCHEM, V67, P653, DOI 10.1146/annurev.biochem.67.1.653; Razzini G, 2000, J BIOL CHEM, V275, P14873, DOI 10.1074/jbc.275.20.14873; Rockman HA, 2002, NATURE, V415, P206, DOI 10.1038/415206a; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; SHI W, 1995, J BIOL CHEM, V270, P2112, DOI 10.1074/jbc.270.5.2112; Shiina T, 2001, J BIOL CHEM, V276, P33019, DOI 10.1074/jbc.M100140200; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; Siderovski DP, 1996, CURR BIOL, V6, P211, DOI 10.1016/S0960-9822(02)00454-2; Smith CM, 1999, PROG BIOPHYS MOL BIO, V71, P313, DOI 10.1016/S0079-6107(98)00059-5; Sondek J, 1996, NATURE, V379, P369, DOI 10.1038/379369a0; Spink KE, 2000, EMBO J, V19, P2270, DOI 10.1093/emboj/19.10.2270; Sterne-Marr R, 2003, J BIOL CHEM, V278, P6050, DOI 10.1074/jbc.M208787200; Tesmer JJG, 1997, CELL, V89, P251, DOI 10.1016/S0092-8674(00)80204-4; Touhara K, 1997, FEBS LETT, V417, P243, DOI 10.1016/S0014-5793(97)01294-5; TOUHARA K, 1994, J BIOL CHEM, V269, P10217; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Yang J, 2002, NAT STRUCT BIOL, V9, P940, DOI 10.1038/nsb870; Yang J, 2002, MOL CELL, V9, P1227, DOI 10.1016/S1097-2765(02)00550-6; ZHENG JH, 1993, PROTEIN SCI, V2, P1559, DOI 10.1002/pro.5560021003; Zhong HL, 2001, J PHARMACOL EXP THER, V297, P837	58	308	320	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 23	2003	300	5623					1256	1262		10.1126/science.1082348	http://dx.doi.org/10.1126/science.1082348			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681NN	12764189				2022-12-24	WOS:000183042400039
J	Yaman, I; Fernandez, J; Liu, HY; Caprara, M; Komar, AA; Koromilas, AE; Zhou, LY; Snider, MD; Scheuner, D; Kaufman, RJ; Hatzoglou, M				Yaman, I; Fernandez, J; Liu, HY; Caprara, M; Komar, AA; Koromilas, AE; Zhou, LY; Snider, MD; Scheuner, D; Kaufman, RJ; Hatzoglou, M			The zipper model of translational control: A small upstream ORF is the switch that controls structural remodeling of an mRNA leader	CELL			English	Article							RIBOSOME ENTRY SITE; MEDIATED TRANSLATION; INTERNAL INITIATION; REGION; ATTENUATION; PSEUDOKNOT; IRES	Transport of the essential amino acids arginine and lysine is critical for the survival of mammalian cells. The adaptive response to nutritional stress involves increased translation of the arginine/lysine transporter (cat-1) mRNA via an internal ribosome entry site (IRES) within the mRNA leader. Induction of cat-1 IRES activity requires both translation of a small upstream open reading frame (uORF) within the IRES and phosphorylation of the translation initiation factor eIF2alpha. We show here that translation of the upstream ORF unfolds an inhibitory structure in the mRNA leader, eliciting a conformational change that yields an active IRES. The IRES, whose activity is induced by amino acid starvation, is created by RNA-RNA interactions between the 5' end of the leader and downstream sequences. This study suggests that the structure of the IRES is dynamic and regulation of this RNA structure is a mechanism of translational control.	Case Western Reserve Univ, Sch Med, Dept Nutr, Cleveland, OH 44106 USA; Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA; Case Western Reserve Univ, Sch Med, Ctr RNA Mol Biol, Cleveland, OH 44106 USA; McGill Univ, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada; Jewish Gen Hosp, Montreal, PQ H3T 1E2, Canada; Univ Michigan, Med Ctr, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Lady Davis Institute; McGill University; McGill University; Howard Hughes Medical Institute; University of Michigan System; University of Michigan	Hatzoglou, M (corresponding author), Case Western Reserve Univ, Sch Med, Dept Nutr, Cleveland, OH 44106 USA.	mxh8@po.cwru.edu	yaman, ibrahim/A-7192-2016	yaman, ibrahim/0000-0002-3987-1984; Komar, Anton/0000-0003-4188-0633	NIAID NIH HHS [AI42394] Funding Source: Medline; NIDDK NIH HHS [R01 DK60596-01] Funding Source: Medline; NIGMS NIH HHS [GM62853, GM26796] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042394] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060596] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062853, R01GM026796] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bonnal S, 2003, NUCLEIC ACIDS RES, V31, P427, DOI 10.1093/nar/gkg003; Fernandez J, 2002, J BIOL CHEM, V277, P2050, DOI 10.1074/jbc.M109199200; Fernandez J, 2001, J BIOL CHEM, V276, P12285, DOI 10.1074/jbc.M009714200; Fletcher SP, 2002, J VIROL, V76, P5024, DOI 10.1128/JVI.76.10.5024-5033.2002; Gaba A, 2001, EMBO J, V20, P6453, DOI 10.1093/emboj/20.22.6453; Garlapati S, 2002, RNA, V8, P601, DOI 10.1017/S135583820202071X; HAHN J, 1982, MOL GEN GENET, V186, P204, DOI 10.1007/BF00331851; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Hellen CUT, 2001, GENE DEV, V15, P1593, DOI 10.1101/gad.891101; Hershey JWB, 2000, COLD SPRING HARBOR M, V39, P33; Hyatt SL, 1997, J BIOL CHEM, V272, P19951, DOI 10.1074/jbc.272.32.19951; Le Quesne JPC, 2001, J MOL BIOL, V310, P111, DOI 10.1006/jmbi.2001.4745; MACEJAK DG, 1991, NATURE, V353, P90, DOI 10.1038/353090a0; Meijer HA, 2002, BIOCHEM J, V367, P1, DOI 10.1042/BJ20011706; PAIN VM, 1994, BIOCHIMIE, V76, P718, DOI 10.1016/0300-9084(94)90076-0; PELLETIER J, 1988, NATURE, V334, P320, DOI 10.1038/334320a0; Rijnbrand RCA, 1996, VIROLOGY, V226, P47, DOI 10.1006/viro.1996.0626; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Schlax PJ, 2001, J BIOL CHEM, V276, P38494, DOI 10.1074/jbc.M106934200; Schlegl J, 1997, RNA, V3, P1159; Vos S, 2002, BIOCHEMISTRY-US, V41, P5383, DOI 10.1021/bi0156310; WANG CY, 1995, RNA, V1, P526; Yanofsky C, 2000, J BACTERIOL, V182, P1, DOI 10.1128/JB.182.1.1-8.2000	23	168	178	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 16	2003	113	4					519	531		10.1016/S0092-8674(03)00345-3	http://dx.doi.org/10.1016/S0092-8674(03)00345-3			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	680MG	12757712	Bronze			2022-12-24	WOS:000182981500013
J	Bansal, D; Miyake, K; Vogel, SS; Groh, S; Chen, CC; Williamson, R; McNeil, PL; Campbell, KP				Bansal, D; Miyake, K; Vogel, SS; Groh, S; Chen, CC; Williamson, R; McNeil, PL; Campbell, KP			Defective membrane repair in dysferlin-deficient muscular dystrophy	NATURE			English	Article							MIYOSHI MYOPATHY; SKELETAL-MUSCLE; GENE; EXOCYTOSIS; EXPRESSION; COMPLEX; ACCUMULATION; DISRUPTIONS; MECHANISM; PROTEINS	Muscular dystrophy includes a diverse group of inherited muscle diseases characterized by wasting and weakness of skeletal muscle(1). Mutations in dysferlin are linked to two clinically distinct muscle diseases, limb-girdle muscular dystrophy type 2B and Miyoshi myopathy, but the mechanism that leads to muscle degeneration is unknown(2,3). Dysferlin is a homologue of the Caenorhabditis elegans fer-1 gene, which mediates vesicle fusion to the plasma membrane in spermatids(4). Here we show that dysferlin-null mice maintain a functional dystrophin glycoprotein complex but nevertheless develop a progressive muscular dystrophy. In normal muscle, membrane patches enriched in dysferlin can be detected in response to sarcolemma injuries. In contrast, there are sub-sarcolemmal accumulations of vesicles in dysferlin-null muscle. Membrane repair assays with a two-photon laser-scanning microscope demonstrated that wildtype muscle fibres efficiently reseal their sarcolemma in the presence of Ca2+. Interestingly, dysferlin-deficient muscle fibres are defective in Ca2+-dependent sarcolemma resealing. Membrane repair is therefore an active process in skeletal muscle fibres, and dysferlin has an essential role in this process. Our findings show that disruption of the muscle membrane repair machinery is responsible for dysferlin-deficient muscle degeneration, and highlight the importance of this basic cellular mechanism of membrane resealing in human disease.	Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Physiol & Biophys, Howard Hughes Med Inst, Iowa City, IA 52242 USA; Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Neurol, Iowa City, IA 52242 USA; Med Coll Georgia, Dept Cellular Biol & Anat, Augusta, GA 30912 USA; NIAAA, Lab Mol Physiol, NIH, Rockville, MD 20852 USA; Univ Iowa, Coll Med, Dept Obstet & Gynecol, Iowa City, IA 52242 USA	Howard Hughes Medical Institute; University of Iowa; University of Iowa; University System of Georgia; Augusta University; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); University of Iowa	Campbell, KP (corresponding author), Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Physiol & Biophys, Howard Hughes Med Inst, Iowa City, IA 52242 USA.	kevin-campbell@uiowa.edu	Chen, Chien-Chang/D-2023-2015; Vogel, Steven/A-3585-2012	Chen, Chien-Chang/0000-0001-8850-4278; Campbell, Kevin/0000-0003-2066-5889; Vogel, Steven/0000-0002-3005-2667	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000452, Z01AA000452] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Achanzar WE, 1997, J CELL SCI, V110, P1073; Anderson LVB, 2000, NEUROMUSCULAR DISORD, V10, P553, DOI 10.1016/S0960-8966(00)00143-7; Anderson LVB, 1999, HUM MOL GENET, V8, P855, DOI 10.1093/hmg/8.5.855; Bashir R, 1998, NAT GENET, V20, P37, DOI 10.1038/1689; Bi GQ, 1995, J CELL BIOL, V131, P1747, DOI 10.1083/jcb.131.6.1747; CLARKE MSF, 1993, J CELL SCI, V106, P121; Cohn RD, 2000, MUSCLE NERVE, V23, P1456, DOI 10.1002/1097-4598(200010)23:10<1456::AID-MUS2>3.0.CO;2-T; Coral-Vazquez R, 1999, CELL, V98, P465, DOI 10.1016/S0092-8674(00)81975-3; Davis DB, 2002, J BIOL CHEM, V277, P22883, DOI 10.1074/jbc.M201858200; Duclos F, 1998, J CELL BIOL, V142, P1461, DOI 10.1083/jcb.142.6.1461; Durbeej M, 2000, MOL CELL, V5, P141, DOI 10.1016/S1097-2765(00)80410-4; Durbeej M, 2002, CURR OPIN GENET DEV, V12, P349, DOI 10.1016/S0959-437X(02)00309-X; ERVASTI JM, 1990, NATURE, V345, P315, DOI 10.1038/345315a0; Liu J, 1998, NAT GENET, V20, P31, DOI 10.1038/1682; Matsuda C, 2001, HUM MOL GENET, V10, P1761, DOI 10.1093/hmg/10.17.1761; McNeil PL, 2000, J CELL SCI, V113, P1891; MCNEIL PL, 1992, AM J PATHOL, V140, P1097; McNeil PL, 2003, P NATL ACAD SCI USA, V100, P4592, DOI 10.1073/pnas.0736739100; McNeil PL, 2001, NAT CELL BIOL, V3, pE124, DOI 10.1038/35074652; Miner JH, 1997, J CELL BIOL, V137, P685, DOI 10.1083/jcb.137.3.685; Miyake K, 1995, J CELL BIOL, V131, P1737, DOI 10.1083/jcb.131.6.1737; OHLENDIECK K, 1991, J CELL BIOL, V115, P1685, DOI 10.1083/jcb.115.6.1685; PETROF BJ, 1993, P NATL ACAD SCI USA, V90, P3710, DOI 10.1073/pnas.90.8.3710; Piccolo F, 2000, ANN NEUROL, V48, P902, DOI 10.1002/1531-8249(200012)48:6<902::AID-ANA11>3.3.CO;2-Q; Reddy A, 2001, CELL, V106, P157, DOI 10.1016/S0092-8674(01)00421-4; STEINHARDT RA, 1994, SCIENCE, V263, P390, DOI 10.1126/science.7904084; Straub V, 1997, J CELL BIOL, V139, P375, DOI 10.1083/jcb.139.2.375	27	706	732	1	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 8	2003	423	6936					168	172		10.1038/nature01573	http://dx.doi.org/10.1038/nature01573			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675MR	12736685				2022-12-24	WOS:000182699600046
J	Yang, WY; Gruebele, M				Yang, WY; Gruebele, M			Folding at the speed limit	NATURE			English	Article							UNFOLDED CYTOCHROME-C; MICROSCOPIC THEORY; CONTACT FORMATION; LAMBDA-REPRESSOR; KINETICS; DYNAMICS; DIFFUSION; PROTEINS; RATES	Many small proteins seem to fold by a simple process explicable by conventional chemical kinetics and transition-state theory. This assumes an instant equilibrium between reactants and a high-energy activated state(1). In reality, equilibration occurs on timescales dependent on the molecules involved, below which such analyses break down(1). The molecular timescale, normally too short to be seen in experiments, can be of a significant length for proteins. To probe it directly, we studied very rapidly folding mutants of the five-helix bundle protein lambda(6-85), whose activated state is significantly populated during folding. A time-dependent rate coefficient below 2 mus signals the onset of the molecular timescale, and hence the ultimate speed limit for folding(2). A simple model shows that the molecular timescale represents the natural pre-factor for transition state models of folding.	Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA; Univ Illinois, Dept Chem, Urbana, IL 61801 USA; Univ Illinois, Dept Phys, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Gruebele, M (corresponding author), Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA.		Yang, Wei Yuan/B-4474-2011					Berne B. J., 1993, ACTIVATED BARRIER CR, P82; Bieri O, 1999, P NATL ACAD SCI USA, V96, P9597, DOI 10.1073/pnas.96.17.9597; Burton RE, 1997, NAT STRUCT BIOL, V4, P305, DOI 10.1038/nsb0497-305; Chang IJ, 2003, P NATL ACAD SCI USA, V100, P3838, DOI 10.1073/pnas.0637283100; Ervin J, 2000, J PHOTOCH PHOTOBIO B, V54, P1, DOI 10.1016/S1011-1344(00)00002-6; Garcia-Mira MM, 2002, SCIENCE, V298, P2191, DOI 10.1126/science.1077809; Ghaemmaghami S, 1998, BIOCHEMISTRY-US, V37, P9179, DOI 10.1021/bi980356b; Gruebele M, 1998, ACCOUNTS CHEM RES, V31, P699, DOI 10.1021/ar970083x; Hagen SJ, 1997, J PHYS CHEM B, V101, P2352, DOI 10.1021/jp9622997; Hagen SJ, 1996, P NATL ACAD SCI USA, V93, P11615, DOI 10.1073/pnas.93.21.11615; Lapidus LJ, 2000, P NATL ACAD SCI USA, V97, P7220, DOI 10.1073/pnas.97.13.7220; Mayor U, 2003, NATURE, V421, P863, DOI 10.1038/nature01428; Metzler R, 1999, P NATL ACAD SCI USA, V96, P11085, DOI 10.1073/pnas.96.20.11085; Myers JK, 1999, BIOCHEMISTRY-US, V38, P6761, DOI 10.1021/bi990088x; Pappenberger G, 2000, P NATL ACAD SCI USA, V97, P17, DOI 10.1073/pnas.97.1.17; Portman JJ, 2001, J CHEM PHYS, V114, P5082, DOI 10.1063/1.1334663; Portman JJ, 2001, J CHEM PHYS, V114, P5069, DOI 10.1063/1.1334662; Sabelko J, 1999, P NATL ACAD SCI USA, V96, P6031, DOI 10.1073/pnas.96.11.6031; Schuler B, 2002, NATURE, V419, P743, DOI 10.1038/nature01060; Silow M, 1997, BIOCHEMISTRY-US, V36, P7633, DOI 10.1021/bi970210x; Silow M, 1997, P NATL ACAD SCI USA, V94, P6084, DOI 10.1073/pnas.94.12.6084; Snow CD, 2002, NATURE, V420, P102, DOI 10.1038/nature01160; Thirumalai D, 1999, J PHYS CHEM B, V103, P608, DOI 10.1021/jp982362n; Yeh IC, 2002, J AM CHEM SOC, V124, P6563, DOI 10.1021/ja025789n	24	361	365	0	71	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 8	2003	423	6936					193	197		10.1038/nature01609	http://dx.doi.org/10.1038/nature01609			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675MR	12736690				2022-12-24	WOS:000182699600052
J	Greene, MJ; Gordon, DM				Greene, MJ; Gordon, DM			Social insects - Cuticular hydrocarbons inform task decisions	NATURE			English	Article							HARVESTER ANTS; COLONIES; DIVISION; DYNAMICS; LABOR		Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA	Stanford University	Greene, MJ (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.	greene@ants.stanford.edu						Gordon D. M., 2000, ANTS WORK INSECT SOC; GORDON DM, 1989, ANIM BEHAV, V38, P194, DOI 10.1016/S0003-3472(89)80082-X; Gordon DM, 2002, AM NAT, V159, P509, DOI 10.1086/339461; Gordon DM, 1996, NATURE, V380, P121, DOI 10.1038/380121a0; GORDON DM, 1987, ANIM BEHAV, V35, P833, DOI 10.1016/S0003-3472(87)80119-7; Gordon DM, 1999, BEHAV ECOL SOCIOBIOL, V45, P370, DOI 10.1007/s002650050573; Holldobler B., 1990, pi; NELSON DR, 1995, BIOCH WAXES, pCH1; ROBINSON GE, 1992, ANNU REV ENTOMOL, V37, P637, DOI 10.1146/annurev.en.37.010192.003225; Wagner D, 2001, J CHEM ECOL, V27, P1805, DOI 10.1023/A:1010408725464; Wagner D, 1998, J CHEM ECOL, V24, P2021, DOI 10.1023/A:1020781508889; WILSON EO, 1984, BEHAV ECOL SOCIOBIOL, V16, P89, DOI 10.1007/BF00293108; WINSTON ML, 1985, CAN J ZOOL, V63, P777, DOI 10.1139/z85-113	13	225	233	0	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 1	2003	423	6935					32	32		10.1038/423032a	http://dx.doi.org/10.1038/423032a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673CG	12721617				2022-12-24	WOS:000182561600031
J	Tabar, L; Yen, MF; Vitak, B; Chen, HHT; Smith, RA; Duffy, SW				Tabar, L; Yen, MF; Vitak, B; Chen, HHT; Smith, RA; Duffy, SW			Mammography service screening and mortality in breast cancer patients: 20-year follow-up before and after introduction of screening	LANCET			English	Article							ALL-CAUSE MORTALITY; SWEDISH RANDOMIZED TRIALS; AGED 40-49 YEARS; CARCINOMA MORTALITY; 2 COUNTY; PROGRAM; UPDATE	Background The long term effect of mammographic service screening is not well established. We aimed to assess the long-term effect of mammographic screening on death from breast cancer, taking into account potential biases from self-selection, changes in breast cancer incidence, and classification of cause of death. Methods We compared deaths from breast cancer diagnosed in the 20 years before screening was introduced (1958-77) with those from breast cancer diagnosed in the 20 years after the introduction of screening (1978-97) in two Swedish counties, in 210 000 women aged 20-69 years. We also compared deaths from all cancers and from all causes in patients diagnosed with breast cancer in the 20 years before and after screening was introduced. In the analysis, data were stratified into age-groups invited for screening (40-69 years) and not invited (20-39 years), and by whether or not the women had actually received screening. We also analysed mortality for the 40-49-year age-group separately. Findings The unadjusted risk of death from breast cancer dropped significantly in the second screening period compared with the first in women aged 40-69 years (relative risk [RR] 0.77 [95% Cl 0.7-0.85]; p<0.0001). No such decline was seen in 20-39 year olds. After adjustment for age, self-selection bias, and changes in breast-cancer incidence in the 40-69 years age-group, breast-cancer mortality was reduced in women who were screened (0.56; 0.49-0.64 p<0.0001), in those who were not screened (0.84 [0.71-0.09]; p=0.03), and in screened and unscreened women combined (0.59 [0.53-0.66]; p<0.0001). After adjustment for age, self-selection bias, and changes in incidence in the 40-49-year age-group, deaths from breast cancer fell significantly in those who were screened (0.52 [0.4-0.67]; p<0.0001); and in all women, screened and unscreened combined (0.55 [0.44-0.7] p<0.0001) but not in unscreened women (p=0.2). In both 40-69-year and 40-49-year age-groups, reductions in deaths from all cancers and from all-causes in women with breast cancer were consistent with these results. Interpretation Taking account of potential biases, changes in clinical practice and changes in the incidence of breast cancer, mammography screening is contributing to substantial reductions in breast cancer mortality in these two Swedish counties.	Queen Mary Univ London, Wolfson Inst Prevent Med, Canc Res UK Dept Epidemiol Math & Stat, London EC1M 6BQ, England; Cent Hosp Falun, Dept Mammog, Falun, Sweden; UCL, Dept Stat Sci, London WC1E 6BT, England; Linkoping Univ Hosp, Dept Med Radiol, S-58185 Linkoping, Sweden; Natl Taiwan Univ, Grad Inst Prevent Med, Taipei 10764, Taiwan; Amer Canc Soc, Atlanta, GA 30329 USA	Cancer Research UK; University of London; Queen Mary University London; Falun Hospital; University of London; University College London; Linkoping University; National Taiwan University; American Cancer Society	Duffy, SW (corresponding author), Queen Mary Univ London, Wolfson Inst Prevent Med, Canc Res UK Dept Epidemiol Math & Stat, Charterhouse Sq, London EC1M 6BQ, England.	stephen.duffy@cancer.org.uk	Tabar, Laszlo Kornel/AGT-3287-2022	Chen, Hsiu-Hsi/0000-0002-5799-6705				Andersson I, 1997, J Natl Cancer Inst Monogr, P63; Antman K, 1999, JAMA-J AM MED ASSOC, V281, P1470, DOI 10.1001/jama.281.16.1470; Berry DA, 1998, BREAST IMAGING, P23, DOI 10.3233/BD-1998-103-405; Bjurstam N, 1997, CANCER, V80, P2091, DOI 10.1002/(SICI)1097-0142(19971201)80:11<2091::AID-CNCR8>3.0.CO;2-#; Black WC, 2002, JNCI-J NATL CANCER I, V94, P167, DOI 10.1093/jnci/94.3.167; Blanks RG, 2000, BRIT MED J, V321, P665, DOI 10.1136/bmj.321.7262.665; Breslow NE, 1987, STAT METHODS CANC RE; Chen HH, 1997, J EPIDEMIOL BIOSTAT, V2, P25; Chen T., 1997, J EPIDEMIOL BIOSTAT, P9; Church TR, 2002, J NATL CANCER I, V94, P861, DOI 10.1093/jnci/94.11.861; Dickersin K, 1999, LANCET, V353, P1896, DOI 10.1016/S0140-6736(99)90074-0; DUFFY SW, 1991, BRIT J CANCER, V64, P1133, DOI 10.1038/bjc.1991.477; Duffy SW, 2002, CANCER-AM CANCER SOC, V95, P458, DOI 10.1002/cncr.10765; Duffy SW, 2002, APPL STAT, V51, P234; Gail MH, 2002, J NATL CANCER I, V94, P862, DOI 10.1093/jnci/94.11.862; Hendrick R E, 1997, J Natl Cancer Inst Monogr, P87; Jonsson H, 2001, J MED SCREEN, V8, P152, DOI 10.1136/jms.8.3.152; Lagerlund M, 2000, EUR J CANCER PREV, V9, P25, DOI 10.1097/00008469-200002000-00004; Lenner P, 1997, J Med Screen, V4, P6; Nystrom L, 2002, LANCET, V359, P909, DOI 10.1016/S0140-6736(02)08020-0; NYSTROM L, 1993, LANCET, V341, P973, DOI 10.1016/0140-6736(93)91067-V; Olsen O, 2001, LANCET, V358, P1340, DOI 10.1016/S0140-6736(01)06449-2; Paci E, 2002, BRIT J CANCER, V87, P65, DOI 10.1038/sj.bjc.6600301; RINGASH J, 2001, CMAJ, V16, P469; Rostgaard K, 2001, STAT MED, V20, P47, DOI 10.1002/1097-0258(20010115)20:1<47::AID-SIM613>3.0.CO;2-5; Tabar L, 2000, RADIOL CLIN N AM, V38, P625, DOI 10.1016/S0033-8389(05)70191-3; TABAR L, 1992, RADIOL CLIN N AM, V30, P187; Tabar L, 2002, J MED SCREEN, V9, P159, DOI 10.1136/jms.9.4.159; TABAR L, 1989, J EPIDEMIOL COMMUN H, V43, P107, DOI 10.1136/jech.43.2.107; TABAR L, 1985, LANCET, V1, P829, DOI 10.1016/S0140-6736(85)92204-4; Tabar L, 2001, CANCER-AM CANCER SOC, V91, P1724, DOI 10.1002/1097-0142(20010501)91:9<1724::AID-CNCR1190>3.0.CO;2-V; Tornberg S, 1994, J Med Screen, V1, P184	32	500	517	0	21	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 26	2003	361	9367					1405	1410		10.1016/S0140-6736(03)13143-1	http://dx.doi.org/10.1016/S0140-6736(03)13143-1			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	672HZ	12727392				2022-12-24	WOS:000182516300007
J	Ben-Yosef, T; Ness, SL; Madeo, AC; Bar-Lev, A; Wolfman, JH; Ahmed, ZM; Desnick, RJ; Willner, JP; Avraham, KB; Ostrer, H; Oddoux, C; Griffith, AJ; Friedman, TB				Ben-Yosef, T; Ness, SL; Madeo, AC; Bar-Lev, A; Wolfman, JH; Ahmed, ZM; Desnick, RJ; Willner, JP; Avraham, KB; Ostrer, H; Oddoux, C; Griffith, AJ; Friedman, TB			Brief report - A mutation of PCDH15 among Ashkenazi Jews with the type 1 Usher syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RECESSIVE DEAFNESS; GENE; POPULATION; FREQUENCY; FAMILIES; PROFILE; DISEASE; CDH23; GJB2		NIDCD, Mol Genet Lab, NIH, Rockville, MD 20850 USA; CUNY Mt Sinai Sch Med, Dept Human Genet, New York, NY 10029 USA; Tel Aviv Univ, Sackler Sch Med, Dept Human Genet & Mol Med, IL-69978 Tel Aviv, Israel; NYU, Sch Med, Human Genet Program, New York, NY USA	National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; Tel Aviv University; Sackler Faculty of Medicine; New York University	Friedman, TB (corresponding author), NIDCD, Mol Genet Lab, NIH, 5 Res Ct,Rm 2A15, Rockville, MD 20850 USA.	friedman@nidcd.nih.gov	Madeo, Anne/K-2880-2012; Madeo, Anne C/AAA-6186-2022	Avraham, Karen B/0000-0002-4913-251X; MADEO, ANNE/0000-0003-2048-9491	NCRR NIH HHS [RR-M01-00071] Funding Source: Medline; NIDCD NIH HHS [1 Z01 DC00060-01, 1 Z01 DC 00039-06] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [Z01DC000060, Z01DC000064, Z01DC000039] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Adato A, 1997, AM J HUM GENET, V61, P813, DOI 10.1086/514899; Ahmed ZM, 2001, AM J HUM GENET, V69, P25, DOI 10.1086/321277; Bach G, 2001, AM J MED GENET, V99, P70, DOI 10.1002/1096-8628(20010215)99:1<70::AID-AJMG1120>3.0.CO;2-0; Bitner-Glindzicz M, 2000, NAT GENET, V26, P56, DOI 10.1038/79178; Bolz H, 2001, NAT GENET, V27, P108, DOI 10.1038/83667; Bork JM, 2001, AM J HUM GENET, V68, P26, DOI 10.1086/316954; DAUSSET J, 1990, GENOMICS, V6, P575, DOI 10.1016/0888-7543(90)90491-C; HINDERINK JB, 1994, ANN OTO RHINOL LARYN, V103, P285, DOI 10.1177/000348949410300405; KRONN D, 1995, AM J HUM GENET, V57, P1250; Liebreich, 1861, DTSCH ARCH KLIN MED, V13, P53; LITTLE S, 1998, CURRENT PORTOCOLS HU, V2; MATOTH Y, 1987, AM J MED GENET, V27, P561; MEULENBELT I, 1995, AM J HUM GENET, V57, P1252; Morell RJ, 1998, NEW ENGL J MED, V339, P1500, DOI 10.1056/NEJM199811193392103; MORTON NE, 1991, ANN NY ACAD SCI, V630, P16, DOI 10.1111/j.1749-6632.1991.tb19572.x; Mustapha M, 2002, HUM GENET, V110, P348, DOI 10.1007/s00439-002-0690-x; Ostrer H, 2001, NAT REV GENET, V2, P891, DOI 10.1038/35098506; Petit C, 2001, ANNU REV GENOM HUM G, V2, P271, DOI 10.1146/annurev.genom.2.1.271; RISCH N, 1995, NAT GENET, V9, P152, DOI 10.1038/ng0295-152; SMITH RJH, 1994, AM J MED GENET, V50, P32, DOI 10.1002/ajmg.1320500107; Sobe T, 1999, AM J MED GENET, V86, P499, DOI 10.1002/(SICI)1096-8628(19991029)86:5<499::AID-AJMG19>3.3.CO;2-F; VERNON M, 1969, J CHRON DIS, V22, P133, DOI 10.1016/0021-9681(69)90055-1; Verpy E, 2000, NAT GENET, V26, P51, DOI 10.1038/79171; Weil D, 2003, HUM MOL GENET, V12, P463, DOI 10.1093/hmg/ddg051; WELL D, 1995, NATURE, V374, P60, DOI 10.1038/374060a0; Young N M, 1995, Ann Otol Rhinol Laryngol Suppl, V166, P342; Zlotogora J, 2000, MOL GENET METAB, V69, P169, DOI 10.1006/mgme.2000.2969	27	70	74	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 24	2003	348	17					1664	1670		10.1056/NEJMoa021502	http://dx.doi.org/10.1056/NEJMoa021502			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	670PB	12711741				2022-12-24	WOS:000182416300006
J	Lipshultz, SE; Sleeper, LA; Towbin, JA; Lowe, AM; Orav, EJ; Cox, GF; Lurie, PR; McCoy, KL; McDonald, MA; Messere, JE; Colan, SD				Lipshultz, SE; Sleeper, LA; Towbin, JA; Lowe, AM; Orav, EJ; Cox, GF; Lurie, PR; McCoy, KL; McDonald, MA; Messere, JE; Colan, SD			The incidence of pediatric cardiomyopathy in two regions of the United States	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IDIOPATHIC DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; CLINICAL PROFILE; NATURAL-HISTORY; FEMALE SEX; CHILDREN; INFANTS; HEART; EPIDEMIOLOGY; MORTALITY	Background: Population-based data on the incidence of pediatric cardiomyopathy are rare because of the lack of large, prospective studies. Methods: Since 1996 the Pediatric Cardiomyopathy Registry sponsored by the National Heart, Lung, and Blood Institute has collected data on all children with newly diagnosed cardiomyopathy in New England and the Central Southwest region (Texas, Oklahoma, and Arkansas) of the United States. We report on all children in these regions who received this diagnosis between 1996 and 1999. Results: We identified 467 cases of cardiomyopathy, for an overall annual incidence of 1.13 per 100,000 children (95 percent confidence interval, 1.03 to 1.23). The incidence was significantly higher among infants younger than 1 year old than among children and adolescents who were 1 to 18 years old (8.34 vs. 0.70 per 100,000, P<0.001). The annual incidence of cardiomyopathy was lower among white children (upper-bound estimate, 1.06 cases per 100,000) than among black children (lower-bound estimate, 1.47 per 100,000; P=0.02) and higher among boys than among girls (1.32 vs. 0.92 per 100,000, P<0.001). The incidence also varied significantly by region: 1.44 cases per 100,000 in New England and 0.98 per 100,000 in the Central Southwest region (P<0.001). When categorized according to type, dilated cardiomyopathy made up 51 percent of the cases, hypertrophic cardiomyopathy 42 percent, and restrictive or other types 3 percent; 4 percent were unspecified. There was no significant difference in the incidence rates according to the year. Conclusions: The estimated incidence of pediatric cardiomyopathy in two large regions of the United States is 1.13 cases per 100,000 children. Most cases are identified at an early age, and the incidence varies according to sex, region, and racial or ethnic origin.	Univ Rochester, Med Ctr, Div Pediat Cardiol, Rochester, NY 14642 USA; Golisano Childrens Hosp Strong, Div Pediat Cardiol, Rochester, NY USA; Univ Rochester, Sch Med & Dent, Dept Pediat, Rochester, NY 14642 USA; Childrens Hosp, Dept Cardiol, Boston, MA 02115 USA; Childrens Hosp, Div Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; New England Res Inst, Watertown, MA 02172 USA; Texas Childrens Hosp, Dept Pediat Cardiol Mol & Human Genet & Cardiovas, Houston, TX 77030 USA; Baylor Coll Med, Houston, TX 77030 USA; Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; Genzyme Corp, Cambridge, MA USA; Albany Med Coll, Dept Pediat, Albany, NY 12208 USA	University of Rochester; University of Rochester; University of Rochester; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; HealthCore, Inc; Baylor College of Medicine; Baylor College of Medicine; Harvard University; Brigham & Women's Hospital; Sanofi-Aventis; Genzyme Corporation; Albany Medical College	Lipshultz, SE (corresponding author), Univ Rochester, Med Ctr, Div Pediat Cardiol, 601 Elmwood Ave,Box 631, Rochester, NY 14642 USA.		Towbin, Jeffrey A./J-5595-2019; Colan, Steven/ABB-4580-2020	Towbin, Jeffrey A./0000-0002-6585-714X; 	NATIONAL CANCER INSTITUTE [R01CA055576, P01CA068484, R01CA079060, R29CA055576] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL053392] Funding Source: NIH RePORTER; NCI NIH HHS [CA79060, CA68484, CA55576] Funding Source: Medline; NHLBI NIH HHS [HL53392] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Arola A, 1997, AM J EPIDEMIOL, V146, P385, DOI 10.1093/oxfordjournals.aje.a009291; Arola A, 1998, PEDIATRICS, V101, P369, DOI 10.1542/peds.101.3.369; BILGIC A, 1990, JPN HEART J, V31, P789; Boneva RS, 2001, CIRCULATION, V103, P2376; Boucek MM, 2001, J HEART LUNG TRANSPL, V20, P39, DOI 10.1016/S1053-2498(00)00243-6; CANNAN CR, 1995, CIRCULATION, V92, P2488, DOI 10.1161/01.CIR.92.9.2488; CARVALHO JS, 2002, PAEDIAT CARDIOLOGY, P1595; *CENS BUR, 1999, EST POP STAT AG SEX; Chang RKR, 2002, CIRCULATION, V106, P1514, DOI 10.1161/01.CIR.0000029104.94858.6F; CHEN SC, 1990, J AM COLL CARDIOL, V15, P189, DOI 10.1016/0735-1097(90)90199-Y; COLAN SD, 1992, J AM COLL CARDIOL, V19, P619, DOI 10.1016/S0735-1097(10)80282-7; CORREAVILLASENOR A, 1991, AM J EPIDEMIOL, V134, P393, DOI 10.1093/oxfordjournals.aje.a116101; COUGHLIN SS, 1993, J CLIN EPIDEMIOL, V46, P1003, DOI 10.1016/0895-4356(93)90167-Y; Cox GF, 2001, CIRCULATION, V104, P588; Evans Roger W, 1982, Heart Transplant, V1, P243; FERENCZ C, 1992, PEDIATR CARDIOL, V13, P65, DOI 10.1007/BF00798206; GILLUM RF, 1986, AM HEART J, V111, P752, DOI 10.1016/0002-8703(86)90111-0; GREENWOOD RD, 1976, AM HEART J, V92, P549, DOI 10.1016/S0002-8703(76)80074-9; Grenier MA, 2000, AM HEART J, V139, pS86, DOI 10.1067/mhj.2000.103933; GRIFFIN ML, 1988, J AM COLL CARDIOL, V11, P139, DOI 10.1016/0735-1097(88)90179-9; KUMAR K, IN PRESS INT J CARDI; Lipshultz, 2000, Prog Pediatr Cardiol, V12, P1, DOI 10.1016/S1058-9813(00)00076-X; Lipshultz SE, 2002, LANCET, V360, P368, DOI 10.1016/S0140-6736(02)09607-1; LIPSHULTZ SE, 1995, NEW ENGL J MED, V332, P1738, DOI 10.1056/NEJM199506293322602; MANOLIO TA, 1992, AM J CARDIOL, V69, P1458, DOI 10.1016/0002-9149(92)90901-A; MARON BJ, 1987, NEW ENGL J MED, V316, P780, DOI 10.1056/NEJM198703263161305; MARON BJ, 1981, PEDIAT CARDIOVASCULA, V11, P35; MARON BJ, 2001, MOSS ADAMS HEART DIS, V2, P1167; Nugent AW, 2003, NEW ENGL J MED, V348, P1639, DOI 10.1056/NEJMoa021737; PONGPANIGH B, 1985, JAP HEART J, V27, P11; SCHMALTZ AA, 1987, EUR HEART J, V8, P100, DOI 10.1093/oxfordjournals.eurheartj.a062236; Schwartz ML, 1996, CIRCULATION, V94, P2021, DOI 10.1161/01.CIR.94.8.2021; Simbre VC, 2002, PEDIATR RES, V51, p37A; STEIN H, 1964, ARCH DIS CHILD, V39, P610, DOI 10.1136/adc.39.208.610; TALIERCIO CP, 1985, J AM COLL CARDIOL, V6, P1126, DOI 10.1016/S0735-1097(85)80319-3; Towbin JA, 1999, CURR OPIN CARDIOL, V14, P250, DOI 10.1097/00001573-199905000-00010; TOWBIN JA, 2000, PEDIAT CARDIOVASCULA, P753; Tsirka AE, 2000, CIRCULATION, V102, P406	38	508	546	0	5	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 24	2003	348	17					1647	1655		10.1056/NEJMoa021715	http://dx.doi.org/10.1056/NEJMoa021715			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	670PB	12711739				2022-12-24	WOS:000182416300004
J	Takemaru, KI; Yamaguchi, S; Lee, YS; Zhang, Y; Carthew, RW; Moon, RT				Takemaru, KI; Yamaguchi, S; Lee, YS; Zhang, Y; Carthew, RW; Moon, RT			Chibby, a nuclear beta-catenin-associated antagonist of the Wnt/Wingless pathway	NATURE			English	Article							MAMMALIAN-CELLS; WINGLESS SIGNAL; XENOPUS EMBRYOS; DROSOPHILA; GENE; ARMADILLO; EXPRESSION; PROTEIN; LEF-1; INTERFERENCE	Inappropriate activation of downstream target genes by the oncoprotein beta-catenin is implicated in development of numerous human cancers(1,2). beta-catenin and its fruitfly counterpart Armadillo act as a coactivator in the canonical Wnt/Wingless pathway by binding to Tcf/Lef transcription factors(3-6). Here we report a conserved nuclear protein, named Chibby, which was identified in a screen for proteins that directly interact with the C-terminal region of beta-catenin. In mammalian cultured cells we demonstrate that Chibby inhibits beta-catenin-mediated transcriptional activation by competing with Lef-1 to bind to beta-catenin. Inhibition of Drosophila Chibby by RNA interference results in segment polarity defects that mimick a wingless gain-of-function phenotype, and overexpression of the wingless target genes engrailed and Ultrabithorax. In addition, epistasis experiments indicate that chibby acts downstream of wingless and upstream of armadillo.	Univ Washington, Ctr Dev Biol, Sch Med, Seattle, WA 98195 USA; Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA	University of Washington; University of Washington Seattle; Northwestern University	Moon, RT (corresponding author), Univ Washington, Howard Hughes Med Inst, Dept Pharmacol, Sch Med, Room K536C,Hlth Sci Bldg,Campus Box 357750, Seattle, WA 98195 USA.		Moon, Randall T/B-1743-2014; Moon, Randall/M-5605-2019	Moon, Randall T/0000-0002-9352-1408; Moon, Randall/0000-0002-9352-1408				ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Broder YC, 1998, CURR BIOL, V8, P1121, DOI 10.1016/S0960-9822(98)70467-1; Brunner E, 1997, NATURE, V385, P829, DOI 10.1038/385829a0; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; CARTHEW RW, 2003, GENE SILENCING; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fukuchi T, 1998, CANCER RES, V58, P3526; Garcia-Rostan G, 2001, AM J PATHOL, V158, P987, DOI 10.1016/S0002-9440(10)64045-X; Hecht A, 1999, J BIOL CHEM, V274, P18017, DOI 10.1074/jbc.274.25.18017; Hsu SC, 1998, MOL CELL BIOL, V18, P4807, DOI 10.1128/MCB.18.8.4807; Kennerdell JR, 1998, CELL, V95, P1017, DOI 10.1016/S0092-8674(00)81725-0; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; LEE YS, IN PRESS METHODS; Miller JR, 1999, ONCOGENE, V18, P7860, DOI 10.1038/sj.onc.1203245; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; NOORDERMEER J, 1992, DEVELOPMENT, V116, P711; PEIFER M, 1994, DEVELOPMENT, V120, P369; PEIFER M, 1990, CELL, V63, P1167, DOI 10.1016/0092-8674(90)90413-9; PEIFER M, 1994, CELL, V76, P789, DOI 10.1016/0092-8674(94)90353-0; Polakis P, 2000, GENE DEV, V14, P1837; Sanson B, 1999, CELL, V98, P207, DOI 10.1016/S0092-8674(00)81015-6; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Takemaru KI, 2000, J CELL BIOL, V149, P249, DOI 10.1083/jcb.149.2.249; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443; Yu X, 1996, DEVELOPMENT, V122, P849; Yu X, 1998, EMBO J, V17, P7021, DOI 10.1093/emboj/17.23.7021	29	227	253	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 24	2003	422	6934					905	909		10.1038/nature01570	http://dx.doi.org/10.1038/nature01570			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670WR	12712206				2022-12-24	WOS:000182432600058
J	Fry, SN; Sayaman, R; Dickinson, MH				Fry, SN; Sayaman, R; Dickinson, MH			The aerodynamics of free-flight maneuvers in Drosophila	SCIENCE			English	Article							MUSCA-DOMESTICA; VISUAL CONTROL; FLY; ORIENTATION; BEHAVIOR	Using three-dimensional infrared high-speed video, we captured the wing and body kinematics of free-flying fruitflies as they performed rapid flight maneuvers. We then "replayed" the wing kinematics on a dynamically scaled robotic model to measure the aerodynamic forces produced by the wings. The results show that fly generates rapid turns with surprisingly subtle modifications in wing motion, which nonetheless generate sufficient torque for the fly to rotate its body through each turn. The magnitude and time course of the torque and body motion during rapid turns indicate that inertia, not friction, dominates the flight dynamics of insects.	CALTECH, Pasadena, CA 91125 USA; Univ Zurich, ETH Zurich, Inst Neuroinformat, CH-8057 Zurich, Switzerland	California Institute of Technology; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich	Dickinson, MH (corresponding author), CALTECH, Pasadena, CA 91125 USA.		Sikandar, Usama/F-6586-2016	Sayaman, Rosalyn/0000-0003-1343-0619				COLLETT TS, 1975, J COMP PHYSIOL, V99, P1, DOI 10.1007/BF01464710; DAVID CT, 1978, PHYSIOL ENTOMOL, V3, P191, DOI 10.1111/j.1365-3032.1978.tb00148.x; GOTZ KG, 1968, KYBERNETIK, V4, P199, DOI 10.1007/BF00272517; REICHARDT W, 1973, NATURWISSENSCHAFTEN, V60, P122, DOI 10.1007/BF00594781; REICHARDT W, 1976, Q REV BIOPHYS, V9, P311, DOI 10.1017/S0033583500002523; Sane SP, 2001, J EXP BIOL, V204, P2607; Schilstra C, 1998, NATURE, V395, P654, DOI 10.1038/27114; Schilstra C, 1999, J EXP BIOL, V202, P1481; Tammero LF, 2002, J EXP BIOL, V205, P327; VOGEL S, 1966, J EXP BIOL, V44, P567; WAGNER H, 1986, PHILOS T ROY SOC B, V312, P527, DOI 10.1098/rstb.1986.0017	11	386	404	3	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 18	2003	300	5618					495	498		10.1126/science.1081944	http://dx.doi.org/10.1126/science.1081944			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668LR	12702878				2022-12-24	WOS:000182295900043
J	Iglehart, JK				Iglehart, JK			Medicare and drug pricing	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							TRENDS											ALBERT H, 2001, COMMUNICATION   0620; *AM SOC CLIN ONC, 2002, AN WAYS MEANS STAFF; American Society of Clinical Oncology, 2001, REF MED PAYM METH CA; [Anonymous], 2001, GAO011118; BURTON TM, 2002, WALL STREET J   0313, pB1; CLOUD DJ, 2000, WALL STREET J   0927, pB1; *CTR MED MED SERV, 2003, DMEPOS COMP BIDD DEM; *DEP HLTH HUM SERV, 2000, OEI030000311 DEP HLT; *DEP HLTH HUM SERV, 2001, OEI030000310 DEP HLT; *DEP HLTH HUM SERV, 2000, OEI030000020 DEP HLT; *DEP HLTH HUM SERV, 1997, OEI039700290 DEP HLT; *DEP HLTH HUM SERV, 1998, OEI039700510 DEP HLT; *DEP HLTH HUM SERV, 1996, OEI039500420 DEP HLT; FREUDENHEIM M, 2002, NY TIMES        0513, pC5; FUHRMANS V, 2001, WALL STREET J   1213, pB4; FUHRMANS V, 2002, WALL STREET J   0607, P1; Gabel J, 2002, HEALTH AFFAIR, V21, P143, DOI 10.1377/hlthaff.21.5.143; *GEN ACC OFF, 2001, GAO0253; Gencarelli DM, 2002, AVERAGE WHOLESALE PR; Iglehart JK, 2002, NEW ENGL J MED, V347, P956, DOI 10.1056/NEJMhpr022143; Iglehart JK, 2002, NEW ENGL J MED, V346, P1924, DOI 10.1056/NEJMhpr020324; JAPSEN B, 2001, CHICAGO TRIBUNE 1122; KOWALCZYK L, 2001, BOSTON GLOBE    1221; Levit K, 2003, HEALTH AFFAIR, V22, P154, DOI 10.1377/hlthaff.22.1.154; MCGINLEY L, 2000, WALL STREET J   0602, pB6; NAIK G, 2002, WALL STREET J   1226, pA8; NICOLA TJ, 2001, REGULATORY LEGISLATI; Pear Robert, 2003, N Y Times Web, pA15; Pear Robert, 2002, NY TIMES        0517, pA1; STRUNK BC, 2001, HLTH AFFAIRS    0926; TAUZIN B, 2001, COMMUNICATION   1114; 2002, FED REG, V67, P79973	32	19	19	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 17	2003	348	16					1590	1597		10.1056/NEJMhpr035135	http://dx.doi.org/10.1056/NEJMhpr035135			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	667TT	12700381				2022-12-24	WOS:000182248900012
J	Joy, DA; Feng, XR; Mu, JB; Furuya, T; Chotivanich, K; Krettli, AU; Ho, M; Wang, A; White, NJ; Suh, E; Beerli, P; Su, XZ				Joy, DA; Feng, XR; Mu, JB; Furuya, T; Chotivanich, K; Krettli, AU; Ho, M; Wang, A; White, NJ; Suh, E; Beerli, P; Su, XZ			Early origin and recent expansion of Plasmodium falciparum	SCIENCE			English	Article							POPULATION-GROWTH; STATISTICAL TESTS; GENE TREES; MALARIA; DNA; NEUTRALITY; DIVERSITY; INFERENCE; EVOLUTION; HISTORY	The emergence of virulent Plasmodium falciparum in Africa within the past 6000 years as a result of a cascade of changes in human behavior and mosquito transmission has recently been hypothesized. Here, we provide genetic evidence for a sudden increase in the African malaria parasite population about 10,000 years ago, followed by migration to other regions on the basis of variation in 100 worldwide mitochondrial DNA sequences. However, both the world and some regional populations appear to be older (50,000 to 100,000 years old), suggesting an earlier wave of migration out of Africa, perhaps during the Pleistocene migration of human beings.	NIAID, Lab Malaria & Vector Res, NIH, Bethesda, MD 20892 USA; Mahidol Univ, Wellcome Trust Mahidol Univ Oxford Trop Med Res P, Bangkok 10400, Thailand; Fiocruz MS, Ctr Pesquisas Rene Rachou, Malaria Lab, BR-30190002 Belo Horizonte, MG, Brazil; Univ Calgary, Dept Microbiol & Infect Dis, Calgary, AB T2N 1N4, Canada; NIH, Ctr Informat Technol, Bethesda, MD 20892 USA; Florida State Univ, Dirac Sci Lib, Sch Computat Sci & Informat Technol, Tallahassee, FL 32306 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Mahidol University; Fundacao Oswaldo Cruz; University of Calgary; National Institutes of Health (NIH) - USA; NIH Center for Information Technology (CIT); State University System of Florida; Florida State University	Joy, DA (corresponding author), NIAID, Lab Malaria & Vector Res, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	djoy@niaid.nih.gov	Furuya, Tetsuya/J-5916-2013; Beerli, Peter/HDN-6405-2022; White, Nicholas J/I-4629-2012; Beerli, Peter/A-3638-2009; White, Nick/AAC-6527-2019; feng, xiaorong/G-4811-2010	Furuya, Tetsuya/0000-0003-3979-7072; Beerli, Peter/0000-0003-0947-5451; White, Nick/0000-0002-1897-1978; feng, xiaorong/0000-0001-8410-3020; Su, Xinzhuan/0000-0003-3246-3248	CENTER FOR INFORMATION TECHNOLOGY [Z01CT000200, ZIHCT000200] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000892, ZIAAI000892] Funding Source: NIH RePORTER	CENTER FOR INFORMATION TECHNOLOGY(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Center for Information Technology (CIT)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Anderson TJC, 2000, MOL BIOL EVOL, V17, P1467, DOI 10.1093/oxfordjournals.molbev.a026247; Bahlo M, 2000, THEOR POPUL BIOL, V57, P79, DOI 10.1006/tpbi.1999.1447; Brunet M, 2002, NATURE, V418, P145, DOI 10.1038/nature00879; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; CASTELLOE J, 1994, MOL PHYLOGENET EVOL, V3, P102, DOI 10.1006/mpev.1994.1013; Coluzzi M, 2002, SCIENCE, V298, P1415, DOI 10.1126/science.1077769; Coluzzi M, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P277; Conway DJ, 2000, MOL BIOCHEM PARASIT, V111, P163, DOI 10.1016/S0166-6851(00)00313-3; Escalante AA, 1998, P NATL ACAD SCI USA, V95, P8124, DOI 10.1073/pnas.95.14.8124; Feagin JE, 2000, INT J PARASITOL, V30, P371, DOI 10.1016/S0020-7519(99)00190-3; FU YX, 1993, GENETICS, V133, P693; Fu YX, 1997, GENETICS, V147, P915; Hughes AL, 2001, P ROY SOC B-BIOL SCI, V268, P1855, DOI 10.1098/rspb.2001.1759; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Kuhner MK, 1998, GENETICS, V149, P429; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Mu JB, 2002, NATURE, V418, P323, DOI 10.1038/nature00836; NEI M, 1986, MOL BIOL EVOL, V3, P418; Pybus OG, 2000, GENETICS, V155, P1429; Rich SM, 1998, P NATL ACAD SCI USA, V95, P4425, DOI 10.1073/pnas.95.8.4425; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; SCHNEIDER S, 2000, ARLEQUIN SOFTWARE; TAJIMA F, 1989, GENETICS, V123, P585; Thomson R, 2000, P NATL ACAD SCI USA, V97, P7360, DOI 10.1073/pnas.97.13.7360; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; Volkman SK, 2001, SCIENCE, V293, P482, DOI 10.1126/science.1059878; Wootton JC, 2002, NATURE, V418, P320, DOI 10.1038/nature00813	27	280	291	0	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 11	2003	300	5617					318	321		10.1126/science.1081449	http://dx.doi.org/10.1126/science.1081449			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665RQ	12690197				2022-12-24	WOS:000182135400054
J	Blount, JD; Metcalfe, NB; Birkhead, TR; Surai, PF				Blount, JD; Metcalfe, NB; Birkhead, TR; Surai, PF			Carotenoid modulation of immune function and sexual attractiveness in zebra finches	SCIENCE			English	Article							BEAK COLOR; SIGNALS; IMMUNOCOMPETENCE; PIGMENTATION; EXPRESSION; FITNESS	One hypothesis for why females in many animal species frequently prefer to mate with the most elaborately ornamented males predicts that availability of carotenoid pigments is a potentially limiting factor for both ornament expression and immune function. An implicit assumption of this hypothesis is that males that can afford to produce more elaborate carotenoid-dependent displays must be healthier individuals with superior immunocompetence. However, whether variation in circulating carotenoid levels causes variation in both immune function and sexual attractiveness has not been determined in any species. In this study, we show that manipulation of dietary carotenoid supply invokes parallel changes in cell-mediated immune function and sexual attractiveness in male zebra finches (Taeniopygia guttata).	Univ Glasgow, Inst Biomed & Life Sci, Div Environm & Evolutionary Biol, Glasgow G12 8QQ, Lanark, Scotland; Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; Scottish Agr Coll, Avian Sci Res Ctr, Auchincruive KA6 5HW, Ayr, Scotland	University of Glasgow; University of Sheffield; Scottish Agricultural College	Blount, JD (corresponding author), Univ Glasgow, Inst Biomed & Life Sci, Div Environm & Evolutionary Biol, Glasgow G12 8QQ, Lanark, Scotland.	j.blount@bio.gla.ac.uk	Surai, Peter/T-6183-2019; Blount, Jonathan/K-7695-2012; Metcalfe, Neil B./C-5997-2009	Blount, Jonathan/0000-0002-0016-0130; Metcalfe, Neil B./0000-0002-1970-9349; Surai, Peter/0000-0002-5012-8681				Andersson Malte, 1994; Birkhead TR, 1999, P ROY SOC B-BIOL SCI, V266, P385, DOI 10.1098/rspb.1999.0649; BURLEY N, 1987, ETHOLOGY, V76, P133; Chew BP, 1996, ANIM FEED SCI TECH, V59, P103, DOI 10.1016/0377-8401(95)00891-8; Collins SA, 1996, ANIM BEHAV, V52, P105, DOI 10.1006/anbe.1996.0156; COLLINS SA, 1994, BEHAV ECOL SOCIOBIOL, V35, P21, DOI 10.1007/s002650050065; DeKogel CH, 1996, ANIM BEHAV, V51, P699, DOI 10.1006/anbe.1996.0073; Gonzalez G, 1999, J ANIM ECOL, V68, P1225, DOI 10.1046/j.1365-2656.1999.00364.x; GRAFEN A, 1990, J THEOR BIOL, V144, P517, DOI 10.1016/S0022-5193(05)80088-8; HAMILTON WD, 1982, SCIENCE, V218, P384, DOI 10.1126/science.7123238; Hill GE, 2000, J AVIAN BIOL, V31, P559, DOI 10.1034/j.1600-048X.2000.310415.x; HILL GE, 1992, AUK, V109, P1; Hill GE, 1999, AM NAT, V154, P589, DOI 10.1086/303264; HOUTMAN AM, 1992, P ROY SOC B-BIOL SCI, V249, P3, DOI 10.1098/rspb.1992.0075; HUDON J, 1994, AUK, V111, P218, DOI 10.2307/4088529; KODRICBROWN A, 1989, BEHAV ECOL SOCIOBIOL, V25, P393, DOI 10.1007/BF00300185; LOZANO GA, 1994, OIKOS, V70, P309, DOI 10.2307/3545643; MCCORKLE F, 1980, POULTRY SCI, V59, P616, DOI 10.3382/ps.0590616; McGraw KJ, 2000, P ROY SOC B-BIOL SCI, V267, P1525, DOI 10.1098/rspb.2000.1174; McGraw KJ, 2002, COMP BIOCHEM PHYS B, V132, P811, DOI 10.1016/S1096-4959(02)00100-8; McGraw KJ, 2001, PHYSIOL BIOCHEM ZOOL, V74, P843, DOI 10.1086/323797; Moller AP, 2000, AVIAN POULT BIOL REV, V11, P137; Olson VA, 1998, TRENDS ECOL EVOL, V13, P510, DOI 10.1016/S0169-5347(98)01484-0; Stahl W., 1999, ANTIOXIDANT FOOD SUP, P183; von Schantz T, 1999, P ROY SOC B-BIOL SCI, V266, P1, DOI 10.1098/rspb.1999.0597; ZAHAVI A, 1975, J THEOR BIOL, V53, P205, DOI 10.1016/0022-5193(75)90111-3	26	521	528	2	175	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 4	2003	300	5616					125	127		10.1126/science.1082142	http://dx.doi.org/10.1126/science.1082142			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663CP	12677066				2022-12-24	WOS:000181988900047
J	Meier, P; Genoud, N; Prinz, M; Maissen, M; Rulicke, T; Zurbriggen, A; Raeber, AJ; Aguzzi, A				Meier, P; Genoud, N; Prinz, M; Maissen, M; Rulicke, T; Zurbriggen, A; Raeber, AJ; Aguzzi, A			Soluble dimeric prion protein binds PrPSc in vivo and antagonizes prion disease	CELL			English	Article							MICE; RESISTANT; PROPAGATION; FORM; REPLICATION; INFECTIVITY; CONVERSION; VARIANT; STRAIN; DOMAIN	Conversion of cellular prion protein (PrPc) into a pathological conformer (PrPSc) is thought to be promoted by PrPSc in a poorly understood process. Here, we report that in wild-type mice, the expression of PrPC rendered soluble and dimeric by fusion to immunoglobulin Fcgamma (PrP-Fc(2)) delays PrPSc accumulation, agent replication, and onset of disease following inoculation with infective prions. In infected PrP-expressing brains, PrP-Fc(2) relocates to lipid rafts and associates with PrPSc without acquiring protease resistance, indicating that PrP-Fc(2) resists conversion. Accordingly, mice expressing PrP-Fc(2) but lacking endogenous PrPc are resistant to scrapie, do not accumulate PrP-Fc(2)(Sc), and do not transmit disease to others. These results indicate that various PrP isoforms engage in a complex in vivo, whose distortion by PrP-Fc(2) affects prion propagation and scrapie pathogenesis. The unique properties of PrP-Fc(2) suggest that soluble PrP derivatives may represent a new class of prion replication antagonists.	Univ Zurich Hosp, Inst Neuropathol, CH-8091 Zurich, Switzerland; Univ Zurich, Inst Lab Anim Sci, CH-8091 Zurich, Switzerland; Univ Bern, Inst Anim Neurol, CH-3012 Bern, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; University of Bern	Aguzzi, A (corresponding author), Univ Zurich Hosp, Inst Neuropathol, Schmelzbergstr, CH-8091 Zurich, Switzerland.	adriano@pathol.unizh.ch	Aguzzi, Adriano/A-3351-2008	Aguzzi, Adriano/0000-0002-0344-6708				Aguzzi A, 2001, NAT REV MOL CELL BIO, V2, P118, DOI 10.1038/35052063; Aguzzi A, 2001, NAT REV NEUROSCI, V2, P745, DOI 10.1038/35094590; AGUZZI A, 2003, IN PRESS ADV IMMUNOL; Behrens A, 2002, TRENDS NEUROSCI, V25, P150, DOI 10.1016/S0166-2236(00)02089-0; BESSEN RA, 1995, NATURE, V375, P698, DOI 10.1038/375698a0; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; BUELER H, 1994, MOL MED, V1, P19; CANFIELD SM, 1991, J EXP MED, V173, P1483, DOI 10.1084/jem.173.6.1483; CARLSON GA, 1994, P NATL ACAD SCI USA, V91, P5690, DOI 10.1073/pnas.91.12.5690; DOHERTY P, 1995, NEURON, V14, P57, DOI 10.1016/0896-6273(95)90240-6; Ettinger R, 1996, P NATL ACAD SCI USA, V93, P13102, DOI 10.1073/pnas.93.23.13102; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; Fischer MB, 2000, NATURE, V408, P479, DOI 10.1038/35044100; Gatti JL, 2002, BIOL REPROD, V67, P393, DOI 10.1095/biolreprod67.2.393; Heppner FL, 2001, SCIENCE, V294, P178, DOI 10.1126/science.1063093; Horiuchi M, 1999, EMBO J, V18, P3193, DOI 10.1093/emboj/18.12.3193; HSIAO K, 1989, NATURE, V338, P342, DOI 10.1038/338342a0; Kaeser PS, 2001, J VIROL, V75, P7097, DOI 10.1128/JVI.75.15.7097-7106.2001; Klein MA, 2001, NAT MED, V7, P488, DOI 10.1038/86567; Klein MA, 1997, NATURE, V390, P687, DOI 10.1038/37789; KOCISKO DA, 1995, P NATL ACAD SCI USA, V92, P3923, DOI 10.1073/pnas.92.9.3923; KOCISKO DA, 1994, NATURE, V370, P471, DOI 10.1038/370471a0; LANSBURY PT, 1994, SCIENCE, V265, P1510, DOI 10.1126/science.8079159; LOPEZ CD, 1990, SCIENCE, V248, P226, DOI 10.1126/science.1970195; LUND J, 1991, J IMMUNOL, V147, P2657; Mabbott NA, 2000, NAT MED, V6, P719, DOI 10.1038/77401; Mabbott NA, 2001, NAT MED, V7, P485, DOI 10.1038/86562; Maissen M, 2001, LANCET, V357, P2026, DOI 10.1016/S0140-6736(00)05110-2; Montrasio F, 2000, SCIENCE, V288, P1257, DOI 10.1126/science.288.5469.1257; Naslavsky N, 1997, J BIOL CHEM, V272, P6324, DOI 10.1074/jbc.272.10.6324; Parizek P, 2001, J BIOL CHEM, V276, P44627, DOI 10.1074/jbc.M107458200; Perini F, 1996, BIOCHEM BIOPH RES CO, V223, P572, DOI 10.1006/bbrc.1996.0936; Perrier V, 2002, P NATL ACAD SCI USA, V99, P13079, DOI 10.1073/pnas.182425299; PRUSINER SB, 1991, SCIENCE, V252, P1515, DOI 10.1126/science.1675487; PRUSINER SB, 1982, ANN NEUROL, V11, P353, DOI 10.1002/ana.410110406; PRUSINER SB, 1993, P NATL ACAD SCI USA, V90, P2793, DOI 10.1073/pnas.90.7.2793; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; SAILER A, 1994, CELL, V77, P967, DOI 10.1016/0092-8674(94)90436-7; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; SCOTT M, 1989, CELL, V59, P847, DOI 10.1016/0092-8674(89)90608-9; TAGLIAVINI F, 1992, BIOCHEM BIOPH RES CO, V184, P1398, DOI 10.1016/S0006-291X(05)80038-5; TAO MH, 1993, J EXP MED, V178, P661, DOI 10.1084/jem.178.2.661; Vey M, 1996, P NATL ACAD SCI USA, V93, P14945, DOI 10.1073/pnas.93.25.14945; Wadsworth JDF, 2001, LANCET, V358, P171, DOI 10.1016/S0140-6736(01)05403-4; WEISSMANN C, 1991, NATURE, V349, P569, DOI 10.1038/349569a0	46	105	113	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 4	2003	113	1					49	60		10.1016/S0092-8674(03)00201-0	http://dx.doi.org/10.1016/S0092-8674(03)00201-0			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	668GX	12679034	Bronze			2022-12-24	WOS:000182282900006
J	Rossouw, M; Nel, HJ; Cooke, GS; van Helden, PD; Hoal, EG				Rossouw, M; Nel, HJ; Cooke, GS; van Helden, PD; Hoal, EG			Association between tuberculosis and a polymorphic NF kappa B binding site in the interferon gamma gene	LANCET			English	Article								Interferon gamma is believed to be crucial for host defence against many infections. To test the hypothesis that a polymorphism in the gene for interferon gamma (IFNG) is associated with susceptibility to tuberculosis, we did two independent investigations. In a case-control study of 313 tuberculosis cases, we noted a significant association between a polymorphism (+874A-->T) in IFNG and tuberculosis in a South African population (p=0.0055). This finding was replicated in a family-based study, in which the transmission disequilibrium test was used in 131 families (p=0.005). The transcription factor NFkappaB binds preferentially to the +874T allele, which is over-represented in controls. This preferential binding suggests that genetically determined variability in interferon gamma and expression might be important for the development of tuberculosis.	Univ Stellenbosch, MRC, Ctr Cellular & Mol Biol, ZA-7505 Tygerberg, South Africa; Univ Stellenbosch, Fac Hlth Sci, Dept Med Biochem, ZA-7505 Tygerberg, South Africa; Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England	Stellenbosch University; Stellenbosch University; University of Oxford; Wellcome Centre for Human Genetics	Hoal, EG (corresponding author), Univ Stellenbosch, MRC, Ctr Cellular & Mol Biol, ZA-7505 Tygerberg, South Africa.			Hoal, Eileen/0000-0002-6444-5688; Cooke, Graham/0000-0001-6475-5056				Bream JH, 2000, IMMUNOGENETICS, V51, P50, DOI 10.1007/s002510050008; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Hoal-van Helden EG, 1999, PEDIATR RES, V45, P459, DOI 10.1203/00006450-199904010-00002; Pravica V, 2000, HUM IMMUNOL, V61, P863, DOI 10.1016/S0198-8859(00)00167-1; Yamada H, 2001, INFECT IMMUN, V69, P7100, DOI 10.1128/IAI.69.11.7100-7105.2001	5	185	189	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 31	2003	361	9372					1871	1872		10.1016/S0140-6736(03)13491-5	http://dx.doi.org/10.1016/S0140-6736(03)13491-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	684KL	12788577				2022-12-24	WOS:000183205800015
J	Kang, RS; Daniels, CM; Francis, SA; Shih, SC; Salerno, WJ; Hicke, L; Radhakrishnan, I				Kang, RS; Daniels, CM; Francis, SA; Shih, SC; Salerno, WJ; Hicke, L; Radhakrishnan, I			Solution structure of a CUE-ubiquitin complex reveals a conserved mode of ubiquitin binding	CELL			English	Article							NMR-SPECTROSCOPY; INTERACTING MOTIF; UBA DOMAINS; MACROMOLECULAR STRUCTURE; PROTEIN; SURFACE; DEGRADATION; PATHWAY; RECOGNITION; ENDOCYTOSIS	Monoubiquitination serves as a regulatory signal in a variety of cellular processes. Monoubiquitin signals are transmitted by binding to a small but rapidly expanding class of ubiquitin binding motifs. Several of these motifs, including the CUE domain, also promote intramolecular monoubiquitination. The solution structure of a CUE domain of the yeast Cue2 protein in complex with ubiquitin reveals intermolecular interactions involving conserved hydrophobic surfaces, including the Leu8-IIe44-Val70 patch on ubiquitin. The contact surface extends beyond this patch and encompasses Lys48, a site of polyubiquitin chain formation. This suggests an occlusion mechanism for inhibiting polyubiquitin chain formation during monoubiquitin signaling. The CUE domain shares a similar overall architecture with the UBA domain, which also contains a conserved hydrophobic patch. Comparative modeling suggests that the UBA domain interacts analogously with ubiquitin. The structure of the CUE-ubiquitin complex may thus serve as a paradigm for ubiquitin recognition and signaling by ubiquitin binding proteins.	Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA	Northwestern University	Radhakrishnan, I (corresponding author), Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA.		Radhakrishnan, Ishwar/AHA-7392-2022; Radhakrishnan, Ishwar/R-8442-2018	Radhakrishnan, Ishwar/0000-0002-0195-9710; Radhakrishnan, Ishwar/0000-0002-0195-9710				BAX A, 1993, ACCOUNTS CHEM RES, V26, P131, DOI 10.1021/ar00028a001; BAX A, 1994, METHOD ENZYMOL, V239, P79; Beal R, 1996, P NATL ACAD SCI USA, V93, P861, DOI 10.1073/pnas.93.2.861; Bertolaet BL, 2001, NAT STRUCT BIOL, V8, P417, DOI 10.1038/87575; Biederer T, 1997, SCIENCE, V278, P1806, DOI 10.1126/science.278.5344.1806; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CARSON M, 1997, MACROMOLECULAR CRYST, P493; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; Chen L, 2001, EMBO REP, V2, P933, DOI 10.1093/embo-reports/kve203; Conaway RC, 2002, SCIENCE, V296, P1254, DOI 10.1126/science.1067466; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Dieckmann T, 1998, NAT STRUCT BIOL, V5, P1042, DOI 10.1038/4220; Donaldson KM, 2003, CURR BIOL, V13, P258, DOI 10.1016/S0960-9822(03)00043-5; Ferentz AE, 2000, Q REV BIOPHYS, V33, P29, DOI 10.1017/S0033583500003589; Garcia-Higuera I, 2001, MOL CELL, V7, P249, DOI 10.1016/S1097-2765(01)00173-3; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hicke L, 2001, CELL, V106, P527, DOI 10.1016/S0092-8674(01)00485-8; Hofmann K, 1996, TRENDS BIOCHEM SCI, V21, P172, DOI 10.1016/S0968-0004(96)30015-7; Hofmann K, 2001, TRENDS BIOCHEM SCI, V26, P347, DOI 10.1016/S0968-0004(01)01835-7; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; Klapisz E, 2002, J BIOL CHEM, V277, P30746, DOI 10.1074/jbc.M203004200; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lee AL, 1999, J BIOMOL NMR, V13, P101, DOI 10.1023/A:1008304220445; Linge JP, 2003, BIOINFORMATICS, V19, P315, DOI 10.1093/bioinformatics/19.2.315; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; Mueller TD, 2002, J MOL BIOL, V319, P1243, DOI 10.1016/S0022-2836(02)00302-9; Muratani M, 2003, NAT REV MOL CELL BIO, V4, P192, DOI 10.1038/nrm1049; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Oldham CE, 2002, CURR BIOL, V12, P1112, DOI 10.1016/S0960-9822(02)00900-4; OTTING G, 1990, Q REV BIOPHYS, V23, P39, DOI 10.1017/S0033583500005412; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Polo S, 2002, NATURE, V416, P451, DOI 10.1038/416451a; Ponting CP, 2000, BIOCHEM J, V351, P527, DOI 10.1042/0264-6021:3510527; Pornillos O, 2002, TRENDS CELL BIOL, V12, P569, DOI 10.1016/S0962-8924(02)02402-9; Radhakrishnan I, 1999, J MOL BIOL, V287, P859, DOI 10.1006/jmbi.1999.2658; Raiborg C, 2002, NAT CELL BIOL, V4, P394, DOI 10.1038/ncb791; Rotin D, 2000, J MEMBRANE BIOL, V176, P1; Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.0.CO;2-Y; Shekhtman A, 2002, BIOCHEM BIOPH RES CO, V296, P1222, DOI 10.1016/S0006-291X(02)02006-5; Shih SC, 2002, NAT CELL BIOL, V4, P389, DOI 10.1038/ncb790; Shih SC, 2003, EMBO J, V22, P1273, DOI 10.1093/emboj/cdg140; Sloper-Mould KE, 2001, J BIOL CHEM, V276, P30483, DOI 10.1074/jbc.M103248200; Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; VIJAYKUMAR S, 1987, J MOL BIOL, V194, P531, DOI 10.1016/0022-2836(87)90679-6; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Wilkinson CRM, 2001, NAT CELL BIOL, V3, P939, DOI 10.1038/ncb1001-939; YAMAZAKI T, 1993, J AM CHEM SOC, V115, P11054, DOI 10.1021/ja00076a099; Young P, 1998, J BIOL CHEM, V273, P5461, DOI 10.1074/jbc.273.10.5461; Zwahlen C, 1997, J AM CHEM SOC, V119, P6711, DOI 10.1021/ja970224q	52	188	191	1	16	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 30	2003	113	5					621	630		10.1016/S0092-8674(03)00362-3	http://dx.doi.org/10.1016/S0092-8674(03)00362-3			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	687VL	12787503	Bronze			2022-12-24	WOS:000183397600012
J	Karamysheva, Z; Wang, LB; Shrode, T; Bednenko, J; Hurley, LA; Shippen, DE				Karamysheva, Z; Wang, LB; Shrode, T; Bednenko, J; Hurley, LA; Shippen, DE			Developmentally programmed gene elimination in Euplotes crassus facilitates a switch in the telomerase catalytic subunit	CELL			English	Article							HIV-1 REVERSE-TRANSCRIPTASE; CILIATED PROTOZOA; DNA; RNA; OCTOCARINATUS; MACRONUCLEAR; REPLICATION; CONTAINS; ELEMENTS; TEMPLATE	The primary function of telomerase is to maintain preexisting telomere tracts. In the ciliate Euplotes crassus, however, telomerase RNP structure and substrate recognition are altered during macronuclear development to facilitate de novo telomere addition. We found that E. crassus harbors three TERT genes encoding the telomerase catalytic subunit that not only vary in their nucleotide and predicted protein sequences, but also in their expression profiles. Expression of EcTERT-1 and -3 correlates with the requirement for telomere maintenance, while that of EcTERT-2 correlates with de novo telomere synthesis. All three genes appear to require ribosomal frameshifting for expression of catalytically active protein. The transcriptionally active form of EcTERT-2 exists only transiently in mated cells and is absent from the vegetative macronucleus. Thus, telomerase expression in Euplotes is controlled by unique regulatory mechanisms that culminate in a developmental switch to a different catalytic subunit with properties suited to de novo telomere addition.	Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Shippen, DE (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, 2128 TAMU, College Stn, TX 77843 USA.			Bednenko, Janna/0000-0001-9220-3531	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM049157, R01GM049157] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM49157] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aigner S, 2000, EMBO J, V19, P6230, DOI 10.1093/emboj/19.22.6230; Aisner DL, 2002, CURR OPIN GENET DEV, V12, P80, DOI 10.1016/S0959-437X(01)00268-4; Artandi SE, 2000, NAT MED, V6, P852, DOI 10.1038/78595; Bachand F, 2001, MOL CELL BIOL, V21, P1888, DOI 10.1128/MCB.21.5.1888-1897.2001; Bednenko J, 1997, EMBO J, V16, P2507, DOI 10.1093/emboj/16.9.2507; Bednenko J, 1998, NUCLEIC ACIDS RES, V26, P3998, DOI 10.1093/nar/26.17.3998; Bryan TM, 1998, P NATL ACAD SCI USA, V95, P8479, DOI 10.1073/pnas.95.15.8479; Bryan TM, 2000, MOL CELL, V6, P493, DOI 10.1016/S1097-2765(00)00048-4; Collins K, 1999, ANNU REV BIOCHEM, V68, P187, DOI 10.1146/annurev.biochem.68.1.187; Doak TG, 2003, EUKARYOT CELL, V2, P95, DOI 10.1128/EC.2.1.95-102.2003; Ducrest AL, 2002, ONCOGENE, V21, P541, DOI 10.1038/sj.onc.1205081; Fan QC, 1996, MOL CELL BIOL, V16, P1267; Farabaugh PJ, 1996, ANNU REV GENET, V30, P507, DOI 10.1146/annurev.genet.30.1.507; FRELS JS, 1995, MOL CELL BIOL, V15, P6488; Friedman KL, 1999, GENE DEV, V13, P2863, DOI 10.1101/gad.13.21.2863; Gesteland RF, 1996, ANNU REV BIOCHEM, V65, P741, DOI 10.1146/annurev.bi.65.070196.003521; Greene EC, 1998, GENE DEV, V12, P2921, DOI 10.1101/gad.12.18.2921; HARPER DS, 1989, P NATL ACAD SCI USA, V86, P3252, DOI 10.1073/pnas.86.9.3252; Harrington L, 1997, GENE DEV, V11, P3109, DOI 10.1101/gad.11.23.3109; Jacobs ME, 2003, EUKARYOT CELL, V2, P103, DOI 10.1128/EC.2.1.103-114.2003; Jacobs ME, 1996, J EUKARYOT MICROBIOL, V43, P442, DOI 10.1111/j.1550-7408.1996.tb04503.x; Jahn CL, 2002, ANNU REV MICROBIOL, V56, P489, DOI 10.1146/annurev.micro.56.012302.160916; JAHN CL, 1993, GENE, V133, P71, DOI 10.1016/0378-1119(93)90226-S; JARACZEWSKI JW, 1993, GENE DEV, V7, P95, DOI 10.1101/gad.7.1.95; Kelleher C, 2002, TRENDS BIOCHEM SCI, V27, P572, DOI 10.1016/S0968-0004(02)02206-5; Klobutcher LA, 2002, CELL, V111, P763, DOI 10.1016/S0092-8674(02)01138-8; KLOBUTCHER LA, 1993, GENE DEV, V7, P84, DOI 10.1101/gad.7.1.84; KOHLSTAEDT LA, 1992, SCIENCE, V256, P1783, DOI 10.1126/science.1377403; Lai CK, 2001, MOL CELL BIOL, V21, P990, DOI 10.1128/MCB.21.4.990-1000.2001; Lingner J, 1997, SCIENCE, V276, P561, DOI 10.1126/science.276.5312.561; Metz AM, 2001, BIOTECHNOL APPL BIOC, V34, P47, DOI 10.1042/BA20010021; Miller MC, 2000, EMBO J, V19, P4412, DOI 10.1093/emboj/19.16.4412; Nakamura TM, 1997, SCIENCE, V277, P955, DOI 10.1126/science.277.5328.955; PATEL PH, 1995, BIOCHEMISTRY-US, V34, P5351, DOI 10.1021/bi00016a006; PRESCOTT DM, 1994, MICROBIOL REV, V58, P233, DOI 10.1128/MMBR.58.2.233-267.1994; PRICE CM, 1994, J EUKARYOT MICROBIOL, V41, P267, DOI 10.1111/j.1550-7408.1994.tb01507.x; Ray S, 2002, MOL CELL BIOL, V22, P5859, DOI 10.1128/MCB.22.16.5859-5868.2002; ROTH M, 1985, CELL, V41, P411, DOI 10.1016/S0092-8674(85)80014-3; SHIPPENLENTZ D, 1990, SCIENCE, V247, P546, DOI 10.1126/science.1689074; Tan M, 2001, J EUKARYOT MICROBIOL, V48, P575, DOI 10.1111/j.1550-7408.2001.tb00193.x; Tan M, 2001, J EUKARYOT MICROBIOL, V48, P80, DOI 10.1111/j.1550-7408.2001.tb00418.x; VERMEESCH JR, 1994, MOL CELL BIOL, V14, P554, DOI 10.1128/MCB.14.1.554; WANG L, 2002, NUCLEIC ACIDS RES, V30, P1	43	39	42	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 30	2003	113	5					565	576		10.1016/S0092-8674(03)00363-5	http://dx.doi.org/10.1016/S0092-8674(03)00363-5			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	687VL	12787498	Bronze			2022-12-24	WOS:000183397600007
J	Mourier, T; Jeffares, DC				Mourier, T; Jeffares, DC			Eukaryotic intron loss	SCIENCE			English	Article							PSEUDOGENES; GENES		Univ Copenhagen, Inst Zool, Dept Evolutionary Biol, DK-2100 Copenhagen, Denmark	University of Copenhagen	Mourier, T (corresponding author), Univ Copenhagen, Inst Zool, Dept Evolutionary Biol, Univ Pk 15, DK-2100 Copenhagen, Denmark.		Mourier, Tobias/C-1164-2015; Jeffares, Daniel/N-2632-2018	Mourier, Tobias/0000-0003-2727-1903; Jeffares, Daniel/0000-0001-7320-0706				Bonen L, 2001, TRENDS GENET, V17, P322, DOI 10.1016/S0168-9525(01)02324-1; Brown JR, 1997, MICROBIOL MOL BIOL R, V61, P456, DOI 10.1128/.61.4.456-502.1997; Derr LK, 1998, GENETICS, V148, P937; Esnault C, 2000, NAT GENET, V24, P363, DOI 10.1038/74184; FINK GR, 1987, CELL, V49, P5, DOI 10.1016/0092-8674(87)90746-X; Gardner MJ, 2002, NATURE, V419, P531, DOI 10.1038/nature01094; GIROUX MJ, 1994, P NATL ACAD SCI USA, V91, P12150, DOI 10.1073/pnas.91.25.12150; GLOCKNER G, COMMUNICATION; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Nixon JEJ, 2002, P NATL ACAD SCI USA, V99, P3701, DOI 10.1073/pnas.042700299; Sakurai A, 2002, GENE, V300, P89, DOI 10.1016/S0378-1119(02)01035-1; SCHANDORFF S, 2000, THESIS U COPENHAGEN; Simpson AGB, 2002, NATURE, V419, P270, DOI 10.1038/419270a; WEINER AM, 1986, ANNU REV BIOCHEM, V55, P631, DOI 10.1146/annurev.bi.55.070186.003215	14	164	174	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 30	2003	300	5624					1393	1393		10.1126/science.1080559	http://dx.doi.org/10.1126/science.1080559			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	683ZW	12775832				2022-12-24	WOS:000183181800034
J	Jacobsson, LTH; Jacobsson, ME; Askling, J; Knowler, WC				Jacobsson, LTH; Jacobsson, ME; Askling, J; Knowler, WC			Perinatal characteristics and risk of rheumatoid arthritis	BRITISH MEDICAL JOURNAL			English	Article									Malmo Univ Hosp, Dept Rheumatol, S-20502 Malmo, Sweden; Karolinska Hosp & Inst, Clin Epidemiol Unit, S-17176 Stockholm, Sweden; NIDDK, Diabet & Arthrit Epidemiol Sect, Phoenix, AZ 85014 USA	Lund University; Skane University Hospital; Karolinska Institutet; Karolinska University Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Jacobsson, LTH (corresponding author), Malmo Univ Hosp, Dept Rheumatol, S-20502 Malmo, Sweden.							Enzer I, 2002, ARTHRITIS RHEUM, V46, P1729, DOI 10.1002/art.10360; KaipiainenSeppanen O, 1996, CLIN EXP RHEUMATOL, V14, P537; MacGregor AJ, 2000, ARTHRITIS RHEUM, V43, P30, DOI 10.1002/1529-0131(200001)43:1<30::AID-ANR5>3.0.CO;2-B; Symmons D, 2000, RHEUMATOLOGY, V39, P835, DOI 10.1093/rheumatology/39.8.835; Walker-Bone K, 2002, RHEUMATOLOGY, V41, P69	5	61	62	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 17	2003	326	7398					1068	1069		10.1136/bmj.326.7398.1068	http://dx.doi.org/10.1136/bmj.326.7398.1068			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	681ZD	12750209	Green Submitted, Bronze, Green Published			2022-12-24	WOS:000183064700017
J	Mounkes, LC; Kozlov, S; Hernandez, L; Sullivan, T; Stewart, CL				Mounkes, LC; Kozlov, S; Hernandez, L; Sullivan, T; Stewart, CL			A progeroid syndrome in mice is caused by defects in A-type lamins	NATURE			English	Article							DREIFUSS MUSCULAR-DYSTROPHY; NUCLEAR-ENVELOPE; GENE; EXPRESSION; MUTATIONS; DISEASE; CELLS	Numerous studies of the underlying causes of ageing have been attempted by examining diseases associated with premature ageing, such as Werner's syndrome and Hutchinson - Gilford progeria syndrome (HGPS). HGPS is a rare genetic disorder resulting in phenotypes suggestive of accelerated ageing, including shortened stature, craniofacial disproportion, very thin skin, alopecia and osteoporosis, with death in the early teens predominantly due to atherosclerosis(1). However, recent reports suggest that developmental abnormalities may also be important in HGPS(1,2). Here we describe the derivation of mice carrying an autosomal recessive mutation in the lamin A gene (Lmna) encoding A-type lamins, major components of the nuclear lamina(3). Homozygous mice display defects consistent with HGPS, including a marked reduction in growth rate and death by 4 weeks of age. Pathologies in bone, muscle and skin are also consistent with progeria. The Lmna mutation resulted in nuclear morphology defects and decreased lifespan of homozygous fibroblasts, suggesting premature cell death. Here we present a mouse model for progeria that may elucidate mechanisms of ageing and development in certain tissue types, especially those developing from the mesenchymal cell lineage.	NCI, Canc & Dev Biol Lab, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Stewart, CL (corresponding author), NCI, Canc & Dev Biol Lab, Frederick, MD 21702 USA.				NATIONAL CANCER INSTITUTE [Z01BC010377] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ackerman J, 2002, PEDIATR PATHOL MOL M, V21, P1, DOI 10.1080/15227950252774110; Bonne G, 1999, NAT GENET, V21, P285, DOI 10.1038/6799; Burke B, 2002, NAT REV MOL CELL BIO, V3, P575, DOI 10.1038/nrm879; Hoeffel JC, 2000, SKELETAL RADIOL, V29, P668, DOI 10.1007/s002560000280; Holaska JM, 2003, J BIOL CHEM, V278, P6969, DOI 10.1074/jbc.M208811200; Hutchison CJ, 2002, NAT REV MOL CELL BIO, V3, P848, DOI 10.1038/nrm950; Kirkland JL, 2002, EXP GERONTOL, V37, P757, DOI 10.1016/S0531-5565(02)00014-1; Lewandoski M, 1997, COLD SPRING HARB SYM, V62, P159; Lewis M, 2003, AGEING RES REV, V2, P95, DOI 10.1016/S1568-1637(02)00044-2; LUFKIN T, 1992, NATURE, V359, P835, DOI 10.1038/359835a0; Morris GE, 2001, TRENDS MOL MED, V7, P572, DOI 10.1016/S1471-4914(01)02128-1; OZAKI T, 1994, ONCOGENE, V9, P2649; Raharjo WH, 2001, J CELL SCI, V114, P4447; Rodrigues GHD, 2002, ANN GENET-PARIS, V45, P151, DOI 10.1016/S0003-3995(02)01119-X; ROEBER R-A, 1990, Journal of Cell Science, V95, P587; Sabourin LA, 1999, J CELL BIOL, V144, P631, DOI 10.1083/jcb.144.4.631; Sarkar PK, 2001, POSTGRAD MED J, V77, P312, DOI 10.1136/pmj.77.907.312; Spann TP, 2002, J CELL BIOL, V156, P603, DOI 10.1083/jcb.200112047; STEWART CL, 1993, METHOD ENZYMOL, V225, P823; Sullivan T, 1999, J CELL BIOL, V147, P913, DOI 10.1083/jcb.147.5.913; Taylor-Jones JM, 2002, MECH AGEING DEV, V123, P649, DOI 10.1016/S0047-6374(01)00411-0; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Uitto Jouni, 2002, Trends in Endocrinology and Metabolism, V13, P140, DOI 10.1016/S1043-2760(02)00595-7; Upchurch DA, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e69; Vigouroux C, 2001, J CELL SCI, V114, P4459; Worman HJ, 2002, TRENDS CELL BIOL, V12, P591, DOI 10.1016/S0962-8924(02)02401-7	26	267	278	1	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 15	2003	423	6937					298	301		10.1038/nature01631	http://dx.doi.org/10.1038/nature01631			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678EX	12748643	Green Published			2022-12-24	WOS:000182853100045
J	Reynolds, SJ; Bartlett, JG; Quinn, TC; Beyrer, C; Bollinger, RC				Reynolds, SJ; Bartlett, JG; Quinn, TC; Beyrer, C; Bollinger, RC			Antiretroviral therapy where resources are limited	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							DRUG-RESISTANCE; POOR SETTINGS; COTE-DIVOIRE; HIV; ADULTS; TUBERCULOSIS; INFECTION; SURVIVAL; ABIDJAN; AFRICA		Johns Hopkins Univ, Sch Med, Div Infect Dis, Baltimore, MD 21205 USA; NIAID, NIH, Bethesda, MD 20892 USA; Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA	Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Reynolds, SJ (corresponding author), Johns Hopkins Univ, Sch Med, Div Infect Dis, Baltimore, MD 21205 USA.		safaiee, malihe/C-5045-2018; Zolfigol, Mohammad Ali/AAH-9281-2020; Habibi, Davood/AAH-3062-2020	Habibi, Davood/0000-0002-2386-8502; Bollinger, Robert/0000-0002-6798-6834; Reynolds, Steven/0000-0002-5403-2759	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000361, Z01AI000361] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Adje C, 2001, J ACQ IMMUN DEF SYND, V26, P501, DOI 10.1097/00126334-200104150-00018; Anglaret X, 1999, LANCET, V353, P1463, DOI 10.1016/S0140-6736(98)07399-1; Attaran A, 2001, LANCET, V357, P57, DOI 10.1016/S0140-6736(00)03576-5; Badri M, 2002, LANCET, V359, P2059, DOI 10.1016/S0140-6736(02)08904-3; Bell JC, 1999, AIDS, V13, P1549, DOI 10.1097/00002030-199908200-00016; Brenner B, 2000, INT J ANTIMICROB AG, V16, P429, DOI 10.1016/S0924-8579(00)00270-3; *BRIT HIV ASS, 2002, GUID TREATM HIV INF; Casseb J, 1999, AIDS PATIENT CARE ST, V13, P213, DOI 10.1089/apc.1999.13.213; *DEP HLTH HUM SERV, 2002, GUID US ANT AG HIV I; Farmer P, 2001, LANCET, V358, P404, DOI 10.1016/S0140-6736(01)05550-7; *GLOB FUND FIGHT A, 2002, PROP COMP APPR FUND; Kam KM, 1998, CLIN IMMUNOL IMMUNOP, V89, P11, DOI 10.1006/clin.1998.4570; Kannangai R, 2000, J CLIN VIROL, V17, P101, DOI 10.1016/S1386-6532(00)00080-9; Kebba A, 2002, AIDS RES HUM RETROV, V18, P1181, DOI 10.1089/08892220260387922; Kitahata MM, 1996, NEW ENGL J MED, V334, P701, DOI 10.1056/NEJM199603143341106; Laurent C, 2002, AIDS, V16, P1363, DOI 10.1097/00002030-200207050-00008; Little SJ, 2002, NEW ENGL J MED, V347, P385, DOI 10.1056/NEJMoa013552; Mbewu A, 2001, B WORLD HEALTH ORGAN, V79, P1152; Porter K, 2001, BRIT MED J, V322, P1087, DOI 10.1136/bmj.322.7294.1087; Rabkin M, 2002, LANCET, V360, P1503, DOI 10.1016/S0140-6736(02)11478-4; Vergne L, 2002, J ACQ IMMUN DEF SYND, V29, P165, DOI 10.1097/00042560-200202010-00009; Weidle PJ, 2002, LANCET, V360, P34, DOI 10.1016/S0140-6736(02)09330-3; *WHO, 2002, SCAL ANT THER RES LI; *WHO UNAIDS, 2000, WHO UNAIDS HAIL CONS; Yeni PG, 2002, JAMA-J AM MED ASSOC, V288, P222, DOI 10.1001/jama.288.2.222	25	24	25	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 1	2003	348	18					1806	1809		10.1056/NEJMsb035366	http://dx.doi.org/10.1056/NEJMsb035366			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	672VK	12724489	Bronze			2022-12-24	WOS:000182543500012
J	Shedlock, DJ; Shen, H				Shedlock, DJ; Shen, H			Requirement for CD4 T cell help in generating functional CD8 T cell memory	SCIENCE			English	Article							CD4-DEFICIENT MICE; VIRAL-INFECTION; VIRUS CHALLENGE; RESPONSES; IMMUNIZATION; LYMPHOCYTES	Although primary CD8 responses to acute infections are independent of CD4 help, it is unknown whether a similar situation applies to secondary responses. We show that depletion of CD4 cells during the recall response has minimal effect, whereas depletion during the priming phase leads to reduced responses by memory CD8 cells to reinfection. Memory CD8 cells generated in CD4(+/+) mice responded normally when transferred into CD4(-/-) hosts, whereas memory CD8 cells generated in CD4(-/-) mice mounted defective recall responses in CD4(-/-) adoptive hosts. These results demonstrate a previously undescribed role for CD4 help in the development of functional CD8 memory.	Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA	University of Pennsylvania	Shen, H (corresponding author), Univ Penn, Sch Med, Dept Microbiol, 3610 Hamilton Walk, Philadelphia, PA 19104 USA.			Shedlock, Devon/0000-0003-1018-7510	NIAID NIH HHS [AI45025, AI07632] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045025] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Belz GT, 2000, P NATL ACAD SCI USA, V97, P2725, DOI 10.1073/pnas.040575197; Bennett SRM, 1998, NATURE, V393, P478, DOI 10.1038/30996; Bourgeois C, 2002, SCIENCE, V297, P2060, DOI 10.1126/science.1072615; den Haan JMM, 2000, P NATL ACAD SCI USA, V97, P12950, DOI 10.1073/pnas.97.24.12950; Foulds KE, 2002, J IMMUNOL, V168, P1528, DOI 10.4049/jimmunol.168.4.1528; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Janssen EM, 2003, NATURE, V421, P852, DOI 10.1038/nature01441; Kaech SM, 2002, NAT REV IMMUNOL, V2, P251, DOI 10.1038/nri778; Liu HY, 2002, J IMMUNOL, V168, P3477, DOI 10.4049/jimmunol.168.7.3477; MATLOUBIAN M, 1994, J VIROL, V68, P8056, DOI 10.1128/JVI.68.12.8056-8063.1994; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; RAHEMTULLA A, 1991, NATURE, V353, P180, DOI 10.1038/353180a0; Riberdy JM, 2000, J VIROL, V74, P9762, DOI 10.1128/JVI.74.20.9762-9765.2000; Ridge JP, 1998, NATURE, V393, P474, DOI 10.1038/30989; Schneider J, 1999, IMMUNOL REV, V170, P29, DOI 10.1111/j.1600-065X.1999.tb01326.x; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; Shedlock DJ, 2003, J IMMUNOL, V170, P2053, DOI 10.4049/jimmunol.170.4.2053; vonHerrath MG, 1996, J VIROL, V70, P1072, DOI 10.1128/JVI.70.2.1072-1079.1996; WHITTON JL, 1993, J VIROL, V67, P348, DOI 10.1128/JVI.67.1.348-352.1993; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205	20	1156	1204	2	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 11	2003	300	5617					337	339		10.1126/science.1082305	http://dx.doi.org/10.1126/science.1082305			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665RQ	12690201				2022-12-24	WOS:000182135400059
J	Li, XY; Qian, Q; Fu, ZM; Wang, YH; Xiong, GS; Zeng, DL; Wang, XQ; Liu, XF; Teng, S; Hiroshi, F; Yuan, M; Luo, D; Han, B; Li, JY				Li, XY; Qian, Q; Fu, ZM; Wang, YH; Xiong, GS; Zeng, DL; Wang, XQ; Liu, XF; Teng, S; Hiroshi, F; Yuan, M; Luo, D; Han, B; Li, JY			Control of tillering in rice	NATURE			English	Article							CELL-DIVISION; SIGNAL-TRANSDUCTION; ARABIDOPSIS ROOT; GENE ENCODES; PATHWAY; FAMILY; GRAS; EVOLUTION; PROTEIN; MEMBER	Tillering in rice (Oryza sativa L.) is an important agronomic trait for grain production, and also a model system for the study of branching in monocotyledonous plants. Rice tiller is a specialized grain-bearing branch that is formed on the unelongated basal internode and grows independently of the mother stem (culm) by means of its own adventitious roots(1). Rice tillering occurs in a two-stage process: the formation of an axillary bud at each leaf axil and its subsequent outgrowth(2). Although the morphology and histology(2,3) and some mutants of rice tillering(4) have been well described, the molecular mechanism of rice tillering remains to be elucidated. Here we report the isolation and characterization of MONOCULM 1 (MOC1), a gene that is important in the control of rice tillering. The moc1 mutant plants have only a main culm without any tillers owing to a defect in the formation of tiller buds. MOC1 encodes a putative GRAS family nuclear protein that is expressed mainly in the axillary buds and functions to initiate axillary buds and to promote their outgrowth.	Chinese Acad Sci, Inst Genet & Dev Biol, Beijing 100101, Peoples R China; Chinese Acad Agr Sci, China Natl Rice Res Inst, Hangzhou 310006, Zhejiang, Peoples R China; China Agr Univ, Beijing 100094, Peoples R China; Chinese Acad Sci, Inst Plant Physiol & Ecol, Shanghai 200032, Peoples R China; Chinese Acad Sci, Natl Ctr Gene Res, Shanghai 200233, Peoples R China	Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Agricultural Sciences; China National Rice Research Institute, CAAS; China Agricultural University; Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Li, JY (corresponding author), Chinese Acad Sci, Inst Genet & Dev Biol, Beijing 100101, Peoples R China.		qian, qian/AAH-8708-2021; Li, Jiayang/AAG-4377-2020	Li, Xueyong/0000-0002-8955-0345				[Anonymous], 1995, RICE GENET NEWSLETT; Bolle C, 2000, GENE DEV, V14, P1269; DiLaurenzio L, 1996, CELL, V86, P423, DOI 10.1016/S0092-8674(00)80115-4; Doebley J, 1997, NATURE, V386, P485, DOI 10.1038/386485a0; FOBERT PR, 1994, EMBO J, V13, P616, DOI 10.1002/j.1460-2075.1994.tb06299.x; Hanada K, 1993, SCI RICE PLANT, V1, P222; Hanada K., 1995, SCI RICE PLANT PHYSL, V2, P61; Harushima Y, 1998, GENETICS, V148, P479; Helariutta Y, 2000, CELL, V101, P555, DOI 10.1016/S0092-8674(00)80865-X; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Hu YX, 2000, PLANT J, V24, P693, DOI 10.1046/j.1365-313x.2000.00915.x; Hubbard L, 2002, GENETICS, V162, P1927; Itoh H, 2002, PLANT CELL, V14, P57, DOI 10.1105/tpc.010319; KATAYAMA TUKUDA, 1931, JOUR IMP AGRIC EXP STA [TOKYO] [NOJI SHIKEN JO IHO], V1, P327; Li YH, 1979, MORPHOLOGY ANATOMY G, P138; Lukens L, 2001, MOL BIOL EVOL, V18, P627, DOI 10.1093/oxfordjournals.molbev.a003843; Niwa Y, 1999, PLANT J, V18, P455, DOI 10.1046/j.1365-313X.1999.00464.x; Otsuga D, 2001, PLANT J, V25, P223, DOI 10.1046/j.1365-313x.2001.00959.x; Peng JR, 1997, GENE DEV, V11, P3194, DOI 10.1101/gad.11.23.3194; Peng JR, 1999, NATURE, V400, P256, DOI 10.1038/22307; Pysh LD, 1999, PLANT J, V18, P111, DOI 10.1046/j.1365-313X.1999.00431.x; Richards DE, 2000, BIOESSAYS, V22, P573, DOI 10.1002/(SICI)1521-1878(200006)22:6&lt;573::AID-BIES10&gt;3.0.CO;2-H; Sato Y, 1996, P NATL ACAD SCI USA, V93, P8117, DOI 10.1073/pnas.93.15.8117; Schmitz G, 2002, P NATL ACAD SCI USA, V99, P1064, DOI 10.1073/pnas.022516199; Schumacher K, 1999, P NATL ACAD SCI USA, V96, P290, DOI 10.1073/pnas.96.1.290; Silverstone AL, 1998, PLANT CELL, V10, P155, DOI 10.1105/tpc.10.2.155; Smith HMS, 1997, PLANT PHYSIOL, V114, P411, DOI 10.1104/pp.114.2.411; Stirnberg P, 2002, DEVELOPMENT, V129, P1131; Yan JQ, 1998, THEOR APPL GENET, V97, P267, DOI 10.1007/s001220050895	29	733	983	28	435	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 10	2003	422	6932					618	621		10.1038/nature01518	http://dx.doi.org/10.1038/nature01518			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665GN	12687001				2022-12-24	WOS:000182111400043
J	Bjedov, I; Tenaillon, O; Gerard, B; Souza, V; Denamur, E; Radman, M; Taddei, F; Matic, I				Bjedov, I; Tenaillon, O; Gerard, B; Souza, V; Denamur, E; Radman, M; Taddei, F; Matic, I			Stress-induced mutagenesis in bacteria	SCIENCE			English	Article							STATIONARY-PHASE MUTATION; DNA-POLYMERASE-II; ESCHERICHIA-COLI; ADAPTIVE MUTATION; MISMATCH REPAIR; GENE-EXPRESSION; POPULATIONS; MUTATORS; RPOS; RECOMBINATION	The evolutionary significance of stress-induced mutagenesis was evaluated by studying mutagenesis in aging colonies ( MAC) of Escherichia coli natural isolates. A large fraction of isolates exhibited a strong MAC, and the high MAC variability reflected the diversity of selective pressures in ecological niches. MAC depends on starvation, oxygen, and RpoS and adenosine 3',5'-monophosphate regulons; thus it may be a by-product of genetic strategies for improving survival under stress. MAC could also be selected through beneficial mutations that it generates, as shown by computer modeling and the patterns of stress-inducible and constitutive mutagenesis. We suggest that irrespective of the causes of their emergence, stress-induced mutations participate in adaptive evolution.	Univ Paris 05, Fac Med Necker Enfants Malad, INSERM, U571, F-75730 Paris 15, France; Univ Paris 07, Fac Med Xavier Bichat, INSERM, EO339, F-75870 Paris, France; Univ Nacl Autonoma Mexico, Inst Ecol, Dept Ecol Evolut, Mexico City 04510, DF, Mexico	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universidad Nacional Autonoma de Mexico	Matic, I (corresponding author), Univ Paris 05, Fac Med Necker Enfants Malad, INSERM, U571, 156 Rue Vaugirard, F-75730 Paris 15, France.		Tenaillon, Olivier/L-9857-2017; Radman, Miroslav/HDM-5955-2022	Tenaillon, Olivier/0000-0002-3796-1601; Taddei, Francois/0000-0002-7894-0647; Radman, Miroslav/0000-0003-0216-3148; Radman, Miroslav/0000-0002-7034-4365; souza, valeria/0000-0002-2992-4229; Bjedov, Ivana/0000-0001-5894-6016				Bregeon D, 1999, J GENET, V78, P21, DOI 10.1007/BF02994699; Bridges BA, 1998, MUTAT RES-DNA REPAIR, V408, P1, DOI 10.1016/S0921-8777(98)00008-1; Chicurel M, 2001, SCIENCE, V292, P1824, DOI 10.1126/science.292.5523.1824; Courcelle J, 2001, GENETICS, V158, P41; CUPPLES CG, 1990, GENETICS, V125, P275; Denamur E, 2002, J BACTERIOL, V184, P605, DOI 10.1128/JB.184.2.605-609.2002; Denamur E, 2000, CELL, V103, P711, DOI 10.1016/S0092-8674(00)00175-6; Duriez P, 2001, MICROBIOL-SGM, V147, P1671, DOI 10.1099/00221287-147-6-1671; ESCARCELLER M, 1994, J BACTERIOL, V176, P6221, DOI 10.1128/jb.176.20.6221-6228.1994; Foster PL, 1999, ANNU REV GENET, V33, P57, DOI 10.1146/annurev.genet.33.1.57; Friedberg E.C., 2016, DNA REPAIR MUTAGENES, V33, P35; Giraud A, 2001, CURR OPIN MICROBIOL, V4, P582, DOI 10.1016/S1369-5274(00)00254-X; HARRIS RS, 1994, SCIENCE, V264, P258, DOI 10.1126/science.8146657; Harris RS, 1997, GENE DEV, V11, P2426, DOI 10.1101/gad.11.18.2426; Hengge-Aronis R, 2002, MICROBIOL MOL BIOL R, V66, P373, DOI 10.1128/MMBR.66.3.373-395.2002; Holliday R, 1995, UNDERSTANDING AGING; Karunakaran P, 2000, J BACTERIOL, V182, P3331, DOI 10.1128/JB.182.12.3331-3335.2000; LeClerc JE, 1996, SCIENCE, V274, P1208, DOI 10.1126/science.274.5290.1208; LENSKI RE, 1995, SCIENCE, V269, P285, DOI 10.1126/science.7618089; Matic I, 1997, SCIENCE, V277, P1833, DOI 10.1126/science.277.5333.1833; McKenzie GJ, 2000, P NATL ACAD SCI USA, V97, P6646, DOI 10.1073/pnas.120161797; McKenzie GJ, 2001, MOL CELL, V7, P571, DOI 10.1016/S1097-2765(01)00204-0; Miller JH, 1998, MUTAT RES-DNA REPAIR, V409, P99, DOI 10.1016/S0921-8777(98)00049-4; Napolitano R, 2000, EMBO J, V19, P6259, DOI 10.1093/emboj/19.22.6259; PETERS AC, 1987, J GEN MICROBIOL, V133, P1257; Runyen-Janecky LJ, 1999, INFECT IMMUN, V67, P1415, DOI 10.1128/IAI.67.3.1415-1423.1999; Saier MH, 1996, ESCHERICHIA COLI SAL, V1, P1325; Saumaa S, 2002, J BACTERIOL, V184, P6957, DOI 10.1128/JB.184.24.6957-6965.2002; SEDGWICK SG, 1985, P NATL ACAD SCI USA, V82, P4172, DOI 10.1073/pnas.82.12.4172; Sommer SS, 2001, MUTAT RES-DNA REPAIR, V487, P1, DOI 10.1016/S0921-8777(01)00108-2; STEELE DF, 1992, GENETICS, V132, P9; Taddei F, 1997, MOL GEN GENET, V256, P277, DOI 10.1007/s004380050570; TADDEI F, 1995, P NATL ACAD SCI USA, V92, P11736, DOI 10.1073/pnas.92.25.11736; Tenaillon O, 2000, P NATL ACAD SCI USA, V97, P10465, DOI 10.1073/pnas.180063397; Tenaillon O, 1999, GENETICS, V152, P485; Tenaillon O, 2001, RES MICROBIOL, V152, P11, DOI 10.1016/S0923-2508(00)01163-3; TESSMAN I, 1994, GENETICS, V136, P439; Tsui HCT, 1997, J BACTERIOL, V179, P7476, DOI 10.1128/jb.179.23.7476-7487.1997	38	404	416	5	111	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 30	2003	300	5624					1404	1409		10.1126/science.1082240	http://dx.doi.org/10.1126/science.1082240			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	683ZW	12775833				2022-12-24	WOS:000183181800037
J	Marra, MA; Jones, SJM; Astell, CR; Holt, RA; Brooks-Wilson, A; Butterfield, YSN; Khattra, J; Asano, JK; Barber, SA; Chan, SY; Cloutier, A; Coughlin, SM; Freeman, D; Girn, N; Griffith, OL; Leach, SR; Mayo, M; McDonald, H; Montgomery, SB; Pandoh, PK; Petrescu, AS; Robertson, AG; Schein, JE; Siddiqui, A; Smailus, DE; Stott, JE; Yang, GS; Plummer, F; Andonov, A; Artsob, H; Bastien, N; Bernard, K; Booth, TF; Bowness, D; Czub, M; Drebot, M; Fernando, L; Flick, R; Garbutt, M; Gray, M; Grolla, A; Jones, S; Feldmann, H; Meyers, A; Kabani, A; Li, Y; Normand, S; Stroher, U; Tipples, GA; Tyler, S; Vogrig, R; Ward, D; Watson, B; Brunham, RC; Krajden, M; Petric, M; Skowronski, DM; Upton, C; Roper, RL				Marra, MA; Jones, SJM; Astell, CR; Holt, RA; Brooks-Wilson, A; Butterfield, YSN; Khattra, J; Asano, JK; Barber, SA; Chan, SY; Cloutier, A; Coughlin, SM; Freeman, D; Girn, N; Griffith, OL; Leach, SR; Mayo, M; McDonald, H; Montgomery, SB; Pandoh, PK; Petrescu, AS; Robertson, AG; Schein, JE; Siddiqui, A; Smailus, DE; Stott, JE; Yang, GS; Plummer, F; Andonov, A; Artsob, H; Bastien, N; Bernard, K; Booth, TF; Bowness, D; Czub, M; Drebot, M; Fernando, L; Flick, R; Garbutt, M; Gray, M; Grolla, A; Jones, S; Feldmann, H; Meyers, A; Kabani, A; Li, Y; Normand, S; Stroher, U; Tipples, GA; Tyler, S; Vogrig, R; Ward, D; Watson, B; Brunham, RC; Krajden, M; Petric, M; Skowronski, DM; Upton, C; Roper, RL			The genome sequence of the SARS-associated coronavirus	SCIENCE			English	Article							PROTEIN FAMILIES; VIRUS; TRANSCRIPTION; GENERATION; DATABASE	We sequenced the 29,751-base genome of the severe acute respiratory syndrome (SARS)-associated coronavirus known as the Tor2 isolate. The genome sequence reveals that this coronavirus is only moderately related to other known coronaviruses, including two human coronaviruses, HCoV-OC43 and HCoV-229E. Phylogenetic analysis of the predicted viral proteins indicates that the virus does not closely resemble any of the three previously known groups of coronaviruses. The genome sequence will aid in the diagnosis of SARS virus infection in humans and potential animal hosts (using polymerase chain reaction and immunological tests), in the development of antivirals (including neutralizing antibodies), and in the identification of putative epitopes for vaccine development.	British Columbia Canc Agcy, Genome Sci Ctr, Vancouver, BC V5Z 4E6, Canada; Natl Microbiol Lab, Winnipeg, MB R3E 3R2, Canada; British Columbia Ctr Dis Control, Vancouver, BC V5Z 4R4, Canada; Univ British Columbia, Ctr Dis Control, Vancouver, BC V5Z 4R4, Canada; Univ Victoria, Dept Biochem & Microbiol, Victoria, BC V8W 3P6, Canada	British Columbia Cancer Agency; University of British Columbia; University of Victoria	Marra, MA (corresponding author), British Columbia Canc Agcy, Genome Sci Ctr, 600 W 10th Ave, Vancouver, BC V5Z 4E6, Canada.	mmarra@bccgsc.ca	Schein, Jacquie E/G-3674-2015; Holt, Robert A/C-3303-2009; Upton, Chris/A-4670-2008; Brooks-Wilson, Angela/E-9399-2012; Marra, Marco A/B-5987-2008; Jones, Steven J/C-3621-2009; Roper, Rachel/A-7935-2013; Griffith, Obi/P-1286-2014	Holt, Robert A/0000-0002-7259-1247; Brooks-Wilson, Angela/0000-0003-1009-6408; Marra, Marco A/0000-0001-7146-7175; Jones, Steven J/0000-0003-3394-2208; Roper, Rachel/0000-0001-6971-7745; Montgomery, Stephen/0000-0002-5200-3903; Griffith, Obi/0000-0002-0843-4271; Upton, Chris/0000-0002-9019-8967				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Apweiler R, 2001, NUCLEIC ACIDS RES, V29, P37, DOI 10.1093/nar/29.1.37; Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; DONNELLY CA, 2003, LANCET          0507; Fauquet C.M., 2000, VIRUS TAXONOMY CLASS, P835; Felsenstein J., 1993, PHYLIP PHYLOGENY INF; Fields B. N., 2001, FIELDS VIROLOGY, V4; Hofmann K., 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Jonassen CM, 1998, J GEN VIROL, V79, P715, DOI 10.1099/0022-1317-79-4-715; Krishnan R, 1996, VIROLOGY, V218, P400, DOI 10.1006/viro.1996.0210; Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781; KUO L, 2002, ANN M AM SOC VIR LEX; Lai MMC, 1997, ADV VIRUS RES, V48, P1, DOI 10.1016/S0065-3527(08)60286-9; LAPPS W, 1987, VIROLOGY, V157, P47, DOI 10.1016/0042-6822(87)90312-6; Munch R, 2003, MICROBES INFECT, V5, P69, DOI 10.1016/S1286-4579(02)00053-9; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Ortego J, 2002, J VIROL, V76, P11518, DOI 10.1128/JVI.76.22.11518-11529.2002; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; PEIRIS JSM, 2003, LANCET          0408; Poutanen SM, 2003, NEW ENGL J MED, V348, P1995, DOI 10.1056/NEJMoa030634; Rota PA, 2003, SCIENCE, V300, P1394, DOI 10.1126/science.1085952; Sawicki DL, 2001, J GEN VIROL, V82, P385, DOI 10.1099/0022-1317-82-2-385; Sawicki SG, 1998, ADV EXP MED BIOL, V440, P215; SAWICKI SG, 1990, J VIROL, V64, P1050, DOI 10.1128/JVI.64.3.1050-1056.1990; SCHAAD MC, 1994, J VIROL, V68, P8169, DOI 10.1128/JVI.68.12.8169-8179.1994; SETHNA PB, 1989, P NATL ACAD SCI USA, V86, P5626, DOI 10.1073/pnas.86.14.5626; Siddell S.G., 1995, CORONAVIRIDAE, P389; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tsai JC, 2003, J VIROL, V77, P841, DOI 10.1128/JVI.77.2.841-850.2003; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Ziebuhr J, 2000, J GEN VIROL, V81, P853, DOI 10.1099/0022-1317-81-4-853	32	1575	1911	5	239	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 30	2003	300	5624					1399	1404		10.1126/science.1085953	http://dx.doi.org/10.1126/science.1085953			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	683ZW	12730501				2022-12-24	WOS:000183181800036
J	Oldfield, TEE; Smith, RJ; Harrop, SR; Leader-Williams, N				Oldfield, TEE; Smith, RJ; Harrop, SR; Leader-Williams, N			Field sports and conservation in the United Kingdom	NATURE			English	Article							AGRI-ENVIRONMENT SCHEMES; PROTECTED AREAS; BIODIVERSITY; COUNTRYSIDE; FARMERS; ENGLAND	Many natural habitats exist on privately owned land outside protected areas(1), but few governments can afford to enforce or subsidize conservation of this biodiversity. Even in some developed countries, conservation subsidy schemes have only achieved limited success(2-4). Fortunately, some landowners may be willing to accept management costs in return for other benefits(5), although this remains controversial when it involves the killing of charismatic species. For example, participants in British field sports, such as fox hunting and game-bird shooting, may voluntarily conserve important habitats that are required by quarry species(6-8). Here we report results from a multidisciplinary study that addressed this issue by focusing on three sites across central England. We found that landowners participating in field sports maintained the most established woodland and planted more new woodland and hedgerows than those who did not, despite the equal availability of subsidies. Therefore, voluntary habitat management appears to be important for biodiversity conservation in Britain. Current debates on the future of field sports in Britain, and similar activities globally, may benefit from considering their utility as incentives to conserve additional habitat on private land.	Univ Kent, Durrell Inst Conservat & Ecol, Canterbury CT2 7NS, Kent, England	University of Kent	Leader-Williams, N (corresponding author), Univ Kent, Durrell Inst Conservat & Ecol, Canterbury CT2 7NS, Kent, England.		Smith, Robert J/D-9660-2011	Smith, Robert J/0000-0003-1599-9171				Baker PJ, 2002, NATURE, V419, P34, DOI 10.1038/419034a; Barr C.J., 1990, COUNTRYSIDE SURVEY 1; Beedell JDC, 1999, J ENVIRON MANAGE, V57, P165, DOI 10.1006/jema.1999.0296; BENNETT AF, 1999, LINKAGE LANDSCAPE RO; BURNS L, 2000, REPORT COMMITTEE INQ; *ENGL NAT, 2002, ANN REP APR 1 2001 3; Garbutt RA, 2002, BIOL CONSERV, V106, P273, DOI 10.1016/S0006-3207(01)00253-1; GLOWKA L, 1994, GUID CONV BIOL DIV; Goodman P.S., 2002, MAINSTREAMING BIODIV, P21; Kleijn D, 2001, NATURE, V413, P723, DOI 10.1038/35099540; Krebs JR, 1999, NATURE, V400, P611, DOI 10.1038/23127; Langholz JA, 2001, BIOSCIENCE, V51, P1079, DOI 10.1641/0006-3568(2001)051[1079:PAPOPO]2.0.CO;2; Leader-Williams N, 2002, NATURE, V419, P878, DOI 10.1038/419878a; LEADERWILLIAMS N, 1990, SCI PROGRESS-UK, V74, P189; LOVELACE D, 2000, MONEY MAKES COUNTRY; Macdonald D. W, 1987, RUNNING FOX; Macdonald DW, 2000, BIOL CONSERV, V94, P221, DOI 10.1016/S0006-3207(99)00173-1; O'Connell M, 2002, BIOL CONSERV, V103, P115, DOI 10.1016/S0006-3207(01)00125-2; Ovenden GN, 1998, J APPL ECOL, V35, P955, DOI 10.1111/j.1365-2664.1998.tb00014.x; ROBERTSON PA, 1988, BIOL CONSERV, V45, P159, DOI 10.1016/0006-3207(88)90136-X; Robinson RA, 2002, J APPL ECOL, V39, P157, DOI 10.1046/j.1365-2664.2002.00695.x; Stoate C, 2002, BIODIVERS CONSERV, V11, P561, DOI 10.1023/A:1015564806990; Sutherland WJ, 2002, TRENDS ECOL EVOL, V17, P148, DOI 10.1016/S0169-5347(01)02421-1; Tapper S., 1999, QUESTION BALANCE GAM; Thomas RC, 1997, BIOL CONSERV, V82, P243, DOI 10.1016/S0006-3207(97)00039-6; *UK GOV, 2001, ACH BETT QUAL LIF GO	26	50	55	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 29	2003	423	6939					531	533		10.1038/nature01678	http://dx.doi.org/10.1038/nature01678			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	683RH	12774120	Bronze			2022-12-24	WOS:000183162900041
J	Lev-Maor, G; Sorek, R; Shomron, N; Ast, G				Lev-Maor, G; Sorek, R; Shomron, N; Ast, G			The birth of an alternatively spliced exon: 3 ' splice-site selection in Alu exons	SCIENCE			English	Article							MESSENGER-RNA; MEDIATED INSERTION; SEQUENCE; ELEMENTS; SUBUNIT; GENES; MUTATION; RECEPTOR; VARIANT; JUNK	Alu repetitive elements can be inserted into mature messenger RNAs via a splicing-mediated process termed exonization. To understand the molecular basis and the regulation of the process of turning intronic Alus into new exons, we compiled and analyzed a data set of human exonized Alus. We revealed a mechanism that governs 3' splice-site selection in these exons during alternative splicing. On the basis of these findings, we identified mutations that activated the exonization of a silent intronic Alu.	Tel Aviv Univ, Sackler Fac Med, Dept Human Genet & Mol Med, IL-69978 Ramat Aviv, Israel; Compugen, IL-69512 Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine	Ast, G (corresponding author), Tel Aviv Univ, Sackler Fac Med, Dept Human Genet & Mol Med, IL-69978 Ramat Aviv, Israel.	gilast@post.tau.ac.il						BROSIUS J, 1992, P NATL ACAD SCI USA, V89, P10706, DOI 10.1073/pnas.89.22.10706; CANCE WG, 1993, INT J CANCER, V54, P571, DOI 10.1002/ijc.2910540409; CARAS IW, 1987, NATURE, V325, P545, DOI 10.1038/325545a0; Chua K, 1999, NATURE, V402, P207, DOI 10.1038/46086; Chua K, 2001, MOL CELL BIOL, V21, P1509, DOI 10.1128/MCB.21.5.1509-1514.2001; JURKA J, 1991, J MOL EVOL, V32, P105, DOI 10.1007/BF02515383; KNEBELMANN B, 1995, HUM MOL GENET, V4, P675, DOI 10.1093/hmg/4.4.675; Lai F, 1997, MOL CELL BIOL, V17, P2413, DOI 10.1128/MCB.17.5.2413; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LEVMAOR G, UNPUB; MAKALOWSKI W, 1994, TRENDS GENET, V10, P188, DOI 10.1016/0168-9525(94)90254-2; Makalowski W, 2000, GENE, V259, P61, DOI 10.1016/S0378-1119(00)00436-4; MANROW RE, 1993, J MOL BIOL, V234, P281, DOI 10.1006/jmbi.1993.1583; Mighell AJ, 1997, FEBS LETT, V417, P1, DOI 10.1016/S0014-5793(97)01259-3; MIHOVILOVIC M, 1993, BIOCHEM BIOPH RES CO, V197, P137, DOI 10.1006/bbrc.1993.2452; Miller M, 1997, GENE, V190, P309, DOI 10.1016/S0378-1119(97)00022-X; MITCHELL GA, 1991, P NATL ACAD SCI USA, V88, P815, DOI 10.1073/pnas.88.3.815; Nekrutenko A, 2001, TRENDS GENET, V17, P619, DOI 10.1016/S0168-9525(01)02445-3; Rowold DJ, 2000, GENETICA, V108, P57, DOI 10.1023/A:1004099605261; Roy-Engel AM, 2002, GENOME RES, V12, P1333, DOI 10.1101/gr.384802; Schmid CW, 1996, PROG NUCLEIC ACID RE, V53, P283, DOI 10.1016/S0079-6603(08)60148-8; Slavov D, 2002, GENE, V299, P83, DOI 10.1016/S0378-1119(02)01016-8; Sorek R, 2002, GENOME RES, V12, P1060, DOI 10.1101/gr.229302; SOREK R, UNPUB; Svineng G, 1998, BIOCHEM J, V330, P1255, DOI 10.1042/bj3301255; Vervoort R, 1998, HUM GENET, V103, P686, DOI 10.1007/PL00008709	26	339	363	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 23	2003	300	5623					1288	1291		10.1126/science.1082588	http://dx.doi.org/10.1126/science.1082588			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681NN	12764196				2022-12-24	WOS:000183042400048
J	Petersen, KF; Befroy, D; Dufour, S; Dziura, J; Ariyan, C; Rothman, DL; DiPietro, L; Cline, GW; Shulman, GI				Petersen, KF; Befroy, D; Dufour, S; Dziura, J; Ariyan, C; Rothman, DL; DiPietro, L; Cline, GW; Shulman, GI			Mitochondrial dysfunction in the elderly: Possible role in insulin resistance	SCIENCE			English	Article							FREE FATTY-ACIDS; SKELETAL-MUSCLE; MECHANISM; ACCUMULATION; SPECTROSCOPY; ACTIVATION; MUTATIONS; HUMANS; LIVER	Insulin resistance is a major factor in the pathogenesis of type 2 diabetes in the elderly. To investigate how insulin resistance arises, we studied healthy, lean, elderly and young participants matched for lean body mass and fat mass. Elderly study participants were markedly insulin-resistant as compared with young controls, and this resistance was attributable to reduced insulin-stimulated muscle glucose metabolism. These changes were associated with increased fat accumulation in muscle and liver tissue assessed by H-1 nuclear magnetic resonance (NMR) spectroscopy, and with a similar to40% reduction in mitochondrial oxidative and phosphorylation activity, as assessed by in vivo C-13/P-31 NMR spectroscopy. These data support the hypothesis that an age-associated decline in mitochondrial function contributes to insulin resistance in the elderly.	Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Surg, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Diagnost Radiol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06520 USA; Yale Univ, Sch Med, John B Pierce Lab, New Haven, CT 06520 USA; Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA	Yale University; Yale University; Yale University; Yale University; Yale University; Yale University; The John B Pierce Laboratory, Inc; Howard Hughes Medical Institute; Yale University	Shulman, GI (corresponding author), Yale Univ, Sch Med, Dept Internal Med, 333 Cedar St, New Haven, CT 06520 USA.	gerald.shulman@yale.edu	Shulman, Gerald I./P-7176-2019	Shulman, Gerald I./0000-0003-1529-5668; Ariyan, Charlotte/0000-0003-0818-3895	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000125] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK049230, K23DK002734, P30DK045735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG009872, P60AG010469, R01AG023686] Funding Source: NIH RePORTER; NCRR NIH HHS [M01 RR-00125, M01 RR000125] Funding Source: Medline; NIA NIH HHS [P60 AG-10469, R01 AG023686-01A1, R01 AG-09872, R01 AG023686] Funding Source: Medline; NIDDK NIH HHS [P30 DK-45735, K-23 DK-02347, K23 DK002734-04, R01 DK-49230, K23 DK002734, P30 DK045735, R01 DK049230] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BAECKE JAH, 1982, AM J CLIN NUTR, V36, P936; BODEN G, 1994, J CLIN INVEST, V93, P2438, DOI 10.1172/JCI117252; Dresner A, 1999, J CLIN INVEST, V103, P253, DOI 10.1172/JCI5001; Griffin ME, 1999, DIABETES, V48, P1270, DOI 10.2337/diabetes.48.6.1270; HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x; HUSE DM, 1989, JAMA-J AM MED ASSOC, V262, P2708, DOI 10.1001/jama.262.19.2708; Itani SI, 2002, DIABETES, V51, P2005, DOI 10.2337/diabetes.51.7.2005; JOHNSON AB, 1992, CLIN SCI, V82, P219, DOI 10.1042/cs0820219; Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944; Kim JK, 2001, P NATL ACAD SCI USA, V98, P7522, DOI 10.1073/pnas.121164498; King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414; KRAEGEN EW, 1991, DIABETES, V40, P1397, DOI 10.2337/diabetes.40.11.1397; Krssak M, 1999, DIABETOLOGIA, V42, P113, DOI 10.1007/s001250051123; Lebon V, 2001, J CLIN INVEST, V108, P733, DOI 10.1172/JCI11775; LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4; Luft R, 1993, Lakartidningen, V90, P2770; Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774; Perseghin G, 1999, DIABETES, V48, P1600, DOI 10.2337/diabetes.48.8.1600; Petersen KF, 2002, J CLIN INVEST, V109, P1345, DOI [10.1172/JCI200215001, 10.1172/JCI0215001]; Petersen KF, 1998, DIABETES, V47, P381, DOI 10.2337/diabetes.47.3.381; REAVEN GM, 1995, PHYSIOL REV, V75, P473, DOI 10.1152/physrev.1995.75.3.473; Roden M, 1996, J CLIN INVEST, V97, P2859, DOI 10.1172/JCI118742; ROWE JW, 1983, J CLIN INVEST, V71, P1581, DOI 10.1172/JCI110914; SAAD MF, 1989, LANCET, V1, P1356; SASAKI A, 1982, DIABETOLOGIA, V22, P154, DOI 10.1007/BF00283743; Seppala-Lindroos A, 2002, J CLIN ENDOCR METAB, V87, P3023, DOI 10.1210/jc.87.7.3023; SHULMAN GI, 2000, J CLIN INVEST, V106, P171, DOI DOI 10.1172/JCI10583; Szczepaniak LS, 1999, AM J PHYSIOL-ENDOC M, V276, pE977, DOI 10.1152/ajpendo.1999.276.5.E977; TROUNCE I, 1989, LANCET, V1, P637, DOI 10.1016/S0140-6736(89)92143-0; Yu CL, 2002, J BIOL CHEM, V277, P50230, DOI 10.1074/jbc.M200958200	30	1524	1584	4	118	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 16	2003	300	5622					1140	1142		10.1126/science.1082889	http://dx.doi.org/10.1126/science.1082889			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678VC	12750520	Green Accepted			2022-12-24	WOS:000182886500044
J	Cossart, R; Aronov, D; Yuste, R				Cossart, R; Aronov, D; Yuste, R			Attractor dynamics of network UP states in the neocortex	NATURE			English	Article							SPONTANEOUS FIRING PATTERNS; LESS-THAN-1 HZ OSCILLATION; CAT VISUAL-CORTEX; FUNCTIONAL ARCHITECTURE; PREFRONTAL CORTEX; NEURONS; PROJECTIONS; MEMORY	The cerebral cortex receives input from lower brain regions, and its function is traditionally considered to be processing that input through successive stages to reach an appropriate output(1,2). However, the cortical circuit contains many interconnections, including those feeding back from higher centres(3-6), and is continuously active even in the absence of sensory inputs(7-9). Such spontaneous firing has a structure that reflects the coordinated activity of specific groups of neurons(10-12). Moreover, the membrane potential of cortical neurons fluctuates spontaneously between a resting ( DOWN) and a depolarized (UP) state(11,13-16), which may also be coordinated. The elevated firing rate in the UP state follows sensory stimulation(16) and provides a substrate for persistent activity, a network state that might mediate working memory(17-21). Using two-photon calcium imaging, we reconstructed the dynamics of spontaneous activity of up to 1,400 neurons in slices of mouse visual cortex. Here we report the occurrence of synchronized UP state transitions ('cortical flashes') that occur in spatially organized ensembles involving small numbers of neurons. Because of their stereotyped spatiotemporal dynamics, we conclude that network UP states are circuit attractors-emergent features of feedback neural networks(22) that could implement memory states or solutions to computational problems.	Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	Columbia University	Cossart, R (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	rcossart@biology.columbia.edu	Cossart, Rosa/AAT-7934-2020; Cossart, Rosa/E-7674-2014	Cossart, Rosa/0000-0003-2111-6638; Cossart, Rosa/0000-0003-2111-6638				Anderson J, 2000, NAT NEUROSCI, V3, P617, DOI 10.1038/75797; Badea T, 2001, J NEUROBIOL, V48, P215, DOI 10.1002/neu.1052; BENYISHAI R, 1995, P NATL ACAD SCI USA, V92, P3844, DOI 10.1073/pnas.92.9.3844; Constantinidis C, 2001, J NEUROSCI, V21, P3646, DOI 10.1523/JNEUROSCI.21-10-03646.2001; COWAN RL, 1994, J NEUROPHYSIOL, V71, P17, DOI 10.1152/jn.1994.71.1.17; Creutzfeldt O., 1995, CORTEX CEREBRI; De No RL, 1938, J NEUROPHYSIOL, V1, P207; Douglas RJ, 1998, SYNAPTIC ORG BRAIN, P459; Durstewitz D, 2000, NAT NEUROSCI, V3, P1184, DOI 10.1038/81460; FUSTER JM, 1991, PROG BRAIN RES, V87, P201; GILBERT CD, 1979, NATURE, V280, P120, DOI 10.1038/280120a0; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; Hebb D.O., 1949, ORG BEHAV; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; HUBEL DH, 1977, PROC R SOC SER B-BIO, V198, P1, DOI 10.1098/rspb.1977.0085; Llinas R., 2002, I VORTEX NEURONS SEL; Majewska A, 2000, PFLUG ARCH EUR J PHY, V441, P398, DOI 10.1007/s004240000435; Mao BQ, 2001, NEURON, V32, P883, DOI 10.1016/S0896-6273(01)00518-9; Mountcastle V.B., 1998, PERCEPTUAL NEUROSCIE; Sanchez-Vives MV, 2000, NAT NEUROSCI, V3, P1027, DOI 10.1038/79848; Seung HS, 2000, NEURON, V26, P259, DOI 10.1016/S0896-6273(00)81155-1; Shu YS, 2003, NATURE, V423, P288, DOI 10.1038/nature01616; Somogyi P, 1998, BRAIN RES REV, V26, P113, DOI 10.1016/S0165-0173(97)00061-1; STERIADE M, 1993, J NEUROSCI, V13, P3284; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; Tsodyks M, 1999, SCIENCE, V286, P1943, DOI 10.1126/science.286.5446.1943; Wang XJ, 2001, TRENDS NEUROSCI, V24, P455, DOI 10.1016/S0166-2236(00)01868-3; WILSON CJ, 1981, BRAIN RES, V220, P67, DOI 10.1016/0006-8993(81)90211-0	28	460	473	1	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 15	2003	423	6937					283	288		10.1038/nature01614	http://dx.doi.org/10.1038/nature01614			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678EX	12748641				2022-12-24	WOS:000182853100042
J	Drosten, C; Gunther, S; Preiser, W; van der Werf, S; Brodt, HR; Becker, S; Rabenau, H; Panning, M; Kolesnikova, L; Fouchier, RAM; Berger, A; Burguiere, AM; Cinatl, J; Eickmann, M; Escriou, N; Grywna, K; Kramme, S; Manuguerra, JC; Muller, S; Rickerts, V; Sturmer, M; Vieth, S; Klenk, HD; Osterhaus, ADME; Schmitz, H; Doerr, HW				Drosten, C; Gunther, S; Preiser, W; van der Werf, S; Brodt, HR; Becker, S; Rabenau, H; Panning, M; Kolesnikova, L; Fouchier, RAM; Berger, A; Burguiere, AM; Cinatl, J; Eickmann, M; Escriou, N; Grywna, K; Kramme, S; Manuguerra, JC; Muller, S; Rickerts, V; Sturmer, M; Vieth, S; Klenk, HD; Osterhaus, ADME; Schmitz, H; Doerr, HW			Identification of a novel coronavirus in patients with severe acute respiratory syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LASSA VIRUS; FEVER	BACKGROUND The severe acute respiratory syndrome (SARS) has recently been identified as a new clinical entity. SARS is thought to be caused by an unknown infectious agent. METHODS Clinical specimens from patients with SARS were searched for unknown viruses with the use of cell cultures and molecular techniques. RESULTS A novel coronavirus was identified in patients with SARS. The virus was isolated in cell culture, and a sequence 300 nucleotides in length was obtained by a polymerase-chain-reaction (PCR)-based random-amplification procedure. Genetic characterization indicated that the virus is only distantly related to known coronaviruses (identical in 50 to 60 percent of the nucleotide sequence). On the basis of the obtained sequence, conventional and real-time PCR assays for specific and sensitive detection of the novel virus were established. Virus was detected in a variety of clinical specimens from patients with SARS but not in controls. High concentrations of viral RNA of up to 100 million molecules per milliliter were found in sputum. Viral RNA was also detected at extremely low concentrations in plasma during the acute phase and in feces during the late convalescent phase. Infected patients showed seroconversion on the Vero cells in which the virus was isolated. CONCLUSIONS The novel coronavirus might have a role in causing SARS.	Bernhard Nocht Inst Trop Med, Dept Virol, Natl Reference Ctr Trop Infect Dis, D-20359 Hamburg, Germany; Goethe Univ Frankfurt, Inst Med Virol, D-6000 Frankfurt, Germany; Goethe Univ Frankfurt, Med Clin 3, D-6000 Frankfurt, Germany; Univ Marburg, Inst Virol, D-3550 Marburg, Germany; Inst Pasteur, Natl Influenza Ctr No France, Paris, France; Erasmus Univ, Inst Virol, Rotterdam, Netherlands	Bernhard Nocht Institut fur Tropenmedizin; Goethe University Frankfurt; Goethe University Frankfurt; Philipps University Marburg; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Erasmus University Rotterdam	Drosten, C (corresponding author), Bernhard Nocht Inst Trop Med, Dept Virol, Natl Reference Ctr Trop Infect Dis, Bernhard Nocht Str 74, D-20359 Hamburg, Germany.	drosten@bni-hamburg.de	Becker, Stefanie/AEM-2050-2022; Panning, Marcus/I-7889-2016; Escriou, Nicolas/A-2392-2016; Preiser, Wolfgang/J-4875-2016; Fouchier, Ron A/A-1911-2014; Becker, Stephan/A-1065-2010	Escriou, Nicolas/0000-0002-1224-6839; Preiser, Wolfgang/0000-0002-0254-7910; Fouchier, Ron A/0000-0001-8095-2869; Becker, Stephan/0000-0002-2794-5659; Gunther, Stephan/0000-0002-6562-0230; Vieth, Simon/0000-0002-2765-1589; Osterhaus, Albert/0000-0002-6074-1172; van der WERF, Sylvie/0000-0002-1148-4456; Sturmer, Martin/0000-0003-4300-9315				[Anonymous], 2003, Wkly Epidemiol Rec, V78, P73; [Anonymous], 2003, WKLY EPIDEMIOL REC, V78, P81; Cho KO, 2001, AM J VET RES, V62, P1436, DOI 10.2460/ajvr.2001.62.1436; Cossart Y, 1998, LANCET, V352, P164, DOI 10.1016/S0140-6736(05)77802-8; Drosten C, 2002, J CLIN MICROBIOL, V40, P2323, DOI 10.1128/JCM.40.7.2323-2330.2002; Felsenstein J, 2000, PHYLIP PHYLOGENY INF; Gunther S, 2000, EMERG INFECT DIS, V6, P466, DOI 10.3201/eid0605.000504; Kew MC, 1996, LANCET, V348, pSII10; Makela MJ, 1998, J CLIN MICROBIOL, V36, P539; Poutanen SM, 2003, NEW ENGL J MED, V348, P1995, DOI 10.1056/NEJMoa030634; Stephensen CB, 1999, VIRUS RES, V60, P181, DOI 10.1016/S0168-1702(99)00017-9; Tsang KW, 2003, NEW ENGL J MED, V348, P1977, DOI 10.1056/NEJMoa030666; WHO, 2003, CUM NUMB REP CAS SEV	13	2992	3380	9	434	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 15	2003	348	20					1967	1976		10.1056/NEJMoa030747	http://dx.doi.org/10.1056/NEJMoa030747			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	677TJ	12690091	Green Published, Bronze			2022-12-24	WOS:000182823400005
J	Alford, MH				Alford, MH			Redistribution of energy available for ocean mixing by long-range propagation of internal waves	NATURE			English	Article							INERTIAL CURRENTS; TIDAL ENERGY; DEEP-OCEAN; WIND; ALTIMETRY; TIDES	Ocean mixing, which affects pollutant dispersal, marine productivity and global climate(1), largely results from the breaking of internal gravity waves-disturbances propagating along the ocean's internal stratification. A global map of internal-wave dissipation would be useful in improving climate models, but would require knowledge of the sources of internal gravity waves and their propagation. Towards this goal, I present here computations of horizontal internal-wave propagation from 60 historical moorings and relate them to the source terms of internal waves as computed previously(2,3). Analysis of the two most energetic frequency ranges-near-inertial frequencies and semidiurnal tidal frequencies-reveals that the fluxes in both frequency bands are of the order of 1 kW m(-1) (that is, 15-50% of the energy input) and are directed away from their respective source regions. However, the energy flux due to near-inertial waves is stronger in winter, whereas the tidal fluxes are uniform throughout the year. Both varieties of internal waves can thus significantly affect the space-time distribution of energy available for global mixing.	Univ Washington, Appl Phys Lab, Seattle, WA 98105 USA; Univ Washington, Sch Oceanog, Seattle, WA 98105 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Alford, MH (corresponding author), Univ Washington, Appl Phys Lab, 1013 NE 40th St, Seattle, WA 98105 USA.	malford@apl.washington.edu						Alford MH, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016614; Alford MH, 2001, J GEOPHYS RES-OCEANS, V106, P16947, DOI 10.1029/2000JC000370; Alford MH, 2001, J PHYS OCEANOGR, V31, P2359, DOI 10.1175/1520-0485(2001)031<2359:ISGTSD>2.0.CO;2; DASARO EA, 1985, J PHYS OCEANOGR, V15, P943, DOI 10.1175/1520-0485(1985)015<0943:UOTSIC>2.0.CO;2; DASARO EA, 1995, J PHYS OCEANOGR, V25, P2909, DOI 10.1175/1520-0485(1995)025<2909:UOICFB>2.0.CO;2; DASARO EA, 1991, P DYN OC INT GRAV WA, V2, P451; Doherty KW, 1999, J ATMOS OCEAN TECH, V16, P1816, DOI 10.1175/1520-0426(1999)016<1816:AMPI>2.0.CO;2; DUSHAW BD, 1995, J PHYS OCEANOGR, V25, P631, DOI 10.1175/1520-0485(1995)025<0631:BABTIT>2.0.CO;2; Egbert GD, 2000, NATURE, V405, P775, DOI 10.1038/35015531; FU LL, 1981, REV GEOPHYS, V19, P141, DOI 10.1029/RG019i001p00141; Ganachaud A, 2000, NATURE, V408, P453, DOI 10.1038/35044048; GARRETT C, 1975, J GEOPHYS RES, V80, P291, DOI 10.1029/JC080i003p00291; Garrett C, 2001, J PHYS OCEANOGR, V31, P962, DOI 10.1175/1520-0485(2001)031<0962:WITNIB>2.0.CO;2; GILL AE, 1984, J PHYS OCEANOGR, V14, P1129, DOI 10.1175/1520-0485(1984)014<1129:OTBOIW>2.0.CO;2; GREGG MC, 1987, J GEOPHYS RES-OCEANS, V92, P5249, DOI 10.1029/JC092iC05p05249; Kunze E, 2002, J PHYS OCEANOGR, V32, P1890, DOI 10.1175/1520-0485(2002)032<1890:IWIMSC>2.0.CO;2; LEDWELL JR, 1993, NATURE, V364, P701, DOI 10.1038/364701a0; Levitus S, 1994, WORLD OCEAN ATLAS 19; Manabe S, 1988, J CLIMATE, V1, P841, DOI 10.1175/1520-0442(1988)001<0841:TSEOAC>2.0.CO;2; Merrifield MA, 2002, J GEOPHYS RES-OCEANS, V107, DOI 10.1029/2001JC000996; Munk W, 1998, DEEP-SEA RES PT I, V45, P1977, DOI 10.1016/S0967-0637(98)00070-3; PINGREE RD, 1991, J PHYS OCEANOGR, V21, P28, DOI 10.1175/1520-0485(1991)021<0028:APABRO>2.0.CO;2; Polzin KL, 1997, SCIENCE, V276, P93, DOI 10.1126/science.276.5309.93; Ray RD, 2001, GEOPHYS RES LETT, V28, P1259, DOI 10.1029/2000GL012447; Ray RD, 1997, PROG OCEANOGR, V40, P135, DOI 10.1016/S0079-6611(97)00025-6; Samelson RM, 1998, J PHYS OCEANOGR, V28, P712, DOI 10.1175/1520-0485(1998)028<0712:LSCWLE>2.0.CO;2; St Laurent L, 2002, J PHYS OCEANOGR, V32, P2882, DOI 10.1175/1520-0485(2002)032<2882:TROITI>2.0.CO;2; Thorpe SA, 1999, J PHYS OCEANOGR, V29, P1085, DOI 10.1175/1520-0485(1999)029<1085:OIWG>2.0.CO;2; Webb DJ, 2001, NATURE, V409, P37, DOI 10.1038/35051171; Wunsch C, 1998, J PHYS OCEANOGR, V28, P2332, DOI 10.1175/1520-0485(1998)028<2332:TWDBTW>2.0.CO;2	30	278	284	7	85	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 8	2003	423	6936					159	162		10.1038/nature01628	http://dx.doi.org/10.1038/nature01628			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675MR	12736682				2022-12-24	WOS:000182699600043
J	Groemping, Y; Lapouge, K; Smerdon, SJ; Rittinger, K				Groemping, Y; Lapouge, K; Smerdon, SJ; Rittinger, K			Molecular basis of phosphorylation-induced activation of the NADPH oxidase	CELL			English	Article							RESPIRATORY BURST OXIDASE; SRC HOMOLOGY-3 DOMAINS; PROTEIN-KINASE-C; CELL-FREE SYSTEM; SH3 DOMAIN; CRYSTAL-STRUCTURE; PX DOMAIN; P47(PHOX); BINDING; RECOGNITION	The multi-subunit NADPH oxidase complex plays a crucial role in host defense against microbial infection through the production of reactive oxygen species. Activation of the NADPH oxidase requires the targeting of a cytoplasmic p40-p47-p67(phox) complex to the membrane bound heterodimeric p22-gp91(phox) flavocytochrome. This interaction is prevented in the resting state due to an auto-inhibited conformation of p47(phox). The X-ray structure of the auto-inhibited form of p47(phox) reveals that tandem SH3 domains function together to maintain the cytoplasmic complex in an inactive form. Further structural and biochemical data show that phosphorylation of p47(phox) activates a molecular switch that relieves the inhibitory intramolecular interaction. This permits p47phox to interact with the cytoplasmic tail of p22(phox) and initiate formation of the active, membrane bound enzyme complex.	Natl Inst Med Res, Div Prot Struct, London NW7 1AA, England	MRC National Institute for Medical Research	Rittinger, K (corresponding author), Natl Inst Med Res, Div Prot Struct, Mill Hill, London NW7 1AA, England.	katrin.rittinger@nimr.mrc.ac.uk	Rittinger, Katrin/D-2586-2014; Rittinger, Katrin/N-3344-2019	Rittinger, Katrin/0000-0002-7698-4435; Rittinger, Katrin/0000-0002-7698-4435; Lapouge, Karine/0000-0003-0620-9553; Smerdon, Stephen/0000-0001-5688-8465	Medical Research Council [MC_U117565398] Funding Source: Medline; MRC [MC_U117565398] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ago T, 1999, J BIOL CHEM, V274, P33644, DOI 10.1074/jbc.274.47.33644; Babior BM, 1999, BLOOD, V93, P1464, DOI 10.1182/blood.V93.5.1464.405a32_1464_1476; Babior BM, 2000, AM J MED, V109, P33, DOI 10.1016/S0002-9343(00)00481-2; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Benard V, 1999, TRENDS PHARMACOL SCI, V20, P365, DOI 10.1016/S0165-6147(99)01367-X; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P958, DOI 10.1107/S0021889891007240; Dalgarno DC, 1997, BIOPOLYMERS, V43, P383; deMendez I, 1997, MOL CELL BIOL, V17, P2177, DOI 10.1128/MCB.17.4.2177; DINAUER MC, 1991, P NATL ACAD SCI USA, V88, P11231, DOI 10.1073/pnas.88.24.11231; ElBenna J, 1996, J BIOL CHEM, V271, P6374; ELBENNA J, 1994, J BIOL CHEM, V269, P23431; Esnouf RM, 1999, ACTA CRYSTALLOGR D, V55, P938, DOI 10.1107/S0907444998017363; FAUST LP, 1995, J CLIN INVEST, V96, P1499, DOI 10.1172/JCI118187; FINAN P, 1994, J BIOL CHEM, V269, P13752; Fontayne A, 2002, BIOCHEMISTRY-US, V41, P7743, DOI 10.1021/bi011953s; Hata K, 1998, J BIOL CHEM, V273, P4232, DOI 10.1074/jbc.273.7.4232; HEYWORTH PG, 1991, J CLIN INVEST, V87, P352, DOI 10.1172/JCI114993; Hiroaki H, 2001, NAT STRUCT BIOL, V8, P526, DOI 10.1038/88591; Huang J, 1999, J BIOL CHEM, V274, P19731, DOI 10.1074/jbc.274.28.19731; Inanami O, 1998, J BIOL CHEM, V273, P9539, DOI 10.1074/jbc.273.16.9539; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kami K, 2002, EMBO J, V21, P4268, DOI 10.1093/emboj/cdf428; Karathanassis D, 2002, EMBO J, V21, P5057, DOI 10.1093/emboj/cdf519; Kishan KVR, 1997, NAT STRUCT BIOL, V4, P739; Kuriyan J, 1997, ANNU REV BIOPH BIOM, V26, P259, DOI 10.1146/annurev.biophys.26.1.259; Lambeth JD, 2000, J BIOCHEM MOL BIOL, V33, P427; Lapouge K, 2002, J BIOL CHEM, V277, P10121, DOI 10.1074/jbc.M112065200; Lee CH, 1996, CELL, V85, P931, DOI 10.1016/S0092-8674(00)81276-3; LETO TL, 1994, P NATL ACAD SCI USA, V91, P10650, DOI 10.1073/pnas.91.22.10650; Leusen Jeanette H. W., 1996, Frontiers in Bioscience (online), V1, pD72; LEUSEN JHW, 1994, J EXP MED, V180, P2329, DOI 10.1084/jem.180.6.2329; Lim WA, 1996, STRUCTURE, V4, P657; Mayer BJ, 2001, J CELL SCI, V114, P1253; MUSACCHIO A, 1994, NAT STRUCT BIOL, V1, P546, DOI 10.1038/nsb0894-546; Nauseef WM, 1999, P ASSOC AM PHYSICIAN, V111, P373, DOI 10.1111/paa.1999.111.5.373; Navaza J, 1997, METHOD ENZYMOL, V276, P581, DOI 10.1016/S0076-6879(97)76079-8; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Noack D, 2001, BLOOD, V97, P305, DOI 10.1182/blood.V97.1.305; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park JW, 1997, J BIOL CHEM, V272, P11035; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; Prehoda KE, 2001, NAT STRUCT BIOL, V8, P570, DOI 10.1038/89586; SEGAL AW, 1993, TRENDS BIOCHEM SCI, V18, P43, DOI 10.1016/0968-0004(93)90051-N; Shiose A, 2000, J BIOL CHEM, V275, P13793, DOI 10.1074/jbc.275.18.13793; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; SUMIMOTO H, 1994, P NATL ACAD SCI USA, V91, P5345, DOI 10.1073/pnas.91.12.5345; Sumimoto H, 1996, J BIOL CHEM, V271, P22152, DOI 10.1074/jbc.271.36.22152; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wilson L, 1997, INFLAMM RES, V46, P265, DOI 10.1007/s000110050185; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; WU XD, 1995, STRUCTURE, V3, P215, DOI 10.1016/S0969-2126(01)00151-4; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0	53	303	314	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 2	2003	113	3					343	355		10.1016/S0092-8674(03)00314-3	http://dx.doi.org/10.1016/S0092-8674(03)00314-3			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	674MP	12732142	Bronze			2022-12-24	WOS:000182640800009
J	Ishitani, R; Nureki, O; Nameki, N; Okada, N; Nishimura, S; Yokoyama, S				Ishitani, R; Nureki, O; Nameki, N; Okada, N; Nishimura, S; Yokoyama, S			Alternative tertiary structure of tRNA for recognition by a posttranscriptional modification enzyme	CELL			English	Article							PHENYLALANINE TRANSFER-RNA; ARCHAEAL TRANSFER-RNA; MINIMAL TRANSFER-RNA; PSEUDOURIDINE SYNTHASE; GUANINE TRANSGLYCOSYLASE; MITOCHONDRIAL GENOMES; THERMOPHILIC ARCHAEA; CRYSTAL-STRUCTURE; WILD-TYPE; SEQUENCES	Transfer RNA (tRNA) canonically has the clover-leaf secondary structure with the acceptor, D, anticodon, and T arms, which are folded into the L-shaped tertiary structure. To strengthen the L form, posttranscriptional modifications occur on nucleotides buried within the core, but the modification enzymes are paradoxically inaccessible to them in the L form. In this study, we determined the crystal structure of tRNA bound with archaeosine tRNA-guanine transglycosylase, which modifies G15 of the D arm in the core. The bound tRNA assumes an alternative conformation ("lambda form") drastically different from the L form. All of the D-arm secondary base pairs and the canonical tertiary interactions are disrupted. Furthermore, a helical structure is reorganized, while the rest of the D arm is single stranded and protruded. Consequently, the enzyme precisely locates the exposed G15 in the active site, by counting the nucleotide number from G1 to G15 in the lambda form.	Univ Tokyo, Dept Biochem & Biophys, Grad Sch Sci, Bunkyo Ku, Tokyo 1130033, Japan; SPring 8, Harima Inst, RIKEN, Sayo, Hyogo 6795148, Japan; RIKEN, Genom Sci Ctr, Yokohama, Kanagawa 2300045, Japan; JST, PRESTO, Yokohama, Kanagawa 2268501, Japan; Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Midori Ku, Yokohama, Kanagawa 2268501, Japan; Banyu Tsukuba Res Inst Merck, Tsukuba, Ibaraki 3002611, Japan	University of Tokyo; Japan Synchrotron Radiation Research Institute; RIKEN; RIKEN; Japan Science & Technology Agency (JST); Tokyo Institute of Technology; Merck & Company	Yokoyama, S (corresponding author), Univ Tokyo, Dept Biochem & Biophys, Grad Sch Sci, Bunkyo Ku, Tokyo 1130033, Japan.	yokoyama@biochem.s.u-tokyo.ac.jp	Nameki, Nobukazu/H-1764-2013; Yokoyama, Shigeyuki/N-6911-2015	Yokoyama, Shigeyuki/0000-0003-3133-7338				AEBI M, 1990, J BIOL CHEM, V265, P16216; Aravind L, 1999, J MOL EVOL, V48, P291, DOI 10.1007/PL00006472; Bai Y, 2000, J BIOL CHEM, V275, P28731, DOI 10.1074/jbc.M002174200; Bjork GR, 1999, FEBS LETT, V452, P47, DOI 10.1016/S0014-5793(99)00528-1; Bjork GR, 1995, TRNA STRUCTURE BIOSY, P165; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Charette M, 2000, IUBMB LIFE, V49, P341; Davis DR., 1998, MODIFICATION EDITING, P85; EDMONDS CG, 1991, J BACTERIOL, V173, P3138, DOI 10.1128/JB.173.10.3138-3148.1991; Ferre-D'Amare AR, 2003, CURR OPIN STRUC BIOL, V13, P49, DOI 10.1016/S0959-440X(02)00002-7; Green R, 1999, BIOCHEMISTRY-US, V38, P1772, DOI 10.1021/bi982246a; GREGSON JM, 1993, J BIOL CHEM, V268, P10076; GUPTA R, 1984, J BIOL CHEM, V259, P9461; Gutgsell N, 2000, RNA, V6, P1870, DOI 10.1017/S1355838200001588; Gutgsell NS, 2001, RNA, V7, P990, DOI 10.1017/S1355838201000243; Heiss NS, 1998, NAT GENET, V19, P32, DOI 10.1038/ng0598-32; Helm M, 1999, NUCLEIC ACIDS RES, V27, P756, DOI 10.1093/nar/27.3.756; Hoang C, 2001, CELL, V107, P929, DOI 10.1016/S0092-8674(01)00618-3; HORIE N, 1985, BIOCHEMISTRY-US, V24, P5711, DOI 10.1021/bi00342a004; Ishitani R, 2002, J MOL BIOL, V318, P665, DOI 10.1016/S0022-2836(02)00090-6; Ishitani R, 2001, ACTA CRYSTALLOGR D, V57, P1659, DOI 10.1107/S0907444901011994; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KAWAI G, 1992, BIOCHEMISTRY-US, V31, P1040, DOI 10.1021/bi00119a012; Khaitovich P, 1999, BIOCHEMISTRY-US, V38, P1780, DOI 10.1021/bi9822473; KIM SH, 1973, SCIENCE, V179, P285, DOI 10.1126/science.179.4070.285; Kiss T, 2002, CELL, V109, P145, DOI 10.1016/S0092-8674(02)00718-3; Kiss T, 2001, EMBO J, V20, P3617, DOI 10.1093/emboj/20.14.3617; Lafontaine DLJ, 1998, GENE DEV, V12, P527, DOI 10.1101/gad.12.4.527; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LIMBACH PA, 1994, NUCLEIC ACIDS RES, V22, P2183, DOI 10.1093/nar/22.12.2183; Marck C, 2002, RNA, V8, P1189, DOI 10.1017/S1355838202022021; McCloskey JA, 2001, NUCLEIC ACIDS RES, V29, P4699, DOI 10.1093/nar/29.22.4699; McCloskey JA, 1998, NUCLEIC ACIDS RES, V26, P196, DOI 10.1093/nar/26.1.196; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Ofengand J, 2002, FEBS LETT, V514, P17, DOI 10.1016/S0014-5793(02)02305-0; Ohtsuki T, 2002, FEBS LETT, V514, P37, DOI 10.1016/S0014-5793(02)02328-1; OKIMOTO R, 1990, EMBO J, V9, P3405, DOI 10.1002/j.1460-2075.1990.tb07542.x; OKIMOTO R, 1992, GENETICS, V130, P471; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; ROE BA, 1985, J BIOL CHEM, V260, P9759; SANNER MF, 1995, P 11 ACM S COMP GEOM, P104; Shi HJ, 2000, RNA, V6, P1091, DOI 10.1017/S1355838200000364; Sprinzl M, 1998, NUCLEIC ACIDS RES, V26, P148, DOI 10.1093/nar/26.1.148; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Watanabe M, 1997, J BIOL CHEM, V272, P20146, DOI 10.1074/jbc.272.32.20146; Watanabe M, 2001, J BIOL CHEM, V276, P2387, DOI 10.1074/jbc.M005043200; Watkins NJ, 1998, RNA, V4, P1549, DOI 10.1017/S1355838298980761; WOLSTENHOLME DR, 1987, P NATL ACAD SCI USA, V84, P1324, DOI 10.1073/pnas.84.5.1324; Yokoyama Shigeyuki, 1995, P207	49	145	150	1	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 2	2003	113	3					383	394		10.1016/S0092-8674(03)00280-0	http://dx.doi.org/10.1016/S0092-8674(03)00280-0			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	674MP	12732145	Bronze			2022-12-24	WOS:000182640800012
J	Miralles, F; Posern, G; Zaromytidou, AI; Treisman, R				Miralles, F; Posern, G; Zaromytidou, AI; Treisman, R			Actin dynamics control SRF activity by regulation of its coactivator MAL	CELL			English	Article							SERUM-RESPONSE-FACTOR; EMBRYONIC STEM-CELLS; GENE-EXPRESSION; TRANSCRIPTIONAL ACTIVATION; TERNARY COMPLEX; RHOA; FAMILY; SIGNAL; DIFFERENTIATION; POLYMERIZATION	Rho GTPases regulate the transcription factor SRF via their ability to induce actin polymerization. SRF activity responds to G actin, but the mechanism of this has remained unclear. We show that Rho-actin signaling regulates the subcellular localization of the myocardin-related SRF coactivator MAL, rearranged in t(1;22)(p13;q13) AML. The MAL-SRF interaction displays the predicted properties of a Rho-regulated SRF cofactor. MAL is predominantly cytoplasmic in serum-starved cells, but accumulates in the nucleus following serum stimulation. Activation of the Rho-actin signaling pathway is necessary and sufficient to promote MAL nuclear accumulation. MAL N-terminal sequences, including two RPEL motifs, are required for the response to signaling, while other regions mediate its nuclear export (or cytoplasmic retention) and nuclear import. MAL associates with unpolymerized actin through its RPEL motifs. Constitutively cytoplasmic MAL derivatives interfere with MAL redistribution and Rho-actin signaling to SRF. MAL associates with several SRF target promoters regulated via the Rho-actin pathway.	Canc Res UK London Res Inst, Transcript Lab, Lincolns Inn Fields Labs, London WC2A 3PX, England	Cancer Research UK	Treisman, R (corresponding author), Canc Res UK London Res Inst, Transcript Lab, Lincolns Inn Fields Labs, Room 401,44 Lincolns Inn Fields, London WC2A 3PX, England.			Treisman, Richard/0000-0002-9658-0067; Miralles, Francesc/0000-0003-3069-2725				Alberts AS, 1998, CELL, V92, P475, DOI 10.1016/S0092-8674(00)80941-1; Arsenian S, 1998, EMBO J, V17, P6289, DOI 10.1093/emboj/17.21.6289; Bhowmick NA, 2001, MOL BIOL CELL, V12, P27, DOI 10.1091/mbc.12.1.27; Copeland JW, 2002, MOL BIOL CELL, V13, P4088, DOI 10.1091/mbc.02-06-0092; Geneste O, 2002, J CELL BIOL, V157, P831, DOI 10.1083/jcb.200203126; Gineitis D, 2001, J BIOL CHEM, V276, P24531, DOI 10.1074/jbc.M102678200; GROSSE R, 2003, IN PRESS EMBO J, V22; Hassler M, 2001, EMBO J, V20, P3018, DOI 10.1093/emboj/20.12.3018; HILL CS, 1995, CELL, V81, P1159, DOI 10.1016/S0092-8674(05)80020-0; HILL CS, 1993, CELL, V73, P395, DOI 10.1016/0092-8674(93)90238-L; HILL CS, 1994, EMBO J, V13, P5421, DOI 10.1002/j.1460-2075.1994.tb06877.x; Ling Y, 1997, EMBO J, V16, P2431, DOI 10.1093/emboj/16.9.2431; Ma ZG, 2001, NAT GENET, V28, P220, DOI 10.1038/90054; Mack CP, 2001, J BIOL CHEM, V276, P341, DOI 10.1074/jbc.M005505200; McCabe JB, 1999, MOL BIOL CELL, V10, P3771, DOI 10.1091/mbc.10.11.3771; Mercher T, 2001, P NATL ACAD SCI USA, V98, P5776, DOI 10.1073/pnas.101001498; Murai K, 2002, MOL CELL BIOL, V22, P7083, DOI 10.1128/MCB.22.20.7083-7092.2002; Oft M, 2002, NAT CELL BIOL, V4, P487, DOI 10.1038/ncb807; Posern G, 2002, MOL BIOL CELL, V13, P4167, DOI 10.1091/mbc.02-05-0068; Posern G, 2000, ONCOGENE, V19, P6361, DOI 10.1038/sj.onc.1204027; Psichari E, 2002, J BIOL CHEM, V277, P29490, DOI 10.1074/jbc.M112368200; Sasazuki T, 2002, J BIOL CHEM, V277, P28853, DOI 10.1074/jbc.M203190200; Schratt G, 2002, J CELL BIOL, V156, P737, DOI 10.1083/jcb.200106008; Schratt G, 2001, MOL CELL BIOL, V21, P2933, DOI 10.1128/MCB.21.8.2933-2943.2001; SKARNES WC, 1992, GENE DEV, V6, P903, DOI 10.1101/gad.6.6.903; Sotiropoulos A, 1999, CELL, V98, P159, DOI 10.1016/S0092-8674(00)81011-9; Tominaga T, 2000, MOL CELL, V5, P13, DOI 10.1016/S1097-2765(00)80399-8; TREISMAN R, 1994, CURR OPIN GENET DEV, V4, P96, DOI 10.1016/0959-437X(94)90097-3; Wang DZ, 2002, P NATL ACAD SCI USA, V99, P14855, DOI 10.1073/pnas.222561499; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Weinhold B, 2000, EMBO J, V19, P5835, DOI 10.1093/emboj/19.21.5835	31	1014	1052	2	48	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 2	2003	113	3					329	342		10.1016/S0092-8674(03)00278-2	http://dx.doi.org/10.1016/S0092-8674(03)00278-2			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	674MP	12732141	Bronze			2022-12-24	WOS:000182640800008
J	Carpenter, SJ; Erickson, JM; Holland, FD				Carpenter, SJ; Erickson, JM; Holland, FD			Migration of a Late Cretaceous fish	NATURE			English	Article							UNITED-STATES; OTOLITHS; CLIMATE	Late Cretaceous sediments from the Western Interior of North America yield exceptionally well preserved fossils(1,2) that serve as proxies for the rapidly changing climate preceding the Cretaceous/ Tertiary boundary (about 67-65 Myr ago)(3,4). Here we reconstruct the ontogenetic history of a Maastrichtian-age fish, Vorhisia vulpes(5), by using the carbon, oxygen and strontium isotope ratios of four aragonite otoliths collected from the Fox Hills Formation of South Dakota. Individuals of V. vulpes spawned in brackish water (about 70-80% seawater) and during their first year migrated to open marine waters of the Western Interior Seaway, where they remained for 3 years before returning to the estuary, presumably to spawn and die. The mean delta(18)O from the marine growth phase of V. vulpes yields a seawater temperature of 18 degreesC, which is consistent with leaf physiognomy and general-circulation-model temperature estimates for the Western Interior during the latest Maastrichtian(4,6,7).	Univ Iowa, Dept Geosci, Paul H Nelson Stable Isotope Lab, Iowa City, IA 52242 USA; Univ Iowa, Ctr Global & Reg Environm Res, Iowa City, IA 52242 USA; St Lawrence Univ, Dept Geol, Canton, NY 13617 USA; Univ N Dakota, Dept Geol & Geol Engn, Grand Forks, ND 58202 USA	University of Iowa; University of Iowa; Saint Lawrence University; University of North Dakota Grand Forks	Carpenter, SJ (corresponding author), Univ Iowa, Dept Geosci, Paul H Nelson Stable Isotope Lab, Iowa City, IA 52242 USA.	scott-j-carpenter@uiowa.edu						Andrus CFT, 2002, SCIENCE, V295, P1508, DOI 10.1126/science.1062004; Barrera E, 1999, GEOL S AM S, P245; BARRON EJ, 1993, PHILOS T R SOC B, V341, P307, DOI 10.1098/rstb.1993.0116; CARPENTER SJ, 1988, J SEDIMENT PETROL, V58, P706; CARPENTER SJ, 2002, GEOL SOC AM ABSTR, P31; Dettman DL, 2000, GEOLOGY, V28, P243, DOI 10.1130/0091-7613(2000)028<0243:OIEFHA>2.3.CO;2; Erickson J.M., 1999, N DAKOTA ACAD SCI P, V53, P124; Erickson J.M., 1992, N DAKOTA GEOLOGICAL, V76, P199; Frizzell D.L., 1965, COPEIA, V1965, P178, DOI DOI 10.2307/1440721; Healey MC, 1987, COMMON STRATEGIES AN, VI, P298; HUDDLESTON R W, 1983, Proceedings of the Biological Society of Washington, V96, P658; Ivany LC, 2000, NATURE, V407, P887, DOI 10.1038/35038044; MCARTHUR JM, 1994, PALAEOGEOGR PALAEOCL, V108, P95, DOI 10.1016/0031-0182(94)90024-8; McCormick S.D., 1987, AM FISH SOC S, V1, P211; Nolf Dirk, 1996, P433; Patterson WP, 1999, GEOLOGY, V27, P199, DOI 10.1130/0091-7613(1999)027<0199:OICFOP>2.3.CO;2; PATTERSON WP, 1993, CLIMATE CHANGE CONTI, P191; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Randall R, 1987, AM FISHERIES SOC S, P27; Schwarcz HP, 1998, CAN J FISH AQUAT SCI, V55, P1798, DOI 10.1139/cjfas-55-8-1798; SHACKLETON NJ, 1975, INIT REP DSDP, V74, P761; Thorrold SR, 1997, GEOCHIM COSMOCHIM AC, V61, P2909, DOI 10.1016/S0016-7037(97)00141-5; URSIN E, 1979, S ZOOL SOC LOND, V44, P63; WAAGE KM, 1968, YALE U B, V27; Weidman CR, 2000, FISH RES, V46, P327, DOI 10.1016/S0165-7836(00)00157-0; Wilf P, 2003, P NATL ACAD SCI USA, V100, P599, DOI 10.1073/pnas.0234701100; WOLFE JA, 1987, PALAEOGEOGR PALAEOCL, V61, P33, DOI 10.1016/0031-0182(87)90040-X; Wurster CM, 2001, PALAEOGEOGR PALAEOCL, V170, P81, DOI 10.1016/S0031-0182(01)00229-2; WURSTER CM, IN PRESS PALEOBIOLOG	29	52	56	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 1	2003	423	6935					70	74		10.1038/nature01575	http://dx.doi.org/10.1038/nature01575			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673CG	12721626				2022-12-24	WOS:000182561600040
J	Stickler, DJ; Jones, GL; Russell, AD				Stickler, DJ; Jones, GL; Russell, AD			Control of encrustation and blockage of Foley catheters	LANCET			English	Article								Urinary catheters often become encrusted and blocked by crystalline Proteus mirabilis biofilms. Results of experiments In a laboratory model of a Foley catheterised bladder Infected with P mirabilis showed that when retention balloons were inflated with a solution of triclosan (10 g/L), the catheters drained freely for at least 7 days. Triclosan became impregnated throughout the silicone catheter material and completely Inhibited the formation of crystalline biofilm, whereas catheters inflated with water became blocked in 24 h. Our observations suggest a way to control a common complication in patients with long-term indwelling bladder catheters.	Cardiff Univ, Cardiff Sch Biosci, Cardiff CF10 3TL, S Glam, Wales; Cardiff Univ, Welsh Sch Pharm, Cardiff, S Glam, Wales	Cardiff University; Cardiff University	Stickler, DJ (corresponding author), Cardiff Univ, Cardiff Sch Biosci, Cardiff CF10 3TL, S Glam, Wales.							BIBBY JM, 1995, CELLS MAT, V2, P183; Jones RD, 2000, AM J INFECT CONTROL, V28, P184, DOI 10.1016/S0196-6553(00)90027-0; Kunin CM, 1997, URINARY TRACT INFECT, V5th, P226; Morris NS, 1997, BRIT J UROL, V80, P58, DOI 10.1046/j.1464-410X.1997.00185.x; Stickler DJ, 2002, J APPL MICROBIOL, V92, p163S, DOI 10.1046/j.1365-2672.92.5s1.6.x	5	59	70	1	10	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 26	2003	361	9367					1435	1437		10.1016/S0140-6736(03)13104-2	http://dx.doi.org/10.1016/S0140-6736(03)13104-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	672HZ	12727400				2022-12-24	WOS:000182516300015
J	Temeles, EJ; Kress, WJ				Temeles, EJ; Kress, WJ			Adaptation in a plant-hummingbird association	SCIENCE			English	Article							AGE-SEX CLASSES; RUFOUS HUMMINGBIRDS; DIMORPHISM; BEHAVIOR	Sexual dimorphism in bill morphology and body size of the Caribbean purple-throated carib hummingbird is associated with a reversal in. oral dimorphism of its Heliconia food plants. This hummingbird is the sole pollinator of H. caribaea and H. bihai, with flowers of the former corresponding to the short, straight bills of males, the larger sex, and flowers of the latter corresponding to the long, curved bills of females. On St. Lucia, H. bihai compensates for the rarity of H. caribaea by evolving a second color morph with flowers that match the bills of males, whereas on Dominica, H. caribaea evolves a second color morph with flowers that match the bills of females. The nectar rewards of all Heliconia morphs are consistent with each sex's choice of the morph that corresponds to its bill morphology and energy requirements, supporting the hypothesis that feeding preferences have driven their coadaptation.	Amherst Coll, Dept Biol, Amherst, MA 01002 USA; Smithsonian Inst, Natl Museum Nat Hist, US Natl Herbarium, MRC166, Washington, DC 20013 USA	Amherst College; Smithsonian Institution; Smithsonian National Museum of Natural History	Temeles, EJ (corresponding author), Amherst Coll, Dept Biol, Amherst, MA 01002 USA.		Temeles, Ethan J./AAD-7366-2021					Bleiweiss R, 1999, P ROY SOC B-BIOL SCI, V266, P2491, DOI 10.1098/rspb.1999.0951; CARPENTER FL, 1993, BEHAV ECOL SOCIOBIOL, V33, P297; CARPENTER FL, 1993, BEHAV ECOL SOCIOBIOL, V33, P305; Colwell RK, 2000, AM NAT, V156, P495, DOI 10.1086/303406; Darwin C., 1859, ORIGIN SPECIES MEANS; Faegri K., 1966, PRINCIPLES POLLINATI; FEINSINGER P, 1982, ECOLOGY, V63, P1574, DOI 10.2307/1938881; FEINSINGER P, 1976, ECOL MONOGR, V46, P257, DOI 10.2307/1942255; Reznick David, 1996, P243; SCHEMSKE DW, 1984, SCIENCE, V225, P519, DOI 10.1126/science.225.4661.519; SELANDER RK, 1966, CONDOR, V68, P113, DOI 10.2307/1365712; TEMELES EJ, 1993, OECOLOGIA, V94, P87, DOI 10.1007/BF00317307; Temeles EJ, 2000, SCIENCE, V289, P441, DOI 10.1126/science.289.5478.441; Wallace Alfred R., 1871, CONTRIBUTIONS THEORY; WOLF LL, 1971, ECOLOGY, V52, P980, DOI 10.2307/1933803; WOLF LL, 1975, AUK, V92, P511, DOI 10.2307/4084604	16	137	140	0	88	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 25	2003	300	5619					630	633		10.1126/science.1080003	http://dx.doi.org/10.1126/science.1080003			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671FB	12714743				2022-12-24	WOS:000182453700039
J	Brent, AE; Schweitzer, R; Tabin, CJ				Brent, AE; Schweitzer, R; Tabin, CJ			A somitic compartment of tendon progenitors	CELL			English	Article							GENE-EXPRESSION; CHICK; SCLERAXIS; ORIGIN; CHONDROGENESIS; MESODERM; MUSCLES; PATTERN; EMBRYO; FATE	We demonstrate that the tendons associated with the axial skeleton derive from a heretofore unappreciated, fourth compartment of the somites. Scleraxis (Scx), a bHLH transcription factor, marks this somitic tendon progenitor population at its inception, and is continuously expressed through differentiation into the mature tendons. Two earlier-formed somitic compartments, the sclerotome and myotome, interact to establish this fourth Scx-positive compartment. The tendon progenitors are induced at the sclerotome's edge, at the expense of skeletogenic Pax1 positive cells and in response to FGF signaling in the adjacent myotome. The tendon primordia thus form in a location abutting the two tissues that the mature tendons must ultimately connect. Tendon progenitor formation may reveal a general mechanism for the specification of other somitic subcompartments.	Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Oregon Hlth & Sci Univ, Dept Cell & Dev Biol, Portland, OR 97201 USA	Harvard University; Harvard Medical School; Oregon Health & Science University	Tabin, CJ (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	tabin@rascal.med.harvard.edu	Schweitzer, Ronen/AAY-2127-2020	Schweitzer, Ronen/0000-0002-7425-5028	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK056246] Funding Source: NIH RePORTER; NIDDK NIH HHS [P01 DK56246] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AHRENS PB, 1977, DEV BIOL, V60, P69, DOI 10.1016/0012-1606(77)90110-5; BERESFORD B, 1983, J EMBRYOL EXP MORPH, V77, P99; Borycki AG, 2000, CURR TOP DEV BIOL, V48, P165; Brand-Saberi B, 2000, CURR TOP DEV BIOL, V48, P1; CHALEPAKIS G, 1991, CELL, V66, P873, DOI 10.1016/0092-8674(91)90434-Z; CHEVALLIER A, 1979, J EMBRYOL EXP MORPH, V49, P73; CHRIST B, 1983, ANAT EMBRYOL, V166, P87, DOI 10.1007/BF00317946; CSERJESI P, 1995, DEVELOPMENT, V121, P1099; Dietrich S, 1997, DEVELOPMENT, V124, P3895; Dockter JL, 1998, DEVELOPMENT, V125, P2113; Edom-Vovard F, 2002, DEV BIOL, V247, P351, DOI 10.1006/dbio.2002.0707; Fraidenraich D, 2000, DEV BIOL, V225, P392, DOI 10.1006/dbio.2000.9839; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Huang RJ, 2000, ANAT EMBRYOL, V202, P195, DOI 10.1007/s004290000110; Huang RJ, 2000, DEVELOPMENT, V127, P527; HURLE JM, 1990, CELL DIFFER DEV, V30, P97, DOI 10.1016/0922-3371(90)90078-B; JOHNSON RL, 1994, CELL, V79, P1165, DOI 10.1016/0092-8674(94)90008-6; Kahane N, 2001, DEVELOPMENT, V128, P2187; Kiefer JC, 2001, DEV BIOL, V232, P77, DOI 10.1006/dbio.2000.0114; KIENY M, 1979, J EMBRYOL EXP MORPH, V49, P153; Logan M, 1998, METHODS, V14, P407, DOI 10.1006/meth.1998.0595; MARCELLE C, 1994, DEVELOPMENT, V120, P683; Monsoro-Burq AH, 2000, CURR TOP DEV BIOL, V48, P43; Morgan BA, 1996, METHOD CELL BIOL, V51, P185, DOI 10.1016/S0091-679X(08)60629-9; Murtaugh LC, 2001, DEV CELL, V1, P411, DOI 10.1016/S1534-5807(01)00039-9; Murtaugh LC, 1999, GENE DEV, V13, P225, DOI 10.1101/gad.13.2.225; ORDAHL CP, 1993, MOL BASIS MORPHOGENE, P165; Peters H, 1999, DEVELOPMENT, V126, P5399; SADOWSKI I, 1988, NATURE, V335, P563, DOI 10.1038/335563a0; Schweitzer R, 2001, DEVELOPMENT, V128, P3855; SEARLS RL, 1969, J EXP ZOOL, V170, P365, DOI 10.1002/jez.1401700313; Shellswell G., 1977, VERTEBRATE LIMB SOMI, P71; Stockdale FE, 2000, DEV DYNAM, V219, P304, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1057>3.0.CO;2-5; Stolte D, 2002, ANAT EMBRYOL, V205, P1, DOI 10.1007/s00429-002-0227-z; UENO H, 1992, J BIOL CHEM, V267, P1470; Williams BA, 1997, DEVELOPMENT, V124, P4983	36	394	411	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 18	2003	113	2					235	248		10.1016/S0092-8674(03)00268-X	http://dx.doi.org/10.1016/S0092-8674(03)00268-X			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	672EP	12705871	Bronze			2022-12-24	WOS:000182508500012
J	Kayed, R; Head, E; Thompson, JL; McIntire, TM; Milton, SC; Cotman, CW; Glabe, CG				Kayed, R; Head, E; Thompson, JL; McIntire, TM; Milton, SC; Cotman, CW; Glabe, CG			Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis	SCIENCE			English	Article							FLUORESCENCE CORRELATION SPECTROSCOPY; ALZHEIMERS-DISEASE; IN-VITRO; BETA; PEPTIDE; FIBRILS; PROTOFIBRILS; DETERMINANT; POTENT	Soluble oligomers are common to most amyloids and may represent the primary toxic species of amyloids, like the Abeta peptide in Alzheimer's disease (AD). Here we show that all of the soluble oligomers tested display a common conformation-dependent structure that is unique to soluble oligomers regardless of sequence. The in vitro toxicity of soluble oligomers is inhibited by oligomer-specific antibody. Soluble oligomers have a unique distribution in human AD brain that is distinct from fibrillar amyloid. These results indicate that different types of soluble amyloid oligomers have a common structure and suggest they share a common mechanism of toxicity.	Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA; Univ Calif Irvine, Inst Brain Aging & Dementia, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Chem, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Glabe, CG (corresponding author), Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA.				NIA NIH HHS [AG16573, AG00538] Funding Source: Medline; NINDS NIH HHS [NS31230] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P50AG016573] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Conway KA, 2000, BIOCHEMISTRY-US, V39, P2552, DOI 10.1021/bi991447r; El-Agnaf OMA, 2001, J MOL BIOL, V310, P157, DOI 10.1006/jmbi.2001.4743; Goldsbury C, 1999, J MOL BIOL, V285, P33, DOI 10.1006/jmbi.1998.2299; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Harper JD, 1999, BIOCHEMISTRY-US, V38, P8972, DOI 10.1021/bi9904149; Hartley DM, 1999, J NEUROSCI, V19, P8876, DOI 10.1523/JNEUROSCI.19-20-08876.1999; Kuo YM, 1996, J BIOL CHEM, V271, P4077; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lashuel HA, 2002, NATURE, V418, P291, DOI 10.1038/418291a; LeVine H, 2002, ARCH BIOCHEM BIOPHYS, V404, P106; Lue LF, 1999, AM J PATHOL, V155, P853, DOI 10.1016/S0002-9440(10)65184-X; McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M; O'Nuallain B, 2002, P NATL ACAD SCI USA, V99, P1485, DOI 10.1073/pnas.022662599; Pitschke M, 1998, NAT MED, V4, P832, DOI 10.1038/nm0798-832; Serio TR, 2000, SCIENCE, V289, P1317, DOI 10.1126/science.289.5483.1317; SOREGHAN B, 1994, J BIOL CHEM, V269, P28551; Tjernberg LO, 1999, CHEM BIOL, V6, P53, DOI 10.1016/S1074-5521(99)80020-9	18	3297	3461	10	675	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 18	2003	300	5618					486	489		10.1126/science.1079469	http://dx.doi.org/10.1126/science.1079469			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668LR	12702875				2022-12-24	WOS:000182295900040
J	Muller, B; Hartmann, B; Pyrowolakis, G; Affolter, M; Basler, K				Muller, B; Hartmann, B; Pyrowolakis, G; Affolter, M; Basler, K			Conversion of an extracellular Dpp/BMP morphogen gradient into an inverse transcriptional gradient	CELL			English	Article							DROSOPHILA WING DEVELOPMENT; SIGNAL-TRANSDUCTION; IMAGINAL DISCS; BINDING-SITES; DPP TARGETS; BRINKER; GENE; REPRESSION; SCHNURRI; ENCODES	Morphogen gradients control body pattern by differentially regulating cellular behavior. Here, we analyze the molecular events underlying the primary response to the Dpp/BMP morphogen in Drosophila. Throughout development, Dpp transduction causes the graded transcriptional downregulation of the brinker (brk) gene. We first provide significance for the brk expression gradient by showing that different Brk levels repress distinct combinations of wing genes expressed at different distances from Dpp-secreting cells. We then dissect the brk regulatory region and identify two separable elements with opposite properties, a constitutive enhancer and a Dpp morphogen-regulated silencer. Furthermore, we present genetic and biochemical evidence that the brk silencer serves as a direct target for a protein complex consisting of the Smad homologs Mad/Medea and the zinc finger protein Schnurri. Together, our results provide the molecular framework for a mechanism by which the extracellular Dpp/BMP morphogen establishes a finely tuned, graded read-out of transcriptional repression.	Univ Basel, Biozentrum, Abt Zellbiol, CH-4056 Basel, Switzerland; Univ Zurich, Inst Mol Biol, CH-8057 Zurich, Switzerland	University of Basel; University of Zurich	Affolter, M (corresponding author), Univ Basel, Biozentrum, Abt Zellbiol, Klingelbergstr 70, CH-4056 Basel, Switzerland.		Mueller, Bruno/E-9888-2017	Mueller, Bruno/0000-0003-2664-7219; Affolter, Markus/0000-0002-5171-0016; Basler, Konrad/0000-0003-3534-1529				Affolter M, 2001, EMBO J, V20, P3298, DOI 10.1093/emboj/20.13.3298; ARORA K, 1995, CELL, V81, P781, DOI 10.1016/0092-8674(95)90539-1; Ashe HL, 2000, DEVELOPMENT, V127, P3305; Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809; Campbell G, 1999, CELL, V96, P553, DOI 10.1016/S0092-8674(00)80659-5; Chen CR, 2002, CELL, V110, P19, DOI 10.1016/S0092-8674(02)00801-2; DRIEVER W, 1989, NATURE, V340, P363, DOI 10.1038/340363a0; Entchev EV, 2000, CELL, V103, P981, DOI 10.1016/S0092-8674(00)00200-2; GRIEDER NC, 1995, CELL, V81, P791, DOI 10.1016/0092-8674(95)90540-5; Grimm S, 1996, SCIENCE, V271, P1601, DOI 10.1126/science.271.5255.1601; Gurdon JB, 1998, CELL, V95, P159, DOI 10.1016/S0092-8674(00)81747-X; Gurdon JB, 2001, NATURE, V413, P797, DOI 10.1038/35101500; Hasson P, 2001, EMBO J, V20, P5725, DOI 10.1093/emboj/20.20.5725; HOCH M, 1993, CURR OPIN GENET DEV, V3, P566, DOI 10.1016/0959-437X(93)90092-4; Holley SA, 1997, BIOESSAYS, V19, P281, DOI 10.1002/bies.950190404; Hudson JB, 1998, DEVELOPMENT, V125, P1407; Inoue H, 1998, MOL BIOL CELL, V9, P2145, DOI 10.1091/mbc.9.8.2145; Jazwinska A, 1999, DEVELOPMENT, V126, P3323; Jazwinska A, 1999, CELL, V96, P563, DOI 10.1016/S0092-8674(00)80660-1; JIANG J, 1993, CELL, V72, P741, DOI 10.1016/0092-8674(93)90402-C; Kim J, 1996, NATURE, V382, P133, DOI 10.1038/382133a0; Kim J, 1997, NATURE, V388, P304, DOI 10.1038/40906; Kirkpatrick H, 2001, J BIOL CHEM, V276, P18216, DOI 10.1074/jbc.M101365200; Lecuit T, 1996, NATURE, V381, P387, DOI 10.1038/381387a0; Lee KJ, 1999, ANNU REV NEUROSCI, V22, P261, DOI 10.1146/annurev.neuro.22.1.261; Marty T, 2000, NAT CELL BIOL, V2, P745, DOI 10.1038/35036383; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Minami M, 1999, NATURE, V398, P242, DOI 10.1038/18451; Morgan T.H., 1897, ROUX ARCH DEV BIOL, V5, P570; Muller B, 2000, DEVELOPMENT, V127, P2999; Nellen D, 1996, CELL, V85, P357, DOI 10.1016/S0092-8674(00)81114-9; Raftery LA, 1999, DEV BIOL, V210, P251, DOI 10.1006/dbio.1999.9282; Ramirez-Weber FA, 1999, CELL, V97, P599, DOI 10.1016/S0092-8674(00)80771-0; Sakuta H, 2001, SCIENCE, V293, P111, DOI 10.1126/science.1058379; SEGALAT L, 1994, MECH DEVELOP, V47, P241, DOI 10.1016/0925-4773(94)90042-6; SMALL S, 1992, EMBO J, V11, P4047, DOI 10.1002/j.1460-2075.1992.tb05498.x; Strigini M, 1999, SEMIN CELL DEV BIOL, V10, P335, DOI 10.1006/scdb.1999.0293; STRUHL G, 1992, CELL, V69, P237, DOI 10.1016/0092-8674(92)90405-2; STRUHL G, 1989, CELL, V57, P1259, DOI 10.1016/0092-8674(89)90062-7; Sturtevant MA, 1997, DEVELOPMENT, V124, P21; Tabata T, 2001, NAT REV GENET, V2, P620, DOI 10.1038/35084577; Tanimoto H, 2000, MOL CELL, V5, P59, DOI 10.1016/S1097-2765(00)80403-7; Teleman AA, 2000, CELL, V103, P971, DOI 10.1016/S0092-8674(00)00199-9; Torres-Vazquez J, 2000, DEV BIOL, V227, P388, DOI 10.1006/dbio.2000.9900; Tsuneizumi K, 1997, NATURE, V389, P627, DOI 10.1038/39362; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Wisotzkey RG, 1998, DEVELOPMENT, V125, P1433; WOLPERT L, 1989, DEVELOPMENT, V107, P3	49	143	145	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 18	2003	113	2					221	233		10.1016/S0092-8674(03)00241-1	http://dx.doi.org/10.1016/S0092-8674(03)00241-1			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	672EP	12705870	Bronze, Green Accepted			2022-12-24	WOS:000182508500011
J	Song, JB; Wu, LL; Chen, Z; Kohanski, RA; Pick, L				Song, JB; Wu, LL; Chen, Z; Kohanski, RA; Pick, L			Axons guided by insulin receptor in Drosophila visual system	SCIENCE			English	Article							ADAPTER PROTEIN; EMBRYONIC-DEVELOPMENT; GUIDANCE; GROWTH; HOMOLOG; MEMORY; DOMAIN; BRAIN; PHOSPHORYLATION; SPECIFICITY	Insulin receptors are abundant in the central nervous system, but their roles remain elusive. Here we show that the insulin receptor functions in axon guidance. The Drosophila insulin receptor (DInR) is required for photoreceptor-cell (R-cell) axons to find their way from the retina to the brain during development of the visual system. DInR functions as a guidance receptor for the adapter protein Dock/Nck. This function is independent of Chico, the Drosophila insulin receptor substrate (IRS) homolog.	Mt Sinai Sch Med, Brookdale Dept Mol Cell & Dev Biol, New York, NY 10029 USA; Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21287 USA; Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21287 USA	Icahn School of Medicine at Mount Sinai; Johns Hopkins University; Johns Hopkins University	Pick, L (corresponding author), Mt Sinai Sch Med, Brookdale Dept Mol Cell & Dev Biol, 1 Gustave Levy Pl, New York, NY 10029 USA.							Ausubel FM, 1992, CURRENT PROTOCOLS MO; Baskin DG, 1999, BRAIN RES, V848, P114, DOI 10.1016/S0006-8993(99)01974-5; Bohni R, 1999, CELL, V97, P865, DOI 10.1016/S0092-8674(00)80799-0; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; Chen C, 1996, ENDOCRINOLOGY, V137, P846, DOI 10.1210/en.137.3.846; Clandinin TR, 2002, NEURON, V35, P827, DOI 10.1016/S0896-6273(02)00876-0; Clemens JC, 1996, J BIOL CHEM, V271, P17002, DOI 10.1074/jbc.271.29.17002; Craft S, 1999, ARCH GEN PSYCHIAT, V56, P1135, DOI 10.1001/archpsyc.56.12.1135; FERNANDEZ R, 1995, EMBO J, V14, P3373, DOI 10.1002/j.1460-2075.1995.tb07343.x; FERNANDEZALMONACID R, 1987, MOL CELL BIOL, V7, P2718, DOI 10.1128/MCB.7.8.2718; Garrity PA, 1996, CELL, V85, P639, DOI 10.1016/S0092-8674(00)81231-3; Hing H, 1999, CELL, V97, P853, DOI 10.1016/S0092-8674(00)80798-9; KOHANSKI RA, UNPUB; Lannert H, 1998, BEHAV NEUROSCI, V112, P1199, DOI 10.1037/0735-7044.112.5.1199; Lee CH, 2001, NEURON, V30, P437, DOI 10.1016/S0896-6273(01)00291-4; Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4; LI W, 1992, MOL CELL BIOL, V12, P5824, DOI 10.1128/MCB.12.12.5824; Louvi A, 1997, DEV BIOL, V189, P33, DOI 10.1006/dbio.1997.8666; Meinertzhagen Ian A., 1993, P1363; Newsome TP, 2000, DEVELOPMENT, V127, P851; PETRUZZELLI L, 1985, J BIOL CHEM, V260, P6072; PETRUZZELLI L, 1986, P NATL ACAD SCI USA, V83, P4710, DOI 10.1073/pnas.83.13.4710; Rao Y, 1998, P NATL ACAD SCI USA, V95, P2077, DOI 10.1073/pnas.95.5.2077; RUAN YM, 1995, J BIOL CHEM, V270, P4236, DOI 10.1074/jbc.270.9.4236; Schmucker D, 2000, CELL, V101, P671, DOI 10.1016/S0092-8674(00)80878-8; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; White MF, 1998, MOL CELL BIOCHEM, V182, P3, DOI 10.1023/A:1006806722619; Wickelgren I, 1998, SCIENCE, V280, P517, DOI 10.1126/science.280.5363.517; WOLFF T, 1997, MOL CELLULAR APPROAC, P474; WOLFF T, 1993, DEV DROSOPHILA MELAN, V2, P1277; Yenush L, 1996, MOL CELL BIOL, V16, P2509; Zaia A, 2000, MECH AGEING DEV, V113, P227, DOI 10.1016/S0047-6374(99)00118-9; Zhao WQ, 1999, J BIOL CHEM, V274, P34893, DOI 10.1074/jbc.274.49.34893	33	122	125	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 18	2003	300	5618					502	505		10.1126/science.1081203	http://dx.doi.org/10.1126/science.1081203			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668LR	12702880				2022-12-24	WOS:000182295900045
J	Casolino, M; Bidoli, V; Morselli, A; Narici, L; DePascale, MP; Picozza, P; Reali, E; Sparvoli, R; Mazzenga, G; Ricci, M; Spillantini, P; Boezio, M; Bonvicini, V; Vacchi, A; Zampa, N; Castellini, G; Sannita, WG; Carlson, P; Galper, A; Korotkov, M; Popov, A; Vavilov, N; Avdeev, S; Fugelsang, C				Casolino, M; Bidoli, V; Morselli, A; Narici, L; DePascale, MP; Picozza, P; Reali, E; Sparvoli, R; Mazzenga, G; Ricci, M; Spillantini, P; Boezio, M; Bonvicini, V; Vacchi, A; Zampa, N; Castellini, G; Sannita, WG; Carlson, P; Galper, A; Korotkov, M; Popov, A; Vavilov, N; Avdeev, S; Fugelsang, C			Space travel - Dual origins of light flashes seen in space	NATURE			English	Article							STATION		Univ Roma Tor Vergata, Dept Phys, I-00133 Rome, Italy; Ist Nazl Fis Nucl, LNF, Rome, Italy; Univ Florence, Dept Phys, I-50121 Florence, Italy; Univ Trieste, Dept Phys, I-34127 Trieste, Italy; CNR, IROE, I-50127 Florence, Italy; Univ Genoa, DISMR, Genoa, Italy; SUNY Stony Brook, Dept Psychiat, Stony Brook, NY 11794 USA; Royal Inst Technol, Stockholm, Sweden; Moscow State Engn Phys Inst, Moscow, Russia; Russian Space Corp Energia Korolin, Moscow, Russia; European Astronaut Ctr, Cologne, Germany	University of Rome Tor Vergata; Istituto Nazionale di Fisica Nucleare (INFN); University of Florence; University of Trieste; Consiglio Nazionale delle Ricerche (CNR); University of Genoa; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Royal Institute of Technology; National Research Nuclear University MEPhI (Moscow Engineering Physics Institute); Roscosmos; United Rocket & Space Corporation; S.P. Korolev Rocket & Space Corporation - Energia; European Space Agency	Casolino, M (corresponding author), Univ Roma Tor Vergata, Dept Phys, I-00133 Rome, Italy.	casolino@roma2.infn.it	Vacchi, Andrea G/C-1291-2010; Casolino, Marco/ABI-1081-2020; Morselli, Aldo/G-6769-2011; Boezio, Mirko/ABC-4188-2020; Galper, Arkady M/M-9610-2015; Sparvoli, Roberta/H-8024-2018; Castellini, Guido/C-6716-2018	Vacchi, Andrea G/0000-0003-3855-5856; Morselli, Aldo/0000-0002-7704-9553; Boezio, Mirko/0000-0002-8015-2981; Sparvoli, Roberta/0000-0002-6314-6117; Bonvicini, Valter/0000-0003-1826-5843; Castellini, Guido/0000-0002-0177-0643; Picozza, Piergiorgio/0000-0002-7986-3321; casolino, marco/0000-0001-6067-5104				Avdeev S, 2002, ACTA ASTRONAUT, V50, P511, DOI 10.1016/S0094-5765(01)00190-4; Bidoli V, 2001, J PHYS G NUCL PARTIC, V27, P2051, DOI 10.1088/0954-3899/27/10/307; BUDINGER TF, 1977, SP412 NASA, P193; CHARMAN WN, 1971, NATURE, V230, P522, DOI 10.1038/230522a0; Hoffman RA, 1977, SP377 NASA, P127; HORNECK G, 1992, NUCL TRACKS RAD MEAS, V20, P185; MCNULTY PJ, 1978, SCIENCE, V201, P341, DOI 10.1126/science.663660; PINSKY LS, 1974, SCIENCE, V183, P957, DOI 10.1126/science.183.4128.957; TOBIAS C A, 1952, J Aviat Med, V23, P345	9	72	73	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 17	2003	422	6933					680	680		10.1038/422680a	http://dx.doi.org/10.1038/422680a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668CG	12700751	Bronze			2022-12-24	WOS:000182272300030
J	Siddiqui, A; Kerb, R; Weale, ME; Brinkmann, U; Smith, A; Goldstein, DB; Wood, NW; Sisodiya, SM				Siddiqui, A; Kerb, R; Weale, ME; Brinkmann, U; Smith, A; Goldstein, DB; Wood, NW; Sisodiya, SM			Association of multidrug resistance in epilepsy with a polymorphism in the drug-transporter gene ABCB1	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HUMAN GENOMIC DIVERSITY; P-GLYCOPROTEIN; MDR1 GENE; REFRACTORY EPILEPSY; EXPRESSION; BRAIN; CELLS	BACKGROUND: One third of patients with epilepsy have drug-resistant epilepsy, which is associated with an increased risk of death and debilitating psychosocial consequences. Because this form is resistant to multiple antiepileptic drugs, the mode of resistance must be nonspecific, involving drug-efflux transporters such as ATP-binding cassette sub-family B member 1 (ABCB1, also known as MDR1 and P-glycoprotein 170). We hypothesized that the CC genotype at the ABCB1 C3435T polymorphism, which is associated with increased expression of the protein, influences the response to antiepileptic-drug treatment. METHODS: ABCB1 3435 was genotyped in 315 patients with epilepsy, classified as drug-resistant in 200 and drug-responsive in 115, and 200 control subjects without epilepsy. Recently devised methods were used to control for population stratification, and linkage disequilibrium was calculated across the gene. RESULTS: As compared with patients with drug-responsive epilepsy, patients with drug-resistant epilepsy were more likely to have the CC genotype at ABCB1 3435 than the TT genotype (odds ratio, 2.66; 95 percent confidence interval, 1.32 to 5.38; P=0.006). There was no genetic stratification between the two groups of patients. The polymorphism fell within an extensive block of linkage disequilibrium spanning much or all of the gene, implying that the polymorphism may not itself be causal but rather may be linked with the causal variant. CONCLUSIONS: These pharmacogenomic results identify a genetic factor associated with resistance to antiepileptic drugs.	UCL, Inst Neurol, Dept Clin & Expt Epilepsy, London WC1N 3BG, England; UCL, Inst Neurol, Dept Mol Pathogenesis, London WC1N 3BG, England; UCL, Dept Biol, London WC1N 3BG, England; Epidauros Biotechnol, Pharmacogenet Lab, Bernried, Germany; Natl Neurol Inst, Singapore, Singapore	University of London; University College London; University of London; University College London; University of London; University College London	Sisodiya, SM (corresponding author), UCL, Inst Neurol, Dept Clin & Expt Epilepsy, London WC1N 3BG, England.	s.sisodiya@ion.ucl.ac.uk	Weale, Michael E/F-2587-2010; Brinkmann, Ulrich/AAF-8216-2019; Goldstein, David/AAY-8125-2020; Wood, Nicholas W/C-2505-2009	Weale, Michael E/0000-0003-4593-1186; Brinkmann, Ulrich/0000-0002-5558-0212; Wood, Nicholas W/0000-0002-9500-3348				Carroll ML, 2001, J MOL BIOL, V311, P17, DOI 10.1006/jmbi.2001.4847; Cascorbi I, 2001, CLIN PHARMACOL THER, V69, P169, DOI 10.1067/mcp.2001.114164; Casetta I, 1999, ACTA NEUROL SCAND, V99, P329, DOI 10.1111/j.1600-0404.1999.tb07360.x; Choo EF, 2000, DRUG METAB DISPOS, V28, P655; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; Dombrowski SM, 2001, EPILEPSIA, V42, P1501, DOI 10.1046/j.1528-1157.2001.12301.x; Drescher S, 2002, BRIT J CLIN PHARMACO, V53, P526, DOI 10.1046/j.1365-2125.2002.01591.x; Farrell RJ, 2000, GASTROENTEROLOGY, V118, P279, DOI 10.1016/S0016-5085(00)70210-1; Fellay J, 2002, LANCET, V359, P30, DOI 10.1016/S0140-6736(02)07276-8; Gelisse P, 2001, J NEUROL NEUROSUR PS, V70, P240, DOI 10.1136/jnnp.70.2.240; Goldstein DB, 2001, NAT GENET, V29, P109, DOI 10.1038/ng1001-109; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Hitzl M, 2001, PHARMACOGENETICS, V11, P293, DOI 10.1097/00008571-200106000-00003; Hoffmeyer S, 2000, P NATL ACAD SCI USA, V97, P3473, DOI 10.1073/pnas.050585397; Kerb R., 2001, Pharmacogenomics Journal, V1, P204; Kim RB, 2001, CLIN PHARMACOL THER, V70, P189, DOI 10.1067/mcp.2001.117412; Lazarowski A, 1999, PEDIATR NEUROL, V21, P731, DOI 10.1016/S0887-8994(99)00074-0; Ling V, 1997, CANCER CHEMOTH PHARM, V40, pS3, DOI 10.1007/s002800051053; Llorente L, 2000, JOINT BONE SPINE, V67, P30; Loscher W, 2002, J PHARMACOL EXP THER, V301, P7, DOI 10.1124/jpet.301.1.7; MacDonald BK, 2001, ANN NEUROL, V50, P830; MacDonald BK, 2000, ANN NEUROL, V48, P833, DOI 10.1002/1531-8249(200012)48:6<833::AID-ANA3>3.3.CO;2-L; MACDONALD BK, 2001, ANN NEUROL, V49, P547; Reich DE, 2001, GENET EPIDEMIOL, V20, P4, DOI 10.1002/1098-2272(200101)20:1<4::AID-GEPI2>3.0.CO;2-T; Roy-Engel AM, 2001, GENETICS, V159, P279; Schinkel AH, 1999, ADV DRUG DELIVER REV, V36, P179, DOI 10.1016/S0169-409X(98)00085-4; Shapiro AB, 1998, ACTA PHYSIOL SCAND, V163, P227; Sisodiya SM, 2002, BRAIN, V125, P22, DOI 10.1093/brain/awf002; Sisodiya SM, 1999, NEUROREPORT, V10, P3437, DOI 10.1097/00001756-199911080-00032; Sisodiya SM, 2001, LANCET, V357, P42, DOI 10.1016/S0140-6736(00)03573-X; Tai HL, 2000, CURR OPIN MOL THER, V2, P459; Tanabe M, 2001, J PHARMACOL EXP THER, V297, P1137; TISHLER DM, 1995, EPILEPSIA, V36, P1, DOI 10.1111/j.1528-1157.1995.tb01657.x; Weir B., 1996, GENETIC DATA ANAL	34	509	556	0	25	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 10	2003	348	15					1442	1448		10.1056/NEJMoa021986	http://dx.doi.org/10.1056/NEJMoa021986			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	665CU	12686700	Green Published			2022-12-24	WOS:000182102700004
J	Buesseler, KO; Boyd, PW				Buesseler, KO; Boyd, PW			Will ocean fertilization work?	SCIENCE			English	Editorial Material							IRON FERTILIZATION; SOUTHERN-OCEAN; PHYTOPLANKTON; BLOOM		Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA; Univ Otago, Dept Chem, Natl Inst Water & Atmospher Res, Ctr Phys & Chem Oceanog, Dunedin 9001, New Zealand	Woods Hole Oceanographic Institution; National Institute of Water & Atmospheric Research (NIWA) - New Zealand; University of Otago	Buesseler, KO (corresponding author), Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA.	kbuesseler@whoi.edu; p.boyd@niwa.co.nz	Boyd, Philip W/J-7624-2014	Boyd, Philip W/0000-0001-7850-1911				Abbott MR, 2001, DEEP-SEA RES PT II, V48, P3891, DOI 10.1016/S0967-0645(01)00073-X; Boyd PW, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014130; Boyd PW, 2000, NATURE, V407, P695, DOI 10.1038/35037500; BUESSELER KO, 2002, EOS S, V83; Charette MA, 2000, GEOCHEM GEOPHY GEOSY, V1, DOI 10.1029/2000GC000069; Chisholm SW, 2001, SCIENCE, V294, P309, DOI 10.1126/science.1065349; COALE K, 2002, EOS S, V83; Feely R.A., 2001, OCEANOGRAPHY, V14, P18, DOI DOI 10.5670/0CEAN0G.2001.03; Johnson KS, 2002, SCIENCE, V296, P467; Lawrence MG, 2002, SCIENCE, V297, P1993; Ledwell JR, 1998, J GEOPHYS RES-OCEANS, V103, P21499, DOI 10.1029/98JC01738; MARKELS M, 2000, 220 ACS ANN M S CO2; Martin JH, 1990, PALEOCEANOGRAPHY, V5, P1, DOI 10.1029/PA005i001p00001; Nodder SD, 2001, GEOPHYS RES LETT, V28, P2409, DOI 10.1029/2001GL013008; SCHLERMEIER Q, 2003, NATURE, V421, P109; Smetacek V., 2001, US JGOFS NEWS, V11, P11; SUNDA WG, 1995, MAR CHEM, V50, P189, DOI 10.1016/0304-4203(95)00035-P	17	79	81	2	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 4	2003	300	5616					67	68		10.1126/science.1082959	http://dx.doi.org/10.1126/science.1082959			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663CP	12677048				2022-12-24	WOS:000181988900026
J	Valle, M; Gillet, R; Kaur, S; Henne, A; Ramakrishnan, V; Frank, J				Valle, M; Gillet, R; Kaur, S; Henne, A; Ramakrishnan, V; Frank, J			Visualizing tmRNA entry into a stalled ribosome	SCIENCE			English	Article							ELONGATION-FACTOR TU; AMINOACYL-TRANSFER-RNA; PROTEIN S1; CONFORMATIONAL-CHANGE; CRYSTAL-STRUCTURE; MESSENGER-RNA; SMPB SYSTEM; EF-TU; BINDING; GTP	Bacterial ribosomes stalled on defective messenger RNAs (mRNAs) are rescued by tmRNA, an similar to300-nucleotide-long molecule that functions as both transfer RNA (tRNA) and mRNA. Translation then switches from the defective message to a short open reading frame on tmRNA that tags the defective nascent peptide chain for degradation. However, the mechanism by which tmRNA can enter and move through the ribosome is unknown. We present a cryo-electron microscopy study at similar to13 to 15 angstroms of the entry of tmRNA into the ribosome. The structure reveals how tmRNA could move through the ribosome despite its complicated topology and also suggests roles for proteins S1 and SmpB in the function of tmRNA.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England; Hlth Res Inc, Wadsworth Ctr, Howard Hughes Med Inst, Albany, NY 12201 USA; Inst Microbiol & Genet, Gottingen Genom Lab, D-37077 Gottingen, Germany; SUNY Albany, Dept Biomed Sci, Albany, NY 12201 USA	MRC Laboratory Molecular Biology; Health Research Inc; Howard Hughes Medical Institute; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Ramakrishnan, V (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	ramak@mrc-lmb.cam.ac.uk; joachim@wadsworth.org	Valle, Mikel/F-7598-2011	Valle, Mikel/0000-0001-8268-6912; Ramakrishnan, V/0000-0002-4699-2194	NIGMS NIH HHS [GM55440, GM 44973, GM29169] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM029169, R01GM029169, R01GM055440] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barends S, 2000, BIOCHEMISTRY-US, V39, P2652, DOI 10.1021/bi992439d; Barends S, 2001, J MOL BIOL, V314, P9, DOI 10.1006/jmbi.2001.5114; BEAR DG, 1976, P NATL ACAD SCI USA, V73, P1824, DOI 10.1073/pnas.73.6.1824; Bordeau V, 2002, BIOCHIMIE, V84, P723, DOI 10.1016/S0300-9084(02)01442-6; Dong G, 2002, EMBO J, V21, P1845, DOI 10.1093/emboj/21.7.1845; Felden B, 1997, RNA, V3, P89; Frank J, 1995, BIOCHEM CELL BIOL, V73, P757, DOI 10.1139/o95-084; Gillet R, 2001, MOL MICROBIOL, V42, P879, DOI 10.1046/j.1365-2958.2001.02701.x; Gottesman S, 1998, GENE DEV, V12, P1338, DOI 10.1101/gad.12.9.1338; Hanawa-Suetsugu K, 2002, NUCLEIC ACIDS RES, V30, P1620, DOI 10.1093/nar/30.7.1620; Karzai AW, 2000, NAT STRUCT BIOL, V7, P449; Karzai AW, 1999, EMBO J, V18, P3793, DOI 10.1093/emboj/18.13.3793; Keiler KC, 2000, P NATL ACAD SCI USA, V97, P7778, DOI 10.1073/pnas.97.14.7778; Keiler KC, 1996, SCIENCE, V271, P990, DOI 10.1126/science.271.5251.990; Knudsen B, 2001, NUCLEIC ACIDS RES, V29, P171, DOI 10.1093/nar/29.1.171; LAUGHREA M, 1977, J MOL BIOL, V112, P399, DOI 10.1016/S0022-2836(77)80189-7; Lee S, 2001, RNA, V7, P999, DOI 10.1017/S1355838201010342; Nameki N, 2000, FEBS LETT, V470, P345, DOI 10.1016/S0014-5793(00)01349-1; NISSEN P, 1995, SCIENCE, V270, P1464, DOI 10.1126/science.270.5241.1464; Pedersen K, 2003, CELL, V112, P131, DOI 10.1016/S0092-8674(02)01248-5; Roche ED, 1999, EMBO J, V18, P4579, DOI 10.1093/emboj/18.16.4579; RODNINA MV, 1995, EMBO J, V14, P2613, DOI 10.1002/j.1460-2075.1995.tb07259.x; Rudinger-Thirion J, 1999, RNA, V5, P989, DOI 10.1017/S135583829999101X; Sengupta J, 2001, P NATL ACAD SCI USA, V98, P11991, DOI 10.1073/pnas.211266898; Stagg SM, 2001, J MOL BIOL, V309, P727, DOI 10.1006/jmbi.2001.4632; Stark H, 2002, NAT STRUCT BIOL, V9, P849, DOI 10.1038/nsb859; Stark H, 1997, NATURE, V389, P403, DOI 10.1038/38770; Valle M, 2002, EMBO J, V21, P3557, DOI 10.1093/emboj/cdf326; Williams KP, 1999, EMBO J, V18, P5423, DOI 10.1093/emboj/18.19.5423; Williams KP, 1996, RNA, V2, P1306; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; Withey JH, 2002, CURR OPIN MICROBIOL, V5, P154, DOI 10.1016/S1369-5274(02)00299-0; Wower IK, 2000, EMBO J, V19, P6612, DOI 10.1093/emboj/19.23.6612; Wower J, 2002, BIOCHEMISTRY-US, V41, P8826, DOI 10.1021/bi0201365; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089; Yusupova GZ, 2001, CELL, V106, P233, DOI 10.1016/S0092-8674(01)00435-4; Zvereva MI, 2001, J BIOL CHEM, V276, P47702, DOI 10.1074/jbc.M106786200; Zwieb C, 1999, NUCLEIC ACIDS RES, V27, P2063, DOI 10.1093/nar/27.10.2063	38	121	128	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 4	2003	300	5616					127	130		10.1126/science.1081798	http://dx.doi.org/10.1126/science.1081798			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663CP	12677067				2022-12-24	WOS:000181988900048
J	Flum, DR; Dellinger, EP; Cheadle, A; Chan, L; Koepsell, T				Flum, DR; Dellinger, EP; Cheadle, A; Chan, L; Koepsell, T			Intraoperative cholangiography and risk of common bile duct injury during cholecystectomy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COMPLICATIONS FOLLOWING CHOLECYSTECTOMY; BILIARY-TRACT COMPLICATIONS; LAPAROSCOPIC CHOLECYSTECTOMY; OPERATIVE CHOLANGIOGRAPHY; UNITED-STATES; ULTRASONOGRAPHY	Context Intraciperative cholangiography (IOC) may decrease the risk of common bile duct (CBD) injury during cholecystectomy by helping to avoid misidentification of the CBD. Objective To characterize the relationship of IOC use and CBD injury while controlling for patient and surgeon characteristics. Design, Setting, and Patients Retrospective nationwide cohort analysis of Medicare patients undergoing cholecystectomy from January 1, 1992, to December 31, 1999. Patients were identified using Current Procedural Terminology codes from the Medicare Part B depository. Common bile duct injury was defined by a second surgical procedure to repair the CBD injury within 1 year of cholecystectomy. Surgeon demographic features were obtained from matching the Medicare Part B data to the American Medical Association Physician Masterfile database. Main Outcome Measure Frequency of CBD injury in patients who did and did not have IOC performed during cholecystectomy, controlling for patient-level (age, sex, race, and case complexity) and surgeon-level (surgeon's age, sex, race, year of surgical procedure, case order, percentage of IOC use in prior surgical procedures, years in medical practice, board certification, and specialization) factors. Results The database search identified 1570361 cholecystectomies and 7911 CBD injuries (0.5%). Common bile duct injury was found in 2380 (0.39%) of 613 706 patients undergoing cholecystectomy with IOC and in 5531 (0.58%) of 956 655 patients undergoing cholecystectomy without IOC (unadjusted relative risk, 1.49; 95% confidence interval, 1.42-1.57). After controlling for patient-level factors and surgeon-level factors, the risk of injury was increased when IOC was not used (adjusted relative risk, 1.71; 95% confidence interval, 1.38-2.28). While surgeons performing IOCs routinely had a lower rate of CBD injuries than those who did not, this difference disappeared when IOC was not used. Conclusions In this study of Medicare patients undergoing cholecystectomy in the 1990s, the risk of CBD injury was significantly higher when IOC was not used. Although IOCs may not prevent all CBD injuries, this study suggests, that the routine use of IOC may decrease the rate of CBD injury.	Univ Washington, Dept Surg, Seattle, WA 98195 USA; Univ Washington, Robert Wood Johnson Clin Scholars Program, Seattle, WA 98195 USA; Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA; Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA; Ctr Medicare & Medicaid Serv, Div Clin Stand & Qual, Seattle, WA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Centers for Medicare & Medicaid Services	Flum, DR (corresponding author), Univ Washington, Dept Surg, BB 431,1959 NE Pacific St,Box 356410, Seattle, WA 98195 USA.	daveflum@u.washington.edu	Flum, David/GPX-7976-2022					Archer SB, 2001, ANN SURG, V234, P549, DOI 10.1097/00000658-200110000-00014; ASBUN HJ, 1994, SURG CLIN N AM, V74, P755, DOI 10.1016/S0039-6109(16)46405-4; Baldwin LM, 2002, MED CARE, V40, P82; Birkmeyer JD, 2002, NEW ENGL J MED, V346, P1128, DOI 10.1056/NEJMsa012337; Birth M, 1996, SURG ENDOSC-ULTRAS, V10, P794, DOI 10.1007/BF00189535; *CDCP NAT CTR HLTH, HOSP CAR STAT BRANCH; Contini S, 1999, J LAPAROENDOSC ADV A, V9, P197, DOI 10.1089/lap.1999.9.197; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Fiore NF, 1997, SURGERY, V122, P817, DOI 10.1016/S0039-6060(97)90092-1; Fletcher DR, 1999, ANN SURG, V229, P449, DOI 10.1097/00000658-199904000-00001; Flum DR, 2003, J AM COLL SURGEONS, V196, P385, DOI 10.1016/S1072-7515(02)01806-9; Flum DR, 2001, ARCH SURG-CHICAGO, V136, P1287, DOI 10.1001/archsurg.136.11.1287; Fowles J B, 1995, Health Care Financ Rev, V16, P189; Gigot JF, 1997, SURG ENDOSC-ULTRAS, V11, P1171, DOI 10.1007/s004649900563; *ING INC, 2000, ICD 9 CM EXP; Johnson SR, 2000, SURGERY, V128, P668, DOI 10.1067/msy.2000.108422; Katkhouda N, 2000, SURG ENDOSC-ULTRAS, V14, P88, DOI 10.1007/s004649900020; Ladocsi LT, 1997, AM SURGEON, V63, P150; Machi J, 1999, J AM COLL SURGEONS, V188, P360, DOI 10.1016/S1072-7515(98)00313-5; Mahmud S, 2002, SURG ENDOSC, V16, P581, DOI 10.1007/s00464-001-9094-6; Mirizzi PL, 1937, SURG GYNECOL OBSTET, V65, P702; Moskovitz A H, 2001, Surg Endosc, V15, P1227; *PHYS INS ASS AM, 2000, LAP INJ STUD 2000, P11; *PHYS INS ASS AM, 2000, RISK MAN REV GEN SUR, P15; Podnos YD, 2001, AM J SURG, V182, P663, DOI 10.1016/S0002-9610(01)00808-X; POSTA CG, 1995, SURG LAPAROSC ENDOSC, V5, P412; Roviaro GC, 1997, J ROY COLL SURG EDIN, V42, P324; SOPER NJ, 1994, SURG CLIN N AM, V74, P953, DOI 10.1016/S0039-6109(16)46397-8; TANIGUCHI Y, 1993, AM J GASTROENTEROL, V88, P1258; Taylor B, 1998, CAN MED ASSOC J, V158, P481; Valinsky LJ, 1999, J CLIN EPIDEMIOL, V52, P893, DOI 10.1016/S0895-4356(99)00043-8; Vecchio R, 1998, INT SURG, V83, P215; Vezakis A, 2000, SURG ENDOSC-ULTRAS, V14, P1118, DOI 10.1007/s004640000076; Wherry DC, 1996, ANN SURG, V224, P145, DOI 10.1097/00000658-199608000-00006; WOODS MS, 1994, AM J SURG, V167, P27, DOI 10.1016/0002-9610(94)90050-7; WOODS MS, 1995, SURG ENDOSC-ULTRAS, V9, P1076; Z'graggen K, 1998, SURG ENDOSC-ULTRAS, V12, P1303, DOI 10.1007/s004649900846; ZEGER SL, 1988, BIOMETRICS, V44, P1049, DOI 10.2307/2531734	38	304	317	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 2	2003	289	13					1639	1644		10.1001/jama.289.13.1639	http://dx.doi.org/10.1001/jama.289.13.1639			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	662JX	12672731				2022-12-24	WOS:000181944500026
J	Shaw, SL; Kamyar, R; Ehrhardt, DW				Shaw, SL; Kamyar, R; Ehrhardt, DW			Sustained microtubule treadmilling in Arabidopsis cortical arrays	SCIENCE			English	Article							LIVING PLANT-CELLS; DYNAMIC INSTABILITY; GROWTH; TUBULIN; ORIENTATION; TURNOVER; SITES	Plant cells create highly structured microtubule arrays at the cell cortex without a central organizing center to anchor the microtubule ends. In vivo imaging of individual microtubules in Arabidopsis plants revealed that new microtubules are initiated at the cell cortex and exhibit dynamics at both ends. Polymerization-biased dynamic instability at one end and slow depolymerization at the other end result in sustained microtubule migration across the cell cortex by a hybrid treadmilling mechanism. This motility causes widespread microtubule repositioning and contributes to changes in array organization through microtubule reorientation and bundling.	Carnegie Inst Sci, Dept Plant Biol, Stanford, CA 94305 USA; Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA	Carnegie Institution for Science; Stanford University	Ehrhardt, DW (corresponding author), Carnegie Inst Sci, Dept Plant Biol, 290 Panama St, Stanford, CA 94305 USA.	ehrhardt@andrew2.stanford.edu		Shaw, Sidney/0000-0001-9195-6128				Baskin TI, 2001, PROTOPLASMA, V215, P150, DOI 10.1007/BF01280311; Bichet A, 2001, PLANT J, V25, P137, DOI 10.1046/j.1365-313x.2001.00946.x; Chan J, 1999, P NATL ACAD SCI USA, V96, P14931, DOI 10.1073/pnas.96.26.14931; CLAYTON L, 1985, J CELL BIOL, V101, P319, DOI 10.1083/jcb.101.1.319; CYR RJ, 1994, ANNU REV CELL BIOL, V10, P153, DOI 10.1146/annurev.cb.10.110194.001101; Erhardt M, 2002, J CELL SCI, V115, P2423; Granger CL, 2001, PROTOPLASMA, V216, P201, DOI 10.1007/BF02673872; GREEN PB, 1965, J CELL BIOL, V27, P343, DOI 10.1083/jcb.27.2.343; GUNNING BES, 1985, J CELL SCI, P157, DOI 10.1242/jcs.1985.Supplement_2.9; HARDHAM AR, 1978, J CELL BIOL, V77, P14, DOI 10.1083/jcb.77.1.14; HUSH JM, 1994, J CELL SCI, V107, P775; Keating TJ, 1997, P NATL ACAD SCI USA, V94, P5078, DOI 10.1073/pnas.94.10.5078; Lloyd C, 2002, PLANT CELL, V14, P2319, DOI 10.1105/tpc.141030; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Rodionov V, 1999, P NATL ACAD SCI USA, V96, P115, DOI 10.1073/pnas.96.1.115; Rodionov VI, 1997, SCIENCE, V275, P215, DOI 10.1126/science.275.5297.215; SAXTON WM, 1984, J CELL BIOL, V99, P2175, DOI 10.1083/jcb.99.6.2175; SHIBAOKA H, 1991, CYTOSKELETAL BASIS P, P159; Thitamadee S, 2002, NATURE, V417, P193, DOI 10.1038/417193a; Vorobjev IA, 1999, J CELL SCI, V112, P2277; Wasteneys GO, 2002, J CELL SCI, V115, P1345; WatermanStorer CM, 1997, CURR BIOL, V7, pR369, DOI 10.1016/S0960-9822(06)00177-1; WatermanStorer CM, 1997, J CELL BIOL, V139, P417, DOI 10.1083/jcb.139.2.417; Whittington AT, 2001, NATURE, V411, P610, DOI 10.1038/35079128; WICK SM, 1985, CELL BIOL INT REP, V9, P357, DOI 10.1016/0309-1651(85)90031-1; YUAN M, 1994, P NATL ACAD SCI USA, V91, P6050, DOI 10.1073/pnas.91.13.6050; Yvon AMC, 1997, J CELL SCI, V110, P2391	27	346	353	1	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 13	2003	300	5626					1715	1718		10.1126/science.1083529	http://dx.doi.org/10.1126/science.1083529			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688WF	12714675				2022-12-24	WOS:000183459700042
J	Mandal, M; Boese, B; Barrick, JE; Winkler, WC; Breaker, RR				Mandal, M; Boese, B; Barrick, JE; Winkler, WC; Breaker, RR			Riboswitches control fundamental biochemical pathways in Bacillus subtilis and other bacteria	CELL			English	Article							GENE-EXPRESSION; SMALL MOLECULES; MESSENGER-RNA; BINDING; OPERON; TRANSCRIPTION; BIOSYNTHESIS; ATTENUATION; METABOLISM; PROTEIN	Riboswitches are metabolite binding domains within certain messenger RNAs that serve as precision sensors for their corresponding targets. Allosteric rearrangement of mRNA structure is mediated by ligand binding, and this results in modulation of gene expression. We have identified a class of riboswitches that selectively recognizes guanine and becomes saturated at concentrations as low as 5 nM. In Bacillus subtilis, this mRNA motif is located on at least five separate transcriptional units that together encode 17 genes that are mostly involved in purine transport and purine nucleotide biosynthesis. Our findings provide further examples of mRNAs that sense metabolites and that control gene expression without the need for protein factors. Furthermore, it is now apparent that riboswitches contribute to the regulation of numerous fundamental metabolic pathways in certain bacteria.	Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; Yale Univ, Dept Chem Engn, New Haven, CT 06520 USA; Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Yale University; Yale University; Yale University	Breaker, RR (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.		Barrick, Jeffrey/A-3046-2012; Breaker, Ronald/E-9679-2010	Barrick, Jeffrey/0000-0003-0888-7358; Breaker, Ronald/0000-0002-2165-536X	NIGMS NIH HHS [GM 559343] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Auger S, 2002, MICROBIOL-SGM, V148, P507, DOI 10.1099/00221287-148-2-507; Babitzke P, 2001, J BACTERIOL, V183, P5795, DOI 10.1128/JB.183.20.5795-5802.2001; BENNER SA, 1989, P NATL ACAD SCI USA, V86, P7054, DOI 10.1073/pnas.86.18.7054; Christiansen LC, 1997, J BACTERIOL, V179, P2540, DOI 10.1128/jb.179.8.2540-2550.1997; EBBOLE DJ, 1987, J BIOL CHEM, V262, P8274; Epshtein V, 2003, P NATL ACAD SCI USA, V100, P5052, DOI 10.1073/pnas.0531307100; GOLD L, 1995, ANNU REV BIOCHEM, V64, P763, DOI 10.1146/annurev.bi.64.070195.003555; Gold L, 1997, P NATL ACAD SCI USA, V94, P59, DOI 10.1073/pnas.94.1.59; Grundy FJ, 1998, MOL MICROBIOL, V30, P737, DOI 10.1046/j.1365-2958.1998.01105.x; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Hermann T, 2000, SCIENCE, V287, P820, DOI 10.1126/science.287.5454.820; Jadhav VR, 2002, BIOCHIMIE, V84, P877, DOI 10.1016/S0300-9084(02)01404-9; Jeffares DC, 1998, J MOL EVOL, V46, P18, DOI 10.1007/PL00006280; Kiga D, 1998, NUCLEIC ACIDS RES, V26, P1755, DOI 10.1093/nar/26.7.1755; Matthews KS, 1998, PROG NUCLEIC ACID RE, V58, P127; MCCONNELL TS, 1993, P NATL ACAD SCI USA, V90, P8362, DOI 10.1073/pnas.90.18.8362; McDaniel BAM, 2003, P NATL ACAD SCI USA, V100, P3083, DOI 10.1073/pnas.0630422100; Mironov AS, 2002, CELL, V111, P747, DOI 10.1016/S0092-8674(02)01134-0; MOSZER I, 1995, MICROBIOL-SGM, V141, P261, DOI 10.1099/13500872-141-2-261; Nahvi A, 2002, CHEM BIOL, V9, P1043, DOI 10.1016/S1074-5521(02)00224-7; Ptashne M., 2002, GENES SIGNALS; Rodionov DA, 2002, J BIOL CHEM, V277, P48949, DOI 10.1074/jbc.M208965200; Seetharaman S, 2001, NAT BIOTECHNOL, V19, P336, DOI 10.1038/86723; Shu D, 2003, J BIOL CHEM, V278, P7119, DOI 10.1074/jbc.M209895200; Soukup GA, 1999, RNA, V5, P1308, DOI 10.1017/S1355838299990891; Soukup GA, 1999, P NATL ACAD SCI USA, V96, P3584, DOI 10.1073/pnas.96.7.3584; Stormo GD, 2001, P NATL ACAD SCI USA, V98, P9465, DOI 10.1073/pnas.181334498; Sudarsan N, 2003, RNA, V9, P644, DOI 10.1261/rna.5090103; Switzer R.L., 2002, BACILLUS SUBTILIS IT, P255; Switzer RL, 1999, PROG NUCLEIC ACID RE, V62, P329; Vitreschak AG, 2002, NUCLEIC ACIDS RES, V30, P3141, DOI 10.1093/nar/gkf433; WENG ML, 1995, P NATL ACAD SCI USA, V92, P7455, DOI 10.1073/pnas.92.16.7455; WHITE HB, 1976, J MOL EVOL, V7, P101, DOI 10.1007/BF01732468; Winkler W, 2002, NATURE, V419, P952, DOI 10.1038/nature01145; Winkler WC, 2002, P NATL ACAD SCI USA, V99, P15908, DOI 10.1073/pnas.212628899	35	534	575	1	82	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 30	2003	113	5					577	586		10.1016/S0092-8674(03)00391-X	http://dx.doi.org/10.1016/S0092-8674(03)00391-X			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	687VL	12787499	Bronze			2022-12-24	WOS:000183397600008
J	Korner, C				Korner, C			Slow in, rapid out - Carbon flux studies and Kyoto targets	SCIENCE			English	Editorial Material							TERRESTRIAL BIOSPHERE; DECIDUOUS FOREST; CO2 ENRICHMENT; BALANCE; EXCHANGE; VARIABILITY; ECOSYSTEMS		Univ Basel, Inst Bot, CH-4056 Basel, Switzerland	University of Basel	Korner, C (corresponding author), Univ Basel, Inst Bot, Schonbeinstr 6, CH-4056 Basel, Switzerland.		Körner, Christian/B-6592-2014	Körner, Christian/0000-0001-7768-7638				Canadell JG, 2000, ECOSYSTEMS, V3, P115, DOI 10.1007/s100210000014; DeLucia EH, 1999, SCIENCE, V284, P1177, DOI 10.1126/science.284.5417.1177; DIXON RK, 1994, SCIENCE, V263, P185, DOI 10.1126/science.263.5144.185; Ehman JL, 2002, GLOBAL CHANGE BIOL, V8, P575, DOI 10.1046/j.1365-2486.2002.00492.x; Frolking S, 1996, GLOBAL CHANGE BIOL, V2, P343, DOI 10.1111/j.1365-2486.1996.tb00086.x; Goulden ML, 1996, SCIENCE, V271, P1576, DOI 10.1126/science.271.5255.1576; Granados J, 2002, GLOBAL CHANGE BIOL, V8, P1109, DOI 10.1046/j.1365-2486.2002.00533.x; Korner C, 2000, ECOL APPL, V10, P1590, DOI 10.2307/2641226; Malhi Y, 1999, PLANT CELL ENVIRON, V22, P715, DOI 10.1046/j.1365-3040.1999.00453.x; Prentice IC, 2000, ECOL APPL, V10, P1553, DOI 10.1890/1051-0761(2000)010[1553:TCBOTT]2.0.CO;2; Schimel DS, 2001, NATURE, V414, P169, DOI 10.1038/35102500; Schulze ED, 2000, SCIENCE, V289, P2058, DOI 10.1126/science.289.5487.2058; Valentini R, 2000, NATURE, V404, P861, DOI 10.1038/35009084	13	173	182	4	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 23	2003	300	5623					1242	1243		10.1126/science.1084460	http://dx.doi.org/10.1126/science.1084460			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681NN	12764181				2022-12-24	WOS:000183042400030
J	Myers, GJ; Davidson, PW; Cox, C; Shamlaye, CF; Palumbo, D; Cernichiari, E; Sloane-Reeves, J; Wilding, GE; Kost, J; Huang, LS; Clarkson, TW				Myers, GJ; Davidson, PW; Cox, C; Shamlaye, CF; Palumbo, D; Cernichiari, E; Sloane-Reeves, J; Wilding, GE; Kost, J; Huang, LS; Clarkson, TW			Prenatal methylmercury exposure from ocean fish consumption in the Seychelles child development study	LANCET			English	Article							IN-UTERO EXPOSURE; MATERNAL HAIR; OUTCOMES; MERCURY; DIET; AGE	Introduction Exposure to methylmercury (MeHg) before birth can adversely affect children's neurodevelopment. The most common form of prenatal exposure is maternal fish consumption, but whether such exposure harms the fetus is unknown. We aimed to identify adverse neurodevelopmental effects in a fish-consuming population. Methods We investigated 779 mother-infant pairs residing in the Republic of Seychelles. Mothers reported consuming fish on average 12 meals per week. Fish in Seychelles contain much the same concentrations of MeHg as commercial ocean fish elsewhere. Prenatal MeHg exposure was determined from maternal hair growing during pregnancy. We assessed neurocognitive, language, memory, motor, perceptual-motor, and behavioural functions in children at age 9 years. The association between prenatal MeHg exposure and the primary endpoints was investigated with multiple linear regression with adjustment for covariates that affect child development. Findings Mean prenatal MeHg exposure was 6.9 parts per million (SD 4.5ppm). Only two endpoints were associated with prenatal MeHg exposure. Increased exposure was associated with decreased performance in the grooved pegboard using the non-dominant hand in males and improved scores in the hyperactivity index of the Conner's teacher rating scale. Covariates affecting child development were appropriately associated with endpoints. Interpretation These data do not support the hypothesis that there is a neurodevelopmental risk from prenatal MeHg exposure resulting solely from ocean fish consumption.	Univ Rochester, Med Ctr, Sch Med & Dent, Dept Biostat & Computat Biol, Rochester, NY 14620 USA; Univ Rochester, Sch Med & Dent, Dept Environm Med, Rochester, NY 14620 USA; NICHD, Dept Neurol, NIH, US Dept HHS, Bethesda, MD USA; NICHD, Dept Pediat, NIH, US Dept HHS, Bethesda, MD USA; NICHD, Dept Epidemiol Stat & Prevent, NIH, US Dept HHS, Bethesda, MD USA; Minist Hlth, Victoria, Seychelles	University of Rochester; University of Rochester; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Myers, GJ (corresponding author), Univ Rochester, Med Ctr, Sch Med & Dent, Dept Biostat & Computat Biol, 601 Elmwood Ave,Box 631, Rochester, NY 14620 USA.		Myers, Gary J/I-4901-2013	Myers, Gary J/0000-0003-4317-015X	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES001247, R01ES010219] Funding Source: NIH RePORTER; NIEHS NIH HHS [R01-ES10219, T32 ES-007, ES-01247] Funding Source: Medline; PHS HHS [R01-08442] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Axtell CD, 1998, ENVIRON HEALTH PERSP, V106, P559, DOI 10.2307/3434230; AXTELL CD, 2000, ENV RES A, V84, P12; Cernichiari E, 1995, NEUROTOXICOLOGY, V16, P705; Cernichiari E, 1995, NEUROTOXICOLOGY, V16, P613; CHOI BH, 1978, J NEUROPATH EXP NEUR, V37, P719, DOI 10.1097/00005072-197811000-00001; Clarkson TW, 2002, ENVIRON HEALTH PERSP, V110, P11, DOI 10.1289/ehp.02110s111; Cox C, 1989, ENV RES, V31, P640; DAVIDSON P, 1974, PERCEPT PSYCHOPHYS, V14, P539; Davidson PW, 1999, JAMA-J AM MED ASSOC, V281, P897; Davidson PW, 1998, JAMA-J AM MED ASSOC, V280, P701, DOI 10.1001/jama.280.8.701; Davidson PW, 1995, NEUROTOXICOLOGY, V16, P677; Davidson PW, 2000, ENVIRON RES, V84, P1, DOI 10.1006/enrs.2000.4084; Daviglus ML, 1997, NEW ENGL J MED, V336, P1046, DOI 10.1056/NEJM199704103361502; Dourson ML, 2001, NEUROTOXICOLOGY, V22, P677, DOI 10.1016/S0161-813X(01)00060-2; Grandjean P, 1997, NEUROTOXICOL TERATOL, V19, P417, DOI 10.1016/S0892-0362(97)00097-4; Harada Y., 1968, MINAMATA DISEASE, P93; IPCS, 1990, ENV HLTH CRIT 101 ME; JULSHAMN K, 1987, SCI TOTAL ENVIRON, V65, P53, DOI 10.1016/0048-9697(87)90160-4; KJELLSTROM T, 1986, 3080 NAT SWED ENV BO; KJELLSTROM T, 1989, 3642 NAT SWED ENV BO; Lapham LW, 1995, NEUROTOXICOLOGY, V16, P689; Marsh DO, 1995, NEUROTOXICOLOGY, V16, P583; MARSH DO, 1987, ARCH NEUROL-CHICAGO, V44, P1017, DOI 10.1001/archneur.1987.00520220023010; MCKEOWNEYSSEN GE, 1983, AM J EPIDEMIOL, V118, P470, DOI 10.1093/oxfordjournals.aje.a113652; MITCHELL JW, 1982, NEW ZEAL MED J, V95, P112; Myers GJ, 1995, NEUROTOXICOLOGY, V16, P653; *NAT I ENV HLTH SC, 1998, WORKSH REP SCI ISS R; National Research Council (U.S.) Committee on the Toxicological Effects of Methylmercury, 2000, TOXICOLOGICAL EFFECT, P1; PHELPS RW, 1980, ARCH ENVIRON HEALTH, V35, P161, DOI 10.1080/00039896.1980.10667486; SAGER PR, 1984, DEV BRAIN RES, V12, P1, DOI 10.1016/0165-3806(84)90170-6	30	416	426	6	72	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 17	2003	361	9370					1686	1692		10.1016/S0140-6736(03)13371-5	http://dx.doi.org/10.1016/S0140-6736(03)13371-5			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	679KB	12767734				2022-12-24	WOS:000182919700009
J	Kitajima, TS; Yokobayashi, S; Yamamoto, M; Watanabe, Y				Kitajima, TS; Yokobayashi, S; Yamamoto, M; Watanabe, Y			Distinct cohesin complexes organize meiotic chromosome domains	SCIENCE			English	Article							SISTER-CHROMATID COHESION; FISSION YEAST; RECOMBINATION; PROTEIN; HETEROCHROMATIN; SEGREGATION; REQUIREMENT; REC8	Meiotic cohesin complexes at centromeres behave differently from those along chromosome arms, but the basis for these differences has remained elusive. The fission yeast cohesin molecule Rec8 largely replaces its mitotic counterpart, Rad21/Scc1, along the entire chromosome during meiosis. Here we show that Rec8 complexes along chromosome arms contain Rec11, whereas those in the vicinity of centromeres have a different partner subunit, Psc3. The arm-associated Rec8-Rec11 complexes are critical for meiotic recombination. The Rec8-Psc3 complexes comprise two different types of assemblies. First, pericentromeric Rec8-Psc3 complexes depend on histone methylation-directed heterochromatin for their localization and are required for cohesion during meiosis II. Second, central core Rec8-Psc3 complexes form independently of heterochromatin and are presumably required for establishing monopolar attachment at meiosis I. These findings define distinct modes of assembly and functions for cohesin complexes at different regions along chromosomes.	Univ Tokyo, Grad Sch Sci, Dept Biochem & Biophys, Tokyo 1130033, Japan; Japan Sci & Technol Corp, SORST, Tokyo 1130033, Japan	University of Tokyo; Japan Science & Technology Agency (JST)	Watanabe, Y (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biochem & Biophys, Tokyo 1130033, Japan.	ywatanab@ims.u-tokyo.ac.jp	Kitajima, Tomoya/A-7049-2016	Kitajima, Tomoya/0000-0002-6486-7143; Watanabe, Yoshinori/0000-0002-5488-4812				Bernard P, 2001, SCIENCE, V294, P2539, DOI 10.1126/science.1064027; Bernard P, 2002, TRENDS CELL BIOL, V12, P419, DOI 10.1016/S0962-8924(02)02344-9; Buonomo SBC, 2000, CELL, V103, P387, DOI 10.1016/S0092-8674(00)00131-8; Cervantes MD, 2000, MOL CELL, V5, P883, DOI 10.1016/S1097-2765(00)80328-7; DEVEAUX LC, 1994, GENE DEV, V8, P203, DOI 10.1101/gad.8.2.203; Hirano T, 2002, GENE DEV, V16, P399, DOI 10.1101/gad.955102; Klein F, 1999, CELL, V98, P91, DOI 10.1016/S0092-8674(00)80609-1; Krawchuk MD, 1999, GENETICS, V153, P57; Lee JY, 2001, ANNU REV CELL DEV BI, V17, P753, DOI 10.1146/annurev.cellbio.17.1.753; Li YF, 1997, MOL MICROBIOL, V23, P869, DOI 10.1046/j.1365-2958.1997.2691632.x; Losada A, 2002, GENE DEV, V16, P3004, DOI 10.1101/gad.249202; MCKEE B, COMMUNICATION; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Nasmyth K, 2001, ANNU REV GENET, V35, P673, DOI 10.1146/annurev.genet.35.102401.091334; Nonaka N, 2002, NAT CELL BIOL, V4, P89, DOI 10.1038/ncb739; Orr-Weaver TL, 1999, CELL, V99, P1, DOI 10.1016/S0092-8674(00)80055-0; Parisi S, 1999, MOL CELL BIOL, V19, P3515; Pasierbek P, 2001, GENE DEV, V15, P1349, DOI 10.1101/gad.192701; Prieto I, 2001, NAT CELL BIOL, V3, P761, DOI 10.1038/35087082; Takahashi K, 2000, SCIENCE, V288, P2215, DOI 10.1126/science.288.5474.2215; Tomonaga T, 2000, GENE DEV, V14, P2757, DOI 10.1101/gad.832000; Toth A, 1999, GENE DEV, V13, P320, DOI 10.1101/gad.13.3.320; Uhlmann F, 2003, CURR BIOL, V13, pR104, DOI 10.1016/S0960-9822(03)00039-3; Watanabe Y, 1999, NATURE, V400, P461, DOI 10.1038/22774; Watanabe Y, 2001, NATURE, V409, P359, DOI 10.1038/35053103; Watanabe Y., UNPUB; YOKOBAYASHI S, IN PRESS MOL CELL BI	27	124	131	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 16	2003	300	5622					1152	1155		10.1126/science.1083634	http://dx.doi.org/10.1126/science.1083634			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678VC	12750522				2022-12-24	WOS:000182886500048
J	Ksiazek, TG; Erdman, D; Goldsmith, CS; Zaki, SR; Peret, T; Emery, S; Tong, SX; Urbani, C; Comer, JA; Lim, W; Rollin, PE; Dowell, SF; Ling, AE; Humphrey, CD; Shieh, WJ; Guarner, J; Paddock, CD; Rota, P; Fields, B; DeRisi, J; Yang, JY; Cox, N; Hughes, JM; LeDuc, JW; Bellini, WJ; Anderson, LJ				Ksiazek, TG; Erdman, D; Goldsmith, CS; Zaki, SR; Peret, T; Emery, S; Tong, SX; Urbani, C; Comer, JA; Lim, W; Rollin, PE; Dowell, SF; Ling, AE; Humphrey, CD; Shieh, WJ; Guarner, J; Paddock, CD; Rota, P; Fields, B; DeRisi, J; Yang, JY; Cox, N; Hughes, JM; LeDuc, JW; Bellini, WJ; Anderson, LJ		SARS Working Grp	A novel coronavirus associated with severe acute respiratory syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PORCINE EPIDEMIC DIARRHEA; ANTIGENIC RELATIONSHIPS; VIRUS-INFECTION; NIPAH VIRUS; PATHOGENESIS; PROPAGATION; ADAPTATION; DIAGNOSIS; GROWTH; FEVER	BACKGROUND A worldwide outbreak of severe acute respiratory syndrome (SARS) has been associated with exposures originating from a single ill health care worker from Guangdong Province, China. We conducted studies to identify the etiologic agent of this outbreak. METHODS We received clinical specimens from patients in seven countries and tested them, using virus-isolation techniques, electron-microscopical and histologic studies, and molecular and serologic assays, in an attempt to identify a wide range of potential pathogens. RESULTS None of the previously described respiratory pathogens were consistently identified. However, a novel coronavirus was isolated from patients who met the case definition of SARS. Cytopathological features were noted in Vero E6 cells inoculated with a throat-swab specimen. Electron-microscopical examination revealed ultrastructural features characteristic of coronaviruses. Immunohistochemical and immunofluorescence staining revealed reactivity with group I coronavirus polyclonal antibodies. Consensus coronavirus primers designed to amplify a fragment of the polymerase gene by reverse transcription-polymerase chain reaction (RT-PCR) were used to obtain a sequence that clearly identified the isolate as a unique coronavirus only distantly related to previously sequenced coronaviruses. With specific diagnostic RT-PCR primers we identified several identical nucleotide sequences in 12 patients from several locations, a finding consistent with a point-source outbreak. Indirect fluorescence antibody tests and enzyme-linked immunosorbent assays made with the new isolate have been used to demonstrate a virus-specific serologic response. This virus may never before have circulated in the U.S. population. CONCLUSIONS A novel coronavirus is associated with this outbreak, and the evidence indicates that this virus has an etiologic role in SARS. Because of the death of Dr. Carlo Urbani, we propose that our first isolate be named the Urbani strain of SARS-associated coronavirus.	Ctr Dis Control & Prevent, Special Pathogens Branch, Natl Ctr Infect Dis, Atlanta, GA 30333 USA; Ctr Dis Control & Prevent, Resp & Enter Virus Brach, Natl Ctr Infect Dis, Atlanta, GA USA; Ctr Dis Control & Prevent, Infect Dis Pathol Act, Natl Ctr Infect Dis, Atlanta, GA USA; Ctr Dis Control & Prevent, Influenza Branch, Natl Ctr Infect Dis, Atlanta, GA USA; Ctr Dis Control & Prevent, Div Bacterial & Mycot Dis, Natl Ctr Infect Dis, Atlanta, GA USA; Ctr Dis Control & Prevent, Off Director, Div Viral & Rickettsial Dis, Natl Ctr Infect Dis, Atlanta, GA USA; WHO, Hanoi, Vietnam; Queen Mary Hosp, Govt Virus Unit, Hong Kong, Hong Kong, Peoples R China; Int Emerging Infect Dis Program, Bangkok, Thailand; Univ Calif San Francisco, San Francisco, CA 94143 USA; Singapore Gen Hosp, Dept Pathol, Singapore, Singapore; Ctr Dis Control, Dept Hlth, Taipei, Taiwan	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; World Health Organization; University of Hong Kong; University of California System; University of California San Francisco; Singapore General Hospital; Centers For Disease Control - Taiwan	Ksiazek, TG (corresponding author), Ctr Dis Control & Prevent, Special Pathogens Branch, Natl Ctr Infect Dis, Atlanta, GA 30333 USA.		Guarner, Jeannette/B-8273-2013	Guarner, Jeannette/0000-0001-5610-3541; Osborne, Jane/0000-0001-9529-7748; Rollin, Pierre/0000-0002-4608-2641				Becker W B, 1967, J Virol, V1, P1019; BOHLANDER SK, 1992, GENOMICS, V13, P1322, DOI 10.1016/0888-7543(92)90057-Y; BRADBURNE AF, 1970, ARCH GES VIRUSFORSCH, V31, P352, DOI 10.1007/BF01253769; BRADBURNE AF, 1972, J HYG-CAMB, V70, P235, DOI 10.1017/S0022172400022294; BRUCKOVA M, 1970, P SOC EXP BIOL MED, V135, P431; Chua KB, 2000, SCIENCE, V288, P1432, DOI 10.1126/science.288.5470.1432; Falsey AR, 2003, J INFECT DIS, V187, P785, DOI 10.1086/367901; Guarner J, 2000, AM J CLIN PATHOL, V114, P227, DOI 10.1309/HV74-N24T-2K2C-3E8Q; Hazelton PR, 2003, EMERG INFECT DIS, V9, P294, DOI 10.3201/eid0903.020327; HOFMANN M, 1988, J CLIN MICROBIOL, V26, P2235, DOI 10.1128/JCM.26.11.2235-2239.1988; JACOBSEGEELS HEL, 1983, J GEN VIROL, V64, P1859, DOI 10.1099/0022-1317-64-9-1859; JOHNSON KM, 1977, LANCET, V1, P569; Jonassen CM, 1998, J GEN VIROL, V79, P715, DOI 10.1099/0022-1317-79-4-715; Ksiazek TG, 1999, J INFECT DIS, V179, pS192, DOI 10.1086/514313; KUSANAGI K, 1992, J VET MED SCI, V54, P313, DOI 10.1292/jvms.54.313; Lavi E, 1996, VIROLOGY, V221, P325, DOI 10.1006/viro.1996.0382; Lee N, 2003, NEW ENGL J MED, V348, P1986, DOI 10.1056/NEJMoa030685; Luby JP, 1999, J CLIN VIROL, V12, P43, DOI 10.1016/S0928-0197(98)00067-1; MCINTOSH K, 1969, J IMMUNOL, V102, P1109; MURRAY K, 1995, SCIENCE, V268, P94, DOI 10.1126/science.7701348; OSHIRO LS, 1971, J GEN VIROL, V12, P161, DOI 10.1099/0022-1317-12-2-161; PATTERSON S, 1982, J GEN VIROL, V60, P307, DOI 10.1099/0022-1317-60-2-307; Poutanen SM, 2003, NEW ENGL J MED, V348, P1995, DOI 10.1056/NEJMoa030634; Smolinsky M.S., 2003, MICROBIAL THREATS HL; Swofford D. L., 1999, PAUP 4 0 PHYLOGENETI; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tsang KW, 2003, NEW ENGL J MED, V348, P1977, DOI 10.1056/NEJMoa030666; Wang D, 2002, P NATL ACAD SCI USA, V99, P15687, DOI 10.1073/pnas.242579699; *WHO, 2003, AC RESP SYNDR CHIN U; Wong KT, 2002, AM J PATHOL, V161, P2153, DOI 10.1016/S0002-9440(10)64493-8; WULFF H, 1975, B WORLD HEALTH ORGAN, V52, P429; ZAKI SR, 1995, AM J PATHOL, V146, P552; 2003, MMWR MORB MORTAL WKL, V52, P241	33	2902	3375	9	797	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 15	2003	348	20					1953	1966		10.1056/NEJMoa030781	http://dx.doi.org/10.1056/NEJMoa030781			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	677TJ	12690092	Bronze			2022-12-24	WOS:000182823400004
J	Priola, SA; Chesebro, B; Caughey, B				Priola, SA; Chesebro, B; Caughey, B			A view from the top - Prion diseases from 10,000 feet	SCIENCE			English	Editorial Material									NIAID, Rocky Mt Labs, Persistent Viral Dis Lab, Hamilton, MT 59840 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Priola, SA (corresponding author), NIAID, Rocky Mt Labs, Persistent Viral Dis Lab, Hamilton, MT 59840 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000752, Z01AI000752, ZIAAI000580, Z01AI000580] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Meier P, 2003, CELL, V113, P49, DOI 10.1016/S0092-8674(03)00201-0; 2003, KEYST S MOL ASP TRAN	2	24	24	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 9	2003	300	5621					917	+		10.1126/science.1085920	http://dx.doi.org/10.1126/science.1085920			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675WD	12738843	Green Submitted			2022-12-24	WOS:000182719800035
J	Zeitlinger, J; Simon, I; Harbison, CT; Hannett, NM; Volkert, TL; Fink, GR; Young, RA				Zeitlinger, J; Simon, I; Harbison, CT; Hannett, NM; Volkert, TL; Fink, GR; Young, RA			Program-specific distribution of a transcription factor dependent on partner transcription factor and MAPK signaling	CELL			English	Article							YEAST STE12 PROTEIN; PHEROMONE RESPONSE PATHWAY; SACCHAROMYCES-CEREVISIAE; CELL-CYCLE; FILAMENTOUS-GROWTH; INVASIVE GROWTH; GENE-EXPRESSION; KINASE CASCADE; DNA-BINDING; TRANSDUCTION	Specialized gene expression programs are induced by signaling pathways that act on transcription factors. Whether these transcription factors can function in multiple developmental programs through a global switch in promoter selection is not known. We have used genome-wide location analysis to show that the yeast Ste12 transcription factor, which regulates mating and filamentous growth, is bound to distinct program-specific target genes dependent on the developmental condition. This condition-dependent distribution of Ste12 requires concurrent binding of the transcription factor Tec1 during filamentation and is differentially regulated by the MAP kinases Fus3 and Kss1. Program-specific distribution across the genome may be a general mechanism by which transcription factors regulate distinct gene expression programs in response to signaling.	Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute	Zeitlinger, J (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.		Young, Richard A/F-6495-2012	Young, Richard A/0000-0001-8855-8647; Simon, Itamar/0000-0002-8517-1903				ANDRIANOPOULOS A, 1994, MOL CELL BIOL, V14, P2503, DOI 10.1128/MCB.14.4.2503; Bardwell L, 1998, P NATL ACAD SCI USA, V95, P15400, DOI 10.1073/pnas.95.26.15400; Barolo S, 2002, GENE DEV, V16, P1167, DOI 10.1101/gad.976502; Baur M, 1997, MOL CELL BIOL, V17, P4330, DOI 10.1128/MCB.17.8.4330; Breitkreutz A, 2002, TRENDS CELL BIOL, V12, P254, DOI 10.1016/S0962-8924(02)02284-5; Breitkreutz A, 2001, CURR BIOL, V11, P1266, DOI 10.1016/S0960-9822(01)00370-0; BRILL JA, 1994, MOL BIOL CELL, V5, P297, DOI 10.1091/mbc.5.3.297; Casamayor A, 2002, CURR OPIN MICROBIOL, V5, P179, DOI 10.1016/S1369-5274(02)00300-4; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Ciapponi L, 2001, GENE DEV, V15, P1540, DOI 10.1101/gad.886301; Cook JG, 1997, NATURE, V390, P85, DOI 10.1038/36355; Cook JG, 1996, GENE DEV, V10, P2831, DOI 10.1101/gad.10.22.2831; Crosby JA, 2000, YEAST, V16, P1365, DOI 10.1002/1097-0061(200011)16:15<1365::AID-YEA630>3.0.CO;2-S; Dickinson JR, 1996, MICROBIOL-UK, V142, P1391, DOI 10.1099/13500872-142-6-1391; DOLAN JW, 1989, P NATL ACAD SCI USA, V86, P5703, DOI 10.1073/pnas.86.15.5703; DOLAN JW, 1990, GENE DEV, V4, P492, DOI 10.1101/gad.4.4.492; Elion EA, 2000, CURR OPIN MICROBIOL, V3, P573, DOI 10.1016/S1369-5274(00)00143-0; ELION EA, 1991, P NATL ACAD SCI USA, V88, P9392, DOI 10.1073/pnas.88.21.9392; ELION EA, 1991, COLD SH Q B, V56, P41; ELION EA, 1993, MOL BIOL CELL, V4, P495, DOI 10.1091/mbc.4.5.495; ERREDE B, 1989, GENE DEV, V3, P1349, DOI 10.1101/gad.3.9.1349; Farley FW, 1999, GENETICS, V151, P1425; GARTNER A, 1992, GENE DEV, V6, P1280, DOI 10.1101/gad.6.7.1280; HAGEN DC, 1991, MOL CELL BIOL, V11, P2952, DOI 10.1128/MCB.11.6.2952; Iyer VR, 2001, NATURE, V409, P533, DOI 10.1038/35054095; KIRKMANCORREIA C, 1993, MOL CELL BIOL, V13, P3765, DOI 10.1128/MCB.13.6.3765; Kohler T, 2002, EUKARYOT CELL, V1, P673, DOI 10.1128/EC.1.5.673-686.2002; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; LIU HP, 1993, SCIENCE, V262, P1741, DOI 10.1126/science.8259520; Lorenz MC, 2000, MOL BIOL CELL, V11, P183, DOI 10.1091/mbc.11.1.183; Madhani HD, 1999, P NATL ACAD SCI USA, V96, P12530, DOI 10.1073/pnas.96.22.12530; Madhani HD, 1997, SCIENCE, V275, P1314, DOI 10.1126/science.275.5304.1314; Madhani HD, 1997, CELL, V91, P673, DOI 10.1016/S0092-8674(00)80454-7; Michelson AM, 2002, P NATL ACAD SCI USA, V99, P546, DOI 10.1073/pnas.032685999; Nelson C, 2003, NATURE, V421, P187, DOI 10.1038/nature01243; Oehlen LJWM, 1996, MOL CELL BIOL, V16, P2830; Olson KA, 2000, MOL CELL BIOL, V20, P4199, DOI 10.1128/MCB.20.12.4199-4209.2000; Pan XW, 2000, CURR OPIN MICROBIOL, V3, P567, DOI 10.1016/S1369-5274(00)00142-9; PETER M, 1993, CELL, V73, P747, DOI 10.1016/0092-8674(93)90254-N; Pi HW, 1997, MOL CELL BIOL, V17, P6410, DOI 10.1128/MCB.17.11.6410; PRIMIG M, 1991, EMBO J, V10, P4209, DOI 10.1002/j.1460-2075.1991.tb04999.x; Pryciak PM, 2001, DEV CELL, V1, P449, DOI 10.1016/S1534-5807(01)00066-1; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Roberts CJ, 2000, SCIENCE, V287, P873, DOI 10.1126/science.287.5454.873; ROBERTS RL, 1994, GENE DEV, V8, P2974, DOI 10.1101/gad.8.24.2974; Rua D, 2001, CURR OPIN MICROBIOL, V4, P720, DOI 10.1016/S1369-5274(01)00274-0; Sabbagh W, 2001, MOL CELL, V8, P683, DOI 10.1016/S1097-2765(01)00322-7; SCHNEIDER BL, 1995, YEAST, V11, P1265, DOI 10.1002/yea.320111306; Simon I, 2001, CELL, V106, P697, DOI 10.1016/S0092-8674(01)00494-9; Simon MA, 2000, CELL, V103, P13, DOI 10.1016/S0092-8674(00)00100-8; SONG OK, 1991, GENE DEV, V5, P741, DOI 10.1101/gad.5.5.741; Tedford K, 1997, CURR BIOL, V7, P228, DOI 10.1016/S0960-9822(06)00118-7; van Drogen F, 2002, CURR BIOL, V12, pR53, DOI 10.1016/S0960-9822(01)00672-8; Vaudry D, 2002, SCIENCE, V296, P1648, DOI 10.1126/science.1071552; Verger A, 2002, BIOESSAYS, V24, P362, DOI 10.1002/bies.10068; Wasylyk B, 1998, TRENDS BIOCHEM SCI, V23, P213, DOI 10.1016/S0968-0004(98)01211-0; White LJ, 2001, SOFTW TEST VERIF REL, V11, P1, DOI 10.1002/stvr.220; Wisdom R, 1999, EXP CELL RES, V253, P180, DOI 10.1006/excr.1999.4685	58	184	193	1	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 2	2003	113	3					395	404		10.1016/S0092-8674(03)00301-5	http://dx.doi.org/10.1016/S0092-8674(03)00301-5			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	674MP	12732146	Bronze			2022-12-24	WOS:000182640800013
J	Galagan, JE; Calvo, SE; Borkovich, KA; Selker, EU; Read, ND; Jaffe, D; FitzHugh, W; Ma, LJ; Smirnov, S; Purcell, S; Rehman, B; Elkins, T; Engels, R; Wang, SG; Nielsen, CB; Butler, J; Endrizzi, M; Qui, DY; Ianakiev, P; Pedersen, DB; Nelson, MA; Werner-Washburne, M; Selitrennikoff, CP; Kinsey, JA; Braun, EL; Zelter, A; Schulte, U; Kothe, GO; Jedd, G; Mewes, W; Staben, C; Marcotte, E; Greenberg, D; Roy, A; Foley, K; Naylor, J; Stabge-Thomann, N; Barrett, R; Gnerre, S; Kamal, M; Kamvysselis, M; Mauceli, E; Bielke, C; Rudd, S; Frishman, D; Krystofova, S; Rasmussen, C; Metzenberg, RL; Perkins, DD; Kroken, S; Cogoni, C; Macino, G; Catcheside, D; Li, WX; Pratt, RJ; Osmani, SA; DeSouza, CPC; Glass, L; Orbach, MJ; Berglund, JA; Voelker, R; Yarden, O; Plamann, M; Seiler, S; Dunlap, J; Radford, A; Aramayo, R; Natvig, DO; Alex, LA; Mannhaupt, G; Ebbole, DJ; Freitag, M; Paulsen, I; Sachs, MS; Lander, ES; Nusbaum, C; Birren, B				Galagan, JE; Calvo, SE; Borkovich, KA; Selker, EU; Read, ND; Jaffe, D; FitzHugh, W; Ma, LJ; Smirnov, S; Purcell, S; Rehman, B; Elkins, T; Engels, R; Wang, SG; Nielsen, CB; Butler, J; Endrizzi, M; Qui, DY; Ianakiev, P; Pedersen, DB; Nelson, MA; Werner-Washburne, M; Selitrennikoff, CP; Kinsey, JA; Braun, EL; Zelter, A; Schulte, U; Kothe, GO; Jedd, G; Mewes, W; Staben, C; Marcotte, E; Greenberg, D; Roy, A; Foley, K; Naylor, J; Stabge-Thomann, N; Barrett, R; Gnerre, S; Kamal, M; Kamvysselis, M; Mauceli, E; Bielke, C; Rudd, S; Frishman, D; Krystofova, S; Rasmussen, C; Metzenberg, RL; Perkins, DD; Kroken, S; Cogoni, C; Macino, G; Catcheside, D; Li, WX; Pratt, RJ; Osmani, SA; DeSouza, CPC; Glass, L; Orbach, MJ; Berglund, JA; Voelker, R; Yarden, O; Plamann, M; Seiler, S; Dunlap, J; Radford, A; Aramayo, R; Natvig, DO; Alex, LA; Mannhaupt, G; Ebbole, DJ; Freitag, M; Paulsen, I; Sachs, MS; Lander, ES; Nusbaum, C; Birren, B			The genome sequence of the filamentous fungus Neurospora crassa	NATURE			English	Article							INDUCED POINT MUTATION; YEAST SACCHAROMYCES-CEREVISIAE; DNA METHYLATION; MELANIN BIOSYNTHESIS; COLLETOTRICHUM-LAGENARIUM; SIGNAL-TRANSDUCTION; ADENYLYL-CYCLASE; SMALL RNAS; GENE; RIP	Neurospora crassa is a central organism in the history of twentieth-century genetics, biochemistry and molecular biology. Here, we report a high-quality draft sequence of the N. crassa genome. The approximately 40-megabase genome encodes about 10,000 protein-coding genes-more than twice as many as in the fission yeast Schizosaccharomyces pombe and only about 25% fewer than in the fruitfly Drosophila melanogaster. Analysis of the gene set yields insights into unexpected aspects of Neurospora biology including the identification of genes potentially associated with red light photobiology, genes implicated in secondary metabolism, and important differences in Ca2+ signalling as compared with plants and animals. Neurospora possesses the widest array of genome defence mechanisms known for any eukaryotic organism, including a process unique to fungi called repeat-induced point mutation (RIP). Genome analysis suggests that RIP has had a profound impact on genome evolution, greatly slowing the creation of new genes through genomic duplication and resulting in a genome with an unusually low proportion of closely related genes.	Whitehead Inst, Ctr Genome Res, Cambridge, MA 02141 USA; Univ Calif Riverside, Dept Plant Pathol, Riverside, CA 92521 USA; Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA; Univ Edinburgh, Inst Cell & Mol Biol, Edinburgh EH9 3JH, Midlothian, Scotland; Celara Genom, Rockville, MD 20850 USA; Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA; Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; Univ Colorado, Hlth Sci Ctr, Dept Cellular & Struct Biol, Denver, CO 80262 USA; Univ Kansas, Sch Med, Dept Microbiol, Kansas City, KS 66160 USA; Univ Florida, Dept Zool, Gainesville, FL 32611 USA; Hebrew Univ Jerusalem, Dept Plant Pathol & Microbiol, Fac Agr Food & Environm Qual Sci, IL-76100 Rehovot, Israel; Univ Dusseldorf, Inst Biochem, D-40225 Dusseldorf, Germany; Rockefeller Univ, Plant Mol Biol Lab, New York, NY 10021 USA; Tech Univ Munich, Dept Genome Oriented Bioinformat, Wissensch Zentrum Weihenstephan, D-85350 Freising Weihenstephan, Germany; GSF, Natl Res Ctr Environm & Hlth, Inst Bioinformat, D-85764 Neuherberg, Germany; Univ Kentucky, TH Morgan Sch Biol Sci, Lexington, KY 40506 USA; Univ Texas, Inst Cellular & Mol Biol, Austin, TX 78712 USA; Inst Genom Res, Rockville, MD 20878 USA; Univ Calif Berkeley, Dept Plant & Mol Biol, Berkeley, CA 94720 USA; Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; Univ Roma La Sapienza, Dipartimento Biotecnol Cellulari & Ematol, Rome, Italy; Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA 5001, Australia; Ohio State Univ, Dept Mol Genet, Columbus, OH 43210 USA; Univ Arizona, Dept Plant Pathol, Tucson, AZ 85721 USA; Univ Missouri, Sch Biol Sci, Kansas City, MO 64110 USA; Dartmouth Coll, Sch Med, Dept Genet, Hanover, NH 03755 USA; Univ Leeds, Sch Biol, Leeds LS2 9JT, W Yorkshire, England; Calif State Polytech Univ Pomona, Dept Chem, Pomona, CA 91768 USA; Texas A&M Univ, Dept Plant Pathol & Microbiol, College Stn, TX 77843 USA; Oregon Hlth & Sci Univ, Dept Environm & Biomol Syst, OGI Sch Sci & Engn, Beaverton, OR 97006 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; Ohio State Univ, Dept Mol Genet, Columbus, OH 43211 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; University of California System; University of California Riverside; University of Oregon; University of Edinburgh; Texas A&M University System; Texas A&M University College Station; University of New Mexico; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Kansas; University of Kansas Medical Center; State University System of Florida; University of Florida; Hebrew University of Jerusalem; Heinrich Heine University Dusseldorf; Rockefeller University; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Kentucky; University of Texas System; University of Texas Austin; J. Craig Venter Institute; University of California System; University of California Berkeley; University of California System; University of California Los Angeles; Sapienza University Rome; Flinders University South Australia; University System of Ohio; Ohio State University; University of Arizona; University of Missouri System; University of Missouri Kansas City; Dartmouth College; University of Leeds; California State University System; California State Polytechnic University Pomona; Texas A&M University System; Texas A&M University College Station; Oregon Health & Science University; Massachusetts Institute of Technology (MIT); University System of Ohio; Ohio State University	Galagan, JE (corresponding author), Whitehead Inst, Ctr Genome Res, 320 Charles St, Cambridge, MA 02141 USA.	jgalag@mit.edu; bwb@genome.wi.mit.edu	Staben, Charles/C-1562-2013; Yarden, Oded/J-5988-2012; Osmani, Stephen A./AAS-3904-2021; Rudd, Stephen A/A-6434-2013; Frishman, Dmitrij/AAT-7815-2020; Berglund, Andrew/AAS-1065-2021; krystofova, svetlana/AAU-8726-2020; Ma, Li-Jun/AAG-2359-2020; Paulsen, Ian T/K-3832-2012; Bell-Pedersen, Deborah/H-8012-2016; Kellis, Manolis/ABE-7385-2020; Mewes, Hans-Werner/A-8204-2019	Rudd, Stephen A/0000-0002-0344-7487; Paulsen, Ian T/0000-0001-9015-9418; Bell-Pedersen, Deborah/0000-0002-1639-8215; Kellis, Manolis/0000-0001-7113-9630; Ma, Li-Jun/0000-0002-2733-3708; Sachs, Matthew/0000-0001-9891-9223; , Oded/0000-0002-4722-535X; Braun, Edward/0000-0003-1643-5212; krystofova, svetlana/0000-0001-7631-2439; Galagan, James/0000-0003-0542-3291; Engels, Reinhard/0000-0003-0921-0736; Mewes, Hans-Werner/0000-0002-9713-6398; Marcotte, Edward/0000-0001-8808-180X; Catcheside, David/0000-0002-7101-6849; Read, Nick/0000-0002-2286-2862; Jedd, Gregory/0000-0002-5428-3873; Aramayo, Rodolfo/0000-0001-9702-6204	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058770] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS039546] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM058770] Funding Source: Medline; NINDS NIH HHS [P01 NS039546] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adams TH, 1998, MICROBIOL MOL BIOL R, V62, P35, DOI 10.1128/MMBR.62.1.35-54.1998; Aign V, 2001, GENETICS, V157, P1015; Aramayo R, 1996, CELL, V86, P103, DOI 10.1016/S0092-8674(00)80081-1; Aubry L, 1999, ANNU REV CELL DEV BI, V15, P469, DOI 10.1146/annurev.cellbio.15.1.469; Batzoglou S, 2002, GENOME RES, V12, P177, DOI 10.1101/gr.208902; Beadle GW, 1941, P NATL ACAD SCI USA, V27, P499, DOI 10.1073/pnas.27.11.499; Bootman MD, 2001, SEMIN CELL DEV BIOL, V12, P3, DOI 10.1006/scdb.2000.0211; CAMBARERI EB, 1991, GENETICS, V127, P699; CAMBARERI EB, 1989, SCIENCE, V244, P1571, DOI 10.1126/science.2544994; Catalanotto C, 2002, GENE DEV, V16, P790, DOI 10.1101/gad.222402; CORNELIUS G, 1989, BIOCHEM BIOPH RES CO, V162, P852, DOI 10.1016/0006-291X(89)92388-7; Davis R.H., 2000, NEUROSPORA CONTRIBUT; Davis RH, 2002, NAT REV GENET, V3, P397, DOI 10.1038/nrg797; Devlin PF, 2001, ANNU REV PHYSIOL, V63, P677, DOI 10.1146/annurev.physiol.63.1.677; DOHLMAN HG, 1991, ANNU REV BIOCHEM, V60, P653, DOI 10.1146/annurev.biochem.60.1.653; Feng B, 2001, INFECT IMMUN, V69, P1781, DOI 10.1128/IAI.69.3.1781-1794.2001; FOSS HM, 1993, SCIENCE, V262, P1737, DOI 10.1126/science.7505062; FREE SJ, 1979, J BACTERIOL, V137, P1219, DOI 10.1128/JB.137.3.1219-1226.1979; Freitag M, 2002, P NATL ACAD SCI USA, V99, P8802, DOI 10.1073/pnas.132212899; Gadd G. M, 1994, GROWING FUNGUS, P183; GIMENO CJ, 1992, CELL, V68, P1077, DOI 10.1016/0092-8674(92)90079-R; Graia F, 2001, MOL MICROBIOL, V40, P586, DOI 10.1046/j.1365-2958.2001.02367.x; Gustin MC, 1998, MICROBIOL MOL BIOL R, V62, P1264, DOI 10.1128/MMBR.62.4.1264-1300.1998; Hutchison CA, 1999, SCIENCE, V286, P2165, DOI 10.1126/science.286.5447.2165; Hutvagner G, 2002, CURR OPIN GENET DEV, V12, P225, DOI 10.1016/S0959-437X(02)00290-3; Ikeda K, 2002, MOL MICROBIOL, V45, P1355, DOI 10.1046/j.1365-2958.2002.03101.x; IRELAN JT, 1994, GENETICS, V138, P1093; Ivey FD, 1999, FUNGAL GENET BIOL, V26, P48, DOI 10.1006/fgbi.1998.1101; Ivey FD, 2002, EUKARYOT CELL, V1, P634, DOI 10.1128/EC.1.4.634-642.2002; Josefsson LG, 1997, EUR J BIOCHEM, V249, P415, DOI 10.1111/j.1432-1033.1997.t01-1-00415.x; Kelkar HS, 2001, GENETICS, V157, P979; KLEIN PS, 1988, SCIENCE, V241, P1467, DOI 10.1126/science.3047871; Kouzminova E, 2001, EMBO J, V20, P4309, DOI 10.1093/emboj/20.15.4309; Kurosawa E., 1926, T NAT HIST SOC FORMO, V16, P213; LAKINTHOMAS PL, 1993, BIOCHEM J, V292, P805, DOI 10.1042/bj2920805; LEE DW, IN PRESS GENETICS; Lengeler KB, 2000, MICROBIOL MOL BIOL R, V64, P746, DOI 10.1128/MMBR.64.4.746-785.2000; Lindegren CC, 1936, J GENET, V32, P243, DOI 10.1007/BF02982680; Linden H, 1999, ADV GENET, V41, P35, DOI 10.1016/S0065-2660(08)60150-9; LU SW, 2001, FUNGAL GENET NEWS, V48, pA246; LUO ZG, 1995, MOL CELL BIOL, V15, P5235; Margolin BS, 1998, GENETICS, V149, P1787; Nelson MA, 1997, FUNGAL GENET BIOL, V21, P348, DOI 10.1006/fgbi.1997.0986; Ohno S., 1970, EVOLUTION GENE DUPLI; Payen A. de, 1843, ANN CHIM PHYS, V9, P5; Perkins D., 2001, NEUROSPORA COMPENDIU; Perkins DD, 1997, GENETICS, V147, P125; Pickford A, 2003, CURR GENET, V42, P220, DOI 10.1007/s00294-002-0351-6; Pott GB, 2000, FUNGAL GENET BIOL, V31, P55, DOI 10.1006/fgbi.2000.1225; Rountree MR, 1997, GENE DEV, V11, P2383, DOI 10.1101/gad.11.18.2383; RUSSELL PJ, 1987, J BACTERIOL, V169, P2902, DOI 10.1128/jb.169.6.2902-2905.1987; Schulte U, 2002, J BIOTECHNOL, V94, P3, DOI 10.1016/S0168-1656(01)00415-1; SELKER EU, 1981, CELL, V24, P819, DOI 10.1016/0092-8674(81)90107-0; SELKER EU, 1987, CELL, V51, P741, DOI 10.1016/0092-8674(87)90097-3; SELKER EU, 1993, SCIENCE, V262, P1724, DOI 10.1126/science.8259516; Selker EU, 2003, NATURE, V422, P893, DOI 10.1038/nature01564; SELKER EU, 1990, ANNU REV GENET, V24, P579, DOI 10.1146/annurev.ge.24.120190.003051; Shear CL, 1927, J AGRIC RES, V34, P1019; Shiu PKT, 2002, GENETICS, V161, P1483; Shiu PKT, 2001, CELL, V107, P905, DOI 10.1016/S0092-8674(01)00609-2; Silverman-Gavrila LB, 2001, EUR J CELL BIOL, V80, P379, DOI 10.1078/0171-9335-00175; SINGER MJ, 1995, MOL CELL BIOL, V15, P5586; TAKANO Y, 1995, MOL GEN GENET, V249, P162, DOI 10.1007/BF00290362; Takano Y, 1997, FUNGAL GENET BIOL, V21, P131, DOI 10.1006/fgbi.1997.0963; *TIDR, 2003, MICR DAT; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; VIGFUSSON NV, 1974, NATURE, V249, P383, DOI 10.1038/249383a0; Watters MK, 1999, GENETICS, V153, P705; Wolffe AP, 1999, SCIENCE, V286, P481, DOI 10.1126/science.286.5439.481; Yuan WM, 2001, J BACTERIOL, V183, P4040, DOI 10.1128/JB.183.13.4040-4051.2001; Zamore PD, 2002, SCIENCE, V296, P1265, DOI 10.1126/science.1072457; 2002, FUNGAL GENOME INITIA	72	1214	2171	0	207	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 24	2003	422	6934					859	868		10.1038/nature01554	http://dx.doi.org/10.1038/nature01554			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670WR	12712197	hybrid, Green Submitted			2022-12-24	WOS:000182432600046
J	Grant, CC; Roberts, M; Scragg, R; Stewart, J; Lennon, D; Kivell, D; Ford, R; Menzies, R				Grant, CC; Roberts, M; Scragg, R; Stewart, J; Lennon, D; Kivell, D; Ford, R; Menzies, R			Delayed immunisation and risk of pertussis in infants: unmatched case-control study	BRITISH MEDICAL JOURNAL			English	Article							IMMUNIZATION		Univ Auckland, Fac Med & Hlth Sci, Dept Paediat, Auckland 1, New Zealand; Univ Auckland, Fac Med & Hlth Sci, Dept Community Hlth, Auckland 1, New Zealand; S Auckland Hlth, Auckland, New Zealand; Canterbury Dist Hlth Board, Christchurch, New Zealand; Auckland Dist Hlth Board, Auckland, New Zealand	University of Auckland; University of Auckland; Auckland District Health Board	Grant, CC (corresponding author), Univ Auckland, Fac Med & Hlth Sci, Dept Paediat, Private Bag 92019, Auckland 1, New Zealand.			Scragg, Robert/0000-0003-0013-2620; Grant, Cameron/0000-0002-4032-7230				CRAMPTON P, 1998, NZ PUBLIC HLTH REPOR, V5, P81; DIETZ VJ, 1993, PEDIATR INFECT DIS J, V12, P353, DOI 10.1097/00006454-199304000-00022; Guris D, 1999, CLIN INFECT DIS, V28, P1230, DOI 10.1086/514776; POLLOCK TM, 1984, ARCH DIS CHILD, V59, P162, DOI 10.1136/adc.59.2.162; REID S, 1994, NEW ZEAL MED J, V107, P460	5	77	77	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 19	2003	326	7394					852	853		10.1136/bmj.326.7394.852	http://dx.doi.org/10.1136/bmj.326.7394.852			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	670BF	12702617	Green Published, Bronze			2022-12-24	WOS:000182386800017
J	Frank, SA; Nowak, MA				Frank, SA; Nowak, MA			Developmental predisposition to cancer	NATURE			English	Article									Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92697 USA; Inst Adv Study, Princeton, NJ 08540 USA	University of California System; University of California Irvine; Institute for Advanced Study - USA	Frank, SA (corresponding author), Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92697 USA.	safrank@uci.edu	Nowak, Martin A/A-6977-2008	Frank, Steven/0000-0001-7348-7794				CAIRNS J, 1975, NATURE, V255, P197, DOI 10.1038/255197a0; Cairns J, 2002, P NATL ACAD SCI USA, V99, P10567, DOI 10.1073/pnas.162369899; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; KNUDSON AG, 1993, P NATL ACAD SCI USA, V90, P10914, DOI 10.1073/pnas.90.23.10914; PREHN RT, 1975, SCIENCE, V190, P1095, DOI 10.1126/science.1188386; Zheng Q, 2002, MATH BIOSCI, V176, P237, DOI 10.1016/S0025-5564(02)00087-1; Zheng Q, 1999, MATH BIOSCI, V162, P1, DOI 10.1016/S0025-5564(99)00045-0	7	70	73	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 3	2003	422	6931					494	494		10.1038/422494a	http://dx.doi.org/10.1038/422494a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	662TW	12673242				2022-12-24	WOS:000181965400029
J	Hutchinson, JR; Famini, D; Lair, R; Kram, R				Hutchinson, JR; Famini, D; Lair, R; Kram, R			Are fast-moving elephants really running?	NATURE			English	Article							LOCOMOTION; MAMMALS; SPEED		Stanford Univ, Biomech Engn Div, Stanford, CA 94305 USA; Univ Calif Davis, Sch Vet Med, Davis, CA 95616 USA; Thai Elephant Conservat Ctr, Lampang 52000, Thailand; Univ Colorado, Dept Kinesiol & Appl Physiol, Boulder, CO 80309 USA	Stanford University; University of California System; University of California Davis; University of Colorado System; University of Colorado Boulder	Hutchinson, JR (corresponding author), Stanford Univ, Biomech Engn Div, Stanford, CA 94305 USA.	jrhutch@stanford.edu	Hutchinson, John/AAH-1593-2020	Hutchinson, John/0000-0002-6767-7038				ALEXANDER RM, 1983, J ZOOL, V201, P135, DOI 10.1111/j.1469-7998.1983.tb04266.x; ALEXANDER RM, 1979, J ZOOL, V189, P135, DOI 10.1111/j.1469-7998.1979.tb03956.x; Cavagna G. A., 1977, SCALE EFFECTS ANIMAL, P111; Dickinson MH, 2000, SCIENCE, V288, P100, DOI 10.1126/science.288.5463.100; FARLEY CT, 1991, SCIENCE, V253, P306, DOI 10.1126/science.1857965; Gambaryan P. P., 1974, MAMMALS RUN; Gatesy SM, 1999, J MORPHOL, V240, P115, DOI 10.1002/(SICI)1097-4687(199905)240:2<115::AID-JMOR3>3.0.CO;2-Y; HEGLUND NC, 1982, J EXP BIOL, V97, P41; HILDEBRAND M, 1980, AM ZOOL, V20, P255; Howell A. B, 1944, SPEED IN ANIMALS; MCMAHON TA, 1987, J APPL PHYSIOL, V62, P2326, DOI 10.1152/jappl.1987.62.6.2326; Muybridge Eadweard, 1902, ANIMALS MOTION, P20	12	94	94	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 3	2003	422	6931					493	494		10.1038/422493a	http://dx.doi.org/10.1038/422493a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	662TW	12673241	Green Submitted			2022-12-24	WOS:000181965400028
J	Shishehbor, MH; Aviles, RJ; Brennan, ML; Fu, XM; Goormastic, M; Pearce, GL; Gokce, N; Keaney, JF; Penn, MS; Sprecher, DL; Vita, JA; Hazen, SL				Shishehbor, MH; Aviles, RJ; Brennan, ML; Fu, XM; Goormastic, M; Pearce, GL; Gokce, N; Keaney, JF; Penn, MS; Sprecher, DL; Vita, JA; Hazen, SL			Association of nitrotyrosine levels with cardiovascular disease and modulation by statin therapy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							C-REACTIVE PROTEIN; ACUTE CORONARY SYNDROMES; NITRIC-OXIDE SYNTHASE; IN-VIVO; ENDOTHELIAL DYSFUNCTION; LIPOPROTEIN OXIDATION; SUPEROXIDE PRODUCTION; HUMAN ATHEROSCLEROSIS; ARTERY DISEASE; MYELOPEROXIDASE	Context Formation of nitric oxide-derived oxidants may serve as a mechanism linking inflammation to development of atherosclerosis. Nitrotyrosine, a specific marker for protein modification by nitric oxide-derived oxidants, is enriched in human atherosclerotic lesions and low-density lipoprotein (LDL) recovered from human atheroma. Objectives To determine whether systemic levels of nitrotyrosine. are associated with the prevalence of coronary artery disease (CAD) and are modulated by hydroxymethylglutaryl coenzyme-A reductase inhibitor (statin) therapy. Design, Setting, and Patients A case-control and interventional study at 2 urban tertiary-care referral centers; recruitment for each was from June 1, 2001, until January 1, 2002. For the case-control study, 100 case-patients with established CAD and 108 patients with no clinically evident CAD were recruited consecutively. In the interventional study, participants aged 21 years or older with hypercholesterolemia (LDL cholesterol greater than or equal to130 mg/dL [greater than or equal to3.5 mmol/L]) underwent nutrition and exercise counseling. Those whose levels did not decrease with 6 to 8 weeks were enrolled in the study (n=35). For 12 weeks, they received 10 mg/d of oral atorvastatin therapy. Main Outcome Measures In the case-control study, the association between systemic levels of protein-bound nitrotyrosine, CAD risk, and presence of CAD. In the interventional study, the change in nitrotyrosine, lipoprotein, and C-reactive protein (CRP) levels. Results Nitrotyrosine levels were significantly higher among patients with CAD (median 9.1 mumol/mol [interquartile range, 4.8-13.8 mumol/mol] tyrosine vs 5.2 mumol/mol [interquartile range, 2.2-8.4 mumol/mol]; P<.001). Patients in the upper quartile of nitrotyrosine (29%; P<.001) had a higher odds of CAD compared with those in the lowest quartile (unadjusted odds ratio, 6.1; 95% confidence interval, 2.6-14.0; P<.001). In multivariate models adjusting for Framingham Global Risk Score and CRP, upper quartiles of nitrotyrosine remained associated with CAD (odds ratio, 4.4; 95% confidence interval, 1.8-10.6; P<.001). Statin therapy reduced nitrotyrosine levels significantly (25%; P<.02) with a magnitude similar to reductions in total cholesterol levels (25%; P<.001) and LDL particle number (29%; P<.001) yet were independent of alterations in lipoproteins and inflammatory markers like CRP. Conclusions The findings from this preliminary study indicate that nitrotyrosine levels are associated with the presence of CAD and appear to be modulated by statin therapy. These results suggest a potential role for nitric oxide-derived oxidants as inflammatory mediators in CAD and may have implications for atherosclerosis risk assessment and monitoring of anti-inflammatory actions of statins.	Cleveland Clin Fdn, Dept Cell Biol, Cleveland, OH 44195 USA; Cleveland Clin Fdn, Dept Cardiovasc Med, Cleveland, OH 44195 USA; Cleveland Clin Fdn, Ctr Cardiovasc Diagnost & Prevent, Cleveland, OH 44195 USA; Boston Univ, Sch Med, Evans Dept Med, Boston, MA 02118 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Boston University	Hazen, SL (corresponding author), Cleveland Clin Fdn, Dept Cell Biol, 9500 Euclid Ave, Cleveland, OH 44195 USA.	hazens@ccf.org	Hazen, Stanley L/ABD-5845-2021	Keaney, John/0000-0002-0866-1837; Gokce, Noyan/0000-0003-2920-3445; Vita, Joseph/0000-0001-5607-1797	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062526, R01HL061878, R01HL070621, P01HL060886] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL60886, HL62526, HL70621, HL61878] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abu-Soud HM, 2000, J BIOL CHEM, V275, P37524, DOI 10.1074/jbc.275.48.37524; Abu-Soud HM, 2000, J BIOL CHEM, V275, P5425, DOI 10.1074/jbc.275.8.5425; Abu-Soud Husam M., 2000, Nitric Oxide, V4, P179; Babior BM, 1999, BLOOD, V93, P1464, DOI 10.1182/blood.V93.5.1464.405a32_1464_1476; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; BECKMANN JS, 1994, BIOL CHEM H-S, V375, P81, DOI 10.1515/bchm3.1994.375.2.81; Brennan ML, 2002, J BIOL CHEM, V277, P17415, DOI 10.1074/jbc.M112400200; Cai H, 2000, CIRC RES, V87, P840, DOI 10.1161/01.RES.87.10.840; Ceriello A, 2001, DIABETOLOGIA, V44, P834; Ceriello A, 2002, CIRCULATION, V106, P1211, DOI 10.1161/01.CIR.0000027569.76671.A8; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; DAUGHERTY A, 1994, J CLIN INVEST, V94, P437, DOI 10.1172/JCI117342; Eiserich JP, 1998, NATURE, V391, P393, DOI 10.1038/34923; Eiserich JP, 2002, SCIENCE, V296, P2391, DOI 10.1126/science.1106830; Freedman JE, 1998, CIRCULATION, V98, P1481, DOI 10.1161/01.CIR.98.15.1481; Galis ZS, 2002, CIRC RES, V90, P251, DOI 10.1161/res.90.3.251; Hazen SL, 1999, CIRC RES, V85, P950; Heinecke JW, 2001, ARTERIOSCL THROM VAS, V21, P1261, DOI 10.1161/hq0801.095084; Ignarro LJ, 2002, CIRC RES, V90, P21, DOI 10.1161/hh0102.102330; Kinlay S, 2001, CURR OPIN LIPIDOL, V12, P383, DOI 10.1097/00041433-200108000-00003; Laufs U, 1998, CIRCULATION, V97, P1129, DOI 10.1161/01.CIR.97.12.1129; Leeuwenburgh C, 1997, J BIOL CHEM, V272, P1433, DOI 10.1074/jbc.272.3.1433; Liao JK, 2002, J CLIN INVEST, V110, P285, DOI 10.1172/JCI200216421; Loscalzo J, 2001, CIRC RES, V88, P756, DOI 10.1161/hh0801.089861; Moncada S, 1999, J ROY SOC MED, V92, P164, DOI 10.1177/014107689909200402; MYERS GL, 1989, CLIN LAB MED, V9, P105, DOI 10.1016/S0272-2712(18)30645-0; Pannala AS, 1999, METHOD ENZYMOL, V301, P319; Podrez EA, 2000, FREE RADICAL BIO MED, V28, P1717, DOI 10.1016/S0891-5849(00)00229-X; Podrez EA, 1999, J CLIN INVEST, V103, P1547, DOI 10.1172/JCI5549; Ridker P M, 2000, Curr Cardiol Rep, V2, P269, DOI 10.1007/s11886-000-0080-8; Ridker PM, 2001, CIRCULATION, V103, P1191; Ridker PM, 2001, NEW ENGL J MED, V344, P1959, DOI 10.1056/NEJM200106283442601; Ridker PM, 1999, CIRCULATION, V100, P230, DOI 10.1161/01.CIR.100.3.230; Rifai N, 1999, CLIN CHEM, V45, P2136; Sorescu D, 2002, CIRCULATION, V105, P1429, DOI 10.1161/01.CIR.0000012917.74432.66; Stroes E, 1998, FEBS LETT, V438, P161, DOI 10.1016/S0014-5793(98)01292-7; Sugiyama S, 2001, AM J PATHOL, V158, P879, DOI 10.1016/S0002-9440(10)64036-9; Wassmann S, 2002, ARTERIOSCL THROM VAS, V22, P300, DOI 10.1161/hq0202.104081; Yusuf S, 2000, NEW ENGL J MED, V342, P145; Zhang ZL, 2001, JAMA-J AM MED ASSOC, V286, P2136, DOI 10.1001/jama.286.17.2136	40	365	396	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 2	2003	289	13					1675	1680		10.1001/jama.289.13.1675	http://dx.doi.org/10.1001/jama.289.13.1675			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	662JX	12672736	Bronze			2022-12-24	WOS:000181944500031
J	Hoag, H				Hoag, H			BSE case rattles Canadian officials	NATURE			English	News Item																			0	5	5	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 29	2003	423	6939					467	467		10.1038/423467b	http://dx.doi.org/10.1038/423467b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	683RH	12774079	Bronze			2022-12-24	WOS:000183162900004
J	Rands, SA; Cowlishaw, G; Pettifor, RA; Rowcliffe, JM; Johnstone, RA				Rands, SA; Cowlishaw, G; Pettifor, RA; Rowcliffe, JM; Johnstone, RA			Spontaneous emergence of leaders and followers in foraging pairs	NATURE			English	Article							DECISION-MAKING; PREDATION; RISK; BEHAVIOR; SEGREGATION; STRATEGIES; POSITION; RUTILUS; MODEL	Animals that forage socially(1) often stand to gain from coordination of their behaviour(2-5). Yet it is not known how group members reach a consensus on the timing of foraging bouts. Here we demonstrate a simple process by which this may occur. We develop a state-dependent, dynamic game model(6) of foraging by a pair of animals, in which each individual chooses between resting or foraging during a series of consecutive periods, so as to maximize its own individual chances of survival(6,7). We find that, if there is an advantage to foraging together(1,2,8), the equilibrium behaviour of both individuals becomes highly synchronized. As a result of this synchronization, differences in the energetic reserves of the two players spontaneously develop, leading them to adopt different behavioural roles. The individual with lower reserves emerges as the 'pace-maker' who determines when the pair should forage, providing a straightforward resolution to the problem of group coordination. Moreover, the strategy that gives rise to this behaviour can be implemented by a simple 'rule of thumb'(9) that requires no detailed knowledge of the state of other individuals.	Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; Zool Soc London, Inst Zool, London NW1 4RY, England	University of Cambridge; Zoological Society of London	Rands, SA (corresponding author), Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England.	s.rands@zoo.cam.ac.uk	Rowcliffe, Marcus/G-3713-2018; Rands, Sean A/B-2243-2008	Rowcliffe, Marcus/0000-0002-4286-6887; Rands, Sean A/0000-0002-7400-005X				Bednekoff PA, 1997, AM NAT, V150, P373, DOI 10.1086/286070; Camazine S., 2001, SELF ORG BIOL SYSTEM, DOI DOI 10.1515/9780691212920; CLARK CW, 1995, OIKOS, V72, P205, DOI 10.2307/3546222; CLARK CW, 1987, ANIM BEHAV, V35, P361, DOI 10.1016/S0003-3472(87)80259-2; Conradt L, 1998, P ROY SOC B-BIOL SCI, V265, P1359, DOI 10.1098/rspb.1998.0442; Conradt L, 2003, NATURE, V421, P155, DOI 10.1038/nature01294; Cuthill Innes C., 1997, P97; ENQUIST M, 1983, J THEOR BIOL, V102, P387, DOI 10.1016/0022-5193(83)90376-4; Giraldeau L.A., 2000, MG BEH ECOL; GOTCEITAS V, 1991, BEHAV ECOL SOCIOBIOL, V29, P255, DOI 10.1007/BF00163982; HAMILTON WD, 1971, J THEOR BIOL, V31, P295, DOI 10.1016/0022-5193(71)90189-5; HOUSTON A, 1988, NATURE, V332, P29, DOI 10.1038/332029a0; Houston AI., 1999, MODELS ADAPTIVE BEHA; Krause J, 1998, BEHAVIOUR, V135, P1031, DOI 10.1163/156853998792913519; KRAUSE J, 1993, OECOLOGIA, V93, P356, DOI 10.1007/BF00317878; KRAUSE J, 1992, BEHAV ECOL SOCIOBIOL, V30, P177, DOI 10.1007/BF00166700; Krause J., 2002, LIVING GROUPS; LEWONTIN RC, 1964, GENETICS, V49, P49; LIMA SL, 1986, ECOLOGY, V67, P377, DOI 10.2307/1938580; Lima SL, 1998, ADV STUD BEHAV, V27, P215; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; MANGEL M, 1990, ANIM BEHAV, V39, P1163, DOI 10.1016/S0003-3472(05)80788-2; Mangel M, 1988, DYNAMIC MODELING BEH; MCNAMARA JM, 1990, ACTA BIOTHEOR, V38, P37, DOI 10.1007/BF00047272; McNamara JM, 1997, J THEOR BIOL, V189, P211, DOI 10.1006/jtbi.1997.0511; Richards SA, 2002, BEHAV ECOL, V13, P427, DOI 10.1093/beheco/13.3.427; ROOK AJ, 1991, APPL ANIM BEHAV SCI, V32, P157, DOI 10.1016/S0168-1591(05)80039-5; Ruckstuhl KE, 2002, BIOL REV, V77, P77, DOI 10.1017/S1464793101005814; Stephens D.W., 1986, pi; SZEKELY T, 1991, BEHAV ECOL SOCIOBIOL, V28, P203	30	235	237	1	88	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 22	2003	423	6938					432	434		10.1038/nature01630	http://dx.doi.org/10.1038/nature01630			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681AJ	12761547				2022-12-24	WOS:000183012000040
J	Jablonski, D; Roy, K; Valentine, JW; Price, RM; Anderson, PS				Jablonski, D; Roy, K; Valentine, JW; Price, RM; Anderson, PS			The impact of the pull of the recent on the history of marine diversity	SCIENCE			English	Article							BIODIVERSITY; ORIGINATION; EXTINCTION	Up to 50% of the increase in marine animal biodiversity through the Cenozoic at the genus level has been attributed to a sampling bias termed "the Pull of the Recent," the extension of stratigraphic ranges of fossil taxa by the relatively complete sampling of the Recent biota. However, 906 of 958 living genera and subgenera of bivalve mollusks having a fossil record occur in the Pliocene or Pleistocene. The Pull of the Recent thus accounts for only 5% of the Cenozoic increase in bivalve diversity, a major component of the marine record, suggesting that the diversity increase is likely to be a genuine biological pattern.	Univ Chicago, Dept Geophys Sci, Chicago, IL 60637 USA; Univ Calif San Diego, Sect Ecol Behav & Evolut, La Jolla, CA 92903 USA; Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA	University of Chicago; University of California System; University of California San Diego; University of California System; University of California Berkeley	Jablonski, D (corresponding author), Univ Chicago, Dept Geophys Sci, 5734 S Ellis Ave, Chicago, IL 60637 USA.	d-jablonski@uchicago.edu						Adrain JM, 2000, SCIENCE, V289, P110, DOI 10.1126/science.289.5476.110; Alroy J, 2001, P NATL ACAD SCI USA, V98, P6261, DOI 10.1073/pnas.111144698; BAMBACH RK, 1993, PALEOBIOLOGY, V19, P372, DOI 10.1017/S0094837300000336; Benton MJ, 2001, GEOL J, V36, P211, DOI 10.1002/gj.877.abs; Best MMR, 2000, PALEOBIOLOGY, V26, P103, DOI 10.1666/0094-8373(2000)026<0103:BTITMS>2.0.CO;2; Crame JA, 2002, GEOL SOC SPEC PUBL, V194, P153, DOI 10.1144/GSL.SP.2002.194.01.12; DARRAGH TA, 1985, ALCHERINGA, V9, P83, DOI 10.1080/03115518508618960; Foote M, 1999, NATURE, V398, P415, DOI 10.1038/18872; Foote M, 2000, PALEOBIOLOGY, V26, P74, DOI 10.1666/0094-8373(2000)26[74:OAECOT]2.0.CO;2; Gage JD, 1991, DEEP SEA BIOL; GLOVER CP, 1993, J GEOL, V101, P729, DOI 10.1086/648271; Harper EM, 1998, ADEQUACY OF THE FOSSIL RECORD, P243; JABLONSKI D, 1995, SCIENCE, V268, P389, DOI 10.1126/science.11536722; Jackson JBC, 2001, SCIENCE, V293, P2401, DOI 10.1126/science.1063789; MARKOV AV, 2000, PALEONTOLOG J, V36, P121; MILLER AI, 1988, PALEOBIOLOGY, V14, P364, DOI 10.1017/S0094837300012100; MOORE RC, 1969, TREATISE INVERTEBRAT, VN; PEASE CM, 1992, PALEOBIOLOGY, V18, P89, DOI 10.1017/S0094837300012239; Peters SE, 2001, PALEOBIOLOGY, V27, P583, DOI 10.1666/0094-8373(2001)027<0583:BITPAR>2.0.CO;2; RAUP D M, 1979, Bulletin of Carnegie Museum of Natural History, P85; Sepkoski J.J., 1996, GLOBAL EVENT STRATIG, P35, DOI [10.1007/978-3-642-79634-0_4, DOI 10.1007/978-3-642-79634-0_4]; Sepkoski J.J., 2002, B AM PALEONTOL, V363, P1; Sepkoski JJ, 1997, J PALEONTOL, V71, P533, DOI 10.1017/S0022336000040026; SEPKOSKI JJ, 1981, NATURE, V293, P435, DOI 10.1038/293435a0; SEPKOSKI JJ, 1988, PALEOBIOLOGY, V14, P221, DOI 10.1017/S0094837300011969; Smith AB, 2001, PHILOS T R SOC B, V356, P351, DOI 10.1098/rstb.2000.0768; Smith Andrew B., 2000, Special Papers in Palaeontology, V63, P1; Valentine J. W., 1969, Palaeontology, V12, P684; VALENTINE JW, 1978, PALEOBIOLOGY, V4, P55, DOI 10.1017/S0094837300005686; VALENTINE JW, 1989, PALEOBIOLOGY, V15, P83, DOI 10.1017/S0094837300009295	30	125	130	1	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 16	2003	300	5622					1133	1135		10.1126/science.1083246	http://dx.doi.org/10.1126/science.1083246			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678VC	12750517				2022-12-24	WOS:000182886500041
J	Krejci, L; Van Komen, S; Li, Y; Villemain, J; Reddy, MS; Klein, H; Ellenberger, T; Sung, P				Krejci, L; Van Komen, S; Li, Y; Villemain, J; Reddy, MS; Klein, H; Ellenberger, T; Sung, P			DNA helicase Srs2 disrupts the Rad51 presynaptic filament	NATURE			English	Article							REPLICATION PROTEIN-A; SACCHAROMYCES-CEREVISIAE; YEAST RAD51; STRAND EXCHANGE; REPAIR; RECOMBINATION; MUTATIONS; GENE; RECA; SGS1	Mutations in the Saccharomyces cerevisiae gene SRS2 result in the yeast's sensitivity to genotoxic agents, failure to recover or adapt from DNA damage checkpoint-mediated cell cycle arrest, slow growth, chromosome loss, and hyper-recombination(1,2). Furthermore, double mutant strains, with mutations in DNA helicase genes SRS2 and SGS1, show low viability that can be overcome by inactivating recombination, implying that untimely recombination is the cause of growth impairment(1,3,4). Here we clarify the role of SRS2 in recombination modulation by purifying its encoded product and examining its interactions with the Rad51 recombinase. Srs2 has a robust ATPase activity that is dependent on single-stranded DNA ( ssDNA) and binds Rad51, but the addition of a catalytic quantity of Srs2 to Rad51-mediated recombination reactions causes severe inhibition of these reactions. We show that Srs2 acts by dislodging Rad51 from ssDNA. Thus, the attenuation of recombination efficiency by Srs2 stems primarily from its ability to dismantle the Rad51 presynaptic filament efficiently. Our findings have implications for the basis of Bloom's and Werner's syndromes, which are caused by mutations in DNA helicases and are characterized by increased frequencies of recombination and a predisposition to cancers and accelerated ageing(5).	Univ Texas, Hlth Sci Ctr, Inst Biotechnol, San Antonio, TX 78245 USA; Univ Texas, Hlth Sci Ctr, Dept Mol Med, San Antonio, TX 78245 USA; Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; NYU, Sch Med, Dept Biochem, New York, NY 10016 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Harvard University; Harvard Medical School; New York University	Krejci, L (corresponding author), Univ Texas, Hlth Sci Ctr, Inst Biotechnol, 15355 Lambda Dr, San Antonio, TX 78245 USA.		Krejci, Lumir/B-7842-2009	Krejci, Lumir/0000-0002-4732-1405; Klein, Hannah/0000-0003-4228-8535				ABOUSSEKHRA A, 1989, NUCLEIC ACIDS RES, V17, P7211, DOI 10.1093/nar/17.18.7211; ABOUSSEKHRA A, 1992, MOL CELL BIOL, V12, P3224, DOI 10.1128/MCB.12.7.3224; Adams MD, 2003, SCIENCE, V299, P265, DOI 10.1126/science.1077198; Bianco P. R., 1998, FRONT BIOSCI, V3, pD570; Chanet R, 1996, MOL CELL BIOL, V16, P4782; Cox MM, 2001, ANNU REV GENET, V35, P53, DOI 10.1146/annurev.genet.35.102401.090016; Gangloff S, 2000, NAT GENET, V25, P192, DOI 10.1038/76055; Klein HL, 2000, NAT GENET, V25, P132, DOI 10.1038/75957; Krejci L, 2001, MOL CELL BIOL, V21, P966, DOI 10.1128/MCB.21.3.966-976.2001; Lee SK, 1999, SCIENCE, V286, P2339, DOI 10.1126/science.286.5448.2339; Liberi G, 2000, EMBO J, V19, P5027, DOI 10.1093/emboj/19.18.5027; Mankouri HW, 2002, NUCLEIC ACIDS RES, V30, P1103, DOI 10.1093/nar/30.5.1103; Mazin AV, 2000, EMBO J, V19, P1148, DOI 10.1093/emboj/19.5.1148; MILNE GT, 1995, GENETICS, V139, P1189; Oakley TJ, 2002, DNA REPAIR, V1, P175, DOI 10.1016/S1568-7864(02)00002-2; OGAWA T, 1993, SCIENCE, V259, P1896, DOI 10.1126/science.8456314; PALLADINO F, 1992, GENETICS, V132, P23; Petukhova G, 1998, NATURE, V393, P91, DOI 10.1038/30037; Petukhova G, 1999, J BIOL CHEM, V274, P33839, DOI 10.1074/jbc.274.48.33839; RONG L, 1993, J BIOL CHEM, V268, P1252; SCHILD D, 1995, GENETICS, V140, P115; Sugiyama T, 1997, J BIOL CHEM, V272, P7940, DOI 10.1074/jbc.272.12.7940; SUNG P, 1994, SCIENCE, V265, P1241, DOI 10.1126/science.8066464; Sung P, 1997, GENE DEV, V11, P1111, DOI 10.1101/gad.11.9.1111; SUNG P, 1995, CELL, V82, P453, DOI 10.1016/0092-8674(95)90434-4; Sung P, 2000, MUTAT RES-FUND MOL M, V451, P257, DOI 10.1016/S0027-5107(00)00054-3; Van Komen S, 2002, J BIOL CHEM, V277, P43578, DOI 10.1074/jbc.M205864200; Vaze MB, 2002, MOL CELL, V10, P373, DOI 10.1016/S1097-2765(02)00593-2; Veaute X, 2003, NATURE, V423, P309, DOI 10.1038/nature01585; Wu L, 2001, J BIOL CHEM, V276, P19375, DOI 10.1074/jbc.M009471200	30	486	494	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 15	2003	423	6937					305	309		10.1038/nature01577	http://dx.doi.org/10.1038/nature01577			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678EX	12748644				2022-12-24	WOS:000182853100047
J	Lunney, JR; Lynn, J; Foley, DJ; Lipson, S; Guralnik, JM				Lunney, JR; Lynn, J; Foley, DJ; Lipson, S; Guralnik, JM			Patterns of functional decline at the end of life	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							OLDER PERSONS; DISABILITY; SERVICES; HOSPICE; DISEASE; HEALTH; ADULTS; HEART	Context Clinicians have observed various patterns of functional decline at the end of life, but few empirical data have tested these patterns in large populations. Objective To determine if functional decline differs among 4 types of illness trajectories: sudden death, cancer death, death from organ failure, and frailty. Design, Setting, and Participants Cohort analysis of data from 4 US regions in the prospective, longitudinal Established Populations for Epidemiologic Studies of the Elderly (EPESE) study. Of the 14456 participants aged 65 years or older who provided interviews at baseline (1981-1987), 4871 died during the first 6 years of follow-up; 4190 (86%) of these provided interviews within 1 year before dying. These decedents were evenly distributed in 12 cohorts based on the number of months between the final interview and death. Main Outcome Measures Self-or proxy-reported physical function (performance of 7 activities of daily living [ADLs]) within 1 year prior to death; predicted ADL dependency prior to death. Results Mean function declined across the 12 cohorts, simulating individual decline in the final year of life. Sudden death decedents were highly functional even in the last month before death (mean [95% confidence interval {CI}] numbers of ADL dependencies: 0.69 [0.19-1.19] at 12 months before death vs 1.22 [0.59-1.85] at the final month of life, P=.20); cancer decedents were highly functional early in their final year but markedly more disabled 3-months prior to death (0.77 [0.30-1.24] vs 4.09 [3.37-4.81], P<.001); organ failure decedents experienced a fluctuating. pattern of decline, with substantially poorer function during the last 3 months before death (2.10 [1.49-2.70] vs 3.66 [2.94-4.38], P<.001); and frail decedents were relatively more disabled in the final year and especially dependent during the last month (2.92 [2.24-3.60] vs 5.84 [5.33-6.35], P<.001). After controlling for age, sex, race, education, marital status, interval between final interview and death, and other demographic differences, frail decedents were more than 8 times more likely than sudden death decedents to be ADL dependent (OR, 8.32 [95% CI, 6.46-10.73); cancer decedents, one and a half times more likely (OR, 1.57 [95% CI, 1.25-1.96]); and organ failure decedents, 3 times more likely (OR, 3.00 [95% CI, 2.39-3.77]). Conclusions Trajectories of functional decline at the end of life are quite variable. Differentiating among expected trajectories and related needs would help shape tailored strategies and better programs of care prior to death.	NIA, Lab Epidemiol Demog & Biometry, NIH, Bethesda, MD 20892 USA; Washington Home Ctr Palliat Care Studies, Washington, DC USA; Hebrew Home Greater Washington, Rockville, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Lunney, JR (corresponding author), NIA, Lab Epidemiol Demog & Biometry, NIH, Gateway Bldg,Suite 3C-309, Bethesda, MD 20892 USA.		Ram, Prem/K-4511-2012		NATIONAL INSTITUTE OF NURSING RESEARCH [K22NR007967] Funding Source: NIH RePORTER; NINR NIH HHS [K22-NR07967] Funding Source: Medline	NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); NINR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))		CORNONIHUNTLEY J, 1986, NIH PUBLICATION; CORNONIHUNTLEY J, NIH PUBLICATION, V2; *FED INT FOR AG RE, 2000, OLD AM 2000 KEY IND; Ferrucci L, 1997, JAMA-J AM MED ASSOC, V277, P728; Ferrucci L, 1996, J GERONTOL A-BIOL, V51, pM123, DOI 10.1093/gerona/51A.3.M123; Fox E, 1999, JAMA-J AM MED ASSOC, V282, P1638, DOI 10.1001/jama.282.17.1638; Glaser B., 1968, TIME DYING, DOI DOI 10.1097/00000446-196812000-00048; GURALNIK JM, 1991, AM J PUBLIC HEALTH, V81, P443, DOI 10.2105/AJPH.81.4.443; Guralnik JM, 2001, J AM GERIATR SOC, V49, pS12; Haan MN, 1997, J AM GERIATR SOC, V45, P667, DOI 10.1111/j.1532-5415.1997.tb01468.x; *I MED, 1997, APPR DEATH IMPR CAR; LAWTON MP, 1990, MILBANK Q, V68, P1, DOI 10.2307/3350075; Lunney JR, 2002, J AM GERIATR SOC, V50, P1108, DOI 10.1046/j.1532-5415.2002.50268.x; Lynn J, 2001, JAMA-J AM MED ASSOC, V285, P925, DOI 10.1001/jama.285.7.925; Magaziner J, 2000, J GERONTOL A-BIOL, V55, pM498, DOI 10.1093/gerona/55.9.M498; MCNEIL J, 2001, AM DISABILITIES 1997; Minino A M, 2001, Natl Vital Stat Rep, V49, P1; Teno J M, 2001, J Palliat Med, V4, P457, DOI 10.1089/109662101753381593; VERBRUGGE LM, 1994, J HEALTH SOC BEHAV, V35, P97, DOI 10.2307/2137359; Visser M, 1998, AM J CLIN NUTR, V68, P584, DOI 10.1093/ajcn/68.3.584; Wolinsky FD, 1997, MED CARE, V35, P1031, DOI 10.1097/00005650-199710000-00005; Wolinsky FD, 1998, J GERONTOL B-PSYCHOL, V53, pS336, DOI 10.1093/geronb/53B.6.S336; Wolinsky FD, 1996, J AGING HEALTH, V8, P155, DOI 10.1177/089826439600800201	23	819	827	1	61	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 14	2003	289	18					2387	2392		10.1001/jama.289.18.2387	http://dx.doi.org/10.1001/jama.289.18.2387			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	677WF	12746362	Bronze			2022-12-24	WOS:000182831200028
J	Golas, MM; Sander, B; Will, CL; Luhrmann, R; Stark, H				Golas, MM; Sander, B; Will, CL; Luhrmann, R; Stark, H			Molecular architecture of the multiprotein splicing factor SF3b	SCIENCE			English	Article							U2 SNRNP PROTEINS; BRANCH-SITE; CRYSTAL-STRUCTURE; ELECTRON CRYOMICROSCOPY; ANGSTROM RESOLUTION; RNA; DOMAIN; COMPLEX; BINDING; MICROSCOPY	The splicing factor SF3b is a multiprotein complex essential for the accurate excision of introns from pre-messenger RNA. As an integral component of the U2 small nuclear ribonucleoprotein (snRNP) and the U11/U12 di-snRNP, SF3b is involved in the recognition of the pre-messenger RNA's branch site within the major and minor spliceosomes. We have determined the three-dimensional structure of the human SF3b complex by single-particle electron cryomicroscopy at a resolution of less than 10 angstroms, allowing identification of protein domains with known structural folds. The best fit of a modeled RNA-recognition motif indicates that the protein p14 is located in the central cavity of the complex. The 22 tandem helical repeats of the protein SF3b155 are located in the outer shell of the complex enclosing p14.	Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany	Max Planck Society	Stark, H (corresponding author), Max Planck Inst Biophys Chem, Fassberg 11, D-37077 Gottingen, Germany.	holger.stark@mpibpc.mpg.de	Sander, Bjoern/AAO-9021-2021	Sander, Bjoern/0000-0001-8495-2321; Holger, Stark/0000-0002-6161-1118				Bottcher C, 1999, FEBS LETT, V463, P255, DOI 10.1016/S0014-5793(99)01475-1; Burge CB, 1999, RNA WORLD, P525; Chacon P, 2002, J MOL BIOL, V317, P375, DOI 10.1006/jmbi.2002.5438; CHAMPIONARNAUD P, 1994, GENE DEV, V8, P1974, DOI 10.1101/gad.8.16.1974; Cingolani G, 1999, NATURE, V399, P221, DOI 10.1038/20367; Das BK, 1999, MOL CELL BIOL, V19, P6796; De Carlo S, 2002, J STRUCT BIOL, V138, P216, DOI 10.1016/S1047-8477(02)00035-7; DUBOCHET J, 1988, Q REV BIOPHYS, V21, P129, DOI 10.1017/S0033583500004297; Gozani O, 1998, MOL CELL BIOL, V18, P4752, DOI 10.1128/MCB.18.8.4752; Gozani O, 1996, GENE DEV, V10, P233, DOI 10.1101/gad.10.2.233; Groves MR, 1999, CELL, V96, P99, DOI 10.1016/S0092-8674(00)80963-0; Kramer A, 1999, J CELL BIOL, V145, P1355, DOI 10.1083/jcb.145.7.1355; MACMILLAN AM, 1994, GENE DEV, V8, P3008, DOI 10.1101/gad.8.24.3008; Marcotrigiano J, 2001, MOL CELL, V7, P193, DOI 10.1016/S1097-2765(01)00167-8; NAGAI K, 1990, NATURE, V348, P515, DOI 10.1038/348515a0; Orlova EV, 1997, J MOL BIOL, V271, P417, DOI 10.1006/jmbi.1997.1182; PEITSCH MC, 1995, BIO-TECHNOL, V13, P658, DOI 10.1038/nbt0795-658; Peitsch MC, 1996, BIOCHEM SOC T, V24, P274, DOI 10.1042/bst0240274; Query CC, 1996, EMBO J, V15, P1392, DOI 10.1002/j.1460-2075.1996.tb00481.x; Shamoo Y, 1997, NAT STRUCT BIOL, V4, P215, DOI 10.1038/nsb0397-215; Stark H, 2001, NATURE, V409, P539, DOI 10.1038/35054102; Tarn WY, 1997, TRENDS BIOCHEM SCI, V22, P132, DOI 10.1016/S0968-0004(97)01018-9; TISCHENDORF GW, 1974, MOL GEN GENET, V134, P187, DOI 10.1007/BF00267715; VALENTINE RC, 1968, BIOCHEMISTRY-US, V7, P2143, DOI 10.1021/bi00846a017; Vetter IR, 1999, CELL, V97, P635, DOI 10.1016/S0092-8674(00)80774-6; Wang CY, 1998, GENE DEV, V12, P1409, DOI 10.1101/gad.12.10.1409; Will CL, 1999, SCIENCE, V284, P2003, DOI 10.1126/science.284.5422.2003; Will CL, 2002, EMBO J, V21, P4978, DOI 10.1093/emboj/cdf480; Will CL, 2001, EMBO J, V20, P4536, DOI 10.1093/emboj/20.16.4536; Xu RM, 1997, STRUCTURE, V5, P559, DOI 10.1016/S0969-2126(97)00211-6	30	201	217	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 9	2003	300	5621					980	984		10.1126/science.1084155	http://dx.doi.org/10.1126/science.1084155			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675WD	12738865				2022-12-24	WOS:000182719800057
J	Huberman, AD; Wang, GY; Liets, LC; Collins, OA; Chapman, B; Chalupa, LM				Huberman, AD; Wang, GY; Liets, LC; Collins, OA; Chapman, B; Chalupa, LM			Eye-specific retinogeniculate segregation independent of normal neuronal activity	SCIENCE			English	Article								The segregation of initially intermingled left and right eye inputs to the dorsal lateral geniculate nucleus (DLGN) during development is thought to be in response to precise spatial and temporal patterns of spontaneous ganglion cell activity. To test this hypothesis, we disrupted the correlated activity of neighboring ganglion cells in the developing ferret retina through immunotoxin depletion of starburst amacrine cells. Despite the absence of this type of correlated activity, left and right eye inputs segregated normally in the DLGN. By contrast, when all spontaneous activity was blocked, the projections from the two eyes remained intermingled. Thus, certain features of normal neural activity patterns are not required for the formation of eye-specific projections to the DLGN.	Univ Calif Davis, Sch Med, Ctr Neurosci, Davis, CA 95616 USA; Univ Calif Davis, Sch Med, Sect Neurobiol Physiol & Behav, Davis, CA 95616 USA; Univ Calif Davis, Sch Med, Dept Ophthalmol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Chapman, B (corresponding author), Univ Calif Davis, Sch Med, Ctr Neurosci, Davis, CA 95616 USA.	bxchapman@ucdavis.edu; lmchalupa@ucdavis.edu			NATIONAL EYE INSTITUTE [R01EY011369, P30EY012576, R01EY003991, R01EY013301] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY011369, EY13301, EY12576, EY03991, EY11369, R01 EY011369-11] Funding Source: Medline; NIMH NIH HHS [P20 MH6095] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		COOK PM, 1999, VISUAL NEUROSCI, V16, P3; Crowley JC, 2000, SCIENCE, V290, P1321, DOI 10.1126/science.290.5495.1321; Crowley JC, 1999, NAT NEUROSCI, V2, P1125, DOI 10.1038/16051; Feller MB, 1996, SCIENCE, V272, P1182, DOI 10.1126/science.272.5265.1182; Feller MB, 1999, NEURON, V22, P653, DOI 10.1016/S0896-6273(00)80724-2; GALLI L, 1988, SCIENCE, V242, P90, DOI 10.1126/science.3175637; Hahm JO, 1999, J COMP NEUROL, V412, P705, DOI 10.1002/(SICI)1096-9861(19991004)412:4<705::AID-CNE11>3.0.CO;2-D; Huberman AD, 2002, J NEUROSCI, V22, P9419; Jones EG, 1985, THALAMUS; LINDEN DC, 1981, J COMP NEUROL, V203, P189, DOI 10.1002/cne.902030204; MAFFEI L, 1990, P NATL ACAD SCI USA, V87, P7; MEISTER M, 1991, SCIENCE, V252, P939, DOI 10.1126/science.2035024; Muir-Robinson G, 2002, J NEUROSCI, V22, P5259; Penn AA, 1998, SCIENCE, V279, P2108, DOI 10.1126/science.279.5359.2108; RAKIC P, 1979, NATURE, V261, P5560; Rossi FM, 2001, P NATL ACAD SCI USA, V98, P6453, DOI 10.1073/pnas.101120998; SHATZ CJ, 1983, J NEUROSCI, V3, P482; SHATZ CJ, 1988, SCIENCE, V242, P87, DOI 10.1126/science.3175636; SKALIORA I, 1993, J NEUROSCI, V13, P313; SRETAVAN DW, 1988, NATURE, V336, P468, DOI 10.1038/336468a0; Stellwagen D, 1999, NEURON, V24, P673, DOI 10.1016/S0896-6273(00)81121-6; Stellwagen D, 2002, NEURON, V33, P357, DOI 10.1016/S0896-6273(02)00577-9; Wang L, 1997, J NEUROPHYSIOL, V78, P689, DOI 10.1152/jn.1997.78.2.689; WONG RO, 1993, NEURON, V11, P5; WONG ROL, 1999, ANN REV NEUROSCI, V22; Zhou ZJ, 1998, J NEUROSCI, V18, P4155	26	92	96	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 9	2003	300	5621					994	998		10.1126/science.1080694	http://dx.doi.org/10.1126/science.1080694			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675WD	12738869	Green Accepted			2022-12-24	WOS:000182719800061
J	Lenski, RE; Ofria, C; Pennock, RT; Adami, C				Lenski, RE; Ofria, C; Pennock, RT; Adami, C			The evolutionary origin of complex features	NATURE			English	Article							DESIGN; RATES; GENE	A long-standing challenge to evolutionary theory has been whether it can explain the origin of complex organismal features. We examined this issue using digital organisms-computer programs that self-replicate, mutate, compete and evolve. Populations of digital organisms often evolved the ability to perform complex logic functions requiring the coordinated execution of many genomic instructions. Complex functions evolved by building on simpler functions that had evolved earlier, provided that these were also selectively favoured. However, no particular intermediate stage was essential for evolving complex functions. The first genotypes able to perform complex functions differed from their non-performing parents by only one or two mutations, but differed from the ancestor by many mutations that were also crucial to the new functions. In some cases, mutations that were deleterious when they appeared served as stepping-stones in the evolution of complex features. These findings show how complex functions can originate by random mutation and natural selection.	Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA; Michigan State Univ, Dept Comp Sci & Engn, E Lansing, MI 48824 USA; Michigan State Univ, Lyman Briggs Sch, E Lansing, MI 48824 USA; Michigan State Univ, Dept Philosophy, E Lansing, MI 48824 USA; CALTECH, Digital Life Lab, Pasadena, CA 91125 USA	Michigan State University; Michigan State University; Michigan State University; Michigan State University; California Institute of Technology	Lenski, RE (corresponding author), Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA.	lenski@msu.edu	Adami, Chris/A-9675-2011; Adami, Christoph/A-5181-2009	Adami, Chris/0000-0002-2915-9504; Lenski, Richard/0000-0002-1064-8375; Ofria, Charles/0000-0003-2924-1732				Adami C., 1998, INTRO ARTIFICIAL LIF; Bedau MA, 1997, FROM ANIM ANIMAT, P125; Chen LB, 1997, P NATL ACAD SCI USA, V94, P3811, DOI 10.1073/pnas.94.8.3811; Darwin C., 1859, ORIGIN SPECIES MEANS; Dawkins Richard, 1986, BLIND WATCHMAKER; Dean AM, 1997, P NATL ACAD SCI USA, V94, P3104, DOI 10.1073/pnas.94.7.3104; Dennett D., 2002, ENCY EVOLUTION, pE83; Dennett Daniel C., 1995, DARWINS DANGEROUS ID; Drake JW, 1998, GENETICS, V148, P1667; Foster JA, 2001, NAT REV GENET, V2, P428, DOI 10.1038/35076523; GOLDSMITH TH, 1990, Q REV BIOL, V65, P281, DOI 10.1086/416840; Holland JH, 1992, ADAPTATION NATURAL A, DOI DOI 10.7551/MITPRESS/1090.001.0001; JACOB F, 1977, SCIENCE, V196, P1161, DOI 10.1126/science.860134; Koza JR, 1992, GENETIC PROGRAMMING; LAND MF, 1992, ANNU REV NEUROSCI, V15, P1, DOI 10.1146/annurev.ne.15.030192.000245; Lenski RE, 1999, NATURE, V400, P661, DOI 10.1038/23245; Lipson H, 2000, NATURE, V406, P974, DOI 10.1038/35023115; MelendezHevia E, 1996, J MOL EVOL, V43, P293, DOI 10.1007/PL00006089; Miller K., 1999, FINDING DARWINS GOD; Mortlock RP, 1984, MICROORGANISMS MODEL; Newcomb RD, 1997, P NATL ACAD SCI USA, V94, P7464, DOI 10.1073/pnas.94.14.7464; NILSSON DE, 1994, P ROY SOC B-BIOL SCI, V256, P53, DOI 10.1098/rspb.1994.0048; Ofria C, 2002, IEEE T EVOLUT COMPUT, V6, P420, DOI 10.1109/TEVC.2002.802442; PIATIGORSKY J, 1991, SCIENCE, V252, P1078, DOI 10.1126/science.252.5009.1078; RAY T., 1992, ARTIF LIFE, P371, DOI DOI 10.1016/S0040-4039(01)97473-8; SALVINIPLAWEN LV, 1977, EVOLUTIONARY BIOL, V10, P207; Wagenaar D, 2000, FROM ANIM ANIMAT, P216; Wilke CO, 2002, TRENDS ECOL EVOL, V17, P528, DOI 10.1016/S0169-5347(02)02612-5; Wilke CO, 2001, NATURE, V412, P331, DOI 10.1038/35085569; Wilkins A.S., 2002, EVOLUTION DEV PATHWA; Yedid G, 2002, NATURE, V420, P810, DOI 10.1038/nature01151; Yedid G, 2001, AM NAT, V157, P465, DOI 10.1086/319928; Yokoyama S, 2001, GENETICS, V158, P1697	33	403	409	2	75	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 8	2003	423	6936					139	144		10.1038/nature01568	http://dx.doi.org/10.1038/nature01568			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675MR	12736677				2022-12-24	WOS:000182699600038
J	Tomlinson, B; Cockram, C				Tomlinson, B; Cockram, C			SARS: experience at Prince of Wales Hospital, Hong Kong	LANCET			English	Editorial Material							CORONAVIRUS; VIRUS		Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital	Tomlinson, B (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China.	btomlinson@cuhk.edu.hk	Tomlinson, Brian/P-5365-2015; Tomlinson, Brian/AAD-9404-2019	Tomlinson, Brian/0000-0001-6717-5444				Buckingham SC, 2002, J INFECT DIS, V185, P1222, DOI 10.1086/340024; *CDCP, 2003, MMWR-MORBID MORTAL W, V52, P241; *CDCP, 2003, CDC LAB AN SUGG NEW; *HONG KONG DEP HLT, MAIN FIND INV OUTBR; LEE N, 2003, N ENGL J MED; Peiris JSM, 2003, LANCET, V361, P1319, DOI 10.1016/S0140-6736(03)13077-2; POUTANEN SM, 2003, N ENGL J MED; Storz J, 2000, J CLIN MICROBIOL, V38, P3291, DOI 10.1128/JCM.38.9.3291-3298.2000; TSANG KW, 2003, N ENGL J MED; *WHO, CAS DEF SURV SEV AC; World Health Organization, 2003, SEV AC RESP SYNDR SA; Yu M, 2000, AVIAN DIS, V44, P297, DOI 10.2307/1592543	12	114	116	1	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 3	2003	361	9368					1486	1487		10.1016/S0140-6736(03)13218-7	http://dx.doi.org/10.1016/S0140-6736(03)13218-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	674WB	12737853	Bronze, Green Published			2022-12-24	WOS:000182658900002
J	Sausville, EA				Sausville, EA			Imatinib for chronic myelogenous leukaemia: a 9 or 24 carat gold standard?	LANCET			English	Editorial Material							ABL TYROSINE KINASE; CHRONIC MYELOID-LEUKEMIA; PHILADELPHIA-CHROMOSOME; INHIBITOR; APOPTOSIS; MESYLATE; PATIENT; STI571; CELLS		NCI, Dev Therapeut Program, Rockville, MD 20852 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Sausville, EA (corresponding author), NCI, Dev Therapeut Program, Rockville, MD 20852 USA.							Cools J, 2003, NEW ENGL J MED, V348, P1201, DOI 10.1056/NEJMoa025217; Druker BJ, 2001, NEW ENGL J MED, V344, P1038, DOI 10.1056/NEJM200104053441402; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Druker BJ, 2000, J CLIN INVEST, V105, P3, DOI 10.1172/JCI9083; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; HURON DR, IN PRESS CLIN CANC R; Joensuu H, 2001, NEW ENGL J MED, V344, P1052, DOI 10.1056/NEJM200104053441404; Kantarjian HM, 2002, CLIN CANCER RES, V8, P2167; Mow BMF, 2002, BLOOD, V99, P664, DOI 10.1182/blood.V99.2.664; Nimmanapalli R, 2001, CANCER RES, V61, P1799; O'Brien SG, 2003, NEW ENGL J MED, V348, P994, DOI 10.1056/NEJMoa022457; Peggs K, 2003, NEW ENGL J MED, V348, P1048, DOI 10.1056/NEJMe030009; Rubin BP, 2002, J CLIN ONCOL, V20, P3586, DOI 10.1200/JCO.2002.01.027; SILVER R, 2000, CANC MED, P1971; Yu CR, 2002, CLIN CANCER RES, V8, P2976	15	6	8	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 26	2003	361	9367					1400	1401		10.1016/S0140-6736(03)13145-5	http://dx.doi.org/10.1016/S0140-6736(03)13145-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	672HZ	12727387				2022-12-24	WOS:000182516300002
J	Nugent, AW; Daubeney, PEF; Chondros, P; Carlin, JB; Cheung, M; Wilkinson, LC; Davis, AM; Kahler, SG; Chow, CW; Wilkinson, JL; Weintraub, RG				Nugent, AW; Daubeney, PEF; Chondros, P; Carlin, JB; Cheung, M; Wilkinson, LC; Davis, AM; Kahler, SG; Chow, CW; Wilkinson, JL; Weintraub, RG		Natl Australian Childhood Cardiomy	The epidemiology of childhood cardiomyopathy in Australia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IDIOPATHIC DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; CARDIOVASCULAR-DISEASE; INTERNATIONAL-SOCIETY; SUDDEN-DEATH; CHILDREN; MYOCARDITIS; HEART; DETERMINANTS; CARDIOLOGY	Background: The incidence and age distribution of primary cardiomyopathy in children are not well defined. We undertook a population-based, retrospective cohort study in Australia to document the epidemiology of childhood cardiomyopathy. Methods: We analyzed all cases of primary cardiomyopathy in children who presented between 1987 and 1996 and who were younger than 10 years of age. Children were recruited from multiple sources, and cases of cardiomyopathy were classified according to World Health Organization guidelines. Results: Over the 10-year period, 314 new cases of primary cardiomyopathy were identified, for an annual incidence of 1.24 per 100,000 children younger than 10 years of age (95 percent confidence interval, 1.11 to 1.38). Dilated cardiomyopathy made up 58.6 percent of cases, hypertrophic cardiomyopathy 25.5 percent, restrictive cardiomyopathy 2.5 percent, and left ventricular noncompaction 9.2 percent of cases. The incidence of all types of cardiomyopathy except restrictive declined rapidly after infancy. In 11 cases (3.5 percent), sudden death was the first symptom. There was a male predominance among children with hypertrophic and unclassified cardiomyopathy. Indigenous children had a higher incidence of dilated cardiomyopathy than nonindigenous children (relative risk, 2.67; 95 percent confidence interval, 1.42 to 4.63) and a higher rate of death as the presenting symptom (16.7 percent vs. 2.6 percent, P=0.02). Lymphocytic myocarditis was present in 25 of 62 children with dilated cardiomyopathy (40.3 percent) who underwent cardiac histologic examination within two months after presentation. Conclusions: Lymphocytic myocarditis and left ventricular noncompaction are important causes of childhood cardiomyopathy in Australia. The timing and severity of presentation in children with cardiomyopathy are related to the type of cardiomyopathy, as well as to genetic and ethnic factors. .	Royal Childrens Hosp, Dept Cardiol, Melbourne, Vic, Australia; Royal Childrens Hosp, Dept Anat Pathol, Melbourne, Vic, Australia; Murdoch Childrens Res Inst, Clin Epidemiol & Biostat Unit, Melbourne, Vic, Australia; Univ Melbourne, Dept Gen Practice, Parkville, Vic 3052, Australia; Univ Melbourne, Dept Paediat, Parkville, Vic 3052, Australia	Royal Children's Hospital Melbourne; Royal Children's Hospital Melbourne; Murdoch Children's Research Institute; University of Melbourne; University of Melbourne	Weintraub, RG (corresponding author), Royal Childrens Hosp, Dept Cardiol, Flemington Rd, Parkville, Vic 3052, Australia.		Chondros, Patty/AAT-6426-2020; Carlin, John B/B-3492-2012; Carlin, John/AAG-4332-2020	Carlin, John B/0000-0002-2694-9463; Carlin, John/0000-0002-2694-9463; Davis, Andrew/0000-0003-2826-8562; Chondros, Patty/0000-0003-0393-8734				ADES LC, 1993, AM J MED GENET, V45, P327, DOI 10.1002/ajmg.1320450309; Aretz H T, 1987, Am J Cardiovasc Pathol, V1, P3; Arola A, 1997, AM J EPIDEMIOL, V146, P385, DOI 10.1093/oxfordjournals.aje.a009291; *AUSTR BUR STAT, 1994, 32300 AUSTR BUR STAT; *AUSTR BUR STAT, 1997, 32010 AUSTR BUR STAT; *AUSTR BUR STAT, 1993, 32010 AUSTR BUR STAT; *AUSTR BUR STAT, 1998, 32300 AUSTR BUR STAT; Boucek MM, 2001, J HEART LUNG TRANSPL, V20, P39, DOI 10.1016/S1053-2498(00)00243-6; Bowles NE, 2000, HERZ, V25, P168, DOI 10.1007/s000590050003; BURCH M, 1994, BRIT HEART J, V72, P246; Carapetis JR, 1999, AUST NZ J PUBL HEAL, V23, P159, DOI 10.1111/j.1467-842X.1999.tb01227.x; CHIN TK, 1990, CIRCULATION, V82, P507, DOI 10.1161/01.CIR.82.2.507; COLAN SD, 1992, J AM COLL CARDIOL, V19, P619, DOI 10.1016/S0735-1097(10)80282-7; FERENCZ C, 1992, PEDIATR CARDIOL, V13, P65, DOI 10.1007/BF00798206; Grenier MA, 2000, AM HEART J, V139, pS86, DOI 10.1067/mhj.2000.103933; Lipshultz SE, 2003, NEW ENGL J MED, V348, P1647, DOI 10.1056/NEJMoa021715; Maron BJ, 2002, JAMA-J AM MED ASSOC, V287, P1308, DOI 10.1001/jama.287.10.1308; Maron BJ, 1996, CIRCULATION, V94, P850, DOI 10.1161/01.CIR.94.4.850; MARTIN AB, 1994, CIRCULATION, V90, P330, DOI 10.1161/01.CIR.90.1.330; MASON JW, 1995, NEW ENGL J MED, V333, P269, DOI 10.1056/NEJM199508033330501; MATITIAU A, 1994, CIRCULATION, V90, P1310, DOI 10.1161/01.CIR.90.3.1310; MICHELS VV, 1992, NEW ENGL J MED, V326, P77, DOI 10.1056/NEJM199201093260201; Nugent AW, 2001, J HEART LUNG TRANSPL, V20, P1152, DOI 10.1016/S1053-2498(01)00334-5; Olson TM, 2002, CIRCULATION, V105, P2337, DOI 10.1161/01.CIR.0000018444.47798.94; Pauschinger M, 1999, CIRCULATION, V99, P1348, DOI 10.1161/01.CIR.99.10.1348; Richardson P, 1996, CIRCULATION, V93, P841, DOI 10.1161/01.CIR.93.5.841; Rivenes SM, 2000, CIRCULATION, V102, P876; SPIRITO P, 1989, NEW ENGL J MED, V320, P749, DOI 10.1056/NEJM198903233201201; *STAT CORP, 1999, STAT STAT SOFTW REL; Venugopalan P, 2001, INT J CARDIOL, V78, P135, DOI 10.1016/S0167-5273(00)00480-0; WILES HB, 1991, AM J CARDIOL, V68, P1372, DOI 10.1016/0002-9149(91)90248-J; Yetman AT, 1998, J AM COLL CARDIOL, V32, P1943, DOI 10.1016/S0735-1097(98)00493-8	32	471	528	0	9	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 24	2003	348	17					1639	1646		10.1056/NEJMoa021737	http://dx.doi.org/10.1056/NEJMoa021737			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	670PB	12711738				2022-12-24	WOS:000182416300003
J	Pedulla, ML; Ford, ME; Houtz, JM; Karthikeyan, T; Wadsworth, C; Lewis, JA; Jacobs-Sera, D; Falbo, J; Gross, J; Pannunzio, NR; Brucker, W; Kumar, V; Kandasamy, J; Keenan, L; Bardarov, S; Kriakov, J; Lawrence, JG; Jacobs, WR; Hendrix, RW; Hatfull, GF				Pedulla, ML; Ford, ME; Houtz, JM; Karthikeyan, T; Wadsworth, C; Lewis, JA; Jacobs-Sera, D; Falbo, J; Gross, J; Pannunzio, NR; Brucker, W; Kumar, V; Kandasamy, J; Keenan, L; Bardarov, S; Kriakov, J; Lawrence, JG; Jacobs, WR; Hendrix, RW; Hatfull, GF			Origins of highly mosaic mycobacteriophage genomes	CELL			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; EVOLUTIONARY RELATIONSHIPS; NUCLEOTIDE-SEQUENCE; PHAGE GENOMICS; BACTERIOPHAGE; TUBERCULOSIS; PROTEIN; TAXONOMY; VIRUSES; RO	Bacteriophages are the most abundant organisms in the biosphere and play major roles in the ecological balance of microbial life. The genomic sequences of ten newly isolated mycobacteriophages suggest that the bacteriophage population as a whole is amazingly diverse and may represent the largest unexplored reservoir of sequence information in the biosphere. Genomic comparison of these mycobacteriophages contributes to our understanding of the mechanisms of viral evolution and provides compelling evidence for the role of illegitimate recombination in horizontal genetic exchange. The promiscuity of these recombination events results in the inclusion of many unexpected genes including those implicated in mycobacterial latency, the cellular and immune responses to mycobacterial infections, and autoimmune diseases such as human lupus. While the role of phages as vehicles of toxin genes is well established, these observations suggest a much broader involvement of phages in bacterial virulence and the host response to bacterial infections.	Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Pittsburgh Bacteriophage Inst, Pittsburgh, PA 15260 USA; Greater Latrobe High Sch, Latrobe, PA 15650 USA; ICMR, TB Res Ctr, Madras 600031, Tamil Nadu, India; Pelham Mem High Sch, Pelham, NY 10803 USA; Albert Einstein Coll Med, Dept Microbiol & Immunol, Howard Hughes Med Inst, Bronx, NY 10461 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT); Howard Hughes Medical Institute; Yeshiva University; Albert Einstein College of Medicine	Hatfull, GF (corresponding author), Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA.	gfh@pitt.edu		Pannunzio, Nick/0000-0002-8290-8236; Jacobs, William/0000-0003-3321-3080	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R22AI026170, R37AI026170, R01AI026170, R01AI028927, R29AI028927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051975] Funding Source: NIH RePORTER; NIAID NIH HHS [AI28927, AI26170] Funding Source: Medline; NIGMS NIH HHS [GM5197508] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ackermann HW, 2001, ARCH VIROL, V146, P843, DOI 10.1007/s007050170120; ACKERMANN HW, 1987, MICROBIOL SCI, V4, P214; Bibb LA, 2002, MOL MICROBIOL, V45, P1515, DOI 10.1046/j.1365-2958.2002.03130.x; Boyd EF, 2001, TRENDS MICROBIOL, V9, P137, DOI 10.1016/S0966-842X(01)01960-6; Brussow H, 2002, CELL, V108, P13, DOI 10.1016/S0092-8674(01)00637-7; Brussow H, 2001, MOL MICROBIOL, V39, P213, DOI 10.1046/j.1365-2958.2001.02228.x; Brussow H, 2001, ANNU REV MICROBIOL, V55, P283, DOI 10.1146/annurev.micro.55.1.283; Chen XG, 2000, GENE DEV, V14, P777; Clark AJ, 2001, J MOL BIOL, V311, P657, DOI 10.1006/jmbi.2001.4868; Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Dobrindt U, 2000, INT J MED MICROBIOL, V290, P519; DOKE S, 1960, J KUMAMOTO MED SOC, V34, P1360; Eltringham IJ, 1999, J CLIN MICROBIOL, V37, P3528, DOI 10.1128/JCM.37.11.3528-3532.1999; Fessler BJ, 2002, BEST PRACT RES CL RH, V16, P281, DOI 10.1053/berh.2001.0226; Flynn JL, 2001, INFECT IMMUN, V69, P4195, DOI 10.1128/IAI.69.7.4195-4201.2001; Ford M. E., 1998, Tubercle and Lung Disease, V79, P63, DOI 10.1054/tuld.1998.0007; Ford ME, 1998, J MOL BIOL, V279, P143, DOI 10.1006/jmbi.1997.1610; FROMAN S, 1954, AM J PUBLIC HEALTH, V44, P1326, DOI 10.2105/AJPH.44.10.1326; Garza DR, 1998, MICROB ECOL, V36, P281, DOI 10.1007/s002489900115; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; HARLEY JB, 1992, RHEUM DIS CLIN N AM, V18, P337; Hatfull GF, 2000, MOLECULAR GENETICS OF MYCOBACTERIA, P37; HATFULL GF, 1993, MOL MICROBIOL, V7, P395, DOI 10.1111/j.1365-2958.1993.tb01131.x; Hatfull Graham F., 1994, P165; Hendrix RW, 1999, P NATL ACAD SCI USA, V96, P2192, DOI 10.1073/pnas.96.5.2192; Hendrix RW, 2002, THEOR POPUL BIOL, V61, P471, DOI 10.1006/tpbi.2002.1590; JACOBS WR, 1993, SCIENCE, V260, P819, DOI 10.1126/science.8484123; JONES WD, 1990, AM REV RESPIR DIS, V142, P1000, DOI 10.1164/ajrccm/142.5.1000; Juhala RJ, 2000, J MOL BIOL, V299, P27, DOI 10.1006/jmbi.2000.3729; KATSURA I, 1987, NATURE, V327, P73, DOI 10.1038/327073a0; KATSURA I, 1984, CELL, V39, P691, DOI 10.1016/0092-8674(84)90476-8; Kell DB, 2000, CURR OPIN MICROBIOL, V3, P238, DOI 10.1016/S1369-5274(00)00082-5; LAAL S, 1991, P NATL ACAD SCI USA, V88, P1054, DOI 10.1073/pnas.88.3.1054; Labbe JC, 2000, P NATL ACAD SCI USA, V97, P13233, DOI 10.1073/pnas.230284297; Lawrence JG, 2002, J BACTERIOL, V184, P4891, DOI 10.1128/JB.184.17.4891-4905.2002; LEVIN ME, 1993, J MOL BIOL, V234, P124, DOI 10.1006/jmbi.1993.1568; MCCAULIFFE DP, 1989, J AUTOIMMUN, V2, P375, DOI 10.1016/0896-8411(89)90166-2; Mediavilla J, 2000, MOL MICROBIOL, V38, P955, DOI 10.1046/j.1365-2958.2000.02183.x; Mukamolova GV, 1998, P NATL ACAD SCI USA, V95, P8916, DOI 10.1073/pnas.95.15.8916; NESBIT CE, 1995, MOL MICROBIOL, V17, P1045, DOI 10.1111/j.1365-2958.1995.mmi_17061045.x; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Recktenwald J, 2002, INFECT IMMUN, V70, P1896, DOI 10.1128/IAI.70.4.1896-1908.2002; ROESSNER CA, 1984, J BACTERIOL, V157, P165, DOI 10.1128/JB.157.1.165-170.1984; Rohwer F, 2000, LIMNOL OCEANOGR, V45, P408, DOI 10.4319/lo.2000.45.2.0408; Rohwer F, 2002, J BACTERIOL, V184, P4529, DOI 10.1128/JB.184.16.4529-4535.2002; Roman LJ, 2002, CHEM REV, V102, P1179, DOI 10.1021/cr000661e; Scanga CA, 2001, INFECT IMMUN, V69, P7711, DOI 10.1128/IAI.69.12.7711-7717.2001; Shi H, 1996, RNA, V2, P769; Shleeva MO, 2002, MICROBIOL-SGM, V148, P1581, DOI 10.1099/00221287-148-5-1581; Short SM, 1999, HYDROBIOLOGIA, V401, P19, DOI 10.1023/A:1003711115967; SIMON MN, 1971, BACTERIOPHAGE LAMBDA, P313; Smith MCM, 1999, NUCLEIC ACIDS RES, V27, P2145, DOI 10.1093/nar/27.10.2145; SONNHAMMER ELL, 1995, GENE-COMBIS, V167, P1; SUSSKIND MM, 1978, MICROBIOL REV, V42, P385, DOI 10.1128/MMBR.42.2.385-413.1978; TIMME TL, 1984, J GEN MICROBIOL, V130, P2059; Wagner PL, 2002, INFECT IMMUN, V70, P3985, DOI 10.1128/IAI.70.8.3985-3993.2002; WESTMORELAND BC, 1969, SCIENCE, V163, P1343, DOI 10.1126/science.163.3873.1343; Wilhelm SW, 1999, BIOSCIENCE, V49, P781, DOI 10.2307/1313569; Wommack KE, 2000, MICROBIOL MOL BIOL R, V64, P69, DOI 10.1128/MMBR.64.1.69-114.2000; XU J, 2000, THESIS U PITTSBURGH	61	469	500	0	50	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 18	2003	113	2					171	182		10.1016/S0092-8674(03)00233-2	http://dx.doi.org/10.1016/S0092-8674(03)00233-2			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	672EP	12705866	Bronze			2022-12-24	WOS:000182508500007
J	Tracey, WD; Wilson, RI; Laurent, G; Benzer, S				Tracey, WD; Wilson, RI; Laurent, G; Benzer, S			painless, a Drosophila gene essential for nociception	CELL			English	Article							CAPSAICIN-RECEPTOR; MECHANOSENSORY TRANSDUCTION; CATION CHANNEL; PROTEIN; IDENTIFICATION; MELANOGASTER; EXPRESSION; ELEGANS; THRESHOLD; NEURONS	We describe a paradigm for nociception in Drosophila. In response to the touch of a probe heated above 38degreesC, Drosophila larvae produce a stereotypical rolling behavior, unlike the response to an unheated probe. In a genetic screen for mutants defective in this noxious heat response, we identified the painless gene. Recordings from wild-type larval nerves identified neurons that initiated strong spiking above 38degreesC, and this activity was absent in the painless mutant. The painless mRNA encodes a protein of the transient receptor potential ion channel family. Painless is required for both thermal and mechanical nociception, but not for sensing light touch painless is expressed in peripheral neurons that extend multiple branched dendrites beneath the larval epidermis, similar to vertebrate pain receptors. An antibody to Painless binds to localized dendritic structures that we hypothesize are involved in nociceptive signaling.	CALTECH, Div Biol 156 29, Pasadena, CA 91125 USA; CALTECH, Div Biol 139 74, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology	Tracey, WD (corresponding author), CALTECH, Div Biol 156 29, Pasadena, CA 91125 USA.	tracey@caltech.edu; benzer@caltech.edu	Laurent, Gilles/A-4583-2012	Laurent, Gilles/0000-0002-2296-114X; Wilson, Rachel/0000-0001-8573-9266; Tracey, W. Daniel/0000-0003-4666-8199				Adams CM, 1998, J CELL BIOL, V140, P143, DOI 10.1083/jcb.140.1.143; Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; BECK PW, 1974, BRAIN RES, V67, P373, DOI 10.1016/0006-8993(74)90488-0; BESSOU P, 1969, J NEUROPHYSIOL, V32, P1025, DOI 10.1152/jn.1969.32.6.1025; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brembs B, 2000, LEARN MEMORY, V7, P104, DOI 10.1101/lm.7.2.104; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Caterina MJ, 1999, NATURE, V398, P436, DOI 10.1038/18906; Chung YD, 2001, NEURON, V29, P415, DOI 10.1016/S0896-6273(01)00215-X; Colbert HA, 1997, J NEUROSCI, V17, P8259; Gao FB, 1999, GENE DEV, V13, P2549, DOI 10.1101/gad.13.19.2549; Grueber WB, 2002, DEVELOPMENT, V129, P2867; HARTENSTEIN V, 1988, DEVELOPMENT, V102, P869; Jaquemar D, 1999, J BIOL CHEM, V274, P7325, DOI 10.1074/jbc.274.11.7325; KERNAN M, 1994, NEURON, V12, P1195, DOI 10.1016/0896-6273(94)90437-5; Liu L, 2003, NAT NEUROSCI, V6, P267, DOI 10.1038/nn1009; MARIATH HA, 1985, J INSECT PHYSIOL, V31, P779, DOI 10.1016/0022-1910(85)90071-X; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; MONTELL C, 1989, NEURON, V2, P1313, DOI 10.1016/0896-6273(89)90069-X; Montell C, 2002, MOL CELL, V9, P229, DOI 10.1016/S1097-2765(02)00448-3; Peier AM, 2002, SCIENCE, V296, P2046, DOI 10.1126/science.1073140; PHILLIPS AM, 1992, NEURON, V8, P631, DOI 10.1016/0896-6273(92)90085-R; Pouzat C, 2002, J NEUROSCI METH, V122, P43, DOI 10.1016/S0165-0270(02)00276-5; Roayaie K, 1998, NEURON, V20, P55, DOI 10.1016/S0896-6273(00)80434-1; Rorth P, 1998, DEVELOPMENT, V125, P1049; Sepp KJ, 1999, GENETICS, V151, P1093; Sherrington CS, 1906, INTEGRATIVE ACTION N, DOI 10.1037/13798-000; Smith GD, 2002, NATURE, V418, P186, DOI 10.1038/nature00894; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Strotmann R, 2000, NAT CELL BIOL, V2, P695, DOI 10.1038/35036318; SUN BH, 1995, J NEUROCHEM, V65, P434, DOI 10.1046/j.1471-4159.1995.65010434.x; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; TILLMAN DB, 1995, J PHYSIOL-LONDON, V485, P767, DOI 10.1113/jphysiol.1995.sp020767; Tobin DM, 2002, NEURON, V35, P307, DOI 10.1016/S0896-6273(02)00757-2; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; VANHEES J, 1981, J NEUROL NEUROSUR PS, V44, P600, DOI 10.1136/jnnp.44.7.600; Walker RG, 2000, SCIENCE, V287, P2229, DOI 10.1126/science.287.5461.2229; Wittenburg N, 1999, P NATL ACAD SCI USA, V96, P10477, DOI 10.1073/pnas.96.18.10477; Xu HX, 2002, NATURE, V418, P181, DOI 10.1038/nature00882; Xu XZS, 2000, NEURON, V26, P647, DOI 10.1016/S0896-6273(00)81201-5; 2002, BDGP	42	501	525	5	90	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 18	2003	113	2					261	273		10.1016/S0092-8674(03)00272-1	http://dx.doi.org/10.1016/S0092-8674(03)00272-1			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	672EP	12705873	Bronze			2022-12-24	WOS:000182508500014
J	Boucher, P; Gotthardt, M; Li, WP; Anderson, RGW; Herz, J				Boucher, P; Gotthardt, M; Li, WP; Anderson, RGW; Herz, J			LRP: Role in vascular wall integrity and protection from atherosclerosis	SCIENCE			English	Article							RECEPTOR-RELATED PROTEIN; MUSCLE CELL-MIGRATION; APOLIPOPROTEIN-E; IN-VIVO; GENE; INACTIVATION; PROGRESSION; MICE	Vascular smooth muscle cell (SMC) proliferation and migration are important events in the development of atherosclerosis. The low-density lipoprotein receptor-related protein (LRP1) mediates suppression of SMC migration induced by platelet-derived growth factor (PDGF). Here we show that LRP1 forms a complex with the PDGF receptor (PDGFR). Inactivation of LRP1 in vascular SMCs of mice causes PDGFR overexpression and abnormal activation of PDGFR signaling, resulting in disruption of the elastic layer, SMC proliferation, aneurysm formation, and marked susceptibility to cholesterol-induced atherosclerosis. The development of these abnormalities was reduced by treatment with Gleevec, an inhibitor of PDGF signaling. Thus, LRP1 has a pivotal role in protecting vascular wall integrity and preventing atherosclerosis by controlling PDGFR activation.	Univ Texas, SW Med Ctr, Dept Mol Genet, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Cell Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Herz, J (corresponding author), Univ Texas, SW Med Ctr, Dept Mol Genet, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.		Gotthardt, Michael/ABE-8274-2021	Gotthardt, Michael/0000-0003-1788-3172; Boucher, Philippe/0000-0002-3928-9812	NHLBI NIH HHS [HL20948, R37 HL063762, HL63762] Funding Source: Medline; NIGMS NIH HHS [GM 52016] Funding Source: Medline; NINDS NIH HHS [NS43408] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948, R01HL063762, R37HL063762] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052016] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043408] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Barnes H, 2001, J BIOL CHEM, V276, P19119, DOI 10.1074/jbc.M011437200; Boucher P, 2002, J BIOL CHEM, V277, P15507, DOI 10.1074/jbc.M200428200; Druker BJ, 2002, TRENDS MOL MED, V8, pS14, DOI 10.1016/S1471-4914(02)02305-5; Goodall S, 2001, CIRCULATION, V104, P304, DOI 10.1161/01.CIR.104.3.304; HERZ J, 1992, CELL, V71, P411, DOI 10.1016/0092-8674(92)90511-A; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; Holtwick R, 2002, P NATL ACAD SCI USA, V99, P7142, DOI 10.1073/pnas.102650499; ISHIBASHI S, 1993, J CLIN INVEST, V92, P883, DOI 10.1172/JCI116663; Ishigami M, 1998, J BIOL CHEM, V273, P20156, DOI 10.1074/jbc.273.32.20156; Lee RT, 2000, ANN MED, V32, P233, DOI 10.3109/07853890009011765; Lijnen HR, 2002, BIOCHEM SOC T, V30, P163, DOI 10.1042/bst0300163; Loukinova E, 2002, J BIOL CHEM, V277, P15499, DOI 10.1074/jbc.M200427200; Nakamura T, 2002, NATURE, V415, P171, DOI 10.1038/415171a; Plenz GAM, 2003, ATHEROSCLEROSIS, V166, P1, DOI 10.1016/S0021-9150(01)00766-3; REDDICK RL, 1994, ARTERIOSCLER THROMB, V14, P141, DOI 10.1161/01.ATV.14.1.141; Rohlmann A, 1996, NAT BIOTECHNOL, V14, P1562, DOI 10.1038/nbt1196-1562; Rohlmann A, 1998, J CLIN INVEST, V101, P689, DOI 10.1172/JCI1240; ROSS R, 1993, TRANSPLANT P, V25, P2041; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Swertfeger DK, 2002, J BIOL CHEM, V277, P4141, DOI 10.1074/jbc.M109124200; Swertfeger DK, 2001, FRONT BIOSCI-LANDMRK, V6, pD526, DOI 10.2741/Swertfeg; Yanagisawa H, 2002, NATURE, V415, P168, DOI 10.1038/415168a	22	449	477	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 11	2003	300	5617					329	332		10.1126/science.1082095	http://dx.doi.org/10.1126/science.1082095			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665RQ	12690199				2022-12-24	WOS:000182135400057
J	Gewin, V				Gewin, V			Biosphere owner sues sponsor	NATURE			English	News Item																		Rosenstiel TN, 2003, NATURE, V421, P256, DOI 10.1038/nature01312; 2003, NATURE, V421, P466	2	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 3	2003	422	6931					461	461		10.1038/422461b	http://dx.doi.org/10.1038/422461b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	662TW	12673218	Bronze			2022-12-24	WOS:000181965400009
J	Fenton, KA; Ison, C; Johnson, AP; Rudd, E; Soltani, M; Martin, I; Nichols, T; Livermore, DM				Fenton, KA; Ison, C; Johnson, AP; Rudd, E; Soltani, M; Martin, I; Nichols, T; Livermore, DM		GRASP Collaboration	Ciprofloxacin resistance in Neisseria gonorrhoeae in England and Wales in 2002	LANCET			English	Article								The Gonococcal Resistance to Antimicrobials Surveillance Programme (GRASP) monitors trends in antimicrobial resistance in consecutive gonococcal isolates from 26 genitourinary medicine clinics in England and Wales. In 2002, 2204 gonococcal isolates were tested, and the overall prevalence of ciprofloxacin resistance (minimum Inhibitory concentration greater than or equal to1 mg/L) was 9.8%, compared with 3.1% in 2001 and 2.1% in 2000. Between 2001 and 2002, prevalence of ciprofloxacin resistance increased two to three-fold, irrespective of recent sexual contact overseas, sex, or residence within or outside of London. These findings suggest that national and local treatment guidelines need to be reviewed urgently.	Hlth Protect Agcy, HIV STI Div, Ctr Communicable Dis Surveillance, London NW9 5EQ, England; Hlth Protect Agcy, Cent Publ Hlth Lab, London NW9 5EQ, England; UCL Royal Free & UCL Med Sch, Ctr Infect Dis Epidemiol, Dept Primary Care, London, England; UCL Royal Free & UCL Med Sch, Ctr Infect Dis Epidemiol, Dept Populat Sci, London, England; UCL Royal Free & UCL Med Sch, Ctr Infect Dis Epidemiol, Dept Sexually Transmitted Dis, London, England; Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis & Microbiol, London, England	Health Protection Agency; Health Protection Agency; Public Health England; University of London; University College London; University of London; University College London; University of London; University College London; Imperial College London	Fenton, KA (corresponding author), Hlth Protect Agcy, HIV STI Div, Ctr Communicable Dis Surveillance, 61 Colindale Ave, London NW9 5EQ, England.	kevin.fenton@hpa.org.uk	Johnson, Alan P/F-4420-2014					*CDC, 2002, SEX TRANSM DIS SURV; *CLIN EFF GROUP AS, 2001 NAT GUID MAN GO; *GRASP STEER GROUP, 2002, GON RES ANT SURV PRO; HARDIH J, SMALL SAMPLE ADJUSTM; Ross JDC, 2002, INT J STD AIDS, V13, P499, DOI 10.1258/09564620260079671	5	75	78	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 31	2003	361	9372					1867	1869		10.1016/S0140-6736(03)13489-7	http://dx.doi.org/10.1016/S0140-6736(03)13489-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	684KL	12788575				2022-12-24	WOS:000183205800013
J	Kryukov, GV; Castellano, S; Novoselov, SV; Lobanov, AV; Zehtab, O; Guigo, R; Gladyshev, VN				Kryukov, GV; Castellano, S; Novoselov, SV; Lobanov, AV; Zehtab, O; Guigo, R; Gladyshev, VN			Characterization of mammalian selenoproteomes	SCIENCE			English	Article							RNA STRUCTURAL MOTIF; SELENOCYSTEINE INSERTION; CONTAINING PROTEINS; MESSENGER-RNAS; HUMAN GENOME; IN-SILICO; SELENIUM; IDENTIFICATION; SEQUENCE; TRANSLATION	In the genetic code, UGA serves as a stop signal and a selenocysteine codon, but no computational methods for identifying its coding function are available. Consequently, most selenoprotein genes are misannotated. We identified selenoprotein genes in sequenced mammalian genomes by methods that rely on identification of selenocysteine insertion RNA structures, the coding potential of UGA codons, and the presence of cysteine-containing homologs. The human selenoproteome consists of 25 selenoproteins.	Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA; Univ Pompeu Fabra, Ctr Regulacio Genom, Inst Municipal Invest Med, Grp Recerca Informat Biomed, Barcelona 08003, Catalonia, Spain	University of Nebraska System; University of Nebraska Lincoln; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG)	Gladyshev, VN (corresponding author), Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA.	vgladyshev1@unl.edu	Castellano, Sergi/A-7437-2016	Castellano, Sergi/0000-0002-5819-4210; Novoselov, Sergey/0000-0003-0104-6492; Gladyshev, Vadim/0000-0002-0372-7016; Kryukov, Gregory/0000-0002-6131-9483	NIGMS NIH HHS [GM61603] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061603] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Behne D, 1996, BIOL TRACE ELEM RES, V55, P99, DOI 10.1007/BF02784172; BERRY MJ, 1991, NATURE, V353, P273, DOI 10.1038/353273a0; Bock A, 2000, Biofactors, V11, P77; Burk RF, 1999, BIOESSAYS, V21, P231, DOI 10.1002/(SICI)1521-1878(199903)21:3<231::AID-BIES7>3.3.CO;2-4; Castellano S, 2001, EMBO REP, V2, P697, DOI 10.1093/embo-reports/kve151; Cataldo L, 1996, MOL REPROD DEV, V45, P320, DOI 10.1002/(SICI)1098-2795(199611)45:3&lt;320::AID-MRD9&gt;3.0.CO;2-U; Combs GF, 2001, BIOFACTORS, V14, P153, DOI 10.1002/biof.5520140120; Copeland PR, 2000, EMBO J, V19, P306, DOI 10.1093/emboj/19.2.306; DEAR TN, 1991, BIOCHEMISTRY-US, V30, P10376, DOI 10.1021/bi00107a003; Fagegaltier D, 2000, EMBO J, V19, P4796, DOI 10.1093/emboj/19.17.4796; Gladyshev VN, 1996, P NATL ACAD SCI USA, V93, P6146, DOI 10.1073/pnas.93.12.6146; Guimaraes MJ, 1996, P NATL ACAD SCI USA, V93, P15086, DOI 10.1073/pnas.93.26.15086; Hatfield DL, 2002, MOL CELL BIOL, V22, P3565, DOI 10.1128/MCB.22.11.3565-3576.2002; Kent WJ, 2001, GENOME RES, V11, P1541, DOI 10.1101/gr.183201; Korotkov KV, 2002, MOL CELL BIOL, V22, P1402, DOI 10.1128/MCB.22.5.1402-1411.2002; Kryukov GV, 1999, J BIOL CHEM, V274, P33888, DOI 10.1074/jbc.274.48.33888; Kryukov GV, 2002, METHOD ENZYMOL, V347, P84; KRYUKOV GV, UNPUB; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lescure A, 1999, J BIOL CHEM, V274, P38147, DOI 10.1074/jbc.274.53.38147; Low SC, 1996, TRENDS BIOCHEM SCI, V21, P203, DOI 10.1016/0968-0004(96)10025-6; Martin-Romero FJ, 2001, J BIOL CHEM, V276, P29798, DOI 10.1074/jbc.M100422200; Rayman MP, 2000, LANCET, V356, P233, DOI 10.1016/S0140-6736(00)02490-9; Tujebajeva RM, 2000, EMBO REP, V1, P158, DOI 10.1093/embo-reports/kvd033; Ursini F, 1999, SCIENCE, V285, P1393, DOI 10.1126/science.285.5432.1393; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Walczak R, 1996, RNA, V2, P367	27	1688	1797	15	235	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 30	2003	300	5624					1439	1443		10.1126/science.1083516	http://dx.doi.org/10.1126/science.1083516			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	683ZW	12775843	Green Submitted			2022-12-24	WOS:000183181800048
J	Horsley, V; Jansen, KM; Mills, ST; Pavlath, GK				Horsley, V; Jansen, KM; Mills, ST; Pavlath, GK			IL-4 acts as a myoblast recruitment factor during mammalian muscle growth	CELL			English	Article							MEDIATED GENE-THERAPY; SKELETAL-MUSCLE; FUSION; CELLS; EXPRESSION; RECEPTOR; DIFFERENTIATION; TRANSCRIPTION; PATHWAY; HYPERTROPHY	Skeletal muscle formation and growth require the fusion of myoblasts to form multinucleated myofibers or myotubes, but few molecules are known to regulate myoblast fusion in mammals. The transcription factor NFATc2 controls myoblast fusion at a specific stage of myogenesis after the initial formation of a myotube and is necessary for further cell growth. By examining genes regulated by NFATc2 in muscle, this study identifies the cytokine IL-4 as a molecular signal that controls myoblast fusion with myotubes. Muscle cells lacking IL-4 or the IL-4alpha receptor subunit form normally but are reduced in size and myonuclear number. IL-4 is expressed by a subset of muscle cells in fusing muscle cultures and requires the IL-4alpha receptor subunit on myoblasts to promote fusion and growth. These data demonstrate that following myotube formation, myotubes recruit myoblast fusion by secretion of IL-4, leading to muscle growth.	Emory Univ, Dept Pharmacol, Atlanta, GA 30322 USA; Emory Univ, Grad Program Biochem Cell & Dev Biol, Atlanta, GA 30322 USA	Emory University; Emory University	Pavlath, GK (corresponding author), Emory Univ, Dept Pharmacol, Atlanta, GA 30322 USA.		Jansen, Kaspar/AAF-2762-2019		NIAMS NIH HHS [AR-48884, AR-47314] Funding Source: Medline; NIDCR NIH HHS [DE-13040] Funding Source: Medline; NIGMS NIH HHS [T32-GM08367] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR047314, R01AR048884] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE013040] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008367] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abbott KL, 1998, MOL BIOL CELL, V9, P2905, DOI 10.1091/mbc.9.10.2905; Allen DL, 1999, MUSCLE NERVE, V22, P1350, DOI 10.1002/(SICI)1097-4598(199910)22:10<1350::AID-MUS3>3.0.CO;2-8; Barks JL, 1997, J IMMUNOL, V159, P4532; Barnoy S, 1996, BIOCHEM BIOPH RES CO, V220, P933, DOI 10.1006/bbrc.1996.0509; BLAU HM, 1995, NEW ENGL J MED, V333, P1554, DOI 10.1056/NEJM199512073332308; Constantin B, 1996, CELL CALCIUM, V19, P365, DOI 10.1016/S0143-4160(96)90109-8; Crabtree GR, 2002, CELL, V109, pS67, DOI 10.1016/S0092-8674(02)00699-2; DARR KC, 1989, J APPL PHYSIOL, V67, P1827, DOI 10.1152/jappl.1989.67.5.1827; DeFife KM, 1997, J IMMUNOL, V158, P3385; Delling U, 2000, MOL CELL BIOL, V20, P6600, DOI 10.1128/MCB.20.17.6600-6611.2000; DOERING JL, 1977, EXP CELL RES, V105, P437, DOI 10.1016/0014-4827(77)90140-9; Donaldson DD, 1998, J IMMUNOL, V161, P2317; Gorza L, 2000, FASEB J, V14, P461, DOI 10.1096/fasebj.14.3.461; HARRIS AJ, 1989, DEVELOPMENT, V107, P771; Hodge MR, 1996, IMMUNITY, V4, P397, DOI 10.1016/S1074-7613(00)80253-8; Horsley V, 2001, J CELL BIOL, V153, P329, DOI 10.1083/jcb.153.2.329; Huerta L, 2002, CYTOMETRY, V47, P100, DOI 10.1002/cyto.10051; KITAZAWA S, 1995, J BIOL CHEM, V270, P4115, DOI 10.1074/jbc.270.8.4115; KONIGSBERG IR, 1971, DEV BIOL, V26, P133, DOI 10.1016/0012-1606(71)90113-8; LIND M, 1995, CYTOKINE, V7, P78, DOI 10.1006/cyto.1995.1010; Marino M, 2001, J NEUROIMMUNOL, V116, P94, DOI 10.1016/S0165-5728(01)00287-9; MCINNES A, 1988, J EXP MED, V167, P598, DOI 10.1084/jem.167.2.598; Mitchell PO, 2001, AM J PHYSIOL-CELL PH, V281, pC1706, DOI 10.1152/ajpcell.2001.281.5.C1706; MNALLY AK, 2002, AM J PATH9OL, V160, P621; Monticelli S, 2002, EUR J IMMUNOL, V32, P2971, DOI 10.1002/1521-4141(2002010)32:10<2971::AID-IMMU2971>3.0.CO;2-G; Murata T, 1998, BLOOD, V91, P3884; Nelms K, 1999, ANNU REV IMMUNOL, V17, P701, DOI 10.1146/annurev.immunol.17.1.701; Pavlath GK, 1998, DEV DYNAM, V212, P495, DOI 10.1002/(SICI)1097-0177(199808)212:4<495::AID-AJA3>3.3.CO;2-I; Phelan JN, 1997, ANAT REC, V247, P179, DOI 10.1002/(SICI)1097-0185(199702)247:2<179::AID-AR4>3.0.CO;2-T; Rahaman SO, 2002, CANCER RES, V62, P1103; RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Rau A, 2001, DEVELOPMENT, V128, P5061; Rengarajan J, 2002, NAT IMMUNOL, V3, P48, DOI 10.1038/ni744; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; ROSEN SD, 1992, TRENDS GLYCOSCI GLYC, V4, P1; ROSENBLATT JD, 1992, J APPL PHYSIOL, V73, P2538, DOI 10.1152/jappl.1992.73.6.2538; SCHLEIMER RP, 1992, J IMMUNOL, V148, P1086; Taylor MV, 2002, CURR BIOL, V12, pR224, DOI 10.1016/S0960-9822(02)00757-1; WAKELAM MJO, 1985, BIOCHEM J, V228, P1; Wunschmann S, 2000, J CLIN MICROBIOL, V38, P3055; YAGAMIHIROMASA T, 1995, NATURE, V377, P652, DOI 10.1038/377652a0; YEOH GCT, 1977, EXP CELL RES, V104, P63, DOI 10.1016/0014-4827(77)90069-6; ZHANG M, 1995, DEV DYNAM, V204, P168, DOI 10.1002/aja.1002040207	44	371	400	1	13	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 16	2003	113	4					483	494		10.1016/S0092-8674(03)00319-2	http://dx.doi.org/10.1016/S0092-8674(03)00319-2			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	680MG	12757709	Bronze			2022-12-24	WOS:000182981500010
J	Strang, J; McCambridge, J; Best, D; Beswick, T; Bearn, J; Rees, S; Gossop, M				Strang, J; McCambridge, J; Best, D; Beswick, T; Bearn, J; Rees, S; Gossop, M			Loss of tolerance and overdose mortality after inpatient opiate detoxification: follow up study	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Inst Psychiat, Natl Addict Ctr, London SE5 8AF, England; Maudsley Hosp & Inst Psychiat, London SE5 8AF, England	University of London; King's College London; South London & Maudsley NHS Trust; University of London; King's College London	Strang, J (corresponding author), Inst Psychiat, Natl Addict Ctr, London SE5 8AF, England.	j.strang@iop.kcl.ac.uk	Strang, John/H-5460-2011	Strang, John/0000-0002-5413-2725; McCambridge, Jim/0000-0002-5461-7001; Best, David/0000-0002-6792-916X				Advisory Council on the Misuse of Drugs, 2000, RED DRUG REL DEATHS; Bird SM, 2003, ADDICTION, V98, P185, DOI 10.1046/j.1360-0443.2003.00264.x; Caplehorn JRM, 1998, DRUG ALCOHOL REV, V17, P9, DOI 10.1080/09595239800187551; Farrell M, 1996, ADDICTION, V91, P321, DOI 10.1111/j.1360-0443.1996.tb02282.x; OPPENHEIMER E, 1994, ADDICTION, V89, P1299, DOI 10.1111/j.1360-0443.1994.tb03309.x	5	207	211	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 3	2003	326	7396					959	960		10.1136/bmj.326.7396.959	http://dx.doi.org/10.1136/bmj.326.7396.959			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	676JC	12727768	Green Published, Bronze, Green Accepted			2022-12-24	WOS:000182746700016
J	Jiang, YX; Ruta, V; Chen, JY; Lee, A; MacKinnon, R				Jiang, YX; Ruta, V; Chen, JY; Lee, A; MacKinnon, R			The principle of gating charge movement in a voltage-dependent K+ channel	NATURE			English	Article							SHAKER POTASSIUM CHANNEL; TRANSMEMBRANE MOVEMENT; ESCHERICHIA-COLI; ION CHANNELS; S4 SEGMENT; WILD-TYPE; ACTIVATION; SENSOR; MUTANT; SITE	The steep dependence of channel opening on membrane voltage allows voltage-dependent K+ channels to turn on almost like a switch. Opening is driven by the movement of gating charges that originate from arginine residues on helical S4 segments of the protein. Each S4 segment forms half of a 'voltage-sensor paddle' on the channel's outer perimeter. Here we show that the voltage-sensor paddles are positioned inside the membrane, near the intracellular surface, when the channel is closed, and that the paddles move a large distance across the membrane from inside to outside when the channel opens. KvAP channels were reconstituted into planar lipid membranes and studied using monoclonal Fab fragments, a voltage-sensor toxin, and avidin binding to tethered biotin. Our findings lead us to conclude that the voltage-sensor paddles operate somewhat like hydrophobic cations attached to levers, enabling the membrane electric field to open and close the pore.	Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Neurobiol & Biophys, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University	MacKinnon, R (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Neurobiol & Biophys, 1230 York Ave, New York, NY 10021 USA.			Ruta, Vanessa/0000-0002-4963-2768				Aggarwal SK, 1996, NEURON, V16, P1169, DOI 10.1016/S0896-6273(00)80143-9; ARMSTRONG CM, 1974, J GEN PHYSIOL, V63, P533, DOI 10.1085/jgp.63.5.533; Aziz QH, 2002, J BIOL CHEM, V277, P42719, DOI 10.1074/jbc.M207258200; Baker OS, 1998, NEURON, V20, P1283, DOI 10.1016/S0896-6273(00)80507-3; Bass RB, 2002, SCIENCE, V298, P1582, DOI 10.1126/science.1077945; Bezanilla F, 2000, PHYSIOL REV, V80, P555, DOI 10.1152/physrev.2000.80.2.555; COLE KS, 1960, BIOPHYS J, V1, P1, DOI 10.1016/S0006-3495(60)86871-3; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Gonzalez C, 2001, P NATL ACAD SCI USA, V98, P9617, DOI 10.1073/pnas.171306298; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Laine M, 2002, BIOPHYS J, V82, p231A; Larsson HP, 1996, NEURON, V16, P387, DOI 10.1016/S0896-6273(00)80056-2; MARTINAC B, 1987, P NATL ACAD SCI USA, V84, P2297, DOI 10.1073/pnas.84.8.2297; Papazian DM, 2002, NOVART FDN SYMP, V245, P178; PAPAZIAN DM, 1995, NEURON, V14, P1293, DOI 10.1016/0896-6273(95)90276-7; PUGLIESE L, 1993, J MOL BIOL, V231, P698, DOI 10.1006/jmbi.1993.1321; Qiu XQ, 1996, J GEN PHYSIOL, V107, P313, DOI 10.1085/jgp.107.3.313; QIU XQ, 1994, J BIOL CHEM, V269, P7483; Ruta V, 2003, NATURE, V422, P180, DOI 10.1038/nature01473; Schoppa NE, 1998, J GEN PHYSIOL, V111, P313, DOI 10.1085/jgp.111.2.313; SCHOPPA NE, 1992, SCIENCE, V255, P1712, DOI 10.1126/science.1553560; Seoh SA, 1996, NEURON, V16, P1159, DOI 10.1016/S0896-6273(00)80142-7; SIGWORTH FJ, 1994, Q REV BIOPHYS, V27, P1, DOI 10.1017/S0033583500002894; SLATIN SL, 1994, NATURE, V371, P158, DOI 10.1038/371158a0; Starace DM, 1997, NEURON, V19, P1319, DOI 10.1016/S0896-6273(00)80422-5; Swartz KJ, 1997, NEURON, V18, P675, DOI 10.1016/S0896-6273(00)80307-4; Tiwari-Woodruff SK, 2000, J GEN PHYSIOL, V115, P123, DOI 10.1085/jgp.115.2.123; Wimley WC, 1996, BIOCHEMISTRY-US, V35, P5109, DOI 10.1021/bi9600153; Yifrach O, 2002, CELL, V111, P231, DOI 10.1016/S0092-8674(02)01013-9; Yusaf SP, 1996, PFLUG ARCH EUR J PHY, V433, P91, DOI 10.1007/s004240050253; ZAGOTTA WN, 1994, J GEN PHYSIOL, V103, P321, DOI 10.1085/jgp.103.2.321; ZAGOTTA WN, 1994, J GEN PHYSIOL, V103, P279, DOI 10.1085/jgp.103.2.279	33	656	685	1	99	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 1	2003	423	6935					42	48		10.1038/nature01581	http://dx.doi.org/10.1038/nature01581			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673CG	12721619				2022-12-24	WOS:000182561600033
J	Giasson, BI; Forman, MS; Higuchi, M; Golbe, LI; Graves, CL; Kotzbauer, PT; Trojanowski, JQ; Lee, VMY				Giasson, BI; Forman, MS; Higuchi, M; Golbe, LI; Graves, CL; Kotzbauer, PT; Trojanowski, JQ; Lee, VMY			Initiation and synergistic fibrillization of tau and alpha-synuclein	SCIENCE			English	Article							PROTEIN-TAU; NEUROFIBRILLARY TANGLES; ALZHEIMERS-DISEASE; FILAMENTS; MUTANT; PHOSPHORYLATION; LOCALIZATION; DEMENTIA; RESIDUES; MISSENSE	Alpha-synuclein (alpha-syn) and tau polymerize into amyloid fibrils and form intraneuronal filamentous inclusions characteristic of neurodegenerative diseases. We demonstrate that alpha-syn induces fibrillization of tau and that coincubation of tau and alpha-syn synergistically promotes fibrillization of both proteins. The in vivo relevance of these findings is grounded in the co-occurrence of alpha-syn and tau filamentous amyloid inclusions in humans, in single transgenic mice that express A53T human alpha-syn in neurons, and in oligodendrocytes of bigenic mice that express wild-type human alpha-syn plus P301L mutant tau. This suggests that interactions between alpha-syn and tau can promote their fibrillization and drive the formation of pathological inclusions in human neurodegenerative diseases.	Univ Penn, Sch Med, Dept Pathol & Lab Med, Ctr Neurodegenerat Dis Res, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Inst Aging, Philadelphia, PA 19104 USA; Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Neurol, New Brunswick, NJ 08903 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Rutgers State University New Brunswick; Rutgers State University Medical Center	Lee, VMY (corresponding author), Univ Penn, Sch Med, Dept Pathol & Lab Med, Ctr Neurodegenerat Dis Res, 3600 Spruce St, Philadelphia, PA 19104 USA.	vmylee@mail.med.upenn.edu						Arrasate M, 1999, FEBS LETT, V446, P199, DOI 10.1016/S0014-5793(99)00210-0; Buee L, 2000, BRAIN RES REV, V33, P95, DOI 10.1016/S0165-0173(00)00019-9; Cabin DE, 2002, J NEUROSCI, V22, P8797; Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311; CRYSTAL A, UNPUB; Duda JE, 2000, J NEUROSCI RES, V61, P121, DOI 10.1002/1097-4547(20000715)61:2<121::AID-JNR1>3.0.CO;2-4; Duda JE, 2002, ACTA NEUROPATHOL, V104, P7, DOI 10.1007/s00401-002-0563-3; Friedhoff P, 1998, P NATL ACAD SCI USA, V95, P15712, DOI 10.1073/pnas.95.26.15712; Giasson BI, 2002, NEURON, V34, P521, DOI 10.1016/S0896-6273(02)00682-7; Giasson BI, 1999, J BIOL CHEM, V274, P7619, DOI 10.1074/jbc.274.12.7619; Giasson BI, 2001, J BIOL CHEM, V276, P2380, DOI 10.1074/jbc.M008919200; Goedert M, 1998, BIOCHEM SOC T, V26, P463, DOI 10.1042/bst0260463; Goedert M, 1996, NATURE, V383, P550, DOI 10.1038/383550a0; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; HANSEN L, 1990, NEUROLOGY, V40, P1; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Jensen PH, 1999, J BIOL CHEM, V274, P25481, DOI 10.1074/jbc.274.36.25481; KSIEZAKREDING H, 1991, NEURON, V6, P717, DOI 10.1016/0896-6273(91)90169-Z; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Lewis J, 2000, NAT GENET, V25, P402, DOI 10.1038/78078; LOPRESTI P, 1995, P NATL ACAD SCI USA, V92, P10369, DOI 10.1073/pnas.92.22.10369; McKeith IG, 1996, NEUROLOGY, V47, P1113, DOI 10.1212/WNL.47.5.1113; Nacharaju P, 1999, FEBS LETT, V447, P195, DOI 10.1016/S0014-5793(99)00294-X; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Richter-Landsberg C, 2000, J NEUROSCI RES, V62, P9, DOI 10.1002/1097-4547(20001001)62:1<9::AID-JNR2>3.0.CO;2-U; SCHWEERS O, 1994, J BIOL CHEM, V269, P24290; Souza JM, 2000, FEBS LETT, V474, P116, DOI 10.1016/S0014-5793(00)01563-5; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Wood SJ, 1999, J BIOL CHEM, V274, P19509, DOI 10.1074/jbc.274.28.19509	29	643	669	2	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 25	2003	300	5619					636	640		10.1126/science.1082324	http://dx.doi.org/10.1126/science.1082324			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671FB	12714745				2022-12-24	WOS:000182453700041
J	Reches, M; Gazit, E				Reches, M; Gazit, E			Casting metal nanowires within discrete self-assembled peptide nanotubes	SCIENCE			English	Article							AMYLOID FIBRIL FORMATION; PI-STACKING; PENTAPEPTIDE; MODEL	Tubular nanostructures are suggested to have a wide range of applications in nanotechnology. We report our observation of the self-assembly of a very short peptide, the Alzheimer's beta-amyloid diphenylalanine structural motif, into discrete and stiff nanotubes. Reduction of ionic silver within the nanotubes, followed by enzymatic degradation of the peptide backbone, resulted in the production of discrete nanowires with a long persistence length. The same dipeptide building block, made of D-phenylalanine, resulted in the production of enzymatically stable nanotubes.	Tel Aviv Univ, George S Wise Fac Life Sci, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel	Tel Aviv University	Gazit, E (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel.	ehudg@post.tau.ac.il	Gazit, Ehud/M-8026-2019; Gazit, Ehud/AHE-9332-2022; Gazit, Ehud/C-3715-2011; Reches, Meital/B-2348-2013	Gazit, Ehud/0000-0001-5764-1720; Gazit, Ehud/0000-0001-5764-1720; Reches, Meital/0000-0001-5652-9868				Azriel R, 2001, J BIOL CHEM, V276, P34156, DOI 10.1074/jbc.M102883200; Bong DT, 2001, ANGEW CHEM INT EDIT, V40, P988, DOI 10.1002/1521-3773(20010316)40:6<988::AID-ANIE9880>3.0.CO;2-N; Claessens CG, 1997, J PHYS ORG CHEM, V10, P254, DOI 10.1002/(SICI)1099-1395(199705)10:5<254::AID-POC875>3.0.CO;2-3; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; ENUSTUN BV, 1963, J AM CHEM SOC, V85, P3317, DOI 10.1021/ja00904a001; Findeis MA, 1999, BIOCHEMISTRY-US, V38, P6791, DOI 10.1021/bi982824n; Findeis Mark A., 2002, Current Topics in Medicinal Chemistry, V2, P417, DOI 10.2174/1568026024607508; Gazit E, 2002, FASEB J, V16, P77, DOI 10.1096/fj.01-0442hyp; Gazit E, 2002, ANGEW CHEM INT EDIT, V41, P257, DOI 10.1002/1521-3773(20020118)41:2<257::AID-ANIE257>3.0.CO;2-M; Gazit E, 2002, CURR MED CHEM, V9, P1725; GHADIRI MR, 1993, NATURE, V366, P324, DOI 10.1038/366324a0; Gorbitz CH, 2001, CHEM-EUR J, V7, P5153, DOI 10.1002/1521-3765(20011203)7:23<5153::AID-CHEM5153>3.0.CO;2-N; HARIS PI, 1995, BIOPOLYMERS, V37, P251, DOI 10.1002/bip.360370404; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; Hartgerink JD, 1996, J AM CHEM SOC, V118, P43, DOI 10.1021/ja953070s; Henglein A, 1999, J PHYS CHEM B, V103, P9533, DOI 10.1021/jp9925334; Matsui H, 2000, J PHYS CHEM B, V104, P3383, DOI 10.1021/jp994117p; Mazor Y, 2002, J MOL BIOL, V322, P1013, DOI 10.1016/S0022-2836(02)00887-2; Perutz MF, 2002, P NATL ACAD SCI USA, V99, P5591, DOI 10.1073/pnas.042681399; Reches M, 2002, J BIOL CHEM, V277, P35475, DOI 10.1074/jbc.M206039200; Shetty AS, 1996, J AM CHEM SOC, V118, P1019, DOI 10.1021/ja9528893; Soto C, 1998, NAT MED, V4, P822, DOI 10.1038/nm0798-822; Sunde M, 1998, Q REV BIOPHYS, V31, P1, DOI 10.1017/S0033583598003400; Tjernberg LO, 1996, J BIOL CHEM, V271, P8545, DOI 10.1074/jbc.271.15.8545; Vauthey S, 2002, P NATL ACAD SCI USA, V99, P5355, DOI 10.1073/pnas.072089599; Waters ML, 2002, CURR OPIN CHEM BIOL, V6, P736, DOI 10.1016/S1367-5931(02)00359-9; Wickner RB, 2000, J STRUCT BIOL, V130, P310, DOI 10.1006/jsbi.2000.4250; Wolfe MS, 2002, NAT REV DRUG DISCOV, V1, P859, DOI 10.1038/nrd938; Zhang SG, 2002, CURR OPIN CHEM BIOL, V6, P865, DOI 10.1016/S1367-5931(02)00391-5	29	1994	2052	21	875	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 25	2003	300	5619					625	627		10.1126/science.1082387	http://dx.doi.org/10.1126/science.1082387			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671FB	12714741				2022-12-24	WOS:000182453700037
J	Sun, JC; Bevan, MJ				Sun, JC; Bevan, MJ			Defective CD8 T cell memory following acute infection without CD4 T cell help	SCIENCE			English	Article							CHRONIC VIRAL-INFECTION; LISTERIA INFECTION; MICE; RESPONSES; LYMPHOCYTES; RESISTANCE	The CD8(+) cytotoxic T cell response to pathogens is thought to be CD4(+) helper T cell independent because infectious agents provide their own inflammatory signals. Mice that lack CD4(+) T cells mount a primary CD8 response to Listeria monocytogenes equal to that of wild-type mice and rapidly clear the infection. However, protective memory to a challenge is gradually lost in the former animals. Memory CD8(+) T cells from normal mice can respond rapidly, but memory CD8(+) T cells that are generated without CD4 help are defective in their ability to respond to secondary encounters with antigen. The results highlight a previously undescribed role for CD4 help in promoting protective CD8 memory development.	Univ Washington, Dept Immunol, Seattle, WA 98195 USA; Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Bevan, MJ (corresponding author), Univ Washington, Dept Immunol, Seattle, WA 98195 USA.		Nogueira, Raquel Tayar/F-6475-2019	Nogueira, Raquel Tayar/0000-0002-0581-763X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI019335, R37AI019335] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIAID NIH HHS [R01 AI019335, R01 AI019335-19, AI 19335] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BATTEGAY M, 1994, J VIROL, V68, P4700, DOI 10.1128/JVI.68.7.4700-4704.1994; Belz GT, 2002, J VIROL, V76, P12388, DOI 10.1128/JVI.76.23.12388-12393.2002; Bennett SRM, 1998, NATURE, V393, P478, DOI 10.1038/30996; Blattman JN, 2002, J EXP MED, V195, P657, DOI 10.1084/jem.20001021; Bourgeois C, 2002, EUR J IMMUNOL, V32, P2199, DOI 10.1002/1521-4141(200208)32:8<2199::AID-IMMU2199>3.0.CO;2-L; Bourgeois C, 2002, SCIENCE, V297, P2060, DOI 10.1126/science.1072615; CARDIN RD, 1996, J EXP MED, V184, P8056; Edelson BT, 1999, J IMMUNOL, V163, P4087; Edelson BT, 2000, CURR OPIN IMMUNOL, V12, P425, DOI 10.1016/S0952-7915(00)00112-6; Gordon S, 2002, CELL, V111, P927, DOI 10.1016/S0092-8674(02)01201-1; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Janssen EM, 2003, NATURE, V421, P852, DOI 10.1038/nature01441; Kalams SA, 1998, J EXP MED, V188, P2199, DOI 10.1084/jem.188.12.2199; LADEL CH, 1994, J IMMUNOL, V153, P3116; Lauvau G, 2001, SCIENCE, V294, P1735, DOI 10.1126/science.1064571; Liu HY, 2002, J IMMUNOL, V168, P3477, DOI 10.4049/jimmunol.168.7.3477; MATLOUBIAN M, 1994, J VIROL, V68, P8056, DOI 10.1128/JVI.68.12.8056-8063.1994; RAHEMTULLA A, 1991, NATURE, V353, P180, DOI 10.1038/353180a0; Riberdy JM, 2000, J VIROL, V74, P9762, DOI 10.1128/JVI.74.20.9762-9765.2000; Ridge JP, 1998, NATURE, V393, P474, DOI 10.1038/30989; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; Shen H, 2003, J IMMUNOL, V170, P1443, DOI 10.4049/jimmunol.170.3.1443; vonHerrath MG, 1996, J VIROL, V70, P1072, DOI 10.1128/JVI.70.2.1072-1079.1996; Zajac AJ, 1998, CURR OPIN IMMUNOL, V10, P444, DOI 10.1016/S0952-7915(98)80119-2; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205	25	998	1033	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 11	2003	300	5617					339	342		10.1126/science.1083317	http://dx.doi.org/10.1126/science.1083317			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665RQ	12690202	Green Accepted			2022-12-24	WOS:000182135400060
J	Wiznitzer, M; Findling, RL				Wiznitzer, M; Findling, RL			Why do psychiatric drug research in children?	LANCET			English	Editorial Material							OBSESSIVE-COMPULSIVE DISORDER; MOOD DISORDERS; PSYCHOPHARMACOLOGY; ADOLESCENTS; PERSPECTIVE; DEPRESSION		Univ Hosp Cleveland, Dept Pediat, Cleveland, OH 44106 USA; Univ Hosp Cleveland, Dept Psychiat, Cleveland, OH 44106 USA; Case Western Reserve Univ, Cleveland, OH 44106 USA	University Hospitals of Cleveland; University Hospitals of Cleveland; Case Western Reserve University	Wiznitzer, M (corresponding author), Univ Hosp Cleveland, Dept Pediat, Cleveland, OH 44106 USA.							Carrey N, 2001, CAN J PSYCHIAT, V46, P810, DOI 10.1177/070674370104600904; HAZELL P, 2002, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD002317; Hyman SE, 2001, BIOL PSYCHIAT, V49, P962, DOI 10.1016/S0006-3223(01)01128-3; Jensen PS, 1999, ARCH GEN PSYCHIAT, V56, P1073; Kaufman J, 2001, BIOL PSYCHIAT, V49, P980, DOI 10.1016/S0006-3223(01)01127-1; Kessler RC, 2001, BIOL PSYCHIAT, V49, P1002, DOI 10.1016/S0006-3223(01)01129-5; March JS, 2001, J CLIN CHILD PSYCHOL, V30, P8, DOI 10.1207/S15374424JCCP3001_3; Michael KD, 2002, CLIN PSYCHOL REV, V22, P247, DOI 10.1016/S0272-7358(01)00089-7; Piacentini J, 2000, PSYCHIAT CLIN N AM, V23, P519, DOI 10.1016/S0193-953X(05)70178-7; *US FDA, 2003, FDA APPR PROZ PED US; Vitiello B, 2001, PEDIATRICS, V108, P983, DOI 10.1542/peds.108.4.983; Weintrob N, 2002, ARCH PEDIAT ADOL MED, V156, P696, DOI 10.1001/archpedi.156.7.696; Zito JM, 2003, ARCH PEDIAT ADOL MED, V157, P17, DOI 10.1001/archpedi.157.1.17	13	17	18	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 5	2003	361	9364					1147	1148		10.1016/S0140-6736(03)12967-4	http://dx.doi.org/10.1016/S0140-6736(03)12967-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	664ZF	12686034				2022-12-24	WOS:000182094600005
J	Janssens, IA; Freibauer, A; Ciais, P; Smith, P; Nabuurs, GJ; Folberth, G; Schlamadinger, B; Hutjes, RWA; Ceulemans, R; Schulze, ED; Valentini, R; Dolman, AJ				Janssens, IA; Freibauer, A; Ciais, P; Smith, P; Nabuurs, GJ; Folberth, G; Schlamadinger, B; Hutjes, RWA; Ceulemans, R; Schulze, ED; Valentini, R; Dolman, AJ			Europe's terrestrial biosphere absorbs 7 to 12% of European anthropogenic CO2 emissions	SCIENCE			English	Article							CARBON-CYCLE; ATMOSPHERIC TRANSPORT; CLIMATE-CHANGE; FORESTS; LAND; SINK; EXCHANGES; BALANCE; FLUXES; OCEANS	Most inverse atmospheric models report considerable uptake of carbon dioxide in Europe's terrestrial biosphere. In contrast, carbon stocks in terrestrial ecosystems increase at a much smaller rate, with carbon gains in forests and grassland soils almost being offset by carbon losses from cropland and peat soils. Accounting for non-carbon dioxide carbon transfers that are not detected by the atmospheric models and for carbon dioxide fluxes bypassing the ecosystem carbon stocks considerably reduces the gap between the small carbon-stock changes and the larger carbon dioxide uptake estimated by atmospheric models. The remaining difference could be because of missing components in the stock-change approach, as well as the large uncertainty in both methods. With the use of the corrected atmosphere- and land-based estimates as a dual constraint, we estimate a net carbon sink between 135 and 205 teragrams per year in Europe's terrestrial biosphere, the equivalent of 7 to 12% of the 1995 anthropogenic carbon emissions.	Univ Antwerp, Dept Biol, B-2160 Antwerp, Belgium; Max Planck Inst Biogeochem, D-07701 Jena, Germany; Lab Sci Climat & Environm, F-91191 Gif Sur Yvette, France; Univ Aberdeen, Dept Plant & Soil Sci, Aberdeen AB24 3FX, Scotland; Alterra Green World Res, NL-6700 AC Wageningen, Netherlands; European Forest Inst, Joensuu 80100, Finland; Joanneum Res, A-8010 Graz, Austria; Univ Tuscia, Dept Forest Sci & Environm, I-01100 Viterbo, Italy; Free Univ Amsterdam, Dept Geoenvironm Sci, NL-1081 HV Amsterdam, Netherlands	University of Antwerp; Max Planck Society; UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); University of Aberdeen; Wageningen University & Research; Tuscia University; Vrije Universiteit Amsterdam	Janssens, IA (corresponding author), Univ Antwerp, Dept Biol, B-2160 Antwerp, Belgium.	ijanssen@uia.ua.ac.be	Schulze, Ernst-Detlef/K-9627-2014; Folberth, Gerd A./F-7376-2010; Janssens, Ivan A/P-1331-2014; Valentini, Riccardo/D-1226-2010; Nabuurs, Gert-Jan/D-8048-2015; Ciais, Philippe/A-6840-2011; Smith, Pete/G-1041-2010; Ceulemans, Reinhart J M/F-2109-2016	Folberth, Gerd A./0000-0002-1075-440X; Janssens, Ivan A/0000-0002-5705-1787; Valentini, Riccardo/0000-0002-6756-5634; Ciais, Philippe/0000-0001-8560-4943; Smith, Pete/0000-0002-3784-1124; Ceulemans, Reinhart J M/0000-0003-4773-9358; Dolman, A.J./0000-0003-0099-0457				ARMENTANO TV, 1986, J ECOL, V74, P755, DOI 10.2307/2260396; ARMENTANO TV, 1990, WETLANDS SHALLOW CON, P281; BALDOCCHI DD, 1988, ECOLOGY, V69, P1331, DOI 10.2307/1941631; BOTCH MS, 1995, GLOBAL BIOGEOCHEM CY, V9, P37, DOI 10.1029/94GB03156; Bousquet P, 2000, SCIENCE, V290, P1342, DOI 10.1126/science.290.5495.1342; Bousquet P, 1999, J GEOPHYS RES-ATMOS, V104, P26161, DOI 10.1029/1999JD900342; CIAIS P, 1995, SCIENCE, V269, P1098, DOI 10.1126/science.269.5227.1098; Cox PM, 2000, NATURE, V408, P184, DOI 10.1038/35041539; Dersch G, 1997, BODENSCHUTZ OSTERREI, P411; Frankignoulle M, 1998, SCIENCE, V282, P434, DOI 10.1126/science.282.5388.434; FREIBAUER A, IN PRESS SOIL SCI RE; GUENTHER A, 1995, J GEOPHYS RES-ATMOS, V100, P8873, DOI 10.1029/94JD02950; Gurney KR, 2002, NATURE, V415, P626, DOI 10.1038/415626a; Intergovernmental Panel on Climate Change, 2001, CLIM CHANG 2001 SCI; Jackson RB, 2002, NATURE, V418, P623, DOI 10.1038/nature00910; Kaminski T, 1999, J GEOPHYS RES-ATMOS, V104, P18555, DOI 10.1029/1999JD900146; KAUPPI PE, 1992, SCIENCE, V256, P70, DOI 10.1126/science.256.5053.70; Lappalainen E., 1996, GLOBAL PEAT RESOURCE; Liski J, 2002, FOREST ECOL MANAG, V169, P159, DOI 10.1016/S0378-1127(02)00306-7; Liski J., 2000, ENVIRON SCI POLICY, V3, P91, DOI [10.1016/S1462-9011(00)00020-4, DOI 10.1016/S1462-9011(00)00020-4]; Ludwig W, 1998, AM J SCI, V298, P265, DOI 10.2475/ajs.298.4.265; MILNE R, 2001, UK EMISSIONS SOURCES; MUCHER CA, 2000, PELCOM PAN EUROPEAN; Nabuurs GJ, 2003, GLOBAL CHANGE BIOL, V9, P152, DOI 10.1046/j.1365-2486.2003.00570.x; Nabuurs GJ, 1997, BIOMASS BIOENERG, V13, P345, DOI 10.1016/S0961-9534(97)00036-6; Nabuurs GJ, 2001, THESIS U JOENSUU FIN; NABUURS GJ, 2001, LONG TERM EFFECTS CL, P220; Olivier J. G. J., 1999, ENVIRON SCI POLICY, V2, P241, DOI DOI 10.1016/S1462-9011(99)00027-1; OLIVIER JGJ, 2002, THESIS U UTRECHT NET; Pacala SW, 2001, SCIENCE, V292, P2316, DOI 10.1126/science.1057320; Papale D, 2003, GLOBAL CHANGE BIOL, V9, P525, DOI 10.1046/j.1365-2486.2003.00609.x; Penman J., 2000, IPCC GOOD PRACTICE G; PISARENKO AI, 2000, DEV FOREST RESOURCES; Rayner PJ, 1999, TELLUS B, V51, P213, DOI 10.1034/j.1600-0889.1999.t01-1-00008.x; Schulze E.D., 2000, CARBON NITROGEN CYCL; Schulze E.D., 1998, IGBP SERIES, P145; Schulze ED, 2000, SCIENCE, V289, P2058, DOI 10.1126/science.289.5487.2058; Shvidenko A, 2002, CLIMATIC CHANGE, V55, P5, DOI 10.1023/A:1020243304744; SLEUTEL S, IN PRESS SOIL USE MA; Smith P, 2000, GLOB CHANGE BIOL, V6, P525, DOI 10.1046/j.1365-2486.2000.00331.x; Stallard RF, 1998, GLOBAL BIOGEOCHEM CY, V12, P231, DOI 10.1029/98GB00741; *TBFRA UN ECE FAO, 2000, TIMB FOR STUD PAP, V17; Valentini R, 2000, NATURE, V404, P861, DOI 10.1038/35009084; Vleeshouwers LM, 2002, GLOBAL CHANGE BIOL, V8, P519, DOI 10.1046/j.1365-2486.2002.00485.x	44	454	522	9	189	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 6	2003	300	5625					1538	1542		10.1126/science.1083592	http://dx.doi.org/10.1126/science.1083592			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686QU	12764201				2022-12-24	WOS:000183333100045
J	Houston, F; Goldmann, W; Chong, A; Jeffrey, M; Gonzalez, L; Foster, J; Parnham, D; Hunter, N				Houston, F; Goldmann, W; Chong, A; Jeffrey, M; Gonzalez, L; Foster, J; Parnham, D; Hunter, N			Prion diseases: BSE in sheep bred for resistance to infection	NATURE			English	Article							BOVINE SPONGIFORM ENCEPHALOPATHY; PRP; SCRAPIE; AGENT; ONSET		Inst Anim Hlth, Newbury RG20 7NN, Berks, England; IAH Neuropathogenesis Unit, Edinburgh EH9 3JF, Midlothian, Scotland; Vet Labs Agcy Lasswade, Penicuik EH26 0PZ, Midlothian, Scotland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute	Houston, F (corresponding author), Inst Anim Hlth, Newbury RG20 7NN, Berks, England.		Jeffrey, Martin/D-2251-2009; González, Lorenzo/A-5325-2010; Houston, Eleanor/A-8036-2011	González, Lorenzo/0000-0003-4199-4526; 				Bossers A, 2000, J VIROL, V74, P1407, DOI 10.1128/JVI.74.3.1407-1414.2000; GOLDMANN W, 1994, J GEN VIROL, V75, P989, DOI 10.1099/0022-1317-75-5-989; Hope J, 2000, J GEN VIROL, V81, P851, DOI 10.1099/0022-1317-81-3-851; Hunter N, 1997, TRENDS MICROBIOL, V5, P331, DOI 10.1016/S0966-842X(97)01081-0; IKEDA T, 1995, J GEN VIROL, V76, P2577, DOI 10.1099/0022-1317-76-10-2577; Jeffrey M, 2002, J COMP PATHOL, V127, P264, DOI 10.1053/jcpa.2002.0592; Jeffrey M, 2001, J COMP PATHOL, V125, P271, DOI 10.1053/jcpa.2001.0499; Jeffrey M, 2001, J COMP PATHOL, V124, P280, DOI 10.1053/jcpa.2001.0465; Kao RR, 2002, SCIENCE, V295, P332, DOI 10.1126/science.1067475; ORourke KI, 1997, J GEN VIROL, V78, P975, DOI 10.1099/0022-1317-78-4-975; Ryder SJ, 2000, J COMP PATHOL, V122, P131, DOI 10.1053/jcpa.1999.0349; VONKEULEN LJ, 1996, J CLIN MICROBIOL, V34, P1228	12	121	125	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 29	2003	423	6939					498	498		10.1038/423498a	http://dx.doi.org/10.1038/423498a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	683RH	12774113				2022-12-24	WOS:000183162900033
J	Ueda, H; Howson, JMM; Esposito, L; Heward, J; Snook, H; Chamberlain, G; Rainbow, DB; Hunter, KMD; Smith, AN; Di Genova, G; Herr, MH; Dahlman, I; Payne, F; Smyth, D; Lowe, C; Twells, RCJ; Howlett, S; Healy, B; Nutland, S; Rance, HE; Everett, V; Smink, LJ; Lam, AC; Cordell, HJ; Walker, NM; Bordin, C; Hulme, J; Motzo, C; Cucca, F; Hess, JF; Metzker, ML; Rogers, J; Gregory, S; Allahabadia, A; Nithiyananthan, R; Tuomilehto-Wolf, E; Tuomilehto, J; Bingley, P; Gillespie, KM; Undlien, DE; Ronningen, KS; Guja, C; Ionescu-Tirgoviste, C; Savage, DA; Maxwell, AP; Carson, DJ; Patterson, CC; Franklyn, JA; Clayton, DG; Peterson, LB; Wicker, LS; Todd, JA; Gough, SCL				Ueda, H; Howson, JMM; Esposito, L; Heward, J; Snook, H; Chamberlain, G; Rainbow, DB; Hunter, KMD; Smith, AN; Di Genova, G; Herr, MH; Dahlman, I; Payne, F; Smyth, D; Lowe, C; Twells, RCJ; Howlett, S; Healy, B; Nutland, S; Rance, HE; Everett, V; Smink, LJ; Lam, AC; Cordell, HJ; Walker, NM; Bordin, C; Hulme, J; Motzo, C; Cucca, F; Hess, JF; Metzker, ML; Rogers, J; Gregory, S; Allahabadia, A; Nithiyananthan, R; Tuomilehto-Wolf, E; Tuomilehto, J; Bingley, P; Gillespie, KM; Undlien, DE; Ronningen, KS; Guja, C; Ionescu-Tirgoviste, C; Savage, DA; Maxwell, AP; Carson, DJ; Patterson, CC; Franklyn, JA; Clayton, DG; Peterson, LB; Wicker, LS; Todd, JA; Gough, SCL			Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease	NATURE			English	Article							DEPENDENT DIABETES-MELLITUS; SOLUBLE FORM; CHROMOSOME 2Q33; GRAVES-DISEASE; CD28; POLYMORPHISM; REGION; EPIDEMIOLOGY; LYMPHOCYTES; REQUIRES	Genes and mechanisms involved in common complex diseases, such as the autoimmune disorders that affect approximately 5% of the population, remain obscure. Here we identify polymorphisms of the cytotoxic T lymphocyte antigen 4 gene (CTLA4)-which encodes a vital negative regulatory molecule of the immune system-as candidates for primary determinants of risk of the common autoimmune disorders Graves' disease, autoimmune hypothyroidism and type 1 diabetes. In humans, disease susceptibility was mapped to a non-coding 6.1 kb 30 region of CTLA4, the common allelic variation of which was correlated with lower messenger RNA levels of the soluble alternative splice form of CTLA4. In the mouse model of type 1 diabetes, susceptibility was also associated with variation in CTLA-4 gene splicing with reduced production of a splice form encoding a molecule lacking the CD80/CD86 ligand-binding domain. Genetic mapping of variants conferring a small disease risk can identify pathways in complex disorders, as exemplified by our discovery of inherited, quantitative alterations of CTLA4 contributing to autoimmune tissue destruction.	Univ Cambridge, Cambridge Inst Med Res, Juvenile Diabet Res Fdn, Wellcome Trust Diabet & Inflammat Lab, Cambridge CB2 2XY, England; Univ Birmingham, Div Med Sci, Birmingham B15 2TT, W Midlands, England; Univ Cagliari, Dipartimento Sci Biomed & Biotecnol, Cagliari, Italy; Merck Res Labs, W Point, PA 19486 USA; Wellsome Trust Sanger Inst, Cambridge CB10 1SA, England; Univ Helsinki, Natl Publ Hlth Inst, Diabet & Genet Epidemiol Unit, Helsinki, Finland; Univ Helsinki, Dept Publ Hlth, Helsinki, Finland; Univ Bristol, Div Med, Diabet & Metab Unit, Bristol BS10 5NG, Avon, England; Univ Oslo, Ulleval Univ Hosp, Inst Med Genet, Oslo, Norway; Rikshosp Univ Hosp, Inst Immunol, Oslo, Norway; Univ Oslo, Norwegian Inst Publ Hlth, Div Epidemiol, Lab Mol Epidemiol, Oslo, Norway; Inst Diabet Nutr & Metab Dis N Paulescu, Diabet Clin, Bucharest, Romania; Queens Univ Belfast, Belfast City Hosp, Dept Med Genet, Belfast BT9 7AB, Antrim, North Ireland; Belfast City Hosp, Reg Nephrol Unit, Belfast BT9 7AB, Antrim, North Ireland; Queens Univ Belfast, Dept Child Hlth, Belfast BT12 6BJ, Antrim, North Ireland; Queens Univ Belfast, Dept Epidemiol & Publ Hlth, Belfast BT12 6BJ, Antrim, North Ireland; Merck Res Labs, Dept Pharmacol, Rahway, NJ 07065 USA	University of Cambridge; University of Birmingham; University of Cagliari; Merck & Company; Wellcome Trust Sanger Institute; Finland National Institute for Health & Welfare; University of Helsinki; University of Helsinki; University of Bristol; University of Oslo; University of Oslo; National Hospital Norway; Norwegian Institute of Public Health (NIPH); University of Oslo; Belfast City Hospital; Queens University Belfast; Belfast City Hospital; Queens University Belfast; Queens University Belfast; Merck & Company	Todd, JA (corresponding author), Univ Cambridge, Cambridge Inst Med Res, Juvenile Diabet Res Fdn, Wellcome Trust Diabet & Inflammat Lab, Wellcome Trust MRC Bldg, Cambridge CB2 2XY, England.		Todd, John A/A-3542-2010; Guja, Cristian/K-2334-2019; Nithiyananthan, Ratnasingam/ABD-7859-2020; Wicker, Linda S/F-7384-2010; Payne, Felicity/GKF-2573-2022	Todd, John A/0000-0003-2740-8148; Payne, Felicity/0000-0003-4228-581X; Cordell, Heather/0000-0002-1879-5572; Dahlman, Ingrid/0000-0003-3819-5977; CUCCA, Francesco/0000-0002-7414-1995; smyth, deborah/0000-0002-6330-2669; Walker, Neil/0000-0001-9796-7688; Gregory, Simon/0000-0002-7805-1743; Howson, Joanna/0000-0001-7618-0050; Maxwell, Alexander P./0000-0002-6110-7253				Allahabadia A, 2001, LANCET, V358, P984, DOI 10.1016/S0140-6736(01)06125-6; Asano M, 1996, J EXP MED, V184, P387, DOI 10.1084/jem.184.2.387; BAIN SC, 1990, AUTOIMMUNITY, V7, P83, DOI 10.3109/08916939008993380; Chikuma S, 2003, J EXP MED, V197, P129, DOI 10.1084/jem.20021646; CLAYTON D, 2001, HDB STAT GENETICS, P519; Colucci F, 1997, P NATL ACAD SCI USA, V94, P8670, DOI 10.1073/pnas.94.16.8670; Cordell HJ, 2002, AM J HUM GENET, V70, P124, DOI 10.1086/338007; Dahlman I, 2002, NAT GENET, V30, P149, DOI 10.1038/ng825; Egen JG, 2002, NAT IMMUNOL, V3, P611, DOI 10.1038/ni0702-611; Finger EB, 2002, NAT IMMUNOL, V3, P1056, DOI 10.1038/ni1102-1056; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Grohmann U, 2002, NAT IMMUNOL, V3, P1097, DOI 10.1038/ni846; Hanawa H, 2002, BLOOD, V99, P2138, DOI 10.1182/blood.V99.6.2138; Hill NJ, 2000, DIABETES, V49, P1744, DOI 10.2337/diabetes.49.10.1744; Howard TD, 2002, J ALLERGY CLIN IMMUN, V110, P743, DOI 10.1067/mai.2002.128723; Huang DR, 2000, J NEUROIMMUNOL, V105, P69, DOI 10.1016/S0165-5728(00)00191-0; Kaijzel EL, 2001, GENES IMMUN, V2, P135, DOI 10.1038/sj.gene.6363747; Kaufman KA, 1999, MOL HUM REPROD, V5, P84, DOI 10.1093/molehr/5.1.84; Kouki T, 2000, J IMMUNOL, V165, P6606, DOI 10.4049/jimmunol.165.11.6606; Kristiansen OP, 2000, GENES IMMUN, V1, P170, DOI 10.1038/sj.gene.6363655; Lamhamedi-Cherradi SE, 2001, DIABETES, V50, P2874, DOI 10.2337/diabetes.50.12.2874; LERNMARK A, 1990, AM J HUM GENET, V47, P1028; Lesage S, 2001, J EXP MED, V194, pF31, DOI 10.1084/jem.194.5.F31; Lin H, 1998, J EXP MED, V188, P199, DOI 10.1084/jem.188.1.199; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Lynch KW, 2001, J BIOL CHEM, V276, P24341, DOI 10.1074/jbc.M102175200; Magistrelli G, 1999, BIOCHEM BIOPH RES CO, V259, P34, DOI 10.1006/bbrc.1999.0725; Magistrelli G, 1999, EUR J IMMUNOL, V29, P3596, DOI 10.1002/(SICI)1521-4141(199911)29:11<3596::AID-IMMU3596>3.0.CO;2-Y; Maloy KJ, 2003, J EXP MED, V197, P111, DOI 10.1084/jem.20021345; Manzotti CN, 2002, EUR J IMMUNOL, V32, P2888, DOI 10.1002/1521-4141(2002010)32:10<2888::AID-IMMU2888>3.0.CO;2-F; Marron MP, 2000, DIABETES, V49, P492, DOI 10.2337/diabetes.49.3.492; Maurer M, 2002, IMMUNOGENETICS, V54, P1, DOI 10.1007/s00251-002-0429-9; Mein CA, 2000, GENOME RES, V10, P330, DOI 10.1101/gr.10.3.330; Nistico L, 1996, HUM MOL GENET, V5, P1075, DOI 10.1093/hmg/5.7.1075; Oaks MK, 2000, CELL IMMUNOL, V201, P144, DOI 10.1006/cimm.2000.1649; Oaks MK, 2000, J IMMUNOL, V164, P5015, DOI 10.4049/jimmunol.164.10.5015; Olivier M, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf052; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; Patterson CC, 1996, DIABETOLOGIA, V39, P1063, DOI 10.1007/BF00400655; Sakaguchi S, 2003, J EXP MED, V197, P397, DOI 10.1084/jem.20030012; Sharpe AH, 2002, NAT REV IMMUNOL, V2, P116, DOI 10.1038/nri727; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; TODD JA, 1991, DIABETIC MED, V8, P906, DOI 10.1111/j.1464-5491.1991.tb01528.x; TUOMILEHTO J, 1992, DIABETOLOGIA, V35, P70, DOI 10.1007/BF00400854; Zheng ZM, 1999, J VIROL, V73, P29, DOI 10.1128/JVI.73.1.29-36.1999	46	1690	1773	1	149	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 29	2003	423	6939					506	511		10.1038/nature01621	http://dx.doi.org/10.1038/nature01621			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	683RH	12724780	Bronze, Green Published			2022-12-24	WOS:000183162900035
J	Donnelly, CA; Ghani, AC; Leung, GM; Hedley, AJ; Fraser, C; Riley, S; Abu-Raddad, LJ; Ho, LM; Thach, TQ; Chau, P; Chan, KP; Lam, TH; Tse, LY; Tsang, T; Liu, SH; Kong, JHB; Lau, EMC; Ferguson, NM; Anderson, RM				Donnelly, CA; Ghani, AC; Leung, GM; Hedley, AJ; Fraser, C; Riley, S; Abu-Raddad, LJ; Ho, LM; Thach, TQ; Chau, P; Chan, KP; Lam, TH; Tse, LY; Tsang, T; Liu, SH; Kong, JHB; Lau, EMC; Ferguson, NM; Anderson, RM			Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong	LANCET			English	Article								Background Health authorities worldwide, especially in the Asia Pacific region, are seeking effective public-health interventions in the continuing epidemic of severe acute respiratory syndrome (SARS). We assessed the epidemiology of SARS in Hong Kong. Methods We included 1425 cases reported up to April 28, 2003. An integrated database was constructed from several sources containing information on epidemiological, demographic, and clinical variables. We estimated the key epidemiological distributions: infection to onset, onset to admission, admission to death, and admission to discharge. We measured associations between the estimated case fatality rate and patients' age and the time from onset to admission. Findings After the initial phase of exponential growth, the rate of confirmed cases fell to less than 20 per day by April 28. Public-health interventions included encouragement to report to hospital rapidly after the onset of clinical symptoms, contact tracing for confirmed and suspected cases, and quarantining, monitoring, and restricting the travel of contacts. The mean incubation period of the disease is estimated to be 6.4 days (95% CI 5.2-7.7). The mean time from onset of clinical symptoms to admission to hospital varied between 3 and 5 days, with longer times earlier in the epidemic. The estimated case fatality rate was 13.2% (9.8-16.8) for patients younger than 60 years and 43.3% (35.2-52.4) for patients aged 60 years or older assuming a parametric gamma distribution. A non-parametric method yielded estimates of 6.8% (4.0-9.6) and 55.0% (45.3-64.7), respectively. Case clusters have played an important part in the course of the epidemic. Interpretation Patients' age was strongly associated with outcome. The time between onset of symptoms and admission to hospital did not alter outcome, but shorter intervals will be important to the wider population by restricting the infectious period before patients are placed in quarantine.	Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London W2 1PG, England; Univ Hong Kong, Dept Community Med, Hong Kong, Hong Kong, Peoples R China; Dept Hlth, Hong Kong, Hong Kong, Peoples R China; Hong Kong Hosp Author, Hong Kong, Hong Kong, Peoples R China; Chinese Univ Hong Kong, Dept Community & Family Med, Hong Kong, Hong Kong, Peoples R China	Imperial College London; University of Hong Kong; Chinese University of Hong Kong	Donnelly, CA (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, St Marys Campus,Norfolk Pl, London W2 1PG, England.		Ghani, Azra/B-8560-2009; Lam, Tai Hing/C-4317-2009; Ferguson, Neil/B-8578-2008; Fraser, Christophe/A-8109-2008; Leung, Gabriel Matthew/C-4336-2009; Hedley, Anthony/C-4305-2009; Thach, Thuan-Quoc/C-4416-2009; Abu-Raddad, Laith J/AAY-1441-2020; Chan, King Pan/C-4523-2009; Hedley, Anthony J/A-9113-2013	Ferguson, Neil/0000-0002-1154-8093; Fraser, Christophe/0000-0003-2399-9657; Thach, Thuan-Quoc/0000-0003-3404-3888; Abu-Raddad, Laith J/0000-0003-0790-0506; ho, lm/0000-0002-2709-927X; Ghani, Azra/0000-0002-0007-4910; Anderson, Roy/0000-0002-9528-3175; Leung, Gabriel/0000-0002-2503-6283; Donnelly, Christl/0000-0002-0195-2463; Riley, Steven/0000-0001-7904-4804	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		[Anonymous], COM NUMB REP PROB CA; Peiris JSM, 2003, LANCET, V361, P1319, DOI 10.1016/S0140-6736(03)13077-2; TSANG KW, CLUSTER CASES SEVERE; *WHO, COR SEEN HUM CAUS SA	4	612	664	1	77	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 24	2003	361	9371					1761	1766		10.1016/S0140-6736(03)13410-1	http://dx.doi.org/10.1016/S0140-6736(03)13410-1			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	682CY	12781533	Bronze, Green Published			2022-12-24	WOS:000183074800006
J	Mizuguchi, S; Uyama, T; Kitagawa, H; Nomura, KH; Dejima, K; Gengyo-Ando, K; Mitani, S; Sugahara, K; Nomura, K				Mizuguchi, S; Uyama, T; Kitagawa, H; Nomura, KH; Dejima, K; Gengyo-Ando, K; Mitani, S; Sugahara, K; Nomura, K			Chondroitin proteoglycans are involved in cell division of Caenorhabditis elegans	NATURE			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; PROTEIN LINKAGE REGION; MOLECULAR-CLONING; IN-VIVO; BIOSYNTHESIS; DROSOPHILA; GLYCOSAMINOGLYCANS; EXPRESSION; INITIATION; ELONGATION	Glycosaminoglycans such as heparan sulphate and chondroitin sulphate are extracellular sugar chains involved in intercellular signalling. Disruptions of genes encoding enzymes that mediate glycosaminoglycan biosynthesis have severe consequences in Drosophila and mice(1-5). Mutations in the Drosophila gene sugarless, which encodes a UDP-glucose dehydrogenase, impair developmental signalling through the Wnt family member Wingless, and signalling by the fibroblast growth factor and Hedgehog pathways. Heparan sulphate is involved in these pathways(6-8), but little is known about the involvement of chondroitin. Undersulphated and oversulphated chondroitin sulphate chains have been implicated in other biological processes, however, including adhesion of erythrocytes infected with malaria parasite to human placenta and regulation of neural development(9,10). To investigate chondroitin functions, we cloned a chondroitin synthase homologue of Caenorhabditis elegans and depleted expression of its product by RNA-mediated interference and deletion mutagenesis. Here we report that blocking chondroitin synthesis results in cytokinesis defects in early embryogenesis. Reversion of cytokinesis is often observed in chondroitin-depleted embryos, and cell division eventually stops, resulting in early embryonic death. Our findings show that chondroitin is required for embryonic cytokinesis and cell division.	Kyushu Univ, Fac Sci 33, Dept Biol, Fukuoka 8128581, Japan; Japan Sci & Technol Corp, SORST, Kawaguchi, Saitama 3320012, Japan; Japan Sci & Technol Corp, PRESTO, Kawaguchi, Saitama 3320012, Japan; Kobe Pharmaceut Univ, Dept Biochem, Higashinada Ku, Kobe, Hyogo 6588558, Japan; Tokyo Womens Med Univ Sch Med, Dept Physiol, Tokyo 1628666, Japan	Kyushu University; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST); Kobe Pharmaceutical University; Tokyo Women's Medical University	Nomura, K (corresponding author), Kyushu Univ, Fac Sci 33, Dept Biol, Fukuoka 8128581, Japan.	k-sugar@kobepharma-u.ac.jp; knomuscb@mbox.nc.kyushu-u.ac.jp	Kitagawa, Hiroshi/AAJ-1344-2020; Gengyo-Ando, Keiko/B-2753-2012; Gengyo-Ando, Keiko/AAC-4504-2019	Kitagawa, Hiroshi/0000-0002-9307-7079; 				Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; BRECHT M, 1986, BIOCHEM J, V239, P445, DOI 10.1042/bj2390445; Bulik DA, 2000, P NATL ACAD SCI USA, V97, P10838, DOI 10.1073/pnas.97.20.10838; Christensen M, 2001, J BIOL CHEM, V276, P45024, DOI 10.1074/jbc.M107652200; Forsberg E, 2001, J CLIN INVEST, V108, P175, DOI 10.1172/JCI13561; Gengyo-Ando K, 2000, BIOCHEM BIOPH RES CO, V269, P64, DOI 10.1006/bbrc.2000.2260; Hacker U, 1997, DEVELOPMENT, V124, P3565; Herman T, 1999, P NATL ACAD SCI USA, V96, P968, DOI 10.1073/pnas.96.3.968; Iozzo RV, 2001, J CLIN INVEST, V108, P165, DOI 10.1172/JCI13560; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kitagawa H, 1998, J BIOL CHEM, V273, P6615, DOI 10.1074/jbc.273.12.6615; Kitagawa H, 2001, J BIOL CHEM, V276, P38721, DOI 10.1074/jbc.M106871200; Kitagawa H, 2001, J BIOL CHEM, V276, P4834, DOI 10.1074/jbc.C000835200; Lander AD, 2000, J CELL BIOL, V148, P227, DOI 10.1083/jcb.148.2.227; Lin XH, 1999, DEVELOPMENT, V126, P3715; Lindahl U., 1972, GLYCOPROTEINS THEIR, P491; Maeda I, 2001, CURR BIOL, V11, P171, DOI 10.1016/S0960-9822(01)00052-5; Miller DM, 1995, METHOD CELL BIOL, V48, P365; Perrimon N, 2000, NATURE, V404, P725, DOI 10.1038/35008000; Reddien PW, 2000, NAT CELL BIOL, V2, P131, DOI 10.1038/35004000; Sugahara K, 2000, CURR OPIN STRUC BIOL, V10, P518, DOI 10.1016/S0959-440X(00)00125-1; Sugahara K, 2000, TRENDS GLYCOSCI GLYC, V12, P321, DOI 10.4052/tigg.12.321; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Toyoda H, 2000, J BIOL CHEM, V275, P2269, DOI 10.1074/jbc.275.4.2269; Tsuda M, 1999, NATURE, V400, P276, DOI 10.1038/22336; Uyama T, 2003, J BIOL CHEM, V278, P3072, DOI 10.1074/jbc.M209446200; Uyama T, 2002, J BIOL CHEM, V277, P8841, DOI 10.1074/jbc.M111434200; Yamada S, 1999, FEBS LETT, V459, P327, DOI 10.1016/S0014-5793(99)01286-7	30	194	207	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 22	2003	423	6938					443	448		10.1038/nature01635	http://dx.doi.org/10.1038/nature01635			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681AJ	12761550				2022-12-24	WOS:000183012000043
J	Lecossier, D; Bouchonnet, F; Clavel, F; Hance, AJ				Lecossier, D; Bouchonnet, F; Clavel, F; Hance, AJ			Hypermutation of HIV-1 DNA in the absence of the Vif protein	SCIENCE			English	Article									INSERM, U552, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm)	Hance, AJ (corresponding author), INSERM, U552, Paris, France.							HANCE AJ, UNPUB; Jarmuz A, 2002, GENOMICS, V79, P285, DOI 10.1006/geno.2002.6718; Martin A, 2002, P NATL ACAD SCI USA, V99, P12304, DOI 10.1073/pnas.192442899; MARTINEZ MA, 1994, P NATL ACAD SCI USA, V91, P11787, DOI 10.1073/pnas.91.25.11787; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939	5	560	588	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 16	2003	300	5622					1112	1112		10.1126/science.1083338	http://dx.doi.org/10.1126/science.1083338			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678VC	12750511				2022-12-24	WOS:000182886500034
J	Staddon, PL; Ramsey, CB; Ostle, N; Ineson, P; Fitter, AH				Staddon, PL; Ramsey, CB; Ostle, N; Ineson, P; Fitter, AH			Rapid turnover of hyphae of mycorrhizal fungi determined by AMS microanalysis of C-14	SCIENCE			English	Article							GLOBAL CLIMATE-CHANGE; PHOSPHORUS INFLOW; UPLAND GRASSLAND; EXTERNAL HYPHAE; ATMOSPHERIC CO2; PLANT-GROWTH; CARBON; SOIL; RADIOCARBON; MYCELIUM	Processes in the soil remain among the least well-characterized components of the carbon cycle. Arbuscular mycorrhizal (AM) fungi are ubiquitous root symbionts in many terrestrial ecosystems and account for a large fraction of photosynthate in a wide range of ecosystems; they therefore play a key role in the terrestrial carbon cycle. A large part of the fungal mycelium is outside the root ( the extraradical mycelium, ERM) and, because of the dispersed growth pattern and the small diameter of the hyphae (<5 micrometers), exceptionally difficult to study quantitatively. Critically, the longevity of these. ne hyphae has never been measured, although it is assumed to be short. To quantify carbon turnover in these hyphae, we exposed mycorrhizal plants to fossil ("carbon-14 - dead") carbon dioxide and collected samples of ERM hyphae ( up to 116 micrograms) over the following 29 days. Analyses of their carbon-14 content by accelerator mass spectrometry (AMS) showed that most ERM hyphae of AM fungi live, on average, 5 to 6 days. This high turnover rate reveals a large and rapid mycorrhizal pathway of carbon in the soil carbon cycle.	Univ York, Dept Biol, York YO10 5YW, N Yorkshire, England; Univ Oxford, Archaeol & Hist Art Res Lab, Radiocarbon Accelerator Unit, Oxford OX1 3QJ, England; Inst Terr Ecol, Merlewood Res Stn, Ctr Ecol & Hydrol, Grange Over Sands LA11 6JU, Cumbria, England	University of York - UK; University of Oxford; UK Centre for Ecology & Hydrology (UKCEH)	Staddon, PL (corresponding author), Riso Natl Lab, Plant Res Dept, Bldg 313,Postbox 49, DK-4000 Roskilde, Denmark.		Ramsey, Christopher Bronk/A-3277-2012; Ostle, Nicholas J/E-4847-2014; Ostle, Nick J/K-6891-2012; Ramsey, Christopher Bronk/AAQ-2227-2021	Ramsey, Christopher Bronk/0000-0002-8641-9309; Ostle, Nicholas J/0000-0003-3263-3702; Ramsey, Christopher Bronk/0000-0002-8641-9309				Atkinson D, 2000, APPL SOIL ECOL, V15, P99, DOI 10.1016/S0929-1393(00)00084-6; Bago B, 1998, NEW PHYTOL, V139, P375, DOI 10.1046/j.1469-8137.1998.00199.x; Bever JD, 2002, PLANT SOIL, V244, P281, DOI 10.1023/A:1020221609080; BRONKRAMSEY C, 1997, NUCL INSTR METHODS P, V123, P539; Cao MK, 1998, NATURE, V393, P249, DOI 10.1038/30460; Fitter AH, 2000, NEW PHYTOL, V147, P179, DOI 10.1046/j.1469-8137.2000.00680.x; Fitter AH, 1997, NEW PHYTOL, V137, P247, DOI 10.1046/j.1469-8137.1997.00804.x; FRIESE CF, 1991, MYCOLOGIA, V83, P409, DOI 10.2307/3760351; Gange A, 2000, TRENDS ECOL EVOL, V15, P369, DOI 10.1016/S0169-5347(00)01940-6; Gaudinski JB, 2001, OECOLOGIA, V129, P420, DOI 10.1007/s004420100746; Hewitt E.J., 1975, PLANT MINERAL NUTR; Hobbie EA, 2002, NEW PHYTOL, V156, P129, DOI 10.1046/j.1469-8137.2002.00496.x; Hodge A, 2001, NATURE, V413, P297, DOI 10.1038/35095041; JAKOBSEN I, 1990, NEW PHYTOL, V115, P77, DOI 10.1111/j.1469-8137.1990.tb00924.x; JAKOBSEN I, 1992, NEW PHYTOL, V120, P371, DOI 10.1111/j.1469-8137.1992.tb01077.x; Johnson D, 2002, NEW PHYTOL, V153, P327, DOI 10.1046/j.0028-646X.2001.00316.x; Johnson D, 2002, SOIL BIOL BIOCHEM, V34, P1521, DOI 10.1016/S0038-0717(02)00126-8; Luo YQ, 2001, NATURE, V413, P622, DOI 10.1038/35098065; Oechel WC, 2000, NATURE, V406, P978, DOI 10.1038/35023137; Ostle N, 2000, RAPID COMMUN MASS SP, V14, P1345, DOI 10.1002/1097-0231(20000815)14:15<1345::AID-RCM22>3.0.CO;2-B; Radajewski S, 2000, NATURE, V403, P646, DOI 10.1038/35001054; Schlesinger WH, 2001, NATURE, V411, P466, DOI 10.1038/35078060; Smith S.E., 2010, MYCORRHIZAL SYMBIOSI; Sokal R. R, 1981, BIOMETRY; Staddon PL, 1999, SOIL BIOL BIOCHEM, V31, P1067, DOI 10.1016/S0038-0717(99)00020-6; Staddon PL, 1999, GLOBAL CHANGE BIOL, V5, P347, DOI 10.1046/j.1365-2486.1999.00230.x; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932	27	270	292	12	178	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 16	2003	300	5622					1138	1140		10.1126/science.1084269	http://dx.doi.org/10.1126/science.1084269			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678VC	12750519	Green Accepted			2022-12-24	WOS:000182886500043
J	O'Brien, TG; Kinnaird, MF				O'Brien, TG; Kinnaird, MF			Caffeine and conservation	SCIENCE			English	Editorial Material									Wildlife Conservat Soc, Bogor, Indonesia	Wildlife Conservation Society - Indonesia	O'Brien, TG (corresponding author), Wildlife Conservat Soc, Jalan Pangrango 8, Bogor, Indonesia.							Kinnaird MF, 2003, CONSERV BIOL, V17, P245, DOI 10.1046/j.1523-1739.2003.02040.x; Mittermeier RA, 1998, CONSERV BIOL, V12, P516, DOI 10.1046/j.1523-1739.1998.012003516.x; RODEN C, 1999, COFFEE; Vandermeer J., 1995, BREAKFAST BIODIVERSI; VANDERNEER J, 2003, TROPICAL AGROECOSYST; Ward J., 1996, COFFEE CONSERVATION; 2001, LAMPUNG FIGURES; 2002, JAKARTA POST    0926, P13	8	67	67	1	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 25	2003	300	5619					587	587		10.1126/science.1082328	http://dx.doi.org/10.1126/science.1082328			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671FB	12714727				2022-12-24	WOS:000182453700023
J	Melton, L				Melton, L			Crime busters	NATURE			English	Article																			0	22	23	1	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 24	2003	422	6934					917	917		10.1038/422917b	http://dx.doi.org/10.1038/422917b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670WR	12712209	Bronze			2022-12-24	WOS:000182432600061
J	Hasbun, R; Vikram, HR; Barakat, LA; Buenconsejo, J; Quagliarello, VJ				Hasbun, R; Vikram, HR; Barakat, LA; Buenconsejo, J; Quagliarello, VJ			Complicated left-sided native valve endocarditis in adults - Risk classification for mortality	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NATIONAL-DEATH-INDEX; INFECTIVE ENDOCARDITIS; BACTERIAL-ENDOCARDITIS; VITAL STATUS; SURGERY; MANAGEMENT; DIAGNOSIS	Context Complicated left-sided native valve endocarditis causes significant morbidity and mortality in adults. Lack of valid data regarding estimation of prognosis makes management of this condition difficult. Objective To derive and externally validate a prognostic classification system for adults with complicated left-sided native valve endocarditis. Design, Setting, and Patients Retrospective observational cohort study conducted from January 1990 to January 2000 at 7 Connecticut hospitals among 513 patients older than 16,years who experienced complicated left-sided native valve endocarditis and who were divided into derivation (n=259) and validation (n=254) cohorts. Main Outcome Measure All-cause mortality at 6 months after baseline. Results In the derivation and validation cohorts, the 6-month mortality rates were 25% and 26%, respectively. Five baseline features were independently associated with 6-month mortality (comorbidity [P=.03], abnormal mental status [P=.02], moderate to severe congestive heart failure [P=.01], bacterial etiology other than viridans streptococci [P<.001 except Staphylococus aureus, P=.004], and medical therapy without valve surgery [P=.002]) and were used to create a prognostic classification system. In the derivation cohort, patients were classified into 4 groups with increasing risk for 6-month mortality: 5%, 15%, 31%, and 59% (P<.001). In the validation cohort, a similar risk among the 4 groups was observed: 7%, 19%, 32%, and 69% (P<.001). Conclusions Adults with complicated left-sided native valve endocarditis can be accurately risk stratified using baseline features into 4 groups of prognostic severity. This prognostic classification system might be useful for facilitating management decisions.	Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA; Yale Univ, Sch Epidemiol & Publ Hlth, New Haven, CT 06520 USA; Griffin Hosp, Derby, CT USA; Hosp St Raphael, Infect Dis Sect, New Haven, CT USA; Tulane Univ, Sch Med, Infect Dis Sect, New Orleans, LA 70112 USA	Yale University; Yale University; Hospital Saint Raphael; Tulane University	Hasbun, R (corresponding author), Yale Univ, Sch Med, Dept Internal Med, POB 208022,800 LCI, New Haven, CT 06520 USA.							Alexiou C, 2000, ANN THORAC SURG, V69, P1448, DOI 10.1016/S0003-4975(00)01139-5; Bayer AS, 1998, CIRCULATION, V98, P2936, DOI 10.1161/01.CIR.98.25.2936; Bishara J, 2001, CLIN INFECT DIS, V33, P1636, DOI 10.1086/323785; Braitman LE, 1996, ANN INTERN MED, V125, P406, DOI 10.7326/0003-4819-125-5-199609010-00008; CARPENTER JL, 1991, REV INFECT DIS, V13, P127; CATES JE, 1951, Q J MED, V20, P93; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; CONCATO J, 1993, ANN INTERN MED, V118, P201, DOI 10.7326/0003-4819-118-3-199302010-00009; CROFT CH, 1983, AM J CARDIOL, V51, P1650, DOI 10.1016/0002-9149(83)90203-5; DINUBILE MJ, 1982, ANN INTERN MED, V96, P650, DOI 10.7326/0003-4819-96-5-650; DURACK DT, 1994, AM J MED, V96, P200, DOI 10.1016/0002-9343(94)90143-0; Feinstein AR, 1985, CLIN EPIDEMIOLOGY AR; GRIFFIN FM, 1972, ANN INTERN MED, V76, P23, DOI 10.7326/0003-4819-76-1-23; Gum PA, 2001, JAMA-J AM MED ASSOC, V286, P1187, DOI 10.1001/jama.286.10.1187; Joffe MM, 1999, AM J EPIDEMIOL, V150, P327; KARALIS DG, 1991, AM J MED, V90, P193; KIMOSE HH, 1990, SCAND J THORAC CARD, V24, P111, DOI 10.3109/14017439009098053; Lash TL, 2001, EPIDEMIOLOGY, V12, P259, DOI 10.1097/00001648-200103000-00021; MCANULTY JH, 1979, JAMA-J AM MED ASSOC, V242, P77, DOI 10.1001/jama.242.1.77; MIDDLEMOST S, 1991, J AM COLL CARDIOL, V18, P663, DOI 10.1016/0735-1097(91)90785-8; MUGGE A, 1993, INFECT DIS CLIN N AM, V7, P877; Mylonakis E, 2001, NEW ENGL J MED, V345, P1318, DOI 10.1056/NEJMra010082; PELLETIER LL, 1977, MEDICINE, V56, P287, DOI 10.1097/00005792-197707000-00002; PRUITT AA, 1978, MEDICINE, V57, P329, DOI 10.1097/00005792-197807000-00004; RICHARDSON JV, 1978, CIRCULATION, V58, P589, DOI 10.1161/01.CIR.58.4.589; STAMPFER MJ, 1984, AM J EPIDEMIOL, V119, P837, DOI 10.1093/oxfordjournals.aje.a113804; STECKELBERG JM, 1991, ANN INTERN MED, V114, P635, DOI 10.7326/0003-4819-114-8-635; VONREYN CF, 1981, ANN INTERN MED, V94, P505, DOI 10.7326/0003-4819-94-4-505; WALLACE AG, 1965, CIRCULATION, V31, P450, DOI 10.1161/01.CIR.31.3.450; WENTWORTH DN, 1983, AM J PUBLIC HEALTH, V73, P1270, DOI 10.2105/AJPH.73.11.1270; WILSON WR, 1982, MAYO CLIN PROC, V57, P162; WILSON WR, 1978, CIRCULATION, V58, P585, DOI 10.1161/01.CIR.58.4.585; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	33	236	246	1	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 16	2003	289	15					1933	1940		10.1001/jama.289.15.1933	http://dx.doi.org/10.1001/jama.289.15.1933			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	667VC	12697795				2022-12-24	WOS:000182253900025
J	Warren, SM; Brunet, LJ; Harland, RM; Economides, AN; Longaker, MT				Warren, SM; Brunet, LJ; Harland, RM; Economides, AN; Longaker, MT			The BMP antagonist noggin regulates cranial suture fusion	NATURE			English	Article							IN-VITRO; BONE-FORMATION; EXPRESSION; PROTEIN; BIOLOGY; GROWTH; VIVO; OSTEOBLASTS; MECHANISMS; MUTATIONS	During skull development, the cranial connective tissue framework undergoes intramembranous ossification to form skull bones (calvaria). As the calvarial bones advance to envelop the brain, fibrous sutures form between the calvarial plates(1). Expansion of the brain is coupled with calvarial growth through a series of tissue interactions within the cranial suture complex(2). Craniosynostosis, or premature cranial suture fusion, results in an abnormal skull shape, blindness and mental retardation(3). Recent studies have demonstrated that gain-of-function mutations in fibroblast growth factor receptors (fgfr) are associated with syndromic forms of craniosynostosis(4,5). Noggin, an antagonist of bone morphogenetic proteins (BMPs), is required for embryonic neural tube, somites and skeleton patterning(6-8). Here we show that noggin is expressed postnatally in the suture mesenchyme of patent, but not fusing, cranial sutures, and that noggin expression is suppressed by FGF2 and syndromic fgfr signalling. Since noggin misexpression prevents cranial suture fusion in vitro and in vivo, we suggest that syndromic fgfr-mediated craniosynostoses may be the result of inappropriate downregulation of noggin expression.	Stanford Univ, Dept Surg, Sch Med, Stanford, CA 94305 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Div Biochem & Mol Biol, Berkeley, CA 94720 USA; Regeneron Pharmaceut Inc, Tarrytown, NY 10591 USA	Stanford University; University of California System; University of California Berkeley; Regeneron	Longaker, MT (corresponding author), Stanford Univ, Dept Surg, Sch Med, Stanford, CA 94305 USA.			Economides, Aris/0000-0002-6508-8942				Albrecht U, 1997, MOL CELLULAR METHODS, P23; Bradley JP, 1996, CLEFT PALATE-CRAN J, V33, P150, DOI 10.1597/1545-1569(1996)033<0150:SICSBV>2.3.CO;2; Bradley JP, 1996, PLAST RECONSTR SURG, V98, P1039, DOI 10.1097/00006534-199611000-00018; Brunet LJ, 1998, SCIENCE, V280, P1455, DOI 10.1126/science.280.5368.1455; Brunkow ME, 2001, AM J HUM GENET, V68, P577, DOI 10.1086/318811; Capdevila J, 1999, MOL CELL, V4, P839, DOI 10.1016/S1097-2765(00)80393-7; Capdevila J, 1998, DEV BIOL, V197, P205, DOI 10.1006/dbio.1997.8824; COHEN MM, 1995, AM J MED GENET, V56, P334, DOI 10.1002/ajmg.1320560327; Dixon ME, 2001, GENET MED, V3, P349, DOI 10.1097/00125817-200109000-00004; Gazzerro E, 1998, J CLIN INVEST, V102, P2106, DOI 10.1172/JCI3459; Greenwald JA, 2001, AM J PATHOL, V158, P441, DOI 10.1016/S0002-9440(10)63987-9; Greenwald JA, 2000, J BONE MINER RES, V15, P2413, DOI 10.1359/jbmr.2000.15.12.2413; Hsu DR, 1998, MOL CELL, V1, P673, DOI 10.1016/S1097-2765(00)80067-2; Mansukhani A, 2000, J CELL BIOL, V149, P1297, DOI 10.1083/jcb.149.6.1297; McCarthy JG, 1990, PLASTIC SURG, P3013; McMahon JA, 1998, GENE DEV, V12, P1438, DOI 10.1101/gad.12.10.1438; Minabe-Saegusa C, 1998, DEV GROWTH DIFFER, V40, P343; Moore R, 2002, DEV BIOL, V243, P99, DOI 10.1006/dbio.2001.0533; Opperman LA, 1997, J BONE MINER RES, V12, P301, DOI 10.1359/jbmr.1997.12.3.301; Paine-Saunders S, 2002, J BIOL CHEM, V277, P2089, DOI 10.1074/jbc.M109151200; Roth DA, 1997, J BONE MINER RES, V12, P311, DOI 10.1359/jbmr.1997.12.3.311; Slavkin HC, 1979, DEV CRANIOFACIAL BIO; THILANDER B, 1995, ACTA ODONTOL SCAND, V53, P144, DOI 10.3109/00016359509005964; WANG EA, 1990, P NATL ACAD SCI USA, V87, P2220, DOI 10.1073/pnas.87.6.2220; Warren SM, 2001, PLAST RECONSTR SURG, V107, P523, DOI 10.1097/00006534-200102000-00034; Wilkie AOM, 1997, HUM MOL GENET, V6, P1647, DOI 10.1093/hmg/6.10.1647; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241; Zimmerman LB, 1996, CELL, V86, P599, DOI 10.1016/S0092-8674(00)80133-6	28	259	272	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 10	2003	422	6932					625	629		10.1038/nature01545	http://dx.doi.org/10.1038/nature01545			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665GN	12687003				2022-12-24	WOS:000182111400045
J	McQuibban, GA; Saurya, S; Freeman, M				McQuibban, GA; Saurya, S; Freeman, M			Mitochondrial membrane remodelling regulated by a conserved rhomboid protease	NATURE			English	Article							CYTOCHROME-C PEROXIDASE; DROSOPHILA EGF RECEPTOR; DOMINANT OPTIC ATROPHY; DYNAMIN-RELATED GTPASE; INTERMEMBRANE SPACE; OUTER-MEMBRANE; YEAST; SEQUENCE; FAMILY; GENE	Rhomboid proteins are intramembrane serine proteases that activate epidermal growth factor receptor (EGFR) signalling in Drosophila(1). Rhomboids are conserved throughout evolution(2-5), and even in eukaryotes their existence in species with no EGFRs implies that they must have additional roles. Here we report that Saccharomyces cerevisiae has two rhomboids, which we have named Rbd1p and Rbd2p. RBD1 deletion results in a respiratory defect; consistent with this, Rbd1p is localized in the inner mitochondrial membrane and mutant cells have disrupted mitochondria. We have identified two substrates of Rbd1p: cytochrome c peroxidase (Ccp1p); and a dynamin-like GTPase (Mgm1p), which is involved in mitochondrial membrane fusion(6-10). Rbd1p mutants are indistinguishable from Mgm1p mutants, indicating that Mgm1p is a key substrate of Rbd1p and explaining the rbd1Delta mitochondrial phenotype. Our data indicate that mitochondrial membrane remodelling is regulated by cleavage of Mgm1p and show that intramembrane proteolysis by rhomboids controls cellular processes other than signalling. In addition, mitochondrial rhomboids are conserved throughout eukaryotes and the mammalian homologue, PARL(11), rescues the yeast mutant, suggesting that these proteins represent a functionally conserved subclass of rhomboid proteases.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	Freeman, M (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.			Freeman, Matthew/0000-0003-0410-5451				Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944; Church C, 1996, J BIOL CHEM, V271, P18499, DOI 10.1074/jbc.271.31.18499; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; DAUM G, 1982, J BIOL CHEM, V257, P3028; Delettre C, 2002, MOL GENET METAB, V75, P97, DOI 10.1006/mgme.2001.3278; Esser K, 2002, J MOL BIOL, V323, P835, DOI 10.1016/S0022-2836(02)01000-8; Ghiglione C, 2002, DEVELOPMENT, V129, P175; Griparic L, 2001, TRAFFIC, V2, P235, DOI 10.1034/j.1600-0854.2001.1r008.x; Guthrie C., 2002, GUIDE YEAST GENETICS; HAHNE K, 1994, CELL, V79, P829, DOI 10.1016/0092-8674(94)90072-8; Hermann GJ, 1998, ANNU REV CELL DEV BI, V14, P265, DOI 10.1146/annurev.cellbio.14.1.265; JONES BA, 1992, GENE DEV, V6, P380, DOI 10.1101/gad.6.3.380; KAPUT J, 1982, J BIOL CHEM, V257, P5054; Klambt C, 2002, CURR BIOL, V12, pR21, DOI 10.1016/S0960-9822(01)00642-X; Koonin EV, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-r19; Lee JR, 2001, CELL, V107, P161, DOI 10.1016/S0092-8674(01)00526-8; Muratsubaki H, 1998, ARCH BIOCHEM BIOPHYS, V352, P175, DOI 10.1006/abbi.1998.0583; Pascall JC, 1998, FEBS LETT, V429, P337, DOI 10.1016/S0014-5793(98)00622-X; Pellegrini L, 2001, J ALZHEIMERS DIS, V3, P181; Satoh M, 2003, BIOCHEM BIOPH RES CO, V300, P482, DOI 10.1016/S0006-291X(02)02874-7; Shepard KA, 1999, J CELL BIOL, V144, P711, DOI 10.1083/jcb.144.4.711; Tsruya R, 2002, GENE DEV, V16, P222, DOI 10.1101/gad.214202; Urban S, 2002, EMBO J, V21, P4277, DOI 10.1093/emboj/cdf434; Urban S, 2002, CURR BIOL, V12, P1507, DOI 10.1016/S0960-9822(02)01092-8; Urban S, 2001, CELL, V107, P173, DOI 10.1016/S0092-8674(01)00525-6; URBAN S, IN PRESS MOL CELL; Wasserman JD, 2000, GENE DEV, V14, P1651; Wong ED, 2003, J CELL BIOL, V160, P303, DOI 10.1083/jcb.200209015; Wong ED, 2000, J CELL BIOL, V151, P341, DOI 10.1083/jcb.151.2.341; Yaffe MP, 1999, NAT CELL BIOL, V1, pE149, DOI 10.1038/14101	30	309	323	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 29	2003	423	6939					537	541		10.1038/nature01633	http://dx.doi.org/10.1038/nature01633			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	683RH	12774122				2022-12-24	WOS:000183162900043
J	Cho, GY; Wu, YT; Ackerman, JL				Cho, GY; Wu, YT; Ackerman, JL			Detection of hydroxyl ions in bone mineral by solid-state NMR spectroscopy	SCIENCE			English	Article							NUCLEAR-MAGNETIC-RESONANCE; CALCIUM PHOSPHATES; HYDROXYAPATITE; TEMPERATURE; CARBONATE; CRYSTALS; PHASES; ENAMEL	Previous measurements of the hydroxyl (OH-) ion content of the calcium phosphate crystals of bone mineral have indicated a substantial depletion or near-absence of OH-, despite its presumed status as a constituent of the hydroxyapatite lattice. Analytical methods for determining bone crystal OH content have depended on procedures or assumptions that may have biased the results, such as chemical pretreatment to eliminate interference from the organic matrix. We demonstrate a two-dimensional solid-state nuclear magnetic resonance (NMR) spectroscopy technique that detects the proton spectrum of bone crystals while suppressing the interfering matrix signals, eliminating the need for specimen pretreatment other than cryogenic grinding. Results on fresh-frozen and ground whole bone of several mammalian species show that the bone crystal OH- is readily detectable; a rough estimate yields an OH- content of human cortical bone of about 20% of the amount expected in stoichiometric hydroxyapatite. This finding sheds light on the biochemical processes underlying normal and abnormal bone mineral metabolism.	Massachusetts Gen Hosp, Dept Radiol, NMR Ctr, Biomat Lab, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Childrens Hosp, Dept Orthopaed Surg, Lab Study Skeletal Disorders & Rehabil, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital	Ackerman, JL (corresponding author), Massachusetts Gen Hosp, Dept Radiol, NMR Ctr, Biomat Lab, Room 2301,149 13th St, Charlestown, MA 02129 USA.		Ackerman, Jerome L./E-2646-2015	Ackerman, Jerome L./0000-0001-5176-7496	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR042258] Funding Source: NIH RePORTER; NCRR NIH HHS [RR03264] Funding Source: Medline; NIAMS NIH HHS [AR42258] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ARENDS J, 1987, J CRYST GROWTH, V84, P515, DOI 10.1016/0022-0248(87)90284-3; AUE WP, 1984, BIOCHEMISTRY-US, V23, P6110, DOI 10.1021/bi00320a032; BERRY EE, 1967, J INORG NUCL CHEM, V29, P317, DOI 10.1016/0022-1902(67)80033-2; BESHAH K, 1990, J SOLID STATE CHEM, V84, P71, DOI 10.1016/0022-4596(90)90185-Z; BILTZ RM, 1971, CALC TISS RES, V7, P259, DOI 10.1007/BF02062614; BLUMENTHAL NC, 1973, CALC TISS RES, V13, P235, DOI 10.1007/BF02015413; Elliott J. C., 1994, STRUCTURE CHEM APATI; Glimcher M. J, 1998, METABOLIC BONE DIS C, P23, DOI [DOI 10.1007/S10641-010-9735-5, 10.1021/cr60164a001, DOI 10.1016/B978-012068700-8/50003-7]; KIM HM, 1995, J BONE MINER RES, V10, P1589; Loong CK, 2000, BONE, V26, P599, DOI 10.1016/S8756-3282(00)00273-8; Ramanathan C, 1999, MAGNET RESON MED, V41, P1214, DOI 10.1002/(SICI)1522-2594(199906)41:6<1214::AID-MRM18>3.0.CO;2-H; REY C, 1995, BONE, V16, P583, DOI 10.1016/8756-3282(95)00101-I; ROTHWELL WP, 1980, J AM CHEM SOC, V102, P2637, DOI 10.1021/ja00528a020; SANTOS RA, 1994, J MAGN RESON SER B, V105, P183, DOI 10.1006/jmrb.1994.1120; Schwarzinger S, 2000, J BIOMOL NMR, V18, P43, DOI 10.1023/A:1008386816521; TERMINE JD, 1973, CALC TISS RES, V13, P73, DOI 10.1007/BF02013723; TOMAZIC BB, 1993, J BIOMED MATER RES, V27, P217, DOI 10.1002/jbm.820270211; VATASSER.GT, 1970, CALC TISS RES, V5, P183, DOI 10.1007/BF02017547; WU Y, IN PRESS CALCIF TISS; WU YT, 1994, J MOL BIOL, V244, P423, DOI 10.1006/jmbi.1994.1740; Wu YT, 2002, J BONE MINER RES, V17, P472, DOI 10.1359/jbmr.2002.17.3.472; YESINOWSKI JP, 1987, J AM CHEM SOC, V109, P6274, DOI 10.1021/ja00255a009	22	234	243	0	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 16	2003	300	5622					1123	1127		10.1126/science.1078470	http://dx.doi.org/10.1126/science.1078470			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678VC	12750514				2022-12-24	WOS:000182886500038
J	Schwarz-Linek, U; Werner, JM; Pickford, AR; Gurusiddappa, S; Kim, JH; Pilka, ES; Briggs, JAG; Gough, TS; Hook, M; Campbell, ID; Potts, JR				Schwarz-Linek, U; Werner, JM; Pickford, AR; Gurusiddappa, S; Kim, JH; Pilka, ES; Briggs, JAG; Gough, TS; Hook, M; Campbell, ID; Potts, JR			Pathogenic bacteria attach to human fibronectin through a tandem beta-zipper	NATURE			English	Article							F1 MODULE PAIR; STAPHYLOCOCCUS-AUREUS; BINDING-PROTEIN; STREPTOCOCCUS-PYOGENES; MEDIATE ADHERENCE; CHEMICAL-SHIFT; NMR; SEQUENCE; DYSGALACTIAE; RESIDUES	Staphylococcus aureus and Streptococcus pyogenes, two important human pathogens, target host fibronectin (Fn) in their adhesion to and invasion of host cells(1,2). Fibronectin-binding proteins (FnBPs), anchored in the bacterial cell wall, have multiple Fn-binding repeats(3) in an unfolded(4,5) region of the protein. The bacterium-binding site in the amino-terminal domain ((1-5)F1) of Fn contains five sequential Fn type 1 (F1) modules. Here we show the structure of a streptococcal (S. dysgalactiae) FnBP peptide (B3)(6,7) in complex with the module pair (1)F1(2)F1. This identifies (1)F1-and (2)F1-binding motifs in B3 that form additional antiparallel beta-strands on sequential F1 modules-the first example of a tandem beta-zipper. Sequence analyses of larger regions of FnBPs from S. pyogenes and S. aureus reveal a repeating pattern of F1-binding motifs that match the pattern of F1 modules in (1-5)F1 of Fn. In the process of Fn-mediated invasion of host cells, therefore, the bacterial proteins seem to exploit the modular structure of Fn by forming extended tandem beta-zippers. This work is a vital step forward in explaining the full mechanism of the integrin-dependent(2,8) FnBP-mediated invasion of host cells.	Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; Texas A&M Univ Syst Hlth Sci Ctr, Inst Biosci & Technol, Ctr Extracellular Matrix Biol, Houston, TX 77030 USA; Univ Oxford, Cent Chem Lab, Oxford Ctr Mol Sci, Oxford OX1 3QH, England	University of Oxford; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Oxford	Potts, JR (corresponding author), Univ Oxford, Dept Biochem, S Parks Rd, Oxford OX1 3QU, England.	jennifer.potts@bioch.ox.ac.uk	Briggs, John/J-3096-2012; Pickford, Andy/AGB-6901-2022; Werner, Joern/E-1148-2013	Schwarz-Linek, Ulrich/0000-0003-0526-223X; Werner, Jorn/0000-0002-4712-1833; Pickford, Andy/0000-0002-7237-0030; Briggs, John/0000-0003-3990-6910				Brunger A.T., 1993, X PLOR VERSION 3 1 S; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DERRICK JP, 1992, NATURE, V359, P752, DOI 10.1038/359752a0; GREENE C, 1995, MOL MICROBIOL, V17, P1143, DOI 10.1111/j.1365-2958.1995.mmi_17061143.x; Hashimoto Y, 2000, J BIOMOL NMR, V17, P203, DOI 10.1023/A:1008341609461; HousePompeo K, 1996, J BIOL CHEM, V271, P1379, DOI 10.1074/jbc.271.3.1379; HUFF S, 1994, J BIOL CHEM, V269, P15563; Ing M, 1997, STAPHYLOCOCCI HUMAN, P331; Jaffe J, 1996, MOL MICROBIOL, V21, P373, DOI 10.1046/j.1365-2958.1996.6331356.x; Joh D, 1998, EUR J BIOCHEM, V258, P897, DOI 10.1046/j.1432-1327.1998.2580897.x; Knodler LA, 2001, NAT REV MOL CELL BIO, V2, P578, DOI 10.1038/35085062; Massey RC, 2001, CELL MICROBIOL, V3, P839, DOI 10.1046/j.1462-5822.2001.00157.x; MCGAVIN MJ, 1993, J BIOL CHEM, V268, P23946; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; Ozeri V, 1998, MOL MICROBIOL, V30, P625, DOI 10.1046/j.1365-2958.1998.01097.x; PATTI JM, 1994, ANNU REV MICROBIOL, V48, P585, DOI 10.1146/annurev.mi.48.100194.003101; Peacock SJ, 1999, MICROBIOL-SGM, V145, P3477, DOI 10.1099/00221287-145-12-3477; Penkett CJ, 2000, BIOCHEMISTRY-US, V39, P2887, DOI 10.1021/bi992267k; Penkett CJ, 1998, BIOCHEMISTRY-US, V37, P17054, DOI 10.1021/bi9814080; Pickford AR, 2001, EMBO J, V20, P1519, DOI 10.1093/emboj/20.7.1519; Potts JR, 1999, BIOCHEMISTRY-US, V38, P8304, DOI 10.1021/bi990202b; Sass HJ, 2000, J BIOMOL NMR, V18, P303, DOI 10.1023/A:1026703605147; Schwarz-Linek U, 2001, FEBS LETT, V497, P137, DOI 10.1016/S0014-5793(01)02418-8; SIGNAS C, 1989, P NATL ACAD SCI USA, V86, P699, DOI 10.1073/pnas.86.2.699; Sinha B, 1999, CELL MICROBIOL, V1, P101, DOI 10.1046/j.1462-5822.1999.00011.x; Talay SR, 2000, CELL MICROBIOL, V2, P521, DOI 10.1046/j.1462-5822.2000.00076.x; TALAY SR, 1994, MOL MICROBIOL, V13, P531, DOI 10.1111/j.1365-2958.1994.tb00448.x; TALAY SR, 1992, INFECT IMMUN, V60, P3837, DOI 10.1128/IAI.60.9.3837-3844.1992; Tjandra N, 1997, NAT STRUCT BIOL, V4, P443, DOI 10.1038/nsb0697-443; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010	30	296	308	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 8	2003	423	6936					177	181		10.1038/nature01589	http://dx.doi.org/10.1038/nature01589			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675MR	12736686				2022-12-24	WOS:000182699600048
J	Leventhal, AG; Wang, YC; Pu, ML; Zhou, YF; Ma, YY				Leventhal, AG; Wang, YC; Pu, ML; Zhou, YF; Ma, YY			GABA and its agonists improved visual cortical function in senescent monkeys	SCIENCE			English	Article							CONTRAST SENSITIVITY; AGE; PERCEPTION; NEURONS; CORTEX	Human cerebral cortical function degrades during old age. Much of this change may result from a degradation of intracortical inhibition during senescence. We used multibarreled microelectrodes to study the effects of electrophoretic application of gamma-aminobutyric acid (GABA), the GABA type a (GABAa) receptor agonist muscimol, and the GABAa receptor antagonist bicuculline, respectively, on the properties of individual V1 cells in old monkeys. Bicuculline exerted a much weaker effect on neuronal responses in old than in young animals, confirming a degradation of GABA-mediated inhibition. On the other hand, the administration of GABA and muscimol resulted in improved visual function. Many treated cells in area V1 of old animals displayed responses typical of young cells. The present results have important implications for the treatment of the sensory, motor, and cognitive declines that accompany old age.	Univ Utah, Sch Med, Dept Neurobiol & Anat, Salt Lake City, UT 84132 USA; Univ Sci & Technol China, Sch Life Sci, Hefei 230027, Anhui, Peoples R China; Chinese Acad Sci, Kunming Inst Zool, Lab Primate Cognit Neurosci, Kunming 650223, Yunnan, Peoples R China	Utah System of Higher Education; University of Utah; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; Kunming Institute of Zoology	Leventhal, AG (corresponding author), Univ Utah, Sch Med, Dept Neurobiol & Anat, Salt Lake City, UT 84132 USA.	audie.leventhal@m.cc.utah.edu			NIA NIH HHS [AG-17922] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG017922] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Caspary DM, 1999, NEUROSCIENCE, V93, P307, DOI 10.1016/S0306-4522(99)00121-9; CASPARY DM, 1995, EXP GERONTOL, V30, P349, DOI 10.1016/0531-5565(94)00052-5; Eysel UT, 1998, NEUROSCIENCE, V84, P25, DOI 10.1016/S0306-4522(97)00378-3; Galarreta M, 2001, SCIENCE, V292, P2295, DOI 10.1126/science.1061395; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; KASAMATSU T, 1982, EXP BRAIN RES, V45, P317, DOI 10.1007/BF01208591; KLINE DW, 1983, J GERONTOL, V38, P211, DOI 10.1093/geronj/38.2.211; KLINE DW, 1991, VISION VISUAL DYSFUN, V16, P150; KLINE DW, 1985, HDB PSYCHOL AGING, P296; Letinic K, 2002, NATURE, V417, P645, DOI 10.1038/nature00779; MATSUMURA M, 1990, NEUROSCI RES, V8, P138, DOI 10.1016/0168-0102(90)90066-N; Ordy J. M., 1991, EFFECTS AGING ENV VI, P1; OWSLEY C, 1987, BRIT J OPHTHALMOL, V71, P791, DOI 10.1136/bjo.71.10.791; OWSLEY C, 1981, INVEST OPHTH VIS SCI, V21, P362; Porciatti V, 1999, VISION RES, V39, P2157, DOI 10.1016/S0042-6989(98)00288-0; Schmolesky MT, 2000, NAT NEUROSCI, V3, P384, DOI 10.1038/73957; SILLITO AM, 1975, J PHYSIOL-LONDON, V250, P287, DOI 10.1113/jphysiol.1975.sp011055; SPEAR PD, 1993, VISION RES, V33, P2589, DOI 10.1016/0042-6989(93)90218-L; Tran DB, 1998, GRAEF ARCH CLIN EXP, V236, P269, DOI 10.1007/s004170050076; WESTON HC, 1948, BRIT J OPHTHALMOL, V32, P645, DOI 10.1136/bjo.32.9.645	20	409	476	2	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 2	2003	300	5620					812	815		10.1126/science.1082874	http://dx.doi.org/10.1126/science.1082874			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673KH	12730605				2022-12-24	WOS:000182579800055
J	Li, RH; Mitra, N; Gratkowski, H; Vilaire, G; Litvinov, R; Nagasami, C; Weisel, JW; Lear, JD; DeGrado, WF; Bennett, JS				Li, RH; Mitra, N; Gratkowski, H; Vilaire, G; Litvinov, R; Nagasami, C; Weisel, JW; Lear, JD; DeGrado, WF; Bennett, JS			Activation of integrin alpha IIb beta 3 by modulation of transmembrane helix associations	SCIENCE			English	Article							IIB-IIIA COMPLEX; INSIDE-OUT ACTIVATION; FIBRINOGEN BINDING; ELECTRON-MICROSCOPY; PLATELETS; MODEL; ALPHA(IIB)BETA(3); REARRANGEMENTS; TRANSDUCTION; PEPTIDES	Transmembrane helices of integrin alpha and beta subunits have been implicated in the regulation of integrin activity. Two mutations, glycine-708 to asparagine-708 (G708N) and methionine-701 to asparagine-701, in the transmembrane helix of the beta3 subunit enabled integrin alphaIIbbeta3 to constitutively bind soluble fibrinogen. Further characterization of the G708N mutant revealed that it induced alphaIIbbeta3 clustering and constitutive phosphorylation of focal adhesion kinase. This mutation also enhanced the tendency of the transmembrane helix to form homotrimers. These results suggest that homomeric associations involving transmembrane domains provide a driving force for integrin activation. They also suggest a structural basis for the coincidence of integrin activation and clustering.	Univ Penn, Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Med, Div Hematol Oncol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	DeGrado, WF (corresponding author), Univ Penn, Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA.		Litvinov, Rustem/E-5291-2011; Li, Renhao/B-1257-2012	Litvinov, Rustem/0000-0003-0643-1496; Li, Renhao/0000-0002-5806-5080	NATIONAL CANCER INSTITUTE [K01CA096706] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL040387, P50HL054500] Funding Source: NIH RePORTER; NCI NIH HHS [K01 CA096706] Funding Source: Medline; NHLBI NIH HHS [HL40387, HL54500] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Adair BD, 2002, P NATL ACAD SCI USA, V99, P14059, DOI 10.1073/pnas.212498199; [Anonymous], UNPUB; Arnaout MA, 2002, CURR OPIN CELL BIOL, V14, P641, DOI 10.1016/S0955-0674(02)00371-X; Basani RB, 2001, J BIOL CHEM, V276, P13975, DOI 10.1074/jbc.M011511200; Beglova N, 2002, NAT STRUCT BIOL, V9, P282, DOI 10.1038/nsb779; BENNETT JS, 1983, P NATL ACAD SCI-BIOL, V80, P2417, DOI 10.1073/pnas.80.9.2417; Bennett JS, 2001, BLOOD, V97, P3093, DOI 10.1182/blood.V97.10.3093; BENNETT JS, 1979, J CLIN INVEST, V64, P1393, DOI 10.1172/JCI109597; Calzada MJ, 2002, J BIOL CHEM, V277, P39899, DOI 10.1074/jbc.M205886200; Choma C, 2000, NAT STRUCT BIOL, V7, P161; FITZGERALD LA, 1985, J BIOL CHEM, V260, P1366; GARTNER TK, 1985, J BIOL CHEM, V260, P1891; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Gottschalk KE, 2002, PROTEIN SCI, V11, P1800, DOI 10.1110/ps.4120102; Gratkowski H, 2001, P NATL ACAD SCI USA, V98, P880, DOI 10.1073/pnas.98.3.880; Hantgan RR, 2003, J BIOL CHEM, V278, P3417, DOI 10.1074/jbc.M208869200; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Li RH, 2001, P NATL ACAD SCI USA, V98, P12462, DOI 10.1073/pnas.221463098; Liddington RC, 2002, J CELL BIOL, V158, P833, DOI 10.1083/jcb.200206011; Litvinov RI, 2002, P NATL ACAD SCI USA, V99, P7426, DOI 10.1073/pnas.112194999; LUKASHEV ME, 1994, J BIOL CHEM, V269, P18311; NERMUT MV, 1988, EMBO J, V7, P4093, DOI 10.1002/j.1460-2075.1988.tb03303.x; SHATTIL SJ, 1985, BLOOD, V66, P92; SHATTIL SJ, 1985, J BIOL CHEM, V260, P1107; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Takagi J, 2001, NAT STRUCT BIOL, V8, P412, DOI 10.1038/87569; Vinogradova O, 2002, CELL, V110, P587, DOI 10.1016/S0092-8674(02)00906-6; WEISEL JW, 1992, J BIOL CHEM, V267, P16637; Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535; Zhou FX, 2001, P NATL ACAD SCI USA, V98, P2250, DOI 10.1073/pnas.041593698	30	243	251	2	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 2	2003	300	5620					795	798		10.1126/science.1079441	http://dx.doi.org/10.1126/science.1079441			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673KH	12730600				2022-12-24	WOS:000182579800050
J	Spruck, CH; de Miguel, MP; Smith, APL; Ryan, A; Stein, P; Schultz, RM; Lincoln, AJ; Donovan, PJ; Reed, SI				Spruck, CH; de Miguel, MP; Smith, APL; Ryan, A; Stein, P; Schultz, RM; Lincoln, AJ; Donovan, PJ; Reed, SI			Requirement of Cks2 for the first metaphase/anaphase transition of mammalian meiosis	SCIENCE			English	Article							CELL-CYCLE; PROTEIN; ARREST; DISRUPTION; XE-P9; MLH1	We generated mice lacking Cks2, one of two mammalian homologs of the yeast Cdk1-binding proteins, Suc1 and Cks1, and found them to be viable but sterile in both sexes. Sterility is due to failure of both male and female germ cells to progress past the first meiotic metaphase. The chromosomal events up through the end of prophase I are normal in both CKS2(-/-) males and females, suggesting that the phenotype is due directly to failure to enter anaphase and not a consequence of a checkpoint-mediated metaphase I arrest.	Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA 19107 USA; Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA; Univ Penn, Dept Biol, Philadelphia, PA 19104 USA	Scripps Research Institute; Jefferson University; University of California System; University of California San Diego; University of Pennsylvania	Reed, SI (corresponding author), Scripps Res Inst, Dept Mol Biol, MB-7,10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	sreed@scripps.edu	Stein, Paula/ABE-9388-2020	Stein, Paula/0000-0002-2040-4593; Smith, Adrian/0000-0001-9732-1422	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD022681] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD022681, R01HD038252] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA074224] Funding Source: NIH RePORTER; NCI NIH HHS [CA74224] Funding Source: Medline; NICHD NIH HHS [HD22681, HD38252] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Baker SM, 1996, NAT GENET, V13, P336, DOI 10.1038/ng0796-336; Barlow C, 1998, DEVELOPMENT, V125, P4007; Dix DJ, 1996, P NATL ACAD SCI USA, V93, P3264, DOI 10.1073/pnas.93.8.3264; Ganoth D, 2001, NAT CELL BIOL, V3, P321, DOI 10.1038/35060126; Hirao Y, 1997, DEVELOPMENT, V124, P5107; Lee JY, 2001, ANNU REV CELL DEV BI, V17, P753, DOI 10.1146/annurev.cellbio.17.1.753; Lipkin SM, 2002, NAT GENET, V31, P385, DOI 10.1038/ng931; MORENO S, 1989, CELL, V58, P361, DOI 10.1016/0092-8674(89)90850-7; Nasmyth K, 2002, SCIENCE, V297, P559, DOI 10.1126/science.1074757; Orr-Weaver TL, 1999, SCIENCE, V285, P344; Patra D, 1996, GENE DEV, V10, P1503, DOI 10.1101/gad.10.12.1503; Patra D, 1998, GENE DEV, V12, P2549, DOI 10.1101/gad.12.16.2549; Pittman DL, 1998, MOL CELL, V1, P697, DOI 10.1016/S1097-2765(00)80069-6; RICHARDSON HE, 1990, GENE DEV, V4, P1332, DOI 10.1101/gad.4.8.1332; Spruck C, 2001, MOL CELL, V7, P639, DOI 10.1016/S1097-2765(01)00210-6; TANG Y, 1993, GENE DEV, V7, P822, DOI 10.1101/gad.7.5.822; Watson ML, 1998, P NATL ACAD SCI USA, V95, P14361, DOI 10.1073/pnas.95.24.14361; Woods LM, 1999, J CELL BIOL, V145, P1395, DOI 10.1083/jcb.145.7.1395	18	100	102	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 25	2003	300	5619					647	650		10.1126/science.1084149	http://dx.doi.org/10.1126/science.1084149			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671FB	12714746				2022-12-24	WOS:000182453700044
J	Schneider, R; Ferrara, A; Salvaterra, R; Omukai, K; Bromm, V				Schneider, R; Ferrara, A; Salvaterra, R; Omukai, K; Bromm, V			Low-mass relics of early star formation	NATURE			English	Article							NUCLEOSYNTHESIS	The earliest stars to form in the Universe were the first sources of light, heat and metals after the Big Bang. The products of their evolution will have had a profound impact on subsequent generations of stars. Recent studies(1-7) of primordial star formation have shown that, in the absence of metals (elements heavier than helium), the formation of stars with masses 100 times that of the Sun would have been strongly favoured, and that low-mass stars could not have formed before a minimum level of metal enrichment had been reached. The value of this minimum level is very uncertain, but is likely to be between 10(-6) and 10(-4) that of the Sun(6,8). Here we show that the recent discovery(9) of the most iron-poor star known indicates the presence of dust in extremely low-metallicity gas, and that this dust is crucial for the formation of lower-mass second-generation stars that could survive until today. The dust provides a pathway for cooling the gas that leads to fragmentation of the precursor molecular cloud into smaller clumps, which become the lower-mass stars.	Osserv Astrofis Arcetri, I-50125 Florence, Italy; Enrico Fermi Ctr, I-00184 Rome, Italy; Scuola Int Super Studi Avanzati, SSISA, I-34100 Trieste, Italy; Natl Astron Observ, Div Theoret Astrophys, Tokyo 1818588, Japan; Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA	Istituto Nazionale Astrofisica (INAF); International School for Advanced Studies (SISSA); National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ); Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution	Schneider, R (corresponding author), Osserv Astrofis Arcetri, Largo Enrico Fermi 5, I-50125 Florence, Italy.	raffa@arcetri.astro.it	Schneider, Raffaella/E-4216-2017; Ferrara, Andrea/A-4357-2011	Schneider, Raffaella/0000-0001-9317-2888; Salvaterra, Ruben/0000-0002-9393-8078				Abel T, 2002, SCIENCE, V295, P93, DOI 10.1126/science.1063991; Bromm V, 2002, ASTROPHYS J, V564, P23, DOI 10.1086/323947; Bromm V, 2001, MON NOT R ASTRON SOC, V328, P969, DOI 10.1046/j.1365-8711.2001.04915.x; Christlieb N, 2002, NATURE, V419, P904, DOI 10.1038/nature01142; Heger A, 2002, ASTROPHYS J, V567, P532, DOI 10.1086/338487; Mackey J, 2003, ASTROPHYS J, V586, P1, DOI 10.1086/367613; Nakamura F, 2002, ASTROPHYS J, V569, P549, DOI 10.1086/339392; Omukai K, 1998, ASTROPHYS J, V508, P141, DOI 10.1086/306395; OMUKAI K, UNPUB ASTROPHYS J; Qian YZ, 2002, ASTROPHYS J, V567, P515, DOI 10.1086/338277; Ripamonti E, 2002, MON NOT R ASTRON SOC, V334, P401, DOI 10.1046/j.1365-8711.2002.05516.x; Schneider R, 2002, ASTROPHYS J, V571, P30, DOI 10.1086/339917; Siess L, 2002, ASTROPHYS J, V570, P329, DOI 10.1086/339733; Truran JW, 2002, PUBL ASTRON SOC PAC, V114, P1293, DOI 10.1086/344585	14	203	204	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 24	2003	422	6934					869	871		10.1038/nature01579	http://dx.doi.org/10.1038/nature01579			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670WR	12712198	Green Submitted			2022-12-24	WOS:000182432600047
J	Peiris, JSM; Lai, ST; Poon, LLM; Guan, Y; Yam, LYC; Lim, W; Nicholls, J; Yee, WKS; Yan, WW; Cheung, MT; Cheng, VCC; Chan, KH; Tsang, DNC; Yung, RWH; Ng, TK; Yuen, KY				Peiris, JSM; Lai, ST; Poon, LLM; Guan, Y; Yam, LYC; Lim, W; Nicholls, J; Yee, WKS; Yan, WW; Cheung, MT; Cheng, VCC; Chan, KH; Tsang, DNC; Yung, RWH; Ng, TK; Yuen, KY		SARS Study Grp	Coronavirus as a possible cause of severe acute respiratory syndrome	LANCET			English	Article							HUMAN-DISEASE; VIRUS; INFECTIONS; DIAGNOSIS	Background An outbreak of severe acute respiratory syndrome (SARS) has been reported in Hong Kong. We investigated the viral cause and clinical presentation among 50 patients. Methods We analysed case notes and microbiological findings for 50 patients with SARS, representing more than five separate epidemiologically linked transmission clusters. We defined the clinical presentation and risk factors associated with severe disease and investigated the causal agents by chest radiography and laboratory testing of nasopharyngeal aspirates and sera samples. We compared the laboratory findings with those submitted for microbiological investigation of other diseases from patients whose identity was masked. Findings Patients, age ranged from 23 to 74 years. Fever, chills, myalgia, and cough were the most frequent complaints. When compared with chest radiographic changes, respiratory symptoms and auscultatory findings were disproportionally mild. Patients who were household contacts of other infected people and had older age, lymphopenia, and liver dysfunction were associated with severe disease. A virus belonging to the family Coronaviridae was isolated from two patients. By use of serological and reverse-transcriptase PCR specific for this virus, 45 of 50 patients with SARS, but no controls, had evidence of infection with this virus. Interpretation A coronavirus was isolated from patients with SARS that might be the primary agent associated with this disease. Serological and molecular tests specific for the virus permitted a definitive laboratory diagnosis to be made and allowed further investigation to define whether other cofactors play a part in disease progression.	Univ Hong Kong, Queen Mary Hosp, Dept Pathol & Microbiol, Hong Kong, Hong Kong, Peoples R China; Princess Margaret Hosp, Dept Med Intens Care & Pathol, Hong Kong, Hong Kong, Peoples R China; Dept Hlth, Govt Virus Unit, Hong Kong, Hong Kong, Peoples R China; Pamela Youde Nethersole Eastern Hosp, Dept Pathol & Med, Hong Kong, Hong Kong, Peoples R China; Kwong Wah Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China; Queen Elizabeth Hosp, Dept Pathol, Kowloon, Hong Kong, Peoples R China	University of Hong Kong; Pamela Youde Nethersole Eastern Hospital; Kwong Wah Hospital	Peiris, JSM (corresponding author), Univ Hong Kong, Queen Mary Hosp, Dept Microbiol, Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China.		Poon, Leo Lit Man/C-4382-2009; Yuen, Kwok Yung/C-4465-2009; Chan, Kwok Hung/ABD-5399-2021; Poon, Leo/AAP-6887-2020; Peiris, Joseph Sriyal Malik/C-4380-2009; Nicholls, John Malcolm/C-4375-2009	Poon, Leo Lit Man/0000-0002-9101-7953; CHENG, Vincent Chi-Chung/0000-0003-1765-7706; Yuen, Kwok-yung/0000-0002-2083-1552; Peiris, Joseph Sriyal Malik/0000-0001-8217-5995; Nicholls, John Malcolm/0000-0001-7217-7444; Guan, Yi/0000-0001-6057-9243	PHS HHS [A195357] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		CAUL EO, 1977, ARCH VIROL, V54, P107, DOI 10.1007/BF01314383; Chan KH, 2002, J CLIN MICROBIOL, V40, P1675, DOI 10.1128/JCM.40.5.1675-1680.2002; Cheung CY, 2002, LANCET, V360, P1831, DOI 10.1016/S0140-6736(02)11772-7; El-Sahly HM, 2000, CLIN INFECT DIS, V31, P96, DOI 10.1086/313937; FOTZ RJ, 1999, CHEST, V115, P901; Fouchier RAM, 2000, J CLIN MICROBIOL, V38, P4096, DOI 10.1128/JCM.38.11.4096-4101.2000; Knipe D, 2001, FIELDS VIROLOGY, P1187; McIntosh K., 1974, Current Topics in Microbiology and Immunology, V63, P85; MCINTOSH K, 1970, AM J EPIDEMIOL, V91, P585, DOI 10.1093/oxfordjournals.aje.a121171; TALBOT PJ, IN PRESS ADV EXP MED; WENZEL RP, 1974, AM REV RESPIR DIS, V109, P621; *WHO, 2003, WKLY EPIDEMIOL REC, V78, P86; *WHO, 2003, WKLY EPIDEMIOL REC, V78, P81; Wiedbrauk DL, 1993, MANUAL CLIN VIROLOGY; Yuen KY, 1998, LANCET, V351, P467, DOI 10.1016/S0140-6736(98)01182-9	15	2011	2316	4	363	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 19	2003	361	9366					1319	1325		10.1016/S0140-6736(03)13077-2	http://dx.doi.org/10.1016/S0140-6736(03)13077-2			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	669HP	12711465	Bronze, Green Published			2022-12-24	WOS:000182346100007
J	Walker, PR; Worobey, M; Rambaut, A; Holmes, EC; Pybus, OG				Walker, PR; Worobey, M; Rambaut, A; Holmes, EC; Pybus, OG			Sexual transmission of HIV in Africa - Other routes of infection are not the dominant contributor to the African epidemic.	NATURE			English	Article							HEPATITIS-C VIRUS		Univ Oxford, Dept Zool, Oxford OX1 3PS, England	University of Oxford	Walker, PR (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.		Holmes, Edward/Y-2789-2019; Pybus, Oliver G/B-2640-2012; Holmes, Edward/GVR-9499-2022; Rambaut, Andrew/B-2481-2009	Holmes, Edward/0000-0001-9596-3552; Pybus, Oliver G/0000-0002-8797-2667; Rambaut, Andrew/0000-0003-4337-3707; Walker, Polly/0000-0003-1969-0059				Gisselquist D, 2003, INT J STD AIDS, V14, P162, DOI 10.1258/095646203762869160; Goldmann DA, 2002, J ALLERGY CLIN IMMUN, V110, pS21, DOI 10.1067/mai.2002.125337; Pybus OG, 2001, SCIENCE, V292, P2323, DOI 10.1126/science.1058321; Smith DB, 1997, J GEN VIROL, V78, P321, DOI 10.1099/0022-1317-78-2-321; *UNAIDS, 2002, REP GLOB HIV AIDS EP	5	40	42	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 17	2003	422	6933					679	679		10.1038/422679a	http://dx.doi.org/10.1038/422679a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668CG	12700750	Bronze			2022-12-24	WOS:000182272300029
J	van der Wal, CH; Eisaman, MD; Andre, A; Walsworth, RL; Phillips, DF; Zibrov, AS; Lukin, MD				van der Wal, CH; Eisaman, MD; Andre, A; Walsworth, RL; Phillips, DF; Zibrov, AS; Lukin, MD			Atomic memory for correlated photon states	SCIENCE			English	Article							ELECTROMAGNETICALLY INDUCED TRANSPARENCY; QUANTUM-NOISE-REDUCTION; SINGLE PHOTONS; LIGHT; ENSEMBLES; COMMUNICATION; ENTANGLEMENT; GENERATION; COHERENCE; STORAGE	We experimentally demonstrate emission of two quantum-mechanically correlated light pulses with a time delay that is coherently controlled via temporal storage of photonic states in an ensemble of rubidium atoms. The experiment is based on Raman scattering, which produces correlated pairs of spin-flipped atoms and photons, followed by coherent conversion of the atomic states into a different photon beam after a controllable delay. This resonant nonlinear optical process is a promising technique for potential applications in quantum communication.	Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; PN Lebedev Phys Inst, Moscow 117924, Russia	Harvard University; Russian Academy of Sciences; Russian Academy of Science Lebedev Physical Institute	Lukin, MD (corresponding author), Harvard Univ, Dept Phys, Cambridge, MA 02138 USA.	lukin@physics.harvard.edu	Eisaman, Matthew/E-8006-2011; Zibrov, Alexander S/G-7419-2014; van der Wal, Caspar H./D-9206-2013	Eisaman, Matthew/0000-0002-3814-6430; van der Wal, Caspar H./0000-0002-9843-3220				AYTUR O, 1990, PHYS REV LETT, V65, P1551, DOI 10.1103/PhysRevLett.65.1551; BOLLER KJ, 1991, PHYS REV LETT, V66, P2593, DOI 10.1103/PhysRevLett.66.2593; Briegel HJ, 1998, PHYS REV LETT, V81, P5932, DOI 10.1103/PhysRevLett.81.5932; Cirac JI, 1997, PHYS REV LETT, V78, P3221, DOI 10.1103/PhysRevLett.78.3221; Duan LM, 2001, NATURE, V414, P413, DOI 10.1038/35106500; FLEISCHHAUER M, 1992, PHYS REV A, V46, P5856, DOI 10.1103/PhysRevA.46.5856; Fleischhauer M, 2000, PHYS REV LETT, V84, P5094, DOI 10.1103/PhysRevLett.84.5094; GHERI KM, 1994, PHYS REV A, V50, P1871, DOI 10.1103/PhysRevA.50.1871; Hald J, 1999, PHYS REV LETT, V83, P1319, DOI 10.1103/PhysRevLett.83.1319; HARRIS SE, 1967, PHYS REV LETT, V18, P732, DOI 10.1103/PhysRevLett.18.732; Harris SE, 1997, PHYS TODAY, V50, P36, DOI 10.1063/1.881806; HARRIS SE, 1990, PHYS REV LETT, V64, P1107, DOI 10.1103/PhysRevLett.64.1107; Hau LV, 1999, NATURE, V397, P594, DOI 10.1038/17561; HEIDMANN A, 1987, PHYS REV LETT, V59, P2555, DOI 10.1103/PhysRevLett.59.2555; HEMMER PR, 1995, OPT LETT, V20, P982, DOI 10.1364/OL.20.000982; HONG CK, 1987, PHYS REV LETT, V59, P2044, DOI 10.1103/PhysRevLett.59.2044; Hood CJ, 2000, SCIENCE, V287, P1447, DOI 10.1126/science.287.5457.1447; Imamoglu A, 1998, PHYS REV LETT, V81, P2836, DOI 10.1103/PhysRevLett.81.2836; Imamoglu A, 1997, PHYS REV LETT, V79, P1467, DOI 10.1103/PhysRevLett.79.1467; Julsgaard B, 2001, NATURE, V413, P400, DOI 10.1038/35096524; Kash MM, 1999, PHYS REV LETT, V82, P5229, DOI 10.1103/PhysRevLett.82.5229; Kuzmich A, 2000, PHYS REV LETT, V85, P1594, DOI 10.1103/PhysRevLett.85.1594; Kuzmich A, 2003, NATURE, V423, P731, DOI 10.1038/nature01714; Kuzmich A, 1997, PHYS REV LETT, V79, P4782, DOI 10.1103/PhysRevLett.79.4782; Liu C, 2001, NATURE, V409, P490, DOI 10.1038/35054017; Lukin MD, 2000, ADV ATOM MOL OPT PHY, V42, P347, DOI 10.1016/S1049-250X(08)60190-1; Lukin MD, 1999, PHYS REV LETT, V82, P1847, DOI 10.1103/PhysRevLett.82.1847; Lukin MD, 2003, REV MOD PHYS, V75, P457, DOI 10.1103/RevModPhys.75.457; Lukin MD, 2000, PHYS REV LETT, V84, P4232, DOI 10.1103/PhysRevLett.84.4232; Phillips DF, 2001, PHYS REV LETT, V86, P783, DOI 10.1103/PhysRevLett.86.783; Pinkse PWH, 2000, NATURE, V404, P365, DOI 10.1038/35006006; RAYMER MG, 1990, PROG OPTICS, V28, P181, DOI 10.1016/S0079-6638(08)70290-7; Scully M. O., 1999, QUANTUM OPT; SMITHEY DT, 1992, PHYS REV LETT, V69, P2650, DOI 10.1103/PhysRevLett.69.2650; VANDERWAL CH, IN PRESS FLUCTUATION; Zibrov AS, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.103601; [No title captured]	37	397	397	4	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 11	2003	301	5630					196	200		10.1126/science.1085946	http://dx.doi.org/10.1126/science.1085946			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	699KN	12764202				2022-12-24	WOS:000184056200037
J	Loayza, D; de Lange, T				Loayza, D; de Lange, T			POT1 as a terminal transducer of TRF1 telomere length control	NATURE			English	Article							MAMMALIAN TELOMERES; HUMAN-CELLS; PROTEIN; CANCER; END; CHROMOSOMES; PROTECTION; TANKYRASE; BINDING; YEAST	Human telomere maintenance is essential for the protection of chromosome ends, and changes in telomere length have been implicated in ageing and cancer(1-4). Human telomere length is regulated by the TTAGGG-repeat-binding protein TRF1 and its interacting partners tankyrase 1, TIN2 and PINX1 ( refs 5-9). As the TRF1 complex binds to the duplex DNA of the telomere, it is unclear how it can affect telomerase, which acts on the single-stranded 30 telomeric overhang. Here we show that the TRF1 complex interacts with a single-stranded telomeric DNA-binding protein - protection of telomeres 1 (POT1) - and that human POT1 controls telomerase-mediated telomere elongation. The presence of POT1 on telomeres was diminished when the amount of single-stranded DNA was reduced. Furthermore, POT1 binding was regulated by the TRF1 complex in response to telomere length. A mutant form of POT1 lacking the DNA-binding domain abrogated TRF1-mediated control of telomere length, and induced rapid and extensive telomere elongation. We propose that the interaction between the TRF1 complex and POT1 affects the loading of POT1 on the single-stranded telomeric DNA, thus transmitting information about telomere length to the telomere terminus, where telomerase is regulated.	Rockefeller Univ, Cell Biol & Genet Lab, New York, NY 10021 USA	Rockefeller University	de Lange, T (corresponding author), Rockefeller Univ, Cell Biol & Genet Lab, 1230 York Ave, New York, NY 10021 USA.		de Lange, Titia/B-8263-2011	de Lange, Titia/0000-0002-9267-367X				Ancelin K, 2002, MOL CELL BIOL, V22, P3474, DOI 10.1128/MCB.22.10.3474-3487.2002; BARNETT MA, 1993, NUCLEIC ACIDS RES, V21, P27, DOI 10.1093/nar/21.1.27; Baumann P, 2002, MOL CELL BIOL, V22, P8079, DOI 10.1128/MCB.22.22.8079-8087.2002; Baumann P, 2001, SCIENCE, V292, P1171, DOI 10.1126/science.1060036; Blackburn EH, 2000, NATURE, V408, P53, DOI 10.1038/35040500; Cook BD, 2002, MOL CELL BIOL, V22, P332, DOI 10.1128/MCB.22.1.332-342.2002; de Lange T, 2001, SCIENCE, V292, P1075; de Lange T, 2002, ONCOGENE, V21, P532, DOI 10.1038/sj.onc.1205080; DELANGE T, 1990, MOL CELL BIOL, V10, P518, DOI 10.1128/MCB.10.2.518; Evans SK, 2000, J CELL SCI, V113, P3357; Granger MP, 2002, CRIT REV ONCOL HEMAT, V41, P29, DOI 10.1016/S1040-8428(01)00188-3; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; HANISH JP, 1994, P NATL ACAD SCI USA, V91, P8861, DOI 10.1073/pnas.91.19.8861; Karlseder J, 2002, SCIENCE, V295, P2446, DOI 10.1126/science.1069523; Kim SH, 1999, NAT GENET, V23, P405, DOI 10.1038/70508; Lei M, 2002, BIOCHEMISTRY-US, V41, P14560, DOI 10.1021/bi026674z; Li BB, 2000, CELL, V101, P471, DOI 10.1016/S0092-8674(00)80858-2; Marcand S, 1997, SCIENCE, V275, P986, DOI 10.1126/science.275.5302.986; Maser RS, 2002, SCIENCE, V297, P565, DOI 10.1126/science.297.5581.565; Mitton-Fry RM, 2002, SCIENCE, V296, P145, DOI 10.1126/science.1068799; Smith S, 2000, CURR BIOL, V10, P1299, DOI 10.1016/S0960-9822(00)00752-1; Smith S, 1998, SCIENCE, V282, P1484, DOI 10.1126/science.282.5393.1484; Smogorzewska A, 2000, MOL CELL BIOL, V20, P1659, DOI 10.1128/MCB.20.5.1659-1668.2000; Sprung CN, 1999, EXP CELL RES, V247, P29, DOI 10.1006/excr.1998.4293; Sprung CN, 1999, P NATL ACAD SCI USA, V96, P6781, DOI 10.1073/pnas.96.12.6781; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; vanSteensel B, 1997, NATURE, V385, P740, DOI 10.1038/385740a0; Zhou XZ, 2001, CELL, V107, P347, DOI 10.1016/S0092-8674(01)00538-4; Zhu XD, 2000, NAT GENET, V25, P347, DOI 10.1038/77139	29	523	560	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 26	2003	423	6943					1013	1018		10.1038/nature01688	http://dx.doi.org/10.1038/nature01688			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694BL	12768206				2022-12-24	WOS:000183753900056
J	Durbin, DR; Elliott, MR; Winston, FK				Durbin, DR; Elliott, MR; Winston, FK			Belt-positioning booster seats and reduction in risk of injury among children in vehicle crashes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RESTRAINT; SAMPLE	Context Although more than a dozen states have ratified laws that require booster seats for children older than 4 years, most states continue to have child restraint laws that only cover children through age 4 years. Lack of booster seat effectiveness data may be a barrier to passage of stronger child restraint laws. Objectives To quantify the association of belt-positioning booster seats compared with seat belts alone and risk of injury among 4- to 7-year-old children and to assess patterns of injury among children in booster seats vs seat belts. Design, Setting, and Population Cross-sectional study of children aged 4 to 7 years in crashes of insured vehicles in 15 states, with data collected via insurance claims records and a telephone survey. A probability sample of 3616 crashes involving 4243 children, weighted to represent 56593 children in 48257 crashes was collected between December 1, 1998, and May 31, 2002. Main Outcome Measure Parent report of clinically significant injuries. Results Injuries occurred among 1.81% of all 4- to 7-year-olds, including 1.95% of those in seat belts and 0.77% of those in belt-positioning booster seats. The odds of injury, adjusting for child, driver, crash, and vehicle characteristics, were 59% lower for children aged 4 to 7 years in belt-positioning boosters than in seat belts (odds ratio, 0.41; 95% confidence interval, 0.20-0.86). Children in belt-positioning booster seats had no injuries to the abdomen, neck/spine/back, or lower extremities, while children in seat belts alone had injuries to all body regions. Conclusion Belt-positioning booster seats were associated with added safety benefits compared with seat belts to children through age 7 years, including reduction of injuries classically associated with improper seat belt fit in children.	Childrens Hosp Philadelphia, Dept Pediat, Div Emergency Med, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine	Durbin, DR (corresponding author), Childrens Hosp Philadelphia, Dept Pediat, Div Emergency Med, 34th St & Civ Ctr Blvd, Philadelphia, PA 19104 USA.		Durbin, Dennis/AAD-7829-2022					*ADV HIGHW AUT SAF, STAT BOOST SEAT LAW; AGRAN PF, 1987, J TRAUMA, V27, P58, DOI 10.1097/00005373-198701000-00011; *AM AC PED, SEL US MOST APPR CAR; Arbogast KB, 2002, J TRAUMA, V52, P693, DOI 10.1097/00005373-200204000-00014; Association for the Advancement of Automotive Medicine, 1990, ABBR INJ SCAL; Braver E R, 1998, Inj Prev, V4, P181; Davidson A.C., 1997, BOOTSTRAP METHODS TH; Durbin DR, 2001, PEDIATR EMERG CARE, V17, P474, DOI 10.1097/00006565-200112000-00021; Durbin DR, 1999, ARCH PEDIAT ADOL MED, V153, P404; Durbin DR, 2001, ACCIDENT ANAL PREV, V33, P407, DOI 10.1016/S0001-4575(00)00054-3; Durbin DR, 2001, PEDIATRICS, V108, part. no., DOI 10.1542/peds.108.6.e109; GARRETT J W, 1962, J Trauma, V2, P220, DOI 10.1097/00005373-196205000-00002; KLINICH K, 1994, STUDY OLDER CHILD RE; KORN EL, 1995, AM STAT, V49, P291, DOI 10.2307/2684203; KULOWSKI J, 1956, ARCH SURG-CHICAGO, V73, P970, DOI 10.1001/archsurg.1956.01280060070015; Miller Ted, 2002, Annu Proc Assoc Adv Automot Med, V46, P249; *NAT HIGHW TRAFF S, CHILD PASS SAF; National Center for Health Statistics. Centers for Disease Control and Prevention (CDC), CLIN GROWTH CHARTS; Simpson EM, 2002, PEDIATRICS, V110, P729, DOI 10.1542/peds.110.4.729; Webber K., 2000, UMTRI RES REV, V31, P1; WILLIAMS AF, 1977, ACCIDENT ANAL PREV, V9, P69, DOI 10.1016/0001-4575(77)90007-0; Winston FK, 2000, PEDIATRICS, V105, P1179, DOI 10.1542/peds.105.6.1179; WINSTON FK, 2000, DTNH2298C05142 NAT H	23	228	236	0	18	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 4	2003	289	21					2835	2840		10.1001/jama.289.21.2835	http://dx.doi.org/10.1001/jama.289.21.2835			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	684KH	12783914				2022-12-24	WOS:000183205500032
J	Abbott, A				Abbott, A			Anthropologists cast doubt on human DNA evidence	NATURE			English	News Item																			0	16	17	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 29	2003	423	6939					468	468		10.1038/423468b	http://dx.doi.org/10.1038/423468b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	683RH	12774081	Bronze			2022-12-24	WOS:000183162900006
J	Veaute, X; Jeusset, J; Soustelle, C; Kowalczykowski, SC; Le Cam, E; Fabre, F				Veaute, X; Jeusset, J; Soustelle, C; Kowalczykowski, SC; Le Cam, E; Fabre, F			The Srs2 helicase prevents recombination by disrupting Rad51 nucleoprotein filaments	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; DNA HELICASE; HOMOLOGOUS RECOMBINATION; YEAST RAD51; MUTATIONS; REPAIR; GENE; SEQUENCE; MUTANTS; PROTEIN	Homologous recombination is a ubiquitous process with key functions in meiotic and vegetative cells for the repair of DNA breaks. It is initiated by the formation of single-stranded DNA on which recombination proteins bind to form a nucleoprotein filament that is active in searching for homology, in the formation of joint molecules and in the exchange of DNA strands(1). This process contributes to genome stability but it is also potentially dangerous to cells if intermediates are formed that cannot be processed normally and thus are toxic or generate genomic rearrangements. Cells must therefore have developed strategies to survey recombination and to prevent the occurrence of such deleterious events. In Saccharomyces cerevisiae, genetic data have shown that the Srs2 helicase negatively modulates recombination(2,3), and later experiments suggested that it reverses intermediate recombination structures(4-7). Here we show that DNA strand exchange mediated in vitro by Rad51 is inhibited by Srs2, and that Srs2 disrupts Rad51 filaments formed on single-stranded DNA. These data provide an explanation for the antirecombinogenic role of Srs2 in vivo and highlight a previously unknown mechanism for recombination control.	CNRS, CEA, DSV,Dept Radiobiol & Radiopathol, UMR 217, F-92265 Fontenay Aux Roses, France; Inst Gustave Roussy, IGR,UPS, CNRS, UMR 81126, F-94805 Villejuif, France; Univ Calif Davis, Ctr Genet & Dev, Sect Microbiol & Mol & Cellular Biol, Davis, CA 95616 USA	CEA; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); UNICANCER; Gustave Roussy; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of California System; University of California Davis	Veaute, X (corresponding author), CNRS, CEA, DSV,Dept Radiobiol & Radiopathol, UMR 217, BP6, F-92265 Fontenay Aux Roses, France.	xavier.veaute@cea.fr; francis.fabre@cea.fr		Le cam, Eric/0000-0002-6832-6117				ABOUSSEKHRA A, 1989, NUCLEIC ACIDS RES, V17, P7211, DOI 10.1093/nar/17.18.7211; ABOUSSEKHRA A, 1992, MOL CELL BIOL, V12, P3224, DOI 10.1128/MCB.12.7.3224; AGUILERA A, 1988, GENETICS, V119, P779; Beloin C, 2003, J BIOL CHEM, V278, P5333, DOI 10.1074/jbc.M207489200; Chanet R, 1996, MOL CELL BIOL, V16, P4782; Fabre F, 2002, P NATL ACAD SCI USA, V99, P16887, DOI 10.1073/pnas.252652399; Gangloff S, 2000, NAT GENET, V25, P192, DOI 10.1038/76055; HEUDE M, 1995, MOL GEN GENET, V248, P59, DOI 10.1007/BF02456614; IGGO RD, 1989, EMBO J, V8, P1827, DOI 10.1002/j.1460-2075.1989.tb03577.x; KAYTOR MD, 1995, GENETICS, V140, P1441; Klein H, 2001, GENETICS, V157, P557; Krejci L, 2003, NATURE, V423, P305, DOI 10.1038/nature01577; LOVETT ST, 1987, GENETICS, V116, P547; MILNE GT, 1995, GENETICS, V139, P1189; PALLADINO F, 1992, GENETICS, V132, P23; Petukhova G, 1998, NATURE, V393, P91, DOI 10.1038/30037; RONG L, 1993, J BIOL CHEM, V268, P1252; Saintigny Y, 2002, MOL CELL BIOL, V22, P6971, DOI 10.1128/MCB.22.20.6971-6978.2002; SCHILD D, 1995, GENETICS, V140, P115; Singleton MR, 2002, J BACTERIOL, V184, P1819, DOI 10.1128/JB.184.7.1819-1826.2002; Sung P, 2000, MUTAT RES-FUND MOL M, V451, P257, DOI 10.1016/S0027-5107(00)00054-3; van Brabant AJ, 2000, ANNU REV GENOM HUM G, V1, P409, DOI 10.1146/annurev.genom.1.1.409; Van Komen S, 2000, MOL CELL, V6, P563, DOI 10.1016/S1097-2765(00)00055-1; Vaze MB, 2002, MOL CELL, V10, P373, DOI 10.1016/S1097-2765(02)00593-2	24	470	474	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 15	2003	423	6937					309	312		10.1038/nature01585	http://dx.doi.org/10.1038/nature01585			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678EX	12748645				2022-12-24	WOS:000182853100048
J	Montcouquiol, M; Rachel, RA; Lanford, PJ; Copeland, NG; Jenkins, NA; Kelley, MW				Montcouquiol, M; Rachel, RA; Lanford, PJ; Copeland, NG; Jenkins, NA; Kelley, MW			Identification of Vangl2 and Scrb1 as planar polarity genes in mammals	NATURE			English	Article							NEURAL-TUBE DEFECTS; DROSOPHILA TISSUE POLARITY; CELL FATE; MOUSE; STRABISMUS; CIRCLETAIL; MUTANT; LOCALIZATION; EXTENSION; MUTATION	In mammals, an example of planar cell polarity (PCP) is the uniform orientation of the hair cell stereociliary bundles within the cochlea. The PCP pathway of Drosophila(1-4) refers to a conserved signalling pathway that regulates the coordinated orientation of cells or structures within the plane of an epithelium. Here we show that a mutation in Vangl2, a mammalian homologue of the Drosophila PCP gene Strabismus/Van Gogh, results in significant disruptions in the polarization of stereociliary bundles in mouse cochlea as a result of defects in the direction of movement and/or anchoring of the kinocilium within each hair cell. Similar, but less severe, defects are observed in animals containing a mutation in the LAP protein family gene Scrb1 (homologous with Drosophila scribble). Polarization defects in animals heterozygous for Vangl2 and Scrb1 are comparable with Vangl2 homozygotes, demonstrating genetic interactions between these genes in the regulation of PCP in mammals. These results demonstrate a role for the PCP pathway in planar polarization in mammals, and identify Scrb1 as a PCP gene.	NIDCD, Sect Dev Neurosci, NIH, Rockville, MD 20850 USA; NCI, Mouse Canc Genet Program, Frederick, MD 21702 USA; Univ Maryland, College Pk, MD 20742 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University System of Maryland; University of Maryland College Park	Montcouquiol, M (corresponding author), NIDCD, Sect Dev Neurosci, NIH, Rockville, MD 20850 USA.	montcouq@nidcd.nih.gov	montcouquiol, mireille/L-6199-2017	montcouquiol, mireille/0000-0001-8739-6519	DIVISION OF BASIC SCIENCES - NCI [Z01BC010556, Z01BC010394] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [Z01DC000059, ZIADC000059] Funding Source: NIH RePORTER	DIVISION OF BASIC SCIENCES - NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Adler PN, 2002, DEV CELL, V2, P525, DOI 10.1016/S1534-5807(02)00176-4; Adler PN, 2001, CURR OPIN CELL BIOL, V13, P635, DOI 10.1016/S0955-0674(00)00263-5; Bilder D, 2000, NATURE, V403, P676, DOI 10.1038/35001108; Chen P, 2002, DEVELOPMENT, V129, P2495; COPP AJ, 1994, DEV BIOL, V165, P20, DOI 10.1006/dbio.1994.1230; Darken RS, 2002, EMBO J, V21, P976, DOI 10.1093/emboj/21.5.976; Goto T, 2002, DEV BIOL, V247, P165, DOI 10.1006/dbio.2002.0673; Hamblet NS, 2002, DEVELOPMENT, V129, P5827, DOI 10.1242/dev.00164; HUDSPETH AJ, 1979, P NATL ACAD SCI USA, V76, P1506, DOI 10.1073/pnas.76.3.1506; Hung AY, 2002, J BIOL CHEM, V277, P5699, DOI 10.1074/jbc.R100065200; Kibar Z, 2001, NAT GENET, V28, P251, DOI 10.1038/90081; Lanford PJ, 1999, NAT GENET, V21, P289, DOI 10.1038/6804; Mlodzik M, 2002, TRENDS GENET, V18, P564, DOI 10.1016/S0168-9525(02)02770-1; Mueller KL, 2002, J NEUROSCI, V22, P9368; Murdoch JN, 2003, HUM MOL GENET, V12, P87, DOI 10.1093/hmg/ddg014; Murdoch JN, 2001, HUM MOL GENET, V10, P2593, DOI 10.1093/hmg/10.22.2593; Murdoch JN, 2001, GENOMICS, V78, P55, DOI 10.1006/geno.2001.6638; Park M, 2002, NAT CELL BIOL, V4, P20, DOI 10.1038/ncb716; Rachel RA, 2002, GENESIS, V33, P55, DOI 10.1002/gene.10088; Rachel RA, 2000, GENESIS, V27, P32, DOI 10.1002/1526-968X(200005)27:1<32::AID-GENE50>3.0.CO;2-T; Rubel E. W, 1978, HDB SENSORY PHYSL, VIX, P135; STRONG LC, 1949, J HERED, V40, P329, DOI 10.1093/oxfordjournals.jhered.a105976; Taylor J, 1998, GENETICS, V150, P199; Wolff T, 1998, DEVELOPMENT, V125, P1149; Wu DK, 1996, J NEUROSCI, V16, P6454	25	539	555	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 8	2003	423	6936					173	177		10.1038/nature01618	http://dx.doi.org/10.1038/nature01618			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675MR	12724779				2022-12-24	WOS:000182699600047
J	Moore, J				Moore, J			Stealth ship sets sail for a quiet life fishing for data	NATURE			English	News Item																			0	2	2	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 1	2003	423	6935					7	7		10.1038/423007b	http://dx.doi.org/10.1038/423007b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673CG	12721594	Bronze			2022-12-24	WOS:000182561600012
J	Butler, D				Butler, D			Agent Orange health investigation stuck at square one	NATURE			English	News Item																		2003, NATURE, V422, P649; 2002, NATURE, V416, P252	2	1	1	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 24	2003	422	6934					793	793		10.1038/422793b	http://dx.doi.org/10.1038/422793b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670WR	12712159	Bronze			2022-12-24	WOS:000182432600011
J	Counter, CM; Press, W; Compton, CC				Counter, CM; Press, W; Compton, CC			Telomere shortening in cultured autografts of patients with burns	LANCET			English	Article							CELLS	In extensive third-degree burns, donor sites for conventional split thickness skin grafts are limited. In such cases, cultured epithelial (keratinocyte) grafts are prepared from small samples of the patient's own skin and expanded In tissue culture, a process that may incur very many cell divisions. Telomeres shorten with each cell division, and are markers of cellular proliferative history. We therefore measured telomere length In healed cultured epithelial autografts from four patients with burns, and noted that their telomeres were shorter than those in non-cultured skin from the same Individuals, and than those in skin of healthy donors older than 80 years. Such great loss of telomeric DNA suggests that engrafted cells might have a shortened lifespan, which could have negative repercussions on the long-term viability of these grafts.	Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Dept Radiat Oncol, Durham, NC 27710 USA; Harvard Inst Med, Harvard Gene Therapy Initiat, Boston, MA USA; McGill Univ, Dept Pathol, Montreal, PQ H3A 2T5, Canada	Duke University; Harvard University; Harvard Medical School; McGill University	Counter, CM (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Dept Radiat Oncol, Durham, NC 27710 USA.			Counter, Christopher M/0000-0003-0748-3079	NATIONAL CANCER INSTITUTE [R01CA082481] Funding Source: NIH RePORTER; NCI NIH HHS [CA82481] Funding Source: Medline; PHS HHS [R01-35242] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Armbruster BN, 2001, MOL CELL BIOL, V21, P7775, DOI 10.1128/MCB.21.22.7775-7786.2001; Collins K, 2002, ONCOGENE, V21, P564, DOI 10.1038/sj.onc.1205083; GALLICO GG, 1984, NEW ENGL J MED, V311, P448, DOI 10.1056/NEJM198408163110706; Kiyono T, 1998, NATURE, V396, P84, DOI 10.1038/23962; Pellegrini G, 1999, TRANSPLANTATION, V68, P868, DOI 10.1097/00007890-199909270-00021	5	23	24	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 19	2003	361	9366					1345	1346		10.1016/S0140-6736(03)13042-5	http://dx.doi.org/10.1016/S0140-6736(03)13042-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	669HP	12711471				2022-12-24	WOS:000182346100013
J	Morrison-Griffiths, S; Walley, TJ; Park, BK; Breckenridge, AM; Pirmohamed, M				Morrison-Griffiths, S; Walley, TJ; Park, BK; Breckenridge, AM; Pirmohamed, M			Reporting of adverse drug reactions by nurses	LANCET			English	Article								Schemes for spontaneous reporting of adverse drug reactions are Important to post-marketing safety surveillance worldwide. In the UK, doctors, dentists, coroners, and pharmacists are allowed to report through the yellow card scheme, but nurses were not until October, 2002. We used a similar programme to assess the role of community and hospital nurses in reporting of adverse drug reactions. The proportion and quality of reports received from nurses was similar to that of those received from doctors: we received reports from one in seven nurses eligible to report, compared with one In eight doctors; 137 of 1.77 nurse reports and 676 of 984 doctor reports were judged to be appropriate according to regulatory authority criteria (95% CI for difference between proportions 1.4-15.0, z=2.3, p=0.02). Our findings suggest that nurses, who form the largest proportion of healthcare staff in the UK, can play a valuable part in improvement of pharmacovigilance.	Univ Liverpool, Dept Pharmacol & Therapeut, Liverpool L69 3GE, Merseyside, England	University of Liverpool	Pirmohamed, M (corresponding author), Univ Liverpool, Dept Pharmacol & Therapeut, Ashton St, Liverpool L69 3GE, Merseyside, England.		Pirmohamed, Munir/H-6004-2011	Pirmohamed, Munir/0000-0002-7534-7266; Morrison-Griffiths, Sally/0000-0002-0250-9076				HALL M, 1995, BRIT J CLIN PHARMACO, V40, P173, DOI 10.1111/j.1365-2125.1995.tb05774.x; Morrison-Griffiths S, 1998, Nurs Times, V94, P52; NARANJO CA, 1981, CLIN PHARMACOL THER, V30, P239, DOI 10.1038/clpt.1981.154; RAWLINS MD, 1995, J ROY COLL PHYS LOND, V29, P41; *UK DEP HLTH, EXT IND NURS PRESCR	5	51	54	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 19	2003	361	9366					1347	1348		10.1016/S0140-6736(03)13043-7	http://dx.doi.org/10.1016/S0140-6736(03)13043-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	669HP	12711472				2022-12-24	WOS:000182346100014
J	Wolfe, SM				Wolfe, SM			Ephedra - Scientific evidence versus money/politics	SCIENCE			English	Editorial Material							ALKALOIDS		Publ Citizens Hlth Res Grp, Washington, DC 20009 USA		Wolfe, SM (corresponding author), Publ Citizens Hlth Res Grp, Washington, DC 20009 USA.							CRABTREE P, 2003, SAN DIEGO UNION 0123, pC1; EVANS D, 2002, BLOOMBERG NEWS  0411; Haller CA, 2000, NEW ENGL J MED, V343, P1833, DOI 10.1056/NEJM200012213432502; Haller CA, 2002, CLIN PHARMACOL THER, V71, P421, DOI 10.1067/mcp.2002.124523; HEATH M, COMMUNICATION; ROAN S, 2002, LOS ANGELES TIM 1209, pF1; Weintraub A, 2002, BUS WEEK, P40; WEISSKOPF M, 2000, TIME            0522, pR20; Willman D., 2001, LOS ANGELES TIM 0311, pA1	9	9	11	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 18	2003	300	5618					437	437		10.1126/science.1081910	http://dx.doi.org/10.1126/science.1081910			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668LR	12702860				2022-12-24	WOS:000182295900021
J	Lodwig, EM; Hosie, AHF; Bordes, A; Findlay, K; Allaway, D; Karunakaran, R; Downie, JA; Poole, PS				Lodwig, EM; Hosie, AHF; Bordes, A; Findlay, K; Allaway, D; Karunakaran, R; Downie, JA; Poole, PS			Amino-acid cycling drives nitrogen fixation in the legume - Rhizobium symbiosis	NATURE			English	Article							PEA ROOT-NODULES; PERIBACTEROID MEMBRANE; TRANSPORT MUTANTS; LEGUMINOSARUM; METABOLISM; IDENTIFICATION; BACTEROIDS; PERMEASE; SHUTTLE; CARBON	The biological reduction of atmospheric N-2 to ammonium (nitrogen fixation) provides about 65% of the biosphere's available nitrogen. Most of this ammonium is contributed by legume rhizobia symbioses(1), which are initiated by the infection of legume hosts by bacteria (rhizobia), resulting in formation of root nodules. Within the nodules, rhizobia are found as bacteroids, which perform the nitrogen fixation: to do this, they obtain sources of carbon and energy from the plant, in the form of dicarboxylic acids(2,3). It has been thought that, in return, bacteroids simply provide the plant with ammonium. But here we show that a more complex amino-acid cycle is essential for symbiotic nitrogen fixation by Rhizobium in pea nodules. The plant provides amino acids to the bacteroids, enabling them to shut down their ammonium assimilation. In return, bacteroids act like plant organelles to cycle amino acids back to the plant for asparagine synthesis. The mutual dependence of this exchange prevents the symbiosis being dominated by the plant, and provides a selective pressure for the evolution of mutualism.	Univ Reading, Sch Anim & Microbial Sci, Reading RG6 6AJ, Berks, England; John Innes Ctr Plant Sci Res, Norwich NR4 7UH, Norfolk, England	University of Reading; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Poole, PS (corresponding author), Univ Reading, Sch Anim & Microbial Sci, POB 228, Reading RG6 6AJ, Berks, England.		Hosie, Arthur/J-9615-2012; Downie, Allan/I-3487-2012	Hosie, Arthur/0000-0002-1327-7901; Downie, Allan/0000-0003-1011-4960; Allaway, David/0000-0003-4602-8933; Ramakrishnan, Karunakaran/0000-0002-6450-1299; Lodwig, Emma/0000-0001-6941-7996; Findlay, Kim/0000-0002-1556-0532				Allaway D, 2000, MOL MICROBIOL, V36, P508, DOI 10.1046/j.1365-2958.2000.01884.x; APPELS MA, 1991, PLANT PHYSIOL, V95, P740, DOI 10.1104/pp.95.3.740; BERINGER JE, 1977, J GEN MICROBIOL, V98, P339, DOI 10.1099/00221287-98-2-339; Craig J, 1999, PLANT J, V17, P353, DOI 10.1046/j.1365-313X.1999.00382.x; FINAN TM, 1983, J BACTERIOL, V154, P1403, DOI 10.1128/JB.154.3.1403-1413.1983; Hosie AHF, 2002, J BACTERIOL, V184, P4071, DOI 10.1128/JB.184.15.4071-4080.2002; Hosie AHF, 2001, MOL MICROBIOL, V40, P1449, DOI 10.1046/j.1365-2958.2001.02497.x; INDIVERI C, 1987, J BIOL CHEM, V262, P15979; Kahn M. L., 1985, Nitrogen fixation research progress. Proceedings of the 6th International Symposium on Nitrogen Fixation, Corvallis, OR, USA, August 4-10. 1985., P193; Mouritzen P, 1997, PLANT PHYSIOL, V115, P519, DOI 10.1104/pp.115.2.519; NEWTON WE, 2000, NITROGEN FIXATION MO, P3; Parsons R, 1996, J EXP BOT, V47, P421, DOI 10.1093/jxb/47.3.421; Patriarca EJ, 2002, MICROBIOL MOL BIOL R, V66, P203, DOI 10.1128/MMBR.66.2.203-222.2002; Poole P, 2000, ADV MICROB PHYSIOL, V43, P117, DOI 10.1016/S0065-2911(00)43004-3; Prell J, 2002, MICROBIOL-SGM, V148, P615, DOI 10.1099/00221287-148-2-615; RONSON CW, 1981, P NATL ACAD SCI-BIOL, V78, P4284, DOI 10.1073/pnas.78.7.4284; ROSENDAHL L, 1992, J PLANT PHYSIOL, V139, P635, DOI 10.1016/S0176-1617(11)80385-8; Rosendahl L, 2001, PLANT SOIL, V230, P31, DOI 10.1023/A:1004628217418; Saalbach G, 2002, PROTEOMICS, V2, P325, DOI 10.1002/1615-9861(200203)2:3<325::AID-PROT325>3.0.CO;2-W; Udvardi M. K., 1988, Molecular Plant-Microbe Interactions, V1, P250, DOI 10.1094/MPMI-1-250; UDVARDI MK, 1988, FEBS LETT, V231, P36, DOI 10.1016/0014-5793(88)80697-5; Vance CP, 2000, PROKARYOTIC NITROGEN FIXATION, P589; Walshaw DL, 1996, MOL MICROBIOL, V21, P1239, DOI 10.1046/j.1365-2958.1996.00078.x; WATSON RJ, 1993, J BACTERIOL, V175, P1919, DOI 10.1128/JB.175.7.1919-1928.1993	24	332	357	10	136	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 17	2003	422	6933					722	726		10.1038/nature01527	http://dx.doi.org/10.1038/nature01527			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668CG	12700763				2022-12-24	WOS:000182272300042
J	Davis, N; Pohlman, A; Gehlbach, B; Kress, JP; McAtee, J; Herlitz, J; Hall, J				Davis, N; Pohlman, A; Gehlbach, B; Kress, JP; McAtee, J; Herlitz, J; Hall, J			Improving the process of informed consent in the critically ill	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CONFUSION ASSESSMENT METHOD; UNIT CAM-ICU; DELIRIUM	Context Invasive procedures are often performed emergently in the intensive care unit (ICU), and patients or their proxies may not be available to provide informed consent. Little is known about the effectiveness of intensivists in obtaining informed consent. Objectives To describe the nature of informed consent in the ICU and to determine if simple interventions could enhance the process. Design, Setting, and Patients Prospective study of 2 cohorts of consecutively admitted patients (N=270) in a 16-bed ICU at a university hospital. All patients admitted to the ICU during the baseline period from November 1, 2001, to December 31, 2001, and during the intervention period from March 1, 2002, to April 30, 2002, were included. Intervention A hospital-approved universal consent form for 8 commonly performed procedures (arterial catheter, central venous catheter, pulmonary artery catheter, or peripherally inserted central catheter placement; lumbar puncture; thoracentesis; paracentesis; and intubation/mechanical ventilation) was administered to patients or proxies. Handouts describing each procedure were available in the ICU waiting area. Physicians and nurses were introduced to the universal consent form during orientation to the ICU. Main Outcome Measures Incidence of informed consent for invasive procedures at baseline and after intervention; whether the patient or proxy provided informed consent; and understanding by the consenter of the procedure as determined by the responses on a questionnaire. Results Fifty-three percent of procedures (155/292) were performed after consent had been obtained during the baseline period compared with 90% (308/340) during the intervention period (absolute difference, 37.4%; P<.001). During baseline, the majority (71.6%; 111/155) of consents were provided by proxies. This was also the case during the intervention period in which 65.6% (202/308) of consents were provided by proxies (absolute difference, 6.0%; P=.23). Comprehension by consenters of indications for and risks of the procedures was high and not different between the 2 periods (P=.75). Conclusions Invasive procedures are frequent in the ICU and consent for them is often obtained by proxy. Providing a universal consent form to patients, proxies, and health care clinicians significantly increased the frequency with which consent was obtained without compromising comprehension of the process by the consenter.	Univ Chicago Hosp & Clin, Pritzker Sch Med, Pulm & Crit Care Med Sect, Chicago, IL 60637 USA; Univ Chicago Hosp & Clin, Off Risk Management, Chicago, IL 60637 USA	University of Chicago; University of Illinois System; University of Chicago; University of Illinois System	Hall, J (corresponding author), Univ Chicago Hosp & Clin, Pritzker Sch Med, Pulm & Crit Care Med Sect, MC 6076,5841 S Maryland Ave, Chicago, IL 60637 USA.			Gehlbach, Brian/0000-0003-3160-1741	PHS HHS [K236M63906] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Azoulay E, 2000, CRIT CARE MED, V28, P3044, DOI 10.1097/00003246-200008000-00061; BLACKHALL LJ, 1995, JAMA-J AM MED ASSOC, V274, P820, DOI 10.1001/jama.274.10.820; *CRIT CAR ASS AM T, 2002, PRIM CRIT CAR PAT TH; Dyson M, 1999, J CLIN NURS, V8, P284, DOI 10.1046/j.1365-2702.1999.00265.x; Ely EW, 2001, JAMA-J AM MED ASSOC, V286, P2703, DOI 10.1001/jama.286.21.2703; Ely EW, 2001, CRIT CARE MED, V29, P1370, DOI 10.1097/00003246-200107000-00012; ETHELLS E, 1996, CMAJ, V155, P177; HALL JA, 1988, MED CARE, V26, P657, DOI 10.1097/00005650-198807000-00002; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Levine R J, 1991, Law Med Health Care, V19, P207; Shelly MP, 1999, INTENS CARE MED, V25, P137, DOI 10.1007/s001340050805; SULMASY DP, 1994, AM J MED, V96, P432, DOI 10.1016/0002-9343(94)90170-8; *U CHIC, 2001, U CHIC HOSP POL PROC	13	51	52	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 16	2003	289	15					1963	1968		10.1001/jama.289.15.1963	http://dx.doi.org/10.1001/jama.289.15.1963			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	667VC	12697799	Bronze			2022-12-24	WOS:000182253900029
J	Spencer, RMC; Zelaznik, HN; Diedrichsen, J; Ivry, RB				Spencer, RMC; Zelaznik, HN; Diedrichsen, J; Ivry, RB			Disrupted timing of discontinuous but not continuous movements by cerebellar lesions	SCIENCE			English	Article							DRAWING MOVEMENTS; DISSOCIATION; PERCEPTION; HUMANS; FMRI	Patients with cerebellar damage are known to exhibit deficits in the temporal control of movements. We report that these deficits are restricted to discontinuous movements. Cerebellar patients exhibited no deficit in temporal variability when producing continuous, rhythmic movements. We hypothesize that the temporal properties of continuous movements are emergent and reflect the operation of other control parameters not associated with the cerebellum. In contrast, discontinuous movements require an explicit representation of the temporal goal, a function of the cerebellum. The requirement for explicit temporal representation provides a parsimonious account of cerebellar involvement in a range of tasks.	Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA; Purdue Univ, Dept Hlth & Kinesiol, Integrat Program Neurosci, W Lafayette, IN 47907 USA	University of California System; University of California Berkeley; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Spencer, RMC (corresponding author), Univ Calif Berkeley, Dept Psychol, 3210 Tolman Hall 1650, Berkeley, CA 94720 USA.	rspencer@socrates.berkeley.edu	Diedrichsen, Jörn/A-7789-2010; Diedrichsen, Jörn/AAQ-2242-2020	Diedrichsen, Jörn/0000-0003-0264-8532; Diedrichsen, Jörn/0000-0003-0264-8532; Spencer, Rebecca/0000-0002-8674-2384; zelaznik, howard/0000-0003-0071-2377	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS017778, P01NS040813, R29NS030256, P01NS017778, R01NS030256] Funding Source: NIH RePORTER; NINDS NIH HHS [NS17778, NS30256, NS40813] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ackermann H, 1997, BRAIN LANG, V60, P323, DOI 10.1006/brln.1997.1826; Ackermann H, 2001, NEUROREPORT, V12, P4087, DOI 10.1097/00001756-200112210-00045; Bastian AJ, 1996, J NEUROPHYSIOL, V76, P492, DOI 10.1152/jn.1996.76.1.492; Burdet E, 2001, NATURE, V414, P446, DOI 10.1038/35106566; DAUM I, 1993, BEHAV NEUROSCI, V107, P748, DOI 10.1037/0735-7044.107.5.748; HOGAN N, 1987, TRENDS NEUROSCI, V10, P170, DOI 10.1016/0166-2236(87)90043-9; Holmes G, 1939, BRAIN, V62, P1, DOI 10.1093/brain/62.1.1; HORE J, 1991, J NEUROPHYSIOL, V65, P563, DOI 10.1152/jn.1991.65.3.563; IVRY R, 1993, ANN NY ACAD SCI, V682, P214, DOI 10.1111/j.1749-6632.1993.tb22970.x; IVRY R, 1997, INT REV NEUROBIOL, V41, P556; Ivry R B, 1989, J Cogn Neurosci, V1, P136, DOI 10.1162/jocn.1989.1.2.136; IVRY RB, 1988, EXP BRAIN RES, V73, P167, DOI 10.1007/BF00279670; IVRY RB, 1993, ATTENTION PERFORM, V14, P771; JACIKSON J, 1991, NATO ADV STUDY I SER, V62, P169; JUEPTNER M, 1995, NEUROLOGY, V45, P1540, DOI 10.1212/WNL.45.8.1540; Kawashima R, 2000, J NEUROPHYSIOL, V83, P1079, DOI 10.1152/jn.2000.83.2.1079; Kennerley SW, 2002, NAT NEUROSCI, V5, P376, DOI 10.1038/nn822; KILLEEN PR, 1987, PSYCHOL REV, V94, P455, DOI 10.1037/0033-295X.94.4.455; Mangels JA, 1998, COGNITIVE BRAIN RES, V7, P15, DOI 10.1016/S0926-6410(98)00005-6; Mussa-Ivaldi FA, 2000, BIOMECHANICS AND NEURAL CONTROL OF POSTURE AND MOVEMENT, P325; Robertson SD, 1999, J EXP PSYCHOL HUMAN, V25, P1316, DOI 10.1037/0096-1523.25.5.1316; Timmann D, 2000, EXP BRAIN RES, V130, P441, DOI 10.1007/s002219900277; TOPKA H, 1993, BRAIN, V116, P961, DOI 10.1093/brain/116.4.961; Turvey M., 1977, PERCEIVING ACTING KN, P211; van Beers RJ, 2002, PHILOS T R SOC B, V357, P1137, DOI 10.1098/rstb.2002.1101; VORBERG D, 1996, HDB PERCEPTION ACTIO, V2, P1581; WoodruffPak DS, 1996, NEUROPSYCHOLOGY, V10, P443; Zelaznik HN, 2000, J MOTOR BEHAV, V32, P193, DOI 10.1080/00222890009601370; Zelaznik HN, 2002, J EXP PSYCHOL HUMAN, V28, P575, DOI 10.1037//0096-1523.28.3.575	29	351	357	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 30	2003	300	5624					1437	1439		10.1126/science.1083661	http://dx.doi.org/10.1126/science.1083661			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	683ZW	12775842				2022-12-24	WOS:000183181800047
J	Wu, JG; Huang, JH; Han, XG; Xie, ZQ; Gao, XM				Wu, JG; Huang, JH; Han, XG; Xie, ZQ; Gao, XM			Three-Gorges Dam - Experiment in habitat fragmentation?	SCIENCE			English	Editorial Material							FOREST FRAGMENTS; ECOLOGY		Arizona State Univ, Dept Plant Biol, Tempe, AZ 85287 USA; Chinese Acad Sci, Inst Bot, Beijing, Peoples R China	Arizona State University; Arizona State University-Tempe; Chinese Academy of Sciences; Institute of Botany, CAS	Wu, JG (corresponding author), Arizona State Univ, Dept Plant Biol, Tempe, AZ 85287 USA.	jingle.wu@asu.edu	Wu, Jianguo/G-6267-2010; Han, Xingguo/K-7552-2016	Wu, Jianguo/0000-0002-1182-3024; Han, Xingguo/0000-0002-1836-975X				[Anonymous], 2000, DAMS DEV NEW FRAM DE; da Fonseca GAB, 2002, SCIENCE, V295, P1835; Diamond J, 2001, SCIENCE, V294, P1847, DOI 10.1126/science.1067012; DIAMOND JM, 1972, P NATL ACAD SCI USA, V69, P3199, DOI 10.1073/pnas.69.11.3199; EDMONDS RL, 1992, GLOBAL ECOL BIOGEOGR, V2, P105, DOI 10.2307/2997637; Haila Y, 2002, ECOL APPL, V12, P321, DOI 10.1890/1051-0761(2002)012[0321:ACGOFR]2.0.CO;2; Hubbell Stephen P., 2001, V32, pi; Laurance WF, 2002, CONSERV BIOL, V16, P605, DOI 10.1046/j.1523-1739.2002.01025.x; Laurance WF, 2001, SCIENCE, V291, P438, DOI 10.1126/science.291.5503.438; Lei X, 1998, SCIENCE, V280, P25, DOI 10.1126/science.280.5360.25; LOVEJOY TE, 1986, CONSERVATION BIOL SC, P251; ROBINSON GR, 1992, SCIENCE, V257, P524, DOI 10.1126/science.257.5069.524; ROBINSON SK, 1995, SCIENCE, V267, P1987, DOI 10.1126/science.267.5206.1987; Schrope M, 2000, NATURE, V408, P395, DOI 10.1038/35044245; Shen Z H, 2000, J WUHAN BOT RES, V18, P99; TERBORGH J, 1974, BIOSCIENCE, V24, P715, DOI 10.2307/1297090; Terborgh J, 2001, SCIENCE, V294, P1923, DOI 10.1126/science.1064397; Wu J., 1995, ENCY ENV BIOL, P371; Wu J., 2000, LANDSCAPE ECOLOGY PA; Wu JG, 1995, Q REV BIOL, V70, P439, DOI 10.1086/419172; XIAO W, 2000, ECOLOGY TERRESTRIAL; Zhenli H., 2001, BIODIVERS SCI, V9, P472, DOI [DOI 10.3321/J.ISSN:1005-0094.2001.04.021, 10.17520/biods.2001068, DOI 10.17520/BIODS.2001068]	22	282	357	16	276	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 23	2003	300	5623					1239	1240		10.1126/science.1083312	http://dx.doi.org/10.1126/science.1083312			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681NN	12764179				2022-12-24	WOS:000183042400028
J	Platt, T; Fuentes-Yaco, C; Frank, KT				Platt, T; Fuentes-Yaco, C; Frank, KT			Spring algal bloom and larval fish survival	NATURE			English	Article									Fisheries & Oceans Canada, Bedford Inst Oceanog, Ocean Sci Div, Dartmouth, NS B2Y 4A2, Canada; Dalhousie Univ, Dept Oceanog, Halifax, NS B3H 4J1, Canada	Bedford Institute of Oceanography; Fisheries & Oceans Canada; Dalhousie University	Platt, T (corresponding author), Fisheries & Oceans Canada, Bedford Inst Oceanog, Ocean Sci Div, Box 1006, Dartmouth, NS B2Y 4A2, Canada.							Cushing D.H., 1974, P399; CUSHING DH, 1990, ADV MAR BIOL, V26, P249, DOI 10.1016/S0065-2881(08)60202-3; Hjort J., 1914, RAPP P V REUN CONS I, V20, P1; KANE J, 1984, MAR ECOL PROG SER, V16, P9, DOI 10.3354/meps016009; MOHN RK, 2002, 2002102 CSAS RES; PLATT T, 1996, O3 CM INT COUN EXPL; Sverdrup H.U., 1953, ICES J MAR SCI, V18, P287, DOI [10.1093/icesjms/18.3.287, DOI 10.1093/ICESJMS/18.3.287]	7	423	435	8	141	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 22	2003	423	6938					398	399		10.1038/423398b	http://dx.doi.org/10.1038/423398b			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681AJ	12761538				2022-12-24	WOS:000183012000029
J	So, LKY; Lau, ACW; Yam, LYC; Cheung, TMT; Poon, E; Yung, RWH; Yuen, KY				So, LKY; Lau, ACW; Yam, LYC; Cheung, TMT; Poon, E; Yung, RWH; Yuen, KY			Development of a standard treatment protocol for severe acute respiratory syndrome	LANCET			English	Editorial Material								A series of 31 patients with probable SARS, diagnosed from WHO criteria, were treated according to a treatment protocol consisting of antibacterials and a combination of ribavirin and methylprednisolone. Through experience with the first 11 patients, we were able to finalise standard dose regimens, including pulsed methylprednisolone. One patient recovered on antibacterial treatment alone, 17 showed rapid and sustained responses, and 13 achieved Improvement with step-up or pulsed methylprednisolone. Four patients required short periods of non-invasive ventilation. No patient required intubation or mechanical ventilation. There was no mortality or treatment morbidity in this series.	Pamela Youde Nethersole Eastern Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China; Pamela Youde Nethersole Eastern Hosp, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; Univ Hong Kong, Queen Mary Hosp, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China	Pamela Youde Nethersole Eastern Hospital; Pamela Youde Nethersole Eastern Hospital; University of Hong Kong	So, LKY (corresponding author), Dept Med, 3 Lok Man Rd, Chaiwan, Hong Kong, Peoples R China.	drewlau@hkstar.com		Yuen, Kwok-yung/0000-0002-2083-1552				Cheung CY, 2002, LANCET, V360, P1831, DOI 10.1016/S0140-6736(02)11772-7; LEE N, MAJOR OUTBREAK SEVER; Peiris JSM, 2003, LANCET, V361, P1319, DOI 10.1016/S0140-6736(03)13077-2; TSANG KW, CLUSTER CASES SEVERE; *WHO, CAS DEF SURV SEV AC	5	229	262	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 10	2003	361	9369					1615	1617		10.1016/S0140-6736(03)13265-5	http://dx.doi.org/10.1016/S0140-6736(03)13265-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	676HY	12747883	Bronze, Green Published			2022-12-24	WOS:000182746300013
J	Bardelli, A; Parsons, DW; Silliman, N; Ptak, J; Szabo, S; Saha, S; Markowitz, S; Willson, JKV; Parmigiani, G; Kinzler, KW; Vogelstein, B; Velculescu, VE				Bardelli, A; Parsons, DW; Silliman, N; Ptak, J; Szabo, S; Saha, S; Markowitz, S; Willson, JKV; Parmigiani, G; Kinzler, KW; Vogelstein, B; Velculescu, VE			Mutational analysis of the tyrosine kinome in colorectal cancers	SCIENCE			English	Article							KINASE		Johns Hopkins, Howard Hughes Med Inst, Baltimore, MD 21231 USA; Johns Hopkins, Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA; Univ Hosp Cleveland, Howard Hughes Med Inst, Cleveland, OH 44106 USA; Univ Hosp Cleveland, Ireland Canc Ctr, Cleveland, OH 44106 USA; Case Western Reserve Univ, Cleveland, OH 44106 USA	Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University; Howard Hughes Medical Institute; University Hospitals of Cleveland; University Hospitals of Cleveland; Case Western Reserve University	Velculescu, VE (corresponding author), Johns Hopkins, Howard Hughes Med Inst, Baltimore, MD 21231 USA.		Velculescu, Victor/ABF-4846-2020; BARDELLI, Alberto/J-9721-2018	Velculescu, Victor/0000-0003-1195-438X; BARDELLI, Alberto/0000-0003-1647-5070; Parsons, Donald/0000-0002-8775-3501	NCI NIH HHS [CA62924, CA43460, CA57345] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R37CA043460, R37CA057345, R01CA057345, R01CA043460, P50CA062924] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Druker BJ, 2002, CANCER CELL, V1, P31, DOI 10.1016/S1535-6108(02)00025-9; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762	3	397	480	1	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 9	2003	300	5621					949	949		10.1126/science.1082596	http://dx.doi.org/10.1126/science.1082596			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675WD	12738854				2022-12-24	WOS:000182719800046
J	Priori, SG; Schwartz, PJ; Napolitano, C; Bloise, R; Ronchetti, E; Grillo, M; Vicentini, A; Spazzolini, C; Nastoli, J; Bottelli, G; Folli, R; Cappelletti, D				Priori, SG; Schwartz, PJ; Napolitano, C; Bloise, R; Ronchetti, E; Grillo, M; Vicentini, A; Spazzolini, C; Nastoli, J; Bottelli, G; Folli, R; Cappelletti, D			Risk stratification in the long-QT syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CARDIAC-ARRHYTHMIAS; MUTATIONS; REGISTRY; GENOTYPE; CHANNEL; THERAPY; KVLQT1; IMPACT; SCN5A; GENES	BACKGROUND: Mutations in potassium-channel genes KCNQ1 (LQT1 locus) and KCNH2 (LQT2 locus) and the sodium-channel gene SCN5A (LQT3 locus) are the most common causes of the long-QT syndrome. We stratified risk according to the genotype, in conjunction with other clinical variables such as sex and the length of the QT interval. METHODS: We evaluated 647 patients (386 with a mutation at the LQT1 locus, 206 with a mutation at the LQT2 locus, and 55 with a mutation at the LQT3 locus) from 193 consecutively genotyped families with the long-QT syndrome. The cumulative probability of a first cardiac event, defined as the occurrence of syncope, cardiac arrest, or sudden death before the age of 40 years and before the initiation of therapy, was determined according to genotype, sex, and the QT interval corrected for heart rate (QTc). Within each genotype we also assessed risk in the four categories derived from the combination of sex and QTc (<500 msec or greater/equal 500 msec). RESULTS: The incidence of a first cardiac event before the age of 40 years and before the initiation of therapy was lower among patients with a mutation at the LQT1 locus (30 percent) than among those with a mutation at the LQT2 locus (46 percent) or those with a mutation at the LQT3 locus (42 percent) (P<0.001 by Fisher's exact test). Multivariate analysis showed that the genetic locus and the QTc, but not sex, were independent predictors of risk. The QTc was an independent predictor of risk among patients with a mutation at the LQT1 locus and those with a mutation at the LQT2 locus but not among those with a mutation at the LQT3 locus, whereas sex was an independent predictor of events only among those with a mutation at the LQT3 locus. CONCLUSIONS: The locus of the causative mutation affects the clinical course of the long-QT syndrome and modulates the effects of the QTc and sex on clinical manifestations. We propose an approach to risk stratification based on these variables.	Univ Pavia, Maugeri Fdn, I-27100 Pavia, Italy; Fdn S Maugeri, Ist Ric & Cura Carattere Sci, Dept Mol Cardiol, Pavia, Italy; Policlin San Matteo, Ist Ric & Cura Carattere, Dept Cardiol, I-27100 Pavia, Italy	Istituti Clinici Scientifici Maugeri IRCCS; University of Pavia; Istituti Clinici Scientifici Maugeri IRCCS; IRCCS Fondazione San Matteo	Priori, SG (corresponding author), Univ Pavia, Maugeri Fdn, Via Ferrata 8, I-27100 Pavia, Italy.		Priori, Silvia G/ABH-6894-2020; napolitano, carlo/ABI-4608-2020; bloise, raffaella/AAC-2922-2020; Spazzolini, Carla/AAA-5023-2020; Schwartz, Peter J./J-4267-2016	Priori, Silvia G/0000-0001-6877-0288; napolitano, carlo/0000-0002-7643-4628; bloise, raffaella/0000-0003-3485-9596; Spazzolini, Carla/0000-0003-1209-0157; Schwartz, Peter J./0000-0003-0367-1048; Nastoli, janni/0000-0002-5888-5951; ronchetti, elena/0000-0002-9185-7848	Telethon [GP0227Y01] Funding Source: Medline	Telethon(Fondazione Telethon)		Donger C, 1997, CIRCULATION, V96, P2778, DOI 10.1161/01.CIR.96.9.2778; Keating MT, 2001, CELL, V104, P569, DOI 10.1016/S0092-8674(01)00243-4; Locati EH, 1998, CIRCULATION, V97, P2237, DOI 10.1161/01.CIR.97.22.2237; Moss AJ, 2002, CIRCULATION, V105, P794, DOI 10.1161/hc0702.105124; MOSS AJ, 1991, CIRCULATION, V84, P1136, DOI 10.1161/01.CIR.84.3.1136; MOSS AJ, 1985, CIRCULATION, V71, P17, DOI 10.1161/01.CIR.71.1.17; Moss AJ, 2000, CIRCULATION, V101, P616, DOI 10.1161/01.CIR.101.6.616; MOSS AJ, 1995, CIRCULATION, V92, P2929, DOI 10.1161/01.CIR.92.10.2929; Priori SG, 2001, EUR HEART J, V22, P1374, DOI 10.1053/euhj.2001.2824; Priori SG, 1999, CIRCULATION, V99, P518, DOI 10.1161/01.CIR.99.4.518; Priori SG, 2002, EUR HEART J, V23, P257; Priori SG, 1999, CIRCULATION, V99, P529, DOI 10.1161/01.CIR.99.4.529; ROMANO C, 1963, Clin Pediatr (Bologna), V45, P656; SCHWARTZ PJ, 1995, CIRCULATION, V92, P3381, DOI 10.1161/01.CIR.92.12.3381; Schwartz PJ, 2001, CIRCULATION, V103, P89; SCHWARTZ PJ, 1983, EUR HEART J, V4, P529, DOI 10.1093/oxfordjournals.eurheartj.a061517; SCHWARTZ PJ, 2000, CARDIAC ELECTROPHYSI, P597; Splawski I, 2000, CIRCULATION, V102, P1178, DOI 10.1161/01.CIR.102.10.1178; WARD O C, 1964, J Ir Med Assoc, V54, P103; Zareba W, 1998, NEW ENGL J MED, V339, P960, DOI 10.1056/NEJM199810013391404	20	965	1006	2	34	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 8	2003	348	19					1866	1874		10.1056/NEJMoa022147	http://dx.doi.org/10.1056/NEJMoa022147			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	675FY	12736279				2022-12-24	WOS:000182684100005
J	Epshtein, V; Nudler, E				Epshtein, V; Nudler, E			Cooperation between RNA polymerase molecules in transcription elongation	SCIENCE			English	Article							ESCHERICHIA-COLI; II ELONGATION; FACTOR-SII; MECHANISM; TERMINATION; COMPLEX; DNA; TRANSLOCATION; PROMOTER; PROTEIN	Transcription elongation is responsible for rapid synthesis of RNA chains of thousands of nucleotides in vivo. In contrast, a single round of transcription performed in vitro is frequently interrupted by pauses and arrests that drastically reduce the elongation rate and the yield of the full-length transcript. Here we demonstrate that most transcriptional delays disappear if more than one RNA polymerase (RNAP) molecule initiates from the same promoter. Anti-arrest and anti-pause effects of trailing RNAP are due to forward translocation of leading (backtracked) complexes. Such cooperation between RNAP molecules links the rate of elongation to the rate of initiation and explains why elongation is still fast and processive in vivo even without anti-arrest factors.	NYU Med Ctr, Dept Biochem, New York, NY 10016 USA	New York University	Nudler, E (corresponding author), NYU Med Ctr, Dept Biochem, New York, NY 10016 USA.	evgeny.nudler@med.nyu.edu		Nudler, Evgeny/0000-0002-8811-3071	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058750] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM58750] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARCHAMBAULT J, 1992, MOL CELL BIOL, V12, P4142, DOI 10.1128/MCB.12.9.4142; BORUKHOV S, 1993, CELL, V72, P459, DOI 10.1016/0092-8674(93)90121-6; Campbell EA, 2001, CELL, V104, P901, DOI 10.1016/S0092-8674(01)00286-0; CONDON C, 1995, MICROBIOL REV, V59, P623, DOI 10.1128/MMBR.59.4.623-645.1995; EPSHTEIN V, UNPUB; FOE VE, 1977, COLD SPRING HARB SYM, V42, P723, DOI 10.1101/SQB.1978.042.01.074; Forde NR, 2002, P NATL ACAD SCI USA, V99, P11682, DOI 10.1073/pnas.142417799; GIARDINA C, 1993, J BIOL CHEM, V268, P23806; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Guajardo R, 1997, J MOL BIOL, V265, P8, DOI 10.1006/jmbi.1996.0707; Gusarov I, 1999, MOL CELL, V3, P495, DOI 10.1016/S1097-2765(00)80477-3; HAMMING J, 1981, NUCLEIC ACIDS RES, V9, P1339, DOI 10.1093/nar/9.6.1339; Hirayoshi K, 1999, METHOD ENZYMOL, V304, P351; IZBAN MG, 1992, GENE DEV, V6, P1342, DOI 10.1101/gad.6.7.1342; JACQUET MA, 1992, MOL MICROBIOL, V6, P1681, DOI 10.1111/j.1365-2958.1992.tb00893.x; Komissarova N, 1997, J BIOL CHEM, V272, P15329, DOI 10.1074/jbc.272.24.15329; LANDICK R, 1987, ESCHERICHIA COLI SAL, P1276; Nudler E, 1997, CELL, V89, P33, DOI 10.1016/S0092-8674(00)80180-4; ORLOVA M, 1995, P NATL ACAD SCI USA, V92, P4596, DOI 10.1073/pnas.92.10.4596; Orphanides G, 2000, NATURE, V407, P471, DOI 10.1038/35035000; Park JS, 2002, CELL, V109, P757, DOI 10.1016/S0092-8674(02)00769-9; Reeder TC, 1996, CELL, V87, P767, DOI 10.1016/S0092-8674(00)81395-1; Reines D, 1996, TRENDS BIOCHEM SCI, V21, P351, DOI 10.1016/0968-0004(96)10045-1; REINES D, 1993, P NATL ACAD SCI USA, V90, P1917, DOI 10.1073/pnas.90.5.1917; SELBY CP, 1993, SCIENCE, V260, P53, DOI 10.1126/science.8465200; Toulme F, 2000, EMBO J, V19, P6853, DOI 10.1093/emboj/19.24.6853; Uptain SM, 1997, ANNU REV BIOCHEM, V66, P117, DOI 10.1146/annurev.biochem.66.1.117; VOGEL U, 1994, J BACTERIOL, V176, P2807, DOI 10.1128/JB.176.10.2807-2813.1994; von Hippel PH, 1998, SCIENCE, V281, P660, DOI 10.1126/science.281.5377.660; YANKULOV K, 1994, CELL, V77, P749, DOI 10.1016/0092-8674(94)90058-2	30	168	174	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 2	2003	300	5620					801	805		10.1126/science.1083219	http://dx.doi.org/10.1126/science.1083219			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673KH	12730602				2022-12-24	WOS:000182579800052
J	Groisman, R; Polanowska, J; Kuraoka, I; Sawada, J; Saijo, M; Drapkin, R; Kisselev, AF; Tanaka, K; Nakatani, Y				Groisman, R; Polanowska, J; Kuraoka, I; Sawada, J; Saijo, M; Drapkin, R; Kisselev, AF; Tanaka, K; Nakatani, Y			The ubiquitin ligase activity in the DDB2 and CSA complexes is differentially regulated by the COP9 signalosome in response to DNA damage	CELL			English	Article							RNA-POLYMERASE-II; TRANSCRIPTION-COUPLED REPAIR; COCKAYNE-SYNDROME; PROTEIN; DEGRADATION; PROTEASOME; CELLS; NEDD8; PATHWAY; DEUBIQUITINATION	Nucleotide excision repair (NER) is a major cellular defense against the carcinogenic effects of ultraviolet light from the sun. Mutational inactivation of NER proteins, like DDB and CSA, leads to hereditary diseases such as xeroderma pigmentosum (XP) and Cockayne syndrome (CS). Here, we show that DDB2 and CSA are each integrated into nearly identical complexes via interaction with DDB1. Both complexes contain cullin 4A and Roc1 and display ubiquitin ligase activity. They also contain the COP9 signalosome (CSN), a known regulator of cullin-based ubiquitin ligases. Strikingly, CSN differentially regulates ubiquitin ligase activity of the DDB2 and CSA complexes in response to UV irradiation. Knockdown of CSN with RNA interference leads to defects in NER. These results suggest that the distinct UV response of the DDB2 and CSA complexes is involved in diverse mechanisms of NER.	Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Brigham & Womens Hosp, Boston, MA 02115 USA; Osaka Univ, Grad Sch Frontier Biosci, Osaka 5650871, Japan; Japan Sci & Technol Corp, CREST, Osaka 5650871, Japan	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Osaka University; Japan Science & Technology Agency (JST)	Nakatani, Y (corresponding author), Dana Farber Canc Inst, Boston, MA 02115 USA.		Polanowska, Jolanta/P-9117-2016; Drapkin, Ronny/E-9944-2016	Polanowska, Jolanta/0000-0001-7666-7010; Drapkin, Ronny/0000-0002-6912-6977; Groisman, Regina/0000-0003-3990-7622; Kuraoka, Isao/0000-0001-6391-3411; Groisman, Sonia/0000-0003-1153-3841				Bootsma D., 1998, GENETIC BASIS HUMAN, P254; Bregman DB, 1996, P NATL ACAD SCI USA, V93, P11586, DOI 10.1073/pnas.93.21.11586; Brummelkamp TR, 2002, CANCER CELL, V2, P243, DOI 10.1016/S1535-6108(02)00122-8; CARREAU M, 1992, MUTAT RES, V274, P57, DOI 10.1016/0921-8777(92)90043-3; Cooper PK, 1997, SCIENCE, V275, P990, DOI 10.1126/science.275.5302.990; Cope GA, 2002, SCIENCE, V298, P608, DOI 10.1126/science.1075901; Elsasser S, 2002, NAT CELL BIOL, V4, P725, DOI 10.1038/ncb845; Friedberg E.C., 2016, DNA REPAIR MUTAGENES, V33, P35; Friedberg EC, 2002, SCIENCE, V296, P1627, DOI 10.1126/science.1070236; Glickman MH, 1998, CELL, V94, P615, DOI 10.1016/S0092-8674(00)81603-7; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; Jackson PK, 2000, TRENDS CELL BIOL, V10, P429, DOI 10.1016/S0962-8924(00)01834-1; Kamiuchi S, 2002, P NATL ACAD SCI USA, V99, P201, DOI 10.1073/pnas.012473199; KEENEY S, 1993, J BIOL CHEM, V268, P21293; Kisselev AF, 2001, CHEM BIOL, V8, P739, DOI 10.1016/S1074-5521(01)00056-4; Le Page F, 2000, CELL, V101, P159, DOI 10.1016/S0092-8674(00)80827-2; Lee SK, 2002, CELL, V109, P823, DOI 10.1016/S0092-8674(02)00795-X; Liakopoulos D, 1998, EMBO J, V17, P2208, DOI 10.1093/emboj/17.8.2208; Logie C, 1997, EMBO J, V16, P6772, DOI 10.1093/emboj/16.22.6772; Lyapina S, 2001, SCIENCE, V292, P1382, DOI 10.1126/science.1059780; Nag A, 2001, MOL CELL BIOL, V21, P6738, DOI 10.1128/MCB.21.20.6738-6747.2001; Nakatsu Y, 2000, J BIOL CHEM, V275, P34931, DOI 10.1074/jbc.M004936200; Ogawa H, 2002, SCIENCE, V296, P1132, DOI 10.1126/science.1069861; Podust VN, 2000, P NATL ACAD SCI USA, V97, P4579, DOI 10.1073/pnas.090465597; Ratner JN, 1998, J BIOL CHEM, V273, P5184, DOI 10.1074/jbc.273.9.5184; Read MA, 2000, MOL CELL BIOL, V20, P2326, DOI 10.1128/MCB.20.7.2326-2333.2000; Reinberg D, 1998, COLD SPRING HARB SYM, V63, P83, DOI 10.1101/sqb.1998.63.83; Schwechheimer C, 2001, SCIENCE, V292, P1379, DOI 10.1126/science.1059776; Selby CP, 1997, P NATL ACAD SCI USA, V94, P11205, DOI 10.1073/pnas.94.21.11205; Svejstrup JQ, 2002, NAT REV MOL CELL BIO, V3, P21, DOI 10.1038/nrm703; TROELSTRA C, 1992, CELL, V71, P939, DOI 10.1016/0092-8674(92)90390-X; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Wakasugi M, 2001, J BIOL CHEM, V276, P15434, DOI 10.1074/jbc.M011177200; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Whitby FG, 1998, J BIOL CHEM, V273, P34983, DOI 10.1074/jbc.273.52.34983; Yang XM, 2002, CURR BIOL, V12, P667, DOI 10.1016/S0960-9822(02)00791-1; Yao TT, 2002, NATURE, V419, P403, DOI 10.1038/nature01071; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a	39	575	612	2	18	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 2	2003	113	3					357	367		10.1016/S0092-8674(03)00316-7	http://dx.doi.org/10.1016/S0092-8674(03)00316-7			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	674MP	12732143	Bronze			2022-12-24	WOS:000182640800010
J	Calle, EE; Rodriguez, C; Walker-Thurmond, K; Thun, MJ				Calle, EE; Rodriguez, C; Walker-Thurmond, K; Thun, MJ			Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BODY-MASS INDEX; OVARIAN-CANCER; RISK-FACTORS; BREAST-CANCER; GALLBLADDER CANCER; PANCREATIC-CANCER; PHYSICAL-ACTIVITY; PROSTATE-CANCER; GASTRIC CARDIA; WEIGHT	Background: The influence of excess body weight on the risk of death from cancer has not been fully characterized. Methods: In a prospectively studied population of more than 900,000 U.S. adults (404,576 men and 495,477 women) who were free of cancer at enrollment in 1982, there were 57,145 deaths from cancer during 16 years of follow-up. We examined the relation in men and women between the body-mass index in 1982 and the risk of death from all cancers and from cancers at individual sites, while controlling for other risk factors in multivariate proportional-hazards models. We calculated the proportion of all deaths from cancer that was attributable to overweight and obesity in the U.S. population on the basis of risk estimates from the current study and national estimates of the prevalence of overweight and obesity in the U.S. adult population. Results: The heaviest members of this cohort (those with a body-mass index [the weight in kilograms divided by the square of the height in meters] of at least 40) had death rates from all cancers combined that were 52 percent higher (for men) and 62 percent higher (for women) than the rates in men and women of normal weight. For men, the relative risk of death was 1.52 (95 percent confidence interval, 1.13 to 2.05); for women, the relative risk was 1.62 (95 percent confidence interval, 1.40 to 1.87). In both men and women, body-mass index was also significantly associated with higher rates of death due to cancer of the esophagus, colon and rectum, liver, gallbladder, pancreas, and kidney; the same was true for death due to non-Hodgkin's lymphoma and multiple myeloma. Significant trends of increasing risk with higher body-mass-index values were observed for death from cancers of the stomach and prostate in men and for death from cancers of the breast, uterus, cervix, and ovary in women. On the basis of associations observed in this study, we estimate that current patterns of overweight and obesity in the United States could account for 14 percent of all deaths from cancer in men and 20 percent of those in women. Conclusions: Increased body weight was associated with increased death rates for all cancers combined and for cancers at multiple specific sites.	Amer Canc Soc, Dept Epidemiol & Surveillance Res, Atlanta, GA 30329 USA	American Cancer Society	Calle, EE (corresponding author), Amer Canc Soc, Dept Epidemiol & Surveillance Res, 1599 Clifton Rd NE, Atlanta, GA 30329 USA.	jcalle@cancer.org						Allison DB, 1999, JAMA-J AM MED ASSOC, V282, P1530, DOI 10.1001/jama.282.16.1530; Andersson SO, 1997, JNCI-J NATL CANCER I, V89, P385, DOI 10.1093/jnci/89.5.385; Bergstrom A, 2001, INT J CANCER, V91, P421, DOI 10.1002/1097-0215(200002)9999:9999&lt;::AID-IJC1053&gt;3.0.CO;2-T; Bergstrom A, 2001, INT J CANCER, V92, P927, DOI 10.1002/ijc.1285; BOYD NF, 1981, JNCI-J NATL CANCER I, V67, P785; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; CALLE EE, 1993, AM J EPIDEMIOL, V137, P235, DOI 10.1093/oxfordjournals.aje.a116664; Calle EE, 2000, AM J EPIDEMIOL, V151, P550, DOI 10.1093/oxfordjournals.aje.a010242; Carroll KK, 1998, LIPIDS, V33, P1055, DOI 10.1007/s11745-998-0305-8; Centers for Disease Control and Prevention (CDC) National Center for Health Statistics (NCHS), 2002, NAT HLTH NUTR EX SUR; Chow WH, 1998, JNCI-J NATL CANCER I, V90, P150, DOI 10.1093/jnci/90.2.150; Cox D. R., 1984, ANAL SURVIVAL DATA; COX DR, 1972, J R STAT SOC B, V34, P187; CRAMER DW, 1984, OBSTET GYNECOL, V63, P833; FARROW DC, 1989, AM J EPIDEMIOL, V129, P1300, DOI 10.1093/oxfordjournals.aje.a115249; FerroLuzzi A, 1995, WHO TECH REP SER, V854, P1; FLANDERS WD, 1984, J CHRON DIS, V37, P449, DOI 10.1016/0021-9681(84)90028-6; Gapstur SM, 2000, JAMA-J AM MED ASSOC, V283, P2552, DOI 10.1001/jama.283.19.2552; Garfinkel L, 1985, Natl Cancer Inst Monogr, V67, P49; Giovannucci E, 1997, CANCER EPIDEM BIOMAR, V6, P557; Henley SJ, 2002, EPIDEMIOLOGY, V13, P268, DOI 10.1097/00001648-200205000-00006; Hill HA, 1996, CANCER CAUSE CONTROL, V7, P19, DOI 10.1007/BF00115635; Holly EA, 1999, AM J EPIDEMIOL, V150, P375, DOI 10.1093/oxfordjournals.aje.a010017; Hunter DJ, 1996, CANCER CAUSE CONTROL, V7, P56, DOI 10.1007/BF00115638; International Agency for Research on Cancer, 2002, IARC HDB CANC PREV, V6; Ji BT, 1997, CANCER EPIDEM BIOMAR, V6, P481; KLEINBAUM DG, 1982, EPIDEMIOLOGIC RES PR, P163; Kolonel LN, 1996, CANCER CAUSE CONTROL, V7, P83, DOI 10.1007/BF00115640; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Kuczmarski RJ, 1997, OBES RES, V5, P542, DOI 10.1002/j.1550-8528.1997.tb00575.x; LEW EA, 1979, J CHRON DIS, V32, P563, DOI 10.1016/0021-9681(79)90119-X; Lindsted KD, 1998, INT J OBESITY, V22, P544, DOI 10.1038/sj.ijo.0800623; MANSON JE, 1995, NEW ENGL J MED, V333, P677, DOI 10.1056/NEJM199509143331101; Michaud DS, 2001, JAMA-J AM MED ASSOC, V286, P921, DOI 10.1001/jama.286.8.921; Mink PJ, 1996, EPIDEMIOLOGY, V7, P38, DOI 10.1097/00001648-199601000-00008; MOLLER H, 1994, EUR J CANCER, V30A, P344, DOI 10.1016/0959-8049(94)90254-2; Nomura AM, 2001, EPIDEMIOL REV, V23, P126, DOI 10.1093/oxfordjournals.epirev.a000777; PALTA M, 1982, AM J EPIDEMIOL, V115, P223, DOI 10.1093/oxfordjournals.aje.a113294; Peto J, 2001, NATURE, V411, P390, DOI 10.1038/35077256; Petrelli JM, 2002, CANCER CAUSE CONTROL, V13, P325, DOI 10.1023/A:1015288615472; Potter JD, 1996, CANCER CAUSE CONTROL, V7, P127, DOI 10.1007/BF00115644; Purdie DM, 2001, CANCER CAUSE CONTROL, V12, P855, DOI 10.1023/A:1012267619561; Reeves MJ, 1996, CANCER, V77, P301, DOI 10.1002/(SICI)1097-0142(19960115)77:2<301::AID-CNCR12>3.0.CO;2-5; Rockhill B, 1998, AM J PUBLIC HEALTH, V88, P15, DOI 10.2105/AJPH.88.1.15; Rodriguez C, 2001, CANCER EPIDEM BIOMAR, V10, P345; Rothman K., 1998, MODERN EPIDEMIOLOGY; Silverman DT, 1998, JNCI-J NATL CANCER I, V90, P1710, DOI 10.1093/jnci/90.22.1710; SLATTERY ML, 1989, AM J EPIDEMIOL, V130, P497, DOI 10.1093/oxfordjournals.aje.a115363; STELLMAN SD, 1986, JNCI-J NATL CANCER I, V76, P1057; STEVENS J, 1990, AM J EPIDEMIOL, V132, P1156, DOI 10.1093/oxfordjournals.aje.a115758; Stevens J, 1998, OBES RES, V6, P268, DOI 10.1002/j.1550-8528.1998.tb00349.x; STEWART AW, 1987, AM J EPIDEMIOL, V125, P122, DOI 10.1093/oxfordjournals.aje.a114494; STROM BL, 1995, CANCER, V76, P1747, DOI 10.1002/1097-0142(19951115)76:10<1747::AID-CNCR2820761011>3.0.CO;2-L; THUN MJ, 1992, JNCI-J NATL CANCER I, V84, P1491, DOI 10.1093/jnci/84.19.1491; VAUGHAN TL, 1995, CANCER EPIDEM BIOMAR, V4, P85; WALTER SD, 1976, BIOMETRICS, V32, P829, DOI 10.2307/2529268; Wee CC, 2000, ANN INTERN MED, V132, P697, DOI 10.7326/0003-4819-132-9-200005020-00003; *WHO, 1977, INT CLASS DIS MAN IN, V1; Willett W., 2012, NUTR EPIDEMIOLOGY; WILLETT WC, 1995, JAMA-J AM MED ASSOC, V273, P461, DOI 10.1001/jama.273.6.461; Willett WC, 1999, NEW ENGL J MED, V341, P427, DOI 10.1056/NEJM199908053410607; Wolk A, 1996, CANCER CAUSE CONTROL, V7, P5, DOI 10.1007/BF00115634; Wolk A, 2001, CANCER CAUSE CONTROL, V12, P13, DOI 10.1023/A:1008995217664; World Cancer Research Fund, 1997, FOOD NUTR PREV CANC, P371; Zatonski WA, 1997, JNCI-J NATL CANCER I, V89, P1132, DOI 10.1093/jnci/89.15.1132	65	5283	5436	23	574	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 24	2003	348	17					1625	1638		10.1056/NEJMoa021423	http://dx.doi.org/10.1056/NEJMoa021423			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	670PB	12711737				2022-12-24	WOS:000182416300002
J	Pluchino, S; Quattrini, A; Brambilla, E; Gritti, A; Salani, G; Dina, G; Galli, R; Del Carro, U; Amadio, S; Bergami, A; Furlan, R; Comi, G; Vescovi, AL; Martino, G				Pluchino, S; Quattrini, A; Brambilla, E; Gritti, A; Salani, G; Dina, G; Galli, R; Del Carro, U; Amadio, S; Bergami, A; Furlan, R; Comi, G; Vescovi, AL; Martino, G			Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis	NATURE			English	Article							CENTRAL-NERVOUS-SYSTEM; STEM-CELLS; TRANSPLANTATION; REMYELINATION; ENCEPHALOMYELITIS; REGENERATION; PROGENITORS; ANTIBODIES; LESIONS; REPAIR	Widespread demyelination and axonal loss are the pathological hallmarks of multiple sclerosis. The multifocal nature of this chronic inflammatory disease of the central nervous system complicates cellular therapy and puts emphasis on both the donor cell origin and the route of cell transplantation. We established syngenic adult neural stem cell cultures and injected them into an animal model of multiple sclerosis-experimental autoimmune encephalomyelitis (EAE) in the mouse-either intravenously or intracerebroventricularly. In both cases, significant numbers of donor cells entered into demyelinating areas of the central nervous system and differentiated into mature brain cells. Within these areas, oligodendrocyte progenitors markedly increased, with many of them being of donor origin and actively remyelinating axons. Furthermore, a significant reduction of astrogliosis and a marked decrease in the extent of demyelination and axonal loss were observed in transplanted animals. The functional impairment caused by EAE was almost abolished in transplanted mice, both clinically and neurophysiologically. Thus, adult neural precursor cells promote multifocal remyelination and functional recovery after intravenous or intrathecal injection in a chronic model of multiple sclerosis.	Hosp San Raffaele, DIBIT, Neuroimmunol Unit, I-20132 Milan, Italy; Hosp San Raffaele, Stem Cell Res Inst, I-20132 Milan, Italy; Hosp San Raffaele, Dept Neurol & Neurophysiol, I-20132 Milan, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Martino, G (corresponding author), Hosp San Raffaele, DIBIT, Neuroimmunol Unit, Via Olgettina 58, I-20132 Milan, Italy.	vescovi@tin.it; martino.gianvito@hsr.it	Gritti, Angela/K-2729-2016; Del Carro, Ubaldo/AAO-3457-2020; Vescovi, Angelo Luigi/A-4919-2015; Messier, Claude/A-2322-2008; BRAMBILLA, ELENA/AAN-3742-2020; Galli, Rossella/AAI-8028-2020; Pluchino, Stefano/AAE-9037-2019; martino, gianvito/AAL-2682-2020; dina, giorgia/AAN-3770-2020; Quattrini, Angelo/J-8373-2018	Gritti, Angela/0000-0002-9845-0370; Del Carro, Ubaldo/0000-0003-3301-5412; Vescovi, Angelo Luigi/0000-0002-1742-4112; Messier, Claude/0000-0002-4791-1763; BRAMBILLA, ELENA/0000-0003-1399-2128; Galli, Rossella/0000-0001-9023-7033; Pluchino, Stefano/0000-0002-6267-9472; martino, gianvito/0000-0003-1295-9131; dina, giorgia/0000-0002-9684-2143; Quattrini, Angelo/0000-0002-8226-8320				Aboody KS, 2000, P NATL ACAD SCI USA, V97, P12846, DOI 10.1073/pnas.97.23.12846; Alexander JS, 2002, J ANAT, V200, P561, DOI 10.1046/j.1469-7580.2002.00057.x; Archer DR, 1997, NAT MED, V3, P54, DOI 10.1038/nm0197-54; BLAKEMORE WF, 1977, NATURE, V266, P68, DOI 10.1038/266068a0; Brocke S, 1999, P NATL ACAD SCI USA, V96, P6896, DOI 10.1073/pnas.96.12.6896; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; Chen JL, 2001, J NEUROL SCI, V189, P49, DOI 10.1016/S0022-510X(01)00557-3; Chopp M, 2002, LANCET NEUROL, V1, P92, DOI 10.1016/S1474-4422(02)00040-6; Clarke D, 2001, CURR OPIN GENET DEV, V11, P575, DOI 10.1016/S0959-437X(00)00235-5; DECKERTSCHLUTER M, 1994, J NEUROPATH EXP NEUR, V53, P457, DOI 10.1097/00005072-199409000-00005; Del Maschio A, 1999, J EXP MED, V190, P1351, DOI 10.1084/jem.190.9.1351; Eclancher F, 1996, BRAIN RES, V737, P201, DOI 10.1016/0006-8993(96)00732-9; Feltri ML, 2002, J CELL BIOL, V156, P199, DOI 10.1083/jcb.200109021; Follenzi A, 2000, NAT GENET, V25, P217, DOI 10.1038/76095; Franklin RJM, 1997, MULT SCLER, V3, P84, DOI 10.1177/135245859700300205; Franklin RJM, 2002, NAT REV NEUROSCI, V3, P705, DOI 10.1038/nrn917; Furlan R, 2001, J IMMUNOL, V167, P1821, DOI 10.4049/jimmunol.167.3.1821; Galli R, 2002, DEVELOPMENT, V129, P1633; Gensert JM, 1997, NEURON, V19, P197, DOI 10.1016/S0896-6273(00)80359-1; Gritti A, 1999, J NEUROSCI, V19, P3287; GROVES AK, 1993, NATURE, V362, P453, DOI 10.1038/362453a0; Hemmer B, 2002, NAT REV NEUROSCI, V3, P291, DOI 10.1038/nrn784; Horner PJ, 2000, NATURE, V407, P963, DOI 10.1038/35039559; Imaizumi T, 2000, NAT BIOTECHNOL, V18, P949, DOI 10.1038/79432; Jefferson S, 1997, MULT SCLER, V3, P162, DOI 10.1177/135245859700300220; Kim JH, 2002, NATURE, V418, P50, DOI 10.1038/nature00900; Learish RD, 1999, ANN NEUROL, V46, P716, DOI 10.1002/1531-8249(199911)46:5<716::AID-ANA6>3.0.CO;2-M; Linker RA, 2002, NAT MED, V8, P620, DOI 10.1038/nm0602-620; Lucchinetti C, 2000, ANN NEUROL, V47, P707, DOI 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q; Moon LDF, 2001, EUR J NEUROSCI, V14, P1667, DOI 10.1046/j.0953-816x.2001.01795.x; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; Teng YD, 2002, P NATL ACAD SCI USA, V99, P3024, DOI 10.1073/pnas.052678899	32	850	923	0	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 17	2003	422	6933					688	694		10.1038/nature01552	http://dx.doi.org/10.1038/nature01552			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668CG	12700753				2022-12-24	WOS:000182272300032
J	Kuypers, MMM; Sliekers, AO; Lavik, G; Schmid, M; Jorgensen, BB; Kuenen, JG; Damste, JSS; Strous, M; Jetten, MSM				Kuypers, MMM; Sliekers, AO; Lavik, G; Schmid, M; Jorgensen, BB; Kuenen, JG; Damste, JSS; Strous, M; Jetten, MSM			Anaerobic ammonium oxidation by anammox bacteria in the Black Sea	NATURE			English	Article							TARGETED OLIGONUCLEOTIDE PROBES; IN-SITU DETECTION; OXIDIZING BACTERIA; MARINE-SEDIMENTS; DIVERSITY; NITROGEN; OCEAN	The availability of fixed inorganic nitrogen (nitrate, nitrite and ammonium) limits primary productivity in many oceanic regions(1). The conversion of nitrate to N(2) by heterotrophic bacteria (denitrification) is believed to be the only important sink for fixed inorganic nitrogen in the ocean(2). Here we provide evidence for bacteria that anaerobically oxidize ammonium with nitrite to N(2) in the world's largest anoxic basin, the Black Sea. Phylogenetic analysis of 16S ribosomal RNA gene sequences shows that these bacteria are related to members of the order Planctomycetales performing the anammox (anaerobic ammonium oxidation) process in ammonium-removing bioreactors(3). Nutrient profiles, fluorescently labelled RNA probes, (15)N tracer experiments and the distribution of specific 'ladderane' membrane lipids(4) indicate that ammonium diffusing upwards from the anoxic deep water is consumed by anammox bacteria below the oxic zone. This is the first time that anammox bacteria have been identified and directly linked to the removal of fixed inorganic nitrogen in the environment. The widespread occurrence of ammonium consumption in suboxic marine settings(5-7) indicates that anammox might be important in the oceanic nitrogen cycle.	Max Planck Inst Marine Microbiol, Dept Biogeochem, D-28359 Bremen, Germany; Delft Univ Technol, Dept Microbiol, NL-2628 BC Delft, Netherlands; Royal Netherlands Inst Sea Res NIOZ, Dept Marine Biogeochem & Toxicol, NL-1790 AB Den Burg, Netherlands; Univ Nijmegen, Dept Microbiol, NL-6526 ED Nijmegen, Netherlands	Max Planck Society; Delft University of Technology; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); Radboud University Nijmegen	Kuypers, MMM (corresponding author), Max Planck Inst Marine Microbiol, Dept Biogeochem, Celsiusstr 1, D-28359 Bremen, Germany.	mkuypers@mpi-bremen.de	Jetten, Mike/B-8834-2011; Damste, Jaap S Sinninghe/F-6128-2011; Strous, Marc/B-4064-2017; Schmid, Markus C/D-2669-2012; Lavik, Gaute/F-6578-2013; Jorgensen, Bo B/C-2214-2013	Jetten, Mike/0000-0002-4691-7039; Damste, Jaap S Sinninghe/0000-0002-8683-1854; Strous, Marc/0000-0001-9600-3828; Jorgensen, Bo B/0000-0001-9398-8027; Sliekers, Olav/0000-0002-8109-2431				AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919, DOI 10.1128/AEM.56.6.1919-1925.1990; BENDER M, 1989, GEOCHIM COSMOCHIM AC, V53, P685, DOI 10.1016/0016-7037(89)90011-2; Berg P, 1998, LIMNOL OCEANOGR, V43, P1500, DOI 10.4319/lo.1998.43.7.1500; Codispoti L.A., 1991, DEEP-SEA RES, V38, P691, DOI 10.1016/S0198-0149(10)80004-4; CODISPOTI LA, 1985, MAR CHEM, V16, P277, DOI 10.1016/0304-4203(85)90051-9; Dalsgaard T, 2002, APPL ENVIRON MICROB, V68, P3802, DOI 10.1128/AEM.68.8.3802-3808.2002; Damste JSS, 2002, NATURE, V419, P708, DOI 10.1038/nature01128; Falkowski PG, 1997, NATURE, V387, P272, DOI 10.1038/387272a0; FROELICH PN, 1979, GEOCHIM COSMOCHIM AC, V43, P1075, DOI 10.1016/0016-7037(79)90095-4; Kuenen JG, 2001, ASM NEWS, V67, P456; LEWIS BL, 1991, DEEP SEA RES S2, V38, P773; Li LN, 1999, BIODIVERS CONSERV, V8, P659, DOI 10.1023/A:1008848203739; MULDER A, 1995, FEMS MICROBIOL ECOL, V16, P177, DOI 10.1016/0168-6496(94)00081-7; MURRAY JW, 1995, ADV CHEM SER, V244, P157, DOI 10.1021/ba-1995-0244.ch007; Neef A, 1998, MICROBIOL-UK, V144, P3257, DOI 10.1099/00221287-144-12-3257; Oguz T, 2001, DEEP-SEA RES PT I, V48, P761, DOI 10.1016/S0967-0637(00)00054-6; Pernthaler J, 2001, METHOD MICROBIOL, V30, P207, DOI 10.1016/S0580-9517(01)30046-6; Redfield A. C, 1963, SEA, P26, DOI DOI 10.1016/J.ORGGEOCHEM.2014.06.002; Richards F.A., 1965, CHEM OCEANOGRAPHY, P611; Schmid M, 2000, SYST APPL MICROBIOL, V23, P93, DOI 10.1016/S0723-2020(00)80050-8; Schmid M, 2001, ENVIRON MICROBIOL, V3, P450, DOI 10.1046/j.1462-2920.2001.00211.x; Sorokin YI., 2002, BIO INL WAT; Strous M, 1999, NATURE, V400, P446, DOI 10.1038/22749; Thamdrup B, 2002, APPL ENVIRON MICROB, V68, P1312, DOI 10.1128/AEM.68.3.1312-1318.2002; WARD BB, 1991, NATO ADV SCI I C-MAT, V351, P111; [No title captured]	26	879	1031	29	809	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 10	2003	422	6932					608	611		10.1038/nature01472	http://dx.doi.org/10.1038/nature01472			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665GN	12686999				2022-12-24	WOS:000182111400040
J	DeCoursey, TE; Morgan, D; Cherny, VV				DeCoursey, TE; Morgan, D; Cherny, VV			The voltage dependence of NADPH oxidase reveals why phagocytes need proton channels	NATURE			English	Article							HYDROGEN-ION CURRENTS; HUMAN-NEUTROPHILS; ELECTRON CURRENTS; HUMAN EOSINOPHILS; SNAIL NEURONS; HUMAN BLOOD; H+ CHANNEL; ACTIVATION; PH; MEMBRANE	The enzyme NADPH oxidase in phagocytes is important in the body's defence against microbes: it produces superoxide anions (O-2(-), precursors to bactericidal reactive oxygen species(1)). Electrons move from intracellular NADPH, across a chain comprising FAD ( flavin adenine dinucleotide) and two haems, to reduce extracellular O-2 to O-2(-). NADPH oxidase is electrogenic(2), generating electron current (I-e) that is measurable under voltage-clamp conditions(3,4). Here we report the complete current-voltage relationship of NADPH oxidase, the first such measurement of a plasma membrane electron transporter. We find that Ie is voltage-independent from -100 mV to >0 mV, but is steeply inhibited by further depolarization, and is abolished at about +190 mV. It was proposed that H+ efflux(2) mediated by voltage-gated proton channels(5,6) compensates I-e, because Zn2+ and Cd2+ inhibit both H+ currents(7-9) and O-2(-) production(10). Here we show that COS-7 cells transfected with four NADPH oxidase components(11), but lacking H+ channels(12), produce O-2(-) in the presence of Zn2+ concentrations that inhibit O-2(-) production in neutrophils and eosinophils. Zn2+ does not inhibit NADPH oxidase directly, but through effects on H+ channels. H+ channels optimize NADPH oxidase function by preventing membrane depolarization to inhibitory voltages.	Rush Presbyterian St Lukes Med Ctr, Dept Mol Biophys & Physiol, Chicago, IL 60612 USA	Rush University	DeCoursey, TE (corresponding author), Rush Presbyterian St Lukes Med Ctr, Dept Mol Biophys & Physiol, 1750 W Harrison, Chicago, IL 60612 USA.	tdecours@rush.edu	DeCoursey, Thomas/A-6820-2009	DeCoursey, Thomas/0000-0002-4263-180X	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061437] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL061437] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Babior BM, 1999, BLOOD, V93, P1464, DOI 10.1182/blood.V93.5.1464.405a32_1464_1476; Banfi B, 1999, J EXP MED, V190, P183, DOI 10.1084/jem.190.2.183; Biberstine-Kinkade KJ, 2001, J BIOL CHEM, V276, P31105, DOI 10.1074/jbc.M103327200; BURTON K, 1953, BIOCHEM J, V54, P86, DOI 10.1042/bj0540086; BYERLY L, 1984, J PHYSIOL-LONDON, V351, P199, DOI 10.1113/jphysiol.1984.sp015241; Cherny VV, 2001, J PHYSIOL-LONDON, V535, P783, DOI 10.1111/j.1469-7793.2001.00783.x; Cherny VV, 1999, J GEN PHYSIOL, V114, P819, DOI 10.1085/jgp.114.6.819; CROSS AR, 1986, BIOCHEM J, V237, P111, DOI 10.1042/bj2370111; DeCoursey TE, 2000, P NATL ACAD SCI USA, V97, P6885, DOI 10.1073/pnas.100047297; DECOURSEY TE, 1993, BIOPHYS J, V65, P1590, DOI 10.1016/S0006-3495(93)81198-6; DeCoursey TE, 2001, J PHYSIOL-LONDON, V535, P767, DOI 10.1111/j.1469-7793.2001.00767.x; Gordienko DV, 1996, J PHYSIOL-LONDON, V496, P299, DOI 10.1113/jphysiol.1996.sp021686; HENDERSON LM, 1987, BIOCHEM J, V246, P325, DOI 10.1042/bj2460325; HENDERSON LM, 1988, BIOCHEM J, V255, P285; HENDERSON LM, 1988, BIOCHEM J, V251, P563, DOI 10.1042/bj2510563; Jankowski A, 1999, J BIOL CHEM, V274, P26098, DOI 10.1074/jbc.274.37.26098; KAPUS A, 1992, BIOCHEM J, V281, P697, DOI 10.1042/bj2810697; Koshkin V, 1997, BBA-BIOENERGETICS, V1319, P139, DOI 10.1016/S0005-2728(96)00154-5; Lauger P., 1991, ELECTROGENIC ION PUM; Lowenthal A, 1999, J BIOL CHEM, V274, P21603, DOI 10.1074/jbc.274.31.21603; MAHAUTSMITH MP, 1989, J EXP BIOL, V145, P455; MARTIN MA, 1988, J IMMUNOL, V140, P3928; Morgan D, 2002, J GEN PHYSIOL, V119, P571, DOI 10.1085/jgp.20018544; MUIRWOOD P, 1974, FEBS LETT, V44, P22, DOI 10.1016/0014-5793(74)80297-8; NANDA A, 1991, P NATL ACAD SCI USA, V88, P10816, DOI 10.1073/pnas.88.23.10816; Price MO, 2002, BLOOD, V99, P2653, DOI 10.1182/blood.V99.8.2653; Reeves EP, 2002, NATURE, V416, P291, DOI 10.1038/416291a; Schrenzel J, 1998, NATURE, V392, P734, DOI 10.1038/33725; Tare M, 1998, J PHYSIOL-LONDON, V506, P303, DOI 10.1111/j.1469-7793.1998.303bw.x; THOMAS RC, 1982, NATURE, V299, P826, DOI 10.1038/299826a0	30	247	251	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 3	2003	422	6931					531	534		10.1038/nature01523	http://dx.doi.org/10.1038/nature01523			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	662TW	12673252				2022-12-24	WOS:000181965400040
J	Atkinson, MR; Savageau, MA; Myers, JT; Ninfa, AJ				Atkinson, MR; Savageau, MA; Myers, JT; Ninfa, AJ			Development of genetic circuitry exhibiting toggle switch or oscillatory behavior in Escherichia coli	CELL			English	Article							GLUTAMINE-SYNTHETASE; NITROGEN STARVATION; GLNA PROMOTER; EXPRESSION; OPERON; CYANOBACTERIA; TRANSCRIPTION; RHYTHMS; PROTEIN; PRODUCT	Analysis of the system design principles of signaling systems requires model systems where all components and regulatory interactions are known. Components of the Lac and Ntr systems were used to construct genetic circuits that display toggle switch or oscillatory behavior. Both devices contain an "activator module" consisting of a modified glnA promoter with lac operators, driving the expression of the activator, NRI. Since NRI activates the glnA promoter, this creates an autoactivated circuit repressible by Lacl. The oscillator contains a "repressor module" consisting of the NRI-activated glnK promoter driving Lacl expression. This circuitry produced synchronous damped oscillations in turbidostat cultures, with periods much longer than the cell cycle. For the toggle switch, Lacl was provided constitutively; the level of active repressor was controlled by using a lacY mutant and varying the concentration of IPTG. This circuitry provided nearly discontinuous expression of activator.	Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Mol & Cellular Biol Program, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Ninfa, AJ (corresponding author), Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063642] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01-GM63642] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Atkinson MR, 2002, MOL MICROBIOL, V46, P1247, DOI 10.1046/j.1365-2958.2002.03211.x; Atkinson MR, 2002, J BACTERIOL, V184, P5358, DOI 10.1128/JB.184.19.5358-5363.2002; Barkai N, 2000, NATURE, V403, P267, DOI 10.1038/35002258; Beckwith J, 1987, ESCHERICHIA COLI SAL, P1444; Blauwkamp TA, 2002, MOL MICROBIOL, V46, P203, DOI 10.1046/j.1365-2958.2002.03153.x; CHEN YM, 1982, J BACTERIOL, V150, P214, DOI 10.1128/JB.150.1.214-220.1982; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Kondo T, 1997, SCIENCE, V275, P224, DOI 10.1126/science.275.5297.224; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mori T, 1996, P NATL ACAD SCI USA, V93, P10183, DOI 10.1073/pnas.93.19.10183; Ninfa AJ, 2000, CURR TOP CELL REGUL, V36, P31; NINFA AJ, 1987, CELL, V50, P1039, DOI 10.1016/0092-8674(87)90170-X; NINFA AJ, 1986, P NATL ACAD SCI USA, V83, P5909, DOI 10.1073/pnas.83.16.5909; OEHLER S, 1990, EMBO J, V9, P973, DOI 10.1002/j.1460-2075.1990.tb08199.x; REITZER LJ, 1985, P NATL ACAD SCI USA, V82, P1979, DOI 10.1073/pnas.82.7.1979; RHEE SG, 1985, METHOD ENZYMOL, V113, P213; ROTHSTEIN DM, 1980, P NATL ACAD SCI-BIOL, V77, P7372, DOI 10.1073/pnas.77.12.7372; Savageau M, 1976, BIOCH SYSTEMS ANAL S; SAVAGEAU MA, 1975, NATURE, V258, P208, DOI 10.1038/258208a0; Savageau MA, 2002, MATH BIOSCI, V180, P237, DOI 10.1016/S0025-5564(02)00113-X; Silhavy T. J., 1984, EXPT GENE FUSIONS, P107; SIMONS RW, 1987, GENE, V53, P85, DOI 10.1016/0378-1119(87)90095-3; SU W, 1990, P NATL ACAD SCI USA, V87, P5504, DOI 10.1073/pnas.87.14.5504	25	513	527	5	81	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 30	2003	113	5					597	607		10.1016/S0092-8674(03)00346-5	http://dx.doi.org/10.1016/S0092-8674(03)00346-5			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	687VL	12787501	Bronze			2022-12-24	WOS:000183397600010
J	Willert, K; Brown, JD; Danenberg, E; Duncan, AW; Weissman, IL; Reya, T; Yates, JR; Nusse, R				Willert, K; Brown, JD; Danenberg, E; Duncan, AW; Weissman, IL; Reya, T; Yates, JR; Nusse, R			Wnt proteins are lipid-modified and can act as stem cell growth factors	NATURE			English	Article							SIGNALING PATHWAY; C-ELEGANS; DROSOPHILA; WINGLESS; IDENTIFICATION; EXPRESSION; CANCER; FORM	Wnt signalling is involved in numerous events in animal development(1), including the proliferation of stem cells(2) and the specification of the neural crest(3). Wnt proteins are potentially important reagents in expanding specific cell types, but in contrast to other developmental signalling molecules such as hedgehog proteins and the bone morphogenetic proteins, Wnt proteins have never been isolated in an active form. Although Wnt proteins are secreted from cells(4-7), secretion is usually inefficient(8) and previous attempts to characterize Wnt proteins have been hampered by their high degree of insolubility. Here we have isolated active Wnt molecules, including the product of the mouse Wnt3a gene. By mass spectrometry, we found the proteins to be palmitoylated on a conserved cysteine. Enzymatic removal of the palmitate or site-directed and natural mutations of the modified cysteine result in loss of activity, and indicate that the lipid is important for signalling. The purified Wnt3a protein induces self-renewal of haematopoietic stem cells, signifying its potential use in tissue engineering.	Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	Howard Hughes Medical Institute; Stanford University; Stanford University; Duke University; Stanford University; Scripps Research Institute	Nusse, R (corresponding author), Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA.			Duncan, Andrew/0000-0003-4962-4191; Danenberg, Esther/0000-0002-1799-4457				BORDIER C, 1981, J BIOL CHEM, V256, P1604; BRADLEY RS, 1995, MOL CELL BIOL, V15, P4616; Brannon M, 1996, DEV BIOL, V180, P344, DOI 10.1006/dbio.1996.0306; BURRUS LW, 1995, EXP CELL RES, V220, P363, DOI 10.1006/excr.1995.1327; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; COUSO JP, 1994, CELL, V79, P259, DOI 10.1016/0092-8674(94)90195-3; Domen J, 2000, J EXP MED, V192, P1707, DOI 10.1084/jem.192.12.1707; Duncan JA, 1998, J BIOL CHEM, V273, P15830, DOI 10.1074/jbc.273.25.15830; Garcia-Castro MI, 2002, SCIENCE, V297, P848, DOI 10.1126/science.1070824; Hofmann K, 2000, TRENDS BIOCHEM SCI, V25, P111, DOI 10.1016/S0968-0004(99)01539-X; Hsieh JC, 1999, P NATL ACAD SCI USA, V96, P3546, DOI 10.1073/pnas.96.7.3546; Kadowaki T, 1996, GENE DEV, V10, P3116, DOI 10.1101/gad.10.24.3116; MacCoss MJ, 2002, P NATL ACAD SCI USA, V99, P7900, DOI 10.1073/pnas.122231399; Maloof JN, 1999, DEVELOPMENT, V126, P37; MASON JO, 1992, MOL BIOL CELL, V3, P521, DOI 10.1091/mbc.3.5.521; McKendry R, 1997, DEV BIOL, V192, P420, DOI 10.1006/dbio.1997.8797; NOORDERMEER J, 1994, NATURE, V367, P80, DOI 10.1038/367080a0; PAPKOFF J, 1990, MOL CELL BIOL, V10, P2723, DOI 10.1128/MCB.10.6.2723; Pepinsky RB, 1998, J BIOL CHEM, V273, P14037, DOI 10.1074/jbc.273.22.14037; Polakis P, 2000, GENE DEV, V14, P1837; REYA T, 2003, NATURE          0427; Rocheleau CE, 1997, CELL, V90, P707, DOI 10.1016/S0092-8674(00)80531-0; ROELINK H, 1991, GENE DEV, V5, P381, DOI 10.1101/gad.5.3.381; Shibamoto S, 1998, GENES CELLS, V3, P659; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Tanaka K, 2002, J BIOL CHEM, V277, P12816, DOI 10.1074/jbc.M200187200; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; VANLEEUWEN F, 1994, NATURE, V368, P342, DOI 10.1038/368342a0; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Wu CH, 2002, J BIOL CHEM, V277, P41762, DOI 10.1074/jbc.M207850200	30	1673	1827	4	216	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 22	2003	423	6938					448	452		10.1038/nature01611	http://dx.doi.org/10.1038/nature01611			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681AJ	12717451				2022-12-24	WOS:000183012000044
J	Lessard, J; Sauvageau, G				Lessard, J; Sauvageau, G			Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells	NATURE			English	Article							ACUTE MYELOID-LEUKEMIA; BONE-MARROW CELLS; ACUTE MYELOGENOUS LEUKEMIA; POLYCOMB-GROUP GENES; HEMATOPOIETIC-CELL; EXPRESSION; HOXA9; T(7-11)(P15-P15); TRANSFORMATION; OVEREXPRESSION	An emerging concept in the field of cancer biology is that a rare population of 'tumour stem cells' exists among the heterogeneous group of cells that constitute a tumour. This concept, best described with human leukaemia, indicates that stem cell function ( whether normal or neoplastic) might be defined by a common set of critical genes. Here we show that the Polycomb group gene Bmi-1 has a key role in regulating the proliferative activity of normal stem and progenitor cells. Most importantly, we provide evidence that the proliferative potential of leukaemic stem and progenitor cells lacking Bmi-1 is compromised because they eventually undergo proliferation arrest and show signs of differentiation and apoptosis, leading to transplant failure of the leukaemia. Complementation studies showed that Bmi-1 completely rescues these proliferative defects. These studies therefore indicate that Bmi-1 has an essential role in regulating the proliferative activity of both normal and leukaemic stem cells.	Clin Res Inst Montreal, Lab Mol Genet Hemopoiet Stem Cells, Montreal, PQ H2W 1R7, Canada; Univ Montreal, Hosp Maisonneuve Rosemont, Dept Med, Montreal, PQ H3C 3J7, Canada; Univ Montreal, Hosp Maisonneuve Rosemont, Div Hematol, Montreal, PQ H3C 3J7, Canada	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Universite de Montreal; Universite de Montreal	Sauvageau, G (corresponding author), Clin Res Inst Montreal, Lab Mol Genet Hemopoiet Stem Cells, 110 Pine Ave W, Montreal, PQ H2W 1R7, Canada.	sauvagg@ircm.qc.ca		Sauvageau, Guy/0000-0002-4333-7266				Appelbaum F R, 2001, Hematology Am Soc Hematol Educ Program, P62; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Borrow J, 1996, NAT GENET, V12, P159, DOI 10.1038/ng0296-159; BRADY G, 1990, Methods in Molecular and Cellular Biology, V2, P17; Dimri GP, 2002, CANCER RES, V62, P4736; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Jordan CT, 2000, LEUKEMIA, V14, P1777, DOI 10.1038/sj.leu.2401903; Kamijo T, 1998, P NATL ACAD SCI USA, V95, P8292, DOI 10.1073/pnas.95.14.8292; Kroon E, 1998, EMBO J, V17, P3714, DOI 10.1093/emboj/17.13.3714; Krosl J, 1998, ONCOGENE, V16, P3403, DOI 10.1038/sj.onc.1201883; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Lessard J, 1999, GENE DEV, V13, P2691, DOI 10.1101/gad.13.20.2691; Lessard J, 1998, BLOOD, V91, P1216, DOI 10.1182/blood.V91.4.1216; Nakamura T, 1996, NAT GENET, V12, P154, DOI 10.1038/ng0296-154; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Park IK, 2002, BLOOD, V99, P488, DOI 10.1182/blood.V99.2.488; Porcher C, 1996, CELL, V86, P47, DOI 10.1016/S0092-8674(00)80076-8; SAUVAGEAU G, 1995, GENE DEV, V9, P1753, DOI 10.1101/gad.9.14.1753; Sauvageau G, 1997, IMMUNITY, V6, P13, DOI 10.1016/S1074-7613(00)80238-1; Testa U, 2002, BLOOD, V100, P2980, DOI 10.1182/blood-2002-03-0852; Thorsteinsdottir U, 2002, BLOOD, V99, P121, DOI 10.1182/blood.V99.1.121; VANDERLUGT NMT, 1994, GENE DEV, V8, P757, DOI 10.1101/gad.8.7.757; Vonlanthen S, 2001, BRIT J CANCER, V84, P1372, DOI 10.1054/bjoc.2001.1791; Weber HO, 2002, ONCOGENE, V21, P3207, DOI 10.1038/sj.onc.1205429	24	1177	1298	3	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 15	2003	423	6937					255	260		10.1038/nature01572	http://dx.doi.org/10.1038/nature01572			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678EX	12714970				2022-12-24	WOS:000182853100034
J	Seto, WH; Tsang, D; Yung, RWH; Ching, TY; Ng, TK; Ho, M; Ho, LM; Peiris, JSM				Seto, WH; Tsang, D; Yung, RWH; Ching, TY; Ng, TK; Ho, M; Ho, LM; Peiris, JSM		Advisors Expert SARS Grp Hosp Auth	Effectiveness of precautions against droplets and contact in prevention of nosocomial transmission of severe acute respiratory syndrome (SARS)	LANCET			English	Article								We did a case-control study in five Hong Kong hospitals, with 241 non-infected and 13 infected staff with documented exposures to 31 index patients with severe acute respiratory syndrome (SARS) during patient care. All participants were surveyed about use of mask, gloves, gowns, and hand-washing, as recommended under droplets and contact precautions when caring for index patients with SARS. 69 staff who reported use of all four measures were not infected, whereas all Infected staff had omitted at least one measure (p=0.0224). Fewer staff who wore masks (p=0.0001), gowns (p=0.006), and washed their hands (p=0.047) became infected compared with those who didn't, but stepwise logistic regression was significant only for masks (p=0.011). Practice of droplets precaution and contact precaution is adequate in significantly reducing the risk of infection after exposures to patients with SARS. The protective role of the mask suggests that in hospitals, infection is transmitted by droplets.	Queen Mary Hosp, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; Queen Elizabeth Hosp, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; Pamela Nethersole Youde Hosp, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; Princess Margaret Hosp, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; Kwong Wah Hosp, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; Univ Hong Kong, Dept Community Med, Hong Kong, Hong Kong, Peoples R China; Univ Hong Kong, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; Kwong Wah Hospital; University of Hong Kong; University of Hong Kong	Seto, WH (corresponding author), Queen Mary Hosp, Dept Microbiol, Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China.		Peiris, Joseph Sriyal Malik/C-4380-2009	Peiris, Joseph Sriyal Malik/0000-0001-8217-5995; Seto, Wing Hong/0000-0002-1139-9200; ho, lm/0000-0002-2709-927X	PHS HHS [A95357] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Garner JS, 1996, AM J INFECT CONTROL, V24, P24; Peiris JSM, 2003, LANCET, V361, P1319, DOI 10.1016/S0140-6736(03)13077-2; Rosling L, 2003, BRIT MED J, V326, P416, DOI 10.1136/bmj.326.7386.416; *US CDC, 2003, INF CONTR PREC AER G; World Health Organization, 2003, WHO ISS GLOB AL CAS	5	551	590	2	54	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 3	2003	361	9368					1519	1520		10.1016/S0140-6736(03)13168-6	http://dx.doi.org/10.1016/S0140-6736(03)13168-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	674WB	12737864	Green Published, Bronze			2022-12-24	WOS:000182658900012
J	Bibikova, M; Beumer, K; Trautman, JK; Carroll, D				Bibikova, M; Beumer, K; Trautman, JK; Carroll, D			Enhancing gene targeting with designed zinc finger nucleases	SCIENCE			English	Article							EMBRYONIC STEM-CELLS; DOUBLE-STRAND BREAKS; HOMOLOGOUS RECOMBINATION; RESTRICTION ENZYMES; DROSOPHILA; CLEAVAGE; MUTAGENESIS; REPLACEMENT; SELECTION; DOMAINS		Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84132 USA	Utah System of Higher Education; University of Utah	Carroll, D (corresponding author), Univ Utah, Sch Med, Dept Biochem, 20 North 1900 East, Salt Lake City, UT 84132 USA.		Wilson, Matthew H/K-3193-2013		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058504] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM58504] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bibikova M, 2001, MOL CELL BIOL, V21, P289, DOI 10.1128/MCB.21.1.289-297.2001; Bibikova M, 2002, GENETICS, V161, P1169; CAPECCHI MR, 1989, SCIENCE, V244, P1288, DOI 10.1126/science.2660260; CHOULIKA A, 1995, MOL CELL BIOL, V15, P1968; Cohen-Tannoudji M, 1998, MOL CELL BIOL, V18, P1444, DOI 10.1128/MCB.18.3.1444; Donoho G, 1998, MOL CELL BIOL, V18, P4070, DOI 10.1128/MCB.18.7.4070; GLOOR GB, 1991, SCIENCE, V253, P1110, DOI 10.1126/science.1653452; Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156, DOI 10.1073/pnas.93.3.1156; Pabo CO, 2001, ANNU REV BIOCHEM, V70, P313, DOI 10.1146/annurev.biochem.70.1.313; Rong YKS, 2002, GENE DEV, V16, P1568, DOI 10.1101/gad.986602; Rong YS, 2000, SCIENCE, V288, P2013, DOI 10.1126/science.288.5473.2013; Segal DJ, 2002, METHODS, V26, P76, DOI 10.1016/S1046-2023(02)00009-9; Segal DJ, 1999, P NATL ACAD SCI USA, V96, P2758, DOI 10.1073/pnas.96.6.2758; Smih F, 1995, NUCLEIC ACIDS RES, V23, P5012, DOI 10.1093/nar/23.24.5012; Smith J, 2000, NUCLEIC ACIDS RES, V28, P3361, DOI 10.1093/nar/28.17.3361; WONG WJ, 2003, P NATL ACAD SCI USA, V100, P2556	16	597	735	4	93	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 2	2003	300	5620					764	764		10.1126/science.1079512	http://dx.doi.org/10.1126/science.1079512			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673KH	12730594				2022-12-24	WOS:000182579800040
J	Liu, YF; Hong, X; Kappler, J; Jiang, L; Zhang, RG; Xu, LG; Pan, CH; Martin, WE; Murphy, RC; Shu, HB; Dai, SD; Zhang, GY				Liu, YF; Hong, X; Kappler, J; Jiang, L; Zhang, RG; Xu, LG; Pan, CH; Martin, WE; Murphy, RC; Shu, HB; Dai, SD; Zhang, GY			Ligand-receptor binding revealed by the TNF family member TALL-1	NATURE			English	Article							TUMOR-NECROSIS-FACTOR; B-CELL MATURATION; CRYSTAL-STRUCTURE; AUTOIMMUNE-DISEASE; LYMPHOCYTE STIMULATOR; BAFF; TACI; BLYS; APRIL; BCMA	The tumour necrosis factor (TNF) ligand TALL-1 and its cognate receptors, BCMA, TACI and BAFF-R, were recently identified as members of the TNF superfamily, which are essential factors contributing to B-cell maturation. The functional, soluble fragment of TALL-1 (sTALL-1) forms a virus-like assembly for its proper function. Here we determine the crystal structures of sTALL-1 complexed with the extracellular domains of BCMA and BAFF-R at 2.6 and 2.5 Angstrom, respectively. The single cysteine-rich domain of BCMA and BAFF-R both have saddle-like architectures, which sit on the horseback-like surface formed by four coil regions on each individual sTALL-1 monomer. Three novel structural modules, D2, X2 and N, were revealed from the current structures. Sequence alignments, structural modelling and mutagenesis revealed that one disulphide bridge in BAFF-R is critical for determining the binding specificity of the extracellular domain eBAFF-R to TALL-1 instead of APRIL, a closely related ligand of TALL-1, which was confirmed by binding experiments in vitro.	Univ Colorado, Hlth Sci Ctr, Sch Med, Natl Jewish Med & Res Ctr,Integrated Dept Immunol, Denver, CO 80206 USA; Univ Colorado, Hlth Sci Ctr, Sch Med, Howard Hughes Med Inst, Denver, CO 80206 USA; Univ Colorado, Hlth Sci Ctr, Sch Med, Dept Pharmacol,Biomol Struct Program, Denver, CO 80206 USA; Peking Univ, Coll Life Sci, Dept Cell Biol & Genet, Beijing 100871, Peoples R China; Argonne Natl Lab, Struct Biol Sect, Argonne, IL 60439 USA	National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Peking University; United States Department of Energy (DOE); Argonne National Laboratory	Zhang, GY (corresponding author), Univ Colorado, Hlth Sci Ctr, Sch Med, Natl Jewish Med & Res Ctr,Integrated Dept Immunol, 1400 Jackson St, Denver, CO 80206 USA.	zhangg@njc.org		Xu, Liangguo/0000-0003-1991-2889				BANNER DW, 1993, CELL, V73, P431, DOI 10.1016/0092-8674(93)90132-A; Bodmer JL, 2002, TRENDS BIOCHEM SCI, V27, P19, DOI 10.1016/S0968-0004(01)01995-8; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carson M, 1997, METHOD ENZYMOL, V277, P493, DOI 10.1016/S0076-6879(97)77027-7; Cha SS, 1999, IMMUNITY, V11, P253, DOI 10.1016/S1074-7613(00)80100-4; ECK MJ, 1992, J BIOL CHEM, V267, P2119; ECK MJ, 1989, J BIOL CHEM, V264, P17595; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; Gross JA, 2000, NATURE, V404, P995, DOI 10.1038/35010115; Gross JA, 2001, IMMUNITY, V15, P289, DOI 10.1016/S1074-7613(01)00183-2; Hahne M, 1998, J EXP MED, V188, P1185, DOI 10.1084/jem.188.6.1185; Hymowitz SG, 1999, MOL CELL, V4, P563, DOI 10.1016/S1097-2765(00)80207-5; JONES EY, 1989, NATURE, V338, P225, DOI 10.1038/338225a0; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KARPUSAS M, 1995, STRUCTURE, V3, P1031, DOI 10.1016/S0969-2126(01)00239-8; Karpusas M, 2002, J MOL BIOL, V315, P1145, DOI 10.1006/jmbi.2001.5296; Kayagaki N, 2002, IMMUNITY, V17, P515, DOI 10.1016/S1074-7613(02)00425-9; Khare SD, 2000, P NATL ACAD SCI USA, V97, P3370, DOI 10.1073/pnas.050580697; Lam J, 2001, J CLIN INVEST, V108, P971, DOI 10.1172/JCI13890; Liu YF, 2002, CELL, V108, P383, DOI 10.1016/S0092-8674(02)00631-1; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Mackay F, 1999, J EXP MED, V190, P1697, DOI 10.1084/jem.190.11.1697; Mackay F, 2002, TRENDS IMMUNOL, V23, P113, DOI 10.1016/S1471-4906(01)02159-7; Marsters SA, 2000, CURR BIOL, V10, P785, DOI 10.1016/S0960-9822(00)00566-2; Mongkolsapaya J, 1999, NAT STRUCT BIOL, V6, P1048; Moore PA, 1999, SCIENCE, V285, P260, DOI 10.1126/science.285.5425.260; Mukhopadhyay A, 1999, J BIOL CHEM, V274, P15978, DOI 10.1074/jbc.274.23.15978; Naismith JH, 1998, TRENDS BIOCHEM SCI, V23, P74, DOI 10.1016/S0968-0004(97)01164-X; Oren DA, 2002, NAT STRUCT BIOL, V9, P288, DOI 10.1038/nsb769; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Roschke V, 2002, J IMMUNOL, V169, P4314, DOI 10.4049/jimmunol.169.8.4314; Schiemann B, 2001, SCIENCE, V293, P2111, DOI 10.1126/science.1061964; Schneider P, 1999, J EXP MED, V189, P1747, DOI 10.1084/jem.189.11.1747; Schneider P, 2001, J EXP MED, V194, P1691, DOI 10.1084/jem.194.11.1691; Shu HB, 2000, P NATL ACAD SCI USA, V97, P9156, DOI 10.1073/pnas.160213497; Shu HB, 1999, J LEUKOCYTE BIOL, V65, P680, DOI 10.1002/jlb.65.5.680; Thompson JS, 2000, J EXP MED, V192, P129, DOI 10.1084/jem.192.1.129; Thompson JS, 2001, SCIENCE, V293, P2108, DOI 10.1126/science.1061965; von Bulow GU, 2001, IMMUNITY, V14, P573, DOI 10.1016/S1074-7613(01)00130-3; Ware CF, 2000, J EXP MED, V192, pF35, DOI 10.1084/jem.192.11.F35; Xia XZ, 2000, J EXP MED, V192, P137, DOI 10.1084/jem.192.1.137; Xu SL, 2001, MOL CELL BIOL, V21, P4067, DOI 10.1128/MCB.21.12.4067-4074.2001; Yan MH, 2000, NAT IMMUNOL, V1, P37, DOI 10.1038/76889; Yan MH, 2001, CURR BIOL, V11, P1547, DOI 10.1016/S0960-9822(01)00481-X; Yu G, 2000, NAT IMMUNOL, V1, P252, DOI 10.1038/79802	45	103	122	1	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 1	2003	423	6935					49	56		10.1038/nature01543	http://dx.doi.org/10.1038/nature01543			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673CG	12721620				2022-12-24	WOS:000182561600034
J	Prochaska, JX; Howk, JC; Wolfe, AM				Prochaska, JX; Howk, JC; Wolfe, AM			The elemental abundance pattern in a galaxy at z=2.626	NATURE			English	Article							LYMAN-BREAK GALAXIES; LY-ALPHA SYSTEMS; NUCLEOSYNTHESIS; ABSORPTION; EVOLUTION; RATIOS; STARS	The discovery of metal-poor stars(1,2) (where metal is any element more massive than helium) has enabled astronomers to probe the chemical enrichment history of the Milky Way(3,4). More recently, element abundances in gas inside high-redshift galaxies has been probed through the absorption lines imprinted on the spectra of background quasars(5-8), but these have typically yielded measurements of only a few elements. Furthermore, interpretation of these abundances is complicated by the fact that differential incorporation of metals into dust can produce an abundance pattern similar to that expected from nucleosynthesis by massive stars(9). Here we report the observation of over 25 elements in a galaxy at redshift z = 2.626. With these data, we can examine nucleosynthetic processes independent of the uncertainty arising from depletion. We find that the galaxy was enriched mainly by massive stars (M > 15 solar masses) and propose that it is the progenitor of a massive elliptical galaxy. The detailed abundance patterns suggest that boron is produced through processes that act independently of metallicity, and may require alternative mechanisms for the nucleosynthesis of germanium.	Univ Calif Santa Cruz, Univ Calif Observ, Lick Observ, Santa Cruz, CA 95064 USA; Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA; Univ Calif San Diego, Ctr Astrophys & Space Sci, La Jolla, CA 92093 USA	University of California System; University of California Santa Cruz; University of California System; University of California San Diego; University of California System; University of California San Diego	Prochaska, JX (corresponding author), Univ Calif Santa Cruz, Univ Calif Observ, Lick Observ, Santa Cruz, CA 95064 USA.		Howk, Jay/D-2577-2013	Prochaska, J. Xavier/0000-0002-7738-6875; Howk, J. Christopher/0000-0002-2591-3792				BURBIDGE EM, 1957, REV MOD PHYS, V29, P547, DOI 10.1103/RevModPhys.29.547; Busso M, 1999, ANNU REV ASTRON ASTR, V37, P239, DOI 10.1146/annurev.astro.37.1.239; CASSE M, 1995, NATURE, V373, P318, DOI 10.1038/373318a0; CHAMBERLAIN JW, 1951, ASTROPHYS J, V114, P52, DOI 10.1086/145451; Fields BD, 1999, ASTROPHYS J, V516, P797, DOI 10.1086/307145; HELFER HL, 1959, ASTROPHYS J, V129, P700, DOI 10.1086/146668; Hoffman RD, 1996, ASTROPHYS J, V460, P478, DOI 10.1086/176986; JURA M, 1978, ASTROPHYS J, V219, P861, DOI 10.1086/155847; Lu LM, 1996, ASTROPHYS J SUPPL S, V107, P475, DOI 10.1086/192373; MCWILLIAM A, 1995, ASTRON J, V109, P2757, DOI 10.1086/117486; Molaro P, 2000, ASTROPHYS J, V541, P54, DOI 10.1086/309439; Pettini M, 2001, ASTROPHYS J, V554, P981, DOI 10.1086/321403; Pettini M, 2000, ASTROPHYS J, V532, P65, DOI 10.1086/308562; Pettini M, 2000, ASTROPHYS J, V528, P96, DOI 10.1086/308176; Prochaska JX, 2002, ASTROPHYS J, V566, P68, DOI 10.1086/338080; PROCHASKA JX, UNPUB ASTROPHYS J SU; Saglia RP, 2002, ASTROPHYS J, V579, pL13, DOI 10.1086/344742; Savage BD, 1996, ANNU REV ASTRON ASTR, V34, P279, DOI 10.1146/annurev.astro.34.1.279; Schramm DN, 1998, REV MOD PHYS, V70, P303, DOI 10.1103/RevModPhys.70.303; Sheinis AI, 2002, PUBL ASTRON SOC PAC, V114, P851, DOI 10.1086/341706; TINSLEY BM, 1979, ASTROPHYS J, V229, P1046, DOI 10.1086/157039; Trager SC, 2000, ASTRON J, V119, P1645, DOI 10.1086/301299; Vladilo G, 2002, ASTRON ASTROPHYS, V391, P407, DOI 10.1051/0004-6361:20020822; VOGT SS, 1994, SPIE, V2198, P362; WHEELER JC, 1989, ANNU REV ASTRON ASTR, V27, P279; White RL, 2000, ASTROPHYS J SUPPL S, V126, P133, DOI 10.1086/313300; WOLFE AM, 1986, ASTROPHYS J SUPPL S, V61, P249, DOI 10.1086/191114; WOLFE AM, UNPUB ASTROPHYS J; WOOSLEY SE, 1995, ASTROPHYS J SUPPL S, V101, P181, DOI 10.1086/192237; WOOSLEY SE, 1990, ASTROPHYS J, V356, P272, DOI 10.1086/168839	30	72	72	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 1	2003	423	6935					57	59		10.1038/nature01524	http://dx.doi.org/10.1038/nature01524			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673CG	12721621	Green Submitted			2022-12-24	WOS:000182561600035
J	Melton, L				Melton, L			On the trail of SNPs	NATURE			English	Article									Novartis Fdn, London, England	Novartis	Melton, L (corresponding author), Novartis Fdn, London, England.								0	22	23	1	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 24	2003	422	6934					917	923		10.1038/422917a	http://dx.doi.org/10.1038/422917a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670WR	12712209	Bronze			2022-12-24	WOS:000182432600060
J	Hu, FB; Li, TY; Colditz, GA; Willett, WC; Manson, JE				Hu, FB; Li, TY; Colditz, GA; Willett, WC; Manson, JE			Television watching and other sedentary behaviors in relation to risk of obesity and type 2 diabetes mellitus in women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PHYSICAL-ACTIVITY; UNITED-STATES; MEN; WEIGHT; CHILDREN; HEALTH	Context Current public health campaigns to reduce obesity and type 2 diabetes have largely focused on increasing exercise, but have paid little attention to the reduction of sedentary behaviors. Objective To examine the-relationship between various sedentary behaviors, especially prolonged television (TV) watching, and risk of obesity and type 2 diabetes in women. Design, Setting, and Participants Prospective cohort study conducted from 1992 to 1998 among women from 11 states in the Nurses' Health Study. The obesity analysis included 50277 women who had a body mass index (BMI) of less than 30 and were free from diagnosed cardiovascular disease, diabetes, or cancer and completed questions on physical activity and sedentary behaviors at baseline. The diabetes analysis included 68497 women who at baseline were free from diagnosed diabetes mellitus, cardiovascular disease, or cancer. Main Outcome Measures Onset of obesity and type 2 diabetes mellitus. Results During 6 years of follow-up, 3757 (7.5%) of 50277 women who had a BMI of less than 30 in 1992 became obese (13MI greater than or equal to30). Overall, we documented 1515 new cases of type 2 diabetes. Time spent watching TV was positively associated with risk of obesity and type 2 diabetes. In the multivariate analyses adjusting for age, smoking, exercise levels, dietary factors, and other covariates, each 2-h/d increment in TV watching was associated with a 23% (95% confidence interval [CI], 17%-30%) increase in obesity and a 14% (95% CI, 5%-23%) increase in risk of diabetes; each 2-h/d increment in sitting at work was associated with a 5% (95% CI, 0%-10%) increase in obesity and a 7% (95% CI, 0%-1.6%) increase in diabetes. In contrast, standing or walking around at home (2 h/d) was associated with a 9% (95% CI, 6%-12%) reduction in obesity and a 12% (95% CI, 7%-16%) reduction in diabetes. Each 1 hour per day of brisk walking was associated with a 24% (95% CI, 19%-29%) reduction in obesity and a 34% (95% CI, 27%-41%) reduction in diabetes We estimated that in our cohort, 30% (95% CI, 24%-36%) of new cases of obesity and 43% (95% CI, 32%-52%) of new cases of diabetes could be prevented by adopting a relatively active lifestyle (<10 h/wk of TV watching and &GE;30 min/d of brisk walking). Conclusions Independent of exercise levels, sedentary behaviors, especially TV watching, were associated with significantly elevated risk of obesity and type 2 diabetes, whereas even light to moderate activity was associated with substantially lower risk. This study emphasize's the importance of reducing prolonged TV watching and other sedentary behaviors for preventing obesity and diabetes.	Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Channing Labs, Boston, MA USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Div Prevent Med, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Hu, FB (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Nutr, 665 Huntington Ave, Boston, MA 02115 USA.		Hu, Frank/C-1919-2013; Colditz, Graham/A-3963-2009	Colditz, Graham/0000-0002-7307-0291	NATIONAL CANCER INSTITUTE [P01CA087969] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058845] Funding Source: NIH RePORTER; NCI NIH HHS [CA87969] Funding Source: Medline; NIDDK NIH HHS [DK58845] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; Andersen RE, 1998, JAMA-J AM MED ASSOC, V279, P938, DOI 10.1001/jama.279.12.938; BURCHFIEL CM, 1995, AM J EPIDEMIOL, V141, P360, DOI 10.1093/aje/141.4.360; Ching PLYH, 1996, AM J PUBLIC HEALTH, V86, P25, DOI 10.2105/AJPH.86.1.25; Coakley EH, 1998, INT J OBESITY, V22, P89, DOI 10.1038/sj.ijo.0800549; COLDITZ GA, 1990, AM J EPIDEMIOL, V132, P501, DOI 10.1093/oxfordjournals.aje.a115686; DIETZ WH, 1985, PEDIATRICS, V75, P807; FALCIGLIA GA, 1980, J NUTR EDUC, V12, P196; Field AE, 2001, ARCH INTERN MED, V161, P1581, DOI 10.1001/archinte.161.13.1581; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Fung TT, 2000, AM J EPIDEMIOL, V152, P1171, DOI 10.1093/aje/152.12.1171; Gortmaker SL, 1996, ARCH PEDIAT ADOL MED, V150, P356, DOI 10.1001/archpedi.1996.02170290022003; GURWITZ JH, 1994, J AM GERIATR SOC, V42, P1235, DOI 10.1111/j.1532-5415.1994.tb06503.x; HARRIS M, 1979, DIABETES, V28, P1039; HELMRICH SP, 1991, NEW ENGL J MED, V325, P147, DOI 10.1056/NEJM199107183250302; Hu FB, 2001, NEW ENGL J MED, V345, P790, DOI 10.1056/NEJMoa010492; Hu FB, 1999, JAMA-J AM MED ASSOC, V282, P1433, DOI 10.1001/jama.282.15.1433; Hu FB, 2001, ARCH INTERN MED, V161, P1542, DOI 10.1001/archinte.161.12.1542; JACOBS DR, 1993, MED SCI SPORT EXER, V25, P81, DOI 10.1249/00005768-199301000-00012; Lank N H, 1992, J Community Health, V17, P377, DOI 10.1007/BF01323999; Lynch J, 1996, ARCH INTERN MED, V156, P1307, DOI 10.1001/archinte.156.12.1307; MANSON JE, 1992, JAMA-J AM MED ASSOC, V268, P63, DOI 10.1001/jama.268.1.63; MANSON JE, 1991, LANCET, V338, P774, DOI 10.1016/0140-6736(91)90664-B; *NIELS MED RES, 1998, NIELS REP TEL; PERRY IJ, 1995, BRIT MED J, V310, P560, DOI 10.1136/bmj.310.6979.560; Robinson TN, 2001, PEDIATR CLIN N AM, V48, P1017, DOI 10.1016/S0031-3955(05)70354-0; Robinson TN, 1999, JAMA-J AM MED ASSOC, V282, P1561, DOI 10.1001/jama.282.16.1561; TUCKER LA, 1989, AM J PUBLIC HEALTH, V79, P516, DOI 10.2105/AJPH.79.4.516; TUCKER LA, 1991, AM J PUBLIC HEALTH, V81, P908, DOI 10.2105/AJPH.81.7.908; van Dam RM, 2002, ANN INTERN MED, V136, P201, DOI 10.7326/0003-4819-136-3-200202050-00008; WACHOLDER S, 1994, AM J EPIDEMIOL, V140, P303, DOI 10.1093/oxfordjournals.aje.a117252; WACHOLDER S, 1994, AM J EPIDEMIOL, V140, P668; WILLETT W, 1983, AM J EPIDEMIOL, V117, P651, DOI 10.1093/oxfordjournals.aje.a113598; WOLF AM, 1994, INT J EPIDEMIOL, V23, P991, DOI 10.1093/ije/23.5.991	34	1163	1203	7	162	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 9	2003	289	14					1785	1791		10.1001/jama.289.14.1785	http://dx.doi.org/10.1001/jama.289.14.1785			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	664ZJ	12684356	Bronze			2022-12-24	WOS:000182094900023
J	Kuo, AL; Gulbis, JM; Antcliff, JF; Rahman, T; Lowe, ED; Zimmer, J; Cuthbertson, J; Ashcroft, FM; Ezaki, T; Doyle, DA				Kuo, AL; Gulbis, JM; Antcliff, JF; Rahman, T; Lowe, ED; Zimmer, J; Cuthbertson, J; Ashcroft, FM; Ezaki, T; Doyle, DA			Crystal structure of the potassium channel KirBac1.1 in the closed state	SCIENCE			English	Article							RECTIFIER K+ CHANNEL; ACETYLCHOLINE-RECEPTOR; RECTIFICATION; PERMEATION; PORE; RESOLUTION; MECHANISM; DYNAMICS; SPERMINE; DOMAINS	The KirBac1.1 channel belongs to the inward-rectifier family of potassium channels. Here we report the structure of the entire prokaryotic Kir channel assembly, in the closed state, refined to a resolution of 3.65 angstroms. We identify the main activation gate and structural elements involved in gating. On the basis of structural evidence presented here, we suggest that gating involves coupling between the intracellular and membrane domains. This further suggests that initiation of gating by membrane or intracellular signals represents different entry points to a common mechanistic pathway.	Univ Oxford, Dept Biochem, Lab Mol Biophys, Oxford OX1 3QU, England; Walter & Eliza Hall Inst Med Res, Struct Biol Div, Parkville, Vic 3050, Australia; Univ Oxford, Physiol Lab, Oxford OX1 3PT, England; Gifu Univ, Grad Sch Med Regenerat & Adv Med Sci, Dept Microbiol & Bioinformat, Gifu 5008705, Japan	University of Oxford; Walter & Eliza Hall Institute; University of Oxford; Gifu University	Doyle, DA (corresponding author), Univ Oxford, Dept Biochem, Lab Mol Biophys, Oxford OX1 3QU, England.		Lowe, Edward/AAP-5381-2021	Lowe, Edward/0000-0002-1757-0208; Zimmer, Jochen/0000-0002-8423-2882				Ashcroft FM, 2000, ION CHANNELS DIS; Beckstein O, 2001, J PHYS CHEM B, V105, P12902, DOI 10.1021/jp012233y; Bright JN, 2002, BIOPOLYMERS, V64, P303, DOI 10.1002/bip.10197; Chang G, 1998, SCIENCE, V282, P2220, DOI 10.1126/science.282.5397.2220; Cortes DM, 2001, J GEN PHYSIOL, V117, P165, DOI 10.1085/jgp.117.2.165; del Camino D, 2000, NATURE, V403, P321, DOI 10.1038/35002099; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Durell SR, 2001, BMC EVOL BIOL, V1, DOI 10.1186/1471-2148-1-14; FAKLER B, 1994, FEBS LETT, V356, P199, DOI 10.1016/0014-5793(94)01258-X; FICKER E, 1994, SCIENCE, V266, P1068, DOI 10.1126/science.7973666; Hille B., 2001, IONIC CHANNELS EXCIT, P814; IMOTO K, 1988, NATURE, V335, P645, DOI 10.1038/335645a0; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Kubo Y, 2001, J PHYSIOL-LONDON, V531, P645, DOI 10.1111/j.1469-7793.2001.0645h.x; LOPATIN AN, 1994, NATURE, V372, P366, DOI 10.1038/372366a0; Loussouarn G, 2000, J BIOL CHEM, V275, P1137, DOI 10.1074/jbc.275.2.1137; LU Z, 1994, NATURE, V371, P243, DOI 10.1038/371243a0; Minor DL, 1999, CELL, V96, P879, DOI 10.1016/S0092-8674(00)80597-8; Nishida M, 2002, CELL, V111, P957, DOI 10.1016/S0092-8674(02)01227-8; Roux B, 1999, SCIENCE, V285, P100, DOI 10.1126/science.285.5424.100; TAGLIALATELA M, 1995, EMBO J, V14, P5532, DOI 10.1002/j.1460-2075.1995.tb00240.x; TAM SC, 1984, J CHEM SOC FARAD T 1, V80, P2255, DOI 10.1039/f19848002255; UNWIN N, 1995, NATURE, V373, P37, DOI 10.1038/373037a0; UNWIN N, 1993, J MOL BIOL, V229, P1101, DOI 10.1006/jmbi.1993.1107; WIBLE BA, 1994, NATURE, V371, P246, DOI 10.1038/371246a0; YANG J, 1995, NEURON, V14, P1047, DOI 10.1016/0896-6273(95)90343-7; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	27	632	650	1	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 20	2003	300	5627					1922	1926		10.1126/science.1085028	http://dx.doi.org/10.1126/science.1085028			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691RN	12738871				2022-12-24	WOS:000183619400039
J	Ohtake, F; Takeyama, K; Matsumoto, T; Kitagawa, H; Yamamoto, Y; Nohara, K; Tohyama, C; Krust, A; Mimura, J; Chambon, P; Yanagisawa, J; Fujii-Kuriyama, Y; Kato, S				Ohtake, F; Takeyama, K; Matsumoto, T; Kitagawa, H; Yamamoto, Y; Nohara, K; Tohyama, C; Krust, A; Mimura, J; Chambon, P; Yanagisawa, J; Fujii-Kuriyama, Y; Kato, S			Modulation of oestrogen receptor signalling by association with the activated dioxin receptor	NATURE			English	Article							ESTROGEN-RECEPTOR; 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN TCDD; TRANSCRIPTION FACTOR; GENE-EXPRESSION; C-FOS; NUCLEAR RECEPTORS; AH RECEPTOR; ENDOMETRIOSIS; ALPHA; INHIBITION	Environmental contaminants affect a wide variety of biological events in many species. Dioxins are typical environmental contaminants that exert adverse oestrogen-related effects(1). Although their anti-oestrogenic actions(2,3) are well described, dioxins can also induce endometriosis(4-7) and oestrogen-dependent tumours(8,9), implying possible oestrogenic effects. However, the molecular mechanism underlying oestrogen-related actions of dioxins remains largely unknown. A heterodimer of the dioxin receptor (AhR) and Arnt, which are basic helix-loop-helix/PAS-family transcription factors, mediates most of the toxic effects of dioxins(10,11). Here we show that the agonist-activated AhR/Arnt heterodimer directly associates with oestrogen receptors ER-alpha and ER-beta. This association results in the recruitment of unliganded ER and the co-activator p300 to oestrogen-responsive gene promoters, leading to activation of transcription and oestrogenic effects. The function of liganded ER is attenuated. Oestrogenic actions of AhR agonists were detected in wild-type ovariectomized mouse uteri, but were absent in AhR(-/-) or ER-alpha(-/-) ovariectomized mice. Our findings suggest a novel mechanism by which ER-mediated oestrogen signalling is modulated by a co-regulatory-like function of activated AhR/Arnt, giving rise to adverse oestrogen-related actions of dioxin-type environmental contaminants.	Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan; Japan Sci & Technol, SORST, Kawaguchi, Saitama 3320012, Japan; Taiho Pharmaceut Co Ltd, Canc Res Lab, Hanno Res Ctr, Hanno, Saitama 3578527, Japan; Natl Inst Environm Studies, Tsukuba, Ibaraki 3058506, Japan; Japan Sci & Technol, CREST, Kawaguchi, Saitama 3320012, Japan; Univ Strasbourg 1, Coll France, CNRS,INSERM, Inst Genet & Biol Mol & Cellulaire, F-67404 Strasbourg, France; Univ Tsukuba, TARA Ctr, Tsukuba, Ibaraki 3058577, Japan	University of Tokyo; Japan Science & Technology Agency (JST); Taiho Pharmaceutical; National Institute for Environmental Studies - Japan; Japan Science & Technology Agency (JST); Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Tsukuba	Kato, S (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1130032, Japan.		Mimura, Junsei/E-7893-2013; Tohyama, Chiharu/AAI-5598-2020	Tohyama, Chiharu/0000-0003-1061-6872				ASTROFF B, 1991, TOXICOL LETT, V56, P305, DOI 10.1016/0378-4274(91)90159-4; Beischlag TV, 2002, MOL CELL BIOL, V22, P4319, DOI 10.1128/MCB.22.12.4319-4333.2002; Bock K W, 1994, Rev Physiol Biochem Pharmacol, V125, P1, DOI 10.1007/BFb0030908; Brown NM, 1998, CARCINOGENESIS, V19, P1623, DOI 10.1093/carcin/19.9.1623; Cummings AM, 1996, TOXICOL APPL PHARM, V138, P131, DOI 10.1006/taap.1996.0106; Daitoku H, 2003, DIABETES, V52, P642, DOI 10.2337/diabetes.52.3.642; Davis BJ, 2000, CANCER RES, V60, P5414; Dupont S, 2000, DEVELOPMENT, V127, P4277; Freedman LP, 1999, CELL, V97, P5, DOI 10.1016/S0092-8674(00)80708-4; GIBBONS A, 1993, SCIENCE, V262, P1373, DOI 10.1126/science.8248776; Kamei Y, 1996, CELL, V85, P403, DOI 10.1016/S0092-8674(00)81118-6; KATO S, 1995, SCIENCE, V270, P1491, DOI 10.1126/science.270.5241.1491; Kobayashi Y, 2000, J BIOL CHEM, V275, P15645, DOI 10.1074/jbc.M000042200; KRISHNAN V, 1995, MOL CELL BIOL, V15, P6710; Kuchenhoff A, 1999, FERTIL STERIL, V71, P354, DOI 10.1016/S0015-0282(98)00437-3; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Mayani A, 1997, HUM REPROD, V12, P373, DOI 10.1093/humrep/12.2.373; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; Mimura J, 1999, GENE DEV, V13, P20, DOI 10.1101/gad.13.1.20; Mimura J, 1997, GENES CELLS, V2, P645, DOI 10.1046/j.1365-2443.1997.1490345.x; Mueller MD, 2000, P NATL ACAD SCI USA, V97, P10972, DOI 10.1073/pnas.200377097; PUGA A, 1992, DNA CELL BIOL, V11, P269, DOI 10.1089/dna.1992.11.269; RIER SE, 1993, FUND APPL TOXICOL, V21, P433, DOI 10.1006/faat.1993.1119; Schmidt JV, 1996, ANNU REV CELL DEV BI, V12, P55, DOI 10.1146/annurev.cellbio.12.1.55; Sogawa K, 1997, J BIOCHEM, V122, P1075; Tian Y, 1998, J STEROID BIOCHEM, V67, P17, DOI 10.1016/S0960-0760(98)00067-3; TORA L, 1989, CELL, V59, P477, DOI 10.1016/0092-8674(89)90031-7; Watanabe M, 2001, EMBO J, V20, P1341, DOI 10.1093/emboj/20.6.1341; WEISZ A, 1990, NUCLEIC ACIDS RES, V18, P5097, DOI 10.1093/nar/18.17.5097; Yanagisawa J, 2002, MOL CELL, V9, P553, DOI 10.1016/S1097-2765(02)00478-1	30	593	631	2	91	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 29	2003	423	6939					545	550		10.1038/nature01606	http://dx.doi.org/10.1038/nature01606			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	683RH	12774124				2022-12-24	WOS:000183162900045
J	Osborn, DPJ; King, MB; Nazareth, I				Osborn, DPJ; King, MB; Nazareth, I			Participation in screening for cardiovascular risk by people with schizophrenia or similar mental illnesses: cross sectional study in general practice	BRITISH MEDICAL JOURNAL			English	Article							PHYSICAL HEALTH		UCL, Dept Psychiat & Behav Sci, London NW3 2PF, England; UCL, Dept Primary Care & Populat, London WC1E 6BT, England	University of London; University College London; University of London; University College London	Osborn, DPJ (corresponding author), UCL, Dept Psychiat & Behav Sci, London NW3 2PF, England.	dosborn@rfc.ucl.ac.uk	King, Michael B/D-7477-2011; Osborn, David/B-8165-2009	King, Michael B/0000-0003-4715-7171; Osborn, David/0000-0003-2519-1539; Nazareth, Irwin/0000-0003-2146-9628				National Institute for Clinical Excellence, 2002, SCHIZ COR INT TREATM; NAZARETH I, 1993, BRIT MED J, V307, P32, DOI 10.1136/bmj.307.6895.32; Osborn DPJ, 2001, WESTERN J MED, V175, P329, DOI 10.1136/ewjm.175.5.329; Phelan M, 2001, BRIT MED J, V322, P443, DOI 10.1136/bmj.322.7284.443; Yardley L, 1998, BRIT J GEN PRACT, V48, P1131	5	49	49	0	6	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 24	2003	326	7399					1122	1123		10.1136/bmj.326.7399.1122	http://dx.doi.org/10.1136/bmj.326.7399.1122			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	685DF	12763984	Green Published, Green Submitted, Bronze			2022-12-24	WOS:000183245000020
J	Reya, T; Duncan, AW; Ailles, L; Domen, J; Scherer, DC; Willert, K; Hintz, L; Nusse, R; Weissman, IL				Reya, T; Duncan, AW; Ailles, L; Domen, J; Scherer, DC; Willert, K; Hintz, L; Nusse, R; Weissman, IL			A role for Wnt signalling in self-renewal of haematopoietic stem cells	NATURE			English	Article							HAIR FOLLICLE MORPHOGENESIS; BETA-CATENIN; AXIS FORMATION; GENE FAMILY; PROLIFERATION; TRANSCRIPTION; EXPANSION; PATHWAY; COMPLEX; MICE	Haematopoietic stem cells (HSCs) have the ability to renew themselves and to give rise to all lineages of the blood; however, the signals that regulate HSC self-renewal remain unclear. Here we show that the Wnt signalling pathway has an important role in this process. Overexpression of activated beta-catenin expands the pool of HSCs in long-term cultures by both phenotype and function. Furthermore, HSCs in their normal microenvironment activate a LEF-1/TCF reporter, which indicates that HCSs respond to Wnt signalling in vivo. To demonstrate the physiological significance of this pathway for HSC proliferation we show that the ectopic expression of axin or a frizzled ligand-binding domain, inhibitors of the Wnt signalling pathway, leads to inhibition of HSC growth in vitro and reduced reconstitution in vivo. Furthermore, activation of Wnt signalling in HSCs induces increased expression of HoxB4 and Notch1, genes previously implicated in self-renewal of HSCs. We conclude that the Wnt signalling pathway is critical for normal HSC homeostasis in vitro and in vivo, and provide insight into a potential molecular hierarchy of regulation of HSC development.	Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94035 USA; Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94035 USA; Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA; Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94035 USA	Duke University; Stanford University; Stanford University; Duke University; Duke University; Howard Hughes Medical Institute; Stanford University	Reya, T (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA.	t.reya@duke.edu		Duncan, Andrew/0000-0003-4962-4191				Antonchuk J, 2002, CELL, V109, P39, DOI 10.1016/S0092-8674(02)00697-9; Audet J, 1998, CURR OPIN BIOTECH, V9, P146, DOI 10.1016/S0958-1669(98)80107-9; Austin TW, 1997, BLOOD, V89, P3624, DOI 10.1182/blood.V89.10.3624.3624_3624_3635; Barth AIM, 1999, P NATL ACAD SCI USA, V96, P4947, DOI 10.1073/pnas.96.9.4947; Bhardwaj G, 2001, NAT IMMUNOL, V2, P172, DOI 10.1038/84282; Cadigan KM, 1998, CELL, V93, P767, DOI 10.1016/S0092-8674(00)81438-5; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Cheshier SP, 1999, P NATL ACAD SCI USA, V96, P3120, DOI 10.1073/pnas.96.6.3120; Domen J, 2000, J EXP MED, V191, P253, DOI 10.1084/jem.191.2.253; Domen J, 2000, J EXP MED, V192, P1707, DOI 10.1084/jem.192.12.1707; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Gat U, 1998, CELL, V95, P605, DOI 10.1016/S0092-8674(00)81631-1; Hart MJ, 1998, CURR BIOL, V8, P573, DOI 10.1016/S0960-9822(98)70226-X; HAWLEY RG, 1992, J EXP MED, V176, P1149, DOI 10.1084/jem.176.4.1149; HING HK, 1994, MECH DEVELOP, V47, P261, DOI 10.1016/0925-4773(94)90044-2; HOOPER JE, 1994, NATURE, V372, P461, DOI 10.1038/372461a0; Hsieh JC, 1999, P NATL ACAD SCI USA, V96, P3546, DOI 10.1073/pnas.96.7.3546; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; INGHAM PW, 1993, DEVELOPMENT, V117, P283; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Kielman MF, 2002, NAT GENET, V32, P594, DOI 10.1038/ng1045; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Maloof JN, 1999, DEVELOPMENT, V126, P37; Miller CL, 1997, P NATL ACAD SCI USA, V94, P13648, DOI 10.1073/pnas.94.25.13648; MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X; MORRISON SJ, 1995, P NATL ACAD SCI USA, V92, P10302, DOI 10.1073/pnas.92.22.10302; Randall TD, 1997, BLOOD, V89, P3596, DOI 10.1182/blood.V89.10.3596.3596_3596_3606; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Reya T, 2000, IMMUNITY, V13, P15, DOI 10.1016/S1074-7613(00)00004-2; Sakanaka C, 1998, P NATL ACAD SCI USA, V95, P3020, DOI 10.1073/pnas.95.6.3020; SPANGRUDE GJ, 1989, SCIENCE, V244, P1030; UCHIDA N, 1992, J EXP MED, V175, P175, DOI 10.1084/jem.175.1.175; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Van den Berg DJ, 1998, BLOOD, V92, P3189, DOI 10.1182/blood.V92.9.3189.421k45_3189_3202; Varnum-Finney B, 2000, NAT MED, V6, P1278, DOI 10.1038/81390; Wang E, 2000, NAT BIOTECHNOL, V18, P457, DOI 10.1038/74546; Weissman IL, 2000, CELL, V100, P157, DOI 10.1016/S0092-8674(00)81692-X; WILLERT K, 2003, NATURE          0427, DOI DOI 10.1038/NATURE01611; Yamamoto H, 1998, MOL CELL BIOL, V18, P2867, DOI 10.1128/MCB.18.5.2867; Zeng L, 1997, CELL, V90, P181, DOI 10.1016/S0092-8674(00)80324-4; Zhu AJ, 1999, DEVELOPMENT, V126, P2285	44	1621	1766	2	107	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 22	2003	423	6938					409	414		10.1038/nature01593	http://dx.doi.org/10.1038/nature01593			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681AJ	12717450				2022-12-24	WOS:000183012000034
J	Enstrom, JE; Kabat, GC				Enstrom, JE; Kabat, GC			Environmental tobacco smoke and tobacco related mortality in a prospective study of Californians, 1960-98	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CORONARY HEART-DISEASE; PASSIVE SMOKING; LUNG-CANCER; METAANALYSIS; EXPOSURE; TRENDS	Objective To measure the relation between environmental tobacco smoke, as estimated by smoking in Spouses, and long term mortality from tobacco related disease. Design Prospective Cohort Study covering 39 years. Setting Adult population of California, United States. Participants 118 094 adults enrolled in late 1959 in the American Cancer Society cancer prevention study, who were followed until 1998. Particular focus is on the 35 561 never smokers who had a spouse in the study with known smoking habits. Main outcome measures Relative risks and 95% confidence intervals for deaths from coronary heart disease, lung cancer, and chronic obstructive pulmonary disease related to smoking in spouses and active cigarette smoking. Results For participants followed from 1960 until 1998 the age adjusted relative risk (95% confidence interval) for never smokers married to ever smokers compared with never smokers married to never smokers was 0.94 (0.85 to 1.05) for coronary heart disease, 0.75 (0.42 to 135) for lung cancer, and 1.27 (0.78 to 2.08) for chronic obstructive pulmonary disease among 9619 men, mid 1.01 (0.94 to 1.08), 0.99 (0.72 to 1.37), mid 1.13 (0.80 to 1.58), respectively, among 25 942 women. No significant associations were found for current or former exposure to environmental tobacco smoke before or after adjusting for seven confounders and before or after excluding participants with pre-existing disease. No significant associations were found during tire shorter follow tip periods of 1960-5, 1966-72, 1973-85 mid 1973-98. Conclusions The results do not support a causal relation between environmental tobacco smoke and tobacco related mortality, although they do not rule out a small effect. The association between exposure to environmental tobacco smoke and coronary heart disease and lung, cancer may be considerably weaker than generally believed.	Univ Calif Los Angeles, Sch Publ Hlth, Los Angeles, CA 90095 USA; SUNY Stony Brook, Dept Prevent Med, Stony Brook, NY 11794 USA	University of California System; University of California Los Angeles; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Enstrom, JE (corresponding author), Univ Calif Los Angeles, Sch Publ Hlth, Los Angeles, CA 90095 USA.	jenstrom@ucla.edu						Bailar JC, 1999, NEW ENGL J MED, V340, P958, DOI 10.1056/NEJM199903253401211; BURNS DM, 1997, SMOKING TOBACCO CONT, V8, P113; Enstrom JE, 1999, EPIDEMIOLOGY, V10, P500, DOI 10.1097/00001648-199909000-00007; ENSTROM JE, 1980, J NATL CANCER I, V65, P1175; FLEISS JL, 1991, J CLIN EPIDEMIOL, V44, P127, DOI 10.1016/0895-4356(91)90261-7; GARFINKEL L, 1981, JNCI-J NATL CANCER I, V66, P1061, DOI 10.1093/jnci/66.6.1061; GORI GB, 1999, PASSIVE SMOKE EPAS B; Green CR, 1997, J HEALTH POLIT POLIC, V22, P1279, DOI 10.1215/03616878-22-5-1279; Hackshaw AK, 1997, BMJ-BRIT MED J, V315, P980, DOI 10.1136/bmj.315.7114.980; HAMMOND E. CUYLER, 1966, NAT CANCER INST MONOGR, V19, P127; He J, 1999, NEW ENGL J MED, V340, P920, DOI 10.1056/NEJM199903253401204; Johnson NJ, 2000, ANN EPIDEMIOL, V10, P224, DOI 10.1016/S1047-2797(99)00052-6; Law MR, 1997, BMJ-BRIT MED J, V315, P973, DOI 10.1136/bmj.315.7114.973; LEE PN, 1992, ENV TOBACCO SMOKE MO; LEVOIS ME, 1995, REGUL TOXICOL PHARM, V21, P184, DOI 10.1006/rtph.1995.1023; LeVois ME, 1998, BRIT MED J, V317, P344, DOI 10.1136/bmj.317.7154.344; *NAT CANC I, 1999, NIH PUBL; *NAT CANC I, 1999, SMOK TOB CONTR MON, V10; SCHAAD UB, 1995, PEDIATR INFECT DIS J, V14, P1, DOI 10.1097/00006454-199501000-00001; SCHAEFER C, 1995, AM J EPIDEMIOL, V141, P1142, DOI 10.1093/oxfordjournals.aje.a117387; Schall LC, 2001, ANN EPIDEMIOL, V11, P292, DOI 10.1016/S1047-2797(00)00217-9; SO Y, 1992, SAS STAT SOFTWARE; TAYLOR AE, 1992, CIRCULATION, V86, P1; Thun M, 1999, ENVIRON HEALTH PERSP, V107, P841, DOI 10.2307/3434563; *US DEP HHS, 2001, WOM SMOK REP SURG GE, P343; *US EPA, 1992, 600690006F EPA; *US EPA, 1992, NIH PUBL	27	125	130	2	17	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 17	2003	326	7398					1057	+		10.1136/bmj.326.7398.1057	http://dx.doi.org/10.1136/bmj.326.7398.1057			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	681ZD	12750205	Bronze, Green Published			2022-12-24	WOS:000183064700013
J	Hay, SI; Were, EC; Renshaw, M; Noor, AM; Ochola, SA; Olusanmi, L; Alipui, N; Snow, RW				Hay, SI; Were, EC; Renshaw, M; Noor, AM; Ochola, SA; Olusanmi, L; Alipui, N; Snow, RW			Forecasting, warning, and detection of malaria epidemics: a case study	LANCET			English	Article							HIGHLANDS; KENYA	Our aim was to assess whether a combination of seasonal climate forecasts, monitoring of meteorological conditions, and early detection of cases could have helped to prevent the 2002 malaria emergency In the highlands of western Kenya. Seasonal climate forecasts did not anticipate the heavy rainfall. Rainfall data gave timely and reliable early warnings; but monthly surveillance of malaria out-patients gave no effective alarm, though it did help to confirm that normal rainfall conditions in Kisii Central and Gucha led to typical resurgent outbreaks whereas exceptional rainfall in Nandi and Kericho led to true malaria epidemics. Management of malaria in the highlands, including improved planning for the annual resurgent outbreak, augmented by simple central nationwide early warning, represents a feasible strategy for increasing epidemic preparedness in Kenya.	Univ Oxford, Dept Zool, TALA Res Grp, Oxford OX1 3PS, England; Minist Hlth, Div Malaria Control, Nairobi, Kenya; UNICEF, ESARO, Nairobi, Kenya; UNICEF, KCO, Nairobi, Kenya; UN Complex Gigiri, Nairobi, Kenya; Kenya Govt Med Res Ctr, Wellcome Trust Collaborat Programme, Nairobi, Kenya; Univ Oxford, John Radcliffe Hosp, Ctr Trop Med, Oxford OX3 9DU, England	University of Oxford; Kenya Medical Research Institute; University of Oxford	Hay, SI (corresponding author), Univ Oxford, Dept Zool, TALA Res Grp, S Parks Rd, Oxford OX1 3PS, England.	simon.hay@zoo.ox.ac.uk	Snow, Robert William/AFR-1436-2022; Hay, Simon Iain/F-8967-2015	Snow, Robert William/0000-0003-3725-6088; Hay, Simon Iain/0000-0002-0611-7272	Wellcome Trust [081829, 056642] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Guyatt HL, 2002, TROP MED INT HEALTH, V7, P298, DOI 10.1046/j.1365-3156.2002.00874.x; Hay SI, 2002, EMERG INFECT DIS, V8, P555, DOI 10.3201/eid0806.010310; NAJERA JA, 1998, MALARIA EPIDEMICS DE, P81; ROBERTS JMD, 1964, J TROP MED HYG, V67, P230; *WHO, 2001, MAL EARL WARN SYST C, P80	5	78	83	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 17	2003	361	9370					1705	1706		10.1016/S0140-6736(03)13366-1	http://dx.doi.org/10.1016/S0140-6736(03)13366-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	679KB	12767739	Green Accepted			2022-12-24	WOS:000182919700014
J	Fredrick, K; Noller, HF				Fredrick, K; Noller, HF			Catalysis of ribosomal translocation by sparsomycin	SCIENCE			English	Article							ANTITUMOR ANTIBIOTIC SPARSOMYCIN; PEPTIDYL TRANSFERASE CENTER; TRANSFER-RNA; PROTEIN-SYNTHESIS; ANGSTROM RESOLUTION; ESCHERICHIA-COLI; STRUCTURAL BASIS; P-SITE; BINDING; INTERMEDIATE	During protein synthesis, transfer RNAs (tRNAs) are translocated from the aminoacyl to peptidyl to exit sites of the ribosome, coupled to the movement of messenger RNA ( mRNA), in a reaction catalyzed by elongation factor G (EF-G) and guanosine triphosphate (GTP). Here, we show that the peptidyl transferase inhibitor sparsomycin triggers accurate translocation in vitro in the absence of EF-G and GTP. Our results provide evidence that translocation is a function inherent to the ribosome and that the energy to drive this process is stored in the tRNA-mRNA-ribosome complex after peptide-bond formation. These findings directly implicate the peptidyl transferase center of the 50S subunit in the mechanism of translocation, a process involving large-scale movement of tRNA and mRNA in the 30S subunit, some 70 angstroms away.	Univ Calif Santa Cruz, Sinsheimer Labs, Ctr Mol Biol RNA, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz	Noller, HF (corresponding author), Univ Calif Santa Cruz, Sinsheimer Labs, Ctr Mol Biol RNA, Santa Cruz, CA 95064 USA.				NIGMS NIH HHS [GM17129] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM017129, R37GM017129] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Bashan A, 2003, MOL CELL, V11, P91, DOI 10.1016/S1097-2765(03)00009-1; BILGIN N, 1990, EMBO J, V9, P735, DOI 10.1002/j.1460-2075.1990.tb08167.x; CABANAS MJ, 1978, BIOCHEM BIOPH RES CO, V83, P991; CUNDLIFFE E, 1990, RIBOSOME, P479; Feinberg JS, 2001, P NATL ACAD SCI USA, V98, P11120, DOI 10.1073/pnas.211184098; Fredrick K, 2002, MOL CELL, V9, P1125, DOI 10.1016/S1097-2765(02)00523-3; FREDRICK K, UNPUB; GAVRILOV.LP, 1971, FEBS LETT, V17, P324, DOI 10.1016/0014-5793(71)80177-1; GAVRILOV.LP, 1972, FEBS LETT, V22, P91, DOI 10.1016/0014-5793(72)80227-8; GAVRILOVA LP, 1976, J MOL BIOL, V101, P537, DOI 10.1016/0022-2836(76)90243-6; Hansen JL, 2002, P NATL ACAD SCI USA, V99, P11670, DOI 10.1073/pnas.172404099; Hansen JL, 2002, MOL CELL, V10, P117, DOI 10.1016/S1097-2765(02)00570-1; HISHIZAW.T, 1970, P NATL ACAD SCI USA, V66, P523, DOI 10.1073/pnas.66.2.523; Jerinic O, 2000, J MOL BIOL, V304, P707, DOI 10.1006/jmbi.2000.4269; LAZARO E, 1991, BIOCHEMISTRY-US, V30, P9642, DOI 10.1021/bi00104a011; LAZARO E, 1991, ANTIMICROB AGENTS CH, V35, P10, DOI 10.1128/AAC.35.1.10; LILL R, 1989, EMBO J, V8, P3933, DOI 10.1002/j.1460-2075.1989.tb08574.x; LILL R, 1986, BIOCHEMISTRY-US, V25, P3245, DOI 10.1021/bi00359a025; MOAZED D, 1989, NATURE, V342, P142, DOI 10.1038/342142a0; MONRO RE, 1969, NATURE, V222, P356, DOI 10.1038/222356a0; Nissen P, 2000, SCIENCE, V289, P920, DOI 10.1126/science.289.5481.920; Noller HF, 2002, FEBS LETT, V514, P11, DOI 10.1016/S0014-5793(02)02327-X; PESTKA S, 1969, J BIOL CHEM, V244, P1533; PESTKA S, 1971, J BIOL CHEM, V246, P7715; PESTKA S, 1969, P NATL ACAD SCI USA, V64, P709, DOI 10.1073/pnas.64.2.709; Porse BT, 1999, P NATL ACAD SCI USA, V96, P9003, DOI 10.1073/pnas.96.16.9003; ROSENDAHL G, 1994, NUCLEIC ACIDS RES, V22, P357, DOI 10.1093/nar/22.3.357; Schlunzen F, 2001, NATURE, V413, P814, DOI 10.1038/35101544; Schmeing TM, 2002, NAT STRUCT BIOL, V9, P225, DOI 10.1038/nsb758; Semenkov YP, 2000, NAT STRUCT BIOL, V7, P1027; Southworth DR, 2002, J MOL BIOL, V324, P611, DOI 10.1016/S0022-2836(02)01196-8; THEOCHARIS DA, 1992, BIOCHEMISTRY-US, V31, P5861, DOI 10.1021/bi00140a023; THOMPSON J, 1991, BIOCHIMIE, V73, P1131, DOI 10.1016/0300-9084(91)90156-U; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089	35	113	116	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 16	2003	300	5622					1159	1162		10.1126/science.1084571	http://dx.doi.org/10.1126/science.1084571			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678VC	12750524				2022-12-24	WOS:000182886500050
J	Garcia-Barros, M; Paris, F; Cordon-Cardo, C; Lyden, D; Rafii, S; Haimovitz-Friedman, A; Fuks, Z; Kolesnick, R				Garcia-Barros, M; Paris, F; Cordon-Cardo, C; Lyden, D; Rafii, S; Haimovitz-Friedman, A; Fuks, Z; Kolesnick, R			Tumor response to radiotherapy regulated by endothelial cell apoptosis	SCIENCE			English	Article							IONIZING-RADIATION; STEM-CELLS; IN-VITRO; SPHINGOMYELINASE; CERAMIDE; CANCER; GROWTH; DEATH; MICE; ANGIOGENESIS	About 50% of cancer patients receive radiation therapy. Here we investigated the hypothesis that tumor response to radiation is determined not only by tumor cell phenotype but also by microvascular sensitivity. MCA/129 fibrosarcomas and B16F1 melanomas grown in apoptosis-resistant acid sphingomyelinase (asmase) -deficient or Bax-deficient mice displayed markedly reduced baseline microvascular endothelial apoptosis and grew 200 to 400% faster than tumors on wild-type microvasculature. Thus, endothelial apoptosis is a homeostatic factor regulating angiogenesis-dependent tumor growth. Moreover, these tumors exhibited reduced endothelial apoptosis upon irradiation and, unlike tumors in wild-type mice, they were resistant to single-dose radiation up to 20 grays (Gy). These studies indicate that microvascular damage regulates tumor cell response to radiation at the clinically relevant dose range.	Mem Sloan Kettering Canc Ctr, Lab Signal Transduct, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Dept Pediat, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10021 USA; Cornell Univ, Coll Med, Dept Hematol Oncol, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University	Kolesnick, R (corresponding author), Mem Sloan Kettering Canc Ctr, Lab Signal Transduct, 1275 York Ave, New York, NY 10021 USA.		Paris, francois E/L-4915-2015	Paris, francois E/0000-0002-0176-7348	NCI NIH HHS [CA 52462, CA 85704] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA085704] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BOSE R, 1995, CELL, V82, P405, DOI 10.1016/0092-8674(95)90429-8; Chao DT, 1998, ANNU REV IMMUNOL, V16, P395, DOI 10.1146/annurev.immunol.16.1.395; Chavakis E, 2002, ARTERIOSCL THROM VAS, V22, P887, DOI 10.1161/01.ATV.0000017728.55907.A9; ELLIS F, 1969, Clinical Radiology, V20, P1, DOI 10.1016/S0009-9260(69)80043-7; Folkman J, 2000, NAT REV MOL CELL BIO, V1, P76, DOI 10.1038/35036100; Folkman J, 2002, CANCER CELL, V1, P113, DOI 10.1016/S1535-6108(02)00038-7; FUKS Z, 1994, CANCER RES, V54, P2582; HAIMOVITZFRIEDMAN A, 1994, J EXP MED, V180, P525, DOI 10.1084/jem.180.2.525; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; HENDRY JH, 1994, RADIOTHER ONCOL, V30, P11, DOI 10.1016/0167-8140(94)90004-3; Jensen JM, 1999, J CLIN INVEST, V104, P1761, DOI 10.1172/JCI5307; Kaplan DH, 1998, P NATL ACAD SCI USA, V95, P7556, DOI 10.1073/pnas.95.13.7556; KIM JH, 1986, CANCER RES, V46, P1120; Kozin SV, 2001, CANCER RES, V61, P39; Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194; Marathe S, 1998, J BIOL CHEM, V273, P4081, DOI 10.1074/jbc.273.7.4081; Mauceri HJ, 1998, NATURE, V394, P287, DOI 10.1038/28412; Morita Y, 2000, NAT MED, V6, P1109, DOI 10.1038/80442; Muller AM, 2002, EXP MOL PATHOL, V72, P221, DOI 10.1006/exmp.2002.2424; MUNRO TR, 1961, BRIT J RADIOL, V34, P246, DOI 10.1259/0007-1285-34-400-246; Ning SC, 2002, RADIAT RES, V157, P45, DOI 10.1667/0033-7587(2002)157[0045:TAASAS]2.0.CO;2; Paris F, 2001, SCIENCE, V293, P293, DOI 10.1126/science.1060191; Platt J, 2000, EUR J CANCER, V36, P2397, DOI 10.1016/S0959-8049(00)00336-1; POTTEN CS, 1990, INT J RADIAT BIOL, V58, P925, DOI 10.1080/09553009014552281; Santana P, 1996, CELL, V86, P189, DOI 10.1016/S0092-8674(00)80091-4; St Croix B, 2000, SCIENCE, V289, P1197; Stewart FM, 2001, BLOOD, V98, P1246, DOI 10.1182/blood.V98.4.1246; TEICHER BA, 1992, CANCER RES, V52, P6702; TROTT KR, 1994, RADIOTHER ONCOL, V30, P1, DOI 10.1016/0167-8140(94)90002-7; WHELDON TE, 1977, BRIT J RADIOL, V50, P843, DOI 10.1259/0007-1285-50-599-843; WITHERS HR, 1970, INT J RADIAT BIOL RE, V17, P261, DOI 10.1080/09553007014550291	31	1195	1270	5	85	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 16	2003	300	5622					1155	1159		10.1126/science.1082504	http://dx.doi.org/10.1126/science.1082504			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678VC	12750523				2022-12-24	WOS:000182886500049
J	Weill, M; Lutfalla, G; Mogensen, K; Chandre, F; Berthomieu, A; Berticat, C; Pasteur, N; Philips, A; Fort, P; Raymond, M				Weill, M; Lutfalla, G; Mogensen, K; Chandre, F; Berthomieu, A; Berticat, C; Pasteur, N; Philips, A; Fort, P; Raymond, M			Insecticide resistance in mosquito vectors	NATURE			English	Article							ACETYLCHOLINESTERASE		Univ Montpellier 2, Inst Sci Evolut, UMR 5554, F-34095 Montpellier, France; CNRS, Def Antivirales & Tumorales UMR 5124, F-34293 Montpellier, France; CNRS, Ctr Rech Biochim Macromol, UPR1086, F-34293 Montpellier, France; IRD, LIN, F-34394 Montpellier, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Institut de Recherche pour le Developpement (IRD)	Weill, M (corresponding author), Univ Montpellier 2, Inst Sci Evolut, UMR 5554, CC 065, F-34095 Montpellier, France.	weill@isem.univ-montp2.fr	PHILIPS, Alexandre/AAB-6047-2020; Lutfalla, Georges/AAW-9386-2021; Fort, Philippe/M-9498-2015; Raymond, Michel/C-9049-2015; Chandre, Fabrice/Q-3429-2019	Fort, Philippe/0000-0001-5997-8722; Chandre, Fabrice/0000-0002-1994-9705; Raymond, Michel/0000-0002-1714-6984; LUTFALLA, Georges/0000-0002-6591-7894; Weill, Mylene/0000-0002-4043-1601				Bourguet D, 1996, PESTIC BIOCHEM PHYS, V55, P122, DOI 10.1006/pest.1996.0041; MUTERO A, 1994, P NATL ACAD SCI USA, V91, P5922, DOI 10.1073/pnas.91.13.5922; N'Guessan R, 2003, MED VET ENTOMOL, V17, P19, DOI 10.1046/j.1365-2915.2003.00406.x; TOUTANT JP, 1989, PROG NEUROBIOL, V32, P423, DOI 10.1016/0301-0082(89)90031-2; Weill M, 2002, P ROY SOC B-BIOL SCI, V269, P2007, DOI 10.1098/rspb.2002.2122	5	344	372	2	79	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 8	2003	423	6936					136	137		10.1038/423136b	http://dx.doi.org/10.1038/423136b			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675MR	12736674				2022-12-24	WOS:000182699600035
J	Hafezparast, M; Klocke, R; Ruhrberg, C; Marquardt, A; Ahmad-Annuar, A; Bowen, S; Lalli, G; Witherden, AS; Hummerich, H; Nicholson, S; Morgan, PJ; Oozageer, R; Priestley, JV; Averill, S; King, VR; Ball, S; Peters, J; Toda, T; Yamamoto, A; Hiraoka, Y; Augustin, M; Korthaus, D; Wattler, S; Wabnitz, P; Dickneite, C; Lampel, S; Boehme, F; Peraus, G; Popp, A; Rudelius, M; Schlegel, J; Fuchs, H; de Angelis, MH; Schiavo, G; Shima, DT; Russ, AP; Stumm, G; Martin, JE; Fisher, EMC				Hafezparast, M; Klocke, R; Ruhrberg, C; Marquardt, A; Ahmad-Annuar, A; Bowen, S; Lalli, G; Witherden, AS; Hummerich, H; Nicholson, S; Morgan, PJ; Oozageer, R; Priestley, JV; Averill, S; King, VR; Ball, S; Peters, J; Toda, T; Yamamoto, A; Hiraoka, Y; Augustin, M; Korthaus, D; Wattler, S; Wabnitz, P; Dickneite, C; Lampel, S; Boehme, F; Peraus, G; Popp, A; Rudelius, M; Schlegel, J; Fuchs, H; de Angelis, MH; Schiavo, G; Shima, DT; Russ, AP; Stumm, G; Martin, JE; Fisher, EMC			Mutations in dynein link motor neuron degeneration to defects in retrograde transport	SCIENCE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; INTERMEDIATE-CHAIN BINDING; AXONAL-TRANSPORT; CYTOPLASMIC DYNEIN; HEAVY-CHAIN; MICE; GENE; DYNACTIN; DISEASE; SOD1	Degenerative disorders of motor neurons include a range of progressive fatal diseases such as amyotrophic lateral sclerosis (ALS), spinal-bulbar muscular atrophy (SBMA), and spinal muscular atrophy (SMA). Although the causative genetic alterations are known for some cases, the molecular basis of many SMA and SBMA-like syndromes and most ALS cases is unknown. Here we show that missense point mutations in the cytoplasmic dynein heavy chain result in progressive motor neuron degeneration in heterozygous mice, and in homozygotes this is accompanied by the formation of Lewy-like inclusion bodies, thus resembling key features of human pathology. These mutations exclusively perturb neuron-specific functions of dynein.	Ingenium Pharmaceut AG, D-82152 Martinsried, Germany; UCL Natl Hosp Neurol & Neurosurg, Inst Neurol, Dept Neurodegenerat Dis, London WC1N 3BG, England; Canc Res UK, Lab Endothelial Cell Biol, London WC2A 3PX, England; Canc Res UK, Lab Cell Regulat, London WC2A 3PX, England; Canc Res UK, Lab Mol Neuropathobiol, London WC2A 3PX, England; Queen Mary Univ London, Royal London Hosp, Dept Histopathol, London E1 1BB, England; Queen Mary Univ London, Barts & London, Dept Neurosci, London E1 4NS, England; MRC, Mammalian Genet Unit, Harwell OX11 0RD, Berks, England; Commun Res Labs, Kansai Adv Res Ctr, CREST Res Project, Cell Biol Grp, Kobe, Hyogo 6512492, Japan; Tech Univ Munich, Inst Pathol, Div Neuropathol, D-81675 Munich, Germany; Gesell Strahlenforsch Natl Res Ctr Environm & Hlt, Inst Expt Genet, D-85764 Neuherberg, Germany	University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; Cancer Research UK; Cancer Research UK; Cancer Research UK; Barts Health NHS Trust; Royal London Hospital; University of London; Queen Mary University London; University of London; Queen Mary University London; Japan Science & Technology Agency (JST); National Institute of Information & Communications Technology (NICT) - Japan; Technical University of Munich	Stumm, G (corresponding author), Ingenium Pharmaceut AG, Fraunhoferstr 13, D-82152 Martinsried, Germany.	e.fisher@prion.ucl.ac.uk	Fisher, Elizabeth MC/C-2168-2008; Hafezparast, Majid/H-6728-2018; Hiraoka, Yasushi/B-5111-2009; de Angelis, Martin Hrabe/F-5531-2012; Yamamoto, Ayumu/AAN-4565-2021; Hafezparast, Majid/N-8292-2019; AHMAD ANNUAR, AZLINA/B-8305-2010; Ruhrberg, Christiana/C-6404-2009	Fisher, Elizabeth MC/0000-0003-2850-9936; Hiraoka, Yasushi/0000-0001-9407-8228; de Angelis, Martin Hrabe/0000-0002-7898-2353; Yamamoto, Ayumu/0000-0001-6960-9461; Hafezparast, Majid/0000-0002-5262-7150; Ruhrberg, Christiana/0000-0002-3212-9381; Schiavo, Giampietro/0000-0002-4319-8745; Schlegel, Jurgen/0000-0002-5544-2717				Ahmad FJ, 1998, J CELL BIOL, V140, P391, DOI 10.1083/jcb.140.2.391; Asai DJ, 2001, TRENDS CELL BIOL, V11, P196, DOI 10.1016/S0962-8924(01)01970-5; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; de Angelis MH, 2000, NAT GENET, V25, P444, DOI 10.1038/78146; Eaton BA, 2002, NEURON, V34, P729, DOI 10.1016/S0896-6273(02)00721-3; Ebens A, 1996, NEURON, V17, P1157, DOI 10.1016/S0896-6273(00)80247-0; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Habura A, 1999, J BIOL CHEM, V274, P15447, DOI 10.1074/jbc.274.22.15447; HAFEZPARAST M, UNPUB; Harada A, 1998, J CELL BIOL, V141, P51, DOI 10.1083/jcb.141.1.51; Julien JP, 2001, CELL, V104, P581, DOI 10.1016/S0092-8674(01)00244-6; King SM, 2000, J CELL SCI, V113, P2521; LA SA, 1991, NATURE, V352, P77; Lalli G, 2002, J CELL BIOL, V156, P233, DOI 10.1083/jcb.200106142; LaMonte BH, 2002, NEURON, V34, P715, DOI 10.1016/S0896-6273(02)00696-7; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Maina F, 1997, GENE DEV, V11, P3341, DOI 10.1101/gad.11.24.3341; Morris NR, 2000, J CELL BIOL, V148, P1097, DOI 10.1083/jcb.148.6.1097; Murakami T, 2001, NEUROSCI LETT, V308, P149, DOI 10.1016/S0304-3940(01)02036-5; Puls I, 2003, NAT GENET, V33, P455, DOI 10.1038/ng1123; Rogers DC, 2001, NEUROSCI LETT, V306, P89, DOI 10.1016/S0304-3940(01)01885-7; Shah JV, 2002, CURR OPIN CELL BIOL, V14, P58, DOI 10.1016/S0955-0674(01)00294-0; Stieber A, 2000, J NEUROL SCI, V173, P63, DOI 10.1016/S0022-510X(99)00301-9; Terada S, 2000, CURR OPIN NEUROBIOL, V10, P566, DOI 10.1016/S0959-4388(00)00129-X; Tsuchiya K, 2000, ACTA NEUROPATHOL, V100, P603, DOI 10.1007/s004010000237; Tynan SH, 2000, J BIOL CHEM, V275, P32769, DOI 10.1074/jbc.M001537200; Vallee RB, 2001, TRENDS CELL BIOL, V11, P155, DOI 10.1016/S0962-8924(01)01956-0; Williamson TL, 1999, NAT NEUROSCI, V2, P50, DOI 10.1038/4553; Witherden AS, 2002, GENE, V283, P71, DOI 10.1016/S0378-1119(01)00853-8; Zhao C, 2001, CELL, V105, P587, DOI 10.1016/S0092-8674(01)00363-4	30	530	548	1	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 2	2003	300	5620					808	812		10.1126/science.1083129	http://dx.doi.org/10.1126/science.1083129			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673KH	12730604				2022-12-24	WOS:000182579800054
J	Lee, SS; Kennedy, S; Tolonen, AC; Ruvkun, G				Lee, SS; Kennedy, S; Tolonen, AC; Ruvkun, G			DAF-16 target genes that control C-elegans life-span and metabolism	SCIENCE			English	Article							INSULIN-RECEPTOR; OXIDATIVE STRESS; LONGEVITY; EXPRESSION; RESISTANCE	Signaling from the DAF-2/insulin receptor to the DAF-16/FOXO transcription factor controls longevity, metabolism, and development in disparate phyla. To identify genes that mediate the conserved biological outputs of daf-2/insulin-like signaling, we used comparative genomics to identify 17 orthologous genes from Caenorhabditis and Drosophila, each of which bears a DAF-16 binding site in the promoter region. One-third of these DAF-16 downstream candidate genes were regulated by daf-2/insulin-like signaling in C. elegans, and RNA interference inactivation of the candidates showed that many of these genes mediate distinct aspects of daf-16 function, including longevity, metabolism, and development.	Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Mol Biol,Dept Genet, Boston, MA 02114 USA; MIT, Dept Biol, Cambridge, MA 02139 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT)	Ruvkun, G (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Mol Biol,Dept Genet, 50 Blossom St, Boston, MA 02114 USA.	ruvkun@molbio.mgh.harvard.edu		Kennedy, Scott/0000-0002-7974-8155; Tolonen, Andrew/0000-0001-5907-4504				Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Ashrafi K, 2003, NATURE, V421, P268, DOI 10.1038/nature01279; Birkenkamp KU, 2003, BIOCHEM SOC T, V31, P292, DOI 10.1042/bst0310292; Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223; Chan SW, 2001, J BIOL CHEM, V276, P28402, DOI 10.1074/jbc.M100313200; Coghlan A, 2002, GENOME RES, V12, P857, DOI 10.1101/gr.172702; DEAN M, 2002, HUMAN ATP BINDING CA; Finch CE, 2001, ANNU REV GENOM HUM G, V2, P435, DOI 10.1146/annurev.genom.2.1.435; FRIEDMAN DB, 1988, GENETICS, V118, P75; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Garofalo RS, 2002, TRENDS ENDOCRIN MET, V13, P156, DOI 10.1016/S1043-2760(01)00548-3; Gildea JJ, 2000, GENETICS, V156, P645; Guarente L, 2001, TRENDS GENET, V17, P391, DOI 10.1016/S0168-9525(01)02339-3; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; Honda Y, 1999, FASEB J, V13, P1385, DOI 10.1096/fasebj.13.11.1385; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Knauf F, 2002, P NATL ACAD SCI USA, V99, P14315, DOI 10.1073/pnas.222531899; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Lee RYN, 2001, CURR BIOL, V11, P1950, DOI 10.1016/S0960-9822(01)00595-4; Lee S. A., UNPUB; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Nakai J, 2002, NAT GENET, V32, P245, DOI 10.1038/ng890; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Rogina B, 2000, SCIENCE, V290, P2137, DOI 10.1126/science.290.5499.2137; Simmer F, 2002, CURR BIOL, V12, P1317, DOI 10.1016/S0960-9822(02)01041-2; Tan PB, 1998, CELL, V93, P569, DOI 10.1016/S0092-8674(00)81186-1; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; WADSWORTH WG, 1989, DEV BIOL, V132, P167, DOI 10.1016/0012-1606(89)90214-5; Wolkow CA, 2000, SCIENCE, V290, P147, DOI 10.1126/science.290.5489.147; Yu H, 2001, J MOL BIOL, V314, P1017, DOI 10.1006/jmbi.2000.5210	32	504	525	2	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 25	2003	300	5619					644	647		10.1126/science.1083614	http://dx.doi.org/10.1126/science.1083614			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671FB	12690206				2022-12-24	WOS:000182453700043
J	Royer, S; Pare, D				Royer, S; Pare, D			Conservation of total synaptic weight through balanced synaptic depression and potentiation	NATURE			English	Article							LONG-TERM POTENTIATION; PYRAMIDAL CELLS; PLASTICITY; HIPPOCAMPUS; LTP; NEURONS; CALCIUM; STORES; EFFICACY; RELEASE	Memory is believed to depend on activity-dependent changes in the strength of synapses(1). In part, this view is based on evidence that the efficacy of synapses can be enhanced or depressed depending on the timing of pre- and postsynaptic activity(2-5). However, when such plastic synapses are incorporated into neural network models, stability problems may develop because the potentiation or depression of synapses increases the likelihood that they will be further strengthened or weakened(6). Here we report biological evidence for a homeostatic mechanism that reconciles the apparently opposite requirements of plasticity and stability. We show that, in intercalated neurons of the amygdala, activity-dependent potentiation or depression of particular glutamatergic inputs leads to opposite changes in the strength of inputs ending at other dendritic sites. As a result, little change in total synaptic weight occurs, even though the relative strength of inputs is modified. Furthermore, hetero- but not homosynaptic alterations are blocked by intracellular dialysis of drugs that prevent Ca2+ release from intracellular stores. Thus, in intercalated neurons at least, inverse heterosynaptic plasticity tends to compensate for homosynaptic long-term potentiation and depression, thus stabilizing total synaptic weight.	Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA	Rutgers State University Newark; Rutgers State University New Brunswick	Pare, D (corresponding author), Rutgers State Univ, Ctr Mol & Behav Neurosci, 197 Univ Ave, Newark, NJ 07102 USA.	pare@axon.rutgers.edu						Abbott LF, 2000, NAT NEUROSCI, V3, P1178, DOI 10.1038/81453; ABRAHAM WC, 1991, BRAIN RES, V546, P336, DOI 10.1016/0006-8993(91)91498-P; Arbib MA, 1995, HDB BRAIN THEORY NEU; Bear MF, 1996, ANNU REV NEUROSCI, V19, P437, DOI 10.1146/annurev.ne.19.030196.002253; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Carroll RC, 2001, NAT REV NEUROSCI, V2, P315, DOI 10.1038/35072500; Coussens CM, 1996, LEARN MEMORY, V3, P106, DOI 10.1101/lm.3.2-3.106; Debanne D, 1998, J PHYSIOL-LONDON, V507, P237, DOI 10.1111/j.1469-7793.1998.237bu.x; DEMAUREX N, 1992, J BIOL CHEM, V267, P2318; Emptage N, 1999, NEURON, V22, P115, DOI 10.1016/S0896-6273(00)80683-2; Feldman DE, 2000, NEURON, V27, P45, DOI 10.1016/S0896-6273(00)00008-8; HOLM S, 1979, SCAND J STAT, V6, P65; Liang Y, 2002, J NEUROPHYSIOL, V87, P1132, DOI 10.1152/jn.00661.2001; LYNCH GS, 1977, NATURE, V266, P737, DOI 10.1038/266737a0; MALENKA RC, 1994, CELL, V78, P535, DOI 10.1016/0092-8674(94)90517-7; Markram H, 1996, NATURE, V382, P807, DOI 10.1038/382807a0; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; MULLER D, 1995, NEURON, V14, P599, DOI 10.1016/0896-6273(95)90316-X; Nishiyama M, 2000, NATURE, V408, P584, DOI 10.1038/35046067; ODonovan MJ, 1997, TRENDS NEUROSCI, V20, P431, DOI 10.1016/S0166-2236(97)01124-7; Royer S, 2002, NEUROSCIENCE, V115, P455, DOI 10.1016/S0306-4522(02)00455-4; Scanziani M, 1996, NATURE, V380, P446, DOI 10.1038/380446a0; Segev C, 1989, METHODS NEURONAL MOD, P9; Soderling TR, 2000, TRENDS NEUROSCI, V23, P75, DOI 10.1016/S0166-2236(99)01490-3; Song S, 2000, NAT NEUROSCI, V3, P919, DOI 10.1038/78829; Turrigiano GG, 1999, TRENDS NEUROSCI, V22, P221, DOI 10.1016/S0166-2236(98)01341-1; Winder DG, 2001, NAT REV NEUROSCI, V2, P461, DOI 10.1038/35081514; Xu L, 1999, J BIOL CHEM, V274, P32680, DOI 10.1074/jbc.274.46.32680	30	241	245	2	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 3	2003	422	6931					518	522		10.1038/nature01530	http://dx.doi.org/10.1038/nature01530			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	662TW	12673250				2022-12-24	WOS:000181965400037
J	Woods, GL; White, KL; Vanderwall, DK; Li, GP; Aston, KI; Bunch, TD; Meerdo, LN; Pate, BJ				Woods, GL; White, KL; Vanderwall, DK; Li, GP; Aston, KI; Bunch, TD; Meerdo, LN; Pate, BJ			A mule cloned from fetal cells by nuclear transfer	SCIENCE			English	Article									Univ Idaho, Dept Vet & Anim Sci, NW Equine Reprod Lab, Moscow, ID 83844 USA; Utah State Univ, Ctr Dev & Mol Biol, Ctr Biotechnol, Dept Anim Dairy & Vet Sci, Logan, UT 84322 USA	Idaho; University of Idaho; Utah System of Higher Education; Utah State University	Woods, GL (corresponding author), Univ Idaho, Dept Vet & Anim Sci, NW Equine Reprod Lab, Moscow, ID 83844 USA.		Migliaccio, Kati/AAC-8451-2020					ALLEN WR, 1993, EQUINE REPROD, pCH63; Hinrichs K, 1998, THERIOGENOLOGY, V49, P13, DOI 10.1016/S0093-691X(97)00398-1; KLINE D, 1992, DEV BIOL, V149, P80, DOI 10.1016/0012-1606(92)90265-I; WOODS G, UNPUB; Woods GL, 2002, THERIOGENOLOGY, V58, P779	5	214	266	0	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 22	2003	301	5636					1063	1063		10.1126/science.1086743	http://dx.doi.org/10.1126/science.1086743			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	713RP	12775846				2022-12-24	WOS:000184872400030
J	Zazula, GD; Froese, DG; Schweger, CE; Mathewes, RW; Beaudoin, AB; Telka, AM; Harington, CR; Westgate, JA				Zazula, GD; Froese, DG; Schweger, CE; Mathewes, RW; Beaudoin, AB; Telka, AM; Harington, CR; Westgate, JA			Ice-age steppe vegetation in east Beringia - Tiny plant fossils indicate how this frozen region once sustained huge herds of mammals	NATURE			English	Article							ALASKA; TUNDRA		Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada; Simon Fraser Univ, Dept Earth Sci, Burnaby, BC V5A 1S6, Canada; Prov Museum Alberta, Edmonton, AB T5N 0M6, Canada; Univ Alberta, Dept Anthropol, Edmonton, AB T6G 2H4, Canada; PALEOTEC Serv, W Ottawa, ON K1R 5K2, Canada; Canadian Museum Nat, Ottawa, ON K1P 6P4, Canada; Univ Toronto, Dept Geol, Toronto, ON M5S 3B1, Canada	Simon Fraser University; Simon Fraser University; University of Alberta; University of Toronto	Zazula, GD (corresponding author), Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada.		Beaudoin, Alwynne B./H-3873-2011; Froese, Duane G/B-6038-2009	Beaudoin, Alwynne B./0000-0002-8895-4567; MATHEWES, ROLF/0000-0001-7637-199X				ANDERSON PM, 1994, QUATERNARY SCI REV, V13, P71, DOI 10.1016/0277-3791(94)90125-2; Birks HH, 2000, J BIOGEOGR, V27, P31, DOI 10.1046/j.1365-2699.2000.00375.x; CWYNAR LC, 1980, SCIENCE, V208, P1375, DOI 10.1126/science.208.4450.1375; EDWARDS ME, 1989, ARCTIC ALPINE RES, V21, P296, DOI 10.2307/1551569; Elias SA, 1996, NATURE, V382, P60, DOI 10.1038/382060a0; Froese D, 2002, QUATERNARY SCI REV, V21, P2137, DOI 10.1016/S0277-3791(02)00038-0; Goetcheus VG, 2001, QUATERNARY SCI REV, V20, P135, DOI 10.1016/S0277-3791(00)00127-X; Guthrie R.D., 1990, FROZEN FAUNA MAMMOTH; Harington C.R., 1996, Current Research in the Pleistocene, V13, P105; Vetter MA, 2000, ARCTIC, V53, P165	10	77	79	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 5	2003	423	6940					603	603		10.1038/423603a	http://dx.doi.org/10.1038/423603a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686BT	12789326	Bronze			2022-12-24	WOS:000183301200027
J	Arlt, W; Allolio, B				Arlt, W; Allolio, B			Adrenal insufficiency	LANCET			English	Review							GLUCOCORTICOID REPLACEMENT THERAPY; DAILY CORTISOL PRODUCTION; BONE-MINERAL DENSITY; ADRENOCORTICOTROPIN STIMULATION TEST; CORTICOTROPIN-RELEASING-HORMONE; INSULIN-INDUCED HYPOGLYCEMIA; AUTOIMMUNE ADDISONS-DISEASE; STEROID-PRODUCING CELLS; KEARNS-SAYRE-SYNDROME; DOSE METYRAPONE TEST	Adrenal insufficiency is caused by either primary adrenal failure (mostly due to autoimmune adrenalitis) or by hypothalamic-pituitary impairment of the corticotropic axis (predominantly due to pituitary disease). It is a rare disease, but is life threatening when overlooked. Main presenting symptoms such as fatigue, anorexia, and weight loss are nonspecific, thus diagnosis is often delayed. The diagnostic work-up is well established but some pitfalls remain, particularly in the identification of secondary adrenal insufficiency. Despite optimised life-saving glucocorticoid-replacement and mineralocorticoid-replacement therapy, health-related quality of life in adrenal insufficiency is more severely impaired than previously thought. Dehydroeplandrosterone-replacement therapy has been introduced that could help to restore quality of life. Monitoring of glucocorticoid-replacement quality is hampered by lack of objective methods of assessment, and is therefore largely based on clinical grounds. Thus, long-term management of patients with adrenal insufficiency remains a challenge, requiring an experienced specialist. However, all doctors should know how to diagnose and manage suspected acute adrenal failure.	Univ Wurzburg, Dept Med, Endocrine & Diabet Unit, D-97080 Wurzburg, Germany; Univ Birmingham, Div Med Sci, Birmingham, W Midlands, England	University of Wurzburg; University of Birmingham	Allolio, B (corresponding author), Univ Wurzburg, Dept Med, Endocrine & Diabet Unit, Josef Schneider Str 2, D-97080 Wurzburg, Germany.	allolio_b@klinik.uni.wuerzburg.de	Arlt, Wiebke/B-6310-2009	Arlt, Wiebke/0000-0001-5106-9719				Aaltonen J, 1997, NAT GENET, V17, P399, DOI 10.1038/ng1297-399; Achermann JC, 1999, NAT GENET, V22, P125, DOI 10.1038/9629; AHONEN P, 1990, NEW ENGL J MED, V322, P1829, DOI 10.1056/NEJM199006283222601; ALLOLIO B, 1990, CLIN ENDOCRINOL, V33, P279, DOI 10.1111/j.1365-2265.1990.tb00492.x; ALLOLIO B, 1983, LANCET, V2, P626; Allolio B, 2002, TRENDS ENDOCRIN MET, V13, P288, DOI 10.1016/S1043-2760(02)00617-3; ALLOLIO B, 1994, CLIN ENDOCRINOL, V40, P769, DOI 10.1111/j.1365-2265.1994.tb02511.x; Allolio B, 1985, AKT ENDOKR STOFFW, V6, P35; ALSHOUMER KAS, 1995, CLIN ENDOCRINOL, V42, P85, DOI 10.1111/j.1365-2265.1995.tb02602.x; Annane D, 2002, JAMA-J AM MED ASSOC, V288, P862, DOI 10.1001/jama.288.7.862; Arlt W, 1999, NEW ENGL J MED, V341, P1013, DOI 10.1056/NEJM199909303411401; Auchus RJ, 1997, CLIN ENDOCRINOL, V46, P21, DOI 10.1046/j.1365-2265.1997.d01-1748.x; BARBATO AL, 1977, ACTA ENDOCRINOL-COP, V84, P600, DOI 10.1530/acta.0.0840600; Bates AS, 1996, J CLIN ENDOCR METAB, V81, P1169, DOI 10.1210/jc.81.3.1169; Beishuizen A, 2001, BEST PRACT RES CL EN, V15, P513, DOI 10.1053/beem.2001.0167; Betterle C, 1999, J CLIN ENDOCR METAB, V84, P618, DOI 10.1210/jc.84.2.618; Betterle C, 2002, ENDOCR REV, V23, P327, DOI 10.1210/er.23.3.327; Boles RG, 1998, EUR J PEDIATR, V157, P643, DOI 10.1007/s004310050902; BORST GC, 1982, NEW ENGL J MED, V306, P1462, DOI 10.1056/NEJM198206173062405; Bose HS, 1996, NEW ENGL J MED, V335, P1870, DOI 10.1056/NEJM199612193352503; BRAATVEDT GD, 1990, BRIT MED J, V301, P1312, DOI 10.1136/bmj.301.6764.1312; Braatvedt GD, 1999, OSTEOPOROSIS INT, V10, P435, DOI 10.1007/s001980050251; Brandon DD, 1999, STEROIDS, V64, P372, DOI 10.1016/S0039-128X(98)00112-3; BRIEGEL J, 1992, INTENS CARE MED, V18, P318, DOI 10.1007/BF01706486; BROIDE J, 1995, J CLIN ENDOCR METAB, V80, P1243, DOI 10.1210/jc.80.4.1243; BURCH WM, 1982, JAMA-J AM MED ASSOC, V247, P2002, DOI 10.1001/jama.247.14.2002; Clark PM, 1998, CLIN ENDOCRINOL, V49, P287; Courtney CH, 2000, CLIN ENDOCRINOL, V53, P309; CUNNINGHAM SK, 1983, ARCH INTERN MED, V143, P2276, DOI 10.1001/archinte.143.12.2276; De Vroede M, 1998, ARCH DIS CHILD, V78, P544, DOI 10.1136/adc.78.6.544; DICKSTEIN G, 1986, ACTA ENDOCRINOL-COP, V112, P28, DOI 10.1530/acta.0.1120028; DICKSTEIN G, 1991, J CLIN ENDOCR METAB, V72, P773, DOI 10.1210/jcem-72-4-773; DIEDERICH S, 1994, DEUT MED WOCHENSCHR, V119, P595, DOI 10.1055/s-2008-1058735; Donner H, 1997, J CLIN ENDOCR METAB, V82, P4130, DOI 10.1210/jc.82.12.4130; DRUCKER D, 1986, CRIT CARE MED, V14, P789, DOI 10.1097/00003246-198609000-00006; ESTEBAN NV, 1991, J CLIN ENDOCR METAB, V72, P39, DOI 10.1210/jcem-72-1-39; Fallo F, 1999, EUR J ENDOCRINOL, V140, P425, DOI 10.1530/eje.0.1400425; FALLO F, 1994, AM J HYPERTENS, V7, P1105, DOI 10.1093/ajh/7.12.1105; FEEK CM, 1981, CLIN ENDOCRINOL, V14, P451, DOI 10.1111/j.1365-2265.1981.tb00634.x; FEEK CM, 1981, CLIN ENDOCRINOL, V15, P75, DOI 10.1111/j.1365-2265.1981.tb02750.x; FIAD TM, 1994, CLIN ENDOCRINOL, V40, P603, DOI 10.1111/j.1365-2265.1994.tb03011.x; FINDLING JW, 1994, J CLIN ENDOCR METAB, V79, P1091, DOI 10.1210/jc.79.4.1091; FINDLING JW, 1987, J CLIN ENDOCR METAB, V64, P592, DOI 10.1210/jcem-64-3-592; Fitzky BU, 1998, P NATL ACAD SCI USA, V95, P8181, DOI 10.1073/pnas.95.14.8181; Flemming TG, 1999, J INTERN MED, V246, P497, DOI 10.1046/j.1365-2796.1999.00538.x; FLORKOWSKI CM, 1994, NEW ZEAL MED J, V107, P52; FRANCKE U, 1987, AM J HUM GENET, V40, P212; Glowniak JV, 1997, SURGERY, V121, P123, DOI 10.1016/S0039-6060(97)90280-4; GRINSPOON SK, 1994, J CLIN ENDOCR METAB, V79, P923, DOI 10.1210/jc.79.4.923; GROVES RW, 1988, J ROY SOC MED, V81, P514, DOI 10.1177/014107688808100906; HAGG E, 1987, CLIN ENDOCRINOL, V26, P221, DOI 10.1111/j.1365-2265.1987.tb00780.x; Handschug K, 2001, HUM MOL GENET, V10, P283, DOI 10.1093/hmg/10.3.283; Hangaard J, 1996, J CLIN ENDOCR METAB, V81, P2502, DOI 10.1210/jc.81.7.2502; HARVEY JN, 1992, CLIN ENDOCRINOL, V37, P97, DOI 10.1111/j.1365-2265.1992.tb02289.x; Henzen C, 2000, LANCET, V355, P542, DOI 10.1016/S0140-6736(99)06290-X; Howlett TA, 1997, CLIN ENDOCRINOL, V46, P263, DOI 10.1046/j.1365-2265.1997.1340955.x; Hunt PJ, 2000, J CLIN ENDOCR METAB, V85, P4650, DOI 10.1210/jc.85.12.4650; Inder WJ, 2002, J CLIN ENDOCR METAB, V87, P2745, DOI 10.1210/jc.87.6.2745; Johannsson G, 2002, J CLIN ENDOCR METAB, V87, P2046, DOI 10.1210/jc.87.5.2046; JURNEY TH, 1987, CHEST, V92, P292, DOI 10.1378/chest.92.2.292; Kannisto S, 2000, J CLIN ENDOCR METAB, V85, P652, DOI 10.1210/jc.85.2.652; Kasperlik-Zaluska AA, 1998, CLIN ENDOCRINOL, V49, P779, DOI 10.1046/j.1365-2265.1998.00611.x; Kawashima A, 1998, RADIOGRAPHICS, V18, P393, DOI 10.1148/radiographics.18.2.9536486; KEHLET H, 1976, CLIN ENDOCRINOL, V5, P37, DOI 10.1111/j.1365-2265.1976.tb01937.x; Kemp EH, 1998, CLIN ENDOCRINOL, V49, P609; KERRIGAN JR, 1993, J CLIN ENDOCR METAB, V76, P1505, DOI 10.1210/jc.76.6.1505; Knapen MH, 1993, ADDISON PATIENTS NET; KONG MF, 1994, CLIN ENDOCRINOL, V41, P757, DOI 10.1111/j.1365-2265.1994.tb02790.x; Kraan GPB, 1998, J CLIN ENDOCR METAB, V83, P1247, DOI 10.1210/jc.83.4.1247; Krasner AS, 1999, JAMA-J AM MED ASSOC, V282, P671, DOI 10.1001/jama.282.7.671; Krude H, 1998, NAT GENET, V19, P155, DOI 10.1038/509; Lam KY, 2001, CLIN ENDOCRINOL, V54, P633, DOI 10.1046/j.1365-2265.2001.01266.x; Lamberts SWJ, 1997, NEW ENGL J MED, V337, P1285, DOI 10.1056/NEJM199710303371807; LANDON J, 1966, J CLIN INVEST, V45, P437, DOI 10.1172/JCI105358; Lange M, 2002, EUR J ENDOCRINOL, V147, P41, DOI 10.1530/eje.0.1470041; Laureti S, 1999, J CLIN ENDOCR METAB, V84, P1762, DOI 10.1210/jc.84.5.1762; LEBRETHON MC, 1994, J CLIN INVEST, V93, P1828, DOI 10.1172/JCI117168; LEDINGHAM IM, 1983, LANCET, V1, P1270; Lindholm J, 2001, CLIN ENDOCRINOL, V54, P283, DOI 10.1046/j.1365-2265.2001.01163.x; LINDHOLM J, 1987, CLIN ENDOCRINOL, V26, P53, DOI 10.1111/j.1365-2265.1987.tb03638.x; Lovas K, 2002, CLIN ENDOCRINOL, V56, P581, DOI 10.1046/j.1365-2265.2002.01466.x; Lovas K, 2002, CLIN ENDOCRINOL, V56, P787, DOI 10.1046/j.1365-2265.2002.t01-1-01552.x; Lutz A, 2000, EUR J ENDOCRINOL, V143, P91, DOI 10.1530/eje.0.1430091; MAISEY DN, 1974, LANCET, V2, P896; MASON AS, 1968, LANCET, V2, P744; Mayenknecht J, 1998, J CLIN ENDOCR METAB, V83, P1558, DOI 10.1210/jc.83.5.1558; Monson JP, 1997, CLIN ENDOCRINOL, V46, P269, DOI 10.1046/j.1365-2265.1997.87897.x; Moser HW, 1997, BRAIN, V120, P1485, DOI 10.1093/brain/120.8.1485; MOSSER J, 1993, NATURE, V361, P726, DOI 10.1038/361726a0; MOSSER J, 1994, HUM MOL GENET, V3, P265, DOI 10.1093/hmg/3.2.265; Murphy H, 1998, J CLIN ENDOCR METAB, V83, P712; Nagamine K, 1997, NAT GENET, V17, P393, DOI 10.1038/ng1297-393; NELSON JC, 1978, AM J MED SCI, V275, P165, DOI 10.1097/00000441-197803000-00006; NERUP J, 1974, ACTA ENDOCRINOL-COP, V76, P127, DOI 10.1530/acta.0.0760127; NEUFELD M, 1981, MEDICINE, V60, P355, DOI 10.1097/00005792-198109000-00003; Nilsson B, 2000, J CLIN ENDOCR METAB, V85, P1420, DOI 10.1210/jc.85.4.1420; NUSSEY SS, 1993, CLIN ENDOCRINOL, V39, P381, DOI 10.1111/j.1365-2265.1993.tb02381.x; OELKERS W, 1989, NEW ENGL J MED, V321, P492, DOI 10.1056/NEJM198908243210802; OELKERS W, 1992, J CLIN ENDOCR METAB, V75, P259, DOI 10.1210/jc.75.1.259; Oelkers W, 1998, EUR J ENDOCRINOL, V139, P567, DOI 10.1530/eje.0.1390567; Peacey SR, 1997, CLIN ENDOCRINOL, V46, P255, DOI 10.1046/j.1365-2265.1997.780907.x; POWRIE JK, 1995, CLIN ENDOCRINOL, V42, P315, DOI 10.1111/j.1365-2265.1995.tb01881.x; Randeva HS, 1999, CLIN ENDOCRINOL, V51, P181, DOI 10.1046/j.1365-2265.1999.00754.x; Regal M, 2001, CLIN ENDOCRINOL, V55, P735, DOI 10.1046/j.1365-2265.2001.01406.x; REINCKE M, 1993, J CLIN ENDOCR METAB, V77, P151, DOI 10.1210/jc.77.1.151; RHEAUME E, 1992, NAT GENET, V1, P239, DOI 10.1038/ng0792-239; RIEDEL M, 1993, EXP CLIN ENDOCRINOL, V101, P106, DOI 10.1055/s-0029-1211215; ROBINSON BG, 1987, CLIN ENDOCRINOL, V27, P437, DOI 10.1111/j.1365-2265.1987.tb01171.x; ROSEN T, 1994, CLIN ENDOCRINOL, V40, P111, DOI 10.1111/j.1365-2265.1994.tb02452.x; ROTHWELL PM, 1991, LANCET, V337, P582, DOI 10.1016/0140-6736(91)91641-7; SALEM M, 1994, ANN SURG, V219, P416, DOI 10.1097/00000658-199404000-00013; Satta MA, 2000, CLIN ENDOCRINOL, V52, P123; SAWCZUK IS, 1986, UROL RADIOL, V8, P44, DOI 10.1007/BF02924072; SCHULTE HM, 1987, CLIN ENDOCRINOL, V27, P655, DOI 10.1111/j.1365-2265.1987.tb02948.x; SCOTT RS, 1978, CLIN ENDOCRINOL, V9, P571, DOI 10.1111/j.1365-2265.1978.tb01516.x; Soule S, 1999, CLIN ENDOCRINOL, V50, P115, DOI 10.1046/j.1365-2265.1999.00625.x; STEIN CA, 1986, ANN INTERN MED, V104, P286, DOI 10.7326/0003-4819-104-2-286_2; STEWART PM, 1988, LANCET, V1, P1208; Stewart PM, 1998, CLIN ENDOCRINOL, V48, P124, DOI 10.1046/j.1365-2265.1998.0429d.x; Streeten DHP, 1996, J CLIN ENDOCR METAB, V81, P285, DOI 10.1210/jc.81.1.285; Tajima T, 2001, J CLIN ENDOCR METAB, V86, P3820, DOI 10.1210/jc.86.8.3820; Thaler LM, 1998, J CLIN ENDOCR METAB, V83, P2726, DOI 10.1210/jc.83.8.2726; Thomas PQ, 2001, HUM MOL GENET, V10, P39, DOI 10.1093/hmg/10.1.39; Tomlinson JW, 2001, LANCET, V357, P425, DOI 10.1016/S0140-6736(00)04006-X; TORDJMAN K, 1995, J CLIN ENDOCR METAB, V80, P1301, DOI 10.1210/jc.80.4.1301; Tordjman K, 2000, CLIN ENDOCRINOL, V52, P633, DOI 10.1046/j.1365-2265.2000.00984.x; TSATSOULIS A, 1988, CLIN ENDOCRINOL, V28, P225, DOI 10.1111/j.1365-2265.1988.tb03659.x; TSIGOS C, 1993, J CLIN INVEST, V92, P2458, DOI 10.1172/JCI116853; Tuchelt H, 2000, CLIN ENDOCRINOL, V53, P301, DOI 10.1046/j.1365-2265.2000.01089.x; Tullio-Pelet A, 2000, NAT GENET, V26, P332, DOI 10.1038/81642; VASIKARAN SD, 1994, CLIN ENDOCRINOL, V41, P261, DOI 10.1111/j.1365-2265.1994.tb02540.x; Vilain E, 1999, J CLIN ENDOCR METAB, V84, P4335, DOI 10.1210/jc.84.12.4335; Wassif CA, 1998, AM J HUM GENET, V63, P55, DOI 10.1086/301936; WATTS NB, 1988, JAMA-J AM MED ASSOC, V259, P708, DOI 10.1001/jama.259.5.708; WEBER A, 1994, HUM MOL GENET, V3, P585, DOI 10.1093/hmg/3.4.585; WEETMAN AP, 1995, BAILLIERE CLIN ENDOC, V9, P157, DOI 10.1016/S0950-351X(95)80899-X; WEITZMAN ED, 1971, J CLIN ENDOCR METAB, V33, P14, DOI 10.1210/jcem-33-1-14; WHITE PC, 1991, J CLIN INVEST, V87, P1664, DOI 10.1172/JCI115182; Wichers M, 1999, CLIN ENDOCRINOL, V50, P759, DOI 10.1046/j.1365-2265.1999.00723.x; Willis AC, 1997, POSTGRAD MED J, V73, P286, DOI 10.1136/pgmj.73.859.286; WINQVIST O, 1992, LANCET, V339, P1559, DOI 10.1016/0140-6736(92)91829-W; WOOD JB, 1965, LANCET, V1, P243; Wu W, 1998, NAT GENET, V18, P147, DOI 10.1038/ng0298-147; ZANARIA E, 1994, NATURE, V372, P635, DOI 10.1038/372635a0; Zelissen P, 1994, ADDISON PATIENTS NET; ZELISSEN PMJ, 1994, ANN INTERN MED, V120, P207, DOI 10.7326/0003-4819-120-3-199402010-00005	146	605	633	0	53	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 31	2003	361	9372					1881	1893		10.1016/S0140-6736(03)13492-7	http://dx.doi.org/10.1016/S0140-6736(03)13492-7			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	684KL	12788587				2022-12-24	WOS:000183205800024
J	Wilson, JF				Wilson, JF			The vaccine crossroads	ANNALS OF INTERNAL MEDICINE			English	Editorial Material																			0	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 20	2003	138	10					857	860		10.7326/0003-4819-138-10-200305200-00037	http://dx.doi.org/10.7326/0003-4819-138-10-200305200-00037			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	679KH	12755580				2022-12-24	WOS:000182920700029
J	Cosma, MP; Pepe, S; Annunziata, I; Newbold, RF; Grompe, M; Parenti, G; Ballabio, A				Cosma, MP; Pepe, S; Annunziata, I; Newbold, RF; Grompe, M; Parenti, G; Ballabio, A			The multiple sulfatase deficiency gene encodes an essential and limiting factor for the activity of sulfatases	CELL			English	Article							ENZYME REPLACEMENT THERAPY; METACHROMATIC LEUKODYSTROPHY; ARYLSULFATASE-A; STEROID SULFATASE; FELINE MODEL; COMPLEMENTATION; FORMYLGLYCINE; FIBROBLASTS; EXPRESSION; SYSTEM	In multiple sulfatase deficiency (MSD), a human inherited disorder, the activities of all sulfatases are impaired due to a defect in posttranslational modification. Here we report the identification, by functional complementation using microcell-mediated chromosome transfer, of a gene that is mutated in MSD and is able to rescue the enzymatic deficiency in patients' cell lines. Functional conservation of this gene was observed among distantly related species, suggesting a critical biological role. Coexpression of SUMF1 with sulfatases results in a strikingly synergistic increase of enzymatic activity, indicating that SUMF1 is both an essential and a limiting factor for sulfatases. These data have profound implications on the feasibility of enzyme replacement therapy for eight distinct inborn errors of metabolism.	Telethon Inst Genet & Med, I-80131 Naples, Italy; Univ Naples Federico 2, Dept Pediat, I-80131 Naples, Italy; Brunel Univ, Brunel Inst Canc Genet & Pharmacogenom, Uxbridge UB8 4SP, Middx, England; Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97201 USA; Univ Naples 2, I-80131 Naples, Italy	Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); University of Naples Federico II; Brunel University; Oregon Health & Science University; Universita della Campania Vanvitelli	Ballabio, A (corresponding author), Telethon Inst Genet & Med, I-80131 Naples, Italy.	ballabio@tigem.it	BALLABIO, Andrea/AAL-2672-2020; Cosma, Maria Pia/E-8731-2015	BALLABIO, Andrea/0000-0003-1381-4604; Cosma, Maria Pia/0000-0003-4207-5097; parenti, giancarlo/0000-0002-6287-5748; Grompe, Markus/0000-0002-6616-4345	Telethon [TGM03S01, TGM06S01] Funding Source: Medline	Telethon(Fondazione Telethon)		BALLABIO A, 1985, HUM GENET, V70, P315, DOI 10.1007/BF00295367; BALLABIO A, 2001, METABOLIC MOL BASIS, P4241; BISCHEL M, 1966, ARCH NEUROL-CHICAGO, V15, P13, DOI 10.1001/archneur.1966.00470130017002; BOEHNKE M, 1991, AM J HUM GENET, V49, P1174; Bond CS, 1997, STRUCTURE, V5, P277, DOI 10.1016/S0969-2126(97)00185-8; BURCH M, 1986, CLIN GENET, V30, P409; BURK R, 1981, AM J HUM GENET, V33, pA72; Byers S, 2000, PEDIATR RES, V47, P743, DOI 10.1203/00006450-200006000-00010; CHANG PL, 1980, P NATL ACAD SCI-BIOL, V77, P6166, DOI 10.1073/pnas.77.10.6166; CONARY JT, 1988, BIOL CHEM H-S, V369, P297, DOI 10.1515/bchm3.1988.369.1.297; Consiglio A, 2001, NAT MED, V7, P310, DOI 10.1038/85454; COUCHOT J, 1974, ARCH FR PEDIATR, V31, P775; Crawley AC, 1997, J CLIN INVEST, V99, P651, DOI 10.1172/JCI119208; CUTHBERT AP, 1995, CYTOGENET CELL GENET, V71, P68, DOI 10.1159/000134066; Dierks T, 1998, J BIOL CHEM, V273, P25560, DOI 10.1074/jbc.273.40.25560; Dierks T, 2003, CELL, V113, P435, DOI 10.1016/S0092-8674(03)00347-7; Ferrante P, 2002, EUR J HUM GENET, V10, P813, DOI 10.1038/sj.ejhg.5200887; Fey J, 2001, J BIOL CHEM, V276, P47021, DOI 10.1074/jbc.M108943200; FRANCA JRD, 1995, J ATMOS CHEM, V22, P81; Ho TT, 2002, J GENE MED, V4, P613, DOI 10.1002/jgm.302; Hopwood JJ, 2001, METABOLIC MOL BASES, P3725; HORWITZ AL, 1979, P NATL ACAD SCI USA, V76, P6496, DOI 10.1073/pnas.76.12.6496; Hunt JD, 1996, ANAL BIOCHEM, V238, P107, DOI 10.1006/abio.1996.0263; Imreh S, 1997, GENE CHROMOSOME CANC, V20, P224; Kolodny E.H., 1995, METABOLIC MOL BASES, V7th, P2693; Lukatela G, 1998, BIOCHEMISTRY-US, V37, P3654, DOI 10.1021/bi9714924; Matzner U, 2000, GENE THER, V7, P1250, DOI 10.1038/sj.gt.3301232; Matzner U, 2002, GENE THER, V9, P53, DOI 10.1038/sj.gt.3301593; Meroni G, 1996, HUM MOL GENET, V5, P423, DOI 10.1093/hmg/5.4.423; Morimoto-Tomita M, 2002, J BIOL CHEM, V277, P49175, DOI 10.1074/jbc.M205131200; Neufeld EF, 2001, MUCOPOLYSACCHARIDOSE, P3421, DOI DOI 10.1036/OMMBID.165; Parenti G, 1997, CURR OPIN GENET DEV, V7, P386, DOI 10.1016/S0959-437X(97)80153-0; Saeki Y, 2001, MOL THER, V3, P591, DOI 10.1006/mthe.2001.0294; Schiller NG, 1998, IDENTITIES-GLOB STUD, V5, P1; SCHMIDT B, 1995, CELL, V82, P271, DOI 10.1016/0092-8674(95)90314-3; STEIN C, 1989, J BIOL CHEM, V264, P1252; Toietta G, 2001, HUM GENE THER, V12, P2007, DOI 10.1089/104303401753204571; VONFIGURA K, 2001, METABOLIC MOL BASES, P3695; Wade-Martins R, 2001, NAT BIOTECHNOL, V19, P1067, DOI 10.1038/nbt1101-1067; ZENGER J L, 1989, American Journal of Human Genetics, V45, pA70	40	258	292	2	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 16	2003	113	4					445	456		10.1016/S0092-8674(03)00348-9	http://dx.doi.org/10.1016/S0092-8674(03)00348-9			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	680MG	12757706	Bronze			2022-12-24	WOS:000182981500007
J	Dierks, T; Schmidt, B; Borissenko, LV; Peng, JH; Preusser, A; Mariappan, M; von Figura, K				Dierks, T; Schmidt, B; Borissenko, LV; Peng, JH; Preusser, A; Mariappan, M; von Figura, K			Multiple sulfatase deficiency is caused by mutations in the gene encoding the human C-alpha-formylglycine generating enzyme	CELL			English	Article							HUMAN ARYLSULFATASE-A; ENDOPLASMIC-RETICULUM; POSTTRANSLATIONAL FORMATION; EUKARYOTIC SULFATASES; PROTEIN MODIFICATION; CRYSTAL-STRUCTURE; CYSTEINE; CONVERSION; FIBROBLASTS; MECHANISM	C-alpha-formylglycine (FGly) is the catalytic residue in the active site of eukaryotic sulfatases. It is posttranslationally generated from a cysteine in the endoplasmic reticulum. The genetic defect of FGly formation causes multiple sulfatase deficiency (MSD), a lysosomal storage disorder. We purified the FGly generating enzyme (FGE) and identified its gene and nine mutations in seven MSD patients. In patient fibroblasts, the activity of sulfatases is partially restored by transduction of FGE encoding cDNA, but not by cDNA carrying an MSD mutation. The gene encoding FGE is highly conserved among pro- and eukaryotes and has a paralog of unknown function in vertebrates. FGE is localized in the endoplasmic reticulum and is predicted to have a tripartite domain structure.	Univ Gottingen, D-37073 Gottingen, Germany	University of Gottingen	von Figura, K (corresponding author), Univ Gottingen, Heinrich Duker Weg 12, D-37073 Gottingen, Germany.	kfigura@gwdg.de	mariappan, malaiyalam/K-9024-2012; Dierks, Thomas/A-3596-2012	Dierks, Thomas/0000-0001-6426-1339				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ANSON DS, 1993, BIOCHEM J, V294, P657, DOI 10.1042/bj2940657; ARTELT P, 1988, GENE, V68, P213, DOI 10.1016/0378-1119(88)90023-6; BASNER R, 1979, PEDIATR RES, V13, P1316, DOI 10.1203/00006450-197912000-00002; Boltes I, 2001, STRUCTURE, V9, P483, DOI 10.1016/S0969-2126(01)00609-8; BURCH M, 1986, CLIN GENET, V30, P409; BURK RD, 1984, J PEDIATR-US, V104, P574, DOI 10.1016/S0022-3476(84)80550-8; CHANG PL, 1983, J INHERIT METAB DIS, V6, P167, DOI 10.1007/BF02310875; CONARY JT, 1988, BIOL CHEM H-S, V369, P297, DOI 10.1515/bchm3.1988.369.1.297; COUCHOT J, 1974, ARCH FR PEDIATR, V31, P775; Dierks T, 1998, FEBS LETT, V423, P61, DOI 10.1016/S0014-5793(98)00065-9; Dierks T, 1997, P NATL ACAD SCI USA, V94, P11963, DOI 10.1073/pnas.94.22.11963; Dierks T, 1998, J BIOL CHEM, V273, P25560, DOI 10.1074/jbc.273.40.25560; Dierks T, 1999, EMBO J, V18, P2084, DOI 10.1093/emboj/18.8.2084; Fey J, 2001, J BIOL CHEM, V276, P47021, DOI 10.1074/jbc.M108943200; FLUHARTY AL, 1979, AM J HUM GENET, V31, P574; FLUHARTY AL, 1978, AM J HUM GENET, V30, P249; GLOSSL J, 1978, CLIN CHIM ACTA, V88, P111, DOI 10.1016/0009-8981(78)90157-2; Gupta Ramneek, 2002, Pac Symp Biocomput, P310; Hansske B, 2002, J CLIN INVEST, V109, P725, DOI 10.1172/JCI200214010; Hopwood JJ, 2001, METABOLIC MOL BASES, P3725; KRESSE H, 1980, BIOCHEM BIOPH RES CO, V97, P41, DOI 10.1016/S0006-291X(80)80131-8; Lubke T, 2001, NAT GENET, V28, P73, DOI 10.1038/ng0501-73; Lukatela G, 1998, BIOCHEMISTRY-US, V37, P3654, DOI 10.1021/bi9714924; Meyer HA, 2000, J BIOL CHEM, V275, P14550, DOI 10.1074/jbc.275.19.14550; Miech C, 1998, J BIOL CHEM, V273, P4835, DOI 10.1074/jbc.273.9.4835; Neufeld EF, 2001, MUCOPOLYSACCHARIDOSE, P3421, DOI DOI 10.1036/OMMBID.165; Peng JH, 2003, J MASS SPECTROM, V38, P80, DOI 10.1002/jms.404; Rampini S, 1970, Helv Paediatr Acta, V25, P436; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; ROMMERSKIRCH W, 1992, P NATL ACAD SCI USA, V89, P2561, DOI 10.1073/pnas.89.7.2561; SCHMIDT B, 1995, CELL, V82, P271, DOI 10.1016/0092-8674(95)90314-3; Selmer T, 1996, EUR J BIOCHEM, V238, P341, DOI 10.1111/j.1432-1033.1996.0341z.x; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Sonnhammer ELL, 1998, NUCLEIC ACIDS RES, V26, P320, DOI 10.1093/nar/26.1.320; STECKEL F, 1985, EUR J BIOCHEM, V151, P141, DOI 10.1111/j.1432-1033.1985.tb09078.x; Szameit C, 1999, J BIOL CHEM, V274, P15375, DOI 10.1074/jbc.274.22.15375; Thiel C, 2002, BIOCHEM J, V367, P195, DOI 10.1042/BJ20020794; VAMOS E, 1981, J INHERIT METAB DIS, V4, P103, DOI 10.1007/BF02263612; von Bulow R, 2001, J MOL BIOL, V305, P269, DOI 10.1006/jmbi.2000.4297; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; WALTER P, 1983, METHOD ENZYMOL, V96, P84; Wheeler DL, 2002, NUCLEIC ACIDS RES, V30, P13, DOI 10.1093/nar/30.1.13; YUTAKA T, 1981, CLIN GENET, V20, P296	44	269	304	1	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 16	2003	113	4					435	444		10.1016/S0092-8674(03)00347-7	http://dx.doi.org/10.1016/S0092-8674(03)00347-7			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	680MG	12757705	Bronze			2022-12-24	WOS:000182981500006
J	Garfield, CF; Chung, PJ; Rathouz, PJ				Garfield, CF; Chung, PJ; Rathouz, PJ			Alcohol advertising in magazines and adolescent readership	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DRINKING; SCHOOL	Context Adolescent drinking is a major public health concern. The federal government does not restrict alcohol advertising to adolescents, but relies on the alcohol industry for self-regulation. Objectives To investigate recent alcohol advertising in magazines and to determine whether advertising frequency is associated with adolescent readership. Design, Setting, and Subjects All alcohol advertisements were counted that appeared from 1997-2001 in 35 of 48 major US magazines, which tracked their adolescent readership (3 refused all alcohol advertisements; and advertisement counts were unavailable for 10). Variation was assessed in the advertisement placement frequency for each major category of alcohol (beer, wine and wine coolers, and distilled liquor) by a magazine's adolescent readership (age 12-19 years), young adult readership (age 20-24 years), and older adult readership (age greater than or equal to25 years); readership demographics (sex, race, and income); year; frequency of publication; and cost per advertisement. Main Outcome Measure Variation in alcohol advertising frequency by adolescent readership. Results Adolescent readership ranged from 1.0 to 7.1 million. The alcohol industry placed 9148 advertisements at a cost of $696 million. Of the 9148 advertisements, 1201 (13%) were for beer, 443 (5%) for wine, and 7504 (82%) for liquor. After adjustment for other magazine characteristics, the advertisement rate ratio was 1.6 times more for beer (95% confidence interval [CI], 1.0-2.6; P=.05) and liquor (95% CI, 1.1-2.3; P=.01) for every additional million adolescent readers. Wine industry advertising was not associated with adolescent readership. Conclusions Magazine advertising by the beer and liquor industries is associated with adolescent readership. industry and federal policymakers should examine ways to regulate advertising that reaches large numbers of adolescents.	Evanston NW Healthcare Res Inst, Dept Pediat, Evanston, IL 60202 USA; Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Los Angeles, CA USA; Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA	Northwestern University; Feinberg School of Medicine; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Chicago	Garfield, CF (corresponding author), Evanston NW Healthcare Res Inst, Dept Pediat, 2650 Ridge Ave, Evanston, IL 60202 USA.	c-garfield@northwestern.edu	Garfield, Craig/AAE-2525-2020	Garfield, Craig/0000-0002-6512-6005				*AM COLL EM PHYS, 2001, ANN EMERG MED, V37, P557; [Anonymous], 1999, Pediatrics, V104, P341; Atkin, 1993, Adolesc Med, V4, P527; ATKIN CK, 1990, J ADOLESCENT HEALTH, V11, P10, DOI 10.1016/0197-0070(90)90125-L; ATKIN CK, 1984, J COMMUN, V28, P71; Chung PJ, 2002, HEALTH AFFAIR, V21, P254, DOI 10.1377/hlthaff.21.2.254; *COMP MED REP, 2001, TARG 2 CONS MAG OCC; *FED TRAD COMM, SELF REG ALC IND REV; Foster SE, 2003, JAMA-J AM MED ASSOC, V289, P989, DOI 10.1001/jama.289.8.989; *GEORG U CTR ALC M, 2002, OV YOUTH TARG ALC AD; GRUBE JW, 1994, AM J PUBLIC HEALTH, V84, P254, DOI 10.2105/AJPH.84.2.254; Grube JW, 1995, EFFECTS MASS MEDIA U, V28, P105; IACOBUCCI D, 2001, KELLOGG MARKETING; Jacobs EA, 2001, PEDIATRICS, V108, P185, DOI 10.1542/peds.108.1.185; Johnston L, 2003, MONITORING FUTURE NA; JOHNSTON LD, 1996, NIH PUBLICATION, V1; MADDEN PA, 1994, AM J PUBLIC HEALTH, V84, P297, DOI 10.2105/AJPH.84.2.297; Martin SE, 2002, ALCOHOL CLIN EXP RES, V26, P900, DOI 10.1097/00000374-200206000-00021; *MED RES INC, 2000, MED REP; *NAT HIGHW TRAFF S, 1998, TRAFF SAF FACTS 1997; *NAT I ALC AB ALC, 1997, YOUTH DRINK RISK FAC; *NAT I ALC AB ALC, 1996, ALC AL 31 DRINK DRIV; *OFF INSP GEN, 1992, YOUTH ALC DANG DEADL; SHELOV S, 1995, PEDIATRICS, V95, P295; Snyder LB, 2000, J STUD ALCOHOL, V61, P896, DOI 10.15288/jsa.2000.61.896; Strasburger, 1993, Adolesc Med, V4, P391; Strasburger VC, 2002, PEDIATR CLIN N AM, V49, P353, DOI 10.1016/S0031-3955(01)00009-8; STRUNIN L, 1992, INT J ADDICT, V27, P129, DOI 10.3109/10826089209068734; U.S. Department of Health and Human Services, 2000, HLTH PEOPL 2010 UND; *US DEP HHS, 1997, 9 SPEC REP US C ALC; Valois RF, 1999, J ADOLESCENT HEALTH, V25, P328, DOI 10.1016/S1054-139X(99)00051-8; Wechsler H, 1998, J AM COLL HEALTH, V47, P57, DOI 10.1080/07448489809595621; 1991, MMWR MORB MORTAL WKL, V40, P178; 2001, US WINE MARKET IMPAC; 2002, US BEER MARKET IMPAC; 2001, US SPIRITS MARKET IM	36	48	49	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 14	2003	289	18					2424	2429		10.1001/jama.289.18.2424	http://dx.doi.org/10.1001/jama.289.18.2424			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	677WF	12746369				2022-12-24	WOS:000182831200035
J	Wardle, DA; Hornberg, G; Zackrisson, O; Kalela-Brundin, M; Coomes, DA				Wardle, DA; Hornberg, G; Zackrisson, O; Kalela-Brundin, M; Coomes, DA			Long-term effects of wildfire on ecosystem properties across an island area gradient	SCIENCE			English	Article							TERRESTRIAL ECOSYSTEMS; CARBON STORAGE; BOREAL FOREST; FIRE; GRASSLAND; BUDGET; SINK	Boreal forest soils play an important role in the global carbon cycle by functioning as a large terrestrial carbon sink or source, and the alteration of fire regime through global change phenomena may influence this role. We studied a system of forested lake islands in the boreal zone of Sweden for which fire frequency increases with increasing island size. Large islands supported higher plant productivity and litter decomposition rates than did smaller ones, and, with increasing time since fire, litter decomposition rates were suppressed sooner than was ecosystem productivity. This contributes to greater carbon storage with increasing time since fire; for every century without a major fire, an additional 0.5 kilograms per square meter of carbon becomes stored in the humus.	Swedish Univ Agr Sci, Fac Forestry, Dept Forest Vegetat Ecol, SE-90183 Umea, Sweden; Landcare Res, Lincoln, New Zealand; Museum Forestry, SE-92123 Lycksele, Sweden; Univ Cambridge, Dept Plant Sci, Cambridge CB2 3EA, England	Swedish University of Agricultural Sciences; Landcare Research - New Zealand; University of Cambridge	Wardle, DA (corresponding author), Swedish Univ Agr Sci, Fac Forestry, Dept Forest Vegetat Ecol, SE-90183 Umea, Sweden.		Coomes, David/H-5630-2011; Wardle, David A./F-6031-2011	Wardle, David A./0000-0002-0476-7335				ANDERSON JM, 1991, ECOL APPL, V1, P326, DOI 10.2307/1941761; BONAN GB, 1989, ANNU REV ECOL SYST, V20, P1, DOI 10.1146/annurev.es.20.110189.000245; Fang JY, 2001, SCIENCE, V292, P2320, DOI 10.1126/science.1058629; FLANNIGAN MD, 1991, CANADIAN J FOREST RE, V21, P61; Goodale CL, 2002, ECOL APPL, V12, P891, DOI 10.2307/3060997; HAAPASAARI M, 1998, ACTA FOR FENN, V135, P1; Harden JW, 2000, GLOBAL CHANGE BIOL, V6, P174, DOI 10.1046/j.1365-2486.2000.06019.x; Houghton RA, 1999, SCIENCE, V285, P574, DOI 10.1126/science.285.5427.574; Houghton RA, 2000, GLOBAL ECOL BIOGEOGR, V9, P145, DOI 10.1046/j.1365-2699.2000.00164.x; Hurtt GC, 2002, P NATL ACAD SCI USA, V99, P1389, DOI 10.1073/pnas.012249999; Keeling RF, 1996, NATURE, V381, P218, DOI 10.1038/381218a0; Larsen CPS, 1997, J BIOGEOGR, V24, P663, DOI 10.1111/j.1365-2699.1997.tb00076.x; OJIMA DS, 1994, BIOGEOCHEMISTRY, V24, P67, DOI 10.1007/BF02390180; PAYETTE S, 1992, P144, DOI 10.1017/CBO9780511565489.006; Schimel DS, 2001, NATURE, V414, P169, DOI 10.1038/35102500; SCHIMEL DS, 1995, GLOBAL CHANGE BIOL, V1, P77, DOI 10.1111/j.1365-2486.1995.tb00008.x; Scurlock JMO, 1998, GLOBAL CHANGE BIOL, V4, P229, DOI 10.1046/j.1365-2486.1998.00151.x; SIREN GUSTAF, 1955, ACTA FOREST FENNICA, V62, P1; Tilman D, 2000, ECOLOGY, V81, P2680, DOI 10.1890/0012-9658(2000)081[2680:FSAECS]2.0.CO;2; Wardle DA, 2002, J BIOGEOGR, V29, P583, DOI 10.1046/j.1365-2699.2002.00708.x; Wardle DA, 1997, SCIENCE, V277, P1296, DOI 10.1126/science.277.5330.1296; ZACKRISSON O, 1977, OIKOS, V29, P22, DOI 10.2307/3543289	22	223	232	10	139	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 9	2003	300	5621					972	975		10.1126/science.1082709	http://dx.doi.org/10.1126/science.1082709			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675WD	12738863				2022-12-24	WOS:000182719800055
J	Burns, KH; Viveiros, MM; Ren, YS; Wang, P; DeMayo, FJ; Frail, DE; Eppig, JJ; Matzuk, MM				Burns, KH; Viveiros, MM; Ren, YS; Wang, P; DeMayo, FJ; Frail, DE; Eppig, JJ; Matzuk, MM			Roles of NPM2 in chromatin and nucleolar organization in oocytes and embryos	SCIENCE			English	Article							SPERM NUCLEI; EGG CYTOPLASM; NUCLEOPLASMIN; MOUSE; GENE; DECONDENSATION; SEQUENCE; NUCLEOPHOSMIN; ACQUISITION; EXPRESSION	Upon fertilization, remodeling of condensed maternal and paternal gamete DNA occurs to form the diploid genome. In Xenopus laevis, nucleoplasmin 2 (NPM2) decondenses sperm DNA in vitro. To study chromatin remodeling in vivo, we isolated mammalian NPM2 orthologs. Mouse NPM2 accumulates in oocyte nuclei and persists in preimplantation embryos. Npm2 knockout females have fertility defects owing to failed preimplantation embryo development. Although sperm DNA decondensation proceeds without NPM2, abnormalities are evident in oocyte and early embryonic nuclei. These defects include an absence of coalesced nucleolar structures and loss of heterochromatin and deacetylated histone H3 that normally circumscribe nucleoli in oocytes and early embryos, respectively. Thus, Npm2 is a maternal effect gene critical for nuclear and nucleolar organization and embryonic development.	Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; Baylor Coll Med, Dept Human Mol Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; Jackson Lab, Bar Harbor, ME 04609 USA; Wyeth Ayerst Res, Collegeville, PA 19426 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Jackson Laboratory; Pfizer	Matzuk, MM (corresponding author), Baylor Coll Med, Dept Pathol, 1 Baylor Plaza, Houston, TX 77030 USA.	mmatzuk@bcm.tmc.edu	Burns, Kathleen/A-3360-2011; Viveiros, Maria/P-4120-2015; DeMayo, Francesco/C-6255-2019	DeMayo, Francesco/0000-0002-9480-7336; Wang, Pei/0000-0003-2373-7315	NICHD NIH HHS [HD33438, HD07495, HD21970, HD42500] Funding Source: Medline; NIGMS NIH HHS [T32GM07330] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD033438] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U01HD021970, R37HD033438, P30HD007495, R01HD042500, R37HD021970] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007330] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bouniol-Baly C, 1999, BIOL REPROD, V60, P580, DOI 10.1095/biolreprod60.3.580; BURGLIN TR, 1987, GENE DEV, V1, P97, DOI 10.1101/gad.1.1.97; CAPECCHI MR, 1994, SCI AM, V270, P52, DOI 10.1038/scientificamerican0394-52; CHAN WY, 1989, BIOCHEMISTRY-US, V28, P1033, DOI 10.1021/bi00429a017; Christians E, 2000, NATURE, V407, P693, DOI 10.1038/35037669; DILWORTH SM, 1987, CELL, V51, P1009, DOI 10.1016/0092-8674(87)90587-3; DINGWALL C, 1987, EMBO J, V6, P69, DOI 10.1002/j.1460-2075.1987.tb04720.x; Gillespie PJ, 2000, NUCLEIC ACIDS RES, V28, P472, DOI 10.1093/nar/28.2.472; Gurtu VE, 2002, GENETICS, V160, P271; Howell CY, 2001, CELL, V104, P829, DOI 10.1016/S0092-8674(01)00280-X; Hunt PA, 2002, SCIENCE, V296, P2181, DOI 10.1126/science.1071907; LATHAM KE, 1992, DEV BIOL, V149, P457, DOI 10.1016/0012-1606(92)90300-6; Ma J, 2001, BIOL REPROD, V64, P1713, DOI 10.1095/biolreprod64.6.1713; MacArthur CA, 1997, GENOMICS, V42, P137, DOI 10.1006/geno.1997.4353; Maeda Y, 1998, ZYGOTE, V6, P39, DOI 10.1017/S0967199400005062; MATTSON BA, 1990, MOL REPROD DEV, V25, P374, DOI 10.1002/mrd.1080250411; Matzuk MM, 2002, SCIENCE, V296, P2178, DOI 10.1126/science.1071965; Meric F, 1997, J BIOL CHEM, V272, P12840, DOI 10.1074/jbc.272.19.12840; OHSUMI K, 1991, DEV BIOL, V148, P295, DOI 10.1016/0012-1606(91)90338-4; PERREAULT SD, 1992, MUTAT RES, V296, P43, DOI 10.1016/0165-1110(92)90031-4; PHILPOTT A, 1991, CELL, V65, P569, DOI 10.1016/0092-8674(91)90089-H; ROBBINS J, 1991, CELL, V64, P615, DOI 10.1016/0092-8674(91)90245-T; SCHMIDTZACHMANN MS, 1988, CHROMOSOMA, V96, P417, DOI 10.1007/BF00303035; Tong ZB, 2000, NAT GENET, V26, P267, DOI 10.1038/81547; USUI N, 1976, J ULTRA MOL STRUCT R, V57, P276, DOI 10.1016/S0022-5320(76)80117-7; WICKRAMASINGHE D, 1991, DEV BIOL, V143, P162, DOI 10.1016/0012-1606(91)90063-9; Wu XM, 2003, NAT GENET, V33, P187, DOI 10.1038/ng1079; Zuccotti M, 1998, BIOL REPROD, V58, P700, DOI 10.1095/biolreprod58.3.700	28	277	291	1	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 25	2003	300	5619					633	636		10.1126/science.1081813	http://dx.doi.org/10.1126/science.1081813			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671FB	12714744				2022-12-24	WOS:000182453700040
J	Gaudet, F; Hodgson, JG; Eden, A; Jackson-Grusby, L; Dausman, J; Gray, JW; Leonhardt, H; Jaenisch, R				Gaudet, F; Hodgson, JG; Eden, A; Jackson-Grusby, L; Dausman, J; Gray, JW; Leonhardt, H; Jaenisch, R			Induction of tumors in mice by genomic hypomethylation	SCIENCE			English	Article							GERM-LINE; 5-METHYLCYTOSINE CONTENT; RETROVIRAL GENOMES; DNA METHYLATION; C-MYC; EXPRESSION; INSTABILITY; CANCER; TRANSMISSION; INTEGRATION	Genome-wide DNA hypomethylation occurs in many human cancers, but whether this epigenetic change is a cause or consequence of tumorigenesis has been unclear. To explore this phenomenon, we generated mice carrying a hypomorphic DNA methyltransferase 1 (Dnmt1) allele, which reduces Dnmt1 expression to 10% of wild-type levels and results in substantial genome-wide hypomethylation in all tissues. The mutant mice were runted at birth, and at 4 to 8 months of age they developed aggressive T cell lymphomas that displayed a high frequency of chromosome 15 trisomy. These results indicate that DNA hypomethylation plays a causal role in tumor formation, possibly by promoting chromosomal instability.	MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02142 USA; Univ Munich, Dept Biol 2, D-80336 Munich, Germany; Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Ctr Comprehens Canc, San Francisco, CA 94143 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); University of Munich; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	Jaenisch, R (corresponding author), MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA.	jaenisch@wi.mit.edu	jia, xu/A-8386-2016; Leonhardt, Heinrich/B-2791-2014		NATIONAL CANCER INSTITUTE [R01CA087869] Funding Source: NIH RePORTER; NCI NIH HHS [CA87869] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Chen RZ, 1998, NATURE, V395, P89, DOI 10.1038/25779; Cory S, 1999, CANCER RES, V59, p1685S; Eden A, 2003, SCIENCE, V300, P455, DOI 10.1126/science.1083557; Ehrlich M, 2002, ONCOGENE, V21, P5400, DOI 10.1038/sj.onc.1205651; FEINBERG AP, 1983, NATURE, V301, P89, DOI 10.1038/301089a0; GAMASOSA MA, 1983, NUCLEIC ACIDS RES, V11, P6883, DOI 10.1093/nar/11.19.6883; Gaudet F, 1998, J BIOL CHEM, V273, P32725, DOI 10.1074/jbc.273.49.32725; GAUDET F, UNPUB; Hodgson G, 2001, NAT GENET, V29, P459, DOI 10.1038/ng771; Jackson-Grusby L, 2001, NAT GENET, V27, P31, DOI 10.1038/83730; JAENISCH R, 1976, P NATL ACAD SCI USA, V73, P1260, DOI 10.1073/pnas.73.4.1260; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; JAENISCH R, 1985, P NATL ACAD SCI USA, V82, P1451, DOI 10.1073/pnas.82.5.1451; JAHNER D, 1980, NATURE, V287, P456, DOI 10.1038/287456a0; JEANPIERRE M, 1993, HUM MOL GENET, V2, P731, DOI 10.1093/hmg/2.6.731; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Karpf AR, 2002, ONCOGENE, V21, P5496, DOI 10.1038/sj.onc.1205602; LAIRD PW, 1995, CELL, V81, P197, DOI 10.1016/0092-8674(95)90329-1; LAPEYRE JN, 1979, BIOCHEM BIOPH RES CO, V87, P698, DOI 10.1016/0006-291X(79)92015-1; Lei H, 1996, DEVELOPMENT, V122, P3195; Lengauer C, 1997, P NATL ACAD SCI USA, V94, P2545, DOI 10.1073/pnas.94.6.2545; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; MACLEOD AR, 1995, J BIOL CHEM, V270, P8037, DOI 10.1074/jbc.270.14.8037; Muto M, 1996, JPN J CANCER RES, V87, P247, DOI 10.1111/j.1349-7006.1996.tb00213.x; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; SELTEN G, 1984, EMBO J, V3, P3215, DOI 10.1002/j.1460-2075.1984.tb02281.x; STEWART C, 1983, SCIENCE, V221, P760, DOI 10.1126/science.6683871; Trinh BN, 2002, MOL CELL BIOL, V22, P2906, DOI 10.1128/MCB.22.9.2906-2917.2002; Tucker KL, 1996, GENE DEV, V10, P1008, DOI 10.1101/gad.10.8.1008; WAINFAN E, 1992, CANCER RES, V52, pS2071; Walsh CP, 1998, NAT GENET, V20, P116, DOI 10.1038/2413; Whitehurst CE, 1999, IMMUNITY, V10, P313, DOI 10.1016/S1074-7613(00)80031-X; WIRSCHUBSKY Z, 1986, INT J CANCER, V38, P739, DOI 10.1002/ijc.2910380518; Xu GL, 1999, NATURE, V402, P187, DOI 10.1038/46052; ZAGONEL V, 1993, LEUKEMIA, V7, P30	35	1133	1193	1	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 18	2003	300	5618					489	492		10.1126/science.1083558	http://dx.doi.org/10.1126/science.1083558			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668LR	12702876				2022-12-24	WOS:000182295900041
J	Kljuic, A; Bazzi, H; Sundberg, JP; Martinez-Mir, A; O'Shaughnessy, R; Mahoney, MG; Levy, M; Montagutelli, X; Ahmad, W; Alta, VM; Gordon, D; Uitto, J; Whiting, D; Ott, J; Fischer, S; Gilliam, TC; Jahoda, CAB; Morris, RJ; Panteleyev, AA; Nguyen, VT; Christiano, AM				Kljuic, A; Bazzi, H; Sundberg, JP; Martinez-Mir, A; O'Shaughnessy, R; Mahoney, MG; Levy, M; Montagutelli, X; Ahmad, W; Alta, VM; Gordon, D; Uitto, J; Whiting, D; Ott, J; Fischer, S; Gilliam, TC; Jahoda, CAB; Morris, RJ; Panteleyev, AA; Nguyen, VT; Christiano, AM			Desmoglein 4 in hair follicle differentiation and epidermal adhesion: Evidence from inherited hypotrichosis and acquired pemphigus vulgaris	CELL			English	Article							SUPRABASAL INTEGRIN EXPRESSION; PALMOPLANTAR KERATODERMA; DESMOSOMAL CADHERINS; CELL-ADHESION; GROWTH-FACTOR; WOOLLY HAIR; KERATINOCYTE; PHENOTYPE; MUTATION; DISEASE	Cell adhesion and communication are interdependent aspects of cell behavior that are critical for morphogenesis and tissue architecture. In the skin, epidermal adhesion is mediated in part by specialized cell-cell junctions known as desmosomes, which are characterized by the presence of desmosomal cadherins, known as desmogleins and desmocollins. We identified a cadherin family member, desmoglein 4, which is expressed in the suprabasal epidermis and hair follicle. The essential role of desmoglein 4 in skin was established by identifying mutations in families with inherited hypotrichosis, as well as in the lanceolate hair mouse. We also show that DSG4 is an autoantigen in pemphigus vulgaris. Characterization of the phenotype of naturally occurring mutant mice revealed disruption of desmosomal adhesion and perturbations in keratinocyte behavior. We provide evidence that desmoglein 4 is a key mediator of keratinocyte cell adhesion in the hair follicle, where it coordinates the transition from proliferation to differentiation.	Columbia Univ, Dept Genet & Dev, New York, NY 10032 USA; Columbia Univ, Dept Dermatol, New York, NY 10032 USA; Columbia Univ, Columbia Genome Ctr, New York, NY 10032 USA; Jackson Lab, Bar Harbor, ME 04609 USA; Thomas Jefferson Univ, Jefferson Med Coll, Dept Dermatol & Cutaneous Biol, Philadelphia, PA 19107 USA; Baylor Coll Med, Houston, TX 77030 USA; Inst Pasteur, Unite Genet Mammiferes, F-75724 Paris, France; Dallas associated Dermatologists, Dallas, TX 75246 USA; Rockefeller Univ, Lab Stat Genet, New York, NY 10021 USA; Univ Durham, Durham DH1 3LE, England; Univ Calif Davis, Dept Dermatol, Sacramento, CA 95817 USA	Columbia University; Columbia University; Columbia University; Jackson Laboratory; Jefferson University; Baylor College of Medicine; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Rockefeller University; Durham University; University of California System; University of California Davis	Christiano, AM (corresponding author), Columbia Univ, Dept Genet & Dev, New York, NY 10032 USA.		Bazzi, Hisham/AAA-6584-2021; Ahmad, Wasim/E-9713-2015; Mahoney, My/A-2716-2009; IBIS, NEUROGENETICA/P-2947-2015; Martinez-Mir, Amalia/K-7715-2018; Ahmad, Wasim/GSD-8904-2022; Panteleyev, Andrey A/R-9151-2016	Bazzi, Hisham/0000-0001-8388-4005; Martinez-Mir, Amalia/0000-0002-1628-8972; Panteleyev, Andrey A/0000-0002-8733-9183; O'Shaughnessy, Ryan/0000-0002-3701-0267; Jahoda, Colin/0000-0002-1762-1220; Nguyen, Vu/0000-0002-1142-6352	NCRR NIH HHS [K26-RR173] Funding Source: Medline; NIAMS NIH HHS [R03 AR47938, P01 AR38923] Funding Source: Medline; PHS HHS [R01-44924] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR047938, P01AR038923] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Ahmad W, 1998, SCIENCE, V279, P720, DOI 10.1126/science.279.5351.720; AUBER L., 1952, TRANS ROY SOC EDINBURGH, V62, P191; BULLOUGH W. S., 1958, BIOLOGY HAIR GROWTH, P171; BUXTON RS, 1993, J CELL BIOL, V121, P481, DOI 10.1083/jcb.121.3.481; CARROLL JM, 1995, CELL, V83, P957, DOI 10.1016/0092-8674(95)90211-2; Chidgey M, 2001, J CELL BIOL, V155, P821, DOI 10.1083/jcb.200105009; Eshkind L, 2002, EUR J CELL BIOL, V81, P592, DOI 10.1078/0171-9335-00278; Frank J, 1999, NATURE, V398, P473, DOI 10.1038/18997; Freedberg IM, 2001, J INVEST DERMATOL, V116, P633, DOI 10.1046/j.1523-1747.2001.01327.x; FRESHNEY RI, 1987, ANIMAL CELLS MANUAL; Frischmeyer PA, 1999, HUM MOL GENET, V8, P1893, DOI 10.1093/hmg/8.10.1893; Garrod DR, 2002, CURR OPIN CELL BIOL, V14, P537, DOI 10.1016/S0955-0674(02)00366-6; Green KJ, 2000, NAT REV MOL CELL BIO, V1, P208, DOI 10.1038/35043032; GRINNELL F, 1990, J TRAUMA, V30, pS144; HARDY MH, 1992, TRENDS GENET, V8, P55, DOI 10.1016/0168-9525(92)90350-D; HARLOW E, 1998, USING ANTIBODIES LAB; Hudson LG, 1998, MICROSC RES TECHNIQ, V43, P444, DOI 10.1002/(SICI)1097-0029(19981201)43:5<444::AID-JEMT10>3.0.CO;2-C; Hunt DM, 2001, EUR J HUM GENET, V9, P197, DOI 10.1038/sj.ejhg.5200605; Jamora C, 2002, NAT CELL BIOL, V4, pE101, DOI 10.1038/ncb0402-e101; JIANG CK, 1993, P NATL ACAD SCI USA, V90, P6786, DOI 10.1073/pnas.90.14.6786; Keith D, 1999, HUM MOL GENET, V8, P143, DOI 10.1093/hmg/8.1.143; Kljuic A, 2003, EXP DERMATOL, V12, P20, DOI 10.1034/j.1600-0625.2003.120103.x; KLJUIC A, IN PRESS EXP DERMATO; Koch PJ, 1997, J CELL BIOL, V137, P1091, DOI 10.1083/jcb.137.5.1091; Kulessa H, 2000, EMBO J, V19, P6664, DOI 10.1093/emboj/19.24.6664; Kurose K, 2000, J DERMATOL SCI, V24, P184, DOI 10.1016/S0923-1811(00)00100-6; Kurzen H, 1998, DIFFERENTIATION, V63, P295, DOI 10.1046/j.1432-0436.1998.6350295.x; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; McGrath JA, 1997, NAT GENET, V17, P240, DOI 10.1038/ng1097-240; McKoy G, 2000, LANCET, V355, P2119, DOI 10.1016/S0140-6736(00)02379-5; McMillan JR, 2001, J DERMATOL, V28, P291, DOI 10.1111/j.1346-8138.2001.tb00136.x; Mendelsohn C, 1999, DEVELOPMENT, V126, P1139; Montagutelli X, 1997, J INVEST DERMATOL, V109, P324, DOI 10.1111/1523-1747.ep12335844; Montagutelli X, 1996, J INVEST DERMATOL, V107, P20, DOI 10.1111/1523-1747.ep12297438; MORRIS RJ, 1994, CELL PROLIFERAT, V27, P279, DOI 10.1111/j.1365-2184.1994.tb01425.x; Nguyen VT, 2000, J CLIN INVEST, V106, P1467, DOI 10.1172/JCI10305; Norgett EE, 2000, HUM MOL GENET, V9, P2761, DOI 10.1093/hmg/9.18.2761; Orwin D F, 1979, Int Rev Cytol, V60, P331, DOI 10.1016/S0074-7696(08)61266-8; Paine-Saunders S, 2002, J BIOL CHEM, V277, P2089, DOI 10.1074/jbc.M109151200; Pulkkinen L, 2003, EXP DERMATOL, V12, P11, DOI 10.1034/j.1600-0625.2003.120102.x; Pulkkinen L, 2002, J INVEST DERMATOL, V119, P1237, DOI 10.1046/j.1523-1747.2002.19645.x; Rikimaru K, 1997, EXP DERMATOL, V6, P214, DOI 10.1111/j.1600-0625.1997.tb00165.x; ROTH SI, 1964, J ULTRA MOL STRUCT R, V11, P33, DOI 10.1016/S0022-5320(64)80091-5; Sambrook J, 1989, MOL CLONING LAB MANU, V2nd; Sobel E, 1996, AM J HUM GENET, V58, P1323; Sundberg JP, 2000, EXP DERMATOL, V9, P206, DOI 10.1034/j.1600-0625.2000.009003206.x; Thompson JD, 1999, NUCLEIC ACIDS RES, V27, P2682, DOI 10.1093/nar/27.13.2682; Tong XM, 2003, TRENDS MOL MED, V9, P79, DOI 10.1016/S1471-4914(02)00025-4; VANSCOTT EJ, 1963, J INVEST DERMATOL, V41, P269, DOI 10.1038/jid.1963.110	49	243	253	0	9	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 18	2003	113	2					249	260		10.1016/S0092-8674(03)00273-3	http://dx.doi.org/10.1016/S0092-8674(03)00273-3			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	672EP	12705872	Bronze			2022-12-24	WOS:000182508500013
J	Alberio, R; Campbell, KHS				Alberio, R; Campbell, KHS			Epigenetics and nuclear transfer	LANCET			English	Editorial Material							CLONED MICE; SOMATIC-CELLS		Univ Nottingham, Sch Biosci, Loughborough LE12 5RD, Leics, England	University of Nottingham	Campbell, KHS (corresponding author), Univ Nottingham, Sch Biosci, Loughborough LE12 5RD, Leics, England.		Alberio, Ramiro/G-5955-2011	Alberio, Ramiro/0000-0001-6560-3919				Alberio R., 2003, Theriogenology, V59, P318; Bordignon V, 2001, DEV BIOL, V233, P192, DOI 10.1006/dbio.2001.0215; Chavatte-Palmer P, 2002, BIOL REPROD, V66, P1596, DOI 10.1095/biolreprod66.6.1596; Humpherys D, 2001, SCIENCE, V293, P95, DOI 10.1126/science.1061402; Humphreys D, 2002, P NATL ACAD SCI USA, V99, P12889, DOI 10.1073/pnas.192433399; Lai LX, 2002, SCIENCE, V295, P1089, DOI 10.1126/science.1068228; Lanza RP, 2001, SCIENCE, V294, P1893, DOI 10.1126/science.1063440; Ogonuki N, 2002, NAT GENET, V30, P253, DOI 10.1038/ng841; Ogura A, 2003, THERIOGENOLOGY, V59, P87, DOI 10.1016/S0093-691X(02)01276-1; Tamashiro KLK, 2002, NAT MED, V8, P262, DOI 10.1038/nm0302-262	10	9	9	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 12	2003	361	9365					1239	1240		10.1016/S0140-6736(03)13029-2	http://dx.doi.org/10.1016/S0140-6736(03)13029-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	666DM	12699948				2022-12-24	WOS:000182161600005
J	Navarro, A; Barton, NH				Navarro, A; Barton, NH			Chromosomal speciation and molecular divergence - Accelerated evolution in rearranged chromosomes	SCIENCE			English	Article							UPPER MIOCENE; GENES; RECOMBINATION; SELECTION; HISTORY; HOMINID; HUMANS; RATES	Humans and their closest evolutionary relatives, the chimpanzees, differ in similar to1.24% of their genomic DNA sequences. The fraction of these changes accumulated during the speciation processes that have separated the two lineages may be of special relevance in understanding the basis of their differences. We analyzed human and chimpanzee sequence data to search for the patterns of divergence and polymorphism predicted by a theoretical model of speciation. According to the model, positively selected changes should accumulate in chromosomes that present. fixed structural differences, such as inversions, between the two species. Protein evolution was more than 2.2 times faster in chromosomes that had undergone structural rearrangements compared with colinear chromosomes. Also, nucleotide variability is slightly lower in rearranged chromosomes. These patterns of divergence and polymorphism may be, at least in part, the molecular footprint of speciation events in the human and chimpanzee lineages.	Univ Pompeu Fabra, Dept Ciencies Expt & Salut, Barcelona 08003, Catalonia, Spain; Univ Edinburgh, Inst Cell Anim & Populat Biol, Edinburgh EH9 3JT, Midlothian, Scotland	Pompeu Fabra University; University of Edinburgh	Navarro, A (corresponding author), Univ Pompeu Fabra, Dept Ciencies Expt & Salut, Doctor Aiguader 80, Barcelona 08003, Catalonia, Spain.	arcadi.navarro@cexs.upf.es	Navarro, Arcadi/F-1592-2011	Navarro, Arcadi/0000-0003-2162-8246				Andolfatto P, 2001, GENET RES, V77, P1, DOI 10.1017/S0016672301004955; Bernardi G, 2000, GENE, V241, P3, DOI 10.1016/S0378-1119(99)00485-0; Brunet M, 2002, NATURE, V418, P145, DOI 10.1038/nature00879; Castresana J, 2002, NUCLEIC ACIDS RES, V30, P1751, DOI 10.1093/nar/30.8.1751; Chen FC, 2001, AM J HUM GENET, V68, P444, DOI 10.1086/318206; Consigliere S, 1996, CHROMOSOME RES, V4, P264, DOI 10.1007/BF02263675; Ebersberger I, 2002, AM J HUM GENET, V70, P1490, DOI 10.1086/340787; EYREWALKER A, 1993, P ROY SOC B-BIOL SCI, V252, P237, DOI 10.1098/rspb.1993.0071; FITCH WM, 1971, BIOCHEM GENET, V5, P231, DOI 10.1007/BF00485794; Haig D, 1999, PHILOS T R SOC B, V354, P1447, DOI 10.1098/rstb.1999.0490; Hudson R.R., 1990, Oxford Surveys in Evolutionary Biology, V7, P1; JANCZEWSKI DN, 1990, J HERED, V81, P375; Johnson T, 2002, GENETICS, V162, P395; Kimura M, 1985, NEUTRAL THEORY MOL E; KING M, 1993, SPECIES EVOLUTION; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Lercher MJ, 2001, MOL BIOL EVOL, V18, P2032, DOI 10.1093/oxfordjournals.molbev.a003744; LI WH, 1993, J MOL EVOL, V36, P96, DOI 10.1007/BF02407308; Lopez P, 2002, MOL BIOL EVOL, V19, P1; Machado CA, 2002, MOL BIOL EVOL, V19, P472, DOI 10.1093/oxfordjournals.molbev.a004103; Navarro A, 2003, EVOLUTION, V57, P447, DOI 10.1554/0014-3820(2003)057[0447:APIGIP]2.0.CO;2; Noor MAF, 2001, P NATL ACAD SCI USA, V98, P12084, DOI 10.1073/pnas.221274498; Orr HA, 1996, GENETICS, V144, P1331; Ortiz-Barrientos D, 2002, GENETICA, V116, P167, DOI 10.1023/A:1021296829109; Przeworski M, 2000, TRENDS GENET, V16, P296, DOI 10.1016/S0168-9525(00)02030-8; Rieseberg LH, 2001, TRENDS ECOL EVOL, V16, P351, DOI 10.1016/S0169-5347(01)02187-5; Rozas J, 1999, BIOINFORMATICS, V15, P174, DOI 10.1093/bioinformatics/15.2.174; Spirito F, 1998, ENDLESS FORMS, P320; Stephens JC, 2001, SCIENCE, V293, P489, DOI 10.1126/science.1059431; Van Doorn GS, 2001, P ROY SOC B-BIOL SCI, V268, P2155, DOI 10.1098/rspb.2001.1780; Vieira J, 2001, GENETICS, V158, P279; Vignaud P, 2002, NATURE, V418, P152, DOI 10.1038/nature00880; Wallis M, 2001, J MOL EVOL, V53, P10, DOI 10.1007/s002390010187; Williams EJB, 2000, NATURE, V407, P900, DOI 10.1038/35038066; Williams EJB, 2002, MOL BIOL EVOL, V19, P1395, DOI 10.1093/oxfordjournals.molbev.a004202; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; YANG Z, 2002, PHYLOGENETIC ANAL MA; Yi SJ, 2002, MOL BIOL EVOL, V19, P2191, DOI 10.1093/oxfordjournals.molbev.a004043; YUNIS JJ, 1982, SCIENCE, V215, P1525, DOI 10.1126/science.7063861	39	303	313	2	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 11	2003	300	5617					321	324		10.1126/science.1080600	http://dx.doi.org/10.1126/science.1080600			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665RQ	12690198	Green Submitted			2022-12-24	WOS:000182135400055
J	Takada, S; Kelkar, A; Theurkauf, WE				Takada, S; Kelkar, A; Theurkauf, WE			Drosophila checkpoint kinase 2 couples centrosome function and spindle assembly to genomic integrity	CELL			English	Article							TOPOISOMERASE-II; DNA-DAMAGE; MITOTIC CATASTROPHE; GAMMA-TUBULIN; CLEAVAGE; CELLS; GENE; CHK2; ATM; INHIBITION	In syncytial Drosophila embryos, damaged or incompletely replicated DNA triggers centrosome disruption in mitosis, leading to defects in spindle assembly and anaphase chromosome segregation. The damaged nuclei drop from the cortex and are not incorporated into the cells that form the embryo proper. A null mutation in the Drosophila checkpoint kinase 2 tumor suppressor homolog [DmChk2) blocks this mitotic response to DNA lesions and also prevents loss of defective nuclei from the cortex. In addition, DNA damage leads to increased DmChk2 localization to the centrosome and spindle microtubules. DmChk2 is therefore essential for a "mitotic catastrophe" signal that disrupts centrosome function in response to genotoxic stress and ensures that mutant and aneuploid nuclei are eliminated from the embryonic precursor pool.	Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Program Cell Dynam, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Theurkauf, WE (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, 373 Plantat St, Worcester, MA 01605 USA.	william.theurkauf@umassmed.edu		Theurkauf, William/0000-0001-7342-1912; Kelkar, Anju/0000-0001-7956-8210	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050898] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM50898] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abdu U, 2002, CURR BIOL, V12, P1645, DOI 10.1016/S0960-9822(02)01165-X; Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Andreassen PR, 2001, CANCER RES, V61, P7660; Brodsky MH, 2000, GENE DEV, V14, P666; Burden DA, 1996, J BIOL CHEM, V271, P29238, DOI 10.1074/jbc.271.46.29238; Clarkson M, 1999, DNA CELL BIOL, V18, P457, DOI 10.1089/104454999315178; de Klein A, 2000, CURR BIOL, V10, P479, DOI 10.1016/S0960-9822(00)00447-4; Durocher D, 2001, CURR OPIN CELL BIOL, V13, P225, DOI 10.1016/S0955-0674(00)00201-5; Foe Victoria E., 1993, P149; Fukasawa K, 1996, SCIENCE, V271, P1744, DOI 10.1126/science.271.5256.1744; HUT HMJ, 2003, IN PRESS MOL BIOL CE; ISHIDA R, 1994, J CELL BIOL, V126, P1341, DOI 10.1083/jcb.126.6.1341; KROSS J, 1982, BIOCHEMISTRY-US, V21, P4310, DOI 10.1021/bi00261a021; LONG BH, 1985, CANCER RES, V45, P3106; Meijers-Heijboer H, 2002, NAT GENET, V31, P55, DOI 10.1038/ng879; Mikhailov A, 2002, CURR BIOL, V12, P1797, DOI 10.1016/S0960-9822(02)01226-5; Oishi I, 1998, MECH DEVELOP, V71, P49, DOI 10.1016/S0925-4773(97)00200-1; Olivier M, 2002, HUM MUTAT, V19, P607, DOI 10.1002/humu.10081; Peters M, 2002, P NATL ACAD SCI USA, V99, P11305, DOI 10.1073/pnas.172382899; POMMIER Y, 1991, NUCLEIC ACIDS RES, V19, P5973, DOI 10.1093/nar/19.21.5973; Pommier Y, 1998, BBA-GENE STRUCT EXPR, V1400, P83, DOI 10.1016/S0167-4781(98)00129-8; RAFF JW, 1989, CELL, V57, P611, DOI 10.1016/0092-8674(89)90130-X; ROBERGE M, 1990, J CELL BIOL, V111, P1753, DOI 10.1083/jcb.111.5.1753; Robinson JT, 1999, J CELL BIOL, V146, P597, DOI 10.1083/jcb.146.3.597; Rong YKS, 2002, GENE DEV, V16, P1568, DOI 10.1101/gad.986602; Roninson IB, 2001, DRUG RESIST UPDATE, V4, P303, DOI 10.1054/drup.2001.0213; SANGER F, 1977, NATURE, V265, P687, DOI 10.1038/265687a0; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; Sibon OCM, 2000, NAT CELL BIOL, V2, P90, DOI 10.1038/35000041; Sibon OCM, 1999, CURR BIOL, V9, P302, DOI 10.1016/S0960-9822(99)80138-9; Sibon OCM, 1997, NATURE, V388, P93, DOI 10.1038/40439; Takai H, 2000, GENE DEV, V14, P1439; TANABE K, 1991, CANCER RES, V51, P4903; THEURKAUF WE, 1994, DROSOPHILA MELANOGAS; Tsvetkov L, 2003, J BIOL CHEM, V278, P8468, DOI 10.1074/jbc.M211202200; Vahteristo P, 2002, AM J HUM GENET, V71, P432, DOI 10.1086/341943; Vahteristo P, 2001, CANCER RES, V61, P5718; Xu JH, 2001, FEBS LETT, V508, P394, DOI 10.1016/S0014-5793(01)03103-9; Yu KR, 2000, NAT CELL BIOL, V2, P609, DOI 10.1038/35023555; ZHENG YX, 1991, CELL, V65, P817, DOI 10.1016/0092-8674(91)90389-G; ZHENG YX, 1995, NATURE, V378, P578, DOI 10.1038/378578a0	41	168	170	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 4	2003	113	1					87	99		10.1016/S0092-8674(03)00202-2	http://dx.doi.org/10.1016/S0092-8674(03)00202-2			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	668GX	12679037	Bronze			2022-12-24	WOS:000182282900009
J	De Sandre-Giovannoli, A; Bernard, R; Cau, P; Navarro, C; Amiel, J; Boccaccio, I; Lyonnet, S; Stewart, CL; Munnich, A; Le Merrer, M; Levy, N				De Sandre-Giovannoli, A; Bernard, R; Cau, P; Navarro, C; Amiel, J; Boccaccio, I; Lyonnet, S; Stewart, CL; Munnich, A; Le Merrer, M; Levy, N			Lamin A truncation in Hutchinson-Gilford progeria	SCIENCE			English	Article							DISEASE		Fac Med Timone, INSERM, U491, Marseille, France; Hop La Timone, Dept Med Genet, Marseille, France; Hop Necker Enfants Malad, INSERM, U393, Paris, France; Hop Conception, Biol Cellulaire Lab, Marseille, France; NCI, Can & Dev Biol Lab, Frederick, MD 21702 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Levy, N (corresponding author), Fac Med Timone, INSERM, U491, Marseille, France.		amiel, jeanne/AGX-1124-2022; amiel, jeanne/H-3501-2017; Lyonnet, Stanislas/H-5483-2017; De Sandre-Giovannoli, Annachiara/AAJ-6992-2020; De Sandre-Giovannoli, Annachiara/L-5759-2016; Cau, Pierre/M-3541-2016; Navarro, Claire/V-8774-2017; LEVY, Nicolas/J-1632-2014	amiel, jeanne/0000-0001-5973-4728; Lyonnet, Stanislas/0000-0001-5426-9417; De Sandre-Giovannoli, Annachiara/0000-0002-2324-2462; De Sandre-Giovannoli, Annachiara/0000-0002-2324-2462; Navarro, Claire/0000-0001-9490-2643; LEVY, Nicolas/0000-0001-5171-6365	NATIONAL CANCER INSTITUTE [Z01BC010377] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Burke B, 2002, NAT REV MOL CELL BIO, V3, P575, DOI 10.1038/nrm879; Novelli G, 2002, AM J HUM GENET, V71, P426, DOI 10.1086/341908; Worman HJ, 2002, TRENDS CELL BIOL, V12, P591, DOI 10.1016/S0962-8924(02)02401-7	3	1004	1042	2	97	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 27	2003	300	5628					2055	2055		10.1126/science.1084125	http://dx.doi.org/10.1126/science.1084125			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694KZ	12702809				2022-12-24	WOS:000183774900035
J	Colombo, K; Grill, SW; Kimple, RJ; Willard, FS; Siderovski, DP; Gonczy, P				Colombo, K; Grill, SW; Kimple, RJ; Willard, FS; Siderovski, DP; Gonczy, P			Translation of polarity cues into asymmetric spindle positioning in Caenorhabditis elegans embryos	SCIENCE			English	Article							C-ELEGANS; CELL-DIVISION; G-ALPHA; DISSOCIATION INHIBITOR; BINDING PROTEIN; GERM-LINE; DROSOPHILA; LOCALIZATION; ORIENTATION; SEGREGATION	Asymmetric divisions are crucial for generating cell diversity; they rely on coupling between polarity cues and spindle positioning, but how this coupling is achieved is poorly understood. In one-cell stage Caenorhabditis elegans embryos, polarity cues set by the PAR proteins mediate asymmetric spindle positioning by governing an imbalance of net pulling forces acting on spindle poles. We found that the GoLoco-containing proteins GPR-1 and GPR-2, as well as the Galpha subunits GOA-1 and GPA-16, were essential for generation of proper pulling forces. GPR-1/2 interacted with guanosine diphosphate-bound GOA-1 and were enriched on the posterior cortex in a par-3- and par-2-dependent manner. Thus, the extent of net pulling forces may depend on cortical Galpha activity, which is regulated by anterior-posterior polarity cues through GPR-1/2.	Swiss Inst Expt Canc Res, CH-1066 Epalinges, Switzerland; Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA	Swiss Institute Experimental Cancer Research; Max Planck Society; University of North Carolina; University of North Carolina Chapel Hill	Gonczy, P (corresponding author), Swiss Inst Expt Canc Res, CH-1066 Epalinges, Switzerland.		Kimple, Randall/L-6460-2019; Siderovski, David Peter/AAA-9603-2019; Grill, Stephan/D-9427-2012	Kimple, Randall/0000-0001-8336-8000; Siderovski, David Peter/0000-0002-0688-8210; Gonczy, Pierre/0000-0002-6305-6883	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062338] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM62338] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Boyd L, 1996, DEVELOPMENT, V122, P3075; Cai Y, 2003, CELL, V112, P51, DOI 10.1016/S0092-8674(02)01170-4; COLOMBO K, UNPUB; De Vries L, 2000, P NATL ACAD SCI USA, V97, P14364, DOI 10.1073/pnas.97.26.14364; ETEMADMOGHADAM B, 1995, CELL, V83, P743, DOI 10.1016/0092-8674(95)90187-6; Gonczy P, 2002, TRENDS CELL BIOL, V12, P332, DOI 10.1016/S0962-8924(02)02306-1; Gonczy P, 2000, NATURE, V408, P331, DOI 10.1038/35042526; Gotta M, 2001, NAT CELL BIOL, V3, P297, DOI 10.1038/35060092; Grill SW, 2001, NATURE, V409, P630, DOI 10.1038/35054572; GRILL SW, UNPUB; GUO S, 1995, CELL, V81, P611, DOI 10.1016/0092-8674(95)90082-9; Hung TJ, 1999, DEVELOPMENT, V126, P127; KEMPHUES KJ, 1988, CELL, V52, P311, DOI 10.1016/S0092-8674(88)80024-2; Kimple RJ, 2001, J BIOL CHEM, V276, P29275, DOI 10.1074/jbc.M103208200; Knoblich JA, 2001, NAT REV MOL CELL BIO, V2, P11, DOI 10.1038/35048085; Miller KG, 2000, GENETICS, V156, P1649; Natochin M, 2001, BIOCHEMISTRY-US, V40, P5322, DOI 10.1021/bi015505w; Pellettieri J, 2002, SCIENCE, V298, P1946, DOI 10.1126/science.1072162; Reese KJ, 2000, MOL CELL, V6, P445, DOI 10.1016/S1097-2765(00)00043-5; Rose LS, 1998, DEVELOPMENT, V125, P1337; Schaefer M, 2000, CURR BIOL, V10, P353, DOI 10.1016/S0960-9822(00)00401-2; Schaefer M, 2001, CELL, V107, P183, DOI 10.1016/S0092-8674(01)00521-9; STROME S, 1983, CELL, V35, P15, DOI 10.1016/0092-8674(83)90203-9; Tsou MFB, 2002, DEVELOPMENT, V129, P4469; Yu FW, 2000, CELL, V100, P399, DOI 10.1016/S0092-8674(00)80676-5; Zhang BL, 1997, NATURE, V390, P477, DOI 10.1038/37297	26	225	235	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 20	2003	300	5627					1957	1961		10.1126/science.1084146	http://dx.doi.org/10.1126/science.1084146			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691RN	12750478				2022-12-24	WOS:000183619400051
J	Lipsitch, M; Cohen, T; Cooper, B; Robins, JM; Ma, S; James, L; Gopalakrishna, G; Chew, SK; Tan, CC; Samore, MH; Fisman, D; Murray, M				Lipsitch, M; Cohen, T; Cooper, B; Robins, JM; Ma, S; James, L; Gopalakrishna, G; Chew, SK; Tan, CC; Samore, MH; Fisman, D; Murray, M			Transmission dynamics and control of severe acute respiratory syndrome	SCIENCE			English	Article							CORONAVIRUS	Severe acute respiratory syndrome (SARS) is a recently described illness of humans that has spread widely over the past 6 months. With the use of detailed epidemiologic data from Singapore and epidemic curves from other settings, we estimated the reproductive number for SARS in the absence of interventions and in the presence of control efforts. We estimate that a single infectious case of SARS will infect about three secondary cases in a population that has not yet instituted control measures. Public-health efforts to reduce transmission are expected to have a substantial impact on reducing the size of the epidemic.	Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Minist Hlth, Epidemiol & Dis Control Div, Singapore 169854, Singapore; Univ Utah, Dept Med, Salt Lake City, UT 84132 USA; McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON L8N 3Z5, Canada; City Hamilton Publ Hlth & Community Serv Dept, Hamilton, ON L8R 3L5, Canada; Massachusetts Gen Hosp, Infect Dis Unit, Boston, MA 02114 USA	Harvard University; Harvard T.H. Chan School of Public Health; Ministry of Health-Singapore; Utah System of Higher Education; University of Utah; McMaster University; Harvard University; Massachusetts General Hospital	Murray, M (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Epidemiol, 677 Huntington Ave, Boston, MA 02115 USA.	mmurray@hsph.harvard.edu	Cooper, Ben/HGC-7082-2022; Cohen, Ted/G-8101-2011	Lipsitch, Marc/0000-0003-1504-9213; Cohen, Ted/0000-0002-8091-7198; Cooper, Ben/0000-0002-9445-7217	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI055985, R01AI032475, R01AI048935, R21AI055825, T32AI007433, R01AI046669] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI 46669, T32 AI07433, R01 AI 32475, R01 AI 48935, K08 AI055985-01A1, K08 AI055985, R21 AI 55825] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ANDERSON R M, 1991; CALLOW KA, 1990, EPIDEMIOL INFECT, V105, P435, DOI 10.1017/S0950268800048019; DONNELLY CA, 2003, LANCET, V361; Dowell SF, 2001, EMERG INFECT DIS, V7, P369; Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747; Kaplan EH, 2002, P NATL ACAD SCI USA, V99, P10935, DOI 10.1073/pnas.162282799; Karlin S., 1975, 1 COURSE STOCHASTIC, V2; Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781; LIPSITCH M, UNPUB; Peiris JSM, 2003, LANCET, V361, P1319, DOI 10.1016/S0140-6736(03)13077-2; *US CDCP, 2003, MMWR-MORBID MORTAL W, V52, P405	11	922	999	2	100	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 20	2003	300	5627					1966	1970		10.1126/science.1086616	http://dx.doi.org/10.1126/science.1086616			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691RN	12766207	Green Submitted, Green Accepted			2022-12-24	WOS:000183619400053
J	Booth, CM; Matukas, LM; Tomlinson, GA; Rachlis, AR; Rose, DB; Dwosh, HA; Walmsley, SL; Mazzulli, T; Avendano, M; Derkach, P; Ephtimios, IE; Kitai, I; Mederski, BD; Shadowitz, SB; Gold, WL; Hawryluck, LA; Rea, E; Chenkin, JS; Cescon, DW; Poutanen, SM; Detsky, AS				Booth, CM; Matukas, LM; Tomlinson, GA; Rachlis, AR; Rose, DB; Dwosh, HA; Walmsley, SL; Mazzulli, T; Avendano, M; Derkach, P; Ephtimios, IE; Kitai, I; Mederski, BD; Shadowitz, SB; Gold, WL; Hawryluck, LA; Rea, E; Chenkin, JS; Cescon, DW; Poutanen, SM; Detsky, AS			Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								Context Severe acute respiratory syndrome (SARS) is an emerging infectious disease that first manifested in humans in China in November 2002 and has subsequently spread worldwide. Objectives To describe the clinical characteristics and short-term outcomes of SARS in the first large group of patients in North America; to describe how these patients were treated and the variables associated with poor outcome. Design, Setting, and Patients Retrospective case series involving 144 adult patients admitted to 10 academic and community hospitals in the greater Toronto, Ontario, area between March 7 and April 10, 2003, with a diagnosis of suspected or probable SARS. Patients were included if they had fever, a known exposure to SARS, and respiratory symptoms or infiltrates observed on chest radiograph. Patients were excluded if an alternative diagnosis was determined. Main Outcome Measures Location of exposure to SARS; features of the history, physical examination, and laboratory tests at admission to the hospital; and 21-day outcomes such as death or intensive care unit (ICU) admission with or without mechanical ventilation. Results Of the 144 patients, 111 (77%) were exposed to SARS in the hospital setting. Features of the clinical examination most commonly found in these patients at admission were self-reported fever (99%), documented elevated temperature (85%), nonproductive cough (69%), myalgia (49%), and dyspnea (42%). Common laboratory features included elevated lactate dehydrogenase (87%), hypocalcemia (60%), and lymphopenia,(54%). Only 2% of patients had rhinorrhea. A total of 126 patients (88%) were treated with ribavirin, although its use was associated with significant toxicity, including hemolysis (in 76%) and decrease in hemoglobin of 2 g/dL (in 49%). Twenty-nine patients (20%) were admitted to the ICU with or without mechanical ventilation, and 8 patients died (21-day mortality, 6.5%; 95% confidence interval [CI], 1.9%-11.8%). Multivariable analysis showed that the presence of diabetes (relative risk [RR], 3.1; 95% CI, 1.4-7.2; P=.01) or other comorbid conditions (RR, 2.5; 95% CI, 1.1-5.8; P=.03) were independently associated with poor outcome (death, ICU admission, or mechanical ventilation). Conclusions The majority of cases in the SARS outbreak in the greater Toronto area were related to hospital exposure. In the event that contact history becomes unreliable, several features of the clinical presentation will be useful in raising the suspicion of SARS. Although SARS is associated with significant morbidity and mortality, especially in patients with diabetes or other comorbid conditions, the vast majority (93.5%) of patients in our cohort survived.	Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada; Univ Toronto, Toronto, ON, Canada; Sunnybrook & Womens Coll, Hlth Sci Ctr, Toronto, ON, Canada; Scarborough Gen Hosp, Toronto, ON, Canada; York Cent Hosp, Toronto, ON, Canada; Univ Hlth Network, Toronto, ON, Canada; Westpk Healthcare Ctr, Toronto, ON, Canada; Markham Stouffville Hosp, Toronto, ON, Canada; RougeValley Hlth Syst, Toronto, ON, Canada; N York Gen Hosp, Toronto, ON, Canada; Toronto Publ Hlth, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Toronto; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Scarborough Hospital; University of Toronto; University Toronto Affiliates; North York General Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; North York General Hospital	Detsky, AS (corresponding author), Mt Sinai Hosp, Suite 427,600 Univ Ave, Toronto, ON M5G 1X5, Canada.	allan.detsky@uhn.on.ca	Poutanen, Susan M./N-8066-2019; Poutanen, Susan M/F-9640-2012; Tomlinson, George A/L-5432-2016	Poutanen, Susan M./0000-0003-4747-2550; Poutanen, Susan M/0000-0003-4747-2550; Tomlinson, George A/0000-0002-9328-6399; Walmsley, Sharon/0000-0002-3959-5692				Borio L, 2002, JAMA-J AM MED ASSOC, V287, P2391, DOI 10.1001/jama.287.18.2391; *BRIT COL GEN SCI, SARS ASS COR; *CDCP, 2003, SEV AC RESP SYNDR CO; *CDCP, SARS COR SEQ; Centers for Disease Control and Prevention, 2003, UPD OUTBR SEV AC RES; CONOVER WJ, 1980, PRACTICAL NON PARAME; Cox D. R., 1984, ANAL SURVIVAL DATA; DROSTEN C, N ENGL J MED; DWOSH HA, IN PRESS CMAJ; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Harrell F. E., 2001, REGRESSION MODELING; *HLTH CAN, SEV AC RESP SYNDR CA; KSIAZEK TG, N ENGL J MED; LEE N, N ENGL J MED; Mandell LA, 2000, CLIN INFECT DIS, V31, P422, DOI 10.1086/313965; *ONT MIN HLTH LONG, 2003, SEV AC RESP SYNDR; POUTANEN SM, N ENGL J MED; TSANG KW, N ENGL J MED; Tukey John W., 1990, STAT SCI, V5, P327, DOI [10.1214/ss/1177012101, DOI 10.1214/SS/1177012101]; WHO, WHO ISS GLOB AL CAS; *WHO, CAS DEF SURV SEV AC; World Health Organization, CUM NUMB REP PROB CA	22	918	1005	1	37	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 4	2003	289	21					2801	2809		10.1001/jama.289.21.JOC30885	http://dx.doi.org/10.1001/jama.289.21.JOC30885			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	684KH	12734147	Bronze			2022-12-24	WOS:000183205500028
J	Transue, ER				Transue, ER			What I have seen	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 28	2003	289	20					2619	2620		10.1001/jama.289.20.2619	http://dx.doi.org/10.1001/jama.289.20.2619			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	682DG	12771095	Bronze			2022-12-24	WOS:000183075600001
J	McKay, L; Clery, H; Carrick-Anderson, K; Hollis, S; Scott, G				McKay, L; Clery, H; Carrick-Anderson, K; Hollis, S; Scott, G			Genital Chlamydia trachomatis infection in a subgroup of young men in the UK	LANCET			English	Article							PREVALENCE	The frequency of genital Chlamydia trachomads infection in young men in the UK has been found to be consistently lower than that in young women, but studies In such populations might have been affected by selection bias. We tested 798 male military recruits for chlamydia as part of their routine medical examination at Glencorse barracks in Scotland. 78 (9.8%) men were infected with chlamydia; rates of infection were similar in all age-groups. 69 (88%) chlamydia-positive men were asymptomatic. This rate is higher than those usually cited, showing the importance of opportunistic testing for chlamydia in men as well as in women.	Royal Infirm, Dept Genitourinary Med, Edinburgh EH3 9YW, Midlothian, Scotland	Royal Infirmary of Edinburgh	Scott, G (corresponding author), Royal Infirm, Dept Genitourinary Med, Lauriston Pl, Edinburgh EH3 9YW, Midlothian, Scotland.							Fenton KA, 2001, LANCET, V358, P1851, DOI 10.1016/S0140-6736(01)06886-6; Pierpoint T, 2000, SEX TRANSM INFECT, V76, P273, DOI 10.1136/sti.76.4.273; Rogstad KE, 2001, SEX TRANSM INFECT, V77, P111, DOI 10.1136/sti.77.2.111; *UK DEP HLTH, 1998, SUMM CONCL CMOS EXP; Van der Pol B, 2000, J CLIN MICROBIOL, V38, P1105, DOI 10.1128/JCM.38.3.1105-1112.2000	5	27	27	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 24	2003	361	9371					1792	1792		10.1016/S0140-6736(03)13398-3	http://dx.doi.org/10.1016/S0140-6736(03)13398-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	682CY	12781541				2022-12-24	WOS:000183074800014
J	Froy, O; Gotter, AL; Casselman, AL; Reppert, SM				Froy, O; Gotter, AL; Casselman, AL; Reppert, SM			Illuminating the circadian clock in monarch butterfly migration	SCIENCE			English	Article								Migratory monarch butterflies use a time-compensated Sun compass to navigate to their overwintering grounds in Mexico. Here, we report that constant light, which disrupts circadian clock function at both the behavioral and molecular levels in monarchs, also disrupts the time-compensated component of flight navigation. We further show that ultraviolet light is important for flight navigation but is not required for photic entrainment of circadian rhythms. Tracing these distinct light-input pathways into the brain should aid our understanding of the clock-compass mechanisms necessary for successful migration.	Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Reppert, SM (corresponding author), Univ Massachusetts, Sch Med, Dept Neurobiol, LRB-728,364 Plantat St, Worcester, MA 01605 USA.	steven.reppert@umassmed.edu	Froy, Oren/C-3550-2009					Brower LP, 1996, J EXP BIOL, V199, P93; Emery P, 2000, NEURON, V26, P493, DOI 10.1016/S0896-6273(00)81181-2; FROY O, UNPUB; Labhart T, 1999, MICROSC RES TECHNIQ, V47, P368, DOI 10.1002/(SICI)1097-0029(19991215)47:6<368::AID-JEMT2>3.0.CO;2-Q; Mouritsen H, 2002, P NATL ACAD SCI USA, V99, P10162, DOI 10.1073/pnas.152137299; Perez SM, 1997, NATURE, V387, P29, DOI 10.1038/387029a0; Sauman I, 1996, NEURON, V17, P889, DOI 10.1016/S0896-6273(00)80220-2; Saunders DS, 1982, INSECT CLOCKS; URQUHART F, 1960, MONARCH BUTTERLY; Wehner R, 2001, J EXP BIOL, V204, P2589; White R.C., UNPUB; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576	12	130	140	7	125	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 23	2003	300	5623					1303	1305		10.1126/science.1084874	http://dx.doi.org/10.1126/science.1084874			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681NN	12764200				2022-12-24	WOS:000183042400053
J	Guo, B; Zhai, DY; Cabezas, E; Welsh, K; Nouraini, S; Satterthwait, AC; Reed, JC				Guo, B; Zhai, DY; Cabezas, E; Welsh, K; Nouraini, S; Satterthwait, AC; Reed, JC			Humanin peptide suppresses apoptosis by interfering with Bax activation	NATURE			English	Article							CELL-DEATH; PROTEINS	Bax (Bcl2-associated X protein) is an apoptosis-inducing protein that participates in cell death during normal development and in various diseases(1). Bax resides in an inactive state in the cytosol of many cells. In response to death stimuli, Bax protein undergoes conformational changes that expose membrane-targeting domains, resulting in its translocation to mitochondrial membranes, where Bax inserts and causes release of cytochrome c and other apoptogenic proteins(2). It is unknown what controls conversion of Bax from the inactive to active conformation. Here we show that Bax interacts with humanin (HN), an anti-apoptotic peptide of 24 amino acids encoded in mammalian genomes(3,4). HN prevents the translocation of Bax from cytosol to mitochondria. Conversely, reducing HN expression by small interfering RNAs sensitizes cells to Bax and increases Bax translocation to membranes. HN peptides also block Bax association with isolated mitochondria, and suppress cytochrome c release in vitro. Notably, the mitochondrial genome contains an identical open reading frame, and the mitochondrial version of HN can also bind and suppress Bax. We speculate therefore that HN arose from mitochondria and transferred to the nuclear genome, providing a mechanism for protecting these organelles from Bax.	Burnham Inst, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute	Reed, JC (corresponding author), Burnham Inst, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	jreed@burnham.org						Atherton E., 1989, SOLID PHASE SYNTHESI; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fesik SW, 2000, CELL, V103, P273, DOI 10.1016/S0092-8674(00)00119-7; Gray MW, 2001, GENOME BIOL, V2; Guo B, 2001, J BIOL CHEM, V276, P2780, DOI 10.1074/jbc.M005889200; Hashimoto Y, 2001, J NEUROSCI, V21, P9235, DOI 10.1523/JNEUROSCI.21-23-09235.2001; Hashimoto Y, 2001, P NATL ACAD SCI USA, V98, P6336, DOI 10.1073/pnas.101133498; Jin C, 2002, NAT REV MOL CELL BIO, V3, P453, DOI 10.1038/nrm832; Jurgensmeier JM, 1998, P NATL ACAD SCI USA, V95, P4997, DOI 10.1073/pnas.95.9.4997; Kermer P, 2002, CELL DEATH DIFFER, V9, P405, DOI 10.1038/sj.cdd.4400972; Nechushtan A, 1999, EMBO J, V18, P2330, DOI 10.1093/emboj/18.9.2330; Nouraini S, 2000, MOL CELL BIOL, V20, P1604, DOI 10.1128/MCB.20.5.1604-1615.2000; Ranger AM, 2001, NAT GENET, V28, P113, DOI 10.1038/88815; Schendel SL, 1998, CELL DEATH DIFFER, V5, P372, DOI 10.1038/sj.cdd.4400365; Stroud RM, 1998, CURR OPIN STRUC BIOL, V8, P525, DOI 10.1016/S0959-440X(98)80132-2; Stryer L., 1988, BIOCHEMISTRY-US; Suzuki M, 2000, CELL, V103, P645, DOI 10.1016/S0092-8674(00)00167-7; Tajima H, 2002, NEUROSCI LETT, V324, P227, DOI 10.1016/S0304-3940(02)00199-4; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Xu QL, 2000, METHOD ENZYMOL, V322, P283; Zelphati O, 2001, J BIOL CHEM, V276, P35103, DOI 10.1074/jbc.M104920200; Zhang L, 2000, SCIENCE, V290, P989, DOI 10.1126/science.290.5493.989	23	444	501	0	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 22	2003	423	6938					456	461		10.1038/nature01627	http://dx.doi.org/10.1038/nature01627			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681AJ	12732850				2022-12-24	WOS:000183012000046
J	Lee, N; Hui, D; Wu, A; Chan, P; Cameron, P; Joynt, GM; Ahuja, A; Yung, MY; Leung, CB; To, KF; Lui, SF; Szeto, CC; Chung, S; Sung, JJY				Lee, N; Hui, D; Wu, A; Chan, P; Cameron, P; Joynt, GM; Ahuja, A; Yung, MY; Leung, CB; To, KF; Lui, SF; Szeto, CC; Chung, S; Sung, JJY			A major outbreak of severe acute respiratory syndrome in Hong Kong	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							OBLITERANS ORGANIZING PNEUMONIA; BRONCHIOLITIS	BACKGROUND There has been an outbreak of the severe acute respiratory syndrome (SARS) worldwide. We report the clinical, laboratory, and radiologic features of 138 cases of suspected SARS during a hospital outbreak in Hong Kong. METHODS From March 11 to 25, 2003, all patients with suspected SARS after exposure to an index patient or ward were admitted to the isolation wards of the Prince of Wales Hospital. Their demographic, clinical, laboratory, and radiologic characteristics were analyzed. Clinical end points included the need for intensive care and death. Univariate and multivariate analyses were performed. RESULTS There were 66 male patients and 72 female patients in this cohort, 69 of whom were health care workers. The most common symptoms included fever (in 100 percent of the patients); chills, rigors, or both (73.2 percent); and myalgia (60.9 percent). Cough and headache were also reported in more than 50 percent of the patients. Other common findings were lymphopenia (in 69.6 percent), thrombocytopenia (44.8 percent), and elevated lactate dehydrogenase and creatine kinase levels (71.0 percent and 32.1 percent, respectively). Peripheral air-space consolidation was commonly observed on thoracic computed tomographic scanning. A total of 32 patients (23.2 percent) were admitted to the intensive care unit; 5 patients died, all of whom had coexisting conditions. In a multivariate analysis, the independent predictors of an adverse outcome were advanced age (odds ratio per decade of life, 1.80; 95 percent confidence interval, 1.16 to 2.81; P=0.009), a high peak lactate dehydrogenase level (odds ratio per 100 U per liter, 2.09; 95 percent confidence interval, 1.28 to 3.42; P=0.003), and an absolute neutrophil count that exceeded the upper limit of the normal range on presentation (odds ratio, 1.60; 95 percent confidence interval, 1.03 to 2.50; P=0.04). CONCLUSIONS SARS is a serious respiratory illness that led to significant morbidity and mortality in our cohort.	Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China; Chinese Univ Hong Kong, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; Chinese Univ Hong Kong, Dept Emergency Med, Hong Kong, Hong Kong, Peoples R China; Chinese Univ Hong Kong, Dept Anesthesia & Intens Care, Hong Kong, Hong Kong, Peoples R China; Chinese Univ Hong Kong, Dept Diagnost Radiol & Organ Imaging, Hong Kong, Hong Kong, Peoples R China; Chinese Univ Hong Kong, Dept Surg, Hong Kong, Hong Kong, Peoples R China; Chinese Univ Hong Kong, Dept Anat & Cellular Pathol, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong	Sung, JJY (corresponding author), Prince Wales Hosp, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China.		Ahuja, Anil T/H-4031-2017; Lee, Nelson/B-6418-2008; Szeto, Cheuk Chun/N-4954-2015; Joynt, Gavin M/C-7606-2009; Hui, David Shu-Cheong/O-2754-2015; Sung, Joseph J. Y./R-3203-2018; Chan, Paul KS/J-9360-2013	Ahuja, Anil T/0000-0002-0726-5402; Lee, Nelson/0000-0002-0783-6607; Szeto, Cheuk Chun/0000-0002-8898-8505; Joynt, Gavin M/0000-0002-5823-3435; Hui, David Shu-Cheong/0000-0003-4382-2445; Sung, Joseph J. Y./0000-0003-3125-5199; Chan, Paul KS/0000-0002-6360-4608; Cameron, Peter/0000-0002-1443-557X				Bartlett John G., 2000, Clinical Infectious Diseases, V31, P347, DOI 10.1086/313954; *CDCP, UPD INT DOM INF CONT; Centers for Disease Control and Prevention, SEV AC RESP SYNDR SA; Epler GR, 2001, ARCH INTERN MED, V161, P158, DOI 10.1001/archinte.161.2.158; MULLER NL, 1990, AM J ROENTGENOL, V154, P983; Niederman MS, 2001, AM J RESP CRIT CARE, V163, P1730, DOI 10.1164/ajrccm.163.7.at1010; *WHO, 2003, CUM NUMB REP CAS SAR; 2003, MMWR MORB MORTAL WKL, V52, P255; 2003, MMWR MORB MORTAL WKL, V52, P241	9	1569	1827	1	134	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 15	2003	348	20					1986	1994		10.1056/NEJMoa030685	http://dx.doi.org/10.1056/NEJMoa030685			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	677TJ	12682352	Bronze			2022-12-24	WOS:000182823400007
J	Kawakami, R; Shinohara, Y; Kato, Y; Sugiyama, H; Shigemoto, R; Ito, I				Kawakami, R; Shinohara, Y; Kato, Y; Sugiyama, H; Shigemoto, R; Ito, I			Asymmetrical allocation of NMDA receptor epsilon 2 subunits in hippocampal circuitry	SCIENCE			English	Article							RAT-BRAIN; LOCALIZATION; EXPRESSION; DIVERSITY; SUBTYPES; POTENT	Despite its implications for higher order functions of the brain, little is currently known about the molecular basis of left-right asymmetry of the brain. Here we report that synaptic distribution of N-methyl-D-aspartate (NMDA) receptor GluRepsilon2 (NR2B) subunits in the adult mouse hippocampus is asymmetrical between the left and right and between the apical and basal dendrites of single neurons. These asymmetrical allocations of epsilon2 subunits differentiate the properties of NMDA receptors and synaptic plasticity between the left and right hippocampus. These results provide a molecular basis for the structural and functional asymmetry of the mature brain.	Kyushu Univ, Fac Sci, Dept Biol, Fukuoka 8128581, Japan; Kyushu Univ, Grad Sch Med Sci, Dept Mol Biol, Fukuoka 8128582, Japan; Grad Univ Adv Studies, Sch Life Sci, Natl Inst Physiol Sci, Div Cerebral Struct, Okazaki, Aichi 4448585, Japan; Japan Sci & Technol Corp, CREST, Kawaguchi, Japan	Kyushu University; Kyushu University; Graduate University for Advanced Studies - Japan; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Japan Science & Technology Agency (JST)	Ito, I (corresponding author), Kyushu Univ, Fac Sci, Dept Biol, Fukuoka 8128581, Japan.	isitoscb@mbox.nc.kyushu-u.ac.jp	Shigemoto, Ryuichi/E-3628-2013; Kawakami, Ryosuke/AAU-6087-2020; 良介, 川上/E-2029-2012	Shigemoto, Ryuichi/0000-0001-8761-9444; 				Amaral David G., 1995, P443; Chizh BA, 2001, TRENDS PHARMACOL SCI, V22, P636, DOI 10.1016/S0165-6147(00)01863-0; Contractor A, 2000, J NEUROSCI, V20, P8269, DOI 10.1523/JNEUROSCI.20-22-08269.2000; Corballis MC, 1998, TRENDS COGN SCI, V2, P152, DOI 10.1016/S1364-6613(98)01156-5; COTMAN CW, 1974, J CELL BIOL, V62, P236, DOI 10.1083/jcb.62.1.236; Cull-Candy S, 2001, CURR OPIN NEUROBIOL, V11, P327, DOI 10.1016/S0959-4388(00)00215-4; Fischer G, 1997, J PHARMACOL EXP THER, V283, P1285; Gottmann K, 1997, J NEUROSCI, V17, P2766; Hollmann M, 1999, HANDB EXP PHARM, V141, P3; Ito I, 1996, NEUROSCI LETT, V203, P69, DOI 10.1016/0304-3940(95)12258-3; Ito I, 2000, NEUROPHARMACOLOGY, V39, P943, DOI 10.1016/S0028-3908(99)00217-8; Kilbride J, 1998, EUR J PHARMACOL, V356, P149, DOI 10.1016/S0014-2999(98)00526-3; Kohr G, 1996, J PHYSIOL-LONDON, V492, P445; KUTSUWADA T, 1992, NATURE, V358, P36, DOI 10.1038/358036a0; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; MORI H, 1995, NEUROPHARMACOLOGY, V34, P1219, DOI 10.1016/0028-3908(95)00109-J; Mutel V, 1998, J NEUROCHEM, V70, P2147; Petralia RS, 1996, NEUROSCIENCE, V71, P949, DOI 10.1016/0306-4522(95)00533-1; Rogers LJ., 2002, COMP VERTEBRATE LATE; Shigemoto R, 1997, J NEUROSCI, V17, P7503, DOI 10.1523/jneurosci.17-19-07503.1997; Springer SP, 1997, LEFT BRAIN RIGHT BRA; Vicini S, 1998, J NEUROPHYSIOL, V79, P555, DOI 10.1152/jn.1998.79.2.555; WATANABE M, 1992, NEUROREPORT, V3, P1138, DOI 10.1097/00001756-199212000-00027; WATANABE M, 1993, J COMP NEUROL, V338, P377, DOI 10.1002/cne.903380305; WILLIAMS K, 1993, NEURON, V10, P267, DOI 10.1016/0896-6273(93)90317-K	26	172	173	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 9	2003	300	5621					990	994		10.1126/science.1082609	http://dx.doi.org/10.1126/science.1082609			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675WD	12738868	Green Accepted			2022-12-24	WOS:000182719800060
J	Marshall, BT; Long, M; Piper, JW; Yago, T; McEver, RP; Zhu, C				Marshall, BT; Long, M; Piper, JW; Yago, T; McEver, RP; Zhu, C			Direct observation of catch bonds involving cell-adhesion molecules	NATURE			English	Article							RECEPTOR-LIGAND BONDS; P-SELECTIN; HUMAN NEUTROPHILS; FORCE; KINETICS; LEUKOCYTES; TRANSIENT; LIFETIME; REQUIRES; BINDING	Bonds between adhesion molecules are often mechanically stressed. A striking example is the tensile force applied to selectin-ligand bonds, which mediate the tethering and rolling of flowing leukocytes on vascular surfaces(1-3). It has been suggested that force could either shorten bond lifetimes, because work done by the force could lower the energy barrier between the bound and free states(4) ('slip'), or prolong bond lifetimes by deforming the molecules such that they lock more tightly(5,6) ('catch'). Whereas slip bonds have been widely observed(7-14), catch bonds have not been demonstrated experimentally. Here, using atomic force microscopy and flow-chamber experiments, we show that increasing force first prolonged and then shortened the lifetimes of P-selectin complexes with P-selectin glycoprotein ligand-1, revealing both catch and slip bond behaviour. Transitions between catch and slip bonds might explain why leukocyte rolling on selectins first increases and then decreases as wall shear stress increases(,)(9,15)(16). This dual response to force provides a mechanism for regulating cell adhesion under conditions of variable mechanical stress.	Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA; Georgia Inst Technol, Coulter Sch Biomed Engn, Atlanta, GA 30332 USA; Oklahoma Med Res Fdn, Cardiovasc Biol Res Program, Oklahoma City, OK 73104 USA; Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73104 USA; Univ Oklahoma, Hlth Sci Ctr, Oklahoma Ctr Med Glycobiol, Oklahoma City, OK 73104 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Zhu, C (corresponding author), Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA.	cheng.zhu@me.gatech.edu	Zhu, Cheng/A-5724-2011					Alon R, 1997, J CELL BIOL, V138, P1169, DOI 10.1083/jcb.138.5.1169; ALON R, 1995, NATURE, V374, P539, DOI 10.1038/374539a0; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Chen SQ, 1997, P NATL ACAD SCI USA, V94, P3172, DOI 10.1073/pnas.94.7.3172; Chen SQ, 1999, J CELL BIOL, V144, P185, DOI 10.1083/jcb.144.1.185; Chen SQ, 2001, P NATL ACAD SCI USA, V98, P950, DOI 10.1073/pnas.98.3.950; DEMBO M, 1988, PROC R SOC SER B-BIO, V234, P55, DOI 10.1098/rspb.1988.0038; Dembo Micah, 1994, V24, P51; Finger EB, 1996, NATURE, V379, P266, DOI 10.1038/379266a0; Fritz J, 1998, P NATL ACAD SCI USA, V95, P12283, DOI 10.1073/pnas.95.21.12283; GENG JG, 1990, NATURE, V343, P757, DOI 10.1038/343757a0; HUTTER JL, 1993, REV SCI INSTRUM, V64, P1868, DOI 10.1063/1.1143970; Isberg RR, 2002, CELL, V110, P1, DOI 10.1016/S0092-8674(02)00821-8; Lawrence MB, 1997, J CELL BIOL, V136, P717, DOI 10.1083/jcb.136.3.717; Leppanen A, 2000, J BIOL CHEM, V275, P39569, DOI 10.1074/jbc.M005005200; MCCONNELL HM, 1986, BIOCHIM BIOPHYS ACTA, V864, P95, DOI 10.1016/0304-4157(86)90016-X; McEver RP, 1997, J CLIN INVEST, V100, P485, DOI 10.1172/JCI119556; McEver RP, 2001, THROMB HAEMOSTASIS, V86, P746; Merkel R, 1999, NATURE, V397, P50, DOI 10.1038/16219; MOORE KL, 1991, J CELL BIOL, V112, P491, DOI 10.1083/jcb.112.3.491; MOORE KL, 1994, J BIOL CHEM, V269, P23318; MOORE KL, 1995, J CELL BIOL, V128, P661, DOI 10.1083/jcb.128.4.661; Pierres A, 1996, P NATL ACAD SCI USA, V93, P15114, DOI 10.1073/pnas.93.26.15114; Ramachandran V, 2001, P NATL ACAD SCI USA, V98, P10166, DOI 10.1073/pnas.171248098; Smith MJ, 1999, BIOPHYS J, V77, P3371, DOI 10.1016/S0006-3495(99)77169-9; Somers WS, 2000, CELL, V103, P467, DOI 10.1016/S0092-8674(00)00138-0; USHIYAMA S, 1993, J BIOL CHEM, V268, P15229; Vestweber D, 1999, PHYSIOL REV, V79, P181, DOI 10.1152/physrev.1999.79.1.181; Wong JY, 1999, BIOPHYS J, V77, P1445, DOI 10.1016/S0006-3495(99)76992-4; Yago T, 2002, J CELL BIOL, V158, P787, DOI 10.1083/jcb.200204041	30	727	755	11	156	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 8	2003	423	6936					190	193		10.1038/nature01605	http://dx.doi.org/10.1038/nature01605			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675MR	12736689	Green Published			2022-12-24	WOS:000182699600051
J	Batlle, JC				Batlle, JC			Legal status of physician-assisted suicide	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							UNITED-STATES; EUTHANASIA; CONSULTATION; OREGON; DEATH		Univ Penn, Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania	Batlle, JC (corresponding author), Univ Penn, Sch Med, Philadelphia, PA 19104 USA.							BAILE WF, 1993, CANCER, V72, P2786, DOI 10.1002/1097-0142(19931101)72:9<2786::AID-CNCR2820720942>3.0.CO;2-2; Cantor NL, 2001, J LAW MED ETHICS, V29, P182; Cohen-Almagor R, 2002, J LAW MED ETHICS, V30, P95, DOI 10.1111/j.1748-720X.2002.tb00725.x; *DEP JUST OFF ATT, 2001, 25342001 AG DEP JUST; Emanuel EJ, 1999, NEW ENGL J MED, V341, P956, DOI 10.1056/NEJM199909233411306; Emanuel EJ, 2002, ARCH INTERN MED, V162, P142, DOI 10.1001/archinte.162.2.142; Ganzini L, 2000, NEW ENGL J MED, V342, P557, DOI 10.1056/NEJM200002243420806; Hamerly JP, 1998, AM J HEALTH-SYST PH, V55, P543, DOI 10.1093/ajhp/55.6.543; Lindsay RA, 2002, J LAW MED ETHICS, V30, P6, DOI 10.1111/j.1748-720X.2002.tb00714.x; Meier DE, 1998, NEW ENGL J MED, V338, P1193, DOI 10.1056/NEJM199804233381706; New York State Task Force on Life and the Law, 1994, DEATH IS SOUGHT ASS; Onwuteaka-Philipsen BD, 2001, J MED ETHICS, V27, P331; PRETTY D, RIGHT DIE CASE EUROP; Sullivan AD, 2001, NEW ENGL J MED, V344, P605, DOI 10.1056/NEJM200102223440811	14	3	3	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 7	2003	289	17					2279	2281		10.1001/jama.289.17.2279	http://dx.doi.org/10.1001/jama.289.17.2279			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	675ET	12734142				2022-12-24	WOS:000182680700033
J	McCarthy, EP; Burns, RB; Ngo-Metzger, Q; Davis, RB; Phillips, RS				McCarthy, EP; Burns, RB; Ngo-Metzger, Q; Davis, RB; Phillips, RS			Hospice use among Medicare managed care and fee-for-service patients dying with cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	25th Annual Meeting of the Society-of-General-Internal-Medicine	MAY 02-04, 2002	ATLANTA, GEORGIA	Soc Gen Internal Med			ILL PATIENTS; PALLIATIVE CARE; LIFE; HMO; REIMBURSEMENT; OUTCOMES; SYSTEMS; DEATH; END	Context For most patients aged 65 years or older with cancer, hospice services are uniformly covered by Medicare. Hospice care is believed to improve care for patients at the end of life. However, few patients use hospice and others enroll too late to maximize the benefits of hospice services. Objectives Because type of insurance may affect use, we examined whether patients with Medicare managed care insurance enrolled in hospice earlier and had longer hospice stays than patients with Medicare fee-for-service (FFS) insurance. Design and Setting Retrospective analysis of the last year of life using the Linked Medicare-Tumor Registry Database in 1 of 9 Surveillance, Epidemiology, and End Results program coverage areas. Patients A total of 260090 Medicare beneficiaries aged 66 years or older diagnosed with first primary lung (n=62 117), colorectal (n=57 260), prostate (n=59 826), female breast (n =37 609), bladder (n =19 598), pancreatic (n =11 378), gastric (n =9599), or liver (n=2703) cancer between January 1, 1973, and December 31, 1996, and who died between January 1, 1988, and December 31, 1998. Main Outcome Measures Time from diagnosis to hospice entry and hospice length of stay for patients enrolled in FFS vs managed care plans after adjusting for patient demographics, tumor registry, year of hospice entry, and type and cancer stage. Results Of the 260090 patients, most were men (59%), white (85%), and enrolled in FFS (89.7%). Only 54937 patients (21.1%) received hospice care before death. Hospice use varied by type of primary cancer ranging from 31.8% of patients with pancreatic cancer to 15.6% with bladder cancer. Managed care patients were more likely to use hospice than FFS patients (32.4% vs 19.8%, P<.001). Among hospice patients, median (interquartile range) length of stay was longer for managed care vs FFS patients (32 days [11-82] vs 25 days [9-66], P<.001). After adjustment, managed care patients had higher rates of hospice enrollment (adjusted hazard ratio [HR], 1.38; 95% CI, 1.35-1.42) and had a longer length of stay (adjusted HR, 0.91; 95% CI, 0.88-0.94) vs FFS patients. Managed care patients were less likely to enroll in hospice within 7 days of their death (18.6% vs 22.6%, P<.001) and somewhat more likely to enroll in hospice more than 180 days before death (7.8% vs 6.1 %, P<.001); the results for each of the 8 cancer diagnoses were similar. Hospice enrollment and length of stay among managed care vs FFS patients differed significantly by region. Conclusion Medicare beneficiaries enrolled in managed care had consistently higher rates of hospice use and significantly longer hospice stays than those enrolled in FFS. Although these differences may reflect patient and family preferences, our findings raise the possibility that some managed care plans are more successful at facilitating or encouraging hospice use for patients dying with cancer.	Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Med, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	McCarthy, EP (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Med, 330 Brookline Ave,Rose 139, Boston, MA 02215 USA.				NCI NIH HHS [5R29 CA79052] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R29CA079052] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		American Cancer Society, 2002, CANC FACTS FIG 2002; BULKIN W, 1988, NEW ENGL J MED, V318, P376, DOI 10.1056/NEJM198802113180609; Cher DJ, 1997, JAMA-J AM MED ASSOC, V278, P1001, DOI 10.1001/jama.278.12.1001; CHRISTAKIS NA, 1994, J GEN INTERN MED, V9, P314, DOI 10.1007/BF02599178; Christakis NA, 1996, NEW ENGL J MED, V335, P172, DOI 10.1056/NEJM199607183350306; Cleary JF, 1997, CANCER, V80, P1335, DOI 10.1002/(SICI)1097-0142(19971001)80:7<1335::AID-CNCR21>3.3.CO;2-5; CLEMENT DG, 1994, JAMA-J AM MED ASSOC, V271, P1487, DOI 10.1001/jama.271.19.1487; *CTR MED MED SERV, 2002, FACT SHEET PROT MED; *CTR MED MED SERV, 2002, US DEP HLTH HUM SERV; *CTR MED MED SERV, 2000, US DEP HLTH HUM SERV; Curtis JR, 1997, JAMA-J AM MED ASSOC, V278, P1025, DOI 10.1001/jama.278.12.1025; Emanuel EJ, 2002, ARCH INTERN MED, V162, P1722, DOI 10.1001/archinte.162.15.1722; *GEN ACC OFF, 2000, MED MOR BEN US HOSP; GREER DS, 1986, J CHRON DIS, V39, P9, DOI 10.1016/0021-9681(86)90103-7; Kinzbrunner B M, 1998, J Palliat Med, V1, P127, DOI 10.1089/jpm.1998.1.127; Lamont EB, 2002, CANCER, V94, P2733, DOI 10.1002/cncr.10530; Lee E, 2013, STAT METHODS SURVIVA; LEVY MH, 1993, J NATL CANCER I, V85, P1283, DOI 10.1093/jnci/85.16.1283; McCarthy EP, 2003, J CLIN ONCOL, V21, P728, DOI 10.1200/JCO.2003.06.142; MILES SH, 1995, WESTERN J MED, V163, P302; Morgan RO, 1997, NEW ENGL J MED, V337, P169, DOI 10.1056/NEJM199707173370306; *NAT HOSP PALL CAR, 2002, DEV QUAL CAR COST EF; Neuman P, 1998, HEALTH AFFAIR, V17, P132, DOI 10.1377/hlthaff.17.4.132; POTOSKY AL, 1993, MED CARE, V31, P732; Randal J, 1996, J NATL CANCER I, V88, P860, DOI 10.1093/jnci/88.13.860; Riley G, 1996, HEALTH CARE FINANC R, V17, P65; Steinberg S M, 1998, J Palliat Med, V1, P387, DOI 10.1089/jpm.1998.1.387; SULMASY DP, 1995, ARCH INTERN MED, V155, P133, DOI 10.1001/archinte.155.2.133; Virnig B A, 1999, Hosp J, V14, P1; Virnig BA, 2001, AM J MANAG CARE, V7, P777; WALLSTON KA, 1988, MED CARE, V26, P177, DOI 10.1097/00005650-198802000-00008; Ware JE, 1996, JAMA-J AM MED ASSOC, V276, P1039, DOI 10.1001/jama.1996.03540130037027	32	107	108	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 7	2003	289	17					2238	2245		10.1001/jama.289.17.2238	http://dx.doi.org/10.1001/jama.289.17.2238			8	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	675ET	12734135	Bronze			2022-12-24	WOS:000182680700026
J	Crespo, M; Bosch, F; Villamor, N; Bellosillo, B; Colomer, D; Rozman, M; Marce, S; Lopez-Guillermo, A; Campo, E; Montserrat, E				Crespo, M; Bosch, F; Villamor, N; Bellosillo, B; Colomer, D; Rozman, M; Marce, S; Lopez-Guillermo, A; Campo, E; Montserrat, E			ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							70-KDA TYROSINE PHOSPHOPROTEIN; V-H GENES; CD38 EXPRESSION; GENOMIC ABERRATIONS; ZETA-CHAIN; B-CELLS; REPERTOIRE; PHENOTYPE; PATHOGENESIS; SURVIVAL	BACKGROUND: The mutational status of immunoglobulin heavy-chain variable-region (IgV(sub H)) genes in the leukemic cells of chronic lymphocytic leukemia (CLL) is an important prognostic factor in the disease. We investigated whether the expression of ZAP-70 by CLL cells correlated with the IgV(sub H) mutational status, disease progression, and survival. METHODS: The expression of ZAP-70 was analyzed in T-cell and B-cell lines and in peripheral-blood samples from 56 patients with CLL with the use of flow cytometry, Western blotting, and immunohistochemistry. The results were correlated with the IgV(sub H) mutational status and clinical outcome. RESULTS: ZAP-70 was detected by flow-cytometric analysis in cells of T-cell lineage and in leukemic cells from 32 of 56 patients with CLL. In all patients in whom at least 20 percent of the leukemic cells were positive for ZAP-70, IgV(sub H) was unmutated, whereas IgV(sub H) mutations were found in 21 of 24 patients in whom less than 20 percent of the leukemic cells were positive for ZAP-70 (P<0.001). Concordant results were obtained when ZAP-70 expression was assessed by immunohistochemistry or Western blotting. The level of ZAP-70 expression did not change over time (median, 37 months) in sequential samples from 30 patients with CLL. Patients with Binet stage A CLL who had at least 20 percent ZAP-70-positive leukemic cells had more rapid progression and poorer survival than those with less than 20 percent ZAP-70-positive cells. CONCLUSIONS: Among patients with CLL, expression of ZAP-70, as detected by flow-cytometric analysis, correlated with IgV(sub H) mutational status, disease progression, and survival.	Hosp Clin Barcelona, Inst Invest Biomed August Pi & Sunyer, Dept Hematol, E-08036 Barcelona, Spain; Hosp Clin Barcelona, Inst Invest Biomed August Pi & Sunyer, Hematopathol Unit, E-08036 Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Bosch, F (corresponding author), Hosp Clin Barcelona, Inst Invest Biomed August Pi & Sunyer, Dept Hematol, Villarroel 170, E-08036 Barcelona, Spain.	fbosch@clinic.ub.es	Campo, Elias/AAC-5593-2019; Bosch, Francesc/AAE-7052-2019; COLOMER, DOLORS/ABG-6894-2020; MARCE, Silvia/J-6651-2017	Campo, Elias/0000-0001-9850-9793; Bosch, Francesc/0000-0001-9241-2886; MARCE, Silvia/0000-0001-9128-6822; Crespo, Marta/0000-0002-7732-7808; Rozman, Maria/0000-0002-2641-1110; COLOMER, DOLORS/0000-0001-7486-8484				Bellosillo B, 2002, BLOOD, V100, P1810, DOI 10.1182/blood-2001-12-0327; BINET JL, 1981, CANCER-AM CANCER SOC, V48, P198, DOI 10.1002/1097-0142(19810701)48:1<198::AID-CNCR2820480131>3.0.CO;2-V; Caligaris-Cappio F, 1999, J CLIN ONCOL, V17, P399, DOI 10.1200/JCO.1999.17.1.399; CAMPBELL MJ, 1992, MOL IMMUNOL, V29, P193, DOI 10.1016/0161-5890(92)90100-C; CHAN AC, 1991, P NATL ACAD SCI USA, V88, P9166, DOI 10.1073/pnas.88.20.9166; CHAN AC, 1992, CELL, V71, P649, DOI 10.1016/0092-8674(92)90598-7; Chen LG, 2002, BLOOD, V100, P4609, DOI 10.1182/blood-2002-06-1683; COOK GP, 1995, IMMUNOL TODAY, V16, P237, DOI 10.1016/0167-5699(95)80166-9; Damle RN, 1999, BLOOD, V94, P1840, DOI 10.1182/blood.V94.6.1840; DEANE M, 1990, EUR J IMMUNOL, V20, P2209, DOI 10.1002/eji.1830201009; Del Poeta G, 2001, BLOOD, V98, P2633, DOI 10.1182/blood.V98.9.2633; Dohner H, 2000, NEW ENGL J MED, V343, P1910, DOI 10.1056/NEJM200012283432602; Fais F, 1998, J CLIN INVEST, V102, P1515, DOI 10.1172/JCI3009; Hamblin BJ, 2000, BLOOD, V95, P2455, DOI 10.1182/blood.V95.7.2455.007a43c_2455_2457; Hamblin TJ, 1999, BLOOD, V94, P1848, DOI 10.1182/blood.V94.6.1848; Ibrahim S, 2001, BLOOD, V98, P181, DOI 10.1182/blood.V98.1.181; ISAKOV N, 1995, J EXP MED, V181, P375, DOI 10.1084/jem.181.1.375; Klein U, 2001, J EXP MED, V194, P1625, DOI 10.1084/jem.194.11.1625; Latour S, 2001, CURR OPIN IMMUNOL, V13, P299, DOI 10.1016/S0952-7915(00)00219-3; Lin K, 2002, BLOOD, V100, P1404, DOI 10.1182/blood-2001-11-0066; Lin K, 2002, BLOOD, V100, P2291; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Montserrat Emili, 2002, Hematol J, V3, P7; Muller-Hermelink, 2001, PATHOLOGY GENETICS T, P168; Oscier DG, 2002, BLOOD, V100, P1177, DOI 10.1182/blood.V100.4.1177.h81602001177_1177_1184; Oscier DG, 1997, BLOOD, V89, P4153, DOI 10.1182/blood.V89.11.4153; RAI KR, 1975, BLOOD, V46, P219, DOI 10.1182/blood.V46.2.219.219; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Rosenwald A, 2001, J EXP MED, V194, P1639, DOI 10.1084/jem.194.11.1639; ROZMAN C, 1995, NEW ENGL J MED, V333, P1515; SCHROEDER HW, 1994, IMMUNOL TODAY, V15, P288, DOI 10.1016/0167-5699(94)90009-4; *SPSS, 1999, SPSS ADV STAT VERS 1; Stilgenbauer S, 2002, LEUKEMIA, V16, P993, DOI 10.1038/sj.leu.2402537; VIVIER E, 1993, EUR J IMMUNOL, V23, P1872, DOI 10.1002/eji.1830230821; ZWEIG MH, 1993, CLIN CHEM, V39, P1589	35	1019	1067	0	31	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 1	2003	348	18					1764	1775		10.1056/NEJMoa023143	http://dx.doi.org/10.1056/NEJMoa023143			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	672VK	12724482				2022-12-24	WOS:000182543500005
J	Hirotsune, S; Yoshida, N; Chen, A; Garrett, L; Sugiyama, F; Takahashi, S; Yagami, K; Wynshaw-Boris, A; Yoshiki, A				Hirotsune, S; Yoshida, N; Chen, A; Garrett, L; Sugiyama, F; Takahashi, S; Yagami, K; Wynshaw-Boris, A; Yoshiki, A			An expressed pseudogene regulates the messenger-RNA stability of its homologous coding gene	NATURE			English	Article								A pseudogene is a gene copy that does not produce a functional, full-length protein(1). The human genome is estimated to contain up to 20,000 pseudogenes(2,3). Although much effort has been devoted to understanding the function of pseudogenes, their biological roles remain largely unknown. Here we report the role of an expressed pseudogene-regulation of messenger-RNA stability-in a transgene-insertion mouse mutant exhibiting polycystic kidneys and bone deformity. The transgene was integrated into the vicinity of the expressing pseudogene of Makorin1, called Makorin1-p1. This insertion reduced transcription of Makorin1-p1, resulting in destabilization of Makorin1 mRNA in trans by way of a cis-acting RNA decay element within the 5' region of Makorin1 that is homologous between Makorin1 and Makorin1-p1. Either Makorin1 or Makorin1-p1 transgenes could rescue these phenotypes. Our findings demonstrate a specific regulatory role of an expressed pseudogene, and point to the functional significance of non-coding RNAs.	Saitama Med Sch, Res Ctr Genom Med, Div Neurosci, Hidaka, Saitama 3501241, Japan; Japan Sci & Technol Corp, PRESTO, Kawaguchi, Saitama, Japan; NHGRI, Genet Dis Res Branch, NIH, Bethesda, MD 20892 USA; Univ Tsukuba, Inst Basic Med Sci, Tsukuba, Ibaraki 3058575, Japan; Univ Tsukuba, Lab Anim Resource Ctr, Tsukuba, Ibaraki 3058575, Japan; Univ Calif San Diego, Sch Med, Ctr Canc, Dept Pediat, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Ctr Canc, Dept Med, La Jolla, CA 92093 USA; RIKEN Tsukuba Inst, Bioresource Ctr, Dept Biol Syst, Expt Anim Div, Tsukuba, Ibaraki 3050074, Japan	Saitama Medical University; Japan Science & Technology Agency (JST); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Tsukuba; University of Tsukuba; University of California System; University of California San Diego; University of California System; University of California San Diego; RIKEN	Hirotsune, S (corresponding author), Saitama Med Sch, Res Ctr Genom Med, Div Neurosci, Yamane 1397-1, Hidaka, Saitama 3501241, Japan.		Yoshiki, Atsushi/O-6162-2019	Yoshiki, Atsushi/0000-0002-9450-5151				Goncalves I, 2000, GENOME RES, V10, P672, DOI 10.1101/gr.10.5.672; GRAY TA, 2000, GENOMICS, V25, P14430; Greally JM, 1999, P NATL ACAD SCI USA, V96, P14430, DOI 10.1073/pnas.96.25.14430; Harrison PM, 2002, GENOME RES, V12, P272, DOI 10.1101/gr.207102; Mighell AJ, 2000, FEBS LETT, V468, P109, DOI 10.1016/S0014-5793(00)01199-6; Nagai Y, 1998, J BONE MINER RES, V13, P664, DOI 10.1359/jbmr.1998.13.4.664; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; VANIN EF, 1985, ANNU REV GENET, V19, P253, DOI 10.1146/annurev.genet.19.1.253	8	320	354	1	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 1	2003	423	6935					91	96		10.1038/nature01535	http://dx.doi.org/10.1038/nature01535			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673CG	12721631				2022-12-24	WOS:000182561600045
J	Selker, EU; Tountas, NA; Cross, SH; Margolin, BS; Murphy, JG; Bird, AP; Freitag, M				Selker, EU; Tountas, NA; Cross, SH; Margolin, BS; Murphy, JG; Bird, AP; Freitag, M			The methylated component of the Neurospora crassa genome	NATURE			English	Article							INDUCED POINT MUTATION; DNA METHYLATION; CYTOSINE METHYLATION; GENE; TRANSPOSONS; ELEMENT; RETROTRANSPOSON; PROTEIN; ISLANDS; REGION	Cytosine methylation is common, but not ubiquitous, in eukaryotes. Mammals(1) and the fungus Neurospora crassa(2,3) have about 2-3% of cytosines methylated. In mammals, methylation is almost exclusively in the under-represented CpG dinucleotides, and most CpGs are methylated(1) whereas in Neurospora, methylation is not preferentially in CpG dinucleotides and the bulk of the genome is unmethylated(4). DNA methylation is essential in mammals(5) but is dispensable in Neurospora(3,6), making this simple eukaryote a favoured organism in which to study methylation. Recent studies indicate that DNA methylation in Neurospora depends on one DNA methyltransferase, DIM-2 (ref. 6), directed by a histone H3 methyltransferase, DIM-5 (ref. 7), but little is known about its cellular and evolutionary functions. As only four methylated sequences have been reported previously in N. crassa, we used methyl-binding-domain agarose chromatography(8) to isolate the methylated component of the genome. DNA sequence analysis shows that the methylated component of the genome consists almost exclusively of relics of transposons that were subject to repeat-induced point mutation-a genome defence system that mutates duplicated sequences(9).	Univ Oregon, Dept Biol, Eugene, OR 97403 USA; Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA; Univ Edinburgh, Inst Cell & Mol Biol, Edinburgh EH9 3JR, Midlothian, Scotland	University of Oregon; University of Oregon; University of Edinburgh	Selker, EU (corresponding author), Univ Oregon, Dept Biol, Eugene, OR 97403 USA.		Murphy, Jonathan/AAD-6655-2019	Murphy, Jonathan/0000-0001-6485-5727; Bird, Adrian/0000-0002-8600-0372; Cross, Sally/0000-0001-6518-6449				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bibbins M, 1998, MOL GEN GENET, V258, P431, DOI 10.1007/s004380050752; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; Cambareri EB, 1998, MOL CELL BIOL, V18, P5465, DOI 10.1128/MCB.18.9.5465; CAMBARERI EB, 1994, MOL GEN GENET, V242, P658, DOI 10.1007/BF00283420; CROSS SH, 1994, NAT GENET, V6, P236, DOI 10.1038/ng0394-236; FOSS HM, 1993, SCIENCE, V262, P1737, DOI 10.1126/science.7505062; Foss HM, 1998, MOL GEN GENET, V259, P60, DOI 10.1007/s004380050789; Galagan JE, 2003, NATURE, V422, P859, DOI 10.1038/nature01554; Kempken F, 2001, CHROMOSOMA, V110, P1, DOI 10.1007/s004120000118; Kouzminova E, 2001, EMBO J, V20, P4309, DOI 10.1093/emboj/20.15.4309; KRUMLAUF R, 1980, J BIOL CHEM, V255, P1138; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Margolin BS, 1998, GENETICS, V149, P1787; MEEHAN RR, 1992, NUCLEIC ACIDS RES, V20, P5085, DOI 10.1093/nar/20.19.5085; METZENBERG RL, 1985, P NATL ACAD SCI USA, V82, P2067, DOI 10.1073/pnas.82.7.2067; Miao VPW, 2000, J MOL BIOL, V300, P249, DOI 10.1006/jmbi.2000.3864; Miura A, 2001, NATURE, V411, P212, DOI 10.1038/35075612; Paszkowski J, 2001, CURR OPIN PLANT BIOL, V4, P123, DOI 10.1016/S1369-5266(00)00147-3; Plasterk RHA, 1999, TRENDS GENET, V15, P326, DOI 10.1016/S0168-9525(99)01777-1; RUSSELL PJ, 1985, MOL GENETICS FILAMEN, P321; SELKER EU, 1993, SCIENCE, V262, P1724, DOI 10.1126/science.8259516; Selker EU, 2002, ADV GENET, V46, P439; Selker EU, 1998, P NATL ACAD SCI USA, V95, P9430, DOI 10.1073/pnas.95.16.9430; Singer T, 2001, GENE DEV, V15, P591, DOI 10.1101/gad.193701; Tamaru H, 2001, NATURE, V414, P277, DOI 10.1038/35104508; Tompa R, 2002, CURR BIOL, V12, P65, DOI 10.1016/S0960-9822(01)00622-4; Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5; Zhou Y, 2001, MOL GENET GENOMICS, V265, P748, DOI 10.1007/s004380100472	30	170	181	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 24	2003	422	6934					893	897		10.1038/nature01564	http://dx.doi.org/10.1038/nature01564			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670WR	12712205	Green Published			2022-12-24	WOS:000182432600055
J	Selevan, SG; Rice, DC; Hogan, KA; Euling, SY; Pfahles-Hutchens, A; Bethel, J				Selevan, SG; Rice, DC; Hogan, KA; Euling, SY; Pfahles-Hutchens, A; Bethel, J			Blood lead concentration and delayed puberty in girls	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NUTRITION EXAMINATION SURVEY; 3RD NATIONAL-HEALTH; ETHNIC-DIFFERENCES; POSTMENARCHEAL PERIOD; AFRICAN-AMERICAN; GROWTH; EXPOSURE; RAT; MATURATION; MENARCHE	BACKGROUND: Environmental lead exposure has been linked to alterations in growth and endocrine function. It is not known whether such exposure affects pubertal development. METHODS: We analyzed the relations between blood lead concentration and pubertal development among girls (defined as females 8 to 18 years of age) who were enrolled in a cross-sectional study (the third National Health and Nutrition Examination Survey) in which race was self-reported or proxy-reported: 600 were non-Hispanic white, 805 were non-Hispanic African-American, and 781 were Mexican-American girls. Puberty was measured on the basis of the age at menarche and Tanner stage for pubic-hair and breast development. RESULTS: Geometric mean lead concentrations were less than 3 microg per deciliter (0.144 micromol per liter) in all three groups. As compared with concentrations of 1 microg per deciliter (0.048 micromol per liter), lead concentrations of 3 microg per deciliter were associated with decreased height (P<0.001), after adjustment for age, race, and other factors, but not with body-mass index or weight. Blood lead concentrations of 3 microg per deciliter were associated with significant delays in breast and pubic-hair development in African-American and Mexican-American girls. The delays were most marked among African-American girls; in this group, the delays in reaching Tanner stages 2, 3, 4, and 5 associated with a lead concentration of 3 microg per deciliter as compared with 1 microg per deciliter were 3.8, 5.3, 5.8, and 2.1 months, respectively, for breast development and 4.0, 5.5, 6.0, and 2.2 months, respectively, for pubic-hair development; the associated delay in age at menarche was 3.6 months. In white girls, there were nonsignificant delays in all pubertal measures in association with a lead concentration of 3 microg per deciliter. CONCLUSIONS: These data suggest that environmental exposure to lead may delay growth and pubertal development in girls, although confirmation is warranted in prospective studies.	US EPA, Natl Ctr Environm Assessment, Off Res & Dev, Washington, DC 20460 USA; US EPA, Off Pollut Prevent Pesticides & Tox Subst, Washington, DC 20460 USA; WESTAT Corp, Rockville, MD 20850 USA	United States Environmental Protection Agency; United States Environmental Protection Agency; Westat	Selevan, SG (corresponding author), US EPA, Natl Ctr Environm Assessment, Off Res & Dev, 8623D, Washington, DC 20460 USA.							Agency for Toxic Substances and Disease Registry, 1999, TOX PROF LEAD; [Anonymous], 1998, MMWR MORB MORTAL WKL, V47, P1; Ballew C, 1999, J PEDIATR-US, V134, P623, DOI 10.1016/S0022-3476(99)70250-7; BELLINGER D, 1991, ENVIRON RES, V54, P151, DOI 10.1016/S0013-9351(05)80097-0; Biro FM, 2001, J PEDIATR-US, V138, P636, DOI 10.1067/mpd.2001.114476; Blanck HM, 2000, EPIDEMIOLOGY, V11, P641, DOI 10.1097/00001648-200011000-00005; Centers for Disease Control, 1991, PREV LEAD POIS YOUNG; Dearth RK, 2002, REPROD TOXICOL, V16, P343, DOI 10.1016/S0890-6238(02)00037-0; Den Hond E, 2002, ENVIRON HEALTH PERSP, V110, P771, DOI 10.1289/ehp.02110771; *ENV PROT AG, 1997, EXP FACT HDB, V1, P4; FRISANCHO AR, 1991, AM J CLIN NUTR, V54, P516, DOI 10.1093/ajcn/54.3.516; Harlow SD, 1997, AM J EPIDEMIOL, V146, P572; Harlow SD, 1996, AM J EPIDEMIOL, V144, P980; HermanGiddens ME, 1997, PEDIATRICS, V99, P505, DOI 10.1542/peds.99.4.505; Kaplowitz PB, 2001, PEDIATRICS, V108, P347, DOI 10.1542/peds.108.2.347; Kim D, 2000, BRAIN BEHAV IMMUN, V14, P305, DOI 10.1006/brbi.2000.0609; KIMMEL CA, 1980, TOXICOL APPL PHARM, V56, P28, DOI 10.1016/0041-008X(80)90129-5; Krstevska-Konstantinova M, 2001, HUM REPROD, V16, P1020, DOI 10.1093/humrep/16.5.1020; Magarey AM, 1999, ACTA PAEDIATR, V88, P139, DOI 10.1080/08035259950170286; MARSHALL WA, 1969, ARCH DIS CHILD, V44, P291, DOI 10.1136/adc.44.235.291; Mood Alexander McFarlane, 1950, INTRO THEORY STAT, P1; *NAT HLTH NUTR EX, 1997, NHANE 3 SERIES 1A, V2; National Center for Health Statistics, 1994, VIT HLTH STAT, V94-1308; PATTERSON CC, 1983, LEAD VERSUS HLTH, P17; POUNDS JG, 1991, ENVIRON HEALTH PERSP, V91, P17, DOI 10.2307/3430978; Prikle JL, 1994, JAMA-J AM MED ASSOC, V272, P284; Ronis MJJ, 1998, J TOXICOL ENV HEAL A, V54, P101, DOI 10.1080/009841098158944; Ronis MJJ, 1998, J TOXICOL ENV HEAL A, V53, P327, DOI 10.1080/009841098159312; Ronis MJJ, 1998, J TOXICOL ENV HEAL A, V54, P77, DOI 10.1080/009841098158935; RUBIN K, 1993, J PEDIATR-US, V123, P863, DOI 10.1016/S0022-3476(05)80381-6; Russell DL, 2001, J PEDIATR-US, V139, P844, DOI 10.1067/mpd.2001.119446; SCHWARTZ J, 1986, PEDIATRICS, V77, P281; SELVIN S, 1991, STAT ANAL EPIDEMIOLO; SHUKLA R, 1991, PEDIATRICS, V88, P886; Vizmanos B, 2000, EUR J CLIN NUTR, V54, P203, DOI 10.1038/sj.ejcn.1600920; Wattigney Wendy A., 1999, Ethnicity and Disease, V9, P181; Wu TJ, 2002, PEDIATRICS, V110, P752, DOI 10.1542/peds.110.4.752; Yanovski JA, 2000, J CLIN ENDOCR METAB, V85, P2660, DOI 10.1210/jc.85.8.2660	38	185	190	0	18	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 17	2003	348	16					1527	1536		10.1056/NEJMoa020880	http://dx.doi.org/10.1056/NEJMoa020880			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	667TT	12700372				2022-12-24	WOS:000182248900003
J	Kagey, MH; Melhuish, TA; Wotton, D				Kagey, MH; Melhuish, TA; Wotton, D			The polycomb protein Pc2 is a SUMO E3	CELL			English	Article							UBIQUITIN-LIKE PROTEIN; HISTONE METHYLTRANSFERASE ACTIVITY; TRITHORAX GROUP PROTEINS; CELLULAR PHOSPHOPROTEIN; PROMYELOCYTIC LEUKEMIA; MULTIPROTEIN COMPLEX; NEGATIVE MODULATION; CONJUGATING ENZYME; NUCLEAR-BODIES; HUMAN HOMOLOG	Polycomb group (PcG) proteins form large multimeric complexes (PcG bodies) which are involved in the stable repression of gene expression. The human PcG protein, Pc2, has been shown to recruit the transcriptional corepressor, CtBP, to PcG bodies. We show that CtBP is sumoylated at a single lysine. In vitro, CtBP sumoylation minimally requires the SUMO E1 and E2 (Ubc9) and SUMO-1. However, Pc2 dramatically enhances CtBP sumoylation. In vivo, this is likely due to the ability of Pc2 to recruit both CtBP and Ubc9 to PcG bodies, thereby bringing together substrate and E2, and stimulating the transfer of SUMO to CtBP. These results demonstrate that Pc2 is a SUMO E3, and suggest that PcG bodies may be sumoylation centers.	Univ Virginia, Ctr Cell Signaling, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA	University of Virginia	Wotton, D (corresponding author), Univ Virginia, Ctr Cell Signaling, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA.	dw2p@virginia.edu		Wotton, David/0000-0002-4652-5350	NICHD NIH HHS [HD 39926] Funding Source: Medline	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Bernier-Villamor V, 2002, CELL, V108, P345, DOI 10.1016/S0092-8674(02)00630-X; Boddy MN, 1996, ONCOGENE, V13, P971; BOYD JM, 1993, EMBO J, V12, P469, DOI 10.1002/j.1460-2075.1993.tb05679.x; Brock HW, 2001, CURR OPIN GENET DEV, V11, P175, DOI 10.1016/S0959-437X(00)00176-3; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Cavalli G, 1998, CURR OPIN CELL BIOL, V10, P354, DOI 10.1016/S0955-0674(98)80011-2; Chinnadurai G, 2002, MOL CELL, V9, P213, DOI 10.1016/S1097-2765(02)00443-4; Criqui-Filipe P, 1999, EMBO J, V18, P3392, DOI 10.1093/emboj/18.12.3392; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Dahiya A, 2001, MOL CELL, V8, P557, DOI 10.1016/S1097-2765(01)00346-X; Desterro JMP, 1997, FEBS LETT, V417, P297, DOI 10.1016/S0014-5793(97)01305-7; DOHMEN RJ, 1995, J BIOL CHEM, V270, P18099, DOI 10.1074/jbc.270.30.18099; Espinas ML, 2000, EMBO REP, V1, P253, DOI 10.1093/embo-reports/kvd046; Francis NJ, 2001, MOL CELL, V8, P545, DOI 10.1016/S1097-2765(01)00316-1; Gerasimova TI, 1998, CELL, V92, P511, DOI 10.1016/S0092-8674(00)80944-7; Gunster MJ, 2001, J CELL BIOCHEM, P129, DOI 10.1002/jcb.1093; Gunster MJ, 1997, MOL CELL BIOL, V17, P2326, DOI 10.1128/MCB.17.4.2326; Hay RT, 2001, TRENDS BIOCHEM SCI, V26, P332, DOI 10.1016/S0968-0004(01)01849-7; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hochstrasser M, 2001, CELL, V107, P5, DOI 10.1016/S0092-8674(01)00519-0; Jackson PK, 2000, TRENDS CELL BIOL, V10, P429, DOI 10.1016/S0962-8924(00)01834-1; Jackson PK, 2001, GENE DEV, V15, P3053, DOI 10.1101/gad.955501; Jacobs JJL, 2002, BBA-REV CANCER, V1602, P151, DOI 10.1016/S0304-419X(02)00052-5; Jentsch S, 2000, TRENDS CELL BIOL, V10, P335, DOI 10.1016/S0962-8924(00)01785-2; Johnson ES, 2001, CELL, V106, P735, DOI 10.1016/S0092-8674(01)00491-3; Johnson ES, 1997, EMBO J, V16, P5509, DOI 10.1093/emboj/16.18.5509; Johnson EW, 1997, J BACK MUSCULOSKELET, V9, P3, DOI 10.3233/BMR-1997-9102; Kahyo T, 2001, MOL CELL, V8, P713, DOI 10.1016/S1097-2765(01)00349-5; Kennison JA, 1995, ANNU REV GENET, V29, P289, DOI 10.1146/annurev.ge.29.120195.001445; Kirsh O, 2002, EMBO J, V21, P2682, DOI 10.1093/emboj/21.11.2682; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Lallemand-Breitenbach V, 2001, J EXP MED, V193, P1361, DOI 10.1084/jem.193.12.1361; Laney JD, 1999, CELL, V97, P427, DOI 10.1016/S0092-8674(00)80752-7; Lapenta V, 1997, GENOMICS, V40, P362, DOI 10.1006/geno.1996.4556; Mannen H, 1996, BIOCHEM BIOPH RES CO, V222, P178, DOI 10.1006/bbrc.1996.0717; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; Mayer RJ, 1998, FOLD DES, V3, pR97, DOI 10.1016/S1359-0278(98)00047-9; Melchior F, 2000, ANNU REV CELL DEV BI, V16, P591, DOI 10.1146/annurev.cellbio.16.1.591; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; MULLER J, 1995, EMBO J, V14, P1209, DOI 10.1002/j.1460-2075.1995.tb07104.x; Muller S, 2001, NAT REV MOL CELL BIO, V2, P202, DOI 10.1038/35056591; Ogawa H, 2002, SCIENCE, V296, P1132, DOI 10.1126/science.1069861; Okura T, 1996, J IMMUNOL, V157, P4277; Pichler A, 2002, CELL, V108, P109, DOI 10.1016/S0092-8674(01)00633-X; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Pirrotta V, 1998, CELL, V93, P333, DOI 10.1016/S0092-8674(00)81162-9; Poux S, 2001, DEVELOPMENT, V128, P75; Rodriguez MS, 1999, EMBO J, V18, P6455, DOI 10.1093/emboj/18.22.6455; Ross S, 2002, MOL CELL, V10, P831, DOI 10.1016/S1097-2765(02)00682-2; Sachdev S, 2001, GENE DEV, V15, P3088, DOI 10.1101/gad.944801; Sampson DA, 2001, J BIOL CHEM, V276, P21664, DOI 10.1074/jbc.M100006200; Sapetschnig A, 2002, EMBO J, V21, P5206, DOI 10.1093/emboj/cdf510; Satijn DPE, 2001, MOL CELL BIOL, V21, P1360, DOI 10.1128/MCB.21.4.1360-1369.2001; Saurin AJ, 1998, J CELL BIOL, V142, P887, DOI 10.1083/jcb.142.4.887; Schaeper U, 1998, J BIOL CHEM, V273, P8549, DOI 10.1074/jbc.273.15.8549; SCHAEPER U, 1995, P NATL ACAD SCI USA, V92, P10467, DOI 10.1073/pnas.92.23.10467; Schmidt D, 2002, P NATL ACAD SCI USA, V99, P2872, DOI 10.1073/pnas.052559499; Schumacher A, 1997, TRENDS GENET, V13, P167, DOI 10.1016/S0168-9525(97)01133-5; Sewalt RGAB, 1999, MOL CELL BIOL, V19, P777; Sewalt RGAB, 2002, MOL CELL BIOL, V22, P5539, DOI 10.1128/MCB.22.15.5539-5553.2002; Sewalt RGAB, 1998, MOL CELL BIOL, V18, P3586, DOI 10.1128/MCB.18.6.3586; Shen ZY, 1996, GENOMICS, V36, P271, DOI 10.1006/geno.1996.0462; SIMON J, 1995, CURR OPIN CELL BIOL, V7, P376, DOI 10.1016/0955-0674(95)80093-X; Simon JA, 2002, CURR OPIN GENET DEV, V12, P210, DOI 10.1016/S0959-437X(02)00288-5; Sternsdorf T, 1997, J CELL BIOL, V139, P1621, DOI 10.1083/jcb.139.7.1621; Takahashi Y, 2001, J BIOL CHEM, V276, P48973, DOI 10.1074/jbc.M109295200; Turner J, 1998, EMBO J, V17, P5129, DOI 10.1093/emboj/17.17.5129; Turner J, 2001, BIOESSAYS, V23, P683, DOI 10.1002/bies.1097; van der Vlag J, 1999, NAT GENET, V23, P474, DOI 10.1038/70602; Weigert R, 1999, NATURE, V402, P429, DOI 10.1038/46587; WU J, 1995, J BIOL CHEM, V270, P14209, DOI 10.1074/jbc.270.23.14209	71	443	466	1	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 4	2003	113	1					127	137		10.1016/S0092-8674(03)00159-4	http://dx.doi.org/10.1016/S0092-8674(03)00159-4			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	668GX	12679040	Bronze			2022-12-24	WOS:000182282900012
J	Murkofsky, RL; Phillips, RS; McCarthy, EP; Davis, RB; Hamel, MB				Murkofsky, RL; Phillips, RS; McCarthy, EP; Davis, RB; Hamel, MB			Length of stay in home care before and after the 1997 Balanced Budget Act	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PROSPECTIVE PAYMENT; FOR-PROFIT; OWNERSHIP; QUALITY; FACILITIES; MORTALITY; SERVICES	Context Prior to 1997, home health agencies (HHAs) were reimbursed on a fee-for-service basis and had incentives to provide more services. The 1997 Balanced Budget Act (BBA) reduced payments for home care services to help control Medicare spending. Objective To examine the length of stay in home care before and after the 1997 BBA. Design and Setting Cross-sectional study of home care patients in the 1996 and 1998 National Home and Hospice Care Surveys, which surveyed 1053 HHAs in 1996 and 1088 HHAs in 1998. Patients Nationally representative random sample of home care patients with Medicare coverage in 1996 (4127 patients) and 1998 (4051 patients). Main Outcome Measure Length of stay in home care (based on the number of days a patient was enrolled in home care services). Results From 1996 to 1998, unadjusted median length of stay decreased by 16 days for all home care patients (60-44 days, P=.002). The decrease affected for-profit HHAs more than not-for-profit HHAs (111-55 days [51% decrease, P=.002] vs 46-36 days [22% decrease, P=.042]). In a Cox proportional hazards model of time to discharge from home care, post-BBA year (1,998) was associated with a shorter length of stay in home care (adjusted hazard ratio [aHR] for home care discharge, 1.39 [95% confidence interval {CI}, 1.19-1.61]), and for-profit status was associated with a longer length of stay in home care (aHR, 0.82 [95% CI, 0.71-0.94]) after adjusting for patient demographics, diagnoses, and functional status. Conclusion After the 1997 BBA, length of stay in home care decreased among Medicare patients, particularly among those receiving care from for-profit HHAs.	Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med,Div Gerontol, Boston, MA 02215 USA; Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med,Div Gen Med & Primary Care, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Murkofsky, RL (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med,Div Gerontol, 1 Deaconess Rd,Palmer 119, Boston, MA 02215 USA.	rmurkofs@bidmc.harvard.edu			NIA NIH HHS [5K12AG00294] Funding Source: Medline; BHP HRSA HHS [5T32PE11001] Funding Source: Medline; DIVISION OF MEDICINE, BUREAU HEALTH PROFESSIONS, HRSA [T32PE011001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K12AG000294] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); BHP HRSA HHS; DIVISION OF MEDICINE, BUREAU HEALTH PROFESSIONS, HRSA(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Devereaux PJ, 2002, CAN MED ASSOC J, V166, P1399; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; FREEMAN L, 1995, MON LABOR REV, V118, P3; Furth SL, 1999, PEDIATRICS, V104, P519, DOI 10.1542/peds.104.3.519; Garg PP, 1999, NEW ENGL J MED, V341, P1653, DOI 10.1056/NEJM199911253412205; Harrington C, 2001, AM J PUBLIC HEALTH, V91, P1452, DOI 10.2105/AJPH.91.9.1452; Himmelstein DU, 1999, JAMA-J AM MED ASSOC, V282, P159, DOI 10.1001/jama.282.2.159; KAHN KL, 1990, JAMA-J AM MED ASSOC, V264, P1984, DOI 10.1001/jama.264.15.1984; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kominski G F, 1993, Health Care Financ Rev, V15, P121; McCall N, 2003, HEALTH SERV RES, V38, P85, DOI 10.1111/1475-6773.00106; MENKE T, 1990, INQUIRY-J HEALTH CAR, V27, P114; MULLER A, 1993, MED CARE, V31, P296, DOI 10.1097/00005650-199304000-00002; MUSHLIN AI, 1988, MED CARE, V26, P1081, DOI 10.1097/00005650-198811000-00006; *NAT CTR HLTH STAT, 1998, NAT HOM HOSP CAR SUR; *NAT CTR HLTH STAT, 1996, NAT HOM HOSP CAR SUR; *NAT CTR HLTH STAT, 2002, NAT HOM HOSP CAR SUR; *NAT CTR HLTH STAT, NAT HLTH CAR SURV; SCHEFFLER RM, 1994, MED CARE, V32, P471, DOI 10.1097/00005650-199405000-00006; SCHLESINGER M, 1989, MED CARE, V27, P244, DOI 10.1097/00005650-198903000-00003; Schlesinger M, 1997, MED CARE, V35, P974, DOI 10.1097/00005650-199709000-00009; Shah BV, 1996, SUDAAN USERS MANUAL; Thomas EJ, 2000, J GEN INTERN MED, V15, P211, DOI 10.1046/j.1525-1497.2000.015004211.x; Tu HT, 2002, NEW ENGL J MED, V346, P1288, DOI 10.1056/NEJMsa011250; *US DEP HHS, 1995, OEI049300260 US DEP; *US DEP HHS, 1995, OEI049300262 US DEP; *US DEP HHS, 1997, PUBL US DEP HHS; *US DEP HHS, 2000, PUBL US DEP HHS; *US DEP HHS, 1999, OEI029900530 US DEP; *US GAO, 1997, GAOHEHS97139R US GAO; *US GAO, 1998, MED HOM HLTH BEN IMP; *US GAO, 1996, GAOHEHS9616 US GAO; *US GAO, 2000, GAOHEHS00176 US GAO; *US GAO, 1998, SUBC HLTH COMM WAYS, P1; Yuan Z, 2000, MED CARE, V38, P231, DOI 10.1097/00005650-200002000-00012; 2002, FED REG         0628, V67, P43616; 1995, FED REG         0810, V60, P40847	37	34	34	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 4	2003	289	21					2841	2848		10.1001/jama.289.21.2841	http://dx.doi.org/10.1001/jama.289.21.2841			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	684KH	12783915	Bronze			2022-12-24	WOS:000183205500033
J	Bogaty, P; Brophy, J				Bogaty, P; Brophy, J			Increasing burden of treatment in the acute coronary syndromes: is it justified?	LANCET			English	Editorial Material							ACUTE MYOCARDIAL-INFARCTION; UNSTABLE ANGINA; CONSERVATIVE STRATEGIES; THROMBOLYSIS; MORTALITY; ASPIRIN		Univ Laval, Quebec Heart Inst, Quebec City, PQ, Canada; McGill Univ, Ctr Hlth, Montreal, PQ, Canada	Laval University; McGill University	Bogaty, P (corresponding author), Hop Laval, Quebec Heart Inst, 2725 Chemin St Foy, Ste Foy, PQ G1V 4G5, Canada.	Peter.Bogaty@med.ulaval.ca	brophy, james/H-6673-2019	brophy, james/0000-0001-8049-6875				ANDERSON HV, 1995, J AM COLL CARDIOL, V26, P1643, DOI 10.1016/0735-1097(95)00404-1; Bazzino O, 1998, NEW ENGL J MED, V338, P1498; Bazzino O, 1998, NEW ENGL J MED, V338, P1488; Boden WE, 1998, NEW ENGL J MED, V338, P1785, DOI 10.1056/NEJM199806183382501; Boersma E, 2002, LANCET, V359, P189, DOI 10.1016/S0140-6736(02)07442-1; BRAUNWALD E, ACC AHA 2002 GUIDELI; CAIRNS JA, 1985, NEW ENGL J MED, V313, P1369, DOI 10.1056/NEJM198511283132201; Cannon CP, 2001, NEW ENGL J MED, V344, P1879, DOI 10.1056/NEJM200106213442501; Choudhry NK, 2002, JAMA-J AM MED ASSOC, V287, P612, DOI 10.1001/jama.287.5.612; Erbel R, 1998, NEW ENGL J MED, V339, P1672, DOI 10.1056/NEJM199812033392304; Fox KAA, 2002, LANCET, V360, P743, DOI 10.1016/S0140-6736(02)09894-X; Franzosi MG, 1998, CIRCULATION, V97, P2202, DOI 10.1161/01.CIR.97.22.2202; Goodman SN, 1999, ANN INTERN MED, V130, P995, DOI 10.7326/0003-4819-130-12-199906150-00008; Heidenreich PA, 2001, J AM COLL CARDIOL, V38, P478, DOI 10.1016/S0735-1097(01)01388-2; LEWIS HD, 1983, NEW ENGL J MED, V309, P396, DOI 10.1056/NEJM198308183090703; Liem AH, 2002, EUR HEART J, V23, P1931, DOI 10.1053/euhj.2002.3291; McPherson K, 2001, QUAL HEALTH CARE, V10, pI61; PFEFFER MA, 1992, NEW ENGL J MED, V327, P669, DOI 10.1056/NEJM199209033271001; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Schwartz GG, 2001, JAMA-J AM MED ASSOC, V285, P1711, DOI 10.1001/jama.285.13.1711; Simoons ML, 2001, LANCET, V357, P1915; Topol E, 1998, NEW ENGL J MED, V339, P436; VOLPI A, 1993, CIRCULATION, V88, P416, DOI 10.1161/01.CIR.88.2.416; Wallentin L, 1999, LANCET, V354, P708; Yusuf S, 2001, NEW ENGL J MED, V345, P494; Yusuf S, 2000, NEW ENGL J MED, V342, P145	26	12	12	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 24	2003	361	9371					1813	1816		10.1016/S0140-6736(03)13407-1	http://dx.doi.org/10.1016/S0140-6736(03)13407-1			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	682CY	12781554				2022-12-24	WOS:000183074800024
J	Fletcher, CV				Fletcher, CV			Enfuvirtide, a new drug for HIV infection	LANCET			English	Editorial Material							PEPTIDE INHIBITOR; VIRUS; PHARMACOKINETICS; FUSION; T-20		Univ Colorado, Hlth Sci Ctr, Dept Clin Pharm, Denver, CO 80262 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Fletcher, CV (corresponding author), Univ Colorado, Hlth Sci Ctr, Dept Clin Pharm, 4200 E 9th Ave, Denver, CO 80262 USA.							CLOTET B, 2002, 14 INT AIDS C BARC S; Kilby JM, 2002, AIDS RES HUM RETROV, V18, P685, DOI 10.1089/088922202760072294; Kilby JM, 1998, NAT MED, V4, P1302, DOI 10.1038/3293; LaBranche CC, 2001, ANTIVIR RES, V50, P95, DOI 10.1016/S0166-3542(01)00130-9; LALEZARI JP, 2003, N ENGL J MED; *ROCH PHARM, 2003, FUZEONTM PACK INS; Zhang XP, 2002, CLIN PHARMACOL THER, V72, P10, DOI 10.1067/mcp.2002.125945	7	35	37	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 10	2003	361	9369					1577	1578		10.1016/S0140-6736(03)13323-5	http://dx.doi.org/10.1016/S0140-6736(03)13323-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	676HY	12747873				2022-12-24	WOS:000182746300003
J	Dror, I; Amitay, T; Yaron, B; Berkowitz, B				Dror, I; Amitay, T; Yaron, B; Berkowitz, B			Salt-pump mechanism for contaminant intrusion into coastal aquifers	SCIENCE			English	Article									Weizmann Inst Sci, Dept Environm Sci & Energy Res, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Berkowitz, B (corresponding author), Weizmann Inst Sci, Dept Environm Sci & Energy Res, IL-76100 Rehovot, Israel.		BERKOWITZ, BRIAN/K-1497-2012	BERKOWITZ, BRIAN/0000-0003-3078-1859				Brendel ML, 1999, FLUID PHASE EQUILIBR, V165, P87, DOI 10.1016/S0378-3812(99)00267-8; Lipiatou E, 1997, DEEP-SEA RES PT II, V44, P881, DOI 10.1016/S0967-0645(96)00093-8; Setschenow J., 1889, Z PHYS CHEM, V4, P117, DOI DOI 10.1515/ZPCH-1889-0109; Tkalich P, 2002, MAR POLLUT BULL, V44, P1219, DOI 10.1016/S0025-326X(02)00178-9; Xie WH, 1997, MAR ENVIRON RES, V44, P429, DOI 10.1016/S0141-1136(97)00017-2; Zhang Q, 2001, J CONTAM HYDROL, V49, P201, DOI 10.1016/S0169-7722(00)00194-7	6	17	17	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 9	2003	300	5621					950	950		10.1126/science.1080075	http://dx.doi.org/10.1126/science.1080075			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675WD	12738855				2022-12-24	WOS:000182719800047
J	Zerhouni, E				Zerhouni, E			Embryonic stem cells - Stem cell programs	SCIENCE			English	Editorial Material									NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA	Zerhouni, E (corresponding author), NIH, Bldg 10, Bethesda, MD 20892 USA.								0	4	5	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 9	2003	300	5621					911	912		10.1126/science.1084819	http://dx.doi.org/10.1126/science.1084819			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675WD	12738840				2022-12-24	WOS:000182719800032
J	Bagri, A; Cheng, HJ; Yaron, A; Pleasure, SJ; Tessier-Lavigne, M				Bagri, A; Cheng, HJ; Yaron, A; Pleasure, SJ; Tessier-Lavigne, M			Stereotyped pruning of long hippocampal axon branches triggered by retraction inducers of the semaphorin family	CELL			English	Article							PROJECTION; CELLS; NEURONS	Like naturally occurring neuronal cell death, stereotyped pruning of long axon branches to temporary targets is a widespread regressive phenomenon in the developing mammalian brain that helps sculpt the pattern of neuronal connections. The mechanisms controlling stereotyped pruning are, however, poorly understood. Here, we provide evidence that semaphorins, activating the Plexin-A3 receptor, function as retraction inducers to trigger-stereotyped pruning of specific hippocampal mossy fiber and pyramidal axon branches. Both pruning events are defective in Plexin-A3 mutants, reflecting a cell-autonomous requirement for Plexin-A3. The distribution of mRNAs for Sema3F and Sema3A makes them candidates for triggering the pruning. In vitro, hippocampal neurons respond to semaphorins by retracting axon branches. These results implicate semaphorins as retraction inducers controlling stereotyped pruning in the mammalian brain.	Univ Calif San Francisco, Dept Neurol, Program Neurosci, San Francisco, CA 94143 USA; Stanford Univ, Dept Biol Sci, Howard Hughes Med Inst, Stanford, CA 94305 USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute; Stanford University	Pleasure, SJ (corresponding author), Univ Calif San Francisco, Dept Neurol, Program Neurosci, San Francisco, CA 94143 USA.	samuelp@itsa.ucsf.edu; marctl@stanford.edu	Cheng, Hwai-Jong/AAY-5067-2021	Cheng, Hwai-Jong/0000-0003-0647-0567				Albright TD, 2000, NEURON, V25, pS1, DOI 10.1016/S0896-6273(00)80912-5; ALTMAN J, 1990, J COMP NEUROL, V301, P343, DOI 10.1002/cne.903010303; BANKER GA, 1979, J COMP NEUROL, V187, P469, DOI 10.1002/cne.901870302; Bernstein M, 1999, CURR OPIN NEUROBIOL, V9, P364, DOI 10.1016/S0959-4388(99)80053-1; Billuart P, 2001, CELL, V107, P195, DOI 10.1016/S0092-8674(01)00522-0; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; Chedotal A, 1998, DEVELOPMENT, V125, P4313; Chen H, 2000, NEURON, V25, P43, DOI 10.1016/S0896-6273(00)80870-3; Cheng HJ, 2001, NEURON, V32, P249, DOI 10.1016/S0896-6273(01)00478-0; Goodman CS, 1999, CELL, V97, P551, DOI 10.1016/S0092-8674(00)80766-7; Hadjantonakis AK, 2001, GENESIS, V29, P133, DOI 10.1002/gene.1016; Hastings NB, 1999, J COMP NEUROL, V413, P146, DOI 10.1002/(SICI)1096-9861(19991011)413:1<146::AID-CNE10>3.0.CO;2-B; HERRMANN K, 1995, P NATL ACAD SCI USA, V92, P11244, DOI 10.1073/pnas.92.24.11244; Kitsukawa T, 1997, NEURON, V19, P995, DOI 10.1016/S0896-6273(00)80392-X; Kolodkin AL, 1998, PROG BRAIN RES, V117, P115; LINKE R, 1995, J COMP NEUROL, V351, P602, DOI 10.1002/cne.903510409; Martin LA, 2002, J NEUROSCI, V22, P3520; Murakami Y, 2001, DEV DYNAM, V220, P246, DOI 10.1002/1097-0177(20010301)220:3<246::AID-DVDY1112>3.0.CO;2-2; OLEARY DDM, 1986, DEV BRAIN RES, V27, P87, DOI 10.1016/0165-3806(86)90235-X; OLEARY DDM, 1990, COLD SH Q B, V55, P453; Raff MC, 2002, SCIENCE, V296, P868, DOI 10.1126/science.1068613; STANFIELD BB, 1985, J COMP NEUROL, V238, P236, DOI 10.1002/cne.902380210; SUPER H, 1994, J COMP NEUROL, V344, P101, DOI 10.1002/cne.903440108; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Weimann JM, 1999, NEURON, V24, P819, DOI 10.1016/S0896-6273(00)81030-2	26	246	248	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 2	2003	113	3					285	299		10.1016/S0092-8674(03)00267-8	http://dx.doi.org/10.1016/S0092-8674(03)00267-8			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	674MP	12732138	Bronze			2022-12-24	WOS:000182640800005
J	Naber, N; Minehardt, TJ; Rice, S; Chen, XR; Grammer, J; Matuska, M; Vale, RD; Kollman, PA; Car, R; Yount, RG; Cooke, R; Pate, E				Naber, N; Minehardt, TJ; Rice, S; Chen, XR; Grammer, J; Matuska, M; Vale, RD; Kollman, PA; Car, R; Yount, RG; Cooke, R; Pate, E			Closing of the nucleotide pocket of kinesin-family motors upon binding to microtubules	SCIENCE			English	Article							CRYSTAL-STRUCTURE; G-PROTEINS; MOLECULAR MOTORS; MECHANISM; MYOSIN; DOMAIN; ATPASE; ACTIVATION; SWITCHES; REVEALS	We have used adenosine diphosphate analogs containing electron paramagnetic resonance (EPR) spin moieties and EPR spectroscopy to show that the nucleotide-binding site of kinesin-family motors closes when the motor.diphosphate complex binds to microtubules. Structural analyses demonstrate that a domain movement in the switch 1 region at the nucleotide site, homologous to domain movements in the switch 1 region in the G proteins [heterotrimeric guanine nucleotide-binding proteins], explains the EPR data. The switch movement primes the motor both for the free energy-yielding nucleotide hydrolysis reaction and for subsequent conformational changes that are crucial for the generation of force and directed motion along the microtubule.	Univ Calif San Francisco, Dept Biochem, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA; Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA; Washington State Univ, Dept Chem, Pullman, WA 99164 USA; Washington State Univ, Dept Math, Pullman, WA 99164 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Princeton University; Washington State University; Washington State University; Washington State University	Naber, N (corresponding author), Univ Calif San Francisco, Dept Biochem, San Francisco, CA 94143 USA.		Gelfand, Vladimir I/D-2545-2013	Gelfand, Vladimir I/0000-0002-6361-2798	NCRR NIH HHS [RR1081] Funding Source: Medline; NIAMS NIH HHS [AR42895, AR39643] Funding Source: Medline; NIDDK NIH HHS [DK05915] Funding Source: Medline; NIGMS NIH HHS [GM29072] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001081] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR039643, P01AR042895] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029072] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		COLEMAN DE, 1994, SCIENCE, V265, P1405, DOI 10.1126/science.8073283; CROWDER MS, 1987, BIOPHYS J, V51, P323, DOI 10.1016/S0006-3495(87)83338-6; Goldberg J, 1998, CELL, V95, P237, DOI 10.1016/S0092-8674(00)81754-7; Griffith O.H., 1976, SPIN LABELING THEORY, P454; Gulick AM, 1998, BIOCHEMISTRY-US, V37, P1769, DOI 10.1021/bi972504o; Hubbell WL, 1996, STRUCTURE, V4, P779, DOI 10.1016/S0969-2126(96)00085-8; Kikkawa M, 2001, NATURE, V411, P439, DOI 10.1038/35078000; KOZIELSKI F, 1997, CELL, V7, P1407; Kull FJ, 2002, J CELL SCI, V115, P15; Kull FJ, 1998, J MUSCLE RES CELL M, V19, P877, DOI 10.1023/A:1005489907021; Kull FJ, 1996, NATURE, V380, P550, DOI 10.1038/380550a0; Ma YZ, 1997, J BIOL CHEM, V272, P717, DOI 10.1074/jbc.272.2.717; Minehardt TJ, 2001, BIOPHYS J, V80, P1151, DOI 10.1016/S0006-3495(01)76092-4; Naber N, 2003, BIOPHYS J, V84, P3190, DOI 10.1016/S0006-3495(03)70043-5; Pate E, 1997, BIOCHEMISTRY-US, V36, P12155, DOI 10.1021/bi970996z; Sablin EP, 1996, NATURE, V380, P555, DOI 10.1038/380555a0; Sablin EP, 2001, CURR OPIN STRUC BIOL, V11, P716, DOI 10.1016/S0959-440X(01)00265-2; Sack S, 1997, BIOCHEMISTRY-US, V36, P16155, DOI 10.1021/bi9722498; Sack S, 1999, EUR J BIOCHEM, V262, P1, DOI 10.1046/j.1432-1327.1999.00341.x; Schief WR, 2001, CURR OPIN CELL BIOL, V13, P19, DOI 10.1016/S0955-0674(00)00169-1; Song YH, 2001, EMBO J, V20, P6213, DOI 10.1093/emboj/20.22.6213; Sprang SR, 1997, CURR OPIN STRUC BIOL, V7, P849, DOI 10.1016/S0959-440X(97)80157-1; THOMAS DD, 1987, ANNU REV PHYSIOL, V49, P691, DOI 10.1146/annurev.ph.49.030187.003355; Turner J, 2001, J BIOL CHEM, V276, P25496, DOI 10.1074/jbc.M100395200; Vale RD, 1996, J CELL BIOL, V135, P291, DOI 10.1083/jcb.135.2.291; YOUNT RG, 1995, BIOPHYS J, V68, pS44; Yun MY, 2001, EMBO J, V20, P2611, DOI 10.1093/emboj/20.11.2611	27	49	50	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 2	2003	300	5620					798	801		10.1126/science.1082374	http://dx.doi.org/10.1126/science.1082374			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673KH	12730601				2022-12-24	WOS:000182579800051
J	Jiang, YX; Lee, A; Chen, JY; Ruta, V; Cadene, M; Chait, BT; MacKinnon, R				Jiang, YX; Lee, A; Chen, JY; Ruta, V; Cadene, M; Chait, BT; MacKinnon, R			X-ray structure of a voltage-dependent K+ channel	NATURE			English	Article							POTASSIUM CHANNEL; GATING CHARGE; TRANSMEMBRANE MOVEMENT; S4 SEGMENT; PERSPECTIVE; SEQUENCE; PROTEIN; ACTIVATION; CONDUCTION; HANATOXIN	Voltage-dependent K+ channels are members of the family of voltage-dependent cation (K+, Na+ and Ca2+) channels that open and allow ion conduction in response to changes in cell membrane voltage. This form of gating underlies the generation of nerve and muscle action potentials, among other processes. Here we present the structure of KvAP, a voltage-dependent K+ channel from Aeropyrum pernix. We have determined a crystal structure of the full-length channel at a resolution of 3.2 Angstrom, and of the isolated voltage-sensor domain at 1.9 Angstrom, both in complex with monoclonal Fab fragments. The channel contains a central ion-conduction pore surrounded by voltage sensors, which form what we call 'voltage-sensor paddles'-hydrophobic, cationic, helix-turn-helix structures on the channel's outer perimeter. Flexible hinges suggest that the voltage-sensor paddles move in response to membrane voltage changes, carrying their positive charge across the membrane.	Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Neurobiol & Biophys, Lab Mass Spectrometry & Gaseous Ion Chem, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University	MacKinnon, R (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Neurobiol & Biophys, Lab Mass Spectrometry & Gaseous Ion Chem, 1230 York Ave, New York, NY 10021 USA.	mackinn@rockvax.rockefeller.edu		Ruta, Vanessa/0000-0002-4963-2768; Cadene, Martine/0000-0003-4936-2662				Aggarwal SK, 1996, NEURON, V16, P1169, DOI 10.1016/S0896-6273(00)80143-9; ARMSTRONG CM, 1974, J GEN PHYSIOL, V63, P533, DOI 10.1085/jgp.63.5.533; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker OS, 1998, NEURON, V20, P1283, DOI 10.1016/S0896-6273(00)80507-3; Bezanilla F, 2000, PHYSIOL REV, V80, P555, DOI 10.1152/physrev.2000.80.2.555; Bezanilla F, 2002, J GEN PHYSIOL, V120, P465, DOI 10.1085/jgp.20028660; Blaustein RO, 2000, NAT STRUCT BIOL, V7, P309; BRUNGER AT, 1991, J MOL BIOL, V221, P239, DOI 10.1016/0022-2836(91)90817-P; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carson M, 1997, METHOD ENZYMOL, V277, P493, DOI 10.1016/S0076-6879(97)77027-7; Cha A, 1997, NEURON, V19, P1127, DOI 10.1016/S0896-6273(00)80403-1; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Gandhi CS, 2002, J GEN PHYSIOL, V120, P455, DOI 10.1085/jgp.20028678; Harlow E., 1989, ANTIBODIES LAB MANUA; Heginbotham L, 1999, J GEN PHYSIOL, V114, P551, DOI 10.1085/jgp.114.4.551; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Horn R, 2002, J GEN PHYSIOL, V120, P449, DOI 10.1085/jgp.20028658; Jiang YX, 2003, NATURE, V423, P42, DOI 10.1038/nature01581; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Larsson HP, 1996, NEURON, V16, P387, DOI 10.1016/S0896-6273(00)80056-2; Lu Z, 2001, NATURE, V413, P809, DOI 10.1038/35101535; Mannuzzu LM, 1996, SCIENCE, V271, P213, DOI 10.1126/science.271.5246.213; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NODA M, 1984, NATURE, V312, P121, DOI 10.1038/312121a0; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Qiu XQ, 1996, J GEN PHYSIOL, V107, P313, DOI 10.1085/jgp.107.3.313; Ruta V, 2003, NATURE, V422, P180, DOI 10.1038/nature01473; SANTACRUZTOLOZA L, 1994, BIOCHEMISTRY-US, V33, P5607, DOI 10.1021/bi00184a033; SCHOPPA NE, 1992, SCIENCE, V255, P1712, DOI 10.1126/science.1553560; Seoh SA, 1996, NEURON, V16, P1159, DOI 10.1016/S0896-6273(00)80142-7; SIGWORTH FJ, 1994, Q REV BIOPHYS, V27, P1, DOI 10.1017/S0033583500002894; SLATIN SL, 1994, NATURE, V371, P158, DOI 10.1038/371158a0; Swartz KJ, 1997, NEURON, V18, P675, DOI 10.1016/S0896-6273(00)80307-4; Swartz KJ, 1997, NEURON, V18, P665, DOI 10.1016/S0896-6273(00)80306-2; TANABE T, 1987, NATURE, V328, P313, DOI 10.1038/328313a0; TEMPEL BL, 1987, SCIENCE, V237, P770, DOI 10.1126/science.2441471; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; YANG NB, 1995, NEURON, V15, P213, DOI 10.1016/0896-6273(95)90078-0; Yusaf SP, 1996, PFLUG ARCH EUR J PHY, V433, P91, DOI 10.1007/s004240050253; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	43	1527	1601	7	228	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 1	2003	423	6935					33	41		10.1038/nature01580	http://dx.doi.org/10.1038/nature01580			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673CG	12721618				2022-12-24	WOS:000182561600032
J	Maller, JL				Maller, JL			Fishing at the cell surface	SCIENCE			English	Editorial Material							PROGESTERONE-RECEPTOR; OOCYTE; PROTEIN; MATURATION; ARREST		Univ Colorado, Sch Med, Howard Hughes Med Inst, Denver, CO 80262 USA; Univ Colorado, Sch Med, Dept Pharmacol, Denver, CO 80262 USA	Howard Hughes Medical Institute; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Maller, JL (corresponding author), Univ Colorado, Sch Med, Howard Hughes Med Inst, Denver, CO 80262 USA.							Bayaa M, 2000, P NATL ACAD SCI USA, V97, P12607, DOI 10.1073/pnas.220302597; Boonyaratanakornkit V, 2001, MOL CELL, V8, P269, DOI 10.1016/S1097-2765(01)00304-5; Duckworth BC, 2002, P NATL ACAD SCI USA, V99, P16794, DOI 10.1073/pnas.222661299; Losel R, 2003, NAT REV MOL CELL BIO, V4, P46, DOI 10.1038/nrm1009; Maller JL, 2001, P NATL ACAD SCI USA, V98, P8, DOI 10.1073/pnas.98.1.8; Mehlmann LM, 2002, SCIENCE, V297, P1343, DOI 10.1126/science.1073978; Schmitt A, 2002, P NATL ACAD SCI USA, V99, P4361, DOI 10.1073/pnas.022056399; Sheng YL, 2001, CURR BIOL, V11, P405, DOI 10.1016/S0960-9822(01)00123-3; Tian JD, 2000, P NATL ACAD SCI USA, V97, P14358, DOI 10.1073/pnas.250492197; YONG Z, 2003, P NATL ACAD SCI USA, V100, P2237; Zhu Y, 2003, P NATL ACAD SCI USA, V100, P2231, DOI 10.1073/pnas.0336132100	11	37	38	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 25	2003	300	5619					594	595		10.1126/science.1083725	http://dx.doi.org/10.1126/science.1083725			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671FB	12714732				2022-12-24	WOS:000182453700028
J	Savic, R; Luo, LB; Eisenberg, A; Maysinger, D				Savic, R; Luo, LB; Eisenberg, A; Maysinger, D			Micellar nanocontainers distribute to defined cytoplasmic organelles	SCIENCE			English	Article							BLOCK-COPOLYMER MICELLES; DRUG-DELIVERY; CELLS; NANOPARTICLES; DIBLOCK; TARGET; NERVE	Block copolymer micelles are water-soluble biocompatible nanocontainers with great potential for delivering hydrophobic drugs. An understanding of their cellular distribution is essential to achieving selective delivery of drugs at the subcellular level. Triple-labeling confocal microscopy in live cells revealed the localization of micelles in several cytoplasmic organelles, including mitochondria, but not in the nucleus. Moreover, micelles change the cellular distribution of and increase the amount of the agent delivered to the cells. These micelles may thus be worth exploring for their potential to selectively deliver drugs to specified subcellular targets.	McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ H3G 1Y6, Canada; McGill Univ, Dept Chem, Montreal, PQ H3A 2K6, Canada	McGill University; McGill University	Maysinger, D (corresponding author), McGill Univ, Dept Pharmacol & Therapeut, 3655 Drummond St, Montreal, PQ H3G 1Y6, Canada.		Maysinger, Dusica/GYU-6332-2022; Eisenberg, Adi/B-8676-2008					Allen C, 2000, DRUG DELIV, V7, P139; De Jaeghere F, 2000, J DRUG TARGET, V8, P143, DOI 10.3109/10611860008996860; Discher DE, 2002, SCIENCE, V297, P967, DOI 10.1126/science.1074972; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Haughland R.P., 1996, HDB FLUORESCENT PROB; Kabanov AV, 2002, CRIT REV THER DRUG, V19, P1, DOI 10.1615/CritRevTherDrugCarrierSyst.v19.i1.10; Kakizawa Y, 2002, ADV DRUG DELIVER REV, V54, P203, DOI 10.1016/S0169-409X(02)00017-0; Kataoka K, 2001, ADV DRUG DELIVER REV, V47, P113, DOI 10.1016/S0169-409X(00)00124-1; Langer R, 2001, SCIENCE, V293, P58, DOI 10.1126/science.1063273; LASIC DD, 1995, SCIENCE, V267, P1275, DOI 10.1126/science.7871422; Liaw J, 1999, PHARM RES-DORDR, V16, P213, DOI 10.1023/A:1012157906528; Liu JQ, 2001, BIOMACROMOLECULES, V2, P362, DOI 10.1021/bm015515c; Luo LB, 2002, BIOCONJUGATE CHEM, V13, P1259, DOI 10.1021/bc025524y; MAYSINGER D, 2002, POLYM BIOMATERIALS, pCH42; Moghimi SM, 2001, PHARMACOL REV, V53, P283; Rapoport N, 2002, J PHARM SCI, V91, P157, DOI 10.1002/jps.10006; Saltzman W. M., 2001, DRUG DELIVERY ENG PR; Szleifer I, 1997, CURR OPIN SOLID ST M, V2, P337, DOI 10.1016/S1359-0286(97)80125-8; Torchilin VP, 2002, ADV DRUG DELIVER REV, V54, P235, DOI 10.1016/S0169-409X(02)00019-4; Vaudry D, 2002, SCIENCE, V296, P1648, DOI 10.1126/science.1071552; Webb RH, 1999, METHOD ENZYMOL, V307, P3; YOKOYAMA M, 1998, BIORELATED POLYM GEL, pCH6; Zhang LF, 1996, SCIENCE, V272, P1777, DOI 10.1126/science.272.5269.1777	23	978	1026	8	240	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 25	2003	300	5619					615	618		10.1126/science.1078192	http://dx.doi.org/10.1126/science.1078192			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671FB	12714738				2022-12-24	WOS:000182453700034
J	Bonifacio, P; Limongi, M; Chieffi, A				Bonifacio, P; Limongi, M; Chieffi, A			How did the metals in a giant star originate?	NATURE			English	Article							CHEMICAL-COMPOSITION; POOR STARS; SUPERNOVAE		Osserv Astron Trieste, Ist Nazl Astrofis, I-34131 Trieste, Italy; Osserv Astron Roma, Ist Nazl Astrofis, I-00040 Rome, Italy; CNR, Ist Astrofis Spaziale, I-00133 Rome, Italy	Istituto Nazionale Astrofisica (INAF); Istituto Nazionale Astrofisica (INAF); Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale Astrofisica (INAF)	Bonifacio, P (corresponding author), Osserv Astron Trieste, Ist Nazl Astrofis, I-34131 Trieste, Italy.	bonifaci@ts.astro.it						Aoki W, 2002, ASTROPHYS J, V576, pL141, DOI 10.1086/343761; Chieffi A, 2002, ASTROPHYS J, V577, P281, DOI 10.1086/342170; Chieffi A, 2002, ASTROPHYS SPACE SC L, V274, P47; Christlieb N, 2002, NATURE, V419, P904, DOI 10.1038/nature01142; Depagne E, 2002, ASTRON ASTROPHYS, V390, P187, DOI 10.1051/0004-6361:20020687	5	19	19	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 24	2003	422	6934					834	834		10.1038/422834a	http://dx.doi.org/10.1038/422834a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	670WR	12712194	Bronze, Green Submitted			2022-12-24	WOS:000182432600042
J	Chan-Yeung, M; Yu, WC				Chan-Yeung, M; Yu, WC			Outbreak of severe acute respiratory syndrome in Hong kong special administrative region: case report	BRITISH MEDICAL JOURNAL			English	Article								Objective To describe the outbreak of severe acute respiratory syndrome in Hong Kong. Design Descriptive case series. Setting Hong Kong, Special Administrative Region, China Results The outbreak started with a visitor from southern China on 21 February At the hospitals where the first cases were treated the disease spread quickly among healthcare workers, and then out into the community as family members became infected. By 1 April, 685 cases had been reported with 16 deaths. Symptoms include high fever and one or more respiratory symptoms (including cough, shortness of breath, and difficulty breathing,). Changes in lung tissue suggest that part of the lung damage is due to cytokines induced by the microbial agent, which has led to empirical treatment with corticosteroids, broad spectrum antiviral agent, and antibacterial cover. There is strong evidence that a novel coronavirus is the pathogen. Precautions for droplet infection should be instituted, including the wearing of masks and rigorous disinfection and hygiene procedures. On 27 March the Department of Health announced drastic measures, including vigorous contact tracing and examination, quarantine of contacts in their homes, and closure of all schools and universities. Conclusion The rapidity of the spread of the disease and the morbidity indicate that the agent responsible is highly infectious and virulent. Strict infection control measures for droplet and contact transmission by healthcare workers, a vigilant healthcare profession, and public education are essential for disease prevention.	Univ Hong Kong, Queen Mary Hosp, Div Resp & Crit Care Med, Hong Kong, Hong Kong, Peoples R China; Princess Margaret Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Chan-Yeung, M (corresponding author), Univ Hong Kong, Queen Mary Hosp, Div Resp & Crit Care Med, 4-F,Professorial Block, Hong Kong, Hong Kong, Peoples R China.							Centers for Disease Control and Prevention, SEV AC RESP SYNDR SA; *GOV HONG KONG SPE, ATYP PNEUM; *HOSP AUTH, 2003, SEV AC RESP SYNDR CL; LEE N, 2003, N ENGL J MED, V7; PERIRIS JSM, 2003, LANCET, V8; TSANG KW, 2003, N ENGL J MED    0401; *WHO, 2003, SEV AC RESP SYNDR	7	79	95	0	7	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 19	2003	326	7394					850	+		10.1136/bmj.326.7394.850	http://dx.doi.org/10.1136/bmj.326.7394.850			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	670BF	12702616	Green Published, Bronze, Green Submitted			2022-12-24	WOS:000182386800016
J	Chang, EF; Merzenich, MM				Chang, EF; Merzenich, MM			Environmental noise retards auditory cortical development	SCIENCE			English	Article							PLASTICITY; CORTEX; MATURATION; EXPERIENCE; CATS; SENSITIVITY; PERIODS; RAT; MAP	The mammalian auditory cortex normally undergoes rapid and progressive functional maturation. Here we show that rearing infant rat pups in continuous, moderate-level noise delayed the emergence of adultlike topographic representational order and the refinement of response selectivity in the primary auditory cortex (A1) long beyond normal developmental benchmarks. When those noise-reared adult rats were subsequently exposed to a pulsed pure-tone stimulus, A1 rapidly reorganized, demonstrating that exposure-driven plasticity characteristic of the critical period was still ongoing. These results demonstrate that A1 organization is shaped by a young animal's exposure to salient, structured acoustic inputs-and implicate noise as a risk factor for abnormal child development.	Univ Calif San Francisco, WM Keck Ctr Integrat Neurosci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Chang, EF (corresponding author), Univ Calif San Francisco, WM Keck Ctr Integrat Neurosci, San Francisco, CA 94143 USA.	echang@itsa.ucsf.edu			NINDS NIH HHS [NS-38416, NS-10414] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AHISSAR E, 1992, SCIENCE, V257, P1412, DOI 10.1126/science.1529342; Bao SW, 2001, NATURE, V412, P79, DOI 10.1038/35083586; CASTREN E, 1992, P NATL ACAD SCI USA, V89, P9444, DOI 10.1073/pnas.89.20.9444; COSTALUPES JA, 1984, J NEUROPHYSIOL, V51, P1326, DOI 10.1152/jn.1984.51.6.1326; CYNADER M, 1980, J NEUROPHYSIOL, V43, P1026, DOI 10.1152/jn.1980.43.4.1026; EDELINE JM, 1993, BEHAV NEUROSCI, V107, P539, DOI 10.1037/0735-7044.107.4.539; Ehret G, 2000, HEARING RES, V141, P107, DOI 10.1016/S0378-5955(99)00213-0; Etzel RA, 1997, PEDIATRICS, V100, P724; Hanover JL, 1999, J NEUROSCI, V19, part. no.; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Iyengar S, 2002, J NEUROSCI, V22, P946, DOI 10.1523/JNEUROSCI.22-03-00946.2002; Kilgard MP, 1998, SCIENCE, V279, P1714, DOI 10.1126/science.279.5357.1714; Klinke R, 1999, SCIENCE, V285, P1729, DOI 10.1126/science.285.5434.1729; Kral A, 2001, AUDIOL NEURO-OTOL, V6, P346, DOI 10.1159/000046845; KUHL PK, 1992, SCIENCE, V255, P606, DOI 10.1126/science.1736364; MARLER P, 1973, P NATL ACAD SCI USA, V70, P1393, DOI 10.1073/pnas.70.5.1393; MOORE DR, 1985, ACTA OTO-LARYNGOL, P19; MOWER GD, 1981, BRAIN RES, V220, P255, DOI 10.1016/0006-8993(81)91216-6; PHILBIN MK, 1994, DEV PSYCHOBIOL, V27, P11; PHILLIPS DP, 1985, HEARING RES, V18, P87, DOI 10.1016/0378-5955(85)90112-1; Ponton CW, 1996, NEUROREPORT, V8, P61, DOI 10.1097/00001756-199612200-00013; SALLY SL, 1988, J NEUROPHYSIOL, V59, P1627, DOI 10.1152/jn.1988.59.5.1627; SANES DH, 1983, SCIENCE, V221, P1183, DOI 10.1126/science.6612332; Shepherd RK, 1997, ACTA OTO-LARYNGOL, P28; Stanton SG, 1996, AUDIT NEUROSCI, V2, P97; White LE, 2001, NATURE, V411, P1049, DOI 10.1038/35082568; WITHINGTONWRAY DJ, 1990, EUR J NEUROSCI, V2, P693, DOI 10.1111/j.1460-9568.1990.tb00459.x; Zhang LI, 2001, NAT NEUROSCI, V4, P1123, DOI 10.1038/nn745; Zhang LI, 2002, P NATL ACAD SCI USA, V99, P2309, DOI 10.1073/pnas.261707398	29	383	392	1	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 18	2003	300	5618					498	502		10.1126/science.1082163	http://dx.doi.org/10.1126/science.1082163			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668LR	12702879				2022-12-24	WOS:000182295900044
J	Inoue, M; Chang, L; Hwang, J; Chiang, SH; Saltiel, AR				Inoue, M; Chang, L; Hwang, J; Chiang, SH; Saltiel, AR			The exocyst complex is required for targeting of Glut4 to the plasma membrane by insulin	NATURE			English	Article							3T3-L1 ADIPOCYTES; 3T3L1 ADIPOCYTES; RHO; TRANSLOCATION; GLUCOSE; TRANSPORT; PROTEINS; TC10; RAB4; GLUCOSE-TRANSPORTER-4	Insulin stimulates glucose transport by promoting exocytosis of the glucose transporter Glut4 (refs 1, 2). The dynamic processes involved in the trafficking of Glut4-containing vesicles, and in their targeting, docking and fusion at the plasma membrane, as well as the signalling processes that govern these events, are not well understood. We recently described tyrosine-phosphorylation events restricted to subdomains of the plasma membrane that result in activation of the G protein TC10 (refs 3, 4). Here we show that TC10 interacts with one of the components of the exocyst complex, Exo70. Exo70 translocates to the plasma membrane in response to insulin through the activation of TC10, where it assembles a multiprotein complex that includes Sec6 and Sec8. Overexpression of an Exo70 mutant blocked insulin-stimulated glucose uptake, but not the trafficking of Glut4 to the plasma membrane. However, this mutant did block the extracellular exposure of the Glut4 protein. So, the exocyst might have a crucial role in the targeting of the Glut4 vesicle to the plasma membrane, perhaps directing the vesicle to the precise site of fusion.	Univ Michigan, Med Ctr, Inst Life Sci, Dept Internal Med, Ann Arbor, MI 48109 USA; Univ Michigan, Med Ctr, Inst Life Sci, Dept Physiol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Saltiel, AR (corresponding author), Univ Michigan, Med Ctr, Inst Life Sci, Dept Internal Med, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.		Saltiel, Alan/L-3632-2019	Chang, Louise/0000-0001-5501-4774; Saltiel, Alan/0000-0002-9726-9828				Bryant NJ, 2002, NAT REV MOL CELL BIO, V3, P267, DOI 10.1038/nrm782; Chamberlain LH, 2002, J BIOL CHEM, V277, P49750, DOI 10.1074/jbc.M206936200; Chang L, 2002, P NATL ACAD SCI USA, V99, P12835, DOI 10.1073/pnas.202495599; Cheatham B, 2000, TRENDS ENDOCRIN MET, V11, P356, DOI 10.1016/S1043-2760(00)00308-8; Chiang SH, 2002, J BIOL CHEM, V277, P13067, DOI 10.1074/jbc.M109471200; Chiang SH, 2001, NATURE, V410, P944, DOI 10.1038/35073608; Cormont M, 1996, MOL CELL BIOL, V16, P6879; Dawson K, 2001, BIOCHEM BIOPH RES CO, V287, P445, DOI 10.1006/bbrc.2001.5620; Guo W, 2000, TRENDS CELL BIOL, V10, P251, DOI 10.1016/S0962-8924(00)01754-2; Hsu SC, 1999, TRENDS CELL BIOL, V9, P150, DOI 10.1016/S0962-8924(99)01516-0; Hwang JB, 1999, J BIOL CHEM, V274, P22813, DOI 10.1074/jbc.274.32.22813; Kee Y, 1997, P NATL ACAD SCI USA, V94, P14438, DOI 10.1073/pnas.94.26.14438; Kimura A, 2001, P NATL ACAD SCI USA, V98, P9098, DOI 10.1073/pnas.151252898; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; Lipschutz JH, 2002, CURR BIOL, V12, pR212, DOI 10.1016/S0960-9822(02)00753-4; Liu J, 2002, MOL CELL BIOL, V22, P3599, DOI 10.1128/MCB.22.11.3599-3609.2002; Millar CA, 1999, MOL BIOL CELL, V10, P3675, DOI 10.1091/mbc.10.11.3675; Neudauer CL, 1998, CURR BIOL, V8, P1151, DOI 10.1016/S0960-9822(07)00486-1; Novick P, 2002, TRENDS CELL BIOL, V12, P247, DOI 10.1016/S0962-8924(02)02293-6; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Sherman LA, 1996, ENDOCRINOLOGY, V137, P266, DOI 10.1210/en.137.1.266; Shisheva A, 1997, BIOCHEMISTRY-US, V36, P6564, DOI 10.1021/bi970202g; Symons M, 1996, TRENDS BIOCHEM SCI, V21, P178, DOI 10.1016/S0968-0004(96)10022-0; Tapon N, 1997, CURR OPIN CELL BIOL, V9, P86, DOI 10.1016/S0955-0674(97)80156-1; TerBush DR, 1996, EMBO J, V15, P6483, DOI 10.1002/j.1460-2075.1996.tb01039.x; Thurmond DC, 1998, J BIOL CHEM, V273, P33876, DOI 10.1074/jbc.273.50.33876; TING AE, 1995, P NATL ACAD SCI USA, V92, P9613, DOI 10.1073/pnas.92.21.9613; VAN AL, 1997, GENE DEV, V11, P2295; Yeaman C, 2001, J CELL BIOL, V155, P593, DOI 10.1083/jcb.200107088	29	264	279	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 10	2003	422	6932					629	633		10.1038/nature01533	http://dx.doi.org/10.1038/nature01533			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665GN	12687004	Green Published			2022-12-24	WOS:000182111400046
J	Serdula, MK; Khan, LK; Dietz, WH				Serdula, MK; Khan, LK; Dietz, WH			Weight-loss Counseling revisited	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									CDCP, Div Nutr & Phys Act, Chron Dis Nutr Branch, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30341 USA	Centers for Disease Control & Prevention - USA	Serdula, MK (corresponding author), CDCP, Div Nutr & Phys Act, Chron Dis Nutr Branch, Natl Ctr Chron Dis Prevent & Hlth Promot, 4770 Buford Hwy NE,Mailstop K26, Atlanta, GA 30341 USA.	mks1@cdc.gov						Anderson DA, 1999, ARCH FAM MED, V8, P156, DOI 10.1001/archfami.8.2.156; Brolin RE, 2002, JAMA-J AM MED ASSOC, V288, P2793, DOI 10.1001/jama.288.22.2793; FIORE MC, 2000, TREATING TOBACCO USE; Freedman MR, 2001, OBES RES, V9, p1S, DOI 10.1038/oby.2001.113; Galuska DA, 1999, JAMA-J AM MED ASSOC, V282, P1576, DOI 10.1001/jama.282.16.1576; Jakicic JM, 2001, MED SCI SPORT EXER, V33, P2145, DOI 10.1097/00005768-200112000-00026; Jeffery RW, 2000, HEALTH PSYCHOL, V19, P5, DOI 10.1037/0278-6133.19.Suppl1.5; *NIH, 2003, PRACT GUID ID EV TRE; *PARTN HLTH WEIGH, 2003, VOL GUID PROV WEIGHT; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; Simkin-Silverman LR, 1997, OBES RES, V5, P603, DOI 10.1002/j.1550-8528.1997.tb00582.x; SIMKINSILVERMAN LR, 2002, OBES RES, V346, P591; Thomas PR, 1995, COMMITTEE DEV CRITER, DOI 10.1037/10510-000; Wadden T, 1993, OBESITY THEORY THERA, P197; Wadden TA, 2000, MED CLIN N AM, V84, P441, DOI 10.1016/j.psc.2004.09.008; WILLIAMSON DF, 1990, ARCH INTERN MED, V150, P665, DOI 10.1001/archinte.150.3.665; Wing RR, 2001, ANNU REV NUTR, V21, P323, DOI 10.1146/annurev.nutr.21.1.323; Yanovski S Z, 1993, Arch Fam Med, V2, P309, DOI 10.1001/archfami.2.3.309; Yanovski SZ, 2002, NEW ENGL J MED, V346, P591, DOI 10.1056/NEJMra012586; [No title captured]	20	73	77	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 9	2003	289	14					1747	1750		10.1001/jama.289.14.1747	http://dx.doi.org/10.1001/jama.289.14.1747			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	664ZJ	12684339				2022-12-24	WOS:000182094900001
J	Davies, M; Bruce, C; Bewley, K; Outlaw, M; Mioulet, V; Lloyd, G; Clegg, C				Davies, M; Bruce, C; Bewley, K; Outlaw, M; Mioulet, V; Lloyd, G; Clegg, C			Pollovirus type 1 in working stocks of typed human rhinoviruses	LANCET			English	Article							WILD	After eradication of circulating polioviruses, reintroduction might arise from cultured laboratory stocks, or from collections of patients' or environmental samples. In an example of a further class of risk, we recorded poliovirus type 1 in at least four working stocks of what had been identified as various serotypes; of human rhinovirus. This finding emphasises the need to urgently assess the possibility of presence of poliovirus, even in apparently well-characterised stocks of other viruses, to screen for the virus where necessary, and to destroy materials in which risk outweighs potential benefit.	Publ Hlth Lab Serv, Ctr Appl Microbiol & Res, Natl Collect Pathogen Viruses, Salisbury SP4 0JG, Wilts, England		Clegg, C (corresponding author), Publ Hlth Lab Serv, Ctr Appl Microbiol & Res, Natl Collect Pathogen Viruses, Porton Down, Salisbury SP4 0JG, Wilts, England.			Bewley, Kevin/0000-0002-9078-6734				Dove AW, 1997, SCIENCE, V277, P779, DOI 10.1126/science.277.5327.779; Minor PD, 2001, LANCET, V358, P166, DOI 10.1016/S0140-6736(01)05399-5; MULDERS MN, 1995, J INFECT DIS, V171, P1399, DOI 10.1093/infdis/171.6.1399; Savolainen C, 2002, J GEN VIROL, V83, P333, DOI 10.1099/0022-1317-83-2-333; *WHO DEP VACC BIOL, 1999, WHOVB9932 DEP VACC B	5	15	17	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 5	2003	361	9364					1187	1188		10.1016/S0140-6736(03)12919-4	http://dx.doi.org/10.1016/S0140-6736(03)12919-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	664ZF	12686044				2022-12-24	WOS:000182094600015
J	Roper, C; Pearce, R; Bredenkamp, B; Gumede, J; Drakeley, C; Mosha, F; Chandramohan, D; Sharp, B				Roper, C; Pearce, R; Bredenkamp, B; Gumede, J; Drakeley, C; Mosha, F; Chandramohan, D; Sharp, B			Antifolate antimalarial resistance in southeast Africa: a population-based analysis	LANCET			English	Article							PLASMODIUM-FALCIPARUM MALARIA; DIHYDROPTEROATE SYNTHASE; DIHYDROFOLATE-REDUCTASE; SULFADOXINE-PYRIMETHAMINE; POINT MUTATION; SYNTHETASE; FAILURE; MARKERS	Background Sulfadoxine-pyrimethamine was first introduced for treatment of malaria in Africa during the early 1980s for cases when chloroquine treatment failed, and has since become the first-line treatment in many countries. Resistance to sulfadoxine-pyrimethamine is now increasing, especially in southeast Africa. Methods We characterised genetic change in dhfr and dhps genes in the Plasmodium falciparum population of KwaZulu-Natal, South Africa, during 1995-99, a period of rapid deterioration of the effectiveness of sulfadoxine-pyrimethamine. We assessed the evolutionary origin of the resistance by analysing polymorphic microsatellite repeats in the flanking region of the dhfr and dhps genes, which show whether resistance alleles originated through shared or independent ancestral mutation events. We then assessed the current extent of dispersal of dhfr and dhps resistance alleles by doing the same analysis in P falciparum sampled from communities in the Kilimanjaro region of northern Tanzania in 2001. Findings The large genetic change during 1995-99 in KwaZulu-Natal, South Africa, in both the health facility and the wider community surveys, was at the dhps locus, apparently because resistance at dhfr was established before 1995. The allelic determinants of resistance in this province share a common evolutionary origin with those found in Kilimanjaro, Tanzania, even though the two sites are 4000 km apart. Interpretation Three resistant dhfr alleles, and one resistant dhps allele, each derived from independent ancestral lineages, have been driven through through southeast Africa. The movement by the dhfr alleles (pyrimethamine resistance) preceded that of the dhps allele (sulfadoxine resistance). Our findings emphasise that gene flow rather than new mutations has been the most common originator of resistance in African countries.	Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Med, London WC1E 7HT, England; MRC, Malaria Res Lead Programme, ZA-4067 Durban, South Africa; Dept Hlth, Malaria Control Programme, Kwa Zulu, South Africa; Kilimanjaro Christian Med Ctr, Joint Malaria Programme, Moshi, Tanzania	University of London; London School of Hygiene & Tropical Medicine; Kilimanjaro Christian Medical Centre	Roper, C (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Med, Keppel St, London WC1E 7HT, England.	Cally.Roper@lshtm.ac.uk	Roper, Cally/K-2989-2013	Roper, Cally/0000-0002-6545-309X				Bahl A, 2002, NUCLEIC ACIDS RES, V30, P87, DOI 10.1093/nar/30.1.87; Bredenkamp BLF, 2001, SAMJ S AFR MED J, V91, P970; Clyde David F, 1967, MALARIA TANZANIA; Cortese JF, 2002, J INFECT DIS, V186, P999, DOI 10.1086/342946; COWMAN AF, 1988, P NATL ACAD SCI USA, V85, P9109, DOI 10.1073/pnas.85.23.9109; Curtis J, 1998, J INFECT DIS, V177, P1429, DOI 10.1086/517831; HARTL DL, 1997, PRINCIPLES POPULATIO, P430; Hastings IM, 2002, PHILOS T ROY SOC B, V357, P505, DOI 10.1098/rstb.2001.1036; JONES AS, 1958, T R SOC TROP MED HYG, V52, P547; Kublin JG, 1998, LANCET, V351, P1629, DOI 10.1016/S0140-6736(98)24022-0; Kublin JG, 2002, J INFECT DIS, V185, P380, DOI 10.1086/338566; Marsh K, 1998, LANCET, V352, P924, DOI 10.1016/S0140-6736(05)61510-3; Mberu EK, 2000, AM J TROP MED HYG, V62, P396, DOI 10.4269/ajtmh.2000.62.396; Nzila AM, 2000, J INFECT DIS, V181, P2023, DOI 10.1086/315520; Omar SA, 2001, T ROY SOC TROP MED H, V95, P315, DOI 10.1016/S0035-9203(01)90250-0; Paget-McNicol S, 2001, PARASITOLOGY, V122, P497, DOI 10.1017/S0031182001007739; PAYNE D, 1988, PARASITOL TODAY, V4, P112, DOI 10.1016/0169-4758(88)90042-7; Pearce RJ, 2003, ANTIMICROB AGENTS CH, V47, P1347, DOI 10.1128/AAC.47.4.1347-1354.2003; PETERSON DS, 1988, P NATL ACAD SCI USA, V85, P9114, DOI 10.1073/pnas.85.23.9114; Plowe CV, 1997, J INFECT DIS, V176, P1590, DOI 10.1086/514159; Sims P, 1998, PARASITOL TODAY, V14, P136, DOI 10.1016/S0169-4758(97)01203-9; Su XZ, 1996, GENOMICS, V33, P430, DOI 10.1006/geno.1996.0218; Su XZ, 1997, CELL, V91, P593, DOI 10.1016/S0092-8674(00)80447-X; Triglia T, 1997, P NATL ACAD SCI USA, V94, P13944, DOI 10.1073/pnas.94.25.13944; Triglia T, 1998, EMBO J, V17, P3807, DOI 10.1093/emboj/17.14.3807; Wang P, 1997, MOL BIOCHEM PARASIT, V89, P161, DOI 10.1016/S0166-6851(97)00114-X; White NJ, 1999, LANCET, V353, P1965, DOI 10.1016/S0140-6736(98)07367-X; Wootton JC, 2002, NATURE, V418, P320, DOI 10.1038/nature00813; Wu YM, 1996, P NATL ACAD SCI USA, V93, P1130, DOI 10.1073/pnas.93.3.1130	29	243	244	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 5	2003	361	9364					1174	1181		10.1016/S0140-6736(03)12951-0	http://dx.doi.org/10.1016/S0140-6736(03)12951-0			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	664ZF	12686039				2022-12-24	WOS:000182094600010
J	Allan, DW; St Pierre, SE; Miguel-Aliaga, I; Thor, S				Allan, DW; St Pierre, SE; Miguel-Aliaga, I; Thor, S			Specification of neuropeptide cell identity by the integration of retrograde BMP signaling and a combinatorial transcription factor code	CELL			English	Article							BONE MORPHOGENETIC PROTEINS; GROWTH CONE GUIDANCE; ZINC-FINGER PROTEIN; DROSOPHILA-MELANOGASTER; CAENORHABDITIS-ELEGANS; SYMPATHETIC NEURONS; PATHWAY SELECTION; NERVOUS-SYSTEM; GENE; EXPRESSION	Individual neurons express only one or a few of the many identified neurotransmitters; and neuropeptides, but the molecular mechanisms controlling their selection are poorly understood. In the Drosophila ventral nerve cord, the six Tv neurons express the neuropeptide gene FMRFamide. Each Tv neuron resides within a neuronal cell group specified by the LIM-homeodomain gene apterous. We find that the zinc-finger gene squeeze acts in Tv cells to promote their unique axon pathfinding to a peripheral target. There, the BMP ligand Glass bottom boat activates the Wishful thinking receptor, initiating a retrograde BMP signal in the Tv neuron. This signal acts together with apterous and squeeze to activate FMRFamide expression. Reconstituting this "code," by combined BMP activation and apterous/squeeze misexpression, triggers ectopic FMRFamide expression in peptidergic neurons. Thus, an intrinsic transcription factor code integrates with an extrinsic retrograde signal to select a specific neuropeptide identity within peptidergic cells.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Thor, S (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.		Thor, Stefan/Y-5804-2019	Thor, Stefan/0000-0001-5095-541X; Miguel-Aliaga, Irene/0000-0002-1082-5108	NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH020017] Funding Source: NIH RePORTER; NIMH NIH HHS [TG T32MH20017] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Aberle H, 2002, NEURON, V33, P545, DOI 10.1016/S0896-6273(02)00589-5; Ai XB, 1999, MOL CELL NEUROSCI, V14, P506, DOI 10.1006/mcne.1999.0798; Allen MJ, 1999, J NEUROSCI, V19, P9374; Barolo S, 2002, GENE DEV, V16, P1167, DOI 10.1101/gad.976502; Benveniste RJ, 1998, DEVELOPMENT, V125, P4757; CHIN AC, 1990, DNA CELL BIOL, V9, P263, DOI 10.1089/dna.1990.9.263; DOCTOR JS, 1992, DEV BIOL, V151, P491, DOI 10.1016/0012-1606(92)90188-M; Dorfman R, 2001, DEVELOPMENT, V128, P965; Duggan Anne, 1995, Current Opinion in Neurobiology, V5, P6, DOI 10.1016/0959-4388(95)80080-8; Edlund T, 1999, CELL, V96, P211, DOI 10.1016/S0092-8674(00)80561-9; Ernsberger U, 1999, CELL TISSUE RES, V297, P339, DOI 10.1007/s004410051363; Finley KD, 1998, NEURON, V21, P1363, DOI 10.1016/S0896-6273(00)80655-8; GORCZYCA MG, 1994, DEVELOPMENT, V120, P2143; Haerry TE, 1998, DEVELOPMENT, V125, P3977; Hall AK, 2002, J NEUROBIOL, V52, P52, DOI 10.1002/neu.10068; Hewes RS, 2003, DEVELOPMENT, V130, P1771, DOI 10.1242/dev.00404; Hokfelt T, 2000, NEUROPHARMACOLOGY, V39, P1337, DOI 10.1016/S0028-3908(00)00010-1; Jarecki J, 1995, J NEUROSCI, V15, P8177; Kaufmann N, 1998, DEVELOPMENT, V125, P453; Keleman K, 2001, NEURON, V32, P605, DOI 10.1016/S0896-6273(01)00505-0; Khalsa O, 1998, DEVELOPMENT, V125, P2723; Kolhekar AS, 1997, J NEUROSCI, V17, P1363, DOI 10.1523/jneurosci.17-04-01363.1997; Koo SJ, 2002, NEURON, V35, P823, DOI 10.1016/S0896-6273(02)00870-X; Landis SC, 1996, PERSPECT DEV NEUROBI, V4, P53; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; LUNDGREN SE, 1995, DEVELOPMENT, V121, P1769; Luo LQ, 1997, CURR OPIN NEUROBIOL, V7, P81, DOI 10.1016/S0959-4388(97)80124-9; Massague J, 2000, GENE DEV, V14, P627; Nakamoto T, 2000, MOL CELL BIOL, V20, P1649, DOI 10.1128/MCB.20.5.1649-1658.2000; Nassel DR, 1996, CURR OPIN NEUROBIOL, V6, P842, DOI 10.1016/S0959-4388(96)80036-5; Nassel DR, 1996, PROG NEUROBIOL, V48, P325, DOI 10.1016/0301-0082(95)00048-8; NASSEL DR, 1988, J COMP NEUROL, V267, P343, DOI 10.1002/cne.902670305; O'Brien MA, 1998, J EXP BIOL, V201, P193; O'Keefe DD, 1998, DEVELOPMENT, V125, P3915; OLSON PF, 1990, EMBO J, V9, P1219, DOI 10.1002/j.1460-2075.1990.tb08229.x; PANGANIBAN GEF, 1990, DEVELOPMENT, V110, P1041; PEARSE AGE, 1980, CLIN ENDOCRINOL META, V9, P211, DOI 10.1016/S0300-595X(80)80030-2; Perrimon N, 1996, GENETICS, V144, P1681; Raftery LA, 1999, DEV BIOL, V210, P251, DOI 10.1006/dbio.1999.9282; ROUGVIE AE, 1995, DEVELOPMENT, V121, P2491; SCHNEIDER LE, 1993, J COMP NEUROL, V337, P446, DOI 10.1002/cne.903370308; SCHNEIDER LE, 1993, NEURON, V10, P279, DOI 10.1016/0896-6273(93)90318-L; SEEGER M, 1993, NEURON, V10, P409, DOI 10.1016/0896-6273(93)90330-T; Skeath JB, 2003, CURR OPIN NEUROBIOL, V13, P8, DOI 10.1016/S0959-4388(03)00007-2; Spradling AC, 1999, GENETICS, V153, P135; St Pierre SE, 2002, DEVELOPMENT, V129, P1273; Taghert PH, 1999, MICROSC RES TECHNIQ, V45, P80, DOI 10.1002/(SICI)1097-0029(19990415)45:2<80::AID-JEMT3>3.0.CO;2-X; Tanimoto H, 2000, MOL CELL, V5, P59, DOI 10.1016/S1097-2765(00)80403-7; THOR S, 1991, NEURON, V7, P881, DOI 10.1016/0896-6273(91)90334-V; Thor S, 1999, NATURE, V397, P76, DOI 10.1038/16275; Torroja L, 1999, CURR BIOL, V9, P489, DOI 10.1016/S0960-9822(99)80215-2; Zhao HJ, 2000, DEVELOPMENT, V127, P1253	52	131	135	0	10	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 4	2003	113	1					73	86		10.1016/S0092-8674(03)00204-6	http://dx.doi.org/10.1016/S0092-8674(03)00204-6			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	668GX	12679036	Bronze			2022-12-24	WOS:000182282900008
J	Nichol, KL; Nordin, J; Mullooly, J; Lask, R; Fillbrandt, K; Iwane, M				Nichol, KL; Nordin, J; Mullooly, J; Lask, R; Fillbrandt, K; Iwane, M			Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							EXCESS MORTALITY; RISK-FACTOR; PREVENTING HOSPITALIZATION; PRECEDING INFECTION; COST-EFFECTIVENESS; BRAIN INFARCTION; REDUCED RISK; ASSOCIATION; EPIDEMIC; ADMISSIONS	BACKGROUND: Upper respiratory tract illnesses have been associated with an increased risk of ischemic heart disease and stroke. During two influenza seasons, we assessed the influence of vaccination against influenza on the risk of hospitalization for heart disease and stroke, hospitalization for pneumonia and influenza, and death from all causes. METHODS: Cohorts of community-dwelling members of three large managed-care organizations who were at least 65 years old were studied during the 1998-1999 and 1999-2000 influenza seasons. Administrative and clinical data were used to evaluate outcomes, with multivariable logistic regression to control for base-line demographic and health characteristics of the subjects. RESULTS: There were 140,055 subjects in the 1998-1999 cohort and 146,328 in the 1999-2000 cohort, of which 55.5 percent and 59.7 percent, respectively, were immunized. At base line, vaccinated subjects were on average sicker, having higher rates of most coexisting conditions, outpatient care, and prior hospitalization for pneumonia than unvaccinated subjects. Unvaccinated subjects, however, were more likely to have been given a prior diagnosis of dementia or stroke. Vaccination against influenza was associated with a reduction in the risk of hospitalization for cardiac disease (reduction of 19 percent during both seasons [P<0.001]), cerebrovascular disease (reduction of 16 percent during the 1998-1999 season [P<0.018] and 23 percent during the 1999-2000 season [P<0.001]), and pneumonia or influenza (reduction of 32 percent during the 1998-1999 season [P<0.001] and 29 percent during the 1999-2000 season [P<0.001]) and a reduction in the risk of death from all causes (reduction of 48 percent during the 1998-1999 season [P<0.001] and 50 percent during the 1999-2000 season [P<0.001]). In analyses according to age, the presence or absence of major medical conditions at base line, and study site, the findings were consistent across all subgroups. CONCLUSIONS: In the elderly, vaccination against influenza is associated with reductions in the risk of hospitalization for heart disease, cerebrovascular disease, and pneumonia or influenza as well as the risk of death from all causes during influenza seasons. These findings highlight the benefits of vaccination and support efforts to increase the rates of vaccination among the elderly.	Vet Affairs Med Ctr, Minneapolis, MN 55417 USA; Univ Minnesota, Minneapolis, MN USA; HealthPartners Res Fdn, Minneapolis, MN USA; Kaiser Permanente NW, Portland, OR USA; Oxford Hlth Plan, New York, NY USA; Ctr Dis Control & Prevent, Atlanta, GA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; University of Minnesota System; University of Minnesota Twin Cities; HealthPartners Institute for Education & Research; Kaiser Permanente; UnitedHealth Group Incorporated; Centers for Disease Control & Prevention - USA	Nichol, KL (corresponding author), Vet Affairs Med Ctr, 1 Vet Dr, Minneapolis, MN 55417 USA.	nicho014@umn.edu		Nordin, James/0000-0002-3359-5843				*ADV COMM IMM PRAC, 2002, MMWR-MORBID MORTAL W, V51, P1; AHMED AEH, 1995, LANCET, V346, P591, DOI 10.1016/S0140-6736(95)91434-X; Ahmed AH, 1997, EPIDEMIOL INFECT, V118, P27, DOI 10.1017/S0950268896007121; ALLING DW, 1981, AM J EPIDEMIOL, V113, P30, DOI 10.1093/oxfordjournals.aje.a113063; [Anonymous], 1997, MMWR MORB MORT WKLY, V46, P1; BAINTON D, 1978, INT J EPIDEMIOL, V7, P231, DOI 10.1093/ije/7.3.231; Becher H, 2000, J Epidemiol Biostat, V5, P277; Bova IY, 1996, STROKE, V27, P2204, DOI 10.1161/01.STR.27.12.2204; *CDCP, 2002, EARL REL SEL EST NAT; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P374; Centers for Disease Control and Prevention (CDC), 2000, MMWR Morb Mortal Wkly Rep, V49, P375; COLLINS S. D., 1932, Public Health Reports, V47, P2159, DOI 10.2307/4580606; COOK RJ, 1995, BRIT MED J, V310, P1056; Crocetti E, 2001, EUR J EPIDEMIOL, V17, P163, DOI 10.1023/A:1017978420601; *DEP HLTH HUM SERV, 2000, HLTH PEOPL 2010, V1; EICKHOFF TC, 1961, JAMA-J AM MED ASSOC, V176, P776, DOI 10.1001/jama.1961.03040220024005; EPSEIN SE, 1999, CIRCULATION, V100, pE20; FEDSON DS, 1994, JAMA-J AM MED ASSOC, V271, P1578; Fleming DM, 1995, EPIDEMIOL INFECT, V115, P581, DOI 10.1017/S095026880005874X; FOSTER DA, 1992, AM J EPIDEMIOL, V136, P296, DOI 10.1093/oxfordjournals.aje.a116495; Gurfinkel EP, 2002, CIRCULATION, V105, P2143, DOI 10.1161/01.CIR.0000016182.85461.F4; Hak E, 2002, CLIN INFECT DIS, V35, P370, DOI 10.1086/341403; HOUSWORTH J, 1974, AM J EPIDEMIOL, V100, P40, DOI 10.1093/oxfordjournals.aje.a112007; Jackson LA, 2002, AM J EPIDEMIOL, V156, P634, DOI 10.1093/aje/kwf073; Jakovljevic D, 1996, STROKE, V27, P1774, DOI 10.1161/01.STR.27.10.1774; Lavallee P, 2002, STROKE, V33, P1172; Lavallee P, 2002, STROKE, V33, P513, DOI 10.1161/hs0202.102328; Mac Donald R, 1999, AM J PREV MED, V16, P173, DOI 10.1016/S0749-3797(98)00159-7; Macko RF, 1996, STROKE, V27, P1999, DOI 10.1161/01.STR.27.11.1999; MATTILA KJ, 1989, J INTERN MED, V225, P293, DOI 10.1111/j.1365-2796.1989.tb00084.x; Meier CR, 1998, LANCET, V351, P1467, DOI 10.1016/S0140-6736(97)11084-4; MULLOOLY JP, 1994, ANN INTERN MED, V121, P947, DOI 10.7326/0003-4819-121-12-199412150-00008; Naghavi M, 2000, CIRCULATION, V102, P3039; Nichol KL, 2001, ARCH INTERN MED, V161, P2702, DOI 10.1001/archinte.161.22.2702; Nichol KL, 1998, ARCH INTERN MED, V158, P1769, DOI 10.1001/archinte.158.16.1769; NICHOL KL, 1994, NEW ENGL J MED, V331, P778, DOI 10.1056/NEJM199409223311206; NICHOL KL, 1998, TXB INFLUENZA, P358; Nordin J, 2001, J INFECT DIS, V184, P665, DOI 10.1086/323085; Ohmit SE, 1995, INT J EPIDEMIOL, V24, P1240, DOI 10.1093/ije/24.6.1240; PuigBarbera J, 1997, J EPIDEMIOL COMMUN H, V51, P526, DOI 10.1136/jech.51.5.526; Siscovick DS, 2000, AM J EPIDEMIOL, V152, P674, DOI 10.1093/aje/152.7.674; SPODICK DH, 1984, AM J CARDIOL, V53, P481, DOI 10.1016/0002-9149(84)90016-X; Stamboulian D, 1999, VACCINE, V17, pS53, DOI 10.1016/S0264-410X(99)00106-1; SYRJANEN J, 1988, BRIT MED J, V296, P1156, DOI 10.1136/bmj.296.6630.1156; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; VALTONEN VV, 1991, ANN MED, V23, P539, DOI 10.3109/07853899109150515; Vu T, 2002, VACCINE, V20, P1831, DOI 10.1016/S0264-410X(02)00041-5	47	562	596	1	23	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 3	2003	348	14					1322	1332		10.1056/NEJMoa025028	http://dx.doi.org/10.1056/NEJMoa025028			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	662LW	12672859				2022-12-24	WOS:000181949100003
J	Jodar, L; LaForce, FM; Ceccarini, C; Aguado, T; Granoff, DM				Jodar, L; LaForce, FM; Ceccarini, C; Aguado, T; Granoff, DM			Meningococcal conjugate vaccine for Africa: a model for development of new vaccines for the poorest countries	LANCET			English	Editorial Material									WHO, CH-1211 Geneva, Switzerland; Programme Appropriate Technol Hlth, Ferney Voltaire, France; Childrens Hosp Oakland, Res Inst, Oakland, CA 94609 USA	World Health Organization; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland	Jodar, L (corresponding author), Int Vaccine Inst, Bldg 81,SNU Campus, Seoul 151600, South Korea.				NIAID NIH HHS [AI46464, R01 AI 45642] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046464, R01AI045642] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Greenwood B, 1999, T ROY SOC TROP MED H, V93, P341, DOI 10.1016/S0035-9203(99)90106-2; LEVINE MM, 1997, NEW GENERATION VACCI, P489; Ramsay ME, 2001, LANCET, V357, P195, DOI 10.1016/S0140-6736(00)03594-7; Sanchez JL, 1997, LANCET, V349, P1825, DOI 10.1016/S0140-6736(97)04486-3; Wenger J, 2001, VACCINE, V19, P1588, DOI 10.1016/S0264-410X(00)00356-X; *WHO, WHOV B0134; Wittet S, 2000, VACCINE, V19, P385, DOI 10.1016/S0264-410X(00)00196-1; 2002, WKLY EPIDEMIOL REC, V18, P152; 2001, WYETH ANN REPORTS; 1997, WKLY EPIDEMIOL REC, V72, P313; 2000, WYETH ANN REPORTS	11	72	73	0	6	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 31	2003	361	9372					1902	1904		10.1016/S0140-6736(03)13494-0	http://dx.doi.org/10.1016/S0140-6736(03)13494-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	684KL	12788589				2022-12-24	WOS:000183205800026
J	Mitsui, K; Tokuzawa, Y; Itoh, H; Segawa, K; Murakami, M; Takahashi, K; Maruyama, M; Maeda, M; Yamanaka, S				Mitsui, K; Tokuzawa, Y; Itoh, H; Segawa, K; Murakami, M; Takahashi, K; Maruyama, M; Maeda, M; Yamanaka, S			The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells	CELL			English	Article							EMBRYONIC STEM-CELLS; LEUKEMIA INHIBITORY FACTOR; TRANSCRIPTION FACTOR; TARGETED DISRUPTION; SELF-RENEWAL; HUMAN BLASTOCYSTS; GENE; DIFFERENTIATION; EXPRESSION; STAT3	Embryonic stem (ES) cells derived from the inner cell mass (ICM) of blastocysts grow infinitely while maintaining pluripotency. Leukemia inhibitory factor (LIF) can maintain self-renewal of mouse ES cells through activation of Stat3. However, LIF/Stat3 is dispensable for maintenance of ICM and human ES cells, suggesting that the pathway is not fundamental for pluripotency. In search of a critical factor(s) that underlies pluripotency in both ICM and ES cells, we performed in silico differential display and identified several genes specifically expressed in mouse ES cells and preimplantation embryos. We found that one of them, encoding the homeoprotein Nanog, was capable of maintaining ES cell self-renewal independently of LIF/Stat3. nanog-deficient ICM failed to generate epiblast and only produced parietal endoderm-like cells. nanog-deficient ES cells lost pluripotency and differentiated into extraembryonic endoderm lineage. These data demonstrate that Nanog is a critical factor underlying pluripotency in both ICM and ES cells.	Nara Inst Sci & Technol, Lab Anim Mol Technol, Res & Educ Ctr Genet Informat, Nara 6300192, Japan; Osaka City Univ, Sch Med, Dept Anat 1, Osaka 5458585, Japan	Nara Institute of Science & Technology; Osaka Metropolitan University	Yamanaka, S (corresponding author), Nara Inst Sci & Technol, Lab Anim Mol Technol, Res & Educ Ctr Genet Informat, Nara 6300192, Japan.	shinyay@gtc.aist-nara-ac.jp	Takahashi, Kazutoshi/ABE-5504-2020; Mitsui, Kaoru/E-1464-2011	Takahashi, Kazutoshi/0000-0002-5329-8395; Mitsui, Kaoru/0000-0003-0534-9845				Aubert J, 2002, NAT BIOTECHNOL, V20, P1240, DOI 10.1038/nbt763; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Ben-Shushan E, 1998, MOL CELL BIOL, V18, P1866, DOI 10.1128/MCB.18.4.1866; Berger CN, 1997, GROWTH FACTORS, V14, P145, DOI 10.3109/08977199709021517; Burdon T, 2002, TRENDS CELL BIOL, V12, P432, DOI 10.1016/S0962-8924(02)02352-8; Colman A, 2001, EMBO REP, V2, P2, DOI 10.1093/embo-reports/kve017; Dani C, 1998, DEV BIOL, V203, P149, DOI 10.1006/dbio.1998.9026; Ernst M, 1996, J BIOL CHEM, V271, P30136, DOI 10.1074/jbc.271.47.30136; Ernst M, 1999, J BIOL CHEM, V274, P9729, DOI 10.1074/jbc.274.14.9729; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Fan Y, 1999, DEV BIOL, V210, P481, DOI 10.1006/dbio.1999.9279; Fujikura J, 2002, GENE DEV, V16, P784, DOI 10.1101/gad.968802; GASSMANN M, 1995, P NATL ACAD SCI USA, V92, P1292, DOI 10.1073/pnas.92.5.1292; Guo Y, 2002, P NATL ACAD SCI USA, V99, P3663, DOI 10.1073/pnas.062041099; Hanna LA, 2002, GENE DEV, V16, P2650, DOI 10.1101/gad.1020502; Harvey RP, 1996, DEV BIOL, V178, P203, DOI 10.1006/dbio.1996.0212; Ihle JN, 1996, CELL, V84, P331, DOI 10.1016/S0092-8674(00)81277-5; Jackson M, 2002, J BIOL CHEM, V277, P38683, DOI 10.1074/jbc.M203459200; Kuo CT, 1997, GENE DEV, V11, P1048, DOI 10.1101/gad.11.8.1048; Lachmann P, 2001, EMBO REP, V2, P165, DOI 10.1093/embo-reports/kve053; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; LI M, 1995, NATURE, V378, P724, DOI 10.1038/378724a0; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Matsuda T, 1999, EMBO J, V18, P4261, DOI 10.1093/emboj/18.15.4261; Meiner VL, 1996, P NATL ACAD SCI USA, V93, P14041, DOI 10.1073/pnas.93.24.14041; Mieth D, 2000, EMBO REP, V1, P4, DOI 10.1093/embo-reports/kvd020; Molkentin JD, 2000, DEV BIOL, V217, P301, DOI 10.1006/dbio.1999.9544; Morrison B, 1998, SWINE HEALTH PROD, V6, P4; MOUNTFORD P, 1994, P NATL ACAD SCI USA, V91, P4303, DOI 10.1073/pnas.91.10.4303; Nakajima K, 1996, EMBO J, V15, P3651, DOI 10.1002/j.1460-2075.1996.tb00734.x; NICHOLS J, 1990, DEVELOPMENT, V110, P1341; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Nichols J, 2001, DEVELOPMENT, V128, P2333; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 2002, MOL CELL BIOL, V22, P1526, DOI 10.1128/MCB.22.5.1526-1536.2002; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; OKAMOTO K, 1990, CELL, V60, P461, DOI 10.1016/0092-8674(90)90597-8; Okuda A, 1998, EMBO J, V17, P2019, DOI 10.1093/emboj/17.7.2019; PALMIERI SL, 1994, DEV BIOL, V166, P259, DOI 10.1006/dbio.1994.1312; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Raz R, 1999, P NATL ACAD SCI USA, V96, P2846, DOI 10.1073/pnas.96.6.2846; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; ROGERS MB, 1991, DEVELOPMENT, V113, P815; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; SCHOLER HR, 1990, EMBO J, V9, P2185, DOI 10.1002/j.1460-2075.1990.tb07388.x; Smith A, 1998, CURR BIOL, V8, pR802, DOI 10.1016/S0960-9822(07)00504-0; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; STEWART CL, 1992, NATURE, V359, P76, DOI 10.1038/359076a0; Sun-Wada GH, 2000, J BIOCHEM-TOKYO, V127, P703, DOI 10.1093/oxfordjournals.jbchem.a022660; Takahashi K, 2003, NATURE, V423, P541, DOI 10.1038/nature01646; Takeda K, 1997, P NATL ACAD SCI USA, V94, P3801, DOI 10.1073/pnas.94.8.3801; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tokuzawa Y, 2003, MOL CELL BIOL, V23, P2699, DOI 10.1128/MCB.23.8.2699-2708.2003; Wang SH, 2003, GENE EXPR PATTERNS, V3, P99, DOI 10.1016/S1567-133X(03)00005-X; WARE CB, 1995, DEVELOPMENT, V121, P1283; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; Yamanaka S, 2000, EMBO J, V19, P5533, DOI 10.1093/emboj/19.20.5533; Yamanaka S, 1998, GENOMICS, V54, P191, DOI 10.1006/geno.1998.5561; Yoshida K, 1996, P NATL ACAD SCI USA, V93, P407, DOI 10.1073/pnas.93.1.407; YUAN HB, 1995, GENE DEV, V9, P2635, DOI 10.1101/gad.9.21.2635	60	2382	2660	10	287	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 30	2003	113	5					631	642		10.1016/S0092-8674(03)00393-3	http://dx.doi.org/10.1016/S0092-8674(03)00393-3			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	687VL	12787504	Bronze			2022-12-24	WOS:000183397600013
J	Turner-Stokes, L				Turner-Stokes, L			Poststroke depression: getting the full picture	LANCET			English	Editorial Material							LESION LOCATION; STROKE PATIENTS; MOOD DISORDERS; BRAIN INJURY		Northwick Pk Hosp & Clin Res Ctr, Acad Dept Rehabil, Reg Rehabil Unit, Harrow HA1 3UJ, Middx, England; Univ London Kings Coll, Harrow HA1 3UJ, Middx, England	Imperial College London; University of London; King's College London	Turner-Stokes, L (corresponding author), Northwick Pk Hosp & Clin Res Ctr, Acad Dept Rehabil, Reg Rehabil Unit, Harrow HA1 3UJ, Middx, England.		Turner-Stokes, Lynne/F-4418-2012	Turner-Stokes, Lynne/0000-0002-3302-9462				Aben I, 2003, J NEUROL NEUROSUR PS, V74, P581, DOI 10.1136/jnnp.74.5.581; ANDERSEN G, 1994, STROKE, V25, P1099, DOI 10.1161/01.STR.25.6.1099; Gainotti G, 1997, STROKE, V28, P2145, DOI 10.1161/01.STR.28.11.2145; Gordon A, 2001, HOSP PRACT, V36, P71, DOI 10.3810/hp.2001.03.232; Hassan N, 2002, CLIN REHABIL, V16, P534, DOI 10.1191/0269215502cr523oa; HERRMANN M, 1995, STROKE, V26, P850, DOI 10.1161/01.STR.26.5.850; HOUSE A, 1990, BRAIN, V113, P1113, DOI 10.1093/brain/113.4.1113; ROBINS AH, 1976, J CHRON DIS, V29, P479, DOI 10.1016/0021-9681(76)90088-6; ROBINSON RG, 1981, ANN NEUROL, V9, P447, DOI 10.1002/ana.410090506; SHARPE M, 1990, PSYCHOL MED, V20, P815, DOI 10.1017/S0033291700036503; Singh A, 1998, CAN J PSYCHIAT, V43, P921, DOI 10.1177/070674379804300907; Staley JK, 1998, BIOL PSYCHIAT, V44, P534, DOI 10.1016/S0006-3223(98)00185-1; STARKSTEIN SE, 1987, BRAIN, V110, P1045, DOI 10.1093/brain/110.4.1045; STARKSTEIN SE, 1988, ARCH NEUROL-CHICAGO, V45, P725, DOI 10.1001/archneur.1988.00520310031013; Sutcliffe LM, 1998, CLIN REHABIL, V12, P506, DOI 10.1191/026921598672167702; Turner-Stokes L, 2003, CLIN REHABIL, V17, P150, DOI 10.1191/0269215503cr595oa	16	18	20	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 24	2003	361	9371					1757	1758						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	682CY	12781530				2022-12-24	WOS:000183074800003
J	Rathore, SS; Foody, JM; Wang, YF; Smith, GL; Herrin, J; Masoudi, FA; Wolfe, P; Havranek, EP; Ordin, DL; Krumholz, HM				Rathore, SS; Foody, JM; Wang, YF; Smith, GL; Herrin, J; Masoudi, FA; Wolfe, P; Havranek, EP; Ordin, DL; Krumholz, HM			Race, quality of care, and outcomes of elderly patients hospitalized with heart failure	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE MYOCARDIAL-INFARCTION; PATIENTS GREATER-THAN-OR-EQUAL-TO-65 YEARS; ENZYME-INHIBITOR THERAPY; RACIAL-DIFFERENCES; UNITED-STATES; HEALTH-CARE; MEDICARE; READMISSION; MORTALITY; SURVIVAL	Context Black patients hospitalized with heart failure reportedly receive poorer quality of care and have worse outcomes than white patients. Because previous studies have been based on selected patient populations treated more than a decade ago, it is unclear if racial differences in quality of care and outcomes currently exist in the United States. Objective To evaluate differences in quality of care and patient outcomes between black and white Medicare beneficiaries hospitalized with heart failure. Design Retrospective analysis of medical record data systematically collected for the National Heart Failure Project. Setting and Patients Nationwide US sample of 29732 fee-for-service Medicare beneficiaries hospitalized with heart failure in 1998 and 1999. Main Outcome Measures Prescription of angiotensin-converting enzyme (ACE) inhibitors, measurement of left ventricular ejection fraction (LVEF), readmission within 1 year of discharge, and mortality within 30 days and 1 year of admission. Results Black patients and white patients had similar crude rates of LVEF assessment (67.8% black vs 66.6% white; P=.29). Among patients classified as ideal for ACE inhibitor use, black patients had higher crude rates of ACE inhibitor use than white patients (81.0% vs 73.8% white; P<.001) but had similar rates of ACE inhibitor or angiotensin receptor blocker (ARB) use (85.7% black vs 82.5% white; P=.08). After multivariable adjustment, black patients had comparable rates of LVEF assessment (risk ratio [RR], 0.99; 95% confidence interval [CI], 0.95-1.03). Black patients remained more likely to be prescribed ACE inhibitors (RR, 1.22; 95% CI, 1.14-1.28) than were white patients in an adjusted analysis, but there were no significant racial differences in the prescription of ACE inhibitors or ARBs (black vs white, RR, 1.03; 95% CI, 0.97-1.07). Black patients had higher rates of readmission within 1 year of discharge (68.2% vs 63.0%; P<.001) but had lower crude 30-day (6.3% vs 10.7%; P<.001) and 1-year (31.5% vs 40.1%; P<.001) mortality rates than white patients. After multivariable adjustment, black patients had a slightly higher rate of readmission than white patients (RR, 1.09; 95% CI, 1.06-1.13) but remained at lower risk of 30-day mortality (RR, 0.78; 95% CI, 0.68-0.91) and 1-year mortality (RR, 0.93; 95% CI, 0.88-0.98). Conclusions Black Medicare patients hospitalized with heart failure received comparable quality of care and had slightly higher rates of readmission but had lower mortality rates up to 1 year after hospitalization than did white patients.	Yale Univ, Sch Med, Dept Internal Med, Sect Cardiovasc Med, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, Sect Hlth Policy & Adm, New Haven, CT 06520 USA; Flying Buttress Associates, Charlottesville, VA USA; Denver Hlth Med Ctr, Dept Med, Div Cardiol, Denver, CO USA; Univ Colorado, Hlth Sci Ctr, Dept Med, Div Geriatr Med, Denver, CO 80262 USA; Univ Colorado, Hlth Sci Ctr, Dept Med, Div Cardiol, Denver, CO 80262 USA; Colorado Fdn Med Care, Aurora, CO USA; Ctr Medicare & Medicaid Serv, Boston, MA USA	Yale University; Yale University; Denver Health Medical Center; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Centers for Medicare & Medicaid Services	Krumholz, HM (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Sect Cardiovasc Med, 333 Cedar St,Room I-456 SHM,POB 208025, New Haven, CT 06520 USA.		, Harlan/AAI-2875-2020; Masoudi, Frederick/Q-7467-2019	Smith, Grace/0000-0002-3171-2911	NIA NIH HHS [K08-AG01011] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [K08AG001011] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Afzal A, 1999, CLIN CARDIOL, V22, P791, DOI 10.1002/clc.4960221207; *AG HEALTHC RES QU, PROGR BRIEF EXC CTR; ALEXANDER M, 1995, JAMA-J AM MED ASSOC, V274, P1037, DOI 10.1001/jama.274.13.1037; Alexander M, 1999, AM HEART J, V137, P919, DOI 10.1016/S0002-8703(99)70417-5; *AM HEART ASS, 2001, 2002 HEART STROK STA; *AM HOSP ASS, 2000, CIRCULATION, V101, pE122; Ayanian JZ, 1999, MED CARE, V37, P1260, DOI 10.1097/00005650-199912000-00009; BOURASSA MG, 1993, J AM COLL CARDIOL, V22, pA14, DOI 10.1016/0735-1097(93)90456-B; Chin MH, 1997, AM J CARDIOL, V79, P1640, DOI 10.1016/S0002-9149(97)00214-2; Croft JB, 1999, ARCH INTERN MED, V159, P505, DOI 10.1001/archinte.159.5.505; Croft JB, 1997, J AM GERIATR SOC, V45, P270, DOI 10.1111/j.1532-5415.1997.tb00939.x; DALEY J, 1988, JAMA-J AM MED ASSOC, V260, P3617, DOI 10.1001/jama.260.24.3617; Dries DL, 2002, J AM COLL CARDIOL, V40, P311, DOI 10.1016/S0735-1097(02)01943-5; Dries DL, 1999, NEW ENGL J MED, V340, P609, DOI 10.1056/NEJM199902253400804; Evangelista LS, 2002, J CARD FAIL, V8, P381, DOI 10.1054/jcaf.2002.129234; Exner DV, 2001, NEW ENGL J MED, V344, P1351, DOI 10.1056/NEJM200105033441802; FLEMING C, 1992, MED CARE, V30, P377, DOI 10.1097/00005650-199205000-00001; GATSONIS CA, 1995, MED CARE, V33, P625, DOI 10.1097/00005650-199506000-00005; GHALI JK, 1988, ARCH INTERN MED, V148, P2013, DOI 10.1001/archinte.148.9.2013; GILLUM RF, 1987, AM HEART J, V113, P1043, DOI 10.1016/0002-8703(87)90077-9; GILLUM RF, 1993, AM HEART J, V126, P1042, DOI 10.1016/0002-8703(93)90738-U; GOLDBERG KC, 1992, JAMA-J AM MED ASSOC, V267, P1473, DOI 10.1001/jama.267.11.1473; Gordon HS, 1996, JAMA-J AM MED ASSOC, V276, P1639, DOI 10.1001/jama.276.20.1639; Hunt SA, 2001, J AM COLL CARDIOL, V38, P2101, DOI 10.1016/S0735-1097(01)01683-7; *I MED, 2002, UN TREATM CONFR RAC; Ibrahim SA, 2003, J GERONTOL A-BIOL, V58, P56; Iglehart JK, 2001, NEW ENGL J MED, V345, P1920, DOI 10.1056/NEJM200112273452617; Jha AK, 2001, JAMA-J AM MED ASSOC, V285, P297, DOI 10.1001/jama.285.3.297; KAHN KL, 1994, JAMA-J AM MED ASSOC, V271, P1169, DOI 10.1001/jama.271.15.1169; Kenward K, 1996, AM J PUBLIC HEALTH, V86, P1481, DOI 10.2105/AJPH.86.10.1481; Krumholz HM, 1997, ARCH INTERN MED, V157, P99, DOI 10.1001/archinte.157.1.99; Luthi JC, 2002, INT J QUAL HEALTH C, V14, P15, DOI 10.1093/intqhc/14.1.15; Masoudi F A, 2000, Congest Heart Fail, V6, P337, DOI 10.1111/j.1527-5299.2000.80175.x; McCullough PA, 2002, J AM COLL CARDIOL, V39, P60, DOI 10.1016/S0735-1097(01)01700-4; OCONNELL JB, 1994, J HEART LUNG TRANSPL, V13, pS107; Philbin EF, 1998, AM J CARDIOL, V82, P76, DOI 10.1016/S0002-9149(98)00233-1; Philbin EF, 2001, AM J CARDIOL, V87, P1367, DOI 10.1016/S0002-9149(01)01554-5; *PRACT MAN INF COR, 1998, INT CLASS DIS 9 REV; Rathore SS, 2003, J AM COLL CARDIOL, V41, p518A; Stafford RS, 1997, ARCH INTERN MED, V157, P2460, DOI 10.1001/archinte.157.21.2460; Sueta CA, 2000, AM J CARDIOL, V86, P1151, DOI 10.1016/S0002-9149(00)01180-2; Sueta CA, 2003, AM J CARDIOL, V91, P363, DOI 10.1016/S0002-9149(02)03173-9; Vaccarino V, 1999, AM HEART J, V138, P835, DOI 10.1016/S0002-8703(99)70007-4; Vaccarino V, 2002, AM HEART J, V143, P1058, DOI 10.1067/mhj.2002.122123; Ventura HO, 2001, J AM COLL CARDIOL, V37, p209A; VINSON JM, 1990, J AM GERIATR SOC, V38, P1290, DOI 10.1111/j.1532-5415.1990.tb03450.x; Wolinsky FD, 1997, MED CARE, V35, P1031, DOI 10.1097/00005650-199710000-00005; Yancy CW, 2001, NEW ENGL J MED, V344, P1358, DOI 10.1056/NEJM200105033441803; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	49	184	185	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 21	2003	289	19					2517	2524		10.1001/jama.289.19.2517	http://dx.doi.org/10.1001/jama.289.19.2517			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	680KL	12759323	Bronze			2022-12-24	WOS:000182976500020
J	Cordenonsi, M; Dupont, S; Maretto, S; Insinga, A; Imbriano, C; Piccolo, S				Cordenonsi, M; Dupont, S; Maretto, S; Insinga, A; Imbriano, C; Piccolo, S			Links between tumor suppressors: p53 is required for TGF-beta gene responses by cooperating with Smads	CELL			English	Article							GROWTH-FACTOR-BETA; P63; EXPRESSION; BINDING; PROTEIN; P73; DIFFERENTIATION; MECHANISM; INDUCER; FORMS	The p53 tumor suppressor belongs to a family of proteins that sense multiple cellular inputs to regulate Cell proliferation, apoptosis, and differentiation. Whether and how these functions of p53 intersect with the activity of extracellular growth factors is not understood. Here, we report that key cellular responses to TGF-beta signals rely on p53 family members. During Xenopus embryonic development, p53 promotes the activation of multiple TGF-beta target genes. Moreover, mesoderm differentiation is inhibited in p53-depleted embryos. In mammalian cells, the full transcriptional activation of the CDK inhibitor p21(WAF1) by TGF-beta requires p53. p53-deficient cells display an impaired cytostatic response to TGF-beta signals. Smad and p53 protein complexes converge on separate cis binding elements on a target promoter and synergistically activate TGF-beta induced transcription. p53 can physically interact in vivo with Smad2 in a TGF-beta-dependent fashion. The results unveil a previously unrecognized link between two primary tumor suppressor pathways in vertebrates.	Univ Padua, Dept Histol Microbiol & Med Biotechnol, Sect Histol & Embryol, I-35121 Padua, Italy; European Inst Oncol, Dept Expt Oncol, I-20141 Milan, Italy; Univ Modena & Reggio Emilia, Dept Biol, I-41100 Modena, Italy	University of Padua; IRCCS European Institute of Oncology (IEO); Universita di Modena e Reggio Emilia	Piccolo, S (corresponding author), Univ Padua, Dept Histol Microbiol & Med Biotechnol, Sect Histol & Embryol, Viale Colombo 3, I-35121 Padua, Italy.	piccolo@civ.bio.unipd.it	Cordenonsi, Michelangelo/K-7692-2016; Imbriano, Carol/C-9376-2015; Imbriano, Carol/ABD-8204-2021; Dupont, Sirio/AAP-8133-2021; Insinga, Alessandra/AAR-9551-2020	Cordenonsi, Michelangelo/0000-0002-8253-5724; Imbriano, Carol/0000-0003-2864-4820; Imbriano, Carol/0000-0003-2864-4820; Insinga, Alessandra/0000-0002-6060-8339; Dupont, Sirio/0000-0002-6869-1966; PICCOLO, STEFANO/0000-0002-2037-0004	Telethon [E.0815] Funding Source: Medline	Telethon(Fondazione Telethon)		Baker JC, 1996, GENE DEV, V10, P1880, DOI 10.1101/gad.10.15.1880; Candia AF, 1997, DEVELOPMENT, V124, P4467; Chen X, 1996, NATURE, V383, P691, DOI 10.1038/383691a0; COX LS, 1994, ONCOGENE, V9, P2951; DATTO MB, 1995, P NATL ACAD SCI USA, V92, P5545, DOI 10.1073/pnas.92.12.5545; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Flores ER, 2002, NATURE, V416, P560, DOI 10.1038/416560a; Fortunel NO, 2000, BLOOD, V96, P2022; Gaiddon C, 2001, MOL CELL BIOL, V21, P1874, DOI 10.1128/MCB.21.5.1874-1887.2001; Gurdon JB, 2001, NATURE, V413, P797, DOI 10.1038/35101500; Hall PA, 2000, CARCINOGENESIS, V21, P153, DOI 10.1093/carcin/21.2.153; Harland R, 1997, ANNU REV CELL DEV BI, V13, P611, DOI 10.1146/annurev.cellbio.13.1.611; HUANG HC, 1995, EMBO J, V14, P5965, DOI 10.1002/j.1460-2075.1995.tb00285.x; KERN SE, 1992, SCIENCE, V256, P827, DOI 10.1126/science.1589764; Lehmann K, 2000, GENE DEV, V14, P2610, DOI 10.1101/gad.181700; Liu B, 2003, BLOOD, V101, P124, DOI 10.1182/blood-2002-02-0398; Lu PF, 2001, MECH DEVELOP, V102, P275, DOI 10.1016/S0925-4773(01)00315-X; MACLEOD KF, 1995, GENE DEV, V9, P935, DOI 10.1101/gad.9.8.935; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Minucci S, 2002, BLOOD, V100, P2989, DOI 10.1182/blood-2001-11-0089; Piccolo S, 1999, NATURE, V397, P707, DOI 10.1038/17820; Prunier C, 2001, MOL CELL BIOL, V21, P3302, DOI 10.1128/MCB.21.10.3302-3313.2001; Qian H, 2002, ONCOGENE, V21, P7901, DOI 10.1038/sj.onc.1205974; Sun BI, 1999, DEVELOPMENT, V126, P1467; Vairapandi M, 1996, ONCOGENE, V12, P2579; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wakefield LM, 2002, CURR OPIN GENET DEV, V12, P22, DOI 10.1016/S0959-437X(01)00259-3; Whitman M, 2001, DEV CELL, V1, P605, DOI 10.1016/S1534-5807(01)00076-4; WOLKOWICZ R, 1995, P NATL ACAD SCI USA, V92, P6842, DOI 10.1073/pnas.92.15.6842; Yang A, 2000, NAT REV MOL CELL BIO, V1, P199, DOI 10.1038/35043127	32	317	328	1	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 2	2003	113	3					301	314		10.1016/S0092-8674(03)00308-8	http://dx.doi.org/10.1016/S0092-8674(03)00308-8			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	674MP	12732139	Bronze, Green Published			2022-12-24	WOS:000182640800006
J	Meyer, AS; Gillespie, JR; Walther, D; Millet, IS; Doniach, S; Frydman, J				Meyer, AS; Gillespie, JR; Walther, D; Millet, IS; Doniach, S; Frydman, J			Closing the folding chamber of the eukaryotic chaperonin requires the transition state of ATP hydrolysis	CELL			English	Article							GROUP-II CHAPERONIN; CYTOPLASMIC CHAPERONIN; CRYSTAL-STRUCTURE; CONFORMATIONAL-CHANGES; IN-VIVO; PROTEIN; BINDING; THERMOSOME; GROEL; RECONSTRUCTION	Chaperonins use ATPase cycling to promote conformational changes leading to protein folding. The prokaryotic chaperonin GroEL requires a cofactor, GroES, which serves as a "lid" enclosing substrates in the central cavity and confers an asymmetry on GroEL required for cooperative transitions driving the reaction. The eukaryotic chaperonin TRiC/CCT does not have such a cofactor but appears to have a "built-in" lid. Whether this seemingly symmetric chaperonin also operates through an asymmetric cycle is unclear. We show that unlike GroEL, TRiC does not close its lid upon nucleotide binding, but instead responds to the trigonal-bipyramidal transition state of ATP hydrolysis. Further, nucleotide analogs inducing this transition state confer an asymmetric conformation on TRiC. Similar to GroEL, lid closure in TRiC confines the substrates in the cavity and is essential for folding. Understanding the distinct mechanisms governing eukaryotic and bacterial chaperonin function may reveal how TRiC has evolved to fold specific eukaryotic proteins.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Stanford Univ, Dept Chem, Stanford, CA 94305 USA; Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA; Incyte Genom Inc, Palo Alto, CA 94304 USA	Stanford University; Stanford University; Stanford University; Incyte	Frydman, J (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.	jfrydman@stanford.edu	Gillespie, Joel/GXW-0158-2022	Walther, Dirk/0000-0002-5755-9265; , judith/0000-0003-2302-6943; Meyer, Anne S./0000-0002-4164-0122; Gillespie, Joel/0000-0002-5075-1609	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056433, R37GM056433] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 56433] Funding Source: Medline; NINR NIH HHS [NRSA 10965] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))		Bada M, 2000, J MOL BIOL, V300, P563, DOI 10.1006/jmbi.2000.3854; BRAIG K, 1994, NATURE, V371, P578, DOI 10.1038/371578a0; Ditzel L, 1998, CELL, V93, P125, DOI 10.1016/S0092-8674(00)81152-6; Doniach S, 2001, CHEM REV, V101, P1763, DOI 10.1021/cr990071k; Ferreyra RG, 2000, METH MOL B, V140, P153; FISHER AJ, 1995, BIOCHEMISTRY-US, V34, P8960, DOI 10.1021/bi00028a004; Frydman J, 1996, SCIENCE, V272, P1497, DOI 10.1126/science.272.5267.1497; FRYDMAN J, 1994, NATURE, V370, P111, DOI 10.1038/370111a0; Frydman J, 2001, ANNU REV BIOCHEM, V70, P603, DOI 10.1146/annurev.biochem.70.1.603; Guinier A., 1955, SMALL ANGLE SCATTERI; Gutsche I, 1999, J MOL BIOL, V293, P295, DOI 10.1006/jmbi.1999.3008; Gutsche I, 2001, J STRUCT BIOL, V135, P139, DOI 10.1006/jsbi.2001.4373; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; HayerHartl MK, 1996, EMBO J, V15, P6111, DOI 10.1002/j.1460-2075.1996.tb00999.x; Horst M, 1996, PROTEIN SCI, V5, P759; Horwich AL, 1998, NAT STRUCT BIOL, V5, P333, DOI 10.1038/nsb0598-333; Kafri G, 2001, PROTEIN SCI, V10, P445, DOI 10.1110/ps.44401; Klumpp M, 1997, CELL, V91, P263, DOI 10.1016/S0092-8674(00)80408-0; Leroux MR, 2000, CURR BIOL, V10, pR260, DOI 10.1016/S0960-9822(00)00432-2; Llorca O, 1999, NAT STRUCT BIOL, V6, P639; Llorca O, 2001, EMBO J, V20, P4065, DOI 10.1093/emboj/20.15.4065; Llorca O, 1998, J BIOL CHEM, V273, P10091, DOI 10.1074/jbc.273.17.10091; MELKI R, 1994, MOL CELL BIOL, V14, P2895, DOI 10.1128/MCB.14.5.2895; Melki R, 1997, BIOCHEMISTRY-US, V36, P5817, DOI 10.1021/bi962830o; MORNET D, 1984, P NATL ACAD SCI-BIOL, V81, P3680, DOI 10.1073/pnas.81.12.3680; Nitsch M, 1998, NAT STRUCT BIOL, V5, P855, DOI 10.1038/2296; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; PENNINGROTH SM, 1980, J BIOL CHEM, V255, P9545; Rayment I, 1996, ANNU REV PHYSIOL, V58, P671; Rye HS, 1997, NATURE, V388, P792, DOI 10.1038/42047; SHLOMAI J, 1980, J BIOL CHEM, V255, P6789; Sigler PB, 1998, ANNU REV BIOCHEM, V67, P581, DOI 10.1146/annurev.biochem.67.1.581; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; Szpikowska BK, 1998, PROTEIN SCI, V7, P1524, DOI 10.1002/pro.5560070705; Walther D, 2000, J APPL CRYSTALLOGR, V33, P350, DOI 10.1107/S0021889899015976; Weissman JS, 1996, CELL, V84, P481, DOI 10.1016/S0092-8674(00)81293-3; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944; Yoshida T, 2002, J MOL BIOL, V315, P73, DOI 10.1006/jmbi.2001.5220; YOUNT RG, 1975, ADV ENZYMOL RAMB, V43, P1	39	142	146	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 2	2003	113	3					369	381		10.1016/S0092-8674(03)00307-6	http://dx.doi.org/10.1016/S0092-8674(03)00307-6			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	674MP	12732144	Bronze			2022-12-24	WOS:000182640800011
J	Scherer, SW; Cheung, J; MacDonald, JR; Osborne, LR; Nakabayashi, K; Herbrick, JA; Carson, AR; Parker-Katiraee, L; Skaug, J; Khaja, R; Zhang, JJ; Hudek, AK; Li, M; Haddad, M; Duggan, GE; Fernandez, BA; Kanematsu, E; Gentles, S; Christopoulos, CC; Choufani, S; Kwasnicka, D; Zheng, XQH; Lai, ZW; Nusskern, D; Zhang, Q; Gu, ZP; Lu, F; Zeesman, S; Nowaczyk, MJ; Teshima, I; Chitayat, D; Shuman, C; Weksberg, R; Zackai, EH; Grebe, TA; Cox, SR; Kirkpatrick, SJ; Rahman, N; Friedman, JM; Heng, HHQ; Pelicci, PG; Lo-Coco, F; Belloni, E; Shaffer, LG; Pober, B; Morton, CC; Gusella, JF; Bruns, GAP; Korf, BR; Quade, BJ; Ligon, AH; Ferguson, H; Higgins, AW; Leach, NT; Herrick, SR; Lemyre, E; Farra, CG; Kim, HG; Summers, AM; Gripp, KW; Roberts, W; Szatmari, P; Winsor, EJT; Grzeschik, KH; Teebi, A; Minassian, BA; Kere, J; Armengol, L; Pujana, MA; Estivill, X; Wilson, MD; Koop, BF; Tosi, S; Moore, GE; Boright, AP; Zlotorynski, E; Kerem, B; Kroisel, PM; Petek, E; Oscier, DG; Mould, SJ; Dohner, H; Dohner, K; Rommens, JM; Vincent, JB; Venter, JC; Li, PW; Mural, RJ; Adams, MD; Tsui, LC				Scherer, SW; Cheung, J; MacDonald, JR; Osborne, LR; Nakabayashi, K; Herbrick, JA; Carson, AR; Parker-Katiraee, L; Skaug, J; Khaja, R; Zhang, JJ; Hudek, AK; Li, M; Haddad, M; Duggan, GE; Fernandez, BA; Kanematsu, E; Gentles, S; Christopoulos, CC; Choufani, S; Kwasnicka, D; Zheng, XQH; Lai, ZW; Nusskern, D; Zhang, Q; Gu, ZP; Lu, F; Zeesman, S; Nowaczyk, MJ; Teshima, I; Chitayat, D; Shuman, C; Weksberg, R; Zackai, EH; Grebe, TA; Cox, SR; Kirkpatrick, SJ; Rahman, N; Friedman, JM; Heng, HHQ; Pelicci, PG; Lo-Coco, F; Belloni, E; Shaffer, LG; Pober, B; Morton, CC; Gusella, JF; Bruns, GAP; Korf, BR; Quade, BJ; Ligon, AH; Ferguson, H; Higgins, AW; Leach, NT; Herrick, SR; Lemyre, E; Farra, CG; Kim, HG; Summers, AM; Gripp, KW; Roberts, W; Szatmari, P; Winsor, EJT; Grzeschik, KH; Teebi, A; Minassian, BA; Kere, J; Armengol, L; Pujana, MA; Estivill, X; Wilson, MD; Koop, BF; Tosi, S; Moore, GE; Boright, AP; Zlotorynski, E; Kerem, B; Kroisel, PM; Petek, E; Oscier, DG; Mould, SJ; Dohner, H; Dohner, K; Rommens, JM; Vincent, JB; Venter, JC; Li, PW; Mural, RJ; Adams, MD; Tsui, LC			Human chromosome 7: DNA sequence and biology	SCIENCE			English	Article							SEGMENTAL DUPLICATIONS; REGION; MAP; LOCALIZATION; SPEECH; GENES	DNA sequence and annotation of the entire human chromosome 7, encompassing nearly 158 million nucleotides of DNA and 1917 gene structures, are presented. To generate a higher order description, additional structural features such as imprinted genes, fragile sites, and segmental duplications were integrated at the level of the DNA sequence with medical genetic data, including 440 chromosome rearrangement breakpoints associated with disease. This approach enabled the discovery of candidate genes for developmental diseases including autism.	Hosp Sick Children, Dept Genet & Genom Biol, Toronto, ON M5G 1X8, Canada; Hosp Sick Children, Div Clin & Metab Genet, Toronto, ON M5G 1X8, Canada; Hosp Sick Children, Child Dev Ctr, Toronto, ON M5G 1X8, Canada; Hosp Sick Children, Dept Paediat, Div Neurol, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Med, Toronto, ON M5S 1A8, Canada; Mem Univ Newfoundland, Fac Med, Discipline Genet, St John, NF A1B 3V6, Canada; Celera Genom, Rockville, MD 20850 USA; Hamilton Hlth Sci Ctr, Hamilton, ON L8N 3Z5, Canada; McMaster Univ, Dept Psychiat & Behav Neurosci, Hamilton, ON L8N 3Z5, Canada; Univ Toronto, Dept Pediat, Toronto, ON M5G 1X8, Canada; Childrens Hosp Philadelphia, Div Human Genet & Mol Biol, Philadelphia, PA 19104 USA; Univ Phoenix Genet Program, Phoenix, AZ 85016 USA; Univ Wisconsin, Dept Med Genet, Madison, WI 53706 USA; Inst Canc Res, Sect Canc Genet, Sutton SM2 5NG, Surrey, England; Univ British Columbia, Dept Med Genet, Vancouver, BC V6H 3N1, Canada; Wayne State Univ, Sch Med, Detroit, MI 48202 USA; European Inst Oncol, Dept Expt Oncol, I-20141 Milan, Italy; Firc Inst Mol Oncol, Canc Genet Unit, I-20134 Milan, Italy; Univ Roma Tor Vergata, Dipartimento Biopatol & Diagnost Immagini, I-00133 Rome, Italy; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Obstet Gynecol & Reprod Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Neurol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Harvard Partners Ctr Genet & Genom, Boston, MA 02115 USA; Harvard Univ, Sch Med, Massachusetts Gen Hosp, Mol Neurogenet Lab, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Childrens Hosp, Dept Pediat, Boston, MA 02115 USA; N York Gen Hosp, Dept Genet, Toronto, ON M2K 1E1, Canada; Alfred I DuPont Hosp Children, Div Med Genet, Wilmington, DE 19899 USA; Univ Toronto, Univ Hlth Network, Prenatal Diag Program, Toronto, ON M5G 1X5, Canada; Univ Toronto, Univ Hlth Network, Dept Lab Med & Pathobiol, Toronto, ON M5G 1X5, Canada; Univ Marburg, Med Zentrum Humangenet, D-35037 Marburg, Germany; Karolinska Inst, Novum, Dept Biosci, S-14157 Stockholm, Sweden; Huddinge Univ Hosp, Clin Res Ctr, S-14157 Stockholm, Sweden; Ctr Genom Regulat, Program Genes & Dis, Barcelona 08003, Catalonia, Spain; Univ Victoria, Dept Biol, Victoria, BC V8W 3N5, Canada; John Radcliffe Hosp, Inst Mol Med, MRC, Mol Haematol Unit, Oxford OX3 9DS, England; Univ London Imperial Coll Sci Technol & Med, Fac Med, Inst Reprod & Dev Biol, Dept Fetal & Maternal Med, London W12 0NN, England; Univ Toronto, Univ Hlth Network, Dept Med, Div Endocrinol, Toronto, ON M5G 2C4, Canada; Hebrew Univ Jerusalem, Inst Life Sci, Dept Genet, IL-91904 Jerusalem, Israel; Karl Franzens Univ Graz, Inst Med Biol & Human Genet, A-8010 Graz, Austria; Royal Bournemouth Hosp, Dept Haematol, Bournemouth BH7 7DW, Dorset, England; Univ Hosp Ulm, Dept Internal Med 3, D-89081 Ulm, Germany; Univ Toronto, Clark Inst, Ctr Addict & Mental Hlth, Toronto, ON M5T 1R8, Canada; Univ Toronto, Dept Psychiat, Toronto, ON M5T 1R8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; Memorial University Newfoundland; McMaster University; McMaster University; University of Toronto; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Wisconsin System; University of Wisconsin Madison; University of London; Institute of Cancer Research - UK; University of British Columbia; Wayne State University; IRCCS European Institute of Oncology (IEO); IFOM - FIRC Institute of Molecular Oncology; University of Rome Tor Vergata; Baylor College of Medicine; Yale University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Boston Children's Hospital; Harvard Medical School; University of Toronto; University Toronto Affiliates; North York General Hospital; Nemours Alfred I. duPont Hospital for Children; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Philipps University Marburg; Karolinska Institutet; Karolinska Institutet; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); University of Victoria; University of Oxford; Imperial College London; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Hebrew University of Jerusalem; University of Graz; Ulm University; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto	Scherer, SW (corresponding author), Hosp Sick Children, Dept Genet & Genom Biol, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	steve@genet.sickkids.on.ca	Rommens, Johanna/AAT-7465-2021; Koop, Ben F./A-8151-2008; MacDonald, Jeffrey Robert/GLU-2255-2022; Choufani, Sanaa/GWC-1820-2022; belloni, elena/H-9909-2013; Kere, Juha/A-9179-2008; Pujana, Miquel Angel/N-3127-2014; Moore, Gudrun/A-2092-2009; Estivill, Xavier/A-3125-2013; Wilson, Michael D/K-6294-2014; Döhner, Hartmut/C-8933-2016; Tsui, Lap-chee/A-1081-2010; Korf, Bruce R/H-4882-2012; Kere, Juha/AAX-9117-2021; Estivill, Xavier/E-2957-2012; Pelicci, Pier Giuseppe/AAL-6572-2020; Tosi, Sabrina/AAA-7199-2022; Scherer, Stephen W./B-3785-2013; Rahman, Nazneen/B-8890-2012; Rahman, Nazneen/D-2802-2013	Koop, Ben F./0000-0003-0045-5200; Choufani, Sanaa/0000-0002-5241-2213; Kere, Juha/0000-0003-1974-0271; Pujana, Miquel Angel/0000-0003-3222-4044; Estivill, Xavier/0000-0002-0723-2256; Wilson, Michael D/0000-0002-4015-3066; Döhner, Hartmut/0000-0003-2116-5536; Kere, Juha/0000-0003-1974-0271; Tosi, Sabrina/0000-0002-0036-0191; Scherer, Stephen W./0000-0002-8326-1999; Cheung, Joseph/0000-0002-1222-7603; Rahman, Nazneen/0000-0003-4376-0440; Friedman, Jan/0000-0002-7482-9570; MacDonald, Jeffrey/0000-0001-5058-2393; Belloni, Elena/0000-0003-3214-0780; Moore, Gudrun/0000-0002-2099-3420; Zheng Bradley, Xiangqun/0000-0002-9324-2708	Canadian Institutes of Health Research [38103] Funding Source: Medline; NIGMS NIH HHS [P01 GM061354] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM061354] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Boocock GRB, 2003, NAT GENET, V33, P97, DOI 10.1038/ng1062; Bouffard GG, 1997, GENOME RES, V7, P59, DOI 10.1101/gr.7.1.59; Cheung J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r25; de la Puente A, 1998, CYTOGENET CELL GENET, V83, P176, DOI 10.1159/000015175; Deloukas P, 2001, NATURE, V414, P865, DOI 10.1038/414865a; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Dunham I, 1999, NATURE, V402, P489, DOI 10.1038/990031; *FANT CONS, 2002, NATURE, V420, P523; Hattori M, 2000, NATURE, V405, P311, DOI 10.1038/35012518; Heilig R, 2003, NATURE, V421, P601, DOI 10.1038/nature01348; HILLIER LW, IN PRESS NATURE; *INT MOL GEN STUD, 1998, HUM MOL GENET, V3, P571; KOBAYASHI K, 1999, ANTURE GENET, V2, P159; KUNZ J, 1994, GENOMICS, V22, P439, DOI 10.1006/geno.1994.1407; Lai CSL, 2001, NATURE, V413, P519, DOI 10.1038/35097076; Lai CSL, 2000, AM J HUM GENET, V67, P357, DOI 10.1086/303011; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Ma B, 2002, BIOINFORMATICS, V18, P440, DOI 10.1093/bioinformatics/18.3.440; Merlo GR, 2002, GENESIS, V33, P97, DOI 10.1002/gene.10098; Mural RJ, 2002, SCIENCE, V296, P1661, DOI 10.1126/science.1069193; Osborne LR, 2001, NAT GENET, V29, P321, DOI 10.1038/ng753; Osborne LR, 1997, GENOMICS, V45, P402, DOI 10.1006/geno.1997.4923; Pevzner P, 2003, GENOME RES, V13, P37, DOI 10.1101/gr.757503; Robledo RF, 2002, GENE DEV, V16, P1089, DOI 10.1101/gad.988402; SCHERER SW, 1994, HUM MOL GENET, V3, P1345; Schuler GD, 1996, SCIENCE, V274, P540, DOI 10.1126/science.274.5287.540; Stein LD, 2002, GENOME RES, V12, P1599, DOI 10.1101/gr.403602; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; WEVRICK R, 1991, NUCLEIC ACIDS RES, V19, P2295, DOI 10.1093/nar/19.9.2295	31	152	526	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 2	2003	300	5620					767	772		10.1126/science.1083423	http://dx.doi.org/10.1126/science.1083423			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673KH	12690205	Green Accepted			2022-12-24	WOS:000182579800041
J	Tian, D; Traw, MB; Chen, JQ; Kreitman, M; Bergelson, J				Tian, D; Traw, MB; Chen, JQ; Kreitman, M; Bergelson, J			Fitness costs of R-gene-mediated resistance in Arabidopsis thaliana	NATURE			English	Article							NUCLEOTIDE-BINDING SITE; DISEASE-RESISTANCE; PSEUDOMONAS-SYRINGAE; DEFENSE RESPONSES; NATURAL-SELECTION; PLANT-RESISTANCE; PATHOGENS; RPS2; POLYMORPHISM; SPECIFICITY	Resistance genes (R-genes) act as an immune system in plants by recognizing pathogens and inducing defensive pathways. Many R-gene loci are present in plant genomes, presumably reflecting the need to maintain a large repertoire of resistance alleles. These loci also often segregate for resistance and susceptibility alleles that natural selection has maintained as polymorphisms within a species for millions of years(1-5). Given the obvious advantage to an individual of being disease resistant, what prevents these resistance alleles from being driven to fixation by natural selection? A cost of resistance(6) is one potential explanation; most models require a lower fitness of resistant individuals in the absence of pathogens for long-term persistence of susceptibility alleles(7). Here we test for the presence of a cost of resistance at the RPM1 locus of Arabidopsis thaliana. Results of a field experiment comparing the fitness of isogenic strains that differ in the presence or absence of RPM1 and its natural promoter reveal a large cost of RPM1, providing the first evidence that costs contribute to the maintenance of an ancient R-gene polymorphism.	Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; Nanjing Univ, Dept Biol, Nanjing 210093, Peoples R China	University of Chicago; Nanjing University	Bergelson, J (corresponding author), Univ Chicago, Dept Ecol & Evolut, 1101 E 57th St, Chicago, IL 60637 USA.	jbergels@midway.uchicago.edu	Traw, Milton Brian/ABD-3275-2020; Bruening, Stefan/B-8505-2011	Traw, Milton Brian/0000-0002-3148-2108; Bergelson, Joy/0000-0001-7893-7387; Chen, Jian-Qun/0000-0003-4376-5655	NIGMS NIH HHS [R01 GM062504, R01 GM057994] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057994, R01GM062504] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bergelson J, 2001, ANNU REV GENET, V35, P469, DOI 10.1146/annurev.genet.35.102401.090954; Bergelson J, 1996, AM NAT, V148, P536, DOI 10.1086/285938; BISGROVE SR, 1994, PLANT CELL, V6, P927, DOI 10.1105/tpc.6.7.927; Boyes DC, 1998, P NATL ACAD SCI USA, V95, P15849, DOI 10.1073/pnas.95.26.15849; Brown JKM, 2002, CURR OPIN PLANT BIOL, V5, P339, DOI 10.1016/S1369-5266(02)00270-4; Caicedo AL, 1999, P NATL ACAD SCI USA, V96, P302, DOI 10.1073/pnas.96.1.302; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Dewdney J, 2000, PLANT J, V24, P205, DOI 10.1046/j.1365-313x.2000.00870.x; GILLESPIE JH, 1975, ECOLOGY, V56, P493, DOI 10.2307/1934983; Grant MR, 1998, P NATL ACAD SCI USA, V95, P15843, DOI 10.1073/pnas.95.26.15843; GRANT MR, 1995, SCIENCE, V269, P843, DOI 10.1126/science.7638602; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Holt BF, 2002, DEV CELL, V2, P807, DOI 10.1016/S1534-5807(02)00174-0; HOWE C, 1995, GENE CLONING MANIPUL; Jakob K, 2002, MOL PLANT MICROBE IN, V15, P1195, DOI 10.1094/MPMI.2002.15.12.1195; JORGENSEN JH, 1990, NORSK LANDBRUKSFOR S, V9, P125; KLEMENT Z, 1963, NATURE, V199, P299, DOI 10.1038/199299b0; Mackey D, 2003, CELL, V112, P379, DOI 10.1016/S0092-8674(03)00040-0; Mackey D, 2002, CELL, V108, P743, DOI 10.1016/S0092-8674(02)00661-X; Mauricio R, 2003, GENETICS, V163, P735; MINDRINOS M, 1994, CELL, V78, P1089, DOI 10.1016/0092-8674(94)90282-8; Moore ERB, 1996, SYST APPL MICROBIOL, V19, P478, DOI 10.1016/S0723-2020(96)80021-X; Oldroyd GED, 1998, P NATL ACAD SCI USA, V95, P10300, DOI 10.1073/pnas.95.17.10300; OW DW, 1995, CRIT REV PLANT SCI, V14, P239, DOI 10.1080/713608117; Rausher MD, 2001, NATURE, V411, P857, DOI 10.1038/35081193; REDEI GP, 1975, ANNU REV GENET, V9, P111, DOI 10.1146/annurev.ge.09.120175.000551; SIMMS EL, 1987, AM NAT, V130, P570, DOI 10.1086/284731; Stahl EA, 1999, NATURE, V400, P667, DOI 10.1038/23260; Stuiver MH, 2001, NATURE, V411, P865, DOI 10.1038/35081200; Tang XY, 1999, PLANT CELL, V11, P15, DOI 10.1105/tpc.11.1.15; Tao Y, 2000, PLANT CELL, V12, P2541, DOI 10.1105/tpc.12.12.2541; Tian DC, 2002, P NATL ACAD SCI USA, V99, P11525, DOI 10.1073/pnas.172203599; Traw MB, 2003, MOL ECOL, V12, P1125, DOI 10.1046/j.1365-294X.2003.01815.x; van der Biezen EA, 1998, TRENDS BIOCHEM SCI, V23, P454, DOI 10.1016/S0968-0004(98)01311-5; Wang ZX, 2001, PLANT MOL BIOL, V47, P653, DOI 10.1023/A:1012457113700; WHALEN MC, 1991, PLANT CELL, V3, P49, DOI 10.1105/tpc.3.1.49	36	551	571	3	143	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 1	2003	423	6935					74	77		10.1038/nature01588	http://dx.doi.org/10.1038/nature01588			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673CG	12721627				2022-12-24	WOS:000182561600041
J	Sharp, D				Sharp, D			Chateau resveratrol	LANCET			English	Editorial Material							FRENCH PARADOX; WINE; MORTALITY; DISEASE		The Lancet, London NW1 7BY, England		Sharp, D (corresponding author), The Lancet, London NW1 7BY, England.							de Lorgeril M, 2002, CARDIOVASC RES, V54, P503, DOI 10.1016/S0008-6363(01)00545-4; Klatsky AL, 2003, SCI AM, V288, P74, DOI 10.1038/scientificamerican0203-74; Laatikainen T, 2003, J EPIDEMIOL COMMUN H, V57, P379, DOI 10.1136/jech.57.5.379; Lindsay J, 2002, AM J EPIDEMIOL, V156, P445, DOI 10.1093/aje/kwf074; MCMICHAEL J, 1979, LANCET, V1, P1186; Mukamal KJ, 2003, NEW ENGL J MED, V348, P109, DOI 10.1056/NEJMoa022095; Rosenkranz S, 2002, FASEB J, V16, P1958, DOI 10.1096/fj.02-0207fje; Simini B, 2000, LANCET, V355, P48, DOI 10.1016/S0140-6736(05)71990-5; STLEGER AS, 1979, LANCET, V1, P1017, DOI 10.1016/S0140-6736(79)92765-X; Waterhouse AL, 2002, ANN NY ACAD SCI, V957, P21, DOI 10.1111/j.1749-6632.2002.tb02903.x; 2003, WINE SCI EXPLORATION, P320	11	4	4	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 26	2003	361	9367					1404	1404		10.1016/S0140-6736(03)13149-2	http://dx.doi.org/10.1016/S0140-6736(03)13149-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	672HZ	12727391				2022-12-24	WOS:000182516300006
J	Berger, A				Berger, A			Science commentary: Pertussis immunisation	BRITISH MEDICAL JOURNAL			English	Editorial Material							REACTOGENICITY; VACCINES											Miller E, 1997, VACCINE, V15, P51, DOI 10.1016/S0264-410X(96)00112-0; Miller E, 2001, VACCINE, V19, P3904, DOI 10.1016/S0264-410X(01)00123-2; MILLER E, 1995, VACCINE, V13, P1183, DOI 10.1016/0264-410X(95)00061-5; Van Buynder PG, 1999, EPIDEMIOL INFECT, V123, P403, DOI 10.1017/S0950268899003052	4	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 19	2003	326	7394					853	853		10.1136/bmj.326.7394.853	http://dx.doi.org/10.1136/bmj.326.7394.853			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	670BF	12702618	Green Published, Bronze			2022-12-24	WOS:000182386800018
J	Saad, EB; Marrouche, NF; Saad, CP; Ha, E; Bash, D; White, RD; Rhodes, J; Prieto, L; Martin, DO; Saliba, WI; Schweikert, RA; Natale, A				Saad, EB; Marrouche, NF; Saad, CP; Ha, E; Bash, D; White, RD; Rhodes, J; Prieto, L; Martin, DO; Saliba, WI; Schweikert, RA; Natale, A			Pulmonary vein stenosis after catheter ablation of atrial fibrillation. Emergence of a new clinical syndrome	ANNALS OF INTERNAL MEDICINE			English	Article							ECTOPIC BEATS; RADIOFREQUENCY ABLATION; INITIATION; SYSTEM	Background: Pulmonary vein isolation is a new, effective curative procedure for selected patients with atrial fibrillation. Pulmonary vein stenosis is a potential complication and may lead to symptoms that are often underrecognized. Objective: To describe the clinical course and symptoms associated with pulmonary vein stenosis developing after ablation in the pulmonary veins. Design: Retrospective study. Setting: Tertiary care referral center. Patients: 335 patients referred for catheter ablation of drug-refractory atrial fibrillation. Intervention: Pulmonary vein electrical isolation using radiofrequency catheter ablation. Measurements: Three months after ablation, patients underwent routine screening for pulmonary vein stenosis with spiral computed tomography. Screening was considered earlier if symptoms suggestive of stenosis developed and was repeated at 6 and 12 months if any pulmonary vein narrowing was observed. Pulmonary vein angiography and dilatation were offered to patients with severe (>70%) stenosis. Results: Severe pulmonary vein stenosis was detected in 18 patients (5% [95% Cl, 3.2% to 8.4%]) a mean (+SD) of 5.2 +/- 2.6 months after ablation. Eight of these 18 patients (44%) were asymptomatic, but 8 (44%) reported shortness of breath, 7 (39%) reported cough, and 5 (28%) reported hemoptysis. Radiologic abnormalities were present in 9 patients (50%) and led to diagnoses of pneumonia (4 patients), lung cancer (1 patient), and pulmonary embolism (2 patients). Pulmonary vein stenosis was not considered in any patient during the initial work-up. Dilatation of the affected vein was performed in 12 patients. Postintervention lung perfusion scans revealed significant improvement in lung flow. Conclusions: Severe pulmonary vein stenosis after catheter ablation of atrial fibrillation is associated with respiritory symptoms that frequently mimic more common diseases, often leading to erroneous diagnostic and therapeutic procedures. Awareness of this syndrome is important for proper and prompt management.	Cleveland Clin Fdn, Dept Cardiovasc Med, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Natale, A (corresponding author), Cleveland Clin Fdn, Dept Cardiovasc Med, 9500 Euclid Ave,Desk F15, Cleveland, OH 44195 USA.	natalea@cce.org		White, Richard D./0000-0002-1133-7819				Chen SA, 2000, J CARDIOVASC ELECTR, V11, P218; Chen SA, 1999, CIRCULATION, V100, P1879, DOI 10.1161/01.CIR.100.18.1879; Cole CR, 2001, CIRCULATION, V104, P567; Cooper JM, 2001, CIRCULATION, V104, P3010, DOI 10.1161/hc5001.101503; Haissaguerre M, 2000, CIRCULATION, V101, P1409, DOI 10.1161/01.CIR.101.12.1409; Haissaguerre M, 1998, NEW ENGL J MED, V339, P659, DOI 10.1056/NEJM199809033391003; Kanagaratnam L, 2001, PACE, V24, P1774, DOI 10.1046/j.1460-9592.2001.01774.x; Lin WS, 2000, CIRCULATION, V101, P1274, DOI 10.1161/01.CIR.101.11.1274; Marrouche NF, 2002, J AM COLL CARDIOL, V40, P464, DOI 10.1016/S0735-1097(02)01972-1; Natale A, 2000, CIRCULATION, V102, P1879, DOI 10.1161/01.CIR.102.16.1879; Natale A, 1999, PACE, V22, P1634, DOI 10.1111/j.1540-8159.1999.tb00383.x; Oral H, 2002, CIRCULATION, V105, P1077, DOI 10.1161/hc0902.104712; Robbins IM, 1998, CIRCULATION, V98, P1769, DOI 10.1161/01.CIR.98.17.1769; Scanavacca MI, 2000, J CARDIOVASC ELECTR, V11, P677, DOI 10.1111/j.1540-8167.2000.tb00030.x; Yang M, 2001, J COMPUT ASSIST TOMO, V25, P34, DOI 10.1097/00004728-200101000-00006; Yu WC, 2001, J CARDIOVASC ELECTR, V12, P887, DOI 10.1046/j.1540-8167.2001.00887.x	16	167	177	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 15	2003	138	8					634	638		10.7326/0003-4819-138-8-200304150-00010	http://dx.doi.org/10.7326/0003-4819-138-8-200304150-00010			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	666JH	12693885				2022-12-24	WOS:000182173800005
J	Foell, D; Ichida, F; Vogl, T; Yu, XY; Chen, R; Miyawaki, T; Sorg, C; Roth, J				Foell, D; Ichida, F; Vogl, T; Yu, XY; Chen, R; Miyawaki, T; Sorg, C; Roth, J			S100A12 (EN-RAGE) in monitoring Kawasaki disease	LANCET			English	Article							RECEPTOR	The calcium-binding protein S100A12 causes inflammation through interaction with the multiligand receptor for advanced glycation end products (RAGE). Blocking of S100A12 showed promising therapeutic effects in mice. We investigated 31 individuals with Kawasaki disease, and recorded an association between expression of S100A12 and activity of Kawasaki disease. Serum concentrations of S100A12 decreased quickly in 28 patients who responded to treatment with gammaglobulin (from 463 mug/L [SD 316] to 184 mug/L [147] within 24 h, p<0.0001). Since the interaction of S100A12 with multiligand receptors has a key role in inflammatory responses, this protein could serve as a novel target for future therapeutic interventions in inflammatory disorders.	Univ Hosp Munster, Dept Paediat, D-48149 Munster, Germany; Univ Hosp Munster, Inst Expt Dermatol, D-48149 Munster, Germany; Toyama Med & Pharmaceut Univ, Dept Paediat, Toyama, Japan	University of Munster; University of Munster; University of Toyama	Foell, D (corresponding author), Univ Hosp Munster, Dept Paediat, Von Esmarch Str 58, D-48149 Munster, Germany.							Brogan PA, 2002, ARCH DIS CHILD, V86, P286, DOI 10.1136/adc.86.4.286; Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6; Schmidt AM, 2001, J CLIN INVEST, V108, P949, DOI 10.1172/JCI14002; Vogl T, 1999, J BIOL CHEM, V274, P25291, DOI 10.1074/jbc.274.36.25291	4	108	116	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 12	2003	361	9365					1270	1272		10.1016/S0140-6736(03)12986-8	http://dx.doi.org/10.1016/S0140-6736(03)12986-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	666DM	12699958				2022-12-24	WOS:000182161600014
J	Blake, WJ; Kaern, M; Cantor, CR; Collins, JJ				Blake, WJ; Kaern, M; Cantor, CR; Collins, JJ			Noise in eukaryotic gene expression	NATURE			English	Article							RNA-POLYMERASE-II; TRANSCRIPTIONAL ACTIVATION; IN-VIVO; SINGLE-CELL; DIFFERENTIATION; STOCHASTICITY; REINITIATION; PROBABILITY; RECRUITMENT; INITIATION	Transcription in eukaryotic cells has been described as quantal(1), with pulses of messenger RNA produced in a probabilistic manner(2,3). This description reflects the inherently stochastic nature(4-9) of gene expression, known to be a major factor in the heterogeneous response of individual cells within a clonal population to an inducing stimulus(10-16). Here we show in Saccharomyces cerevisiae that stochasticity (noise) arising from transcription contributes significantly to the level of heterogeneity within a eukaryotic clonal population, in contrast to observations in prokaryotes(15), and that such noise can be modulated at the translational level. We use a stochastic model of transcription initiation specific to eukaryotes to show that pulsatile mRNA production, through reinitiation, is crucial for the dependence of noise on transcriptional efficiency, highlighting a key difference between eukaryotic and prokaryotic sources of noise. Furthermore, we explore the propagation of noise in a gene cascade network and demonstrate experimentally that increased noise in the transcription of a regulatory protein leads to increased cell-cell variability in the target gene output, resulting in prolonged bistable expression states. This result has implications for the role of noise in phenotypic variation and cellular differentiation.	Boston Univ, Ctr Biodynam, Boston, MA 02215 USA; Boston Univ, Ctr Adv Biotechnol, Bioinformat Program, Boston, MA 02215 USA; Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA	Boston University; Boston University; Boston University	Collins, JJ (corresponding author), Boston Univ, Ctr Biodynam, 44 Cummington St, Boston, MA 02215 USA.		Kaern, Mads/GVU-6867-2022	Kaern, Mads/0000-0002-9371-666X				Becskei A, 2001, EMBO J, V20, P2528, DOI 10.1093/emboj/20.10.2528; Bhaumik SR, 2001, GENE DEV, V15, P1935, DOI 10.1101/gad.911401; Biggar SR, 2001, EMBO J, V20, P3167, DOI 10.1093/emboj/20.12.3167; CHATTERJEE S, 1995, NATURE, V374, P820, DOI 10.1038/374820a0; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; FIERING S, 1990, GENE DEV, V4, P1823, DOI 10.1101/gad.4.10.1823; Hahn S, 1998, COLD SPRING HARB SYM, V63, P181, DOI 10.1101/sqb.1998.63.181; Hasty J, 2000, P NATL ACAD SCI USA, V97, P2075, DOI 10.1073/pnas.040411297; Hume DA, 2000, BLOOD, V96, P2323, DOI 10.1182/blood.V96.7.2323.h8002323_2323_2328; Kemkemer R, 2002, P NATL ACAD SCI USA, V99, P13783, DOI 10.1073/pnas.212386999; Kepler TB, 2001, BIOPHYS J, V81, P3116, DOI 10.1016/S0006-3495(01)75949-8; KLAGES N, 1995, NATURE, V374, P822, DOI 10.1038/374822a0; KO MSH, 1991, J THEOR BIOL, V153, P181, DOI 10.1016/S0022-5193(05)80421-7; KO MSH, 1990, EMBO J, V9, P2835, DOI 10.1002/j.1460-2075.1990.tb07472.x; Larschan E, 2001, GENE DEV, V15, P1946, DOI 10.1101/gad.911501; McAdams HH, 1997, P NATL ACAD SCI USA, V94, P814, DOI 10.1073/pnas.94.3.814; NOVICK A, 1957, P NATL ACAD SCI USA, V43, P553, DOI 10.1073/pnas.43.7.553; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Ptashne M, 1997, NATURE, V386, P569, DOI 10.1038/386569a0; ROSS IL, 1994, IMMUNOL CELL BIOL, V72, P177, DOI 10.1038/icb.1994.26; Rossi FMV, 2000, MOL CELL, V6, P723, DOI 10.1016/S1097-2765(00)00070-8; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Stewart JJ, 2001, J BIOL CHEM, V276, P30078, DOI 10.1074/jbc.M105276200; Struhl K, 1996, CELL, V84, P179, DOI 10.1016/S0092-8674(00)80970-8; Swain PS, 2002, P NATL ACAD SCI USA, V99, P12795, DOI 10.1073/pnas.162041399; Thattai M, 2001, P NATL ACAD SCI USA, V98, P8614, DOI 10.1073/pnas.151588598; Thattai M, 2002, BIOPHYS J, V82, P2943, DOI 10.1016/S0006-3495(02)75635-X; VANROON MA, 1989, DEV BIOL, V136, P508, DOI 10.1016/0012-1606(89)90276-5; WALTERS MC, 1995, P NATL ACAD SCI USA, V92, P7125, DOI 10.1073/pnas.92.15.7125; Yean D, 1997, MOL CELL BIOL, V17, P3809, DOI 10.1128/MCB.17.7.3809	30	1212	1243	1	133	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 10	2003	422	6932					633	637		10.1038/nature01546	http://dx.doi.org/10.1038/nature01546			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665GN	12687005				2022-12-24	WOS:000182111400047
J	Harris, LH; Paltrow, L				Harris, LH; Paltrow, L			The status of pregnant women and fetuses in US criminal law	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PRENATAL COCAINE EXPOSURE; PERINATAL ETHICS		Univ Michigan, Ann Arbor, MI 48109 USA; Natl Advocates Pregnant Women, New York, NY USA	University of Michigan System; University of Michigan	Harris, LH (corresponding author), Univ Michigan, Ann Arbor, MI 48109 USA.							*AM MED ASS, 2002, MOT AM MED ASS LEAV; ANNAS GJ, 1990, HASTINGS CENT REP, V20, P27, DOI 10.2307/3562763; Chavkin W, 2001, JAMA-J AM MED ASSOC, V285, P1626, DOI 10.1001/jama.285.12.1626; CHERVENAK FA, 1985, OBSTET GYNECOL, V66, P442; Frank DA, 2001, JAMA-J AM MED ASSOC, V285, P1613, DOI 10.1001/jama.285.12.1613; Harris LH, 2000, OBSTET GYNECOL, V96, P786, DOI 10.1016/S0029-7844(00)01021-8; HODGE JG, 1999, AM LAW REPORTS, V70, P461; Humphries Drew, 1999, CRACK MOTHERS PREGNA; Marwick C, 1998, JAMA-J AM MED ASSOC, V279, P1149, DOI 10.1001/jama.279.15.1149; NELSON IJ, 1998, ETHICAL LEGAL ANAL 3; PALTROW L, 2000, GOVT RESPONSES PREGN; POLAND ML, 1993, DRUG ALCOHOL DEPEN, V31, P199, DOI 10.1016/0376-8716(93)90001-7; Rose-Jacobs R, 2002, J DEV BEHAV PEDIATR, V23, P340, DOI 10.1097/00004703-200210000-00007; *US DEP HHS, 1993, US DEP HHS PUBL; 2002, FED REG, V67, P61955	15	19	19	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 2	2003	289	13					1697	1699		10.1001/jama.289.13.1697	http://dx.doi.org/10.1001/jama.289.13.1697			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	662JX	12672741	Bronze			2022-12-24	WOS:000181944500036
J	Mizutani, A; Chahl, JS; Srinivasan, MV				Mizutani, A; Chahl, JS; Srinivasan, MV			Motion camouflage in dragonflies	NATURE			English	Article									Australian Natl Univ, Res Sch Biol Sci, Ctr Visual Sci, Canberra, ACT 2601, Australia; Def Sci & Technol Org, Weapons Syst Div, Edinburgh, SA 5111, Australia	Australian National University; Defence Science & Technology	Mizutani, A (corresponding author), Australian Natl Univ, Res Sch Biol Sci, Ctr Visual Sci, POB 475, Canberra, ACT 2601, Australia.		Srinivasan, Mandyam V/G-5571-2010	Chahl, Javaan/0000-0001-6496-0543; Muthukumarasamy, Srinivasan/0000-0002-2948-6206				COLLETT TS, 1975, J COMP PHYSIOL, V99, P1, DOI 10.1007/BF01464710; CURLO E, 1976, ETHOLOGY PREDATION; SRINIVASAN MV, 1995, P ROY SOC B-BIOL SCI, V259, P19, DOI 10.1098/rspb.1995.0004; SRINIVASAN MV, 1903, VISUAL MOTION ITS RO, P139; TSAI RY, 1987, IEEE T ROBOTIC AUTOM, V3, P323, DOI 10.1109/JRA.1987.1087109; *US OFF NAV RES, INS VIS BAS SEEK CON	6	96	102	2	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 5	2003	423	6940					604	604		10.1038/423604a	http://dx.doi.org/10.1038/423604a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686BT	12789327	Bronze			2022-12-24	WOS:000183301200028
J	Crackower, MA; Kolas, NK; Noguchi, J; Sarao, R; Kikuchi, K; Kaneko, H; Kobayashi, E; Kawai, Y; Kozieradzki, I; Landers, R; Mo, R; Hui, CC; Nieves, E; Cohen, PE; Osborne, LR; Wada, T; Kunieda, T; Moens, PB; Penninger, JM				Crackower, MA; Kolas, NK; Noguchi, J; Sarao, R; Kikuchi, K; Kaneko, H; Kobayashi, E; Kawai, Y; Kozieradzki, I; Landers, R; Mo, R; Hui, CC; Nieves, E; Cohen, PE; Osborne, LR; Wada, T; Kunieda, T; Moens, PB; Penninger, JM			Essential role of Fkbp6 in male fertility and homologous chromosome pairing in meiosis	SCIENCE			English	Article							SYNAPTONEMAL COMPLEX; MEIOTIC PROPHASE; GENE; RAT; SYNAPSIS; SPERMATOCYTES; RECOMBINATION; MOUSE; AS/AS	Meiosis is a critical stage of gametogenesis in which alignment and synapsis of chromosomal pairs occur, allowing for the recombination of maternal and paternal genomes. Here we show that FK506 binding protein (Fkbp6) localizes to meiotic chromosome cores and regions of homologous chromosome synapsis. Targeted inactivation of Fkbp6 in mice results in aspermic males and the absence of normal pachytene spermatocytes. Moreover, we identified the deletion of Fkbp6 exon 8 as the causative mutation in spontaneously male sterile as/as mutant rats. Loss of Fkbp6 results in abnormal pairing and misalignments between homologous chromosomes, nonhomologous partner switches, and autosynapsis of X chromosome cores in meiotic spermatocytes. Fertility and meiosis are normal in Fkbp6 mutant females. Thus, Fkbp6 is a component of the synaptonemal complex essential for sex-specific fertility and for the fidelity of homologous chromosome pairing in meiosis.	Austrian Acad Sci, Inst Mol Biotechnol, IMBA, A-1030 Vienna, Austria; Albert Einstein Coll Med, AECOM, Dept Biochem, Lab Macromol Anal & Proteom, Bronx, NY 10461 USA; Natl Inst Agrobiol Sci, Germ Cell Conservat Lab, Tsukuba, Ibaraki 3058602, Japan; Natl Lifestock Breeding Ctr, Fukushima 961851, Japan; Okayama Univ, Grad Sch Nat Sci & Technol, Okayama 7000082, Japan; Hosp Sick Children, Program Dev Biol, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Med, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5S 1A8, Canada; York Univ, Dept Biol, N York, ON M3J 1P3, Canada	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); Yeshiva University; Albert Einstein College of Medicine; National Institute of Agrobiological Sciences - Japan; Okayama University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; York University - Canada	Penninger, JM (corresponding author), Austrian Acad Sci, Inst Mol Biotechnol, IMBA, Dr Bohrgasse 7, A-1030 Vienna, Austria.	josef.penninger@oeaw.ac.at	Penninger, Josef M/I-6860-2013	Penninger, Josef M/0000-0002-8194-3777	Canadian Institutes of Health Research [38103] Funding Source: Medline	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))		ATAGI Y, 1993, J VET MED SCI, V55, P301, DOI 10.1292/jvms.55.301; Bayes M, 2001, MOL REPROD DEV, V60, P414, DOI 10.1002/mrd.1104; Cohen PE, 2001, BIOESSAYS, V23, P996, DOI 10.1002/bies.1145; Dix DJ, 1997, DEVELOPMENT, V124, P4595; DRESSER ME, 1980, CHROMOSOMA, V76, P1, DOI 10.1007/BF00292222; FAWCETT DW, 1956, J BIOPHYS BIOCHEM CY, V2, P403, DOI 10.1083/jcb.2.4.403; Hunt PA, 2002, SCIENCE, V296, P2181, DOI 10.1126/science.1071907; IKADAI H, 1992, J VET MED SCI, V54, P745, DOI 10.1292/jvms.54.745; Liu D, 1998, NAT GENET, V20, P377, DOI 10.1038/3855; LYON MF, 1970, NATURE, V227, P1217, DOI 10.1038/2271217a0; Masson JY, 2001, TRENDS BIOCHEM SCI, V26, P131, DOI 10.1016/S0968-0004(00)01742-4; Matzuk MM, 2002, NAT CELL BIOL, V4, pS41; Meng X, 1998, GENOMICS, V52, P130, DOI 10.1006/geno.1998.5412; Moens PB, 2002, J CELL SCI, V115, P1611; MOSES MJ, 1956, J BIOPHYS BIOCHEM CY, V2, P215, DOI 10.1083/jcb.2.2.215; Nasmyth K, 2002, SCIENCE, V297, P559, DOI 10.1126/science.1074757; Noguchi J, 1999, MAMM GENOME, V10, P189, DOI 10.1007/s003359900967; Odorisio T, 1998, NAT GENET, V18, P257, DOI 10.1038/ng0398-257; Osborne LR, 1999, MOL GENET METAB, V67, P1, DOI 10.1006/mgme.1999.2844; TAI PKK, 1992, SCIENCE, V256, P1315, DOI 10.1126/science.1376003; Yuan L, 2002, SCIENCE, V296, P1115, DOI 10.1126/science.1070594; Yuan L, 2000, MOL CELL, V5, P73, DOI 10.1016/S1097-2765(00)80404-9; Zickler D, 1999, ANNU REV GENET, V33, P603, DOI 10.1146/annurev.genet.33.1.603	23	152	169	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 23	2003	300	5623					1291	1295		10.1126/science.1083022	http://dx.doi.org/10.1126/science.1083022			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681NN	12764197	Green Accepted			2022-12-24	WOS:000183042400049
J	Kim, JM; Wu, H; Green, G; Winkler, CA; Kopp, JB; Miner, JH; Unanue, ER; Shaw, AS				Kim, JM; Wu, H; Green, G; Winkler, CA; Kopp, JB; Miner, JH; Unanue, ER; Shaw, AS			CD2-associated protein haploinsufficiency is linked to glomerular disease susceptibility	SCIENCE			English	Article							NEPHROTIC SYNDROME; DOWN-REGULATION; COMPLEX; MEMBRANE	Loss of CD2-associated protein (CD2AP), a component of the filtration complex in the kidney, causes death in mice at 6 weeks of age. Mice with CD2AP haploin-sufficiency developed glomerular changes at 9 months of age and had increased susceptibility to glomerular injury by nephrotoxic antibodies or immune complexes. Electron microscopic analysis of podocytes revealed defects in the formation of multivesicular bodies, suggesting an impairment of the intracellular degradation pathway. Two human patients with focal segmental glomerulosclerosis had a mutation predicted to ablate expression of one CD2AP allele, implicating CD2AP as a determinant of human susceptibility to glomerular disease.	Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Internal Med, Div Renal, St Louis, MO 63110 USA; NCI, Mol Epidemiol Sect, Lab Genom Divers, NIH, Frederick, MD 21702 USA; NIDDKD, Kidney Dis Sect, NIH, Bethesda, MD 20892 USA	Washington University (WUSTL); Washington University (WUSTL); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Shaw, AS (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.	shaw@pathology.wustl.edu	Kopp, Jeffrey B/O-2681-2015	Kopp, Jeffrey B/0000-0001-9052-186X	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK043308, ZIADK043308] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALPERS CE, 1993, AM J KIDNEY DIS, V22, P448, DOI 10.1016/S0272-6386(12)70151-8; Boute N, 2000, NAT GENET, V24, P349, DOI 10.1038/74166; Dikic I, 2002, FEBS LETT, V529, P110, DOI 10.1016/S0014-5793(02)03188-5; KANWAR YS, 1981, RENAL PHYSIOL BIOCH, V4, P121; Kaplan J, 2001, CURR OPIN NEPHROL HY, V10, P183, DOI 10.1097/00041552-200103000-00005; Kaplan JM, 2000, NAT GENET, V24, P251, DOI 10.1038/73456; KELLEY VE, 1972, LAB INVEST, V27, P149; KERJASCHKI D, 1989, J IMMUNOL, V143, P546; Kerjaschki D, 1997, J CLIN INVEST, V100, P2303, DOI 10.1172/JCI119768; KIM J, UNPUB; KORBET SM, 1985, MEDICINE, V64, P228, DOI 10.1097/00005792-198507000-00004; Kriz W, 2002, MICROSC RES TECHNIQ, V57, P189, DOI 10.1002/jemt.10072; Lemmon SK, 2000, CURR OPIN CELL BIOL, V12, P457, DOI 10.1016/S0955-0674(00)00117-4; MOUNT SM, 1982, NUCLEIC ACIDS RES, V10, P459, DOI 10.1093/nar/10.2.459; Petrelli A, 2002, NATURE, V416, P187, DOI 10.1038/416187a; RENNKE HG, 1975, J CELL BIOL, V67, P638, DOI 10.1083/jcb.67.3.638; ROSENMANN E, 1977, NEPHRON, V18, P301, DOI 10.1159/000180846; SEILER MW, 1975, SCIENCE, V189, P390, DOI 10.1126/science.1145209; Shih NY, 1999, SCIENCE, V286, P312, DOI 10.1126/science.286.5438.312; Soubeyran P, 2002, NATURE, V416, P183, DOI 10.1038/416183a; Tucker JK, 2002, AM J MED SCI, V323, P90, DOI 10.1097/00000441-200202000-00006; XIAO W, 2001, HUM MUTAT, V17, P349; Yo Y, 2003, NEPHRON EXP NEPHROL, V93, P92, DOI 10.1159/000069551	23	364	410	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 23	2003	300	5623					1298	1300		10.1126/science.1081068	http://dx.doi.org/10.1126/science.1081068			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681NN	12764198				2022-12-24	WOS:000183042400051
J	Sanford, E; Roth, MS; Johns, GC; Wares, JP; Somero, GN				Sanford, E; Roth, MS; Johns, GC; Wares, JP; Somero, GN			Local selection and latitudinal variation in a marine predator-prey interaction	SCIENCE			English	Article							GEOGRAPHIC-VARIATION; INTERACTION STRENGTH; GRADIENT; BIOGEOGRAPHY; EVOLUTION	Although pairs of species often interact over broad geographic ranges, few studies have explored how interactions vary across these large spatial scales. Surveys along 1500 kilometers of the Pacific coast of North America documented marked variation in the frequency of predation by the snail Nucella canaliculata on the intertidal mussel Mytilus californianus. Laboratory rearing experiments suggest that regional differences in drilling behavior have a genetic basis, and mitochondrial sequence variation confirms that gene flow is low among these snail populations. Marine communities separated by hundreds of kilometers may have intrinsically different dynamics, with interactions shaped by restricted gene flow and spatially varying selection.	Stanford Univ, Hopkins Marine Stn, Pacific Grove, CA 93950 USA; Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA; Univ Calif Davis, Ctr Populat Biol, Davis, CA 95616 USA	Stanford University; Brown University; University of California System; University of California Davis	Sanford, E (corresponding author), Stanford Univ, Hopkins Marine Stn, Pacific Grove, CA 93950 USA.	eric_sanford@brown.edu	Somero, George/AAC-3321-2019	Somero, George/0000-0003-1431-6455; Roth, Melissa/0000-0001-7389-5982; Wares, John/0000-0003-1827-0669				Barber PH, 2000, NATURE, V406, P692, DOI 10.1038/35021135; BRAY NA, 1993, J GEOPHYS RES-OCEANS, V98, P18119, DOI 10.1029/93JC01142; Brown JH, 1995, MACROECOLOGY; Connolly SR, 1998, AM NAT, V151, P311, DOI 10.1086/286121; Connolly SR, 2001, ECOLOGY, V82, P1799, DOI 10.2307/2680048; Dawson MN, 2001, J BIOGEOGR, V28, P723, DOI 10.1046/j.1365-2699.2001.00572.x; DETHIER MN, 1988, MAR ECOL PROG SER, V50, P97, DOI 10.3354/meps050097; DUNGAN ML, 1982, SCIENCE, V216, P989, DOI 10.1126/science.216.4549.989; Endler J.A., 1977, Monographs in Population Biology, pi; Endler J. A., 1999, GEOGRAPHIC VARIATION; Grosberg R, 2001, MARINE COMMUNITY ECOLOGY, P61; Hellberg ME, 2001, SCIENCE, V292, P1707, DOI 10.1126/science.1060102; LEIGHTON BJ, 1991, DIS AQUAT ORGAN, V10, P71, DOI 10.3354/dao010071; Marko PB, 1998, EVOLUTION, V52, P757, DOI 10.1111/j.1558-5646.1998.tb03700.x; MENGE BA, 1994, ECOL MONOGR, V64, P249, DOI 10.2307/2937163; Navarrete SA, 1996, ECOL MONOGR, V66, P409, DOI 10.2307/2963488; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; PAINE RT, 1974, OECOLOGIA, V15, P93, DOI 10.1007/BF00345739; Power ME, 1996, BIOSCIENCE, V46, P609, DOI 10.2307/1312990; SANFORD E, UNPUB; Sotka EE, 2002, ECOLOGY, V83, P2721, DOI 10.2307/3072010; SOTKA EE, UNPUB; Stachowicz JJ, 2000, AM NAT, V156, P59, DOI 10.1086/303366; Suchanek T.H., 1986, ECOLOGY ROCKY COASTS, P71; Taylor MS, 2003, SCIENCE, V299, P107, DOI 10.1126/science.1079365; Thompson JN, 1998, TRENDS ECOL EVOL, V13, P329, DOI 10.1016/S0169-5347(98)01378-0	26	116	116	1	114	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 16	2003	300	5622					1135	+		10.1126/science.1083437	http://dx.doi.org/10.1126/science.1083437			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678VC	12750518				2022-12-24	WOS:000182886500042
J	Dunn, N				Dunn, N			10-minute consultation - Adverse drug event	BRITISH MEDICAL JOURNAL			English	Article									Univ Southampton, Sch Med, Southampton SO16 5ST, Hants, England	University of Southampton	Dunn, N (corresponding author), Univ Southampton, Sch Med, Southampton SO16 5ST, Hants, England.								0	1	2	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 10	2003	326	7397					1018	1018		10.1136/bmj.326.7397.1018	http://dx.doi.org/10.1136/bmj.326.7397.1018			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	679KG	12742925	Bronze, Green Published			2022-12-24	WOS:000182920500019
J	Tsuda, A; Takeda, S; Saito, H; Nishioka, J; Nojiri, Y; Kudo, I; Kiyosawa, H; Shiomoto, A; Imai, K; Ono, T; Shimamoto, A; Tsumune, D; Yoshimura, T; Aono, T; Hinuma, A; Kinugasa, M; Suzuki, K; Sohrin, Y; Noiri, Y; Tani, H; Deguchi, Y; Tsurushima, N; Ogawa, H; Fukami, K; Kuma, K; Saino, T				Tsuda, A; Takeda, S; Saito, H; Nishioka, J; Nojiri, Y; Kudo, I; Kiyosawa, H; Shiomoto, A; Imai, K; Ono, T; Shimamoto, A; Tsumune, D; Yoshimura, T; Aono, T; Hinuma, A; Kinugasa, M; Suzuki, K; Sohrin, Y; Noiri, Y; Tani, H; Deguchi, Y; Tsurushima, N; Ogawa, H; Fukami, K; Kuma, K; Saino, T			A mesoscale iron enrichment in the western Subarctic Pacific induces a large centric diatom bloom	SCIENCE			English	Article							PHYTOPLANKTON BLOOM; SOUTHERN-OCEAN; FERTILIZATION; PRODUCTIVITY	We have performed an in situ test of the iron limitation hypothesis in the subarctic North Pacific Ocean. A single enrichment of dissolved iron caused a large increase in phytoplankton standing stock and decreases in macronutrients and dissolved carbon dioxide. The dominant phytoplankton species shifted after the iron addition from pennate diatoms to a centric diatom, Chaetoceros debilis, that showed a very high growth rate, 2.6 doublings per day. We conclude that the bioavailability of iron regulates the magnitude of the phytoplankton biomass and the key phytoplankton species that determine the biogeochemical sensitivity to iron supply of high-nitrate, low-chlorophyll waters.	Hokkaido Natl Res Inst, Kushira, Hokkaido 0850802, Japan; Univ Tokyo, Dept Aquat Biosci, Bunkyo Ku, Tokyo 1138657, Japan; Tohoku Natl Fisheries Res Inst, Shiogama, Miyagi 9850001, Japan; Cent Res Inst Elect Power Ind, Chiba 2701194, Japan; Natl Inst Environm Studies, Tsukuba, Ibaraki 3058506, Japan; Hokkaido Univ, Grad Sch Fisheries Sci, Hakodate, Hokkaido 0418611, Japan; Marine Biol Res Inst Japan, Shinagawa Ku, Tokyo 1420042, Japan; Natl Res Inst Far Seas Fisheries, Shizuoka 4248633, Japan; Japan Sci & Technol Corp, Kawaguchi, Saitama 3320012, Japan; Kansai Environm Engn Ctr, Osaka 5410052, Japan; Natl Inst Radiol Sci, Hitachinaka, Ibaraki 3111202, Japan; Nagoya Univ, Hydrospher Atmospher Res Ctr, Chikusa Ku, Nagoya, Aichi 4648601, Japan; Kyoto Univ, Inst Chem Res, Kyoto 6110011, Japan; Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058569, Japan; Univ Tokyo, Ocean Res Inst, Nakano Ku, Tokyo 1648639, Japan; Kochi Univ, Nanko Ku, Kochi 7838502, Japan	University of Tokyo; Japan Fisheries Research & Education Agency (FRA); Central Research Institute of Electric Power Industry - Japan; National Institute for Environmental Studies - Japan; Hokkaido University; Japan Fisheries Research & Education Agency (FRA); Japan Science & Technology Agency (JST); National Institutes for Quantum Science & Technology; Nagoya University; Kyoto University; National Institute of Advanced Industrial Science & Technology (AIST); University of Tokyo; Kochi University	Tsuda, A (corresponding author), Univ Tokyo, Ocean Res Inst, Nakano Ku, Tokyo 1648639, Japan.		SAITO, HIROAKI/J-6948-2017; Nojiri, Yukihiro/D-1999-2010; Suzuki, Koji/GVS-9807-2022; Kuma, Kenshi/B-2799-2012; 毅, 芳村/M-1778-2017; Nishioka, Jun/F-5314-2011; Tsurushima, Nobuo/L-6336-2018; Suzuki, Koji/A-4349-2013; Suzuki, Koji/AAD-2630-2022; Sohrin, Yoshiki/A-8133-2011	SAITO, HIROAKI/0000-0002-5502-9076; Nojiri, Yukihiro/0000-0001-9885-9195; Suzuki, Koji/0000-0001-5354-1044; Kuma, Kenshi/0000-0001-8851-5997; 毅, 芳村/0000-0001-5700-2590; Nishioka, Jun/0000-0003-1723-9344; Tsurushima, Nobuo/0000-0002-4741-7482; Suzuki, Koji/0000-0001-5354-1044; Sohrin, Yoshiki/0000-0001-6744-6048; Takeda, Shigenobu/0000-0002-4997-1583				Bishop JKB, 2002, SCIENCE, V298, P817, DOI 10.1126/science.1074961; Boyd PW, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014210; Boyd PW, 2000, NATURE, V407, P695, DOI 10.1038/35037500; Boyd PW, 2001, DEEP-SEA RES PT II, V48, P2529, DOI 10.1016/S0967-0645(01)00007-8; Broecker WS, 1998, PALEOCEANOGRAPHY, V13, P352, DOI 10.1029/98PA00920; Cavender-Bares KK, 1999, LIMNOL OCEANOGR, V44, P237, DOI 10.4319/lo.1999.44.2.0237; CHISHOLM SW, 1991, LIMNOL OCEANOGR, V36, pU1507; Coale KH, 1996, NATURE, V383, P495, DOI 10.1038/383495a0; Dalton R, 2002, NATURE, V420, P722, DOI 10.1038/420722a; DUCE RA, 1991, LIMNOL OCEANOGR, V36, P1715, DOI 10.4319/lo.1991.36.8.1715; Falkowski PG, 1998, SCIENCE, V281, P200, DOI 10.1126/science.281.5374.200; Fung IY, 2000, GLOBAL BIOGEOCHEM CY, V14, P281, DOI 10.1029/1999GB900059; Harrison PJ, 1999, PROG OCEANOGR, V43, P205, DOI 10.1016/S0079-6611(99)00015-4; KUDO I, UNPUB; KUMAR N, 1995, NATURE, V378, P675, DOI 10.1038/378675a0; MARTIN JH, 1994, NATURE, V371, P123, DOI 10.1038/371123a0; Martin JH, 1990, PALEOCEANOGRAPHY, V5, P1, DOI 10.1029/PA005i001p00001; McQuoid MR, 1996, J PHYCOL, V32, P889, DOI 10.1111/j.0022-3646.1996.00889.x; NISHIOKA J, IN PRESS GEOPHYS RES; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; SAINO T, 1990, J OCEANOGR, V54, P583; Suzuki Y, 1995, J PHYCOL, V31, P880, DOI 10.1111/j.0022-3646.1995.00880.x	22	391	415	4	116	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 9	2003	300	5621					958	961		10.1126/science.1082000	http://dx.doi.org/10.1126/science.1082000			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675WD	12738858				2022-12-24	WOS:000182719800050
J	Evenson, RE; Gollin, D				Evenson, RE; Gollin, D			Assessing the impact of the Green Revolution, 1960 to 2000	SCIENCE			English	Review								We summarize the findings of a recently completed study of the productivity impacts of international crop genetic improvement research in developing countries. Over the period 1960 to 2000, international agricultural research centers, in collaboration with national research programs, contributed to the development of "modern varieties" for many crops. These varieties have contributed to large increases in crop production. Productivity gains, however, have been uneven across crops and regions. Consumers generally benefited from declines in food prices. Farmers benefited only where cost reductions exceeded price reductions.	Yale Univ, Dept Econ, New Haven, CT 06520 USA; Williams Coll, Dept Econ, Williamstown, MA 01267 USA	Yale University; Williams College	Evenson, RE (corresponding author), Yale Univ, Dept Econ, New Haven, CT 06520 USA.							[Anonymous], 2003, CROP VARIETY IMPROVE; Dalrymple DG, 1986, Development and spread of high -yielding wheat varieties in developing countries, V7th; DALTON TJ, 2003, CROP VARIETY IMPROVE, pCH6; EVENSON RE, 2003, CROP VARIET IMPROVEM, pCH23; EVENSON RE, 2003, CROP VFARIETY IMPROV, pCH21; Griffin K., 1979, POLITICAL EC AGRARIA; Hewitt de Alcantara Cynthia, 1976, MODERNIZING MEXICAN; JOHNSON NL, 2003, CROP VARIETY IMPROVE, pCH16; JOHNSON NL, 2003, CROP VARIETY IMPROVE, pCH12; MANYONG VM, 2003, CROP VARIETY IMPROVE, pCH8; MCKINSEY JW, 2003, CROP VARIETY IMPROVE, pCH19; Shiva V, 1993, MONOCULTURES MIND PE	12	1065	1111	22	590	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 2	2003	300	5620					758	762		10.1126/science.1078710	http://dx.doi.org/10.1126/science.1078710			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673KH	12730592				2022-12-24	WOS:000182579800038
J	Abbott, A; Oyranoski, D				Abbott, A; Oyranoski, D			Biologists seek to head off future sources of infection	NATURE			English	News Item																			0	7	8	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 1	2003	423	6935					3	3		10.1038/423003b	http://dx.doi.org/10.1038/423003b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673CG	12721586	Green Published, Bronze			2022-12-24	WOS:000182561600004
J	Gayle, HD				Gayle, HD			Curbing the global AIDS epidemic	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							TRANSMISSION; HIV-1		Bill & Melinda Gates Fdn, Seattle, WA USA	Bill & Melinda Gates Foundation	Gayle, HD (corresponding author), Bill & Melinda Gates Fdn, Seattle, WA USA.							Blower S, 2001, AIDS, V15, P1309, DOI 10.1097/00002030-200107060-00014; Coates TJ, 2000, LANCET, V356, P103, DOI 10.1016/S0140-6736(00)02446-6; de Ven PV, 1999, AIDS, V13, P2289, DOI 10.1097/00002030-199911120-00011; DESJARLAIS DC, 1995, JAMA-J AM MED ASSOC, V274, P1226, DOI 10.1001/jama.274.15.1226; Ford K, 1996, AIDS, V10, P213, DOI 10.1097/00002030-199602000-00013; *GLOB HIV PREV WOR, 2002, GLOB MOB HIV PREV BL; Gray RH, 2001, LANCET, V357, P1149, DOI 10.1016/S0140-6736(00)04331-2; GROSSKURTH H, 1995, LANCET, V346, P530, DOI 10.1016/S0140-6736(95)91380-7; Guay LA, 1999, LANCET, V354, P795, DOI 10.1016/S0140-6736(99)80008-7; Jha P, 2002, SCIENCE, V295, P2036, DOI 10.1126/science.295.5562.2036; *NAT INT COUNC, 2002, NIC PUBL ICA; *PROGR COORD BOARD, 2002, REP PROGR COORD BOAR; Stover J, 2002, LANCET, V360, P73, DOI 10.1016/S0140-6736(02)09339-X; *UNAIDS, 2002, REP GLOB HIV AIDS EP; WHO, 2002, SCAL ANT THER RES LI	15	17	17	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 1	2003	348	18					1802	1805		10.1056/NEJMsb030352	http://dx.doi.org/10.1056/NEJMsb030352			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	672VK	12724488				2022-12-24	WOS:000182543500011
J	Balague, F; Dudler, J; Nordin, M				Balague, F; Dudler, J; Nordin, M			Low-back pain in children	LANCET			English	Editorial Material									Hop Cantonal Fribourg, Serv Rhumatol Med Phys & Rehabil, CH-1708 Fribourg, Switzerland; CHU Vaudois, Serv Rhumatol Med Phys & Rehabil, CH-1011 Lausanne, Switzerland; NYU Med Ctr, Hosp Joint Dis, Occupat & Ind Orthoped Ctr, New York, NY 10016 USA	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); New York University; NYU Langone Medical Center; Hospital for Joint Disease NYULMC	Balague, F (corresponding author), Hop Cantonal Fribourg, Serv Rhumatol Med Phys & Rehabil, CH-1708 Fribourg, Switzerland.			Dudler, Jean/0000-0001-8533-5800				Chambers CT, 1997, ARCH PEDIAT ADOL MED, V151, P449, DOI 10.1001/archpedi.1997.02170420019003; de Inocencio J, 1998, PEDIATRICS, V102, part. no., DOI 10.1542/peds.102.6.e63; KING AJC, 1992, HLTH CANADAS YOUTH V; Roese I, 1996, Rehabilitation (Stuttg), V35, P103; Silman A., 2001, EPIDEMIOLOGY RHEUMAT, V2nd; Waddell G, 2002, BACK PAIN INCAPACITY; Watson KD, 2003, ARCH DIS CHILD, V88, P12, DOI 10.1136/adc.88.1.12; Watson KD, 2002, PAIN, V97, P87, DOI 10.1016/S0304-3959(02)00008-8	8	54	55	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 26	2003	361	9367					1403	1404		10.1016/S0140-6736(03)13148-0	http://dx.doi.org/10.1016/S0140-6736(03)13148-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	672HZ	12727390				2022-12-24	WOS:000182516300005
J	Grossman, SR; Deato, ME; Brignone, C; Chan, HM; Kung, AL; Tagami, H; Nakatani, Y; Livingston, DM				Grossman, SR; Deato, ME; Brignone, C; Chan, HM; Kung, AL; Tagami, H; Nakatani, Y; Livingston, DM			Polyubiquitination of p53 by a ubiquitin ligase activity of p300	SCIENCE			English	Article							PROTEASOME-MEDIATED DEGRADATION; PROTEIN; BINDING; MDM2; COMPLEXES; PROMOTES	Rapid turnover of the tumor suppressor protein p53 requires the MDM2 ubiquitin ligase, and both interact with p300-CREB-binding protein transcriptional coactivator proteins. p53 is stabilized by the binding of p300 to the oncoprotein E1A, suggesting that p300 regulates p53 degradation. Purified p300 exhibited intrinsic ubiquitin ligase activity that was inhibited by E1A. In vitro, p300 with MDM2 catalyzed p53 polyubiquitination, whereas MDM2 catalyzed p53 monoubiquitination. E1A expression caused a decrease in polyubiquitinated but not monoubiquitinated p53 in cells. Thus, generation of the polyubiquitinated forms of p53 that are targeted for proteasome degradation requires the intrinsic ubiquitin ligase activities of MDM2 and p300.	Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Adult Oncol, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Livingston, DM (corresponding author), Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA.		Kung, Andrew/AAL-2384-2020; Kung, Andrew L/AEU-0826-2022	Kung, Andrew L/0000-0002-9091-488X	NATIONAL CANCER INSTITUTE [R01CA015751, R37CA015751] Funding Source: NIH RePORTER; NCI NIH HHS [CA15751] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Chiou SK, 1997, J VIROL, V71, P3515, DOI 10.1128/JVI.71.5.3515-3525.1997; Conaway RC, 2002, SCIENCE, V296, P1254, DOI 10.1126/science.1067466; Grossman SR, 1998, MOL CELL, V2, P405, DOI 10.1016/S1097-2765(00)80140-9; Grossman SR, 2001, EUR J BIOCHEM, V268, P2773, DOI 10.1046/j.1432-1327.2001.02226.x; Hatakeyama S, 2001, J BIOL CHEM, V276, P33111, DOI 10.1074/jbc.M102755200; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hochstrasser M, 2000, NAT CELL BIOL, V2, pE153, DOI 10.1038/35019643; Ito A, 2002, EMBO J, V21, P6236, DOI 10.1093/emboj/cdf616; Koegl M, 1999, CELL, V96, P635, DOI 10.1016/S0092-8674(00)80574-7; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Kurokawa R, 1998, SCIENCE, V279, P700, DOI 10.1126/science.279.5351.700; Lai ZH, 2001, J BIOL CHEM, V276, P31357, DOI 10.1074/jbc.M011517200; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; Maki CG, 1996, CANCER RES, V56, P2649; Pickart CM, 2000, TRENDS BIOCHEM SCI, V25, P544, DOI 10.1016/S0968-0004(00)01681-9; Prives C, 1999, J PATHOL, V187, P112; Querido E, 1997, J VIROL, V71, P3526, DOI 10.1128/JVI.71.5.3526-3533.1997; Rodriguez MS, 2000, MOL CELL BIOL, V20, P8458, DOI 10.1128/MCB.20.22.8458-8467.2000; Zhu QZ, 2001, CANCER RES, V61, P64; Zhu QZ, 2001, J BIOL CHEM, V276, P29695, DOI 10.1074/jbc.M102634200	20	373	386	1	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 11	2003	300	5617					342	344		10.1126/science.1080386	http://dx.doi.org/10.1126/science.1080386			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665RQ	12690203				2022-12-24	WOS:000182135400061
J	Brennecke, J; Hipfner, DR; Stark, A; Russell, RB; Cohen, SM				Brennecke, J; Hipfner, DR; Stark, A; Russell, RB; Cohen, SM			bantam encodes a developmentally regulated microRNA that controls cell proliferation and regulates the proapoptotic gene hid in Drosophila	CELL			English	Article							SMALL RNAS; WINGLESS; GROWTH; EXPRESSION; SURVIVAL; ELEGANS; MYC; IDENTIFICATION; INITIATION; APOPTOSIS	Cell proliferation, cell death, and pattern formation are coordinated in animal development. Although many proteins that control cell proliferation and apoptosis have been identified, the means by which these effectors are linked to the patterning machinery remain poorly understood. Here, we report that the bantam gene of Drosophila encodes a 21 nucleotide microRNA that promotes tissue growth. bantam expression is temporally and spatially regulated in response to patterning cues. bantam microRNA simultaneously stimulates cell proliferation and prevents apoptosis. We identify the pro-apoptotic gene hid as a target for regulation by bantam miRNA, providing an explanation for bantam's anti-apoptotic activity.	European Mol Biol Lab, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Cohen, SM (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.	cohen@embl.de	Cohen, Stephen M/G-9930-2011; Russell, Robert/GWU-6389-2022; Brennecke, Julius/C-1626-2015; Stark, Alexander/D-1473-2012; Brennecke, Julius/T-5883-2019; Russell, Rob/AAH-9145-2019	Cohen, Stephen M/0000-0003-2858-9163; Russell, Robert/0000-0002-7213-1398; Brennecke, Julius/0000-0002-5141-0814; Stark, Alexander/0000-0003-2611-0841; Brennecke, Julius/0000-0002-5141-0814; Russell, Rob/0000-0002-1905-4717				Ambros V, 2000, CURR OPIN GENET DEV, V10, P428, DOI 10.1016/S0959-437X(00)00108-8; Ambros V, 2001, CELL, V107, P823, DOI 10.1016/S0092-8674(01)00616-X; Baonza A, 2000, P NATL ACAD SCI USA, V97, P2609, DOI 10.1073/pnas.040576497; Baulcombe D, 2002, SCIENCE, V297, P2002, DOI 10.1126/science.1077906; Bergmann A, 1998, CELL, V95, P331, DOI 10.1016/S0092-8674(00)81765-1; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Cadigan KM, 1998, CELL, V93, P767, DOI 10.1016/S0092-8674(00)81438-5; Carmell MA, 2002, GENE DEV, V16, P2733, DOI 10.1101/gad.1026102; Chen CM, 1999, DEVELOPMENT, V126, P5441; Conlon I, 1999, CELL, V96, P235, DOI 10.1016/S0092-8674(00)80563-2; Datar SA, 2000, EMBO J, V19, P4543, DOI 10.1093/emboj/19.17.4543; DECELIS JF, 1994, MECH DEVELOP, V46, P109, DOI 10.1016/0925-4773(94)90080-9; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; DURMANSCHEEL M, 2002, NATURE, V417, P299; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; EVAN G, 1994, PHILOS T R SOC B, V345, P269, DOI 10.1098/rstb.1994.0105; Go MJ, 1998, DEVELOPMENT, V125, P2031; GRETHER ME, 1995, GENE DEV, V9, P1694, DOI 10.1101/gad.9.14.1694; Hipfner DR, 2002, GENETICS, V161, P1527; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Johnston LA, 1998, NATURE, V394, P82, DOI 10.1038/27925; Johnston LA, 2002, BIOESSAYS, V24, P54, DOI 10.1002/bies.10021; Johnston LA, 1999, CELL, V98, P779, DOI 10.1016/S0092-8674(00)81512-3; Kurada P, 1998, CELL, V95, P319, DOI 10.1016/S0092-8674(00)81764-X; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Llave C, 2002, PLANT CELL, V14, P1605, DOI 10.1105/tpc.003210; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Martin-Castellanos C, 2002, DEVELOPMENT, V129, P1003; Martinez J, 2002, CELL, V110, P563, DOI 10.1016/S0092-8674(02)00908-X; Mata J, 2000, CELL, V101, P511, DOI 10.1016/S0092-8674(00)80861-2; Meyer CA, 2000, EMBO J, V19, P4533, DOI 10.1093/emboj/19.17.4533; Moreno E, 2002, NATURE, V416, P755, DOI 10.1038/416755a; Mourelatos Z, 2002, GENE DEV, V16, P720, DOI 10.1101/gad.974702; Neufeld TP, 1998, CELL, V93, P1183, DOI 10.1016/S0092-8674(00)81462-2; Neumann C, 1997, BIOESSAYS, V19, P721, DOI 10.1002/bies.950190813; Neumann CJ, 1997, DEVELOPMENT, V124, P871; Neumann CJ, 1996, DEVELOPMENT, V122, P1781; OBROCHTA DA, 1985, NATURE, V313, P138, DOI 10.1038/313138a0; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Ortega S, 2002, BBA-REV CANCER, V1602, P73, DOI 10.1016/S0304-419X(02)00037-9; Pasquinelli AE, 2002, ANNU REV CELL DEV BI, V18, P495, DOI 10.1146/annurev.cellbio.18.012502.105832; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Pelengaris S, 2002, CELL, V109, P321, DOI 10.1016/S0092-8674(02)00738-9; PHILLIPS RG, 1993, DEVELOPMENT, V118, P427; Prober DA, 2000, CELL, V100, P435, DOI 10.1016/S0092-8674(00)80679-0; Prober DA, 2002, GENE DEV, V16, P2286, DOI 10.1101/gad.991102; Prober DA, 2001, CURR OPIN GENET DEV, V11, P19, DOI 10.1016/S0959-437X(00)00151-9; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Reinscheid RK, 2000, PEPTIDES, V21, P901, DOI 10.1016/S0196-9781(00)00226-6; Rorth P, 1996, P NATL ACAD SCI USA, V93, P12418, DOI 10.1073/pnas.93.22.12418; Ruvkun G, 2001, SCIENCE, V294, P797, DOI 10.1126/science.1066315; Slack FJ, 2000, MOL CELL, V5, P659, DOI 10.1016/S1097-2765(00)80245-2; Stocker H, 2000, CURR OPIN GENET DEV, V10, P529, DOI 10.1016/S0959-437X(00)00123-4; Teleman AA, 2001, CELL, V105, P559, DOI 10.1016/S0092-8674(01)00377-4; Thompson B, 2002, NAT CELL BIOL, V4, P367, DOI 10.1038/ncb786; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Yoo SJ, 2002, NAT CELL BIOL, V4, P416, DOI 10.1038/ncb793; Yu SY, 2002, DEVELOPMENT, V129, P3269; Zeng WL, 2000, NATURE, V403, P789, DOI 10.1038/35001615; Zeng Y, 2002, MOL CELL, V9, P1327, DOI 10.1016/S1097-2765(02)00541-5; Zhang J, 1998, DEVELOPMENT, V125, P3075	66	1612	1811	3	117	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 4	2003	113	1					25	36		10.1016/S0092-8674(03)00231-9	http://dx.doi.org/10.1016/S0092-8674(03)00231-9			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	668GX	12679032	Bronze			2022-12-24	WOS:000182282900004
J	Wilf, P; Cuneo, NR; Johnson, KR; Hicks, JF; Wing, SL; Obradovich, JD				Wilf, P; Cuneo, NR; Johnson, KR; Hicks, JF; Wing, SL; Obradovich, JD			High plant diversity in Eocene South America: Evidence from Patagonia	SCIENCE			English	Article							RAIN-FOREST; CLIMATE; VEGETATION; HISTORY; HYPOTHESIS; SPECIATION; EVOLUTION; TAPHONOMY; AMAZONIA; TERTIARY	Tropical South America has the highest plant diversity of any region today, but this richness is usually characterized as a geologically recent development (Neogene or Pleistocene). From caldera-lake beds exposed at Laguna del Hunco in Patagonia, Argentina, paleolatitude similar to47degreesS, we report 102 leaf species. Radioisotopic and paleomagnetic analyses indicate that the. ora was deposited 52 million years ago, the time of the early Eocene climatic optimum, when tropical plant taxa and warm, equable climates reached middle latitudes of both hemispheres. Adjusted for sample size, observed richness exceeds that of any other Eocene leaf. ora, supporting an ancient history of high plant diversity in warm areas of South America.	Penn State Univ, Dept Geosci, University Pk, PA 16802 USA; Univ Michigan, Museum Paleontol, Ann Arbor, MI 48109 USA; Univ Penn, Dept Earth & Environm Sci, Philadelphia, PA 19104 USA; Museo Paleontol Egidio Feruglio, RA-9100 Trelew, Chubut, Argentina; Denver Museum Nat & Sci, Dept Earth Sci, Denver, CO 80205 USA; Smithsonian Inst, Dept Paleobiol, Washington, DC 20560 USA; US Geol Survey, Lakewood, CO 80225 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Michigan System; University of Michigan; University of Pennsylvania; Smithsonian Institution; Smithsonian National Museum of Natural History; United States Department of the Interior; United States Geological Survey	Wilf, P (corresponding author), Penn State Univ, Dept Geosci, University Pk, PA 16802 USA.	pwilf@geosc.psu.edu		Wilf, Peter/0000-0001-6813-1937; Wing, Scott/0000-0002-2954-8905				[Anonymous], 1994, PALAEOCLIMATES; [Anonymous], 1925, J HOPKINS U STUD GEO; [Anonymous], 1978, COURIER FORSCHUNGSIN; ARAGON E., 1997, REV ASOC GEOL ARGENT, V52, P243; ARAUJO D.S.D., 1997, CENTRES PLANT DIVERS, V3, P373; ARCHANGELSKY S, 1974, AMEGHINIANA, V11, P413; Behrensmeyer AK, 2000, PALEOBIOLOGY, V26, P103, DOI 10.1666/0094-8373(2000)26[103:TAP]2.0.CO;2; Berry E.W., 1938, GEOLOGICAL SOC AM SP, V12, P1, DOI DOI 10.1130/SPE12-P1; Burnham RJ, 1999, ANN MO BOT GARD, V86, P546, DOI 10.2307/2666185; BURNHAM RJ, 1994, US GEOLOGICAL SURVEY, V2085, P1; Burry EW, 1925, P NATL ACAD SCI USA, V11, P404, DOI 10.1073/pnas.11.7.404; BUSH MB, 1994, J BIOGEOGR, V21, P5, DOI 10.2307/2845600; CHRISTOPHEL DC, 1980, AUST J BOT, V28, P249, DOI 10.1071/BT9800249; Colinvaux PA, 2001, PALAEOGEOGR PALAEOCL, V166, P51, DOI 10.1016/S0031-0182(00)00201-7; Colinvaux PA, 2001, AMAZONIANA, V16, P609; Cowling SA, 2001, QUATERNARY RES, V55, P140, DOI 10.1006/qres.2000.2197; Davies-Vollum KS, 1998, PALAIOS, V13, P28, DOI 10.2307/3515279; DUTTONG AL, 2002, PALEOCEANOGRAPHY, V17, DOI DOI 10.1029/2000PA000503; Evanoff E., 2001, P DENVER MUSEUM NA 4, V1, P1; FISHER R, 1953, PROC R SOC LON SER-A, V217, P295, DOI 10.1098/rspa.1953.0064; GENTRY AH, 1988, P NATL ACAD SCI USA, V85, P156, DOI 10.1073/pnas.85.1.156; GREENWOOD DR, 1995, GEOLOGY, V23, P1044, DOI 10.1130/0091-7613(1995)023<1044:ECCALT>2.3.CO;2; GREENWOOD DR, IN PRESS GEOL SOC, V369; Haberle SG, 1999, QUATERNARY RES, V51, P27, DOI 10.1006/qres.1998.2020; HAFFER J, 1969, SCIENCE, V165, P131, DOI 10.1126/science.165.3889.131; Haffer J, 2001, AMAZONIANA, V16, P579; Hay WW, 1999, GEOL S AM S, P1; Herendeen PS, 2000, AM J BOT, V87, P1358, DOI 10.2307/2656727; Hill RS, 1999, AUST J BOT, V47, P639, DOI 10.1071/BT98093; HILL RS, 1994, HIST AUSTR VEGETATIO, P390; HOORN C, 1994, PALAEOGEOGR PALAEOCL, V109, P1, DOI 10.1016/0031-0182(94)90117-1; Jaramillo CA, 2002, PALEOBIOLOGY, V28, P222, DOI 10.1666/0094-8373(2002)028<0222:ROTVTP>2.0.CO;2; Johnson KR, 2002, SCIENCE, V296, P2379, DOI 10.1126/science.1072102; Kershaw P, 2001, ANNU REV ECOL SYST, V32, P397, DOI 10.1146/annurev.ecolsys.32.081501.114059; KIRSCHVINK JL, 1980, GEOPHYS J ROY ASTR S, V62, P699, DOI 10.1111/j.1365-246X.1980.tb02601.x; MacGinitie H.D., 1969, U CALIF PUBLS GEOL S, V83, P1; MacGINITIE HARRY D., 1953, CARNEGIE INST WASHINGTON PUBL, V599, P1; MacGinitie HD., 1941, CARNEGIE I WASHINGTO, V534, P1; Manchester S. R., 2001, PROC DENVER MUS NAT, V4, P137; Marshall L.G., 1990, Revista Geologica de Chile, V17, P57; Mazzoni M. M., 1991, REV ASOC GEOL ARGENT, V46, P150; Melchor RN, 2002, PALAIOS, V17, P16, DOI 10.1669/0883-1351(2002)017<0016:ISAPOE>2.0.CO;2; Morley R.J., 2000, ORIGIN EVOLUTION TRO; Nores M, 1999, J BIOGEOGR, V26, P475, DOI 10.1046/j.1365-2699.1999.t01-1-00311.x; PASSMORE SM, 2002, GEOLOGICAL SOC AM AB, V34, P556; Petersen C.S., 1946, B DIRECCION GEN MINA, V59, P1; RAMOS VA, 2000, TECTONIC EVOLUTION S, P561; Remy R.R., 1992, US GEOL SURV B, VB1787BB, P1; Richardson JE, 2001, SCIENCE, V293, P2242, DOI 10.1126/science.1061421; ROMERO EJ, 1986, ANN MO BOT GARD, V73, P449, DOI 10.2307/2399123; ROMERO EJ, 1993, BIOLOGICAL RELATIONSHIPS BETWEEN AFRICA AND SOUTH AMERICA, P62; ROMERO EJ, 1976, B TORREY BOT CLUB, V103, P126, DOI 10.2307/2484888; Rull V, 1999, REV PALAEOBOT PALYNO, V107, P83, DOI 10.1016/S0034-6667(99)00014-7; SPICER RA, 1987, PALEOBIOLOGY, V13, P227; van der Hammen T, 2000, QUATERNARY SCI REV, V19, P725, DOI 10.1016/S0277-3791(99)00024-4; Villagran C, 1997, REV CHIL HIST NAT, V70, P241; Wilde V, 1998, REV PALAEOBOT PALYNO, V101, P7, DOI 10.1016/S0034-6667(97)00067-5; Wilf P, 1997, PALEOBIOLOGY, V23, P373, DOI 10.1017/S0094837300019746; Wilf P, 2000, GEOL SOC AM BULL, V112, P292, DOI 10.1130/0016-7606(2000)112<0292:LPEECC>2.3.CO;2; Wilf P, 1998, GEOLOGY, V26, P203, DOI 10.1130/0091-7613(1998)026<0203:UFLAPI>2.3.CO;2; Wilf P, 2001, P NATL ACAD SCI USA, V98, P6221, DOI 10.1073/pnas.111069498; Wing S., 2000, WARM CLIMATES EARTH, V7, P197; WING SL, 1993, PHILOS T ROY SOC B, V341, P243, DOI 10.1098/rstb.1993.0109; Wolfe J.A., 1987, S GEO SURV B, V1597, P1; Wolfe JA, 1998, GEOL SOC AM BULL, V110, P664, DOI 10.1130/0016-7606(1998)110<0664:PEOEAO>2.3.CO;2; WOLFE JA, 1989, PALEOBIOLOGY, V15, P180, DOI 10.1017/S0094837300009350; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; ZACHOS JC, 1994, PALEOCEANOGRAPHY, V9, P353, DOI 10.1029/93PA03266	68	215	229	1	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 4	2003	300	5616					122	125		10.1126/science.1080475	http://dx.doi.org/10.1126/science.1080475			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663CP	12677065				2022-12-24	WOS:000181988900046
J	Zicha, D; Dobbie, IM; Holt, MR; Monypenny, J; Soong, DYH; Gray, C; Dunn, GA				Zicha, D; Dobbie, IM; Holt, MR; Monypenny, J; Soong, DYH; Gray, C; Dunn, GA			Rapid actin transport during cell protrusion	SCIENCE			English	Article							FILAMENT TURNOVER; DIFFUSION; DYNAMICS	Transformed rat fibroblasts expressing two variants of green fluorescent protein, each fused to beta-actin, were used to study actin dynamics during cell protrusion. The recently developed FLAP (fluorescence localization after photobleaching) method permits the tracking of one fluorophore after localized photobleaching by using the other as a colocalized reference. Here, by visualizing the ratio of bleached to total molecules, we found that actin was delivered to protruding zones of the leading edge of the cell at speeds that exceeded 5 micrometers per second. Monte Carlo modeling confirmed that this flow cannot be explained by diffusion and may involve active transport.	Kings Coll London, Randall Ctr, London SE1 1UL, England; Canc Res UK, Light Microscopy, Lincolns Inn Fields Labs, London WC2A 3PX, England; Natl Univ Ireland, Dept Biochem, Genome Stabil Lab, Galway, Ireland	University of London; King's College London; Cancer Research UK; Ollscoil na Gaillimhe-University of Galway	Dunn, GA (corresponding author), Kings Coll London, Randall Ctr, New Hunts House,Guys Campus, London SE1 1UL, England.	graham.a.dunn@kcl.ac.uk	Zicha, Daniel/H-9310-2016	Dobbie, Ian/0000-0002-5531-5865; Holt, Mark/0000-0001-7775-8539; Zicha, Daniel/0000-0002-8808-8064	MRC [G0100152] Funding Source: UKRI; Medical Research Council [G0100152, G0100152(56891)] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Dunn GA, 2002, J MICROSC-OXFORD, V205, P109, DOI 10.1046/j.0022-2720.2001.001007.x; DUNN GA, 1995, J CELL SCI, V108, P1239; McGrath JL, 1998, BIOPHYS J, V75, P2070, DOI 10.1016/S0006-3495(98)77649-0; Olveczky BP, 1998, BIOPHYS J, V74, P2722, DOI 10.1016/S0006-3495(98)77978-0; Pantaloni D, 2001, SCIENCE, V292, P1502, DOI 10.1126/science.1059975; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Watanabe N, 2002, SCIENCE, V295, P1083, DOI 10.1126/science.1067470; Worthylake RA, 2001, J CELL BIOL, V154, P147, DOI 10.1083/jcb.200103048	9	134	139	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 4	2003	300	5616					142	145		10.1126/science.1082026	http://dx.doi.org/10.1126/science.1082026			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663CP	12677069				2022-12-24	WOS:000181988900052
J	Rogers, RR; Krause, DW; Rogers, KC				Rogers, RR; Krause, DW; Rogers, KC			Cannibalism in the Madagascan dinosaur Majungatholus atopus	NATURE			English	Article							DYNAMICS	Many lines of evidence have been brought to bear on the question of theropod feeding ecology, including functional and physiological considerations, morphological constraints, taphonomic associations, and telling - although rare - indications of direct ingestion(1-7). Tooth marks of theropods, although rarely described and generally left unassigned to a particular taxon, can provide unique clues into predator - prey interaction(8), and can also yield insights into the extent of carcass utilization(9,10). Here we describe a sample of tooth-marked dinosaur bone recovered from three well-documented localities in the Upper Cretaceous Maevarano Formation of Madagascar that provides insights into the feeding ecology of the abelisaurid theropod Majungatholus atopus(11). Intensely tooth-marked elements from multiple individuals show that Majungatholus defleshed dinosaur carcasses. Furthermore, Majungatholus clearly fed upon the remains of not only sauropods, but also conspecifics, and thus was a cannibal. Cannibalism is a common ecological strategy among extant carnivores, but until now the evidence in relation to carnivorous dinosaurs has been sparse and anecdotal.	Macalester Coll, Dept Geol, St Paul, MN 55105 USA; SUNY Stony Brook, Dept Anat Sci, Stony Brook, NY 11794 USA; Sci Museum Minnesota, Dept Paleontol, St Paul, MN 55102 USA	Macalester College; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Rogers, RR (corresponding author), Macalester Coll, Dept Geol, 1600 Grand Ave, St Paul, MN 55105 USA.	rogers@macalester.edu						AUFFENBERG W, 1981, BEHAV ECOLOGY KOMODO, V406; BERTRAM BCR, 1975, J ZOOL, V177, P463; Buckley GA, 1999, SPEC PAP PALAEONTOL, P149; Buffetaut E., 1979, Bulletin de la Societe Geologique de France, V21, P183; Carrano MT, 2002, J VERTEBR PALEONTOL, V22, P510, DOI 10.1671/0272-4634(2002)022[0510:TOOMKA]2.0.CO;2; Chin K, 1998, NATURE, V393, P680, DOI 10.1038/31461; Colbert E. H, 1989, MUSEUM NO ARIZONA B, V57, P1; COLBERT EH, 1995, LITTLE DINOSAURS GHO, V250; COOPER M R, 1981, Occasional Papers of the National Museums and Monuments of Rhodesia Series B Natural Sciences, V6, P689; Erickson GM, 1996, NATURE, V382, P706, DOI 10.1038/382706a0; Farlow J.O., 1991, Modern Geology, V16, P161; FARLOW JO, 1976, ECOLOGY, V57, P841, DOI 10.2307/1941052; FIORILLO AR, 1991, PALAEOGEOGR PALAEOCL, V88, P157, DOI 10.1016/0031-0182(91)90062-V; FOX LR, 1975, ANNU REV ECOL SYST, V6, P87, DOI 10.1146/annurev.es.06.110175.000511; Gay Robert J., 2002, Journal of Vertebrate Paleontology, V22, p57A; Hunt Adrian P., 1994, Gaia, V10, P225; Jacobsen Aase Roland, 1998, Historical Biology, V13, P17; Krause D.W., 1999, GSA TODAY, V9, P1; Maxwell WD, 1995, J VERTEBR PALEONTOL, V15, P707, DOI 10.1080/02724634.1995.10011256; POLIS GA, 1984, MAMMAL REV, V14, P187, DOI 10.1111/j.1365-2907.1984.tb00345.x; POLIS GA, 1981, ANNU REV ECOL SYST, V12, P225, DOI 10.1146/annurev.es.12.110181.001301; Rayfield EJ, 2001, NATURE, V409, P1033, DOI 10.1038/35059070; Rogers KC, 2001, NATURE, V412, P530, DOI 10.1038/35087566; Rogers RR, 2000, J GEOL, V108, P275, DOI 10.1086/314403; Sampson SD, 1998, SCIENCE, V280, P1048, DOI 10.1126/science.280.5366.1048; Varricchio DJ, 2001, J PALEONTOL, V75, P401, DOI 10.1666/0022-3360(2001)075<0401:GCFACT>2.0.CO;2	26	74	77	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 3	2003	422	6931					515	518		10.1038/nature01532	http://dx.doi.org/10.1038/nature01532			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	662TW	12673249				2022-12-24	WOS:000181965400036
J	Olveczky, BP; Baccus, SA; Meister, M				Olveczky, BP; Baccus, SA; Meister, M			Segregation of object and background motion in the retina	NATURE			English	Article							LATERAL GENICULATE-NUCLEUS; POLYAXONAL AMACRINE CELLS; MACAQUE MONKEY RETINA; GANGLION-CELLS; SPATIAL SUMMATION; CONTRAST SENSITIVITY; RABBIT RETINA; RESPONSES; PHYSIOLOGY; SIGNALS	An important task in vision is to detect objects moving within a stationary scene. During normal viewing this is complicated by the presence of eye movements that continually scan the image across the retina, even during fixation. To detect moving objects, the brain must distinguish local motion within the scene from the global retinal image drift due to fixational eye movements. We have found that this process begins in the retina: a subset of retinal ganglion cells responds to motion in the receptive field centre, but only if the wider surround moves with a different trajectory. This selectivity for differential motion is independent of direction, and can be explained by a model of retinal circuitry that invokes pooling over nonlinear interneurons. The suppression by global image motion is probably mediated by polyaxonal, wide-field amacrine cells with transient responses. We show how a population of ganglion cells selective for differential motion can rapidly flag moving objects, and even segregate multiple moving objects.	Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; MIT, Div Hlth Sci & Technol, Cambridge, MA 02138 USA; Harvard Univ, Program Neurosci, Boston, MA 02115 USA	Harvard University; Massachusetts Institute of Technology (MIT); Harvard University	Meister, M (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, 16 Divin Ave, Cambridge, MA 02138 USA.			Meister, Markus/0000-0003-2136-6506; Olveczky, Bence/0000-0003-2499-2705				[Anonymous], EYE MOVEMENTS THEIR; Baccus SA, 2002, NEURON, V36, P909, DOI 10.1016/S0896-6273(02)01050-4; BENDER DB, 1986, BRAIN RES, V381, P372, DOI 10.1016/0006-8993(86)90092-2; BLAKEMORE C, 1986, J PHYSIOL-LONDON, V380, P453, DOI 10.1113/jphysiol.1986.sp016297; BORN RT, 1992, NATURE, V357, P497, DOI 10.1038/357497a0; Chichilnisky EJ, 2001, NETWORK-COMP NEURAL, V12, P199, DOI 10.1088/0954-898X/12/2/306; Cook PB, 1998, J NEUROSCI, V18, P2301; Coppola D, 1996, P NATL ACAD SCI USA, V93, P8001, DOI 10.1073/pnas.93.15.8001; DACEY DM, 1989, J COMP NEUROL, V284, P275, DOI 10.1002/cne.902840210; Demb JB, 2001, J NEUROSCI, V21, P7447, DOI 10.1523/JNEUROSCI.21-19-07447.2001; DeVries SH, 1999, J NEUROPHYSIOL, V81, P908, DOI 10.1152/jn.1999.81.2.908; ENROTHCUGELL C, 1980, J PHYSIOL-LONDON, V302, P49; FAMIGLIETTI EV, 1992, J COMP NEUROL, V316, P406, DOI 10.1002/cne.903160403; FROST BJ, 1983, SCIENCE, V220, P744, DOI 10.1126/science.6836313; Gibson J. J., 1950, PERCEPTION VISUAL WO; GRAHAM CH, 1965, VISION VISUAL PERCEP, P575; Greschner M, 2002, NAT NEUROSCI, V5, P341, DOI 10.1038/nn821; GROSSMAN GE, 1989, J NEUROPHYSIOL, V62, P264, DOI 10.1152/jn.1989.62.1.264; HAMMOND P, 1982, EXP BRAIN RES, V47, P457; HOCHSTEIN S, 1976, J PHYSIOL-LONDON, V262, P265, DOI 10.1113/jphysiol.1976.sp011595; KAPLAN E, 1986, P NATL ACAD SCI USA, V83, P2755, DOI 10.1073/pnas.83.8.2755; MANTEUFFEL G, 1977, NATURWISSENSCHAFTEN, V64, P533, DOI 10.1007/BF00483559; MEISTER M, 1994, J NEUROSCI METH, V51, P95, DOI 10.1016/0165-0270(94)90030-2; Ouchi H, 1977, JAPANESE OPTICAL GEO; Passaglia CL, 2001, J NEUROSCI, V21, P5794, DOI 10.1523/JNEUROSCI.21-15-05794.2001; Regan David, 2000, HUMAN PERCEPTION OBJ; Ross J, 2001, TRENDS NEUROSCI, V24, P113, DOI 10.1016/S0166-2236(00)01685-4; SHAPLEY R, 1981, NATURE, V292, P543, DOI 10.1038/292543a0; SHAPLEY RM, 1979, J PHYSIOL-LONDON, V290, P141, DOI 10.1113/jphysiol.1979.sp012765; Singer W, 1999, NEURON, V24, P49, DOI 10.1016/S0896-6273(00)80821-1; SKAVENSKI AA, 1979, VISION RES, V19, P675, DOI 10.1016/0042-6989(79)90243-8; Stafford DK, 1997, VISUAL NEUROSCI, V14, P507, DOI 10.1017/S0952523800012165; STEINMAN RM, 1980, VISION RES, V20, P415, DOI 10.1016/0042-6989(80)90032-2; STERLING P, 1969, J NEUROPHYSIOL, V32, P1, DOI 10.1152/jn.1969.32.1.1; VANDERSTEEN J, 1984, EXP BRAIN RES, V56, P263, DOI 10.1007/BF00236282; Vernon Magdalen D., 1962, PSYCHOL PERCEPTION; VICTOR JD, 1979, J GEN PHYSIOL, V74, P671, DOI 10.1085/jgp.74.6.671; Volgyi B, 2001, J COMP NEUROL, V440, P109, DOI 10.1002/cne.1373; Warland DK, 1997, J NEUROPHYSIOL, V78, P2336, DOI 10.1152/jn.1997.78.5.2336; WERBLIN F, 1988, VISUAL NEUROSCI, V1, P317, DOI 10.1017/S0952523800001978; WERBLIN FS, 1972, SCIENCE, V175, P1008, DOI 10.1126/science.175.4025.1008; Wu SM, 2000, J NEUROSCI, V20, P4462, DOI 10.1523/JNEUROSCI.20-12-04462.2000; Yarbus A.L., 1967, EYE MOVEMENTS VISION, DOI 10.1007/978-1-4899-5379-7	43	274	277	2	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 22	2003	423	6938					401	408		10.1038/nature01652	http://dx.doi.org/10.1038/nature01652			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681AJ	12754524				2022-12-24	WOS:000183012000033
J	Park, IK; Qian, DL; Kiel, M; Becker, MW; Pihalja, M; Weissman, IL; Morrison, SJ; Clarke, MF				Park, IK; Qian, DL; Kiel, M; Becker, MW; Pihalja, M; Weissman, IL; Morrison, SJ; Clarke, MF			Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells	NATURE			English	Article							GENE-EXPRESSION; POLYCOMB; MICE; DEFECTS; REGULATOR; DELETION; LOCUS; MDM2; P53	A central issue in stem cell biology is to understand the mechanisms that regulate the self-renewal of haematopoietic stem cells (HSCs), which are required for haematopoiesis to persist for the lifetime of the animal(1). We found that adult and fetal mouse and adult human HSCs express the proto-oncogene Bmi-1. The number of HSCs in the fetal liver of Bmi-1(-/-) mice(2) was normal. In postnatal Bmi-1(-/-) mice, the number of HSCs was markedly reduced. Transplanted fetal liver and bone marrow cells obtained from Bmi-1(-/-) mice were able to contribute only transiently to haematopoiesis. There was no detectable self-renewal of adult HSCs, indicating a cell autonomous defect in Bmi-1(-/-) mice. A gene expression analysis revealed that the expression of stem cell associated genes(3), cell survival genes, transcription factors, and genes modulating proliferation including p16(Ink4a) and p19(Arf) was altered in bone marrow cells of the Bmi-1(-/-) mice. Expression of p16(Ink4a) and p19(Arf) in normal HSCs resulted in proliferative arrest and p53-dependent cell death, respectively. Our results indicate that Bmi-1 is essential for the generation of self-renewing adult HSCs.	Univ Michigan, Div Hematol Oncol, Ann Arbor, MI 48109 USA; Univ Michigan, Howard Hughes Med Inst, Dept Internal Med, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA	University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Stanford University	Clarke, MF (corresponding author), Univ Michigan, Div Hematol Oncol, Ann Arbor, MI 48109 USA.		Morrison, Sean/ABD-5326-2021	Becker, Michael/0000-0001-9890-8815; Morrison, Sean/0000-0003-1587-8329				Akashi K, 2003, BLOOD, V101, P383, DOI 10.1182/blood-2002-06-1780; Antonchuk J, 2002, CELL, V109, P39, DOI 10.1016/S0092-8674(02)00697-9; Antonchuk J, 2001, EXP HEMATOL, V29, P1125, DOI 10.1016/S0301-472X(01)00681-6; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; COTTA C, 2001, RETROVIRAL TRANSDUCT, P243; Domen J, 2000, J EXP MED, V191, P253, DOI 10.1084/jem.191.2.253; Fisher RC, 1999, BLOOD, V94, P1283, DOI 10.1182/blood.V94.4.1283.416k16_1283_1290; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Kiyono T, 1998, NATURE, V396, P84, DOI 10.1038/23962; Lawrence HJ, 1997, BLOOD, V89, P1922, DOI 10.1182/blood.V89.6.1922; Lessard J, 1998, BLOOD, V91, P1216, DOI 10.1182/blood.V91.4.1216; LESSARD J, 2003, NATURE          0420; Mahmoudi T, 2001, ONCOGENE, V20, P3055, DOI 10.1038/sj.onc.1204330; MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X; MORRISON SJ, 1995, P NATL ACAD SCI USA, V92, P10302, DOI 10.1073/pnas.92.22.10302; Nichogiannopoulou A, 1999, J EXP MED, V190, P1201, DOI 10.1084/jem.190.9.1201; Ohta H, 2002, J EXP MED, V195, P759, DOI 10.1084/jem.20011911; Park IK, 2002, BLOOD, V99, P488, DOI 10.1182/blood.V99.2.488; Parks IK, 2001, J BIOL CHEM, V276, P915, DOI 10.1074/jbc.M005947200; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Porcher C, 1996, CELL, V86, P47, DOI 10.1016/S0092-8674(00)80076-8; QUELLE DE, 1995, CELL, V83, P993; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; SHIVDASANI RA, 1995, NATURE, V373, P432, DOI 10.1038/373432a0; vanderLugt NMT, 1996, MECH DEVELOP, V58, P153, DOI 10.1016/S0925-4773(96)00570-9; VANDERLUGT NMT, 1994, GENE DEV, V8, P757, DOI 10.1101/gad.8.7.757; Weber JD, 1999, NAT CELL BIOL, V1, P20, DOI 10.1038/8991; Wright DE, 2002, J EXP MED, V195, P1145, DOI 10.1084/jem.20011284; Zhang YP, 1998, CELL, V92, P725, DOI 10.1016/S0092-8674(00)81401-4	30	1486	1605	2	71	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 15	2003	423	6937					302	305		10.1038/nature01587	http://dx.doi.org/10.1038/nature01587			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678EX	12714971	Green Published			2022-12-24	WOS:000182853100046
J	Schmitz, B; Haggstrom, T; Tassinari, M				Schmitz, B; Haggstrom, T; Tassinari, M			Sediment-dispersed extraterrestrial chromite traces a major asteroid disruption event	SCIENCE			English	Article							METEORITES; IMPACT; ARENIG; SWEDEN; FAMILY	Abundant extraterrestrial chromite grains from decomposed meteorites occur in middle Ordovician (480 million years ago) marine limestone over an area of similar to250,000 square kilometers in southern Sweden. The chromite anomaly gives support for an increase of two orders of magnitude in the influx of meteorites to Earth during the mid-Ordovician, as previously indicated by fossil meteorites. Extraterrestrial chromite grains in mid-Ordovician limestone can be used to constrain in detail the temporal variations influx of extraterrestrial matter after one of the largest asteroid disruption events in the asteroid belt in late solar-system history.	Rice Univ, Dept Earth Sci, Houston, TX 77251 USA; Ctr Earth Sci, SE-40530 Gothenburg, Sweden	Rice University	Schmitz, B (corresponding author), Rice Univ, Dept Earth Sci, POB 1892, Houston, TX 77251 USA.							Bland P. A., 2001, ACCRETION EXTRATERRE, P267; BOGARD DD, 1995, METEORITICS, V30, P244, DOI 10.1111/j.1945-5100.1995.tb01124.x; BUNCH TE, 1967, GEOCHIM COSMOCHIM AC, V31, P1569; Dronov A., 2001, WOGOGOB 2001, P8; Gersonde R, 1997, NATURE, V390, P357, DOI 10.1038/37044; Grieve R. A, 2001, ACCRETION EXTRATERRE, P379, DOI DOI 10.1007/978-1-4419-8694-8_19; HESSLAND I, 1949, B GEOLOGICAL I U UPP, V33, P1; HEYMANN D, 1967, ICARUS, V6, P189, DOI 10.1016/0019-1035(67)90017-6; JIANHUA Z, 1998, THESIS STOCKHOLM U; KEIL K, 1994, PLANET SPACE SCI, V42, P1109, DOI 10.1016/0032-0633(94)90011-6; KEIL K, 1962, J GEOPHYS RES, V67, P4055, DOI 10.1029/JZ067i010p04055; Kunz J, 1997, METEORIT PLANET SCI, V32, P647, DOI 10.1111/j.1945-5100.1997.tb01550.x; Lindstrom M, 1979, GEOL PALAEONTOL, V13, P9; LINDSTROM M, 1971, GEOL RUNDSCH, V60, P419, DOI DOI 10.1007/BF02000464; LOFGREN A, 1995, GEOL MAG, V132, P693, DOI 10.1017/S0016756800018926; Lofgren A, 2000, GEOL MAG, V137, P53, DOI 10.1017/S0016756800003484; Nesvorny D, 2002, ICARUS, V157, P155, DOI 10.1006/icar.2002.6830; NYSTROM JO, 1988, NATURE, V336, P572, DOI 10.1038/336572a0; Rubin AE, 1997, METEORIT PLANET SCI, V32, P231, DOI 10.1111/j.1945-5100.1997.tb01262.x; Schmitz B, 2001, EARTH PLANET SC LETT, V194, P1, DOI 10.1016/S0012-821X(01)00559-3; Stouge S., 2001, WOGOGOB 2001, P42; Villumsen J., 2001, WOGOGOB 2001; Zappala V, 1998, ICARUS, V134, P176, DOI 10.1006/icar.1998.5946	23	112	113	1	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 9	2003	300	5621					961	964		10.1126/science.1082182	http://dx.doi.org/10.1126/science.1082182			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675WD	12738859				2022-12-24	WOS:000182719800051
J	Anderson, RM; Bitterman, KJ; Wood, JG; Medvedik, O; Sinclair, DA				Anderson, RM; Bitterman, KJ; Wood, JG; Medvedik, O; Sinclair, DA			Nicotinamide and PNC1 govern lifespan extension by calorie restriction in Saccharomyces cerevisiae	NATURE			English	Article							NAD(+) SALVAGE PATHWAY; SILENCING PROTEIN SIR2; DEACETYLASE ACTIVITY; YEAST; SPAN; EXPRESSION; LONGEVITY; GENE; METHYLTRANSFERASE; IDENTIFICATION	Calorie restriction extends lifespan in a broad range of organisms, from yeasts to mammals. Numerous hypotheses have been proposed to explain this phenomenon, including decreased oxidative damage and altered energy metabolism. In Saccharomyces cerevisiae, lifespan extension by calorie restriction requires the NAD(+)-dependent histone deacetylase, Sir2 (ref. 1). We have recently shown that Sir2 and its closest human homologue SIRT1, a p53 deacetylase, are strongly inhibited by the vitamin B3 precursor nicotinamide2. Here we show that increased expression of PNC1 (pyrazinamidase/nicotinamidase 1), which encodes an enzyme that deaminates nicotinamide, is both necessary and sufficient for lifespan extension by calorie restriction and low-intensity stress. We also identify PNC1 as a longevity gene that is responsive to all stimuli that extend lifespan. We provide evidence that nicotinamide depletion is sufficient to activate Sir2 and that this is the mechanism by which PNC1 regulates longevity. We conclude that yeast lifespan extension by calorie restriction is the consequence of an active cellular response to a low-intensity stress and speculate that nicotinamide might regulate critical cellular processes in higher organisms.	Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Sinclair, DA (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA.			Sinclair, David/0000-0002-9936-436X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068072] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG028730, R01AG028730, P01AG027916, R01AG019719, R01AG019972] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG019719, P01 AG027916, R01 AG028730, R01 AG019972, R37 AG028730] Funding Source: Medline; NIGMS NIH HHS [R01 GM068072] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AKSOY S, 1994, J BIOL CHEM, V269, P14835; Anderson RM, 2002, J BIOL CHEM, V277, P18881, DOI 10.1074/jbc.M111773200; Bitterman KJ, 2002, J BIOL CHEM, V277, P45099, DOI 10.1074/jbc.M205670200; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Ghislain M, 2002, YEAST, V19, P215, DOI 10.1002/yea.810; Grant RS, 1998, J NEUROCHEM, V70, P1759; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jiang JC, 2000, FASEB J, V14, P2135; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kaeberlein M, 2002, MOL CELL BIOL, V22, P8056, DOI 10.1128/MCB.22.22.8056-8066.2002; Kassem HS, 2002, INT J CANCER, V101, P454, DOI 10.1002/ijc.10631; Lal A, 1999, CANCER RES, V59, P5403; Landry J, 2000, BIOCHEM BIOPH RES CO, V278, P685, DOI 10.1006/bbrc.2000.3854; Landry J, 2000, P NATL ACAD SCI USA, V97, P5807, DOI 10.1073/pnas.110148297; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; Lin SS, 2001, J BIOL CHEM, V276, P36000, DOI 10.1074/jbc.M103509200; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Niewmierzycka A, 1999, J BIOL CHEM, V274, P814, DOI 10.1074/jbc.274.2.814; Perichon R, 1998, CELL MOL LIFE SCI, V54, P641, DOI 10.1007/s000180050192; Rogina B, 2002, SCIENCE, V298, P1745, DOI 10.1126/science.1078986; Sandmeier JJ, 2002, GENETICS, V160, P877; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; Smith JS, 2000, P NATL ACAD SCI USA, V97, P6658, DOI 10.1073/pnas.97.12.6658; Swiecilo A, 2000, ACTA BIOCHIM POL, V47, P355; Tanny JC, 2001, P NATL ACAD SCI USA, V98, P415, DOI 10.1073/pnas.031563798; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; UNKEFER CJ, 1984, J BIOL CHEM, V259, P2311; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Virag L, 2002, PHARMACOL REV, V54, P375, DOI 10.1124/pr.54.3.375	30	573	601	0	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 8	2003	423	6936					181	185		10.1038/nature01578	http://dx.doi.org/10.1038/nature01578			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675MR	12736687	Green Accepted			2022-12-24	WOS:000182699600049
J	Glynn, SA; Busch, MP; Schreiber, GB; Murphy, EL; Wright, DJ; Tu, Y; Kleinman, SH				Glynn, SA; Busch, MP; Schreiber, GB; Murphy, EL; Wright, DJ; Tu, Y; Kleinman, SH		NHLBI REDS Study Grp	Effect of a national disaster on blood supply and safety - The September 11 experience	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DONORS; RECRUITMENT; RISK	Context An understanding of characteristics of blood donors donating in times of crisis may help. predict blood supply safety and donor return patterns. Objectives. To characterize the volume of donations and prevalence of infectious disease markers in blood donated by US donors responding to the September 11, 2001, terrorist attacks, and. to evaluate return rates in those who donated for the first time. Design Cross-sectional survey data from the National Heart, Lung, and Blood Institute Retrovirus Epidemiology Donor Study for 4 weeks before:and 4 weeks starting with September 11, 2001, and the corresponding 8-week period in 2000. Setting and Participants A total of 327065 volunteer blood donors making 373628 allogeneic donations at 5 large regional US blood centers. Main Outcome.-Measures Changes in number of donations overall and by first-time and repeat status, prevalence of infectious disease markers, estimated risks of transfusion-transmitted viral infections, and first-time donor return rates. Results About 20000 allogeneic donations were collected Weekly in the 4 weeks preceding September 11, whereas approximate to49000 (2.5-fold increase) and approximate to26000 to 28000 (1.3-fold to 1.4-fold increases) donations were made per week in the first and in the second through fourth weeks starting with September 11; respectively. All demographic groups donated more than usual after the attacks, and after adjusting for seasonal and annual variation there was a 5.2-fold (95% confidence interval, 5.0-5.4) increase in the number of first-time donations vs a 1.5-fold (1.4-1.5) increase in the number of repeat donations made in the first week starting on September 11 vs the 4 weeks before. The weekly proportion of repeat donors returning after not donating for 10 or more years increased from 2% before September 11 to 6% in the first week starting with September 11. Donations confirmed positive for human immunodeficiency virus (HIV); hepatitis C virus (HCV), and hepatitis B surface antigen nearly tripled between 1 week before September 11 (0.1%) and 1 week after the attacks'(0.3%), largely explained by the increase in first-time and lapsed repeat donors: Estimated viral residual risks increased slightly after the attacks (HIV, 1/1.5 million vs 1/1.8 million donations; HCV, 1/1.3 million vs 1/1.6 million; hepatitis B virus, 1/140 000 vs 1/170000). First-time donor 12-month return rates for 2000 and 2001 were similar, approximate to28% (P=.37) for donors in the first week starting with September 11 (or September 12, 2000) and 30% (P=.69) for the second to,fourth weeks. Conclusions The September 11 events resulted in an influx of first-time donors without substantial increase in absolute risk of transfusion-transmissible viral infections. First-time donor return rates were equally relatively low before and after the attacks, suggesting that those donating in times of crisis have return behaviors similar to those of other first-time donors. Their relatively low return rates reinforce the need for education about. the importance of donating regularly.	Westat Corp, Rockville, MD 20850 USA; Blood Ctr Pacific, San Francisco, CA USA; Univ Calif San Francisco, San Francisco, CA 94143 USA	Westat; University of California System; University of California San Francisco	Glynn, SA (corresponding author), Westat Corp, WB 280,1441 W Montgomery Ave, Rockville, MD 20850 USA.				DIVISION OF BLOOD DISEASES AND RESOURCES [N01HB097077, N01HB097078, N01HB097080, N01HB097079, N01HB097081, N01HB097082, N01HB047114] Funding Source: NIH RePORTER; NHLBI NIH HHS [N01-HB-97081, N01-HB-97080, N01-HB-97079, N01-HB-97078, N01-HB-97077, N01-HB-47114, N01-HB-97082] Funding Source: Medline	DIVISION OF BLOOD DISEASES AND RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		*ADV COMM BLOOD SA, 2002, 16 M ADV COMM BLOOD; *AM ASS BLOOD BANK, 2002, REP REC; *AM ASS BLOOD BANK, 2001, REC DEP HLTH HUM SER; *AM ASS BLOOD BANK, 2001, AABB WKLY REP, V7, P1; Becker C, 2001, MOD HLTH, P18; BUSCH M, 2002, 27 C INT SOC BLOOD T; BUSCH MP, 1991, TRANSFUSION, V31, P719, DOI 10.1046/j.1537-2995.1991.31892023497.x; Dodd RY, 2002, TRANSFUSION, V42, P975, DOI 10.1046/j.1537-2995.2002.00174.x; Dodd RY, 2002, TRANSFUSION, V42, P1240, DOI 10.1046/j.1537-2995.2002.00231.x; DOHERTY B, 2001, AM BLOOD CTR NE 0919; DRAKE AW, 1978, PUBLIC ATTITUDES DEC, P1; EDWARDS PW, 1985, PERS INDIV DIFFER, V6, P743, DOI 10.1016/0191-8869(85)90085-6; FIENBERG SE, 1980, ANAL CROSS CLASSIFIE, P16; GIMBLE JG, 1994, TRANSFUSION, V34, P586, DOI 10.1046/j.1537-2995.1994.34794330012.x; Glynn SA, 2002, TRANSFUSION, V42, P966, DOI 10.1046/j.1537-2995.2002.00200.x; Glynn SA, 2002, TRANSFUSION, V42, P216, DOI 10.1046/j.1537-2995.2002.00008.x; Glynn SA, 2001, TRANSFUSION, V41, P736, DOI 10.1046/j.1537-2995.2001.41060736.x; HONAWAR V, 2001, WASHINGTON TIME 0921, pB4; Janssen RS, 1998, JAMA-J AM MED ASSOC, V280, P42, DOI 10.1001/jama.280.1.42; MECKLER L, 2002, STANDARD TIMES  0910, pA7; OSWALT RM, 1977, TRANSFUSION, V17, P123, DOI 10.1046/j.1537-2995.1977.17277151916.x; PILIAVIN JA, 1990, TRANSFUSION, V30, P444, DOI 10.1046/j.1537-2995.1990.30590296381.x; *SAS I INC, 1989, SAS STAT US GUID VER, P405; Schmidt PJ, 2002, NEW ENGL J MED, V346, P617, DOI 10.1056/NEJM200202213460813; Schmidt PJ, 1985, SUPPORTIVE THERAPY H, P371; US Food and Drug Administration (FDA), 2002, REV PREV MEAS RED PO; Villarosa L, 2001, NY TIMES        1220, pB6; Williams AE, 1997, JAMA-J AM MED ASSOC, V277, P967, DOI 10.1001/jama.277.12.967; Wu Y, 2000, TRANSFUSION, V40, p16S; Wu Y, 2001, TRANSFUSION, V41, P360, DOI 10.1046/j.1537-2995.2001.41030360.x; [No title captured]	31	80	86	0	18	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 7	2003	289	17					2246	2253		10.1001/jama.289.17.2246	http://dx.doi.org/10.1001/jama.289.17.2246			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	675ET	12734136				2022-12-24	WOS:000182680700027
J	Porteus, MH; Baltimore, D				Porteus, MH; Baltimore, D			Chimeric nucleases stimulate gene targeting in human cells	SCIENCE			English	Article							HOMOLOGOUS RECOMBINATION; RESTRICTION ENZYMES; CLEAVAGE		CALTECH, Dept Biol, Pasadena, CA 91125 USA	California Institute of Technology	Porteus, MH (corresponding author), Univ Texas, SW Med Ctr Dallas, Dept Pediat & Biochem, Dallas, TX 75390 USA.	matthew.porteus@UTSouthwestern.edu; baltimo@caltech.edu	Wilson, Matthew H/K-3193-2013		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM039458] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01-GM39458] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bibikova M, 2001, MOL CELL BIOL, V21, P289, DOI 10.1128/MCB.21.1.289-297.2001; Bibikova M, 2002, GENETICS, V161, P1169; CAPECCHI MR, 1989, SCIENCE, V244, P1288, DOI 10.1126/science.2660260; Chandrasegaran S, 1999, BIOL CHEM, V380, P841, DOI 10.1515/BC.1999.103; DOETSCHMAN T, 1987, NATURE, V330, P576, DOI 10.1038/330576a0; Jasin M, 1996, TRENDS GENET, V12, P224, DOI 10.1016/0168-9525(96)10019-6; SEDIVY JM, 1989, P NATL ACAD SCI USA, V86, P227, DOI 10.1073/pnas.86.1.227; SHI YG, 1995, SCIENCE, V268, P282, DOI 10.1126/science.7536342; Smith J, 2000, NUCLEIC ACIDS RES, V28, P3361, DOI 10.1093/nar/28.17.3361; Wolfe SA, 2000, ANNU REV BIOPH BIOM, V29, P183, DOI 10.1146/annurev.biophys.29.1.183	10	544	695	3	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 2	2003	300	5620					763	763		10.1126/science.1078395	http://dx.doi.org/10.1126/science.1078395			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673KH	12730593	Green Accepted			2022-12-24	WOS:000182579800039
J	Schlessinger, J				Schlessinger, J			Autoinhibition control	SCIENCE			English	Editorial Material							RECEPTOR; REVEALS; KINASE		Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA	Yale University	Schlessinger, J (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, 333 Cedar St, New Haven, CT 06520 USA.	joseph.schlessinger@yale.edu						Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Cho HS, 2002, SCIENCE, V297, P1330, DOI 10.1126/science.1074611; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; Ferguson KM, 2003, MOL CELL, V11, P507, DOI 10.1016/S1097-2765(03)00047-9; Hubbard SR, 1997, EMBO J, V16, P5572, DOI 10.1093/emboj/16.18.5572; Sawano A, 2002, DEV CELL, V3, P245, DOI 10.1016/S1534-5807(02)00224-1; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Tonks NK, 2001, CURR OPIN CELL BIOL, V13, P182, DOI 10.1016/S0955-0674(00)00196-4; Wybenga-Groot LE, 2001, CELL, V106, P745, DOI 10.1016/S0092-8674(01)00496-2	10	88	89	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 2	2003	300	5620					750	752		10.1126/science.1082024	http://dx.doi.org/10.1126/science.1082024			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673KH	12730587				2022-12-24	WOS:000182579800033
J	Raffle, AE; Alden, B; Quinn, M; Babb, PJ; Brett, MT				Raffle, AE; Alden, B; Quinn, M; Babb, PJ; Brett, MT			Outcomes of screening to prevent cancer: analysis of cumulative incidence of cervical abnormality and modelling of cases and deaths prevented	BRITISH MEDICAL JOURNAL			English	Article							INTRAEPITHELIAL NEOPLASIA; NATURAL-HISTORY; PROGRESSION; MORTALITY; CYTOLOGY; CONSENT; ENGLAND; TRENDS; WOMEN	Objective To determine the frequency of different outcomes in women participating in cervical screening. Design Analysis of screening records from 348 419 women, and modelling of cases of cervical cancer and deaths with and without screening. Setting Cervical screening programme in Bristol. Results For every 10 000 women screened from 1976 to 1996,1564 had abnormal cytology, 818 were investigated, and 543 had abnormal histology. One hundred and seventy six had persistent abnormality for two years or more. In the absence of screening 80 women would be expected to develop cancer of the cervix by 2011, of whom 25 would die. With screening 10 of these deaths would be avoided. Comparison of cumulative abnormality rates with numbers expected to develop cancer in the absence of screening suggests that at least 80% of high grade dyskaryosis and of high grade dysplasia would not progress to cancer. The lifetime risk of having abnormal cytology detected could be as high as 40% for women born since 1960. Conclusions Screening is labour and resource intensive. It involves treatment for many women not destined to develop invasive cancer. The increased intervention rate for cervical abnormality in England is due to change in practice, not a cohort effect, and is probably the reason for the marked fall in incidence and mortality during the 1990s. For other cancers there is scope for major iatrogenic harm from screening because of invasive tests and treatments.	Avon Hlth Author, Bristol BS2 8EE, Avon, England; Off Natl Stat, Natl Canc Intelligence Ctr, London SW1V 2QQ, England; Southmead Gen Hosp, Dept Cellular Pathol, Bristol BS10 5NB, Avon, England	Southmead Hospital	Raffle, AE (corresponding author), Avon Hlth Author, King Sq House, Bristol BS2 8EE, Avon, England.							Anderson CM, 1999, CYTOPATHOLOGY, V10, P221, DOI 10.1046/j.1365-2303.1999.00198.x; Bos AB, 1997, BRIT J CANCER, V75, P124, DOI 10.1038/bjc.1997.20; Dillner J, 2000, J CLIN VIROL, V19, P7, DOI 10.1016/S1386-6532(00)00126-8; EVANS DMD, 1986, J CLIN PATHOL, V39, P933, DOI 10.1136/jcp.39.9.933; Foster P, 1998, J MED ETHICS, V24, P151, DOI 10.1136/jme.24.3.151; Frable WJ, 1998, ACTA CYTOL, V42, P76, DOI 10.1159/000331537; Furber SE, 1997, AUST NZ J OBSTET GYN, V37, P107, DOI 10.1111/j.1479-828X.1997.tb02230.x; General Medical Council (UK), 1998, SEEK PAT CONS ETH CO; Holowaty P, 1999, JNCI-J NATL CANCER I, V91, P252, DOI 10.1093/jnci/91.3.252; MARTEAU TM, 1990, BRIT J OBSTET GYNAEC, V97, P859, DOI 10.1111/j.1471-0528.1990.tb02586.x; OSTOR AG, 1993, INT J GYNECOL PATHOL, V12, P186; Quinn M, 1999, BRIT MED J, V318, P904, DOI 10.1136/bmj.318.7188.904; Quinn M, 2001, CANC TRENDS ENGLAND; Raffle A E, 2001, Health Expect, V4, P92, DOI 10.1046/j.1369-6513.2001.00138.x; Raffle AE, 1999, LANCET, V354, P431, DOI 10.1016/S0140-6736(05)75855-4; RAFFLE AE, 1995, LANCET, V345, P1469, DOI 10.1016/S0140-6736(95)91036-0; Sasieni P, 1999, BRIT MED J, V318, P1244; Slater D, 1998, LANCET, V351, P1130, DOI 10.1016/S0140-6736(05)79410-1; Slater DN, 2000, CYTOPATHOLOGY, V11, P166, DOI 10.1046/j.1365-2303.2000.00248.x; *UK NAT SCREEN COM, 2000, 2 REP	20	87	88	0	5	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 26	2003	326	7395					901	904A		10.1136/bmj.326.7395.901	http://dx.doi.org/10.1136/bmj.326.7395.901			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	673WQ	12714468	Green Published, Bronze			2022-12-24	WOS:000182603600014
J	Jonsson, KB; Zahradnik, R; Larsson, T; White, KE; Sugimoto, T; Imanishi, Y; Yamamoto, T; Hampson, G; Koshiyama, H; Ljunggren, O; Oba, K; Yang, IM; Miyauchi, A; Econs, MJ; Lavigne, J; Juppner, H				Jonsson, KB; Zahradnik, R; Larsson, T; White, KE; Sugimoto, T; Imanishi, Y; Yamamoto, T; Hampson, G; Koshiyama, H; Ljunggren, O; Oba, K; Yang, IM; Miyauchi, A; Econs, MJ; Lavigne, J; Juppner, H			Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TUMOR-INDUCED OSTEOMALACIA; RICKETS; FGF-23; GENE	Background: Mutations in fibroblast growth factor 23 (FGF-23) cause autosomal dominant hypophosphatemic rickets. Clinical and laboratory findings in this disorder are similar to those in oncogenic osteomalacia, in which tumors abundantly express FGF-23 messenger RNA, and to those in X-linked hypophosphatemia, which is caused by inactivating mutations in a phosphate-regulating endopeptidase called PHEX. Recombinant FGF-23 induces phosphaturia and hypophosphatemia in vivo, suggesting that it has a role in phosphate regulation. To determine whether FGF-23 circulates in healthy persons and whether it is elevated in those with oncogenic osteomalacia or X-linked hypophosphatemia, an immunometric assay was developed to measure it. Methods: Using affinity-purified, polyclonal antibodies against [Tyr223]FGF-23(206-222)amide and [Tyr224]FGF-23(225-244)amide, we developed a two-site enzyme-linked immunosorbent assay that detects equivalently recombinant human FGF-23, the mutant form in which glutamine is substituted for arginine at position 179 (R179Q), and synthetic human FGF-23(207-244)amide. Plasma or serum samples from 147 healthy adults (mean [+/-SD] age, 48.4+/-19.6 years) and 26 healthy children (mean age, 10.9+/-5.5 years) and from 17 patients with oncogenic osteomalacia (mean age, 43.0+/-13.3 years) and 21 patients with X-linked hypophosphatemia (mean age, 34.9+/-17.2 years) were studied. Results: Mean FGF-23 concentrations in the healthy adults and children were 55+/-50 and 69+/-36 reference units (RU) per milliliter, respectively. Four patients with oncogenic osteomalacia had concentrations ranging from 426 to 7970 RU per milliliter, which normalized after tumor resection. FGF-23 concentrations were 481+/-528 RU per milliliter in those with suspected oncogenic osteomalacia and 353+/-510 RU per milliliter (range, 31 to 2335) in those with X-linked hypophosphatemia. Conclusions: FGF-23 is readily detectable in the plasma or serum of healthy persons and can be markedly elevated in those with oncogenic osteomalacia or X-linked hypophosphatemia, suggesting that this growth factor has a role in phosphate homeostasis. FGF-23 measurements might improve the management of phosphate-wasting disorders.	Massachusetts Gen Hosp, Dept Med, Endocrine Unit, Boston, MA 02114 USA; Massachusetts Gen Hosp, MassGen Hosp Children, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA USA; Uppsala Univ, Dept Surg Sci, Uppsala, Sweden; Uppsala Univ, Dept Med Sci, Uppsala, Sweden; Immutopics, San Clemente, CA USA; Indiana Univ, Sch Med, Dept Med, Indianapolis, IN USA; Indiana Univ, Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA; Kobe Univ, Grad Sch Med, Dept Clin Mol Med, Div Endocrinol & Metab, Kobe, Hyogo 657, Japan; Osaka City Univ, Grad Sch Med, Dept Metab Endocrinol & Mol Med, Osaka 558, Japan; Minoh City Hosp, Dept Pediat, Osaka, Japan; Osaka Univ, Grad Sch Med, Dept Pediat, Osaka, Japan; St Thomas Hosp, Dept Chem Pathol, London, England; Hyogo Kenritsu Amagasaki Hosp, Dept Med, Div Endocrinol & Metab, Amagasaki, Hyogo, Japan; Kyushu Univ, Grad Sch Med Sci, Dept Med & Bioregulatory Sci, Fukuoka 812, Japan; Aso Iizuka Hosp, Fukuoka, Japan; Kuyunghee Univ, Dept Internal Med, Seoul, South Korea; Natl Hyogo Chuo Hosp, Sanda, Hyogo, Japan	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Uppsala University; Uppsala University; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Kobe University; Osaka Metropolitan University; Osaka University; Guy's & St Thomas' NHS Foundation Trust; Kyushu University; Kyung Hee University	Juppner, H (corresponding author), Massachusetts Gen Hosp, Dept Med, Endocrine Unit, Wellman 5, Boston, MA 02114 USA.		Koshiyama, Hiroyuki/H-3877-2011; , kenneth/GPF-8006-2022; Miyauchi, Akimitsu/GYU-7403-2022	Econs, Michael/0000-0003-0940-1911	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R29AR042228, K24AR002095, R01AR042228] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063934, R37DK046718, R01DK046718] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR42228, K24-AR02095] Funding Source: Medline; NIDDK NIH HHS [DK46718, DK063934-01] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bai XY, 2003, J BIOL CHEM, V278, P9843, DOI 10.1074/jbc.M210490200; Bowe AE, 2001, BIOCHEM BIOPH RES CO, V284, P977, DOI 10.1006/bbrc.2001.5084; De Beur SMJ, 2002, J BONE MINER RES, V17, P1102, DOI 10.1359/jbmr.2002.17.6.1102; Holm IA, 1997, AM J HUM GENET, V60, P790; NUSSBAUM SR, 1987, CLIN CHEM, V33, P1364; SABBAGH Y, PHEX LOCUS DATA BASE; Seufert J, 2001, NEW ENGL J MED, V345, P1883, DOI 10.1056/NEJMoa010839; Shimada T, 2001, P NATL ACAD SCI USA, V98, P6500, DOI 10.1073/pnas.101545198; Shimada T, 2002, ENDOCRINOLOGY, V143, P3179, DOI 10.1210/en.143.8.3179; Shimada T, 2001, J BONE MINER RES, V16, pS151; White KE, 2001, J CLIN ENDOCR METAB, V86, P497, DOI 10.1210/jc.86.2.497; White KE, 2001, KIDNEY INT, V60, P2079, DOI 10.1046/j.1523-1755.2001.00064.x; White KE, 2000, NAT GENET, V26, P345, DOI 10.1038/81664; Yamashita T, 2000, BIOCHEM BIOPH RES CO, V277, P494, DOI 10.1006/bbrc.2000.3696; Yang In Myung, 1997, Korean Journal of Internal Medicine (English Edition), V12, P89	15	643	674	0	13	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 24	2003	348	17					1656	1663		10.1056/NEJMoa020881	http://dx.doi.org/10.1056/NEJMoa020881			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	670PB	12711740				2022-12-24	WOS:000182416300005
J	Wang, YX; Lee, CH; Tiep, S; Yu, RT; Ham, JY; Kang, HJ; Evans, RM				Wang, YX; Lee, CH; Tiep, S; Yu, RT; Ham, JY; Kang, HJ; Evans, RM			Peroxisome-proliferator-activated receptor delta activates fat metabolism to prevent obesity	CELL			English	Article							INSULIN-RESISTANCE; PPAR-GAMMA; ADAPTIVE THERMOGENESIS; CHOLESTEROL EFFLUX; NUCLEAR RECEPTORS; LEPTIN RECEPTOR; ADIPOSE-TISSUE; DB/DB MICE; MACROPHAGES; MECHANISMS	In contrast to the well-established roles of PPARgamma and PPARalpha in lipid metabolism, little is known for PPARdelta in this process. We show here that targeted activation of PPARdelta in adipose tissue specifically induces expression of genes required for fatty acid oxidation and energy dissipation, which in turn leads to improved lipid profiles and reduced adiposity. Importantly, these animals are completely resistant to both high-fat diet-induced and genetically predisposed (Lepr(db/db)) obesity. As predicted, acute treatment of Lepr(db/db) mice with a PPARdelta agonist depletes lipid accumulation. In parallel, PPARdelta-deficient mice challenged with high-fat diet show reduced energy uncoupling and are prone to obesity. In vitro, activation of PPARdelta in adipocytes and skeletal muscle cells promotes fatty acid oxidation and utilization. Our findings suggest that PPARdelta serves as a widespread regulator of fat burning and identify PPARdelta as a potential target in treatment of obesity and its associated disorders.	Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; Seoul Natl Univ, Sch Earth & Environm Sci, Oceanog Program, Marine Biotechnol Lab, Seoul 151747, South Korea	Salk Institute; Howard Hughes Medical Institute; Salk Institute; Seoul National University (SNU)	Evans, RM (corresponding author), Salk Inst Biol Studies, Gene Express Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.		Evans, Ronald/AAF-4001-2019	Evans, Ronald/0000-0002-9986-5965; Yu, Ruth/0000-0002-9527-9627				Akiyama TE, 2002, MOL CELL BIOL, V22, P2607, DOI 10.1128/MCB.22.8.2607-2619.2002; Barak Y, 2002, P NATL ACAD SCI USA, V99, P303, DOI 10.1073/pnas.012610299; Barak Y, 1999, MOL CELL, V4, P585, DOI 10.1016/S1097-2765(00)80209-9; Berg AH, 2001, NAT MED, V7, P947, DOI 10.1038/90992; Berger J, 2002, ANNU REV MED, V53, P409, DOI 10.1146/annurev.med.53.082901.104018; Blough E, 1999, BIOTECHNIQUES, V26, P202, DOI 10.2144/99262bm05; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; Chawla A, 2001, MOL CELL, V7, P161, DOI 10.1016/S1097-2765(01)00164-2; Chen H, 1996, CELL, V84, P491, DOI 10.1016/S0092-8674(00)81294-5; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; Hamm JK, 2001, J BIOL CHEM, V276, P18464, DOI 10.1074/jbc.M100797200; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Kersten S, 2000, NATURE, V405, P421, DOI 10.1038/35013000; Kopecky J, 1996, AM J PHYSIOL-ENDOC M, V270, pE768, DOI 10.1152/ajpendo.1996.270.5.E768; Lee GH, 1996, NATURE, V379, P632, DOI 10.1038/379632a0; Leibowitz MD, 2000, FEBS LETT, V473, P333, DOI 10.1016/S0014-5793(00)01554-4; Li AC, 2000, J CLIN INVEST, V106, P523, DOI 10.1172/JCI10370; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; Michalik L, 2001, J CELL BIOL, V154, P799, DOI 10.1083/jcb.200011148; Moitra J, 1998, GENE DEV, V12, P3168, DOI 10.1101/gad.12.20.3168; Oliver WR, 2001, P NATL ACAD SCI USA, V98, P5306, DOI 10.1073/pnas.091021198; Peters JM, 2000, MOL CELL BIOL, V20, P5119, DOI 10.1128/MCB.20.14.5119-5128.2000; Picard F, 2002, CELL, V111, P931, DOI 10.1016/S0092-8674(02)01169-8; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Reddy JK, 2001, ANNU REV NUTR, V21, P193, DOI 10.1146/annurev.nutr.21.1.193; Rosen ED, 2001, J BIOL CHEM, V276, P37731, DOI 10.1074/jbc.R100034200; ROSS SR, 1990, P NATL ACAD SCI USA, V87, P9590, DOI 10.1073/pnas.87.24.9590; Shimomura I, 1998, GENE DEV, V12, P3182, DOI 10.1101/gad.12.20.3182; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Tan NS, 2001, GENE DEV, V15, P3263, DOI 10.1101/gad.207501; Vosper H, 2001, J BIOL CHEM, V276, P44258, DOI 10.1074/jbc.M108482200; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yamauchi T, 2001, J BIOL CHEM, V276, P41245, DOI 10.1074/jbc.M103241200; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984	35	1053	1138	1	95	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 18	2003	113	2					159	170		10.1016/S0092-8674(03)00269-1	http://dx.doi.org/10.1016/S0092-8674(03)00269-1			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	672EP	12705865	Bronze			2022-12-24	WOS:000182508500006
J	De Deyn, GB; Raaijmakers, CE; Zoomer, HR; Berg, MP; de Ruiter, PC; Verhoef, HA; Bezemer, TM; van der Putten, WH				De Deyn, GB; Raaijmakers, CE; Zoomer, HR; Berg, MP; de Ruiter, PC; Verhoef, HA; Bezemer, TM; van der Putten, WH			Soil invertebrate fauna enhances grassland succession and diversity	NATURE			English	Article							PLANT; COMMUNITY; HERBIVORY; FEEDBACK; MYCORRHIZAE; DYNAMICS; MOSAICS; BIOTA	One of the most important areas in ecology is to elucidate the factors that drive succession in ecosystems and thus influence the diversity of species in natural vegetation. Significant mechanisms in this process are known to be resource limitation(1-3) and the effects of aboveground vertebrate herbivores(4,5). More recently, symbiotic and pathogenic soil microbes have been shown to exert a profound effect on the composition of vegetation(6-9) and changes therein(10,11). However, the influence of invertebrate soil fauna on succession has so far received little attention(12,13). Here we report that invertebrate soil fauna might enhance both secondary succession and local plant species diversity. Soil fauna from a series of secondary grassland succession stages selectively suppress early successional dominant(14) plant species, thereby enhancing the relative abundance of subordinate(14) species and also that of species from later succession stages. Soil fauna from the mid-succession stage had the strongest effect. Our results clearly show that soil fauna strongly affects the composition of natural vegetation and we suggest that this knowledge might improve the restoration and conservation of plant species diversity.	Netherlands Inst Ecol, NIOO, KNAW, Ctr Terr Ecol,Dept Multitrop Interact, NL-6666 ZG Heteren, Netherlands; Vrije Univ Amsterdam, Inst Ecol Sci, Dept Anim Ecol, NL-1081 HV Amsterdam, Netherlands; Univ Utrecht, Copernicus Res Inst Sustainable Dev & Innovat, Dept Environm Sci, NL-3508 TC Utrecht, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Vrije Universiteit Amsterdam; Utrecht University	De Deyn, GB (corresponding author), Netherlands Inst Ecol, NIOO, KNAW, Ctr Terr Ecol,Dept Multitrop Interact, POB 40, NL-6666 ZG Heteren, Netherlands.	g.dedeyn@nioo.knaw.nl	De Deyn, Gerlinde B/C-1593-2009; De Deyn, Gerlinde/F-7080-2017; De Deyn, Gerlinde/AFI-8702-2022; van der Putten, Wim H/C-3707-2011; Bezemer, Martijn/A-4068-2009	De Deyn, Gerlinde B/0000-0003-4823-6912; De Deyn, Gerlinde/0000-0003-4823-6912; De Deyn, Gerlinde/0000-0003-4823-6912; van der Putten, Wim H/0000-0002-9341-4442; Bezemer, Martijn/0000-0002-2878-3479; Berg, Matty P./0000-0001-8442-8503				ALMUFTI MM, 1977, J ECOL, V65, P759, DOI 10.2307/2259378; Bever JD, 1997, J ECOL, V85, P561, DOI 10.2307/2960528; BEVER JD, 1994, ECOLOGY, V75, P1965, DOI 10.2307/1941601; Blomqvist MM, 2000, OIKOS, V90, P582, DOI 10.1034/j.1600-0706.2000.900316.x; Bradford MA, 2002, SCIENCE, V298, P615, DOI 10.1126/science.1075805; BROWN VK, 1989, OIKOS, V54, P67, DOI 10.2307/3565898; BROWN VK, 1992, VEGETATIO, V101, P3, DOI 10.1007/BF00031910; Carson WP, 2000, ECOL MONOGR, V70, P73, DOI 10.1890/0012-9615(2000)070[0073:HAPSCC]2.0.CO;2; Clements F.E., 1916, PLANT SUCCESSION ANA; Crawley MJ, 1997, PLANT ECOL; Grime JP, 1998, J ECOL, V86, P902, DOI 10.1046/j.1365-2745.1998.00306.x; Hartnett DC, 1999, ECOLOGY, V80, P1187, DOI 10.1890/0012-9658(1999)080[1187:MIPCSA]2.0.CO;2; JOHNSON NC, 1991, OECOLOGIA, V86, P349, DOI 10.1007/BF00317600; Klironomos JN, 2002, NATURE, V417, P67, DOI 10.1038/417067a; MARRS RH, 1993, ADV ECOL RES, V24, P241, DOI 10.1016/S0065-2504(08)60044-6; Olff H, 2000, OECOLOGIA, V125, P45, DOI 10.1007/PL00008890; Olff H, 1998, TRENDS ECOL EVOL, V13, P261, DOI 10.1016/S0169-5347(98)01364-0; Oostenbrink I.C., 1960, NEMATOLOGY, P439; Packer A, 2000, NATURE, V404, P278, DOI 10.1038/35005072; PETERS JH, 1988, CANCER LETT, V39, P287, DOI 10.1016/0304-3835(88)90072-9; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Tilman D., 1982, Monographs in Population Biology, pi; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932; VANDERPUTTEN WH, 1993, NATURE, V362, P53; VANSTRAALEN NM, 1982, PEDOBIOLOGIA, V24, P197; Wardle DA, 1997, OIKOS, V80, P470, DOI 10.2307/3546620; YEATES GW, 1993, J NEMATOL, V25, P315	27	408	432	19	397	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 17	2003	422	6933					711	713		10.1038/nature01548	http://dx.doi.org/10.1038/nature01548			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668CG	12700759				2022-12-24	WOS:000182272300038
J	Han, AD; Pan, F; Stroud, JC; Youn, HD; Liu, JO; Chen, L				Han, AD; Pan, F; Stroud, JC; Youn, HD; Liu, JO; Chen, L			Sequence-specific recruitment of transcriptional co-repressor Cabin1 by myocyte enhancer factor-2	NATURE			English	Article							HISTONE DEACETYLASES; CRYSTAL-STRUCTURE; TERNARY COMPLEX; FACTOR MEF2; MADS-BOX; ACTIVATION; DNA; APOPTOSIS; DIFFERENTIATION; CALCINEURIN	The myocyte enhancer factor-2 (MEF2) family of transcription factors has important roles in the development and function of T cells, neuronal cells and muscle cells(1-3). MEF2 is capable of repressing or activating transcription by association with a variety of co-repressors or co-activators in a calcium-dependent manner(1,4,5). Transcriptional repression by MEF2 has attracted particular attention because of its potential role in hypertrophic responses of cardiomyocytes(6). Several MEF2 co-repressors, such as Cabin1/Cain and class II histone deacetylases (HDACs), have been identified(7-12). However, the molecular mechanism of their recruitment to specific promoters by MEF2 remains largely unknown. Here we report a crystal structure of the MADS-box/MEF2S domain of human MEF2B bound to a motif of the transcriptional co-repressor Cabin1 and DNA at 2.2 Angstrom resolution. The crystal structure reveals a stably folded MEF2S domain on the surface of the MADS box. Cabin1 adopts an amphipathic alpha-helix to bind a hydrophobic groove on the MEF2S domain, forming a triple-helical interaction. Our studies of the ternary Cabin1/MEF2/DNA complex show a general mechanism by which MEF2 recruits transcriptional co-repressor Cabin1 and class II HDACs to specific DNA sites.	Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; Johns Hopkins Univ, Sch Med, Dept Pharmacol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	University of Colorado System; University of Colorado Boulder; Johns Hopkins University; Johns Hopkins University	Chen, L (corresponding author), Univ Colorado, Dept Chem & Biochem, Campus Box 215, Boulder, CO 80309 USA.		Stroud, James C/B-3230-2012; chen, Lin/A-3392-2008; Youn, Hong-Duk/J-2774-2012	Stroud, James C/0000-0003-0850-4812; chen, Lin/0000-0003-4798-6199; 	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076334] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI049905] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL076334] Funding Source: Medline; NIAID NIH HHS [R21 AI049905] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		[Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; BJORKMAN PJ, 1987, NATURE, V329, P506, DOI 10.1038/329506a0; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P958, DOI 10.1107/S0021889891007240; Hassler M, 2001, EMBO J, V20, P3018, DOI 10.1093/emboj/20.12.3018; Huang K, 2000, EMBO J, V19, P2615, DOI 10.1093/emboj/19.11.2615; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Lai MM, 1998, J BIOL CHEM, V273, P18325, DOI 10.1074/jbc.273.29.18325; Lemercier C, 2000, J BIOL CHEM, V275, P15594, DOI 10.1074/jbc.M908437199; Lu JR, 2000, MOL CELL, V6, P233, DOI 10.1016/S1097-2765(00)00025-3; Lu JR, 2000, P NATL ACAD SCI USA, V97, P4070, DOI 10.1073/pnas.080064097; Mao ZX, 1999, SCIENCE, V286, P785, DOI 10.1126/science.286.5440.785; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; McKinsey TA, 2002, TRENDS BIOCHEM SCI, V27, P40, DOI 10.1016/S0968-0004(01)02031-X; Miska EA, 1999, EMBO J, V18, P5099, DOI 10.1093/emboj/18.18.5099; Molkentin JD, 1996, MOL CELL BIOL, V16, P2627; Molkentin JD, 1995, CELL, V83, P1125, DOI 10.1016/0092-8674(95)90139-6; Otwinowski Z., 1993, P CCP4 STUD WEEK DAT, P56; PELLEGRINI L, 1995, NATURE, V376, P490, DOI 10.1038/376490a0; Santelli E, 2000, J MOL BIOL, V297, P437, DOI 10.1006/jmbi.2000.3568; Sartorelli V, 1997, MOL CELL BIOL, V17, P1010, DOI 10.1128/MCB.17.2.1010; Sparrow DB, 1999, EMBO J, V18, P5085, DOI 10.1093/emboj/18.18.5085; Sun L, 1998, IMMUNITY, V8, P703, DOI 10.1016/S1074-7613(00)80575-0; Tan S, 1998, NATURE, V391, P660, DOI 10.1038/35563; WORONICZ JD, 1995, MOL CELL BIOL, V15, P6364; Youn HD, 2000, J BIOL CHEM, V275, P22563, DOI 10.1074/jbc.C000304200; Youn HD, 1999, SCIENCE, V286, P790, DOI 10.1126/science.286.5440.790; Youn HD, 2000, IMMUNITY, V13, P85, DOI 10.1016/S1074-7613(00)00010-8; Zhang CL, 2002, CELL, V110, P479, DOI 10.1016/S0092-8674(02)00861-9	30	81	93	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 17	2003	422	6933					730	734		10.1038/nature01555	http://dx.doi.org/10.1038/nature01555			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668CG	12700764				2022-12-24	WOS:000182272300044
J	Edwards, IR				Edwards, IR			Withdrawing drugs: nefazodone, the start of the latest saga	LANCET			English	Editorial Material									Uppsala Monitoring Ctr, S-75320 Uppsala, Sweden		Edwards, IR (corresponding author), Uppsala Monitoring Ctr, S-75320 Uppsala, Sweden.							Abraham J, 2003, DRUG SAFETY, V26, P135, DOI 10.2165/00002018-200326030-00001; BISCARINI L, 2000, MEYLERS SIDE EFFECTS, P266; Edwards IR, 1997, DRUG SAFETY, V17, P216, DOI 10.2165/00002018-199717040-00002; Graham DJ, 2001, JAMA-J AM MED ASSOC, V286, P831, DOI 10.1001/jama.286.7.831; *PUBL CIT, 2003, HRG PUBL, V1657; *PUBL CIT, 2003, PUBL CIT CALLS FDA B; SANJAY AP, 2003, LANCET, V361, P1136; Smalley W, 2000, JAMA-J AM MED ASSOC, V284, P3036, DOI 10.1001/jama.284.23.3036; van Grootheest ACK, 2002, DRUG SAFETY, V25, P1051, DOI 10.2165/00002018-200225150-00001	9	11	13	1	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 12	2003	361	9365					1240	1240		10.1016/S0140-6736(03)13030-9	http://dx.doi.org/10.1016/S0140-6736(03)13030-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	666DM	12699949				2022-12-24	WOS:000182161600006
J	Moore, B; Zhou, L; Rolland, F; Hall, Q; Cheng, WH; Liu, YX; Hwang, I; Jones, T; Sheen, J				Moore, B; Zhou, L; Rolland, F; Hall, Q; Cheng, WH; Liu, YX; Hwang, I; Jones, T; Sheen, J			Role of the Arabidopsis glucose sensor HXK1 in nutrient, light, and hormonal signaling	SCIENCE			English	Article							GENE-EXPRESSION; HEXOKINASE	Glucose modulates many vital processes in photosynthetic plants. Analyses of Arabidopsis glucose insensitive2 (gin2) mutants de. ne the physiological functions of a specific hexokinase (HXK1) in the plant glucose-signaling network. HXK1 coordinates intrinsic signals with extrinsic light intensity. HXK1 mutants lacking catalytic activity still support various signaling functions in gene expression, cell proliferation, root and in florescence growth, and leaf expansion and senescence, thus demonstrating the uncoupling of glucose signaling from glucose metabolism. The gin2 mutants are also insensitive to auxin and hypersensitive to cytokinin. Plants use HXK as a glucose sensor to interrelate nutrient, light, and hormone signaling networks for controlling growth and development in response to the changing environment.	Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Sheen, J (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA.	sheen@molbio.mgh.harvard.edu	Cheng, Wan-Hsing/ABH-1421-2020	Cheng, Wan-Hsing/0000-0003-4924-7429; Rolland, Filip/0000-0003-2601-0752				Dai N, 1999, PLANT CELL, V11, P1253, DOI 10.1105/tpc.11.7.1253; Gray WM, 2001, NATURE, V414, P271, DOI 10.1038/35104500; Hwang I, 2001, NATURE, V413, P383, DOI 10.1038/35096500; JANG JC, 1994, PLANT CELL, V6, P1665, DOI 10.1105/tpc.6.11.1665; Jang JC, 1997, PLANT CELL, V9, P5, DOI 10.1105/tpc.9.1.5; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Koch KE, 1996, ANNU REV PLANT PHYS, V47, P509, DOI 10.1146/annurev.arplant.47.1.509; KOPCZAK SD, 1992, PLANT CELL, V4, P539, DOI 10.1105/tpc.4.5.539; Kraakman LS, 1999, BIOCHEM J, V343, P159, DOI 10.1042/0264-6021:3430159; Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390; Li JM, 1996, SCIENCE, V272, P398, DOI 10.1126/science.272.5260.398; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; MA H, 1989, MOL CELL BIOL, V9, P5630, DOI 10.1128/MCB.9.12.5630; Pego JV, 2000, TRENDS PLANT SCI, V5, P531, DOI 10.1016/S1360-1385(00)01783-0; Quirino BF, 2000, TRENDS PLANT SCI, V5, P278, DOI 10.1016/S1360-1385(00)01655-1; Rolland F, 2002, PLANT CELL, V14, pS185, DOI 10.1105/tpc.010455; Rolland F, 2001, TRENDS BIOCHEM SCI, V26, P310, DOI 10.1016/S0968-0004(01)01805-9; SHEEN J, UNPUB; Stitt M, 1999, PLANT CELL ENVIRON, V22, P583, DOI 10.1046/j.1365-3040.1999.00386.x; Stulke J, 1999, CURR OPIN MICROBIOL, V2, P195, DOI 10.1016/S1369-5274(99)80034-4; SUN TP, 1992, PLANT CELL, V4, P119, DOI 10.1105/tpc.4.2.119; Vaulont S, 2000, J BIOL CHEM, V275, P31555, DOI 10.1074/jbc.R000016200; Wang KLC, 2002, PLANT CELL, V14, pS131, DOI 10.1105/tpc.001768; WINTERMANS JF, 1965, BIOCHIM BIOPHYS ACTA, V109, P448, DOI 10.1016/0926-6585(65)90170-6; Zhou L, 1998, P NATL ACAD SCI USA, V95, P10294, DOI 10.1073/pnas.95.17.10294; Zinke I, 2002, EMBO J, V21, P6162, DOI 10.1093/emboj/cdf600	26	828	888	16	217	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 11	2003	300	5617					332	336		10.1126/science.1080585	http://dx.doi.org/10.1126/science.1080585			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665RQ	12690200				2022-12-24	WOS:000182135400058
J	Strausberg, RL; Schreiber, SL				Strausberg, RL; Schreiber, SL			From knowing to controlling: A path from Genomics to drugs using small molecule probes	SCIENCE			English	Article							STOCK SOLUTION APPROACH; CHEMICAL GENETICS; ONE-BEAD	The National Cancer Institute Initiative in Chemical Genetics is designed to encourage the development of small molecular probes. The probes are useful for activating or inactivating protein functions, thereby providing resources that help discern the functions of gene products in normal and disease cells, as well as in tissues. This initiative includes "ChemBank," a suite of informatics tools and databases aimed at promoting the development and use of chemical genetics by scientists worldwide. The information generated with such tools should provide a critical link from genomic discovery to drug development.	NCI, Canc Genom Off, Bethesda, MD 20892 USA; Harvard Univ, Dept Chem & Biol Chem, Howard Hughes Med Inst, Cambridge, MA 02115 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Center for Cancer Genomics (CCG); Harvard University; Howard Hughes Medical Institute	Strausberg, RL (corresponding author), NCI, Canc Genom Off, 31 Ctr Dr, Bethesda, MD 20892 USA.							Blackwell HE, 2001, CHEM BIOL, V8, P1167, DOI 10.1016/S1074-5521(01)00085-0; Clemons PA, 2001, CHEM BIOL, V8, P1183, DOI 10.1016/S1074-5521(01)00086-2; Mayer TU, 1999, SCIENCE, V286, P971, DOI 10.1126/science.286.5441.971; Riggins GJ, 2001, HUM MOL GENET, V10, P663, DOI 10.1093/hmg/10.7.663; Schreiber SL, 2003, CHEM ENG NEWS, V81, P51, DOI 10.1021/cen-v081n009.p051; Schreiber SL, 2000, SCIENCE, V287, P1964, DOI 10.1126/science.287.5460.1964; Shuey DJ, 2002, DRUG DISCOV TODAY, V7, P1040, DOI 10.1016/S1359-6446(02)02474-1; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Van Dyke T, 2002, CELL, V108, P135, DOI 10.1016/S0092-8674(02)00621-9	9	229	237	2	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 11	2003	300	5617					294	295		10.1126/science.1083395	http://dx.doi.org/10.1126/science.1083395			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665RQ	12690189	Green Published			2022-12-24	WOS:000182135400045
J	Decosas, J				Decosas, J			HIV prevention and treatment in South Africa: affordable and desirable	LANCET			English	Editorial Material									Plan Ghana, Plan W Africa Reg Off, Accra, Ghana		Decosas, J (corresponding author), Plan Ghana, Plan W Africa Reg Off, PMB Osu Main PO, Accra, Ghana.							*ACT SOC S AFR, 2002, AIDS DEM MOD ACT SOC; FASSIN D, 2003, BRIT MED J, V320, P495; Galvao J, 2002, LANCET, V360, P1862, DOI 10.1016/S0140-6736(02)11775-2; GEFFEN N, 2003, 28 CSSR U CAP TOWN; *HLTH SYST TRUST, 2002, INT FIND PMTCT PIL S; Meda N, 2002, AIDS, V16, P2323, DOI 10.1097/00002030-200211220-00013; World Health Organization, 2002, WORLD HLTH REPORT 20	7	5	5	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 5	2003	361	9364					1146	1147		10.1016/S0140-6736(03)12966-2	http://dx.doi.org/10.1016/S0140-6736(03)12966-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	664ZF	12686033				2022-12-24	WOS:000182094600004
J	Liu, QL; D'Silva, P; Walter, W; Marszalek, J; Craig, EA				Liu, QL; D'Silva, P; Walter, W; Marszalek, J; Craig, EA			Regulated cycling of mitochondrial Hsp70 at the protein import channel	SCIENCE			English	Article							MATRIX; MOTOR; ATP; DISSOCIATION; SSC1	Hsp70 of the mitochondrial matrix (mtHsp70) provides a critical driving force for the import of proteins into mitochondria. Tim44, a peripheral inner-membrane protein, tethers it to the import channel. Here, regulated interactions were found to maximize occupancy of the active, adenosine 5'-triphosphate (ATP)-bound mtHsp70 at the channel through its intrinsic high affinity for Tim44, as well as through release of adenosine diphosphate (ADP)-bound mtHsp70 from Tim44 by the cofactor Mge1. A model peptide substrate rapidly released mtHsp70 from Tim44, even in the absence of ATP hydrolysis. In vivo, the analogous interaction of translocating polypeptide would release mtHsp70 from the channel. Consistent with the ratchet model of translocation, subsequent hydrolysis of ATP would trap the polypeptide, driving import by preventing its movement back toward the cytosol.	Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; Univ Wisconsin, Grad Program Biomol Chem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Craig, EA (corresponding author), Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA.	ecraig@wisc.edu	D'Silva, Patrick/L-6653-2019	Marszalek, Jaroslaw/0000-0002-6978-1189	NIGMS NIH HHS [R01GM27870] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM027870] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Dekker PJT, 1997, J MOL BIOL, V270, P321, DOI 10.1006/jmbi.1997.1131; Horst M, 1996, PROTEIN SCI, V5, P759; KANG PJ, 1990, NATURE, V348, P137, DOI 10.1038/348137a0; Liu QL, 2001, J BIOL CHEM, V276, P6112, DOI 10.1074/jbc.M009519200; MAARSE AC, 1992, EMBO J, V11, P3619, DOI 10.1002/j.1460-2075.1992.tb05446.x; Matouschek A, 2000, EMBO REP, V1, P404, DOI 10.1093/embo-reports/kvd093; Miao BJ, 1997, J MOL BIOL, V265, P541, DOI 10.1006/jmbi.1996.0762; Moro F, 1999, EMBO J, V18, P3667, DOI 10.1093/emboj/18.13.3667; Neupert W, 2002, NAT REV MOL CELL BIO, V3, P555, DOI 10.1038/nrm878; Okamoto K, 2002, EMBO J, V21, P3659, DOI 10.1093/emboj/cdf358; Pfanner N, 2001, NAT REV MOL CELL BIO, V2, P339, DOI 10.1038/35073006; SCHERER PE, 1990, EMBO J, V9, P4315, DOI 10.1002/j.1460-2075.1990.tb07880.x; SCHERER PE, 1992, P NATL ACAD SCI USA, V89, P11930, DOI 10.1073/pnas.89.24.11930; Schneider HC, 1996, EMBO J, V15, P5796, DOI 10.1002/j.1460-2075.1996.tb00966.x; SCHNEIDER HC, 1994, NATURE, V371, P768, DOI 10.1038/371768a0; Voisine C, 1999, CELL, V97, P565, DOI 10.1016/S0092-8674(00)80768-0; VOISINE C, UNPUB; VONAHSEN O, 1995, J BIOL CHEM, V270, P29848; Weiss C, 1999, P NATL ACAD SCI USA, V96, P8890, DOI 10.1073/pnas.96.16.8890	20	138	140	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 4	2003	300	5616					139	141		10.1126/science.1083379	http://dx.doi.org/10.1126/science.1083379			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663CP	12677068				2022-12-24	WOS:000181988900051
J	Perkins, BA; Ficociello, LH; Silva, KH; Finkelstein, DM; Warram, JH; Krolewski, AS				Perkins, BA; Ficociello, LH; Silva, KH; Finkelstein, DM; Warram, JH; Krolewski, AS			Regression of microalbuminuria in type 1 diabetes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							FILTRATION-RATE; NEPHROPATHY; RISK; PREVALENCE; ALBUMIN; COMPLICATIONS; PROTEINURIA; PROGRESSION; PREDICTORS; REMISSION	BACKGROUND: In the present study, we aimed to determine the frequency of a significant reduction in urinary albumin excretion and factors affecting such reduction in patients with type 1 diabetes and microalbuminuria. METHODS: The study included 386 patients with persistent microalbuminuria, indicated by repeated measurements of urinary albumin excretion (estimated on the basis of albumin-to-creatinine ratios) in the range of 30 to 299 microg per minute during an initial two-year evaluation period. Subsequent measurements during the next six years were grouped into two-year periods, averaged, and analyzed for regression of microalbuminuria, which was defined as a 50 percent reduction in urinary albumin excretion from one two-year period to the next. RESULTS: Regression of microalbuminuria was frequent, with a six-year cumulative incidence of 58 percent (95 percent confidence interval, 52 to 64 percent). The use of angiotensin-converting-enzyme inhibitors was not associated with the regression of microalbuminuria. However, microalbuminuria of short duration, salutary levels of glycosylated hemoglobin (less than 8 percent), low systolic blood pressure (less than 115 mm Hg), and low levels of both cholesterol and triglycerides (less than 198 mg per deciliter [5.12 mmol per liter] and 145 mg per deciliter [1.64 mmol per liter], respectively) were independently associated with the regression of microalbuminuria. Patients with salutary levels of all modifiable factors had a hazard ratio for regression of 3.0 (95 percent confidence interval, 1.5 to 6.0), as compared with patients with no salutary levels of any modifiable factor. CONCLUSIONS: Frequent regression of microalbuminuria in patients with type 1 diabetes indicates that elevated urinary albumin excretion does not imply inexorably progressive nephropathy. Identification of the multiple determinants of the regression of microalbuminuria has implications for current theories about the mechanisms of early diabetic nephropathy.	Joslin Diabet Ctr, Sect Genet & Epidemiol, Div Res, Boston, MA 02215 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA USA; Massachusetts Gen Hosp, Ctr Biostat, Boston, MA 02114 USA; Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Harvard T.H. Chan School of Public Health	Krolewski, AS (corresponding author), Joslin Diabet Ctr, Sect Genet & Epidemiol, Div Res, 1 Joslin Pl, Boston, MA 02215 USA.	andrzej.krolewski@joslin.harvard.edu		Ficociello, Linda/0000-0003-3523-0028	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK041526] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01-DK41526] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		[Anonymous], 1999, Diabet Med, V16, P918; Caramori ML, 2000, DIABETES, V49, P1399, DOI 10.2337/diabetes.49.9.1399; Chaturvedi N, 2001, ANN INTERN MED, V134, P370, DOI 10.7326/0003-4819-134-5-200103060-00009; Chaturvedi N, 1996, BMJ-BRIT MED J, V312, P253; Chaturvedi N, 2001, KIDNEY INT, V60, P219, DOI 10.1046/j.1523-1755.2001.00789.x; CLOSE CF, 1995, BMJ-BRIT MED J, V311, P973; COONROD BA, 1993, DIABETES CARE, V16, P1376, DOI 10.2337/diacare.16.10.1376; COOPER ME, 1988, DIABETIC MED, V5, P361, DOI 10.1111/j.1464-5491.1988.tb01006.x; COOPER ME, 1988, DIABETIC MED, V5, P422; DCCT Res Grp, 1987, DIABETES CARE, V10, P1; Diabet Control Complications DCCT Res Grp, 1995, KIDNEY INT, V47, P1703; Ellis D, 1996, AM J KIDNEY DIS, V27, P809, DOI 10.1016/S0272-6386(96)90518-1; FELDTRASMUSSEN B, 1991, DIABETOLOGIA, V34, P164, DOI 10.1007/BF00418270; FORSBLOM CM, 1992, BRIT MED J, V305, P1051, DOI 10.1136/bmj.305.6861.1051; Gaede P, 1999, LANCET, V353, P617, DOI 10.1016/S0140-6736(98)07368-1; Garg AX, 2002, KIDNEY INT, V61, P2165, DOI 10.1046/j.1523-1755.2002.00356.x; Genuth S, 2002, JAMA-J AM MED ASSOC, V287, P2563; Hovind P, 2001, DIABETES CARE, V24, P1972, DOI 10.2337/diacare.24.11.1972; HUMES HD, 1989, AM J PHYSIOL, V256, pF688, DOI 10.1152/ajprenal.1989.256.4.F688; Kitamura M, 1999, KIDNEY INT, V55, P1639, DOI 10.1046/j.1523-1755.1999.00425.x; Krolewski AS, 1999, KIDNEY INT, V55, P1582, DOI 10.1046/j.1523-1755.1999.00371.x; KROLEWSKI AS, 1995, NEW ENGL J MED, V332, P1251, DOI 10.1056/NEJM199505113321902; MATHIESEN ER, 1995, DIABETIC MED, V12, P482, DOI 10.1111/j.1464-5491.1995.tb00528.x; MOGENSEN CE, 1984, NEW ENGL J MED, V311, P89, DOI 10.1056/NEJM198407123110204; Oldfield MD, 2001, J CLIN INVEST, V108, P1853; ORCHARD TJ, 1990, DIABETES, V39, P1116, DOI 10.2337/diabetes.39.9.1116; Osicka TM, 1997, CLIN SCI, V93, P65, DOI 10.1042/cs0930065; PARVING HH, 1982, ACTA ENDOCRINOL-COP, V100, P550, DOI 10.1530/acta.0.1000550; Raats CJI, 2000, KIDNEY INT, V57, P385, DOI 10.1046/j.1523-1755.2000.00858.x; Raptis AE, 2001, EXP CLIN ENDOCR DIAB, V109, pS424, DOI 10.1055/s-2001-18600; Remuzzi G, 1997, KIDNEY INT, V51, P2, DOI 10.1038/ki.1997.2; RUDBERG S, 1992, KIDNEY INT, V41, P822, DOI 10.1038/ki.1992.126; Schreiner G F, 1995, Curr Opin Nephrol Hypertens, V4, P369; Scott LJ, 2001, DIABETES, V50, P2842, DOI 10.2337/diabetes.50.12.2842; Stockand JD, 1997, AM J KIDNEY DIS, V29, P971, DOI 10.1016/S0272-6386(97)90476-5; VIBERTI GC, 1982, LANCET, V1, P1430; WANG PH, 1993, LANCET, V341, P1306, DOI 10.1016/0140-6736(93)90816-Y; Warram JH, 2000, DIABETES, V49, P94, DOI 10.2337/diabetes.49.1.94; Warram JH, 1996, J AM SOC NEPHROL, V7, P930; Wilmer WA, 1999, AM J KIDNEY DIS, V34, P308, DOI 10.1016/S0272-6386(99)70360-4; Wong T, 1999, J Am Pharm Assoc (Wash), V39, P785; Zoja C, 1995, AM J KIDNEY DIS, V26, P934, DOI 10.1016/0272-6386(95)90058-6	42	552	581	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 5	2003	348	23					2285	2293		10.1056/NEJMoa021835	http://dx.doi.org/10.1056/NEJMoa021835			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	686AA	12788992				2022-12-24	WOS:000183296300003
J	Brugarolas, J; Clark, JW; Chabner, B				Brugarolas, J; Clark, JW; Chabner, B			Using "rationally designed drugs" rationally	LANCET			English	Editorial Material							CHRONIC MYELOGENOUS LEUKEMIA; ABL TYROSINE KINASE; INHIBITOR; BCR/ABL; CELLS; MICE; INDUCTION		Dana Farber Canc Inst, Boston, MA 02115 USA; Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts General Hospital	Brugarolas, J (corresponding author), Dana Farber Canc Inst, Boston, MA 02115 USA.							Brugarolas J, 2001, LANCET, V357, P249, DOI 10.1016/S0140-6736(00)03608-4; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; DALEY GQ, 1990, SCIENCE, V247, P824, DOI 10.1126/science.2406902; Demetri GD, 2002, EUR J CANCER, V38, pS52, DOI 10.1016/S0959-8049(02)80603-7; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; HEISTERKAMP N, 1990, NATURE, V344, P251, DOI 10.1038/344251a0; KELLIHER MA, 1990, P NATL ACAD SCI USA, V87, P6649, DOI 10.1073/pnas.87.17.6649; le Coutre P, 1999, J NATL CANCER I, V91, P163, DOI 10.1093/jnci/91.2.163; O'Brien SG, 2003, NEW ENGL J MED, V348, P994, DOI 10.1056/NEJMoa022457; Rothenberg ML, 2003, NAT REV CANCER, V3, P303, DOI 10.1038/nrc1047; SZCZYLIK C, 1991, SCIENCE, V253, P562, DOI 10.1126/science.1857987	13	5	6	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 24	2003	361	9371					1758	1759		10.1016/S0140-6736(03)13446-0	http://dx.doi.org/10.1016/S0140-6736(03)13446-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	682CY	12781531				2022-12-24	WOS:000183074800004
J	Peiris, JSM; Chu, CM; Cheng, VCC; Chan, KS; Hung, IFN; Poon, LLM; Law, KI; Tang, BSF; Hon, TYW; Chan, CS; Chan, KH; Ng, JSC; Zheng, BJ; Ng, WL; Lai, RWM; Guan, Y; Yuen, KY				Peiris, JSM; Chu, CM; Cheng, VCC; Chan, KS; Hung, IFN; Poon, LLM; Law, KI; Tang, BSF; Hon, TYW; Chan, CS; Chan, KH; Ng, JSC; Zheng, BJ; Ng, WL; Lai, RWM; Guan, Y; Yuen, KY		HKU UCH SARS Study Grp	Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study	LANCET			English	Article							VIRUS	Background We investigated the temporal progression of the clinical, radiological, and virological changes in a community outbreak of severe acute respiratory syndrome (SARS). Methods We followed up 75 patients for 3 weeks managed with a standard treatment protocol of ribavirin and corticosteroids, and assessed the, pattern of clinical disease, viral load, risk factors for poor clinical outcome, and the usefulness of virological diagnostic methods. Findings Fever and pneumonia initially improved but 64 (85%) patients developed recurrent fever after a mean of 8-9 (SD 3.1) days, 55 (73%) had watery diarrhoea after 7.5 (2.3) days, 60 (80%) had radiological worsening after 7.4 (2.2) days, and respiratory symptoms worsened in 34 (45%) after 8.6 (3.0) days. In 34 (45%) patients, improvement of initial pulmonary lesions was associated with appearance of new radiological lesions at other sites. Nine (12%) patients developed spontaneous pneumomediastinum and 15 (20%) developed acute respiratory distress syndrome (ARDS) in week 3. Quantitative reverse-transcriptase (RT) PCR of nasopharyngeal aspirates in 14 patients (four with ARDS) showed peak viral load at day 10, and at day 15 a load lower than at admission. Age and chronic hepatitis B virus infection treated with lamivudine were independent significant risk factors for progression to ARDS (p=0.001). SARS-associated coronavirus in faeces was seen on RT-PCR in 65 (97%) of 67 patients at day 14. The mean time to seroconversion was 20 days. Interpretation The consistent clinical progression, shifting radiological infiltrates, and an inverted V viral-load profile suggest that worsening in week 2 is unrelated to uncontrolled viral replication but may be related to immunopathological damage.	Univ Hong Kong, Queen Mary Hosp, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; Univ Hong Kong, Queen Mary Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China; United Christian Hosp, Dept Med Intens Care Radiol & Pathol, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; United Christian Hospital	Yuen, KY (corresponding author), Univ Hong Kong, Queen Mary Hosp, Dept Microbiol, Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China.		Poon, Leo/AAP-6887-2020; Yuen, Kwok Yung/C-4465-2009; Hung, Ivan FN/ABD-5916-2021; Poon, Leo Lit Man/C-4382-2009; Chan, Chung Sing/C-4577-2009; Peiris, Joseph Sriyal Malik/C-4380-2009	Hung, Ivan FN/0000-0002-1556-2538; Poon, Leo Lit Man/0000-0002-9101-7953; Peiris, Joseph Sriyal Malik/0000-0001-8217-5995; Yuen, Kwok-yung/0000-0002-2083-1552; Guan, Yi/0000-0001-6057-9243; Chu, Chung Ming/0000-0002-9959-1271; CHENG, Vincent Chi-Chung/0000-0003-1765-7706	PHS HHS [A195357] Funding Source: Medline; Wellcome Trust Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); Wellcome Trust(Wellcome TrustEuropean Commission)		BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; *CDCP, SARS COR SEQ; *HA, HA GUID SEV AC RESP; Ho W, 2003, LANCET, V361, P1313, DOI 10.1016/S0140-6736(03)13085-1; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; KSIAZEK TG, NOVEL CORONAVIRUS AS; LEE N, MAJOR OUTBREAK SEVER; Majeski EI, 2003, AM J RESP CELL MOL, V28, P208, DOI 10.1165/rcmb.4891; Ning Q, 1998, J IMMUNOL, V160, P3487; OLLIFF JFC, 1989, CLIN RADIOL, V40, P463, DOI 10.1016/S0009-9260(89)80245-4; Peiris JSM, 2003, LANCET, V361, P1319, DOI 10.1016/S0140-6736(03)13077-2; POON LLM, RAPID DIAGNOSIS CORO; POUTANEN SM, IDENTIFICATION SEVER; *SEV AC RESP SYNDR, MULT COUNTR OUTBR; TSANG KW, CLUSTER CASES SEVERE; TURNER RB, 1986, J INFECT DIS, V154, P443, DOI 10.1093/infdis/154.3.443; TUTOR JD, 1995, PEDIATR PULM, V19, P393, DOI 10.1002/ppul.1950190614; ATYPICAL PNEUMONIA	18	1637	1795	3	210	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 24	2003	361	9371					1767	1772		10.1016/S0140-6736(03)13412-5	http://dx.doi.org/10.1016/S0140-6736(03)13412-5			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	682CY	12781535	Green Published, Bronze			2022-12-24	WOS:000183074800008
J	Burke, JM; Rieseberg, LH				Burke, JM; Rieseberg, LH			Fitness effects of transgenic disease resistance in sunflowers	SCIENCE			English	Article							GENE FLOW; INTROGRESSION		Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA; Indiana Univ, Dept Biol, Bloomington, IN 47405 USA	Vanderbilt University; Indiana University System; Indiana University Bloomington	Burke, JM (corresponding author), Vanderbilt Univ, Dept Biol Sci, 221 Kirkland Hall, Nashville, TN 37235 USA.		Burke, John M/A-3502-2013; Rieseberg, Loren H/B-3591-2013	Burke, John M/0000-0002-1412-5539; Rieseberg, Loren H/0000-0002-2712-2417				Burke JM, 2002, AM J BOT, V89, P1550, DOI 10.3732/ajb.89.9.1550; Ellstrand NC, 1999, ANNU REV ECOL SYST, V30, P539, DOI 10.1146/annurev.ecolsys.30.1.539; Linder CR, 1998, THEOR APPL GENET, V96, P339, DOI 10.1007/s001220050746; NOYES RD, 1981, PHYSIOL PLANT PATHOL, V18, P123; Rieseberg LH, 2001, TAXON, V50, P47, DOI 10.2307/1224511	5	107	122	1	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 23	2003	300	5623					1250	1250		10.1126/science.1084960	http://dx.doi.org/10.1126/science.1084960			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681NN	12764188	Green Submitted			2022-12-24	WOS:000183042400037
J	Sharma, S; tenOever, BR; Grandvaux, N; Zhou, GP; Lin, RT; Hiscott, J				Sharma, S; tenOever, BR; Grandvaux, N; Zhou, GP; Lin, RT; Hiscott, J			Triggering the interferon antiviral response through an IKK-related pathway	SCIENCE			English	Article							KAPPA-B KINASE; REGULATORY FACTOR-3; TRANSCRIPTION FACTORS; VIRUS-INFECTION; ACTIVATION; PHOSPHORYLATION; DISTINCT; COMPLEX; IRF-3; ASSOCIATION	Rapid induction of type I interferon expression, a central event in establishing the innate antiviral response, requires cooperative activation of numerous transcription factors. Although signaling pathways that activate the transcription factors nuclear factor kappaB and ATF-2/c-Jun have been well characterized, activation of the interferon regulatory factors IRF-3 and IRF-7 has remained a critical missing link in understanding interferon signaling. We report here that the IkappaB kinase (IKK)-related kinases IKKepsilon and TANK-binding kinase 1 are components of the virus-activated kinase that phosphorylate IRF-3 and IRF-7. These studies illustrate an essential role for an IKK-related kinase pathway in triggering the host antiviral response to viral infection.	McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, Dept Microbiol & Immunol, Montreal, PQ H3T 1E2, Canada; McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, Dept Med, Montreal, PQ H3T 1E2, Canada	Lady Davis Institute; McGill University; Lady Davis Institute; McGill University	Lin, RT (corresponding author), McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, Dept Microbiol & Immunol, 3755 Cote St Catherine, Montreal, PQ H3T 1E2, Canada.		Lin, Rongtuan/A-1442-2008	Lin, Rongtuan/0000-0002-2238-3503				Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Bonnard M, 2000, EMBO J, V19, P4976, DOI 10.1093/emboj/19.18.4976; Chariot A, 2002, J BIOL CHEM, V277, P37029, DOI 10.1074/jbc.M205069200; Huang Q, 2001, SCIENCE, V294, P870, DOI 10.1126/science.294.5543.870; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Lin RT, 1998, MOL CELL BIOL, V18, P2986, DOI 10.1128/MCB.18.5.2986; Lin RT, 2000, MOL CELL BIOL, V20, P6342, DOI 10.1128/MCB.20.17.6342-6353.2000; Marie I, 1998, EMBO J, V17, P6660, DOI 10.1093/emboj/17.22.6660; Nomura F, 2000, GENES CELLS, V5, P191; Peters RT, 2000, MOL CELL, V5, P513, DOI 10.1016/S1097-2765(00)80445-1; Peters RT, 2001, BBA-REV CANCER, V1471, pM57, DOI 10.1016/S0304-419X(00)00024-X; Pomerantz JL, 1999, EMBO J, V18, P6694, DOI 10.1093/emboj/18.23.6694; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Sen GC, 2001, ANNU REV MICROBIOL, V55, P255, DOI 10.1146/annurev.micro.55.1.255; Servant MJ, 2003, J BIOL CHEM, V278, P9441, DOI 10.1074/jbc.M209851200; Servant MJ, 2001, J BIOL CHEM, V276, P355, DOI 10.1074/jbc.M007790200; Shimada T, 1999, INT IMMUNOL, V11, P1357, DOI 10.1093/intimm/11.8.1357; Smith EJ, 2001, J BIOL CHEM, V276, P8951, DOI 10.1074/jbc.M008717200; tenOever BR, 2002, J VIROL, V76, P3659, DOI 10.1128/JVI.76.8.3659-3669.2002; Tojima Y, 2000, NATURE, V404, P778, DOI 10.1038/35008109; Wathelet MG, 1998, MOL CELL, V1, P507, DOI 10.1016/S1097-2765(00)80051-9; Weaver BK, 1998, MOL CELL BIOL, V18, P1359, DOI 10.1128/MCB.18.3.1359; Yoneyama M, 1998, EMBO J, V17, P1087, DOI 10.1093/emboj/17.4.1087	24	1295	1361	1	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 16	2003	300	5622					1148	1151		10.1126/science.1081315	http://dx.doi.org/10.1126/science.1081315			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678VC	12702806				2022-12-24	WOS:000182886500047
J	Fouchier, RAM; Kuiken, T; Schutten, M; van Amerongen, G; van Doornum, J; van den Hoogen, BG; Peiris, M; Lim, W; Stohr, K; Osterhaus, ADME				Fouchier, RAM; Kuiken, T; Schutten, M; van Amerongen, G; van Doornum, J; van den Hoogen, BG; Peiris, M; Lim, W; Stohr, K; Osterhaus, ADME			Aetiology - Koch's postulates fulfilled for SARS virus	NATURE			English	Article									Erasmus Med Ctr, Dept Virol, NL-3015 GE Rotterdam, Netherlands; Univ Hong Kong, Queen Mary Hosp, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; 9F Publ Hlth Lab Ctr, Govt Virus Unit, Kowloon, Hong Kong, Peoples R China	Erasmus University Rotterdam; Erasmus MC; University of Hong Kong	Fouchier, RAM (corresponding author), Erasmus Med Ctr, Dept Virol, NL-3015 GE Rotterdam, Netherlands.		Fouchier, Ron A/A-1911-2014; van den Hoogen, Bernadette/J-5461-2013; Peiris, Joseph Sriyal Malik/C-4380-2009	Fouchier, Ron A/0000-0001-8095-2869; Peiris, Joseph Sriyal Malik/0000-0001-8217-5995; Osterhaus, Albert/0000-0002-6074-1172				[Anonymous], 2003, WKLY EPIDEMIOL REC, V78, P81; DROSTEN C, IN PRESS N ENGL J ME; KSIAZEK TG, IN PRESS N ENGL J ME; Peiris JSM, 2003, LANCET, V361, P1319, DOI 10.1016/S0140-6736(03)13077-2; POUTANEN SM, IN PRESS N ENGL J ME; Rivers TM, 1937, J BACTERIOL, V33, P1; van den Hoogen BG, 2001, NAT MED, V7, P719, DOI 10.1038/89098	7	546	610	2	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 15	2003	423	6937					240	240		10.1038/423240a	http://dx.doi.org/10.1038/423240a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678EX	12748632	Green Published, Bronze			2022-12-24	WOS:000182853100032
J	Wolf-Maier, K; Cooper, RS; Banegas, JR; Giampaoli, S; Hense, HW; Joffres, M; Kastarinen, M; Poulter, N; Primatesta, P; Rodriguez-Artalejo, F; Stegmayr, B; Thamm, M; Tuomilehto, J; Vanuzzo, D; Vescio, F				Wolf-Maier, K; Cooper, RS; Banegas, JR; Giampaoli, S; Hense, HW; Joffres, M; Kastarinen, M; Poulter, N; Primatesta, P; Rodriguez-Artalejo, F; Stegmayr, B; Thamm, M; Tuomilehto, J; Vanuzzo, D; Vescio, F			Hypertension, prevalence and blood pressure levels in 6 European countries, Canada, and the United States	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-HEART-DISEASE; MONICA PROJECT; CARDIOVASCULAR-DISEASE; REGIONAL-VARIATIONS; CASE-FATALITY; HEALTH SURVEY; RISK-FACTORS; TRENDS; MORTALITY; STROKE	Context Geographic variations in cardiovascular disease (CVD) and associated risk factors have been recognized worldwide. However, little attention has been directed to potential differences in hypertension between Europe and North America. Objective To determine whether higher blood pressure (BP) levels and hypertension are more prevalent in Europe than in the United States and Canada. Design, Setting, and Participants Sample surveys that were national in scope and conducted in the 1990s were identified in Germany, Finland, Sweden,, England, Spain, Italy, Canada, and the United States. Collaborating investigators provided tabular data in a consistent format by age and sex for persons at least 35 years of age. Population registries were the main basis for sampling. Survey sizes ranged from 1800 to 23 100, with response rates of 61% to 87.5%. The data were analyzed to provide age-specific and age-adjusted estimates of BP and hypertension prevalence by country and region (eg, European vs North American). Main Outcome Measures Blood pressure levels and prevalence of hypertension in Europe, the United States, and Canada. Results Average BP was 136/83 mm Hg in the European countries and 127/77 mm Hg in Canada and the United States among men and women combined who were 35 to 74 years of age. This difference already existed among younger persons (35-39 years) in whom treatment was uncommon (ie, 124/78 mm Hg and 115/75 mm Hg, respectively), and the slope with age was,steeper in the European countries. For all age groups, BP measurements were lowest in the United States,and highest in Germany. The age- and sex-adjusted prevalence of hypertension was 28% in the North American countries and 44% in the European countries at the 140/90 mm Hg threshold. The findings for men and women by region were similar. Hypertension prevalence was strongly correlated with stroke mortality (r=0.78) and more modestly with total CVD (r=0.44). Conclusions Despite extensive research on geographic patterns of CVD, the 60% higher prevalence of hypertension in Europe compared with the United States and Canada has not been generally appreciated. The implication of this finding for national prevention strategies should be vigorously explored.	Loyola Univ, Stritch Sch Med, Dept Epidemiol & Prevent Med, Maywood, IL 60153 USA; Univ Autonoma Madrid, Fac Med, Dept Med Prevent & Salud Publ, Madrid, Spain; Ist Super Sanita, Epidemiol & Biostat Lab, I-00161 Rome, Italy; Univ Munster, Inst Epidemiol & Social Med, Munster, Germany; Dalhousie Univ, Fac Med, Dept Epidemiol & Community Hlth, Halifax, NS, Canada; Kuopio Univ Hosp, Dept Internal Med, SF-70210 Kuopio, Finland; Univ London Imperial Coll Sci Technol & Med, Cardiovasc Studies Unit, London, England; UCL, Sch Med, Dept Epidemiol & Publ Hlth, London W1N 8AA, England; Univ Umea Hosp, Dept Med, S-90185 Umea, Sweden; Robert Koch Inst, D-1000 Berlin, Germany; Univ Helsinki, Dept Publ Hlth, Helsinki, Finland; Natl Publ Hlth Inst, Dept Epidemiol & Hlth Promot, Helsinki, Finland; Agenzia Reg Friuli Venezia Giulia, Udine, Italy	Loyola University Chicago; Autonomous University of Madrid; Istituto Superiore di Sanita (ISS); University of Munster; Dalhousie University; Kuopio University Hospital; University of Eastern Finland; Imperial College London; University of London; University College London; UCL Medical School; Umea University; Robert Koch Institute; University of Helsinki; Finland National Institute for Health & Welfare	Cooper, RS (corresponding author), Loyola Univ, Stritch Sch Med, Dept Epidemiol & Prevent Med, 2160 S 1st Ave, Maywood, IL 60153 USA.	rcooper@lumc.edu	Vescio, Fenicia/N-5776-2017	Vescio, Fenicia/0000-0002-3285-919X				Ataman SL, 1996, J CLIN EPIDEMIOL, V49, P869, DOI 10.1016/0895-4356(96)00111-4; Banegas JR, 1998, HYPERTENSION, V32, P998, DOI 10.1161/01.HYP.32.6.998; Banegas JR, 2002, J HYPERTENS, V20, P2157, DOI 10.1097/00004872-200211000-00014; Bazzano LA, 2002, STROKE, V33, P1183, DOI 10.1161/01.STR.0000014607.90464.88; Beer-Borst S, 2000, J EPIDEMIOL COMMUN H, V54, P424, DOI 10.1136/jech.54.6.424; BURT VL, 1995, HYPERTENSION, V25, P305, DOI 10.1161/01.HYP.25.3.305; BURT VL, 1995, HYPERTENSION, V26, P60, DOI 10.1161/01.HYP.26.1.60; Cooper R, 1997, AM J PUBLIC HEALTH, V87, P160, DOI 10.2105/AJPH.87.2.160; Cooper R, 2000, CIRCULATION, V102, P3137; ELLIOTT P, 1988, BRIT MED J, V297, P319; Gasse C, 2001, J HUM HYPERTENS, V15, P27, DOI 10.1038/sj.jhh.1001120; Giampaoli S, 2001, Ital Heart J Suppl, V2, P294; Hajjar I, 2003, J NUTR, V133, P211, DOI 10.1093/jn/133.1.211; Joffres MR, 1997, AM J HYPERTENS, V10, P1097; Joffres MR, 2001, AM J HYPERTENS, V14, P1099, DOI 10.1016/S0895-7061(01)02211-7; Kastarinen MJ, 1998, J HYPERTENS, V16, P1379, DOI 10.1097/00004872-199816090-00019; Keys A., 1980, SCIENCE, DOI DOI 10.1126/SCIENCE.208.4448.1138; KING H, 1991, B WORLD HEALTH ORGAN, V69, P643; Kotchen TA, 1997, CIRCULATION, V96, P1071, DOI 10.1161/01.CIR.96.4.1071; O'Brien, 1997, Blood Press Monit, V2, P31; O'Brien E, 2001, BMJ-BRIT MED J, V322, P531, DOI 10.1136/bmj.322.7285.531; Primatesta P, 2001, HYPERTENSION, V38, P827, DOI 10.1161/hyp.38.4.827; Primatesta P, 2001, HYPERTENSION, V37, P187, DOI 10.1161/01.HYP.37.2.187; *PROD GED DMAK, 1999, WORLD DRINK TRENDS; Rehm J, 2000, EUR J EPIDEMIOL, V16, P669, DOI 10.1023/A:1007693009604; Rywik SL, 1998, ANN EPIDEMIOL, V8, P3, DOI 10.1016/S1047-2797(97)00177-4; Sacks FM, 2001, NEW ENGL J MED, V344, P3, DOI 10.1056/NEJM200101043440101; Sempos CT, 2000, ANN EPIDEMIOL, V10, P441, DOI 10.1016/S1047-2797(00)00068-5; Stegmayr B, 1996, CEREBROVASC DIS, V6, P80, DOI 10.1159/000108002; STEWART AW, 1994, INT J EPIDEMIOL, V23, P505; Strasser T, 1998, AM J HYPERTENS, V11, P756, DOI 10.1016/S0895-7061(98)00070-3; THAMM M, 1999, GESUNDHEITSWESEN, V61; THOM TJ, 1994, CIRCULATION, V90, P574, DOI 10.1161/01.CIR.90.1.574; THORVALDSEN P, 1995, STROKE, V26, P361, DOI 10.1161/01.STR.26.3.361; Tunstall-Pedoe H, 1999, LANCET, V353, P1547, DOI 10.1016/S0140-6736(99)04021-0; TYROLER HA, 1979, NAT I HLTH PUBLICATI; *UN STAT DIV INT C, 2002, CAP REAL VAL FIN EXP; *WHO MONICA PROJ, 1988, WORLD HLTH STAT Q, V41, P115; *WHO REG OFF EUR, 2002, COUNTR INF; Wolf HK, 1997, J HUM HYPERTENS, V11, P733, DOI 10.1038/sj.jhh.1000531	40	1257	1328	1	68	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 14	2003	289	18					2363	2369		10.1001/jama.289.18.2363	http://dx.doi.org/10.1001/jama.289.18.2363			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	677WF	12746359	Bronze			2022-12-24	WOS:000182831200025
J	McClain, CS; Rosenfeld, B; Breitbart, W				McClain, CS; Rosenfeld, B; Breitbart, W			Effect of spiritual well-being on end-of-life despair in terminally-ill cancer patients	LANCET			English	Article							HOPELESSNESS; DEPRESSION; SUICIDE; DESIRE; DEATH; DISTRESS; RELIGION; SCALE	Background The importance of spirituality in coping with a terminal illness is becoming increasingly recognised. We aimed to assess the relation between spiritual well-being, depression, and end-of-life despair in terminally-ill cancer patients. Methods 160 patients in a palliative care hospital with a life expectancy of less than 3 months were interviewed with a series of standardised instruments, including the functional assessment of chronic illness therapy-spiritual well-being scale, the Hamilton depression rating scale, the Beck hopelessness scale, and the schedule of attitudes toward hastened death. Suicidal ideation was based on responses to the Hamilton depression rating scale. Findings Significant correlations were seen between spiritual well-being and desire for hastened death (r=-0.51), hopelessness (r=-0.68), and suicidal ideation (r=-0.41). Results of multiple regression analyses showed that spiritual well-being was the strongest predictor of each outcome variable and provided a unique significant contribution beyond that of depression and relevant covariates. Additionally, depression was highly correlated with desire for hastened death in participants low in spiritual well-being (r=-0.40, p<0.0001) but not in those high in spiritual well-being (r=0.20, p=0.06). Interpretation Spiritual well-being offers some protection against end-of-life despair in those for whom death is imminent. Our findings have important implications for palliative care practice. Controlled research assessing the effect of spirituality-based interventions is needed to establish what methods can help engender a sense of peace and meaning.	Fordham Univ, Dept Psychol, Bronx, NY 10458 USA; Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA	Fordham University; Memorial Sloan Kettering Cancer Center	Rosenfeld, B (corresponding author), Fordham Univ, Dept Psychol, 441 E Fordham Rd, Bronx, NY 10458 USA.	rosenfeld@fordham.edu	Pais-Ribeiro, Jose/K-1260-2013	Pais-Ribeiro, Jose/0000-0003-2882-8056	NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR005183] Funding Source: NIH RePORTER; NINR NIH HHS [NR-05183] Funding Source: Medline	NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); NINR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))		Akechi T, 2001, PSYCHOSOMATICS, V42, P141, DOI 10.1176/appi.psy.42.2.141; BECK AT, 1974, J CONSULT CLIN PSYCH, V42, P861, DOI 10.1037/h0037562; Brady MJ, 1999, PSYCHO-ONCOLOGY, V8, P417, DOI 10.1002/(SICI)1099-1611(199909/10)8:5<417::AID-PON398>3.0.CO;2-4; Breitbart W, 2000, JAMA-J AM MED ASSOC, V284, P2907, DOI 10.1001/jama.284.22.2907; BROADHEAD WE, 1988, MED CARE, V26, P709, DOI 10.1097/00005650-198807000-00006; CHOCHINOV HM, 1995, AM J PSYCHIAT, V152, P1185; COWARD DD, 1988, ONCOL NURS FORUM, V25, P75; Durkheim E., 2002, SUICIDE STUDY SOCIOL, DOI [10.1522/cla.due.sui2, 10.2307/2088294]; Fehring R J, 1997, Oncol Nurs Forum, V24, P663; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gil S, 2001, J PSYCHOSOC ONCOL, V19, P21, DOI 10.1300/J077v19n01_02; Greenstein M, 2000, AM J PSYCHOTHER, V54, P486, DOI 10.1176/appi.psychotherapy.2000.54.4.486; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Karnofsky DA, 1949, EVALUATION CHEMOTHER, P191; Kearney M, 2000, HANDBOOK OF PSYCHIATRY IN PALLIATIVE MEDICINE, P357; KENNELLY L, 2001, DISS ABSTR INT, V61, P5236; Kleespies PM, 2000, J CLIN PSYCHOL, V56, P1153, DOI 10.1002/1097-4679(200009)56:9<1153::AID-JCLP4>3.0.CO;2-Y; McCullough M E, 1999, Twin Res, V2, P126, DOI 10.1375/136905299320565997; Mickley J R, 1992, Image J Nurs Sch, V24, P267; Muldoon M, 1995, J RELIG HEALTH, V34, P329, DOI 10.1007/BF02248742; Nelson CJ, 2002, PSYCHOSOMATICS, V43, P213, DOI 10.1176/appi.psy.43.3.213; Pessin H, 2002, AM BEHAV SCI, V46, P357, DOI 10.1177/000276402237769; PORTENOY RK, 1994, EUR J CANCER, V30A, P1326, DOI 10.1016/0959-8049(94)90182-1; Rabkin JG, 2000, PSYCHOSOM MED, V62, P271, DOI 10.1097/00006842-200003000-00020; Siegrist M, 1996, J SOC PSYCHOL, V136, P559, DOI 10.1080/00224545.1996.9714040; STACK S, 1991, SOC PSYCH PSYCH EPID, V26, P168; Taylor EJ., 1998, PSYCHOSOCIAL NURSING, P71	27	462	471	2	87	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 10	2003	361	9369					1603	1607		10.1016/S0140-6736(03)13310-7	http://dx.doi.org/10.1016/S0140-6736(03)13310-7			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	676HY	12747880				2022-12-24	WOS:000182746300010
J	Ramanan, SV				Ramanan, SV			The aggressive treatment of hypertension	LANCET			English	Editorial Material									Univ Connecticut, Sch Med, St Francis Hosp & Med Ctr, Hartford, CT 06105 USA	Saint Francis Hospital & Medical Center; University of Connecticut	Ramanan, SV (corresponding author), Univ Connecticut, Sch Med, St Francis Hosp & Med Ctr, 1000 Asylum Ave,Suite 1012, Hartford, CT 06105 USA.								0	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 3	2003	361	9368					1510	1510		10.1016/S0140-6736(03)13176-5	http://dx.doi.org/10.1016/S0140-6736(03)13176-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	674WB	12737860				2022-12-24	WOS:000182658900009
J	Parham, P				Parham, P			The unsung heroes	NATURE			English	Editorial Material							CELLS		Stanford Univ, Sch Med, Stanford, CA 94305 USA	Stanford University	Parham, P (corresponding author), Stanford Univ, Sch Med, 300 Pasteur Dr, Stanford, CA 94305 USA.							Martin MP, 2002, NAT GENET, V31, P429, DOI 10.1038/ng934; Moretta A, 2002, NAT REV IMMUNOL, V2, P957, DOI 10.1038/nri956; Parham P, 1999, IMMUNOL REV, V167, P5, DOI 10.1111/j.1600-065X.1999.tb01378.x; Scalzo AA, 2002, TRENDS MICROBIOL, V10, P470, DOI 10.1016/S0966-842X(02)02441-1	4	40	41	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 1	2003	423	6935					20	20		10.1038/423020a	http://dx.doi.org/10.1038/423020a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	673CG	12721604	Bronze			2022-12-24	WOS:000182561600020
J	Woo, HA; Chae, HZ; Hwang, SC; Yang, KS; Kang, SW; Kim, K; Rhee, SG				Woo, HA; Chae, HZ; Hwang, SC; Yang, KS; Kang, SW; Kim, K; Rhee, SG			Reversing the inactivation of peroxiredoxins caused by cysteine sulfinic acid formation	SCIENCE			English	Article							THIOL-SPECIFIC ANTIOXIDANT; THIOREDOXIN PEROXIDASE; 2-CYS PEROXIREDOXIN; HYDROGEN-PEROXIDE; CRYSTAL-STRUCTURE; OXIDATION; PROTEINS; ACTIVATION; REDUCTASE; CATALYSIS	The active-site cysteine of peroxiredoxins is selectively oxidized to cysteine sulfinic acid during catalysis, which leads to inactivation of peroxidase activity. This oxidation was thought to be irreversible. However, by metabolic labeling of mammalian cells with S-35, we show that the sulfinic form of peroxiredoxin I, produced during the exposure of cells to H2O2, is rapidly reduced to the catalytically active thiol form. The mammalian cells' ability to reduce protein sulfinic acid might serve as a mechanism to repair oxidatively damaged proteins or represent a new type of cyclic modification by which the function of various proteins is regulated.	NHLBI, Lab Cell Signaling, NIH, Bethesda, MD 20892 USA; Ewha Womans Univ, Ctr Cell Signaling Res, Seoul 120750, South Korea; Ewha Womans Univ, Div Mol Life Sci, Seoul 120750, South Korea	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Ewha Womans University; Ewha Womans University	Rhee, SG (corresponding author), NHLBI, Lab Cell Signaling, NIH, Bldg 10, Bethesda, MD 20892 USA.		Woo, Hyun Ae/AAT-9586-2021	Hwang, Sung Chul/0000-0003-2401-619X	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [Z01HL005506] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		CHAE HZ, 1994, P NATL ACAD SCI USA, V91, P7017, DOI 10.1073/pnas.91.15.7017; CHAE HZ, 1994, J BIOL CHEM, V269, P27670; CHAE HZ, 1994, P NATL ACAD SCI USA, V91, P7022, DOI 10.1073/pnas.91.15.7022; Claiborne A, 1999, BIOCHEMISTRY-US, V38, P15407, DOI 10.1021/bi992025k; Eichhorn E, 1999, J BIOL CHEM, V274, P26639, DOI 10.1074/jbc.274.38.26639; Finkel T, 1998, CURR OPIN CELL BIOL, V10, P248, DOI 10.1016/S0955-0674(98)80147-6; Fu XY, 2001, J BIOL CHEM, V276, P41279, DOI 10.1074/jbc.M106958200; Hamann M, 2002, METHOD ENZYMOL, V348, P146, DOI 10.1016/S0076-6879(02)48634-X; Hirotsu S, 1999, P NATL ACAD SCI USA, V96, P12333, DOI 10.1073/pnas.96.22.12333; Hofmann B, 2002, BIOL CHEM, V383, P347, DOI 10.1515/BC.2002.040; Jin DY, 1997, J BIOL CHEM, V272, P30952, DOI 10.1074/jbc.272.49.30952; Kang SW, 1998, J BIOL CHEM, V273, P6297, DOI 10.1074/jbc.273.11.6297; KICE JL, 1980, ADV PHYS ORG CHEM, V17, P65; Kim JR, 2000, ANAL BIOCHEM, V283, P214, DOI 10.1006/abio.2000.4623; Levine RL, 2000, IUBMB LIFE, V50, P301, DOI 10.1080/15216540051081056; Mitsumoto A, 2001, FREE RADICAL BIO MED, V30, P625, DOI 10.1016/S0891-5849(00)00503-7; Murakami T, 2000, PROTEIN SCI, V9, P1024, DOI 10.1110/ps.9.5.1024; Rabilloud T, 2002, J BIOL CHEM, V277, P19396, DOI 10.1074/jbc.M106585200; Rhee S.G., 2000, SCI STKE; Rhee SG, 2001, IUBMB LIFE, V52, P35, DOI 10.1080/15216540252774748; Schroder E, 2000, STRUCTURE, V8, P605, DOI 10.1016/S0969-2126(00)00147-7; Shen HM, 2002, FREE RADICAL BIO MED, V33, P552, DOI 10.1016/S0891-5849(02)00918-8; STADTMAN ER, 1992, SCIENCE, V257, P1220, DOI 10.1126/science.1355616; YANG KC, UNPUB; Yang KS, 2002, J BIOL CHEM, V277, P38029, DOI 10.1074/jbc.M206626200; Zhang P, 1997, J BIOL CHEM, V272, P30615, DOI 10.1074/jbc.272.49.30615	26	445	466	1	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 25	2003	300	5619					653	656		10.1126/science.1080273	http://dx.doi.org/10.1126/science.1080273			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671FB	12714748				2022-12-24	WOS:000182453700046
J	Wilson, JF				Wilson, JF			Advancing the war on malaria	ANNALS OF INTERNAL MEDICINE			English	News Item													Wilson, Jennifer/Q-3623-2019	Wilson, Jennifer/0000-0003-4025-3136					0	1	2	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 15	2003	138	8					693	696		10.7326/0003-4819-138-8-200304150-00039	http://dx.doi.org/10.7326/0003-4819-138-8-200304150-00039			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	666JH	12693913				2022-12-24	WOS:000182173800032
J	Prandoni, P; Bilora, F; Marchiori, A; Bernardi, E; Petrobelli, F; Lensing, AWA; Prins, MH; Girolami, A				Prandoni, P; Bilora, F; Marchiori, A; Bernardi, E; Petrobelli, F; Lensing, AWA; Prins, MH; Girolami, A			An association between atherosclerosis and venous thrombosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DEEP-VEIN THROMBOSIS; RISK-FACTORS; PULMONARY-EMBOLISM; D-DIMER; CAROTID ATHEROSCLEROSIS; GENERAL-POPULATION; THROMBOEMBOLISM; DISEASE; THROMBOPHILIA; MECHANISMS	BACKGROUND: In about a third of patients with venous thromboembolism, the cause of the disorder is unexplained. In patients with atherosclerosis, activation of both platelets and blood coagulation and an increase in fibrin turnover are detectable, which may lead to thrombotic complications. Whether atherosclerosis is associated with an increased risk of venous thrombosis is unknown. METHODS: We performed ultrasonography of the carotid arteries in 299 unselected patients who had deep venous thrombosis of the legs without symptomatic atherosclerosis and in 150 control subjects. Patients with spontaneous thrombosis, patients with secondary thrombosis from acquired risk factors, and control subjects were assessed for plaques. RESULTS: At least one carotid plaque was detected in 72 of the 153 patients with spontaneous thrombosis (47.1 percent; 95 percent confidence interval, 39.1 to 55.0), 40 of the 146 with secondary thrombosis (27.4 percent; 95 percent confidence interval, 20.2 to 34.6), and 48 of the 150 control subjects (32.0 percent; 95 percent confidence interval, 24.5 to 39.5). The odds ratios for carotid plaques in patients with spontaneous thrombosis, as compared with patients with secondary thrombosis and with controls, were 2.3 (95 percent confidence interval, 1.4 to 3.7) and 1.8 (95 percent confidence interval, 1.1 to 2.9), respectively. In a multivariate analysis that accounted for risk factors for atherosclerosis, the strength of this association did not change. CONCLUSIONS: There is an association between atherosclerotic disease and spontaneous venous thrombosis. Atherosclerosis may induce venous thrombosis, or the two conditions may share common risk factors.	Univ Padua, Chair Internal Med 2, Dept Med & Surg Sci, Sch Med, I-35128 Padua, Italy; Univ Amsterdam, Acad Med Ctr, Ctr Vasc Med, NL-1105 AZ Amsterdam, Netherlands; Univ Maastricht, Dept Clin Epidemiol, Maastricht, Netherlands	University of Padua; University of Amsterdam; Academic Medical Center Amsterdam; Maastricht University	Prandoni, P (corresponding author), Univ Padua, Chair Internal Med 2, Dept Med & Surg Sci, Sch Med, Via Osped Civile 105, I-35128 Padua, Italy.	paoprand@tin.it						ANDERSON FA, 1991, ARCH INTERN MED, V151, P933, DOI 10.1001/archinte.151.5.933; Andreescu ACM, 2002, THROMB HAEMOSTASIS, V87, P47, DOI 10.1055/s-0037-1612942; Bauer KA, 2001, ANN INTERN MED, V135, P367, DOI 10.7326/0003-4819-135-5-200109040-00013; BERNSTEIN EF, 1993, CEREBRAL REVASCULARI, P73; Binaghi F, 1998, Minerva Cardioangiol, V46, P217; COGO A, 1994, ARCH INTERN MED, V154, P164, DOI 10.1001/archinte.154.2.164; Drouet L, 1998, ARCH MAL COEUR VAISS, V91, P41; Ebrahim S, 1999, STROKE, V30, P841, DOI 10.1161/01.STR.30.4.841; EIKELBOOM BC, 1993, CEREBRAL REVASCULARI, P451; FitzGerald GA, 1997, THROMB HAEMOSTASIS, V78, P280; Foley P W, 1997, Cardiovasc Surg, V5, P157; Gaustadnes M, 1999, BLOOD COAGUL FIBRIN, V10, P251, DOI 10.1097/00001721-199907000-00006; Goldhaber SZ, 1997, JAMA-J AM MED ASSOC, V277, P642, DOI 10.1001/jama.277.8.642; Grady D, 2000, ANN INTERN MED, V132, P689, DOI 10.7326/0003-4819-132-9-200005020-00002; Hansson PO, 1997, ARCH INTERN MED, V157, P1665, DOI 10.1001/archinte.157.15.1665; Heit JA, 2002, SEMIN THROMB HEMOST, V28, P3, DOI 10.1055/s-2002-32312; Hollander M, 2002, CIRCULATION, V105, P2872, DOI 10.1161/01.CIR.0000018650.58984.75; Holvoet P, 1997, CURR OPIN LIPIDOL, V8, P320, DOI 10.1097/00041433-199710000-00012; Joakimsen O, 1999, ARTERIOSCL THROM VAS, V19, P3007, DOI 10.1161/01.ATV.19.12.3007; Kearon C, 2000, HEMOSTASIS THROMBOSI, V4th, P1153; Koenig W, 2001, ARTERIOSCL THROM VAS, V21, P1701, DOI 10.1161/hq1001.097020; Lensing AWA, 1999, LANCET, V353, P479, DOI 10.1016/S0140-6736(98)04298-6; Libby P, 2000, CLIN CARDIOL, V23, P3, DOI 10.1002/clc.4960231103; Libby P, 2000, HEMOSTASIS THROMBOSI, P743; Libertiny G, 1999, BRIT J SURG, V86, P907, DOI 10.1046/j.1365-2168.1999.01129.x; MARDER VJ, 2000, HEMOSTASIS THROMBOSI, P1243; NORDSTROM M, 1992, J INTERN MED, V232, P155, DOI 10.1111/j.1365-2796.1992.tb00565.x; Oger E, 2000, THROMB HAEMOSTASIS, V83, P657; Palareti G, 2002, THROMB HAEMOSTASIS, V87, P7; PRANDONI P, 1992, NEW ENGL J MED, V327, P1128, DOI 10.1056/NEJM199210153271604; Prandoni P, 1996, ANN INTERN MED, V125, P1, DOI 10.7326/0003-4819-125-1-199607010-00001; PRANDONI P, 1999, PULMONARY EMBOLISM, P2; PRATI P, 1992, STROKE, V23, P1705, DOI 10.1161/01.STR.23.12.1705; PRINS MH, 1991, ARCH INTERN MED, V151, P1721, DOI 10.1001/archinte.151.9.1721; Ray JG, 2001, CURR CONTR TRIALS C, V2, P165, DOI 10.1186/CVM-2-4-165; Ray JG, 2001, ARCH INTERN MED, V161, P1405, DOI 10.1001/archinte.161.11.1405; Silverstein MD, 1998, ARCH INTERN MED, V158, P585, DOI 10.1001/archinte.158.6.585; Simioni P, 1997, NEW ENGL J MED, V336, P399, DOI 10.1056/NEJM199702063360602; Simioni P, 1996, THROMB HAEMOSTASIS, V76, P187; Simioni P, 1999, THROMB HAEMOSTASIS, V81, P198, DOI 10.1055/s-0037-1614442; Simioni P, 1996, THROMB HAEMOSTASIS, V76, P883; Simioni P, 2000, BLOOD, V96, P3329; Sueishi K, 1998, SEMIN THROMB HEMOST, V24, P255, DOI 10.1055/s-2007-995851; Tierney L. M., 2000, CURRENT MED DIAGNOSI, V39th; TRIPLETT DA, 2001, HEMOSTASIS NEWS, V6, P1; Vaya A, 2002, BRIT J HAEMATOL, V118, P255, DOI 10.1046/j.1365-2141.2002.03563.x; ZIERLER RE, 1993, VASCULAR DIAGNOSIS, P328	47	484	507	0	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 10	2003	348	15					1435	1441		10.1056/NEJMoa022157	http://dx.doi.org/10.1056/NEJMoa022157			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	665CU	12686699	Bronze, Green Published			2022-12-24	WOS:000182102700003
J	Tu, YZ; Wu, S; Shi, XH; Chen, K; Wu, CY				Tu, YZ; Wu, S; Shi, XH; Chen, K; Wu, CY			Migfilin and Mig-2 link focal adhesions to filamin and the actin cytoskeleton and function in cell shape modulation	CELL			English	Article							ONLY PROTEIN PINCH; CAENORHABDITIS-ELEGANS; INTEGRIN ADHESION; BINDING PROTEIN; TRANSMEMBRANE LINKAGE; EXTRACELLULAR-MATRIX; CYTOPLASMIC DOMAIN; TARGETS FILAMIN; PLASMA-MEMBRANE; ADAPTER PROTEIN	Cell-extracellular matrix adhesion is an important determinant of cell morphology. We show here that migfilin, a LIM-containing protein, localizes to cell-matrix adhesions, associates with actin filaments, and is essential for cell shape modulation. Migfilin interacts with the cell-matrix adhesion protein Mig-2 (mitogen inducible gene-2), a mammalian homolog of UNC-112, and the actin binding protein filamin through its C- and N-terminal domains, respectively. Loss of Mig-2 or migfilin impairs cell shape modulation. Mig-2 recruits migfilin to cell-matrix adhesions, while the interaction with filamin mediates the association of migfilin with actin filaments. Migfilin therefore functions as an important scaffold at cell-matrix adhesions. Together, Mig-2, migfilin and filamin define a connection between cell matrix adhesions and the actin cytoskeleton and participate in the orchestration of actin assembly and cell shape modulation.	Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Wu, CY (corresponding author), Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15261 USA.				NIDDK NIH HHS [DK54639] Funding Source: Medline; NIGMS NIH HHS [GM65188] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054639] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065188] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bellanger JM, 2000, NAT CELL BIOL, V2, P888, DOI 10.1038/35046533; Brown NH, 2000, MATRIX BIOL, V19, P191, DOI 10.1016/S0945-053X(00)00064-0; Brown NH, 2000, DEV BIOL, V223, P1, DOI 10.1006/dbio.2000.9711; Brown NH, 2002, DEV CELL, V3, P569, DOI 10.1016/S1534-5807(02)00290-3; Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463; Calderwood DA, 2000, J BIOL CHEM, V275, P22607, DOI 10.1074/jbc.R900037199; Calderwood DA, 2001, NAT CELL BIOL, V3, P1060, DOI 10.1038/ncb1201-1060; Critchley DR, 2000, CURR OPIN CELL BIOL, V12, P133, DOI 10.1016/S0955-0674(99)00067-8; CUNNINGHAM CC, 1992, SCIENCE, V255, P325, DOI 10.1126/science.1549777; Elbashir SM, 2002, METHODS, V26, P199, DOI 10.1016/S1046-2023(02)00023-3; Flanagan LA, 2001, J CELL BIOL, V155, P511, DOI 10.1083/jcb.200105148; Fox JW, 1998, NEURON, V21, P1315, DOI 10.1016/S0896-6273(00)80651-0; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; GORLIN JB, 1990, J CELL BIOL, V111, P1089, DOI 10.1083/jcb.111.3.1089; Hannigan GE, 1996, NATURE, V379, P91, DOI 10.1038/379091a0; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Hobert O, 1999, J CELL BIOL, V144, P45, DOI 10.1083/jcb.144.1.45; HORWITZ A, 1986, NATURE, V320, P531, DOI 10.1038/320531a0; Hudson DF, 2002, TRENDS CELL BIOL, V12, P281, DOI 10.1016/S0962-8924(02)02281-X; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Jockusch BM, 1995, ANNU REV CELL DEV BI, V11, P379, DOI 10.1146/annurev.cellbio.11.1.379; KOMORIYA A, 1991, J BIOL CHEM, V266, P15075; Li FG, 1999, J CELL SCI, V112, P4589; Liu SC, 2000, J CELL SCI, V113, P3563; Loo DT, 1998, J BIOL CHEM, V273, P23304, DOI 10.1074/jbc.273.36.23304; Mackinnon AC, 2002, CURR BIOL, V12, P787, DOI 10.1016/S0960-9822(02)00810-2; Nakamura F, 2002, J BIOL CHEM, V277, P9148, DOI 10.1074/jbc.M111297200; Nikolopoulos SN, 2000, J CELL BIOL, V151, P1435, DOI 10.1083/jcb.151.7.1435; Ohta Y, 1999, P NATL ACAD SCI USA, V96, P2122, DOI 10.1073/pnas.96.5.2122; Olski TM, 2001, J CELL SCI, V114, P525; Pfaff M, 1998, J BIOL CHEM, V273, P6104, DOI 10.1074/jbc.273.11.6104; Richardson A, 1997, MOL CELL BIOL, V17, P6906, DOI 10.1128/MCB.17.12.6906; Rogalski TM, 2000, J CELL BIOL, V150, P253, DOI 10.1083/jcb.150.1.253; SHARMA CP, 1995, J IMMUNOL, V154, P3461; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; TAMKUN JW, 1986, CELL, V46, P271, DOI 10.1016/0092-8674(86)90744-0; Tu YZ, 2001, J CELL BIOL, V153, P585, DOI 10.1083/jcb.153.3.585; Tu YZ, 1998, MOL BIOL CELL, V9, P3367, DOI 10.1091/mbc.9.12.3367; Tu YZ, 1999, MOL CELL BIOL, V19, P2425; Vadlamudi RK, 2002, NAT CELL BIOL, V4, P681, DOI 10.1038/ncb838; van der Flier A, 2002, J CELL BIOL, V156, P361, DOI 10.1083/jcb.200103037; van der Flier A, 2001, BBA-MOL CELL RES, V1538, P99, DOI 10.1016/S0167-4889(01)00072-6; WICK M, 1994, J CELL SCI, V107, P227; WILLIAMS BD, 1994, J CELL BIOL, V124, P475, DOI 10.1083/jcb.124.4.475; Wu CY, 2001, J CELL BIOL, V155, P505, DOI 10.1083/jcb.200108077; Yamaji S, 2001, J CELL BIOL, V153, P1251, DOI 10.1083/jcb.153.6.1251; Zamir E, 2001, J CELL SCI, V114, P3583; Zervas CG, 2002, CURR BIOL, V12, pR350, DOI 10.1016/S0960-9822(02)00856-4; Zervas CG, 2001, J CELL BIOL, V152, P1007, DOI 10.1083/jcb.152.5.1007; Zhang YJ, 2002, J BIOL CHEM, V277, P318, DOI 10.1074/jbc.M108257200	50	295	311	0	26	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 4	2003	113	1					37	47		10.1016/S0092-8674(03)00163-6	http://dx.doi.org/10.1016/S0092-8674(03)00163-6			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	668GX	12679033	Bronze			2022-12-24	WOS:000182282900005
J	Abbott, A				Abbott, A			Axeing of website article sparks row at Max Planck	NATURE			English	News Item																		Gura T, 2002, NATURE, V416, P250, DOI 10.1038/416250a	1	1	1	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 3	2003	422	6931					460	460		10.1038/422460b	http://dx.doi.org/10.1038/422460b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	662TW	12673216	Bronze			2022-12-24	WOS:000181965400007
J	Richardson, DS; Komdeur, J; Burke, T				Richardson, DS; Komdeur, J; Burke, T			Altruism and infidelity among warblers	NATURE			English	Article							ACROCEPHALUS-SECHELLENSIS; SEYCHELLES		Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; Lund Univ, Dept Anim Ecol, S-22362 Lund, Sweden; Univ Groningen, Zool Lab, NL-9750 AA Haren, Netherlands; Univ Melbourne, Dept Zool, Parkville, Vic 3010, Australia	University of Sheffield; Lund University; University of Groningen; University of Melbourne	Richardson, DS (corresponding author), Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England.		Komdeur, Jan/X-1261-2019; Richardson, David S/A-5082-2010; Burke, Terry/B-3196-2011	Komdeur, Jan/0000-0002-9241-0124; Richardson, David S/0000-0001-7226-9074; Burke, Terry/0000-0003-3848-1244				EMLEN ST, 1995, P NATL ACAD SCI USA, V92, P8092, DOI 10.1073/pnas.92.18.8092; Goodnight KF, 1999, MOL ECOL, V8, P1231, DOI 10.1046/j.1365-294x.1999.00664.x; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; Hatchwell BJ, 2001, P ROY SOC B-BIOL SCI, V268, P885, DOI 10.1098/rspb.2001.1598; Komdeur J, 1996, P ROY SOC B-BIOL SCI, V263, P661, DOI 10.1098/rspb.1996.0099; KOMDEUR J, 1994, P ROY SOC B-BIOL SCI, V256, P47, DOI 10.1098/rspb.1994.0047; KOMDEUR J, 1994, BEHAV ECOL SOCIOBIOL, V34, P175, DOI 10.1007/BF00167742; Richardson DS, 2001, MOL ECOL, V10, P2263, DOI 10.1046/j.0962-1083.2001.01355.x; Richardson DS, 2002, EVOLUTION, V56, P2313; Russell AF, 2001, P ROY SOC B-BIOL SCI, V268, P2169, DOI 10.1098/rspb.2001.1790	10	49	50	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 10	2003	422	6932					580	580		10.1038/422580a	http://dx.doi.org/10.1038/422580a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665GN	12686989	Green Published			2022-12-24	WOS:000182111400029
J	Michalek, J; Collins, RH; Hill, BJ; Brenchley, JM; Douek, DC				Michalek, J; Collins, RH; Hill, BJ; Brenchley, JM; Douek, DC			Identification and monitoring of graft-versus-host specific T-cell clone in stem cell transplantation	LANCET			English	Article							DISEASE	Allogeneic haemopoietic stem cell transplantation can be complicated by acute graft-versus-host disease (GVHD). If the alloreactive T-cell clones responsible for this disorder could be identified before stem cell transplantation, they could be quantitatively monitored afterwards to allow initiation of immunosuppression before GVHD becomes apparent. We identified an alloreactive CD4(+) T-cell clone from a donor before stem cell transplantation, and then monitored its frequency in the recipient's peripheral blood after transplantation by use of clonotypic quantitative real-time PCR. Greatly increased concentrations of this clone (nearly 100% of circulating CD4(+) T cells) preceded and closely correlated with the onset of clinical GVHD, suggesting that a sole alloreactive T-cell clone was responsible for initiation of this disease in vivo. This simple identification and monitoring of potentially GVHD-causing clones can be undertaken before stem cell transplantation with no previous knowledge of the alloantigen responsible, and could allow earlier diagnosis and intervention in GVHD.	NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; Univ Texas, SW Med Ctr, Ctr Canc Immunobiol, Dallas, TX 75235 USA; Univ Texas, SW Med Ctr, Dept Internal Med, Bone Marrow Transplant Unit, Dallas, TX USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Douek, DC (corresponding author), NIAID, Vaccine Res Ctr, NIH, 40 Convent Dr, Bethesda, MD 20892 USA.		Brenchley, Jason/AAC-5085-2019	Brenchley, Jason/0000-0001-8357-2984				Andre-Schmutz I, 2002, LANCET, V360, P130, DOI 10.1016/S0140-6736(02)09413-8; Dickinson AM, 2002, NAT MED, V8, P410, DOI 10.1038/nm0402-410; Douek DC, 2002, J IMMUNOL, V168, P3099, DOI 10.4049/jimmunol.168.6.3099; Murphy WJ, 1999, CURR OPIN IMMUNOL, V11, P509, DOI 10.1016/S0952-7915(99)00002-3; Mutis T, 1999, NAT MED, V5, P839, DOI 10.1038/10563	5	66	93	0	6	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 5	2003	361	9364					1183	1185		10.1016/S0140-6736(03)12917-0	http://dx.doi.org/10.1016/S0140-6736(03)12917-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	664ZF	12781582				2022-12-24	WOS:000182094600013
J	Seibert, C; Barbouche, E; Fagan, J; Myint, E; Wetterneck, T; Wittemyer, M				Seibert, C; Barbouche, E; Fagan, J; Myint, E; Wetterneck, T; Wittemyer, M			Prescribing oral contraceptives for women older than 35 years of age	ANNALS OF INTERNAL MEDICINE			English	Review							HORMONE REPLACEMENT THERAPY; VENOUS THROMBOEMBOLIC DISEASE; METABOLIC RISK MARKERS; BONE-MINERAL DENSITY; G ETHINYL ESTRADIOL; BREAST-CANCER RISK; FACTOR-V-LEIDEN; YOUNG-WOMEN; UNITED-STATES; MYOCARDIAL-INFARCTION	This paper addresses the use of combined oral contraceptives in women older than 35 years of age, including the potential risks and benefits, pretreatment assessment, common side effects and their management, appropriate follow-up, and diagnosis of menopause. The case-based discussion also focuses on issues that pertain to women who smoke, have hypertension, or have dyslipidemia.	Univ Wisconsin, Sch Med, UW Hlth Clin E, Dept Med, Madison, WI 53706 USA; Virginia Mason Med Ctr, Lynnwood, WA USA	University of Wisconsin System; University of Wisconsin Madison; University Wisconsin Health; Virginia Mason Medical Center	Seibert, C (corresponding author), Univ Wisconsin, Sch Med, UW Hlth Clin E, Dept Med, 5249 E Terrace Dr, Madison, WI 53706 USA.	cseibert@facstaff.wisc.edu						ABMA J, 1997, VITAL HLTH STAT, V23; Adesanya OO, 1996, J REPROD MED, V41, P431; AKERLUND M, 1993, BRIT J OBSTET GYNAEC, V100, P832, DOI 10.1111/j.1471-0528.1993.tb14309.x; *AM COLL OBST GYN, 1996, GUID WOM HLTH CAR; [Anonymous], 1983, JAMA, V249, P1596; [Anonymous], 1986, NEW ENGL J MED, V315, P405; Barrett D H, 1994, Arch Fam Med, V3, P438, DOI 10.1001/archfami.3.5.438; Berg AO, 2001, AM J PREV MED, V20, P73, DOI 10.1016/S0749-3797(01)00266-5; Bloemenkamp KWM, 1999, ARCH INTERN MED, V159, P65, DOI 10.1001/archinte.159.1.65; BLOEMENKAMP KWM, 1995, LANCET, V346, P1593, DOI 10.1016/S0140-6736(95)91929-5; Bousser MG, 2000, CEPHALALGIA, V20, P147, DOI 10.1046/j.1468-2982.2000.00050.x; Brinton LA, 1998, MENOPAUSE, V5, P145; Brinton LA, 1997, CONTRACEPTION, V55, P197, DOI 10.1016/S0010-7824(97)00012-7; Burkman RT, 1998, CONTRACEPTION, V58, p35S, DOI 10.1016/S0010-7824(98)00081-X; BURKMAN RT, 2000, INT J FERTIL S2, V45, P134; Burt VK, 1998, HARVARD REV PSYCHIAT, V6, P121, DOI 10.3109/10673229809000320; Calle EE, 1996, LANCET, V347, P1713, DOI 10.1016/S0140-6736(96)90806-5; Cardoso F, 1997, INT J GYNECOL OBSTET, V59, P237, DOI 10.1016/S0020-7292(97)00239-7; CASPER RF, 1991, FERTIL STERIL, V55, P292; Castracane VD, 1995, CONTRACEPTION, V52, P371; CAUFIELD KA, 1998, WOMENS HLTH PRIMARY, P161; Chang CL, 1999, BMJ-BRIT MED J, V318, P13; ChasanTaber L, 1996, CIRCULATION, V94, P483, DOI 10.1161/01.CIR.94.3.483; Coney P, 2001, CONTRACEPTION, V63, P297, DOI 10.1016/S0010-7824(01)00208-6; CONNELL EB, 1993, J REPROD MED, V38, P1036; Connelly PW, 1999, CAN J CARDIOL, V15, P419; COOPER C, 1993, BONE, V14, P41, DOI 10.1016/8756-3282(93)90254-8; Corson SL, 1996, INT J FERTIL MENOP S, V41, P77; Crook D, 1997, CONTRACEPTION, V55, P219, DOI 10.1016/S0010-7824(97)00010-3; Crosignani PG, 2000, HUM REPROD, V15, P1865; CULLBERG G, 1985, ACTA OBSTET GYN SCAN, V64, P195, DOI 10.3109/00016348509155112; DEWIS P, 1985, CLIN ENDOCRINOL, V22, P29, DOI 10.1111/j.1365-2265.1985.tb01061.x; DICKEY RP, 1994, MANAGING CONTRACEPTI, P60; DIEHL AK, 1991, GASTROENTEROL CLIN N, V20, P1; Dong W, 1997, J HYPERTENS, V15, P1063, DOI 10.1097/00004872-199715100-00003; Douketis JD, 1997, ARCH INTERN MED, V157, P1522, DOI 10.1001/archinte.157.14.1522; Dunn N, 1999, BRIT MED J, V318, P1579, DOI 10.1136/bmj.318.7198.1579; Eck LH, 1997, AM J CLIN NUTR, V65, P419, DOI 10.1093/ajcn/65.2.419; EDGREN RA, 1989, CONTRACEPTION, V40, P285, DOI 10.1016/0010-7824(89)90093-0; FARLEY TMM, 1995, LANCET, V346, P1582; Farley TMM, 1998, CONTRACEPTION, V57, P211, DOI 10.1016/S0010-7824(98)00019-5; Farmer RDT, 2000, BRIT J CLIN PHARMACO, V49, P580, DOI 10.1046/j.1365-2125.2000.00198.x; Farmer RDT, 1998, AM J OBSTET GYNECOL, V179, pS78, DOI 10.1053/ob.1998.v179.a92634; Franceschi S, 1998, CONTRACEPTION, V58, P335, DOI 10.1016/S0010-7824(98)00128-0; Fruzzetti F, 1999, AM J OBSTET GYNECOL, V180, pS369, DOI 10.1016/S0002-9378(99)70698-8; Gabrick DM, 2000, JAMA-J AM MED ASSOC, V284, P1791, DOI 10.1001/jama.284.14.1791; GAMBACCIANI M, 1994, MATURITAS, V19, P125, DOI 10.1016/0378-5122(94)90062-0; GERSTMAN BB, 1991, AM J EPIDEMIOL, V133, P32, DOI 10.1093/oxfordjournals.aje.a115799; Gillum LA, 2000, JAMA-J AM MED ASSOC, V284, P72, DOI 10.1001/jama.284.1.72; GODSLAND IF, 1995, CONTRACEPTION, V52, P143, DOI 10.1016/0010-7824(95)00153-2; Godsland IF, 1996, CONTRACEPTION, V53, P9, DOI 10.1016/0010-7824(95)00260-X; Goldhaber SZ, 1997, JAMA-J AM MED ASSOC, V277, P642, DOI 10.1001/jama.277.8.642; Hankinson SE, 1997, CANCER CAUSE CONTROL, V8, P65, DOI 10.1023/A:1018435205695; HANKINSON SE, 1992, OBSTET GYNECOL, V80, P708; HANNAFORD PC, 1994, STROKE, V25, P935, DOI 10.1161/01.STR.25.5.935; Hannaford PC, 1996, CONTRACEPTION, V54, P125, DOI 10.1016/S0010-7824(96)00167-9; HATCHER RA, 1999, MANAGING CONTRACEPTI, P97; Hatcher RA, 1998, CONTRACEPTIVE TECHNO, P405; Heinemann LAJ, 1998, CONTRACEPTION, V57, P29, DOI 10.1016/S0010-7824(97)00204-7; Helmerhorst FM, 1998, HUM REPROD, V13, P2981, DOI 10.1093/humrep/13.11.2981; Henshaw SK, 1998, FAM PLANN PERSPECT, V30, P24, DOI 10.2307/2991522; JICK H, 1995, LANCET, V346, P1589, DOI 10.1016/S0140-6736(95)91928-7; Kaunitz AM, 2001, AM J OBSTET GYNECOL, V185, pS32, DOI 10.1067/mob.2001.116525; KAUNITZ AM, 2001, DIALOGUES CONTRACEPT, V6, P4; Kemmeren JM, 2001, BRIT MED J, V323, P131, DOI 10.1136/bmj.323.7305.131; Klein NA, 1998, CLIN OBSTET GYNECOL, V41, P912, DOI 10.1097/00003081-199812000-00017; KNOPP RH, 1993, AM J OBSTET GYNECOL, V168, P1994, DOI 10.1016/S0002-9378(12)90941-2; KRETTEK JE, 1993, OBSTET GYNECOL, V81, P728; Kuohung W, 2000, CONTRACEPTION, V61, P77, DOI 10.1016/S0010-7824(00)00086-X; Lewis MA, 1997, CONTRACEPTION, V56, P129, DOI 10.1016/S0010-7824(97)00118-2; Lewis MA, 1998, AM J OBSTET GYNECOL, V179, pS68, DOI 10.1053/ob.1998.v179.a93122; Lewis MA, 1996, CONTRACEPTION, V54, P5, DOI 10.1016/0010-7824(96)00112-6; LIDEGAARD O, 1995, BRIT J OBSTET GYNAEC, V102, P153, DOI 10.1111/j.1471-0528.1995.tb09070.x; LIDEGAARD O, 1993, BRIT MED J, V306, P956, DOI 10.1136/bmj.306.6883.956; Lidegaard O, 1998, AM J OBSTET GYNECOL, V179, pS62, DOI 10.1053/ob.1998.v179.a91674; Lidegaard O, 1999, AM J OBSTET GYNECOL, V180, pS357, DOI 10.1016/S0002-9378(99)70696-4; Lidegaard O, 1998, CONTRACEPTION, V57, P303, DOI 10.1016/S0010-7824(98)00032-8; Lidegaard O, 1997, ACTA OBSTET GYN SCAN, V76, P252; Lobo RA, 1996, FERTIL STERIL, V65, P1100, DOI 10.1016/S0015-0282(16)58321-6; Lobo RA, 1998, CLIN OBSTET GYNECOL, V41, P895, DOI 10.1097/00003081-199812000-00015; Lucky AW, 1997, J AM ACAD DERMATOL, V37, P746, DOI 10.1016/S0190-9622(97)70112-9; Magnusson CM, 1999, INT J CANCER, V80, P231, DOI 10.1002/(SICI)1097-0215(19990118)80:2<231::AID-IJC11>3.3.CO;2-I; MALONE KE, 1993, EPIDEMIOL REV, V15, P80, DOI 10.1093/oxfordjournals.epirev.a036119; Marchbanks PA, 2002, NEW ENGL J MED, V346, P2025, DOI 10.1056/NEJMoa013202; Martinelli I, 1998, NEW ENGL J MED, V338, P1793, DOI 10.1056/NEJM199806183382502; MCKINLAY SM, 1992, MATURITAS, V14, P103, DOI 10.1016/0378-5122(92)90003-M; MEADE TW, 1977, LANCET, V2, P948; *MED EC, 2000, RED BOOK 2000 DRUG T, P313; Michaelsson K, 1999, LANCET, V353, P1481, DOI 10.1016/S0140-6736(98)09044-8; Newcomb PA, 1996, CANCER CAUSE CONTROL, V7, P525, DOI 10.1007/BF00051885; Oddens BJ, 1999, CONTRACEPTION, V59, P277, DOI 10.1016/S0010-7824(99)00034-7; Petitti DB, 1996, NEW ENGL J MED, V335, P8, DOI 10.1056/NEJM199607043350102; PORTER JB, 1985, OBSTET GYNECOL, V66, P1; Poulter NR, 1996, LANCET, V348, P505; POULTER NR, 1995, LANCET, V346, P1575; Poulter NR, 1996, LANCET, V348, P498; Poulter NR, 1997, LANCET, V349, P1202, DOI 10.1016/S0140-6736(97)02358-1; RAMCHARAN S, 1981, NIH PUBLICATION, V3; Redmond GP, 1997, OBSTET GYNECOL, V89, P615, DOI 10.1016/S0029-7844(97)00059-8; REUBINOFF BE, 1995, FERTIL STERIL, V63, P516, DOI 10.1016/S0015-0282(16)57419-6; Rosenberg L, 1996, AM J EPIDEMIOL, V143, P25; Rosenberg M, 1998, CONTRACEPTION, V58, P345, DOI 10.1016/S0010-7824(98)00127-9; Rosenberg MJ, 1996, CONTRACEPTION, V53, P85, DOI 10.1016/0010-7824(95)00270-7; Rosenberg MJ, 1998, AM J OBSTET GYNECOL, V179, P577, DOI 10.1016/S0002-9378(98)70047-X; Rosenberg MJ, 1996, AM J OBSTET GYNECOL, V174, P628, DOI 10.1016/S0002-9378(96)70440-4; Rosing J, 1999, AM J OBSTET GYNECOL, V180, pS375, DOI 10.1016/S0002-9378(99)70699-X; Rossing MA, 1996, AM J EPIDEMIOL, V144, P161, DOI 10.1093/oxfordjournals.aje.a008903; SALEH WA, 1993, AM J OBSTET GYNECOL, V168, P1740, DOI 10.1016/0002-9378(93)90685-C; Schiff I, 1999, AM J OBSTET GYNECOL, V180, pS383, DOI 10.1016/S0002-9378(99)70700-3; Schlesselman JJ, 1997, HUM REPROD, V12, P1851, DOI 10.1093/humrep/12.9.1851; SCHLESSELMAN JJ, 1995, OBSTET GYNECOL, V85, P793, DOI 10.1016/0029-7844(95)00022-J; Schmidt PJ, 2000, AM J OBSTET GYNECOL, V183, P414, DOI 10.1067/mob.2000.106004; Schwartz SM, 1998, STROKE, V29, P2277, DOI 10.1161/01.STR.29.11.2277; Schwartz SM, 1997, ANN INTERN MED, V127, P596, DOI 10.7326/0003-4819-127-8_Part_1-199710150-00003; Schwingl PJ, 1999, AM J OBSTET GYNECOL, V180, P241, DOI 10.1016/S0002-9378(99)70182-1; SCRAGG RKR, 1984, BRIT MED J, V288, P1795, DOI 10.1136/bmj.288.6433.1795; Seifer DB, 1998, FERTIL STERIL, V69, P387; SHARGIL AA, 1985, INT J FERTIL, V30, P15; Sherif K, 1999, AM J OBSTET GYNECOL, V180, pS343, DOI 10.1016/S0002-9378(99)70694-0; Shulman LP, 2000, OBSTET GYN CLIN N AM, V27, P695, DOI 10.1016/S0889-8545(05)70168-6; Shulman LP, 1999, INT J FERTIL WOMEN M, V44, P78; Sidney S, 1996, OBSTET GYNECOL, V88, P939, DOI 10.1016/S0029-7844(96)00351-1; SPEROFF L, 1993, OBSTET GYNECOL, V81, P1034; SPEROFF L, 1994, CLIN GYNECOLOGIC END, P722; Spitzer WO, 1998, AM J OBSTET GYNECOL, V179, pS43, DOI 10.1053/ob.1998.v179.a93059; Spitzer WO, 1996, BRIT MED J, V312, P83; Stahl SM, 1998, PSYCHOPHARMACOL BULL, V34, P319; STERGACHIS A, 1992, AM J OBSTET GYNECOL, V167, P1165, DOI 10.1016/S0002-9378(12)90406-8; Stern RS, 2000, J AM ACAD DERMATOL, V43, P1042, DOI 10.1067/mjd.2000.110901; Stewart FH, 2001, JAMA-J AM MED ASSOC, V285, P2232, DOI 10.1001/jama.285.17.2232; STROM BL, 1986, CLIN PHARMACOL THER, V39, P335, DOI 10.1038/clpt.1986.49; Sulak P, 1999, CONTRACEPTION, V59, P161, DOI 10.1016/S0010-7824(99)00026-8; Tanis BC, 2001, NEW ENGL J MED, V345, P1787, DOI 10.1056/NEJMoa003216; Thorneycroft IH, 1999, AM J OBSTET GYNECOL, V180, pS280, DOI 10.1016/S0002-9378(99)70719-2; Thorneycroft IH, 1999, AM J OBSTET GYNECOL, V180, pS288, DOI 10.1016/S0002-9378(99)70720-9; THORVALDSEN P, 1995, STROKE, V26, P361, DOI 10.1161/01.STR.26.3.361; Tomasson H, 1996, ACTA OBSTET GYN SCAN, V75, P157, DOI 10.3109/00016349609033309; Tryggvadottir L, 1997, BRIT J CANCER, V75, P139, DOI 10.1038/bjc.1997.23; Tyden T, 1999, ADV CONTRACEPT, V15, P133, DOI 10.1023/A:1006749709993; TZOURIO C, 1995, BMJ-BRIT MED J, V310, P830, DOI 10.1136/bmj.310.6983.830; Ursin G, 1999, AM J EPIDEMIOL, V150, P561; US Preventive Services Task Force, 1996, GUID CLIN PREV SERV, P73; Van Winter JT, 1998, AM FAM PHYSICIAN, V58, P1373; Vandenbroucke JP, 1996, BRIT MED J, V313, P1127, DOI 10.1136/bmj.313.7065.1127; Vessey M, 1998, CONTRACEPTION, V57, P231, DOI 10.1016/S0010-7824(98)00026-2; VESSEY MP, 1984, BRIT MED J, V289, P530, DOI 10.1136/bmj.289.6444.530-a; VOLPE A, 1993, CONTRACEPTION, V47, P229, DOI 10.1016/0010-7824(93)90040-E; Warren MP, 1998, CLIN OBSTET GYNECOL, V41, P976, DOI 10.1097/00003081-199812000-00024; Weiss G, 1999, AM J OBSTET GYNECOL, V180, pS295, DOI 10.1016/S0002-9378(99)70721-0; Westhoff CL, 1998, AM J OBSTET GYNECOL, V179, pS38, DOI 10.1053/ob.1998.v179.a91673; *WHO, 2000, IMPR ACC QUAL CAR FA, P1; *WHO US AG INT DEV, 1994, REC UPD SEL PRACT CO, V1; WINGO PA, 1991, OBSTET GYNECOL, V78, P161; 1999, FERTIL STERIL S3, V71, pS1; 1998, HUM REPROD, V13, P2325; 2000, AM COLL OBSTERTRICIA, V18, P1071; 1996, CONTRACEPTION, V54, pS1	157	24	26	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 7	2003	138	1					54	64		10.7326/0003-4819-138-1-200301070-00013	http://dx.doi.org/10.7326/0003-4819-138-1-200301070-00013			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	645TV	12513046				2022-12-24	WOS:000180996200008
J	Lusk, C				Lusk, C			Tree-species competition and coexistence	NATURE			English	Article							NEOTROPICAL FOREST; NEW-ZEALAND; HISTORY		Univ Concepcion, Dept Bot, Concepcion, Chile	Universidad de Concepcion	Lusk, C (corresponding author), Univ Concepcion, Dept Bot, Casilla 160-C, Concepcion, Chile.	clusk@udec.cl	Komdeur, Jan/X-1261-2019; Richardson, David S/A-5082-2010; Burke, Terry/B-3196-2011	Komdeur, Jan/0000-0002-9241-0124; Richardson, David S/0000-0001-7226-9074; Burke, Terry/0000-0003-3848-1244				CHESSON PL, 1981, AM NAT, V117, P923, DOI 10.1086/283778; Harms KE, 2001, J ECOL, V89, P947, DOI 10.1111/j.1365-2745.2001.00615.x; Harper J. L, 1977, POPULATION BIOL PLAN; Hubbell SP, 1999, SCIENCE, V283, P554, DOI 10.1126/science.283.5401.554; Kelly CK, 2002, NATURE, V417, P437, DOI 10.1038/417437a; LIEBERMAN M, 1995, J TROP ECOL, V11, P161, DOI 10.1017/S0266467400008609; LORIMER CG, 1985, CAN J FOREST RES, V15, P200, DOI 10.1139/x85-038; LUSK C, 1992, J ECOL, V80, P379, DOI 10.2307/2260684; OGDEN J, 1981, J BIOGEOGR, V8, P405, DOI 10.2307/2844759; STEWART GH, 1990, VEGETATIO, V87, P101, DOI 10.1007/BF00042947	10	49	50	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 10	2003	422	6932					580	581		10.1038/422580b	http://dx.doi.org/10.1038/422580b			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665GN	12686989				2022-12-24	WOS:000182111400030
